data_1h2o_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1h2o _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.549 HG12 ' CE1' ' A' ' 121' ' ' HIS . 58.5 t -122.31 137.12 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.201 -1.176 . . . . 0.0 110.319 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.64 ' CD1' ' CD1' ' A' ' 128' ' ' ILE . 11.6 m-85 -95.71 146.88 24.17 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.318 -0.864 . . . . 0.0 109.967 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.3 m -127.35 117.26 21.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.179 -0.95 . . . . 0.0 110.597 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.621 ' CE2' ' CG2' ' A' ' 133' ' ' VAL . 67.1 m-85 -129.74 132.86 46.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.381 -0.825 . . . . 0.0 109.655 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 23.1 pt-20 -130.22 153.53 48.49 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.146 -0.971 . . . . 0.0 110.703 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.472 ' O ' ' CG ' ' A' ' 8' ' ' GLU . 5.9 t -131.79 165.93 22.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.459 -0.776 . . . . 0.0 109.574 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.472 ' CG ' ' O ' ' A' ' 7' ' ' SER . 87.5 mt-10 -154.12 121.97 5.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.088 -1.007 . . . . 0.0 110.706 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.618 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.2 p90 -149.53 -178.31 6.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.355 -0.841 . . . . 0.0 109.625 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.515 ' CG2' ' HA ' ' A' ' 113' ' ' ILE . 8.6 p -142.37 174.57 10.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.196 -0.94 . . . . 0.0 110.651 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.484 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 4.7 t -159.79 162.19 34.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.461 -0.774 . . . . 0.0 110.125 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -83.48 -20.28 34.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.217 -0.927 . . . . 0.0 110.187 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.524 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 2.9 mp -74.08 149.66 87.45 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.317 -0.865 . . . . 0.0 110.072 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.524 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 41.3 Cg_endo -67.59 142.23 58.08 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.055 1.555 . . . . 0.0 110.473 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.623 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.2 Cg_endo -72.44 -30.95 11.88 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 124.013 1.533 . . . . 0.0 112.804 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.7 Cg_endo -70.4 -23.79 27.47 Favored 'Trans proline' 0 C--N 1.319 -0.983 0 N-CA-C 110.115 -0.764 . . . . 0.0 110.115 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.538 ' O ' ' CE1' ' A' ' 158' ' ' TYR . 58.5 mtp180 -82.24 -44.11 16.75 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.22 -0.925 . . . . 0.0 108.662 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.584 ' CD2' ' CG2' ' A' ' 147' ' ' ILE . 0.2 OUTLIER -70.85 -31.4 68.09 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.04 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.522 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 70.4 t80 -63.69 -58.82 5.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.478 -0.764 . . . . 0.0 109.509 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 75.1 mttt -50.23 -41.24 49.64 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.42 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.664 ' CB ' ' CZ ' ' A' ' 158' ' ' TYR . . . -70.55 -36.25 73.57 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.406 -0.809 . . . . 0.0 110.928 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.586 ' CE1' HD12 ' A' ' 147' ' ' ILE . 0.2 OUTLIER -79.18 -40.25 31.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.24 -0.912 . . . . 0.0 111.14 -178.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.484 HG12 ' CD1' ' A' ' 81' ' ' TYR . 7.5 t -103.75 -54.85 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.975 -1.078 . . . . 0.0 111.741 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.473 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 5.9 mp -80.02 -1.39 39.55 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.013 -1.054 . . . . 0.0 112.012 -178.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.532 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -146.52 14.49 1.24 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.68 -1.263 . . . . 0.0 110.61 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -60.65 -16.46 39.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.273 -0.892 . . . . 0.0 110.78 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -70.87 -22.11 62.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.065 -1.022 . . . . 0.0 110.556 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.447 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 6.9 p30 -132.1 3.27 4.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.106 -0.996 . . . . 0.0 110.427 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.586 ' CD1' ' CD1' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -92.27 -39.42 11.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.235 -0.916 . . . . 0.0 109.972 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.589 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 97.6 t -77.11 -40.77 2.38 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.398 -0.813 . . . . 0.0 110.961 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.3 Cg_endo -77.85 7.87 3.72 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.32 1.168 . . . . 0.0 110.55 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -121.48 -38.22 2.8 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.159 -0.963 . . . . 0.0 109.078 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.586 ' CD1' ' CD1' ' A' ' 29' ' ' LEU . 5.6 mt -80.2 -39.13 18.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-O 121.563 0.697 . . . . 0.0 109.271 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.72 80.01 32.67 Favored Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.572 -0.705 . . . . 0.0 109.877 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -73.13 1.14 6.95 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.101 1.579 . . . . 0.0 110.83 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -87.97 -17.44 31.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.139 -0.976 . . . . 0.0 109.919 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -101.19 -56.44 2.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.394 -0.816 . . . . 0.0 110.038 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.576 ' CD1' ' CG1' ' A' ' 30' ' ' VAL . 1.3 mp -107.39 145.53 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.467 -0.771 . . . . 0.0 109.914 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -112.6 -23.46 10.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.891 . . . . 0.0 110.586 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.551 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -163.02 158.2 21.83 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.097 -1.002 . . . . 0.0 110.223 -179.788 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.8 m -140.87 124.5 16.91 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.295 -0.878 . . . . 0.0 109.917 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 60.3 tt0 -137.56 108.22 6.6 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.107 -0.996 . . . . 0.0 110.452 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.44 HG12 ' HG2' ' A' ' 54' ' ' LYS . 13.6 mt -54.84 131.44 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.191 -0.943 . . . . 0.0 110.008 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.516 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 20.3 mt -97.5 -34.86 10.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.921 . . . . 0.0 110.616 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.571 ' CD1' HD11 ' A' ' 53' ' ' ILE . 1.9 m95 -123.03 161.79 23.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.248 -0.907 . . . . 0.0 110.73 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.459 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 40.18 -133.57 2.39 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.432 ' HA ' HG23 ' A' ' 43' ' ' ILE . 0.5 OUTLIER -157.68 20.14 0.27 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.384 -1.068 . . . . 0.0 110.069 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.402 ' N ' HG22 ' A' ' 52' ' ' THR . . . 128.57 -21.72 5.34 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.475 ' O ' HG23 ' A' ' 71' ' ' ILE . . . -65.73 -175.91 6.01 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.482 ' HA ' HG23 ' A' ' 71' ' ' ILE . 46.1 Cg_endo -73.23 128.69 13.18 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 124.032 1.543 . . . . 0.0 110.559 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.19 -14.33 55.2 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.643 -1.783 . . . . 0.0 108.643 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -67.86 164.07 20.53 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.565 -0.962 . . . . 0.0 109.789 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.571 HD11 ' CD1' ' A' ' 45' ' ' TRP . 59.9 mt -131.95 121.59 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.398 -0.813 . . . . 0.0 109.467 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.44 ' HG2' HG12 ' A' ' 43' ' ' ILE . 66.9 mttt -106.01 135.81 46.79 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.144 -0.972 . . . . 0.0 110.317 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.516 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 21.1 tttp -104.73 89.6 3.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.353 -0.842 . . . . 0.0 110.01 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.519 ' CG2' HG12 ' A' ' 38' ' ' ILE . 61.8 mt -79.91 138.69 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 109.867 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 40' ' ' HIS . 1.4 p -116.49 152.94 33.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.908 . . . . 0.0 110.589 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.574 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 18.7 m-85 -115.27 169.82 8.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.435 -0.791 . . . . 0.0 110.012 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.951 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.467 ' CD2' ' CD2' ' A' ' 66' ' ' TYR . 1.5 t80 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.313 0.578 . . . . 0.0 110.254 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.574 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -129.6 99.95 0.48 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.488 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 25.8 p90 -140.33 171.69 13.79 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -1.139 . . . . 0.0 110.304 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.519 HG13 ' CA ' ' A' ' 88' ' ' GLY . 5.8 m -141.08 173.81 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.335 -0.853 . . . . 0.0 110.563 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.516 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 23.2 mttt -123.2 127.31 48.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.499 -0.751 . . . . 0.0 109.625 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.557 ' CD2' HD11 ' A' ' 85' ' ' LEU . 16.5 m170 -113.74 126.52 55.31 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.102 -0.999 . . . . 0.0 111.049 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 52' ' ' THR . 64.8 tttt -104.22 106.63 17.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.326 -0.859 . . . . 0.0 109.533 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.519 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 31.1 mm -49.8 136.02 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.191 -0.943 . . . . 0.0 110.38 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.463 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 8.3 t0 -111.76 -39.86 4.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.359 -0.838 . . . . 0.0 109.55 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.465 ' OG ' ' HB2' ' A' ' 82' ' ' SER . 53.4 p -168.42 160.44 11.2 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.464 -0.773 . . . . 0.0 109.617 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 73' ' ' SER . 1.5 mt -147.52 154.9 10.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.192 -0.942 . . . . 0.0 110.292 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 79' ' ' TYR . 4.7 m-20 -135.66 79.09 1.76 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.213 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.522 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 63.5 mttt -63.02 -12.82 28.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.153 -0.967 . . . . 0.0 110.066 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -95.61 -31.78 13.12 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.31 -0.869 . . . . 0.0 109.497 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.501 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -106.01 -5.86 19.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.593 -0.692 . . . . 0.0 109.673 179.825 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.54 ' N ' ' O ' ' A' ' 75' ' ' ASP . 4.6 m-85 66.34 50.22 1.34 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.555 -0.716 . . . . 0.0 110.42 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.534 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -120.42 150.32 40.97 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.241 -0.912 . . . . 0.0 109.227 179.379 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.577 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 19.9 t80 -139.09 134.29 32.72 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.14 -0.975 . . . . 0.0 110.299 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.465 ' HB2' ' OG ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -140.6 120.22 13.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.272 -0.892 . . . . 0.0 110.695 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.629 ' CE2' ' CB ' ' A' ' 100' ' ' TYR . 19.5 p90 -138.0 170.97 15.11 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 110.246 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.451 HG21 ' O ' ' A' ' 98' ' ' ILE . 86.7 m -121.64 130.83 53.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.412 -0.805 . . . . 0.0 109.802 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.557 HD11 ' CD2' ' A' ' 69' ' ' HIS . 5.2 tp -95.32 137.88 33.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.091 -1.006 . . . . 0.0 110.124 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.1 pt -120.41 -15.04 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.322 -0.862 . . . . 0.0 110.389 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.516 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 25.3 tt0 -129.37 158.64 38.58 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.134 -0.978 . . . . 0.0 110.262 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.519 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 151.16 115.76 0.7 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -50.44 -20.97 1.27 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.251 -1.146 . . . . 0.0 110.345 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.568 ' O ' ' CE1' ' A' ' 132' ' ' HIS . . . -72.77 -18.75 61.46 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.19 -0.943 . . . . 0.0 110.41 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 95' ' ' LEU . 74.9 mt -69.33 -7.79 40.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.167 -0.958 . . . . 0.0 110.185 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 46.75 -171.8 0.03 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 49.8 p-10 -91.64 34.68 0.97 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.214 -1.168 . . . . 0.0 109.675 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.1 p -131.31 -41.64 1.09 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.441 -0.787 . . . . 0.0 110.397 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.634 ' CD2' ' N ' ' A' ' 95' ' ' LEU . 3.1 mm? -79.91 157.02 27.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.906 . . . . 0.0 110.352 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.449 ' HG3' ' HB2' ' A' ' 123' ' ' LYS . 48.0 mm-40 -141.08 -80.9 0.25 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.326 -0.859 . . . . 0.0 109.631 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.529 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 36.8 mttp -80.31 126.53 31.27 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.484 -0.76 . . . . 0.0 110.318 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.62 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 5.7 mm -116.58 138.93 45.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 120.586 -1.321 . . . . 0.0 109.621 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.451 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -114.76 130.12 56.8 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.465 179.219 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.629 ' CB ' ' CE2' ' A' ' 83' ' ' TYR . 9.3 m-85 -125.36 134.01 52.34 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.42 -0.8 . . . . 0.0 110.032 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.46 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 78.0 tt0 -136.56 136.12 39.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 0.0 110.478 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.435 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 91.8 m -136.73 137.8 40.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.287 -0.883 . . . . 0.0 109.762 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -135.37 145.56 47.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.063 -1.023 . . . . 0.0 110.49 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.492 ' C ' ' CG2' ' A' ' 105' ' ' VAL . 6.2 mt -126.43 151.79 47.26 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.33 -0.856 . . . . 0.0 110.067 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.492 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -150.97 -169.23 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.247 -0.908 . . . . 0.0 110.247 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -120.49 151.14 39.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.336 -0.852 . . . . 0.0 110.265 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.474 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 6.1 p -105.08 167.9 9.16 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 110.164 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.474 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.3 Cg_endo -72.7 -13.25 27.04 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.059 1.557 . . . . 0.0 110.438 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 74.1 m -97.02 12.45 32.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.184 -0.947 . . . . 0.0 110.252 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 92.29 -32.82 5.24 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -60.36 -175.0 1.11 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 28.8 p -130.57 135.36 47.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -1.16 . . . . 0.0 110.376 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.515 ' HA ' ' CG2' ' A' ' 10' ' ' THR . 11.0 mt -88.33 151.31 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.294 -0.879 . . . . 0.0 110.065 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.608 ' CG2' ' CE2' ' A' ' 9' ' ' PHE . 11.9 mt -131.49 116.67 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -0.936 . . . . 0.0 110.35 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.8 tttm -108.61 124.14 50.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.164 -0.96 . . . . 0.0 109.892 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.7 t -120.46 162.06 20.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.237 -0.914 . . . . 0.0 110.397 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.46 ' HB ' ' HB3' ' A' ' 101' ' ' GLU . 37.5 m -160.02 151.97 20.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.373 -0.829 . . . . 0.0 109.932 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 7.5 m -148.35 157.1 43.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.205 -0.935 . . . . 0.0 110.275 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.467 ' C ' ' CD1' ' A' ' 120' ' ' TYR . 68.4 m-70 -141.54 162.05 36.42 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.195 -0.94 . . . . 0.0 110.536 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.502 ' N ' ' CD1' ' A' ' 120' ' ' TYR . 11.1 m-85 -127.68 152.36 47.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.358 -0.839 . . . . 0.0 110.302 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.549 ' CE1' HG12 ' A' ' 2' ' ' VAL . 74.2 m-70 -134.99 86.69 2.27 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.201 -0.937 . . . . 0.0 109.518 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.525 ' CG2' HD23 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -70.79 146.75 49.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.397 -0.814 . . . . 0.0 110.74 -179.341 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.449 ' HB2' ' HG3' ' A' ' 96' ' ' GLU . 2.0 ttpt -92.83 119.1 31.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.373 -0.83 . . . . 0.0 110.057 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 105.58 -125.32 8.2 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -137.43 61.61 1.61 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.328 -1.101 . . . . 0.0 110.231 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.479 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 35.5 m -124.28 179.32 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.246 -0.909 . . . . 0.0 110.08 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -140.52 158.53 43.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.177 -0.952 . . . . 0.0 110.345 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.64 ' CD1' ' CD1' ' A' ' 3' ' ' PHE . 5.1 mp -78.23 172.98 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.247 -0.908 . . . . 0.0 110.183 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.449 ' O ' ' N ' ' A' ' 132' ' ' HIS . 7.3 mttp -107.02 128.02 53.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.363 -0.835 . . . . 0.0 109.888 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.435 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 91.8 mt-10 -42.77 -53.45 4.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.214 -0.928 . . . . 0.0 110.244 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -47.52 -26.19 1.33 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.188 -0.945 . . . . 0.0 109.912 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.568 ' CE1' ' O ' ' A' ' 90' ' ' ALA . 11.3 t-160 -85.37 -62.39 1.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.297 -0.877 . . . . 0.0 110.137 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.621 ' CG2' ' CE2' ' A' ' 5' ' ' TYR . 7.7 p -62.36 -41.0 89.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.378 -0.826 . . . . 0.0 109.962 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 27.6 tttp -64.8 -44.14 90.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.337 -0.852 . . . . 0.0 109.89 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.86 -32.8 74.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.374 -0.829 . . . . 0.0 109.913 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -64.9 -31.86 82.33 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -60.53 -32.66 71.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.273 -1.133 . . . . 0.0 109.955 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 142' ' ' ASN . 99.0 mt-10 -83.6 -33.35 25.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.38 -0.825 . . . . 0.0 109.878 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 24.3 mttt -68.86 -35.06 76.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.34 -0.85 . . . . 0.0 109.881 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.427 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -86.18 -40.89 15.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.297 -0.877 . . . . 0.0 109.934 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.1 m -67.55 -53.45 28.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.419 -0.801 . . . . 0.0 109.846 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 138' ' ' GLU . 98.8 m-20 -49.43 -47.47 48.02 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.226 -0.921 . . . . 0.0 109.924 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.426 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 9.3 tp -55.6 -48.16 75.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.281 -0.887 . . . . 0.0 109.882 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.565 ' CE1' ' CE2' ' A' ' 22' ' ' PHE . 13.6 m-85 -53.31 -36.13 60.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.444 -0.785 . . . . 0.0 109.843 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -74.56 -16.51 60.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.359 -0.838 . . . . 0.0 109.862 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 143' ' ' LEU . 24.0 mt -84.41 -35.63 22.97 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.281 -0.887 . . . . 0.0 109.01 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.586 HD12 ' CE1' ' A' ' 22' ' ' PHE . 24.7 mt -68.26 -41.61 83.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.484 ' CG ' ' OG ' ' A' ' 11' ' ' SER . 97.2 mt-10 -48.36 -40.98 27.3 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.158 -0.964 . . . . 0.0 108.794 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 19.5 m -72.05 -26.74 62.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.28 -0.887 . . . . 0.0 109.351 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.578 ' O ' ' CD2' ' A' ' 154' ' ' HIS . 62.7 t80 -57.89 -52.2 66.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.535 -0.728 . . . . 0.0 109.883 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.578 HD22 ' CE1' ' A' ' 158' ' ' TYR . 64.7 mt -80.01 -36.42 35.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.285 -0.884 . . . . 0.0 110.362 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.466 ' HB2' HD12 ' A' ' 13' ' ' ILE . 35.8 tttt -60.05 -19.69 54.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.163 -0.961 . . . . 0.0 109.236 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.454 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -111.1 -32.22 2.66 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.6 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 5.8 m-70 -105.97 93.0 7.04 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.324 -1.103 . . . . 0.0 110.039 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.503 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 46.6 Cg_endo -72.94 3.66 4.29 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.018 1.536 . . . . 0.0 110.96 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -114.19 -10.29 12.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.085 -1.009 . . . . 0.0 109.899 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.581 ' O ' ' CD1' ' A' ' 158' ' ' TYR . . . -46.92 108.74 0.15 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.333 -0.855 . . . . 0.0 110.053 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.664 ' CZ ' ' CB ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 35.46 30.83 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.719 -0.613 . . . . 0.0 110.515 -179.624 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.701 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.568 HG12 ' CE1' ' A' ' 121' ' ' HIS . 63.6 t -122.93 122.53 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.191 -1.182 . . . . 0.0 110.264 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.568 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 43.1 m-85 -80.2 154.16 28.12 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.28 -0.887 . . . . 0.0 110.302 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 56.5 m -138.35 94.47 2.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.882 . . . . 0.0 110.1 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.588 ' CE1' ' CG2' ' A' ' 133' ' ' VAL . 75.1 m-85 -116.15 136.41 53.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.889 . . . . 0.0 110.026 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 21.5 pt-20 -135.92 151.91 50.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.202 -0.936 . . . . 0.0 110.404 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.3 m -121.38 157.83 29.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.337 -0.852 . . . . 0.0 109.92 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -135.44 121.11 19.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.115 -0.99 . . . . 0.0 110.386 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.638 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.9 p90 -146.03 -174.12 4.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.347 -0.846 . . . . 0.0 109.948 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.509 ' CG2' ' HA ' ' A' ' 113' ' ' ILE . 5.7 p -141.43 173.03 11.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.201 -0.937 . . . . 0.0 110.627 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.479 ' CB ' ' CD ' ' A' ' 148' ' ' GLU . 97.6 p -156.68 135.04 11.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.399 -0.813 . . . . 0.0 110.2 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -62.05 -31.02 71.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.211 -0.931 . . . . 0.0 110.134 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.526 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 2.3 mp -64.55 150.62 93.43 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.869 . . . . 0.0 109.944 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.526 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 42.0 Cg_endo -68.32 143.15 57.3 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.044 1.549 . . . . 0.0 110.771 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.635 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.5 Cg_endo -72.25 -30.92 12.42 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 O-C-N 124.042 1.549 . . . . 0.0 112.737 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.635 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.1 Cg_endo -69.53 -22.71 32.75 Favored 'Trans proline' 0 N--CA 1.485 0.988 0 N-CA-C 110.07 -0.781 . . . . 0.0 110.07 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.519 ' NE ' ' HB2' ' A' ' 159' ' ' ASN . 42.2 mtp180 -83.5 -42.89 16.37 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.579 ' CD2' ' CG2' ' A' ' 147' ' ' ILE . 0.3 OUTLIER -71.33 -32.69 68.87 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 178.833 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.607 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 81.4 t80 -63.02 -61.63 2.26 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.538 -0.726 . . . . 0.0 109.577 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.484 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 14.9 mttp -53.61 -32.88 53.0 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.383 -0.823 . . . . 0.0 109.351 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.667 ' CB ' ' CZ ' ' A' ' 158' ' ' TYR . . . -74.26 -47.45 35.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.363 -0.836 . . . . 0.0 110.568 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.636 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 0.2 OUTLIER -66.67 -46.76 74.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.542 -0.724 . . . . 0.0 111.215 -179.141 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.585 ' CG1' ' CD1' ' A' ' 74' ' ' ILE . 6.1 t -97.45 -60.3 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.109 -0.995 . . . . 0.0 111.914 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' A' ' 20' ' ' LYS . 8.5 mp -69.5 -0.19 6.23 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.16 -0.962 . . . . 0.0 111.824 -178.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.493 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -146.16 10.95 1.17 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.692 -1.255 . . . . 0.0 110.811 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -53.38 -19.02 3.0 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.164 -0.96 . . . . 0.0 110.863 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -80.01 -26.87 39.65 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.005 -1.059 . . . . 0.0 110.573 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -127.12 13.05 7.21 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.255 -0.903 . . . . 0.0 110.337 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.589 ' CD1' ' CD1' ' A' ' 33' ' ' ILE . 0.8 OUTLIER -103.9 -45.29 4.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.105 -0.997 . . . . 0.0 110.259 179.921 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.601 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 3.1 t -64.77 -41.83 59.22 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.326 -0.858 . . . . 0.0 110.556 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.0 Cg_endo -78.79 8.87 3.51 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.442 1.233 . . . . 0.0 110.628 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -118.64 -25.47 6.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.153 -0.967 . . . . 0.0 109.263 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.589 ' CD1' ' CD1' ' A' ' 29' ' ' LEU . 20.1 mt -80.01 -57.42 5.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 121.612 0.72 . . . . 0.0 109.427 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -145.06 105.55 4.46 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.541 -0.724 . . . . 0.0 109.818 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.426 ' O ' ' NZ ' ' A' ' 39' ' ' LYS . 44.2 Cg_endo -70.66 -0.77 8.18 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 124.042 1.549 . . . . 0.0 110.824 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -82.87 -10.42 58.84 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.075 -1.016 . . . . 0.0 109.645 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.416 ' HB1' HD11 ' A' ' 38' ' ' ILE . . . -101.93 -63.31 1.16 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.334 -0.853 . . . . 0.0 110.121 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.532 HG12 ' CG2' ' A' ' 56' ' ' ILE . 1.3 mp -113.09 154.2 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.446 -0.784 . . . . 0.0 109.985 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.518 ' HG2' ' N ' ' A' ' 59' ' ' GLY . 66.5 mmtt -114.16 -27.5 7.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 0.0 110.457 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.574 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.1 OUTLIER -159.32 151.72 21.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.955 . . . . 0.0 110.179 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.1 m -138.13 120.71 16.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.393 -0.817 . . . . 0.0 109.677 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -134.09 109.97 9.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.157 -0.964 . . . . 0.0 110.785 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 29.9 mt -55.71 133.81 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.312 -0.868 . . . . 0.0 109.794 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 13.3 tp -105.28 -23.45 12.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.248 -0.908 . . . . 0.0 110.823 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.576 ' CD2' HD13 ' A' ' 53' ' ' ILE . 1.8 m95 -129.58 159.37 36.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.043 -1.036 . . . . 0.0 110.855 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.467 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 41.91 -136.23 3.12 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -151.25 21.54 0.75 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.307 -1.114 . . . . 0.0 110.068 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.4 ' N ' HG22 ' A' ' 52' ' ' THR . . . 122.89 -20.96 7.58 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.478 ' O ' HG23 ' A' ' 71' ' ' ILE . . . -67.8 -173.41 7.03 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.491 ' HA ' HG23 ' A' ' 71' ' ' ILE . 44.5 Cg_endo -72.81 128.86 13.72 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.071 1.564 . . . . 0.0 110.517 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.45 -13.46 51.13 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -72.11 165.24 24.73 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.548 -0.972 . . . . 0.0 109.596 179.54 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.576 HD13 ' CD2' ' A' ' 45' ' ' TRP . 63.0 mt -135.35 120.57 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.333 -0.855 . . . . 0.0 109.697 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 39.3 mttm -103.53 128.6 50.72 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.208 -0.932 . . . . 0.0 110.27 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 54.9 tttt -97.6 91.65 5.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.197 -0.939 . . . . 0.0 109.874 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.532 ' CG2' HG12 ' A' ' 38' ' ' ILE . 89.4 mt -79.98 141.6 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.299 -0.876 . . . . 0.0 110.049 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.474 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -120.12 147.33 45.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 110.471 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.591 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 14.1 m-85 -114.21 162.27 16.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.325 -0.859 . . . . 0.0 110.003 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.518 ' N ' ' HG2' ' A' ' 39' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.576 ' O ' ' CD1' ' A' ' 64' ' ' TYR . 2.3 p90 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 121.317 0.579 . . . . 0.0 110.208 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.591 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -142.48 85.79 0.19 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.535 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 13.6 p90 -132.74 171.97 13.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.293 -1.122 . . . . 0.0 110.251 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.484 HG13 ' CA ' ' A' ' 88' ' ' GLY . 4.4 m -140.21 176.9 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.917 . . . . 0.0 110.477 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.516 ' CE ' ' OE1' ' A' ' 87' ' ' GLU . 82.3 mttt -133.03 102.9 5.78 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.426 -0.796 . . . . 0.0 109.746 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.525 ' CD2' HD11 ' A' ' 85' ' ' LEU . 15.1 m170 -95.65 127.73 41.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.24 -0.912 . . . . 0.0 111.061 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 52' ' ' THR . 17.1 tttt -96.59 114.84 26.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 109.436 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.52 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 37.0 mm -52.81 132.07 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.142 -0.974 . . . . 0.0 110.347 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.471 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 23.5 t0 -105.21 -46.86 4.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.487 -0.758 . . . . 0.0 109.982 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 77.5 p -177.68 160.93 1.61 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.466 -0.771 . . . . 0.0 110.376 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.585 ' CD1' ' CG1' ' A' ' 23' ' ' VAL . 6.6 tt -153.24 170.06 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.375 -0.828 . . . . 0.0 109.703 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.5 m-20 -142.19 84.35 1.87 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.079 -1.013 . . . . 0.0 110.395 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.607 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 18.7 tttm -58.93 -14.26 8.67 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.12 -0.988 . . . . 0.0 110.273 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -92.82 -34.33 13.9 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.349 -0.845 . . . . 0.0 109.517 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.503 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 2.3 m-80 -102.71 -3.75 26.04 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.655 0.74 . . . . 0.0 109.267 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.588 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 76.1 m-85 62.39 55.48 2.3 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.338 0.589 . . . . 0.0 110.873 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.486 ' HB3' ' CG ' ' A' ' 103' ' ' LYS . 0.7 OUTLIER -131.09 153.87 48.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.449 -0.782 . . . . 0.0 109.523 179.124 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.614 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 76.0 t80 -151.99 149.48 28.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.183 -0.948 . . . . 0.0 110.352 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.494 ' HB2' ' HA ' ' A' ' 101' ' ' GLU . 13.5 t -157.63 151.14 23.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.249 -0.907 . . . . 0.0 110.386 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.614 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 7.2 p90 -152.18 177.03 10.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.441 -0.787 . . . . 0.0 110.734 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.476 ' CG2' ' O ' ' A' ' 98' ' ' ILE . 42.0 m -127.38 125.85 41.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.547 -0.721 . . . . 0.0 109.735 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.525 HD11 ' CD2' ' A' ' 69' ' ' HIS . 11.2 tp -95.77 133.63 39.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.006 -1.059 . . . . 0.0 110.407 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.43 HG23 HD11 ' A' ' 86' ' ' ILE . 10.3 pt -111.53 -34.7 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.238 -0.914 . . . . 0.0 110.408 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.516 ' OE1' ' CE ' ' A' ' 68' ' ' LYS . 76.9 tt0 -115.16 153.27 31.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.326 -0.859 . . . . 0.0 110.18 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.505 ' N ' HD11 ' A' ' 91' ' ' LEU . . . 161.19 127.72 0.9 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -57.54 -20.29 30.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.271 -1.135 . . . . 0.0 110.095 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.83 -19.78 54.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.318 -0.864 . . . . 0.0 110.171 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.505 HD11 ' N ' ' A' ' 88' ' ' GLY . 55.1 mt -67.58 -28.21 67.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.931 . . . . 0.0 110.19 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 49.18 -178.09 0.02 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -81.99 8.23 11.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -1.166 . . . . 0.0 110.166 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.468 ' O ' HG21 ' A' ' 122' ' ' THR . 33.6 p -98.64 -32.71 11.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.206 -0.934 . . . . 0.0 110.144 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.556 ' CD2' ' CG2' ' A' ' 122' ' ' THR . 76.5 mt -108.62 158.13 17.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.43 -0.793 . . . . 0.0 110.128 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.1 tp10 -139.35 -79.93 0.31 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.168 -0.957 . . . . 0.0 110.196 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.493 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 29.3 mttp -80.15 127.46 32.35 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.542 -0.724 . . . . 0.0 110.555 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.53 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 6.0 mm -117.83 142.78 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.885 -1.134 . . . . 0.0 110.027 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.445 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -123.64 133.67 53.89 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.409 -0.807 . . . . 0.0 109.112 178.859 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 6.8 m-85 -128.03 131.39 49.17 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.164 -0.96 . . . . 0.0 110.541 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.494 ' HA ' ' HB2' ' A' ' 82' ' ' SER . 85.1 tt0 -135.51 139.4 43.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.277 -0.889 . . . . 0.0 110.066 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.472 ' N ' ' O ' ' A' ' 81' ' ' TYR . 85.7 m -141.52 149.14 40.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 110.217 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.486 ' CG ' ' HB3' ' A' ' 80' ' ' SER . 0.0 OUTLIER -142.32 140.71 32.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.262 -0.899 . . . . 0.0 110.39 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.588 ' HB2' ' HB3' ' A' ' 79' ' ' TYR . 2.9 mt -115.37 155.68 26.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 110.063 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.485 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 1.9 t -151.48 -169.49 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.093 -1.005 . . . . 0.0 110.217 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -123.88 154.4 39.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.411 -0.806 . . . . 0.0 110.247 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.446 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.4 p -113.02 170.96 4.72 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.23 -0.919 . . . . 0.0 110.233 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.3 Cg_endo -72.11 -14.58 28.93 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.048 1.552 . . . . 0.0 110.553 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.2 p -97.82 11.41 37.35 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.224 -0.923 . . . . 0.0 110.174 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 91.92 -31.07 6.13 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -56.64 -172.57 0.17 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 1.1 p -136.46 135.95 39.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.168 -1.195 . . . . 0.0 110.277 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.509 ' HA ' ' CG2' ' A' ' 10' ' ' THR . 17.0 mt -89.23 149.47 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.33 -0.856 . . . . 0.0 110.024 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.582 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 23.3 mt -131.29 118.28 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 110.393 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 103' ' ' LYS . 72.2 tttt -105.8 120.75 42.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.945 . . . . 0.0 109.97 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 0.4 OUTLIER -113.04 151.68 30.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.234 -0.916 . . . . 0.0 110.528 -179.719 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 81.8 m -154.37 124.31 6.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.373 -0.829 . . . . 0.0 110.252 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.564 ' OG ' ' CE1' ' A' ' 100' ' ' TYR . 2.1 t -125.81 163.14 23.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 110.094 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.445 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 71.0 m-70 -138.94 154.35 48.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -0.911 . . . . 0.0 110.177 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 21.4 m-85 -124.99 135.94 53.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.896 . . . . 0.0 110.44 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.568 ' CE1' HG12 ' A' ' 2' ' ' VAL . 73.6 m-70 -118.79 93.45 4.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.138 -0.976 . . . . 0.0 109.763 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.556 ' CG2' ' CD2' ' A' ' 95' ' ' LEU . 1.7 p -75.06 155.87 36.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.3 -0.875 . . . . 0.0 110.435 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.4 ttpt -107.94 100.93 10.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.344 -0.847 . . . . 0.0 110.157 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 121.4 -135.91 10.85 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -120.39 67.28 0.84 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.194 -1.18 . . . . 0.0 110.193 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.5 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 32.4 m -135.41 155.66 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.246 -0.909 . . . . 0.0 110.199 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -118.78 179.07 4.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.23 -0.919 . . . . 0.0 110.234 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.519 ' CD1' ' CD2' ' A' ' 95' ' ' LEU . 16.5 mm -80.18 172.69 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.276 -0.89 . . . . 0.0 110.227 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.458 ' O ' ' N ' ' A' ' 132' ' ' HIS . 61.9 mttt -96.13 130.61 43.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 109.908 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.424 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 94.7 mt-10 -45.41 -35.17 3.5 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.232 -0.918 . . . . 0.0 110.207 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.514 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 59.2 tt0 -68.25 -21.9 64.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.203 -0.935 . . . . 0.0 110.005 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.458 ' N ' ' O ' ' A' ' 129' ' ' LYS . 13.4 t-160 -87.86 -49.41 7.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.247 -0.908 . . . . 0.0 110.176 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.588 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 2.6 p -69.47 -28.75 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.454 -0.779 . . . . 0.0 110.132 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -104.95 -69.74 0.8 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.181 -0.949 . . . . 0.0 110.089 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -56.56 -19.63 16.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.193 -0.942 . . . . 0.0 109.811 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 132' ' ' HIS . . . -76.21 -30.23 57.36 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.465 ' CE ' ' O ' ' A' ' 133' ' ' VAL . 25.0 mttt -66.68 -30.91 71.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -1.159 . . . . 0.0 110.025 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -81.46 -29.58 33.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.259 -0.9 . . . . 0.0 110.008 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 18.7 mtpp -70.38 -45.99 64.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.9 . . . . 0.0 110.005 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -71.75 -33.28 68.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.318 -0.864 . . . . 0.0 110.067 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.9 t -58.84 -46.27 88.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.354 -0.842 . . . . 0.0 110.001 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -53.02 -43.38 66.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.242 -0.911 . . . . 0.0 109.985 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.472 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 14.1 tp -57.3 -50.13 73.9 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.348 -0.845 . . . . 0.0 109.911 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -54.02 -40.1 66.74 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.357 -0.839 . . . . 0.0 109.685 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -73.12 -15.12 61.49 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.295 -0.878 . . . . 0.0 110.089 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 143' ' ' LEU . 29.9 mt -82.03 -35.4 28.84 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.152 -0.967 . . . . 0.0 108.86 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.636 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 23.5 mt -67.96 -47.49 78.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.479 ' CD ' ' CB ' ' A' ' 11' ' ' SER . 77.6 mt-10 -47.85 -45.14 29.83 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.334 -0.854 . . . . 0.0 108.822 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.473 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 94.3 m -62.04 -39.58 92.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.269 -0.894 . . . . 0.0 109.313 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.583 ' CD1' HG12 ' A' ' 33' ' ' ILE . 57.5 t80 -47.08 -51.34 17.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.498 -0.751 . . . . 0.0 109.837 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.583 HD22 ' CE1' ' A' ' 158' ' ' TYR . 68.6 mt -80.11 -34.77 37.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.434 -0.792 . . . . 0.0 110.418 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.473 ' HB3' ' HA ' ' A' ' 149' ' ' THR . 37.2 tttm -60.72 -14.81 23.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 109.18 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.465 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -120.12 -27.3 2.07 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.576 ' CD2' ' O ' ' A' ' 150' ' ' TYR . 10.3 m-70 -106.12 92.58 6.78 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.134 -1.215 . . . . 0.0 110.279 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.498 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 48.3 Cg_endo -73.86 2.23 6.2 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.035 1.545 . . . . 0.0 110.7 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -113.95 -5.14 13.18 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.064 -1.022 . . . . 0.0 110.019 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.578 ' O ' ' CD1' ' A' ' 158' ' ' TYR . . . -57.78 108.32 0.56 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 109.957 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.667 ' CZ ' ' CB ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER 35.31 31.45 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.702 -0.624 . . . . 0.0 110.689 -179.748 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.519 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.901 -1.047 . . . . 0.0 109.78 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 60.3 t -114.2 126.69 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.232 -1.158 . . . . 0.0 110.274 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.562 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 41.8 m-85 -81.36 158.51 24.66 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.208 -0.932 . . . . 0.0 110.428 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.527 HG21 ' CE1' ' A' ' 119' ' ' HIS . 91.8 m -141.97 94.2 2.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.318 -0.864 . . . . 0.0 109.928 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.628 ' CE1' ' CG2' ' A' ' 133' ' ' VAL . 75.9 m-85 -116.04 138.04 51.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.193 -0.942 . . . . 0.0 110.069 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 12.5 pt-20 -140.05 154.29 47.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.239 -0.913 . . . . 0.0 110.41 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.7 m -135.64 135.94 40.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.311 -0.868 . . . . 0.0 109.805 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.488 ' HG3' ' HG3' ' A' ' 115' ' ' LYS . 5.5 tt0 -114.42 140.6 48.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.133 -0.979 . . . . 0.0 110.766 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.588 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 4.1 p90 -157.4 -172.73 4.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.541 -0.724 . . . . 0.0 109.581 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.47 HG23 HG12 ' A' ' 113' ' ' ILE . 8.8 p -140.0 173.13 11.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.091 -1.006 . . . . 0.0 110.6 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.437 ' CB ' ' CD ' ' A' ' 148' ' ' GLU . 86.0 p -156.04 134.68 11.74 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.44 -0.787 . . . . 0.0 110.094 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -59.73 -39.22 83.96 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.156 -0.965 . . . . 0.0 110.189 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.533 ' CD1' ' HB2' ' A' ' 152' ' ' LYS . 2.5 mp -59.94 150.62 68.47 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.432 -0.793 . . . . 0.0 109.892 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.531 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 41.5 Cg_endo -67.53 142.04 57.71 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.041 1.548 . . . . 0.0 110.559 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.626 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.0 Cg_endo -72.15 -31.08 12.5 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.982 1.517 . . . . 0.0 112.667 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.4 Cg_endo -70.33 -21.49 30.75 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 N-CA-C 110.086 -0.774 . . . . 0.0 110.086 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.537 ' NE ' ' CB ' ' A' ' 159' ' ' ASN . 36.3 mtp180 -82.94 -46.08 13.37 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.52 ' HG ' ' CG2' ' A' ' 147' ' ' ILE . 0.8 OUTLIER -71.02 -32.53 69.33 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.941 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.575 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 86.5 t80 -62.84 -59.3 5.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.555 -0.715 . . . . 0.0 109.512 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.508 ' O ' ' N ' ' A' ' 25' ' ' ASP . 29.5 mttt -50.99 -39.02 54.6 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.629 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.659 ' CB ' ' CZ ' ' A' ' 158' ' ' TYR . . . -72.27 -42.53 65.46 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.451 -0.781 . . . . 0.0 110.838 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.634 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 0.2 OUTLIER -72.72 -40.17 66.33 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.317 -0.865 . . . . 0.0 111.17 -178.9 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.578 HG12 ' CD1' ' A' ' 81' ' ' TYR . 4.2 t -103.52 -55.8 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.026 -1.046 . . . . 0.0 111.588 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.515 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 7.3 mp -79.94 -1.12 38.0 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.06 -1.025 . . . . 0.0 111.889 -178.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.529 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.9 OUTLIER -153.36 30.62 0.48 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.658 -1.276 . . . . 0.0 110.726 -179.9 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -74.5 -23.39 58.84 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.224 -0.922 . . . . 0.0 110.39 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -67.58 -17.33 64.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -0.936 . . . . 0.0 110.022 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.473 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 3.4 p30 -128.31 10.5 6.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.306 -0.871 . . . . 0.0 109.977 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.518 HD11 ' CD1' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -93.54 -49.8 5.72 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.336 -0.852 . . . . 0.0 110.283 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.66 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 2.2 m -74.96 -28.86 0.83 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.373 -0.829 . . . . 0.0 112.171 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.66 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 51.7 Cg_endo -78.65 5.6 5.47 Favored 'Trans proline' 0 C--N 1.319 -1.026 0 O-C-N 122.67 0.826 . . . . 0.0 110.5 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -126.91 -34.25 2.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 109.431 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.518 ' CD1' HD11 ' A' ' 29' ' ' LEU . 24.1 mt -80.01 -24.89 11.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 121.653 0.74 . . . . 0.0 109.219 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -170.89 97.4 0.43 Allowed Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.637 -0.665 . . . . 0.0 109.725 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -69.89 -3.29 11.79 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.987 1.519 . . . . 0.0 110.664 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -90.52 4.85 49.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 0.0 110.007 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.486 ' C ' ' CD1' ' A' ' 38' ' ' ILE . . . -109.41 -45.39 3.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.321 -0.862 . . . . 0.0 110.033 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.53 ' HB ' ' CG2' ' A' ' 30' ' ' VAL . 1.9 mp -131.47 126.6 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.371 -0.831 . . . . 0.0 110.049 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.44 ' N ' ' O ' ' A' ' 57' ' ' THR . 18.2 ttpt -78.05 -36.59 48.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.202 -0.936 . . . . 0.0 110.316 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.491 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -170.97 136.73 1.13 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.278 -0.889 . . . . 0.0 110.027 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.6 m -111.86 124.83 53.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.331 -0.856 . . . . 0.0 110.149 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.491 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 42.2 tt0 -133.41 109.32 9.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.213 -0.929 . . . . 0.0 110.32 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 19.6 mt -56.29 133.68 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.236 -0.915 . . . . 0.0 110.019 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.4 tp -104.69 -27.52 11.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.284 -0.885 . . . . 0.0 110.547 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.574 ' CD1' HD11 ' A' ' 53' ' ' ILE . 1.9 m95 -127.6 160.56 31.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 0.0 110.775 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.469 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 42.18 -133.94 4.06 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -156.35 19.7 0.35 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.323 -1.104 . . . . 0.0 110.108 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.91 -17.04 6.81 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.467 ' O ' HG23 ' A' ' 71' ' ' ILE . . . -72.27 -172.77 19.65 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.481 ' HA ' HG23 ' A' ' 71' ' ' ILE . 44.9 Cg_endo -73.53 129.1 13.33 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.008 1.53 . . . . 0.0 110.567 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.18 -12.86 55.49 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -70.65 164.57 24.7 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.537 -0.978 . . . . 0.0 109.82 179.705 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.574 HD11 ' CD1' ' A' ' 45' ' ' TRP . 52.7 mt -134.21 121.19 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.388 -0.82 . . . . 0.0 109.79 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 4.9 mtmp? -106.07 138.52 42.11 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.118 -0.989 . . . . 0.0 110.281 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.442 ' HG2' ' HG2' ' A' ' 68' ' ' LYS . 2.1 mtpt -109.98 89.25 2.96 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.321 -0.862 . . . . 0.0 110.15 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.528 ' CG2' HG13 ' A' ' 38' ' ' ILE . 88.9 mt -79.95 141.82 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 110.011 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 3.5 p -115.06 159.6 20.64 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.268 -0.895 . . . . 0.0 110.517 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.525 ' N ' ' O ' ' A' ' 65' ' ' GLY . 16.4 m-85 -120.29 145.65 46.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.36 -0.838 . . . . 0.0 110.154 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.925 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.207 0.527 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -134.33 87.29 0.26 Allowed Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.532 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 12.5 p90 -133.15 164.08 27.84 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.169 -1.195 . . . . 0.0 110.167 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.528 HG13 ' CA ' ' A' ' 88' ' ' GLY . 6.0 m -133.17 175.31 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.358 -0.839 . . . . 0.0 110.583 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.45 ' HB2' HG12 ' A' ' 86' ' ' ILE . 85.2 mttt -129.21 127.21 40.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.523 -0.736 . . . . 0.0 109.5 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.522 ' NE2' HD11 ' A' ' 85' ' ' LEU . 12.6 m170 -115.94 120.01 37.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.138 -0.976 . . . . 0.0 111.079 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 52' ' ' THR . 19.9 tttt -96.41 115.81 28.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 0.0 109.459 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.518 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 24.6 mm -61.08 129.69 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.206 -0.934 . . . . 0.0 110.491 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 82' ' ' SER . 93.8 m-20 -105.39 -42.95 5.1 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.368 -0.833 . . . . 0.0 110.204 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 35.3 m -166.9 158.65 12.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.367 -0.833 . . . . 0.0 109.946 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.458 HG12 HG12 ' A' ' 23' ' ' VAL . 1.7 mt -144.24 156.74 15.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.225 -0.922 . . . . 0.0 110.321 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.529 ' O ' ' N ' ' A' ' 79' ' ' TYR . 4.4 m-20 -135.13 78.8 1.75 Allowed 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.238 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.575 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 88.5 mttt -62.23 -12.98 23.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.131 -0.981 . . . . 0.0 110.062 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -95.14 -31.58 13.47 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.268 -0.895 . . . . 0.0 109.585 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.497 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -107.4 -4.27 18.71 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.528 -0.732 . . . . 0.0 109.725 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.529 ' N ' ' O ' ' A' ' 75' ' ' ASP . 6.7 m-85 64.97 50.63 1.87 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.484 -0.76 . . . . 0.0 110.277 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.523 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -120.75 149.94 41.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.285 -0.885 . . . . 0.0 109.315 179.497 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.681 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 30.7 t80 -139.34 133.39 31.07 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.156 -0.965 . . . . 0.0 110.364 -179.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 19.2 m -137.06 124.92 22.59 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.29 -0.881 . . . . 0.0 110.486 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.681 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 20.5 p90 -143.24 170.76 15.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.251 -0.905 . . . . 0.0 110.396 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.476 ' OG1' ' OD2' ' A' ' 72' ' ' ASP . 21.4 m -121.34 133.55 55.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.436 -0.79 . . . . 0.0 109.9 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.529 ' HB3' ' HB ' ' A' ' 98' ' ' ILE . 4.5 tp -100.31 126.62 46.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.826 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.45 HG12 ' HB2' ' A' ' 68' ' ' LYS . 10.6 pt -111.46 -11.95 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.201 -0.937 . . . . 0.0 110.331 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.462 ' O ' HD12 ' A' ' 85' ' ' LEU . 37.4 tp10 -128.67 167.3 17.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.183 -0.948 . . . . 0.0 110.426 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.528 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 140.99 112.84 0.98 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -48.13 -26.22 1.79 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.234 -1.157 . . . . 0.0 110.451 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.42 -19.68 65.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.197 -0.939 . . . . 0.0 110.315 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.462 ' O ' ' O ' ' A' ' 92' ' ' GLY . 64.2 mt -69.77 -31.42 69.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.143 -0.973 . . . . 0.0 110.253 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 48.65 -177.11 0.02 OUTLIER Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -79.16 3.4 17.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.19 -1.182 . . . . 0.0 110.125 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.439 HG22 ' CG2' ' A' ' 126' ' ' VAL . 1.8 m -88.46 -37.13 16.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.265 -0.897 . . . . 0.0 109.812 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.576 ' CD2' ' CG2' ' A' ' 122' ' ' THR . 44.7 mt -109.72 167.19 10.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.285 -0.885 . . . . 0.0 109.936 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -147.03 -79.94 0.15 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.131 -0.981 . . . . 0.0 110.026 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 15.3 mttp -80.26 126.84 31.64 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.567 -0.708 . . . . 0.0 110.441 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.614 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 6.5 mm -115.37 141.65 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.775 -1.203 . . . . 0.0 109.978 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.466 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -119.09 129.7 55.21 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.433 -0.792 . . . . 0.0 108.97 178.811 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.614 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 10.0 m-85 -124.96 136.11 53.44 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.435 -0.791 . . . . 0.0 110.587 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -139.26 128.89 24.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.331 -0.856 . . . . 0.0 110.04 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.405 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 89.8 m -127.47 141.37 51.68 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.15 -0.969 . . . . 0.0 110.135 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 115' ' ' LYS . 2.5 mttt -136.52 139.65 42.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.932 . . . . 0.0 110.317 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.524 ' CD2' HG12 ' A' ' 114' ' ' ILE . 5.4 mt -123.27 152.63 41.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.237 -0.914 . . . . 0.0 110.093 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.473 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -149.72 -169.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.252 -0.905 . . . . 0.0 110.036 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -124.87 163.14 22.86 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.348 -0.845 . . . . 0.0 110.204 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.461 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 3.0 p -121.73 169.21 9.67 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.0 110.296 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.461 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 47.3 Cg_endo -73.03 -8.76 22.68 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.066 1.561 . . . . 0.0 110.606 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 79.8 p -102.77 9.8 38.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.187 -0.946 . . . . 0.0 110.376 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 111' ' ' GLY . . . 94.2 -36.91 3.56 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 110' ' ' GLY . . . -54.45 -174.5 0.09 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.513 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 13.9 p -135.51 136.61 41.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.161 -1.199 . . . . 0.0 110.372 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.47 HG12 HG23 ' A' ' 10' ' ' THR . 21.1 mt -90.38 147.08 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.324 -0.86 . . . . 0.0 110.151 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.575 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 19.3 mt -131.46 127.28 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.208 -0.933 . . . . 0.0 110.443 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.488 ' HG3' ' HG3' ' A' ' 8' ' ' GLU . 44.4 tttp -116.23 120.15 38.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.274 -0.891 . . . . 0.0 109.902 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 2.3 t -114.28 158.7 21.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.144 -0.972 . . . . 0.0 110.56 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 96.6 m -158.77 122.2 3.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.433 -0.792 . . . . 0.0 109.919 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.6 m -122.43 153.16 39.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 0.0 110.266 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.527 ' CE1' HG21 ' A' ' 4' ' ' THR . 28.7 m-70 -133.01 162.72 30.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.267 -0.896 . . . . 0.0 110.265 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.474 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 30.3 m-85 -131.68 137.98 48.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.273 -0.892 . . . . 0.0 110.466 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.498 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 69.5 m-70 -117.08 93.07 4.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.231 -0.918 . . . . 0.0 109.342 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.576 ' CG2' ' CD2' ' A' ' 95' ' ' LEU . 1.4 p -76.96 160.42 29.18 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.375 -0.828 . . . . 0.0 110.85 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 34.2 tttp -137.12 105.76 5.84 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.577 -0.702 . . . . 0.0 109.938 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.455 ' O ' ' CB ' ' A' ' 125' ' ' ASN . . . 126.35 20.62 1.95 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 2.7 t30 67.39 60.42 0.48 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.046 -1.267 . . . . 0.0 110.651 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.522 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 20.5 m -138.62 145.54 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.176 -0.953 . . . . 0.0 109.739 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.42 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 92.4 mt-10 -104.37 -176.18 3.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.132 -0.98 . . . . 0.0 110.787 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.571 ' CD1' ' CD2' ' A' ' 95' ' ' LEU . 20.8 mm -86.17 173.39 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.375 -0.828 . . . . 0.0 110.229 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' A' ' 132' ' ' HIS . 37.9 mttt -97.24 131.27 44.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.282 -0.886 . . . . 0.0 110.027 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.448 ' HA ' ' OE1' ' A' ' 130' ' ' GLU . 69.9 mm-40 -45.86 -41.51 11.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.093 -1.004 . . . . 0.0 110.189 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.496 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 39.7 tt0 -64.05 -18.01 63.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 109.975 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.457 ' N ' ' O ' ' A' ' 129' ' ' LYS . 10.0 t-160 -93.0 -51.75 4.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 0.0 110.326 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.628 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 2.7 p -67.01 -26.43 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.893 . . . . 0.0 110.19 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -107.72 -70.05 0.82 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -0.918 . . . . 0.0 110.153 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -55.55 -19.78 11.11 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.199 -0.938 . . . . 0.0 109.798 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -75.09 -28.88 61.46 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.418 ' HE2' ' O ' ' A' ' 133' ' ' VAL . 29.7 mttm -65.71 -31.66 72.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.285 -1.127 . . . . 0.0 109.951 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -79.86 -28.87 39.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.948 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -69.31 -35.38 75.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 0.0 109.939 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.03 -40.28 39.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.194 -0.941 . . . . 0.0 109.984 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.8 t -58.21 -47.49 83.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.381 -0.825 . . . . 0.0 109.937 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -54.82 -40.54 69.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.917 . . . . 0.0 109.985 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.447 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 21.7 mt -65.33 -39.29 92.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.89 . . . . 0.0 109.885 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.475 ' HA ' HD11 ' A' ' 147' ' ' ILE . 26.6 m-85 -62.6 -35.3 79.1 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.343 -0.848 . . . . 0.0 109.801 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 145' ' ' LYS . 21.9 tttm -71.72 -12.63 61.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.356 -0.84 . . . . 0.0 110.039 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' A' ' 143' ' ' LEU . 19.2 mt -83.22 -37.35 23.7 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.179 -0.951 . . . . 0.0 108.875 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.634 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 15.6 mt -67.57 -46.61 82.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.466 ' O ' HG12 ' A' ' 13' ' ' ILE . 68.5 mt-10 -56.84 -45.59 82.26 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.459 -0.776 . . . . 0.0 109.516 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 23.3 m -62.84 -36.65 83.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 109.6 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.572 ' O ' ' CD2' ' A' ' 154' ' ' HIS . 87.7 t80 -54.19 -46.43 72.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.414 -0.804 . . . . 0.0 109.894 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.578 HD22 ' CE1' ' A' ' 158' ' ' TYR . 65.6 mt -79.99 -33.65 39.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.387 -0.821 . . . . 0.0 110.339 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.533 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . 34.4 tttm -62.68 -16.86 59.16 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.229 -0.919 . . . . 0.0 109.562 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.451 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -115.3 -31.16 2.08 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.615 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 5.1 m-70 -105.95 94.2 8.78 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.36 -1.083 . . . . 0.0 110.19 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.511 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.8 Cg_endo -73.68 6.25 2.91 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.099 1.578 . . . . 0.0 111.049 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -115.42 -8.19 12.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.034 -1.041 . . . . 0.0 109.788 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.572 ' O ' ' CD1' ' A' ' 158' ' ' TYR . . . -53.34 106.55 0.18 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.439 -0.788 . . . . 0.0 110.035 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.659 ' CZ ' ' CB ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 36.23 30.27 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.687 -0.633 . . . . 0.0 110.466 -179.617 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.537 ' CB ' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 118.07 -0.967 . . . . 0.0 109.661 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.556 HG12 ' CE1' ' A' ' 121' ' ' HIS . 92.3 t -114.04 135.1 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.288 -1.125 . . . . 0.0 110.179 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.645 ' CD1' ' CD1' ' A' ' 128' ' ' ILE . 13.2 m-85 -91.76 156.58 17.45 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.278 -0.889 . . . . 0.0 109.972 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.538 HG21 ' CE1' ' A' ' 119' ' ' HIS . 25.3 m -135.81 113.36 10.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.098 -1.001 . . . . 0.0 110.412 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.592 ' CD2' ' CG2' ' A' ' 133' ' ' VAL . 71.1 m-85 -128.46 145.22 51.17 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.372 -0.83 . . . . 0.0 109.945 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 22.1 pt-20 -140.13 152.62 46.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.139 -0.976 . . . . 0.0 110.676 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.2 p -143.06 136.37 28.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.484 -0.76 . . . . 0.0 109.624 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.412 ' HG3' ' HG3' ' A' ' 115' ' ' LYS . 4.8 tt0 -123.28 141.81 51.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.02 -1.05 . . . . 0.0 110.912 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.589 ' CE2' ' HB ' ' A' ' 114' ' ' ILE . 3.2 p90 -157.8 -178.08 7.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.517 -0.739 . . . . 0.0 109.592 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.509 ' CG2' ' HA ' ' A' ' 113' ' ' ILE . 11.5 p -141.53 175.42 9.7 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.057 -1.027 . . . . 0.0 110.707 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.424 ' OG ' ' CD ' ' A' ' 148' ' ' GLU . 3.5 t -159.05 161.78 36.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.502 -0.749 . . . . 0.0 110.22 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -81.34 -36.51 29.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.272 -0.893 . . . . 0.0 110.207 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.539 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 3.1 mp -60.68 150.4 75.74 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.347 -0.845 . . . . 0.0 109.869 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.539 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 40.1 Cg_endo -65.1 142.31 73.62 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.878 1.462 . . . . 0.0 110.59 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.603 ' CD ' ' CD ' ' A' ' 16' ' ' PRO . 40.0 Cg_endo -73.01 -30.82 10.46 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 124.042 1.549 . . . . 0.0 113.049 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.603 ' CD ' ' CD ' ' A' ' 15' ' ' PRO . 45.0 Cg_endo -73.12 -20.27 21.82 Favored 'Trans proline' 0 C--N 1.317 -1.114 0 N-CA-C 110.125 -0.76 . . . . 0.0 110.125 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.533 ' NE ' ' HB2' ' A' ' 159' ' ' ASN . 39.7 ttm180 -83.53 -50.52 8.18 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.502 ' C ' ' CD2' ' A' ' 18' ' ' LEU . 1.1 tt -62.14 -25.98 68.05 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.5 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 52.5 t80 -68.76 -55.38 11.47 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.537 0.684 . . . . 0.0 109.449 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.491 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 15.8 mttt -49.55 -33.69 15.52 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.173 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.6 ' HB3' ' CE2' ' A' ' 158' ' ' TYR . . . -78.98 -50.52 10.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.346 -0.846 . . . . 0.0 110.725 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.643 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 0.2 OUTLIER -62.74 -37.41 86.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.496 -0.752 . . . . 0.0 111.47 -178.809 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.564 HG12 ' CD1' ' A' ' 81' ' ' TYR . 3.3 t -109.4 -55.62 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 120.973 -1.079 . . . . 0.0 111.731 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.518 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 7.3 mp -76.43 0.1 20.92 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.998 -1.064 . . . . 0.0 111.278 -178.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.541 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -152.19 16.52 0.64 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.876 -1.14 . . . . 0.0 110.452 179.729 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -55.66 -41.62 73.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.164 -0.96 . . . . 0.0 109.891 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.433 ' OD2' HG13 ' A' ' 43' ' ' ILE . 76.5 m-20 -57.26 -24.26 53.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.288 -0.883 . . . . 0.0 110.075 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.465 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 77.6 m-20 -120.45 13.9 11.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.383 -0.823 . . . . 0.0 110.056 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.518 ' CD2' ' HB1' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -100.78 -46.24 5.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.885 . . . . 0.0 110.094 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.59 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 2.8 t -70.22 -42.41 16.28 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.362 -0.836 . . . . 0.0 110.781 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 46.9 Cg_endo -76.4 4.54 5.37 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.482 1.254 . . . . 0.0 110.671 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 28' ' ' ASN . 21.1 mttm -120.02 -32.22 4.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.935 . . . . 0.0 109.077 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.587 HG12 ' CD1' ' A' ' 150' ' ' TYR . 6.8 mt -80.05 -35.27 15.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.444 0.64 . . . . 0.0 109.588 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -160.44 98.17 1.42 Allowed Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.442 -0.786 . . . . 0.0 110.17 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.22 0.1 8.4 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.989 1.521 . . . . 0.0 110.678 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -90.57 -19.37 23.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.141 -0.974 . . . . 0.0 110.36 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.92 -42.65 11.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.184 -0.948 . . . . 0.0 110.369 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.541 HG12 ' CG2' ' A' ' 56' ' ' ILE . 1.1 mp -128.81 144.13 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.415 -0.803 . . . . 0.0 110.328 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.46 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 37.9 ttmt -78.97 -41.76 28.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.325 -0.86 . . . . 0.0 109.854 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.545 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -178.42 161.57 1.39 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.327 -0.858 . . . . 0.0 110.166 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.429 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 15.5 m -123.3 122.39 38.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.138 -0.976 . . . . 0.0 110.037 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -127.9 111.91 14.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.183 -0.948 . . . . 0.0 110.558 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.471 HD11 HG22 ' A' ' 43' ' ' ILE . 24.9 mt -60.05 143.73 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.304 -0.873 . . . . 0.0 109.948 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.455 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 1.5 mt -119.26 -26.28 5.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 110.487 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.541 ' CD2' HD13 ' A' ' 53' ' ' ILE . 1.6 m95 -123.09 162.03 23.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.162 -0.961 . . . . 0.0 110.496 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.465 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 42.08 -141.95 1.45 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -149.08 24.6 0.92 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -1.13 . . . . 0.0 110.335 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 120.59 -15.59 9.78 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.476 ' O ' HG23 ' A' ' 71' ' ' ILE . . . -77.82 -172.87 39.69 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.465 ' HA ' HG21 ' A' ' 71' ' ' ILE . 43.5 Cg_endo -72.04 129.43 15.21 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 O-C-N 123.987 1.519 . . . . 0.0 110.59 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.43 -14.09 47.2 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.564 -1.814 . . . . 0.0 108.564 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -70.63 164.43 24.98 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.51 -0.994 . . . . 0.0 109.581 179.67 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.541 HD13 ' CD2' ' A' ' 45' ' ' TRP . 51.7 mt -135.28 121.23 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 109.997 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 96.2 mttt -107.77 140.72 40.42 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.187 -0.946 . . . . 0.0 110.401 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.455 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 25.9 tttt -109.2 90.6 3.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.243 -0.911 . . . . 0.0 110.144 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.541 ' CG2' HG12 ' A' ' 38' ' ' ILE . 82.1 mt -80.04 140.51 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.233 -0.917 . . . . 0.0 110.289 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.505 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 3.0 p -111.11 158.66 18.62 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.311 -0.868 . . . . 0.0 110.83 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.527 ' N ' ' O ' ' A' ' 65' ' ' GLY . 29.8 m-85 -116.33 133.82 55.58 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.175 -0.953 . . . . 0.0 110.105 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.342 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.876 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.144 0.497 . . . . 0.0 110.24 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -129.61 90.44 0.31 Allowed Glycine 0 N--CA 1.487 2.04 0 N-CA-C 108.29 -1.924 . . . . 0.0 108.29 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.532 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 16.9 p90 -140.36 165.45 27.38 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.055 -1.262 . . . . 0.0 110.304 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.524 HG13 ' CA ' ' A' ' 88' ' ' GLY . 5.1 m -131.54 173.48 14.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.459 -0.776 . . . . 0.0 110.321 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.518 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 22.9 mttt -125.49 124.5 41.51 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.62 -0.675 . . . . 0.0 109.656 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.512 ' NE2' HD11 ' A' ' 85' ' ' LEU . 14.7 m170 -112.29 122.01 46.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.191 -0.943 . . . . 0.0 110.777 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 52' ' ' THR . 86.6 tttt -98.62 111.23 23.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.184 -0.948 . . . . 0.0 109.516 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.518 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 24.1 mm -52.46 130.19 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.117 -0.989 . . . . 0.0 109.979 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.447 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 11.9 t0 -108.83 -45.86 3.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.354 -0.841 . . . . 0.0 110.377 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 73.3 m -164.91 157.68 16.4 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.317 -0.865 . . . . 0.0 109.921 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.464 HG12 HG12 ' A' ' 23' ' ' VAL . 1.9 mt -142.96 158.05 17.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.249 -0.907 . . . . 0.0 110.496 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.54 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 3.1 m-20 -132.79 77.81 1.76 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 120.078 -0.649 . . . . 0.0 109.973 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.5 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 84.4 mttt -61.26 -15.65 37.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.133 -0.979 . . . . 0.0 110.413 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -93.33 -31.06 14.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.191 -0.943 . . . . 0.0 109.645 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.499 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -106.69 -5.41 18.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.574 -0.704 . . . . 0.0 109.796 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.544 ' CZ ' ' HB3' ' A' ' 16' ' ' PRO . 5.3 m-85 66.02 50.46 1.45 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.504 -0.747 . . . . 0.0 110.292 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.54 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -120.12 154.67 34.39 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 0.0 109.447 179.51 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.615 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 24.5 t80 -142.94 129.74 20.45 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.117 -0.99 . . . . 0.0 110.439 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.462 ' OG ' ' HG3' ' A' ' 101' ' ' GLU . 73.8 m -136.41 120.33 17.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.397 -0.814 . . . . 0.0 110.332 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.642 ' CE2' ' CB ' ' A' ' 100' ' ' TYR . 11.8 p90 -135.06 174.92 10.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.272 -0.893 . . . . 0.0 110.207 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.3 m -123.73 127.35 48.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.371 -0.831 . . . . 0.0 110.104 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.519 ' HB3' ' CG2' ' A' ' 98' ' ' ILE . 5.1 tp -95.37 136.62 35.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.302 -0.874 . . . . 0.0 109.669 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.4 pt -123.59 -14.61 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.233 -0.917 . . . . 0.0 110.48 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.518 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 20.2 tt0 -129.93 129.25 43.6 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.054 -1.029 . . . . 0.0 110.675 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.524 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 177.68 128.54 1.17 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -59.52 -13.66 9.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -1.134 . . . . 0.0 110.415 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.52 -32.01 26.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 110.299 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.498 ' HG ' ' N ' ' A' ' 92' ' ' GLY . 1.8 pp -90.99 -27.42 18.68 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.28 -0.888 . . . . 0.0 110.569 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.498 ' N ' ' HG ' ' A' ' 91' ' ' LEU . . . -59.69 -31.89 72.52 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.445 ' O ' ' CG2' ' A' ' 94' ' ' THR . 87.2 m-20 -45.5 -40.02 7.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -1.168 . . . . 0.0 110.414 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.455 ' OG1' HD23 ' A' ' 95' ' ' LEU . 1.3 p -160.03 -33.73 0.06 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.274 -0.891 . . . . 0.0 110.682 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.573 ' CD1' ' CG2' ' A' ' 122' ' ' THR . 1.6 mm? -79.99 167.47 20.42 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.14 -0.975 . . . . 0.0 110.656 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.484 ' HG2' ' N ' ' A' ' 97' ' ' LYS . 43.6 tt0 -128.36 -77.72 0.56 Allowed 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.496 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 89.4 mttt -80.19 145.13 32.43 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.621 -0.675 . . . . 0.0 109.565 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.591 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 8.0 mm -128.45 143.31 41.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 120.733 -1.229 . . . . 0.0 110.11 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.454 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -117.04 128.26 54.98 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.404 -0.81 . . . . 0.0 109.362 179.076 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.642 ' CB ' ' CE2' ' A' ' 83' ' ' TYR . 8.7 m-85 -124.38 134.05 53.24 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.216 -0.928 . . . . 0.0 110.256 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.462 ' HG3' ' OG ' ' A' ' 82' ' ' SER . 81.6 tt0 -138.58 133.74 32.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.254 -0.904 . . . . 0.0 110.333 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.471 ' N ' ' O ' ' A' ' 81' ' ' TYR . 41.2 m -131.75 152.62 50.8 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.225 -0.922 . . . . 0.0 110.091 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 115' ' ' LYS . 6.8 mttm -146.73 138.14 24.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.2 -0.938 . . . . 0.0 110.507 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.536 ' CD2' HG12 ' A' ' 114' ' ' ILE . 5.7 mt -120.0 152.09 38.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.205 -0.934 . . . . 0.0 109.831 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.458 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 1.9 t -148.65 -169.45 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.046 -1.034 . . . . 0.0 110.129 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -123.94 163.52 21.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.332 -0.855 . . . . 0.0 110.195 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.467 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 3.0 p -122.48 169.62 9.36 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.246 -0.909 . . . . 0.0 110.201 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.8 Cg_endo -72.9 -9.01 23.2 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.061 1.559 . . . . 0.0 110.491 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.8 p -103.16 9.6 38.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.24 -0.913 . . . . 0.0 110.274 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 111' ' ' GLY . . . 94.54 -39.43 2.9 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 110' ' ' GLY . . . -51.66 -176.44 0.03 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.522 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.4 p -133.68 135.92 44.4 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -1.163 . . . . 0.0 110.467 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.509 ' HA ' ' CG2' ' A' ' 10' ' ' THR . 17.2 mt -88.78 148.0 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -0.845 . . . . 0.0 109.716 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.589 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 18.8 mt -131.89 121.87 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.238 -0.914 . . . . 0.0 110.58 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 103' ' ' LYS . 14.4 tttp -109.99 128.63 55.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.0 109.787 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.9 152.41 44.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.094 -1.004 . . . . 0.0 110.444 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 38.6 m -152.56 134.91 15.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 110.094 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.441 ' C ' ' CD2' ' A' ' 119' ' ' HIS . 14.4 m -133.44 156.5 47.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.273 -0.892 . . . . 0.0 110.135 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.538 ' CE1' HG21 ' A' ' 4' ' ' THR . 20.2 m-70 -140.77 170.04 16.51 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.168 -0.957 . . . . 0.0 110.423 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.577 ' N ' ' CD1' ' A' ' 120' ' ' TYR . 8.8 m-85 -129.7 156.36 44.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.306 -0.871 . . . . 0.0 110.453 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.556 ' CE1' HG12 ' A' ' 2' ' ' VAL . 83.6 m-70 -135.13 96.75 3.56 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.211 -0.93 . . . . 0.0 109.545 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.573 ' CG2' ' CD1' ' A' ' 95' ' ' LEU . 6.1 p -64.48 160.7 18.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.395 -0.816 . . . . 0.0 110.925 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 28.7 tttt -119.57 90.94 3.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.493 -0.754 . . . . 0.0 110.17 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 108.95 -109.22 2.75 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -132.15 79.8 1.88 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.253 -1.145 . . . . 0.0 110.252 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.508 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 7.9 m -146.63 179.5 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.321 -0.862 . . . . 0.0 110.048 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.508 ' CG ' ' O ' ' A' ' 126' ' ' VAL . 81.7 mt-10 -156.13 167.09 31.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.203 -0.936 . . . . 0.0 110.277 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.645 ' CD1' ' CD1' ' A' ' 3' ' ' PHE . 2.8 mp -88.7 172.43 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.231 -0.918 . . . . 0.0 110.16 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.494 ' O ' ' N ' ' A' ' 132' ' ' HIS . 8.8 mttm -110.42 127.61 55.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.376 -0.827 . . . . 0.0 109.729 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.488 ' HB3' ' CE ' ' A' ' 134' ' ' LYS . 93.6 mt-10 -44.7 -49.27 10.54 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.112 -0.993 . . . . 0.0 109.904 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.509 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 44.8 tt0 -52.83 -20.6 3.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.646 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 129' ' ' LYS . 12.3 t-160 -87.21 -63.72 1.26 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.456 -0.777 . . . . 0.0 110.031 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.592 ' CG2' ' CD2' ' A' ' 5' ' ' TYR . 8.3 p -59.86 -38.56 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.339 -0.851 . . . . 0.0 109.834 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.488 ' CE ' ' HB3' ' A' ' 130' ' ' GLU . 55.9 mttm -69.65 -46.51 65.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 0.0 109.743 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.509 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -65.6 -30.79 71.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.295 -0.878 . . . . 0.0 109.801 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.47 -32.79 75.75 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 39.9 mttt -61.87 -33.93 75.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.374 -1.074 . . . . 0.0 109.845 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.504 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 83.0 tt0 -83.89 -33.76 24.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 109.842 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 46.1 mttm -71.06 -34.57 71.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.433 -0.792 . . . . 0.0 109.741 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.98 -40.62 46.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.366 -0.833 . . . . 0.0 109.829 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.0 t -60.92 -39.41 89.27 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.429 -0.795 . . . . 0.0 109.929 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 138' ' ' GLU . 75.9 m-20 -60.46 -45.05 95.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.266 -0.896 . . . . 0.0 109.955 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.412 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 46.7 mt -59.68 -40.02 86.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.296 -0.878 . . . . 0.0 110.009 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -61.07 -40.4 93.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.449 -0.782 . . . . 0.0 109.95 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.428 ' HA ' ' OE1' ' A' ' 148' ' ' GLU . 87.6 mttt -70.37 -13.96 62.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.286 -0.884 . . . . 0.0 109.98 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.527 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 35.1 mt -83.84 -36.7 23.27 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.196 -0.94 . . . . 0.0 108.83 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.643 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 47.4 mt -68.32 -46.55 80.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.468 ' O ' HG12 ' A' ' 13' ' ' ILE . 74.1 mt-10 -53.27 -44.57 68.33 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.361 -0.837 . . . . 0.0 109.284 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.428 ' O ' ' C ' ' A' ' 150' ' ' TYR . 42.3 m -70.31 -40.88 73.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.33 -0.856 . . . . 0.0 109.388 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.587 ' CD1' HG12 ' A' ' 33' ' ' ILE . 86.8 t80 -43.11 -45.32 5.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.444 -0.785 . . . . 0.0 109.73 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.631 ' CD2' ' CE2' ' A' ' 158' ' ' TYR . 51.3 mt -80.05 -45.62 17.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.37 -0.831 . . . . 0.0 110.459 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.457 ' HB2' HD12 ' A' ' 13' ' ' ILE . 21.7 ttpp -59.72 -15.23 18.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.365 -0.834 . . . . 0.0 109.525 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -112.41 -29.95 3.03 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.56 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 7.1 m-70 -114.18 96.01 40.82 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.294 -1.121 . . . . 0.0 110.012 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.423 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.1 Cg_endo -73.52 5.96 3.0 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.161 1.611 . . . . 0.0 111.267 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -108.28 -7.22 15.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.908 -1.12 . . . . 0.0 109.82 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.581 ' HB1' ' CE2' ' A' ' 150' ' ' TYR . . . -75.63 101.72 5.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.435 -0.791 . . . . 0.0 110.147 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.631 ' CE2' ' CD2' ' A' ' 151' ' ' LEU . 0.3 OUTLIER 34.71 32.67 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.461 0.648 . . . . 0.0 110.288 -179.417 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.533 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.871 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.639 ' CG1' ' CE1' ' A' ' 121' ' ' HIS . 22.2 t -124.21 138.24 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -1.139 . . . . 0.0 110.403 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.649 ' CE1' ' CD1' ' A' ' 128' ' ' ILE . 9.5 m-85 -103.21 156.57 17.62 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.318 -0.864 . . . . 0.0 109.897 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.437 HG22 ' CE1' ' A' ' 119' ' ' HIS . 7.1 m -126.58 112.75 15.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.131 -0.981 . . . . 0.0 110.592 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.591 ' CD1' ' CG1' ' A' ' 133' ' ' VAL . 59.7 m-85 -120.6 143.71 48.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.183 -0.948 . . . . 0.0 110.177 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 21.9 pt-20 -144.7 152.74 40.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.173 -0.954 . . . . 0.0 110.33 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.462 ' O ' ' CG ' ' A' ' 8' ' ' GLU . 2.3 t -128.23 171.1 12.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.334 -0.854 . . . . 0.0 109.989 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.462 ' CG ' ' O ' ' A' ' 7' ' ' SER . 78.7 mt-10 -154.18 115.98 4.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.931 . . . . 0.0 110.422 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.3 p90 -147.93 -174.65 4.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.396 -0.815 . . . . 0.0 109.731 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.477 ' CG2' ' HA ' ' A' ' 113' ' ' ILE . 7.7 p -141.91 175.66 9.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.091 -1.006 . . . . 0.0 110.527 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.461 ' HB2' ' HG2' ' A' ' 148' ' ' GLU . 85.6 p -157.36 126.91 6.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.543 -0.723 . . . . 0.0 110.23 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -53.64 -35.14 60.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.288 -0.882 . . . . 0.0 110.053 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.534 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 2.5 mp -65.18 150.78 95.07 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.309 -0.869 . . . . 0.0 109.881 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.534 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 41.8 Cg_endo -67.4 142.72 60.83 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.965 1.508 . . . . 0.0 110.619 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.637 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.6 Cg_endo -72.63 -31.04 11.24 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 124.036 1.545 . . . . 0.0 112.811 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.637 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.1 Cg_endo -70.18 -20.65 32.6 Favored 'Trans proline' 0 N--CA 1.485 1.013 0 N-CA-C 110.145 -0.752 . . . . 0.0 110.145 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.525 ' NE ' ' CB ' ' A' ' 159' ' ' ASN . 43.4 mtp180 -84.71 -48.98 8.89 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.496 ' C ' ' CD2' ' A' ' 18' ' ' LEU . 1.3 tt -67.89 -28.36 67.45 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.583 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 83.5 t80 -68.39 -61.41 1.85 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.435 -0.791 . . . . 0.0 109.067 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 34.2 mttm -46.6 -32.81 3.69 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.751 -0.78 . . . . 0.0 109.114 179.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.649 ' CB ' ' CZ ' ' A' ' 158' ' ' TYR . . . -79.85 -40.55 28.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.358 -0.839 . . . . 0.0 110.64 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.637 ' CD1' ' CD1' ' A' ' 147' ' ' ILE . 0.2 OUTLIER -70.98 -42.51 69.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.33 -0.856 . . . . 0.0 111.429 -178.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.574 HG11 ' CE1' ' A' ' 81' ' ' TYR . 4.3 t -104.18 -51.53 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.064 -1.023 . . . . 0.0 111.47 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.481 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 7.4 mp -80.05 0.44 31.83 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.183 -0.948 . . . . 0.0 111.37 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.54 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.4 OUTLIER -155.66 30.44 0.37 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.838 -1.164 . . . . 0.0 110.97 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.454 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -70.27 -28.81 65.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.105 -0.997 . . . . 0.0 109.86 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.468 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 60.9 m-20 -68.18 -12.44 60.94 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.297 -0.877 . . . . 0.0 109.848 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.48 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 79.8 m-20 -131.0 8.86 4.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.351 -0.843 . . . . 0.0 109.948 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.528 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -94.4 -49.99 5.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.356 -0.84 . . . . 0.0 110.466 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.665 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 6.6 p -77.87 -26.94 0.54 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.367 -0.833 . . . . 0.0 112.457 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.665 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 50.5 Cg_endo -78.25 7.17 4.22 Favored 'Trans proline' 0 C--N 1.319 -0.994 0 O-C-N 122.592 0.785 . . . . 0.0 110.703 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -135.38 -32.9 0.91 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.23 -0.919 . . . . 0.0 110.066 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.531 HG12 ' CD1' ' A' ' 150' ' ' TYR . 9.6 mt -80.0 -40.05 20.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.363 -0.836 . . . . 0.0 109.993 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -158.96 98.61 1.65 Allowed Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.275 -0.89 . . . . 0.0 110.374 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.04 2.31 6.8 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.032 1.543 . . . . 0.0 110.585 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -88.75 -16.17 32.87 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.186 -0.946 . . . . 0.0 110.129 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.518 ' CB ' HD22 ' A' ' 143' ' ' LEU . . . -95.92 -32.7 12.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 110.256 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.536 ' CD1' HG22 ' A' ' 30' ' ' VAL . 1.1 mp -145.81 133.91 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.338 -0.851 . . . . 0.0 109.883 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 57' ' ' THR . 27.7 ttpp -82.63 -25.98 32.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.886 . . . . 0.0 110.44 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.533 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -175.31 157.84 2.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.194 -0.941 . . . . 0.0 110.261 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.2 m -135.45 121.29 19.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.421 -0.8 . . . . 0.0 109.565 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.516 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 48.3 tt0 -138.88 111.81 7.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.006 -1.059 . . . . 0.0 110.689 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 27.9 mt -50.63 143.24 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.412 -0.805 . . . . 0.0 109.896 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 11.6 tp -116.83 -21.8 8.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.308 -0.87 . . . . 0.0 110.348 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.559 ' CD2' HD13 ' A' ' 53' ' ' ILE . 1.7 m95 -131.5 163.29 28.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.237 -0.915 . . . . 0.0 110.615 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.46 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 42.63 -134.25 4.44 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -155.51 19.12 0.4 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -1.108 . . . . 0.0 110.231 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.69 -16.21 7.0 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.479 ' O ' HG23 ' A' ' 71' ' ' ILE . . . -74.81 -173.73 31.94 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.494 ' HA ' HG23 ' A' ' 71' ' ' ILE . 44.6 Cg_endo -72.97 129.53 14.38 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 124.055 1.555 . . . . 0.0 110.466 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.3 -14.96 47.31 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -69.86 167.38 17.43 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.521 -0.988 . . . . 0.0 109.463 179.536 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.559 HD13 ' CD2' ' A' ' 45' ' ' TRP . 43.3 mt -134.94 120.75 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.202 -0.936 . . . . 0.0 110.18 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.462 ' HD2' HD12 ' A' ' 71' ' ' ILE . 17.7 mtpt -102.91 130.48 49.97 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.193 -0.942 . . . . 0.0 110.111 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -98.42 91.57 5.25 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.184 -0.948 . . . . 0.0 109.906 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.525 ' CG2' HG12 ' A' ' 38' ' ' ILE . 93.4 mt -80.02 138.73 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.371 -0.831 . . . . 0.0 110.046 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.49 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 3.1 p -114.93 155.9 26.02 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.232 -0.918 . . . . 0.0 110.476 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.544 ' N ' ' O ' ' A' ' 65' ' ' GLY . 20.1 m-85 -117.93 142.46 47.32 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.358 -0.839 . . . . 0.0 110.038 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.98 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.259 0.552 . . . . 0.0 110.27 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -140.74 113.38 0.86 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 15.6 p90 -154.65 170.65 21.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.082 -1.246 . . . . 0.0 110.122 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.534 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 6.0 m -141.28 174.52 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.27 -0.894 . . . . 0.0 110.764 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.507 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 25.1 mttt -126.21 120.7 30.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.547 -0.72 . . . . 0.0 109.489 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.566 ' CD2' ' CD1' ' A' ' 85' ' ' LEU . 18.3 m170 -108.76 129.13 55.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.223 -0.923 . . . . 0.0 111.037 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 52' ' ' THR . 44.3 tttp -100.43 112.95 25.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.225 -0.922 . . . . 0.0 109.474 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.537 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 31.0 mm -52.08 130.77 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.1 -1.0 . . . . 0.0 110.239 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.463 ' OD2' ' OG1' ' A' ' 84' ' ' THR . 58.8 m-20 -106.45 -36.85 6.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 0.0 110.258 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.468 ' O ' HD13 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -178.55 166.24 1.77 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.178 -0.952 . . . . 0.0 109.635 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.475 HG12 HG12 ' A' ' 23' ' ' VAL . 0.9 OUTLIER -151.82 155.9 6.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 119.016 -1.074 . . . . 0.0 111.386 -179.682 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.504 ' O ' ' N ' ' A' ' 79' ' ' TYR . 2.3 m-20 -132.78 76.12 1.67 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.303 0.573 . . . . 0.0 109.919 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.583 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 45.9 mttt -60.83 -12.51 11.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.226 -0.921 . . . . 0.0 110.406 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -92.82 -31.97 14.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.298 -0.876 . . . . 0.0 109.483 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.494 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -107.43 -6.16 17.25 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.534 -0.729 . . . . 0.0 109.839 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.573 ' CZ ' ' HB3' ' A' ' 16' ' ' PRO . 4.0 m-85 69.11 48.83 0.66 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.558 -0.714 . . . . 0.0 110.183 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.487 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.5 OUTLIER -119.58 147.18 44.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.232 -0.917 . . . . 0.0 109.543 179.626 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.68 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 76.1 t80 -140.35 143.28 35.67 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.093 -1.004 . . . . 0.0 110.6 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.436 ' C ' ' HB2' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -148.69 141.26 24.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -0.877 . . . . 0.0 110.098 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.68 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 10.7 p90 -151.52 175.66 12.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.144 -0.973 . . . . 0.0 110.699 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.463 ' OG1' ' OD2' ' A' ' 72' ' ' ASP . 6.5 m -122.58 127.84 49.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.467 -0.771 . . . . 0.0 109.688 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.566 ' CD1' ' CD2' ' A' ' 69' ' ' HIS . 2.9 tp -94.98 128.25 41.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.166 -0.959 . . . . 0.0 110.314 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.412 HG23 HD11 ' A' ' 86' ' ' ILE . 14.3 pt -114.81 0.51 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.33 -0.856 . . . . 0.0 110.392 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.507 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 72.4 tt0 -149.32 154.42 38.96 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.253 -0.904 . . . . 0.0 110.198 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.521 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 150.94 130.55 1.72 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -57.34 -16.04 7.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.329 -1.1 . . . . 0.0 110.2 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.419 ' O ' ' CE1' ' A' ' 132' ' ' HIS . . . -66.44 -30.28 70.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.225 -0.922 . . . . 0.0 110.201 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 21.1 mt -58.06 -15.57 9.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -0.866 . . . . 0.0 110.036 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 93' ' ' ASP . . . 48.12 30.73 7.77 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 92' ' ' GLY . 93.1 m-20 56.56 15.36 2.05 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.251 -1.147 . . . . 0.0 110.379 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 65.6 p -108.18 -52.78 2.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.931 . . . . 0.0 109.604 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.532 HD11 ' CD2' ' A' ' 120' ' ' TYR . 14.9 mt -80.36 164.1 23.38 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.499 -0.751 . . . . 0.0 109.741 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.422 ' OE1' ' HD3' ' A' ' 123' ' ' LYS . 42.3 tt0 -132.19 -78.35 0.5 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 110.326 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.517 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 54.6 mttt -80.2 128.4 33.48 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.49 -0.756 . . . . 0.0 110.638 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.643 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 4.7 mm -120.45 141.53 40.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 120.682 -1.261 . . . . 0.0 109.692 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.462 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -122.38 126.59 48.33 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.429 -0.794 . . . . 0.0 108.986 178.79 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.643 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 12.7 m-85 -122.59 133.51 54.54 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.294 -0.879 . . . . 0.0 110.491 -179.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.509 ' N ' ' O ' ' A' ' 117' ' ' THR . 49.6 tt0 -136.24 134.38 38.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.36 -0.837 . . . . 0.0 110.259 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 94.0 m -131.67 140.56 49.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.263 -0.898 . . . . 0.0 110.069 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.76 139.34 50.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.307 -0.871 . . . . 0.0 110.229 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.518 ' CD2' HG12 ' A' ' 114' ' ' ILE . 11.4 mt -115.51 149.74 37.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.345 -0.847 . . . . 0.0 109.991 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.479 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 1.9 t -150.44 -168.43 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.202 -0.936 . . . . 0.0 110.21 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.461 ' O ' HD13 ' A' ' 113' ' ' ILE . . . -121.37 158.47 28.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.285 -0.884 . . . . 0.0 110.115 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.469 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 9.5 p -114.91 167.04 10.44 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.19 -0.944 . . . . 0.0 110.321 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.469 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.9 Cg_endo -72.23 -4.23 14.82 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.074 1.565 . . . . 0.0 110.39 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 65.4 m -107.06 0.7 23.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.238 -0.914 . . . . 0.0 110.245 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.63 -41.07 2.26 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -54.31 -177.61 0.13 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.528 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 6.7 p -124.61 140.29 53.08 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.226 -1.161 . . . . 0.0 110.321 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.477 ' HA ' ' CG2' ' A' ' 10' ' ' THR . 19.5 mt -92.9 147.55 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.33 -0.857 . . . . 0.0 110.129 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.612 ' CG2' ' CE2' ' A' ' 9' ' ' PHE . 8.7 mt -130.96 126.89 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.283 -0.886 . . . . 0.0 110.144 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -119.72 111.15 17.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.154 -0.966 . . . . 0.0 110.144 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 2.4 m -96.64 159.71 14.78 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.229 -0.919 . . . . 0.0 110.552 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 101' ' ' GLU . 25.4 m -160.11 117.98 2.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.516 -0.74 . . . . 0.0 109.959 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.424 ' CB ' ' CD1' ' A' ' 100' ' ' TYR . 96.7 p -125.31 161.78 26.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.09 -1.006 . . . . 0.0 110.453 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.462 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 62.9 m-70 -140.15 131.84 27.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.307 -0.871 . . . . 0.0 110.225 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.532 ' CD2' HD11 ' A' ' 95' ' ' LEU . 3.2 m-85 -98.16 148.15 23.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.393 -0.817 . . . . 0.0 109.672 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.639 ' CE1' ' CG1' ' A' ' 2' ' ' VAL . 88.6 m-70 -129.13 93.19 3.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.055 -1.028 . . . . 0.0 110.054 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.528 ' CG2' HG22 ' A' ' 126' ' ' VAL . 2.0 p -66.41 156.93 33.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.249 -0.907 . . . . 0.0 110.228 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.422 ' HD3' ' OE1' ' A' ' 96' ' ' GLU . 17.6 tptt -116.54 115.83 26.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.336 -0.852 . . . . 0.0 110.197 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 99.57 -118.28 6.13 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -132.82 73.11 1.51 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.189 -1.183 . . . . 0.0 110.166 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.528 HG22 ' CG2' ' A' ' 122' ' ' THR . 14.1 m -139.69 153.11 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.262 -0.899 . . . . 0.0 110.154 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -126.37 170.04 12.34 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.215 -0.928 . . . . 0.0 110.28 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.649 ' CD1' ' CE1' ' A' ' 3' ' ' PHE . 3.4 mp -100.01 172.77 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.191 -0.943 . . . . 0.0 110.161 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.443 ' N ' ' CG2' ' A' ' 128' ' ' ILE . 10.5 mttt -116.32 132.18 56.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.896 . . . . 0.0 109.811 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 129' ' ' LYS . 95.0 mt-10 -42.55 -42.96 3.54 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.266 -0.897 . . . . 0.0 110.185 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -52.4 -37.99 57.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.157 -0.964 . . . . 0.0 109.911 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.419 ' CE1' ' O ' ' A' ' 90' ' ' ALA . 13.7 t-160 -74.54 -57.45 3.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.331 -0.856 . . . . 0.0 110.072 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.591 ' CG1' ' CD1' ' A' ' 5' ' ' TYR . 79.4 t -58.97 -36.35 61.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.421 -0.799 . . . . 0.0 109.891 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 31.0 tttt -71.69 -44.07 64.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.3 -0.875 . . . . 0.0 109.945 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.4 ' O ' ' HG3' ' A' ' 139' ' ' LYS . . . -61.47 -27.55 68.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.998 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -74.15 -28.64 63.85 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -73.41 -34.04 65.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.294 -1.121 . . . . 0.0 110.006 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -82.1 -31.46 30.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 109.967 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 135' ' ' ALA . 43.3 mttm -72.57 -33.95 67.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.889 . . . . 0.0 110.004 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -80.31 -34.4 36.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 110.123 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 71.4 m -63.66 -41.56 98.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.332 -0.855 . . . . 0.0 110.045 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -58.66 -45.16 89.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.273 -0.892 . . . . 0.0 110.105 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.518 HD22 ' CB ' ' A' ' 37' ' ' ALA . 2.6 mt -61.03 -40.25 92.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -0.885 . . . . 0.0 110.104 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.408 ' CE1' ' CE2' ' A' ' 22' ' ' PHE . 17.6 m-85 -62.35 -34.06 75.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.377 -0.827 . . . . 0.0 109.961 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 145' ' ' LYS . 30.3 tttm -76.04 -14.18 60.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.338 -0.851 . . . . 0.0 110.24 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 19.6 mt -84.07 -37.13 22.47 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.059 -1.026 . . . . 0.0 109.023 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.637 ' CD1' ' CD1' ' A' ' 22' ' ' PHE . 24.5 mt -69.14 -43.32 81.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.472 ' HB3' HD11 ' A' ' 13' ' ' ILE . 83.8 mt-10 -53.04 -44.65 67.56 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.392 -0.818 . . . . 0.0 109.347 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 28.5 m -66.69 -33.13 74.97 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 109.762 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.577 ' O ' ' CD2' ' A' ' 154' ' ' HIS . 89.3 t80 -55.02 -49.65 71.0 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.409 -0.807 . . . . 0.0 110.04 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.576 HD22 ' CE1' ' A' ' 158' ' ' TYR . 74.7 mt -76.17 -36.08 58.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -0.872 . . . . 0.0 110.419 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.475 ' HB2' HD12 ' A' ' 13' ' ' ILE . 8.5 tttp -60.19 -15.35 23.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.253 -0.905 . . . . 0.0 109.308 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.464 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -120.05 -24.12 2.82 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.577 ' CD2' ' O ' ' A' ' 150' ' ' TYR . 12.9 m-70 -106.1 92.41 6.57 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.296 -1.12 . . . . 0.0 110.162 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.4 Cg_endo -73.2 4.17 4.02 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.025 1.54 . . . . 0.0 110.937 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -120.33 -6.73 9.83 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.994 -1.066 . . . . 0.0 109.919 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.576 ' HB1' ' CE2' ' A' ' 150' ' ' TYR . . . -53.91 106.11 0.17 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.889 . . . . 0.0 109.826 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.649 ' CZ ' ' CB ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 36.23 30.38 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.661 -0.649 . . . . 0.0 110.518 -179.466 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.525 ' CB ' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.802 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.586 HG22 ' CD2' ' A' ' 121' ' ' HIS . 2.6 p -79.96 149.54 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.357 -1.084 . . . . 0.0 110.712 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.56 ' HB2' ' CE2' ' A' ' 5' ' ' TYR . 5.1 m-85 -86.74 169.65 12.45 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.664 -0.647 . . . . 0.0 110.145 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.536 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 3.3 m -123.82 129.82 51.63 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.102 -0.999 . . . . 0.0 110.47 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.56 ' CE2' ' HB2' ' A' ' 3' ' ' PHE . 39.1 m-85 -142.68 133.72 25.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.316 -0.865 . . . . 0.0 110.028 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.452 ' HG2' ' OG1' ' A' ' 117' ' ' THR . 30.9 mt-10 -143.9 145.22 32.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -0.926 . . . . 0.0 110.515 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.458 ' O ' ' HG2' ' A' ' 8' ' ' GLU . 5.6 t -118.5 169.88 9.4 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.395 -0.815 . . . . 0.0 109.85 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 7' ' ' SER . 60.7 mt-10 -152.53 123.07 7.29 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.14 -0.975 . . . . 0.0 110.643 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.637 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 1.9 p90 -148.93 -176.94 5.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.406 -0.809 . . . . 0.0 109.735 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.465 HG23 HG12 ' A' ' 113' ' ' ILE . 11.1 p -139.23 -179.91 6.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.132 -0.98 . . . . 0.0 110.696 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.402 ' HB2' HD13 ' A' ' 114' ' ' ILE . 10.2 t -159.99 168.65 25.16 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.429 -0.794 . . . . 0.0 110.102 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -92.04 -28.78 16.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.162 -0.961 . . . . 0.0 110.164 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.545 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 2.6 mp -70.6 151.04 95.51 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.319 -0.863 . . . . 0.0 110.129 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.545 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 40.3 Cg_endo -65.92 142.74 70.17 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.965 1.508 . . . . 0.0 110.509 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.615 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.7 Cg_endo -73.31 -30.48 10.26 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 O-C-N 123.992 1.522 . . . . 0.0 113.048 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.7 Cg_endo -71.13 -24.41 23.59 Favored 'Trans proline' 0 C--N 1.317 -1.084 0 N-CA-C 110.184 -0.737 . . . . 0.0 110.184 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.516 ' CZ ' ' HA ' ' A' ' 159' ' ' ASN . 1.5 mtp85 -83.05 -44.95 14.61 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.551 ' CD2' ' CG2' ' A' ' 147' ' ' ILE . 0.2 OUTLIER -65.59 -30.93 71.72 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.727 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.562 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 44.7 t80 -66.27 -54.94 18.98 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.413 -0.804 . . . . 0.0 109.685 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.504 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 20.1 mttt -51.98 -31.72 30.45 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.107 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.641 ' CB ' ' CE2' ' A' ' 158' ' ' TYR . . . -80.04 -46.44 16.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.612 -0.68 . . . . 0.0 110.87 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.644 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 0.4 OUTLIER -66.44 -40.01 89.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.379 -0.826 . . . . 0.0 111.536 -178.618 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.471 HG11 ' CE1' ' A' ' 81' ' ' TYR . 3.4 t -107.6 -62.6 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.797 -1.19 . . . . 0.0 111.472 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.504 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 7.4 mp -62.78 -11.48 18.01 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.143 -0.973 . . . . 0.0 111.324 -178.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 1.2 m-20 -143.76 28.4 1.43 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.829 -1.169 . . . . 0.0 110.59 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -68.27 -21.03 64.82 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.246 -0.909 . . . . 0.0 110.296 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -72.35 -13.73 61.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -0.95 . . . . 0.0 110.173 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.5 ' O ' ' CG ' ' A' ' 32' ' ' LYS . 5.5 p30 -133.74 8.96 3.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.372 -0.83 . . . . 0.0 110.01 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.522 HD11 ' CD1' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -93.45 -45.72 7.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.325 -0.86 . . . . 0.0 109.913 179.872 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.592 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 2.5 t -73.37 -42.71 6.9 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.448 -0.782 . . . . 0.0 110.777 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.8 Cg_endo -78.01 7.57 3.93 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.448 1.236 . . . . 0.0 110.733 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.5 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 42.8 mmtm -124.32 -32.76 3.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.161 -0.962 . . . . 0.0 109.569 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.522 ' CD1' HD11 ' A' ' 29' ' ' LEU . 12.7 mt -80.04 -33.31 14.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.542 -0.724 . . . . 0.0 109.476 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -156.8 94.87 2.25 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.475 -0.766 . . . . 0.0 110.07 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.26 -1.2 9.77 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.046 1.551 . . . . 0.0 110.614 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -91.88 -6.66 51.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.147 -0.971 . . . . 0.0 110.248 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -99.21 -69.04 0.78 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.224 -0.922 . . . . 0.0 110.25 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.535 ' CD1' HG13 ' A' ' 30' ' ' VAL . 1.3 mp -103.46 149.1 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.35 -0.844 . . . . 0.0 110.154 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 40' ' ' HIS . 8.0 ttmm -86.93 -37.04 17.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 110.26 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.521 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER 177.71 134.77 0.07 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.186 -0.946 . . . . 0.0 110.502 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.5 m -94.67 135.73 35.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.158 -0.963 . . . . 0.0 109.804 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.521 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 42.4 tt0 -140.05 114.38 9.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.182 -0.948 . . . . 0.0 110.446 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.453 HD11 HG22 ' A' ' 43' ' ' ILE . 14.2 mt -61.85 138.28 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.164 -0.96 . . . . 0.0 109.962 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 13.3 tp -114.91 -25.86 8.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.23 -0.919 . . . . 0.0 110.468 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.562 ' CG ' HD13 ' A' ' 53' ' ' ILE . 1.8 m95 -127.77 163.99 23.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.217 -0.927 . . . . 0.0 110.588 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.473 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 42.23 -132.67 4.4 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.428 ' N ' ' OG1' ' A' ' 52' ' ' THR . 0.6 OUTLIER -156.34 20.23 0.35 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -1.12 . . . . 0.0 110.15 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.04 -22.97 6.65 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.474 ' O ' HG23 ' A' ' 71' ' ' ILE . . . -71.11 -171.96 12.42 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.459 ' HA ' HG21 ' A' ' 71' ' ' ILE . 44.2 Cg_endo -72.12 128.97 14.5 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 124.045 1.55 . . . . 0.0 110.497 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.32 -15.45 42.75 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.1 m -72.03 161.71 30.51 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.594 -0.945 . . . . 0.0 109.382 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.562 HD13 ' CG ' ' A' ' 45' ' ' TRP . 50.0 mt -132.16 119.8 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.292 -0.88 . . . . 0.0 109.993 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 21.7 mtpt -102.29 134.76 45.06 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.151 -0.968 . . . . 0.0 110.339 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 17.9 tttm -102.39 93.7 5.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.32 -0.863 . . . . 0.0 110.008 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.526 ' CG2' HG12 ' A' ' 38' ' ' ILE . 84.7 mt -80.08 138.79 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.233 -0.917 . . . . 0.0 110.052 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.45 ' O ' HG22 ' A' ' 38' ' ' ILE . 1.4 p -113.73 151.75 31.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 0.0 110.446 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.574 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 24.0 m-85 -115.55 150.11 37.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.367 -0.833 . . . . 0.0 110.062 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.936 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.226 0.536 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.574 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -126.56 99.71 0.55 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.545 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 11.6 p90 -138.5 165.58 26.48 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.187 -1.184 . . . . 0.0 110.158 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.522 HG13 ' CA ' ' A' ' 88' ' ' GLY . 5.8 m -139.2 175.06 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.252 -0.905 . . . . 0.0 110.567 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.443 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 72.8 mttt -129.79 114.98 16.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.525 -0.735 . . . . 0.0 109.928 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.513 ' NE2' HD11 ' A' ' 85' ' ' LEU . 20.1 m170 -103.36 123.16 46.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.343 -0.848 . . . . 0.0 110.742 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 52' ' ' THR . 40.3 tttp -94.85 111.95 23.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 0.0 109.664 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.526 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 39.2 mm -47.3 137.13 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.209 -0.932 . . . . 0.0 110.417 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.515 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 11.1 t0 -112.11 -36.77 5.25 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.398 -0.814 . . . . 0.0 109.934 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 179.92 163.08 1.03 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.319 -0.863 . . . . 0.0 109.657 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.439 HG12 HG12 ' A' ' 23' ' ' VAL . 0.7 OUTLIER -146.75 155.75 11.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.056 -1.028 . . . . 0.0 111.157 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 79' ' ' TYR . 2.5 m-20 -132.57 78.2 1.79 Allowed 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.011 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.562 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 34.0 mttp -61.03 -17.97 55.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.228 -0.92 . . . . 0.0 110.346 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -92.32 -31.01 15.53 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.226 -0.921 . . . . 0.0 109.567 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.497 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -103.78 -6.55 21.35 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.571 -0.706 . . . . 0.0 109.893 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.539 ' N ' ' O ' ' A' ' 75' ' ' ASP . 3.8 m-30 66.02 52.11 1.24 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.536 -0.727 . . . . 0.0 110.14 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.522 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.6 OUTLIER -125.18 147.66 48.95 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.246 -0.909 . . . . 0.0 109.672 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.642 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 58.1 t80 -137.26 135.63 37.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.146 -0.971 . . . . 0.0 110.118 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.439 ' O ' ' N ' ' A' ' 72' ' ' ASP . 26.3 m -141.31 127.58 19.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.077 -1.014 . . . . 0.0 110.779 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.642 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 10.9 p90 -138.72 174.52 10.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.373 -0.83 . . . . 0.0 109.966 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.7 m -125.87 129.19 48.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 0.0 109.738 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.529 ' HB3' ' CG2' ' A' ' 98' ' ' ILE . 3.5 tp -97.07 132.69 42.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.11 -0.994 . . . . 0.0 110.318 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.3 pt -118.81 -24.25 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.394 -0.816 . . . . 0.0 110.148 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.443 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 68.0 tt0 -121.73 147.17 46.25 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.262 -0.899 . . . . 0.0 110.159 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.522 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 165.03 124.65 0.72 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -52.05 -25.01 7.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -1.163 . . . . 0.0 110.22 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.32 -24.03 59.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.166 -0.959 . . . . 0.0 110.226 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.505 HD11 ' N ' ' A' ' 88' ' ' GLY . 72.1 mt -63.98 -32.55 74.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.903 . . . . 0.0 110.167 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 46.81 -173.48 0.02 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 52.3 p30 -83.19 7.02 17.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.262 -1.14 . . . . 0.0 110.163 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.502 ' O ' ' CG2' ' A' ' 126' ' ' VAL . 60.7 p -92.58 -33.72 14.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.319 -0.863 . . . . 0.0 110.137 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.53 HD22 ' CG2' ' A' ' 122' ' ' THR . 61.9 mt -108.03 172.41 6.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.333 -0.854 . . . . 0.0 110.278 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.517 ' OE1' ' N ' ' A' ' 123' ' ' LYS . 48.5 mp0 -149.9 -82.36 0.11 Allowed 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.772 0.796 . . . . 0.0 109.311 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.516 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 59.7 mttt -80.44 127.57 32.57 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.782 -0.574 . . . . 0.0 110.72 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.621 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 5.4 mm -117.8 140.4 41.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 120.563 -1.336 . . . . 0.0 109.293 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.48 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -120.31 126.59 50.92 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.094 179.099 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.621 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 11.7 m-85 -122.61 135.55 54.65 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.407 -0.808 . . . . 0.0 110.367 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.517 ' CB ' ' HB ' ' A' ' 117' ' ' THR . 3.5 mt-10 -138.78 131.02 28.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.316 -0.865 . . . . 0.0 110.122 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 34.1 m -128.27 133.91 48.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.323 -0.86 . . . . 0.0 109.853 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.47 145.86 51.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.137 -0.977 . . . . 0.0 110.531 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.519 ' CD2' HG12 ' A' ' 114' ' ' ILE . 10.9 mt -122.47 153.59 38.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.3 -0.875 . . . . 0.0 110.01 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.479 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 1.9 t -151.12 -168.79 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.183 -0.948 . . . . 0.0 110.125 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.471 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -126.39 147.52 49.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.288 -0.883 . . . . 0.0 110.189 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.461 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 2.6 p -105.87 169.79 6.57 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.14 -0.975 . . . . 0.0 110.273 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.461 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 47.3 Cg_endo -73.19 -9.44 23.3 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.004 1.528 . . . . 0.0 110.403 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 63.1 p -97.37 6.63 47.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.305 -0.872 . . . . 0.0 110.326 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 96.18 -37.71 3.34 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -56.67 -172.42 0.17 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 25.1 p -133.99 137.14 44.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.259 -1.142 . . . . 0.0 110.276 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.465 HG12 HG23 ' A' ' 10' ' ' THR . 18.4 mt -86.77 150.31 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.313 -0.867 . . . . 0.0 110.218 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.612 ' CG2' ' CE2' ' A' ' 9' ' ' PHE . 16.5 mt -131.45 120.01 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.233 -0.917 . . . . 0.0 110.192 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.4 tttm -106.7 124.72 50.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.134 -0.979 . . . . 0.0 110.093 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -111.56 154.37 24.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.23 -0.919 . . . . 0.0 110.469 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.517 ' HB ' ' CB ' ' A' ' 101' ' ' GLU . 88.0 m -145.97 145.2 30.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.385 -0.822 . . . . 0.0 110.249 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.7 m -155.49 120.76 4.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.908 . . . . 0.0 109.857 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.48 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 41.1 m-70 -112.14 157.57 20.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.151 -0.968 . . . . 0.0 110.559 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.587 ' CG ' HD12 ' A' ' 128' ' ' ILE . 10.2 m-85 -125.78 119.89 29.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.371 -0.831 . . . . 0.0 110.511 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.586 ' CD2' HG22 ' A' ' 2' ' ' VAL . 69.9 m-70 -98.79 101.84 13.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.265 -0.897 . . . . 0.0 109.601 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.53 ' CG2' HD22 ' A' ' 95' ' ' LEU . 0.8 OUTLIER -88.26 142.46 27.73 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.131 -0.981 . . . . 0.0 110.499 -179.507 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.517 ' N ' ' OE1' ' A' ' 96' ' ' GLU . 18.4 tttt -113.32 109.73 19.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.382 -0.824 . . . . 0.0 110.202 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 104.06 -153.26 17.73 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.416 ' C ' HG11 ' A' ' 126' ' ' VAL . 21.3 t30 -97.62 77.71 2.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.323 -1.104 . . . . 0.0 110.206 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.502 ' CG2' ' O ' ' A' ' 94' ' ' THR . 22.3 m -142.76 161.68 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.2 -0.937 . . . . 0.0 110.133 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -146.95 153.94 40.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.199 -0.938 . . . . 0.0 110.273 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.587 HD12 ' CG ' ' A' ' 120' ' ' TYR . 3.1 mt -80.18 172.98 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 110.115 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.474 ' N ' ' CG2' ' A' ' 128' ' ' ILE . 63.2 mttt -96.42 133.67 40.54 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.414 -0.804 . . . . 0.0 109.716 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 97.4 mt-10 -42.87 -36.53 1.53 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.268 -0.895 . . . . 0.0 110.169 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.523 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 81.2 tt0 -57.51 -42.17 82.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 109.922 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.518 ' HB3' ' CG2' ' A' ' 128' ' ' ILE . 6.1 t-160 -65.37 -53.66 40.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.333 -0.854 . . . . 0.0 110.221 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.474 HG12 ' CE1' ' A' ' 5' ' ' TYR . 96.6 t -67.7 -33.87 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.43 -0.794 . . . . 0.0 110.287 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 25.6 mttm -98.11 -69.33 0.76 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.212 -0.93 . . . . 0.0 110.205 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -54.71 -19.61 6.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.18 -0.95 . . . . 0.0 109.626 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 132' ' ' HIS . . . -73.17 -30.23 63.25 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.471 ' CE ' ' HB3' ' A' ' 5' ' ' TYR . 66.0 mttm -79.5 -31.45 42.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.335 -1.097 . . . . 0.0 109.932 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -72.45 -52.92 13.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.281 -0.887 . . . . 0.0 109.93 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.507 ' CG ' ' N ' ' A' ' 140' ' ' ALA . 10.1 pttp -56.88 -41.26 77.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.41 -0.806 . . . . 0.0 109.821 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.507 ' N ' ' CG ' ' A' ' 139' ' ' LYS . . . -70.4 -39.73 74.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.349 -0.845 . . . . 0.0 109.853 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 137' ' ' LYS . 16.7 t -55.62 -43.41 76.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.414 -0.804 . . . . 0.0 109.852 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -57.34 -42.47 82.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.347 -0.846 . . . . 0.0 109.873 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.413 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 64.3 mt -57.85 -41.82 83.17 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.28 -0.887 . . . . 0.0 109.906 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -59.45 -36.79 76.62 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.422 -0.799 . . . . 0.0 109.845 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.408 ' HA ' ' OE1' ' A' ' 148' ' ' GLU . 95.6 mttt -71.68 -15.07 62.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.322 -0.861 . . . . 0.0 109.878 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.463 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 24.2 mt -84.95 -35.34 22.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.28 -0.887 . . . . 0.0 109.045 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.644 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 60.0 mt -70.47 -40.75 77.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 119.772 -0.771 . . . . 0.0 108.97 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.469 ' O ' HD12 ' A' ' 13' ' ' ILE . 52.0 mt-10 -59.46 -44.08 93.06 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.423 -0.798 . . . . 0.0 109.329 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.436 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 33.7 m -67.75 -30.19 69.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.318 -0.864 . . . . 0.0 109.453 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.586 ' CE2' ' OH ' ' A' ' 158' ' ' TYR . 73.3 t80 -57.84 -49.72 75.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.463 -0.773 . . . . 0.0 109.802 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.628 ' CD2' ' CE2' ' A' ' 158' ' ' TYR . 77.5 mt -79.94 -26.61 40.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.209 -0.932 . . . . 0.0 109.983 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.534 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . 50.8 tttt -72.65 -26.49 61.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.375 -0.828 . . . . 0.0 109.491 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.468 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -105.4 -32.02 4.11 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.553 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 6.6 m-70 -106.92 92.31 7.4 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.302 -1.117 . . . . 0.0 109.947 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.6 Cg_endo -73.84 6.9 2.62 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.131 1.595 . . . . 0.0 111.15 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -108.87 -4.49 16.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.936 -1.103 . . . . 0.0 110.008 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.556 ' C ' ' CG ' ' A' ' 158' ' ' TYR . . . -77.65 101.72 6.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.382 -0.824 . . . . 0.0 110.1 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.641 ' CE2' ' CB ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER 35.15 31.8 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.691 -0.63 . . . . 0.0 110.507 -179.49 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.516 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.744 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 93.9 t -124.42 137.77 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -1.135 . . . . 0.0 110.206 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.639 ' CD1' ' CD1' ' A' ' 128' ' ' ILE . 10.1 m-85 -98.89 145.71 26.72 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.248 -0.908 . . . . 0.0 109.843 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.558 HG21 ' CE1' ' A' ' 119' ' ' HIS . 3.2 m -120.89 127.56 51.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.155 -0.966 . . . . 0.0 110.677 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.606 ' CE2' ' CG2' ' A' ' 133' ' ' VAL . 61.5 m-85 -139.92 131.21 26.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.395 -0.815 . . . . 0.0 109.765 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 22.4 pt-20 -131.75 153.3 50.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.043 -1.036 . . . . 0.0 110.774 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.7 m -132.37 144.67 50.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.417 -0.802 . . . . 0.0 109.71 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -135.58 121.99 20.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.162 -0.961 . . . . 0.0 110.719 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.638 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.0 p90 -147.19 -177.03 5.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.363 -0.836 . . . . 0.0 109.691 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.536 ' CG2' ' HA ' ' A' ' 113' ' ' ILE . 5.7 p -142.52 170.35 15.88 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.115 -0.991 . . . . 0.0 110.739 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.427 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 1.4 t -155.06 157.48 37.61 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.41 -0.807 . . . . 0.0 110.243 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -76.07 -38.34 57.19 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.125 -0.984 . . . . 0.0 109.993 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.54 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 3.3 mp -58.37 150.02 56.52 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.44 -0.788 . . . . 0.0 109.98 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.54 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 39.6 Cg_endo -66.1 144.71 76.64 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.909 1.478 . . . . 0.0 110.116 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.623 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 38.4 Cg_endo -72.41 -31.46 11.31 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.961 1.506 . . . . 0.0 113.002 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 44.0 Cg_endo -71.72 -22.0 24.49 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 N-CA-C 109.757 -0.901 . . . . 0.0 109.757 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.535 ' HG2' ' CD2' ' A' ' 151' ' ' LEU . 42.0 ttm180 -81.89 -47.57 12.61 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.517 ' HA ' ' CD1' ' A' ' 151' ' ' LEU . 0.7 OUTLIER -66.26 -26.26 67.27 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.645 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.57 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 51.6 t80 -67.88 -50.72 54.76 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.513 0.673 . . . . 0.0 109.798 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.492 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 34.7 mttm -58.46 -33.63 69.96 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.624 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.613 ' CB ' ' CE1' ' A' ' 158' ' ' TYR . . . -80.04 -26.22 39.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.449 -0.782 . . . . 0.0 110.749 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.564 ' CD1' HD12 ' A' ' 147' ' ' ILE . 1.4 t80 -87.18 -46.72 9.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.17 -0.956 . . . . 0.0 111.474 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.505 HG11 ' CE1' ' A' ' 81' ' ' TYR . 3.5 t -98.84 -54.73 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.018 -1.051 . . . . 0.0 111.098 -179.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.492 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 8.0 mp -67.81 -5.59 17.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.174 -0.954 . . . . 0.0 110.735 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -144.35 17.82 1.71 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.118 -0.989 . . . . 0.0 110.443 -179.866 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -56.99 -23.12 43.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.188 -0.945 . . . . 0.0 110.164 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -79.55 -14.34 58.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.309 -0.869 . . . . 0.0 110.335 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.458 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 80.5 m-20 -132.37 9.14 4.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.183 -0.948 . . . . 0.0 110.415 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.584 ' CD1' ' CD1' ' A' ' 33' ' ' ILE . 0.4 OUTLIER -105.3 -43.61 4.95 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.176 -0.952 . . . . 0.0 110.432 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.603 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 3.0 t -74.39 -41.4 4.84 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.339 -0.851 . . . . 0.0 110.956 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.9 Cg_endo -77.8 10.73 2.48 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.313 1.165 . . . . 0.0 110.896 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 28' ' ' ASN . 15.4 mttm -124.87 -34.92 2.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.115 -0.99 . . . . 0.0 109.355 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.584 ' CD1' ' CD1' ' A' ' 29' ' ' LEU . 6.7 mt -80.12 -44.15 22.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.487 -0.758 . . . . 0.0 109.628 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.87 95.06 14.1 Favored Pre-proline 0 N--CA 1.487 1.398 0 O-C-N 121.407 -0.808 . . . . 0.0 110.189 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.16 -0.41 9.09 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.047 1.551 . . . . 0.0 110.513 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -90.41 -27.42 19.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.218 -0.926 . . . . 0.0 110.039 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.446 ' HB1' HD11 ' A' ' 38' ' ' ILE . . . -87.53 -47.83 8.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.355 -0.841 . . . . 0.0 110.11 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.525 HD12 ' CG1' ' A' ' 30' ' ' VAL . 1.0 OUTLIER -125.68 130.19 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.495 -0.753 . . . . 0.0 109.926 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -89.17 -26.96 21.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.36 -0.837 . . . . 0.0 110.056 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.548 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -172.11 150.08 2.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.918 . . . . 0.0 110.197 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.6 m -128.58 123.3 33.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.339 -0.851 . . . . 0.0 109.904 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.527 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 69.5 tt0 -134.13 111.57 10.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.147 -0.97 . . . . 0.0 110.733 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.456 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 38.2 mt -53.65 143.61 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.292 -0.88 . . . . 0.0 109.892 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' A' ' 53' ' ' ILE . 30.3 tp -120.82 -27.3 5.06 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.224 -0.922 . . . . 0.0 110.447 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.568 ' CD2' HD13 ' A' ' 53' ' ' ILE . 1.7 m95 -123.92 162.83 22.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.294 -0.879 . . . . 0.0 110.516 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.466 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 42.84 -135.97 4.07 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.415 ' N ' ' OG1' ' A' ' 52' ' ' THR . 0.2 OUTLIER -152.64 22.95 0.6 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.392 -1.063 . . . . 0.0 110.052 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 120.09 -19.75 9.33 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.476 ' O ' HG22 ' A' ' 71' ' ' ILE . . . -74.16 -169.82 21.43 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.472 ' HA ' HG23 ' A' ' 71' ' ' ILE . 45.3 Cg_endo -72.13 128.12 13.53 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 123.925 1.487 . . . . 0.0 110.649 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.4 -14.57 47.09 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.527 -1.829 . . . . 0.0 108.527 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.1 m -71.79 160.42 32.63 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.553 -0.969 . . . . 0.0 109.329 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.568 HD13 ' CD2' ' A' ' 45' ' ' TRP . 59.5 mt -132.48 119.36 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 110.276 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 48.6 mttm -102.56 124.8 48.77 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.355 -0.84 . . . . 0.0 110.163 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.4 tttt -92.31 93.9 8.87 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.29 -0.881 . . . . 0.0 110.004 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.521 ' CG2' HG12 ' A' ' 38' ' ' ILE . 70.7 mt -80.1 144.26 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.187 -0.945 . . . . 0.0 110.05 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 40' ' ' HIS . 1.2 p -115.08 153.93 29.82 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.359 -0.838 . . . . 0.0 110.347 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.524 ' N ' ' O ' ' A' ' 65' ' ' GLY . 19.3 m-85 -114.53 137.87 51.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.158 -0.964 . . . . 0.0 110.107 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.969 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.117 0.484 . . . . 0.0 110.095 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -138.78 116.53 1.28 Allowed Glycine 0 N--CA 1.486 2.033 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.545 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 13.9 p90 -156.4 174.47 15.37 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.088 -1.242 . . . . 0.0 110.208 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.484 ' HB ' HD12 ' A' ' 85' ' ' LEU . 6.8 m -144.16 174.97 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.872 . . . . 0.0 110.658 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.517 ' O ' ' CD1' ' A' ' 85' ' ' LEU . 22.7 mttm -132.22 104.36 6.72 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.515 -0.741 . . . . 0.0 109.687 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.53 ' CD2' HD11 ' A' ' 85' ' ' LEU . 12.5 m170 -95.57 126.09 40.62 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.26 -0.9 . . . . 0.0 111.103 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 52' ' ' THR . 23.8 tttt -98.48 108.67 21.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.351 -0.843 . . . . 0.0 109.434 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.51 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 30.2 mm -42.38 139.78 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.222 -0.924 . . . . 0.0 110.15 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.478 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 13.1 t0 -116.55 -41.22 3.11 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.187 -0.945 . . . . 0.0 110.46 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 22.9 m -168.94 158.86 9.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 109.917 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.42 HD13 ' C ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -148.93 154.33 9.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 C-N-CA 119.142 -1.023 . . . . 0.0 111.131 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 79' ' ' TYR . 2.4 m-20 -133.91 77.82 1.73 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 120.269 -0.573 . . . . 0.0 110.092 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.57 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 36.7 tttm -61.6 -15.66 41.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.099 -1.001 . . . . 0.0 110.199 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -92.93 -30.53 15.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.259 -0.9 . . . . 0.0 109.593 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.502 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.2 m-80 -105.04 -9.15 18.04 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.69 -0.632 . . . . 0.0 109.882 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.579 ' CZ ' ' HB3' ' A' ' 16' ' ' PRO . 2.9 m-85 70.13 51.31 0.4 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.62 -0.675 . . . . 0.0 110.277 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.465 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -125.17 149.01 48.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.908 . . . . 0.0 109.669 179.711 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.676 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 58.5 t80 -138.86 139.96 38.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.162 -0.961 . . . . 0.0 110.235 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.418 ' O ' ' HB3' ' A' ' 72' ' ' ASP . 3.3 m -148.52 121.37 8.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.208 -0.932 . . . . 0.0 110.439 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.676 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 8.8 p90 -131.41 175.12 9.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.291 -0.881 . . . . 0.0 110.42 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.446 HG21 ' O ' ' A' ' 98' ' ' ILE . 19.7 m -127.82 126.06 40.96 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.346 -0.846 . . . . 0.0 109.948 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.53 HD11 ' CD2' ' A' ' 69' ' ' HIS . 14.0 tp -97.57 135.5 39.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.018 -1.051 . . . . 0.0 110.277 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.471 ' O ' ' CD1' ' A' ' 91' ' ' LEU . 9.5 pt -115.81 -31.27 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.219 -0.926 . . . . 0.0 110.255 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.489 ' C ' ' CD1' ' A' ' 91' ' ' LEU . 39.4 tt0 -107.86 165.65 11.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.28 -0.887 . . . . 0.0 110.09 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.464 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 151.55 140.17 3.1 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -60.04 -31.93 70.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.276 -1.132 . . . . 0.0 110.228 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 91' ' ' LEU . . . -67.02 -39.61 87.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.29 -0.881 . . . . 0.0 110.213 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.521 ' CD2' ' CD2' ' A' ' 95' ' ' LEU . 11.4 mt -42.31 -51.96 4.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.367 -0.833 . . . . 0.0 110.135 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 43.54 -167.4 0.02 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.409 ' C ' ' OD1' ' A' ' 93' ' ' ASP . 55.8 p-10 -79.43 3.22 19.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -1.146 . . . . 0.0 110.176 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.462 ' O ' HG21 ' A' ' 122' ' ' THR . 0.1 OUTLIER -92.32 -51.93 4.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.231 -0.918 . . . . 0.0 110.185 -179.907 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.544 HD12 ' CD1' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -107.56 159.59 16.32 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.406 -0.809 . . . . 0.0 109.416 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.481 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 62.9 tt0 -134.88 -80.33 0.44 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.306 -0.871 . . . . 0.0 110.182 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 46.8 mttt -80.27 152.74 28.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.633 -0.667 . . . . 0.0 110.78 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.631 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 4.7 mm -138.66 142.99 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.175 -0.953 . . . . 0.0 109.701 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.459 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.8 OUTLIER -121.38 127.39 51.16 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.356 -0.84 . . . . 0.0 109.151 178.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.631 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 10.3 m-85 -122.52 135.19 54.59 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 110.517 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.447 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 74.4 tt0 -138.14 141.38 40.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.312 -0.867 . . . . 0.0 110.356 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 81' ' ' TYR . 32.7 m -137.66 149.94 46.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.412 -0.805 . . . . 0.0 109.732 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 115' ' ' LYS . 7.9 mttt -145.54 138.14 25.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.114 -0.991 . . . . 0.0 110.725 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.521 ' CD2' HG12 ' A' ' 114' ' ' ILE . 5.9 mt -118.75 151.69 37.56 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.298 -0.876 . . . . 0.0 109.497 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.476 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 1.9 t -150.23 -169.85 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.042 -1.036 . . . . 0.0 110.371 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -121.44 141.87 50.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.42 -0.8 . . . . 0.0 110.141 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.478 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 7.9 p -99.25 167.51 11.12 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.209 -0.932 . . . . 0.0 110.29 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.478 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.7 Cg_endo -72.32 -1.12 9.68 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.013 1.533 . . . . 0.0 110.596 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 52.0 p -106.65 4.14 27.58 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.248 -0.907 . . . . 0.0 110.303 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 100.21 -32.83 6.86 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -61.97 -172.11 1.27 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.529 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.0 OUTLIER -131.56 128.77 39.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.217 -1.167 . . . . 0.0 110.413 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.536 ' HA ' ' CG2' ' A' ' 10' ' ' THR . 10.3 mt -82.19 152.14 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.321 -0.862 . . . . 0.0 110.039 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.584 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 15.7 mt -132.31 119.03 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.2 -0.938 . . . . 0.0 110.436 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.486 ' O ' ' N ' ' A' ' 103' ' ' LYS . 26.6 tttt -108.63 119.04 38.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 110.075 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 2.0 t -110.87 158.16 19.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 110.306 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 43.1 m -160.01 139.74 11.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.21 -0.931 . . . . 0.0 110.3 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 41.9 t -143.58 159.67 42.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.214 -0.929 . . . . 0.0 110.116 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.558 ' CE1' HG21 ' A' ' 4' ' ' THR . 69.8 m-70 -142.34 159.1 42.9 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.157 -0.964 . . . . 0.0 110.527 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.495 ' HB2' ' HB2' ' A' ' 3' ' ' PHE . 8.7 m-85 -117.86 150.78 38.61 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.36 -0.837 . . . . 0.0 110.279 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.481 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 95.2 m-70 -128.39 82.76 2.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.138 -0.976 . . . . 0.0 109.896 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.462 HG21 ' O ' ' A' ' 94' ' ' THR . 1.2 p -71.74 152.13 43.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.347 -0.845 . . . . 0.0 110.082 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.406 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 7.3 ttpt -109.89 118.29 36.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.255 -0.903 . . . . 0.0 110.335 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 101.59 -143.44 16.07 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -112.72 73.41 0.81 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.302 -1.116 . . . . 0.0 110.207 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 5.9 m -140.67 156.49 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.273 -0.892 . . . . 0.0 110.147 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -128.2 154.7 45.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.266 -0.896 . . . . 0.0 110.261 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.639 ' CD1' ' CD1' ' A' ' 3' ' ' PHE . 3.0 mt -74.9 172.74 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.337 -0.852 . . . . 0.0 110.2 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.463 ' O ' ' N ' ' A' ' 132' ' ' HIS . 40.9 mmtm -104.07 125.9 50.78 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.347 -0.846 . . . . 0.0 110.053 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 129' ' ' LYS . 96.0 mt-10 -43.65 -54.05 5.31 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.223 -0.923 . . . . 0.0 110.038 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.446 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 42.9 tt0 -46.32 -25.04 0.56 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.207 -0.933 . . . . 0.0 109.797 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.463 ' N ' ' O ' ' A' ' 129' ' ' LYS . 12.1 t-160 -81.54 -64.56 1.16 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.435 -0.791 . . . . 0.0 110.071 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.606 ' CG2' ' CE2' ' A' ' 5' ' ' TYR . 8.8 p -66.14 -39.47 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.359 -0.838 . . . . 0.0 110.031 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 38.0 tttp -63.59 -42.46 98.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 109.968 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.446 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -66.77 -32.27 73.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.353 -0.842 . . . . 0.0 109.883 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.64 -26.98 74.13 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 45.1 mttp -65.11 -35.43 81.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.336 -1.096 . . . . 0.0 110.021 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -82.69 -36.48 25.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.32 -0.862 . . . . 0.0 109.868 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 41.0 mttt -73.29 -26.93 61.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.387 -0.821 . . . . 0.0 109.854 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.407 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -81.54 -38.77 25.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.368 -0.833 . . . . 0.0 109.92 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.401 ' OG ' ' NZ ' ' A' ' 145' ' ' LYS . 18.9 t -64.01 -47.15 81.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.335 -0.853 . . . . 0.0 109.947 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -54.86 -44.68 74.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.247 -0.908 . . . . 0.0 109.867 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.471 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 9.4 tp -57.2 -45.88 83.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 0.0 109.859 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.468 ' HA ' HD11 ' A' ' 147' ' ' ILE . 28.0 m-85 -54.44 -41.32 69.26 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.234 -0.916 . . . . 0.0 109.507 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.401 ' NZ ' ' OG ' ' A' ' 141' ' ' SER . 18.7 mttp -72.82 -12.98 61.19 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.438 -0.789 . . . . 0.0 110.035 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 143' ' ' LEU . 16.1 mt -83.75 -36.2 23.82 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.177 -0.952 . . . . 0.0 108.921 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.564 HD12 ' CD1' ' A' ' 22' ' ' PHE . 25.8 mt -68.05 -44.31 84.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.496 ' OE2' ' CD1' ' A' ' 18' ' ' LEU . 60.8 mm-40 -53.66 -46.22 70.53 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.473 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 25.7 m -65.83 -39.11 90.51 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.354 -0.841 . . . . 0.0 109.351 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.575 ' CE2' ' OH ' ' A' ' 158' ' ' TYR . 58.0 t80 -43.64 -56.85 3.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.435 -0.791 . . . . 0.0 109.829 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.535 ' CD2' ' HG2' ' A' ' 17' ' ' ARG . 12.4 mt -75.16 -39.72 60.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.541 -0.724 . . . . 0.0 110.432 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.531 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . 25.1 tttm -60.83 -17.77 51.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.122 -0.986 . . . . 0.0 109.364 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.467 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -113.46 -29.59 2.9 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.538 ' CD2' ' O ' ' A' ' 150' ' ' TYR . 12.2 m-70 -105.82 89.84 3.87 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.285 -1.126 . . . . 0.0 110.009 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.513 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 45.6 Cg_endo -71.12 1.85 4.9 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.052 1.554 . . . . 0.0 110.989 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -108.33 -16.31 14.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.049 -1.032 . . . . 0.0 110.107 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.593 ' O ' ' CD1' ' A' ' 158' ' ' TYR . . . -71.41 99.56 2.01 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.2 -0.937 . . . . 0.0 109.848 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.613 ' CE1' ' CB ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER 35.06 32.54 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 CA-C-O 121.564 0.697 . . . . 0.0 109.569 -179.24 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.536 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--N 1.303 -1.451 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.94 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.456 ' O ' ' OG1' ' A' ' 122' ' ' THR . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.508 ' CG1' ' O ' ' A' ' 120' ' ' TYR . 77.4 t -125.29 138.57 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -1.157 . . . . 0.0 110.2 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.645 ' CD1' ' CD1' ' A' ' 128' ' ' ILE . 11.7 m-85 -98.02 136.13 38.72 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.205 -0.934 . . . . 0.0 109.624 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.514 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 8.5 m -119.19 136.81 54.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.093 -1.004 . . . . 0.0 110.815 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.633 ' CE2' ' CG2' ' A' ' 133' ' ' VAL . 57.0 m-85 -147.18 124.83 11.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.474 -0.766 . . . . 0.0 109.83 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.58 ' CG ' ' CG2' ' A' ' 117' ' ' THR . 5.0 mt-10 -123.54 132.77 53.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.277 -0.889 . . . . 0.0 110.494 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.456 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 50.7 m -119.01 157.8 27.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.325 -0.86 . . . . 0.0 109.898 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 7' ' ' SER . 50.5 mp0 -146.37 123.98 11.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.111 -0.993 . . . . 0.0 110.804 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.635 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.0 p90 -141.71 -175.88 4.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.886 . . . . 0.0 109.632 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.469 HG23 HG12 ' A' ' 113' ' ' ILE . 8.6 p -142.5 169.84 16.83 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.009 -1.057 . . . . 0.0 110.794 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.486 ' O ' ' N ' ' A' ' 112' ' ' SER . 4.0 t -153.83 162.15 41.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.422 -0.799 . . . . 0.0 110.174 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -85.1 -28.47 25.57 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.127 -0.983 . . . . 0.0 110.164 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.535 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 9.1 mm -67.9 150.79 97.63 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 0.0 109.891 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.535 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 40.4 Cg_endo -66.12 143.35 71.3 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.932 1.491 . . . . 0.0 110.325 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.627 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.2 Cg_endo -72.55 -31.13 11.35 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 124.023 1.539 . . . . 0.0 112.888 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.6 Cg_endo -70.1 -23.83 28.83 Favored 'Trans proline' 0 C--N 1.316 -1.147 0 N-CA-C 110.177 -0.74 . . . . 0.0 110.177 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.574 ' O ' ' CE1' ' A' ' 158' ' ' TYR . 46.2 mtp180 -83.68 -42.47 16.6 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.541 ' HG ' ' CG2' ' A' ' 147' ' ' ILE . 0.6 OUTLIER -71.85 -31.56 66.62 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.467 ' HB2' ' O ' ' A' ' 15' ' ' PRO . 54.3 t80 -65.39 -54.93 21.56 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.461 -0.774 . . . . 0.0 109.042 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 25' ' ' ASP . 70.1 mttt -48.63 -48.54 39.43 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.724 -0.79 . . . . 0.0 109.355 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.651 ' CB ' ' CZ ' ' A' ' 158' ' ' TYR . . . -67.75 -28.77 67.91 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.334 -0.854 . . . . 0.0 111.135 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.573 ' CD1' HD12 ' A' ' 147' ' ' ILE . 0.9 OUTLIER -80.92 -46.54 15.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 111.411 -178.814 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.564 HG11 ' CE1' ' A' ' 81' ' ' TYR . 3.4 t -104.44 -51.36 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.942 -1.099 . . . . 0.0 111.761 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.473 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 7.2 mp -79.97 -4.61 53.22 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.097 -1.002 . . . . 0.0 111.966 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.541 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 1.0 OUTLIER -149.17 23.95 0.93 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.717 -1.239 . . . . 0.0 110.643 -179.632 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.521 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -67.01 -32.94 74.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.17 -0.956 . . . . 0.0 110.301 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.427 ' HA ' ' OG ' ' A' ' 41' ' ' SER . 81.4 m-20 -56.54 -17.68 9.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.357 -0.839 . . . . 0.0 110.559 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 25' ' ' ASP . 4.2 p30 -128.94 -0.93 5.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.15 -0.969 . . . . 0.0 110.523 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.526 ' CD2' ' CZ ' ' A' ' 150' ' ' TYR . 1.1 tm? -88.57 -43.76 11.14 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.112 -0.992 . . . . 0.0 110.17 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.598 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 5.0 t -74.59 -40.86 4.36 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.437 -0.79 . . . . 0.0 111.319 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.0 Cg_endo -77.54 10.91 2.33 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 123.448 1.236 . . . . 0.0 111.005 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.486 ' CD ' ' O ' ' A' ' 28' ' ' ASN . 31.9 mtpt -120.65 -34.65 3.54 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.029 -1.044 . . . . 0.0 109.031 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.576 HD13 ' CD1' ' A' ' 150' ' ' TYR . 10.6 mt -80.19 -32.58 13.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 121.53 0.681 . . . . 0.0 109.657 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -159.65 98.35 1.54 Allowed Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.412 -0.805 . . . . 0.0 110.097 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.8 -0.75 8.86 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.034 1.544 . . . . 0.0 110.809 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -85.03 -19.08 32.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 109.788 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.441 ' HB1' HD11 ' A' ' 38' ' ' ILE . . . -85.76 -86.05 0.14 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.415 -0.803 . . . . 0.0 110.082 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' A' ' 57' ' ' THR . 1.9 mp -90.75 139.94 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.279 -0.888 . . . . 0.0 110.112 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.425 ' O ' ' CB ' ' A' ' 40' ' ' HIS . 4.8 ttmm -87.81 -26.74 22.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.353 -0.842 . . . . 0.0 110.18 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.56 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER 177.03 157.19 0.31 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.177 -0.952 . . . . 0.0 110.193 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.427 ' OG ' ' HA ' ' A' ' 27' ' ' ASP . 79.4 p -117.3 134.21 55.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.356 -0.84 . . . . 0.0 110.023 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.56 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 29.0 tp10 -138.69 106.87 5.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.091 -1.005 . . . . 0.0 110.246 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.462 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 20.0 mt -62.59 137.16 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 110.098 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.511 HD23 ' CE ' ' A' ' 55' ' ' LYS . 13.0 tp -114.08 -23.51 9.49 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.239 -0.913 . . . . 0.0 110.534 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.468 ' HB2' ' N ' ' A' ' 53' ' ' ILE . 1.7 m95 -127.06 161.61 28.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.049 -1.032 . . . . 0.0 110.63 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.458 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 41.76 -132.09 3.97 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -157.24 19.78 0.3 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.296 -1.12 . . . . 0.0 110.154 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.91 -18.22 7.09 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.476 ' O ' HG23 ' A' ' 71' ' ' ILE . . . -74.51 -171.64 26.87 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.475 ' HA ' HG23 ' A' ' 71' ' ' ILE . 46.0 Cg_endo -73.38 129.54 13.99 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.103 1.581 . . . . 0.0 110.665 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.34 -9.44 49.55 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.1 m -76.88 167.17 22.29 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.567 -0.96 . . . . 0.0 109.921 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.468 ' N ' ' HB2' ' A' ' 45' ' ' TRP . 65.6 mt -137.35 120.24 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.322 -0.861 . . . . 0.0 109.871 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 70.7 mttt -106.03 138.37 42.34 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.211 -0.93 . . . . 0.0 110.411 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.511 ' CE ' HD23 ' A' ' 44' ' ' LEU . 43.5 mttt -102.53 95.86 6.52 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.308 -0.87 . . . . 0.0 110.06 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.477 ' HB ' HG22 ' A' ' 67' ' ' VAL . 52.1 mt -80.05 135.41 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 109.846 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.46 ' OG1' ' N ' ' A' ' 40' ' ' HIS . 1.6 p -104.77 155.8 18.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.374 -0.828 . . . . 0.0 110.452 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.458 ' CZ ' HG21 ' A' ' 67' ' ' VAL . 23.9 m-85 -118.73 169.89 9.45 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.316 -0.865 . . . . 0.0 110.083 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.919 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.515 ' CE2' ' CD2' ' A' ' 66' ' ' TYR . 8.5 t80 . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.19 0.519 . . . . 0.0 110.075 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.484 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -129.31 136.18 8.84 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.562 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 11.7 p90 -179.49 161.38 1.04 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.349 -1.089 . . . . 0.0 109.952 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.495 HG13 ' CA ' ' A' ' 88' ' ' GLY . 7.1 m -141.95 171.83 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.681 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.464 ' O ' HD22 ' A' ' 85' ' ' LEU . 50.9 mttt -123.31 115.03 21.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.597 -0.689 . . . . 0.0 109.801 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -106.29 126.19 51.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.141 -0.974 . . . . 0.0 110.633 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 52' ' ' THR . 27.2 ttpp -97.43 126.58 42.77 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.322 -0.861 . . . . 0.0 109.77 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.508 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 26.1 mm -66.22 122.02 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 0.0 110.219 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.416 ' O ' ' OG ' ' A' ' 73' ' ' SER . 17.1 t0 -98.14 -43.34 7.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.359 -0.838 . . . . 0.0 110.118 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 9.8 m -169.0 159.42 9.28 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.382 -0.824 . . . . 0.0 109.616 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.5 mt -144.19 158.22 15.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.141 -0.975 . . . . 0.0 110.386 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 79' ' ' TYR . 4.3 m-20 -134.39 78.76 1.77 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.088 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.421 ' HB2' ' HE3' ' A' ' 76' ' ' LYS . 38.1 mtmt -62.52 -14.03 37.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.195 -0.94 . . . . 0.0 110.233 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -93.68 -33.06 13.81 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.266 -0.896 . . . . 0.0 109.521 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.484 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -104.65 -8.18 19.1 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.605 -0.685 . . . . 0.0 109.841 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.536 ' N ' ' O ' ' A' ' 75' ' ' ASP . 3.2 m-85 68.95 50.86 0.58 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.447 -0.783 . . . . 0.0 110.12 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.532 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -120.96 155.3 34.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.318 -0.864 . . . . 0.0 109.405 179.638 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.564 ' CE1' HG11 ' A' ' 23' ' ' VAL . 26.8 t80 -143.21 133.17 24.14 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.177 -0.952 . . . . 0.0 110.216 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 37.9 m -136.75 122.73 20.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 110.488 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.612 ' N ' ' CD1' ' A' ' 83' ' ' TYR . 3.1 p90 -139.42 179.98 6.23 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.179 -0.951 . . . . 0.0 110.039 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.527 ' CG2' ' O ' ' A' ' 98' ' ' ILE . 39.3 m -132.02 142.46 49.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 110.332 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.563 ' CB ' ' HB ' ' A' ' 98' ' ' ILE . 0.2 OUTLIER -98.04 119.35 36.52 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.261 -0.9 . . . . 0.0 110.278 179.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.449 ' CG1' ' HB2' ' A' ' 68' ' ' LYS . 31.2 pt -102.64 -12.85 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.2 -0.938 . . . . 0.0 110.062 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.458 ' HG3' ' N ' ' A' ' 88' ' ' GLY . 47.8 tp10 -141.82 166.7 24.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.311 -0.868 . . . . 0.0 110.214 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.495 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 148.87 120.33 1.07 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -50.15 -24.39 2.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.341 -1.094 . . . . 0.0 110.229 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.5 ' CB ' ' NE2' ' A' ' 132' ' ' HIS . . . -74.09 -22.61 59.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.926 . . . . 0.0 110.27 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.465 ' O ' ' O ' ' A' ' 92' ' ' GLY . 37.7 mt -66.86 -27.09 67.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.229 -0.919 . . . . 0.0 110.307 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 48.91 -178.04 0.01 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 93' ' ' ASP . 38.1 p30 -81.61 8.67 9.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -1.16 . . . . 0.0 110.267 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.456 ' O ' HG23 ' A' ' 126' ' ' VAL . 71.2 p -96.3 -39.62 9.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -0.906 . . . . 0.0 110.182 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.546 ' CD2' ' CG1' ' A' ' 128' ' ' ILE . 47.3 mt -98.8 153.59 18.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.389 -0.819 . . . . 0.0 110.193 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.467 ' HG3' ' HB2' ' A' ' 123' ' ' LYS . 41.9 mm-40 -131.91 -80.31 0.51 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.242 -0.911 . . . . 0.0 110.253 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.51 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 17.6 mttt -80.19 128.73 33.86 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.595 -0.691 . . . . 0.0 110.756 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.583 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 11.3 mm -115.65 146.76 19.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 120.777 -1.202 . . . . 0.0 109.582 178.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.482 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.0 OUTLIER -123.41 123.77 41.41 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.258 -0.901 . . . . 0.0 109.046 178.564 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.585 ' HB3' ' CE2' ' A' ' 83' ' ' TYR . 15.0 m-85 -121.34 133.13 55.1 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.457 -0.777 . . . . 0.0 109.732 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.459 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 21.1 tt0 -142.07 144.05 33.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.09 -1.006 . . . . 0.0 110.782 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 62.1 m -140.13 146.03 38.32 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.455 -0.778 . . . . 0.0 109.594 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -139.52 138.38 36.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.096 -1.002 . . . . 0.0 110.658 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.52 ' CD2' HG12 ' A' ' 114' ' ' ILE . 7.1 mt -118.6 150.3 39.92 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.4 -0.813 . . . . 0.0 109.965 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.452 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 1.8 t -147.72 -171.38 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.188 -0.945 . . . . 0.0 110.212 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -122.75 138.19 54.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.419 -0.801 . . . . 0.0 110.171 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.447 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 4.2 p -99.2 167.74 10.77 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.289 -0.882 . . . . 0.0 110.22 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.447 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.1 Cg_endo -72.27 -4.27 14.9 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.12 1.59 . . . . 0.0 110.349 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 36.5 m -93.82 -18.73 21.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 110.309 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 118.18 -30.37 6.08 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 11' ' ' SER . . . -64.72 -142.96 0.03 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 11' ' ' SER . 26.4 p -155.71 128.57 7.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.287 -1.125 . . . . 0.0 109.968 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.469 HG12 HG23 ' A' ' 10' ' ' THR . 15.2 mt -79.96 149.14 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -0.908 . . . . 0.0 110.085 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.629 ' CG2' ' CZ ' ' A' ' 9' ' ' PHE . 15.6 mt -131.36 119.45 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.414 -0.804 . . . . 0.0 110.25 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -104.83 121.35 43.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.098 -1.001 . . . . 0.0 110.072 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.12 152.65 21.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -0.868 . . . . 0.0 110.216 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.58 ' CG2' ' CG ' ' A' ' 6' ' ' GLU . 12.1 m -159.97 122.39 3.37 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.316 -0.865 . . . . 0.0 110.568 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.506 ' C ' ' CG ' ' A' ' 119' ' ' HIS . 15.0 t -133.55 160.13 38.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.361 -0.837 . . . . 0.0 109.669 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.522 ' NE2' HG23 ' A' ' 117' ' ' THR . 33.7 m-70 -147.19 164.2 33.89 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.061 -1.025 . . . . 0.0 110.642 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.54 ' N ' ' CD1' ' A' ' 120' ' ' TYR . 6.3 m-85 -126.93 150.53 49.29 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.253 -0.904 . . . . 0.0 110.443 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.51 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 93.6 m-70 -129.78 84.71 2.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.255 -0.903 . . . . 0.0 109.723 178.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.51 ' CG2' HD22 ' A' ' 95' ' ' LEU . 1.2 p -63.64 154.8 31.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.302 -0.874 . . . . 0.0 110.179 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.467 ' HB2' ' HG3' ' A' ' 96' ' ' GLU . 43.4 tttt -113.73 117.56 31.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 110.048 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 99.25 -115.95 5.45 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.476 ' O ' ' ND2' ' A' ' 125' ' ' ASN . 0.7 OUTLIER -138.27 67.4 1.41 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.301 -1.117 . . . . 0.0 110.138 179.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 94' ' ' THR . 27.9 m -131.92 167.23 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.886 . . . . 0.0 110.085 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -140.76 161.41 37.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 110.255 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.645 ' CD1' ' CD1' ' A' ' 3' ' ' PHE . 3.5 mp -84.17 172.8 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.252 -0.905 . . . . 0.0 110.127 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.462 ' N ' ' CG2' ' A' ' 128' ' ' ILE . 16.2 mttm -108.25 129.92 55.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.384 -0.823 . . . . 0.0 109.683 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 73.1 mm-40 -43.86 -49.69 8.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.079 -1.013 . . . . 0.0 109.885 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.506 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 51.6 tt0 -48.54 -23.09 0.87 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.154 -0.966 . . . . 0.0 109.651 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.5 ' NE2' ' CB ' ' A' ' 90' ' ' ALA . 13.5 t-160 -88.48 -66.42 0.92 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.372 -0.83 . . . . 0.0 110.142 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.633 ' CG2' ' CE2' ' A' ' 5' ' ' TYR . 7.3 p -59.91 -40.21 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.345 -0.847 . . . . 0.0 109.84 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 31.5 tptt -66.69 -47.39 72.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.285 -0.884 . . . . 0.0 109.795 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.506 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -63.32 -34.18 77.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.74 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.86 -33.89 85.47 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 21.9 mttp -62.87 -37.87 88.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.366 -1.079 . . . . 0.0 109.78 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -78.81 -37.54 40.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.491 -0.756 . . . . 0.0 109.826 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 135' ' ' ALA . 20.9 mttm -66.89 -33.24 75.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.411 -0.805 . . . . 0.0 109.801 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.1 -45.71 26.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.311 -0.868 . . . . 0.0 109.829 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 137' ' ' LYS . 15.0 m -59.13 -42.8 91.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.425 -0.797 . . . . 0.0 109.798 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -59.88 -46.26 89.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.31 -0.869 . . . . 0.0 109.816 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 143' ' ' LEU . 18.9 mt -58.13 -35.63 71.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.373 -0.829 . . . . 0.0 109.722 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.452 ' HA ' HD11 ' A' ' 147' ' ' ILE . 22.6 m-85 -64.27 -34.33 77.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.372 -0.83 . . . . 0.0 109.774 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -71.95 -16.9 62.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.332 -0.855 . . . . 0.0 109.848 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.51 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 19.5 mt -81.23 -36.65 29.73 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.231 -0.918 . . . . 0.0 108.728 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.573 HD12 ' CD1' ' A' ' 22' ' ' PHE . 27.8 mt -70.43 -49.03 56.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.478 ' O ' HG13 ' A' ' 13' ' ' ILE . 97.9 mt-10 -53.07 -38.83 62.84 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.379 -0.825 . . . . 0.0 109.056 178.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.401 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 35.2 m -76.49 -30.18 57.13 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.271 -0.893 . . . . 0.0 109.011 178.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.592 ' O ' ' CD2' ' A' ' 154' ' ' HIS . 54.0 t80 -50.52 -52.95 33.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.591 -0.693 . . . . 0.0 109.566 179.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.586 HD22 ' CE1' ' A' ' 158' ' ' TYR . 40.6 mt -80.15 -25.0 40.01 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.457 -0.777 . . . . 0.0 109.812 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.401 ' HB3' ' HA ' ' A' ' 149' ' ' THR . 14.4 tttp -63.38 -17.42 62.6 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.329 -0.857 . . . . 0.0 109.311 179.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.46 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -120.3 -27.14 2.07 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.626 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 4.0 m-70 -106.38 91.24 5.56 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.191 -1.182 . . . . 0.0 110.285 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.473 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.8 Cg_endo -73.38 2.51 5.6 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.022 1.538 . . . . 0.0 110.82 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -113.17 -9.58 13.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.12 -0.987 . . . . 0.0 109.879 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.589 ' O ' ' CD1' ' A' ' 158' ' ' TYR . . . -47.8 111.08 0.38 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.386 -0.821 . . . . 0.0 110.176 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.651 ' CZ ' ' CB ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 35.13 31.56 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.695 -0.628 . . . . 0.0 110.658 -179.804 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.65 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.576 HG23 ' CE1' ' A' ' 121' ' ' HIS . 93.5 t -128.04 126.57 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -1.161 . . . . 0.0 110.226 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.587 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 38.9 m-85 -87.18 161.36 18.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 0.0 110.415 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 33.8 m -138.63 92.18 2.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.886 . . . . 0.0 110.272 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.587 ' CE2' ' HB3' ' A' ' 3' ' ' PHE . 72.5 m-85 -110.43 126.61 54.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.245 -0.909 . . . . 0.0 109.643 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 116' ' ' SER . 21.2 pt-20 -132.47 152.2 51.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -0.916 . . . . 0.0 110.699 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 61.6 m -129.87 138.86 51.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.367 -0.833 . . . . 0.0 109.581 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -112.99 139.92 48.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.117 -0.989 . . . . 0.0 110.816 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.598 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.8 p90 -155.97 -175.23 5.32 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.431 -0.793 . . . . 0.0 109.511 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.476 HG23 HG12 ' A' ' 113' ' ' ILE . 8.1 p -139.9 174.57 10.38 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.99 -1.069 . . . . 0.0 110.814 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.447 ' CB ' ' CD ' ' A' ' 148' ' ' GLU . 54.1 p -158.59 127.41 5.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.447 -0.783 . . . . 0.0 110.124 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -55.1 -38.24 67.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.231 -0.918 . . . . 0.0 110.036 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.539 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 3.1 mp -59.07 150.36 62.26 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.416 -0.803 . . . . 0.0 110.015 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.539 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 40.9 Cg_endo -66.41 142.29 65.19 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.938 1.493 . . . . 0.0 110.37 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.606 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.0 Cg_endo -72.4 -31.2 11.68 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.874 1.46 . . . . 0.0 112.881 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 44.2 Cg_endo -72.78 -19.85 23.41 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 N-CA-C 109.984 -0.814 . . . . 0.0 109.984 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.537 ' NE ' ' HB2' ' A' ' 159' ' ' ASN . 36.7 ttm180 -83.55 -47.62 11.11 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.505 ' C ' ' CD2' ' A' ' 18' ' ' LEU . 1.1 tt -67.51 -32.42 73.21 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.549 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 57.2 t80 -64.17 -53.99 40.66 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.479 -0.763 . . . . 0.0 109.402 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.482 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 17.8 mttm -49.6 -41.43 42.09 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.801 -0.76 . . . . 0.0 109.326 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.65 ' CB ' ' CZ ' ' A' ' 158' ' ' TYR . . . -76.65 -33.54 58.32 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.398 -0.814 . . . . 0.0 111.04 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.644 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 0.6 OUTLIER -71.49 -49.08 44.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.036 -1.04 . . . . 0.0 111.323 -178.803 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.465 ' HB ' HD13 ' A' ' 24' ' ' LEU . 4.9 t -104.75 -49.25 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.015 -1.053 . . . . 0.0 111.437 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.482 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 7.2 mp -76.99 -5.42 48.61 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.088 -1.007 . . . . 0.0 111.218 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.54 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -157.2 54.98 0.51 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.861 -1.15 . . . . 0.0 110.418 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.458 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -92.04 -10.07 40.47 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.341 -0.849 . . . . 0.0 110.05 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.514 ' O ' ' CG ' ' A' ' 31' ' ' PRO . 41.8 t0 -73.26 -20.32 60.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.326 -0.859 . . . . 0.0 109.919 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -128.46 14.02 6.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.353 -0.842 . . . . 0.0 109.888 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.529 ' HG ' ' CB ' ' A' ' 21' ' ' ALA . 0.4 OUTLIER -98.23 -46.19 5.92 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.363 -0.836 . . . . 0.0 110.321 -179.876 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.657 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.4 m -89.16 -33.35 0.4 Allowed Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.369 -0.832 . . . . 0.0 111.074 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.3 Cg_endo -80.22 7.59 4.62 Favored 'Trans proline' 0 C--N 1.317 -1.097 0 O-C-N 123.06 1.032 . . . . 0.0 110.318 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 51.6 tttt -131.99 -33.24 1.37 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.298 -0.876 . . . . 0.0 109.972 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.563 HD12 ' CG ' ' A' ' 150' ' ' TYR . 11.9 mt -80.02 -43.0 22.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.386 -0.821 . . . . 0.0 109.876 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.2 95.47 3.16 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.298 -0.876 . . . . 0.0 110.233 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -76.92 6.2 4.38 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.125 1.592 . . . . 0.0 110.774 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -89.59 -9.44 49.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.077 -1.014 . . . . 0.0 110.214 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.427 ' C ' HD11 ' A' ' 38' ' ' ILE . . . -104.12 -41.78 5.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 110.23 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.531 HG12 ' CG2' ' A' ' 56' ' ' ILE . 1.4 mp -136.43 121.07 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.429 -0.794 . . . . 0.0 109.88 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 57' ' ' THR . 6.7 ttpp -56.79 -29.94 63.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -0.914 . . . . 0.0 110.249 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.532 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER 173.53 179.38 0.1 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.245 -0.91 . . . . 0.0 110.004 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.524 ' N ' ' CG ' ' A' ' 40' ' ' HIS . 56.3 m -139.97 148.46 41.94 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.234 -0.916 . . . . 0.0 110.245 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.532 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 36.4 tp10 -152.85 111.2 3.69 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.155 -0.965 . . . . 0.0 110.601 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.48 HG22 HD11 ' A' ' 43' ' ' ILE . 29.8 mt -60.51 133.1 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.198 -0.939 . . . . 0.0 109.895 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.525 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 18.2 mt -107.27 -27.06 10.75 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.176 -0.952 . . . . 0.0 110.686 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.571 ' CD2' HD13 ' A' ' 53' ' ' ILE . 1.8 m95 -126.18 161.19 28.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.118 -0.989 . . . . 0.0 110.826 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.461 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 41.95 -133.81 3.86 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.431 ' O ' ' CG ' ' A' ' 47' ' ' ASP . 9.5 t0 -154.67 19.17 0.46 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.309 -1.112 . . . . 0.0 110.011 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.436 ' O ' HG22 ' A' ' 71' ' ' ILE . . . 124.01 -17.29 7.63 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.493 ' O ' ' CG2' ' A' ' 71' ' ' ILE . . . -70.31 -172.55 11.15 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.482 ' HA ' HG23 ' A' ' 71' ' ' ILE . 45.4 Cg_endo -73.62 129.08 13.23 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 O-C-N 124.093 1.575 . . . . 0.0 110.589 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.38 -11.66 56.82 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -71.71 164.75 25.37 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.522 -0.987 . . . . 0.0 109.699 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.571 HD13 ' CD2' ' A' ' 45' ' ' TRP . 47.3 mt -133.35 120.9 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.345 -0.847 . . . . 0.0 109.725 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 28.4 mttm -104.36 131.4 51.75 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.205 -0.935 . . . . 0.0 110.291 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.525 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 73.0 tttt -101.81 93.26 5.22 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.215 -0.928 . . . . 0.0 110.05 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.531 ' CG2' HG12 ' A' ' 38' ' ' ILE . 74.6 mt -80.0 147.34 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.216 -0.927 . . . . 0.0 110.065 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 39' ' ' LYS . 2.2 p -116.69 150.59 37.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.29 -0.881 . . . . 0.0 110.729 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.576 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 22.3 m-85 -113.79 126.84 55.66 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.411 -0.806 . . . . 0.0 110.037 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.43 ' N ' ' HB2' ' A' ' 39' ' ' LYS . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.256 0.551 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.576 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -120.98 94.49 0.55 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.537 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 11.8 p90 -131.17 169.13 16.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -1.182 . . . . 0.0 110.217 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.486 HG13 ' CA ' ' A' ' 88' ' ' GLY . 4.1 m -135.25 177.9 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.233 -0.917 . . . . 0.0 110.345 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.533 ' O ' ' CD1' ' A' ' 85' ' ' LEU . 83.2 mttt -134.91 106.8 7.02 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.377 -0.827 . . . . 0.0 109.872 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.588 ' CD2' HD11 ' A' ' 85' ' ' LEU . 14.5 m170 -98.32 125.78 43.57 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.217 -0.927 . . . . 0.0 111.247 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.577 ' CE ' ' CG2' ' A' ' 86' ' ' ILE . 5.8 mtmp? -93.3 119.13 32.09 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.29 -0.881 . . . . 0.0 109.496 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.524 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 37.8 mm -58.36 128.39 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.128 -0.983 . . . . 0.0 110.519 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 82' ' ' SER . 94.3 m-20 -101.81 -43.82 5.71 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.382 -0.824 . . . . 0.0 109.939 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.498 ' N ' ' OG ' ' A' ' 82' ' ' SER . 22.7 m -169.49 158.89 8.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.407 -0.808 . . . . 0.0 109.736 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.417 HG12 HG12 ' A' ' 23' ' ' VAL . 1.6 mt -142.99 158.27 17.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.175 -0.953 . . . . 0.0 110.465 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 79' ' ' TYR . 4.4 m-20 -134.32 77.81 1.72 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.682 -0.636 . . . . 0.0 109.927 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.549 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 14.7 ttpp -61.14 -16.25 42.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.088 -1.008 . . . . 0.0 110.238 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -93.15 -30.34 15.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.287 -0.883 . . . . 0.0 109.623 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.487 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -106.38 -7.28 17.73 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.481 -0.762 . . . . 0.0 109.958 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.55 ' CZ ' ' HB3' ' A' ' 16' ' ' PRO . 2.7 m-85 67.59 51.19 0.85 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.49 -0.756 . . . . 0.0 110.008 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.532 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -123.41 151.2 42.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.305 -0.872 . . . . 0.0 109.324 179.618 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.684 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 31.1 t80 -137.93 141.07 40.58 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.174 -0.954 . . . . 0.0 110.414 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.498 ' OG ' ' N ' ' A' ' 73' ' ' SER . 1.2 p -143.38 126.48 16.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.243 -0.911 . . . . 0.0 110.56 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.684 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 26.8 p90 -149.17 170.86 17.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.33 -0.856 . . . . 0.0 110.233 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.497 ' CG2' ' O ' ' A' ' 98' ' ' ILE . 40.7 m -127.05 150.51 49.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.308 -0.87 . . . . 0.0 109.88 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.588 HD11 ' CD2' ' A' ' 69' ' ' HIS . 8.0 tp -111.42 124.79 52.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.0 -1.063 . . . . 0.0 110.354 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.577 ' CG2' ' CE ' ' A' ' 70' ' ' LYS . 14.4 pt -105.21 -27.08 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.382 -0.824 . . . . 0.0 110.23 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.458 ' OE1' ' HE3' ' A' ' 68' ' ' LYS . 81.7 tt0 -123.38 155.73 36.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -0.86 . . . . 0.0 110.227 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.486 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 162.26 137.99 2.32 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -65.07 -19.21 65.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.22 -1.164 . . . . 0.0 110.16 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.93 -17.8 45.83 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.288 -0.882 . . . . 0.0 110.278 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.589 ' CD2' ' CD1' ' A' ' 98' ' ' ILE . 14.1 mt -61.38 -29.02 69.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.269 -0.894 . . . . 0.0 110.03 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 47.27 -175.61 0.01 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 54.6 p30 -83.85 6.76 20.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.192 -1.181 . . . . 0.0 109.773 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 50.0 p -98.93 -42.42 7.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.366 -0.834 . . . . 0.0 110.225 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.553 ' CD2' ' CG2' ' A' ' 122' ' ' THR . 74.6 mt -100.44 161.67 13.45 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.39 -0.819 . . . . 0.0 110.137 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -142.46 -81.27 0.21 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.307 -0.871 . . . . 0.0 109.609 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.493 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 7.8 mtpp -80.2 143.74 33.54 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.688 -0.632 . . . . 0.0 110.352 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.589 ' CD1' ' CD2' ' A' ' 91' ' ' LEU . 0.6 OUTLIER -138.06 134.86 45.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.049 -1.032 . . . . 0.0 109.489 179.092 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.494 ' CB ' ' HB2' ' A' ' 119' ' ' HIS . 0.1 OUTLIER -109.9 141.06 43.16 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.467 -0.771 . . . . 0.0 109.875 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 2.8 m-85 -127.8 143.16 51.14 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.319 -0.863 . . . . 0.0 110.341 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.46 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 68.2 tt0 -149.79 119.43 6.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.317 -0.864 . . . . 0.0 110.193 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 64.4 m -119.66 150.76 39.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.166 -0.959 . . . . 0.0 109.923 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 115' ' ' LYS . 20.8 mttt -142.65 133.71 25.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.237 -0.915 . . . . 0.0 110.515 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.529 ' CD2' HG12 ' A' ' 114' ' ' ILE . 5.4 mt -116.74 147.35 42.11 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.193 -0.942 . . . . 0.0 109.799 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.483 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -150.69 -168.75 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.195 -0.941 . . . . 0.0 110.107 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -112.75 156.15 23.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.356 -0.84 . . . . 0.0 109.973 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.46 ' HA ' HD13 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -114.42 170.21 5.71 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.257 -0.902 . . . . 0.0 110.36 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -76.04 0.77 8.95 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.069 1.563 . . . . 0.0 110.471 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 59.0 p -109.9 8.96 24.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.236 -0.915 . . . . 0.0 110.268 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 93.41 -26.39 15.91 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.428 ' C ' ' OG ' ' A' ' 107' ' ' SER . . . -70.24 -172.41 10.81 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.523 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 5.2 p -124.78 127.2 46.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.124 -1.221 . . . . 0.0 110.428 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.476 HG12 HG23 ' A' ' 10' ' ' THR . 73.9 mt -79.9 148.28 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.303 -0.873 . . . . 0.0 110.199 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.591 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 18.0 mt -132.45 127.48 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.188 -0.945 . . . . 0.0 110.563 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 103' ' ' LYS . 38.1 tttp -118.08 118.59 32.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.255 -0.903 . . . . 0.0 109.797 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.1 t -113.9 155.17 26.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.114 -0.991 . . . . 0.0 110.656 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 78.6 m -149.87 133.37 16.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.365 -0.834 . . . . 0.0 110.192 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 28.0 p -126.47 142.99 51.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.237 -0.914 . . . . 0.0 110.238 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.494 ' HB2' ' CB ' ' A' ' 99' ' ' SER . 85.5 m-70 -122.67 157.37 32.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.152 -0.967 . . . . 0.0 110.436 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.514 ' CD2' HG13 ' A' ' 128' ' ' ILE . 28.5 m-85 -128.32 137.34 51.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.248 -0.908 . . . . 0.0 110.354 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.576 ' CE1' HG23 ' A' ' 2' ' ' VAL . 47.4 m-70 -117.71 88.79 2.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.095 -1.003 . . . . 0.0 109.491 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.553 ' CG2' ' CD2' ' A' ' 95' ' ' LEU . 1.1 p -72.92 160.16 32.57 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.46 -0.775 . . . . 0.0 110.411 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 15.5 tttt -113.9 111.85 22.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.372 -0.83 . . . . 0.0 110.214 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 113.64 -133.87 11.49 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -123.5 64.33 1.02 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.217 -1.166 . . . . 0.0 110.255 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.446 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 24.2 m -130.73 162.52 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.258 -0.901 . . . . 0.0 110.142 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.414 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 93.0 mt-10 -134.67 161.62 34.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 0.0 110.307 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.524 ' CD1' HD22 ' A' ' 95' ' ' LEU . 20.6 mm -67.29 173.12 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 0.0 110.056 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.472 ' O ' ' N ' ' A' ' 132' ' ' HIS . 12.5 mttt -111.75 132.8 54.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.0 110.029 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.458 ' HA ' ' OE1' ' A' ' 130' ' ' GLU . 69.4 mm-40 -44.61 -35.16 2.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.195 -0.941 . . . . 0.0 110.133 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.432 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 50.1 tt0 -67.81 -23.81 65.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 109.967 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.472 ' N ' ' O ' ' A' ' 129' ' ' LYS . 16.4 t-160 -83.16 -49.33 9.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.297 -0.877 . . . . 0.0 110.217 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.571 HG13 ' CD1' ' A' ' 5' ' ' TYR . 98.8 t -59.61 -34.29 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.388 -0.82 . . . . 0.0 110.076 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -73.87 -51.14 17.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.893 . . . . 0.0 110.037 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.442 ' O ' ' HG3' ' A' ' 139' ' ' LYS . . . -59.29 -32.95 70.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.251 -0.905 . . . . 0.0 110.016 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.34 -27.93 73.11 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 81.0 mttt -78.9 -31.71 45.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.246 -1.15 . . . . 0.0 110.125 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -88.72 -30.03 19.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 0.0 109.92 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 135' ' ' ALA . 25.9 mttm -72.17 -31.11 65.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.349 -0.845 . . . . 0.0 109.94 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -86.64 -41.64 14.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.258 -0.901 . . . . 0.0 109.961 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 36.0 t -53.22 -43.25 67.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.338 -0.851 . . . . 0.0 110.088 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -57.38 -42.87 83.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -0.847 . . . . 0.0 110.005 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.408 HD23 ' CB ' ' A' ' 37' ' ' ALA . 52.7 mt -63.9 -37.75 88.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -0.914 . . . . 0.0 109.941 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -63.14 -35.15 79.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.433 -0.792 . . . . 0.0 109.857 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -75.15 -10.68 59.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.289 -0.882 . . . . 0.0 110.278 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.528 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 24.0 mt -85.18 -36.67 20.87 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.11 -0.994 . . . . 0.0 109.099 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.644 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 32.3 mt -71.2 -44.12 74.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.472 ' O ' HG12 ' A' ' 13' ' ' ILE . 85.2 mt-10 -58.08 -42.22 85.14 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.446 -0.784 . . . . 0.0 109.614 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 28.2 m -70.19 -39.97 74.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.191 -0.943 . . . . 0.0 109.54 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.573 ' CE2' ' HB1' ' A' ' 157' ' ' ALA . 93.1 t80 -49.37 -42.44 42.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.437 -0.789 . . . . 0.0 109.995 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.592 HD22 ' CE2' ' A' ' 158' ' ' TYR . 42.6 mt -80.16 -44.72 19.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.322 -0.862 . . . . 0.0 110.33 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.455 ' HB2' HD12 ' A' ' 13' ' ' ILE . 29.9 tttt -61.03 -14.45 23.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.337 -0.852 . . . . 0.0 109.629 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -113.31 -30.05 2.8 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.56 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 8.0 m-70 -112.64 96.09 35.35 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.357 -1.084 . . . . 0.0 110.025 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.48 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.9 Cg_endo -73.78 7.68 2.28 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.155 1.608 . . . . 0.0 111.279 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 157' ' ' ALA . 39.3 p30 -109.84 -9.56 14.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.952 -1.093 . . . . 0.0 109.582 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.573 ' HB1' ' CE2' ' A' ' 150' ' ' TYR . . . -66.01 101.14 0.65 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.548 -0.72 . . . . 0.0 110.182 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.65 ' CZ ' ' CB ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER 35.05 32.63 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.218 0 CA-C-O 121.406 0.622 . . . . 0.0 110.164 -179.602 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.537 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.305 -1.365 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.935 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.585 HG22 ' CG ' ' A' ' 121' ' ' HIS . 3.4 p -88.11 148.13 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.332 -1.099 . . . . 0.0 110.538 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.519 ' N ' HG21 ' A' ' 2' ' ' VAL . 18.2 m-85 -83.95 172.25 12.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.403 -0.811 . . . . 0.0 110.118 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.549 HG21 ' CE1' ' A' ' 119' ' ' HIS . 92.8 m -141.1 124.83 16.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.289 -0.882 . . . . 0.0 110.46 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.556 ' CZ ' HG12 ' A' ' 133' ' ' VAL . 74.4 m-85 -126.04 144.63 50.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.321 -0.862 . . . . 0.0 109.932 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 20.5 pt-20 -139.34 149.54 44.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.208 -0.932 . . . . 0.0 110.581 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -135.44 144.54 46.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.453 -0.779 . . . . 0.0 109.595 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -130.33 119.48 22.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.113 -0.992 . . . . 0.0 110.634 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.641 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.0 p90 -144.61 -177.89 5.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.393 -0.817 . . . . 0.0 109.793 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.516 ' CG2' ' HA ' ' A' ' 113' ' ' ILE . 9.4 p -141.9 171.89 13.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.175 -0.953 . . . . 0.0 110.678 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -152.36 154.99 36.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.46 -0.775 . . . . 0.0 110.247 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -77.01 -27.88 54.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.293 -0.88 . . . . 0.0 109.928 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.525 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 1.8 mp -71.39 150.54 94.07 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.351 -0.843 . . . . 0.0 109.849 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.538 ' HG2' ' CG ' ' A' ' 17' ' ' ARG . 41.0 Cg_endo -66.43 141.49 61.82 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.99 1.521 . . . . 0.0 110.498 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.607 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 41.2 Cg_endo -73.64 -30.21 9.94 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 124.068 1.562 . . . . 0.0 113.125 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 44.6 Cg_endo -71.56 -28.3 17.69 Favored 'Trans proline' 0 C--N 1.318 -1.034 0 N-CA-C 110.288 -0.697 . . . . 0.0 110.288 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.538 ' CG ' ' HG2' ' A' ' 14' ' ' PRO . 6.3 mtp180 -79.92 -42.91 23.12 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.526 ' HG ' ' CG2' ' A' ' 147' ' ' ILE . 0.4 OUTLIER -66.51 -30.07 70.32 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.575 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.58 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 52.0 t80 -63.83 -51.99 62.16 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.51 0.671 . . . . 0.0 109.851 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.468 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 22.9 mttt -55.94 -40.04 72.59 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.525 -0.734 . . . . 0.0 109.94 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.604 ' CB ' ' CE1' ' A' ' 158' ' ' TYR . . . -77.86 -26.8 49.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.263 -0.898 . . . . 0.0 110.946 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.572 ' CD1' HD11 ' A' ' 147' ' ' ILE . 3.4 t80 -81.8 -49.12 10.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.095 -1.003 . . . . 0.0 111.579 -178.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.561 HG11 ' CE1' ' A' ' 81' ' ' TYR . 5.5 t -102.03 -53.71 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.098 -1.001 . . . . 0.0 111.462 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.468 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 7.6 mp -66.0 -8.7 24.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.137 -0.977 . . . . 0.0 111.016 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.564 ' OD2' ' CE2' ' A' ' 158' ' ' TYR . 2.7 m-20 -145.0 21.79 1.58 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.963 -1.086 . . . . 0.0 110.524 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -59.73 -14.85 16.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.201 -0.937 . . . . 0.0 110.414 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -80.08 -25.03 40.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -0.914 . . . . 0.0 110.483 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.461 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 6.9 p30 -126.8 14.39 7.46 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.128 -0.982 . . . . 0.0 110.606 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.577 HD23 ' CE1' ' A' ' 150' ' ' TYR . 1.2 tm? -100.71 -43.09 6.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.239 -0.913 . . . . 0.0 109.858 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.606 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 4.8 t -77.41 -40.81 2.26 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.464 -0.772 . . . . 0.0 111.193 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 47.6 Cg_endo -77.6 10.65 2.45 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.444 1.234 . . . . 0.0 111.051 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 28' ' ' ASN . 16.6 mttm -122.27 -30.74 3.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.985 -1.072 . . . . 0.0 109.496 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.565 HD13 ' CD1' ' A' ' 150' ' ' TYR . 7.5 mt -80.13 -55.48 8.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.579 -0.701 . . . . 0.0 109.821 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.51 103.96 5.02 Favored Pre-proline 0 C--N 1.304 -1.409 0 O-C-N 121.404 -0.81 . . . . 0.0 110.238 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.33 0.34 7.54 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.015 1.534 . . . . 0.0 110.526 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -81.62 -20.59 39.42 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.116 -0.99 . . . . 0.0 109.475 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -91.5 -42.32 10.33 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.467 -0.771 . . . . 0.0 109.927 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.531 HG12 ' CG2' ' A' ' 56' ' ' ILE . 1.1 mp -137.7 140.1 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.43 -0.794 . . . . 0.0 109.944 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.3 ttmm -82.25 -36.37 27.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 110.208 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.544 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -176.44 154.98 1.36 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.262 -0.898 . . . . 0.0 110.192 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.5 m -124.2 116.8 23.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.287 -0.883 . . . . 0.0 109.975 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.538 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 35.8 tp10 -122.79 113.27 18.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.193 -0.942 . . . . 0.0 110.449 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.524 HG22 HD11 ' A' ' 43' ' ' ILE . 23.2 mt -60.67 133.94 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.322 -0.861 . . . . 0.0 109.98 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.516 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 26.7 mt -106.97 -23.5 12.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.247 -0.908 . . . . 0.0 110.517 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.568 ' CD1' HD13 ' A' ' 53' ' ' ILE . 1.6 m95 -130.94 161.25 32.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.127 -0.983 . . . . 0.0 110.559 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.466 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 41.98 -133.56 3.95 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -157.7 20.65 0.27 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -1.104 . . . . 0.0 110.059 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.46 ' O ' HG22 ' A' ' 71' ' ' ILE . . . 125.49 -19.92 6.61 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.47 ' O ' HG22 ' A' ' 71' ' ' ILE . . . -67.79 -175.21 8.48 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.465 ' HA ' HG23 ' A' ' 71' ' ' ILE . 47.1 Cg_endo -73.92 129.54 13.47 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 123.932 1.49 . . . . 0.0 110.66 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.94 -13.99 52.66 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.466 ' OG1' ' HA2' ' A' ' 46' ' ' GLY . 1.0 OUTLIER -68.0 166.38 15.95 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.516 -0.991 . . . . 0.0 109.907 179.751 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.568 HD13 ' CD1' ' A' ' 45' ' ' TRP . 40.7 mt -133.27 121.68 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.315 -0.865 . . . . 0.0 109.662 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.471 ' HG2' HG12 ' A' ' 43' ' ' ILE . 20.7 mttm -111.15 132.29 54.41 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.144 -0.973 . . . . 0.0 110.411 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.516 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 17.7 tttt -101.36 89.93 3.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 109.904 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.531 ' CG2' HG12 ' A' ' 38' ' ' ILE . 83.0 mt -79.98 144.4 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.296 -0.877 . . . . 0.0 110.168 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 4.8 p -117.31 159.11 23.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.295 -0.878 . . . . 0.0 110.603 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.513 ' N ' ' O ' ' A' ' 65' ' ' GLY . 22.5 m-85 -119.61 149.54 41.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.381 -0.824 . . . . 0.0 110.076 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.964 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.306 0.574 . . . . 0.0 110.342 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -134.1 91.61 0.25 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.538 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 15.2 p90 -129.92 166.7 19.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.137 -1.213 . . . . 0.0 110.276 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.525 HG13 ' CA ' ' A' ' 88' ' ' GLY . 6.4 m -142.92 172.27 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 110.696 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.523 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 23.3 mttm -125.19 124.48 41.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.621 -0.675 . . . . 0.0 109.543 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.53 ' CD2' HD11 ' A' ' 85' ' ' LEU . 11.3 m170 -113.41 126.1 54.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.143 -0.973 . . . . 0.0 111.157 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.478 ' HE3' ' CD1' ' A' ' 86' ' ' ILE . 48.3 mttt -97.82 117.15 31.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.373 -0.829 . . . . 0.0 109.509 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.522 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 22.4 mm -60.07 128.64 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.082 -1.011 . . . . 0.0 110.311 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 82' ' ' SER . 89.4 m-20 -102.5 -45.34 5.09 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.314 -0.867 . . . . 0.0 110.179 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 19.1 m -168.08 159.07 10.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.385 -0.822 . . . . 0.0 110.094 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.456 HG12 HG12 ' A' ' 23' ' ' VAL . 2.0 mt -141.26 158.79 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.292 -0.88 . . . . 0.0 110.118 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 79' ' ' TYR . 4.5 m-20 -135.37 80.02 1.81 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.502 -0.749 . . . . 0.0 110.116 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.58 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 17.8 mttt -62.39 -18.16 60.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.135 -0.978 . . . . 0.0 110.4 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -91.91 -31.79 15.53 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.133 -0.979 . . . . 0.0 109.633 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.489 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -103.58 -6.63 21.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.591 -0.693 . . . . 0.0 109.799 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.569 ' CZ ' ' HB3' ' A' ' 16' ' ' PRO . 4.1 m-85 65.91 51.8 1.32 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.494 -0.754 . . . . 0.0 110.056 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.531 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -123.38 157.9 32.33 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.081 -1.012 . . . . 0.0 109.595 179.812 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.688 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 32.3 t80 -144.56 141.01 29.16 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.196 -0.94 . . . . 0.0 110.259 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.6 OUTLIER -145.89 127.02 14.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.208 -0.932 . . . . 0.0 110.929 -179.799 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.688 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 20.0 p90 -146.6 170.67 16.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.436 -0.79 . . . . 0.0 109.796 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.457 ' OG1' ' OD2' ' A' ' 72' ' ' ASP . 35.2 m -124.44 135.43 53.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.159 -0.963 . . . . 0.0 110.427 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.558 ' HB3' ' CG2' ' A' ' 98' ' ' ILE . 6.3 tp -99.49 124.35 44.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.283 -0.886 . . . . 0.0 109.702 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.478 ' CD1' ' HE3' ' A' ' 70' ' ' LYS . 14.3 pt -106.41 -15.77 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.387 -0.821 . . . . 0.0 110.459 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.523 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 24.9 tt0 -121.3 176.11 5.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.147 -0.97 . . . . 0.0 110.339 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.525 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 137.09 123.58 2.24 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -57.78 -15.37 7.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -1.142 . . . . 0.0 110.205 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.504 ' HB3' ' NE2' ' A' ' 132' ' ' HIS . . . -73.92 -40.48 63.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -0.88 . . . . 0.0 110.167 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.562 ' CD2' ' CD2' ' A' ' 95' ' ' LEU . 10.1 mt -42.17 -48.05 4.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.406 -0.809 . . . . 0.0 110.119 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 43.23 -164.72 0.03 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -81.19 2.57 27.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -1.142 . . . . 0.0 110.172 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 52.2 p -92.62 -42.51 9.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.287 -0.883 . . . . 0.0 110.17 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.577 HD21 ' CD2' ' A' ' 120' ' ' TYR . 0.2 OUTLIER -119.55 159.91 23.43 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.367 -0.833 . . . . 0.0 109.339 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.458 ' HG2' ' N ' ' A' ' 97' ' ' LYS . 53.9 tt0 -136.32 -82.02 0.39 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.344 -0.848 . . . . 0.0 110.178 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 5.3 mttt -80.24 139.36 36.73 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.768 -0.583 . . . . 0.0 110.558 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.605 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 3.6 mm -123.06 139.97 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.963 -1.086 . . . . 0.0 109.887 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.479 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -117.48 126.77 53.19 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.279 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.605 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 8.7 m-85 -119.56 137.63 53.72 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.237 -0.914 . . . . 0.0 110.722 -178.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.453 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 80.9 tt0 -143.2 134.57 26.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.353 -0.842 . . . . 0.0 110.143 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.401 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 85.6 m -133.77 145.11 49.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -0.917 . . . . 0.0 110.18 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.6 mttt -140.53 140.72 35.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 0.0 110.671 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.517 ' CD2' HG12 ' A' ' 114' ' ' ILE . 10.1 mt -121.05 149.57 42.51 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.236 -0.915 . . . . 0.0 110.142 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.466 ' O ' ' HG3' ' A' ' 15' ' ' PRO . 1.9 t -146.05 -169.71 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.207 -0.933 . . . . 0.0 110.03 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -126.68 160.56 30.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.256 -0.902 . . . . 0.0 110.275 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.426 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.2 p -119.32 170.55 6.54 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.225 -0.922 . . . . 0.0 110.144 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.426 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 45.7 Cg_endo -72.8 -14.8 26.89 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 124.11 1.584 . . . . 0.0 110.575 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 24.8 p -94.7 7.15 46.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -0.903 . . . . 0.0 110.273 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 94.46 -31.16 6.99 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -58.26 -172.41 0.34 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.513 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 10.4 p -137.25 137.63 39.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.194 -1.18 . . . . 0.0 110.39 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.516 ' HA ' ' CG2' ' A' ' 10' ' ' THR . 16.2 mt -92.58 149.59 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.402 -0.811 . . . . 0.0 110.088 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.578 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 18.5 mt -131.23 128.63 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.22 -0.925 . . . . 0.0 110.228 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.1 tttp -118.11 108.73 15.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.084 -1.01 . . . . 0.0 110.209 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.434 ' OG ' ' CZ ' ' A' ' 9' ' ' PHE . 0.9 OUTLIER -103.25 157.33 17.08 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.238 -0.914 . . . . 0.0 110.441 -179.854 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 24.8 m -154.87 119.56 4.83 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.337 -0.852 . . . . 0.0 110.438 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 86.5 p -119.01 148.1 43.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.403 -0.811 . . . . 0.0 110.041 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.549 ' CE1' HG21 ' A' ' 4' ' ' THR . 24.6 m-70 -132.42 152.93 51.29 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.201 -0.937 . . . . 0.0 110.668 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.577 ' CD2' HD21 ' A' ' 95' ' ' LEU . 9.8 m-85 -121.82 119.92 33.05 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.271 -0.893 . . . . 0.0 110.614 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.585 ' CG ' HG22 ' A' ' 2' ' ' VAL . 80.4 m-70 -92.62 104.1 16.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.558 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.433 HG22 ' HA ' ' A' ' 127' ' ' GLU . 0.8 OUTLIER -77.96 144.75 36.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.141 -0.975 . . . . 0.0 110.374 -179.593 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.423 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 31.5 tttp -105.57 126.93 52.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.278 -0.889 . . . . 0.0 110.207 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.37 -138.92 21.14 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.415 ' C ' HG11 ' A' ' 126' ' ' VAL . 24.4 t30 -113.87 59.64 0.67 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -1.142 . . . . 0.0 110.274 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.415 HG11 ' C ' ' A' ' 125' ' ' ASN . 26.2 m -131.28 161.7 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.319 -0.863 . . . . 0.0 110.194 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.433 ' HA ' HG22 ' A' ' 122' ' ' THR . 85.3 mt-10 -137.6 139.7 40.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.266 -0.896 . . . . 0.0 110.25 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.529 ' CD1' ' HB3' ' A' ' 120' ' ' TYR . 2.7 mp -59.77 173.25 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.191 -0.943 . . . . 0.0 110.148 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.45 ' N ' ' CG2' ' A' ' 128' ' ' ILE . 21.4 mttm -92.45 127.41 37.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 110.089 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -45.39 -44.72 12.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.149 -0.969 . . . . 0.0 110.136 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 29.0 tp10 -53.29 -30.26 37.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.194 -0.941 . . . . 0.0 110.04 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.504 ' NE2' ' HB3' ' A' ' 90' ' ' ALA . 11.1 t-160 -76.35 -57.82 3.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -0.932 . . . . 0.0 110.239 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.556 HG12 ' CZ ' ' A' ' 5' ' ' TYR . 72.3 t -59.19 -34.22 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.377 -0.827 . . . . 0.0 110.063 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -72.41 -49.1 36.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.332 -0.855 . . . . 0.0 110.111 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.87 -29.66 69.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.095 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.72 -32.08 80.29 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 17.3 mttp -65.04 -36.84 85.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.251 -1.146 . . . . 0.0 110.036 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -75.35 -35.44 61.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.307 -0.87 . . . . 0.0 110.041 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -70.12 -30.84 68.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.363 -0.836 . . . . 0.0 109.92 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.482 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -74.61 -41.28 60.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.287 -0.883 . . . . 0.0 110.134 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 61.3 p -64.68 -39.36 93.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.371 -0.831 . . . . 0.0 109.991 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -60.87 -48.11 83.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 110.004 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 27.6 mt -57.87 -38.54 75.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.271 -0.893 . . . . 0.0 109.957 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.482 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 19.7 m-85 -62.87 -33.79 76.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.448 -0.783 . . . . 0.0 109.905 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.406 ' HA ' ' OE1' ' A' ' 148' ' ' GLU . 92.8 mttt -74.85 -15.03 60.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -0.904 . . . . 0.0 110.202 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.52 HD21 ' CG2' ' A' ' 33' ' ' ILE . 28.2 mt -85.25 -36.69 20.76 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.222 -0.923 . . . . 0.0 109.043 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.572 HD11 ' CD1' ' A' ' 22' ' ' PHE . 16.1 mt -72.09 -41.41 67.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.478 ' HB3' HD12 ' A' ' 13' ' ' ILE . 86.5 mt-10 -59.13 -42.81 91.5 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.431 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 15.5 m -74.12 -27.96 61.11 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.601 ' CE2' ' OH ' ' A' ' 158' ' ' TYR . 50.2 t80 -52.07 -61.85 2.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.563 -0.71 . . . . 0.0 109.836 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.49 HD11 ' CB ' ' A' ' 17' ' ' ARG . 36.0 mt -72.24 -30.08 64.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.346 -0.846 . . . . 0.0 109.71 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.469 ' HB2' HD13 ' A' ' 13' ' ' ILE . 27.8 tttp -65.27 -33.84 76.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.343 -0.848 . . . . 0.0 109.253 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.455 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -99.0 -30.74 6.56 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.59 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 5.4 m-70 -107.26 87.2 3.02 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.327 -1.101 . . . . 0.0 109.796 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 46.1 Cg_endo -72.08 2.62 4.71 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.068 1.562 . . . . 0.0 110.955 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -108.24 -12.61 15.05 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.96 -1.087 . . . . 0.0 110.197 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.593 ' O ' ' CD1' ' A' ' 158' ' ' TYR . . . -69.2 99.71 1.19 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.253 -0.905 . . . . 0.0 109.846 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.604 ' CE1' ' CB ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER 34.77 32.33 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 CA-C-O 121.518 0.675 . . . . 0.0 109.871 -179.21 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.533 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.446 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.826 -179.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 40.4 t -126.85 139.95 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -1.135 . . . . 0.0 110.239 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.633 ' CD1' ' CD1' ' A' ' 128' ' ' ILE . 16.2 m-85 -101.94 160.6 14.35 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.213 -0.93 . . . . 0.0 109.728 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.426 HG21 ' CE1' ' A' ' 119' ' ' HIS . 5.1 m -124.42 108.32 12.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.118 -0.989 . . . . 0.0 110.508 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.576 ' CE1' HG13 ' A' ' 133' ' ' VAL . 25.3 m-85 -120.47 126.18 49.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.26 -0.9 . . . . 0.0 109.969 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 25.8 pt-20 -139.37 159.66 41.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.924 . . . . 0.0 110.394 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.2 t -138.65 148.93 44.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.862 . . . . 0.0 110.012 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -131.81 123.28 27.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.195 -0.941 . . . . 0.0 110.257 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.638 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.0 p90 -145.94 -174.07 4.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.194 -0.941 . . . . 0.0 109.952 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.448 HG23 ' HA ' ' A' ' 113' ' ' ILE . 8.7 p -139.28 175.52 9.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.134 -0.979 . . . . 0.0 110.496 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.477 ' CB ' ' CD ' ' A' ' 148' ' ' GLU . 79.8 p -158.08 139.4 13.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.306 -0.871 . . . . 0.0 110.229 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -64.74 -28.71 69.77 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 0.0 109.888 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.548 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 8.3 mm -68.96 149.88 97.74 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.365 -0.835 . . . . 0.0 109.904 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.548 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 40.5 Cg_endo -65.6 146.47 84.57 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.971 1.511 . . . . 0.0 110.44 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.638 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.1 Cg_endo -71.51 -31.73 13.26 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.969 1.51 . . . . 0.0 112.828 -179.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 40.8 Cg_endo -69.41 -21.38 35.2 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 N-CA-C 110.059 -0.785 . . . . 0.0 110.059 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.565 ' NE ' ' CB ' ' A' ' 159' ' ' ASN . 52.7 mtp180 -85.68 -44.87 12.2 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.534 ' HG ' ' CG2' ' A' ' 147' ' ' ILE . 1.1 tt -71.34 -30.07 65.74 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.61 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 71.4 t80 -66.88 -61.76 1.78 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.521 -0.737 . . . . 0.0 109.13 178.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.516 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 52.6 mttt -52.78 -34.33 52.84 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.338 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.598 ' HB3' ' CZ ' ' A' ' 158' ' ' TYR . . . -72.21 -53.75 11.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.33 -0.856 . . . . 0.0 110.749 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.583 ' CD1' HD12 ' A' ' 147' ' ' ILE . 0.3 OUTLIER -59.86 -53.2 60.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.507 -0.745 . . . . 0.0 111.425 -178.897 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.599 HG12 ' CD1' ' A' ' 81' ' ' TYR . 11.1 t -91.26 -63.86 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.992 -1.068 . . . . 0.0 111.767 -178.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.516 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 4.7 mp -65.12 -3.57 3.9 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.22 -0.925 . . . . 0.0 111.793 -178.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.52 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.8 OUTLIER -140.46 9.54 2.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.658 -1.276 . . . . 0.0 110.788 179.882 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -51.57 -26.83 9.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.176 -0.953 . . . . 0.0 110.31 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -76.63 -13.95 60.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.947 . . . . 0.0 110.502 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.438 ' O ' ' HD2' ' A' ' 32' ' ' LYS . 72.0 m-80 -134.97 10.64 3.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.211 -0.93 . . . . 0.0 110.345 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.2 OUTLIER -104.24 -40.97 5.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.185 -0.947 . . . . 0.0 110.38 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.592 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 2.8 t -81.08 -41.55 1.13 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.28 -0.888 . . . . 0.0 111.178 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.3 Cg_endo -77.17 11.17 2.14 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.387 1.204 . . . . 0.0 111.074 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.438 ' HD2' ' O ' ' A' ' 28' ' ' ASN . 17.1 mttm -123.25 -31.51 3.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.943 -1.098 . . . . 0.0 109.471 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.479 ' CG2' ' CD2' ' A' ' 146' ' ' LEU . 9.3 mt -80.12 -44.96 22.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.52 -0.737 . . . . 0.0 109.611 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -141.07 99.11 6.66 Favored Pre-proline 0 C--N 1.304 -1.39 0 O-C-N 121.371 -0.831 . . . . 0.0 110.115 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.12 -2.82 11.71 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.951 1.501 . . . . 0.0 110.524 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -89.02 -23.15 22.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 109.949 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 58' ' ' PHE . . . -85.54 -70.39 0.59 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.323 -0.86 . . . . 0.0 110.06 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.52 ' CD1' HG13 ' A' ' 30' ' ' VAL . 1.8 mp -101.11 122.08 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.449 -0.782 . . . . 0.0 110.01 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.476 ' N ' ' O ' ' A' ' 57' ' ' THR . 10.7 ttmt -75.2 -32.11 61.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.154 -0.966 . . . . 0.0 110.487 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.53 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -176.25 148.41 0.78 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.162 -0.961 . . . . 0.0 110.171 -179.882 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.3 m -122.31 118.43 28.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.35 -0.844 . . . . 0.0 109.718 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.501 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 42.4 tt0 -129.18 110.37 11.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.149 -0.969 . . . . 0.0 110.422 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.416 HD11 HG22 ' A' ' 43' ' ' ILE . 38.3 mt -53.06 144.91 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.372 -0.83 . . . . 0.0 110.046 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.0 tp -119.72 -25.13 5.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.237 -0.914 . . . . 0.0 110.544 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.491 ' HB2' ' N ' ' A' ' 53' ' ' ILE . 1.7 m95 -127.81 162.97 25.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.113 -0.992 . . . . 0.0 110.646 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.46 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 42.56 -140.3 2.21 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -149.2 24.79 0.91 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.285 -1.126 . . . . 0.0 110.017 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 118.4 -12.19 12.51 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.517 ' O ' ' CG2' ' A' ' 71' ' ' ILE . . . -81.97 -168.95 42.27 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.493 ' HA ' HG23 ' A' ' 71' ' ' ILE . 44.2 Cg_endo -72.54 128.28 13.37 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.042 1.548 . . . . 0.0 110.694 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.88 -12.45 49.66 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.1 m -72.85 162.28 29.68 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.616 -0.931 . . . . 0.0 109.47 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.491 ' N ' ' HB2' ' A' ' 45' ' ' TRP . 66.1 mt -133.84 119.4 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.235 -0.916 . . . . 0.0 110.103 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.505 ' HE3' ' CD1' ' A' ' 71' ' ' ILE . 52.5 mttt -102.59 130.72 49.55 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.2 -0.938 . . . . 0.0 110.179 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 53.6 tttm -102.24 92.42 4.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.242 -0.911 . . . . 0.0 110.164 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.407 ' HB ' HG22 ' A' ' 67' ' ' VAL . 97.5 mt -80.45 140.61 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.142 -0.974 . . . . 0.0 110.394 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 1.4 p -110.16 150.94 27.91 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.351 -0.843 . . . . 0.0 110.267 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.571 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 24.7 m-85 -113.83 149.08 35.53 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.221 -0.924 . . . . 0.0 110.077 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.859 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.213 0.53 . . . . 0.0 110.228 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.571 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -130.26 88.69 0.3 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 13.7 p90 -133.77 166.68 22.07 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.192 -1.181 . . . . 0.0 110.292 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.5 HG13 ' CA ' ' A' ' 88' ' ' GLY . 4.4 m -133.93 175.74 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.384 -0.823 . . . . 0.0 110.253 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.516 ' CE ' ' OE1' ' A' ' 87' ' ' GLU . 33.3 mttt -135.52 103.96 5.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.426 -0.797 . . . . 0.0 109.834 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.485 ' CD2' HD11 ' A' ' 85' ' ' LEU . 15.4 m170 -94.19 129.18 40.9 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.292 -0.88 . . . . 0.0 111.073 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 52' ' ' THR . 70.0 tttt -97.21 111.55 23.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.458 -0.776 . . . . 0.0 109.18 178.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.53 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 27.3 mm -52.91 125.61 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.093 -1.005 . . . . 0.0 110.354 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.473 ' OD2' ' OG1' ' A' ' 84' ' ' THR . 95.0 m-20 -99.37 -48.6 4.74 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.374 -0.829 . . . . 0.0 109.666 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 1.4 m 177.8 160.68 0.51 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.544 -0.722 . . . . 0.0 110.054 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.549 ' CD1' HG12 ' A' ' 23' ' ' VAL . 3.2 tt -145.31 165.92 10.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.392 -0.817 . . . . 0.0 109.785 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.8 m-20 -128.95 76.89 1.75 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.099 -1.0 . . . . 0.0 110.132 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.61 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 65.3 mttm -55.43 -16.66 3.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.16 -0.962 . . . . 0.0 110.367 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -92.8 -30.67 15.35 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.348 -0.845 . . . . 0.0 109.705 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.518 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.2 m-80 -106.61 -0.13 24.01 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.561 -0.712 . . . . 0.0 109.475 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.597 ' CE1' ' HB3' ' A' ' 16' ' ' PRO . 72.8 m-85 62.06 52.84 3.15 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.297 0.57 . . . . 0.0 110.863 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.441 ' HB3' ' HG3' ' A' ' 103' ' ' LYS . 0.7 OUTLIER -130.56 152.01 50.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 109.84 179.305 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.668 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 74.5 t80 -149.46 133.86 17.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.022 -1.049 . . . . 0.0 110.368 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 36.1 m -139.66 147.08 40.52 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.176 -0.952 . . . . 0.0 110.525 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.668 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 7.8 p90 -148.47 177.88 9.08 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.346 -0.846 . . . . 0.0 110.666 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.473 ' OG1' ' OD2' ' A' ' 72' ' ' ASP . 15.6 m -127.88 123.32 34.76 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.441 -0.787 . . . . 0.0 109.924 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.512 ' CD1' ' O ' ' A' ' 68' ' ' LYS . 12.2 tp -94.34 134.0 37.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.021 -1.05 . . . . 0.0 110.292 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.491 HG22 HD11 ' A' ' 86' ' ' ILE . 13.6 pt -114.89 -33.32 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 110.334 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.516 ' OE1' ' CE ' ' A' ' 68' ' ' LYS . 29.3 tt0 -114.11 134.07 55.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 110.38 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.5 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . -176.92 122.38 0.84 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -55.77 -17.07 5.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.16 -1.2 . . . . 0.0 110.235 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -91.35 -34.15 15.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.934 . . . . 0.0 110.469 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.474 ' O ' ' O ' ' A' ' 95' ' ' LEU . 1.9 pp -84.9 -16.97 39.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.256 -0.903 . . . . 0.0 110.404 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.87 -23.8 75.62 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -49.45 -65.56 0.55 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.288 -1.125 . . . . 0.0 110.358 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 80.5 p -137.28 8.4 2.91 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.463 -0.773 . . . . 0.0 110.175 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.527 HD12 ' CD2' ' A' ' 120' ' ' TYR . 11.4 mt -119.41 177.73 4.81 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.3 -0.875 . . . . 0.0 110.051 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.427 ' HG2' ' N ' ' A' ' 97' ' ' LYS . 39.4 tt0 -146.29 -78.73 0.17 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.332 -0.855 . . . . 0.0 109.772 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.489 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 16.1 mttm -80.16 142.57 34.63 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.87 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.644 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 5.2 mm -135.39 140.97 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.924 -1.11 . . . . 0.0 110.548 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.422 ' OG ' ' HD2' ' A' ' 119' ' ' HIS . 0.1 OUTLIER -118.55 137.15 53.42 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.59 -0.694 . . . . 0.0 109.235 178.434 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.644 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 8.4 m-85 -131.99 131.52 42.62 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.124 -0.985 . . . . 0.0 110.872 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.45 ' HG2' ' OG ' ' A' ' 82' ' ' SER . 7.1 mt-10 -129.52 133.47 47.26 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.409 -0.807 . . . . 0.0 109.91 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.51 ' N ' ' O ' ' A' ' 81' ' ' TYR . 43.4 m -127.41 144.9 50.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.925 . . . . 0.0 110.023 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.441 ' HG3' ' HB3' ' A' ' 80' ' ' SER . 2.2 mttt -141.94 136.49 30.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.944 . . . . 0.0 110.256 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.553 ' HB2' ' HB3' ' A' ' 79' ' ' TYR . 3.7 mt -120.91 151.01 40.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 110.102 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.495 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -151.62 -169.14 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.306 -0.872 . . . . 0.0 110.063 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -119.39 138.6 52.98 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.308 -0.87 . . . . 0.0 110.115 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.458 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 28.8 p -94.67 164.9 18.46 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.177 -0.952 . . . . 0.0 110.245 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.5 Cg_endo -72.5 -2.68 12.15 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.057 1.556 . . . . 0.0 110.59 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 81.8 p -102.14 0.86 35.4 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.225 -0.922 . . . . 0.0 110.263 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.73 -31.83 8.25 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -67.87 -173.98 7.59 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.483 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.1 p -126.29 131.42 51.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.235 -1.156 . . . . 0.0 110.237 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.448 ' HA ' HG23 ' A' ' 10' ' ' THR . 11.1 mt -82.3 150.26 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.415 -0.803 . . . . 0.0 110.196 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.591 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 15.4 mt -130.34 110.43 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 110.4 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.42 ' O ' ' N ' ' A' ' 103' ' ' LYS . 51.6 tttt -99.34 128.34 45.45 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.201 -0.937 . . . . 0.0 109.923 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 0.7 OUTLIER -123.02 153.39 39.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.182 -0.949 . . . . 0.0 110.537 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 28.7 m -159.99 127.71 4.67 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.396 -0.815 . . . . 0.0 110.286 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.471 ' CB ' ' CD1' ' A' ' 100' ' ' TYR . 24.6 p -132.13 160.16 36.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.242 -0.911 . . . . 0.0 110.225 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.426 ' CE1' HG21 ' A' ' 4' ' ' THR . 94.9 m-70 -132.3 135.76 46.44 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.11 -0.994 . . . . 0.0 110.625 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.527 ' CD2' HD12 ' A' ' 95' ' ' LEU . 4.4 m-30 -97.66 146.84 24.93 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.293 -0.879 . . . . 0.0 110.108 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.489 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 94.0 m-70 -126.73 92.11 3.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.074 -1.016 . . . . 0.0 109.86 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.485 HG21 ' CD2' ' A' ' 95' ' ' LEU . 1.8 p -66.62 164.38 16.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.449 -0.782 . . . . 0.0 110.311 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.419 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 34.4 tptt -147.48 114.81 6.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.368 -0.832 . . . . 0.0 110.257 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 125' ' ' ASN . . . 111.26 25.61 4.94 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 2.9 t30 65.1 62.45 0.71 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.198 -1.178 . . . . 0.0 110.179 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.454 ' O ' HG22 ' A' ' 122' ' ' THR . 20.2 m -140.35 143.44 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.244 -0.91 . . . . 0.0 110.316 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.469 ' N ' ' OE1' ' A' ' 127' ' ' GLU . 47.0 mp0 -114.03 165.99 12.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 110.257 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.633 ' CD1' ' CD1' ' A' ' 3' ' ' PHE . 3.1 mt -89.42 173.15 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.259 -0.901 . . . . 0.0 110.134 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.467 ' N ' ' CG2' ' A' ' 128' ' ' ILE . 8.1 mttm -111.55 152.66 27.28 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.361 -0.837 . . . . 0.0 110.009 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -58.57 -34.98 71.67 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.222 -0.924 . . . . 0.0 109.979 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.507 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 46.5 tt0 -62.57 -33.09 74.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.279 -0.888 . . . . 0.0 109.91 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 18.3 t-160 -76.45 -52.31 10.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -0.883 . . . . 0.0 110.104 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.576 HG13 ' CE1' ' A' ' 5' ' ' TYR . 57.8 t -62.28 -41.07 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.394 -0.816 . . . . 0.0 109.889 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -71.97 -47.26 53.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.268 -0.895 . . . . 0.0 109.854 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.507 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -61.57 -33.87 74.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.262 -0.899 . . . . 0.0 109.902 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.13 -29.7 66.29 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 37.1 mttm -74.15 -33.0 63.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.205 -1.174 . . . . 0.0 109.921 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -79.25 -35.73 41.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.354 -0.841 . . . . 0.0 109.933 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -70.2 -33.2 71.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.352 -0.842 . . . . 0.0 109.779 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.426 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -76.49 -41.04 48.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.348 -0.845 . . . . 0.0 109.957 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 35.3 t -59.87 -43.81 94.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.385 -0.822 . . . . 0.0 109.848 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -59.28 -42.41 91.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.299 -0.875 . . . . 0.0 109.881 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.465 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 18.7 mt -61.75 -36.36 80.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 109.946 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.464 ' HA ' HD11 ' A' ' 147' ' ' ILE . 30.1 m-85 -64.41 -37.12 86.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.348 -0.845 . . . . 0.0 109.568 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 25.9 mttm -70.28 -12.9 61.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.418 -0.801 . . . . 0.0 109.977 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.479 ' CD2' ' CG2' ' A' ' 33' ' ' ILE . 9.2 mt -81.57 -36.43 29.06 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.138 -0.976 . . . . 0.0 108.855 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.583 HD12 ' CD1' ' A' ' 22' ' ' PHE . 8.2 mt -68.39 -49.41 66.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.477 ' CD ' ' CB ' ' A' ' 11' ' ' SER . 69.9 mt-10 -52.62 -42.54 64.7 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.566 -0.709 . . . . 0.0 109.675 179.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.428 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 54.1 m -70.81 -34.66 71.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.065 -1.022 . . . . 0.0 109.526 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.598 ' CD2' ' OH ' ' A' ' 158' ' ' TYR . 51.9 t80 -51.24 -60.85 2.66 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.519 -0.738 . . . . 0.0 109.924 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.556 HD22 ' CE1' ' A' ' 158' ' ' TYR . 38.1 mt -73.07 -27.9 62.0 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.393 -0.817 . . . . 0.0 109.995 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.473 ' HA ' HD13 ' A' ' 13' ' ' ILE . 60.1 tttm -57.2 -19.96 23.97 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.201 -0.937 . . . . 0.0 108.486 178.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -128.08 -4.09 5.62 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.572 ' CG ' ' O ' ' A' ' 150' ' ' TYR . 63.6 m170 -113.39 86.52 10.08 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.171 -1.193 . . . . 0.0 110.235 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -73.59 2.21 6.05 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.038 1.546 . . . . 0.0 110.859 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -124.04 4.38 8.64 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.122 -0.987 . . . . 0.0 110.005 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 158' ' ' TYR . . . -69.13 108.81 3.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.296 -0.877 . . . . 0.0 110.053 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.598 ' OH ' ' CD2' ' A' ' 150' ' ' TYR . 0.3 OUTLIER 35.3 35.14 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.633 -0.667 . . . . 0.0 110.952 -179.363 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.565 ' CB ' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.417 0 CA-C-O 117.953 -1.023 . . . . 0.0 109.824 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.594 HG22 ' CG ' ' A' ' 121' ' ' HIS . 5.0 p -85.79 153.68 3.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 121.27 -1.135 . . . . 0.0 110.064 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.545 ' N ' HG21 ' A' ' 2' ' ' VAL . 16.2 m-85 -89.92 167.36 12.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.309 -0.87 . . . . 0.0 110.433 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 55.1 m -145.67 102.26 3.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.302 -0.874 . . . . 0.0 110.221 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.63 ' CZ ' ' CG2' ' A' ' 133' ' ' VAL . 84.8 m-85 -116.09 151.76 34.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.316 -0.865 . . . . 0.0 109.936 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 19.6 pt-20 -143.01 151.63 41.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.142 -0.974 . . . . 0.0 110.366 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.4 t -128.6 151.77 49.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.41 -0.806 . . . . 0.0 109.839 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.456 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 92.8 mt-10 -134.3 116.05 14.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.947 . . . . 0.0 110.488 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.2 p90 -142.66 -175.12 4.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -0.852 . . . . 0.0 109.778 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.47 HG23 HG12 ' A' ' 113' ' ' ILE . 6.6 p -137.75 173.35 11.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.144 -0.973 . . . . 0.0 110.634 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.459 ' OG ' ' OG ' ' A' ' 112' ' ' SER . 84.0 p -149.56 144.22 26.09 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.397 -0.815 . . . . 0.0 110.23 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -72.57 -32.37 65.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.226 -0.921 . . . . 0.0 109.958 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.555 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 6.5 mm -72.51 151.35 91.66 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.517 -0.739 . . . . 0.0 109.653 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.555 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 39.1 Cg_endo -64.61 140.58 69.16 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.889 1.468 . . . . 0.0 110.692 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.625 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 41.9 Cg_endo -73.08 -30.49 10.69 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 124.145 1.603 . . . . 0.0 112.871 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.3 Cg_endo -69.84 -23.57 30.31 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 O-C-N 122.448 0.71 . . . . 0.0 110.357 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.509 ' NH2' ' O ' ' A' ' 158' ' ' TYR . 1.6 mmp_? -83.42 -46.8 12.11 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.505 ' C ' ' CD2' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -65.54 -31.05 71.9 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.601 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.487 ' HB2' ' O ' ' A' ' 15' ' ' PRO . 59.4 t80 -64.66 -54.49 30.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.56 -0.712 . . . . 0.0 109.26 178.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 25' ' ' ASP . 25.2 mttt -47.99 -42.84 28.91 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.796 -0.761 . . . . 0.0 109.459 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.601 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -73.07 -35.61 66.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.469 -0.77 . . . . 0.0 110.927 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.582 ' CD1' HD12 ' A' ' 147' ' ' ILE . 0.2 OUTLIER -74.57 -42.85 58.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 111.42 -178.659 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.526 HG12 ' CD1' ' A' ' 81' ' ' TYR . 5.7 t -107.5 -50.36 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.956 -1.09 . . . . 0.0 111.74 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.553 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 7.3 mp -79.44 -5.64 55.14 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.077 -1.014 . . . . 0.0 111.483 -178.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.528 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 1.1 m-20 -151.2 30.36 0.62 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.796 -1.19 . . . . 0.0 110.651 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.517 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -72.87 -21.23 60.96 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.243 -0.91 . . . . 0.0 110.615 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.458 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 39.2 t0 -66.63 -24.14 66.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.014 -1.054 . . . . 0.0 110.201 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.478 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 4.4 p30 -124.55 12.81 8.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.33 -0.856 . . . . 0.0 110.078 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.515 HD11 ' CD1' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -94.08 -48.45 6.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.364 -0.835 . . . . 0.0 110.221 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.663 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 3.7 p -76.89 -28.37 0.66 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.305 -0.872 . . . . 0.0 112.231 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.663 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 52.5 Cg_endo -79.23 5.31 5.87 Favored 'Trans proline' 0 C--N 1.319 -1.026 0 O-C-N 122.672 0.827 . . . . 0.0 110.272 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -128.78 -37.38 1.75 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 109.346 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.536 HG12 ' CD1' ' A' ' 150' ' ' TYR . 11.3 mt -79.97 -25.9 11.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-O 121.646 0.736 . . . . 0.0 109.151 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -157.22 77.32 3.93 Favored Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 121.628 -0.67 . . . . 0.0 109.841 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.29 -5.49 16.65 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.984 1.518 . . . . 0.0 110.565 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -87.65 -15.74 36.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.0 109.8 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -93.71 -69.27 0.76 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.38 -0.825 . . . . 0.0 110.151 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.503 HG12 ' CG2' ' A' ' 56' ' ' ILE . 1.7 mp -99.86 126.96 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.315 -0.866 . . . . 0.0 110.086 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.512 ' HB2' ' N ' ' A' ' 59' ' ' GLY . 27.7 ttpt -76.3 -25.41 54.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.357 -0.839 . . . . 0.0 110.639 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.545 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER 179.75 164.67 1.1 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.065 -1.022 . . . . 0.0 110.497 -179.75 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.454 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 18.5 m -137.53 128.6 27.57 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.466 -0.771 . . . . 0.0 109.81 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.525 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 48.5 tt0 -135.54 111.55 9.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.149 -0.969 . . . . 0.0 110.596 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.445 HG12 ' HG2' ' A' ' 54' ' ' LYS . 21.2 mt -59.54 140.26 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 109.859 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.522 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 39.0 mt -115.68 -27.91 6.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.145 -0.972 . . . . 0.0 110.268 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.57 ' CD1' HD11 ' A' ' 53' ' ' ILE . 1.4 m95 -123.58 157.95 32.54 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.246 -0.908 . . . . 0.0 110.418 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.427 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 43.53 -134.08 5.56 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.58 20.67 0.4 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.302 -1.117 . . . . 0.0 109.995 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.434 ' O ' HG22 ' A' ' 71' ' ' ILE . . . 125.56 -20.31 6.53 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.024 -1.631 . . . . 0.0 109.024 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.465 ' O ' ' HB ' ' A' ' 71' ' ' ILE . . . -69.98 -172.47 10.27 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.474 ' HA ' HG23 ' A' ' 71' ' ' ILE . 45.5 Cg_endo -73.47 129.61 13.99 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.991 1.522 . . . . 0.0 110.653 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.79 -11.4 53.08 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.654 -1.778 . . . . 0.0 108.654 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.433 ' HB ' ' O ' ' A' ' 49' ' ' GLY . 1.0 OUTLIER -72.73 164.83 25.93 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.519 -0.989 . . . . 0.0 109.958 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.57 HD11 ' CD1' ' A' ' 45' ' ' TRP . 59.3 mt -135.49 120.09 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.4 -0.812 . . . . 0.0 109.698 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.445 ' HG2' HG12 ' A' ' 43' ' ' ILE . 93.8 mttt -108.49 134.85 50.7 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.195 -0.941 . . . . 0.0 110.624 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.522 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 32.9 tttt -101.53 92.68 5.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.262 -0.899 . . . . 0.0 110.084 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.503 ' CG2' HG12 ' A' ' 38' ' ' ILE . 84.2 mt -79.92 141.26 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.179 -0.951 . . . . 0.0 110.197 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.493 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 2.1 p -115.12 158.77 21.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 110.412 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 28.6 m-85 -119.31 135.94 54.48 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.368 -0.832 . . . . 0.0 110.12 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.512 ' N ' ' HB2' ' A' ' 39' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.22 0.533 . . . . 0.0 110.402 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.545 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -136.36 94.71 0.23 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.533 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 17.2 p90 -139.43 168.8 19.01 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.163 -1.199 . . . . 0.0 110.336 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.53 HG13 ' CA ' ' A' ' 88' ' ' GLY . 6.2 m -139.38 173.29 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.375 -0.828 . . . . 0.0 110.507 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.516 ' CE ' ' OE1' ' A' ' 87' ' ' GLU . 22.1 mttm -124.01 126.28 46.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.554 -0.716 . . . . 0.0 109.629 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.645 ' CD2' ' CD1' ' A' ' 85' ' ' LEU . 16.4 m170 -110.56 134.39 52.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.167 -0.958 . . . . 0.0 110.788 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 52' ' ' THR . 29.6 ttpt -108.2 115.72 30.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.288 -0.883 . . . . 0.0 109.436 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.528 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 28.6 mm -62.95 120.67 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.3 -0.875 . . . . 0.0 110.561 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 82' ' ' SER . 83.8 m-20 -93.7 -42.58 9.08 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.521 -0.737 . . . . 0.0 109.717 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.466 ' OG ' ' HB2' ' A' ' 82' ' ' SER . 90.6 p -169.66 159.25 8.12 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.436 -0.79 . . . . 0.0 109.744 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.457 HG12 HG12 ' A' ' 23' ' ' VAL . 1.9 mt -142.34 156.36 19.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.213 -0.93 . . . . 0.0 110.354 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.535 ' O ' ' N ' ' A' ' 79' ' ' TYR . 5.1 m-20 -134.59 79.11 1.78 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.623 -0.673 . . . . 0.0 110.143 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.462 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 67.5 mttm -62.83 -14.33 44.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.128 -0.982 . . . . 0.0 110.224 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -94.24 -32.29 13.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.241 -0.912 . . . . 0.0 109.592 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.495 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -104.75 -6.85 19.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.517 -0.739 . . . . 0.0 109.665 179.771 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.557 ' CZ ' ' HB3' ' A' ' 16' ' ' PRO . 4.1 m-85 67.21 50.62 0.98 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.571 -0.706 . . . . 0.0 110.224 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.528 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -121.11 151.53 39.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -0.922 . . . . 0.0 109.304 179.441 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.582 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 22.5 t80 -139.91 136.7 34.15 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.207 -0.933 . . . . 0.0 110.191 -178.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 4.8 m -139.45 121.55 15.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.93 . . . . 0.0 110.942 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.582 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 8.6 p90 -141.15 175.44 9.64 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.342 -0.849 . . . . 0.0 109.737 179.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.46 ' OG1' ' OD2' ' A' ' 72' ' ' ASP . 82.1 m -131.77 143.11 49.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.912 . . . . 0.0 110.23 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.645 ' CD1' ' CD2' ' A' ' 69' ' ' HIS . 19.1 tp -96.67 121.01 38.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 110.126 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.402 HG23 HD11 ' A' ' 86' ' ' ILE . 20.3 pt -105.86 -17.95 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.392 -0.818 . . . . 0.0 109.982 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.516 ' OE1' ' CE ' ' A' ' 68' ' ' LYS . 83.1 tt0 -138.18 151.49 47.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -0.889 . . . . 0.0 110.374 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.53 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 164.94 133.5 1.51 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -64.18 -15.3 59.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.297 -1.119 . . . . 0.0 110.245 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.13 -18.59 45.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.302 -0.874 . . . . 0.0 110.207 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.582 ' CD2' ' CD1' ' A' ' 98' ' ' ILE . 16.4 mt -63.82 -19.8 65.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.225 -0.922 . . . . 0.0 110.073 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 46.29 -173.29 0.02 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.418 ' OD1' HG22 ' A' ' 94' ' ' THR . 59.5 p30 -87.93 12.36 13.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.133 -1.216 . . . . 0.0 109.823 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.528 ' HB ' ' CG2' ' A' ' 126' ' ' VAL . 23.2 p -107.07 -29.88 9.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.366 -0.834 . . . . 0.0 110.173 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.521 HD23 ' CD1' ' A' ' 128' ' ' ILE . 67.5 mt -107.95 161.29 15.07 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.269 -0.894 . . . . 0.0 110.405 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -142.28 -82.96 0.19 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.335 -0.853 . . . . 0.0 109.994 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.497 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 62.2 mttt -80.37 140.26 36.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.687 -0.633 . . . . 0.0 110.763 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.582 ' CD1' ' CD2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -135.0 135.55 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.967 -1.083 . . . . 0.0 109.602 178.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.478 ' HB2' ' CD2' ' A' ' 119' ' ' HIS . 0.5 OUTLIER -108.96 133.36 53.06 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.315 -0.866 . . . . 0.0 109.956 179.626 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 5.6 m-85 -122.78 132.3 54.16 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.312 -0.867 . . . . 0.0 110.252 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 117' ' ' THR . 2.9 mt-10 -134.65 130.43 36.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 0.0 110.242 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.454 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 26.0 m -129.41 135.94 49.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.222 -0.924 . . . . 0.0 109.858 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.4 mttm -134.18 135.78 43.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.156 -0.965 . . . . 0.0 110.599 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.527 ' CD2' HG12 ' A' ' 114' ' ' ILE . 7.1 mt -115.72 151.16 35.63 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.29 -0.882 . . . . 0.0 109.932 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.464 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 2.0 t -148.04 -169.04 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.133 -0.98 . . . . 0.0 110.0 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -124.37 154.09 40.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.288 -0.882 . . . . 0.0 110.137 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.454 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 5.1 p -113.7 168.1 8.39 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.896 . . . . 0.0 110.195 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.454 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 48.1 Cg_endo -72.92 -4.24 15.04 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.021 1.537 . . . . 0.0 110.474 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 34.3 p -104.89 8.71 34.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.284 -0.885 . . . . 0.0 110.279 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 94.5 -34.43 4.74 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -59.09 -171.78 0.4 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.508 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 3.1 p -134.82 136.05 42.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -1.167 . . . . 0.0 110.359 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.47 HG12 HG23 ' A' ' 10' ' ' THR . 22.4 mt -88.89 148.82 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.325 -0.859 . . . . 0.0 110.078 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.572 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 18.2 mt -132.3 124.51 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.205 -0.934 . . . . 0.0 110.46 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.456 ' HG3' ' HG2' ' A' ' 8' ' ' GLU . 75.3 tttt -113.59 109.82 19.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.2 -0.938 . . . . 0.0 110.014 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.447 ' OG ' ' CZ ' ' A' ' 9' ' ' PHE . 1.2 m -101.01 159.35 15.29 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.251 -0.906 . . . . 0.0 110.643 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.489 HG21 ' NE2' ' A' ' 119' ' ' HIS . 60.8 m -154.16 133.61 12.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.327 -0.858 . . . . 0.0 110.045 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.8 m -136.25 144.53 44.87 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.13 -0.981 . . . . 0.0 110.478 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.489 ' NE2' HG21 ' A' ' 117' ' ' THR . 20.8 m-70 -132.05 146.74 52.26 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.295 -0.878 . . . . 0.0 110.325 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.551 ' CD2' HG13 ' A' ' 128' ' ' ILE . 40.2 m-85 -121.59 120.53 35.06 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.18 -0.95 . . . . 0.0 110.542 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.594 ' CG ' HG22 ' A' ' 2' ' ' VAL . 87.2 m-70 -92.85 103.72 16.03 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.4 -0.812 . . . . 0.0 109.368 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.507 ' OG1' ' CG2' ' A' ' 126' ' ' VAL . 1.6 t -88.39 173.71 8.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.014 -1.054 . . . . 0.0 110.856 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 40.0 tttm -141.8 117.1 10.12 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 120.284 -0.567 . . . . 0.0 110.221 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 113.2 -123.98 6.4 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -133.25 62.03 1.66 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.313 -1.11 . . . . 0.0 110.204 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.528 ' CG2' ' HB ' ' A' ' 94' ' ' THR . 34.8 m -137.54 153.46 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.22 -0.925 . . . . 0.0 110.203 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.448 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 90.4 mt-10 -127.05 169.57 13.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.188 -0.945 . . . . 0.0 110.29 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.551 HG13 ' CD2' ' A' ' 120' ' ' TYR . 15.8 mm -67.77 173.09 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.884 . . . . 0.0 110.244 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.445 ' N ' ' CG2' ' A' ' 128' ' ' ILE . 17.5 mttp -99.08 149.53 22.94 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.265 -0.897 . . . . 0.0 110.041 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.12 -20.09 16.02 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.091 -1.006 . . . . 0.0 109.841 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.514 ' O ' ' N ' ' A' ' 135' ' ' ALA . 94.3 mt-10 -71.63 -39.91 70.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.369 -0.832 . . . . 0.0 109.904 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.464 ' HB2' ' CG2' ' A' ' 128' ' ' ILE . 6.3 m170 -65.18 -45.72 83.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.297 -0.877 . . . . 0.0 109.949 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.63 ' CG2' ' CZ ' ' A' ' 5' ' ' TYR . 58.3 t -64.95 -42.79 95.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.506 -0.746 . . . . 0.0 110.264 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 33.1 tttm -102.87 -63.57 1.15 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.283 -0.886 . . . . 0.0 110.31 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 131' ' ' GLU . . . -56.78 -19.54 17.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.122 -0.986 . . . . 0.0 110.025 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 131' ' ' GLU . . . -76.91 -31.16 54.39 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.221 -1.551 . . . . 0.0 109.221 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.491 ' CE ' ' O ' ' A' ' 133' ' ' VAL . 27.4 mttt -72.85 -30.07 63.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.324 -1.103 . . . . 0.0 110.18 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -82.91 -32.23 27.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.315 -0.866 . . . . 0.0 110.044 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 50.5 mttt -70.45 -38.46 74.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.391 -0.818 . . . . 0.0 110.028 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.402 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -78.74 -30.83 46.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.321 -0.862 . . . . 0.0 109.88 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 137' ' ' LYS . 47.1 m -66.67 -45.29 79.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.35 -0.844 . . . . 0.0 110.011 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -50.99 -51.2 55.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.303 -0.873 . . . . 0.0 109.947 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.469 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 10.6 tp -55.47 -49.31 72.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.258 -0.901 . . . . 0.0 109.742 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.402 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 17.7 m-85 -53.62 -38.84 64.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.44 -0.788 . . . . 0.0 109.746 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -73.38 -16.72 61.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.273 -0.892 . . . . 0.0 109.852 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 143' ' ' LEU . 17.7 mt -81.98 -35.68 28.69 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.234 -0.917 . . . . 0.0 108.706 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.582 HD12 ' CD1' ' A' ' 22' ' ' PHE . 53.5 mt -66.66 -47.17 84.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.479 ' O ' HG13 ' A' ' 13' ' ' ILE . 84.1 mt-10 -52.26 -45.42 65.39 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.307 -0.87 . . . . 0.0 109.324 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 36.4 m -64.68 -30.97 72.0 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.152 -0.968 . . . . 0.0 109.535 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.584 ' CD2' ' OH ' ' A' ' 158' ' ' TYR . 71.1 t80 -60.94 -50.48 73.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.474 -0.766 . . . . 0.0 109.815 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.622 ' CD2' ' CE1' ' A' ' 158' ' ' TYR . 92.5 mt -80.03 -36.92 35.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.223 -0.923 . . . . 0.0 110.03 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.536 ' CB ' HD13 ' A' ' 13' ' ' ILE . 16.6 tttt -64.03 -20.29 65.81 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.392 -0.817 . . . . 0.0 109.516 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -110.67 -32.78 2.6 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.581 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 5.8 m-70 -109.6 94.3 16.21 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.267 -1.137 . . . . 0.0 110.203 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.71 6.25 3.38 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.08 1.569 . . . . 0.0 111.046 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -109.8 -2.37 17.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.994 -1.066 . . . . 0.0 109.966 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.564 ' HB1' ' CE2' ' A' ' 150' ' ' TYR . . . -74.39 104.61 5.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.368 -0.832 . . . . 0.0 110.199 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.622 ' CE1' ' CD2' ' A' ' 151' ' ' LEU . 1.5 p90 34.65 37.28 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.726 -0.609 . . . . 0.0 110.842 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.497 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.69 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 98.7 t -128.02 132.07 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.208 -1.172 . . . . 0.0 110.205 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.641 ' CE1' ' CD1' ' A' ' 128' ' ' ILE . 12.3 m-85 -93.19 148.21 22.22 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.205 -0.934 . . . . 0.0 110.117 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.402 HG22 ' CE1' ' A' ' 119' ' ' HIS . 10.3 m -128.1 111.48 13.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.173 -0.955 . . . . 0.0 110.344 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.635 ' CD2' ' CG2' ' A' ' 133' ' ' VAL . 69.1 m-85 -123.38 140.25 53.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.341 -0.85 . . . . 0.0 110.16 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -140.28 151.33 45.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.224 -0.923 . . . . 0.0 110.359 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.7 t -138.77 160.97 38.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.386 -0.821 . . . . 0.0 109.918 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.411 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 85.8 mt-10 -142.14 115.77 9.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.102 -0.999 . . . . 0.0 110.368 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.6 p90 -140.42 -175.04 4.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.311 -0.868 . . . . 0.0 109.843 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.49 ' CG2' ' HA ' ' A' ' 113' ' ' ILE . 2.4 p -137.52 167.38 21.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.118 -0.989 . . . . 0.0 110.493 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.445 ' HA ' ' OE2' ' A' ' 148' ' ' GLU . 75.5 p -138.93 147.93 42.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.38 -0.825 . . . . 0.0 110.168 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -69.96 -32.96 71.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.236 -0.915 . . . . 0.0 110.254 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.547 ' N ' ' CD1' ' A' ' 13' ' ' ILE . 2.6 mp -79.58 148.56 69.93 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.378 -0.826 . . . . 0.0 109.915 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.56 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 40.0 Cg_endo -64.99 152.72 81.4 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.937 1.493 . . . . 0.0 110.722 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.672 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 36.7 Cg_endo -63.35 -35.87 59.34 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.793 1.418 . . . . 0.0 113.035 -178.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.672 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 38.0 Cg_endo -63.89 -21.3 68.99 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 N-CA-C 109.811 -0.88 . . . . 0.0 109.811 178.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.531 ' CG ' ' HG2' ' A' ' 14' ' ' PRO . 6.6 mmp_? -80.28 -45.25 18.23 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.597 ' CD1' ' N ' ' A' ' 18' ' ' LEU . 9.3 mp -73.31 -40.87 64.16 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.251 -0.98 . . . . 0.0 108.576 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.617 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 36.9 t80 -52.72 -59.95 3.86 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 119.869 -0.733 . . . . 0.0 110.155 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 40.4 mttp -56.03 -38.27 70.33 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.404 -0.81 . . . . 0.0 110.18 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.579 ' HB1' ' CZ ' ' A' ' 158' ' ' TYR . . . -78.56 -62.76 1.58 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.125 -0.984 . . . . 0.0 110.878 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.547 ' N ' ' O ' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -49.2 -41.49 37.17 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.65 -0.656 . . . . 0.0 112.006 -178.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.597 HG12 ' CD1' ' A' ' 81' ' ' TYR . 11.5 t -106.32 -62.93 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.767 -1.208 . . . . 0.0 111.813 -178.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 20' ' ' LYS . 7.4 mp -68.5 -1.07 5.84 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.243 -0.911 . . . . 0.0 111.69 -178.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.556 ' OD2' ' CD2' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -149.63 15.7 0.88 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.704 -1.248 . . . . 0.0 110.756 179.743 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -57.45 -40.68 78.99 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.142 -0.974 . . . . 0.0 110.12 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.48 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 14.0 t70 -62.75 -11.42 17.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.268 -0.895 . . . . 0.0 109.901 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.456 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 84.7 m-20 -132.89 10.07 4.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.42 -0.8 . . . . 0.0 109.701 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.526 HD22 ' CZ ' ' A' ' 158' ' ' TYR . 0.2 OUTLIER -95.57 -49.06 5.56 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.396 -0.815 . . . . 0.0 110.387 -179.764 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.662 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 3.5 m -83.48 -26.22 0.39 Allowed Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.396 -0.815 . . . . 0.0 112.707 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.662 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 47.0 Cg_endo -76.88 2.93 7.01 Favored 'Trans proline' 0 C--N 1.318 -1.039 0 O-C-N 122.511 0.743 . . . . 0.0 110.476 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.7 tttm -128.95 -35.15 1.88 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.29 -0.882 . . . . 0.0 109.541 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.59 HG12 ' CD1' ' A' ' 150' ' ' TYR . 40.1 mt -80.03 -35.27 15.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.599 -0.688 . . . . 0.0 109.596 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -161.9 97.5 1.22 Allowed Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.582 -0.699 . . . . 0.0 109.833 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.57 2.21 6.05 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.069 1.563 . . . . 0.0 110.793 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -84.11 -10.09 58.07 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.146 -0.971 . . . . 0.0 109.812 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.438 ' C ' ' CD1' ' A' ' 38' ' ' ILE . . . -97.88 -47.19 5.65 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.392 -0.817 . . . . 0.0 109.912 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.522 ' CG1' ' CG2' ' A' ' 56' ' ' ILE . 2.1 mp -134.75 108.01 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.463 -0.773 . . . . 0.0 109.899 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 57' ' ' THR . 39.3 ttpt -55.29 -16.99 3.89 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.223 -0.923 . . . . 0.0 110.298 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.545 ' CG ' ' N ' ' A' ' 41' ' ' SER . 0.2 OUTLIER 173.03 175.16 0.11 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.081 -1.012 . . . . 0.0 110.11 -179.739 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.545 ' N ' ' CG ' ' A' ' 40' ' ' HIS . 25.2 m -152.11 149.77 29.17 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.361 -0.837 . . . . 0.0 109.827 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -155.56 112.15 3.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.163 -0.961 . . . . 0.0 110.711 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 41.1 mt -62.55 136.5 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.306 -0.871 . . . . 0.0 109.808 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.523 ' CD2' ' HE3' ' A' ' 55' ' ' LYS . 4.9 tp -114.19 -24.47 8.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.156 -0.965 . . . . 0.0 110.717 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.554 ' CG ' HD13 ' A' ' 53' ' ' ILE . 1.8 m95 -124.93 161.35 26.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.116 -0.99 . . . . 0.0 110.782 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.458 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 42.23 -139.73 2.19 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -147.85 24.79 1.06 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.368 -1.078 . . . . 0.0 109.878 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 117.88 -18.9 11.39 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.512 ' O ' ' CG2' ' A' ' 71' ' ' ILE . . . -72.87 -169.27 14.09 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.498 ' HA ' HG23 ' A' ' 71' ' ' ILE . 45.8 Cg_endo -73.21 128.9 13.39 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.093 1.575 . . . . 0.0 110.724 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.81 -11.55 49.52 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.1 m -75.08 163.84 27.15 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.643 -0.916 . . . . 0.0 109.78 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.554 HD13 ' CG ' ' A' ' 45' ' ' TRP . 85.6 mt -134.13 118.87 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 0.0 109.942 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 1.0 OUTLIER -106.55 124.11 49.11 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.322 -0.861 . . . . 0.0 110.567 -179.565 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.523 ' HE3' ' CD2' ' A' ' 44' ' ' LEU . 75.8 mttt -90.53 95.2 10.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.258 -0.901 . . . . 0.0 109.826 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.522 ' CG2' ' CG1' ' A' ' 38' ' ' ILE . 99.6 mt -79.98 139.97 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.142 -0.974 . . . . 0.0 110.083 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -112.99 146.65 38.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.315 -0.865 . . . . 0.0 110.434 -179.736 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.571 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 21.7 m-85 -110.04 154.8 22.7 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.289 -0.882 . . . . 0.0 110.052 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.876 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.312 0.577 . . . . 0.0 110.321 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.571 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -132.61 90.25 0.27 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.991 -1.643 . . . . 0.0 108.991 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.538 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 12.1 p90 -130.29 166.57 20.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.081 -1.246 . . . . 0.0 110.158 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.478 ' HB ' HD12 ' A' ' 85' ' ' LEU . 5.3 m -140.02 175.64 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.337 -0.852 . . . . 0.0 110.579 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.524 ' CE ' HG23 ' A' ' 53' ' ' ILE . 69.6 tttt -131.17 103.09 6.29 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.506 -0.746 . . . . 0.0 109.875 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.58 ' CD2' HD11 ' A' ' 85' ' ' LEU . 13.4 m170 -98.15 121.77 40.48 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.207 -0.933 . . . . 0.0 111.036 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 52' ' ' THR . 82.8 tttt -91.45 120.35 32.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.301 -0.874 . . . . 0.0 109.348 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.537 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 26.2 mm -58.62 126.88 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.165 -0.959 . . . . 0.0 110.229 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.476 ' O ' ' HB3' ' A' ' 73' ' ' SER . 90.9 m-20 -98.36 -51.1 4.09 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.447 -0.783 . . . . 0.0 109.769 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.476 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 91.3 p -178.45 159.2 1.16 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.5 -0.75 . . . . 0.0 110.316 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.534 ' CD1' HG12 ' A' ' 23' ' ' VAL . 3.5 tt -144.41 167.33 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.502 -0.749 . . . . 0.0 109.236 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -131.13 81.05 1.97 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.944 -1.098 . . . . 0.0 110.523 -179.376 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.617 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 82.1 tttt -55.99 -14.56 2.62 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.29 -0.881 . . . . 0.0 110.604 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -90.76 -30.44 17.04 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.24 -0.912 . . . . 0.0 109.658 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.501 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -113.3 -1.44 14.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.486 -0.759 . . . . 0.0 109.731 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.575 ' HA ' ' CD1' ' A' ' 19' ' ' PHE . 56.1 m-85 64.87 50.04 2.05 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.389 0.614 . . . . 0.0 110.369 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.507 ' O ' ' CG1' ' A' ' 74' ' ' ILE . 0.6 OUTLIER -118.51 152.57 35.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 109.524 179.394 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.622 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 82.5 t80 -151.04 140.85 21.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.066 -1.021 . . . . 0.0 110.262 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 74.3 m -147.81 147.61 30.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.259 -0.901 . . . . 0.0 110.442 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.622 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 8.8 p90 -149.82 175.59 11.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.344 -0.848 . . . . 0.0 110.361 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.475 ' OG1' ' OD2' ' A' ' 72' ' ' ASP . 44.3 m -125.58 128.16 47.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.404 -0.81 . . . . 0.0 109.888 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.58 HD11 ' CD2' ' A' ' 69' ' ' HIS . 8.6 tp -98.77 131.64 44.75 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.216 -0.993 . . . . 0.0 110.284 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.518 ' O ' ' CD1' ' A' ' 91' ' ' LEU . 9.1 pt -117.19 -29.51 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.199 -0.938 . . . . 0.0 110.419 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -110.39 138.77 46.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -0.888 . . . . 0.0 110.19 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 175.82 134.25 1.9 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -53.38 -31.22 43.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -1.112 . . . . 0.0 110.305 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.484 ' HB3' ' CE1' ' A' ' 132' ' ' HIS . . . -69.73 -38.73 76.98 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.297 -0.877 . . . . 0.0 110.243 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.52 HD22 ' CD2' ' A' ' 95' ' ' LEU . 15.5 mt -41.19 -61.71 0.97 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.503 -0.748 . . . . 0.0 110.284 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 49.14 -178.01 0.02 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -67.01 -7.5 23.02 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.25 -1.147 . . . . 0.0 110.213 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.452 ' O ' HG23 ' A' ' 122' ' ' THR . 61.2 p -79.98 -60.97 2.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 110.213 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.535 HD12 ' CD1' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -102.25 159.39 15.44 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.352 -0.843 . . . . 0.0 109.387 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.482 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 61.1 tt0 -137.74 -79.7 0.37 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.208 -0.932 . . . . 0.0 110.576 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 10.1 mttt -80.24 144.81 32.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.592 -0.692 . . . . 0.0 111.023 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.632 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 4.6 mm -133.1 144.7 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.208 -0.932 . . . . 0.0 109.487 178.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.457 ' N ' HG21 ' A' ' 98' ' ' ILE . 1.1 m -123.9 127.72 48.41 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.28 -0.887 . . . . 0.0 109.377 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.632 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 12.0 m-85 -123.54 133.4 53.99 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.194 -0.941 . . . . 0.0 110.581 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.45 ' HG3' ' OG ' ' A' ' 82' ' ' SER . 62.9 tt0 -135.59 137.41 41.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.279 -0.888 . . . . 0.0 110.109 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.508 ' N ' ' O ' ' A' ' 81' ' ' TYR . 23.4 m -135.24 146.41 48.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.165 -0.959 . . . . 0.0 110.281 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 115' ' ' LYS . 12.1 mttt -138.94 139.53 38.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.328 -0.858 . . . . 0.0 110.131 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.54 ' HB2' ' CB ' ' A' ' 79' ' ' TYR . 2.7 mt -118.66 154.21 33.07 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.215 -0.928 . . . . 0.0 110.542 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.493 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -152.34 -169.35 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.332 -0.855 . . . . 0.0 109.925 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -121.45 158.47 28.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.329 -0.857 . . . . 0.0 110.215 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.462 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 5.8 p -118.01 168.08 10.06 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.235 -0.916 . . . . 0.0 110.176 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.6 Cg_endo -72.41 -12.66 27.48 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.003 1.528 . . . . 0.0 110.378 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 95.8 p -95.84 2.61 53.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.245 -0.909 . . . . 0.0 110.176 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 99.35 -29.04 12.7 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.08 -172.53 1.91 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.483 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 2.1 m -133.3 133.68 42.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -1.109 . . . . 0.0 110.378 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.49 ' HA ' ' CG2' ' A' ' 10' ' ' THR . 20.8 mt -86.05 144.67 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.358 -0.838 . . . . 0.0 109.939 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.588 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 20.6 mt -131.03 114.01 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.173 -0.954 . . . . 0.0 110.441 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 103' ' ' LYS . 35.2 tttt -100.48 120.77 40.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.914 . . . . 0.0 109.837 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.1 t -115.99 154.87 29.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.205 -0.935 . . . . 0.0 110.53 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.45 HG23 ' NE2' ' A' ' 119' ' ' HIS . 38.5 m -156.73 131.64 8.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.352 -0.842 . . . . 0.0 110.133 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 91.7 p -132.72 155.81 48.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.137 -0.977 . . . . 0.0 110.319 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 32.3 m-70 -135.83 164.28 28.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.331 -0.856 . . . . 0.0 110.182 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.512 ' CB ' HD12 ' A' ' 128' ' ' ILE . 11.0 m-85 -124.77 148.54 48.06 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.292 -0.88 . . . . 0.0 110.196 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.478 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 97.1 m-70 -129.21 85.37 2.31 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.135 -0.978 . . . . 0.0 109.698 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.53 ' CG2' ' HA ' ' A' ' 95' ' ' LEU . 1.4 p -81.77 157.73 24.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.326 -0.859 . . . . 0.0 110.427 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.2 tttm -113.6 127.06 55.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.435 -0.791 . . . . 0.0 110.202 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 99.45 -153.24 19.62 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -102.97 64.17 0.84 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.219 -1.166 . . . . 0.0 110.182 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.469 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 20.1 m -130.62 154.36 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.186 -0.946 . . . . 0.0 110.214 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -133.6 159.37 40.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.261 -0.899 . . . . 0.0 110.195 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.641 ' CD1' ' CE1' ' A' ' 3' ' ' PHE . 4.3 mp -80.86 173.24 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.27 -0.894 . . . . 0.0 110.211 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.454 ' N ' HG23 ' A' ' 128' ' ' ILE . 10.6 mttp -108.26 132.89 53.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.321 -0.862 . . . . 0.0 110.124 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -47.1 -47.73 23.1 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.191 -0.943 . . . . 0.0 110.169 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.503 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 54.7 tt0 -50.97 -28.59 10.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.202 -0.936 . . . . 0.0 109.973 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.484 ' CE1' ' HB3' ' A' ' 90' ' ' ALA . 14.2 t-160 -79.74 -60.63 2.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.268 -0.895 . . . . 0.0 110.114 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.635 ' CG2' ' CD2' ' A' ' 5' ' ' TYR . 7.3 p -65.55 -38.49 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.428 -0.795 . . . . 0.0 110.185 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 26.1 tttp -68.77 -47.33 66.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.233 -0.917 . . . . 0.0 110.238 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.503 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -61.43 -27.02 68.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.91 . . . . 0.0 110.226 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.41 -28.09 71.74 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 49.0 mttt -69.58 -39.99 76.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.221 -1.164 . . . . 0.0 110.211 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -75.18 -34.82 61.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.407 -0.808 . . . . 0.0 110.054 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.439 ' O ' ' HG ' ' A' ' 143' ' ' LEU . 28.5 mttt -67.85 -32.85 73.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.33 -0.856 . . . . 0.0 109.925 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.7 -45.03 47.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.295 -0.878 . . . . 0.0 110.014 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 36.8 m -59.5 -38.62 81.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.444 -0.785 . . . . 0.0 110.049 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -61.52 -41.85 97.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.208 -0.932 . . . . 0.0 109.898 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 139' ' ' LYS . 38.1 mt -60.07 -41.73 93.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.269 -0.894 . . . . 0.0 109.859 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.453 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 24.7 m-85 -56.83 -37.3 71.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.441 -0.787 . . . . 0.0 109.982 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 55.9 mttt -66.5 -25.05 66.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.334 -0.854 . . . . 0.0 109.904 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.524 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 15.9 mt -83.02 -34.69 26.22 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.276 -0.89 . . . . 0.0 108.952 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.547 HD12 ' CE1' ' A' ' 22' ' ' PHE . 79.8 mt -69.54 -34.91 63.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.538 -0.726 . . . . 0.0 109.451 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.53 ' O ' ' CB ' ' A' ' 152' ' ' LYS . 97.0 mt-10 -62.84 -39.06 93.2 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.494 -0.754 . . . . 0.0 109.869 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 86.1 m -72.15 -40.0 68.35 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.299 -0.875 . . . . 0.0 109.96 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.59 ' CD1' HG12 ' A' ' 33' ' ' ILE . 68.6 t80 -55.82 -50.54 70.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.479 -0.763 . . . . 0.0 110.023 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.57 HD22 ' CE1' ' A' ' 158' ' ' TYR . 33.6 mt -79.88 -40.2 28.86 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.331 -0.856 . . . . 0.0 110.464 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.53 ' CB ' ' O ' ' A' ' 148' ' ' GLU . 40.5 tttp -66.12 -22.84 66.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.267 -0.896 . . . . 0.0 109.456 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -103.09 -35.97 3.52 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.613 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 3.8 m-70 -110.77 93.94 18.45 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.397 -1.061 . . . . 0.0 109.978 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.48 5.64 3.62 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.06 1.558 . . . . 0.0 111.022 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 41.6 p30 -107.54 -2.92 19.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.05 -1.031 . . . . 0.0 109.84 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.587 ' HB1' ' CE2' ' A' ' 150' ' ' TYR . . . -70.5 102.58 2.25 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.413 -0.804 . . . . 0.0 110.126 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.579 ' CZ ' ' HB1' ' A' ' 21' ' ' ALA . 1.4 p90 33.72 36.67 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.737 -0.602 . . . . 0.0 110.729 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.527 ' HB2' ' CD ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.776 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.504 ' CG1' ' O ' ' A' ' 120' ' ' TYR . 82.3 t -135.78 144.92 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -1.161 . . . . 0.0 110.358 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.638 ' CD1' ' CD1' ' A' ' 128' ' ' ILE . 9.8 m-85 -107.71 134.23 50.98 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.238 -0.914 . . . . 0.0 110.031 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.6 m -101.8 111.09 23.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.233 -0.917 . . . . 0.0 110.328 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.607 ' CE1' ' CG1' ' A' ' 133' ' ' VAL . 28.7 m-85 -115.26 126.01 54.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.137 -0.977 . . . . 0.0 109.795 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 23.1 pt-20 -140.29 154.77 46.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.183 -0.948 . . . . 0.0 110.524 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.466 ' O ' ' HB3' ' A' ' 116' ' ' SER . 49.4 m -139.53 135.61 33.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.336 -0.853 . . . . 0.0 109.729 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.438 ' HG3' ' HG3' ' A' ' 115' ' ' LYS . 2.4 tt0 -116.15 138.86 50.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.1 -1.0 . . . . 0.0 110.72 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.631 ' CZ ' ' CG2' ' A' ' 114' ' ' ILE . 5.8 p90 -158.98 -173.04 4.04 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.506 -0.746 . . . . 0.0 109.814 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.517 ' CG2' ' HA ' ' A' ' 113' ' ' ILE . 7.4 p -141.57 172.02 13.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.137 -0.977 . . . . 0.0 110.519 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 112' ' ' SER . 89.9 p -159.95 140.2 11.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.282 -0.886 . . . . 0.0 110.264 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.458 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 97.2 mt-10 -64.32 -39.08 93.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.28 -0.887 . . . . 0.0 110.106 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.537 ' CD1' ' HB2' ' A' ' 152' ' ' LYS . 2.7 mp -51.37 150.2 6.62 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.313 -0.867 . . . . 0.0 109.791 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.525 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 41.7 Cg_endo -67.99 137.1 40.16 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.974 1.513 . . . . 0.0 110.505 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.614 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 41.8 Cg_endo -73.68 -28.95 11.18 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 124.072 1.564 . . . . 0.0 112.933 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 15' ' ' PRO . 43.4 Cg_endo -73.68 -21.33 19.2 Favored 'Trans proline' 0 C--N 1.319 -1.001 0 O-C-N 122.408 0.688 . . . . 0.0 110.534 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.589 ' NE ' ' CB ' ' A' ' 159' ' ' ASN . 57.6 ttt180 -85.7 -50.9 6.82 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.522 ' HG ' ' CG2' ' A' ' 147' ' ' ILE . 1.7 tt -57.13 -27.66 62.03 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.58 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 64.9 t80 -69.57 -54.65 13.04 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.488 0.661 . . . . 0.0 109.477 178.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.495 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 49.5 mttt -55.31 -29.65 58.68 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 122.158 0.98 . . . . 0.0 108.376 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.662 ' CB ' ' CE1' ' A' ' 158' ' ' TYR . . . -77.36 -63.46 1.37 Allowed 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.647 0.737 . . . . 0.0 110.797 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.635 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 0.1 OUTLIER -60.72 -28.92 69.02 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.612 -0.68 . . . . 0.0 111.401 -178.599 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.567 HG11 ' CE1' ' A' ' 81' ' ' TYR . 4.3 t -108.63 -66.39 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.046 -1.034 . . . . 0.0 111.406 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.495 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 8.6 mp -68.91 -10.97 60.04 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.162 -0.961 . . . . 0.0 111.205 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.487 ' O ' ' N ' ' A' ' 29' ' ' LEU . 0.3 OUTLIER -138.2 16.89 2.79 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.889 -1.132 . . . . 0.0 110.075 179.721 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -51.76 -44.91 63.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 110.177 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.456 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 61.8 m-20 -62.07 -12.41 19.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.181 -0.949 . . . . 0.0 110.157 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.467 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 77.8 m-20 -124.2 -7.71 7.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 110.42 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.55 HD11 ' N ' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -85.0 -46.04 11.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.201 -0.937 . . . . 0.0 110.37 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.594 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 2.9 t -69.51 -41.86 18.2 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.35 -0.844 . . . . 0.0 111.002 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.1 Cg_endo -78.55 9.72 3.08 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.54 1.284 . . . . 0.0 110.792 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.449 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 21.7 mttm -121.17 -29.43 4.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.174 -0.954 . . . . 0.0 109.307 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.594 HG12 ' CD1' ' A' ' 150' ' ' TYR . 14.9 mt -80.21 -64.99 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-O 121.607 0.718 . . . . 0.0 109.388 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.01 106.51 9.61 Favored Pre-proline 0 C--N 1.303 -1.451 0 O-C-N 121.708 -0.62 . . . . 0.0 109.876 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.3 0.49 5.97 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.078 1.567 . . . . 0.0 111.035 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -81.13 -13.3 58.81 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.032 -1.042 . . . . 0.0 109.418 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.428 ' HB1' HD11 ' A' ' 38' ' ' ILE . . . -96.95 -67.66 0.84 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.393 -0.817 . . . . 0.0 110.15 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.588 ' CG1' ' CG2' ' A' ' 56' ' ' ILE . 2.3 mp -109.6 127.82 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.491 -0.756 . . . . 0.0 110.158 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 57' ' ' THR . 22.2 ttpt -85.8 -27.68 24.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.272 -0.893 . . . . 0.0 110.366 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.554 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -163.39 148.83 11.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.122 -0.986 . . . . 0.0 110.037 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.452 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 4.2 m -131.54 122.97 27.02 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.314 -0.866 . . . . 0.0 109.953 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -138.15 111.25 7.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.14 -0.975 . . . . 0.0 110.661 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.488 HD11 HG22 ' A' ' 43' ' ' ILE . 28.5 mt -56.87 133.5 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.336 -0.852 . . . . 0.0 109.837 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.518 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 25.3 mt -104.67 -29.78 10.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.913 . . . . 0.0 110.605 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.567 ' CG ' HD13 ' A' ' 53' ' ' ILE . 2.0 m95 -122.46 160.43 25.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.208 -0.932 . . . . 0.0 110.706 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.46 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 41.39 -138.74 1.91 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -152.33 22.2 0.64 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -1.197 . . . . 0.0 110.15 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 126.35 -22.94 5.84 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.477 ' O ' HG22 ' A' ' 71' ' ' ILE . . . -68.43 -174.35 8.79 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.48 ' HA ' HG23 ' A' ' 71' ' ' ILE . 44.5 Cg_endo -72.33 128.8 14.11 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 123.986 1.519 . . . . 0.0 110.593 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.46 ' HA3' ' HE2' ' A' ' 70' ' ' LYS . . . 105.19 -13.54 48.45 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.504 -1.838 . . . . 0.0 108.504 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -71.74 160.73 32.11 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.616 -0.932 . . . . 0.0 109.327 179.589 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.567 HD13 ' CG ' ' A' ' 45' ' ' TRP . 80.6 mt -131.71 119.37 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 110.215 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 0.4 OUTLIER -101.54 126.47 48.36 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.276 -0.89 . . . . 0.0 110.03 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.518 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 22.2 tttm -96.97 90.68 5.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 110.101 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.588 ' CG2' ' CG1' ' A' ' 38' ' ' ILE . 94.1 mt -80.11 139.41 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.299 -0.876 . . . . 0.0 110.065 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.494 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 1.2 p -115.17 153.14 31.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.888 . . . . 0.0 110.301 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.581 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 14.7 m-85 -114.27 176.06 5.21 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.314 -0.866 . . . . 0.0 110.168 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 58' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.562 ' O ' ' CD1' ' A' ' 64' ' ' TYR . 5.4 p90 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.242 0.544 . . . . 0.0 110.171 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.581 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -137.71 85.75 0.23 Allowed Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.531 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 12.4 p90 -133.52 171.65 13.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -1.166 . . . . 0.0 110.249 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.462 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 4.0 m -140.3 177.66 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.332 -0.855 . . . . 0.0 110.35 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.526 ' O ' ' CD1' ' A' ' 85' ' ' LEU . 23.7 mttm -134.81 104.76 6.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.412 -0.805 . . . . 0.0 109.804 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.561 ' CD2' HD11 ' A' ' 85' ' ' LEU . 14.8 m170 -96.9 127.54 42.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.196 -0.94 . . . . 0.0 110.862 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 52' ' ' THR . 77.8 tttt -98.2 113.74 25.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.91 . . . . 0.0 109.414 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.534 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 33.0 mm -44.53 136.19 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.101 -1.0 . . . . 0.0 110.162 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.534 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 23.8 t0 -109.89 -43.57 3.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.419 -0.801 . . . . 0.0 109.969 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.468 ' O ' HD13 ' A' ' 74' ' ' ILE . 62.3 p -170.81 161.2 7.17 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.484 -0.886 . . . . 0.0 109.947 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.468 HD13 ' O ' ' A' ' 73' ' ' SER . 0.9 OUTLIER -149.44 154.36 9.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 119.277 -0.969 . . . . 0.0 111.005 -179.754 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.527 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 2.3 m-20 -136.1 79.96 1.8 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.809 -0.557 . . . . 0.0 110.288 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.58 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 22.2 mttp -59.94 -14.85 17.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.246 -0.909 . . . . 0.0 110.365 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -93.65 -30.88 14.7 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.22 -0.925 . . . . 0.0 109.753 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.505 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -108.25 -3.82 18.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.533 -0.729 . . . . 0.0 109.723 -179.947 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.567 ' CZ ' ' HB3' ' A' ' 16' ' ' PRO . 5.5 m-85 65.36 47.24 2.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.469 -0.77 . . . . 0.0 110.361 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.527 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.6 OUTLIER -116.62 147.41 41.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -0.896 . . . . 0.0 109.289 179.534 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.567 ' CE1' HG11 ' A' ' 23' ' ' VAL . 90.3 t80 -141.88 139.89 32.72 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.07 -1.019 . . . . 0.0 110.344 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 72' ' ' ASP . 1.3 m -143.72 135.41 26.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.255 -0.903 . . . . 0.0 110.348 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.592 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 20.2 p90 -142.86 170.25 16.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.343 -0.848 . . . . 0.0 110.3 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.518 ' CG2' ' O ' ' A' ' 98' ' ' ILE . 93.5 m -127.31 125.58 41.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.33 -0.856 . . . . 0.0 109.763 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.561 HD11 ' CD2' ' A' ' 69' ' ' HIS . 10.8 tp -95.09 129.86 42.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.068 -1.02 . . . . 0.0 110.444 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.468 HG23 HD11 ' A' ' 86' ' ' ILE . 11.0 pt -106.25 -32.89 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.323 -0.861 . . . . 0.0 110.175 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.509 ' OE1' ' CE ' ' A' ' 68' ' ' LYS . 86.9 tt0 -118.5 160.72 21.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.337 -0.852 . . . . 0.0 110.107 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.462 ' HA2' HG13 ' A' ' 67' ' ' VAL . . . 151.86 151.65 5.69 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -73.27 -25.28 60.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -1.155 . . . . 0.0 110.185 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.19 -20.04 63.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.302 -0.874 . . . . 0.0 110.157 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 92' ' ' GLY . 77.0 mt -69.36 -33.57 73.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.269 -0.894 . . . . 0.0 110.137 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 49.77 -179.71 0.02 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -78.14 3.17 15.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.215 -1.168 . . . . 0.0 109.984 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.8 m -93.89 -49.81 5.64 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.204 -0.935 . . . . 0.0 109.849 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.506 HD22 ' CG2' ' A' ' 122' ' ' THR . 42.1 mt -93.6 163.16 13.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.443 -0.786 . . . . 0.0 109.914 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.404 ' CD ' ' HB2' ' A' ' 123' ' ' LYS . 12.3 mt-10 -140.38 -79.85 0.28 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.216 -0.928 . . . . 0.0 109.982 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 29.2 mtmt -80.14 141.24 35.91 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.586 -0.696 . . . . 0.0 109.999 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.634 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 6.3 mm -130.38 140.87 47.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 120.85 -1.157 . . . . 0.0 110.149 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.484 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -123.81 130.04 51.99 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.642 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.634 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 11.6 m-85 -125.35 134.72 52.1 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.21 -0.931 . . . . 0.0 110.603 -178.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -134.52 131.15 37.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.436 -0.79 . . . . 0.0 110.211 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 32.3 m -130.26 140.71 50.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -0.894 . . . . 0.0 109.911 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.442 ' HB2' ' HB3' ' A' ' 115' ' ' LYS . 8.9 mttp -131.79 137.55 48.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.181 -0.95 . . . . 0.0 110.763 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.529 ' CD2' HG12 ' A' ' 114' ' ' ILE . 7.3 mt -116.5 150.66 37.54 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.277 -0.89 . . . . 0.0 109.839 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.49 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -150.91 -169.45 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.11 -0.993 . . . . 0.0 110.064 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -126.83 155.98 42.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.368 -0.833 . . . . 0.0 110.091 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.447 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.7 p -114.6 169.43 6.63 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.279 -0.888 . . . . 0.0 110.309 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.447 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.2 Cg_endo -72.62 -10.69 25.49 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.14 1.6 . . . . 0.0 110.49 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 95.5 p -98.19 5.53 48.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.273 -0.892 . . . . 0.0 110.37 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.1 -34.89 4.76 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 12' ' ' GLU . . . -57.65 -173.86 0.33 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.453 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 54.0 p -133.76 138.41 45.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.198 -1.178 . . . . 0.0 110.434 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.517 ' HA ' ' CG2' ' A' ' 10' ' ' THR . 23.0 mt -91.36 147.26 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.367 -0.833 . . . . 0.0 110.085 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.631 ' CG2' ' CZ ' ' A' ' 9' ' ' PHE . 22.8 mt -133.58 123.26 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.215 -0.928 . . . . 0.0 110.328 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.442 ' HB3' ' HB2' ' A' ' 103' ' ' LYS . 72.4 tttt -107.96 121.66 45.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.233 -0.917 . . . . 0.0 110.089 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -104.32 154.68 19.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.187 -0.946 . . . . 0.0 110.419 -179.854 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 20.9 m -158.76 148.82 19.52 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.432 -0.793 . . . . 0.0 110.2 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 5' ' ' TYR . 86.2 p -157.03 156.28 32.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.297 -0.877 . . . . 0.0 110.154 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.484 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 85.7 m-70 -134.9 137.95 43.66 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.162 -0.961 . . . . 0.0 110.51 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.504 ' O ' ' CG1' ' A' ' 2' ' ' VAL . 3.9 m-30 -104.01 139.29 39.33 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.345 -0.847 . . . . 0.0 110.262 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.501 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 92.1 m-70 -121.96 90.49 3.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.981 -1.074 . . . . 0.0 109.565 179.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.528 ' HB ' ' CG2' ' A' ' 126' ' ' VAL . 1.8 p -72.22 156.69 38.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.28 -0.888 . . . . 0.0 110.66 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.473 ' HG2' ' N ' ' A' ' 124' ' ' GLY . 42.4 tttt -100.31 149.01 24.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.461 -0.775 . . . . 0.0 109.946 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.473 ' N ' ' HG2' ' A' ' 123' ' ' LYS . . . 69.4 -122.88 13.04 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -138.69 70.28 1.38 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -1.195 . . . . 0.0 110.244 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.528 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 32.5 m -122.9 164.21 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 0.0 109.972 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -131.86 152.39 51.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.098 -1.001 . . . . 0.0 110.406 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.638 ' CD1' ' CD1' ' A' ' 3' ' ' PHE . 2.8 mp -84.35 172.4 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.269 -0.895 . . . . 0.0 110.205 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.438 ' N ' ' CG2' ' A' ' 128' ' ' ILE . 5.8 tttp -112.31 179.03 4.11 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.323 -0.86 . . . . 0.0 109.853 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -82.39 5.46 20.33 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.172 -0.955 . . . . 0.0 108.822 178.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -93.83 -31.56 14.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.386 -0.821 . . . . 0.0 109.906 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 15.8 t-160 -85.93 -36.16 20.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.29 -0.881 . . . . 0.0 110.083 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.607 ' CG1' ' CE1' ' A' ' 5' ' ' TYR . 37.0 t -77.56 -43.21 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.351 -0.843 . . . . 0.0 110.095 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 57.5 tttm -65.51 -44.21 87.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 0.0 110.114 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.44 -37.23 85.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.24 -0.913 . . . . 0.0 110.027 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -64.09 -30.72 78.57 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 81.0 mttt -61.9 -31.67 71.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.366 -1.079 . . . . 0.0 109.998 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.483 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 70.0 mm-40 -82.29 -36.92 26.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.319 -0.863 . . . . 0.0 109.962 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -70.48 -30.52 67.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.337 -0.852 . . . . 0.0 109.975 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.57 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -88.43 -37.74 15.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.894 . . . . 0.0 110.094 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 137' ' ' LYS . 66.3 m -71.24 -52.58 18.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.416 -0.802 . . . . 0.0 109.97 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.483 ' ND2' ' O ' ' A' ' 138' ' ' GLU . 92.3 m-20 -54.62 -43.41 72.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.275 -0.891 . . . . 0.0 109.971 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.46 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 13.0 tp -59.7 -42.74 93.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.895 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.57 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 7.7 m-85 -55.17 -39.1 69.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.331 -0.856 . . . . 0.0 109.587 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.451 ' O ' ' HG2' ' A' ' 145' ' ' LYS . 51.0 tttt -74.53 -15.02 60.88 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.419 -0.801 . . . . 0.0 109.859 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.46 ' HB2' ' O ' ' A' ' 143' ' ' LEU . 29.2 mt -80.86 -35.15 33.11 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.178 -0.951 . . . . 0.0 108.712 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.635 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 17.4 mt -68.83 -51.59 43.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.492 ' HB3' ' CD1' ' A' ' 13' ' ' ILE . 52.6 mt-10 -56.46 -40.9 75.64 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.543 -0.723 . . . . 0.0 109.764 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 98.0 m -66.97 -41.81 86.2 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.144 -0.973 . . . . 0.0 109.811 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.594 ' CD1' HG12 ' A' ' 33' ' ' ILE . 87.1 t80 -56.19 -46.18 79.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.344 -0.847 . . . . 0.0 109.997 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.549 ' CD2' ' NE ' ' A' ' 17' ' ' ARG . 33.2 mt -80.15 -28.98 38.78 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.227 -0.921 . . . . 0.0 110.344 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.537 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . 21.4 tttt -72.23 -28.06 62.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.327 -0.858 . . . . 0.0 109.822 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.464 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -101.47 -33.61 4.75 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.56 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 5.9 m-70 -106.94 92.4 7.54 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.339 -1.095 . . . . 0.0 109.71 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 48.5 Cg_endo -73.68 8.22 2.02 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.288 1.678 . . . . 0.0 111.439 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -112.5 1.47 15.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.915 -1.116 . . . . 0.0 109.817 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.593 ' HB1' ' CE2' ' A' ' 150' ' ' TYR . . . -73.4 100.98 3.35 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.367 -0.833 . . . . 0.0 110.421 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.662 ' CE1' ' CB ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER 34.53 39.55 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.747 -0.596 . . . . 0.0 110.691 -179.737 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.589 ' CB ' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.416 0 CA-C-O 118.007 -0.996 . . . . 0.0 109.722 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.519 ' CG1' ' O ' ' A' ' 120' ' ' TYR . 70.9 t -140.21 125.32 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.197 -1.178 . . . . 0.0 110.169 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.596 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 66.0 m-85 -88.93 126.09 35.24 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.141 -0.974 . . . . 0.0 110.108 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.0 m -117.38 107.24 14.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.235 -0.916 . . . . 0.0 110.431 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.653 ' CE1' ' CG2' ' A' ' 133' ' ' VAL . 69.5 m-85 -111.49 126.11 54.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.184 -0.948 . . . . 0.0 110.164 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.516 ' CG ' HG22 ' A' ' 117' ' ' THR . 2.4 mt-10 -117.6 144.79 44.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.295 -0.878 . . . . 0.0 110.564 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.47 ' C ' ' CG ' ' A' ' 8' ' ' GLU . 20.0 m -128.0 164.64 21.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.331 -0.856 . . . . 0.0 109.842 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.47 ' CG ' ' C ' ' A' ' 7' ' ' SER . 68.4 mt-10 -153.12 124.65 7.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.064 -1.022 . . . . 0.0 110.757 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.636 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.0 p90 -145.24 -176.22 5.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.308 -0.87 . . . . 0.0 109.728 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.523 HG23 ' CG1' ' A' ' 113' ' ' ILE . 6.8 p -142.5 174.56 10.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.062 -1.024 . . . . 0.0 110.687 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.485 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 7.9 t -159.99 164.96 32.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.37 -0.831 . . . . 0.0 110.142 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -89.69 -22.85 22.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.306 -0.871 . . . . 0.0 110.213 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.538 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 8.4 mm -68.1 150.71 97.64 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.264 -0.898 . . . . 0.0 109.984 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.538 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 41.0 Cg_endo -66.98 145.05 72.63 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 124.029 1.541 . . . . 0.0 110.598 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.642 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.1 Cg_endo -71.18 -31.99 13.68 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.873 1.459 . . . . 0.0 112.765 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.642 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.1 Cg_endo -69.23 -22.76 34.06 Favored 'Trans proline' 0 C--N 1.318 -1.047 0 N-CA-C 109.988 -0.812 . . . . 0.0 109.988 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.536 ' NE ' ' CB ' ' A' ' 159' ' ' ASN . 52.3 mtp180 -81.79 -43.13 18.75 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.594 ' CD2' ' CG2' ' A' ' 147' ' ' ILE . 0.2 OUTLIER -73.53 -33.78 64.89 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.702 -0.799 . . . . 0.0 108.939 178.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.583 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 59.8 t80 -60.27 -60.51 3.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.511 -0.743 . . . . 0.0 109.765 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.493 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 23.1 mttt -53.77 -38.9 64.92 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.735 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.654 ' CB ' ' CZ ' ' A' ' 158' ' ' TYR . . . -69.17 -36.42 77.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.456 -0.778 . . . . 0.0 110.904 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.577 ' CD1' HD12 ' A' ' 147' ' ' ILE . 0.3 OUTLIER -79.09 -49.21 12.99 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.31 -0.869 . . . . 0.0 110.974 -179.127 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.463 ' HB ' HD13 ' A' ' 24' ' ' LEU . 3.7 t -94.34 -53.97 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.202 -0.936 . . . . 0.0 111.813 -178.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.55 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 7.4 mp -80.03 -1.05 38.06 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.972 -1.08 . . . . 0.0 112.129 -178.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.534 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -147.78 23.46 1.1 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.704 -1.247 . . . . 0.0 110.725 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -65.76 -12.35 53.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.089 -1.007 . . . . 0.0 110.193 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.503 ' HA ' ' CB ' ' A' ' 41' ' ' SER . 92.0 m-20 -80.08 -13.76 59.05 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.205 -0.934 . . . . 0.0 110.443 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -135.46 6.19 3.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.192 -0.943 . . . . 0.0 110.595 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.483 HD23 ' CZ ' ' A' ' 150' ' ' TYR . 0.2 OUTLIER -96.59 -40.56 8.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.214 -0.929 . . . . 0.0 109.888 179.901 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.604 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 4.1 t -82.45 -41.01 0.92 Allowed Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.437 -0.79 . . . . 0.0 111.013 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.7 Cg_endo -78.95 11.43 2.57 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.365 1.192 . . . . 0.0 110.771 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -124.41 -34.04 2.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.065 -1.022 . . . . 0.0 109.438 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.545 HD13 ' CD1' ' A' ' 150' ' ' TYR . 7.5 mt -80.12 -38.75 18.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.489 -0.757 . . . . 0.0 109.399 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.77 96.68 7.43 Favored Pre-proline 0 C--N 1.304 -1.379 0 O-C-N 121.463 -0.773 . . . . 0.0 110.03 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.35 -2.52 11.37 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.003 1.528 . . . . 0.0 110.513 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -88.48 -26.41 22.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.135 -0.978 . . . . 0.0 109.711 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -86.08 -73.43 0.45 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.4 -0.813 . . . . 0.0 109.969 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.522 HG13 ' CG2' ' A' ' 56' ' ' ILE . 2.1 mp -102.6 137.15 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.407 -0.808 . . . . 0.0 110.045 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.2 ttpp -96.18 -32.28 12.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 110.376 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.576 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -167.94 156.68 9.29 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.213 -0.93 . . . . 0.0 110.09 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.503 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 11.0 p -115.83 144.89 43.37 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.273 -0.892 . . . . 0.0 110.266 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.576 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 73.3 tt0 -149.0 97.74 2.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.248 -0.908 . . . . 0.0 110.327 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 19.1 mt -57.52 130.78 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.173 -0.955 . . . . 0.0 110.06 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.523 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 31.0 mt -102.55 -35.25 8.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 110.64 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.505 ' HB2' ' CB ' ' A' ' 53' ' ' ILE . 1.9 m95 -122.91 162.85 21.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.108 -0.995 . . . . 0.0 110.658 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.454 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 41.79 -136.51 2.92 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.418 ' O ' ' CG ' ' A' ' 47' ' ' ASP . 11.1 t0 -154.26 22.41 0.49 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -1.143 . . . . 0.0 109.907 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 122.82 -20.47 7.7 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.819 -1.712 . . . . 0.0 108.819 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.471 ' O ' HG23 ' A' ' 71' ' ' ILE . . . -68.42 -171.92 6.85 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.48 ' HA ' HG23 ' A' ' 71' ' ' ILE . 45.8 Cg_endo -73.81 129.13 13.12 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.051 1.553 . . . . 0.0 110.626 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.84 -9.18 56.66 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -73.49 159.13 33.65 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.523 -0.986 . . . . 0.0 109.94 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.505 ' CB ' ' HB2' ' A' ' 45' ' ' TRP . 78.1 mt -126.85 119.61 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.354 -0.841 . . . . 0.0 109.406 179.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -105.15 135.25 46.84 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 110.451 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.523 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 76.7 tttt -104.22 93.43 4.82 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.364 -0.835 . . . . 0.0 110.05 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.522 ' CG2' HG13 ' A' ' 38' ' ' ILE . 66.3 mt -79.98 134.19 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.206 -0.934 . . . . 0.0 109.942 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.523 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 1.7 p -106.98 155.89 19.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.371 -0.831 . . . . 0.0 110.213 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.43 ' N ' ' O ' ' A' ' 65' ' ' GLY . 22.6 m-85 -111.48 151.24 28.84 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.319 -0.863 . . . . 0.0 110.205 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 58' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.117 0.484 . . . . 0.0 109.934 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.469 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -135.92 133.94 6.92 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.544 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 10.5 p90 -178.16 169.34 1.9 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.335 -1.097 . . . . 0.0 110.181 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.483 HG13 ' CA ' ' A' ' 88' ' ' GLY . 4.1 m -141.92 176.92 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.395 -0.816 . . . . 0.0 110.54 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.474 ' O ' HD22 ' A' ' 85' ' ' LEU . 68.8 tttt -127.69 122.95 34.29 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.363 -0.836 . . . . 0.0 109.792 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.426 ' NE2' ' HG ' ' A' ' 85' ' ' LEU . 9.0 m170 -116.26 126.62 53.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.088 -1.007 . . . . 0.0 110.993 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 52' ' ' THR . 15.2 tttt -102.76 117.23 34.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.295 -0.878 . . . . 0.0 109.403 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.531 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 25.5 mm -60.13 126.61 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.243 -0.911 . . . . 0.0 110.334 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.48 ' N ' ' O ' ' A' ' 82' ' ' SER . 41.9 m-20 -97.95 -36.89 10.0 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.35 -0.844 . . . . 0.0 109.724 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.464 ' OG ' ' HB2' ' A' ' 82' ' ' SER . 35.0 p -178.58 157.33 0.97 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.327 -0.858 . . . . 0.0 109.887 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.461 HD12 ' CG1' ' A' ' 23' ' ' VAL . 1.3 mt -139.67 158.24 27.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.257 -0.902 . . . . 0.0 110.051 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.52 ' HB2' ' HB3' ' A' ' 80' ' ' SER . 0.8 OUTLIER -142.77 82.47 1.77 Allowed 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.537 179.698 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.583 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 48.7 tttm -66.21 -14.62 62.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.309 -0.869 . . . . 0.0 110.214 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -87.69 -29.37 21.17 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.395 -0.816 . . . . 0.0 108.907 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.494 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.2 m-80 -108.07 -5.66 16.9 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.403 0.62 . . . . 0.0 109.358 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.542 ' CB ' ' HB2' ' A' ' 104' ' ' LEU . 50.5 m-85 64.58 53.04 1.65 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.681 -0.637 . . . . 0.0 110.608 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.52 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 11.8 t -125.33 175.75 7.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 110.242 179.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.594 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 20.8 t80 -156.8 145.83 20.21 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.959 -0.697 . . . . 0.0 110.182 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.48 ' O ' ' N ' ' A' ' 72' ' ' ASP . 0.4 OUTLIER -147.34 124.06 11.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.265 -0.897 . . . . 0.0 110.819 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.627 ' N ' ' CD1' ' A' ' 83' ' ' TYR . 2.5 p90 -145.77 -179.92 7.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.37 -0.831 . . . . 0.0 109.708 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.509 ' CG2' ' O ' ' A' ' 98' ' ' ILE . 18.6 m -135.62 146.88 48.34 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.132 -0.98 . . . . 0.0 110.567 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.567 ' CB ' ' HB ' ' A' ' 98' ' ' ILE . 0.2 OUTLIER -102.43 117.82 35.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.29 -0.881 . . . . 0.0 110.257 179.67 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 22.3 pt -113.13 -6.12 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.228 -0.92 . . . . 0.0 110.138 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -145.92 128.29 15.89 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.319 -0.863 . . . . 0.0 110.39 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.483 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . -178.59 120.32 0.7 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -52.56 -27.33 16.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -1.161 . . . . 0.0 110.158 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.07 -20.98 62.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.935 . . . . 0.0 110.154 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' A' ' 92' ' ' GLY . 32.9 mt -69.55 -24.74 63.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.237 -0.914 . . . . 0.0 110.222 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 50.03 -176.87 0.04 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -81.22 6.9 12.62 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -1.143 . . . . 0.0 110.222 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 26.2 p -94.21 -28.72 15.48 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.227 -0.921 . . . . 0.0 110.096 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.567 ' CD2' ' CD1' ' A' ' 128' ' ' ILE . 90.3 mt -110.35 151.66 27.17 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.302 -0.874 . . . . 0.0 110.014 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.42 ' HG3' ' HB2' ' A' ' 123' ' ' LYS . 11.5 mt-10 -133.79 -80.81 0.46 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.172 -0.955 . . . . 0.0 110.281 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.517 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 70.8 mttt -80.36 127.2 32.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.549 -0.719 . . . . 0.0 110.898 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.593 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 13.0 mm -116.98 146.73 21.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 120.722 -1.237 . . . . 0.0 109.664 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.483 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.5 OUTLIER -124.99 124.8 42.78 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.504 -0.879 . . . . 0.0 108.704 178.223 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.593 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 15.3 m-85 -121.15 140.81 51.5 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.366 -0.834 . . . . 0.0 110.454 -178.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.485 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 20.2 tt0 -145.42 136.92 25.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.284 -0.885 . . . . 0.0 110.331 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 60.6 m -135.16 129.69 34.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.32 -0.863 . . . . 0.0 109.635 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.98 144.57 50.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.946 . . . . 0.0 110.691 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.542 ' HB2' ' CB ' ' A' ' 79' ' ' TYR . 7.4 mt -117.52 155.58 29.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.292 -0.88 . . . . 0.0 109.973 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.487 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 1.9 t -151.35 -169.2 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.133 -0.979 . . . . 0.0 110.185 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -121.87 144.07 49.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.37 -0.831 . . . . 0.0 110.234 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.461 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 3.4 p -101.2 169.41 7.81 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.182 -0.949 . . . . 0.0 110.253 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.461 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 47.6 Cg_endo -73.15 -10.91 24.84 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.111 1.585 . . . . 0.0 110.565 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.6 m -99.45 4.29 46.07 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.226 -0.921 . . . . 0.0 110.185 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 102.05 -36.93 3.92 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -56.79 178.17 0.79 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 20.6 p -122.76 130.0 52.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.228 -1.16 . . . . 0.0 110.284 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.523 ' CG1' HG23 ' A' ' 10' ' ' THR . 5.9 mt -80.33 149.41 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.252 -0.905 . . . . 0.0 110.077 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.581 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 6.5 mt -128.59 118.97 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 0.0 110.189 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 38.7 tttt -101.15 128.98 46.99 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.159 -0.963 . . . . 0.0 110.157 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.446 ' HB3' ' HB2' ' A' ' 7' ' ' SER . 0.0 OUTLIER -110.99 152.13 27.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.215 -0.928 . . . . 0.0 110.047 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.585 ' CG2' ' CE1' ' A' ' 119' ' ' HIS . 33.4 m -160.09 125.29 3.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.212 -0.93 . . . . 0.0 110.499 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.505 ' HB3' ' CE1' ' A' ' 100' ' ' TYR . 3.1 m -135.46 142.94 45.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.314 -0.866 . . . . 0.0 109.746 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.585 ' CE1' ' CG2' ' A' ' 117' ' ' THR . 33.1 m-70 -129.49 136.19 49.57 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.082 -1.011 . . . . 0.0 110.293 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.6 ' N ' ' CD1' ' A' ' 120' ' ' TYR . 3.0 m-30 -104.54 151.78 23.19 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.308 -0.87 . . . . 0.0 110.745 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.517 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 82.1 m-70 -129.78 86.97 2.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.297 -0.877 . . . . 0.0 109.43 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.529 ' CG2' HD22 ' A' ' 95' ' ' LEU . 1.4 p -63.23 156.11 26.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.375 -0.828 . . . . 0.0 110.56 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.42 ' HB2' ' HG3' ' A' ' 96' ' ' GLU . 4.3 tttm -103.86 106.52 17.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.399 -0.813 . . . . 0.0 110.07 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 103.45 -123.41 7.78 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -136.62 94.61 3.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.233 -1.157 . . . . 0.0 110.252 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.497 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 14.9 m -141.95 -177.77 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.277 -0.889 . . . . 0.0 110.128 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -134.23 144.5 48.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -0.933 . . . . 0.0 110.48 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.585 HG12 ' CZ ' ' A' ' 3' ' ' PHE . 12.0 mm -64.94 172.54 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 110.154 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 132' ' ' HIS . 18.8 mttt -97.78 127.89 44.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.345 -0.847 . . . . 0.0 109.847 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 129' ' ' LYS . 94.6 mt-10 -44.13 -52.8 6.98 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.131 -0.981 . . . . 0.0 109.937 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.509 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 50.7 tt0 -52.54 -20.53 3.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.203 -0.935 . . . . 0.0 109.706 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.479 ' N ' ' O ' ' A' ' 129' ' ' LYS . 14.0 t-160 -85.31 -61.85 1.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.395 -0.816 . . . . 0.0 110.259 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.653 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 1.8 p -66.37 -20.92 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.306 -0.872 . . . . 0.0 110.285 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -104.42 -72.51 0.7 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.922 . . . . 0.0 110.027 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.509 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -56.57 -22.4 33.28 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 109.77 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -75.46 -27.87 62.67 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -68.83 -33.9 74.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.174 -1.192 . . . . 0.0 110.145 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.419 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 78.4 tt0 -75.95 -24.14 55.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.315 -0.866 . . . . 0.0 110.109 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 67.7 mttt -78.94 -27.98 43.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.335 -0.853 . . . . 0.0 109.991 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -81.85 -36.1 28.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.289 -0.882 . . . . 0.0 110.072 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.8 t -65.25 -46.32 81.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.4 -0.812 . . . . 0.0 110.141 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.419 ' ND2' ' O ' ' A' ' 138' ' ' GLU . 93.5 m-20 -51.69 -47.58 63.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.343 -0.848 . . . . 0.0 110.028 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.473 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 14.0 tp -56.68 -50.03 73.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.903 . . . . 0.0 109.936 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.467 ' CG ' ' CZ ' ' A' ' 9' ' ' PHE . 18.0 m-85 -55.87 -39.26 71.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.334 -0.854 . . . . 0.0 109.708 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -75.97 -11.09 59.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.417 -0.802 . . . . 0.0 110.089 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 143' ' ' LEU . 11.7 mt -83.42 -37.84 22.7 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.211 -0.931 . . . . 0.0 108.804 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.594 ' CG2' ' CD2' ' A' ' 18' ' ' LEU . 63.5 mt -69.06 -48.49 69.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.485 ' CG ' ' OG ' ' A' ' 11' ' ' SER . 96.8 mt-10 -47.27 -38.01 11.69 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.414 -0.804 . . . . 0.0 109.009 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.412 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 11.0 m -79.94 -25.4 40.48 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.318 -0.864 . . . . 0.0 109.237 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.587 ' CD2' ' OH ' ' A' ' 158' ' ' TYR . 64.9 t80 -54.85 -51.8 64.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.583 -0.698 . . . . 0.0 109.824 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.581 HD22 ' CE1' ' A' ' 158' ' ' TYR . 45.0 mt -79.89 -28.97 39.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.479 -0.763 . . . . 0.0 109.994 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.438 ' CA ' HD13 ' A' ' 13' ' ' ILE . 21.1 tttt -64.18 -13.04 45.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.317 -0.864 . . . . 0.0 109.488 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.475 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -124.19 -24.13 1.86 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.58 ' CD2' ' O ' ' A' ' 150' ' ' TYR . 10.4 m-70 -105.53 93.62 7.36 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.147 -1.208 . . . . 0.0 110.165 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.0 Cg_endo -73.43 4.12 4.19 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 124.12 1.589 . . . . 0.0 111.038 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -119.44 -1.53 10.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.023 -1.048 . . . . 0.0 110.126 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.56 ' O ' ' CD1' ' A' ' 158' ' ' TYR . . . -59.76 105.51 0.38 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.339 -0.85 . . . . 0.0 110.159 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.654 ' CZ ' ' CB ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER 35.64 30.53 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.606 -0.684 . . . . 0.0 110.738 -179.754 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.536 ' CB ' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.726 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.591 HG22 ' CD2' ' A' ' 121' ' ' HIS . 2.8 p -80.47 151.56 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.297 -1.119 . . . . 0.0 110.219 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.623 ' CD1' ' CD1' ' A' ' 128' ' ' ILE . 15.9 m-85 -90.14 176.39 6.79 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.276 -0.89 . . . . 0.0 110.046 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.543 HG21 ' CE1' ' A' ' 119' ' ' HIS . 94.9 m -140.88 106.11 5.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.247 -0.908 . . . . 0.0 110.294 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.637 ' CD1' ' CG1' ' A' ' 133' ' ' VAL . 22.2 m-85 -113.36 129.5 56.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -0.895 . . . . 0.0 109.987 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 22.4 pt-20 -130.41 152.99 49.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.233 -0.917 . . . . 0.0 110.569 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.3 m -138.18 147.18 43.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.373 -0.829 . . . . 0.0 109.84 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -131.36 117.12 18.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.132 -0.98 . . . . 0.0 110.556 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.4 p90 -139.21 -176.72 4.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.313 -0.867 . . . . 0.0 110.014 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.474 HG23 HG12 ' A' ' 113' ' ' ILE . 7.6 p -136.05 174.95 10.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.188 -0.945 . . . . 0.0 110.662 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.465 ' HB3' ' OE2' ' A' ' 148' ' ' GLU . 80.5 p -160.02 128.51 4.88 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.392 -0.817 . . . . 0.0 110.288 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.61 -28.86 68.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.195 -0.941 . . . . 0.0 109.924 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.53 ' CD1' ' HB2' ' A' ' 152' ' ' LYS . 1.3 mp -65.89 148.33 98.34 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.334 -0.854 . . . . 0.0 109.828 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.487 ' CG ' ' HD3' ' A' ' 17' ' ' ARG . 40.7 Cg_endo -66.49 141.65 62.09 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.892 1.469 . . . . 0.0 110.491 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.617 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.3 Cg_endo -72.87 -30.88 10.79 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 124.017 1.535 . . . . 0.0 112.886 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.6 Cg_endo -70.68 -22.33 28.0 Favored 'Trans proline' 0 C--N 1.319 -1.001 0 N-CA-C 110.195 -0.733 . . . . 0.0 110.195 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.573 ' NE ' ' CB ' ' A' ' 159' ' ' ASN . 43.4 mtp180 -84.31 -43.28 14.95 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.59 ' CD2' ' CG2' ' A' ' 147' ' ' ILE . 0.2 OUTLIER -72.73 -34.74 67.27 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.018 179.05 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.492 ' HB2' ' O ' ' A' ' 15' ' ' PRO . 52.5 t80 -64.5 -56.21 15.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.333 -0.854 . . . . 0.0 109.573 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 25' ' ' ASP . 28.7 mttt -52.74 -36.41 57.68 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.734 -0.787 . . . . 0.0 109.564 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.647 ' CB ' ' CZ ' ' A' ' 158' ' ' TYR . . . -78.03 -36.58 48.38 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.372 -0.83 . . . . 0.0 111.056 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.64 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 0.3 OUTLIER -73.91 -42.71 60.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.195 -0.94 . . . . 0.0 111.191 -179.057 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.464 HG12 HG12 ' A' ' 74' ' ' ILE . 4.6 t -105.99 -49.97 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.018 -1.051 . . . . 0.0 111.61 -178.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.487 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 7.1 mp -79.84 -9.95 59.72 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.26 -0.9 . . . . 0.0 111.399 -178.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.9 OUTLIER -149.44 38.82 0.79 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.85 -1.156 . . . . 0.0 110.555 -179.755 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -78.92 -24.97 43.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.333 -0.854 . . . . 0.0 110.504 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.462 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 91.8 m-20 -65.34 -21.15 66.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.154 -0.966 . . . . 0.0 110.221 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.48 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 4.1 p30 -125.4 13.0 8.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.315 -0.866 . . . . 0.0 109.89 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.529 HD11 ' CD1' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -94.28 -52.04 4.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.441 -0.787 . . . . 0.0 110.327 -179.89 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.66 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 3.8 p -75.1 -28.87 0.82 Allowed Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.275 -0.89 . . . . 0.0 112.288 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.66 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 51.9 Cg_endo -79.1 7.58 4.3 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 O-C-N 122.704 0.844 . . . . 0.0 110.581 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -129.66 -29.73 2.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.172 -0.955 . . . . 0.0 110.009 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.57 HG12 ' CD1' ' A' ' 150' ' ' TYR . 75.5 mt -80.04 -44.13 22.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.41 -0.806 . . . . 0.0 109.788 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -160.43 103.21 1.35 Allowed Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.376 -0.827 . . . . 0.0 110.121 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.46 0.29 7.69 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.077 1.567 . . . . 0.0 110.641 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -83.48 -15.57 49.0 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.182 -0.949 . . . . 0.0 109.67 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -92.13 -64.84 1.06 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.414 -0.804 . . . . 0.0 109.993 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.518 ' CD1' HG22 ' A' ' 30' ' ' VAL . 2.1 mp -114.88 131.19 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.426 -0.796 . . . . 0.0 109.941 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 57' ' ' THR . 15.8 ttpt -77.42 -23.43 50.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.203 -0.936 . . . . 0.0 110.48 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.543 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -178.94 161.45 1.18 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.106 -0.996 . . . . 0.0 110.102 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.4 m -134.61 124.34 25.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.329 -0.857 . . . . 0.0 109.977 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.543 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 44.5 tt0 -137.68 110.92 7.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -0.938 . . . . 0.0 110.661 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 33.8 mt -56.25 136.27 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.33 -0.857 . . . . 0.0 109.787 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.462 ' HB2' ' CD ' ' A' ' 55' ' ' LYS . 7.6 tp -108.76 -26.1 10.48 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.174 -0.953 . . . . 0.0 110.575 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.536 ' CG ' HD13 ' A' ' 53' ' ' ILE . 2.0 m95 -128.65 163.3 25.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.123 -0.985 . . . . 0.0 110.845 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.459 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 41.8 -137.72 2.55 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.94 24.13 0.66 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.326 -1.102 . . . . 0.0 110.02 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 119.04 -16.32 10.88 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.463 ' O ' HG23 ' A' ' 71' ' ' ILE . . . -73.66 -170.02 19.66 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.482 ' HA ' HG23 ' A' ' 71' ' ' ILE . 47.1 Cg_endo -73.75 128.85 12.88 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.99 1.521 . . . . 0.0 110.559 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.444 ' HA3' ' HE3' ' A' ' 70' ' ' LYS . . . 102.64 -12.32 56.55 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 108.707 -1.757 . . . . 0.0 108.707 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -71.36 161.6 30.8 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.534 -0.98 . . . . 0.0 109.56 179.674 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.536 HD13 ' CG ' ' A' ' 45' ' ' TRP . 45.0 mt -130.78 119.93 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.329 -0.857 . . . . 0.0 109.959 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.512 ' CE ' HD12 ' A' ' 71' ' ' ILE . 29.3 mttm -103.11 127.17 50.49 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.151 -0.968 . . . . 0.0 110.228 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.462 ' CD ' ' HB2' ' A' ' 44' ' ' LEU . 7.8 mtpt -96.06 92.69 6.57 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.378 -0.826 . . . . 0.0 110.098 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.517 ' CG2' HG12 ' A' ' 38' ' ' ILE . 95.2 mt -79.95 141.87 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 109.914 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 39' ' ' LYS . 2.4 p -116.4 152.07 34.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.3 -0.875 . . . . 0.0 110.582 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.577 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 23.5 m-85 -117.5 145.87 43.92 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.37 -0.832 . . . . 0.0 110.104 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.901 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.3 t80 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.324 0.583 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.577 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -135.53 96.61 0.27 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.546 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 13.6 p90 -136.1 169.13 18.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -1.182 . . . . 0.0 110.197 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.519 HG13 ' CA ' ' A' ' 88' ' ' GLY . 6.5 m -139.54 175.32 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.233 -0.917 . . . . 0.0 110.636 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.522 ' O ' ' CD1' ' A' ' 85' ' ' LEU . 42.7 mttt -133.41 104.63 6.51 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.465 -0.772 . . . . 0.0 109.905 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.547 ' CD2' HD11 ' A' ' 85' ' ' LEU . 13.3 m170 -96.13 129.6 43.38 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.197 -0.94 . . . . 0.0 111.138 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 52' ' ' THR . 21.6 tttp -96.92 116.7 29.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.327 -0.858 . . . . 0.0 109.395 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.523 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 26.8 mm -57.26 128.59 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.172 -0.955 . . . . 0.0 110.346 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 82' ' ' SER . 85.0 m-20 -101.58 -43.79 5.78 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.341 -0.849 . . . . 0.0 110.013 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.42 ' OG ' ' HB2' ' A' ' 82' ' ' SER . 62.0 p -173.67 158.67 3.38 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.434 -0.791 . . . . 0.0 109.946 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.464 HG12 HG12 ' A' ' 23' ' ' VAL . 2.0 mt -139.3 157.4 27.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.229 -0.92 . . . . 0.0 110.228 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 79' ' ' TYR . 4.5 m-20 -135.41 79.2 1.77 Allowed 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.371 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -61.38 -17.74 55.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -0.923 . . . . 0.0 110.174 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -92.48 -30.68 15.59 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.28 -0.887 . . . . 0.0 109.577 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.502 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -104.15 -3.22 24.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.566 -0.709 . . . . 0.0 109.574 179.731 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.605 ' CE1' ' HB3' ' A' ' 16' ' ' PRO . 70.0 m-85 60.18 54.57 3.99 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.599 -0.688 . . . . 0.0 110.756 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.508 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 0.9 OUTLIER -129.47 157.62 41.49 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.278 -0.889 . . . . 0.0 109.689 179.435 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.686 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 45.3 t80 -142.54 138.86 31.18 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.259 -0.901 . . . . 0.0 110.104 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 4.3 m -142.12 132.2 24.65 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.826 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.686 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 21.3 p90 -149.65 170.94 17.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.358 -0.839 . . . . 0.0 110.407 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.505 ' CG2' ' O ' ' A' ' 98' ' ' ILE . 50.4 m -126.72 129.52 48.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.436 -0.79 . . . . 0.0 110.077 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.547 HD11 ' CD2' ' A' ' 69' ' ' HIS . 10.7 tp -95.84 133.55 39.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.084 -1.01 . . . . 0.0 110.378 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.8 pt -111.22 -33.49 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.199 -0.938 . . . . 0.0 110.209 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.454 ' OE1' ' HE3' ' A' ' 68' ' ' LYS . 77.3 tt0 -116.17 155.3 28.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.376 -0.828 . . . . 0.0 110.139 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.519 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 156.29 129.38 1.17 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -60.15 -20.21 57.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -1.161 . . . . 0.0 110.222 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.69 -16.14 60.77 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.276 -0.89 . . . . 0.0 110.252 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.48 HD13 ' N ' ' A' ' 88' ' ' GLY . 75.7 mt -69.1 -25.51 64.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.278 -0.889 . . . . 0.0 110.189 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 49.28 -178.66 0.02 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 55.1 p30 -83.15 10.27 8.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.229 -1.16 . . . . 0.0 110.171 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.508 ' O ' ' CG2' ' A' ' 126' ' ' VAL . 29.7 p -103.08 -33.84 9.1 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.235 -0.916 . . . . 0.0 110.098 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.534 HD23 ' CD1' ' A' ' 128' ' ' ILE . 96.7 mt -103.8 160.6 14.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 110.052 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.471 ' HG2' ' N ' ' A' ' 97' ' ' LYS . 54.4 tt0 -140.05 -82.18 0.26 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.337 -0.852 . . . . 0.0 109.689 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.476 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 42.0 mttm -80.43 135.66 36.2 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.625 -0.672 . . . . 0.0 110.139 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.623 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 4.2 mm -123.1 139.29 50.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 120.866 -1.146 . . . . 0.0 109.982 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.461 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -121.96 129.34 52.41 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.783 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.623 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 9.9 m-85 -123.3 133.66 54.14 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.158 -0.964 . . . . 0.0 110.876 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -135.49 129.95 33.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.444 -0.785 . . . . 0.0 109.711 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 37.4 m -134.14 144.13 48.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.186 -0.946 . . . . 0.0 110.494 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 80' ' ' SER . 5.1 tttt -139.45 144.67 38.14 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.346 -0.846 . . . . 0.0 110.303 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.549 ' HB2' ' HB3' ' A' ' 79' ' ' TYR . 12.7 mt -109.37 155.09 21.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.225 -0.922 . . . . 0.0 110.461 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.493 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -151.17 -168.86 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.359 -0.838 . . . . 0.0 109.608 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.464 ' O ' HD13 ' A' ' 113' ' ' ILE . . . -122.59 154.67 37.63 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.173 -0.955 . . . . 0.0 110.526 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.458 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 55.4 p -114.52 164.56 16.08 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.389 -0.819 . . . . 0.0 110.064 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 47.6 Cg_endo -72.63 -1.77 10.82 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.959 1.505 . . . . 0.0 110.505 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.7 t -97.24 -22.6 16.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.103 -0.998 . . . . 0.0 110.31 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 111' ' ' GLY . . . 125.42 -38.11 2.37 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 110' ' ' GLY . . . -60.29 -147.13 0.01 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 47.5 p -150.43 133.21 15.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.173 -1.193 . . . . 0.0 110.148 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.486 ' HB ' ' HB ' ' A' ' 105' ' ' VAL . 23.4 mt -82.6 149.52 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.246 -0.909 . . . . 0.0 110.241 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.572 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 10.1 mt -129.74 113.47 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.894 . . . . 0.0 110.02 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.424 ' N ' ' O ' ' A' ' 103' ' ' LYS . 15.3 ttpt -94.99 122.26 37.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.088 -1.007 . . . . 0.0 110.216 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.91 147.27 42.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.895 . . . . 0.0 110.293 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 81.6 m -150.22 129.14 12.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.363 -0.836 . . . . 0.0 110.327 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.57 ' OG ' ' CE1' ' A' ' 100' ' ' TYR . 15.4 t -128.4 154.18 46.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.271 -0.893 . . . . 0.0 110.198 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.543 ' CE1' HG21 ' A' ' 4' ' ' THR . 91.5 m-70 -132.87 121.8 23.44 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.348 -0.845 . . . . 0.0 110.3 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.528 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 5.7 m-30 -95.3 119.37 33.69 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.183 -0.948 . . . . 0.0 110.489 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.591 ' CD2' HG22 ' A' ' 2' ' ' VAL . 76.4 m-70 -95.47 107.45 19.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.358 -0.839 . . . . 0.0 109.558 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.504 ' CG2' HD22 ' A' ' 95' ' ' LEU . 1.7 p -77.85 155.79 30.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.107 -0.995 . . . . 0.0 110.387 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.451 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 36.9 tttp -119.6 113.51 20.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.378 -0.826 . . . . 0.0 110.226 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.38 -135.89 12.61 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.406 ' C ' HG11 ' A' ' 126' ' ' VAL . 14.6 t30 -113.2 76.39 0.98 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.258 -1.143 . . . . 0.0 110.235 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.508 ' CG2' ' O ' ' A' ' 94' ' ' THR . 33.5 m -137.09 161.73 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.223 -0.923 . . . . 0.0 110.105 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -141.94 155.69 45.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 110.192 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.623 ' CD1' ' CD1' ' A' ' 3' ' ' PHE . 1.9 mp -84.03 173.43 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.22 -0.925 . . . . 0.0 110.113 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.535 ' N ' ' CG2' ' A' ' 128' ' ' ILE . 9.0 mttt -119.24 142.98 47.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.451 -0.78 . . . . 0.0 109.901 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.431 ' O ' ' HG2' ' A' ' 134' ' ' LYS . 93.6 mt-10 -48.17 -34.47 10.04 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.154 -0.966 . . . . 0.0 110.152 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.498 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 69.1 tt0 -63.84 -32.33 73.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 0.0 109.971 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 13.9 t-160 -77.66 -51.61 10.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.296 -0.877 . . . . 0.0 110.048 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.637 ' CG1' ' CD1' ' A' ' 5' ' ' TYR . 49.6 t -60.69 -38.66 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.39 -0.819 . . . . 0.0 109.979 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' A' ' 130' ' ' GLU . 62.2 mmtt -77.37 -45.01 27.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.316 -0.865 . . . . 0.0 110.122 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.498 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -62.25 -38.31 88.78 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.304 -0.872 . . . . 0.0 110.019 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -63.43 -30.77 78.59 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 77.5 mttt -77.33 -30.93 54.24 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.353 -1.087 . . . . 0.0 110.0 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -75.65 -34.1 60.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.367 -0.833 . . . . 0.0 109.959 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 39.3 mttt -73.36 -37.29 66.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.376 -0.828 . . . . 0.0 109.815 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.512 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -74.76 -32.37 62.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.251 -0.906 . . . . 0.0 109.88 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 137' ' ' LYS . 69.6 m -66.93 -49.33 65.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -0.881 . . . . 0.0 109.904 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -51.56 -47.3 63.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.25 -0.906 . . . . 0.0 109.895 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.431 ' O ' HG13 ' A' ' 147' ' ' ILE . 13.7 tp -57.14 -50.02 74.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -0.899 . . . . 0.0 109.732 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.512 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 21.6 m-85 -52.9 -35.17 57.76 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.388 -0.82 . . . . 0.0 109.673 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 37.2 mttt -78.18 -18.25 55.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.376 -0.828 . . . . 0.0 109.811 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 26.0 mt -82.43 -35.76 27.28 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.255 -0.903 . . . . 0.0 108.778 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.64 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 34.7 mt -69.6 -45.47 77.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.465 ' OE2' ' HB3' ' A' ' 11' ' ' SER . 91.9 mt-10 -53.21 -40.16 64.27 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.353 -0.842 . . . . 0.0 109.428 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.2 m -67.27 -28.23 67.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.309 -0.869 . . . . 0.0 109.447 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.575 ' CE2' ' HB1' ' A' ' 157' ' ' ALA . 80.5 t80 -63.42 -48.08 79.29 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.517 -0.74 . . . . 0.0 109.817 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.572 HD22 ' CE1' ' A' ' 158' ' ' TYR . 81.6 mt -79.91 -37.67 34.17 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.309 -0.87 . . . . 0.0 110.211 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.53 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . 43.5 tptt -60.7 -16.99 45.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.362 -0.836 . . . . 0.0 109.318 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.456 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -116.39 -30.13 2.14 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.573 ' CD2' ' O ' ' A' ' 150' ' ' TYR . 8.2 m-70 -106.05 93.97 8.6 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.222 -1.164 . . . . 0.0 110.223 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.466 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 48.1 Cg_endo -74.02 6.25 3.06 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 124.066 1.561 . . . . 0.0 111.048 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 35.4 p30 -115.77 -5.68 12.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.014 -1.054 . . . . 0.0 109.906 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.575 ' HB1' ' CE2' ' A' ' 150' ' ' TYR . . . -57.76 107.38 0.45 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.379 -0.826 . . . . 0.0 110.112 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.647 ' CZ ' ' CB ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 36.56 29.61 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.654 -0.654 . . . . 0.0 110.573 -179.429 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.573 ' CB ' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.644 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.485 ' CG1' ' O ' ' A' ' 120' ' ' TYR . 94.9 t -118.97 146.54 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.214 -1.168 . . . . 0.0 110.331 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.643 ' CD1' ' CD1' ' A' ' 128' ' ' ILE . 9.8 m-85 -101.03 142.55 32.34 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.285 -0.884 . . . . 0.0 109.518 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 m -118.45 131.88 56.25 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.982 -1.074 . . . . 0.0 110.887 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.646 ' CE2' ' CG2' ' A' ' 133' ' ' VAL . 72.0 m-85 -141.25 124.57 16.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.434 -0.791 . . . . 0.0 109.836 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.59 ' CG ' ' CG2' ' A' ' 117' ' ' THR . 10.2 mt-10 -132.23 136.34 46.92 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 0.0 110.319 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.0 m -125.51 164.08 21.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.235 -0.916 . . . . 0.0 110.093 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.446 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 87.1 mt-10 -146.26 127.18 14.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.298 -0.876 . . . . 0.0 110.445 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.633 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.1 p90 -147.32 -175.17 4.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.308 -0.87 . . . . 0.0 109.818 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.496 ' CG2' ' HA ' ' A' ' 113' ' ' ILE . 5.1 p -142.04 170.78 15.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.097 -1.002 . . . . 0.0 110.64 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.47 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 5.0 t -148.93 164.29 34.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.388 -0.82 . . . . 0.0 110.062 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -85.85 -22.0 27.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.267 -0.895 . . . . 0.0 110.192 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.539 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 8.8 mm -80.9 150.22 68.59 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.316 -0.865 . . . . 0.0 110.07 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.548 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 40.6 Cg_endo -66.17 146.36 81.33 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.044 1.55 . . . . 0.0 110.377 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.647 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.2 Cg_endo -71.18 -31.95 13.75 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.897 1.472 . . . . 0.0 112.912 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.647 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.1 Cg_endo -68.51 -20.59 41.28 Favored 'Trans proline' 0 C--N 1.317 -1.107 0 N-CA-C 110.114 -0.764 . . . . 0.0 110.114 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.529 ' NE ' ' HB2' ' A' ' 159' ' ' ASN . 47.9 mtp180 -85.78 -43.77 13.05 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.517 ' CD2' HD23 ' A' ' 104' ' ' LEU . 1.2 tt -75.21 -34.45 61.49 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.464 ' HB2' ' O ' ' A' ' 15' ' ' PRO . 60.8 t80 -65.75 -55.42 17.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.394 -0.816 . . . . 0.0 109.342 179.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 25' ' ' ASP . 64.3 mttt -53.62 -38.44 64.05 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.884 -0.727 . . . . 0.0 109.558 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.644 ' CB ' ' CZ ' ' A' ' 158' ' ' TYR . . . -74.4 -39.74 62.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.465 -0.772 . . . . 0.0 110.961 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.584 ' CD1' HD12 ' A' ' 147' ' ' ILE . 0.4 OUTLIER -75.21 -38.47 60.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.315 -0.865 . . . . 0.0 111.073 -178.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.448 HG11 ' CE1' ' A' ' 81' ' ' TYR . 4.5 t -105.22 -55.21 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.039 -1.038 . . . . 0.0 111.691 -179.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.463 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 7.3 mp -80.03 -4.64 53.5 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.178 -0.952 . . . . 0.0 111.841 -178.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 20' ' ' LYS . 1.0 OUTLIER -150.7 32.49 0.62 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.706 -1.246 . . . . 0.0 110.724 -179.61 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.508 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -74.44 -20.63 59.96 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.257 -0.902 . . . . 0.0 110.321 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.443 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 94.8 m-20 -67.75 -24.45 65.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.232 -0.918 . . . . 0.0 110.103 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.487 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 4.4 p30 -123.51 12.93 9.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.326 -0.859 . . . . 0.0 109.897 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.522 HD11 ' CD1' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -92.92 -50.33 5.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.356 -0.84 . . . . 0.0 110.184 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.647 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 2.2 m -74.26 -29.44 0.97 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.353 -0.842 . . . . 0.0 112.166 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 53.1 Cg_endo -79.15 3.57 7.33 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 O-C-N 122.785 0.887 . . . . 0.0 110.287 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -124.66 -34.71 2.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.319 -0.863 . . . . 0.0 109.326 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.574 HG12 ' CD1' ' A' ' 150' ' ' TYR . 18.4 mt -79.99 -36.65 17.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.625 -0.672 . . . . 0.0 109.837 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -175.33 102.95 0.26 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.545 -0.722 . . . . 0.0 109.831 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.77 1.57 6.26 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.031 1.543 . . . . 0.0 110.808 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -84.54 0.05 51.33 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.141 -0.974 . . . . 0.0 109.894 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.426 ' HB2' HD11 ' A' ' 38' ' ' ILE . . . -101.03 -51.17 3.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.28 -0.887 . . . . 0.0 110.024 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.518 HG12 ' CG2' ' A' ' 56' ' ' ILE . 1.8 mp -134.45 125.09 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.449 -0.782 . . . . 0.0 109.948 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' A' ' 57' ' ' THR . 21.8 ttpt -61.47 -26.82 68.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.25 -0.906 . . . . 0.0 110.319 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.574 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER 173.24 162.08 0.14 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.153 -0.967 . . . . 0.0 110.107 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.1 m -128.34 125.11 38.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.384 -0.822 . . . . 0.0 110.048 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.574 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 40.5 tt0 -130.16 111.37 12.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.195 -0.94 . . . . 0.0 110.426 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.503 HG22 HD12 ' A' ' 43' ' ' ILE . 36.3 mt -63.35 135.44 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.351 -0.843 . . . . 0.0 110.044 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 16.0 tp -110.45 -27.47 9.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.246 -0.909 . . . . 0.0 110.362 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.488 ' HB2' ' CB ' ' A' ' 53' ' ' ILE . 1.8 m95 -124.14 159.48 29.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -0.958 . . . . 0.0 110.605 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 45' ' ' TRP . . . 42.06 -136.82 3.07 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.419 ' O ' ' CG ' ' A' ' 47' ' ' ASP . 11.9 t0 -152.72 24.75 0.58 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.361 -1.082 . . . . 0.0 109.77 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.466 ' O ' HG22 ' A' ' 71' ' ' ILE . . . 119.97 -21.97 8.73 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.477 ' O ' HG22 ' A' ' 71' ' ' ILE . . . -65.17 -172.82 3.62 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.479 ' HA ' HG23 ' A' ' 71' ' ' ILE . 46.1 Cg_endo -73.44 128.64 12.95 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.997 1.525 . . . . 0.0 110.612 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.32 -13.23 54.98 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -68.61 163.25 24.12 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.569 -0.959 . . . . 0.0 109.663 179.729 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.488 ' CB ' ' HB2' ' A' ' 45' ' ' TRP . 61.6 mt -133.09 120.53 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.305 -0.872 . . . . 0.0 109.748 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.451 ' HG2' HG12 ' A' ' 43' ' ' ILE . 89.8 mttt -109.57 130.52 55.5 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.159 -0.963 . . . . 0.0 110.487 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -96.03 96.3 8.78 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.275 -0.891 . . . . 0.0 109.869 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.518 ' CG2' HG12 ' A' ' 38' ' ' ILE . 73.1 mt -79.87 143.82 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 109.998 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 39' ' ' LYS . 2.4 p -116.67 155.84 28.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 110.863 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.509 ' N ' ' O ' ' A' ' 65' ' ' GLY . 27.2 m-85 -119.07 154.76 32.65 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.473 -0.767 . . . . 0.0 109.917 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.836 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.168 0.508 . . . . 0.0 110.284 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -134.89 113.86 1.19 Allowed Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.634 -1.787 . . . . 0.0 108.634 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.544 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 12.6 p90 -155.93 162.24 40.41 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.113 -1.228 . . . . 0.0 110.208 -179.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.471 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 6.7 m -135.01 172.68 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.301 -0.874 . . . . 0.0 110.542 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.526 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 22.5 mttt -119.07 131.34 55.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.549 -0.719 . . . . 0.0 109.71 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.644 ' CD2' ' CD1' ' A' ' 85' ' ' LEU . 11.6 m170 -116.11 129.99 56.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.17 -0.956 . . . . 0.0 110.758 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 52' ' ' THR . 13.5 ttpt -107.71 108.84 20.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.279 -0.888 . . . . 0.0 109.547 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.527 ' CG2' HD12 ' A' ' 74' ' ' ILE . 27.8 mm -53.03 124.4 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.243 -0.911 . . . . 0.0 110.437 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 82' ' ' SER . 93.4 m-20 -96.71 -43.04 7.72 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.445 -0.784 . . . . 0.0 109.723 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 15.2 m -170.79 157.55 5.58 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.338 -0.851 . . . . 0.0 109.685 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.527 HD12 ' CG2' ' A' ' 71' ' ' ILE . 1.4 mp -135.66 149.66 28.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 110.226 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 79' ' ' TYR . 9.3 m-20 -131.22 77.26 1.77 Allowed 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.711 -0.795 . . . . 0.0 110.677 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.403 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 35.8 mttp -63.71 -16.0 59.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.182 -0.949 . . . . 0.0 109.888 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -93.8 -34.66 13.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.351 -0.843 . . . . 0.0 109.301 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.501 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -99.18 -4.11 32.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.595 -0.691 . . . . 0.0 109.452 179.362 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.589 ' CE1' ' HB3' ' A' ' 16' ' ' PRO . 65.5 m-85 60.11 57.02 3.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.558 -0.714 . . . . 0.0 110.305 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.491 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -130.73 163.08 28.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.383 -0.823 . . . . 0.0 109.595 179.539 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.523 ' OH ' ' CD1' ' A' ' 71' ' ' ILE . 15.2 t80 -144.64 138.33 27.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.921 . . . . 0.0 109.975 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.501 ' O ' ' N ' ' A' ' 72' ' ' ASP . 38.2 m -140.12 121.58 15.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.161 -0.962 . . . . 0.0 111.064 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.595 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 5.3 p90 -139.07 177.69 7.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.457 -0.777 . . . . 0.0 109.556 178.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.463 ' OG1' ' OD2' ' A' ' 72' ' ' ASP . 44.3 m -133.75 137.06 44.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.064 -1.023 . . . . 0.0 110.522 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.644 ' CD1' ' CD2' ' A' ' 69' ' ' HIS . 16.5 tp -93.37 118.31 31.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.236 -0.915 . . . . 0.0 109.831 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.7 pt -107.44 -22.23 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.427 -0.796 . . . . 0.0 110.036 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.526 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 64.9 tt0 -129.59 130.6 45.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.207 -0.933 . . . . 0.0 110.627 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.507 ' N ' HD22 ' A' ' 91' ' ' LEU . . . -176.87 107.94 0.25 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 90' ' ' ALA . 29.4 p-10 -42.34 -25.99 0.09 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.253 -1.145 . . . . 0.0 110.504 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.476 ' N ' ' OD1' ' A' ' 89' ' ' ASP . . . -75.47 -37.93 59.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.083 -1.01 . . . . 0.0 110.445 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.507 HD22 ' N ' ' A' ' 88' ' ' GLY . 1.6 pp -86.99 -25.7 24.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.885 . . . . 0.0 110.537 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.431 ' N ' ' HG ' ' A' ' 91' ' ' LEU . . . -63.11 -36.11 93.0 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.449 ' O ' ' CG2' ' A' ' 94' ' ' THR . 57.1 t0 -44.11 -34.91 1.95 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.174 -1.192 . . . . 0.0 110.403 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.449 ' CG2' ' O ' ' A' ' 93' ' ' ASP . 1.7 p -160.05 -35.07 0.06 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.273 -0.892 . . . . 0.0 110.432 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.596 ' CD2' ' CG1' ' A' ' 128' ' ' ILE . 5.9 mt -79.96 177.71 8.73 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.213 -0.929 . . . . 0.0 110.286 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -148.64 -78.98 0.14 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.363 -0.836 . . . . 0.0 109.479 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.53 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 8.1 mttt -80.14 135.59 36.34 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.63 -0.669 . . . . 0.0 110.486 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.537 ' CG2' ' HB3' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -136.34 132.35 49.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 120.704 -1.247 . . . . 0.0 109.292 178.651 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.518 ' OG ' ' NE2' ' A' ' 121' ' ' HIS . 0.6 OUTLIER -107.37 132.6 52.98 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.383 -0.823 . . . . 0.0 109.909 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.595 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 5.8 m-85 -122.74 132.73 54.37 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.495 -0.753 . . . . 0.0 110.316 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.453 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 9.3 tt0 -135.81 125.31 25.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.205 -0.934 . . . . 0.0 110.295 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.445 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 72.2 m -118.5 154.83 31.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.232 -0.917 . . . . 0.0 109.516 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.449 ' N ' ' O ' ' A' ' 115' ' ' LYS . 31.4 mttt -144.1 132.35 21.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.028 -1.045 . . . . 0.0 110.389 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.517 HD23 ' CD2' ' A' ' 18' ' ' LEU . 2.8 mt -120.01 145.45 46.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.284 -0.885 . . . . 0.0 110.177 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.506 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -153.07 -168.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.378 -0.826 . . . . 0.0 109.891 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -114.76 140.91 48.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.356 -0.84 . . . . 0.0 110.117 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.436 ' HB3' HG13 ' A' ' 113' ' ' ILE . 53.9 p -97.22 162.99 20.84 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.249 -0.907 . . . . 0.0 110.21 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.3 Cg_endo -71.92 -2.99 12.35 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.982 1.517 . . . . 0.0 110.393 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 52.9 p -100.98 2.84 41.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.295 -0.878 . . . . 0.0 110.207 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 101.2 -31.48 8.6 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -70.73 -172.55 12.15 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.524 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 24.5 p -122.03 131.37 53.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.278 -1.131 . . . . 0.0 110.369 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.496 ' HA ' ' CG2' ' A' ' 10' ' ' THR . 21.7 mt -80.07 143.88 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.887 . . . . 0.0 109.742 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.584 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 19.4 mt -131.08 109.78 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.104 -0.997 . . . . 0.0 110.63 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.449 ' O ' ' N ' ' A' ' 103' ' ' LYS . 30.0 tttt -99.33 130.5 45.62 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.277 -0.889 . . . . 0.0 109.825 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.83 151.58 39.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.958 . . . . 0.0 110.53 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.59 ' CG2' ' CG ' ' A' ' 6' ' ' GLU . 25.9 m -146.72 151.84 37.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.35 -0.844 . . . . 0.0 110.302 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 91.3 p -155.84 139.96 16.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.915 . . . . 0.0 110.282 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.501 ' NE2' HG23 ' A' ' 117' ' ' THR . 54.4 m-70 -127.92 157.02 41.7 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.211 -0.931 . . . . 0.0 110.394 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.485 ' O ' ' CG1' ' A' ' 2' ' ' VAL . 7.0 m-85 -120.41 141.62 49.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.197 -0.939 . . . . 0.0 110.733 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.53 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 98.2 m-70 -122.29 96.65 5.13 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.109 -0.994 . . . . 0.0 109.857 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.511 ' CG2' HD22 ' A' ' 95' ' ' LEU . 1.3 p -75.93 156.39 34.26 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.351 -0.843 . . . . 0.0 110.323 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 44.4 tttm -113.17 108.3 17.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.216 -0.927 . . . . 0.0 110.266 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 105.4 -124.07 7.79 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -127.9 75.05 1.58 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.269 -1.136 . . . . 0.0 110.204 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.469 HG21 ' CG2' ' A' ' 122' ' ' THR . 16.4 m -141.49 152.71 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.236 -0.915 . . . . 0.0 110.279 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -127.77 161.78 28.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.298 -0.877 . . . . 0.0 110.098 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.643 ' CD1' ' CD1' ' A' ' 3' ' ' PHE . 5.1 mp -86.66 172.36 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.248 -0.907 . . . . 0.0 110.378 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.477 ' O ' ' N ' ' A' ' 132' ' ' HIS . 10.0 mttp -108.01 127.16 53.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.414 -0.804 . . . . 0.0 109.539 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.492 ' CA ' ' HG3' ' A' ' 134' ' ' LYS . 97.4 mt-10 -42.86 -55.03 3.88 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.214 -0.929 . . . . 0.0 110.069 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.404 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 49.0 tt0 -47.22 -24.24 0.68 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.936 . . . . 0.0 109.751 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.477 ' N ' ' O ' ' A' ' 129' ' ' LYS . 9.7 t-160 -86.19 -64.89 1.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.361 -0.837 . . . . 0.0 110.175 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.646 ' CG2' ' CE2' ' A' ' 5' ' ' TYR . 7.2 p -63.38 -41.46 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.399 -0.813 . . . . 0.0 110.222 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.492 ' HG3' ' CA ' ' A' ' 130' ' ' GLU . 27.5 mttt -63.04 -43.55 98.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.175 -0.953 . . . . 0.0 109.823 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.458 ' O ' ' HG3' ' A' ' 139' ' ' LYS . . . -67.94 -26.15 65.82 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.339 -0.851 . . . . 0.0 109.792 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -71.66 -33.02 63.76 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.478 ' HE2' ' CD1' ' A' ' 5' ' ' TYR . 25.9 mttp -63.37 -34.67 78.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -1.129 . . . . 0.0 109.894 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -79.07 -31.94 44.6 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.366 -0.834 . . . . 0.0 109.936 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 135' ' ' ALA . 83.6 mttt -65.46 -39.36 91.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.347 -0.846 . . . . 0.0 109.857 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.85 -46.6 52.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.875 . . . . 0.0 109.916 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.6 t -55.97 -42.32 76.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.421 -0.799 . . . . 0.0 109.917 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -59.2 -43.03 92.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.922 . . . . 0.0 109.882 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 47.5 mt -60.57 -36.74 79.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.261 -0.899 . . . . 0.0 109.783 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.462 ' HA ' HD11 ' A' ' 147' ' ' ILE . 22.7 m-85 -63.2 -31.93 73.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.377 -0.827 . . . . 0.0 109.823 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -73.64 -18.59 61.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.286 -0.884 . . . . 0.0 109.916 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.496 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 32.2 mt -82.19 -35.57 28.19 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.271 -0.893 . . . . 0.0 108.701 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.584 HD12 ' CD1' ' A' ' 22' ' ' PHE . 26.8 mt -73.0 -47.06 49.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 178.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.481 ' O ' HG13 ' A' ' 13' ' ' ILE . 90.8 mt-10 -57.57 -33.75 68.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.475 -0.766 . . . . 0.0 109.406 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 19.8 m -77.1 -26.19 53.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.206 -0.934 . . . . 0.0 109.267 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.574 ' CD1' HG12 ' A' ' 33' ' ' ILE . 87.9 t80 -62.28 -51.38 67.94 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.605 -0.684 . . . . 0.0 110.03 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.567 ' CD2' ' CE2' ' A' ' 158' ' ' TYR . 71.4 mt -74.53 -29.13 61.27 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.331 -0.856 . . . . 0.0 110.196 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.442 ' HA ' HD13 ' A' ' 13' ' ' ILE . 65.9 tttt -63.19 -17.76 62.76 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.231 -0.918 . . . . 0.0 109.593 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.456 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -122.29 -19.7 3.14 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.573 ' CD2' ' O ' ' A' ' 150' ' ' TYR . 14.4 m-70 -106.91 91.74 6.7 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.128 -1.219 . . . . 0.0 110.3 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 49.1 Cg_endo -73.92 4.76 3.91 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.054 1.555 . . . . 0.0 110.871 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -117.55 -6.12 11.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.095 -1.003 . . . . 0.0 109.809 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.57 ' HB1' ' CE2' ' A' ' 150' ' ' TYR . . . -59.81 104.92 0.33 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.345 -0.847 . . . . 0.0 110.131 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.644 ' CZ ' ' CB ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 35.77 31.12 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.662 -0.649 . . . . 0.0 110.507 -179.492 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.529 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.792 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.491 HG23 ' ND1' ' A' ' 121' ' ' HIS . 39.1 t -124.37 142.84 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.236 -1.155 . . . . 0.0 110.338 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.636 ' CD1' ' CD1' ' A' ' 128' ' ' ILE . 7.9 m-85 -104.62 147.01 28.11 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.339 -0.851 . . . . 0.0 109.667 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.566 HG21 ' CE1' ' A' ' 119' ' ' HIS . 4.0 m -113.28 110.17 19.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.047 -1.033 . . . . 0.0 110.756 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.631 ' CE1' ' CG1' ' A' ' 133' ' ' VAL . 28.8 m-85 -119.58 125.98 50.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.295 -0.878 . . . . 0.0 109.977 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 116' ' ' SER . 22.7 pt-20 -139.99 154.17 47.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.151 -0.968 . . . . 0.0 110.363 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.1 t -127.04 162.93 24.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.312 -0.867 . . . . 0.0 109.992 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -142.82 121.4 12.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.183 -0.948 . . . . 0.0 110.368 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.651 ' CZ ' ' CD2' ' A' ' 144' ' ' PHE . 3.0 p90 -149.24 -172.69 4.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.347 -0.845 . . . . 0.0 109.765 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.476 ' CG2' ' HA ' ' A' ' 113' ' ' ILE . 9.4 p -142.16 173.21 11.73 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.216 -0.928 . . . . 0.0 110.695 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.501 ' HB2' ' CG ' ' A' ' 148' ' ' GLU . 22.9 p -158.03 134.06 9.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.499 -0.75 . . . . 0.0 110.199 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.411 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 97.6 mt-10 -61.11 -39.18 89.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 110.111 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.537 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 3.0 mp -53.99 150.4 14.99 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.43 -0.794 . . . . 0.0 109.998 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.537 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 41.1 Cg_endo -66.89 141.07 57.38 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.958 1.504 . . . . 0.0 110.466 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.601 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.7 Cg_endo -73.44 -30.11 10.41 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 O-C-N 124.04 1.548 . . . . 0.0 112.996 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.2 Cg_endo -71.11 -22.74 25.62 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 O-C-N 122.443 0.707 . . . . 0.0 110.398 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.518 ' NH2' ' HB3' ' A' ' 159' ' ' ASN . 39.7 mtp180 -84.8 -45.58 12.21 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.533 ' HG ' ' CG2' ' A' ' 147' ' ' ILE . 1.0 OUTLIER -66.44 -30.14 70.43 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.663 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.567 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 69.0 t80 -67.19 -59.72 3.2 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.484 -0.76 . . . . 0.0 109.561 178.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.485 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 8.5 mttp -49.34 -29.4 6.09 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.679 ' CB ' ' CZ ' ' A' ' 158' ' ' TYR . . . -75.63 -65.72 0.86 Allowed 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.708 0.765 . . . . 0.0 110.934 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.652 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 0.1 OUTLIER -57.59 -33.57 68.34 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.775 -0.578 . . . . 0.0 111.754 -178.382 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.52 HG12 ' CD1' ' A' ' 81' ' ' TYR . 3.9 t -104.39 -61.46 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.853 -1.154 . . . . 0.0 111.49 -178.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.485 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 7.9 mp -77.01 -0.14 23.39 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.166 -0.959 . . . . 0.0 111.599 -178.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.537 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -142.2 6.88 1.75 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.753 -1.217 . . . . 0.0 110.83 179.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . -47.35 -41.78 20.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.089 -1.007 . . . . 0.0 110.044 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.459 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 86.7 m-20 -64.13 -18.12 64.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -0.893 . . . . 0.0 110.034 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.436 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 81.5 m-20 -127.96 11.13 6.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.875 . . . . 0.0 110.158 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.547 HD13 ' HB2' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -95.95 -46.73 6.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.332 -0.855 . . . . 0.0 110.153 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.662 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 6.8 p -78.09 -26.9 0.53 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.898 . . . . 0.0 112.333 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.662 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.9 Cg_endo -78.14 5.82 5.12 Favored 'Trans proline' 0 C--N 1.318 -1.057 0 O-C-N 122.656 0.819 . . . . 0.0 110.539 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -126.15 -27.62 3.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.194 -0.941 . . . . 0.0 109.815 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.556 HG12 ' CD1' ' A' ' 150' ' ' TYR . 14.1 mt -79.96 -43.06 22.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.427 -0.796 . . . . 0.0 109.734 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -161.37 102.63 1.22 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.436 -0.79 . . . . 0.0 110.142 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.65 -0.51 8.96 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.045 1.55 . . . . 0.0 110.546 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -84.16 -17.04 41.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 0.0 109.712 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.41 -70.45 0.66 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.427 -0.796 . . . . 0.0 109.96 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.524 HG12 ' CG2' ' A' ' 56' ' ' ILE . 1.6 mp -103.96 129.28 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.456 -0.778 . . . . 0.0 109.904 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.417 ' NZ ' ' O ' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -72.65 -27.66 62.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.262 -0.899 . . . . 0.0 110.433 -179.941 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.545 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER 178.0 155.45 0.36 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.069 -1.019 . . . . 0.0 110.198 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.9 m -130.75 123.55 29.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.339 -0.851 . . . . 0.0 109.965 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.523 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 79.6 tt0 -133.98 111.87 10.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.098 -1.001 . . . . 0.0 110.52 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 21.3 mt -54.58 142.64 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.327 -0.858 . . . . 0.0 110.02 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.9 tp -118.56 -25.95 6.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.296 -0.878 . . . . 0.0 110.293 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.515 ' CG ' HD13 ' A' ' 53' ' ' ILE . 1.6 m95 -123.76 158.07 32.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.332 -0.855 . . . . 0.0 110.471 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.455 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 43.21 -139.61 2.98 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -150.17 24.59 0.82 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.4 -1.059 . . . . 0.0 109.896 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 121.43 -18.41 8.79 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.478 ' O ' HG23 ' A' ' 71' ' ' ILE . . . -72.09 -173.33 19.99 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.47 ' HA ' HG21 ' A' ' 71' ' ' ILE . 44.2 Cg_endo -72.57 129.01 14.11 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 124.005 1.529 . . . . 0.0 110.613 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.2 -14.31 48.03 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -69.87 166.3 19.76 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.574 -0.956 . . . . 0.0 109.412 179.565 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.515 HD13 ' CG ' ' A' ' 45' ' ' TRP . 51.6 mt -138.46 119.99 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 110.151 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -104.13 127.26 51.71 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.232 -0.917 . . . . 0.0 110.456 -179.909 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.4 tttt -95.4 90.95 5.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.273 -0.892 . . . . 0.0 109.955 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.524 ' CG2' HG12 ' A' ' 38' ' ' ILE . 94.5 mt -79.97 140.37 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.279 -0.888 . . . . 0.0 110.353 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.487 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 2.4 p -111.1 161.78 15.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.327 -0.858 . . . . 0.0 110.025 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.488 ' CD2' ' N ' ' A' ' 66' ' ' TYR . 22.0 m-85 -116.97 166.07 12.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.194 -0.941 . . . . 0.0 110.344 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 58' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.316 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.1 t80 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.194 0.521 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -133.58 134.22 7.36 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 108.609 -1.797 . . . . 0.0 108.609 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.555 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 11.6 p90 -178.78 162.86 1.37 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.173 -1.192 . . . . 0.0 110.162 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.529 ' CG1' ' HA3' ' A' ' 88' ' ' GLY . 4.4 m -142.62 173.59 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.316 -0.865 . . . . 0.0 110.33 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.467 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 77.7 mttt -125.01 124.37 41.84 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.564 -0.71 . . . . 0.0 109.768 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.57 ' CD2' HD11 ' A' ' 85' ' ' LEU . 15.2 m170 -112.97 122.85 48.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.171 -0.956 . . . . 0.0 110.809 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 52' ' ' THR . 46.7 tttp -101.98 109.72 21.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.323 -0.86 . . . . 0.0 109.549 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.529 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 27.9 mm -48.7 136.64 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.123 -0.986 . . . . 0.0 110.21 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.473 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 14.4 t0 -114.41 -43.02 3.23 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.853 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.46 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 16.7 m -165.4 158.69 16.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.457 -0.777 . . . . 0.0 109.855 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.423 HG12 HG12 ' A' ' 23' ' ' VAL . 1.4 mt -145.77 156.01 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.208 -0.933 . . . . 0.0 110.249 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.539 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 2.7 m-20 -135.56 79.21 1.77 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.547 -0.721 . . . . 0.0 110.086 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.567 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 22.1 tttp -61.78 -13.31 22.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.319 -0.863 . . . . 0.0 110.275 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -94.47 -31.23 14.04 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.237 -0.914 . . . . 0.0 109.724 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.508 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -108.47 -3.42 18.17 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.458 -0.776 . . . . 0.0 109.735 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.517 ' N ' ' O ' ' A' ' 75' ' ' ASP . 7.2 m-30 64.68 50.39 2.1 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.568 -0.707 . . . . 0.0 110.304 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.539 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.6 OUTLIER -118.53 153.44 34.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.316 -0.865 . . . . 0.0 109.25 179.352 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.529 ' OH ' ' CD1' ' A' ' 71' ' ' ILE . 22.0 t80 -141.41 132.46 26.18 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.047 -1.033 . . . . 0.0 110.398 -179.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.453 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 4.3 m -137.6 120.06 15.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.161 -0.962 . . . . 0.0 110.665 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.626 ' CE2' ' CB ' ' A' ' 100' ' ' TYR . 21.2 p90 -135.96 170.88 15.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.142 -0.973 . . . . 0.0 110.349 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 43.5 m -121.31 132.24 54.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.399 -0.813 . . . . 0.0 109.941 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.57 HD11 ' CD2' ' A' ' 69' ' ' HIS . 3.5 tp -98.53 126.03 43.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.177 -0.952 . . . . 0.0 110.153 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 14.3 pt -105.12 -11.22 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.278 -0.889 . . . . 0.0 110.056 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.467 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 4.3 tt0 -134.93 164.23 28.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.196 -0.94 . . . . 0.0 110.25 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.529 ' HA3' ' CG1' ' A' ' 67' ' ' VAL . . . 149.66 116.57 0.81 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -54.89 -20.2 8.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.24 -1.153 . . . . 0.0 110.171 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.575 ' O ' ' CE1' ' A' ' 132' ' ' HIS . . . -73.23 -8.91 57.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.366 -0.834 . . . . 0.0 110.213 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 88' ' ' GLY . 19.4 mt -81.54 -7.03 59.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.301 -0.874 . . . . 0.0 110.088 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 45.61 -170.43 0.02 OUTLIER Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -89.32 24.21 2.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -1.154 . . . . 0.0 109.885 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.419 ' OG1' HD21 ' A' ' 95' ' ' LEU . 11.1 p -118.18 -44.34 2.69 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.395 -0.815 . . . . 0.0 110.402 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.623 ' CD2' ' N ' ' A' ' 95' ' ' LEU . 3.1 mm? -79.93 162.71 24.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.392 -0.817 . . . . 0.0 110.388 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.43 ' CD ' ' HB2' ' A' ' 123' ' ' LYS . 10.5 mt-10 -146.16 -80.99 0.15 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.367 -0.833 . . . . 0.0 109.798 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.533 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 36.8 mttp -80.25 127.28 32.17 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.575 -0.703 . . . . 0.0 110.34 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.635 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 5.1 mm -117.68 137.5 51.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 120.446 -1.409 . . . . 0.0 110.0 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.477 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.3 OUTLIER -114.35 131.02 56.69 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.754 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.635 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 7.6 m-85 -125.42 134.8 51.99 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.317 -0.864 . . . . 0.0 110.576 -178.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 117' ' ' THR . 1.9 tt0 -138.95 131.46 28.73 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.413 -0.805 . . . . 0.0 110.128 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 61.0 m -132.99 142.07 48.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.308 -0.87 . . . . 0.0 109.855 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -134.38 143.2 47.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 0.0 110.527 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.505 ' HB2' ' CB ' ' A' ' 79' ' ' TYR . 14.2 mt -119.0 150.68 39.53 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.396 -0.815 . . . . 0.0 109.916 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.449 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 2.0 t -146.5 -168.99 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.177 -0.952 . . . . 0.0 110.061 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -124.19 160.9 26.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.313 -0.867 . . . . 0.0 110.14 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.452 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.5 p -119.42 170.17 7.14 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.912 . . . . 0.0 110.224 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 45.9 Cg_endo -72.32 -17.13 27.63 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.059 1.557 . . . . 0.0 110.484 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 59.8 p -93.28 -1.09 56.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.232 -0.918 . . . . 0.0 110.27 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.31 -36.98 4.04 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.411 ' HA3' ' HA ' ' A' ' 12' ' ' GLU . . . -54.3 -175.49 0.09 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.466 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 85.7 p -131.41 137.47 48.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.24 -1.153 . . . . 0.0 110.283 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.476 ' HA ' ' CG2' ' A' ' 10' ' ' THR . 16.6 mt -90.61 146.57 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.216 -0.928 . . . . 0.0 110.076 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.582 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 6.7 mt -128.32 127.13 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.283 -0.886 . . . . 0.0 110.134 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -119.77 108.79 14.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -0.912 . . . . 0.0 110.035 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.7 m -95.19 158.72 15.34 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.22 -0.925 . . . . 0.0 110.37 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 101' ' ' GLU . 60.6 m -160.13 122.44 3.31 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.386 -0.821 . . . . 0.0 109.903 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 94.8 p -126.18 171.19 11.09 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.137 -0.977 . . . . 0.0 110.466 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.566 ' CE1' HG21 ' A' ' 4' ' ' THR . 89.2 m-70 -145.27 140.05 27.54 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.334 -0.854 . . . . 0.0 110.288 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.537 ' CD2' HD13 ' A' ' 95' ' ' LEU . 3.2 m-30 -105.84 146.66 29.62 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.322 -0.861 . . . . 0.0 110.634 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.533 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 59.6 m-70 -131.69 96.48 3.97 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.188 -0.945 . . . . 0.0 109.265 178.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.533 ' CG2' HD23 ' A' ' 95' ' ' LEU . 1.1 p -80.04 153.44 28.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.325 -0.859 . . . . 0.0 110.959 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.43 ' HB2' ' CD ' ' A' ' 96' ' ' GLU . 7.9 tttp -96.49 132.85 41.63 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.652 -0.655 . . . . 0.0 110.082 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 87.12 -144.88 19.53 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.42 ' C ' HG11 ' A' ' 126' ' ' VAL . 36.7 t30 -118.65 74.0 0.94 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.296 -1.12 . . . . 0.0 110.17 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.445 HG21 ' HB ' ' A' ' 122' ' ' THR . 21.8 m -131.9 167.19 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.226 -0.921 . . . . 0.0 110.139 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -128.4 152.91 47.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.206 -0.934 . . . . 0.0 110.236 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.636 ' CD1' ' CD1' ' A' ' 3' ' ' PHE . 3.5 mt -77.45 173.09 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.283 -0.886 . . . . 0.0 110.164 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.483 ' N ' HG23 ' A' ' 128' ' ' ILE . 27.1 mttt -104.78 141.63 36.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.406 -0.809 . . . . 0.0 110.025 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' ' 134' ' ' LYS . 97.6 mt-10 -54.52 -42.65 71.1 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.121 -0.987 . . . . 0.0 110.002 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -55.93 -38.28 70.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.245 -0.909 . . . . 0.0 109.897 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.575 ' CE1' ' O ' ' A' ' 90' ' ' ALA . 16.3 t-160 -69.47 -53.88 17.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.244 -0.91 . . . . 0.0 110.099 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.631 ' CG1' ' CE1' ' A' ' 5' ' ' TYR . 97.1 t -60.1 -38.39 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.416 -0.803 . . . . 0.0 109.87 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 130' ' ' GLU . 64.9 mttt -71.06 -38.3 72.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.259 -0.901 . . . . 0.0 109.958 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.97 -20.83 62.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -0.869 . . . . 0.0 110.016 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.15 -25.7 54.51 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 82.7 mttt -77.24 -31.72 55.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.266 -1.138 . . . . 0.0 110.121 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -75.36 -31.74 60.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.334 -0.854 . . . . 0.0 110.028 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -73.88 -31.95 63.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 0.0 109.944 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.573 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -76.16 -35.41 59.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 110.161 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 84.5 p -67.52 -46.73 71.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.299 -0.876 . . . . 0.0 110.02 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -58.71 -46.16 87.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.187 -0.946 . . . . 0.0 110.008 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 19.6 mt -60.63 -36.36 78.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.913 . . . . 0.0 110.033 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.651 ' CD2' ' CZ ' ' A' ' 9' ' ' PHE . 7.2 m-85 -63.35 -40.08 96.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.366 -0.834 . . . . 0.0 109.865 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 145' ' ' LYS . 11.8 tttp -73.43 -9.56 58.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.35 -0.843 . . . . 0.0 110.128 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 13.0 mt -84.72 -39.63 18.28 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.235 -0.915 . . . . 0.0 108.95 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.652 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 4.6 mt -68.61 -45.17 82.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.501 ' CG ' ' HB2' ' A' ' 11' ' ' SER . 84.4 mt-10 -58.59 -45.34 89.31 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.481 -0.762 . . . . 0.0 109.564 179.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 18.9 m -68.24 -32.1 72.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.111 -0.993 . . . . 0.0 109.576 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.57 ' CE2' ' HB1' ' A' ' 157' ' ' ALA . 92.7 t80 -57.26 -47.93 80.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.586 -0.696 . . . . 0.0 109.97 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.591 HD22 ' CZ ' ' A' ' 158' ' ' TYR . 73.3 mt -74.52 -37.73 62.99 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.331 -0.855 . . . . 0.0 110.517 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.46 ' HB2' HD12 ' A' ' 13' ' ' ILE . 14.2 tttm -62.19 -13.62 29.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.248 -0.908 . . . . 0.0 109.59 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.463 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -119.96 -26.2 2.35 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.146 -1.581 . . . . 0.0 109.146 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.568 ' CD2' ' O ' ' A' ' 150' ' ' TYR . 12.8 m-70 -105.97 93.88 8.36 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.338 -1.095 . . . . 0.0 110.109 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.0 Cg_endo -73.23 5.06 3.34 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.111 1.585 . . . . 0.0 111.118 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 32.6 p30 -122.01 -4.8 9.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.006 -1.059 . . . . 0.0 109.833 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.593 ' HB3' ' CZ ' ' A' ' 158' ' ' TYR . . . -47.8 110.85 0.36 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.43 -0.793 . . . . 0.0 110.193 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.679 ' CZ ' ' CB ' ' A' ' 21' ' ' ALA . 0.4 OUTLIER 33.76 33.08 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.766 -0.583 . . . . 0.0 110.872 -179.431 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.518 ' HB3' ' NH2' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 117.98 -1.009 . . . . 0.0 109.769 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 49.0 t -114.71 147.7 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.188 -1.183 . . . . 0.0 110.37 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.566 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 60.8 m-85 -106.72 165.77 11.07 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.336 -0.852 . . . . 0.0 110.336 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 66.5 m -146.85 98.27 3.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.269 -0.894 . . . . 0.0 110.305 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.573 ' CZ ' HG23 ' A' ' 133' ' ' VAL . 87.7 m-85 -111.54 140.92 45.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.197 -0.94 . . . . 0.0 109.876 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 20.6 pt-20 -138.56 151.72 47.55 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.141 -0.975 . . . . 0.0 110.43 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.46 ' OG ' ' HB2' ' A' ' 116' ' ' SER . 88.2 p -123.23 157.12 33.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.328 -0.857 . . . . 0.0 109.782 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -137.28 121.85 18.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.16 -0.962 . . . . 0.0 110.434 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.635 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.3 p90 -148.63 -172.78 4.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.281 -0.887 . . . . 0.0 109.8 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.458 HG23 HG12 ' A' ' 113' ' ' ILE . 17.3 p -141.73 -178.96 5.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.167 -0.958 . . . . 0.0 110.731 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.419 ' HB2' HD13 ' A' ' 114' ' ' ILE . 3.0 t -160.01 160.1 32.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.471 -0.768 . . . . 0.0 110.226 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.44 ' HB2' ' HE2' ' A' ' 152' ' ' LYS . 97.2 mt-10 -84.45 -30.37 25.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.256 -0.903 . . . . 0.0 110.03 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.544 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 11.6 mm -70.58 150.27 95.5 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.46 -0.775 . . . . 0.0 109.942 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.544 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 40.1 Cg_endo -66.2 143.89 72.86 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.022 1.538 . . . . 0.0 110.384 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.64 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.2 Cg_endo -72.27 -31.41 11.76 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.983 1.517 . . . . 0.0 112.849 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.64 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.7 Cg_endo -69.41 -21.47 35.05 Favored 'Trans proline' 0 C--N 1.316 -1.154 0 N-CA-C 110.13 -0.758 . . . . 0.0 110.13 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.527 ' NE ' ' HB2' ' A' ' 159' ' ' ASN . 54.6 mtp180 -84.36 -46.13 12.06 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.505 ' C ' ' CD2' ' A' ' 18' ' ' LEU . 1.1 tt -69.61 -29.31 66.8 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.485 ' HB2' ' O ' ' A' ' 15' ' ' PRO . 76.5 t80 -66.7 -59.55 3.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.51 -0.744 . . . . 0.0 109.328 178.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.484 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 14.9 mttp -50.25 -35.3 26.38 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.199 179.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.653 ' CB ' ' CZ ' ' A' ' 158' ' ' TYR . . . -77.51 -41.01 40.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.394 -0.816 . . . . 0.0 110.703 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.635 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 1.6 t80 -69.56 -43.74 72.3 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.253 -0.904 . . . . 0.0 111.128 -178.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.568 HG12 ' CD1' ' A' ' 81' ' ' TYR . 4.3 t -104.31 -52.41 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.062 -1.024 . . . . 0.0 111.664 -179.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.512 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 7.2 mp -78.34 0.4 25.66 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.11 -0.994 . . . . 0.0 111.304 -178.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.546 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.4 OUTLIER -157.55 39.29 0.28 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.912 -1.118 . . . . 0.0 110.43 179.796 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.466 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -77.48 -24.81 50.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.279 -0.888 . . . . 0.0 110.128 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.461 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 87.3 m-20 -65.54 -16.46 63.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 110.145 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -129.9 13.04 5.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.352 -0.842 . . . . 0.0 110.016 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.527 HD11 ' CD1' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -99.84 -46.64 5.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.273 -0.892 . . . . 0.0 110.042 -179.944 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.598 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 3.5 t -84.92 -41.5 0.67 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.381 -0.824 . . . . 0.0 110.819 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.8 Cg_endo -78.98 9.93 3.13 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 O-C-N 123.47 1.247 . . . . 0.0 110.693 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.9 tptt -126.84 -34.44 2.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.079 -1.013 . . . . 0.0 109.428 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.527 ' CD1' HD11 ' A' ' 29' ' ' LEU . 62.3 mt -80.14 -43.35 22.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.569 -0.707 . . . . 0.0 109.546 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.26 100.4 4.16 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.54 -0.725 . . . . 0.0 109.919 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.37 -0.27 7.89 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 124.108 1.583 . . . . 0.0 110.803 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -84.25 -12.44 54.72 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.097 -1.002 . . . . 0.0 109.627 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.419 ' HB2' HD11 ' A' ' 38' ' ' ILE . . . -99.89 -65.08 0.99 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.491 -0.755 . . . . 0.0 109.987 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.514 HG13 ' CG2' ' A' ' 56' ' ' ILE . 1.9 mp -113.82 117.83 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.428 -0.795 . . . . 0.0 109.86 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' A' ' 57' ' ' THR . 9.1 ttpt -72.02 -30.94 65.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.321 -0.862 . . . . 0.0 110.518 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.548 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -169.02 151.88 4.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.196 -0.94 . . . . 0.0 110.211 -179.674 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.9 m -130.17 123.63 30.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.468 -0.77 . . . . 0.0 109.793 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.507 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 68.6 tt0 -134.25 113.3 11.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.04 -1.037 . . . . 0.0 110.6 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.478 HG22 HD11 ' A' ' 43' ' ' ILE . 44.7 mt -59.15 141.83 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.207 -0.933 . . . . 0.0 109.898 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.484 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 32.4 mt -116.29 -28.21 6.6 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.239 -0.913 . . . . 0.0 110.546 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.512 ' HB2' ' CB ' ' A' ' 53' ' ' ILE . 1.8 m95 -123.7 163.99 20.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.098 -1.001 . . . . 0.0 110.633 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 45' ' ' TRP . . . 42.34 -144.01 1.11 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -146.78 25.7 1.16 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.282 -1.128 . . . . 0.0 110.133 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 117.34 -15.22 13.19 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.126 -1.589 . . . . 0.0 109.126 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.516 ' O ' ' CG2' ' A' ' 71' ' ' ILE . . . -78.15 -167.6 31.04 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.473 ' HA ' HG23 ' A' ' 71' ' ' ILE . 46.2 Cg_endo -73.39 129.48 13.91 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.026 1.54 . . . . 0.0 110.641 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.27 -11.16 54.86 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -72.2 157.47 37.67 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.524 -0.986 . . . . 0.0 109.839 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.512 ' CB ' ' HB2' ' A' ' 45' ' ' TRP . 57.6 mt -129.71 120.06 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.0 109.875 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 93.1 mttt -106.24 132.47 52.26 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.164 -0.96 . . . . 0.0 110.531 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.484 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 77.7 tttt -101.64 92.69 4.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.319 -0.863 . . . . 0.0 109.92 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.514 ' CG2' HG13 ' A' ' 38' ' ' ILE . 91.5 mt -79.95 144.29 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.931 . . . . 0.0 110.289 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 39' ' ' LYS . 2.6 p -117.8 156.07 28.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 110.486 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.572 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 16.1 m-85 -115.49 148.15 39.81 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.352 -0.843 . . . . 0.0 110.039 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.912 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.235 0.541 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.572 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -130.08 97.73 0.4 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.538 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 12.8 p90 -138.88 167.13 22.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.145 -1.209 . . . . 0.0 110.112 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.521 ' CG1' ' HA3' ' A' ' 88' ' ' GLY . 6.3 m -139.2 174.88 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.243 -0.911 . . . . 0.0 110.72 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.486 ' NZ ' ' OE1' ' A' ' 87' ' ' GLU . 30.1 mttt -128.85 122.35 30.22 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.516 -0.74 . . . . 0.0 109.743 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.533 ' CD2' ' CD1' ' A' ' 85' ' ' LEU . 13.2 m170 -109.46 126.56 53.62 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.16 -0.962 . . . . 0.0 110.88 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 52' ' ' THR . 54.9 tttt -97.63 121.86 40.03 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.273 -0.892 . . . . 0.0 109.609 179.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.538 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 30.7 mm -64.96 122.37 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.162 -0.961 . . . . 0.0 110.522 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 82' ' ' SER . 27.9 m-20 -98.18 -47.6 5.41 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.427 -0.796 . . . . 0.0 109.968 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 44.7 m -167.8 157.95 10.5 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.349 -0.845 . . . . 0.0 109.751 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.468 HG12 HG12 ' A' ' 23' ' ' VAL . 3.6 mt -135.35 160.52 40.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.228 -0.92 . . . . 0.0 110.355 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.584 ' HB2' ' HB2' ' A' ' 80' ' ' SER . 17.4 m-20 -132.7 83.1 2.04 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.606 -0.684 . . . . 0.0 110.161 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.484 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 45.1 mttm -72.95 -10.1 59.43 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.354 -0.841 . . . . 0.0 110.218 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -93.14 -39.26 11.14 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.317 -0.864 . . . . 0.0 109.315 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.501 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 1.1 p30 -111.78 12.25 20.97 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.466 0.651 . . . . 0.0 110.761 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.508 ' CZ ' ' HB3' ' A' ' 16' ' ' PRO . 7.3 m-85 54.19 60.79 3.37 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.449 -0.782 . . . . 0.0 112.858 178.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.584 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 1.1 m -128.03 156.87 42.07 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.954 -1.091 . . . . 0.0 109.484 177.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.683 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 31.2 t80 -142.13 137.32 30.83 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.158 -0.964 . . . . 0.0 110.444 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 50.7 m -140.74 125.98 18.61 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.447 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.683 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 7.2 p90 -141.69 176.53 8.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.281 -0.887 . . . . 0.0 110.02 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.465 ' OG1' ' OD2' ' A' ' 72' ' ' ASP . 46.0 m -126.8 132.82 50.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.298 -0.876 . . . . 0.0 109.868 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.542 ' HB3' ' HB ' ' A' ' 98' ' ' ILE . 12.4 tp -98.16 121.87 40.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.171 -0.955 . . . . 0.0 110.227 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.467 HG23 HD11 ' A' ' 86' ' ' ILE . 9.7 pt -104.59 -16.63 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.294 -0.879 . . . . 0.0 110.531 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.486 ' OE1' ' NZ ' ' A' ' 68' ' ' LYS . 54.4 tt0 -129.11 165.35 21.41 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.148 -0.97 . . . . 0.0 110.385 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.521 ' HA3' ' CG1' ' A' ' 67' ' ' VAL . . . 149.51 120.96 1.07 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -56.52 -19.31 14.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.299 -1.118 . . . . 0.0 110.183 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.99 -18.18 54.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.295 -0.878 . . . . 0.0 110.228 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 92' ' ' GLY . 77.1 mt -66.98 -27.61 67.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.223 -0.923 . . . . 0.0 110.162 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 50.15 179.51 0.02 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 57.6 p-10 -79.64 5.65 12.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.243 -1.151 . . . . 0.0 110.07 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.449 ' O ' HG21 ' A' ' 122' ' ' THR . 43.0 p -93.65 -34.91 13.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.89 . . . . 0.0 110.099 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.588 ' CD2' ' CG2' ' A' ' 122' ' ' THR . 19.5 mt -104.83 162.05 13.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 110.034 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.42 ' CD ' ' HB2' ' A' ' 123' ' ' LYS . 54.4 mt-10 -142.68 -80.3 0.21 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.297 -0.877 . . . . 0.0 109.978 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.516 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 53.7 mttp -80.14 126.16 30.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.595 -0.691 . . . . 0.0 110.409 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.643 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 5.3 mm -115.52 140.55 36.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 120.615 -1.303 . . . . 0.0 109.826 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.451 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -118.35 128.24 54.46 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.676 -0.81 . . . . 0.0 108.941 178.874 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.643 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 11.0 m-85 -123.53 135.33 53.96 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.313 -0.867 . . . . 0.0 110.533 -178.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.461 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 72.8 tt0 -139.14 136.29 34.96 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.276 -0.89 . . . . 0.0 110.146 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 50.3 m -137.36 138.94 40.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -0.926 . . . . 0.0 110.234 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.8 tttt -133.05 147.01 52.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.196 -0.94 . . . . 0.0 110.391 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.531 ' CD2' HG12 ' A' ' 114' ' ' ILE . 7.8 mt -121.82 153.8 37.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.273 -0.892 . . . . 0.0 110.241 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.455 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -149.49 -168.78 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.19 -0.944 . . . . 0.0 110.061 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -126.01 150.27 48.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.329 -0.857 . . . . 0.0 110.213 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.463 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 2.7 p -108.13 169.65 6.37 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.934 . . . . 0.0 110.345 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.7 Cg_endo -73.11 -11.41 25.2 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 O-C-N 124.106 1.582 . . . . 0.0 110.448 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 58.5 p -96.89 5.74 49.95 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.157 -0.965 . . . . 0.0 110.293 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.08 -38.17 3.2 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -55.61 -172.91 0.12 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.472 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 5.7 p -131.97 138.29 48.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.255 -1.144 . . . . 0.0 110.271 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.461 HD13 ' O ' ' A' ' 106' ' ' ALA . 20.5 mt -89.96 149.81 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.29 -0.881 . . . . 0.0 110.151 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.626 ' CG2' ' CZ ' ' A' ' 9' ' ' PHE . 11.5 mt -131.23 126.73 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.228 -0.92 . . . . 0.0 110.222 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -118.09 110.2 17.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.163 -0.96 . . . . 0.0 110.219 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.46 ' HB2' ' OG ' ' A' ' 7' ' ' SER . 1.6 m -98.57 160.71 14.1 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.236 -0.915 . . . . 0.0 110.44 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 52.9 m -160.03 124.46 3.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.376 -0.827 . . . . 0.0 109.984 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 90.5 p -129.03 157.5 41.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.201 -0.937 . . . . 0.0 110.469 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 47.1 m-70 -134.52 161.45 35.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.263 -0.898 . . . . 0.0 110.037 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.476 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 25.9 m-85 -128.35 142.03 51.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.231 -0.918 . . . . 0.0 110.722 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.516 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 87.8 m-70 -124.56 96.04 4.75 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.214 -0.929 . . . . 0.0 109.124 178.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.588 ' CG2' ' CD2' ' A' ' 95' ' ' LEU . 1.8 p -86.0 153.93 21.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.292 -0.88 . . . . 0.0 111.099 -178.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.42 ' HB2' ' CD ' ' A' ' 96' ' ' GLU . 20.7 tttt -101.92 121.64 42.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.547 -0.721 . . . . 0.0 109.963 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 105.4 -140.7 15.17 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -122.88 76.52 1.37 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.3 -1.117 . . . . 0.0 110.346 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.527 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 21.4 m -136.49 162.36 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.19 -0.944 . . . . 0.0 110.06 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.407 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 87.1 mt-10 -129.93 159.29 37.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.173 -0.955 . . . . 0.0 110.434 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.527 ' CD1' HD22 ' A' ' 95' ' ' LEU . 19.6 mm -66.96 173.1 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.332 -0.855 . . . . 0.0 110.149 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 132' ' ' HIS . 7.4 mtpp -113.02 135.14 54.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.386 -0.821 . . . . 0.0 109.95 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -44.03 -43.14 6.55 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.174 -0.954 . . . . 0.0 110.027 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.5 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 48.7 tt0 -62.92 -24.02 67.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -0.898 . . . . 0.0 109.891 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 129' ' ' LYS . 14.8 t-160 -79.9 -50.91 9.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.379 -0.826 . . . . 0.0 110.113 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.573 HG23 ' CZ ' ' A' ' 5' ' ' TYR . 46.9 t -60.92 -40.03 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.324 -0.86 . . . . 0.0 109.973 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -75.73 -50.43 15.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.399 -0.813 . . . . 0.0 110.149 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.5 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -61.69 -28.17 69.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.214 -0.929 . . . . 0.0 110.049 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.5 -28.81 64.86 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 38.9 mttm -69.53 -31.48 69.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.262 -1.14 . . . . 0.0 110.085 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 142' ' ' ASN . 99.0 mt-10 -77.16 -32.53 56.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.32 -0.862 . . . . 0.0 110.163 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.519 ' O ' ' CD1' ' A' ' 143' ' ' LEU . 35.6 mttt -68.42 -31.62 71.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.313 -0.867 . . . . 0.0 110.22 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.567 ' O ' ' CD1' ' A' ' 144' ' ' PHE . . . -90.28 -41.52 11.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.308 -0.87 . . . . 0.0 110.201 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.3 m -68.98 -47.33 65.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.407 -0.808 . . . . 0.0 110.14 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 138' ' ' GLU . 97.1 m-20 -55.14 -47.68 74.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.183 -0.948 . . . . 0.0 110.035 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.519 ' CD1' ' O ' ' A' ' 139' ' ' LYS . 76.0 mt -57.54 -42.09 82.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.313 -0.867 . . . . 0.0 109.91 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.567 ' CD1' ' O ' ' A' ' 140' ' ' ALA . 4.8 m-85 -58.61 -36.33 73.87 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.304 -0.872 . . . . 0.0 109.774 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 33.8 tttm -64.25 -26.0 68.31 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.319 -0.863 . . . . 0.0 109.777 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.453 ' HB3' HG23 ' A' ' 33' ' ' ILE . 16.6 mt -78.23 -34.27 49.36 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.635 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 47.5 mt -69.22 -51.64 41.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.468 ' O ' ' HG3' ' A' ' 152' ' ' LYS . 94.6 mt-10 -54.56 -42.16 70.63 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.37 -0.831 . . . . 0.0 109.169 178.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.457 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 88.5 m -63.72 -44.4 93.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.369 -0.832 . . . . 0.0 109.375 179.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.584 ' CE2' ' HB1' ' A' ' 157' ' ' ALA . 89.9 t80 -46.32 -44.96 17.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.577 -0.702 . . . . 0.0 109.704 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.584 HD22 ' CE1' ' A' ' 158' ' ' TYR . 77.2 mt -80.02 -31.34 39.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.434 -0.791 . . . . 0.0 110.231 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.528 ' CG ' HG12 ' A' ' 13' ' ' ILE . 45.0 mttt -65.39 -16.4 63.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.187 -0.946 . . . . 0.0 109.602 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.461 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -116.94 -28.17 2.53 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.565 ' CD2' ' O ' ' A' ' 150' ' ' TYR . 7.7 m-70 -106.04 93.2 7.43 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.329 -1.101 . . . . 0.0 110.028 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 46.6 Cg_endo -73.46 4.95 3.52 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.096 1.577 . . . . 0.0 110.951 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -116.25 -8.53 11.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.07 -1.019 . . . . 0.0 109.758 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.584 ' HB1' ' CE2' ' A' ' 150' ' ' TYR . . . -48.48 107.76 0.14 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.407 -0.808 . . . . 0.0 110.059 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.653 ' CZ ' ' CB ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 35.61 30.85 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.599 -0.688 . . . . 0.0 110.644 -179.768 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.527 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.784 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.601 HG22 ' CG ' ' A' ' 121' ' ' HIS . 7.4 p -91.62 154.0 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.262 -1.14 . . . . 0.0 110.386 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.585 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 15.3 m-85 -92.22 173.68 7.7 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.174 -0.953 . . . . 0.0 110.494 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.6 m -152.23 93.37 1.8 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.288 -0.882 . . . . 0.0 110.197 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.639 ' CZ ' ' CG2' ' A' ' 133' ' ' VAL . 81.4 m-85 -116.0 145.84 42.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.172 -0.955 . . . . 0.0 109.905 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 21.4 pt-20 -141.99 152.62 43.6 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.169 -0.957 . . . . 0.0 110.534 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 52.6 m -126.58 146.47 50.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.323 -0.86 . . . . 0.0 109.888 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -121.5 129.04 52.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.166 -0.959 . . . . 0.0 110.485 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.64 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.3 p90 -149.18 -175.57 5.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.35 -0.844 . . . . 0.0 109.802 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.481 HG23 HG12 ' A' ' 113' ' ' ILE . 17.3 p -140.44 177.92 7.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.138 -0.976 . . . . 0.0 110.725 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.524 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 2.5 t -158.14 158.99 35.71 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.479 -0.763 . . . . 0.0 110.069 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -85.4 -15.4 43.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.288 -0.883 . . . . 0.0 110.054 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.538 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 11.4 mm -82.4 149.67 61.98 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.33 -0.856 . . . . 0.0 110.056 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.538 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 41.8 Cg_endo -66.93 145.59 74.8 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.03 1.542 . . . . 0.0 110.306 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.638 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.2 Cg_endo -71.39 -31.96 13.2 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.978 1.514 . . . . 0.0 112.848 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 40.6 Cg_endo -68.31 -22.31 40.07 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 122.51 0.742 . . . . 0.0 110.245 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.534 ' NE ' ' CB ' ' A' ' 159' ' ' ASN . 46.0 mtp180 -85.1 -42.89 14.37 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.505 HD23 ' CD2' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -73.76 -33.37 64.24 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.947 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.567 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 59.5 t80 -65.65 -55.54 16.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.396 -0.815 . . . . 0.0 109.281 178.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 25' ' ' ASP . 12.0 mttt -51.83 -40.17 60.04 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.825 -0.75 . . . . 0.0 109.436 179.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.661 ' CB ' ' CZ ' ' A' ' 158' ' ' TYR . . . -73.96 -38.73 64.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.4 -0.813 . . . . 0.0 111.009 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.623 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 0.3 OUTLIER -75.26 -36.86 61.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.07 -1.019 . . . . 0.0 110.912 -179.231 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.466 HG12 HG12 ' A' ' 74' ' ' ILE . 5.1 t -107.26 -58.56 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.189 -0.944 . . . . 0.0 111.59 -179.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.465 HD11 ' HA ' ' A' ' 20' ' ' LYS . 7.0 mp -76.54 -1.8 29.19 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.138 -0.976 . . . . 0.0 111.534 -178.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.526 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.8 OUTLIER -154.91 49.49 0.58 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.936 -1.103 . . . . 0.0 110.099 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.478 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -87.43 -29.58 21.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.306 -0.871 . . . . 0.0 110.69 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -61.95 -18.0 58.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 0.0 110.425 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.524 ' O ' ' CG ' ' A' ' 32' ' ' LYS . 4.6 p30 -126.08 11.5 7.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 110.065 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.538 HD11 ' CD1' ' A' ' 33' ' ' ILE . 0.4 OUTLIER -97.52 -53.82 3.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -0.859 . . . . 0.0 110.154 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.594 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 2.9 t -71.8 -41.46 9.28 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.273 -0.892 . . . . 0.0 110.876 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 47.5 Cg_endo -76.77 7.44 3.54 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 O-C-N 123.399 1.21 . . . . 0.0 110.968 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.524 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 47.7 mmtm -127.24 -35.46 2.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.086 -1.009 . . . . 0.0 109.403 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.557 HG12 ' CD1' ' A' ' 150' ' ' TYR . 10.1 mt -80.12 -33.73 14.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.583 -0.698 . . . . 0.0 109.382 179.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.43 91.33 4.45 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.583 -0.698 . . . . 0.0 110.068 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.82 2.07 6.34 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.104 1.581 . . . . 0.0 110.797 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -87.34 -15.23 38.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.094 -1.004 . . . . 0.0 109.869 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -107.64 -43.97 4.37 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.3 -0.875 . . . . 0.0 110.188 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.546 HG12 ' CE1' ' A' ' 58' ' ' PHE . 3.4 mt -127.45 142.37 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.392 -0.817 . . . . 0.0 110.116 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.496 ' CB ' ' O ' ' A' ' 59' ' ' GLY . 8.7 tppt? -119.62 -21.06 7.47 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.282 -0.887 . . . . 0.0 110.689 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.564 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.5 OUTLIER -153.46 152.48 31.05 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.05 -1.031 . . . . 0.0 110.465 -179.671 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.458 ' N ' ' CD2' ' A' ' 40' ' ' HIS . 17.5 m -150.99 118.31 6.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.509 -0.744 . . . . 0.0 109.573 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -133.97 109.3 8.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.181 -0.95 . . . . 0.0 110.788 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.47 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 21.9 mt -54.18 137.62 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.257 -0.902 . . . . 0.0 109.748 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.9 tp -107.07 -30.1 9.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.116 -0.99 . . . . 0.0 110.995 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.571 ' CD2' HD13 ' A' ' 53' ' ' ILE . 2.0 m95 -124.08 164.64 19.0 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.153 -0.967 . . . . 0.0 110.875 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.467 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 41.24 -137.91 2.04 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.429 ' O ' ' CG ' ' A' ' 47' ' ' ASP . 11.5 t0 -154.33 24.25 0.48 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.312 -1.111 . . . . 0.0 109.85 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 120.07 -17.83 9.82 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.467 ' O ' HG22 ' A' ' 71' ' ' ILE . . . -68.29 -174.54 8.73 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.469 ' HA ' HG23 ' A' ' 71' ' ' ILE . 46.0 Cg_endo -73.74 128.34 12.42 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 123.937 1.493 . . . . 0.0 110.639 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.96 -13.12 56.14 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -66.59 162.13 21.63 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.516 -0.99 . . . . 0.0 109.629 179.672 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.571 HD13 ' CD2' ' A' ' 45' ' ' TRP . 48.2 mt -128.56 121.61 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.241 -0.912 . . . . 0.0 109.756 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 98.7 mttt -107.78 134.19 51.09 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.173 -0.955 . . . . 0.0 110.319 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.573 ' HE2' ' CD1' ' A' ' 66' ' ' TYR . 14.5 tptm -105.65 90.32 3.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.266 -0.896 . . . . 0.0 109.802 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.573 HG23 ' CE1' ' A' ' 58' ' ' PHE . 73.0 mt -79.96 145.63 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.32 -0.863 . . . . 0.0 110.339 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.492 ' OG1' ' CD2' ' A' ' 40' ' ' HIS . 0.6 OUTLIER -122.55 144.87 48.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.374 -0.829 . . . . 0.0 109.88 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.609 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 13.5 m-85 -113.26 170.27 8.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.087 -1.008 . . . . 0.0 110.142 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.496 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.673 ' CE1' ' CE2' ' A' ' 66' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.308 0.575 . . . . 0.0 109.927 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.609 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -145.82 60.98 0.48 Allowed Glycine 0 N--CA 1.483 1.829 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 179.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.673 ' CE2' ' CE1' ' A' ' 64' ' ' TYR . 10.5 p90 -125.12 166.19 16.87 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.206 -1.173 . . . . 0.0 109.894 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.532 HG13 ' CA ' ' A' ' 88' ' ' GLY . 6.3 m -140.54 172.26 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 110.68 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.482 ' HD3' ' CD ' ' A' ' 55' ' ' LYS . 0.8 OUTLIER -120.72 120.46 35.73 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.64 -0.662 . . . . 0.0 109.555 179.507 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.524 ' NE2' HD11 ' A' ' 85' ' ' LEU . 12.6 m170 -110.42 119.36 38.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.126 -0.984 . . . . 0.0 111.106 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 52' ' ' THR . 13.4 tttp -96.69 99.4 11.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.183 -0.948 . . . . 0.0 109.444 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.525 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 30.1 mm -42.38 135.92 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.351 -0.843 . . . . 0.0 110.159 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.473 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 90.2 m-20 -104.2 -39.83 6.36 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.291 -0.881 . . . . 0.0 110.033 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 1.4 m -179.38 162.14 1.13 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.246 -0.909 . . . . 0.0 109.6 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.466 HG12 HG12 ' A' ' 23' ' ' VAL . 0.9 OUTLIER -143.99 153.2 15.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.024 -179.812 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' A' ' 78' ' ' ASN . 5.5 m-20 -134.58 78.49 1.75 Allowed 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.501 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.567 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 20.8 tttt -61.65 -15.74 42.5 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.221 -0.925 . . . . 0.0 110.167 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -92.39 -36.0 13.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.242 -0.912 . . . . 0.0 109.41 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.522 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.8 m-80 -96.52 -5.3 39.71 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.639 -0.663 . . . . 0.0 109.387 179.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.522 ' HB2' ' O ' ' A' ' 78' ' ' ASN . 76.4 m-85 62.08 55.95 2.37 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.566 0.698 . . . . 0.0 110.619 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.467 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 1.3 m -132.33 159.15 40.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.365 -0.834 . . . . 0.0 109.714 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.692 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 64.7 t80 -146.56 146.09 30.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.19 -0.943 . . . . 0.0 109.811 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.533 ' OG ' ' CG ' ' A' ' 101' ' ' GLU . 0.2 OUTLIER -153.48 138.14 16.94 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.167 -0.958 . . . . 0.0 110.861 -179.729 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.692 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 11.5 p90 -150.89 173.43 14.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.427 -0.796 . . . . 0.0 110.2 179.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.471 ' OG1' ' OD2' ' A' ' 72' ' ' ASP . 58.2 m -124.92 131.58 53.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.421 -0.799 . . . . 0.0 109.934 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.524 HD11 ' NE2' ' A' ' 69' ' ' HIS . 2.0 tp -100.1 129.09 46.1 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.201 -0.937 . . . . 0.0 110.044 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.441 HG12 ' HB3' ' A' ' 68' ' ' LYS . 12.8 pt -115.27 -13.56 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -0.891 . . . . 0.0 110.027 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.43 ' O ' HD12 ' A' ' 85' ' ' LEU . 18.1 tt0 -128.68 154.63 46.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.884 . . . . 0.0 110.232 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.532 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 154.8 128.28 1.16 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -64.9 -10.87 32.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.273 -1.133 . . . . 0.0 110.242 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.91 -17.35 41.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.275 -0.891 . . . . 0.0 110.166 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.483 HD23 ' CG1' ' A' ' 98' ' ' ILE . 51.2 mt -69.01 -19.08 64.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.893 . . . . 0.0 110.234 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 49.09 -177.36 0.02 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -84.36 11.88 7.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.259 -1.142 . . . . 0.0 110.173 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 69.7 p -102.84 -38.18 7.52 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.281 -0.887 . . . . 0.0 110.181 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.528 HD22 ' CG2' ' A' ' 122' ' ' THR . 76.5 mt -95.17 166.22 12.02 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.381 -0.824 . . . . 0.0 109.995 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.459 ' HG3' ' HB2' ' A' ' 123' ' ' LYS . 9.9 mt-10 -146.64 -81.36 0.14 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.263 -0.898 . . . . 0.0 109.787 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 49.2 mttt -80.39 130.09 34.94 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.728 -0.607 . . . . 0.0 110.254 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.605 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 5.7 mm -118.0 140.61 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 120.921 -1.112 . . . . 0.0 109.778 178.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.473 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.5 OUTLIER -121.51 128.61 52.24 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.762 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 10.7 m-85 -123.62 134.99 53.7 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.346 -0.846 . . . . 0.0 110.433 -178.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.533 ' CG ' ' OG ' ' A' ' 82' ' ' SER . 7.7 mt-10 -133.61 141.56 47.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.32 -0.863 . . . . 0.0 109.945 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.475 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 18.9 m -138.27 142.88 39.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.092 -1.005 . . . . 0.0 109.975 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.13 138.54 38.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.242 -0.911 . . . . 0.0 110.327 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.519 ' CD2' HG12 ' A' ' 114' ' ' ILE . 5.2 mt -124.86 145.8 49.61 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.259 -0.901 . . . . 0.0 110.227 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.499 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -152.76 -168.54 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.405 -0.81 . . . . 0.0 109.945 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -113.89 141.01 47.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.266 -0.896 . . . . 0.0 110.001 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.536 ' HB3' ' CG1' ' A' ' 113' ' ' ILE . 1.3 p -96.12 170.3 7.77 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.118 -0.989 . . . . 0.0 110.406 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 50.0 Cg_endo -78.81 4.57 6.34 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.105 1.582 . . . . 0.0 110.456 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 51.9 m -110.15 5.22 21.8 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -0.871 . . . . 0.0 110.283 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 99.36 -27.65 19.11 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.463 ' O ' ' OG ' ' A' ' 107' ' ' SER . . . -75.77 -173.94 35.5 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 22.4 p -118.53 132.44 56.21 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.181 -1.188 . . . . 0.0 110.301 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.536 ' CG1' ' HB3' ' A' ' 107' ' ' SER . 23.9 mt -82.84 147.61 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 109.903 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.604 ' CG2' ' CE2' ' A' ' 9' ' ' PHE . 9.7 mt -130.63 122.69 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.305 -0.872 . . . . 0.0 110.566 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.7 tttp -111.93 117.33 32.44 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.383 -0.823 . . . . 0.0 109.762 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 0.5 OUTLIER -110.83 152.69 26.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.246 -0.909 . . . . 0.0 110.69 -179.55 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 53.6 m -149.57 132.57 16.2 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.42 -0.8 . . . . 0.0 110.1 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.4 m -131.12 150.53 52.11 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.198 -0.939 . . . . 0.0 110.321 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.473 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 20.9 m-70 -137.9 135.4 36.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.343 -0.848 . . . . 0.0 110.037 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.544 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 11.5 m-85 -113.27 122.22 46.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.133 -0.979 . . . . 0.0 110.631 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.601 ' CG ' HG22 ' A' ' 2' ' ' VAL . 88.7 m-70 -91.22 121.77 33.27 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.528 ' CG2' HD22 ' A' ' 95' ' ' LEU . 1.2 p -98.11 149.23 22.73 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.059 -1.025 . . . . 0.0 110.974 -178.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.459 ' HB2' ' HG3' ' A' ' 96' ' ' GLU . 20.2 tttt -104.09 108.7 20.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.54 -0.725 . . . . 0.0 110.163 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 108.65 -136.36 13.47 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 26.4 t30 -119.94 54.37 1.03 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.105 -1.232 . . . . 0.0 110.341 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 17.7 m -115.65 170.24 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.311 -0.868 . . . . 0.0 110.113 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.401 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 96.4 mt-10 -134.25 -177.79 4.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.199 -0.938 . . . . 0.0 110.333 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.582 HG12 ' CD1' ' A' ' 3' ' ' PHE . 8.2 mm -84.73 172.25 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.216 -0.928 . . . . 0.0 110.405 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.422 ' N ' HG23 ' A' ' 128' ' ' ILE . 47.5 mttt -94.95 131.03 41.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.437 -0.79 . . . . 0.0 109.825 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.413 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 95.9 mt-10 -48.97 -40.96 32.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.193 -0.942 . . . . 0.0 110.109 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.466 ' HA ' ' HB1' ' A' ' 135' ' ' ALA . 49.0 tt0 -66.67 -8.89 30.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.221 -0.924 . . . . 0.0 109.753 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.465 ' O ' ' HA2' ' A' ' 136' ' ' GLY . 8.4 t-160 -103.24 -55.02 2.49 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.896 . . . . 0.0 110.196 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.639 ' CG2' ' CZ ' ' A' ' 5' ' ' TYR . 2.1 p -61.62 -29.61 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.449 -0.782 . . . . 0.0 110.227 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.456 ' HA ' ' HE3' ' A' ' 137' ' ' LYS . 28.3 tttt -108.91 -71.85 0.75 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.952 . . . . 0.0 110.061 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.466 ' HB1' ' HA ' ' A' ' 131' ' ' GLU . . . -55.79 -21.05 17.34 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 109.68 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 132' ' ' HIS . . . -74.46 -30.91 59.6 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 6.0 mtmp? -66.74 -31.87 72.8 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.25 -1.147 . . . . 0.0 109.949 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -72.96 -34.24 66.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.298 -0.876 . . . . 0.0 109.959 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.457 ' HA ' ' OD1' ' A' ' 142' ' ' ASN . 52.6 mttt -67.91 -38.83 83.43 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.404 -0.81 . . . . 0.0 109.804 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.83 -40.05 91.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.311 -0.868 . . . . 0.0 109.837 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.428 ' O ' ' HG3' ' A' ' 145' ' ' LYS . 22.8 t -56.71 -38.12 71.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.374 -0.829 . . . . 0.0 109.904 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.457 ' OD1' ' HA ' ' A' ' 139' ' ' LYS . 15.7 m120 -56.9 -48.49 78.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.304 -0.872 . . . . 0.0 109.997 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.454 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 1.2 mp -61.68 -34.19 75.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.87 . . . . 0.0 109.962 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.472 ' HA ' HD11 ' A' ' 147' ' ' ILE . 19.8 m-85 -64.68 -38.22 90.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.291 -0.881 . . . . 0.0 109.728 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 141' ' ' SER . 57.7 mttt -71.67 -12.23 61.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 109.946 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.492 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 17.8 mt -81.3 -36.65 29.53 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.233 -0.917 . . . . 0.0 108.882 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.623 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 17.3 mt -69.56 -50.37 51.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.524 ' CG ' ' OG ' ' A' ' 11' ' ' SER . 57.1 mt-10 -58.37 -37.71 75.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.466 -0.771 . . . . 0.0 109.453 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 20.2 m -67.57 -33.76 75.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.166 -0.959 . . . . 0.0 109.511 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.575 ' O ' ' CD2' ' A' ' 154' ' ' HIS . 87.6 t80 -58.91 -45.87 89.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.392 -0.817 . . . . 0.0 109.613 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.584 HD22 ' CE1' ' A' ' 158' ' ' TYR . 70.9 mt -80.0 -28.88 39.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.385 -0.822 . . . . 0.0 110.029 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.451 ' HA ' HD13 ' A' ' 13' ' ' ILE . 82.5 tttt -65.34 -14.91 61.88 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.193 -0.942 . . . . 0.0 109.518 179.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.451 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -119.84 -27.45 2.1 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.591 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 6.1 m-70 -106.44 93.61 8.59 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.22 -1.165 . . . . 0.0 110.301 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.468 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.9 Cg_endo -74.21 4.6 4.19 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 124.07 1.563 . . . . 0.0 110.833 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -115.61 -7.33 12.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.069 -1.019 . . . . 0.0 109.791 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.581 ' O ' ' CD1' ' A' ' 158' ' ' TYR . . . -51.35 108.26 0.24 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.433 -0.792 . . . . 0.0 110.077 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.661 ' CZ ' ' CB ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 35.73 30.7 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.615 -0.678 . . . . 0.0 110.672 -179.637 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.534 ' CB ' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.4 0 O-C-N 121.095 -1.003 . . . . 0.0 109.684 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.568 HG12 ' CE1' ' A' ' 121' ' ' HIS . 58.1 t -122.8 134.25 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.173 -1.193 . . . . 0.0 110.412 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.578 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 32.0 m-85 -89.19 161.11 16.63 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.258 -0.901 . . . . 0.0 110.235 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 92.1 m -144.26 96.57 2.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.229 -0.92 . . . . 0.0 110.079 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.622 ' CE1' ' CG2' ' A' ' 133' ' ' VAL . 77.8 m-85 -115.41 144.66 43.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.15 -0.969 . . . . 0.0 110.172 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 116' ' ' SER . 21.0 pt-20 -138.6 152.41 48.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 0.0 110.218 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 65.2 m -122.37 150.29 42.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.251 -0.906 . . . . 0.0 110.047 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -133.13 120.07 20.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 110.356 -179.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.644 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.7 p90 -149.37 -173.76 4.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.293 -0.879 . . . . 0.0 109.92 179.751 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.53 ' CG2' ' HA ' ' A' ' 113' ' ' ILE . 3.3 p -140.32 171.8 13.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.12 -0.987 . . . . 0.0 110.474 -179.657 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.454 ' HB3' ' OE2' ' A' ' 148' ' ' GLU . 99.7 p -151.46 136.05 17.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.297 -0.877 . . . . 0.0 110.157 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -61.78 -31.91 72.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.172 -0.955 . . . . 0.0 110.244 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.548 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 8.1 mm -70.94 149.21 94.9 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.381 -0.824 . . . . 0.0 109.951 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.548 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 39.9 Cg_endo -65.39 143.59 76.95 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.073 1.565 . . . . 0.0 110.676 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.641 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.9 Cg_endo -71.82 -31.56 12.72 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 124.073 1.565 . . . . 0.0 112.74 -179.37 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.3 Cg_endo -69.02 -21.91 36.25 Favored 'Trans proline' 0 C--N 1.318 -1.051 0 N-CA-C 110.01 -0.804 . . . . 0.0 110.01 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.531 ' NE ' ' CB ' ' A' ' 159' ' ' ASN . 41.5 mtp180 -82.08 -47.45 12.58 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.583 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.591 ' CD2' ' CG2' ' A' ' 147' ' ' ILE . 0.2 OUTLIER -70.38 -35.08 73.28 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.093 178.929 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.486 ' HB2' ' O ' ' A' ' 15' ' ' PRO . 80.4 t80 -61.0 -59.26 5.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.479 -0.763 . . . . 0.0 109.738 179.116 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' A' ' 25' ' ' ASP . 17.6 mttp -51.64 -35.9 43.86 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.724 -0.791 . . . . 0.0 109.503 179.622 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.644 ' CB ' ' CZ ' ' A' ' 158' ' ' TYR . . . -77.55 -32.36 53.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.464 -0.772 . . . . 0.0 111.048 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.629 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 0.1 OUTLIER -80.53 -41.9 23.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.233 -0.917 . . . . 0.0 111.081 -179.099 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.473 HG12 ' CD1' ' A' ' 81' ' ' TYR . 3.7 t -103.91 -51.17 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.118 -0.989 . . . . 0.0 111.386 -179.106 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 7.3 mp -80.14 -9.8 59.73 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.132 -0.98 . . . . 0.0 111.684 -178.878 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 20' ' ' LYS . 1.2 m-20 -148.48 36.57 0.81 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.768 -1.207 . . . . 0.0 110.711 -179.664 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -76.98 -25.7 53.05 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.301 -0.875 . . . . 0.0 110.309 179.676 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -66.16 -15.25 62.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.195 -0.941 . . . . 0.0 109.919 179.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.474 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 4.4 p30 -130.55 11.26 5.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.343 -0.848 . . . . 0.0 109.953 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.53 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -94.42 -48.99 5.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.374 -0.829 . . . . 0.0 110.042 179.689 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.65 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 2.1 m -73.91 -29.65 1.04 Allowed Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.373 -0.829 . . . . 0.0 112.039 -179.826 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 52.9 Cg_endo -78.81 4.06 6.79 Favored 'Trans proline' 0 C--N 1.32 -0.946 0 O-C-N 122.714 0.85 . . . . 0.0 110.128 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -124.34 -36.08 2.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.301 -0.874 . . . . 0.0 109.103 179.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.559 HG12 ' CD1' ' A' ' 150' ' ' TYR . 53.2 mt -79.96 -25.25 11.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 121.622 0.725 . . . . 0.0 109.25 179.19 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.89 91.97 0.52 Allowed Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.702 -0.624 . . . . 0.0 109.738 179.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -70.77 -2.85 11.56 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.0 1.526 . . . . 0.0 110.632 -179.676 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -91.98 10.73 27.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -0.913 . . . . 0.0 109.938 179.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.439 ' HB1' HD11 ' A' ' 38' ' ' ILE . . . -114.65 -49.74 2.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.326 -0.859 . . . . 0.0 109.995 179.854 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.521 ' N ' HD11 ' A' ' 38' ' ' ILE . 1.8 mp -119.87 134.63 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.486 -0.759 . . . . 0.0 109.905 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.1 ttmm -87.59 -24.64 23.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.311 -0.868 . . . . 0.0 110.357 -179.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.546 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -179.32 153.53 0.59 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.2 -0.938 . . . . 0.0 110.172 -179.847 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 m -127.32 124.44 38.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.345 -0.847 . . . . 0.0 109.923 179.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.493 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 49.7 tt0 -136.44 111.81 9.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.173 -0.954 . . . . 0.0 110.46 -179.823 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.472 HG22 HD11 ' A' ' 43' ' ' ILE . 22.2 mt -57.88 134.11 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.22 -0.925 . . . . 0.0 110.052 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.525 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 19.0 mt -103.45 -28.67 11.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.188 -0.945 . . . . 0.0 110.675 -179.79 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.547 ' CD1' HD11 ' A' ' 53' ' ' ILE . 2.0 m95 -129.51 165.18 22.18 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.096 -1.003 . . . . 0.0 110.731 -179.751 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.448 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 41.57 -135.26 3.11 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.658 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -157.2 19.7 0.3 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.299 -1.118 . . . . 0.0 110.099 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.74 -15.82 7.02 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.473 ' O ' HG23 ' A' ' 71' ' ' ILE . . . -76.58 -170.4 31.61 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.48 ' HA ' HG23 ' A' ' 71' ' ' ILE . 47.5 Cg_endo -73.67 129.33 13.48 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.028 1.541 . . . . 0.0 110.662 -179.831 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.98 -9.57 56.64 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 -179.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -73.23 159.04 34.06 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.601 -0.941 . . . . 0.0 109.84 179.835 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.547 HD11 ' CD1' ' A' ' 45' ' ' TRP . 55.5 mt -128.85 121.35 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.382 -0.823 . . . . 0.0 109.79 179.538 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 6.4 mtpm? -104.63 145.03 30.9 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.155 -0.966 . . . . 0.0 110.262 -179.795 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.525 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 13.1 tttt -115.62 89.99 3.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -0.856 . . . . 0.0 110.024 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.572 HG23 ' CE1' ' A' ' 58' ' ' PHE . 64.7 mt -79.98 136.07 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -0.926 . . . . 0.0 110.139 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.465 ' OG1' ' O ' ' A' ' 40' ' ' HIS . 1.4 p -108.98 152.66 24.67 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.211 -0.931 . . . . 0.0 110.396 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.583 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 20.1 m-85 -115.51 152.53 32.81 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.249 -0.907 . . . . 0.0 110.072 179.53 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.953 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.192 0.52 . . . . 0.0 110.299 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.583 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -132.63 84.36 0.29 Allowed Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.679 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.517 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 13.8 p90 -131.09 164.01 26.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.283 -1.127 . . . . 0.0 110.027 -179.795 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.53 HG13 ' CA ' ' A' ' 88' ' ' GLY . 5.7 m -134.08 174.54 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.927 . . . . 0.0 110.583 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.529 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 28.9 mttt -128.17 121.0 28.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.483 -0.76 . . . . 0.0 109.604 179.583 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.521 ' NE2' HD11 ' A' ' 85' ' ' LEU . 15.5 m170 -110.52 122.28 47.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.14 -0.975 . . . . 0.0 110.969 -179.384 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 52' ' ' THR . 81.0 tttt -95.48 117.44 30.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.187 -0.945 . . . . 0.0 109.359 178.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.519 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 23.6 mm -61.98 124.6 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.201 -0.937 . . . . 0.0 110.6 -179.31 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.483 ' HB2' ' O ' ' A' ' 82' ' ' SER . 94.4 m-20 -99.79 -41.88 7.07 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.403 -0.811 . . . . 0.0 109.693 179.512 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.456 ' OG ' ' HB2' ' A' ' 82' ' ' SER . 90.0 p -171.24 158.35 5.4 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.299 -0.875 . . . . 0.0 109.848 179.617 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.446 HG12 HG12 ' A' ' 23' ' ' VAL . 4.9 mt -137.4 158.47 35.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.265 -0.897 . . . . 0.0 110.273 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.58 ' HB2' ' HB2' ' A' ' 80' ' ' SER . 3.2 m-20 -133.68 83.32 2.04 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.579 -0.7 . . . . 0.0 110.166 -179.589 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.477 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 20.8 mttt -73.43 -9.89 59.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.438 -0.789 . . . . 0.0 110.167 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -93.54 -38.97 11.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.249 -0.907 . . . . 0.0 109.289 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.501 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 0.9 OUTLIER -111.3 7.45 21.06 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.466 0.651 . . . . 0.0 110.807 -179.772 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.572 ' CZ ' ' HB3' ' A' ' 16' ' ' PRO . 5.6 m-85 59.03 60.88 2.28 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.379 -0.826 . . . . 0.0 112.859 177.847 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.58 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 1.0 OUTLIER -127.9 156.01 43.28 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.989 -1.069 . . . . 0.0 109.329 177.875 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.691 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 24.7 t80 -140.76 136.55 32.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.14 -0.975 . . . . 0.0 110.49 -179.254 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 1.1 m -139.49 125.69 20.05 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.302 -0.874 . . . . 0.0 110.324 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.691 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 23.7 p90 -147.01 169.92 18.21 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.234 -0.916 . . . . 0.0 110.404 179.558 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.464 ' OG1' ' OD2' ' A' ' 72' ' ' ASP . 60.7 m -122.06 132.04 54.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.449 -0.782 . . . . 0.0 109.998 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.522 ' HB3' ' HB ' ' A' ' 98' ' ' ILE . 2.5 tp -97.41 122.9 41.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.184 -0.947 . . . . 0.0 110.125 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.406 HG23 HD11 ' A' ' 86' ' ' ILE . 13.9 pt -105.15 -15.2 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -0.926 . . . . 0.0 110.293 -179.648 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.529 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 31.6 tt0 -131.14 162.4 29.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.187 -0.946 . . . . 0.0 110.5 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.53 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 152.18 117.46 0.73 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -52.94 -21.16 4.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.174 -1.192 . . . . 0.0 110.3 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.84 -22.96 55.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.896 . . . . 0.0 110.279 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.519 HD23 ' CG1' ' A' ' 98' ' ' ILE . 26.8 mt -66.64 -26.8 67.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.918 . . . . 0.0 110.178 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 49.27 -178.44 0.02 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.431 ' OD1' HG21 ' A' ' 94' ' ' THR . 57.9 p30 -79.05 4.48 14.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -1.167 . . . . 0.0 110.226 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.452 ' O ' HG21 ' A' ' 122' ' ' THR . 43.9 p -90.69 -32.47 16.18 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.269 -0.894 . . . . 0.0 110.114 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.577 ' CD2' ' CG2' ' A' ' 122' ' ' THR . 62.8 mt -111.04 162.76 14.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.373 -0.829 . . . . 0.0 110.089 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.456 ' HG3' ' HB2' ' A' ' 123' ' ' LYS . 71.3 mm-40 -142.63 -80.01 0.22 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.124 -0.985 . . . . 0.0 110.201 -179.726 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.5 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 58.4 mttm -80.21 126.82 31.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.584 -0.698 . . . . 0.0 110.481 -179.823 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.633 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 5.7 mm -117.36 140.57 39.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 120.744 -1.223 . . . . 0.0 109.999 179.149 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.464 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -119.39 129.58 54.88 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.829 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.633 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 10.1 m-85 -124.54 135.55 53.26 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.274 -0.891 . . . . 0.0 110.609 -178.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.462 ' O ' ' N ' ' A' ' 117' ' ' THR . 6.4 mt-10 -138.54 128.79 25.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.335 -0.853 . . . . 0.0 110.039 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 79.3 m -131.25 146.12 52.18 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.135 -0.978 . . . . 0.0 110.202 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 115' ' ' LYS . 4.5 tttt -140.72 145.25 36.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.312 -0.868 . . . . 0.0 110.324 -179.834 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.521 ' CD2' HG12 ' A' ' 114' ' ' ILE . 4.5 mt -124.73 153.8 41.83 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.294 -0.879 . . . . 0.0 110.239 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.495 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -151.45 -168.94 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.177 -0.952 . . . . 0.0 109.982 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -122.76 160.73 25.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.261 -0.899 . . . . 0.0 110.317 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.467 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 2.1 p -117.35 170.26 6.34 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.302 -0.874 . . . . 0.0 110.197 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 47.2 Cg_endo -72.89 -17.11 25.7 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.022 1.538 . . . . 0.0 110.452 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 73.4 m -95.17 9.46 39.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.334 -0.854 . . . . 0.0 110.272 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 94.54 -33.42 5.33 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -55.51 -172.39 0.11 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.46 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -136.53 137.47 40.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -1.148 . . . . 0.0 110.349 -179.998 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.53 ' HA ' ' CG2' ' A' ' 10' ' ' THR . 25.0 mt -90.39 147.74 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.349 -0.844 . . . . 0.0 110.017 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.579 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 23.2 mt -131.48 114.22 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.231 -0.918 . . . . 0.0 110.593 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 103' ' ' LYS . 16.6 tttt -102.9 130.91 50.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.221 -0.924 . . . . 0.0 109.758 179.467 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 3.3 t -123.03 160.09 27.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.096 -1.003 . . . . 0.0 110.558 -179.637 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 29.8 m -156.36 126.98 6.73 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.332 -0.855 . . . . 0.0 110.038 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 83.5 p -130.38 152.58 49.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.114 -0.991 . . . . 0.0 110.489 -179.75 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.464 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 50.4 m-70 -134.93 158.12 45.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.371 -0.831 . . . . 0.0 109.917 179.599 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.479 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 26.8 m-85 -129.59 135.42 48.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.133 -0.979 . . . . 0.0 110.488 -179.624 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.568 ' CE1' HG12 ' A' ' 2' ' ' VAL . 87.5 m-70 -117.25 95.92 5.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.117 -0.99 . . . . 0.0 109.819 179.38 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.577 ' CG2' ' CD2' ' A' ' 95' ' ' LEU . 2.4 p -77.86 158.51 29.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.909 . . . . 0.0 110.616 -179.522 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.456 ' HB2' ' HG3' ' A' ' 96' ' ' GLU . 63.4 tttt -113.12 99.25 7.69 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.372 -0.83 . . . . 0.0 110.191 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 121.84 -128.98 7.47 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -125.9 71.37 1.24 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.336 -1.097 . . . . 0.0 110.173 -179.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.506 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 35.5 m -138.58 155.93 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.188 -0.945 . . . . 0.0 110.092 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -123.51 174.32 7.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.319 -0.863 . . . . 0.0 110.284 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.466 ' CD1' HD22 ' A' ' 95' ' ' LEU . 20.9 mm -76.93 171.77 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.28 -0.888 . . . . 0.0 110.047 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 132' ' ' HIS . 22.3 mttt -99.17 129.9 45.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.191 -0.943 . . . . 0.0 109.986 179.785 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.513 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 93.8 mt-10 -44.05 -43.6 6.9 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.214 -0.929 . . . . 0.0 109.947 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.502 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 47.8 tt0 -58.61 -24.13 60.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.245 -0.909 . . . . 0.0 109.845 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.479 ' N ' ' O ' ' A' ' 129' ' ' LYS . 14.8 t-160 -86.67 -57.05 3.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.328 -0.857 . . . . 0.0 110.135 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.622 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 2.3 p -63.04 -22.31 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.417 -0.802 . . . . 0.0 110.262 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 54.1 mttt -112.0 -73.74 0.66 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.143 -0.973 . . . . 0.0 110.328 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.502 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -53.45 -20.53 4.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.901 . . . . 0.0 109.642 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.55 -29.55 65.62 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.071 -1.611 . . . . 0.0 109.071 179.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.444 ' O ' ' OG ' ' A' ' 141' ' ' SER . 23.7 mttm -64.21 -30.09 71.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.298 -1.119 . . . . 0.0 109.954 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 70.2 tt0 -77.4 -28.32 52.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.379 -0.825 . . . . 0.0 110.156 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.8 mmtp -73.9 -34.8 64.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 110.055 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -80.6 -34.68 34.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.873 . . . . 0.0 110.007 179.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' A' ' 137' ' ' LYS . 33.2 m -63.86 -45.15 90.76 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.401 -0.812 . . . . 0.0 109.943 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -54.94 -42.77 72.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.283 -0.886 . . . . 0.0 110.015 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.45 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 80.8 mt -60.59 -46.1 91.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.294 -0.879 . . . . 0.0 110.083 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -59.31 -37.32 77.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.374 -0.829 . . . . 0.0 109.818 179.793 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -72.15 -12.97 61.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.306 -0.872 . . . . 0.0 110.068 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.45 ' HB2' ' O ' ' A' ' 143' ' ' LEU . 34.4 mt -83.72 -35.58 24.33 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.215 -0.928 . . . . 0.0 108.912 179.25 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.629 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 60.7 mt -68.9 -46.22 79.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.479 ' O ' HG13 ' A' ' 13' ' ' ILE . 84.7 mt-10 -50.43 -35.32 28.06 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.4 -0.812 . . . . 0.0 109.353 179.089 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 3.0 m -75.39 -20.48 58.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.222 -0.924 . . . . 0.0 109.49 179.321 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.567 ' O ' ' CD2' ' A' ' 154' ' ' HIS . 80.1 t80 -69.5 -48.95 58.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.517 -0.739 . . . . 0.0 109.915 179.605 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.573 HD22 ' CE1' ' A' ' 158' ' ' TYR . 48.2 mt -80.03 -31.56 39.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.351 -0.843 . . . . 0.0 110.021 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.524 ' CA ' HD13 ' A' ' 13' ' ' ILE . 7.5 ttpp -64.74 -14.19 57.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.306 -0.872 . . . . 0.0 109.428 179.285 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.439 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -118.35 -30.54 1.7 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 179.708 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.597 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 5.7 m-70 -106.07 94.41 9.3 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.272 -1.134 . . . . 0.0 110.15 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.51 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.9 Cg_endo -73.96 4.58 4.08 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.985 1.519 . . . . 0.0 110.873 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -113.37 -8.8 13.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.972 -1.08 . . . . 0.0 109.819 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.571 ' O ' ' CD1' ' A' ' 158' ' ' TYR . . . -53.65 104.47 0.1 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.374 -0.829 . . . . 0.0 109.979 179.762 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.644 ' CZ ' ' CB ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 35.33 30.96 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.733 -0.604 . . . . 0.0 110.703 -179.663 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.531 ' CB ' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.409 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.745 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.235 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 2.7 p -80.75 149.56 5.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.113 -1.228 . . . . 0.0 110.795 -179.491 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.546 ' CE1' HD11 ' A' ' 128' ' ' ILE . 72.5 m-85 -93.76 169.01 10.63 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.611 -0.681 . . . . 0.0 110.49 -179.579 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.433 ' CG2' ' CE1' ' A' ' 119' ' ' HIS . 86.0 m -139.93 105.06 5.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.345 -0.847 . . . . 0.0 110.126 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.634 ' CD2' ' CG1' ' A' ' 133' ' ' VAL . 65.7 m-85 -114.23 144.68 42.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.909 . . . . 0.0 110.034 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 21.5 pt-20 -134.27 150.5 51.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.173 -0.954 . . . . 0.0 110.254 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.461 ' O ' ' CG ' ' A' ' 8' ' ' GLU . 24.8 p -125.95 169.38 12.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.344 -0.847 . . . . 0.0 109.986 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.461 ' CG ' ' O ' ' A' ' 7' ' ' SER . 80.9 mt-10 -153.95 117.19 4.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.163 -0.961 . . . . 0.0 110.628 -179.852 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.2 p90 -142.58 -178.05 5.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.325 -0.859 . . . . 0.0 109.875 179.562 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 16.5 p -136.71 179.78 6.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.182 -0.949 . . . . 0.0 110.544 -179.783 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 112' ' ' SER . 2.2 t -160.05 159.12 31.6 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.297 -0.877 . . . . 0.0 110.55 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -85.55 -12.11 52.44 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.207 -0.933 . . . . 0.0 109.824 179.805 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.532 ' CG1' ' HB2' ' A' ' 152' ' ' LYS . 2.3 mp -88.29 151.02 48.17 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.356 -0.84 . . . . 0.0 109.984 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.531 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 40.9 Cg_endo -66.69 139.9 54.39 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.046 1.55 . . . . 0.0 110.664 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.608 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 41.3 Cg_endo -73.25 -30.03 10.84 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 124.069 1.563 . . . . 0.0 112.843 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.9 Cg_endo -71.72 -23.56 22.61 Favored 'Trans proline' 0 C--N 1.319 -1.002 0 N-CA-C 110.052 -0.788 . . . . 0.0 110.052 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.523 ' CZ ' ' HA ' ' A' ' 159' ' ' ASN . 1.1 mtp85 -82.05 -44.89 16.0 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.008 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.556 ' CD2' ' CG2' ' A' ' 147' ' ' ILE . 0.2 OUTLIER -67.07 -34.0 76.71 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.528 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.605 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 74.9 t80 -59.38 -56.59 20.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.639 -0.663 . . . . 0.0 109.642 178.738 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.493 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 29.6 mttp -52.35 -37.53 56.41 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.721 -0.791 . . . . 0.0 109.421 179.462 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.602 ' HB1' ' CZ ' ' A' ' 158' ' ' TYR . . . -75.63 -43.38 48.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.466 -0.772 . . . . 0.0 110.76 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.575 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 0.3 OUTLIER -65.36 -45.8 82.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.341 -0.849 . . . . 0.0 111.074 -179.065 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.595 ' CG1' ' CD1' ' A' ' 74' ' ' ILE . 10.4 t -104.2 -60.89 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.084 -1.01 . . . . 0.0 111.766 -179.051 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.493 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 7.5 mp -66.13 -11.36 48.66 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.171 -0.956 . . . . 0.0 111.537 -178.64 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 20' ' ' LYS . 1.2 m-20 -148.17 44.18 1.05 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.886 -1.134 . . . . 0.0 110.27 -179.778 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -82.8 -22.14 34.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.297 -0.877 . . . . 0.0 110.47 -179.831 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -68.76 -19.9 64.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.127 -0.983 . . . . 0.0 110.214 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.515 ' O ' ' CB ' ' A' ' 32' ' ' LYS . 4.6 p30 -125.34 13.15 8.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 0.0 109.772 179.836 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.534 HD11 ' CD1' ' A' ' 33' ' ' ILE . 0.4 OUTLIER -97.01 -54.16 3.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.453 -0.779 . . . . 0.0 110.175 -179.939 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.585 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 2.6 t -70.28 -42.78 16.73 Favored Pre-proline 0 C--N 1.299 -1.597 0 O-C-N 121.296 -0.877 . . . . 0.0 110.57 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 50.3 Cg_endo -79.32 8.27 3.98 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.601 1.316 . . . . 0.0 110.617 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.515 ' CB ' ' O ' ' A' ' 28' ' ' ASN . 81.4 tttt -125.41 -31.39 3.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.187 -0.945 . . . . 0.0 109.745 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.566 HG12 ' CD1' ' A' ' 150' ' ' TYR . 22.0 mt -79.76 -35.53 16.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.523 -0.736 . . . . 0.0 109.701 179.578 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -160.66 99.82 1.35 Allowed Pre-proline 0 N--CA 1.487 1.377 0 O-C-N 121.433 -0.792 . . . . 0.0 110.187 179.764 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.96 0.14 8.21 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.201 1.632 . . . . 0.0 110.516 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -86.26 -13.02 47.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.261 -0.899 . . . . 0.0 109.823 179.699 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -98.46 -49.38 4.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.374 -0.829 . . . . 0.0 110.401 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.533 HG12 ' CG2' ' A' ' 56' ' ' ILE . 1.2 mp -130.56 137.93 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.327 -0.858 . . . . 0.0 110.324 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.416 ' O ' ' HB3' ' A' ' 40' ' ' HIS . 7.1 ttmt -70.97 -39.72 72.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.409 -0.807 . . . . 0.0 110.411 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.548 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER 179.03 159.32 0.61 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.277 -0.889 . . . . 0.0 110.284 179.852 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.9 m -121.03 131.61 54.39 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.225 -0.922 . . . . 0.0 110.045 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -135.2 114.28 12.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -0.924 . . . . 0.0 110.428 -179.829 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.421 HG12 ' HG2' ' A' ' 54' ' ' LYS . 28.3 mt -60.37 138.39 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.185 -0.947 . . . . 0.0 110.031 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.524 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 22.8 mt -111.74 -29.28 7.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.917 . . . . 0.0 110.462 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.515 ' CD1' HD11 ' A' ' 53' ' ' ILE . 1.8 m95 -125.33 163.89 21.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.216 -0.927 . . . . 0.0 110.698 -179.773 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.458 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 42.06 -138.23 2.58 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -151.15 21.1 0.76 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -1.154 . . . . 0.0 110.208 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 123.3 -18.93 7.73 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.486 ' O ' HG22 ' A' ' 71' ' ' ILE . . . -72.9 -172.83 23.01 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.491 ' HA ' HG23 ' A' ' 71' ' ' ILE . 43.5 Cg_endo -71.72 128.66 14.52 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.993 1.523 . . . . 0.0 110.683 -179.783 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.09 -14.09 48.59 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 -179.487 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -70.87 161.42 31.04 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.554 -0.968 . . . . 0.0 109.647 179.682 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.515 HD11 ' CD1' ' A' ' 45' ' ' TRP . 56.2 mt -130.7 120.7 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.334 -0.854 . . . . 0.0 109.887 179.599 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 58.6 mttm -105.53 140.98 37.79 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.168 -0.957 . . . . 0.0 110.394 -179.716 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.524 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 78.0 tttt -106.99 88.58 2.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.313 -0.867 . . . . 0.0 110.159 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.533 ' CG2' HG12 ' A' ' 38' ' ' ILE . 79.0 mt -79.86 137.46 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.265 -0.897 . . . . 0.0 110.15 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.506 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 5.6 p -109.29 161.78 14.94 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.18 -0.95 . . . . 0.0 110.658 -179.786 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.552 ' N ' ' O ' ' A' ' 65' ' ' GLY . 31.5 m-85 -115.73 128.64 56.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.47 -0.769 . . . . 0.0 110.211 179.777 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.979 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.266 0.555 . . . . 0.0 110.312 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.552 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -137.59 119.12 1.8 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 179.678 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 15.4 p90 -158.01 168.56 26.77 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.038 -1.272 . . . . 0.0 110.072 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.528 HG13 ' CA ' ' A' ' 88' ' ' GLY . 7.1 m -139.49 173.32 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.249 -0.907 . . . . 0.0 110.899 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.509 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 27.8 mttt -125.13 117.78 24.65 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.372 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.564 ' CD2' HD11 ' A' ' 85' ' ' LEU . 17.8 m170 -103.81 125.39 50.22 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.214 -0.929 . . . . 0.0 111.085 -178.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 52' ' ' THR . 25.6 tttt -97.76 106.51 18.83 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.383 -0.823 . . . . 0.0 109.374 179.002 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.527 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 43.3 mm -44.35 133.97 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.09 -1.006 . . . . 0.0 110.153 -179.227 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.522 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 46.3 t0 -107.49 -54.11 2.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.481 -0.762 . . . . 0.0 109.899 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.46 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 5.4 m -172.28 158.25 4.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.453 -0.779 . . . . 0.0 110.277 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.595 ' CD1' ' CG1' ' A' ' 23' ' ' VAL . 4.0 tt -149.77 165.54 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.274 -0.891 . . . . 0.0 110.03 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.6 OUTLIER -133.78 82.06 1.96 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.299 -0.876 . . . . 0.0 110.014 -179.788 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.605 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 90.3 mttt -55.29 -15.14 2.19 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.316 -0.865 . . . . 0.0 110.841 -179.863 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -92.5 -30.4 15.72 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.189 -0.945 . . . . 0.0 109.798 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.512 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -111.34 -1.33 16.05 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.552 -0.717 . . . . 0.0 109.63 179.962 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.577 ' CZ ' ' HB3' ' A' ' 16' ' ' PRO . 10.7 m-85 65.69 48.23 1.98 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.769 -0.582 . . . . 0.0 110.608 -179.864 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.529 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.5 OUTLIER -116.55 148.07 41.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.157 -0.964 . . . . 0.0 109.364 179.386 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.578 ' CD1' HG12 ' A' ' 23' ' ' VAL . 86.9 t80 -148.45 144.63 27.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.122 -0.987 . . . . 0.0 110.414 -179.261 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.466 ' HB3' ' HG3' ' A' ' 101' ' ' GLU . 4.8 p -151.45 145.23 25.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.271 -0.893 . . . . 0.0 110.349 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.586 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 18.0 p90 -148.13 172.02 14.97 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.219 -0.926 . . . . 0.0 110.471 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.411 ' HB ' ' HB3' ' A' ' 70' ' ' LYS . 97.1 m -122.16 123.58 41.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.344 -0.848 . . . . 0.0 109.964 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.564 HD11 ' CD2' ' A' ' 69' ' ' HIS . 0.9 OUTLIER -90.61 129.25 36.76 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.148 -0.97 . . . . 0.0 110.249 -179.827 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 16.7 pt -112.03 0.65 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.279 -0.888 . . . . 0.0 110.298 -179.789 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.509 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 57.3 tt0 -145.66 154.87 42.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.272 -0.892 . . . . 0.0 110.171 -179.922 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.528 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 156.9 126.93 0.95 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -64.26 -25.97 68.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.334 -1.097 . . . . 0.0 110.208 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.552 ' O ' ' CE1' ' A' ' 132' ' ' HIS . . . -70.27 -25.44 63.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -0.916 . . . . 0.0 110.122 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.522 ' CD2' HG13 ' A' ' 98' ' ' ILE . 22.3 mt -64.68 -36.56 84.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.31 -0.868 . . . . 0.0 110.072 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.11 175.69 36.73 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -72.58 -2.29 19.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -1.152 . . . . 0.0 109.967 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.462 ' OG1' HD21 ' A' ' 95' ' ' LEU . 30.3 p -91.42 -38.8 12.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.895 . . . . 0.0 110.455 -179.866 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.567 ' CD2' ' N ' ' A' ' 95' ' ' LEU . 2.4 mm? -79.88 154.92 28.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.262 -0.899 . . . . 0.0 110.964 -179.453 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.462 ' OE1' ' HB2' ' A' ' 123' ' ' LYS . 37.5 tt0 -142.44 -84.21 0.18 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.13 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.519 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 28.5 mttt -80.42 125.14 29.55 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.705 -0.622 . . . . 0.0 110.595 179.076 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.552 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 3.2 mm -118.02 137.96 50.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 120.575 -1.328 . . . . 0.0 109.151 178.199 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.461 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -118.31 129.67 55.58 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.325 -0.859 . . . . 0.0 109.299 179.306 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.586 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 8.8 m-85 -124.13 132.63 53.66 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.42 -0.8 . . . . 0.0 110.236 -179.282 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.466 ' HG3' ' HB3' ' A' ' 82' ' ' SER . 76.9 tt0 -134.5 138.7 44.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.18 -0.95 . . . . 0.0 110.21 179.776 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 90.5 m -141.34 125.51 17.39 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.161 -0.962 . . . . 0.0 110.199 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.443 ' HG3' ' HB3' ' A' ' 80' ' ' SER . 1.0 OUTLIER -116.86 149.42 40.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.881 . . . . 0.0 110.114 179.818 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.525 ' HB2' ' CB ' ' A' ' 79' ' ' TYR . 14.7 mt -123.24 148.86 45.43 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.199 -0.938 . . . . 0.0 110.622 -179.957 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.443 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -149.5 -168.91 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.408 -0.807 . . . . 0.0 109.419 179.546 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -136.92 141.52 42.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.13 -0.981 . . . . 0.0 110.873 179.9 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.533 ' CB ' ' HD2' ' A' ' 108' ' ' PRO . 0.8 OUTLIER -91.79 -179.91 1.22 Allowed Pre-proline 0 C--N 1.302 -1.477 0 O-C-N 121.533 -0.729 . . . . 0.0 109.374 179.183 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.533 ' HD2' ' CB ' ' A' ' 107' ' ' SER . 40.7 Cg_endo -66.54 85.09 0.28 Allowed 'Trans proline' 0 C--N 1.303 -1.861 0 O-C-N 123.649 1.342 . . . . 0.0 109.646 179.376 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 108' ' ' PRO . 4.0 p 44.38 37.41 2.01 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.423 -0.798 . . . . 0.0 109.735 -178.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -125.75 38.16 2.33 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 11' ' ' SER . . . 98.11 -138.75 14.07 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 -179.495 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 11' ' ' SER . 3.7 p -149.43 143.38 25.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.279 -1.13 . . . . 0.0 109.835 179.653 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.477 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 35.9 mt -91.4 147.9 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.24 -0.912 . . . . 0.0 110.307 -179.74 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.578 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 7.6 mt -134.02 111.62 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.186 -0.946 . . . . 0.0 110.208 -179.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 48.4 tttt -97.08 137.67 35.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.231 -0.918 . . . . 0.0 110.239 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 0.8 OUTLIER -134.44 154.55 51.33 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 0.0 110.376 -179.887 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 8.8 m -146.58 158.21 43.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.33 -0.856 . . . . 0.0 110.188 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 99.4 p -151.28 134.96 16.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 110.393 -179.9 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.462 ' O ' HD11 ' A' ' 98' ' ' ILE . 55.4 m-70 -120.78 147.9 44.71 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.287 -0.883 . . . . 0.0 110.384 -179.92 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.585 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 9.3 m-85 -122.4 118.78 29.2 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.268 -0.895 . . . . 0.0 111.161 -179.445 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.576 ' CD2' HG22 ' A' ' 2' ' ' VAL . 90.0 m-70 -104.12 109.69 21.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.073 -1.017 . . . . 0.0 109.353 178.331 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.534 ' HB ' ' CG2' ' A' ' 126' ' ' VAL . 0.6 OUTLIER -88.95 136.5 32.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.294 -0.879 . . . . 0.0 110.866 -179.107 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.462 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 25.3 tttt -109.37 129.49 55.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.484 -0.76 . . . . 0.0 110.1 179.545 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.471 ' O ' ' CB ' ' A' ' 125' ' ' ASN . . . 110.44 15.33 11.47 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 9.1 t30 67.82 54.27 0.64 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.265 -1.138 . . . . 0.0 110.33 179.907 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.534 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 20.3 m -133.4 160.34 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.351 -0.843 . . . . 0.0 109.948 179.744 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -121.3 162.16 20.77 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.225 -0.922 . . . . 0.0 110.576 -179.724 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.548 ' CD1' ' HB3' ' A' ' 120' ' ' TYR . 2.9 mp -83.95 173.45 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.393 -0.817 . . . . 0.0 109.96 179.766 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.507 ' N ' ' CG2' ' A' ' 128' ' ' ILE . 32.4 mttt -108.67 133.79 52.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.413 -0.804 . . . . 0.0 109.894 179.835 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -46.51 -36.26 6.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.183 -0.948 . . . . 0.0 110.198 -179.887 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.432 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 61.7 tt0 -63.31 -29.94 71.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 110.09 179.885 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.552 ' CE1' ' O ' ' A' ' 90' ' ' ALA . 14.5 t-160 -78.18 -51.3 10.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 110.222 179.905 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.634 ' CG1' ' CD2' ' A' ' 5' ' ' TYR . 43.0 t -64.28 -43.45 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.356 -0.84 . . . . 0.0 110.098 179.882 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 7.1 tptm -67.1 -45.87 75.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 110.154 179.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.45 ' O ' ' HG3' ' A' ' 139' ' ' LYS . . . -62.27 -30.06 70.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.212 -0.93 . . . . 0.0 110.035 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.58 -29.39 69.78 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 83.5 mttt -66.99 -33.9 76.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.213 -1.169 . . . . 0.0 110.077 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -81.7 -29.93 32.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.892 . . . . 0.0 110.104 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' ' 135' ' ' ALA . 93.9 mttt -67.29 -41.5 85.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.33 -0.856 . . . . 0.0 110.069 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.16 -41.0 51.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.198 -0.939 . . . . 0.0 110.065 179.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 137' ' ' LYS . 48.8 m -56.99 -48.17 79.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.453 -0.78 . . . . 0.0 110.031 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -55.52 -42.33 74.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.185 -0.947 . . . . 0.0 110.095 179.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.437 ' O ' HG13 ' A' ' 147' ' ' ILE . 61.4 mt -61.52 -40.77 95.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 109.976 179.869 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -60.56 -37.77 82.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.407 -0.808 . . . . 0.0 109.878 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.44 ' HA ' ' OE1' ' A' ' 148' ' ' GLU . 87.8 mttt -71.67 -17.5 62.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.317 -0.864 . . . . 0.0 110.039 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.531 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 34.4 mt -84.11 -35.92 23.34 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.281 -0.887 . . . . 0.0 108.967 179.386 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.575 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 53.4 mt -72.27 -42.46 65.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 119.678 -0.809 . . . . 0.0 108.836 178.735 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.47 ' HB3' HD11 ' A' ' 13' ' ' ILE . 69.4 mt-10 -56.18 -39.11 71.89 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.479 -0.763 . . . . 0.0 109.409 179.03 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.5 m -73.99 -24.43 59.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.944 . . . . 0.0 109.617 179.415 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.579 ' CE2' ' OH ' ' A' ' 158' ' ' TYR . 80.3 t80 -64.68 -49.3 71.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.383 -0.823 . . . . 0.0 110.083 179.822 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.629 ' CD2' ' CE2' ' A' ' 158' ' ' TYR . 84.8 mt -79.94 -29.34 39.67 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.225 -0.922 . . . . 0.0 110.059 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.532 ' HB2' ' CG1' ' A' ' 13' ' ' ILE . 78.3 tttt -70.21 -27.14 64.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.33 -0.856 . . . . 0.0 109.594 179.523 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.452 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -104.04 -33.27 4.07 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.718 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.577 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 5.4 m-70 -107.12 92.34 7.72 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.354 -1.086 . . . . 0.0 109.982 179.734 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 48.4 Cg_endo -74.23 6.35 3.1 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.04 1.547 . . . . 0.0 111.075 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -107.06 -4.94 18.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.999 -1.063 . . . . 0.0 109.756 179.772 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.57 ' HB1' ' CE2' ' A' ' 150' ' ' TYR . . . -75.18 102.44 4.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.411 -0.806 . . . . 0.0 110.019 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.629 ' CE2' ' CD2' ' A' ' 151' ' ' LEU . 0.4 OUTLIER 34.86 32.18 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.69 -0.631 . . . . 0.0 110.572 -179.521 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.523 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.71 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.587 HG22 ' CD2' ' A' ' 121' ' ' HIS . 3.0 p -82.86 153.84 3.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.253 -1.145 . . . . 0.0 110.122 -179.917 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.629 ' CD1' ' CD1' ' A' ' 128' ' ' ILE . 8.4 m-85 -89.23 170.16 10.83 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.329 -0.857 . . . . 0.0 110.014 -179.658 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 50.0 m -137.76 107.56 6.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.111 -0.993 . . . . 0.0 110.364 -179.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.632 ' CD1' ' CG2' ' A' ' 133' ' ' VAL . 47.7 m-85 -112.21 136.67 51.34 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.182 -0.949 . . . . 0.0 110.109 179.804 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 20.8 pt-20 -129.84 152.1 49.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.222 -0.924 . . . . 0.0 110.537 -179.794 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.3 t -139.28 156.22 47.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.401 -0.812 . . . . 0.0 109.902 179.791 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -147.62 124.37 11.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.154 -0.966 . . . . 0.0 110.391 -179.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.637 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.3 p90 -151.6 -176.38 5.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.388 -0.82 . . . . 0.0 109.892 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.486 ' CG2' ' HA ' ' A' ' 113' ' ' ILE . 8.8 p -141.74 174.41 10.6 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.114 -0.991 . . . . 0.0 110.661 -179.642 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.5 t -153.08 159.08 42.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.428 -0.795 . . . . 0.0 110.155 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -81.94 -20.48 38.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.234 -0.916 . . . . 0.0 110.237 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.542 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 8.1 mm -80.11 150.68 71.88 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.334 -0.854 . . . . 0.0 109.98 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.542 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 40.0 Cg_endo -65.55 143.09 74.07 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.073 1.565 . . . . 0.0 110.789 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.635 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 41.5 Cg_endo -73.34 -30.69 9.99 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 124.109 1.584 . . . . 0.0 113.066 -179.501 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.635 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.3 Cg_endo -69.9 -23.38 30.23 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 O-C-N 122.471 0.722 . . . . 0.0 110.228 -179.899 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.516 ' NH2' ' HA ' ' A' ' 159' ' ' ASN . 2.1 mtp180 -85.16 -43.48 13.8 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.108 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.516 ' CD2' HD23 ' A' ' 104' ' ' LEU . 1.0 OUTLIER -69.89 -30.27 67.66 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.845 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' A' ' 15' ' ' PRO . 50.7 t80 -68.58 -53.7 21.23 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.393 -0.817 . . . . 0.0 109.549 179.126 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.486 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 10.8 mttt -53.41 -33.86 55.54 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.681 -0.807 . . . . 0.0 109.181 179.568 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.606 ' HB1' ' CZ ' ' A' ' 158' ' ' TYR . . . -76.4 -53.65 7.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.485 -0.759 . . . . 0.0 111.158 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.575 ' CE1' HD13 ' A' ' 147' ' ' ILE . 0.5 OUTLIER -60.0 -46.08 90.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.501 -0.749 . . . . 0.0 111.922 -178.429 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.477 HG12 HG12 ' A' ' 74' ' ' ILE . 3.3 t -100.88 -60.6 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.886 -1.134 . . . . 0.0 111.847 -178.665 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.486 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 6.8 mp -67.96 -5.36 16.68 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.172 -0.955 . . . . 0.0 111.647 -178.494 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.486 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 1.1 m-20 -149.04 30.14 0.79 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.669 -1.269 . . . . 0.0 110.946 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -70.05 -23.88 63.17 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.21 -0.931 . . . . 0.0 110.675 179.798 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -69.68 -17.52 63.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.08 -1.013 . . . . 0.0 109.774 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.451 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 7.1 p30 -129.42 13.28 6.03 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.375 -0.828 . . . . 0.0 109.774 179.597 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.551 HD22 ' CZ ' ' A' ' 158' ' ' TYR . 0.3 OUTLIER -94.37 -49.16 5.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.437 -0.789 . . . . 0.0 110.138 179.812 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.648 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 5.8 p -73.2 -28.87 1.01 Allowed Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.141 -0.974 . . . . 0.0 112.051 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.648 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 52.1 Cg_endo -79.56 1.21 9.39 Favored 'Trans proline' 0 C--N 1.319 -1.019 0 O-C-N 122.717 0.851 . . . . 0.0 110.263 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.449 ' HD2' ' O ' ' A' ' 28' ' ' ASN . 51.8 mttm -124.68 -30.0 3.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.292 -0.88 . . . . 0.0 109.869 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.58 HG12 ' CD1' ' A' ' 150' ' ' TYR . 10.8 mt -77.57 -39.14 26.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.482 -0.761 . . . . 0.0 109.76 179.822 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -170.24 102.27 0.44 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.417 -0.802 . . . . 0.0 110.14 179.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.78 1.2 7.27 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.066 1.561 . . . . 0.0 110.647 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -87.27 -8.64 56.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.099 -1.0 . . . . 0.0 110.039 179.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.31 -51.02 3.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.312 -0.868 . . . . 0.0 110.308 -179.929 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.553 ' CD1' HG22 ' A' ' 30' ' ' VAL . 1.1 mp -127.11 138.87 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.426 -0.796 . . . . 0.0 110.11 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.423 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 37.7 ttmt -73.85 -40.53 63.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.318 -0.864 . . . . 0.0 110.098 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.534 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -178.49 156.11 0.9 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.336 -0.852 . . . . 0.0 110.252 179.752 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.4 m -120.0 119.93 34.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.23 -0.919 . . . . 0.0 109.996 179.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.464 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 35.0 tp10 -124.25 114.39 19.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.289 -0.882 . . . . 0.0 110.387 -179.923 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.462 HD11 HG22 ' A' ' 43' ' ' ILE . 21.4 mt -60.04 145.03 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.189 -0.945 . . . . 0.0 110.069 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.49 ' N ' ' O ' ' A' ' 53' ' ' ILE . 4.8 mp -121.77 -27.29 4.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.224 -0.923 . . . . 0.0 110.328 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.574 ' CG ' HD11 ' A' ' 53' ' ' ILE . 1.6 m95 -123.78 163.19 21.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.272 -0.893 . . . . 0.0 110.482 -179.833 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.448 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 43.12 -138.37 3.39 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.81 23.52 0.51 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.309 -1.112 . . . . 0.0 109.994 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 121.73 -13.9 9.23 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.478 ' O ' HG23 ' A' ' 71' ' ' ILE . . . -81.54 -169.61 42.65 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.85 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.49 ' HA ' HG23 ' A' ' 71' ' ' ILE . 45.0 Cg_endo -72.79 129.5 14.53 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 124.086 1.572 . . . . 0.0 110.557 -179.905 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.49 -12.95 51.16 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 -179.569 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -71.52 161.3 31.24 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.589 -0.948 . . . . 0.0 109.374 179.635 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.574 HD11 ' CG ' ' A' ' 45' ' ' TRP . 58.3 mt -134.29 120.37 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.242 -0.911 . . . . 0.0 109.971 179.683 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 96.0 mttt -107.3 128.95 54.91 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.164 -0.96 . . . . 0.0 110.56 -179.595 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -93.01 91.38 7.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -0.881 . . . . 0.0 109.768 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.536 ' CG2' HG12 ' A' ' 38' ' ' ILE . 96.7 mt -80.02 144.11 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.2 -0.937 . . . . 0.0 110.212 -179.753 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.517 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 7.2 p -117.62 163.73 16.01 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.201 -0.937 . . . . 0.0 110.744 -179.649 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.533 ' N ' ' O ' ' A' ' 65' ' ' GLY . 28.6 m-85 -122.4 141.38 51.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.323 -0.861 . . . . 0.0 110.118 179.283 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.343 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.953 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.181 0.515 . . . . 0.0 110.303 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -138.67 102.27 0.35 Allowed Glycine 0 N--CA 1.487 2.096 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 179.669 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.543 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 13.9 p90 -143.44 166.7 24.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.218 -1.166 . . . . 0.0 110.175 -179.685 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.531 HG13 ' CA ' ' A' ' 88' ' ' GLY . 6.1 m -139.35 174.13 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.354 -0.841 . . . . 0.0 110.618 179.78 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.517 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 20.1 mttt -125.56 122.04 35.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.529 -0.732 . . . . 0.0 109.642 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.519 ' NE2' HD12 ' A' ' 85' ' ' LEU . 10.8 m170 -108.56 123.75 49.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.179 -0.951 . . . . 0.0 110.854 -179.436 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 52' ' ' THR . 18.9 tttm -97.65 116.09 29.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.258 -0.901 . . . . 0.0 109.79 179.428 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.523 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 23.6 mm -58.04 132.43 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.994 -1.066 . . . . 0.0 110.365 -179.563 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 82' ' ' SER . 94.1 m-20 -105.34 -42.76 5.16 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.372 -0.83 . . . . 0.0 109.889 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 3.2 m -175.09 159.67 2.63 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.389 -0.82 . . . . 0.0 109.948 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.477 HG12 HG12 ' A' ' 23' ' ' VAL . 2.2 mt -138.62 159.84 30.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.193 -0.942 . . . . 0.0 110.209 179.97 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 79' ' ' TYR . 5.6 m-20 -137.58 80.56 1.81 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.489 -0.757 . . . . 0.0 110.392 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.456 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 22.3 tttt -63.28 -18.9 64.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.133 -0.979 . . . . 0.0 110.259 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -91.6 -32.24 15.58 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.275 -0.89 . . . . 0.0 109.363 179.755 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.507 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -101.25 -4.13 27.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.643 -0.661 . . . . 0.0 109.604 179.619 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.587 ' CE1' ' HB3' ' A' ' 16' ' ' PRO . 85.2 m-85 60.43 55.44 3.49 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.454 0.645 . . . . 0.0 110.581 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.495 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -129.93 165.61 21.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.434 -0.791 . . . . 0.0 109.876 179.495 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.696 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 42.6 t80 -149.71 143.79 25.68 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.219 -0.925 . . . . 0.0 109.903 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 25.9 m -148.76 131.45 15.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.122 -0.986 . . . . 0.0 111.223 -179.724 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.696 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 9.1 p90 -144.36 175.66 9.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.35 -0.844 . . . . 0.0 110.064 179.041 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.478 ' N ' ' O ' ' A' ' 70' ' ' LYS . 27.1 m -127.25 128.42 45.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.348 -0.845 . . . . 0.0 109.824 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.533 ' HB3' ' CG2' ' A' ' 98' ' ' ILE . 7.4 tp -95.39 125.31 39.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.093 -1.004 . . . . 0.0 110.077 -179.85 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.6 pt -109.79 -12.65 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.244 -0.91 . . . . 0.0 110.333 -179.565 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.517 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 18.0 tt0 -124.64 172.84 8.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 0.0 110.191 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.531 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 137.58 112.08 1.09 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.984 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -56.42 -16.83 6.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.319 -1.106 . . . . 0.0 110.205 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.63 -17.71 57.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 0.0 110.146 179.87 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.454 HD12 ' O ' ' A' ' 87' ' ' GLU . 65.7 mt -66.78 -23.82 66.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.284 -0.885 . . . . 0.0 110.209 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 50.56 -179.69 0.03 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -79.96 6.45 11.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.303 -1.116 . . . . 0.0 110.206 179.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 39.4 p -94.36 -31.55 13.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.236 -0.915 . . . . 0.0 110.238 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.554 HD12 ' CD2' ' A' ' 120' ' ' TYR . 83.6 mt -107.29 163.93 12.61 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.351 -0.843 . . . . 0.0 110.092 179.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.47 ' HG2' ' N ' ' A' ' 97' ' ' LYS . 61.4 tt0 -144.77 -82.85 0.15 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.299 -0.876 . . . . 0.0 109.668 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.494 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 18.7 mttt -80.37 131.57 35.64 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.778 -0.576 . . . . 0.0 110.343 179.683 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.635 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 4.7 mm -119.53 138.67 49.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 120.845 -1.16 . . . . 0.0 109.63 178.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.453 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.3 m -118.85 123.27 44.31 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 119.711 -0.795 . . . . 0.0 108.985 178.786 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.635 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 13.0 m-85 -119.27 132.61 55.93 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.39 -0.819 . . . . 0.0 110.322 -179.076 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.445 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 85.1 tt0 -132.07 140.26 48.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.263 -0.898 . . . . 0.0 110.061 179.788 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.454 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 32.6 m -133.01 153.95 50.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.924 . . . . 0.0 109.929 179.939 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.449 ' N ' ' O ' ' A' ' 115' ' ' LYS . 7.7 mttt -149.66 133.05 16.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.143 -0.973 . . . . 0.0 110.456 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.534 ' HB2' ' HB3' ' A' ' 79' ' ' TYR . 3.5 mt -115.42 152.49 32.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.196 -0.94 . . . . 0.0 110.03 179.812 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.483 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 1.8 t -151.38 -169.52 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.227 -0.921 . . . . 0.0 110.185 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.471 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -124.52 145.64 49.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.35 -0.844 . . . . 0.0 110.305 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.445 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.3 p -103.8 171.12 5.39 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.281 -0.887 . . . . 0.0 110.2 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.445 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 45.7 Cg_endo -72.54 -13.79 27.53 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.074 1.565 . . . . 0.0 110.585 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 67.8 m -95.84 11.64 32.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.188 -0.945 . . . . 0.0 110.354 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 91.34 -34.93 4.1 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.847 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -55.18 -172.07 0.08 OUTLIER Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.785 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.528 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.4 p -134.98 134.19 40.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.124 -1.221 . . . . 0.0 110.387 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.486 ' HA ' ' CG2' ' A' ' 10' ' ' THR . 15.4 mt -85.74 147.12 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.37 -0.831 . . . . 0.0 109.91 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.574 ' CG2' ' CE2' ' A' ' 9' ' ' PHE . 19.4 mt -131.1 110.8 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.166 -0.959 . . . . 0.0 110.407 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.449 ' O ' ' N ' ' A' ' 103' ' ' LYS . 63.3 tttm -97.93 134.87 40.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.191 -0.943 . . . . 0.0 109.683 179.444 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.67 147.99 51.51 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.219 -0.926 . . . . 0.0 110.354 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 32.9 m -148.54 148.06 29.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.4 -0.812 . . . . 0.0 110.292 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 88.5 p -148.36 155.08 40.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.29 -0.881 . . . . 0.0 110.136 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.453 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 34.1 m-70 -139.14 129.81 26.0 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.168 -0.958 . . . . 0.0 110.373 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.557 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 3.6 m-30 -99.56 120.58 39.88 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.279 -0.888 . . . . 0.0 110.599 -179.555 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.587 ' CD2' HG22 ' A' ' 2' ' ' VAL . 82.4 m-70 -95.51 107.56 19.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.196 -0.94 . . . . 0.0 109.674 179.074 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.531 ' CG2' HD22 ' A' ' 95' ' ' LEU . 1.6 p -77.81 157.39 29.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.917 . . . . 0.0 110.174 -179.854 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 37.6 tttt -114.46 114.0 25.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.193 -0.942 . . . . 0.0 110.237 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 93.26 -132.7 11.35 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.402 ' C ' HG11 ' A' ' 126' ' ' VAL . 4.1 t-20 -115.72 77.19 1.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.215 -1.168 . . . . 0.0 110.147 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.402 HG11 ' C ' ' A' ' 125' ' ' ASN . 32.8 m -142.02 154.39 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.178 -0.951 . . . . 0.0 110.242 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -132.05 164.22 26.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.234 -0.916 . . . . 0.0 110.214 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.629 ' CD1' ' CD1' ' A' ' 3' ' ' PHE . 3.2 mp -92.05 171.83 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.154 -0.966 . . . . 0.0 110.375 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.489 ' N ' ' CG2' ' A' ' 128' ' ' ILE . 60.8 mmtt -113.71 129.98 56.49 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.481 -0.762 . . . . 0.0 109.768 179.742 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.505 ' O ' ' CB ' ' A' ' 134' ' ' LYS . 92.4 mt-10 -43.24 -50.63 6.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.134 -0.979 . . . . 0.0 110.026 -179.841 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -48.28 -23.53 0.92 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.208 -0.933 . . . . 0.0 109.892 179.702 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.456 ' N ' ' O ' ' A' ' 129' ' ' LYS . 12.0 t-80 -87.49 -64.66 1.11 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.302 -0.874 . . . . 0.0 110.322 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.632 ' CG2' ' CD1' ' A' ' 5' ' ' TYR . 2.4 p -65.75 -28.48 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.394 -0.817 . . . . 0.0 110.086 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.505 ' CB ' ' O ' ' A' ' 130' ' ' GLU . 13.6 tptt -72.64 -48.79 36.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.163 -0.961 . . . . 0.0 109.937 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.62 -25.11 67.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.328 -0.858 . . . . 0.0 110.065 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.17 -31.34 69.15 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.412 ' O ' ' OG ' ' A' ' 141' ' ' SER . 82.0 mttt -64.92 -32.72 74.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.264 -1.139 . . . . 0.0 110.106 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -79.67 -40.24 29.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.334 -0.854 . . . . 0.0 110.005 179.81 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -69.71 -34.27 73.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.304 -0.873 . . . . 0.0 109.87 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.01 -35.39 66.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.323 -0.861 . . . . 0.0 109.885 179.718 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 137' ' ' LYS . 48.0 m -66.48 -42.95 86.69 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.276 -0.89 . . . . 0.0 109.939 179.701 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -56.36 -48.96 75.77 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.273 -0.892 . . . . 0.0 109.932 179.81 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.464 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 0.6 OUTLIER -55.8 -44.25 77.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.346 -0.846 . . . . 0.0 109.866 179.817 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.458 ' HA ' HD11 ' A' ' 147' ' ' ILE . 13.7 m-85 -55.81 -39.68 71.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.431 -0.793 . . . . 0.0 109.834 179.715 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.455 ' HA ' ' OE1' ' A' ' 148' ' ' GLU . 95.8 mttt -73.21 -12.46 60.88 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.405 -0.81 . . . . 0.0 110.229 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 143' ' ' LEU . 16.3 mt -83.77 -36.02 23.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.16 -0.962 . . . . 0.0 108.989 179.396 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.575 HD13 ' CE1' ' A' ' 22' ' ' PHE . 19.9 mt -69.66 -45.51 77.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.94 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.475 ' O ' HG13 ' A' ' 13' ' ' ILE . 38.8 mt-10 -58.98 -43.12 91.33 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.702 -0.799 . . . . 0.0 109.471 179.113 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 17.9 m -66.26 -24.49 66.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.291 -0.88 . . . . 0.0 109.564 179.453 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.58 ' CD1' HG12 ' A' ' 33' ' ' ILE . 81.8 t80 -67.02 -46.99 72.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.508 -0.745 . . . . 0.0 109.952 179.794 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.642 ' CD2' ' CE2' ' A' ' 158' ' ' TYR . 68.4 mt -79.74 -30.22 40.8 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.141 -0.975 . . . . 0.0 110.006 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.532 ' HB2' ' CG1' ' A' ' 13' ' ' ILE . 21.0 tttm -71.23 -25.83 62.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.899 . . . . 0.0 109.289 179.062 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -102.9 -33.51 4.34 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.119 -1.593 . . . . 0.0 109.119 179.543 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.58 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 5.4 m-70 -108.61 92.76 10.69 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.277 -1.131 . . . . 0.0 109.933 179.692 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -74.01 6.23 3.07 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.033 1.544 . . . . 0.0 111.168 -179.864 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -108.71 0.09 20.34 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.965 -1.084 . . . . 0.0 109.937 179.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.552 ' C ' ' CG ' ' A' ' 158' ' ' TYR . . . -83.13 102.14 11.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.303 -0.873 . . . . 0.0 110.048 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.642 ' CE2' ' CD2' ' A' ' 151' ' ' LEU . 0.3 OUTLIER 35.67 31.27 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.725 -0.609 . . . . 0.0 110.184 -179.377 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.516 ' HA ' ' NH2' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.714 -179.723 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.588 HG22 ' CD2' ' A' ' 121' ' ' HIS . 3.0 p -79.98 150.87 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.375 -1.073 . . . . 0.0 110.503 -179.795 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.531 ' N ' HG21 ' A' ' 2' ' ' VAL . 3.9 m-85 -87.75 175.41 7.87 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.446 -0.784 . . . . 0.0 110.025 -179.87 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.8 m -147.56 101.97 3.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.115 -0.991 . . . . 0.0 110.463 179.899 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.405 ' CD1' HG11 ' A' ' 133' ' ' VAL . 88.0 m-85 -112.67 127.19 56.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.293 -0.879 . . . . 0.0 109.976 179.811 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.584 ' CG ' ' N ' ' A' ' 7' ' ' SER . 17.2 tt0 -110.66 175.48 5.41 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.265 -0.897 . . . . 0.0 109.95 -179.544 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.584 ' N ' ' CG ' ' A' ' 6' ' ' GLU . 0.2 OUTLIER -156.71 166.76 32.48 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.716 -0.615 . . . . 0.0 109.634 179.756 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -156.53 132.3 9.59 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.983 -1.073 . . . . 0.0 110.955 -179.849 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.625 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 2.9 p90 -155.9 -175.82 5.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.505 -0.747 . . . . 0.0 109.581 179.43 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.46 HG23 HG12 ' A' ' 113' ' ' ILE . 23.4 p -134.7 179.23 6.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.019 -1.051 . . . . 0.0 110.887 -179.559 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.49 ' HB3' ' CD1' ' A' ' 114' ' ' ILE . 87.7 p -159.99 139.08 10.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.572 -0.705 . . . . 0.0 110.06 179.76 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -67.15 -29.85 69.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.129 -0.982 . . . . 0.0 110.287 -179.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.545 ' CD1' ' HB2' ' A' ' 152' ' ' LYS . 1.8 mp -71.7 151.8 93.47 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.291 -0.881 . . . . 0.0 109.793 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.531 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 40.3 Cg_endo -66.44 141.63 62.33 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 124.072 1.564 . . . . 0.0 110.522 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.605 ' CD ' ' CD ' ' A' ' 16' ' ' PRO . 40.9 Cg_endo -73.23 -30.4 10.49 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 124.092 1.575 . . . . 0.0 113.085 -179.256 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.605 ' CD ' ' CD ' ' A' ' 15' ' ' PRO . 43.6 Cg_endo -71.79 -21.65 24.7 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 N-CA-C 110.178 -0.739 . . . . 0.0 110.178 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.482 ' HD3' ' CG ' ' A' ' 14' ' ' PRO . 44.8 mtp180 -84.77 -46.04 11.78 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.084 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.502 ' C ' ' CD2' ' A' ' 18' ' ' LEU . 1.1 tt -67.81 -29.99 69.3 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.755 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.489 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 76.3 t80 -66.84 -57.13 7.61 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.459 -0.776 . . . . 0.0 109.3 178.748 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.494 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 9.8 mttp -48.76 -36.74 17.17 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.266 179.441 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.6 ' HB1' ' CZ ' ' A' ' 158' ' ' TYR . . . -74.69 -43.2 56.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.427 -0.795 . . . . 0.0 110.779 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.642 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 0.1 OUTLIER -68.45 -48.24 65.06 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.521 -0.737 . . . . 0.0 111.672 -178.45 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.503 HG11 ' CE1' ' A' ' 81' ' ' TYR . 3.5 t -100.3 -51.87 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.835 -1.166 . . . . 0.0 111.603 -178.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.507 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 7.2 mp -77.79 0.02 25.32 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.116 -0.99 . . . . 0.0 111.265 -179.015 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.547 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -154.15 30.92 0.44 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.97 -1.081 . . . . 0.0 110.515 179.881 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -67.33 -29.57 69.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.233 -0.917 . . . . 0.0 109.999 179.778 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -69.26 -15.6 63.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 0.0 110.069 179.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 78.8 m-20 -125.86 9.81 7.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -0.904 . . . . 0.0 110.196 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -100.34 -48.8 4.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.907 . . . . 0.0 110.245 179.906 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.589 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 2.9 t -74.46 -42.15 5.07 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.43 -0.793 . . . . 0.0 110.974 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 47.7 Cg_endo -78.15 9.01 3.24 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.499 1.263 . . . . 0.0 110.626 -179.919 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 28' ' ' ASN . 33.7 mttt -127.11 -37.27 2.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.185 -0.947 . . . . 0.0 109.464 179.678 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.526 HG12 ' CD1' ' A' ' 150' ' ' TYR . 6.8 mt -80.04 -39.44 19.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.537 -0.727 . . . . 0.0 109.562 179.536 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -155.12 100.33 2.31 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.378 -0.827 . . . . 0.0 110.189 179.819 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.21 -0.85 9.22 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.978 1.515 . . . . 0.0 110.632 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -84.47 -8.0 59.09 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.102 -0.999 . . . . 0.0 109.816 179.75 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.416 ' HB2' HD11 ' A' ' 38' ' ' ILE . . . -98.24 -63.4 1.13 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.303 -0.873 . . . . 0.0 110.234 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.52 ' CD1' HG12 ' A' ' 30' ' ' VAL . 2.0 mp -115.56 137.56 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.378 -0.826 . . . . 0.0 110.191 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 57' ' ' THR . 13.7 ttpt -84.66 -19.2 33.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.381 -0.824 . . . . 0.0 110.207 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.545 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER 178.69 159.85 0.59 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.204 -0.935 . . . . 0.0 109.962 -179.961 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -135.4 126.13 27.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.366 -0.834 . . . . 0.0 109.936 179.798 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.439 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 36.9 tt0 -139.92 113.42 8.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.234 -0.916 . . . . 0.0 110.55 -179.826 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.509 HD11 HG22 ' A' ' 43' ' ' ILE . 43.4 mt -53.87 142.22 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.262 -0.899 . . . . 0.0 109.861 179.535 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.45 HD22 ' CB ' ' A' ' 55' ' ' LYS . 0.4 OUTLIER -114.64 -30.05 6.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.107 -0.996 . . . . 0.0 110.455 -179.862 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.566 ' CD2' HD13 ' A' ' 53' ' ' ILE . 1.7 m95 -126.48 164.97 19.99 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.261 -0.899 . . . . 0.0 110.416 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.46 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 41.78 -135.65 3.19 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.745 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.11 22.68 0.5 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.28 -1.13 . . . . 0.0 110.093 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 121.59 -19.14 8.57 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.473 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -71.82 -171.57 15.2 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.479 ' HA ' HG23 ' A' ' 71' ' ' ILE . 45.9 Cg_endo -73.19 129.11 13.65 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 123.939 1.494 . . . . 0.0 110.478 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.74 -14.0 53.35 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.499 -1.84 . . . . 0.0 108.499 -179.392 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -70.48 160.96 31.45 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.613 -0.933 . . . . 0.0 109.381 179.536 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.566 HD13 ' CD2' ' A' ' 45' ' ' TRP . 57.6 mt -128.99 119.54 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.221 -0.924 . . . . 0.0 110.059 179.782 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.472 ' HE3' ' CD1' ' A' ' 71' ' ' ILE . 20.6 mttm -101.2 129.82 47.19 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.292 -0.88 . . . . 0.0 110.134 -179.892 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 34.7 ttpt -100.79 91.84 4.8 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.21 -0.931 . . . . 0.0 110.155 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.468 ' HB ' HG21 ' A' ' 67' ' ' VAL . 88.8 mt -80.07 144.16 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.894 . . . . 0.0 110.208 -179.948 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.499 ' O ' ' N ' ' A' ' 39' ' ' LYS . 1.0 OUTLIER -113.87 150.97 32.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.312 -0.867 . . . . 0.0 110.303 -179.997 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.577 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 20.8 m-85 -115.47 147.55 40.48 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.269 -0.894 . . . . 0.0 110.142 179.744 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.887 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.208 0.528 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.577 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -131.8 84.88 0.3 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.533 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 11.7 p90 -128.12 163.17 25.22 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.23 -1.159 . . . . 0.0 110.262 -179.658 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.496 HG23 ' CZ ' ' A' ' 58' ' ' PHE . 5.3 m -136.08 175.66 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.369 -0.832 . . . . 0.0 110.251 179.496 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.516 ' O ' ' CD1' ' A' ' 85' ' ' LEU . 26.8 mttm -135.56 104.87 5.97 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.382 -0.824 . . . . 0.0 109.829 179.754 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.529 ' CD2' HD11 ' A' ' 85' ' ' LEU . 14.2 m170 -95.6 130.08 42.58 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.301 -0.874 . . . . 0.0 111.121 -179.317 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 52' ' ' THR . 31.6 tttt -96.88 113.91 25.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.332 -0.855 . . . . 0.0 109.331 179.034 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.507 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 28.9 mm -53.52 131.11 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.197 -0.939 . . . . 0.0 110.313 -179.421 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.473 ' OD2' ' OG1' ' A' ' 84' ' ' THR . 86.1 m-20 -106.09 -46.66 4.03 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.405 -0.809 . . . . 0.0 110.332 -179.799 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 48.0 m -164.94 159.15 17.83 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.324 -0.86 . . . . 0.0 110.039 -179.793 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.464 HG12 HG12 ' A' ' 23' ' ' VAL . 1.7 mt -145.23 157.9 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.189 -0.944 . . . . 0.0 110.655 -179.881 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.537 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 2.2 m-20 -136.93 80.0 1.79 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.611 -0.681 . . . . 0.0 109.938 179.35 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.489 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 44.7 tttt -63.46 -13.27 38.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.189 -0.944 . . . . 0.0 110.431 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -95.79 -30.45 13.69 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.249 -0.907 . . . . 0.0 109.458 179.665 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.5 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -106.52 -7.54 17.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.572 -0.705 . . . . 0.0 109.813 -179.956 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.537 ' CZ ' ' HB3' ' A' ' 16' ' ' PRO . 2.8 m-85 68.62 51.12 0.64 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.558 -0.714 . . . . 0.0 110.177 -179.695 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.537 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -122.68 149.58 43.85 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.256 -0.903 . . . . 0.0 109.409 179.599 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.69 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 31.5 t80 -137.22 149.14 46.98 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.101 -0.999 . . . . 0.0 110.504 -179.204 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.461 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 75.0 m -154.92 129.0 8.84 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.177 -0.952 . . . . 0.0 110.922 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.69 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 26.1 p90 -148.17 169.5 19.9 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.328 -0.858 . . . . 0.0 110.536 179.318 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.473 ' OG1' ' OD2' ' A' ' 72' ' ' ASP . 18.0 m -124.52 129.85 51.38 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.299 -0.876 . . . . 0.0 110.127 -179.8 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.529 HD11 ' CD2' ' A' ' 69' ' ' HIS . 16.0 tp -96.43 136.78 36.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.945 -1.097 . . . . 0.0 110.34 179.735 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.422 HG23 HD11 ' A' ' 86' ' ' ILE . 11.4 pt -118.17 -30.87 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.212 -0.93 . . . . 0.0 110.364 -179.44 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.445 ' OE2' ' OH ' ' A' ' 66' ' ' TYR . 64.3 tt0 -114.53 156.26 24.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.276 -0.89 . . . . 0.0 110.159 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.466 ' HA2' HG13 ' A' ' 67' ' ' VAL . . . 152.69 130.89 1.6 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 89' ' ' ASP . 36.9 p-10 -60.94 -15.31 29.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -1.138 . . . . 0.0 110.09 179.91 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.07 -19.94 53.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 110.166 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.473 ' O ' ' HB2' ' A' ' 95' ' ' LEU . 59.1 mt -70.09 -26.96 64.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.92 . . . . 0.0 110.054 179.909 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 44.74 -169.36 0.02 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -87.36 7.33 29.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.247 -1.149 . . . . 0.0 109.911 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.405 ' O ' HG23 ' A' ' 126' ' ' VAL . 30.1 p -98.84 -28.19 13.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.359 -0.838 . . . . 0.0 109.959 179.91 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.592 ' CD1' ' CD1' ' A' ' 128' ' ' ILE . 41.2 mt -111.91 169.56 8.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.449 -0.782 . . . . 0.0 110.156 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.431 ' HG2' ' C ' ' A' ' 95' ' ' LEU . 66.2 mm-40 -151.2 -81.38 0.1 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.318 -0.864 . . . . 0.0 109.877 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 19.4 mttt -80.33 133.78 35.98 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.727 -0.608 . . . . 0.0 110.564 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.553 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 6.7 mm -123.44 142.01 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.876 -1.14 . . . . 0.0 109.886 179.07 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.471 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.3 OUTLIER -123.42 134.41 53.96 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.39 -0.819 . . . . 0.0 109.021 178.866 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 7.2 m-85 -129.82 132.3 46.44 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.303 -0.873 . . . . 0.0 110.624 -179.021 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -136.41 136.08 39.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.401 -0.812 . . . . 0.0 109.884 179.465 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 39.3 m -136.36 139.6 42.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 110.111 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 115' ' ' LYS . 1.1 tttp -134.52 143.24 47.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.241 -0.912 . . . . 0.0 110.502 -179.87 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.518 ' HB2' ' HB2' ' A' ' 79' ' ' TYR . 7.2 mt -124.52 151.91 44.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.247 -0.908 . . . . 0.0 109.844 179.587 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.481 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 1.9 t -150.06 -169.76 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.176 -0.953 . . . . 0.0 110.288 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -125.34 160.74 28.59 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.399 -0.813 . . . . 0.0 110.21 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.455 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 3.1 p -119.16 169.03 8.73 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.197 -0.939 . . . . 0.0 110.282 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 48.3 Cg_endo -73.37 -4.11 14.85 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.069 1.563 . . . . 0.0 110.7 -179.891 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 39.2 p -105.83 9.93 32.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.085 -1.009 . . . . 0.0 110.298 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 111' ' ' GLY . . . 93.38 -37.84 3.3 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.894 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 110' ' ' GLY . . . -54.27 -172.65 0.06 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.533 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 9.0 p -138.79 136.0 35.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.14 -1.212 . . . . 0.0 110.414 179.937 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.46 HG12 HG23 ' A' ' 10' ' ' THR . 61.4 mt -87.67 149.03 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.346 -0.846 . . . . 0.0 109.944 179.772 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.625 ' CG2' ' CE2' ' A' ' 9' ' ' PHE . 4.6 mt -131.82 116.12 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.224 -0.922 . . . . 0.0 110.389 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 103' ' ' LYS . 39.5 tttt -100.12 148.29 24.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.374 -0.829 . . . . 0.0 110.011 179.708 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.2 t -145.55 155.39 43.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.184 -0.947 . . . . 0.0 110.388 -179.816 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 25.9 m -157.87 126.19 5.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.444 -0.785 . . . . 0.0 109.888 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 3.6 m -121.66 154.85 36.27 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.126 -0.984 . . . . 0.0 110.296 -179.851 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.471 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 56.2 m-70 -137.87 147.27 44.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.276 -0.89 . . . . 0.0 110.392 -179.998 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.6 ' CD2' HG13 ' A' ' 128' ' ' ILE . 58.8 m-85 -126.04 121.95 34.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.299 -0.876 . . . . 0.0 110.208 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.588 ' CD2' HG22 ' A' ' 2' ' ' VAL . 70.4 m-70 -95.55 103.95 15.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.277 -0.889 . . . . 0.0 109.956 179.793 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.519 ' CG2' HG22 ' A' ' 126' ' ' VAL . 0.9 OUTLIER -91.1 142.71 27.46 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.14 -0.975 . . . . 0.0 110.29 -179.792 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.6 tttt -103.73 124.98 49.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.328 -0.858 . . . . 0.0 110.325 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 98.1 -122.51 7.52 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -134.19 67.61 1.51 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.277 -1.131 . . . . 0.0 110.311 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.519 HG22 ' CG2' ' A' ' 122' ' ' THR . 31.0 m -131.5 168.11 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 109.932 179.915 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.434 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 89.7 mt-10 -143.93 157.86 44.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.161 -0.962 . . . . 0.0 110.588 -179.828 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.6 HG13 ' CD2' ' A' ' 120' ' ' TYR . 20.5 mm -61.47 173.41 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.379 -0.826 . . . . 0.0 110.106 179.736 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.49 ' N ' ' CG2' ' A' ' 128' ' ' ILE . 22.9 mttt -96.62 130.8 43.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.334 -0.854 . . . . 0.0 109.66 179.456 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 129' ' ' LYS . 95.5 mt-10 -42.06 -42.9 3.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 110.307 -179.708 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.527 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 31.0 tt0 -55.51 -33.91 64.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.912 . . . . 0.0 109.892 179.636 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.502 ' HB3' ' CG2' ' A' ' 128' ' ' ILE . 5.9 t-160 -75.49 -56.77 4.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.275 -0.891 . . . . 0.0 110.431 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.405 HG11 ' CD1' ' A' ' 5' ' ' TYR . 86.7 t -60.82 -33.03 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.326 -0.858 . . . . 0.0 110.394 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 38.6 mttp -104.04 -71.17 0.74 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.148 -0.97 . . . . 0.0 110.499 -179.688 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -55.93 -19.28 11.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.081 -1.012 . . . . 0.0 109.867 -179.883 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 132' ' ' HIS . . . -76.71 -29.85 57.02 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.819 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 46.4 mttt -68.13 -32.36 72.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.269 -1.136 . . . . 0.0 110.222 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -79.06 -34.21 43.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 110.027 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -66.35 -39.07 88.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.33 -0.856 . . . . 0.0 110.002 179.864 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.87 -42.92 60.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.411 -0.806 . . . . 0.0 110.032 179.76 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.0 t -54.55 -43.11 71.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.323 -0.861 . . . . 0.0 109.905 179.765 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -57.43 -44.82 84.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.349 -0.845 . . . . 0.0 109.919 179.702 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 46.5 mt -58.53 -38.08 77.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.285 -0.884 . . . . 0.0 109.836 179.713 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -62.26 -33.94 75.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.425 -0.797 . . . . 0.0 109.705 179.543 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -72.94 -15.46 61.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.327 -0.858 . . . . 0.0 109.855 179.756 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 14.0 mt -82.34 -37.15 26.13 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.258 -0.901 . . . . 0.0 108.721 179.203 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.642 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 19.1 mt -68.69 -47.35 77.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.751 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.513 ' HB3' ' CD1' ' A' ' 13' ' ' ILE . 88.8 mt-10 -56.18 -43.86 78.82 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.498 -0.751 . . . . 0.0 109.466 179.037 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 42.8 m -65.2 -34.34 78.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.159 -0.963 . . . . 0.0 109.37 179.329 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.596 ' CE2' ' OH ' ' A' ' 158' ' ' TYR . 81.3 t80 -59.15 -47.61 84.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.562 -0.711 . . . . 0.0 109.581 179.341 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.55 HD22 ' CE2' ' A' ' 158' ' ' TYR . 32.8 mt -80.08 -33.37 38.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 110.222 179.655 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.545 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . 27.4 tttt -60.09 -23.21 63.62 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.228 -0.92 . . . . 0.0 109.257 179.364 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.471 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -109.69 -30.5 3.49 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.607 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 5.4 m-70 -105.68 92.22 5.88 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.28 -1.13 . . . . 0.0 110.084 179.817 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 46.3 Cg_endo -72.18 2.93 4.43 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.009 1.531 . . . . 0.0 111.069 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -113.57 -11.5 13.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.067 -1.02 . . . . 0.0 109.764 179.729 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.615 ' C ' ' CG ' ' A' ' 158' ' ' TYR . . . -46.84 102.31 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.412 -0.805 . . . . 0.0 109.688 179.615 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.615 ' CG ' ' C ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER 58.71 -59.12 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.458 0 CA-C-O 121.592 0.71 . . . . 0.0 110.543 -179.33 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.589 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--N 1.293 -1.874 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.169 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.549 HG12 ' CE1' ' A' ' 121' ' ' HIS . 58.5 t -122.31 137.12 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.201 -1.176 . . . . 0.0 110.319 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.64 ' CD1' ' CD1' ' A' ' 128' ' ' ILE . 11.6 m-85 -95.71 146.88 24.17 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.318 -0.864 . . . . 0.0 109.967 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.3 m -127.35 117.26 21.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.179 -0.95 . . . . 0.0 110.597 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.621 ' CE2' ' CG2' ' A' ' 133' ' ' VAL . 67.1 m-85 -129.74 132.86 46.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.381 -0.825 . . . . 0.0 109.655 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 23.1 pt-20 -130.22 153.53 48.49 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.146 -0.971 . . . . 0.0 110.703 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.472 ' O ' ' CG ' ' A' ' 8' ' ' GLU . 5.9 t -131.79 165.93 22.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.459 -0.776 . . . . 0.0 109.574 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.472 ' CG ' ' O ' ' A' ' 7' ' ' SER . 87.5 mt-10 -154.12 121.97 5.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.088 -1.007 . . . . 0.0 110.706 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.618 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.2 p90 -149.53 -178.31 6.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.355 -0.841 . . . . 0.0 109.625 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.515 ' CG2' ' HA ' ' A' ' 113' ' ' ILE . 8.6 p -142.37 174.57 10.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.196 -0.94 . . . . 0.0 110.651 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.484 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 4.7 t -159.79 162.19 34.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.461 -0.774 . . . . 0.0 110.125 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -83.48 -20.28 34.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.217 -0.927 . . . . 0.0 110.187 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.524 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 2.9 mp -74.08 149.66 87.45 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.317 -0.865 . . . . 0.0 110.072 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.524 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 41.3 Cg_endo -67.59 142.23 58.08 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.055 1.555 . . . . 0.0 110.473 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.623 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.2 Cg_endo -72.44 -30.95 11.88 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 124.013 1.533 . . . . 0.0 112.804 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.7 Cg_endo -70.4 -23.79 27.47 Favored 'Trans proline' 0 C--N 1.319 -0.983 0 N-CA-C 110.115 -0.764 . . . . 0.0 110.115 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.538 ' O ' ' CE1' ' A' ' 158' ' ' TYR . 58.5 mtp180 -82.24 -44.11 16.75 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.22 -0.925 . . . . 0.0 108.662 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.584 ' CD2' ' CG2' ' A' ' 147' ' ' ILE . 0.2 OUTLIER -70.85 -31.4 68.09 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.04 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.522 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 70.4 t80 -63.69 -58.82 5.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.478 -0.764 . . . . 0.0 109.509 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 75.1 mttt -50.23 -41.24 49.64 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.42 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.664 ' CB ' ' CZ ' ' A' ' 158' ' ' TYR . . . -70.55 -36.25 73.57 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.406 -0.809 . . . . 0.0 110.928 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.586 ' CE1' HD12 ' A' ' 147' ' ' ILE . 0.2 OUTLIER -79.18 -40.25 31.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.24 -0.912 . . . . 0.0 111.14 -178.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.484 HG12 ' CD1' ' A' ' 81' ' ' TYR . 7.5 t -103.75 -54.85 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.975 -1.078 . . . . 0.0 111.741 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.473 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 5.9 mp -80.02 -1.39 39.55 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.013 -1.054 . . . . 0.0 112.012 -178.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.532 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -146.52 14.49 1.24 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.68 -1.263 . . . . 0.0 110.61 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -60.65 -16.46 39.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.273 -0.892 . . . . 0.0 110.78 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -70.87 -22.11 62.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.065 -1.022 . . . . 0.0 110.556 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.447 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 6.9 p30 -132.1 3.27 4.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.106 -0.996 . . . . 0.0 110.427 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.586 ' CD1' ' CD1' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -92.27 -39.42 11.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.235 -0.916 . . . . 0.0 109.972 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.589 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 97.6 t -77.11 -40.77 2.38 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.398 -0.813 . . . . 0.0 110.961 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.3 Cg_endo -77.85 7.87 3.72 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.32 1.168 . . . . 0.0 110.55 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -121.48 -38.22 2.8 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.159 -0.963 . . . . 0.0 109.078 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.586 ' CD1' ' CD1' ' A' ' 29' ' ' LEU . 5.6 mt -80.2 -39.13 18.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-O 121.563 0.697 . . . . 0.0 109.271 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.72 80.01 32.67 Favored Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.572 -0.705 . . . . 0.0 109.877 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -73.13 1.14 6.95 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.101 1.579 . . . . 0.0 110.83 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -87.97 -17.44 31.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.139 -0.976 . . . . 0.0 109.919 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -101.19 -56.44 2.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.394 -0.816 . . . . 0.0 110.038 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.576 ' CD1' ' CG1' ' A' ' 30' ' ' VAL . 1.3 mp -107.39 145.53 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.467 -0.771 . . . . 0.0 109.914 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -112.6 -23.46 10.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.891 . . . . 0.0 110.586 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.551 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -163.02 158.2 21.83 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.097 -1.002 . . . . 0.0 110.223 -179.788 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.8 m -140.87 124.5 16.91 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.295 -0.878 . . . . 0.0 109.917 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 60.3 tt0 -137.56 108.22 6.6 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.107 -0.996 . . . . 0.0 110.452 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.44 HG12 ' HG2' ' A' ' 54' ' ' LYS . 13.6 mt -54.84 131.44 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.191 -0.943 . . . . 0.0 110.008 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.516 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 20.3 mt -97.5 -34.86 10.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.921 . . . . 0.0 110.616 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.571 ' CD1' HD11 ' A' ' 53' ' ' ILE . 1.9 m95 -123.03 161.79 23.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.248 -0.907 . . . . 0.0 110.73 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.459 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 40.18 -133.57 2.39 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.432 ' HA ' HG23 ' A' ' 43' ' ' ILE . 0.5 OUTLIER -157.68 20.14 0.27 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.384 -1.068 . . . . 0.0 110.069 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.402 ' N ' HG22 ' A' ' 52' ' ' THR . . . 128.57 -21.72 5.34 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.475 ' O ' HG23 ' A' ' 71' ' ' ILE . . . -65.73 -175.91 6.01 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.482 ' HA ' HG23 ' A' ' 71' ' ' ILE . 46.1 Cg_endo -73.23 128.69 13.18 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 124.032 1.543 . . . . 0.0 110.559 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.19 -14.33 55.2 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.643 -1.783 . . . . 0.0 108.643 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -67.86 164.07 20.53 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.565 -0.962 . . . . 0.0 109.789 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.571 HD11 ' CD1' ' A' ' 45' ' ' TRP . 59.9 mt -131.95 121.59 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.398 -0.813 . . . . 0.0 109.467 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.44 ' HG2' HG12 ' A' ' 43' ' ' ILE . 66.9 mttt -106.01 135.81 46.79 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.144 -0.972 . . . . 0.0 110.317 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.516 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 21.1 tttp -104.73 89.6 3.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.353 -0.842 . . . . 0.0 110.01 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.519 ' CG2' HG12 ' A' ' 38' ' ' ILE . 61.8 mt -79.91 138.69 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 109.867 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 40' ' ' HIS . 1.4 p -116.49 152.94 33.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.908 . . . . 0.0 110.589 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.574 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 18.7 m-85 -115.27 169.82 8.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.435 -0.791 . . . . 0.0 110.012 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -136.05 29.93 2.78 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -54.08 -23.52 14.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.277 -1.131 . . . . 0.0 110.302 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -176.38 -166.87 34.28 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.2 p -64.58 -45.71 85.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.248 -1.148 . . . . 0.0 110.172 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -46.89 135.53 9.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 0.0 110.149 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.467 ' CD2' ' CD2' ' A' ' 66' ' ' TYR . 1.5 t80 -69.45 122.1 18.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 0.0 110.254 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.574 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -129.6 99.95 0.48 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.488 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 25.8 p90 -140.33 171.69 13.79 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -1.139 . . . . 0.0 110.304 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.519 HG13 ' CA ' ' A' ' 88' ' ' GLY . 5.8 m -141.08 173.81 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.335 -0.853 . . . . 0.0 110.563 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.516 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 23.2 mttt -123.2 127.31 48.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.499 -0.751 . . . . 0.0 109.625 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.557 ' CD2' HD11 ' A' ' 85' ' ' LEU . 16.5 m170 -113.74 126.52 55.31 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.102 -0.999 . . . . 0.0 111.049 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 52' ' ' THR . 64.8 tttt -104.22 106.63 17.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.326 -0.859 . . . . 0.0 109.533 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.519 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 31.1 mm -49.8 136.02 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.191 -0.943 . . . . 0.0 110.38 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.463 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 8.3 t0 -111.76 -39.86 4.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.359 -0.838 . . . . 0.0 109.55 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.465 ' OG ' ' HB2' ' A' ' 82' ' ' SER . 53.4 p -168.42 160.44 11.2 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.464 -0.773 . . . . 0.0 109.617 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 73' ' ' SER . 1.5 mt -147.52 154.9 10.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.192 -0.942 . . . . 0.0 110.292 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 79' ' ' TYR . 4.7 m-20 -135.66 79.09 1.76 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.213 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.522 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 63.5 mttt -63.02 -12.82 28.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.153 -0.967 . . . . 0.0 110.066 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -95.61 -31.78 13.12 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.31 -0.869 . . . . 0.0 109.497 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.501 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -106.01 -5.86 19.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.593 -0.692 . . . . 0.0 109.673 179.825 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.54 ' N ' ' O ' ' A' ' 75' ' ' ASP . 4.6 m-85 66.34 50.22 1.34 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.555 -0.716 . . . . 0.0 110.42 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.534 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -120.42 150.32 40.97 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.241 -0.912 . . . . 0.0 109.227 179.379 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.577 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 19.9 t80 -139.09 134.29 32.72 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.14 -0.975 . . . . 0.0 110.299 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.465 ' HB2' ' OG ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -140.6 120.22 13.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.272 -0.892 . . . . 0.0 110.695 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.629 ' CE2' ' CB ' ' A' ' 100' ' ' TYR . 19.5 p90 -138.0 170.97 15.11 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 110.246 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.451 HG21 ' O ' ' A' ' 98' ' ' ILE . 86.7 m -121.64 130.83 53.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.412 -0.805 . . . . 0.0 109.802 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.557 HD11 ' CD2' ' A' ' 69' ' ' HIS . 5.2 tp -95.32 137.88 33.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.091 -1.006 . . . . 0.0 110.124 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.1 pt -120.41 -15.04 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.322 -0.862 . . . . 0.0 110.389 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.516 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 25.3 tt0 -129.37 158.64 38.58 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.134 -0.978 . . . . 0.0 110.262 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.519 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 151.16 115.76 0.7 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -50.44 -20.97 1.27 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.251 -1.146 . . . . 0.0 110.345 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.568 ' O ' ' CE1' ' A' ' 132' ' ' HIS . . . -72.77 -18.75 61.46 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.19 -0.943 . . . . 0.0 110.41 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 95' ' ' LEU . 74.9 mt -69.33 -7.79 40.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.167 -0.958 . . . . 0.0 110.185 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 46.75 -171.8 0.03 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 49.8 p-10 -91.64 34.68 0.97 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.214 -1.168 . . . . 0.0 109.675 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.1 p -131.31 -41.64 1.09 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.441 -0.787 . . . . 0.0 110.397 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.634 ' CD2' ' N ' ' A' ' 95' ' ' LEU . 3.1 mm? -79.91 157.02 27.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.906 . . . . 0.0 110.352 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.449 ' HG3' ' HB2' ' A' ' 123' ' ' LYS . 48.0 mm-40 -141.08 -80.9 0.25 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.326 -0.859 . . . . 0.0 109.631 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.529 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 36.8 mttp -80.31 126.53 31.27 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.484 -0.76 . . . . 0.0 110.318 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.62 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 5.7 mm -116.58 138.93 45.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 120.586 -1.321 . . . . 0.0 109.621 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.451 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -114.76 130.12 56.8 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.465 179.219 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.629 ' CB ' ' CE2' ' A' ' 83' ' ' TYR . 9.3 m-85 -125.36 134.01 52.34 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.42 -0.8 . . . . 0.0 110.032 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.46 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 78.0 tt0 -136.56 136.12 39.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 0.0 110.478 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.435 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 91.8 m -136.73 137.8 40.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.287 -0.883 . . . . 0.0 109.762 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -135.37 145.56 47.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.063 -1.023 . . . . 0.0 110.49 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.492 ' C ' ' CG2' ' A' ' 105' ' ' VAL . 6.2 mt -126.43 151.79 47.26 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.33 -0.856 . . . . 0.0 110.067 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.492 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -150.97 -169.23 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.247 -0.908 . . . . 0.0 110.247 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -120.49 151.14 39.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.336 -0.852 . . . . 0.0 110.265 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.474 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 6.1 p -105.08 167.9 9.16 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 110.164 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.474 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.3 Cg_endo -72.7 -13.25 27.04 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.059 1.557 . . . . 0.0 110.438 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 74.1 m -97.02 12.45 32.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.184 -0.947 . . . . 0.0 110.252 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 92.29 -32.82 5.24 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -60.36 -175.0 1.11 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 28.8 p -130.57 135.36 47.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -1.16 . . . . 0.0 110.376 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.515 ' HA ' ' CG2' ' A' ' 10' ' ' THR . 11.0 mt -88.33 151.31 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.294 -0.879 . . . . 0.0 110.065 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.608 ' CG2' ' CE2' ' A' ' 9' ' ' PHE . 11.9 mt -131.49 116.67 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -0.936 . . . . 0.0 110.35 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.8 tttm -108.61 124.14 50.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.164 -0.96 . . . . 0.0 109.892 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.7 t -120.46 162.06 20.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.237 -0.914 . . . . 0.0 110.397 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.46 ' HB ' ' HB3' ' A' ' 101' ' ' GLU . 37.5 m -160.02 151.97 20.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.373 -0.829 . . . . 0.0 109.932 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 7.5 m -148.35 157.1 43.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.205 -0.935 . . . . 0.0 110.275 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.467 ' C ' ' CD1' ' A' ' 120' ' ' TYR . 68.4 m-70 -141.54 162.05 36.42 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.195 -0.94 . . . . 0.0 110.536 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.502 ' N ' ' CD1' ' A' ' 120' ' ' TYR . 11.1 m-85 -127.68 152.36 47.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.358 -0.839 . . . . 0.0 110.302 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.549 ' CE1' HG12 ' A' ' 2' ' ' VAL . 74.2 m-70 -134.99 86.69 2.27 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.201 -0.937 . . . . 0.0 109.518 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.525 ' CG2' HD23 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -70.79 146.75 49.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.397 -0.814 . . . . 0.0 110.74 -179.341 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.449 ' HB2' ' HG3' ' A' ' 96' ' ' GLU . 2.0 ttpt -92.83 119.1 31.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.373 -0.83 . . . . 0.0 110.057 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 105.58 -125.32 8.2 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -137.43 61.61 1.61 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.328 -1.101 . . . . 0.0 110.231 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.479 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 35.5 m -124.28 179.32 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.246 -0.909 . . . . 0.0 110.08 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -140.52 158.53 43.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.177 -0.952 . . . . 0.0 110.345 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.64 ' CD1' ' CD1' ' A' ' 3' ' ' PHE . 5.1 mp -78.23 172.98 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.247 -0.908 . . . . 0.0 110.183 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.449 ' O ' ' N ' ' A' ' 132' ' ' HIS . 7.3 mttp -107.02 128.02 53.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.363 -0.835 . . . . 0.0 109.888 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.435 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 91.8 mt-10 -42.77 -53.45 4.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.214 -0.928 . . . . 0.0 110.244 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -47.52 -26.19 1.33 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.188 -0.945 . . . . 0.0 109.912 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.568 ' CE1' ' O ' ' A' ' 90' ' ' ALA . 11.3 t-160 -85.37 -62.39 1.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.297 -0.877 . . . . 0.0 110.137 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.621 ' CG2' ' CE2' ' A' ' 5' ' ' TYR . 7.7 p -62.36 -41.0 89.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.378 -0.826 . . . . 0.0 109.962 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 27.6 tttp -64.8 -44.14 90.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.337 -0.852 . . . . 0.0 109.89 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.86 -32.8 74.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.374 -0.829 . . . . 0.0 109.913 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -64.9 -31.86 82.33 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -60.53 -32.66 71.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.273 -1.133 . . . . 0.0 109.955 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 142' ' ' ASN . 99.0 mt-10 -83.6 -33.35 25.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.38 -0.825 . . . . 0.0 109.878 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 24.3 mttt -68.86 -35.06 76.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.34 -0.85 . . . . 0.0 109.881 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.427 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -86.18 -40.89 15.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.297 -0.877 . . . . 0.0 109.934 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.1 m -67.55 -53.45 28.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.419 -0.801 . . . . 0.0 109.846 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 138' ' ' GLU . 98.8 m-20 -49.43 -47.47 48.02 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.226 -0.921 . . . . 0.0 109.924 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.426 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 9.3 tp -55.6 -48.16 75.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.281 -0.887 . . . . 0.0 109.882 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.565 ' CE1' ' CE2' ' A' ' 22' ' ' PHE . 13.6 m-85 -53.31 -36.13 60.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.444 -0.785 . . . . 0.0 109.843 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -74.56 -16.51 60.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.359 -0.838 . . . . 0.0 109.862 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 143' ' ' LEU . 24.0 mt -84.41 -35.63 22.97 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.281 -0.887 . . . . 0.0 109.01 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.586 HD12 ' CE1' ' A' ' 22' ' ' PHE . 24.7 mt -68.26 -41.61 83.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.484 ' CG ' ' OG ' ' A' ' 11' ' ' SER . 97.2 mt-10 -48.36 -40.98 27.3 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.158 -0.964 . . . . 0.0 108.794 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 19.5 m -72.05 -26.74 62.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.28 -0.887 . . . . 0.0 109.351 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.578 ' O ' ' CD2' ' A' ' 154' ' ' HIS . 62.7 t80 -57.89 -52.2 66.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.535 -0.728 . . . . 0.0 109.883 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.578 HD22 ' CE1' ' A' ' 158' ' ' TYR . 64.7 mt -80.01 -36.42 35.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.285 -0.884 . . . . 0.0 110.362 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.466 ' HB2' HD12 ' A' ' 13' ' ' ILE . 35.8 tttt -60.05 -19.69 54.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.163 -0.961 . . . . 0.0 109.236 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.454 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -111.1 -32.22 2.66 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.6 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 5.8 m-70 -105.97 93.0 7.04 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.324 -1.103 . . . . 0.0 110.039 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.503 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 46.6 Cg_endo -72.94 3.66 4.29 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.018 1.536 . . . . 0.0 110.96 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -114.19 -10.29 12.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.085 -1.009 . . . . 0.0 109.899 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.581 ' O ' ' CD1' ' A' ' 158' ' ' TYR . . . -46.92 108.74 0.15 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.333 -0.855 . . . . 0.0 110.053 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.664 ' CZ ' ' CB ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 35.46 30.83 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.719 -0.613 . . . . 0.0 110.515 -179.624 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.701 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.568 HG12 ' CE1' ' A' ' 121' ' ' HIS . 63.6 t -122.93 122.53 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.191 -1.182 . . . . 0.0 110.264 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.568 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 43.1 m-85 -80.2 154.16 28.12 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.28 -0.887 . . . . 0.0 110.302 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 56.5 m -138.35 94.47 2.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.882 . . . . 0.0 110.1 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.588 ' CE1' ' CG2' ' A' ' 133' ' ' VAL . 75.1 m-85 -116.15 136.41 53.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.889 . . . . 0.0 110.026 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 21.5 pt-20 -135.92 151.91 50.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.202 -0.936 . . . . 0.0 110.404 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.3 m -121.38 157.83 29.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.337 -0.852 . . . . 0.0 109.92 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -135.44 121.11 19.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.115 -0.99 . . . . 0.0 110.386 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.638 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.9 p90 -146.03 -174.12 4.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.347 -0.846 . . . . 0.0 109.948 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.509 ' CG2' ' HA ' ' A' ' 113' ' ' ILE . 5.7 p -141.43 173.03 11.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.201 -0.937 . . . . 0.0 110.627 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.479 ' CB ' ' CD ' ' A' ' 148' ' ' GLU . 97.6 p -156.68 135.04 11.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.399 -0.813 . . . . 0.0 110.2 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -62.05 -31.02 71.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.211 -0.931 . . . . 0.0 110.134 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.526 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 2.3 mp -64.55 150.62 93.43 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.869 . . . . 0.0 109.944 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.526 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 42.0 Cg_endo -68.32 143.15 57.3 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.044 1.549 . . . . 0.0 110.771 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.635 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.5 Cg_endo -72.25 -30.92 12.42 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 O-C-N 124.042 1.549 . . . . 0.0 112.737 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.635 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.1 Cg_endo -69.53 -22.71 32.75 Favored 'Trans proline' 0 N--CA 1.485 0.988 0 N-CA-C 110.07 -0.781 . . . . 0.0 110.07 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.519 ' NE ' ' HB2' ' A' ' 159' ' ' ASN . 42.2 mtp180 -83.5 -42.89 16.37 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.579 ' CD2' ' CG2' ' A' ' 147' ' ' ILE . 0.3 OUTLIER -71.33 -32.69 68.87 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 178.833 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.607 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 81.4 t80 -63.02 -61.63 2.26 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.538 -0.726 . . . . 0.0 109.577 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.484 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 14.9 mttp -53.61 -32.88 53.0 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.383 -0.823 . . . . 0.0 109.351 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.667 ' CB ' ' CZ ' ' A' ' 158' ' ' TYR . . . -74.26 -47.45 35.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.363 -0.836 . . . . 0.0 110.568 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.636 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 0.2 OUTLIER -66.67 -46.76 74.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.542 -0.724 . . . . 0.0 111.215 -179.141 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.585 ' CG1' ' CD1' ' A' ' 74' ' ' ILE . 6.1 t -97.45 -60.3 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.109 -0.995 . . . . 0.0 111.914 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' A' ' 20' ' ' LYS . 8.5 mp -69.5 -0.19 6.23 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.16 -0.962 . . . . 0.0 111.824 -178.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.493 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -146.16 10.95 1.17 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.692 -1.255 . . . . 0.0 110.811 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -53.38 -19.02 3.0 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.164 -0.96 . . . . 0.0 110.863 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -80.01 -26.87 39.65 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.005 -1.059 . . . . 0.0 110.573 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -127.12 13.05 7.21 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.255 -0.903 . . . . 0.0 110.337 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.589 ' CD1' ' CD1' ' A' ' 33' ' ' ILE . 0.8 OUTLIER -103.9 -45.29 4.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.105 -0.997 . . . . 0.0 110.259 179.921 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.601 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 3.1 t -64.77 -41.83 59.22 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.326 -0.858 . . . . 0.0 110.556 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.0 Cg_endo -78.79 8.87 3.51 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.442 1.233 . . . . 0.0 110.628 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -118.64 -25.47 6.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.153 -0.967 . . . . 0.0 109.263 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.589 ' CD1' ' CD1' ' A' ' 29' ' ' LEU . 20.1 mt -80.01 -57.42 5.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 121.612 0.72 . . . . 0.0 109.427 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -145.06 105.55 4.46 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.541 -0.724 . . . . 0.0 109.818 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.426 ' O ' ' NZ ' ' A' ' 39' ' ' LYS . 44.2 Cg_endo -70.66 -0.77 8.18 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 124.042 1.549 . . . . 0.0 110.824 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -82.87 -10.42 58.84 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.075 -1.016 . . . . 0.0 109.645 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.416 ' HB1' HD11 ' A' ' 38' ' ' ILE . . . -101.93 -63.31 1.16 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.334 -0.853 . . . . 0.0 110.121 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.532 HG12 ' CG2' ' A' ' 56' ' ' ILE . 1.3 mp -113.09 154.2 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.446 -0.784 . . . . 0.0 109.985 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.518 ' HG2' ' N ' ' A' ' 59' ' ' GLY . 66.5 mmtt -114.16 -27.5 7.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 0.0 110.457 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.574 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.1 OUTLIER -159.32 151.72 21.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.955 . . . . 0.0 110.179 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.1 m -138.13 120.71 16.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.393 -0.817 . . . . 0.0 109.677 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -134.09 109.97 9.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.157 -0.964 . . . . 0.0 110.785 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 29.9 mt -55.71 133.81 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.312 -0.868 . . . . 0.0 109.794 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 13.3 tp -105.28 -23.45 12.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.248 -0.908 . . . . 0.0 110.823 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.576 ' CD2' HD13 ' A' ' 53' ' ' ILE . 1.8 m95 -129.58 159.37 36.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.043 -1.036 . . . . 0.0 110.855 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.467 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 41.91 -136.23 3.12 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -151.25 21.54 0.75 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.307 -1.114 . . . . 0.0 110.068 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.4 ' N ' HG22 ' A' ' 52' ' ' THR . . . 122.89 -20.96 7.58 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.478 ' O ' HG23 ' A' ' 71' ' ' ILE . . . -67.8 -173.41 7.03 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.491 ' HA ' HG23 ' A' ' 71' ' ' ILE . 44.5 Cg_endo -72.81 128.86 13.72 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.071 1.564 . . . . 0.0 110.517 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.45 -13.46 51.13 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -72.11 165.24 24.73 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.548 -0.972 . . . . 0.0 109.596 179.54 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.576 HD13 ' CD2' ' A' ' 45' ' ' TRP . 63.0 mt -135.35 120.57 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.333 -0.855 . . . . 0.0 109.697 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 39.3 mttm -103.53 128.6 50.72 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.208 -0.932 . . . . 0.0 110.27 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 54.9 tttt -97.6 91.65 5.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.197 -0.939 . . . . 0.0 109.874 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.532 ' CG2' HG12 ' A' ' 38' ' ' ILE . 89.4 mt -79.98 141.6 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.299 -0.876 . . . . 0.0 110.049 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.474 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -120.12 147.33 45.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 110.471 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.591 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 14.1 m-85 -114.21 162.27 16.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.325 -0.859 . . . . 0.0 110.003 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.518 ' N ' ' HG2' ' A' ' 39' ' ' LYS . . . -110.61 8.71 30.23 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -120.5 179.01 4.45 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.229 -1.159 . . . . 0.0 110.223 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 62' ' ' SER . . . 74.54 -165.58 54.77 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 61' ' ' GLY . 13.2 m -46.67 174.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -1.143 . . . . 0.0 110.239 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' A' ' 62' ' ' SER . 86.8 mt-30 -43.48 -84.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.921 . . . . 0.0 110.156 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.576 ' O ' ' CD1' ' A' ' 64' ' ' TYR . 2.3 p90 -80.93 131.16 35.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.344 -0.847 . . . . 0.0 110.208 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.591 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -142.48 85.79 0.19 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.535 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 13.6 p90 -132.74 171.97 13.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.293 -1.122 . . . . 0.0 110.251 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.484 HG13 ' CA ' ' A' ' 88' ' ' GLY . 4.4 m -140.21 176.9 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.917 . . . . 0.0 110.477 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.516 ' CE ' ' OE1' ' A' ' 87' ' ' GLU . 82.3 mttt -133.03 102.9 5.78 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.426 -0.796 . . . . 0.0 109.746 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.525 ' CD2' HD11 ' A' ' 85' ' ' LEU . 15.1 m170 -95.65 127.73 41.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.24 -0.912 . . . . 0.0 111.061 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 52' ' ' THR . 17.1 tttt -96.59 114.84 26.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 109.436 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.52 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 37.0 mm -52.81 132.07 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.142 -0.974 . . . . 0.0 110.347 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.471 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 23.5 t0 -105.21 -46.86 4.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.487 -0.758 . . . . 0.0 109.982 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 77.5 p -177.68 160.93 1.61 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.466 -0.771 . . . . 0.0 110.376 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.585 ' CD1' ' CG1' ' A' ' 23' ' ' VAL . 6.6 tt -153.24 170.06 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.375 -0.828 . . . . 0.0 109.703 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.5 m-20 -142.19 84.35 1.87 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.079 -1.013 . . . . 0.0 110.395 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.607 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 18.7 tttm -58.93 -14.26 8.67 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.12 -0.988 . . . . 0.0 110.273 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -92.82 -34.33 13.9 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.349 -0.845 . . . . 0.0 109.517 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.503 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 2.3 m-80 -102.71 -3.75 26.04 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.655 0.74 . . . . 0.0 109.267 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.588 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 76.1 m-85 62.39 55.48 2.3 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.338 0.589 . . . . 0.0 110.873 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.486 ' HB3' ' CG ' ' A' ' 103' ' ' LYS . 0.7 OUTLIER -131.09 153.87 48.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.449 -0.782 . . . . 0.0 109.523 179.124 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.614 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 76.0 t80 -151.99 149.48 28.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.183 -0.948 . . . . 0.0 110.352 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.494 ' HB2' ' HA ' ' A' ' 101' ' ' GLU . 13.5 t -157.63 151.14 23.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.249 -0.907 . . . . 0.0 110.386 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.614 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 7.2 p90 -152.18 177.03 10.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.441 -0.787 . . . . 0.0 110.734 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.476 ' CG2' ' O ' ' A' ' 98' ' ' ILE . 42.0 m -127.38 125.85 41.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.547 -0.721 . . . . 0.0 109.735 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.525 HD11 ' CD2' ' A' ' 69' ' ' HIS . 11.2 tp -95.77 133.63 39.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.006 -1.059 . . . . 0.0 110.407 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.43 HG23 HD11 ' A' ' 86' ' ' ILE . 10.3 pt -111.53 -34.7 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.238 -0.914 . . . . 0.0 110.408 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.516 ' OE1' ' CE ' ' A' ' 68' ' ' LYS . 76.9 tt0 -115.16 153.27 31.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.326 -0.859 . . . . 0.0 110.18 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.505 ' N ' HD11 ' A' ' 91' ' ' LEU . . . 161.19 127.72 0.9 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -57.54 -20.29 30.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.271 -1.135 . . . . 0.0 110.095 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.83 -19.78 54.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.318 -0.864 . . . . 0.0 110.171 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.505 HD11 ' N ' ' A' ' 88' ' ' GLY . 55.1 mt -67.58 -28.21 67.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.931 . . . . 0.0 110.19 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 49.18 -178.09 0.02 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -81.99 8.23 11.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -1.166 . . . . 0.0 110.166 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.468 ' O ' HG21 ' A' ' 122' ' ' THR . 33.6 p -98.64 -32.71 11.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.206 -0.934 . . . . 0.0 110.144 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.556 ' CD2' ' CG2' ' A' ' 122' ' ' THR . 76.5 mt -108.62 158.13 17.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.43 -0.793 . . . . 0.0 110.128 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.1 tp10 -139.35 -79.93 0.31 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.168 -0.957 . . . . 0.0 110.196 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.493 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 29.3 mttp -80.15 127.46 32.35 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.542 -0.724 . . . . 0.0 110.555 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.53 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 6.0 mm -117.83 142.78 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.885 -1.134 . . . . 0.0 110.027 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.445 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -123.64 133.67 53.89 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.409 -0.807 . . . . 0.0 109.112 178.859 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 6.8 m-85 -128.03 131.39 49.17 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.164 -0.96 . . . . 0.0 110.541 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.494 ' HA ' ' HB2' ' A' ' 82' ' ' SER . 85.1 tt0 -135.51 139.4 43.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.277 -0.889 . . . . 0.0 110.066 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.472 ' N ' ' O ' ' A' ' 81' ' ' TYR . 85.7 m -141.52 149.14 40.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 110.217 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.486 ' CG ' ' HB3' ' A' ' 80' ' ' SER . 0.0 OUTLIER -142.32 140.71 32.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.262 -0.899 . . . . 0.0 110.39 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.588 ' HB2' ' HB3' ' A' ' 79' ' ' TYR . 2.9 mt -115.37 155.68 26.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 110.063 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.485 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 1.9 t -151.48 -169.49 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.093 -1.005 . . . . 0.0 110.217 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -123.88 154.4 39.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.411 -0.806 . . . . 0.0 110.247 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.446 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.4 p -113.02 170.96 4.72 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.23 -0.919 . . . . 0.0 110.233 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.3 Cg_endo -72.11 -14.58 28.93 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.048 1.552 . . . . 0.0 110.553 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.2 p -97.82 11.41 37.35 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.224 -0.923 . . . . 0.0 110.174 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 91.92 -31.07 6.13 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -56.64 -172.57 0.17 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 1.1 p -136.46 135.95 39.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.168 -1.195 . . . . 0.0 110.277 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.509 ' HA ' ' CG2' ' A' ' 10' ' ' THR . 17.0 mt -89.23 149.47 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.33 -0.856 . . . . 0.0 110.024 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.582 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 23.3 mt -131.29 118.28 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 110.393 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 103' ' ' LYS . 72.2 tttt -105.8 120.75 42.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.945 . . . . 0.0 109.97 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 0.4 OUTLIER -113.04 151.68 30.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.234 -0.916 . . . . 0.0 110.528 -179.719 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 81.8 m -154.37 124.31 6.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.373 -0.829 . . . . 0.0 110.252 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.564 ' OG ' ' CE1' ' A' ' 100' ' ' TYR . 2.1 t -125.81 163.14 23.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 110.094 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.445 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 71.0 m-70 -138.94 154.35 48.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -0.911 . . . . 0.0 110.177 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 21.4 m-85 -124.99 135.94 53.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.896 . . . . 0.0 110.44 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.568 ' CE1' HG12 ' A' ' 2' ' ' VAL . 73.6 m-70 -118.79 93.45 4.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.138 -0.976 . . . . 0.0 109.763 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.556 ' CG2' ' CD2' ' A' ' 95' ' ' LEU . 1.7 p -75.06 155.87 36.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.3 -0.875 . . . . 0.0 110.435 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.4 ttpt -107.94 100.93 10.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.344 -0.847 . . . . 0.0 110.157 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 121.4 -135.91 10.85 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -120.39 67.28 0.84 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.194 -1.18 . . . . 0.0 110.193 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.5 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 32.4 m -135.41 155.66 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.246 -0.909 . . . . 0.0 110.199 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -118.78 179.07 4.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.23 -0.919 . . . . 0.0 110.234 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.519 ' CD1' ' CD2' ' A' ' 95' ' ' LEU . 16.5 mm -80.18 172.69 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.276 -0.89 . . . . 0.0 110.227 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.458 ' O ' ' N ' ' A' ' 132' ' ' HIS . 61.9 mttt -96.13 130.61 43.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 109.908 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.424 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 94.7 mt-10 -45.41 -35.17 3.5 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.232 -0.918 . . . . 0.0 110.207 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.514 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 59.2 tt0 -68.25 -21.9 64.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.203 -0.935 . . . . 0.0 110.005 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.458 ' N ' ' O ' ' A' ' 129' ' ' LYS . 13.4 t-160 -87.86 -49.41 7.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.247 -0.908 . . . . 0.0 110.176 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.588 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 2.6 p -69.47 -28.75 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.454 -0.779 . . . . 0.0 110.132 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -104.95 -69.74 0.8 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.181 -0.949 . . . . 0.0 110.089 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -56.56 -19.63 16.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.193 -0.942 . . . . 0.0 109.811 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 132' ' ' HIS . . . -76.21 -30.23 57.36 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.465 ' CE ' ' O ' ' A' ' 133' ' ' VAL . 25.0 mttt -66.68 -30.91 71.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -1.159 . . . . 0.0 110.025 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -81.46 -29.58 33.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.259 -0.9 . . . . 0.0 110.008 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 18.7 mtpp -70.38 -45.99 64.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.9 . . . . 0.0 110.005 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -71.75 -33.28 68.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.318 -0.864 . . . . 0.0 110.067 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.9 t -58.84 -46.27 88.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.354 -0.842 . . . . 0.0 110.001 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -53.02 -43.38 66.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.242 -0.911 . . . . 0.0 109.985 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.472 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 14.1 tp -57.3 -50.13 73.9 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.348 -0.845 . . . . 0.0 109.911 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -54.02 -40.1 66.74 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.357 -0.839 . . . . 0.0 109.685 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -73.12 -15.12 61.49 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.295 -0.878 . . . . 0.0 110.089 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 143' ' ' LEU . 29.9 mt -82.03 -35.4 28.84 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.152 -0.967 . . . . 0.0 108.86 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.636 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 23.5 mt -67.96 -47.49 78.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.479 ' CD ' ' CB ' ' A' ' 11' ' ' SER . 77.6 mt-10 -47.85 -45.14 29.83 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.334 -0.854 . . . . 0.0 108.822 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.473 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 94.3 m -62.04 -39.58 92.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.269 -0.894 . . . . 0.0 109.313 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.583 ' CD1' HG12 ' A' ' 33' ' ' ILE . 57.5 t80 -47.08 -51.34 17.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.498 -0.751 . . . . 0.0 109.837 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.583 HD22 ' CE1' ' A' ' 158' ' ' TYR . 68.6 mt -80.11 -34.77 37.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.434 -0.792 . . . . 0.0 110.418 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.473 ' HB3' ' HA ' ' A' ' 149' ' ' THR . 37.2 tttm -60.72 -14.81 23.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 109.18 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.465 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -120.12 -27.3 2.07 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.576 ' CD2' ' O ' ' A' ' 150' ' ' TYR . 10.3 m-70 -106.12 92.58 6.78 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.134 -1.215 . . . . 0.0 110.279 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.498 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 48.3 Cg_endo -73.86 2.23 6.2 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.035 1.545 . . . . 0.0 110.7 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -113.95 -5.14 13.18 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.064 -1.022 . . . . 0.0 110.019 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.578 ' O ' ' CD1' ' A' ' 158' ' ' TYR . . . -57.78 108.32 0.56 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 109.957 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.667 ' CZ ' ' CB ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER 35.31 31.45 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.702 -0.624 . . . . 0.0 110.689 -179.748 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.519 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.901 -1.047 . . . . 0.0 109.78 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 60.3 t -114.2 126.69 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.232 -1.158 . . . . 0.0 110.274 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.562 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 41.8 m-85 -81.36 158.51 24.66 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.208 -0.932 . . . . 0.0 110.428 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.527 HG21 ' CE1' ' A' ' 119' ' ' HIS . 91.8 m -141.97 94.2 2.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.318 -0.864 . . . . 0.0 109.928 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.628 ' CE1' ' CG2' ' A' ' 133' ' ' VAL . 75.9 m-85 -116.04 138.04 51.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.193 -0.942 . . . . 0.0 110.069 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 12.5 pt-20 -140.05 154.29 47.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.239 -0.913 . . . . 0.0 110.41 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.7 m -135.64 135.94 40.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.311 -0.868 . . . . 0.0 109.805 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.488 ' HG3' ' HG3' ' A' ' 115' ' ' LYS . 5.5 tt0 -114.42 140.6 48.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.133 -0.979 . . . . 0.0 110.766 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.588 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 4.1 p90 -157.4 -172.73 4.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.541 -0.724 . . . . 0.0 109.581 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.47 HG23 HG12 ' A' ' 113' ' ' ILE . 8.8 p -140.0 173.13 11.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.091 -1.006 . . . . 0.0 110.6 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.437 ' CB ' ' CD ' ' A' ' 148' ' ' GLU . 86.0 p -156.04 134.68 11.74 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.44 -0.787 . . . . 0.0 110.094 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -59.73 -39.22 83.96 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.156 -0.965 . . . . 0.0 110.189 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.533 ' CD1' ' HB2' ' A' ' 152' ' ' LYS . 2.5 mp -59.94 150.62 68.47 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.432 -0.793 . . . . 0.0 109.892 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.531 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 41.5 Cg_endo -67.53 142.04 57.71 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.041 1.548 . . . . 0.0 110.559 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.626 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.0 Cg_endo -72.15 -31.08 12.5 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.982 1.517 . . . . 0.0 112.667 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.4 Cg_endo -70.33 -21.49 30.75 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 N-CA-C 110.086 -0.774 . . . . 0.0 110.086 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.537 ' NE ' ' CB ' ' A' ' 159' ' ' ASN . 36.3 mtp180 -82.94 -46.08 13.37 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.52 ' HG ' ' CG2' ' A' ' 147' ' ' ILE . 0.8 OUTLIER -71.02 -32.53 69.33 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.941 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.575 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 86.5 t80 -62.84 -59.3 5.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.555 -0.715 . . . . 0.0 109.512 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.508 ' O ' ' N ' ' A' ' 25' ' ' ASP . 29.5 mttt -50.99 -39.02 54.6 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.629 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.659 ' CB ' ' CZ ' ' A' ' 158' ' ' TYR . . . -72.27 -42.53 65.46 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.451 -0.781 . . . . 0.0 110.838 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.634 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 0.2 OUTLIER -72.72 -40.17 66.33 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.317 -0.865 . . . . 0.0 111.17 -178.9 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.578 HG12 ' CD1' ' A' ' 81' ' ' TYR . 4.2 t -103.52 -55.8 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.026 -1.046 . . . . 0.0 111.588 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.515 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 7.3 mp -79.94 -1.12 38.0 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.06 -1.025 . . . . 0.0 111.889 -178.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.529 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.9 OUTLIER -153.36 30.62 0.48 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.658 -1.276 . . . . 0.0 110.726 -179.9 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -74.5 -23.39 58.84 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.224 -0.922 . . . . 0.0 110.39 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -67.58 -17.33 64.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -0.936 . . . . 0.0 110.022 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.473 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 3.4 p30 -128.31 10.5 6.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.306 -0.871 . . . . 0.0 109.977 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.518 HD11 ' CD1' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -93.54 -49.8 5.72 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.336 -0.852 . . . . 0.0 110.283 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.66 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 2.2 m -74.96 -28.86 0.83 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.373 -0.829 . . . . 0.0 112.171 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.66 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 51.7 Cg_endo -78.65 5.6 5.47 Favored 'Trans proline' 0 C--N 1.319 -1.026 0 O-C-N 122.67 0.826 . . . . 0.0 110.5 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -126.91 -34.25 2.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 109.431 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.518 ' CD1' HD11 ' A' ' 29' ' ' LEU . 24.1 mt -80.01 -24.89 11.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 121.653 0.74 . . . . 0.0 109.219 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -170.89 97.4 0.43 Allowed Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.637 -0.665 . . . . 0.0 109.725 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -69.89 -3.29 11.79 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.987 1.519 . . . . 0.0 110.664 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.439 ' HB2' ' OE2' ' A' ' 60' ' ' GLU . 12.0 pt20 -90.52 4.85 49.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 0.0 110.007 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.486 ' C ' ' CD1' ' A' ' 38' ' ' ILE . . . -109.41 -45.39 3.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.321 -0.862 . . . . 0.0 110.033 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.53 ' HB ' ' CG2' ' A' ' 30' ' ' VAL . 1.9 mp -131.47 126.6 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.371 -0.831 . . . . 0.0 110.049 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.44 ' N ' ' O ' ' A' ' 57' ' ' THR . 18.2 ttpt -78.05 -36.59 48.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.202 -0.936 . . . . 0.0 110.316 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.491 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -170.97 136.73 1.13 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.278 -0.889 . . . . 0.0 110.027 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.6 m -111.86 124.83 53.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.331 -0.856 . . . . 0.0 110.149 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.491 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 42.2 tt0 -133.41 109.32 9.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.213 -0.929 . . . . 0.0 110.32 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 19.6 mt -56.29 133.68 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.236 -0.915 . . . . 0.0 110.019 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.4 tp -104.69 -27.52 11.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.284 -0.885 . . . . 0.0 110.547 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.574 ' CD1' HD11 ' A' ' 53' ' ' ILE . 1.9 m95 -127.6 160.56 31.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 0.0 110.775 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.469 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 42.18 -133.94 4.06 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -156.35 19.7 0.35 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.323 -1.104 . . . . 0.0 110.108 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.91 -17.04 6.81 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.467 ' O ' HG23 ' A' ' 71' ' ' ILE . . . -72.27 -172.77 19.65 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.481 ' HA ' HG23 ' A' ' 71' ' ' ILE . 44.9 Cg_endo -73.53 129.1 13.33 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.008 1.53 . . . . 0.0 110.567 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.18 -12.86 55.49 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -70.65 164.57 24.7 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.537 -0.978 . . . . 0.0 109.82 179.705 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.574 HD11 ' CD1' ' A' ' 45' ' ' TRP . 52.7 mt -134.21 121.19 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.388 -0.82 . . . . 0.0 109.79 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 4.9 mtmp? -106.07 138.52 42.11 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.118 -0.989 . . . . 0.0 110.281 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.442 ' HG2' ' HG2' ' A' ' 68' ' ' LYS . 2.1 mtpt -109.98 89.25 2.96 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.321 -0.862 . . . . 0.0 110.15 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.528 ' CG2' HG13 ' A' ' 38' ' ' ILE . 88.9 mt -79.95 141.82 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 110.011 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 3.5 p -115.06 159.6 20.64 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.268 -0.895 . . . . 0.0 110.517 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.525 ' N ' ' O ' ' A' ' 65' ' ' GLY . 16.4 m-85 -120.29 145.65 46.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.36 -0.838 . . . . 0.0 110.154 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -98.28 11.62 63.56 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.439 ' OE2' ' HB2' ' A' ' 36' ' ' GLN . 94.0 mt-10 -128.67 156.65 43.11 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.284 -1.127 . . . . 0.0 110.165 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 62' ' ' SER . . . 99.1 -155.77 19.99 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.417 ' O ' ' O ' ' A' ' 61' ' ' GLY . 83.1 p -55.0 -169.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.164 -1.198 . . . . 0.0 110.152 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -71.55 -25.71 62.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.187 -0.945 . . . . 0.0 110.198 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -129.13 111.18 12.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.231 -0.918 . . . . 0.0 110.16 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -134.33 87.29 0.26 Allowed Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.532 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 12.5 p90 -133.15 164.08 27.84 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.169 -1.195 . . . . 0.0 110.167 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.528 HG13 ' CA ' ' A' ' 88' ' ' GLY . 6.0 m -133.17 175.31 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.358 -0.839 . . . . 0.0 110.583 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.45 ' HB2' HG12 ' A' ' 86' ' ' ILE . 85.2 mttt -129.21 127.21 40.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.523 -0.736 . . . . 0.0 109.5 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.522 ' NE2' HD11 ' A' ' 85' ' ' LEU . 12.6 m170 -115.94 120.01 37.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.138 -0.976 . . . . 0.0 111.079 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 52' ' ' THR . 19.9 tttt -96.41 115.81 28.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 0.0 109.459 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.518 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 24.6 mm -61.08 129.69 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.206 -0.934 . . . . 0.0 110.491 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 82' ' ' SER . 93.8 m-20 -105.39 -42.95 5.1 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.368 -0.833 . . . . 0.0 110.204 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 35.3 m -166.9 158.65 12.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.367 -0.833 . . . . 0.0 109.946 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.458 HG12 HG12 ' A' ' 23' ' ' VAL . 1.7 mt -144.24 156.74 15.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.225 -0.922 . . . . 0.0 110.321 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.529 ' O ' ' N ' ' A' ' 79' ' ' TYR . 4.4 m-20 -135.13 78.8 1.75 Allowed 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.238 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.575 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 88.5 mttt -62.23 -12.98 23.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.131 -0.981 . . . . 0.0 110.062 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -95.14 -31.58 13.47 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.268 -0.895 . . . . 0.0 109.585 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.497 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -107.4 -4.27 18.71 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.528 -0.732 . . . . 0.0 109.725 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.529 ' N ' ' O ' ' A' ' 75' ' ' ASP . 6.7 m-85 64.97 50.63 1.87 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.484 -0.76 . . . . 0.0 110.277 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.523 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -120.75 149.94 41.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.285 -0.885 . . . . 0.0 109.315 179.497 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.681 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 30.7 t80 -139.34 133.39 31.07 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.156 -0.965 . . . . 0.0 110.364 -179.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 19.2 m -137.06 124.92 22.59 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.29 -0.881 . . . . 0.0 110.486 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.681 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 20.5 p90 -143.24 170.76 15.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.251 -0.905 . . . . 0.0 110.396 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.476 ' OG1' ' OD2' ' A' ' 72' ' ' ASP . 21.4 m -121.34 133.55 55.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.436 -0.79 . . . . 0.0 109.9 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.529 ' HB3' ' HB ' ' A' ' 98' ' ' ILE . 4.5 tp -100.31 126.62 46.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.826 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.45 HG12 ' HB2' ' A' ' 68' ' ' LYS . 10.6 pt -111.46 -11.95 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.201 -0.937 . . . . 0.0 110.331 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.462 ' O ' HD12 ' A' ' 85' ' ' LEU . 37.4 tp10 -128.67 167.3 17.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.183 -0.948 . . . . 0.0 110.426 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.528 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 140.99 112.84 0.98 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -48.13 -26.22 1.79 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.234 -1.157 . . . . 0.0 110.451 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.42 -19.68 65.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.197 -0.939 . . . . 0.0 110.315 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.462 ' O ' ' O ' ' A' ' 92' ' ' GLY . 64.2 mt -69.77 -31.42 69.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.143 -0.973 . . . . 0.0 110.253 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 48.65 -177.11 0.02 OUTLIER Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -79.16 3.4 17.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.19 -1.182 . . . . 0.0 110.125 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.439 HG22 ' CG2' ' A' ' 126' ' ' VAL . 1.8 m -88.46 -37.13 16.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.265 -0.897 . . . . 0.0 109.812 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.576 ' CD2' ' CG2' ' A' ' 122' ' ' THR . 44.7 mt -109.72 167.19 10.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.285 -0.885 . . . . 0.0 109.936 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -147.03 -79.94 0.15 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.131 -0.981 . . . . 0.0 110.026 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 15.3 mttp -80.26 126.84 31.64 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.567 -0.708 . . . . 0.0 110.441 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.614 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 6.5 mm -115.37 141.65 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.775 -1.203 . . . . 0.0 109.978 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.466 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -119.09 129.7 55.21 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.433 -0.792 . . . . 0.0 108.97 178.811 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.614 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 10.0 m-85 -124.96 136.11 53.44 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.435 -0.791 . . . . 0.0 110.587 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -139.26 128.89 24.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.331 -0.856 . . . . 0.0 110.04 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.405 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 89.8 m -127.47 141.37 51.68 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.15 -0.969 . . . . 0.0 110.135 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 115' ' ' LYS . 2.5 mttt -136.52 139.65 42.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.932 . . . . 0.0 110.317 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.524 ' CD2' HG12 ' A' ' 114' ' ' ILE . 5.4 mt -123.27 152.63 41.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.237 -0.914 . . . . 0.0 110.093 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.473 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -149.72 -169.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.252 -0.905 . . . . 0.0 110.036 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -124.87 163.14 22.86 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.348 -0.845 . . . . 0.0 110.204 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.461 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 3.0 p -121.73 169.21 9.67 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.0 110.296 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.461 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 47.3 Cg_endo -73.03 -8.76 22.68 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.066 1.561 . . . . 0.0 110.606 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 79.8 p -102.77 9.8 38.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.187 -0.946 . . . . 0.0 110.376 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 111' ' ' GLY . . . 94.2 -36.91 3.56 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 110' ' ' GLY . . . -54.45 -174.5 0.09 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.513 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 13.9 p -135.51 136.61 41.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.161 -1.199 . . . . 0.0 110.372 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.47 HG12 HG23 ' A' ' 10' ' ' THR . 21.1 mt -90.38 147.08 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.324 -0.86 . . . . 0.0 110.151 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.575 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 19.3 mt -131.46 127.28 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.208 -0.933 . . . . 0.0 110.443 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.488 ' HG3' ' HG3' ' A' ' 8' ' ' GLU . 44.4 tttp -116.23 120.15 38.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.274 -0.891 . . . . 0.0 109.902 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 2.3 t -114.28 158.7 21.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.144 -0.972 . . . . 0.0 110.56 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 96.6 m -158.77 122.2 3.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.433 -0.792 . . . . 0.0 109.919 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.6 m -122.43 153.16 39.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 0.0 110.266 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.527 ' CE1' HG21 ' A' ' 4' ' ' THR . 28.7 m-70 -133.01 162.72 30.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.267 -0.896 . . . . 0.0 110.265 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.474 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 30.3 m-85 -131.68 137.98 48.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.273 -0.892 . . . . 0.0 110.466 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.498 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 69.5 m-70 -117.08 93.07 4.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.231 -0.918 . . . . 0.0 109.342 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.576 ' CG2' ' CD2' ' A' ' 95' ' ' LEU . 1.4 p -76.96 160.42 29.18 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.375 -0.828 . . . . 0.0 110.85 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 34.2 tttp -137.12 105.76 5.84 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.577 -0.702 . . . . 0.0 109.938 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.455 ' O ' ' CB ' ' A' ' 125' ' ' ASN . . . 126.35 20.62 1.95 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 2.7 t30 67.39 60.42 0.48 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.046 -1.267 . . . . 0.0 110.651 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.522 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 20.5 m -138.62 145.54 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.176 -0.953 . . . . 0.0 109.739 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.42 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 92.4 mt-10 -104.37 -176.18 3.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.132 -0.98 . . . . 0.0 110.787 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.571 ' CD1' ' CD2' ' A' ' 95' ' ' LEU . 20.8 mm -86.17 173.39 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.375 -0.828 . . . . 0.0 110.229 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' A' ' 132' ' ' HIS . 37.9 mttt -97.24 131.27 44.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.282 -0.886 . . . . 0.0 110.027 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.448 ' HA ' ' OE1' ' A' ' 130' ' ' GLU . 69.9 mm-40 -45.86 -41.51 11.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.093 -1.004 . . . . 0.0 110.189 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.496 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 39.7 tt0 -64.05 -18.01 63.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 109.975 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.457 ' N ' ' O ' ' A' ' 129' ' ' LYS . 10.0 t-160 -93.0 -51.75 4.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 0.0 110.326 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.628 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 2.7 p -67.01 -26.43 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.893 . . . . 0.0 110.19 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -107.72 -70.05 0.82 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -0.918 . . . . 0.0 110.153 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -55.55 -19.78 11.11 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.199 -0.938 . . . . 0.0 109.798 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -75.09 -28.88 61.46 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.418 ' HE2' ' O ' ' A' ' 133' ' ' VAL . 29.7 mttm -65.71 -31.66 72.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.285 -1.127 . . . . 0.0 109.951 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -79.86 -28.87 39.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.948 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -69.31 -35.38 75.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 0.0 109.939 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.03 -40.28 39.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.194 -0.941 . . . . 0.0 109.984 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.8 t -58.21 -47.49 83.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.381 -0.825 . . . . 0.0 109.937 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -54.82 -40.54 69.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.917 . . . . 0.0 109.985 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.447 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 21.7 mt -65.33 -39.29 92.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.89 . . . . 0.0 109.885 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.475 ' HA ' HD11 ' A' ' 147' ' ' ILE . 26.6 m-85 -62.6 -35.3 79.1 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.343 -0.848 . . . . 0.0 109.801 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 145' ' ' LYS . 21.9 tttm -71.72 -12.63 61.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.356 -0.84 . . . . 0.0 110.039 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' A' ' 143' ' ' LEU . 19.2 mt -83.22 -37.35 23.7 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.179 -0.951 . . . . 0.0 108.875 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.634 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 15.6 mt -67.57 -46.61 82.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.466 ' O ' HG12 ' A' ' 13' ' ' ILE . 68.5 mt-10 -56.84 -45.59 82.26 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.459 -0.776 . . . . 0.0 109.516 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 23.3 m -62.84 -36.65 83.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 109.6 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.572 ' O ' ' CD2' ' A' ' 154' ' ' HIS . 87.7 t80 -54.19 -46.43 72.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.414 -0.804 . . . . 0.0 109.894 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.578 HD22 ' CE1' ' A' ' 158' ' ' TYR . 65.6 mt -79.99 -33.65 39.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.387 -0.821 . . . . 0.0 110.339 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.533 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . 34.4 tttm -62.68 -16.86 59.16 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.229 -0.919 . . . . 0.0 109.562 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.451 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -115.3 -31.16 2.08 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.615 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 5.1 m-70 -105.95 94.2 8.78 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.36 -1.083 . . . . 0.0 110.19 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.511 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.8 Cg_endo -73.68 6.25 2.91 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.099 1.578 . . . . 0.0 111.049 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -115.42 -8.19 12.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.034 -1.041 . . . . 0.0 109.788 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.572 ' O ' ' CD1' ' A' ' 158' ' ' TYR . . . -53.34 106.55 0.18 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.439 -0.788 . . . . 0.0 110.035 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.659 ' CZ ' ' CB ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 36.23 30.27 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.687 -0.633 . . . . 0.0 110.466 -179.617 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.537 ' CB ' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 118.07 -0.967 . . . . 0.0 109.661 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.556 HG12 ' CE1' ' A' ' 121' ' ' HIS . 92.3 t -114.04 135.1 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.288 -1.125 . . . . 0.0 110.179 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.645 ' CD1' ' CD1' ' A' ' 128' ' ' ILE . 13.2 m-85 -91.76 156.58 17.45 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.278 -0.889 . . . . 0.0 109.972 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.538 HG21 ' CE1' ' A' ' 119' ' ' HIS . 25.3 m -135.81 113.36 10.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.098 -1.001 . . . . 0.0 110.412 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.592 ' CD2' ' CG2' ' A' ' 133' ' ' VAL . 71.1 m-85 -128.46 145.22 51.17 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.372 -0.83 . . . . 0.0 109.945 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 22.1 pt-20 -140.13 152.62 46.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.139 -0.976 . . . . 0.0 110.676 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.2 p -143.06 136.37 28.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.484 -0.76 . . . . 0.0 109.624 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.412 ' HG3' ' HG3' ' A' ' 115' ' ' LYS . 4.8 tt0 -123.28 141.81 51.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.02 -1.05 . . . . 0.0 110.912 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.589 ' CE2' ' HB ' ' A' ' 114' ' ' ILE . 3.2 p90 -157.8 -178.08 7.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.517 -0.739 . . . . 0.0 109.592 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.509 ' CG2' ' HA ' ' A' ' 113' ' ' ILE . 11.5 p -141.53 175.42 9.7 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.057 -1.027 . . . . 0.0 110.707 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.424 ' OG ' ' CD ' ' A' ' 148' ' ' GLU . 3.5 t -159.05 161.78 36.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.502 -0.749 . . . . 0.0 110.22 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -81.34 -36.51 29.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.272 -0.893 . . . . 0.0 110.207 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.539 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 3.1 mp -60.68 150.4 75.74 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.347 -0.845 . . . . 0.0 109.869 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.539 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 40.1 Cg_endo -65.1 142.31 73.62 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.878 1.462 . . . . 0.0 110.59 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.603 ' CD ' ' CD ' ' A' ' 16' ' ' PRO . 40.0 Cg_endo -73.01 -30.82 10.46 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 124.042 1.549 . . . . 0.0 113.049 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.603 ' CD ' ' CD ' ' A' ' 15' ' ' PRO . 45.0 Cg_endo -73.12 -20.27 21.82 Favored 'Trans proline' 0 C--N 1.317 -1.114 0 N-CA-C 110.125 -0.76 . . . . 0.0 110.125 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.533 ' NE ' ' HB2' ' A' ' 159' ' ' ASN . 39.7 ttm180 -83.53 -50.52 8.18 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.502 ' C ' ' CD2' ' A' ' 18' ' ' LEU . 1.1 tt -62.14 -25.98 68.05 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.5 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 52.5 t80 -68.76 -55.38 11.47 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.537 0.684 . . . . 0.0 109.449 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.491 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 15.8 mttt -49.55 -33.69 15.52 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.173 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.6 ' HB3' ' CE2' ' A' ' 158' ' ' TYR . . . -78.98 -50.52 10.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.346 -0.846 . . . . 0.0 110.725 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.643 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 0.2 OUTLIER -62.74 -37.41 86.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.496 -0.752 . . . . 0.0 111.47 -178.809 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.564 HG12 ' CD1' ' A' ' 81' ' ' TYR . 3.3 t -109.4 -55.62 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 120.973 -1.079 . . . . 0.0 111.731 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.518 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 7.3 mp -76.43 0.1 20.92 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.998 -1.064 . . . . 0.0 111.278 -178.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.541 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -152.19 16.52 0.64 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.876 -1.14 . . . . 0.0 110.452 179.729 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -55.66 -41.62 73.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.164 -0.96 . . . . 0.0 109.891 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.433 ' OD2' HG13 ' A' ' 43' ' ' ILE . 76.5 m-20 -57.26 -24.26 53.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.288 -0.883 . . . . 0.0 110.075 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.465 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 77.6 m-20 -120.45 13.9 11.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.383 -0.823 . . . . 0.0 110.056 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.518 ' CD2' ' HB1' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -100.78 -46.24 5.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.885 . . . . 0.0 110.094 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.59 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 2.8 t -70.22 -42.41 16.28 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.362 -0.836 . . . . 0.0 110.781 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 46.9 Cg_endo -76.4 4.54 5.37 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.482 1.254 . . . . 0.0 110.671 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 28' ' ' ASN . 21.1 mttm -120.02 -32.22 4.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.935 . . . . 0.0 109.077 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.587 HG12 ' CD1' ' A' ' 150' ' ' TYR . 6.8 mt -80.05 -35.27 15.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.444 0.64 . . . . 0.0 109.588 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -160.44 98.17 1.42 Allowed Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.442 -0.786 . . . . 0.0 110.17 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.22 0.1 8.4 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.989 1.521 . . . . 0.0 110.678 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -90.57 -19.37 23.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.141 -0.974 . . . . 0.0 110.36 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.92 -42.65 11.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.184 -0.948 . . . . 0.0 110.369 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.541 HG12 ' CG2' ' A' ' 56' ' ' ILE . 1.1 mp -128.81 144.13 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.415 -0.803 . . . . 0.0 110.328 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.46 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 37.9 ttmt -78.97 -41.76 28.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.325 -0.86 . . . . 0.0 109.854 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.545 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -178.42 161.57 1.39 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.327 -0.858 . . . . 0.0 110.166 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.429 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 15.5 m -123.3 122.39 38.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.138 -0.976 . . . . 0.0 110.037 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -127.9 111.91 14.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.183 -0.948 . . . . 0.0 110.558 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.471 HD11 HG22 ' A' ' 43' ' ' ILE . 24.9 mt -60.05 143.73 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.304 -0.873 . . . . 0.0 109.948 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.455 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 1.5 mt -119.26 -26.28 5.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 110.487 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.541 ' CD2' HD13 ' A' ' 53' ' ' ILE . 1.6 m95 -123.09 162.03 23.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.162 -0.961 . . . . 0.0 110.496 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.465 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 42.08 -141.95 1.45 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -149.08 24.6 0.92 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -1.13 . . . . 0.0 110.335 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 120.59 -15.59 9.78 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.476 ' O ' HG23 ' A' ' 71' ' ' ILE . . . -77.82 -172.87 39.69 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.465 ' HA ' HG21 ' A' ' 71' ' ' ILE . 43.5 Cg_endo -72.04 129.43 15.21 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 O-C-N 123.987 1.519 . . . . 0.0 110.59 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.43 -14.09 47.2 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.564 -1.814 . . . . 0.0 108.564 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -70.63 164.43 24.98 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.51 -0.994 . . . . 0.0 109.581 179.67 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.541 HD13 ' CD2' ' A' ' 45' ' ' TRP . 51.7 mt -135.28 121.23 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 109.997 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 96.2 mttt -107.77 140.72 40.42 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.187 -0.946 . . . . 0.0 110.401 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.455 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 25.9 tttt -109.2 90.6 3.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.243 -0.911 . . . . 0.0 110.144 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.541 ' CG2' HG12 ' A' ' 38' ' ' ILE . 82.1 mt -80.04 140.51 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.233 -0.917 . . . . 0.0 110.289 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.505 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 3.0 p -111.11 158.66 18.62 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.311 -0.868 . . . . 0.0 110.83 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.527 ' N ' ' O ' ' A' ' 65' ' ' GLY . 29.8 m-85 -116.33 133.82 55.58 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.175 -0.953 . . . . 0.0 110.105 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.08 -32.25 83.49 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -60.11 161.03 7.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.202 -1.175 . . . . 0.0 110.229 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 62' ' ' SER . . . 49.74 71.41 0.62 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 61' ' ' GLY . 23.4 m -42.69 -27.76 0.19 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.28 -1.129 . . . . 0.0 110.272 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.404 ' N ' ' O ' ' A' ' 61' ' ' GLY . 69.6 mt-30 -51.54 -72.51 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.183 -0.948 . . . . 0.0 110.119 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -173.18 100.75 0.12 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.242 -0.911 . . . . 0.0 110.24 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -129.61 90.44 0.31 Allowed Glycine 0 N--CA 1.487 2.04 0 N-CA-C 108.29 -1.924 . . . . 0.0 108.29 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.532 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 16.9 p90 -140.36 165.45 27.38 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.055 -1.262 . . . . 0.0 110.304 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.524 HG13 ' CA ' ' A' ' 88' ' ' GLY . 5.1 m -131.54 173.48 14.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.459 -0.776 . . . . 0.0 110.321 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.518 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 22.9 mttt -125.49 124.5 41.51 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.62 -0.675 . . . . 0.0 109.656 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.512 ' NE2' HD11 ' A' ' 85' ' ' LEU . 14.7 m170 -112.29 122.01 46.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.191 -0.943 . . . . 0.0 110.777 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 52' ' ' THR . 86.6 tttt -98.62 111.23 23.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.184 -0.948 . . . . 0.0 109.516 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.518 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 24.1 mm -52.46 130.19 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.117 -0.989 . . . . 0.0 109.979 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.447 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 11.9 t0 -108.83 -45.86 3.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.354 -0.841 . . . . 0.0 110.377 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 73.3 m -164.91 157.68 16.4 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.317 -0.865 . . . . 0.0 109.921 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.464 HG12 HG12 ' A' ' 23' ' ' VAL . 1.9 mt -142.96 158.05 17.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.249 -0.907 . . . . 0.0 110.496 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.54 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 3.1 m-20 -132.79 77.81 1.76 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 120.078 -0.649 . . . . 0.0 109.973 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.5 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 84.4 mttt -61.26 -15.65 37.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.133 -0.979 . . . . 0.0 110.413 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -93.33 -31.06 14.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.191 -0.943 . . . . 0.0 109.645 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.499 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -106.69 -5.41 18.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.574 -0.704 . . . . 0.0 109.796 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.544 ' CZ ' ' HB3' ' A' ' 16' ' ' PRO . 5.3 m-85 66.02 50.46 1.45 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.504 -0.747 . . . . 0.0 110.292 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.54 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -120.12 154.67 34.39 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 0.0 109.447 179.51 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.615 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 24.5 t80 -142.94 129.74 20.45 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.117 -0.99 . . . . 0.0 110.439 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.462 ' OG ' ' HG3' ' A' ' 101' ' ' GLU . 73.8 m -136.41 120.33 17.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.397 -0.814 . . . . 0.0 110.332 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.642 ' CE2' ' CB ' ' A' ' 100' ' ' TYR . 11.8 p90 -135.06 174.92 10.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.272 -0.893 . . . . 0.0 110.207 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.3 m -123.73 127.35 48.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.371 -0.831 . . . . 0.0 110.104 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.519 ' HB3' ' CG2' ' A' ' 98' ' ' ILE . 5.1 tp -95.37 136.62 35.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.302 -0.874 . . . . 0.0 109.669 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.4 pt -123.59 -14.61 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.233 -0.917 . . . . 0.0 110.48 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.518 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 20.2 tt0 -129.93 129.25 43.6 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.054 -1.029 . . . . 0.0 110.675 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.524 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 177.68 128.54 1.17 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -59.52 -13.66 9.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -1.134 . . . . 0.0 110.415 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.52 -32.01 26.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 110.299 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.498 ' HG ' ' N ' ' A' ' 92' ' ' GLY . 1.8 pp -90.99 -27.42 18.68 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.28 -0.888 . . . . 0.0 110.569 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.498 ' N ' ' HG ' ' A' ' 91' ' ' LEU . . . -59.69 -31.89 72.52 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.445 ' O ' ' CG2' ' A' ' 94' ' ' THR . 87.2 m-20 -45.5 -40.02 7.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -1.168 . . . . 0.0 110.414 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.455 ' OG1' HD23 ' A' ' 95' ' ' LEU . 1.3 p -160.03 -33.73 0.06 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.274 -0.891 . . . . 0.0 110.682 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.573 ' CD1' ' CG2' ' A' ' 122' ' ' THR . 1.6 mm? -79.99 167.47 20.42 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.14 -0.975 . . . . 0.0 110.656 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.484 ' HG2' ' N ' ' A' ' 97' ' ' LYS . 43.6 tt0 -128.36 -77.72 0.56 Allowed 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.496 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 89.4 mttt -80.19 145.13 32.43 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.621 -0.675 . . . . 0.0 109.565 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.591 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 8.0 mm -128.45 143.31 41.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 120.733 -1.229 . . . . 0.0 110.11 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.454 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -117.04 128.26 54.98 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.404 -0.81 . . . . 0.0 109.362 179.076 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.642 ' CB ' ' CE2' ' A' ' 83' ' ' TYR . 8.7 m-85 -124.38 134.05 53.24 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.216 -0.928 . . . . 0.0 110.256 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.462 ' HG3' ' OG ' ' A' ' 82' ' ' SER . 81.6 tt0 -138.58 133.74 32.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.254 -0.904 . . . . 0.0 110.333 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.471 ' N ' ' O ' ' A' ' 81' ' ' TYR . 41.2 m -131.75 152.62 50.8 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.225 -0.922 . . . . 0.0 110.091 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 115' ' ' LYS . 6.8 mttm -146.73 138.14 24.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.2 -0.938 . . . . 0.0 110.507 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.536 ' CD2' HG12 ' A' ' 114' ' ' ILE . 5.7 mt -120.0 152.09 38.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.205 -0.934 . . . . 0.0 109.831 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.458 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 1.9 t -148.65 -169.45 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.046 -1.034 . . . . 0.0 110.129 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -123.94 163.52 21.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.332 -0.855 . . . . 0.0 110.195 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.467 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 3.0 p -122.48 169.62 9.36 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.246 -0.909 . . . . 0.0 110.201 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.8 Cg_endo -72.9 -9.01 23.2 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.061 1.559 . . . . 0.0 110.491 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.8 p -103.16 9.6 38.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.24 -0.913 . . . . 0.0 110.274 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 111' ' ' GLY . . . 94.54 -39.43 2.9 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 110' ' ' GLY . . . -51.66 -176.44 0.03 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.522 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.4 p -133.68 135.92 44.4 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -1.163 . . . . 0.0 110.467 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.509 ' HA ' ' CG2' ' A' ' 10' ' ' THR . 17.2 mt -88.78 148.0 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -0.845 . . . . 0.0 109.716 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.589 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 18.8 mt -131.89 121.87 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.238 -0.914 . . . . 0.0 110.58 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 103' ' ' LYS . 14.4 tttp -109.99 128.63 55.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.0 109.787 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.9 152.41 44.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.094 -1.004 . . . . 0.0 110.444 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 38.6 m -152.56 134.91 15.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 110.094 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.441 ' C ' ' CD2' ' A' ' 119' ' ' HIS . 14.4 m -133.44 156.5 47.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.273 -0.892 . . . . 0.0 110.135 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.538 ' CE1' HG21 ' A' ' 4' ' ' THR . 20.2 m-70 -140.77 170.04 16.51 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.168 -0.957 . . . . 0.0 110.423 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.577 ' N ' ' CD1' ' A' ' 120' ' ' TYR . 8.8 m-85 -129.7 156.36 44.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.306 -0.871 . . . . 0.0 110.453 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.556 ' CE1' HG12 ' A' ' 2' ' ' VAL . 83.6 m-70 -135.13 96.75 3.56 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.211 -0.93 . . . . 0.0 109.545 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.573 ' CG2' ' CD1' ' A' ' 95' ' ' LEU . 6.1 p -64.48 160.7 18.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.395 -0.816 . . . . 0.0 110.925 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 28.7 tttt -119.57 90.94 3.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.493 -0.754 . . . . 0.0 110.17 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 108.95 -109.22 2.75 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -132.15 79.8 1.88 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.253 -1.145 . . . . 0.0 110.252 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.508 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 7.9 m -146.63 179.5 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.321 -0.862 . . . . 0.0 110.048 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.508 ' CG ' ' O ' ' A' ' 126' ' ' VAL . 81.7 mt-10 -156.13 167.09 31.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.203 -0.936 . . . . 0.0 110.277 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.645 ' CD1' ' CD1' ' A' ' 3' ' ' PHE . 2.8 mp -88.7 172.43 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.231 -0.918 . . . . 0.0 110.16 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.494 ' O ' ' N ' ' A' ' 132' ' ' HIS . 8.8 mttm -110.42 127.61 55.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.376 -0.827 . . . . 0.0 109.729 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.488 ' HB3' ' CE ' ' A' ' 134' ' ' LYS . 93.6 mt-10 -44.7 -49.27 10.54 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.112 -0.993 . . . . 0.0 109.904 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.509 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 44.8 tt0 -52.83 -20.6 3.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.646 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 129' ' ' LYS . 12.3 t-160 -87.21 -63.72 1.26 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.456 -0.777 . . . . 0.0 110.031 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.592 ' CG2' ' CD2' ' A' ' 5' ' ' TYR . 8.3 p -59.86 -38.56 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.339 -0.851 . . . . 0.0 109.834 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.488 ' CE ' ' HB3' ' A' ' 130' ' ' GLU . 55.9 mttm -69.65 -46.51 65.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 0.0 109.743 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.509 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -65.6 -30.79 71.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.295 -0.878 . . . . 0.0 109.801 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.47 -32.79 75.75 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 39.9 mttt -61.87 -33.93 75.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.374 -1.074 . . . . 0.0 109.845 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.504 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 83.0 tt0 -83.89 -33.76 24.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 109.842 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 46.1 mttm -71.06 -34.57 71.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.433 -0.792 . . . . 0.0 109.741 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.98 -40.62 46.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.366 -0.833 . . . . 0.0 109.829 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.0 t -60.92 -39.41 89.27 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.429 -0.795 . . . . 0.0 109.929 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 138' ' ' GLU . 75.9 m-20 -60.46 -45.05 95.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.266 -0.896 . . . . 0.0 109.955 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.412 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 46.7 mt -59.68 -40.02 86.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.296 -0.878 . . . . 0.0 110.009 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -61.07 -40.4 93.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.449 -0.782 . . . . 0.0 109.95 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.428 ' HA ' ' OE1' ' A' ' 148' ' ' GLU . 87.6 mttt -70.37 -13.96 62.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.286 -0.884 . . . . 0.0 109.98 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.527 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 35.1 mt -83.84 -36.7 23.27 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.196 -0.94 . . . . 0.0 108.83 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.643 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 47.4 mt -68.32 -46.55 80.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.468 ' O ' HG12 ' A' ' 13' ' ' ILE . 74.1 mt-10 -53.27 -44.57 68.33 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.361 -0.837 . . . . 0.0 109.284 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.428 ' O ' ' C ' ' A' ' 150' ' ' TYR . 42.3 m -70.31 -40.88 73.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.33 -0.856 . . . . 0.0 109.388 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.587 ' CD1' HG12 ' A' ' 33' ' ' ILE . 86.8 t80 -43.11 -45.32 5.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.444 -0.785 . . . . 0.0 109.73 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.631 ' CD2' ' CE2' ' A' ' 158' ' ' TYR . 51.3 mt -80.05 -45.62 17.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.37 -0.831 . . . . 0.0 110.459 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.457 ' HB2' HD12 ' A' ' 13' ' ' ILE . 21.7 ttpp -59.72 -15.23 18.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.365 -0.834 . . . . 0.0 109.525 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -112.41 -29.95 3.03 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.56 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 7.1 m-70 -114.18 96.01 40.82 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.294 -1.121 . . . . 0.0 110.012 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.423 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.1 Cg_endo -73.52 5.96 3.0 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.161 1.611 . . . . 0.0 111.267 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -108.28 -7.22 15.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.908 -1.12 . . . . 0.0 109.82 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.581 ' HB1' ' CE2' ' A' ' 150' ' ' TYR . . . -75.63 101.72 5.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.435 -0.791 . . . . 0.0 110.147 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.631 ' CE2' ' CD2' ' A' ' 151' ' ' LEU . 0.3 OUTLIER 34.71 32.67 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.461 0.648 . . . . 0.0 110.288 -179.417 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.533 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.871 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.639 ' CG1' ' CE1' ' A' ' 121' ' ' HIS . 22.2 t -124.21 138.24 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -1.139 . . . . 0.0 110.403 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.649 ' CE1' ' CD1' ' A' ' 128' ' ' ILE . 9.5 m-85 -103.21 156.57 17.62 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.318 -0.864 . . . . 0.0 109.897 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.437 HG22 ' CE1' ' A' ' 119' ' ' HIS . 7.1 m -126.58 112.75 15.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.131 -0.981 . . . . 0.0 110.592 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.591 ' CD1' ' CG1' ' A' ' 133' ' ' VAL . 59.7 m-85 -120.6 143.71 48.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.183 -0.948 . . . . 0.0 110.177 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 21.9 pt-20 -144.7 152.74 40.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.173 -0.954 . . . . 0.0 110.33 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.462 ' O ' ' CG ' ' A' ' 8' ' ' GLU . 2.3 t -128.23 171.1 12.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.334 -0.854 . . . . 0.0 109.989 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.462 ' CG ' ' O ' ' A' ' 7' ' ' SER . 78.7 mt-10 -154.18 115.98 4.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.931 . . . . 0.0 110.422 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.3 p90 -147.93 -174.65 4.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.396 -0.815 . . . . 0.0 109.731 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.477 ' CG2' ' HA ' ' A' ' 113' ' ' ILE . 7.7 p -141.91 175.66 9.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.091 -1.006 . . . . 0.0 110.527 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.461 ' HB2' ' HG2' ' A' ' 148' ' ' GLU . 85.6 p -157.36 126.91 6.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.543 -0.723 . . . . 0.0 110.23 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -53.64 -35.14 60.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.288 -0.882 . . . . 0.0 110.053 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.534 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 2.5 mp -65.18 150.78 95.07 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.309 -0.869 . . . . 0.0 109.881 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.534 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 41.8 Cg_endo -67.4 142.72 60.83 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.965 1.508 . . . . 0.0 110.619 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.637 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.6 Cg_endo -72.63 -31.04 11.24 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 124.036 1.545 . . . . 0.0 112.811 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.637 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.1 Cg_endo -70.18 -20.65 32.6 Favored 'Trans proline' 0 N--CA 1.485 1.013 0 N-CA-C 110.145 -0.752 . . . . 0.0 110.145 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.525 ' NE ' ' CB ' ' A' ' 159' ' ' ASN . 43.4 mtp180 -84.71 -48.98 8.89 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.496 ' C ' ' CD2' ' A' ' 18' ' ' LEU . 1.3 tt -67.89 -28.36 67.45 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.583 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 83.5 t80 -68.39 -61.41 1.85 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.435 -0.791 . . . . 0.0 109.067 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 34.2 mttm -46.6 -32.81 3.69 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.751 -0.78 . . . . 0.0 109.114 179.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.649 ' CB ' ' CZ ' ' A' ' 158' ' ' TYR . . . -79.85 -40.55 28.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.358 -0.839 . . . . 0.0 110.64 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.637 ' CD1' ' CD1' ' A' ' 147' ' ' ILE . 0.2 OUTLIER -70.98 -42.51 69.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.33 -0.856 . . . . 0.0 111.429 -178.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.574 HG11 ' CE1' ' A' ' 81' ' ' TYR . 4.3 t -104.18 -51.53 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.064 -1.023 . . . . 0.0 111.47 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.481 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 7.4 mp -80.05 0.44 31.83 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.183 -0.948 . . . . 0.0 111.37 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.54 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.4 OUTLIER -155.66 30.44 0.37 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.838 -1.164 . . . . 0.0 110.97 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.454 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -70.27 -28.81 65.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.105 -0.997 . . . . 0.0 109.86 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.468 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 60.9 m-20 -68.18 -12.44 60.94 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.297 -0.877 . . . . 0.0 109.848 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.48 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 79.8 m-20 -131.0 8.86 4.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.351 -0.843 . . . . 0.0 109.948 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.528 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -94.4 -49.99 5.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.356 -0.84 . . . . 0.0 110.466 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.665 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 6.6 p -77.87 -26.94 0.54 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.367 -0.833 . . . . 0.0 112.457 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.665 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 50.5 Cg_endo -78.25 7.17 4.22 Favored 'Trans proline' 0 C--N 1.319 -0.994 0 O-C-N 122.592 0.785 . . . . 0.0 110.703 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -135.38 -32.9 0.91 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.23 -0.919 . . . . 0.0 110.066 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.531 HG12 ' CD1' ' A' ' 150' ' ' TYR . 9.6 mt -80.0 -40.05 20.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.363 -0.836 . . . . 0.0 109.993 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -158.96 98.61 1.65 Allowed Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.275 -0.89 . . . . 0.0 110.374 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.04 2.31 6.8 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.032 1.543 . . . . 0.0 110.585 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -88.75 -16.17 32.87 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.186 -0.946 . . . . 0.0 110.129 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.518 ' CB ' HD22 ' A' ' 143' ' ' LEU . . . -95.92 -32.7 12.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 110.256 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.536 ' CD1' HG22 ' A' ' 30' ' ' VAL . 1.1 mp -145.81 133.91 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.338 -0.851 . . . . 0.0 109.883 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 57' ' ' THR . 27.7 ttpp -82.63 -25.98 32.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.886 . . . . 0.0 110.44 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.533 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -175.31 157.84 2.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.194 -0.941 . . . . 0.0 110.261 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.2 m -135.45 121.29 19.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.421 -0.8 . . . . 0.0 109.565 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.516 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 48.3 tt0 -138.88 111.81 7.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.006 -1.059 . . . . 0.0 110.689 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 27.9 mt -50.63 143.24 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.412 -0.805 . . . . 0.0 109.896 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 11.6 tp -116.83 -21.8 8.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.308 -0.87 . . . . 0.0 110.348 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.559 ' CD2' HD13 ' A' ' 53' ' ' ILE . 1.7 m95 -131.5 163.29 28.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.237 -0.915 . . . . 0.0 110.615 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.46 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 42.63 -134.25 4.44 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -155.51 19.12 0.4 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -1.108 . . . . 0.0 110.231 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.69 -16.21 7.0 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.479 ' O ' HG23 ' A' ' 71' ' ' ILE . . . -74.81 -173.73 31.94 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.494 ' HA ' HG23 ' A' ' 71' ' ' ILE . 44.6 Cg_endo -72.97 129.53 14.38 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 124.055 1.555 . . . . 0.0 110.466 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.3 -14.96 47.31 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -69.86 167.38 17.43 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.521 -0.988 . . . . 0.0 109.463 179.536 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.559 HD13 ' CD2' ' A' ' 45' ' ' TRP . 43.3 mt -134.94 120.75 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.202 -0.936 . . . . 0.0 110.18 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.462 ' HD2' HD12 ' A' ' 71' ' ' ILE . 17.7 mtpt -102.91 130.48 49.97 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.193 -0.942 . . . . 0.0 110.111 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -98.42 91.57 5.25 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.184 -0.948 . . . . 0.0 109.906 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.525 ' CG2' HG12 ' A' ' 38' ' ' ILE . 93.4 mt -80.02 138.73 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.371 -0.831 . . . . 0.0 110.046 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.49 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 3.1 p -114.93 155.9 26.02 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.232 -0.918 . . . . 0.0 110.476 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.544 ' N ' ' O ' ' A' ' 65' ' ' GLY . 20.1 m-85 -117.93 142.46 47.32 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.358 -0.839 . . . . 0.0 110.038 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -113.93 34.22 5.08 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.4 -24.38 44.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.356 -1.085 . . . . 0.0 110.373 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 177.78 -163.88 32.5 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 65.7 m -63.7 -45.73 88.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -1.105 . . . . 0.0 110.196 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -46.47 134.06 9.48 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.264 -0.898 . . . . 0.0 110.146 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -72.09 127.21 31.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.291 -0.88 . . . . 0.0 110.27 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -140.74 113.38 0.86 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 15.6 p90 -154.65 170.65 21.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.082 -1.246 . . . . 0.0 110.122 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.534 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 6.0 m -141.28 174.52 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.27 -0.894 . . . . 0.0 110.764 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.507 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 25.1 mttt -126.21 120.7 30.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.547 -0.72 . . . . 0.0 109.489 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.566 ' CD2' ' CD1' ' A' ' 85' ' ' LEU . 18.3 m170 -108.76 129.13 55.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.223 -0.923 . . . . 0.0 111.037 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 52' ' ' THR . 44.3 tttp -100.43 112.95 25.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.225 -0.922 . . . . 0.0 109.474 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.537 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 31.0 mm -52.08 130.77 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.1 -1.0 . . . . 0.0 110.239 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.463 ' OD2' ' OG1' ' A' ' 84' ' ' THR . 58.8 m-20 -106.45 -36.85 6.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 0.0 110.258 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.468 ' O ' HD13 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -178.55 166.24 1.77 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.178 -0.952 . . . . 0.0 109.635 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.475 HG12 HG12 ' A' ' 23' ' ' VAL . 0.9 OUTLIER -151.82 155.9 6.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 119.016 -1.074 . . . . 0.0 111.386 -179.682 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.504 ' O ' ' N ' ' A' ' 79' ' ' TYR . 2.3 m-20 -132.78 76.12 1.67 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.303 0.573 . . . . 0.0 109.919 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.583 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 45.9 mttt -60.83 -12.51 11.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.226 -0.921 . . . . 0.0 110.406 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -92.82 -31.97 14.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.298 -0.876 . . . . 0.0 109.483 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.494 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -107.43 -6.16 17.25 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.534 -0.729 . . . . 0.0 109.839 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.573 ' CZ ' ' HB3' ' A' ' 16' ' ' PRO . 4.0 m-85 69.11 48.83 0.66 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.558 -0.714 . . . . 0.0 110.183 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.487 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.5 OUTLIER -119.58 147.18 44.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.232 -0.917 . . . . 0.0 109.543 179.626 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.68 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 76.1 t80 -140.35 143.28 35.67 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.093 -1.004 . . . . 0.0 110.6 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.436 ' C ' ' HB2' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -148.69 141.26 24.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -0.877 . . . . 0.0 110.098 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.68 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 10.7 p90 -151.52 175.66 12.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.144 -0.973 . . . . 0.0 110.699 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.463 ' OG1' ' OD2' ' A' ' 72' ' ' ASP . 6.5 m -122.58 127.84 49.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.467 -0.771 . . . . 0.0 109.688 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.566 ' CD1' ' CD2' ' A' ' 69' ' ' HIS . 2.9 tp -94.98 128.25 41.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.166 -0.959 . . . . 0.0 110.314 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.412 HG23 HD11 ' A' ' 86' ' ' ILE . 14.3 pt -114.81 0.51 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.33 -0.856 . . . . 0.0 110.392 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.507 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 72.4 tt0 -149.32 154.42 38.96 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.253 -0.904 . . . . 0.0 110.198 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.521 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 150.94 130.55 1.72 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -57.34 -16.04 7.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.329 -1.1 . . . . 0.0 110.2 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.419 ' O ' ' CE1' ' A' ' 132' ' ' HIS . . . -66.44 -30.28 70.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.225 -0.922 . . . . 0.0 110.201 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 21.1 mt -58.06 -15.57 9.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -0.866 . . . . 0.0 110.036 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 93' ' ' ASP . . . 48.12 30.73 7.77 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 92' ' ' GLY . 93.1 m-20 56.56 15.36 2.05 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.251 -1.147 . . . . 0.0 110.379 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 65.6 p -108.18 -52.78 2.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.931 . . . . 0.0 109.604 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.532 HD11 ' CD2' ' A' ' 120' ' ' TYR . 14.9 mt -80.36 164.1 23.38 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.499 -0.751 . . . . 0.0 109.741 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.422 ' OE1' ' HD3' ' A' ' 123' ' ' LYS . 42.3 tt0 -132.19 -78.35 0.5 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 110.326 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.517 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 54.6 mttt -80.2 128.4 33.48 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.49 -0.756 . . . . 0.0 110.638 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.643 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 4.7 mm -120.45 141.53 40.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 120.682 -1.261 . . . . 0.0 109.692 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.462 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -122.38 126.59 48.33 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.429 -0.794 . . . . 0.0 108.986 178.79 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.643 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 12.7 m-85 -122.59 133.51 54.54 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.294 -0.879 . . . . 0.0 110.491 -179.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.509 ' N ' ' O ' ' A' ' 117' ' ' THR . 49.6 tt0 -136.24 134.38 38.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.36 -0.837 . . . . 0.0 110.259 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 94.0 m -131.67 140.56 49.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.263 -0.898 . . . . 0.0 110.069 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.76 139.34 50.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.307 -0.871 . . . . 0.0 110.229 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.518 ' CD2' HG12 ' A' ' 114' ' ' ILE . 11.4 mt -115.51 149.74 37.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.345 -0.847 . . . . 0.0 109.991 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.479 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 1.9 t -150.44 -168.43 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.202 -0.936 . . . . 0.0 110.21 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.461 ' O ' HD13 ' A' ' 113' ' ' ILE . . . -121.37 158.47 28.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.285 -0.884 . . . . 0.0 110.115 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.469 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 9.5 p -114.91 167.04 10.44 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.19 -0.944 . . . . 0.0 110.321 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.469 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.9 Cg_endo -72.23 -4.23 14.82 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.074 1.565 . . . . 0.0 110.39 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 65.4 m -107.06 0.7 23.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.238 -0.914 . . . . 0.0 110.245 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.63 -41.07 2.26 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -54.31 -177.61 0.13 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.528 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 6.7 p -124.61 140.29 53.08 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.226 -1.161 . . . . 0.0 110.321 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.477 ' HA ' ' CG2' ' A' ' 10' ' ' THR . 19.5 mt -92.9 147.55 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.33 -0.857 . . . . 0.0 110.129 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.612 ' CG2' ' CE2' ' A' ' 9' ' ' PHE . 8.7 mt -130.96 126.89 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.283 -0.886 . . . . 0.0 110.144 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -119.72 111.15 17.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.154 -0.966 . . . . 0.0 110.144 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 2.4 m -96.64 159.71 14.78 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.229 -0.919 . . . . 0.0 110.552 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 101' ' ' GLU . 25.4 m -160.11 117.98 2.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.516 -0.74 . . . . 0.0 109.959 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.424 ' CB ' ' CD1' ' A' ' 100' ' ' TYR . 96.7 p -125.31 161.78 26.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.09 -1.006 . . . . 0.0 110.453 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.462 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 62.9 m-70 -140.15 131.84 27.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.307 -0.871 . . . . 0.0 110.225 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.532 ' CD2' HD11 ' A' ' 95' ' ' LEU . 3.2 m-85 -98.16 148.15 23.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.393 -0.817 . . . . 0.0 109.672 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.639 ' CE1' ' CG1' ' A' ' 2' ' ' VAL . 88.6 m-70 -129.13 93.19 3.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.055 -1.028 . . . . 0.0 110.054 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.528 ' CG2' HG22 ' A' ' 126' ' ' VAL . 2.0 p -66.41 156.93 33.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.249 -0.907 . . . . 0.0 110.228 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.422 ' HD3' ' OE1' ' A' ' 96' ' ' GLU . 17.6 tptt -116.54 115.83 26.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.336 -0.852 . . . . 0.0 110.197 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 99.57 -118.28 6.13 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -132.82 73.11 1.51 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.189 -1.183 . . . . 0.0 110.166 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.528 HG22 ' CG2' ' A' ' 122' ' ' THR . 14.1 m -139.69 153.11 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.262 -0.899 . . . . 0.0 110.154 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -126.37 170.04 12.34 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.215 -0.928 . . . . 0.0 110.28 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.649 ' CD1' ' CE1' ' A' ' 3' ' ' PHE . 3.4 mp -100.01 172.77 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.191 -0.943 . . . . 0.0 110.161 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.443 ' N ' ' CG2' ' A' ' 128' ' ' ILE . 10.5 mttt -116.32 132.18 56.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.896 . . . . 0.0 109.811 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 129' ' ' LYS . 95.0 mt-10 -42.55 -42.96 3.54 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.266 -0.897 . . . . 0.0 110.185 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -52.4 -37.99 57.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.157 -0.964 . . . . 0.0 109.911 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.419 ' CE1' ' O ' ' A' ' 90' ' ' ALA . 13.7 t-160 -74.54 -57.45 3.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.331 -0.856 . . . . 0.0 110.072 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.591 ' CG1' ' CD1' ' A' ' 5' ' ' TYR . 79.4 t -58.97 -36.35 61.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.421 -0.799 . . . . 0.0 109.891 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 31.0 tttt -71.69 -44.07 64.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.3 -0.875 . . . . 0.0 109.945 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.4 ' O ' ' HG3' ' A' ' 139' ' ' LYS . . . -61.47 -27.55 68.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.998 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -74.15 -28.64 63.85 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -73.41 -34.04 65.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.294 -1.121 . . . . 0.0 110.006 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -82.1 -31.46 30.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 109.967 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 135' ' ' ALA . 43.3 mttm -72.57 -33.95 67.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.889 . . . . 0.0 110.004 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -80.31 -34.4 36.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 110.123 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 71.4 m -63.66 -41.56 98.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.332 -0.855 . . . . 0.0 110.045 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -58.66 -45.16 89.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.273 -0.892 . . . . 0.0 110.105 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.518 HD22 ' CB ' ' A' ' 37' ' ' ALA . 2.6 mt -61.03 -40.25 92.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -0.885 . . . . 0.0 110.104 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.408 ' CE1' ' CE2' ' A' ' 22' ' ' PHE . 17.6 m-85 -62.35 -34.06 75.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.377 -0.827 . . . . 0.0 109.961 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 145' ' ' LYS . 30.3 tttm -76.04 -14.18 60.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.338 -0.851 . . . . 0.0 110.24 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 19.6 mt -84.07 -37.13 22.47 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.059 -1.026 . . . . 0.0 109.023 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.637 ' CD1' ' CD1' ' A' ' 22' ' ' PHE . 24.5 mt -69.14 -43.32 81.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.472 ' HB3' HD11 ' A' ' 13' ' ' ILE . 83.8 mt-10 -53.04 -44.65 67.56 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.392 -0.818 . . . . 0.0 109.347 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 28.5 m -66.69 -33.13 74.97 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 109.762 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.577 ' O ' ' CD2' ' A' ' 154' ' ' HIS . 89.3 t80 -55.02 -49.65 71.0 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.409 -0.807 . . . . 0.0 110.04 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.576 HD22 ' CE1' ' A' ' 158' ' ' TYR . 74.7 mt -76.17 -36.08 58.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -0.872 . . . . 0.0 110.419 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.475 ' HB2' HD12 ' A' ' 13' ' ' ILE . 8.5 tttp -60.19 -15.35 23.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.253 -0.905 . . . . 0.0 109.308 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.464 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -120.05 -24.12 2.82 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.577 ' CD2' ' O ' ' A' ' 150' ' ' TYR . 12.9 m-70 -106.1 92.41 6.57 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.296 -1.12 . . . . 0.0 110.162 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.4 Cg_endo -73.2 4.17 4.02 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.025 1.54 . . . . 0.0 110.937 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -120.33 -6.73 9.83 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.994 -1.066 . . . . 0.0 109.919 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.576 ' HB1' ' CE2' ' A' ' 150' ' ' TYR . . . -53.91 106.11 0.17 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.889 . . . . 0.0 109.826 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.649 ' CZ ' ' CB ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 36.23 30.38 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.661 -0.649 . . . . 0.0 110.518 -179.466 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.525 ' CB ' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.802 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.586 HG22 ' CD2' ' A' ' 121' ' ' HIS . 2.6 p -79.96 149.54 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.357 -1.084 . . . . 0.0 110.712 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.56 ' HB2' ' CE2' ' A' ' 5' ' ' TYR . 5.1 m-85 -86.74 169.65 12.45 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.664 -0.647 . . . . 0.0 110.145 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.536 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 3.3 m -123.82 129.82 51.63 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.102 -0.999 . . . . 0.0 110.47 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.56 ' CE2' ' HB2' ' A' ' 3' ' ' PHE . 39.1 m-85 -142.68 133.72 25.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.316 -0.865 . . . . 0.0 110.028 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.452 ' HG2' ' OG1' ' A' ' 117' ' ' THR . 30.9 mt-10 -143.9 145.22 32.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -0.926 . . . . 0.0 110.515 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.458 ' O ' ' HG2' ' A' ' 8' ' ' GLU . 5.6 t -118.5 169.88 9.4 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.395 -0.815 . . . . 0.0 109.85 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 7' ' ' SER . 60.7 mt-10 -152.53 123.07 7.29 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.14 -0.975 . . . . 0.0 110.643 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.637 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 1.9 p90 -148.93 -176.94 5.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.406 -0.809 . . . . 0.0 109.735 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.465 HG23 HG12 ' A' ' 113' ' ' ILE . 11.1 p -139.23 -179.91 6.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.132 -0.98 . . . . 0.0 110.696 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.402 ' HB2' HD13 ' A' ' 114' ' ' ILE . 10.2 t -159.99 168.65 25.16 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.429 -0.794 . . . . 0.0 110.102 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -92.04 -28.78 16.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.162 -0.961 . . . . 0.0 110.164 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.545 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 2.6 mp -70.6 151.04 95.51 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.319 -0.863 . . . . 0.0 110.129 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.545 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 40.3 Cg_endo -65.92 142.74 70.17 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.965 1.508 . . . . 0.0 110.509 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.615 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.7 Cg_endo -73.31 -30.48 10.26 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 O-C-N 123.992 1.522 . . . . 0.0 113.048 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.7 Cg_endo -71.13 -24.41 23.59 Favored 'Trans proline' 0 C--N 1.317 -1.084 0 N-CA-C 110.184 -0.737 . . . . 0.0 110.184 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.516 ' CZ ' ' HA ' ' A' ' 159' ' ' ASN . 1.5 mtp85 -83.05 -44.95 14.61 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.551 ' CD2' ' CG2' ' A' ' 147' ' ' ILE . 0.2 OUTLIER -65.59 -30.93 71.72 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.727 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.562 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 44.7 t80 -66.27 -54.94 18.98 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.413 -0.804 . . . . 0.0 109.685 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.504 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 20.1 mttt -51.98 -31.72 30.45 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.107 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.641 ' CB ' ' CE2' ' A' ' 158' ' ' TYR . . . -80.04 -46.44 16.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.612 -0.68 . . . . 0.0 110.87 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.644 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 0.4 OUTLIER -66.44 -40.01 89.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.379 -0.826 . . . . 0.0 111.536 -178.618 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.471 HG11 ' CE1' ' A' ' 81' ' ' TYR . 3.4 t -107.6 -62.6 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.797 -1.19 . . . . 0.0 111.472 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.504 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 7.4 mp -62.78 -11.48 18.01 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.143 -0.973 . . . . 0.0 111.324 -178.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 1.2 m-20 -143.76 28.4 1.43 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.829 -1.169 . . . . 0.0 110.59 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -68.27 -21.03 64.82 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.246 -0.909 . . . . 0.0 110.296 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -72.35 -13.73 61.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -0.95 . . . . 0.0 110.173 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.5 ' O ' ' CG ' ' A' ' 32' ' ' LYS . 5.5 p30 -133.74 8.96 3.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.372 -0.83 . . . . 0.0 110.01 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.522 HD11 ' CD1' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -93.45 -45.72 7.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.325 -0.86 . . . . 0.0 109.913 179.872 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.592 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 2.5 t -73.37 -42.71 6.9 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.448 -0.782 . . . . 0.0 110.777 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.8 Cg_endo -78.01 7.57 3.93 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.448 1.236 . . . . 0.0 110.733 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.5 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 42.8 mmtm -124.32 -32.76 3.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.161 -0.962 . . . . 0.0 109.569 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.522 ' CD1' HD11 ' A' ' 29' ' ' LEU . 12.7 mt -80.04 -33.31 14.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.542 -0.724 . . . . 0.0 109.476 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -156.8 94.87 2.25 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.475 -0.766 . . . . 0.0 110.07 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.26 -1.2 9.77 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.046 1.551 . . . . 0.0 110.614 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -91.88 -6.66 51.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.147 -0.971 . . . . 0.0 110.248 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -99.21 -69.04 0.78 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.224 -0.922 . . . . 0.0 110.25 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.535 ' CD1' HG13 ' A' ' 30' ' ' VAL . 1.3 mp -103.46 149.1 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.35 -0.844 . . . . 0.0 110.154 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 40' ' ' HIS . 8.0 ttmm -86.93 -37.04 17.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 110.26 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.521 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER 177.71 134.77 0.07 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.186 -0.946 . . . . 0.0 110.502 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.5 m -94.67 135.73 35.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.158 -0.963 . . . . 0.0 109.804 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.521 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 42.4 tt0 -140.05 114.38 9.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.182 -0.948 . . . . 0.0 110.446 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.453 HD11 HG22 ' A' ' 43' ' ' ILE . 14.2 mt -61.85 138.28 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.164 -0.96 . . . . 0.0 109.962 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 13.3 tp -114.91 -25.86 8.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.23 -0.919 . . . . 0.0 110.468 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.562 ' CG ' HD13 ' A' ' 53' ' ' ILE . 1.8 m95 -127.77 163.99 23.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.217 -0.927 . . . . 0.0 110.588 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.473 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 42.23 -132.67 4.4 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.428 ' N ' ' OG1' ' A' ' 52' ' ' THR . 0.6 OUTLIER -156.34 20.23 0.35 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -1.12 . . . . 0.0 110.15 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.04 -22.97 6.65 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.474 ' O ' HG23 ' A' ' 71' ' ' ILE . . . -71.11 -171.96 12.42 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.459 ' HA ' HG21 ' A' ' 71' ' ' ILE . 44.2 Cg_endo -72.12 128.97 14.5 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 124.045 1.55 . . . . 0.0 110.497 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.32 -15.45 42.75 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.1 m -72.03 161.71 30.51 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.594 -0.945 . . . . 0.0 109.382 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.562 HD13 ' CG ' ' A' ' 45' ' ' TRP . 50.0 mt -132.16 119.8 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.292 -0.88 . . . . 0.0 109.993 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 21.7 mtpt -102.29 134.76 45.06 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.151 -0.968 . . . . 0.0 110.339 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 17.9 tttm -102.39 93.7 5.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.32 -0.863 . . . . 0.0 110.008 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.526 ' CG2' HG12 ' A' ' 38' ' ' ILE . 84.7 mt -80.08 138.79 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.233 -0.917 . . . . 0.0 110.052 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.45 ' O ' HG22 ' A' ' 38' ' ' ILE . 1.4 p -113.73 151.75 31.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 0.0 110.446 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.574 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 24.0 m-85 -115.55 150.11 37.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.367 -0.833 . . . . 0.0 110.062 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -125.09 44.28 1.28 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -73.6 -23.66 59.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.342 -1.093 . . . . 0.0 110.336 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -165.11 -170.45 30.09 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 91.4 p -66.54 -40.59 89.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -1.155 . . . . 0.0 110.202 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -49.72 147.13 3.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.31 -0.869 . . . . 0.0 110.126 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -82.39 117.83 22.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.304 -0.872 . . . . 0.0 110.146 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.574 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -126.56 99.71 0.55 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.545 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 11.6 p90 -138.5 165.58 26.48 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.187 -1.184 . . . . 0.0 110.158 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.522 HG13 ' CA ' ' A' ' 88' ' ' GLY . 5.8 m -139.2 175.06 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.252 -0.905 . . . . 0.0 110.567 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.443 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 72.8 mttt -129.79 114.98 16.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.525 -0.735 . . . . 0.0 109.928 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.513 ' NE2' HD11 ' A' ' 85' ' ' LEU . 20.1 m170 -103.36 123.16 46.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.343 -0.848 . . . . 0.0 110.742 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 52' ' ' THR . 40.3 tttp -94.85 111.95 23.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 0.0 109.664 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.526 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 39.2 mm -47.3 137.13 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.209 -0.932 . . . . 0.0 110.417 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.515 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 11.1 t0 -112.11 -36.77 5.25 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.398 -0.814 . . . . 0.0 109.934 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 179.92 163.08 1.03 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.319 -0.863 . . . . 0.0 109.657 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.439 HG12 HG12 ' A' ' 23' ' ' VAL . 0.7 OUTLIER -146.75 155.75 11.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.056 -1.028 . . . . 0.0 111.157 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 79' ' ' TYR . 2.5 m-20 -132.57 78.2 1.79 Allowed 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.011 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.562 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 34.0 mttp -61.03 -17.97 55.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.228 -0.92 . . . . 0.0 110.346 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -92.32 -31.01 15.53 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.226 -0.921 . . . . 0.0 109.567 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.497 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -103.78 -6.55 21.35 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.571 -0.706 . . . . 0.0 109.893 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.539 ' N ' ' O ' ' A' ' 75' ' ' ASP . 3.8 m-30 66.02 52.11 1.24 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.536 -0.727 . . . . 0.0 110.14 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.522 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.6 OUTLIER -125.18 147.66 48.95 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.246 -0.909 . . . . 0.0 109.672 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.642 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 58.1 t80 -137.26 135.63 37.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.146 -0.971 . . . . 0.0 110.118 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.439 ' O ' ' N ' ' A' ' 72' ' ' ASP . 26.3 m -141.31 127.58 19.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.077 -1.014 . . . . 0.0 110.779 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.642 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 10.9 p90 -138.72 174.52 10.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.373 -0.83 . . . . 0.0 109.966 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.7 m -125.87 129.19 48.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 0.0 109.738 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.529 ' HB3' ' CG2' ' A' ' 98' ' ' ILE . 3.5 tp -97.07 132.69 42.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.11 -0.994 . . . . 0.0 110.318 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.3 pt -118.81 -24.25 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.394 -0.816 . . . . 0.0 110.148 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.443 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 68.0 tt0 -121.73 147.17 46.25 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.262 -0.899 . . . . 0.0 110.159 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.522 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 165.03 124.65 0.72 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -52.05 -25.01 7.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -1.163 . . . . 0.0 110.22 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.32 -24.03 59.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.166 -0.959 . . . . 0.0 110.226 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.505 HD11 ' N ' ' A' ' 88' ' ' GLY . 72.1 mt -63.98 -32.55 74.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.903 . . . . 0.0 110.167 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 46.81 -173.48 0.02 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 52.3 p30 -83.19 7.02 17.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.262 -1.14 . . . . 0.0 110.163 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.502 ' O ' ' CG2' ' A' ' 126' ' ' VAL . 60.7 p -92.58 -33.72 14.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.319 -0.863 . . . . 0.0 110.137 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.53 HD22 ' CG2' ' A' ' 122' ' ' THR . 61.9 mt -108.03 172.41 6.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.333 -0.854 . . . . 0.0 110.278 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.517 ' OE1' ' N ' ' A' ' 123' ' ' LYS . 48.5 mp0 -149.9 -82.36 0.11 Allowed 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.772 0.796 . . . . 0.0 109.311 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.516 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 59.7 mttt -80.44 127.57 32.57 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.782 -0.574 . . . . 0.0 110.72 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.621 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 5.4 mm -117.8 140.4 41.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 120.563 -1.336 . . . . 0.0 109.293 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.48 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -120.31 126.59 50.92 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.094 179.099 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.621 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 11.7 m-85 -122.61 135.55 54.65 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.407 -0.808 . . . . 0.0 110.367 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.517 ' CB ' ' HB ' ' A' ' 117' ' ' THR . 3.5 mt-10 -138.78 131.02 28.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.316 -0.865 . . . . 0.0 110.122 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 34.1 m -128.27 133.91 48.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.323 -0.86 . . . . 0.0 109.853 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.47 145.86 51.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.137 -0.977 . . . . 0.0 110.531 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.519 ' CD2' HG12 ' A' ' 114' ' ' ILE . 10.9 mt -122.47 153.59 38.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.3 -0.875 . . . . 0.0 110.01 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.479 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 1.9 t -151.12 -168.79 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.183 -0.948 . . . . 0.0 110.125 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.471 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -126.39 147.52 49.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.288 -0.883 . . . . 0.0 110.189 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.461 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 2.6 p -105.87 169.79 6.57 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.14 -0.975 . . . . 0.0 110.273 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.461 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 47.3 Cg_endo -73.19 -9.44 23.3 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.004 1.528 . . . . 0.0 110.403 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 63.1 p -97.37 6.63 47.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.305 -0.872 . . . . 0.0 110.326 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 96.18 -37.71 3.34 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -56.67 -172.42 0.17 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 25.1 p -133.99 137.14 44.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.259 -1.142 . . . . 0.0 110.276 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.465 HG12 HG23 ' A' ' 10' ' ' THR . 18.4 mt -86.77 150.31 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.313 -0.867 . . . . 0.0 110.218 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.612 ' CG2' ' CE2' ' A' ' 9' ' ' PHE . 16.5 mt -131.45 120.01 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.233 -0.917 . . . . 0.0 110.192 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.4 tttm -106.7 124.72 50.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.134 -0.979 . . . . 0.0 110.093 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -111.56 154.37 24.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.23 -0.919 . . . . 0.0 110.469 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.517 ' HB ' ' CB ' ' A' ' 101' ' ' GLU . 88.0 m -145.97 145.2 30.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.385 -0.822 . . . . 0.0 110.249 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.7 m -155.49 120.76 4.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.908 . . . . 0.0 109.857 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.48 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 41.1 m-70 -112.14 157.57 20.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.151 -0.968 . . . . 0.0 110.559 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.587 ' CG ' HD12 ' A' ' 128' ' ' ILE . 10.2 m-85 -125.78 119.89 29.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.371 -0.831 . . . . 0.0 110.511 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.586 ' CD2' HG22 ' A' ' 2' ' ' VAL . 69.9 m-70 -98.79 101.84 13.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.265 -0.897 . . . . 0.0 109.601 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.53 ' CG2' HD22 ' A' ' 95' ' ' LEU . 0.8 OUTLIER -88.26 142.46 27.73 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.131 -0.981 . . . . 0.0 110.499 -179.507 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.517 ' N ' ' OE1' ' A' ' 96' ' ' GLU . 18.4 tttt -113.32 109.73 19.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.382 -0.824 . . . . 0.0 110.202 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 104.06 -153.26 17.73 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.416 ' C ' HG11 ' A' ' 126' ' ' VAL . 21.3 t30 -97.62 77.71 2.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.323 -1.104 . . . . 0.0 110.206 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.502 ' CG2' ' O ' ' A' ' 94' ' ' THR . 22.3 m -142.76 161.68 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.2 -0.937 . . . . 0.0 110.133 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -146.95 153.94 40.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.199 -0.938 . . . . 0.0 110.273 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.587 HD12 ' CG ' ' A' ' 120' ' ' TYR . 3.1 mt -80.18 172.98 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 110.115 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.474 ' N ' ' CG2' ' A' ' 128' ' ' ILE . 63.2 mttt -96.42 133.67 40.54 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.414 -0.804 . . . . 0.0 109.716 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 97.4 mt-10 -42.87 -36.53 1.53 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.268 -0.895 . . . . 0.0 110.169 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.523 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 81.2 tt0 -57.51 -42.17 82.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 109.922 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.518 ' HB3' ' CG2' ' A' ' 128' ' ' ILE . 6.1 t-160 -65.37 -53.66 40.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.333 -0.854 . . . . 0.0 110.221 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.474 HG12 ' CE1' ' A' ' 5' ' ' TYR . 96.6 t -67.7 -33.87 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.43 -0.794 . . . . 0.0 110.287 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 25.6 mttm -98.11 -69.33 0.76 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.212 -0.93 . . . . 0.0 110.205 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -54.71 -19.61 6.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.18 -0.95 . . . . 0.0 109.626 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 132' ' ' HIS . . . -73.17 -30.23 63.25 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.471 ' CE ' ' HB3' ' A' ' 5' ' ' TYR . 66.0 mttm -79.5 -31.45 42.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.335 -1.097 . . . . 0.0 109.932 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -72.45 -52.92 13.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.281 -0.887 . . . . 0.0 109.93 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.507 ' CG ' ' N ' ' A' ' 140' ' ' ALA . 10.1 pttp -56.88 -41.26 77.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.41 -0.806 . . . . 0.0 109.821 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.507 ' N ' ' CG ' ' A' ' 139' ' ' LYS . . . -70.4 -39.73 74.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.349 -0.845 . . . . 0.0 109.853 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 137' ' ' LYS . 16.7 t -55.62 -43.41 76.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.414 -0.804 . . . . 0.0 109.852 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -57.34 -42.47 82.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.347 -0.846 . . . . 0.0 109.873 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.413 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 64.3 mt -57.85 -41.82 83.17 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.28 -0.887 . . . . 0.0 109.906 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -59.45 -36.79 76.62 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.422 -0.799 . . . . 0.0 109.845 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.408 ' HA ' ' OE1' ' A' ' 148' ' ' GLU . 95.6 mttt -71.68 -15.07 62.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.322 -0.861 . . . . 0.0 109.878 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.463 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 24.2 mt -84.95 -35.34 22.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.28 -0.887 . . . . 0.0 109.045 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.644 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 60.0 mt -70.47 -40.75 77.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 119.772 -0.771 . . . . 0.0 108.97 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.469 ' O ' HD12 ' A' ' 13' ' ' ILE . 52.0 mt-10 -59.46 -44.08 93.06 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.423 -0.798 . . . . 0.0 109.329 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.436 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 33.7 m -67.75 -30.19 69.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.318 -0.864 . . . . 0.0 109.453 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.586 ' CE2' ' OH ' ' A' ' 158' ' ' TYR . 73.3 t80 -57.84 -49.72 75.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.463 -0.773 . . . . 0.0 109.802 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.628 ' CD2' ' CE2' ' A' ' 158' ' ' TYR . 77.5 mt -79.94 -26.61 40.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.209 -0.932 . . . . 0.0 109.983 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.534 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . 50.8 tttt -72.65 -26.49 61.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.375 -0.828 . . . . 0.0 109.491 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.468 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -105.4 -32.02 4.11 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.553 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 6.6 m-70 -106.92 92.31 7.4 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.302 -1.117 . . . . 0.0 109.947 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.6 Cg_endo -73.84 6.9 2.62 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.131 1.595 . . . . 0.0 111.15 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -108.87 -4.49 16.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.936 -1.103 . . . . 0.0 110.008 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.556 ' C ' ' CG ' ' A' ' 158' ' ' TYR . . . -77.65 101.72 6.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.382 -0.824 . . . . 0.0 110.1 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.641 ' CE2' ' CB ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER 35.15 31.8 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.691 -0.63 . . . . 0.0 110.507 -179.49 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.516 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.744 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 93.9 t -124.42 137.77 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -1.135 . . . . 0.0 110.206 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.639 ' CD1' ' CD1' ' A' ' 128' ' ' ILE . 10.1 m-85 -98.89 145.71 26.72 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.248 -0.908 . . . . 0.0 109.843 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.558 HG21 ' CE1' ' A' ' 119' ' ' HIS . 3.2 m -120.89 127.56 51.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.155 -0.966 . . . . 0.0 110.677 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.606 ' CE2' ' CG2' ' A' ' 133' ' ' VAL . 61.5 m-85 -139.92 131.21 26.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.395 -0.815 . . . . 0.0 109.765 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 22.4 pt-20 -131.75 153.3 50.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.043 -1.036 . . . . 0.0 110.774 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.7 m -132.37 144.67 50.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.417 -0.802 . . . . 0.0 109.71 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -135.58 121.99 20.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.162 -0.961 . . . . 0.0 110.719 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.638 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.0 p90 -147.19 -177.03 5.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.363 -0.836 . . . . 0.0 109.691 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.536 ' CG2' ' HA ' ' A' ' 113' ' ' ILE . 5.7 p -142.52 170.35 15.88 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.115 -0.991 . . . . 0.0 110.739 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.427 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 1.4 t -155.06 157.48 37.61 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.41 -0.807 . . . . 0.0 110.243 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -76.07 -38.34 57.19 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.125 -0.984 . . . . 0.0 109.993 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.54 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 3.3 mp -58.37 150.02 56.52 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.44 -0.788 . . . . 0.0 109.98 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.54 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 39.6 Cg_endo -66.1 144.71 76.64 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.909 1.478 . . . . 0.0 110.116 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.623 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 38.4 Cg_endo -72.41 -31.46 11.31 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.961 1.506 . . . . 0.0 113.002 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 44.0 Cg_endo -71.72 -22.0 24.49 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 N-CA-C 109.757 -0.901 . . . . 0.0 109.757 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.535 ' HG2' ' CD2' ' A' ' 151' ' ' LEU . 42.0 ttm180 -81.89 -47.57 12.61 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.517 ' HA ' ' CD1' ' A' ' 151' ' ' LEU . 0.7 OUTLIER -66.26 -26.26 67.27 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.645 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.57 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 51.6 t80 -67.88 -50.72 54.76 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.513 0.673 . . . . 0.0 109.798 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.492 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 34.7 mttm -58.46 -33.63 69.96 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.624 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.613 ' CB ' ' CE1' ' A' ' 158' ' ' TYR . . . -80.04 -26.22 39.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.449 -0.782 . . . . 0.0 110.749 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.564 ' CD1' HD12 ' A' ' 147' ' ' ILE . 1.4 t80 -87.18 -46.72 9.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.17 -0.956 . . . . 0.0 111.474 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.505 HG11 ' CE1' ' A' ' 81' ' ' TYR . 3.5 t -98.84 -54.73 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.018 -1.051 . . . . 0.0 111.098 -179.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.492 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 8.0 mp -67.81 -5.59 17.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.174 -0.954 . . . . 0.0 110.735 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -144.35 17.82 1.71 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.118 -0.989 . . . . 0.0 110.443 -179.866 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -56.99 -23.12 43.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.188 -0.945 . . . . 0.0 110.164 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -79.55 -14.34 58.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.309 -0.869 . . . . 0.0 110.335 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.458 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 80.5 m-20 -132.37 9.14 4.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.183 -0.948 . . . . 0.0 110.415 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.584 ' CD1' ' CD1' ' A' ' 33' ' ' ILE . 0.4 OUTLIER -105.3 -43.61 4.95 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.176 -0.952 . . . . 0.0 110.432 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.603 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 3.0 t -74.39 -41.4 4.84 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.339 -0.851 . . . . 0.0 110.956 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.9 Cg_endo -77.8 10.73 2.48 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.313 1.165 . . . . 0.0 110.896 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 28' ' ' ASN . 15.4 mttm -124.87 -34.92 2.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.115 -0.99 . . . . 0.0 109.355 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.584 ' CD1' ' CD1' ' A' ' 29' ' ' LEU . 6.7 mt -80.12 -44.15 22.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.487 -0.758 . . . . 0.0 109.628 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.87 95.06 14.1 Favored Pre-proline 0 N--CA 1.487 1.398 0 O-C-N 121.407 -0.808 . . . . 0.0 110.189 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.16 -0.41 9.09 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.047 1.551 . . . . 0.0 110.513 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -90.41 -27.42 19.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.218 -0.926 . . . . 0.0 110.039 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.446 ' HB1' HD11 ' A' ' 38' ' ' ILE . . . -87.53 -47.83 8.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.355 -0.841 . . . . 0.0 110.11 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.525 HD12 ' CG1' ' A' ' 30' ' ' VAL . 1.0 OUTLIER -125.68 130.19 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.495 -0.753 . . . . 0.0 109.926 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -89.17 -26.96 21.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.36 -0.837 . . . . 0.0 110.056 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.548 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -172.11 150.08 2.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.918 . . . . 0.0 110.197 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.6 m -128.58 123.3 33.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.339 -0.851 . . . . 0.0 109.904 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.527 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 69.5 tt0 -134.13 111.57 10.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.147 -0.97 . . . . 0.0 110.733 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.456 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 38.2 mt -53.65 143.61 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.292 -0.88 . . . . 0.0 109.892 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' A' ' 53' ' ' ILE . 30.3 tp -120.82 -27.3 5.06 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.224 -0.922 . . . . 0.0 110.447 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.568 ' CD2' HD13 ' A' ' 53' ' ' ILE . 1.7 m95 -123.92 162.83 22.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.294 -0.879 . . . . 0.0 110.516 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.466 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 42.84 -135.97 4.07 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.415 ' N ' ' OG1' ' A' ' 52' ' ' THR . 0.2 OUTLIER -152.64 22.95 0.6 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.392 -1.063 . . . . 0.0 110.052 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 120.09 -19.75 9.33 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.476 ' O ' HG22 ' A' ' 71' ' ' ILE . . . -74.16 -169.82 21.43 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.472 ' HA ' HG23 ' A' ' 71' ' ' ILE . 45.3 Cg_endo -72.13 128.12 13.53 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 123.925 1.487 . . . . 0.0 110.649 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.4 -14.57 47.09 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.527 -1.829 . . . . 0.0 108.527 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.1 m -71.79 160.42 32.63 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.553 -0.969 . . . . 0.0 109.329 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.568 HD13 ' CD2' ' A' ' 45' ' ' TRP . 59.5 mt -132.48 119.36 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 110.276 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 48.6 mttm -102.56 124.8 48.77 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.355 -0.84 . . . . 0.0 110.163 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.4 tttt -92.31 93.9 8.87 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.29 -0.881 . . . . 0.0 110.004 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.521 ' CG2' HG12 ' A' ' 38' ' ' ILE . 70.7 mt -80.1 144.26 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.187 -0.945 . . . . 0.0 110.05 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 40' ' ' HIS . 1.2 p -115.08 153.93 29.82 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.359 -0.838 . . . . 0.0 110.347 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.524 ' N ' ' O ' ' A' ' 65' ' ' GLY . 19.3 m-85 -114.53 137.87 51.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.158 -0.964 . . . . 0.0 110.107 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.9 29.3 8.14 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -48.35 -29.45 3.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.182 -1.187 . . . . 0.0 110.201 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 118.64 -119.29 4.3 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' A' ' 63' ' ' GLN . 55.7 p -60.27 165.42 3.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.288 -1.125 . . . . 0.0 110.316 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.424 ' HB2' ' O ' ' A' ' 62' ' ' SER . 98.8 mt-30 54.42 97.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.29 -0.881 . . . . 0.0 110.349 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.403 ' C ' ' O ' ' A' ' 63' ' ' GLN . 0.7 OUTLIER -44.13 140.81 1.97 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.9 . . . . 0.0 110.095 179.869 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -138.78 116.53 1.28 Allowed Glycine 0 N--CA 1.486 2.033 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.545 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 13.9 p90 -156.4 174.47 15.37 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.088 -1.242 . . . . 0.0 110.208 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.484 ' HB ' HD12 ' A' ' 85' ' ' LEU . 6.8 m -144.16 174.97 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.872 . . . . 0.0 110.658 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.517 ' O ' ' CD1' ' A' ' 85' ' ' LEU . 22.7 mttm -132.22 104.36 6.72 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.515 -0.741 . . . . 0.0 109.687 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.53 ' CD2' HD11 ' A' ' 85' ' ' LEU . 12.5 m170 -95.57 126.09 40.62 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.26 -0.9 . . . . 0.0 111.103 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 52' ' ' THR . 23.8 tttt -98.48 108.67 21.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.351 -0.843 . . . . 0.0 109.434 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.51 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 30.2 mm -42.38 139.78 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.222 -0.924 . . . . 0.0 110.15 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.478 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 13.1 t0 -116.55 -41.22 3.11 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.187 -0.945 . . . . 0.0 110.46 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 22.9 m -168.94 158.86 9.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 109.917 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.42 HD13 ' C ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -148.93 154.33 9.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 C-N-CA 119.142 -1.023 . . . . 0.0 111.131 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 79' ' ' TYR . 2.4 m-20 -133.91 77.82 1.73 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 120.269 -0.573 . . . . 0.0 110.092 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.57 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 36.7 tttm -61.6 -15.66 41.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.099 -1.001 . . . . 0.0 110.199 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -92.93 -30.53 15.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.259 -0.9 . . . . 0.0 109.593 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.502 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.2 m-80 -105.04 -9.15 18.04 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.69 -0.632 . . . . 0.0 109.882 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.579 ' CZ ' ' HB3' ' A' ' 16' ' ' PRO . 2.9 m-85 70.13 51.31 0.4 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.62 -0.675 . . . . 0.0 110.277 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.465 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -125.17 149.01 48.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.908 . . . . 0.0 109.669 179.711 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.676 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 58.5 t80 -138.86 139.96 38.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.162 -0.961 . . . . 0.0 110.235 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.418 ' O ' ' HB3' ' A' ' 72' ' ' ASP . 3.3 m -148.52 121.37 8.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.208 -0.932 . . . . 0.0 110.439 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.676 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 8.8 p90 -131.41 175.12 9.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.291 -0.881 . . . . 0.0 110.42 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.446 HG21 ' O ' ' A' ' 98' ' ' ILE . 19.7 m -127.82 126.06 40.96 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.346 -0.846 . . . . 0.0 109.948 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.53 HD11 ' CD2' ' A' ' 69' ' ' HIS . 14.0 tp -97.57 135.5 39.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.018 -1.051 . . . . 0.0 110.277 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.471 ' O ' ' CD1' ' A' ' 91' ' ' LEU . 9.5 pt -115.81 -31.27 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.219 -0.926 . . . . 0.0 110.255 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.489 ' C ' ' CD1' ' A' ' 91' ' ' LEU . 39.4 tt0 -107.86 165.65 11.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.28 -0.887 . . . . 0.0 110.09 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.464 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 151.55 140.17 3.1 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -60.04 -31.93 70.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.276 -1.132 . . . . 0.0 110.228 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 91' ' ' LEU . . . -67.02 -39.61 87.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.29 -0.881 . . . . 0.0 110.213 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.521 ' CD2' ' CD2' ' A' ' 95' ' ' LEU . 11.4 mt -42.31 -51.96 4.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.367 -0.833 . . . . 0.0 110.135 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 43.54 -167.4 0.02 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.409 ' C ' ' OD1' ' A' ' 93' ' ' ASP . 55.8 p-10 -79.43 3.22 19.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -1.146 . . . . 0.0 110.176 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.462 ' O ' HG21 ' A' ' 122' ' ' THR . 0.1 OUTLIER -92.32 -51.93 4.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.231 -0.918 . . . . 0.0 110.185 -179.907 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.544 HD12 ' CD1' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -107.56 159.59 16.32 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.406 -0.809 . . . . 0.0 109.416 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.481 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 62.9 tt0 -134.88 -80.33 0.44 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.306 -0.871 . . . . 0.0 110.182 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 46.8 mttt -80.27 152.74 28.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.633 -0.667 . . . . 0.0 110.78 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.631 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 4.7 mm -138.66 142.99 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.175 -0.953 . . . . 0.0 109.701 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.459 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.8 OUTLIER -121.38 127.39 51.16 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.356 -0.84 . . . . 0.0 109.151 178.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.631 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 10.3 m-85 -122.52 135.19 54.59 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 110.517 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.447 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 74.4 tt0 -138.14 141.38 40.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.312 -0.867 . . . . 0.0 110.356 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 81' ' ' TYR . 32.7 m -137.66 149.94 46.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.412 -0.805 . . . . 0.0 109.732 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 115' ' ' LYS . 7.9 mttt -145.54 138.14 25.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.114 -0.991 . . . . 0.0 110.725 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.521 ' CD2' HG12 ' A' ' 114' ' ' ILE . 5.9 mt -118.75 151.69 37.56 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.298 -0.876 . . . . 0.0 109.497 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.476 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 1.9 t -150.23 -169.85 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.042 -1.036 . . . . 0.0 110.371 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -121.44 141.87 50.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.42 -0.8 . . . . 0.0 110.141 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.478 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 7.9 p -99.25 167.51 11.12 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.209 -0.932 . . . . 0.0 110.29 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.478 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.7 Cg_endo -72.32 -1.12 9.68 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.013 1.533 . . . . 0.0 110.596 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 52.0 p -106.65 4.14 27.58 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.248 -0.907 . . . . 0.0 110.303 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 100.21 -32.83 6.86 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -61.97 -172.11 1.27 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.529 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.0 OUTLIER -131.56 128.77 39.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.217 -1.167 . . . . 0.0 110.413 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.536 ' HA ' ' CG2' ' A' ' 10' ' ' THR . 10.3 mt -82.19 152.14 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.321 -0.862 . . . . 0.0 110.039 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.584 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 15.7 mt -132.31 119.03 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.2 -0.938 . . . . 0.0 110.436 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.486 ' O ' ' N ' ' A' ' 103' ' ' LYS . 26.6 tttt -108.63 119.04 38.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 110.075 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 2.0 t -110.87 158.16 19.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 110.306 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 43.1 m -160.01 139.74 11.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.21 -0.931 . . . . 0.0 110.3 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 41.9 t -143.58 159.67 42.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.214 -0.929 . . . . 0.0 110.116 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.558 ' CE1' HG21 ' A' ' 4' ' ' THR . 69.8 m-70 -142.34 159.1 42.9 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.157 -0.964 . . . . 0.0 110.527 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.495 ' HB2' ' HB2' ' A' ' 3' ' ' PHE . 8.7 m-85 -117.86 150.78 38.61 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.36 -0.837 . . . . 0.0 110.279 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.481 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 95.2 m-70 -128.39 82.76 2.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.138 -0.976 . . . . 0.0 109.896 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.462 HG21 ' O ' ' A' ' 94' ' ' THR . 1.2 p -71.74 152.13 43.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.347 -0.845 . . . . 0.0 110.082 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.406 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 7.3 ttpt -109.89 118.29 36.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.255 -0.903 . . . . 0.0 110.335 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 101.59 -143.44 16.07 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -112.72 73.41 0.81 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.302 -1.116 . . . . 0.0 110.207 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 5.9 m -140.67 156.49 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.273 -0.892 . . . . 0.0 110.147 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -128.2 154.7 45.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.266 -0.896 . . . . 0.0 110.261 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.639 ' CD1' ' CD1' ' A' ' 3' ' ' PHE . 3.0 mt -74.9 172.74 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.337 -0.852 . . . . 0.0 110.2 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.463 ' O ' ' N ' ' A' ' 132' ' ' HIS . 40.9 mmtm -104.07 125.9 50.78 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.347 -0.846 . . . . 0.0 110.053 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 129' ' ' LYS . 96.0 mt-10 -43.65 -54.05 5.31 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.223 -0.923 . . . . 0.0 110.038 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.446 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 42.9 tt0 -46.32 -25.04 0.56 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.207 -0.933 . . . . 0.0 109.797 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.463 ' N ' ' O ' ' A' ' 129' ' ' LYS . 12.1 t-160 -81.54 -64.56 1.16 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.435 -0.791 . . . . 0.0 110.071 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.606 ' CG2' ' CE2' ' A' ' 5' ' ' TYR . 8.8 p -66.14 -39.47 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.359 -0.838 . . . . 0.0 110.031 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 38.0 tttp -63.59 -42.46 98.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 109.968 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.446 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -66.77 -32.27 73.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.353 -0.842 . . . . 0.0 109.883 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.64 -26.98 74.13 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 45.1 mttp -65.11 -35.43 81.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.336 -1.096 . . . . 0.0 110.021 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -82.69 -36.48 25.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.32 -0.862 . . . . 0.0 109.868 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 41.0 mttt -73.29 -26.93 61.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.387 -0.821 . . . . 0.0 109.854 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.407 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -81.54 -38.77 25.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.368 -0.833 . . . . 0.0 109.92 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.401 ' OG ' ' NZ ' ' A' ' 145' ' ' LYS . 18.9 t -64.01 -47.15 81.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.335 -0.853 . . . . 0.0 109.947 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -54.86 -44.68 74.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.247 -0.908 . . . . 0.0 109.867 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.471 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 9.4 tp -57.2 -45.88 83.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 0.0 109.859 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.468 ' HA ' HD11 ' A' ' 147' ' ' ILE . 28.0 m-85 -54.44 -41.32 69.26 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.234 -0.916 . . . . 0.0 109.507 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.401 ' NZ ' ' OG ' ' A' ' 141' ' ' SER . 18.7 mttp -72.82 -12.98 61.19 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.438 -0.789 . . . . 0.0 110.035 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 143' ' ' LEU . 16.1 mt -83.75 -36.2 23.82 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.177 -0.952 . . . . 0.0 108.921 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.564 HD12 ' CD1' ' A' ' 22' ' ' PHE . 25.8 mt -68.05 -44.31 84.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.496 ' OE2' ' CD1' ' A' ' 18' ' ' LEU . 60.8 mm-40 -53.66 -46.22 70.53 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.473 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 25.7 m -65.83 -39.11 90.51 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.354 -0.841 . . . . 0.0 109.351 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.575 ' CE2' ' OH ' ' A' ' 158' ' ' TYR . 58.0 t80 -43.64 -56.85 3.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.435 -0.791 . . . . 0.0 109.829 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.535 ' CD2' ' HG2' ' A' ' 17' ' ' ARG . 12.4 mt -75.16 -39.72 60.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.541 -0.724 . . . . 0.0 110.432 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.531 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . 25.1 tttm -60.83 -17.77 51.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.122 -0.986 . . . . 0.0 109.364 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.467 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -113.46 -29.59 2.9 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.538 ' CD2' ' O ' ' A' ' 150' ' ' TYR . 12.2 m-70 -105.82 89.84 3.87 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.285 -1.126 . . . . 0.0 110.009 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.513 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 45.6 Cg_endo -71.12 1.85 4.9 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.052 1.554 . . . . 0.0 110.989 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -108.33 -16.31 14.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.049 -1.032 . . . . 0.0 110.107 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.593 ' O ' ' CD1' ' A' ' 158' ' ' TYR . . . -71.41 99.56 2.01 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.2 -0.937 . . . . 0.0 109.848 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.613 ' CE1' ' CB ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER 35.06 32.54 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 CA-C-O 121.564 0.697 . . . . 0.0 109.569 -179.24 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.536 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--N 1.303 -1.451 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.94 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.456 ' O ' ' OG1' ' A' ' 122' ' ' THR . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.508 ' CG1' ' O ' ' A' ' 120' ' ' TYR . 77.4 t -125.29 138.57 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -1.157 . . . . 0.0 110.2 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.645 ' CD1' ' CD1' ' A' ' 128' ' ' ILE . 11.7 m-85 -98.02 136.13 38.72 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.205 -0.934 . . . . 0.0 109.624 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.514 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 8.5 m -119.19 136.81 54.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.093 -1.004 . . . . 0.0 110.815 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.633 ' CE2' ' CG2' ' A' ' 133' ' ' VAL . 57.0 m-85 -147.18 124.83 11.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.474 -0.766 . . . . 0.0 109.83 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.58 ' CG ' ' CG2' ' A' ' 117' ' ' THR . 5.0 mt-10 -123.54 132.77 53.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.277 -0.889 . . . . 0.0 110.494 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.456 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 50.7 m -119.01 157.8 27.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.325 -0.86 . . . . 0.0 109.898 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 7' ' ' SER . 50.5 mp0 -146.37 123.98 11.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.111 -0.993 . . . . 0.0 110.804 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.635 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.0 p90 -141.71 -175.88 4.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.886 . . . . 0.0 109.632 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.469 HG23 HG12 ' A' ' 113' ' ' ILE . 8.6 p -142.5 169.84 16.83 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.009 -1.057 . . . . 0.0 110.794 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.486 ' O ' ' N ' ' A' ' 112' ' ' SER . 4.0 t -153.83 162.15 41.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.422 -0.799 . . . . 0.0 110.174 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -85.1 -28.47 25.57 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.127 -0.983 . . . . 0.0 110.164 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.535 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 9.1 mm -67.9 150.79 97.63 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 0.0 109.891 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.535 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 40.4 Cg_endo -66.12 143.35 71.3 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.932 1.491 . . . . 0.0 110.325 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.627 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.2 Cg_endo -72.55 -31.13 11.35 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 124.023 1.539 . . . . 0.0 112.888 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.6 Cg_endo -70.1 -23.83 28.83 Favored 'Trans proline' 0 C--N 1.316 -1.147 0 N-CA-C 110.177 -0.74 . . . . 0.0 110.177 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.574 ' O ' ' CE1' ' A' ' 158' ' ' TYR . 46.2 mtp180 -83.68 -42.47 16.6 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.541 ' HG ' ' CG2' ' A' ' 147' ' ' ILE . 0.6 OUTLIER -71.85 -31.56 66.62 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.467 ' HB2' ' O ' ' A' ' 15' ' ' PRO . 54.3 t80 -65.39 -54.93 21.56 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.461 -0.774 . . . . 0.0 109.042 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 25' ' ' ASP . 70.1 mttt -48.63 -48.54 39.43 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.724 -0.79 . . . . 0.0 109.355 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.651 ' CB ' ' CZ ' ' A' ' 158' ' ' TYR . . . -67.75 -28.77 67.91 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.334 -0.854 . . . . 0.0 111.135 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.573 ' CD1' HD12 ' A' ' 147' ' ' ILE . 0.9 OUTLIER -80.92 -46.54 15.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 111.411 -178.814 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.564 HG11 ' CE1' ' A' ' 81' ' ' TYR . 3.4 t -104.44 -51.36 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.942 -1.099 . . . . 0.0 111.761 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.473 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 7.2 mp -79.97 -4.61 53.22 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.097 -1.002 . . . . 0.0 111.966 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.541 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 1.0 OUTLIER -149.17 23.95 0.93 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.717 -1.239 . . . . 0.0 110.643 -179.632 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.521 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -67.01 -32.94 74.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.17 -0.956 . . . . 0.0 110.301 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.427 ' HA ' ' OG ' ' A' ' 41' ' ' SER . 81.4 m-20 -56.54 -17.68 9.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.357 -0.839 . . . . 0.0 110.559 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 25' ' ' ASP . 4.2 p30 -128.94 -0.93 5.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.15 -0.969 . . . . 0.0 110.523 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.526 ' CD2' ' CZ ' ' A' ' 150' ' ' TYR . 1.1 tm? -88.57 -43.76 11.14 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.112 -0.992 . . . . 0.0 110.17 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.598 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 5.0 t -74.59 -40.86 4.36 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.437 -0.79 . . . . 0.0 111.319 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.0 Cg_endo -77.54 10.91 2.33 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 123.448 1.236 . . . . 0.0 111.005 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.486 ' CD ' ' O ' ' A' ' 28' ' ' ASN . 31.9 mtpt -120.65 -34.65 3.54 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.029 -1.044 . . . . 0.0 109.031 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.576 HD13 ' CD1' ' A' ' 150' ' ' TYR . 10.6 mt -80.19 -32.58 13.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 121.53 0.681 . . . . 0.0 109.657 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -159.65 98.35 1.54 Allowed Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.412 -0.805 . . . . 0.0 110.097 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.8 -0.75 8.86 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.034 1.544 . . . . 0.0 110.809 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -85.03 -19.08 32.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 109.788 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.441 ' HB1' HD11 ' A' ' 38' ' ' ILE . . . -85.76 -86.05 0.14 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.415 -0.803 . . . . 0.0 110.082 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' A' ' 57' ' ' THR . 1.9 mp -90.75 139.94 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.279 -0.888 . . . . 0.0 110.112 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.425 ' O ' ' CB ' ' A' ' 40' ' ' HIS . 4.8 ttmm -87.81 -26.74 22.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.353 -0.842 . . . . 0.0 110.18 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.56 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER 177.03 157.19 0.31 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.177 -0.952 . . . . 0.0 110.193 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.427 ' OG ' ' HA ' ' A' ' 27' ' ' ASP . 79.4 p -117.3 134.21 55.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.356 -0.84 . . . . 0.0 110.023 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.56 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 29.0 tp10 -138.69 106.87 5.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.091 -1.005 . . . . 0.0 110.246 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.462 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 20.0 mt -62.59 137.16 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 110.098 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.511 HD23 ' CE ' ' A' ' 55' ' ' LYS . 13.0 tp -114.08 -23.51 9.49 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.239 -0.913 . . . . 0.0 110.534 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.468 ' HB2' ' N ' ' A' ' 53' ' ' ILE . 1.7 m95 -127.06 161.61 28.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.049 -1.032 . . . . 0.0 110.63 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.458 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 41.76 -132.09 3.97 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -157.24 19.78 0.3 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.296 -1.12 . . . . 0.0 110.154 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.91 -18.22 7.09 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.476 ' O ' HG23 ' A' ' 71' ' ' ILE . . . -74.51 -171.64 26.87 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.475 ' HA ' HG23 ' A' ' 71' ' ' ILE . 46.0 Cg_endo -73.38 129.54 13.99 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.103 1.581 . . . . 0.0 110.665 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.34 -9.44 49.55 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.1 m -76.88 167.17 22.29 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.567 -0.96 . . . . 0.0 109.921 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.468 ' N ' ' HB2' ' A' ' 45' ' ' TRP . 65.6 mt -137.35 120.24 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.322 -0.861 . . . . 0.0 109.871 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 70.7 mttt -106.03 138.37 42.34 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.211 -0.93 . . . . 0.0 110.411 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.511 ' CE ' HD23 ' A' ' 44' ' ' LEU . 43.5 mttt -102.53 95.86 6.52 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.308 -0.87 . . . . 0.0 110.06 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.477 ' HB ' HG22 ' A' ' 67' ' ' VAL . 52.1 mt -80.05 135.41 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 109.846 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.46 ' OG1' ' N ' ' A' ' 40' ' ' HIS . 1.6 p -104.77 155.8 18.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.374 -0.828 . . . . 0.0 110.452 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.458 ' CZ ' HG21 ' A' ' 67' ' ' VAL . 23.9 m-85 -118.73 169.89 9.45 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.316 -0.865 . . . . 0.0 110.083 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -46.85 150.95 1.8 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 61' ' ' GLY . 79.8 tt0 -57.97 -40.25 80.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -1.177 . . . . 0.0 110.262 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' A' ' 60' ' ' GLU . . . 42.99 -163.61 0.03 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.8 m -67.21 -40.82 86.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -1.126 . . . . 0.0 110.032 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.416 ' O ' ' C ' ' A' ' 64' ' ' TYR . 95.3 mt-30 -123.7 140.91 52.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.343 -0.848 . . . . 0.0 110.018 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.515 ' CE2' ' CD2' ' A' ' 66' ' ' TYR . 8.5 t80 -43.32 141.04 1.4 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.172 -0.955 . . . . 0.0 110.075 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.484 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -129.31 136.18 8.84 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.562 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 11.7 p90 -179.49 161.38 1.04 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.349 -1.089 . . . . 0.0 109.952 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.495 HG13 ' CA ' ' A' ' 88' ' ' GLY . 7.1 m -141.95 171.83 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.681 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.464 ' O ' HD22 ' A' ' 85' ' ' LEU . 50.9 mttt -123.31 115.03 21.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.597 -0.689 . . . . 0.0 109.801 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -106.29 126.19 51.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.141 -0.974 . . . . 0.0 110.633 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 52' ' ' THR . 27.2 ttpp -97.43 126.58 42.77 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.322 -0.861 . . . . 0.0 109.77 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.508 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 26.1 mm -66.22 122.02 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 0.0 110.219 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.416 ' O ' ' OG ' ' A' ' 73' ' ' SER . 17.1 t0 -98.14 -43.34 7.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.359 -0.838 . . . . 0.0 110.118 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 9.8 m -169.0 159.42 9.28 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.382 -0.824 . . . . 0.0 109.616 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.5 mt -144.19 158.22 15.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.141 -0.975 . . . . 0.0 110.386 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 79' ' ' TYR . 4.3 m-20 -134.39 78.76 1.77 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.088 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.421 ' HB2' ' HE3' ' A' ' 76' ' ' LYS . 38.1 mtmt -62.52 -14.03 37.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.195 -0.94 . . . . 0.0 110.233 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -93.68 -33.06 13.81 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.266 -0.896 . . . . 0.0 109.521 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.484 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -104.65 -8.18 19.1 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.605 -0.685 . . . . 0.0 109.841 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.536 ' N ' ' O ' ' A' ' 75' ' ' ASP . 3.2 m-85 68.95 50.86 0.58 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.447 -0.783 . . . . 0.0 110.12 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.532 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -120.96 155.3 34.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.318 -0.864 . . . . 0.0 109.405 179.638 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.564 ' CE1' HG11 ' A' ' 23' ' ' VAL . 26.8 t80 -143.21 133.17 24.14 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.177 -0.952 . . . . 0.0 110.216 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 37.9 m -136.75 122.73 20.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 110.488 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.612 ' N ' ' CD1' ' A' ' 83' ' ' TYR . 3.1 p90 -139.42 179.98 6.23 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.179 -0.951 . . . . 0.0 110.039 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.527 ' CG2' ' O ' ' A' ' 98' ' ' ILE . 39.3 m -132.02 142.46 49.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 110.332 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.563 ' CB ' ' HB ' ' A' ' 98' ' ' ILE . 0.2 OUTLIER -98.04 119.35 36.52 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.261 -0.9 . . . . 0.0 110.278 179.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.449 ' CG1' ' HB2' ' A' ' 68' ' ' LYS . 31.2 pt -102.64 -12.85 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.2 -0.938 . . . . 0.0 110.062 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.458 ' HG3' ' N ' ' A' ' 88' ' ' GLY . 47.8 tp10 -141.82 166.7 24.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.311 -0.868 . . . . 0.0 110.214 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.495 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 148.87 120.33 1.07 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -50.15 -24.39 2.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.341 -1.094 . . . . 0.0 110.229 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.5 ' CB ' ' NE2' ' A' ' 132' ' ' HIS . . . -74.09 -22.61 59.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.926 . . . . 0.0 110.27 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.465 ' O ' ' O ' ' A' ' 92' ' ' GLY . 37.7 mt -66.86 -27.09 67.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.229 -0.919 . . . . 0.0 110.307 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 48.91 -178.04 0.01 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 93' ' ' ASP . 38.1 p30 -81.61 8.67 9.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -1.16 . . . . 0.0 110.267 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.456 ' O ' HG23 ' A' ' 126' ' ' VAL . 71.2 p -96.3 -39.62 9.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -0.906 . . . . 0.0 110.182 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.546 ' CD2' ' CG1' ' A' ' 128' ' ' ILE . 47.3 mt -98.8 153.59 18.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.389 -0.819 . . . . 0.0 110.193 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.467 ' HG3' ' HB2' ' A' ' 123' ' ' LYS . 41.9 mm-40 -131.91 -80.31 0.51 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.242 -0.911 . . . . 0.0 110.253 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.51 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 17.6 mttt -80.19 128.73 33.86 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.595 -0.691 . . . . 0.0 110.756 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.583 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 11.3 mm -115.65 146.76 19.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 120.777 -1.202 . . . . 0.0 109.582 178.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.482 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.0 OUTLIER -123.41 123.77 41.41 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.258 -0.901 . . . . 0.0 109.046 178.564 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.585 ' HB3' ' CE2' ' A' ' 83' ' ' TYR . 15.0 m-85 -121.34 133.13 55.1 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.457 -0.777 . . . . 0.0 109.732 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.459 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 21.1 tt0 -142.07 144.05 33.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.09 -1.006 . . . . 0.0 110.782 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 62.1 m -140.13 146.03 38.32 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.455 -0.778 . . . . 0.0 109.594 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -139.52 138.38 36.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.096 -1.002 . . . . 0.0 110.658 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.52 ' CD2' HG12 ' A' ' 114' ' ' ILE . 7.1 mt -118.6 150.3 39.92 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.4 -0.813 . . . . 0.0 109.965 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.452 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 1.8 t -147.72 -171.38 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.188 -0.945 . . . . 0.0 110.212 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -122.75 138.19 54.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.419 -0.801 . . . . 0.0 110.171 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.447 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 4.2 p -99.2 167.74 10.77 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.289 -0.882 . . . . 0.0 110.22 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.447 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.1 Cg_endo -72.27 -4.27 14.9 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.12 1.59 . . . . 0.0 110.349 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 36.5 m -93.82 -18.73 21.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 110.309 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 118.18 -30.37 6.08 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 11' ' ' SER . . . -64.72 -142.96 0.03 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 11' ' ' SER . 26.4 p -155.71 128.57 7.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.287 -1.125 . . . . 0.0 109.968 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.469 HG12 HG23 ' A' ' 10' ' ' THR . 15.2 mt -79.96 149.14 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -0.908 . . . . 0.0 110.085 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.629 ' CG2' ' CZ ' ' A' ' 9' ' ' PHE . 15.6 mt -131.36 119.45 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.414 -0.804 . . . . 0.0 110.25 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -104.83 121.35 43.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.098 -1.001 . . . . 0.0 110.072 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.12 152.65 21.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -0.868 . . . . 0.0 110.216 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.58 ' CG2' ' CG ' ' A' ' 6' ' ' GLU . 12.1 m -159.97 122.39 3.37 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.316 -0.865 . . . . 0.0 110.568 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.506 ' C ' ' CG ' ' A' ' 119' ' ' HIS . 15.0 t -133.55 160.13 38.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.361 -0.837 . . . . 0.0 109.669 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.522 ' NE2' HG23 ' A' ' 117' ' ' THR . 33.7 m-70 -147.19 164.2 33.89 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.061 -1.025 . . . . 0.0 110.642 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.54 ' N ' ' CD1' ' A' ' 120' ' ' TYR . 6.3 m-85 -126.93 150.53 49.29 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.253 -0.904 . . . . 0.0 110.443 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.51 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 93.6 m-70 -129.78 84.71 2.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.255 -0.903 . . . . 0.0 109.723 178.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.51 ' CG2' HD22 ' A' ' 95' ' ' LEU . 1.2 p -63.64 154.8 31.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.302 -0.874 . . . . 0.0 110.179 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.467 ' HB2' ' HG3' ' A' ' 96' ' ' GLU . 43.4 tttt -113.73 117.56 31.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 110.048 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 99.25 -115.95 5.45 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.476 ' O ' ' ND2' ' A' ' 125' ' ' ASN . 0.7 OUTLIER -138.27 67.4 1.41 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.301 -1.117 . . . . 0.0 110.138 179.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 94' ' ' THR . 27.9 m -131.92 167.23 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.886 . . . . 0.0 110.085 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -140.76 161.41 37.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 110.255 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.645 ' CD1' ' CD1' ' A' ' 3' ' ' PHE . 3.5 mp -84.17 172.8 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.252 -0.905 . . . . 0.0 110.127 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.462 ' N ' ' CG2' ' A' ' 128' ' ' ILE . 16.2 mttm -108.25 129.92 55.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.384 -0.823 . . . . 0.0 109.683 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 73.1 mm-40 -43.86 -49.69 8.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.079 -1.013 . . . . 0.0 109.885 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.506 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 51.6 tt0 -48.54 -23.09 0.87 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.154 -0.966 . . . . 0.0 109.651 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.5 ' NE2' ' CB ' ' A' ' 90' ' ' ALA . 13.5 t-160 -88.48 -66.42 0.92 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.372 -0.83 . . . . 0.0 110.142 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.633 ' CG2' ' CE2' ' A' ' 5' ' ' TYR . 7.3 p -59.91 -40.21 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.345 -0.847 . . . . 0.0 109.84 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 130' ' ' GLU . 31.5 tptt -66.69 -47.39 72.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.285 -0.884 . . . . 0.0 109.795 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.506 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -63.32 -34.18 77.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.74 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.86 -33.89 85.47 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 21.9 mttp -62.87 -37.87 88.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.366 -1.079 . . . . 0.0 109.78 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -78.81 -37.54 40.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.491 -0.756 . . . . 0.0 109.826 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 135' ' ' ALA . 20.9 mttm -66.89 -33.24 75.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.411 -0.805 . . . . 0.0 109.801 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.1 -45.71 26.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.311 -0.868 . . . . 0.0 109.829 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 137' ' ' LYS . 15.0 m -59.13 -42.8 91.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.425 -0.797 . . . . 0.0 109.798 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -59.88 -46.26 89.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.31 -0.869 . . . . 0.0 109.816 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 143' ' ' LEU . 18.9 mt -58.13 -35.63 71.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.373 -0.829 . . . . 0.0 109.722 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.452 ' HA ' HD11 ' A' ' 147' ' ' ILE . 22.6 m-85 -64.27 -34.33 77.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.372 -0.83 . . . . 0.0 109.774 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -71.95 -16.9 62.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.332 -0.855 . . . . 0.0 109.848 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.51 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 19.5 mt -81.23 -36.65 29.73 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.231 -0.918 . . . . 0.0 108.728 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.573 HD12 ' CD1' ' A' ' 22' ' ' PHE . 27.8 mt -70.43 -49.03 56.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.478 ' O ' HG13 ' A' ' 13' ' ' ILE . 97.9 mt-10 -53.07 -38.83 62.84 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.379 -0.825 . . . . 0.0 109.056 178.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.401 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 35.2 m -76.49 -30.18 57.13 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.271 -0.893 . . . . 0.0 109.011 178.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.592 ' O ' ' CD2' ' A' ' 154' ' ' HIS . 54.0 t80 -50.52 -52.95 33.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.591 -0.693 . . . . 0.0 109.566 179.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.586 HD22 ' CE1' ' A' ' 158' ' ' TYR . 40.6 mt -80.15 -25.0 40.01 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.457 -0.777 . . . . 0.0 109.812 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.401 ' HB3' ' HA ' ' A' ' 149' ' ' THR . 14.4 tttp -63.38 -17.42 62.6 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.329 -0.857 . . . . 0.0 109.311 179.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.46 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -120.3 -27.14 2.07 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.626 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 4.0 m-70 -106.38 91.24 5.56 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.191 -1.182 . . . . 0.0 110.285 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.473 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.8 Cg_endo -73.38 2.51 5.6 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.022 1.538 . . . . 0.0 110.82 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -113.17 -9.58 13.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.12 -0.987 . . . . 0.0 109.879 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.589 ' O ' ' CD1' ' A' ' 158' ' ' TYR . . . -47.8 111.08 0.38 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.386 -0.821 . . . . 0.0 110.176 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.651 ' CZ ' ' CB ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 35.13 31.56 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.695 -0.628 . . . . 0.0 110.658 -179.804 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.65 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.576 HG23 ' CE1' ' A' ' 121' ' ' HIS . 93.5 t -128.04 126.57 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -1.161 . . . . 0.0 110.226 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.587 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 38.9 m-85 -87.18 161.36 18.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 0.0 110.415 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 33.8 m -138.63 92.18 2.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.886 . . . . 0.0 110.272 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.587 ' CE2' ' HB3' ' A' ' 3' ' ' PHE . 72.5 m-85 -110.43 126.61 54.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.245 -0.909 . . . . 0.0 109.643 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 116' ' ' SER . 21.2 pt-20 -132.47 152.2 51.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -0.916 . . . . 0.0 110.699 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 61.6 m -129.87 138.86 51.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.367 -0.833 . . . . 0.0 109.581 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -112.99 139.92 48.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.117 -0.989 . . . . 0.0 110.816 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.598 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.8 p90 -155.97 -175.23 5.32 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.431 -0.793 . . . . 0.0 109.511 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.476 HG23 HG12 ' A' ' 113' ' ' ILE . 8.1 p -139.9 174.57 10.38 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.99 -1.069 . . . . 0.0 110.814 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.447 ' CB ' ' CD ' ' A' ' 148' ' ' GLU . 54.1 p -158.59 127.41 5.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.447 -0.783 . . . . 0.0 110.124 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -55.1 -38.24 67.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.231 -0.918 . . . . 0.0 110.036 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.539 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 3.1 mp -59.07 150.36 62.26 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.416 -0.803 . . . . 0.0 110.015 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.539 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 40.9 Cg_endo -66.41 142.29 65.19 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.938 1.493 . . . . 0.0 110.37 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.606 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.0 Cg_endo -72.4 -31.2 11.68 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.874 1.46 . . . . 0.0 112.881 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 44.2 Cg_endo -72.78 -19.85 23.41 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 N-CA-C 109.984 -0.814 . . . . 0.0 109.984 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.537 ' NE ' ' HB2' ' A' ' 159' ' ' ASN . 36.7 ttm180 -83.55 -47.62 11.11 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.505 ' C ' ' CD2' ' A' ' 18' ' ' LEU . 1.1 tt -67.51 -32.42 73.21 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.549 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 57.2 t80 -64.17 -53.99 40.66 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.479 -0.763 . . . . 0.0 109.402 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.482 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 17.8 mttm -49.6 -41.43 42.09 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.801 -0.76 . . . . 0.0 109.326 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.65 ' CB ' ' CZ ' ' A' ' 158' ' ' TYR . . . -76.65 -33.54 58.32 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.398 -0.814 . . . . 0.0 111.04 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.644 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 0.6 OUTLIER -71.49 -49.08 44.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.036 -1.04 . . . . 0.0 111.323 -178.803 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.465 ' HB ' HD13 ' A' ' 24' ' ' LEU . 4.9 t -104.75 -49.25 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.015 -1.053 . . . . 0.0 111.437 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.482 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 7.2 mp -76.99 -5.42 48.61 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.088 -1.007 . . . . 0.0 111.218 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.54 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -157.2 54.98 0.51 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.861 -1.15 . . . . 0.0 110.418 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.458 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -92.04 -10.07 40.47 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.341 -0.849 . . . . 0.0 110.05 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.514 ' O ' ' CG ' ' A' ' 31' ' ' PRO . 41.8 t0 -73.26 -20.32 60.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.326 -0.859 . . . . 0.0 109.919 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -128.46 14.02 6.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.353 -0.842 . . . . 0.0 109.888 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.529 ' HG ' ' CB ' ' A' ' 21' ' ' ALA . 0.4 OUTLIER -98.23 -46.19 5.92 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.363 -0.836 . . . . 0.0 110.321 -179.876 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.657 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.4 m -89.16 -33.35 0.4 Allowed Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.369 -0.832 . . . . 0.0 111.074 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.3 Cg_endo -80.22 7.59 4.62 Favored 'Trans proline' 0 C--N 1.317 -1.097 0 O-C-N 123.06 1.032 . . . . 0.0 110.318 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 51.6 tttt -131.99 -33.24 1.37 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.298 -0.876 . . . . 0.0 109.972 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.563 HD12 ' CG ' ' A' ' 150' ' ' TYR . 11.9 mt -80.02 -43.0 22.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.386 -0.821 . . . . 0.0 109.876 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.2 95.47 3.16 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.298 -0.876 . . . . 0.0 110.233 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -76.92 6.2 4.38 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.125 1.592 . . . . 0.0 110.774 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -89.59 -9.44 49.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.077 -1.014 . . . . 0.0 110.214 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.427 ' C ' HD11 ' A' ' 38' ' ' ILE . . . -104.12 -41.78 5.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 110.23 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.531 HG12 ' CG2' ' A' ' 56' ' ' ILE . 1.4 mp -136.43 121.07 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.429 -0.794 . . . . 0.0 109.88 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 57' ' ' THR . 6.7 ttpp -56.79 -29.94 63.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -0.914 . . . . 0.0 110.249 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.532 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER 173.53 179.38 0.1 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.245 -0.91 . . . . 0.0 110.004 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.524 ' N ' ' CG ' ' A' ' 40' ' ' HIS . 56.3 m -139.97 148.46 41.94 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.234 -0.916 . . . . 0.0 110.245 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.532 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 36.4 tp10 -152.85 111.2 3.69 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.155 -0.965 . . . . 0.0 110.601 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.48 HG22 HD11 ' A' ' 43' ' ' ILE . 29.8 mt -60.51 133.1 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.198 -0.939 . . . . 0.0 109.895 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.525 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 18.2 mt -107.27 -27.06 10.75 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.176 -0.952 . . . . 0.0 110.686 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.571 ' CD2' HD13 ' A' ' 53' ' ' ILE . 1.8 m95 -126.18 161.19 28.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.118 -0.989 . . . . 0.0 110.826 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.461 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 41.95 -133.81 3.86 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.431 ' O ' ' CG ' ' A' ' 47' ' ' ASP . 9.5 t0 -154.67 19.17 0.46 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.309 -1.112 . . . . 0.0 110.011 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.436 ' O ' HG22 ' A' ' 71' ' ' ILE . . . 124.01 -17.29 7.63 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.493 ' O ' ' CG2' ' A' ' 71' ' ' ILE . . . -70.31 -172.55 11.15 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.482 ' HA ' HG23 ' A' ' 71' ' ' ILE . 45.4 Cg_endo -73.62 129.08 13.23 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 O-C-N 124.093 1.575 . . . . 0.0 110.589 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.38 -11.66 56.82 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -71.71 164.75 25.37 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.522 -0.987 . . . . 0.0 109.699 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.571 HD13 ' CD2' ' A' ' 45' ' ' TRP . 47.3 mt -133.35 120.9 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.345 -0.847 . . . . 0.0 109.725 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 28.4 mttm -104.36 131.4 51.75 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.205 -0.935 . . . . 0.0 110.291 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.525 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 73.0 tttt -101.81 93.26 5.22 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.215 -0.928 . . . . 0.0 110.05 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.531 ' CG2' HG12 ' A' ' 38' ' ' ILE . 74.6 mt -80.0 147.34 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.216 -0.927 . . . . 0.0 110.065 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 39' ' ' LYS . 2.2 p -116.69 150.59 37.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.29 -0.881 . . . . 0.0 110.729 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.576 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 22.3 m-85 -113.79 126.84 55.66 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.411 -0.806 . . . . 0.0 110.037 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.43 ' N ' ' HB2' ' A' ' 39' ' ' LYS . . . -91.49 50.39 2.96 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -71.78 -25.1 61.88 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.336 -1.097 . . . . 0.0 110.294 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 173.07 -160.66 31.49 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 63' ' ' GLN . 8.7 t -61.16 -52.12 66.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -1.136 . . . . 0.0 110.205 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 62' ' ' SER . 92.4 mt-30 -42.81 147.61 0.29 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.251 -0.906 . . . . 0.0 110.154 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.86 113.8 23.86 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.24 -0.912 . . . . 0.0 110.175 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.576 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -120.98 94.49 0.55 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.537 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 11.8 p90 -131.17 169.13 16.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -1.182 . . . . 0.0 110.217 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.486 HG13 ' CA ' ' A' ' 88' ' ' GLY . 4.1 m -135.25 177.9 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.233 -0.917 . . . . 0.0 110.345 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.533 ' O ' ' CD1' ' A' ' 85' ' ' LEU . 83.2 mttt -134.91 106.8 7.02 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.377 -0.827 . . . . 0.0 109.872 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.588 ' CD2' HD11 ' A' ' 85' ' ' LEU . 14.5 m170 -98.32 125.78 43.57 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.217 -0.927 . . . . 0.0 111.247 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.577 ' CE ' ' CG2' ' A' ' 86' ' ' ILE . 5.8 mtmp? -93.3 119.13 32.09 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.29 -0.881 . . . . 0.0 109.496 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.524 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 37.8 mm -58.36 128.39 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.128 -0.983 . . . . 0.0 110.519 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 82' ' ' SER . 94.3 m-20 -101.81 -43.82 5.71 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.382 -0.824 . . . . 0.0 109.939 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.498 ' N ' ' OG ' ' A' ' 82' ' ' SER . 22.7 m -169.49 158.89 8.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.407 -0.808 . . . . 0.0 109.736 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.417 HG12 HG12 ' A' ' 23' ' ' VAL . 1.6 mt -142.99 158.27 17.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.175 -0.953 . . . . 0.0 110.465 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 79' ' ' TYR . 4.4 m-20 -134.32 77.81 1.72 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.682 -0.636 . . . . 0.0 109.927 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.549 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 14.7 ttpp -61.14 -16.25 42.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.088 -1.008 . . . . 0.0 110.238 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -93.15 -30.34 15.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.287 -0.883 . . . . 0.0 109.623 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.487 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -106.38 -7.28 17.73 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.481 -0.762 . . . . 0.0 109.958 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.55 ' CZ ' ' HB3' ' A' ' 16' ' ' PRO . 2.7 m-85 67.59 51.19 0.85 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.49 -0.756 . . . . 0.0 110.008 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.532 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -123.41 151.2 42.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.305 -0.872 . . . . 0.0 109.324 179.618 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.684 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 31.1 t80 -137.93 141.07 40.58 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.174 -0.954 . . . . 0.0 110.414 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.498 ' OG ' ' N ' ' A' ' 73' ' ' SER . 1.2 p -143.38 126.48 16.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.243 -0.911 . . . . 0.0 110.56 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.684 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 26.8 p90 -149.17 170.86 17.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.33 -0.856 . . . . 0.0 110.233 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.497 ' CG2' ' O ' ' A' ' 98' ' ' ILE . 40.7 m -127.05 150.51 49.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.308 -0.87 . . . . 0.0 109.88 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.588 HD11 ' CD2' ' A' ' 69' ' ' HIS . 8.0 tp -111.42 124.79 52.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.0 -1.063 . . . . 0.0 110.354 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.577 ' CG2' ' CE ' ' A' ' 70' ' ' LYS . 14.4 pt -105.21 -27.08 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.382 -0.824 . . . . 0.0 110.23 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.458 ' OE1' ' HE3' ' A' ' 68' ' ' LYS . 81.7 tt0 -123.38 155.73 36.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -0.86 . . . . 0.0 110.227 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.486 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 162.26 137.99 2.32 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -65.07 -19.21 65.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.22 -1.164 . . . . 0.0 110.16 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.93 -17.8 45.83 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.288 -0.882 . . . . 0.0 110.278 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.589 ' CD2' ' CD1' ' A' ' 98' ' ' ILE . 14.1 mt -61.38 -29.02 69.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.269 -0.894 . . . . 0.0 110.03 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 47.27 -175.61 0.01 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 54.6 p30 -83.85 6.76 20.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.192 -1.181 . . . . 0.0 109.773 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 50.0 p -98.93 -42.42 7.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.366 -0.834 . . . . 0.0 110.225 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.553 ' CD2' ' CG2' ' A' ' 122' ' ' THR . 74.6 mt -100.44 161.67 13.45 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.39 -0.819 . . . . 0.0 110.137 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -142.46 -81.27 0.21 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.307 -0.871 . . . . 0.0 109.609 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.493 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 7.8 mtpp -80.2 143.74 33.54 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.688 -0.632 . . . . 0.0 110.352 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.589 ' CD1' ' CD2' ' A' ' 91' ' ' LEU . 0.6 OUTLIER -138.06 134.86 45.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.049 -1.032 . . . . 0.0 109.489 179.092 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.494 ' CB ' ' HB2' ' A' ' 119' ' ' HIS . 0.1 OUTLIER -109.9 141.06 43.16 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.467 -0.771 . . . . 0.0 109.875 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 2.8 m-85 -127.8 143.16 51.14 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.319 -0.863 . . . . 0.0 110.341 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.46 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 68.2 tt0 -149.79 119.43 6.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.317 -0.864 . . . . 0.0 110.193 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 64.4 m -119.66 150.76 39.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.166 -0.959 . . . . 0.0 109.923 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 115' ' ' LYS . 20.8 mttt -142.65 133.71 25.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.237 -0.915 . . . . 0.0 110.515 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.529 ' CD2' HG12 ' A' ' 114' ' ' ILE . 5.4 mt -116.74 147.35 42.11 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.193 -0.942 . . . . 0.0 109.799 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.483 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -150.69 -168.75 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.195 -0.941 . . . . 0.0 110.107 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -112.75 156.15 23.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.356 -0.84 . . . . 0.0 109.973 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.46 ' HA ' HD13 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -114.42 170.21 5.71 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.257 -0.902 . . . . 0.0 110.36 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -76.04 0.77 8.95 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.069 1.563 . . . . 0.0 110.471 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 59.0 p -109.9 8.96 24.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.236 -0.915 . . . . 0.0 110.268 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 93.41 -26.39 15.91 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.428 ' C ' ' OG ' ' A' ' 107' ' ' SER . . . -70.24 -172.41 10.81 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.523 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 5.2 p -124.78 127.2 46.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.124 -1.221 . . . . 0.0 110.428 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.476 HG12 HG23 ' A' ' 10' ' ' THR . 73.9 mt -79.9 148.28 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.303 -0.873 . . . . 0.0 110.199 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.591 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 18.0 mt -132.45 127.48 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.188 -0.945 . . . . 0.0 110.563 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 103' ' ' LYS . 38.1 tttp -118.08 118.59 32.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.255 -0.903 . . . . 0.0 109.797 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.1 t -113.9 155.17 26.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.114 -0.991 . . . . 0.0 110.656 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 78.6 m -149.87 133.37 16.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.365 -0.834 . . . . 0.0 110.192 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 28.0 p -126.47 142.99 51.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.237 -0.914 . . . . 0.0 110.238 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.494 ' HB2' ' CB ' ' A' ' 99' ' ' SER . 85.5 m-70 -122.67 157.37 32.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.152 -0.967 . . . . 0.0 110.436 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.514 ' CD2' HG13 ' A' ' 128' ' ' ILE . 28.5 m-85 -128.32 137.34 51.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.248 -0.908 . . . . 0.0 110.354 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.576 ' CE1' HG23 ' A' ' 2' ' ' VAL . 47.4 m-70 -117.71 88.79 2.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.095 -1.003 . . . . 0.0 109.491 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.553 ' CG2' ' CD2' ' A' ' 95' ' ' LEU . 1.1 p -72.92 160.16 32.57 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.46 -0.775 . . . . 0.0 110.411 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 15.5 tttt -113.9 111.85 22.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.372 -0.83 . . . . 0.0 110.214 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 113.64 -133.87 11.49 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -123.5 64.33 1.02 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.217 -1.166 . . . . 0.0 110.255 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.446 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 24.2 m -130.73 162.52 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.258 -0.901 . . . . 0.0 110.142 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.414 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 93.0 mt-10 -134.67 161.62 34.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 0.0 110.307 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.524 ' CD1' HD22 ' A' ' 95' ' ' LEU . 20.6 mm -67.29 173.12 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 0.0 110.056 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.472 ' O ' ' N ' ' A' ' 132' ' ' HIS . 12.5 mttt -111.75 132.8 54.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.0 110.029 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.458 ' HA ' ' OE1' ' A' ' 130' ' ' GLU . 69.4 mm-40 -44.61 -35.16 2.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.195 -0.941 . . . . 0.0 110.133 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.432 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 50.1 tt0 -67.81 -23.81 65.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 109.967 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.472 ' N ' ' O ' ' A' ' 129' ' ' LYS . 16.4 t-160 -83.16 -49.33 9.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.297 -0.877 . . . . 0.0 110.217 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.571 HG13 ' CD1' ' A' ' 5' ' ' TYR . 98.8 t -59.61 -34.29 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.388 -0.82 . . . . 0.0 110.076 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -73.87 -51.14 17.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.893 . . . . 0.0 110.037 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.442 ' O ' ' HG3' ' A' ' 139' ' ' LYS . . . -59.29 -32.95 70.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.251 -0.905 . . . . 0.0 110.016 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.34 -27.93 73.11 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 81.0 mttt -78.9 -31.71 45.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.246 -1.15 . . . . 0.0 110.125 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -88.72 -30.03 19.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 0.0 109.92 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 135' ' ' ALA . 25.9 mttm -72.17 -31.11 65.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.349 -0.845 . . . . 0.0 109.94 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -86.64 -41.64 14.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.258 -0.901 . . . . 0.0 109.961 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 36.0 t -53.22 -43.25 67.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.338 -0.851 . . . . 0.0 110.088 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -57.38 -42.87 83.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -0.847 . . . . 0.0 110.005 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.408 HD23 ' CB ' ' A' ' 37' ' ' ALA . 52.7 mt -63.9 -37.75 88.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -0.914 . . . . 0.0 109.941 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -63.14 -35.15 79.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.433 -0.792 . . . . 0.0 109.857 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -75.15 -10.68 59.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.289 -0.882 . . . . 0.0 110.278 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.528 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 24.0 mt -85.18 -36.67 20.87 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.11 -0.994 . . . . 0.0 109.099 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.644 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 32.3 mt -71.2 -44.12 74.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.472 ' O ' HG12 ' A' ' 13' ' ' ILE . 85.2 mt-10 -58.08 -42.22 85.14 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.446 -0.784 . . . . 0.0 109.614 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 28.2 m -70.19 -39.97 74.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.191 -0.943 . . . . 0.0 109.54 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.573 ' CE2' ' HB1' ' A' ' 157' ' ' ALA . 93.1 t80 -49.37 -42.44 42.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.437 -0.789 . . . . 0.0 109.995 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.592 HD22 ' CE2' ' A' ' 158' ' ' TYR . 42.6 mt -80.16 -44.72 19.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.322 -0.862 . . . . 0.0 110.33 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.455 ' HB2' HD12 ' A' ' 13' ' ' ILE . 29.9 tttt -61.03 -14.45 23.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.337 -0.852 . . . . 0.0 109.629 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -113.31 -30.05 2.8 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.56 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 8.0 m-70 -112.64 96.09 35.35 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.357 -1.084 . . . . 0.0 110.025 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.48 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.9 Cg_endo -73.78 7.68 2.28 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.155 1.608 . . . . 0.0 111.279 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 157' ' ' ALA . 39.3 p30 -109.84 -9.56 14.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.952 -1.093 . . . . 0.0 109.582 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.573 ' HB1' ' CE2' ' A' ' 150' ' ' TYR . . . -66.01 101.14 0.65 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.548 -0.72 . . . . 0.0 110.182 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.65 ' CZ ' ' CB ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER 35.05 32.63 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.218 0 CA-C-O 121.406 0.622 . . . . 0.0 110.164 -179.602 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.537 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.305 -1.365 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.935 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.585 HG22 ' CG ' ' A' ' 121' ' ' HIS . 3.4 p -88.11 148.13 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.332 -1.099 . . . . 0.0 110.538 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.519 ' N ' HG21 ' A' ' 2' ' ' VAL . 18.2 m-85 -83.95 172.25 12.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.403 -0.811 . . . . 0.0 110.118 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.549 HG21 ' CE1' ' A' ' 119' ' ' HIS . 92.8 m -141.1 124.83 16.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.289 -0.882 . . . . 0.0 110.46 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.556 ' CZ ' HG12 ' A' ' 133' ' ' VAL . 74.4 m-85 -126.04 144.63 50.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.321 -0.862 . . . . 0.0 109.932 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 20.5 pt-20 -139.34 149.54 44.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.208 -0.932 . . . . 0.0 110.581 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -135.44 144.54 46.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.453 -0.779 . . . . 0.0 109.595 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -130.33 119.48 22.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.113 -0.992 . . . . 0.0 110.634 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.641 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.0 p90 -144.61 -177.89 5.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.393 -0.817 . . . . 0.0 109.793 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.516 ' CG2' ' HA ' ' A' ' 113' ' ' ILE . 9.4 p -141.9 171.89 13.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.175 -0.953 . . . . 0.0 110.678 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -152.36 154.99 36.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.46 -0.775 . . . . 0.0 110.247 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -77.01 -27.88 54.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.293 -0.88 . . . . 0.0 109.928 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.525 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 1.8 mp -71.39 150.54 94.07 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.351 -0.843 . . . . 0.0 109.849 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.538 ' HG2' ' CG ' ' A' ' 17' ' ' ARG . 41.0 Cg_endo -66.43 141.49 61.82 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.99 1.521 . . . . 0.0 110.498 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.607 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 41.2 Cg_endo -73.64 -30.21 9.94 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 124.068 1.562 . . . . 0.0 113.125 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 44.6 Cg_endo -71.56 -28.3 17.69 Favored 'Trans proline' 0 C--N 1.318 -1.034 0 N-CA-C 110.288 -0.697 . . . . 0.0 110.288 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.538 ' CG ' ' HG2' ' A' ' 14' ' ' PRO . 6.3 mtp180 -79.92 -42.91 23.12 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.526 ' HG ' ' CG2' ' A' ' 147' ' ' ILE . 0.4 OUTLIER -66.51 -30.07 70.32 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.575 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.58 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 52.0 t80 -63.83 -51.99 62.16 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.51 0.671 . . . . 0.0 109.851 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.468 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 22.9 mttt -55.94 -40.04 72.59 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.525 -0.734 . . . . 0.0 109.94 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.604 ' CB ' ' CE1' ' A' ' 158' ' ' TYR . . . -77.86 -26.8 49.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.263 -0.898 . . . . 0.0 110.946 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.572 ' CD1' HD11 ' A' ' 147' ' ' ILE . 3.4 t80 -81.8 -49.12 10.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.095 -1.003 . . . . 0.0 111.579 -178.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.561 HG11 ' CE1' ' A' ' 81' ' ' TYR . 5.5 t -102.03 -53.71 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.098 -1.001 . . . . 0.0 111.462 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.468 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 7.6 mp -66.0 -8.7 24.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.137 -0.977 . . . . 0.0 111.016 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.564 ' OD2' ' CE2' ' A' ' 158' ' ' TYR . 2.7 m-20 -145.0 21.79 1.58 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.963 -1.086 . . . . 0.0 110.524 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -59.73 -14.85 16.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.201 -0.937 . . . . 0.0 110.414 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -80.08 -25.03 40.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -0.914 . . . . 0.0 110.483 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.461 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 6.9 p30 -126.8 14.39 7.46 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.128 -0.982 . . . . 0.0 110.606 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.577 HD23 ' CE1' ' A' ' 150' ' ' TYR . 1.2 tm? -100.71 -43.09 6.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.239 -0.913 . . . . 0.0 109.858 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.606 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 4.8 t -77.41 -40.81 2.26 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.464 -0.772 . . . . 0.0 111.193 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 47.6 Cg_endo -77.6 10.65 2.45 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.444 1.234 . . . . 0.0 111.051 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 28' ' ' ASN . 16.6 mttm -122.27 -30.74 3.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.985 -1.072 . . . . 0.0 109.496 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.565 HD13 ' CD1' ' A' ' 150' ' ' TYR . 7.5 mt -80.13 -55.48 8.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.579 -0.701 . . . . 0.0 109.821 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.51 103.96 5.02 Favored Pre-proline 0 C--N 1.304 -1.409 0 O-C-N 121.404 -0.81 . . . . 0.0 110.238 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.33 0.34 7.54 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.015 1.534 . . . . 0.0 110.526 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -81.62 -20.59 39.42 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.116 -0.99 . . . . 0.0 109.475 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -91.5 -42.32 10.33 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.467 -0.771 . . . . 0.0 109.927 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.531 HG12 ' CG2' ' A' ' 56' ' ' ILE . 1.1 mp -137.7 140.1 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.43 -0.794 . . . . 0.0 109.944 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.3 ttmm -82.25 -36.37 27.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 110.208 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.544 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -176.44 154.98 1.36 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.262 -0.898 . . . . 0.0 110.192 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.5 m -124.2 116.8 23.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.287 -0.883 . . . . 0.0 109.975 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.538 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 35.8 tp10 -122.79 113.27 18.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.193 -0.942 . . . . 0.0 110.449 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.524 HG22 HD11 ' A' ' 43' ' ' ILE . 23.2 mt -60.67 133.94 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.322 -0.861 . . . . 0.0 109.98 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.516 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 26.7 mt -106.97 -23.5 12.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.247 -0.908 . . . . 0.0 110.517 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.568 ' CD1' HD13 ' A' ' 53' ' ' ILE . 1.6 m95 -130.94 161.25 32.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.127 -0.983 . . . . 0.0 110.559 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.466 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 41.98 -133.56 3.95 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -157.7 20.65 0.27 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -1.104 . . . . 0.0 110.059 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.46 ' O ' HG22 ' A' ' 71' ' ' ILE . . . 125.49 -19.92 6.61 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.47 ' O ' HG22 ' A' ' 71' ' ' ILE . . . -67.79 -175.21 8.48 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.465 ' HA ' HG23 ' A' ' 71' ' ' ILE . 47.1 Cg_endo -73.92 129.54 13.47 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 123.932 1.49 . . . . 0.0 110.66 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.94 -13.99 52.66 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.466 ' OG1' ' HA2' ' A' ' 46' ' ' GLY . 1.0 OUTLIER -68.0 166.38 15.95 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.516 -0.991 . . . . 0.0 109.907 179.751 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.568 HD13 ' CD1' ' A' ' 45' ' ' TRP . 40.7 mt -133.27 121.68 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.315 -0.865 . . . . 0.0 109.662 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.471 ' HG2' HG12 ' A' ' 43' ' ' ILE . 20.7 mttm -111.15 132.29 54.41 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.144 -0.973 . . . . 0.0 110.411 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.516 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 17.7 tttt -101.36 89.93 3.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 109.904 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.531 ' CG2' HG12 ' A' ' 38' ' ' ILE . 83.0 mt -79.98 144.4 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.296 -0.877 . . . . 0.0 110.168 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 4.8 p -117.31 159.11 23.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.295 -0.878 . . . . 0.0 110.603 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.513 ' N ' ' O ' ' A' ' 65' ' ' GLY . 22.5 m-85 -119.61 149.54 41.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.381 -0.824 . . . . 0.0 110.076 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -111.91 30.69 7.55 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -48.74 -26.55 2.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.305 -1.115 . . . . 0.0 110.274 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 171.94 -160.85 32.68 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.6 m -63.05 -41.01 99.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.263 -1.139 . . . . 0.0 110.224 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -49.94 149.5 2.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.168 -0.957 . . . . 0.0 110.09 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -85.1 123.15 30.29 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.2 -0.938 . . . . 0.0 110.342 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -134.1 91.61 0.25 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.538 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 15.2 p90 -129.92 166.7 19.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.137 -1.213 . . . . 0.0 110.276 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.525 HG13 ' CA ' ' A' ' 88' ' ' GLY . 6.4 m -142.92 172.27 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 110.696 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.523 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 23.3 mttm -125.19 124.48 41.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.621 -0.675 . . . . 0.0 109.543 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.53 ' CD2' HD11 ' A' ' 85' ' ' LEU . 11.3 m170 -113.41 126.1 54.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.143 -0.973 . . . . 0.0 111.157 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.478 ' HE3' ' CD1' ' A' ' 86' ' ' ILE . 48.3 mttt -97.82 117.15 31.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.373 -0.829 . . . . 0.0 109.509 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.522 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 22.4 mm -60.07 128.64 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.082 -1.011 . . . . 0.0 110.311 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 82' ' ' SER . 89.4 m-20 -102.5 -45.34 5.09 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.314 -0.867 . . . . 0.0 110.179 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 19.1 m -168.08 159.07 10.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.385 -0.822 . . . . 0.0 110.094 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.456 HG12 HG12 ' A' ' 23' ' ' VAL . 2.0 mt -141.26 158.79 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.292 -0.88 . . . . 0.0 110.118 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 79' ' ' TYR . 4.5 m-20 -135.37 80.02 1.81 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.502 -0.749 . . . . 0.0 110.116 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.58 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 17.8 mttt -62.39 -18.16 60.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.135 -0.978 . . . . 0.0 110.4 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -91.91 -31.79 15.53 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.133 -0.979 . . . . 0.0 109.633 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.489 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -103.58 -6.63 21.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.591 -0.693 . . . . 0.0 109.799 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.569 ' CZ ' ' HB3' ' A' ' 16' ' ' PRO . 4.1 m-85 65.91 51.8 1.32 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.494 -0.754 . . . . 0.0 110.056 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.531 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -123.38 157.9 32.33 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.081 -1.012 . . . . 0.0 109.595 179.812 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.688 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 32.3 t80 -144.56 141.01 29.16 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.196 -0.94 . . . . 0.0 110.259 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.6 OUTLIER -145.89 127.02 14.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.208 -0.932 . . . . 0.0 110.929 -179.799 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.688 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 20.0 p90 -146.6 170.67 16.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.436 -0.79 . . . . 0.0 109.796 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.457 ' OG1' ' OD2' ' A' ' 72' ' ' ASP . 35.2 m -124.44 135.43 53.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.159 -0.963 . . . . 0.0 110.427 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.558 ' HB3' ' CG2' ' A' ' 98' ' ' ILE . 6.3 tp -99.49 124.35 44.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.283 -0.886 . . . . 0.0 109.702 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.478 ' CD1' ' HE3' ' A' ' 70' ' ' LYS . 14.3 pt -106.41 -15.77 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.387 -0.821 . . . . 0.0 110.459 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.523 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 24.9 tt0 -121.3 176.11 5.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.147 -0.97 . . . . 0.0 110.339 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.525 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 137.09 123.58 2.24 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -57.78 -15.37 7.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -1.142 . . . . 0.0 110.205 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.504 ' HB3' ' NE2' ' A' ' 132' ' ' HIS . . . -73.92 -40.48 63.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -0.88 . . . . 0.0 110.167 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.562 ' CD2' ' CD2' ' A' ' 95' ' ' LEU . 10.1 mt -42.17 -48.05 4.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.406 -0.809 . . . . 0.0 110.119 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 43.23 -164.72 0.03 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -81.19 2.57 27.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -1.142 . . . . 0.0 110.172 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 52.2 p -92.62 -42.51 9.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.287 -0.883 . . . . 0.0 110.17 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.577 HD21 ' CD2' ' A' ' 120' ' ' TYR . 0.2 OUTLIER -119.55 159.91 23.43 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.367 -0.833 . . . . 0.0 109.339 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.458 ' HG2' ' N ' ' A' ' 97' ' ' LYS . 53.9 tt0 -136.32 -82.02 0.39 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.344 -0.848 . . . . 0.0 110.178 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 5.3 mttt -80.24 139.36 36.73 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.768 -0.583 . . . . 0.0 110.558 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.605 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 3.6 mm -123.06 139.97 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.963 -1.086 . . . . 0.0 109.887 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.479 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -117.48 126.77 53.19 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.279 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.605 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 8.7 m-85 -119.56 137.63 53.72 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.237 -0.914 . . . . 0.0 110.722 -178.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.453 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 80.9 tt0 -143.2 134.57 26.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.353 -0.842 . . . . 0.0 110.143 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.401 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 85.6 m -133.77 145.11 49.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -0.917 . . . . 0.0 110.18 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.6 mttt -140.53 140.72 35.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 0.0 110.671 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.517 ' CD2' HG12 ' A' ' 114' ' ' ILE . 10.1 mt -121.05 149.57 42.51 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.236 -0.915 . . . . 0.0 110.142 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.466 ' O ' ' HG3' ' A' ' 15' ' ' PRO . 1.9 t -146.05 -169.71 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.207 -0.933 . . . . 0.0 110.03 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -126.68 160.56 30.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.256 -0.902 . . . . 0.0 110.275 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.426 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.2 p -119.32 170.55 6.54 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.225 -0.922 . . . . 0.0 110.144 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.426 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 45.7 Cg_endo -72.8 -14.8 26.89 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 124.11 1.584 . . . . 0.0 110.575 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 24.8 p -94.7 7.15 46.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -0.903 . . . . 0.0 110.273 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 94.46 -31.16 6.99 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -58.26 -172.41 0.34 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.513 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 10.4 p -137.25 137.63 39.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.194 -1.18 . . . . 0.0 110.39 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.516 ' HA ' ' CG2' ' A' ' 10' ' ' THR . 16.2 mt -92.58 149.59 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.402 -0.811 . . . . 0.0 110.088 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.578 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 18.5 mt -131.23 128.63 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.22 -0.925 . . . . 0.0 110.228 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.1 tttp -118.11 108.73 15.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.084 -1.01 . . . . 0.0 110.209 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.434 ' OG ' ' CZ ' ' A' ' 9' ' ' PHE . 0.9 OUTLIER -103.25 157.33 17.08 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.238 -0.914 . . . . 0.0 110.441 -179.854 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 24.8 m -154.87 119.56 4.83 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.337 -0.852 . . . . 0.0 110.438 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 86.5 p -119.01 148.1 43.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.403 -0.811 . . . . 0.0 110.041 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.549 ' CE1' HG21 ' A' ' 4' ' ' THR . 24.6 m-70 -132.42 152.93 51.29 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.201 -0.937 . . . . 0.0 110.668 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.577 ' CD2' HD21 ' A' ' 95' ' ' LEU . 9.8 m-85 -121.82 119.92 33.05 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.271 -0.893 . . . . 0.0 110.614 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.585 ' CG ' HG22 ' A' ' 2' ' ' VAL . 80.4 m-70 -92.62 104.1 16.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.558 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.433 HG22 ' HA ' ' A' ' 127' ' ' GLU . 0.8 OUTLIER -77.96 144.75 36.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.141 -0.975 . . . . 0.0 110.374 -179.593 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.423 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 31.5 tttp -105.57 126.93 52.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.278 -0.889 . . . . 0.0 110.207 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.37 -138.92 21.14 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.415 ' C ' HG11 ' A' ' 126' ' ' VAL . 24.4 t30 -113.87 59.64 0.67 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -1.142 . . . . 0.0 110.274 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.415 HG11 ' C ' ' A' ' 125' ' ' ASN . 26.2 m -131.28 161.7 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.319 -0.863 . . . . 0.0 110.194 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.433 ' HA ' HG22 ' A' ' 122' ' ' THR . 85.3 mt-10 -137.6 139.7 40.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.266 -0.896 . . . . 0.0 110.25 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.529 ' CD1' ' HB3' ' A' ' 120' ' ' TYR . 2.7 mp -59.77 173.25 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.191 -0.943 . . . . 0.0 110.148 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.45 ' N ' ' CG2' ' A' ' 128' ' ' ILE . 21.4 mttm -92.45 127.41 37.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 110.089 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -45.39 -44.72 12.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.149 -0.969 . . . . 0.0 110.136 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 29.0 tp10 -53.29 -30.26 37.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.194 -0.941 . . . . 0.0 110.04 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.504 ' NE2' ' HB3' ' A' ' 90' ' ' ALA . 11.1 t-160 -76.35 -57.82 3.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -0.932 . . . . 0.0 110.239 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.556 HG12 ' CZ ' ' A' ' 5' ' ' TYR . 72.3 t -59.19 -34.22 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.377 -0.827 . . . . 0.0 110.063 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -72.41 -49.1 36.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.332 -0.855 . . . . 0.0 110.111 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.87 -29.66 69.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.095 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.72 -32.08 80.29 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 17.3 mttp -65.04 -36.84 85.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.251 -1.146 . . . . 0.0 110.036 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -75.35 -35.44 61.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.307 -0.87 . . . . 0.0 110.041 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -70.12 -30.84 68.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.363 -0.836 . . . . 0.0 109.92 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.482 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -74.61 -41.28 60.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.287 -0.883 . . . . 0.0 110.134 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 61.3 p -64.68 -39.36 93.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.371 -0.831 . . . . 0.0 109.991 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -60.87 -48.11 83.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 110.004 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 27.6 mt -57.87 -38.54 75.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.271 -0.893 . . . . 0.0 109.957 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.482 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 19.7 m-85 -62.87 -33.79 76.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.448 -0.783 . . . . 0.0 109.905 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.406 ' HA ' ' OE1' ' A' ' 148' ' ' GLU . 92.8 mttt -74.85 -15.03 60.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -0.904 . . . . 0.0 110.202 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.52 HD21 ' CG2' ' A' ' 33' ' ' ILE . 28.2 mt -85.25 -36.69 20.76 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.222 -0.923 . . . . 0.0 109.043 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.572 HD11 ' CD1' ' A' ' 22' ' ' PHE . 16.1 mt -72.09 -41.41 67.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.478 ' HB3' HD12 ' A' ' 13' ' ' ILE . 86.5 mt-10 -59.13 -42.81 91.5 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.431 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 15.5 m -74.12 -27.96 61.11 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.601 ' CE2' ' OH ' ' A' ' 158' ' ' TYR . 50.2 t80 -52.07 -61.85 2.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.563 -0.71 . . . . 0.0 109.836 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.49 HD11 ' CB ' ' A' ' 17' ' ' ARG . 36.0 mt -72.24 -30.08 64.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.346 -0.846 . . . . 0.0 109.71 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.469 ' HB2' HD13 ' A' ' 13' ' ' ILE . 27.8 tttp -65.27 -33.84 76.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.343 -0.848 . . . . 0.0 109.253 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.455 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -99.0 -30.74 6.56 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.59 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 5.4 m-70 -107.26 87.2 3.02 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.327 -1.101 . . . . 0.0 109.796 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 46.1 Cg_endo -72.08 2.62 4.71 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.068 1.562 . . . . 0.0 110.955 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -108.24 -12.61 15.05 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.96 -1.087 . . . . 0.0 110.197 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.593 ' O ' ' CD1' ' A' ' 158' ' ' TYR . . . -69.2 99.71 1.19 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.253 -0.905 . . . . 0.0 109.846 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.604 ' CE1' ' CB ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER 34.77 32.33 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 CA-C-O 121.518 0.675 . . . . 0.0 109.871 -179.21 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.533 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.446 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.826 -179.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 40.4 t -126.85 139.95 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -1.135 . . . . 0.0 110.239 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.633 ' CD1' ' CD1' ' A' ' 128' ' ' ILE . 16.2 m-85 -101.94 160.6 14.35 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.213 -0.93 . . . . 0.0 109.728 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.426 HG21 ' CE1' ' A' ' 119' ' ' HIS . 5.1 m -124.42 108.32 12.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.118 -0.989 . . . . 0.0 110.508 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.576 ' CE1' HG13 ' A' ' 133' ' ' VAL . 25.3 m-85 -120.47 126.18 49.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.26 -0.9 . . . . 0.0 109.969 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 25.8 pt-20 -139.37 159.66 41.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.924 . . . . 0.0 110.394 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.2 t -138.65 148.93 44.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.862 . . . . 0.0 110.012 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -131.81 123.28 27.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.195 -0.941 . . . . 0.0 110.257 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.638 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.0 p90 -145.94 -174.07 4.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.194 -0.941 . . . . 0.0 109.952 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.448 HG23 ' HA ' ' A' ' 113' ' ' ILE . 8.7 p -139.28 175.52 9.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.134 -0.979 . . . . 0.0 110.496 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.477 ' CB ' ' CD ' ' A' ' 148' ' ' GLU . 79.8 p -158.08 139.4 13.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.306 -0.871 . . . . 0.0 110.229 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -64.74 -28.71 69.77 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 0.0 109.888 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.548 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 8.3 mm -68.96 149.88 97.74 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.365 -0.835 . . . . 0.0 109.904 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.548 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 40.5 Cg_endo -65.6 146.47 84.57 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.971 1.511 . . . . 0.0 110.44 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.638 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.1 Cg_endo -71.51 -31.73 13.26 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.969 1.51 . . . . 0.0 112.828 -179.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 40.8 Cg_endo -69.41 -21.38 35.2 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 N-CA-C 110.059 -0.785 . . . . 0.0 110.059 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.565 ' NE ' ' CB ' ' A' ' 159' ' ' ASN . 52.7 mtp180 -85.68 -44.87 12.2 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.534 ' HG ' ' CG2' ' A' ' 147' ' ' ILE . 1.1 tt -71.34 -30.07 65.74 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.61 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 71.4 t80 -66.88 -61.76 1.78 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.521 -0.737 . . . . 0.0 109.13 178.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.516 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 52.6 mttt -52.78 -34.33 52.84 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.338 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.598 ' HB3' ' CZ ' ' A' ' 158' ' ' TYR . . . -72.21 -53.75 11.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.33 -0.856 . . . . 0.0 110.749 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.583 ' CD1' HD12 ' A' ' 147' ' ' ILE . 0.3 OUTLIER -59.86 -53.2 60.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.507 -0.745 . . . . 0.0 111.425 -178.897 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.599 HG12 ' CD1' ' A' ' 81' ' ' TYR . 11.1 t -91.26 -63.86 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.992 -1.068 . . . . 0.0 111.767 -178.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.516 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 4.7 mp -65.12 -3.57 3.9 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.22 -0.925 . . . . 0.0 111.793 -178.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.52 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.8 OUTLIER -140.46 9.54 2.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.658 -1.276 . . . . 0.0 110.788 179.882 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -51.57 -26.83 9.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.176 -0.953 . . . . 0.0 110.31 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -76.63 -13.95 60.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.947 . . . . 0.0 110.502 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.438 ' O ' ' HD2' ' A' ' 32' ' ' LYS . 72.0 m-80 -134.97 10.64 3.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.211 -0.93 . . . . 0.0 110.345 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.2 OUTLIER -104.24 -40.97 5.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.185 -0.947 . . . . 0.0 110.38 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.592 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 2.8 t -81.08 -41.55 1.13 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.28 -0.888 . . . . 0.0 111.178 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.3 Cg_endo -77.17 11.17 2.14 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.387 1.204 . . . . 0.0 111.074 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.438 ' HD2' ' O ' ' A' ' 28' ' ' ASN . 17.1 mttm -123.25 -31.51 3.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.943 -1.098 . . . . 0.0 109.471 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.479 ' CG2' ' CD2' ' A' ' 146' ' ' LEU . 9.3 mt -80.12 -44.96 22.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.52 -0.737 . . . . 0.0 109.611 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -141.07 99.11 6.66 Favored Pre-proline 0 C--N 1.304 -1.39 0 O-C-N 121.371 -0.831 . . . . 0.0 110.115 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.12 -2.82 11.71 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.951 1.501 . . . . 0.0 110.524 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.447 ' O ' ' HG3' ' A' ' 60' ' ' GLU . 13.5 pt20 -89.02 -23.15 22.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 109.949 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 58' ' ' PHE . . . -85.54 -70.39 0.59 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.323 -0.86 . . . . 0.0 110.06 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.52 ' CD1' HG13 ' A' ' 30' ' ' VAL . 1.8 mp -101.11 122.08 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.449 -0.782 . . . . 0.0 110.01 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.476 ' N ' ' O ' ' A' ' 57' ' ' THR . 10.7 ttmt -75.2 -32.11 61.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.154 -0.966 . . . . 0.0 110.487 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.53 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -176.25 148.41 0.78 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.162 -0.961 . . . . 0.0 110.171 -179.882 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.3 m -122.31 118.43 28.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.35 -0.844 . . . . 0.0 109.718 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.501 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 42.4 tt0 -129.18 110.37 11.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.149 -0.969 . . . . 0.0 110.422 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.416 HD11 HG22 ' A' ' 43' ' ' ILE . 38.3 mt -53.06 144.91 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.372 -0.83 . . . . 0.0 110.046 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.0 tp -119.72 -25.13 5.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.237 -0.914 . . . . 0.0 110.544 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.491 ' HB2' ' N ' ' A' ' 53' ' ' ILE . 1.7 m95 -127.81 162.97 25.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.113 -0.992 . . . . 0.0 110.646 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.46 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 42.56 -140.3 2.21 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -149.2 24.79 0.91 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.285 -1.126 . . . . 0.0 110.017 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 118.4 -12.19 12.51 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.517 ' O ' ' CG2' ' A' ' 71' ' ' ILE . . . -81.97 -168.95 42.27 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.493 ' HA ' HG23 ' A' ' 71' ' ' ILE . 44.2 Cg_endo -72.54 128.28 13.37 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.042 1.548 . . . . 0.0 110.694 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.88 -12.45 49.66 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.1 m -72.85 162.28 29.68 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.616 -0.931 . . . . 0.0 109.47 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.491 ' N ' ' HB2' ' A' ' 45' ' ' TRP . 66.1 mt -133.84 119.4 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.235 -0.916 . . . . 0.0 110.103 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.505 ' HE3' ' CD1' ' A' ' 71' ' ' ILE . 52.5 mttt -102.59 130.72 49.55 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.2 -0.938 . . . . 0.0 110.179 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 53.6 tttm -102.24 92.42 4.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.242 -0.911 . . . . 0.0 110.164 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.407 ' HB ' HG22 ' A' ' 67' ' ' VAL . 97.5 mt -80.45 140.61 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.142 -0.974 . . . . 0.0 110.394 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 1.4 p -110.16 150.94 27.91 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.351 -0.843 . . . . 0.0 110.267 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.571 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 24.7 m-85 -113.83 149.08 35.53 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.221 -0.924 . . . . 0.0 110.077 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -101.79 6.95 54.98 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 36' ' ' GLN . 97.4 mt-10 -119.91 155.35 32.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -1.151 . . . . 0.0 110.225 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.91 -153.41 21.17 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 84.5 p -56.34 -172.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.2 -1.176 . . . . 0.0 110.25 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -73.66 -27.94 61.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.907 . . . . 0.0 110.204 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -120.53 101.59 7.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.289 -0.882 . . . . 0.0 110.228 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.571 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -130.26 88.69 0.3 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 13.7 p90 -133.77 166.68 22.07 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.192 -1.181 . . . . 0.0 110.292 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.5 HG13 ' CA ' ' A' ' 88' ' ' GLY . 4.4 m -133.93 175.74 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.384 -0.823 . . . . 0.0 110.253 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.516 ' CE ' ' OE1' ' A' ' 87' ' ' GLU . 33.3 mttt -135.52 103.96 5.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.426 -0.797 . . . . 0.0 109.834 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.485 ' CD2' HD11 ' A' ' 85' ' ' LEU . 15.4 m170 -94.19 129.18 40.9 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.292 -0.88 . . . . 0.0 111.073 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 52' ' ' THR . 70.0 tttt -97.21 111.55 23.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.458 -0.776 . . . . 0.0 109.18 178.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.53 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 27.3 mm -52.91 125.61 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.093 -1.005 . . . . 0.0 110.354 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.473 ' OD2' ' OG1' ' A' ' 84' ' ' THR . 95.0 m-20 -99.37 -48.6 4.74 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.374 -0.829 . . . . 0.0 109.666 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 1.4 m 177.8 160.68 0.51 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.544 -0.722 . . . . 0.0 110.054 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.549 ' CD1' HG12 ' A' ' 23' ' ' VAL . 3.2 tt -145.31 165.92 10.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.392 -0.817 . . . . 0.0 109.785 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.8 m-20 -128.95 76.89 1.75 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.099 -1.0 . . . . 0.0 110.132 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.61 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 65.3 mttm -55.43 -16.66 3.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.16 -0.962 . . . . 0.0 110.367 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -92.8 -30.67 15.35 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.348 -0.845 . . . . 0.0 109.705 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.518 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.2 m-80 -106.61 -0.13 24.01 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.561 -0.712 . . . . 0.0 109.475 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.597 ' CE1' ' HB3' ' A' ' 16' ' ' PRO . 72.8 m-85 62.06 52.84 3.15 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.297 0.57 . . . . 0.0 110.863 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.441 ' HB3' ' HG3' ' A' ' 103' ' ' LYS . 0.7 OUTLIER -130.56 152.01 50.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 109.84 179.305 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.668 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 74.5 t80 -149.46 133.86 17.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.022 -1.049 . . . . 0.0 110.368 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 36.1 m -139.66 147.08 40.52 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.176 -0.952 . . . . 0.0 110.525 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.668 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 7.8 p90 -148.47 177.88 9.08 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.346 -0.846 . . . . 0.0 110.666 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.473 ' OG1' ' OD2' ' A' ' 72' ' ' ASP . 15.6 m -127.88 123.32 34.76 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.441 -0.787 . . . . 0.0 109.924 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.512 ' CD1' ' O ' ' A' ' 68' ' ' LYS . 12.2 tp -94.34 134.0 37.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.021 -1.05 . . . . 0.0 110.292 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.491 HG22 HD11 ' A' ' 86' ' ' ILE . 13.6 pt -114.89 -33.32 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 110.334 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.516 ' OE1' ' CE ' ' A' ' 68' ' ' LYS . 29.3 tt0 -114.11 134.07 55.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 110.38 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.5 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . -176.92 122.38 0.84 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -55.77 -17.07 5.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.16 -1.2 . . . . 0.0 110.235 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -91.35 -34.15 15.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.934 . . . . 0.0 110.469 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.474 ' O ' ' O ' ' A' ' 95' ' ' LEU . 1.9 pp -84.9 -16.97 39.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.256 -0.903 . . . . 0.0 110.404 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.87 -23.8 75.62 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -49.45 -65.56 0.55 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.288 -1.125 . . . . 0.0 110.358 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 80.5 p -137.28 8.4 2.91 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.463 -0.773 . . . . 0.0 110.175 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.527 HD12 ' CD2' ' A' ' 120' ' ' TYR . 11.4 mt -119.41 177.73 4.81 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.3 -0.875 . . . . 0.0 110.051 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.427 ' HG2' ' N ' ' A' ' 97' ' ' LYS . 39.4 tt0 -146.29 -78.73 0.17 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.332 -0.855 . . . . 0.0 109.772 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.489 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 16.1 mttm -80.16 142.57 34.63 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.87 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.644 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 5.2 mm -135.39 140.97 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.924 -1.11 . . . . 0.0 110.548 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.422 ' OG ' ' HD2' ' A' ' 119' ' ' HIS . 0.1 OUTLIER -118.55 137.15 53.42 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.59 -0.694 . . . . 0.0 109.235 178.434 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.644 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 8.4 m-85 -131.99 131.52 42.62 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.124 -0.985 . . . . 0.0 110.872 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.45 ' HG2' ' OG ' ' A' ' 82' ' ' SER . 7.1 mt-10 -129.52 133.47 47.26 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.409 -0.807 . . . . 0.0 109.91 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.51 ' N ' ' O ' ' A' ' 81' ' ' TYR . 43.4 m -127.41 144.9 50.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.925 . . . . 0.0 110.023 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.441 ' HG3' ' HB3' ' A' ' 80' ' ' SER . 2.2 mttt -141.94 136.49 30.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.944 . . . . 0.0 110.256 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.553 ' HB2' ' HB3' ' A' ' 79' ' ' TYR . 3.7 mt -120.91 151.01 40.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 110.102 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.495 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -151.62 -169.14 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.306 -0.872 . . . . 0.0 110.063 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -119.39 138.6 52.98 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.308 -0.87 . . . . 0.0 110.115 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.458 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 28.8 p -94.67 164.9 18.46 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.177 -0.952 . . . . 0.0 110.245 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.5 Cg_endo -72.5 -2.68 12.15 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.057 1.556 . . . . 0.0 110.59 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 81.8 p -102.14 0.86 35.4 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.225 -0.922 . . . . 0.0 110.263 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.73 -31.83 8.25 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -67.87 -173.98 7.59 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.483 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.1 p -126.29 131.42 51.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.235 -1.156 . . . . 0.0 110.237 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.448 ' HA ' HG23 ' A' ' 10' ' ' THR . 11.1 mt -82.3 150.26 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.415 -0.803 . . . . 0.0 110.196 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.591 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 15.4 mt -130.34 110.43 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 110.4 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.42 ' O ' ' N ' ' A' ' 103' ' ' LYS . 51.6 tttt -99.34 128.34 45.45 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.201 -0.937 . . . . 0.0 109.923 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 0.7 OUTLIER -123.02 153.39 39.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.182 -0.949 . . . . 0.0 110.537 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 28.7 m -159.99 127.71 4.67 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.396 -0.815 . . . . 0.0 110.286 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.471 ' CB ' ' CD1' ' A' ' 100' ' ' TYR . 24.6 p -132.13 160.16 36.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.242 -0.911 . . . . 0.0 110.225 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.426 ' CE1' HG21 ' A' ' 4' ' ' THR . 94.9 m-70 -132.3 135.76 46.44 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.11 -0.994 . . . . 0.0 110.625 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.527 ' CD2' HD12 ' A' ' 95' ' ' LEU . 4.4 m-30 -97.66 146.84 24.93 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.293 -0.879 . . . . 0.0 110.108 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.489 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 94.0 m-70 -126.73 92.11 3.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.074 -1.016 . . . . 0.0 109.86 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.485 HG21 ' CD2' ' A' ' 95' ' ' LEU . 1.8 p -66.62 164.38 16.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.449 -0.782 . . . . 0.0 110.311 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.419 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 34.4 tptt -147.48 114.81 6.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.368 -0.832 . . . . 0.0 110.257 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 125' ' ' ASN . . . 111.26 25.61 4.94 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 2.9 t30 65.1 62.45 0.71 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.198 -1.178 . . . . 0.0 110.179 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.454 ' O ' HG22 ' A' ' 122' ' ' THR . 20.2 m -140.35 143.44 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.244 -0.91 . . . . 0.0 110.316 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.469 ' N ' ' OE1' ' A' ' 127' ' ' GLU . 47.0 mp0 -114.03 165.99 12.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 110.257 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.633 ' CD1' ' CD1' ' A' ' 3' ' ' PHE . 3.1 mt -89.42 173.15 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.259 -0.901 . . . . 0.0 110.134 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.467 ' N ' ' CG2' ' A' ' 128' ' ' ILE . 8.1 mttm -111.55 152.66 27.28 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.361 -0.837 . . . . 0.0 110.009 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -58.57 -34.98 71.67 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.222 -0.924 . . . . 0.0 109.979 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.507 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 46.5 tt0 -62.57 -33.09 74.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.279 -0.888 . . . . 0.0 109.91 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 18.3 t-160 -76.45 -52.31 10.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -0.883 . . . . 0.0 110.104 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.576 HG13 ' CE1' ' A' ' 5' ' ' TYR . 57.8 t -62.28 -41.07 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.394 -0.816 . . . . 0.0 109.889 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -71.97 -47.26 53.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.268 -0.895 . . . . 0.0 109.854 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.507 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -61.57 -33.87 74.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.262 -0.899 . . . . 0.0 109.902 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.13 -29.7 66.29 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 37.1 mttm -74.15 -33.0 63.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.205 -1.174 . . . . 0.0 109.921 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -79.25 -35.73 41.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.354 -0.841 . . . . 0.0 109.933 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -70.2 -33.2 71.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.352 -0.842 . . . . 0.0 109.779 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.426 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -76.49 -41.04 48.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.348 -0.845 . . . . 0.0 109.957 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 35.3 t -59.87 -43.81 94.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.385 -0.822 . . . . 0.0 109.848 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -59.28 -42.41 91.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.299 -0.875 . . . . 0.0 109.881 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.465 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 18.7 mt -61.75 -36.36 80.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 109.946 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.464 ' HA ' HD11 ' A' ' 147' ' ' ILE . 30.1 m-85 -64.41 -37.12 86.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.348 -0.845 . . . . 0.0 109.568 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 25.9 mttm -70.28 -12.9 61.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.418 -0.801 . . . . 0.0 109.977 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.479 ' CD2' ' CG2' ' A' ' 33' ' ' ILE . 9.2 mt -81.57 -36.43 29.06 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.138 -0.976 . . . . 0.0 108.855 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.583 HD12 ' CD1' ' A' ' 22' ' ' PHE . 8.2 mt -68.39 -49.41 66.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.477 ' CD ' ' CB ' ' A' ' 11' ' ' SER . 69.9 mt-10 -52.62 -42.54 64.7 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.566 -0.709 . . . . 0.0 109.675 179.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.428 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 54.1 m -70.81 -34.66 71.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.065 -1.022 . . . . 0.0 109.526 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.598 ' CD2' ' OH ' ' A' ' 158' ' ' TYR . 51.9 t80 -51.24 -60.85 2.66 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.519 -0.738 . . . . 0.0 109.924 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.556 HD22 ' CE1' ' A' ' 158' ' ' TYR . 38.1 mt -73.07 -27.9 62.0 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.393 -0.817 . . . . 0.0 109.995 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.473 ' HA ' HD13 ' A' ' 13' ' ' ILE . 60.1 tttm -57.2 -19.96 23.97 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.201 -0.937 . . . . 0.0 108.486 178.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -128.08 -4.09 5.62 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.572 ' CG ' ' O ' ' A' ' 150' ' ' TYR . 63.6 m170 -113.39 86.52 10.08 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.171 -1.193 . . . . 0.0 110.235 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -73.59 2.21 6.05 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.038 1.546 . . . . 0.0 110.859 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -124.04 4.38 8.64 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.122 -0.987 . . . . 0.0 110.005 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 158' ' ' TYR . . . -69.13 108.81 3.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.296 -0.877 . . . . 0.0 110.053 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.598 ' OH ' ' CD2' ' A' ' 150' ' ' TYR . 0.3 OUTLIER 35.3 35.14 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.633 -0.667 . . . . 0.0 110.952 -179.363 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.565 ' CB ' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.417 0 CA-C-O 117.953 -1.023 . . . . 0.0 109.824 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.594 HG22 ' CG ' ' A' ' 121' ' ' HIS . 5.0 p -85.79 153.68 3.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 121.27 -1.135 . . . . 0.0 110.064 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.545 ' N ' HG21 ' A' ' 2' ' ' VAL . 16.2 m-85 -89.92 167.36 12.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.309 -0.87 . . . . 0.0 110.433 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 55.1 m -145.67 102.26 3.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.302 -0.874 . . . . 0.0 110.221 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.63 ' CZ ' ' CG2' ' A' ' 133' ' ' VAL . 84.8 m-85 -116.09 151.76 34.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.316 -0.865 . . . . 0.0 109.936 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 19.6 pt-20 -143.01 151.63 41.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.142 -0.974 . . . . 0.0 110.366 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.4 t -128.6 151.77 49.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.41 -0.806 . . . . 0.0 109.839 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.456 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 92.8 mt-10 -134.3 116.05 14.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.947 . . . . 0.0 110.488 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.2 p90 -142.66 -175.12 4.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -0.852 . . . . 0.0 109.778 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.47 HG23 HG12 ' A' ' 113' ' ' ILE . 6.6 p -137.75 173.35 11.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.144 -0.973 . . . . 0.0 110.634 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.459 ' OG ' ' OG ' ' A' ' 112' ' ' SER . 84.0 p -149.56 144.22 26.09 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.397 -0.815 . . . . 0.0 110.23 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -72.57 -32.37 65.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.226 -0.921 . . . . 0.0 109.958 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.555 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 6.5 mm -72.51 151.35 91.66 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.517 -0.739 . . . . 0.0 109.653 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.555 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 39.1 Cg_endo -64.61 140.58 69.16 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.889 1.468 . . . . 0.0 110.692 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.625 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 41.9 Cg_endo -73.08 -30.49 10.69 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 124.145 1.603 . . . . 0.0 112.871 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.3 Cg_endo -69.84 -23.57 30.31 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 O-C-N 122.448 0.71 . . . . 0.0 110.357 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.509 ' NH2' ' O ' ' A' ' 158' ' ' TYR . 1.6 mmp_? -83.42 -46.8 12.11 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.505 ' C ' ' CD2' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -65.54 -31.05 71.9 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.601 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.487 ' HB2' ' O ' ' A' ' 15' ' ' PRO . 59.4 t80 -64.66 -54.49 30.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.56 -0.712 . . . . 0.0 109.26 178.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 25' ' ' ASP . 25.2 mttt -47.99 -42.84 28.91 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.796 -0.761 . . . . 0.0 109.459 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.601 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -73.07 -35.61 66.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.469 -0.77 . . . . 0.0 110.927 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.582 ' CD1' HD12 ' A' ' 147' ' ' ILE . 0.2 OUTLIER -74.57 -42.85 58.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 111.42 -178.659 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.526 HG12 ' CD1' ' A' ' 81' ' ' TYR . 5.7 t -107.5 -50.36 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.956 -1.09 . . . . 0.0 111.74 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.553 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 7.3 mp -79.44 -5.64 55.14 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.077 -1.014 . . . . 0.0 111.483 -178.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.528 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 1.1 m-20 -151.2 30.36 0.62 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.796 -1.19 . . . . 0.0 110.651 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.517 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -72.87 -21.23 60.96 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.243 -0.91 . . . . 0.0 110.615 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.458 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 39.2 t0 -66.63 -24.14 66.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.014 -1.054 . . . . 0.0 110.201 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.478 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 4.4 p30 -124.55 12.81 8.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.33 -0.856 . . . . 0.0 110.078 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.515 HD11 ' CD1' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -94.08 -48.45 6.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.364 -0.835 . . . . 0.0 110.221 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.663 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 3.7 p -76.89 -28.37 0.66 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.305 -0.872 . . . . 0.0 112.231 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.663 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 52.5 Cg_endo -79.23 5.31 5.87 Favored 'Trans proline' 0 C--N 1.319 -1.026 0 O-C-N 122.672 0.827 . . . . 0.0 110.272 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -128.78 -37.38 1.75 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 109.346 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.536 HG12 ' CD1' ' A' ' 150' ' ' TYR . 11.3 mt -79.97 -25.9 11.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-O 121.646 0.736 . . . . 0.0 109.151 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -157.22 77.32 3.93 Favored Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 121.628 -0.67 . . . . 0.0 109.841 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.29 -5.49 16.65 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.984 1.518 . . . . 0.0 110.565 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -87.65 -15.74 36.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.0 109.8 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -93.71 -69.27 0.76 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.38 -0.825 . . . . 0.0 110.151 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.503 HG12 ' CG2' ' A' ' 56' ' ' ILE . 1.7 mp -99.86 126.96 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.315 -0.866 . . . . 0.0 110.086 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.512 ' HB2' ' N ' ' A' ' 59' ' ' GLY . 27.7 ttpt -76.3 -25.41 54.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.357 -0.839 . . . . 0.0 110.639 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.545 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER 179.75 164.67 1.1 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.065 -1.022 . . . . 0.0 110.497 -179.75 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.454 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 18.5 m -137.53 128.6 27.57 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.466 -0.771 . . . . 0.0 109.81 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.525 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 48.5 tt0 -135.54 111.55 9.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.149 -0.969 . . . . 0.0 110.596 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.445 HG12 ' HG2' ' A' ' 54' ' ' LYS . 21.2 mt -59.54 140.26 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 109.859 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.522 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 39.0 mt -115.68 -27.91 6.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.145 -0.972 . . . . 0.0 110.268 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.57 ' CD1' HD11 ' A' ' 53' ' ' ILE . 1.4 m95 -123.58 157.95 32.54 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.246 -0.908 . . . . 0.0 110.418 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.427 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 43.53 -134.08 5.56 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.58 20.67 0.4 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.302 -1.117 . . . . 0.0 109.995 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.434 ' O ' HG22 ' A' ' 71' ' ' ILE . . . 125.56 -20.31 6.53 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.024 -1.631 . . . . 0.0 109.024 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.465 ' O ' ' HB ' ' A' ' 71' ' ' ILE . . . -69.98 -172.47 10.27 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.474 ' HA ' HG23 ' A' ' 71' ' ' ILE . 45.5 Cg_endo -73.47 129.61 13.99 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.991 1.522 . . . . 0.0 110.653 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.79 -11.4 53.08 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.654 -1.778 . . . . 0.0 108.654 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.433 ' HB ' ' O ' ' A' ' 49' ' ' GLY . 1.0 OUTLIER -72.73 164.83 25.93 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.519 -0.989 . . . . 0.0 109.958 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.57 HD11 ' CD1' ' A' ' 45' ' ' TRP . 59.3 mt -135.49 120.09 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.4 -0.812 . . . . 0.0 109.698 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.445 ' HG2' HG12 ' A' ' 43' ' ' ILE . 93.8 mttt -108.49 134.85 50.7 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.195 -0.941 . . . . 0.0 110.624 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.522 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 32.9 tttt -101.53 92.68 5.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.262 -0.899 . . . . 0.0 110.084 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.503 ' CG2' HG12 ' A' ' 38' ' ' ILE . 84.2 mt -79.92 141.26 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.179 -0.951 . . . . 0.0 110.197 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.493 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 2.1 p -115.12 158.77 21.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 110.412 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 28.6 m-85 -119.31 135.94 54.48 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.368 -0.832 . . . . 0.0 110.12 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.512 ' N ' ' HB2' ' A' ' 39' ' ' LYS . . . -92.66 -2.87 66.93 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -113.75 140.72 48.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.187 -1.184 . . . . 0.0 110.226 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 112.21 -153.12 17.57 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 60.5 p -56.15 -168.46 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.261 -1.141 . . . . 0.0 110.145 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -76.76 -29.48 56.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.201 -0.937 . . . . 0.0 110.24 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -125.91 105.86 9.23 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.102 -0.999 . . . . 0.0 110.402 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.545 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -136.36 94.71 0.23 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.533 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 17.2 p90 -139.43 168.8 19.01 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.163 -1.199 . . . . 0.0 110.336 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.53 HG13 ' CA ' ' A' ' 88' ' ' GLY . 6.2 m -139.38 173.29 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.375 -0.828 . . . . 0.0 110.507 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.516 ' CE ' ' OE1' ' A' ' 87' ' ' GLU . 22.1 mttm -124.01 126.28 46.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.554 -0.716 . . . . 0.0 109.629 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.645 ' CD2' ' CD1' ' A' ' 85' ' ' LEU . 16.4 m170 -110.56 134.39 52.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.167 -0.958 . . . . 0.0 110.788 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 52' ' ' THR . 29.6 ttpt -108.2 115.72 30.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.288 -0.883 . . . . 0.0 109.436 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.528 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 28.6 mm -62.95 120.67 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.3 -0.875 . . . . 0.0 110.561 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 82' ' ' SER . 83.8 m-20 -93.7 -42.58 9.08 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.521 -0.737 . . . . 0.0 109.717 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.466 ' OG ' ' HB2' ' A' ' 82' ' ' SER . 90.6 p -169.66 159.25 8.12 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.436 -0.79 . . . . 0.0 109.744 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.457 HG12 HG12 ' A' ' 23' ' ' VAL . 1.9 mt -142.34 156.36 19.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.213 -0.93 . . . . 0.0 110.354 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.535 ' O ' ' N ' ' A' ' 79' ' ' TYR . 5.1 m-20 -134.59 79.11 1.78 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.623 -0.673 . . . . 0.0 110.143 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.462 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 67.5 mttm -62.83 -14.33 44.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.128 -0.982 . . . . 0.0 110.224 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -94.24 -32.29 13.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.241 -0.912 . . . . 0.0 109.592 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.495 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -104.75 -6.85 19.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.517 -0.739 . . . . 0.0 109.665 179.771 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.557 ' CZ ' ' HB3' ' A' ' 16' ' ' PRO . 4.1 m-85 67.21 50.62 0.98 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.571 -0.706 . . . . 0.0 110.224 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.528 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -121.11 151.53 39.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -0.922 . . . . 0.0 109.304 179.441 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.582 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 22.5 t80 -139.91 136.7 34.15 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.207 -0.933 . . . . 0.0 110.191 -178.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 4.8 m -139.45 121.55 15.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.93 . . . . 0.0 110.942 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.582 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 8.6 p90 -141.15 175.44 9.64 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.342 -0.849 . . . . 0.0 109.737 179.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.46 ' OG1' ' OD2' ' A' ' 72' ' ' ASP . 82.1 m -131.77 143.11 49.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.912 . . . . 0.0 110.23 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.645 ' CD1' ' CD2' ' A' ' 69' ' ' HIS . 19.1 tp -96.67 121.01 38.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 110.126 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.402 HG23 HD11 ' A' ' 86' ' ' ILE . 20.3 pt -105.86 -17.95 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.392 -0.818 . . . . 0.0 109.982 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.516 ' OE1' ' CE ' ' A' ' 68' ' ' LYS . 83.1 tt0 -138.18 151.49 47.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -0.889 . . . . 0.0 110.374 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.53 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 164.94 133.5 1.51 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -64.18 -15.3 59.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.297 -1.119 . . . . 0.0 110.245 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.13 -18.59 45.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.302 -0.874 . . . . 0.0 110.207 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.582 ' CD2' ' CD1' ' A' ' 98' ' ' ILE . 16.4 mt -63.82 -19.8 65.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.225 -0.922 . . . . 0.0 110.073 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 46.29 -173.29 0.02 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.418 ' OD1' HG22 ' A' ' 94' ' ' THR . 59.5 p30 -87.93 12.36 13.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.133 -1.216 . . . . 0.0 109.823 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.528 ' HB ' ' CG2' ' A' ' 126' ' ' VAL . 23.2 p -107.07 -29.88 9.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.366 -0.834 . . . . 0.0 110.173 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.521 HD23 ' CD1' ' A' ' 128' ' ' ILE . 67.5 mt -107.95 161.29 15.07 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.269 -0.894 . . . . 0.0 110.405 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -142.28 -82.96 0.19 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.335 -0.853 . . . . 0.0 109.994 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.497 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 62.2 mttt -80.37 140.26 36.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.687 -0.633 . . . . 0.0 110.763 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.582 ' CD1' ' CD2' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -135.0 135.55 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.967 -1.083 . . . . 0.0 109.602 178.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.478 ' HB2' ' CD2' ' A' ' 119' ' ' HIS . 0.5 OUTLIER -108.96 133.36 53.06 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.315 -0.866 . . . . 0.0 109.956 179.626 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 5.6 m-85 -122.78 132.3 54.16 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.312 -0.867 . . . . 0.0 110.252 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 117' ' ' THR . 2.9 mt-10 -134.65 130.43 36.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 0.0 110.242 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.454 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 26.0 m -129.41 135.94 49.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.222 -0.924 . . . . 0.0 109.858 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.4 mttm -134.18 135.78 43.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.156 -0.965 . . . . 0.0 110.599 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.527 ' CD2' HG12 ' A' ' 114' ' ' ILE . 7.1 mt -115.72 151.16 35.63 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.29 -0.882 . . . . 0.0 109.932 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.464 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 2.0 t -148.04 -169.04 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.133 -0.98 . . . . 0.0 110.0 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -124.37 154.09 40.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.288 -0.882 . . . . 0.0 110.137 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.454 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 5.1 p -113.7 168.1 8.39 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.896 . . . . 0.0 110.195 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.454 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 48.1 Cg_endo -72.92 -4.24 15.04 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.021 1.537 . . . . 0.0 110.474 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 34.3 p -104.89 8.71 34.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.284 -0.885 . . . . 0.0 110.279 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 94.5 -34.43 4.74 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -59.09 -171.78 0.4 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.508 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 3.1 p -134.82 136.05 42.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -1.167 . . . . 0.0 110.359 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.47 HG12 HG23 ' A' ' 10' ' ' THR . 22.4 mt -88.89 148.82 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.325 -0.859 . . . . 0.0 110.078 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.572 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 18.2 mt -132.3 124.51 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.205 -0.934 . . . . 0.0 110.46 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.456 ' HG3' ' HG2' ' A' ' 8' ' ' GLU . 75.3 tttt -113.59 109.82 19.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.2 -0.938 . . . . 0.0 110.014 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.447 ' OG ' ' CZ ' ' A' ' 9' ' ' PHE . 1.2 m -101.01 159.35 15.29 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.251 -0.906 . . . . 0.0 110.643 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.489 HG21 ' NE2' ' A' ' 119' ' ' HIS . 60.8 m -154.16 133.61 12.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.327 -0.858 . . . . 0.0 110.045 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.8 m -136.25 144.53 44.87 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.13 -0.981 . . . . 0.0 110.478 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.489 ' NE2' HG21 ' A' ' 117' ' ' THR . 20.8 m-70 -132.05 146.74 52.26 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.295 -0.878 . . . . 0.0 110.325 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.551 ' CD2' HG13 ' A' ' 128' ' ' ILE . 40.2 m-85 -121.59 120.53 35.06 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.18 -0.95 . . . . 0.0 110.542 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.594 ' CG ' HG22 ' A' ' 2' ' ' VAL . 87.2 m-70 -92.85 103.72 16.03 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.4 -0.812 . . . . 0.0 109.368 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.507 ' OG1' ' CG2' ' A' ' 126' ' ' VAL . 1.6 t -88.39 173.71 8.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.014 -1.054 . . . . 0.0 110.856 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 40.0 tttm -141.8 117.1 10.12 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 120.284 -0.567 . . . . 0.0 110.221 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 113.2 -123.98 6.4 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -133.25 62.03 1.66 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.313 -1.11 . . . . 0.0 110.204 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.528 ' CG2' ' HB ' ' A' ' 94' ' ' THR . 34.8 m -137.54 153.46 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.22 -0.925 . . . . 0.0 110.203 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.448 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 90.4 mt-10 -127.05 169.57 13.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.188 -0.945 . . . . 0.0 110.29 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.551 HG13 ' CD2' ' A' ' 120' ' ' TYR . 15.8 mm -67.77 173.09 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.884 . . . . 0.0 110.244 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.445 ' N ' ' CG2' ' A' ' 128' ' ' ILE . 17.5 mttp -99.08 149.53 22.94 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.265 -0.897 . . . . 0.0 110.041 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.12 -20.09 16.02 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.091 -1.006 . . . . 0.0 109.841 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.514 ' O ' ' N ' ' A' ' 135' ' ' ALA . 94.3 mt-10 -71.63 -39.91 70.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.369 -0.832 . . . . 0.0 109.904 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.464 ' HB2' ' CG2' ' A' ' 128' ' ' ILE . 6.3 m170 -65.18 -45.72 83.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.297 -0.877 . . . . 0.0 109.949 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.63 ' CG2' ' CZ ' ' A' ' 5' ' ' TYR . 58.3 t -64.95 -42.79 95.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.506 -0.746 . . . . 0.0 110.264 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 33.1 tttm -102.87 -63.57 1.15 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.283 -0.886 . . . . 0.0 110.31 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 131' ' ' GLU . . . -56.78 -19.54 17.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.122 -0.986 . . . . 0.0 110.025 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 131' ' ' GLU . . . -76.91 -31.16 54.39 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.221 -1.551 . . . . 0.0 109.221 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.491 ' CE ' ' O ' ' A' ' 133' ' ' VAL . 27.4 mttt -72.85 -30.07 63.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.324 -1.103 . . . . 0.0 110.18 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -82.91 -32.23 27.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.315 -0.866 . . . . 0.0 110.044 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 50.5 mttt -70.45 -38.46 74.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.391 -0.818 . . . . 0.0 110.028 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.402 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -78.74 -30.83 46.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.321 -0.862 . . . . 0.0 109.88 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 137' ' ' LYS . 47.1 m -66.67 -45.29 79.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.35 -0.844 . . . . 0.0 110.011 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -50.99 -51.2 55.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.303 -0.873 . . . . 0.0 109.947 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.469 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 10.6 tp -55.47 -49.31 72.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.258 -0.901 . . . . 0.0 109.742 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.402 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 17.7 m-85 -53.62 -38.84 64.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.44 -0.788 . . . . 0.0 109.746 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -73.38 -16.72 61.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.273 -0.892 . . . . 0.0 109.852 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 143' ' ' LEU . 17.7 mt -81.98 -35.68 28.69 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.234 -0.917 . . . . 0.0 108.706 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.582 HD12 ' CD1' ' A' ' 22' ' ' PHE . 53.5 mt -66.66 -47.17 84.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.479 ' O ' HG13 ' A' ' 13' ' ' ILE . 84.1 mt-10 -52.26 -45.42 65.39 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.307 -0.87 . . . . 0.0 109.324 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 36.4 m -64.68 -30.97 72.0 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.152 -0.968 . . . . 0.0 109.535 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.584 ' CD2' ' OH ' ' A' ' 158' ' ' TYR . 71.1 t80 -60.94 -50.48 73.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.474 -0.766 . . . . 0.0 109.815 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.622 ' CD2' ' CE1' ' A' ' 158' ' ' TYR . 92.5 mt -80.03 -36.92 35.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.223 -0.923 . . . . 0.0 110.03 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.536 ' CB ' HD13 ' A' ' 13' ' ' ILE . 16.6 tttt -64.03 -20.29 65.81 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.392 -0.817 . . . . 0.0 109.516 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -110.67 -32.78 2.6 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.581 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 5.8 m-70 -109.6 94.3 16.21 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.267 -1.137 . . . . 0.0 110.203 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.71 6.25 3.38 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.08 1.569 . . . . 0.0 111.046 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -109.8 -2.37 17.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.994 -1.066 . . . . 0.0 109.966 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.564 ' HB1' ' CE2' ' A' ' 150' ' ' TYR . . . -74.39 104.61 5.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.368 -0.832 . . . . 0.0 110.199 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.622 ' CE1' ' CD2' ' A' ' 151' ' ' LEU . 1.5 p90 34.65 37.28 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.726 -0.609 . . . . 0.0 110.842 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.497 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.69 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 98.7 t -128.02 132.07 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.208 -1.172 . . . . 0.0 110.205 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.641 ' CE1' ' CD1' ' A' ' 128' ' ' ILE . 12.3 m-85 -93.19 148.21 22.22 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.205 -0.934 . . . . 0.0 110.117 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.402 HG22 ' CE1' ' A' ' 119' ' ' HIS . 10.3 m -128.1 111.48 13.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.173 -0.955 . . . . 0.0 110.344 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.635 ' CD2' ' CG2' ' A' ' 133' ' ' VAL . 69.1 m-85 -123.38 140.25 53.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.341 -0.85 . . . . 0.0 110.16 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -140.28 151.33 45.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.224 -0.923 . . . . 0.0 110.359 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.7 t -138.77 160.97 38.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.386 -0.821 . . . . 0.0 109.918 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.411 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 85.8 mt-10 -142.14 115.77 9.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.102 -0.999 . . . . 0.0 110.368 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.6 p90 -140.42 -175.04 4.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.311 -0.868 . . . . 0.0 109.843 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.49 ' CG2' ' HA ' ' A' ' 113' ' ' ILE . 2.4 p -137.52 167.38 21.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.118 -0.989 . . . . 0.0 110.493 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.445 ' HA ' ' OE2' ' A' ' 148' ' ' GLU . 75.5 p -138.93 147.93 42.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.38 -0.825 . . . . 0.0 110.168 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -69.96 -32.96 71.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.236 -0.915 . . . . 0.0 110.254 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.547 ' N ' ' CD1' ' A' ' 13' ' ' ILE . 2.6 mp -79.58 148.56 69.93 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.378 -0.826 . . . . 0.0 109.915 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.56 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 40.0 Cg_endo -64.99 152.72 81.4 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.937 1.493 . . . . 0.0 110.722 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.672 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 36.7 Cg_endo -63.35 -35.87 59.34 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.793 1.418 . . . . 0.0 113.035 -178.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.672 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 38.0 Cg_endo -63.89 -21.3 68.99 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 N-CA-C 109.811 -0.88 . . . . 0.0 109.811 178.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.531 ' CG ' ' HG2' ' A' ' 14' ' ' PRO . 6.6 mmp_? -80.28 -45.25 18.23 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.597 ' CD1' ' N ' ' A' ' 18' ' ' LEU . 9.3 mp -73.31 -40.87 64.16 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.251 -0.98 . . . . 0.0 108.576 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.617 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 36.9 t80 -52.72 -59.95 3.86 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 119.869 -0.733 . . . . 0.0 110.155 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 40.4 mttp -56.03 -38.27 70.33 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.404 -0.81 . . . . 0.0 110.18 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.579 ' HB1' ' CZ ' ' A' ' 158' ' ' TYR . . . -78.56 -62.76 1.58 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.125 -0.984 . . . . 0.0 110.878 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.547 ' N ' ' O ' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -49.2 -41.49 37.17 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.65 -0.656 . . . . 0.0 112.006 -178.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.597 HG12 ' CD1' ' A' ' 81' ' ' TYR . 11.5 t -106.32 -62.93 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.767 -1.208 . . . . 0.0 111.813 -178.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 20' ' ' LYS . 7.4 mp -68.5 -1.07 5.84 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.243 -0.911 . . . . 0.0 111.69 -178.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.556 ' OD2' ' CD2' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -149.63 15.7 0.88 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.704 -1.248 . . . . 0.0 110.756 179.743 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -57.45 -40.68 78.99 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.142 -0.974 . . . . 0.0 110.12 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.48 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 14.0 t70 -62.75 -11.42 17.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.268 -0.895 . . . . 0.0 109.901 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.456 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 84.7 m-20 -132.89 10.07 4.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.42 -0.8 . . . . 0.0 109.701 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.526 HD22 ' CZ ' ' A' ' 158' ' ' TYR . 0.2 OUTLIER -95.57 -49.06 5.56 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.396 -0.815 . . . . 0.0 110.387 -179.764 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.662 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 3.5 m -83.48 -26.22 0.39 Allowed Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.396 -0.815 . . . . 0.0 112.707 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.662 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 47.0 Cg_endo -76.88 2.93 7.01 Favored 'Trans proline' 0 C--N 1.318 -1.039 0 O-C-N 122.511 0.743 . . . . 0.0 110.476 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.7 tttm -128.95 -35.15 1.88 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.29 -0.882 . . . . 0.0 109.541 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.59 HG12 ' CD1' ' A' ' 150' ' ' TYR . 40.1 mt -80.03 -35.27 15.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.599 -0.688 . . . . 0.0 109.596 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -161.9 97.5 1.22 Allowed Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.582 -0.699 . . . . 0.0 109.833 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.57 2.21 6.05 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.069 1.563 . . . . 0.0 110.793 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -84.11 -10.09 58.07 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.146 -0.971 . . . . 0.0 109.812 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.438 ' C ' ' CD1' ' A' ' 38' ' ' ILE . . . -97.88 -47.19 5.65 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.392 -0.817 . . . . 0.0 109.912 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.522 ' CG1' ' CG2' ' A' ' 56' ' ' ILE . 2.1 mp -134.75 108.01 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.463 -0.773 . . . . 0.0 109.899 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 57' ' ' THR . 39.3 ttpt -55.29 -16.99 3.89 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.223 -0.923 . . . . 0.0 110.298 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.545 ' CG ' ' N ' ' A' ' 41' ' ' SER . 0.2 OUTLIER 173.03 175.16 0.11 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.081 -1.012 . . . . 0.0 110.11 -179.739 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.545 ' N ' ' CG ' ' A' ' 40' ' ' HIS . 25.2 m -152.11 149.77 29.17 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.361 -0.837 . . . . 0.0 109.827 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -155.56 112.15 3.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.163 -0.961 . . . . 0.0 110.711 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 41.1 mt -62.55 136.5 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.306 -0.871 . . . . 0.0 109.808 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.523 ' CD2' ' HE3' ' A' ' 55' ' ' LYS . 4.9 tp -114.19 -24.47 8.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.156 -0.965 . . . . 0.0 110.717 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.554 ' CG ' HD13 ' A' ' 53' ' ' ILE . 1.8 m95 -124.93 161.35 26.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.116 -0.99 . . . . 0.0 110.782 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.458 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 42.23 -139.73 2.19 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -147.85 24.79 1.06 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.368 -1.078 . . . . 0.0 109.878 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 117.88 -18.9 11.39 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.512 ' O ' ' CG2' ' A' ' 71' ' ' ILE . . . -72.87 -169.27 14.09 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.498 ' HA ' HG23 ' A' ' 71' ' ' ILE . 45.8 Cg_endo -73.21 128.9 13.39 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.093 1.575 . . . . 0.0 110.724 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.81 -11.55 49.52 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.1 m -75.08 163.84 27.15 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.643 -0.916 . . . . 0.0 109.78 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.554 HD13 ' CG ' ' A' ' 45' ' ' TRP . 85.6 mt -134.13 118.87 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 0.0 109.942 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 1.0 OUTLIER -106.55 124.11 49.11 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.322 -0.861 . . . . 0.0 110.567 -179.565 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.523 ' HE3' ' CD2' ' A' ' 44' ' ' LEU . 75.8 mttt -90.53 95.2 10.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.258 -0.901 . . . . 0.0 109.826 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.522 ' CG2' ' CG1' ' A' ' 38' ' ' ILE . 99.6 mt -79.98 139.97 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.142 -0.974 . . . . 0.0 110.083 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -112.99 146.65 38.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.315 -0.865 . . . . 0.0 110.434 -179.736 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.571 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 21.7 m-85 -110.04 154.8 22.7 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.289 -0.882 . . . . 0.0 110.052 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -103.62 -4.95 45.84 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -101.11 145.24 29.02 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.224 -1.163 . . . . 0.0 110.248 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.22 128.93 4.95 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.0 t -54.21 -43.88 71.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.21 -1.17 . . . . 0.0 110.178 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.409 ' O ' ' C ' ' A' ' 64' ' ' TYR . 91.1 mt-30 -96.12 157.86 15.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.27 -0.894 . . . . 0.0 110.183 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.409 ' C ' ' O ' ' A' ' 63' ' ' GLN . 0.7 OUTLIER -43.71 140.96 1.66 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.28 -0.888 . . . . 0.0 110.321 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.571 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -132.61 90.25 0.27 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.991 -1.643 . . . . 0.0 108.991 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.538 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 12.1 p90 -130.29 166.57 20.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.081 -1.246 . . . . 0.0 110.158 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.478 ' HB ' HD12 ' A' ' 85' ' ' LEU . 5.3 m -140.02 175.64 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.337 -0.852 . . . . 0.0 110.579 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.524 ' CE ' HG23 ' A' ' 53' ' ' ILE . 69.6 tttt -131.17 103.09 6.29 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.506 -0.746 . . . . 0.0 109.875 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.58 ' CD2' HD11 ' A' ' 85' ' ' LEU . 13.4 m170 -98.15 121.77 40.48 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.207 -0.933 . . . . 0.0 111.036 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 52' ' ' THR . 82.8 tttt -91.45 120.35 32.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.301 -0.874 . . . . 0.0 109.348 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.537 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 26.2 mm -58.62 126.88 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.165 -0.959 . . . . 0.0 110.229 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.476 ' O ' ' HB3' ' A' ' 73' ' ' SER . 90.9 m-20 -98.36 -51.1 4.09 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.447 -0.783 . . . . 0.0 109.769 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.476 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 91.3 p -178.45 159.2 1.16 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.5 -0.75 . . . . 0.0 110.316 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.534 ' CD1' HG12 ' A' ' 23' ' ' VAL . 3.5 tt -144.41 167.33 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.502 -0.749 . . . . 0.0 109.236 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -131.13 81.05 1.97 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.944 -1.098 . . . . 0.0 110.523 -179.376 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.617 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 82.1 tttt -55.99 -14.56 2.62 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.29 -0.881 . . . . 0.0 110.604 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -90.76 -30.44 17.04 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.24 -0.912 . . . . 0.0 109.658 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.501 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -113.3 -1.44 14.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.486 -0.759 . . . . 0.0 109.731 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.575 ' HA ' ' CD1' ' A' ' 19' ' ' PHE . 56.1 m-85 64.87 50.04 2.05 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.389 0.614 . . . . 0.0 110.369 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.507 ' O ' ' CG1' ' A' ' 74' ' ' ILE . 0.6 OUTLIER -118.51 152.57 35.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 109.524 179.394 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.622 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 82.5 t80 -151.04 140.85 21.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.066 -1.021 . . . . 0.0 110.262 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 74.3 m -147.81 147.61 30.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.259 -0.901 . . . . 0.0 110.442 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.622 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 8.8 p90 -149.82 175.59 11.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.344 -0.848 . . . . 0.0 110.361 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.475 ' OG1' ' OD2' ' A' ' 72' ' ' ASP . 44.3 m -125.58 128.16 47.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.404 -0.81 . . . . 0.0 109.888 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.58 HD11 ' CD2' ' A' ' 69' ' ' HIS . 8.6 tp -98.77 131.64 44.75 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.216 -0.993 . . . . 0.0 110.284 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.518 ' O ' ' CD1' ' A' ' 91' ' ' LEU . 9.1 pt -117.19 -29.51 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.199 -0.938 . . . . 0.0 110.419 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -110.39 138.77 46.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -0.888 . . . . 0.0 110.19 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 175.82 134.25 1.9 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -53.38 -31.22 43.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -1.112 . . . . 0.0 110.305 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.484 ' HB3' ' CE1' ' A' ' 132' ' ' HIS . . . -69.73 -38.73 76.98 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.297 -0.877 . . . . 0.0 110.243 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.52 HD22 ' CD2' ' A' ' 95' ' ' LEU . 15.5 mt -41.19 -61.71 0.97 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.503 -0.748 . . . . 0.0 110.284 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 49.14 -178.01 0.02 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -67.01 -7.5 23.02 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.25 -1.147 . . . . 0.0 110.213 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.452 ' O ' HG23 ' A' ' 122' ' ' THR . 61.2 p -79.98 -60.97 2.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 110.213 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.535 HD12 ' CD1' ' A' ' 98' ' ' ILE . 0.1 OUTLIER -102.25 159.39 15.44 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.352 -0.843 . . . . 0.0 109.387 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.482 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 61.1 tt0 -137.74 -79.7 0.37 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.208 -0.932 . . . . 0.0 110.576 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 10.1 mttt -80.24 144.81 32.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.592 -0.692 . . . . 0.0 111.023 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.632 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 4.6 mm -133.1 144.7 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.208 -0.932 . . . . 0.0 109.487 178.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.457 ' N ' HG21 ' A' ' 98' ' ' ILE . 1.1 m -123.9 127.72 48.41 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.28 -0.887 . . . . 0.0 109.377 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.632 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 12.0 m-85 -123.54 133.4 53.99 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.194 -0.941 . . . . 0.0 110.581 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.45 ' HG3' ' OG ' ' A' ' 82' ' ' SER . 62.9 tt0 -135.59 137.41 41.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.279 -0.888 . . . . 0.0 110.109 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.508 ' N ' ' O ' ' A' ' 81' ' ' TYR . 23.4 m -135.24 146.41 48.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.165 -0.959 . . . . 0.0 110.281 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 115' ' ' LYS . 12.1 mttt -138.94 139.53 38.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.328 -0.858 . . . . 0.0 110.131 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.54 ' HB2' ' CB ' ' A' ' 79' ' ' TYR . 2.7 mt -118.66 154.21 33.07 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.215 -0.928 . . . . 0.0 110.542 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.493 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -152.34 -169.35 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.332 -0.855 . . . . 0.0 109.925 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -121.45 158.47 28.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.329 -0.857 . . . . 0.0 110.215 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.462 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 5.8 p -118.01 168.08 10.06 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.235 -0.916 . . . . 0.0 110.176 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.6 Cg_endo -72.41 -12.66 27.48 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.003 1.528 . . . . 0.0 110.378 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 95.8 p -95.84 2.61 53.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.245 -0.909 . . . . 0.0 110.176 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 99.35 -29.04 12.7 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.08 -172.53 1.91 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.483 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 2.1 m -133.3 133.68 42.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -1.109 . . . . 0.0 110.378 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.49 ' HA ' ' CG2' ' A' ' 10' ' ' THR . 20.8 mt -86.05 144.67 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.358 -0.838 . . . . 0.0 109.939 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.588 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 20.6 mt -131.03 114.01 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.173 -0.954 . . . . 0.0 110.441 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 103' ' ' LYS . 35.2 tttt -100.48 120.77 40.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.914 . . . . 0.0 109.837 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.1 t -115.99 154.87 29.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.205 -0.935 . . . . 0.0 110.53 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.45 HG23 ' NE2' ' A' ' 119' ' ' HIS . 38.5 m -156.73 131.64 8.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.352 -0.842 . . . . 0.0 110.133 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 91.7 p -132.72 155.81 48.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.137 -0.977 . . . . 0.0 110.319 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 32.3 m-70 -135.83 164.28 28.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.331 -0.856 . . . . 0.0 110.182 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.512 ' CB ' HD12 ' A' ' 128' ' ' ILE . 11.0 m-85 -124.77 148.54 48.06 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.292 -0.88 . . . . 0.0 110.196 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.478 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 97.1 m-70 -129.21 85.37 2.31 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.135 -0.978 . . . . 0.0 109.698 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.53 ' CG2' ' HA ' ' A' ' 95' ' ' LEU . 1.4 p -81.77 157.73 24.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.326 -0.859 . . . . 0.0 110.427 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.2 tttm -113.6 127.06 55.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.435 -0.791 . . . . 0.0 110.202 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 99.45 -153.24 19.62 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -102.97 64.17 0.84 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.219 -1.166 . . . . 0.0 110.182 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.469 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 20.1 m -130.62 154.36 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.186 -0.946 . . . . 0.0 110.214 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -133.6 159.37 40.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.261 -0.899 . . . . 0.0 110.195 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.641 ' CD1' ' CE1' ' A' ' 3' ' ' PHE . 4.3 mp -80.86 173.24 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.27 -0.894 . . . . 0.0 110.211 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.454 ' N ' HG23 ' A' ' 128' ' ' ILE . 10.6 mttp -108.26 132.89 53.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.321 -0.862 . . . . 0.0 110.124 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -47.1 -47.73 23.1 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.191 -0.943 . . . . 0.0 110.169 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.503 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 54.7 tt0 -50.97 -28.59 10.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.202 -0.936 . . . . 0.0 109.973 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.484 ' CE1' ' HB3' ' A' ' 90' ' ' ALA . 14.2 t-160 -79.74 -60.63 2.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.268 -0.895 . . . . 0.0 110.114 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.635 ' CG2' ' CD2' ' A' ' 5' ' ' TYR . 7.3 p -65.55 -38.49 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.428 -0.795 . . . . 0.0 110.185 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 26.1 tttp -68.77 -47.33 66.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.233 -0.917 . . . . 0.0 110.238 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.503 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -61.43 -27.02 68.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.91 . . . . 0.0 110.226 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.41 -28.09 71.74 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 49.0 mttt -69.58 -39.99 76.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.221 -1.164 . . . . 0.0 110.211 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -75.18 -34.82 61.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.407 -0.808 . . . . 0.0 110.054 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.439 ' O ' ' HG ' ' A' ' 143' ' ' LEU . 28.5 mttt -67.85 -32.85 73.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.33 -0.856 . . . . 0.0 109.925 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.7 -45.03 47.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.295 -0.878 . . . . 0.0 110.014 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 36.8 m -59.5 -38.62 81.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.444 -0.785 . . . . 0.0 110.049 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -61.52 -41.85 97.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.208 -0.932 . . . . 0.0 109.898 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 139' ' ' LYS . 38.1 mt -60.07 -41.73 93.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.269 -0.894 . . . . 0.0 109.859 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.453 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 24.7 m-85 -56.83 -37.3 71.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.441 -0.787 . . . . 0.0 109.982 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 55.9 mttt -66.5 -25.05 66.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.334 -0.854 . . . . 0.0 109.904 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.524 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 15.9 mt -83.02 -34.69 26.22 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.276 -0.89 . . . . 0.0 108.952 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.547 HD12 ' CE1' ' A' ' 22' ' ' PHE . 79.8 mt -69.54 -34.91 63.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.538 -0.726 . . . . 0.0 109.451 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.53 ' O ' ' CB ' ' A' ' 152' ' ' LYS . 97.0 mt-10 -62.84 -39.06 93.2 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.494 -0.754 . . . . 0.0 109.869 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 86.1 m -72.15 -40.0 68.35 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.299 -0.875 . . . . 0.0 109.96 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.59 ' CD1' HG12 ' A' ' 33' ' ' ILE . 68.6 t80 -55.82 -50.54 70.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.479 -0.763 . . . . 0.0 110.023 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.57 HD22 ' CE1' ' A' ' 158' ' ' TYR . 33.6 mt -79.88 -40.2 28.86 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.331 -0.856 . . . . 0.0 110.464 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.53 ' CB ' ' O ' ' A' ' 148' ' ' GLU . 40.5 tttp -66.12 -22.84 66.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.267 -0.896 . . . . 0.0 109.456 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -103.09 -35.97 3.52 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.613 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 3.8 m-70 -110.77 93.94 18.45 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.397 -1.061 . . . . 0.0 109.978 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.48 5.64 3.62 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.06 1.558 . . . . 0.0 111.022 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 41.6 p30 -107.54 -2.92 19.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.05 -1.031 . . . . 0.0 109.84 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.587 ' HB1' ' CE2' ' A' ' 150' ' ' TYR . . . -70.5 102.58 2.25 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.413 -0.804 . . . . 0.0 110.126 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.579 ' CZ ' ' HB1' ' A' ' 21' ' ' ALA . 1.4 p90 33.72 36.67 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.737 -0.602 . . . . 0.0 110.729 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.527 ' HB2' ' CD ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.776 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.504 ' CG1' ' O ' ' A' ' 120' ' ' TYR . 82.3 t -135.78 144.92 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -1.161 . . . . 0.0 110.358 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.638 ' CD1' ' CD1' ' A' ' 128' ' ' ILE . 9.8 m-85 -107.71 134.23 50.98 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.238 -0.914 . . . . 0.0 110.031 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.6 m -101.8 111.09 23.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.233 -0.917 . . . . 0.0 110.328 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.607 ' CE1' ' CG1' ' A' ' 133' ' ' VAL . 28.7 m-85 -115.26 126.01 54.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.137 -0.977 . . . . 0.0 109.795 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 23.1 pt-20 -140.29 154.77 46.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.183 -0.948 . . . . 0.0 110.524 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.466 ' O ' ' HB3' ' A' ' 116' ' ' SER . 49.4 m -139.53 135.61 33.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.336 -0.853 . . . . 0.0 109.729 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.438 ' HG3' ' HG3' ' A' ' 115' ' ' LYS . 2.4 tt0 -116.15 138.86 50.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.1 -1.0 . . . . 0.0 110.72 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.631 ' CZ ' ' CG2' ' A' ' 114' ' ' ILE . 5.8 p90 -158.98 -173.04 4.04 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.506 -0.746 . . . . 0.0 109.814 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.517 ' CG2' ' HA ' ' A' ' 113' ' ' ILE . 7.4 p -141.57 172.02 13.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.137 -0.977 . . . . 0.0 110.519 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 112' ' ' SER . 89.9 p -159.95 140.2 11.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.282 -0.886 . . . . 0.0 110.264 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.458 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 97.2 mt-10 -64.32 -39.08 93.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.28 -0.887 . . . . 0.0 110.106 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.537 ' CD1' ' HB2' ' A' ' 152' ' ' LYS . 2.7 mp -51.37 150.2 6.62 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.313 -0.867 . . . . 0.0 109.791 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.525 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 41.7 Cg_endo -67.99 137.1 40.16 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.974 1.513 . . . . 0.0 110.505 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.614 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 41.8 Cg_endo -73.68 -28.95 11.18 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 124.072 1.564 . . . . 0.0 112.933 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 15' ' ' PRO . 43.4 Cg_endo -73.68 -21.33 19.2 Favored 'Trans proline' 0 C--N 1.319 -1.001 0 O-C-N 122.408 0.688 . . . . 0.0 110.534 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.589 ' NE ' ' CB ' ' A' ' 159' ' ' ASN . 57.6 ttt180 -85.7 -50.9 6.82 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.522 ' HG ' ' CG2' ' A' ' 147' ' ' ILE . 1.7 tt -57.13 -27.66 62.03 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.58 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 64.9 t80 -69.57 -54.65 13.04 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.488 0.661 . . . . 0.0 109.477 178.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.495 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 49.5 mttt -55.31 -29.65 58.68 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 122.158 0.98 . . . . 0.0 108.376 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.662 ' CB ' ' CE1' ' A' ' 158' ' ' TYR . . . -77.36 -63.46 1.37 Allowed 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.647 0.737 . . . . 0.0 110.797 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.635 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 0.1 OUTLIER -60.72 -28.92 69.02 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.612 -0.68 . . . . 0.0 111.401 -178.599 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.567 HG11 ' CE1' ' A' ' 81' ' ' TYR . 4.3 t -108.63 -66.39 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.046 -1.034 . . . . 0.0 111.406 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.495 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 8.6 mp -68.91 -10.97 60.04 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.162 -0.961 . . . . 0.0 111.205 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.487 ' O ' ' N ' ' A' ' 29' ' ' LEU . 0.3 OUTLIER -138.2 16.89 2.79 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.889 -1.132 . . . . 0.0 110.075 179.721 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -51.76 -44.91 63.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 110.177 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.456 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 61.8 m-20 -62.07 -12.41 19.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.181 -0.949 . . . . 0.0 110.157 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.467 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 77.8 m-20 -124.2 -7.71 7.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 110.42 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.55 HD11 ' N ' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -85.0 -46.04 11.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.201 -0.937 . . . . 0.0 110.37 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.594 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 2.9 t -69.51 -41.86 18.2 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.35 -0.844 . . . . 0.0 111.002 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.1 Cg_endo -78.55 9.72 3.08 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.54 1.284 . . . . 0.0 110.792 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.449 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 21.7 mttm -121.17 -29.43 4.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.174 -0.954 . . . . 0.0 109.307 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.594 HG12 ' CD1' ' A' ' 150' ' ' TYR . 14.9 mt -80.21 -64.99 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-O 121.607 0.718 . . . . 0.0 109.388 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.01 106.51 9.61 Favored Pre-proline 0 C--N 1.303 -1.451 0 O-C-N 121.708 -0.62 . . . . 0.0 109.876 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.3 0.49 5.97 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.078 1.567 . . . . 0.0 111.035 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -81.13 -13.3 58.81 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.032 -1.042 . . . . 0.0 109.418 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.428 ' HB1' HD11 ' A' ' 38' ' ' ILE . . . -96.95 -67.66 0.84 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.393 -0.817 . . . . 0.0 110.15 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.588 ' CG1' ' CG2' ' A' ' 56' ' ' ILE . 2.3 mp -109.6 127.82 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.491 -0.756 . . . . 0.0 110.158 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 57' ' ' THR . 22.2 ttpt -85.8 -27.68 24.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.272 -0.893 . . . . 0.0 110.366 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.554 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -163.39 148.83 11.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.122 -0.986 . . . . 0.0 110.037 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.452 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 4.2 m -131.54 122.97 27.02 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.314 -0.866 . . . . 0.0 109.953 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -138.15 111.25 7.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.14 -0.975 . . . . 0.0 110.661 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.488 HD11 HG22 ' A' ' 43' ' ' ILE . 28.5 mt -56.87 133.5 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.336 -0.852 . . . . 0.0 109.837 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.518 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 25.3 mt -104.67 -29.78 10.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.913 . . . . 0.0 110.605 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.567 ' CG ' HD13 ' A' ' 53' ' ' ILE . 2.0 m95 -122.46 160.43 25.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.208 -0.932 . . . . 0.0 110.706 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.46 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 41.39 -138.74 1.91 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -152.33 22.2 0.64 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -1.197 . . . . 0.0 110.15 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 126.35 -22.94 5.84 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.477 ' O ' HG22 ' A' ' 71' ' ' ILE . . . -68.43 -174.35 8.79 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.48 ' HA ' HG23 ' A' ' 71' ' ' ILE . 44.5 Cg_endo -72.33 128.8 14.11 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 123.986 1.519 . . . . 0.0 110.593 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.46 ' HA3' ' HE2' ' A' ' 70' ' ' LYS . . . 105.19 -13.54 48.45 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.504 -1.838 . . . . 0.0 108.504 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -71.74 160.73 32.11 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.616 -0.932 . . . . 0.0 109.327 179.589 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.567 HD13 ' CG ' ' A' ' 45' ' ' TRP . 80.6 mt -131.71 119.37 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 110.215 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 0.4 OUTLIER -101.54 126.47 48.36 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.276 -0.89 . . . . 0.0 110.03 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.518 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 22.2 tttm -96.97 90.68 5.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 110.101 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.588 ' CG2' ' CG1' ' A' ' 38' ' ' ILE . 94.1 mt -80.11 139.41 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.299 -0.876 . . . . 0.0 110.065 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.494 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 1.2 p -115.17 153.14 31.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.888 . . . . 0.0 110.301 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.581 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 14.7 m-85 -114.27 176.06 5.21 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.314 -0.866 . . . . 0.0 110.168 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 58' ' ' PHE . . . -43.68 141.82 2.57 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' A' ' 61' ' ' GLY . 80.9 tt0 -53.63 -34.83 59.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -1.179 . . . . 0.0 110.209 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 60' ' ' GLU . . . 43.43 -157.88 0.11 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.48 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 29.6 m -72.27 -29.28 63.75 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.341 -1.093 . . . . 0.0 110.193 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.48 ' NE2' ' O ' ' A' ' 62' ' ' SER . 76.0 mm-40 -140.02 158.41 44.1 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.267 -0.896 . . . . 0.0 110.177 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.562 ' O ' ' CD1' ' A' ' 64' ' ' TYR . 5.4 p90 -50.51 138.6 17.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.267 -0.896 . . . . 0.0 110.171 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.581 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -137.71 85.75 0.23 Allowed Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.531 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 12.4 p90 -133.52 171.65 13.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -1.166 . . . . 0.0 110.249 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.462 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 4.0 m -140.3 177.66 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.332 -0.855 . . . . 0.0 110.35 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.526 ' O ' ' CD1' ' A' ' 85' ' ' LEU . 23.7 mttm -134.81 104.76 6.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.412 -0.805 . . . . 0.0 109.804 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.561 ' CD2' HD11 ' A' ' 85' ' ' LEU . 14.8 m170 -96.9 127.54 42.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.196 -0.94 . . . . 0.0 110.862 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 52' ' ' THR . 77.8 tttt -98.2 113.74 25.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.91 . . . . 0.0 109.414 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.534 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 33.0 mm -44.53 136.19 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.101 -1.0 . . . . 0.0 110.162 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.534 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 23.8 t0 -109.89 -43.57 3.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.419 -0.801 . . . . 0.0 109.969 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.468 ' O ' HD13 ' A' ' 74' ' ' ILE . 62.3 p -170.81 161.2 7.17 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.484 -0.886 . . . . 0.0 109.947 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.468 HD13 ' O ' ' A' ' 73' ' ' SER . 0.9 OUTLIER -149.44 154.36 9.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 119.277 -0.969 . . . . 0.0 111.005 -179.754 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.527 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 2.3 m-20 -136.1 79.96 1.8 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.809 -0.557 . . . . 0.0 110.288 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.58 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 22.2 mttp -59.94 -14.85 17.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.246 -0.909 . . . . 0.0 110.365 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -93.65 -30.88 14.7 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.22 -0.925 . . . . 0.0 109.753 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.505 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -108.25 -3.82 18.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.533 -0.729 . . . . 0.0 109.723 -179.947 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.567 ' CZ ' ' HB3' ' A' ' 16' ' ' PRO . 5.5 m-85 65.36 47.24 2.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.469 -0.77 . . . . 0.0 110.361 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.527 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.6 OUTLIER -116.62 147.41 41.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -0.896 . . . . 0.0 109.289 179.534 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.567 ' CE1' HG11 ' A' ' 23' ' ' VAL . 90.3 t80 -141.88 139.89 32.72 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.07 -1.019 . . . . 0.0 110.344 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 72' ' ' ASP . 1.3 m -143.72 135.41 26.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.255 -0.903 . . . . 0.0 110.348 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.592 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 20.2 p90 -142.86 170.25 16.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.343 -0.848 . . . . 0.0 110.3 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.518 ' CG2' ' O ' ' A' ' 98' ' ' ILE . 93.5 m -127.31 125.58 41.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.33 -0.856 . . . . 0.0 109.763 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.561 HD11 ' CD2' ' A' ' 69' ' ' HIS . 10.8 tp -95.09 129.86 42.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.068 -1.02 . . . . 0.0 110.444 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.468 HG23 HD11 ' A' ' 86' ' ' ILE . 11.0 pt -106.25 -32.89 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.323 -0.861 . . . . 0.0 110.175 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.509 ' OE1' ' CE ' ' A' ' 68' ' ' LYS . 86.9 tt0 -118.5 160.72 21.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.337 -0.852 . . . . 0.0 110.107 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.462 ' HA2' HG13 ' A' ' 67' ' ' VAL . . . 151.86 151.65 5.69 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -73.27 -25.28 60.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -1.155 . . . . 0.0 110.185 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.19 -20.04 63.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.302 -0.874 . . . . 0.0 110.157 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 92' ' ' GLY . 77.0 mt -69.36 -33.57 73.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.269 -0.894 . . . . 0.0 110.137 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 49.77 -179.71 0.02 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -78.14 3.17 15.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.215 -1.168 . . . . 0.0 109.984 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.8 m -93.89 -49.81 5.64 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.204 -0.935 . . . . 0.0 109.849 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.506 HD22 ' CG2' ' A' ' 122' ' ' THR . 42.1 mt -93.6 163.16 13.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.443 -0.786 . . . . 0.0 109.914 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.404 ' CD ' ' HB2' ' A' ' 123' ' ' LYS . 12.3 mt-10 -140.38 -79.85 0.28 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.216 -0.928 . . . . 0.0 109.982 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 29.2 mtmt -80.14 141.24 35.91 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.586 -0.696 . . . . 0.0 109.999 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.634 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 6.3 mm -130.38 140.87 47.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 120.85 -1.157 . . . . 0.0 110.149 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.484 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -123.81 130.04 51.99 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.642 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.634 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 11.6 m-85 -125.35 134.72 52.1 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.21 -0.931 . . . . 0.0 110.603 -178.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -134.52 131.15 37.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.436 -0.79 . . . . 0.0 110.211 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 32.3 m -130.26 140.71 50.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -0.894 . . . . 0.0 109.911 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.442 ' HB2' ' HB3' ' A' ' 115' ' ' LYS . 8.9 mttp -131.79 137.55 48.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.181 -0.95 . . . . 0.0 110.763 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.529 ' CD2' HG12 ' A' ' 114' ' ' ILE . 7.3 mt -116.5 150.66 37.54 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.277 -0.89 . . . . 0.0 109.839 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.49 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -150.91 -169.45 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.11 -0.993 . . . . 0.0 110.064 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -126.83 155.98 42.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.368 -0.833 . . . . 0.0 110.091 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.447 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.7 p -114.6 169.43 6.63 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.279 -0.888 . . . . 0.0 110.309 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.447 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.2 Cg_endo -72.62 -10.69 25.49 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.14 1.6 . . . . 0.0 110.49 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 95.5 p -98.19 5.53 48.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.273 -0.892 . . . . 0.0 110.37 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.1 -34.89 4.76 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 12' ' ' GLU . . . -57.65 -173.86 0.33 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.453 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 54.0 p -133.76 138.41 45.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.198 -1.178 . . . . 0.0 110.434 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.517 ' HA ' ' CG2' ' A' ' 10' ' ' THR . 23.0 mt -91.36 147.26 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.367 -0.833 . . . . 0.0 110.085 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.631 ' CG2' ' CZ ' ' A' ' 9' ' ' PHE . 22.8 mt -133.58 123.26 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.215 -0.928 . . . . 0.0 110.328 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.442 ' HB3' ' HB2' ' A' ' 103' ' ' LYS . 72.4 tttt -107.96 121.66 45.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.233 -0.917 . . . . 0.0 110.089 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -104.32 154.68 19.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.187 -0.946 . . . . 0.0 110.419 -179.854 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 20.9 m -158.76 148.82 19.52 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.432 -0.793 . . . . 0.0 110.2 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 5' ' ' TYR . 86.2 p -157.03 156.28 32.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.297 -0.877 . . . . 0.0 110.154 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.484 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 85.7 m-70 -134.9 137.95 43.66 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.162 -0.961 . . . . 0.0 110.51 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.504 ' O ' ' CG1' ' A' ' 2' ' ' VAL . 3.9 m-30 -104.01 139.29 39.33 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.345 -0.847 . . . . 0.0 110.262 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.501 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 92.1 m-70 -121.96 90.49 3.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.981 -1.074 . . . . 0.0 109.565 179.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.528 ' HB ' ' CG2' ' A' ' 126' ' ' VAL . 1.8 p -72.22 156.69 38.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.28 -0.888 . . . . 0.0 110.66 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.473 ' HG2' ' N ' ' A' ' 124' ' ' GLY . 42.4 tttt -100.31 149.01 24.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.461 -0.775 . . . . 0.0 109.946 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.473 ' N ' ' HG2' ' A' ' 123' ' ' LYS . . . 69.4 -122.88 13.04 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -138.69 70.28 1.38 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -1.195 . . . . 0.0 110.244 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.528 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 32.5 m -122.9 164.21 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 0.0 109.972 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -131.86 152.39 51.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.098 -1.001 . . . . 0.0 110.406 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.638 ' CD1' ' CD1' ' A' ' 3' ' ' PHE . 2.8 mp -84.35 172.4 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.269 -0.895 . . . . 0.0 110.205 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.438 ' N ' ' CG2' ' A' ' 128' ' ' ILE . 5.8 tttp -112.31 179.03 4.11 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.323 -0.86 . . . . 0.0 109.853 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -82.39 5.46 20.33 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.172 -0.955 . . . . 0.0 108.822 178.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -93.83 -31.56 14.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.386 -0.821 . . . . 0.0 109.906 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 15.8 t-160 -85.93 -36.16 20.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.29 -0.881 . . . . 0.0 110.083 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.607 ' CG1' ' CE1' ' A' ' 5' ' ' TYR . 37.0 t -77.56 -43.21 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.351 -0.843 . . . . 0.0 110.095 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 57.5 tttm -65.51 -44.21 87.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 0.0 110.114 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.44 -37.23 85.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.24 -0.913 . . . . 0.0 110.027 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -64.09 -30.72 78.57 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 81.0 mttt -61.9 -31.67 71.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.366 -1.079 . . . . 0.0 109.998 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.483 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 70.0 mm-40 -82.29 -36.92 26.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.319 -0.863 . . . . 0.0 109.962 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -70.48 -30.52 67.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.337 -0.852 . . . . 0.0 109.975 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.57 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -88.43 -37.74 15.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.894 . . . . 0.0 110.094 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 137' ' ' LYS . 66.3 m -71.24 -52.58 18.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.416 -0.802 . . . . 0.0 109.97 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.483 ' ND2' ' O ' ' A' ' 138' ' ' GLU . 92.3 m-20 -54.62 -43.41 72.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.275 -0.891 . . . . 0.0 109.971 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.46 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 13.0 tp -59.7 -42.74 93.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.895 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.57 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 7.7 m-85 -55.17 -39.1 69.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.331 -0.856 . . . . 0.0 109.587 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.451 ' O ' ' HG2' ' A' ' 145' ' ' LYS . 51.0 tttt -74.53 -15.02 60.88 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.419 -0.801 . . . . 0.0 109.859 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.46 ' HB2' ' O ' ' A' ' 143' ' ' LEU . 29.2 mt -80.86 -35.15 33.11 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.178 -0.951 . . . . 0.0 108.712 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.635 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 17.4 mt -68.83 -51.59 43.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.492 ' HB3' ' CD1' ' A' ' 13' ' ' ILE . 52.6 mt-10 -56.46 -40.9 75.64 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.543 -0.723 . . . . 0.0 109.764 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 98.0 m -66.97 -41.81 86.2 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.144 -0.973 . . . . 0.0 109.811 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.594 ' CD1' HG12 ' A' ' 33' ' ' ILE . 87.1 t80 -56.19 -46.18 79.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.344 -0.847 . . . . 0.0 109.997 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.549 ' CD2' ' NE ' ' A' ' 17' ' ' ARG . 33.2 mt -80.15 -28.98 38.78 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.227 -0.921 . . . . 0.0 110.344 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.537 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . 21.4 tttt -72.23 -28.06 62.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.327 -0.858 . . . . 0.0 109.822 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.464 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -101.47 -33.61 4.75 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.56 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 5.9 m-70 -106.94 92.4 7.54 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.339 -1.095 . . . . 0.0 109.71 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 48.5 Cg_endo -73.68 8.22 2.02 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.288 1.678 . . . . 0.0 111.439 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -112.5 1.47 15.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.915 -1.116 . . . . 0.0 109.817 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.593 ' HB1' ' CE2' ' A' ' 150' ' ' TYR . . . -73.4 100.98 3.35 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.367 -0.833 . . . . 0.0 110.421 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.662 ' CE1' ' CB ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER 34.53 39.55 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.747 -0.596 . . . . 0.0 110.691 -179.737 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.589 ' CB ' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.416 0 CA-C-O 118.007 -0.996 . . . . 0.0 109.722 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.519 ' CG1' ' O ' ' A' ' 120' ' ' TYR . 70.9 t -140.21 125.32 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.197 -1.178 . . . . 0.0 110.169 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.596 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 66.0 m-85 -88.93 126.09 35.24 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.141 -0.974 . . . . 0.0 110.108 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.0 m -117.38 107.24 14.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.235 -0.916 . . . . 0.0 110.431 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.653 ' CE1' ' CG2' ' A' ' 133' ' ' VAL . 69.5 m-85 -111.49 126.11 54.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.184 -0.948 . . . . 0.0 110.164 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.516 ' CG ' HG22 ' A' ' 117' ' ' THR . 2.4 mt-10 -117.6 144.79 44.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.295 -0.878 . . . . 0.0 110.564 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.47 ' C ' ' CG ' ' A' ' 8' ' ' GLU . 20.0 m -128.0 164.64 21.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.331 -0.856 . . . . 0.0 109.842 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.47 ' CG ' ' C ' ' A' ' 7' ' ' SER . 68.4 mt-10 -153.12 124.65 7.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.064 -1.022 . . . . 0.0 110.757 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.636 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.0 p90 -145.24 -176.22 5.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.308 -0.87 . . . . 0.0 109.728 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.523 HG23 ' CG1' ' A' ' 113' ' ' ILE . 6.8 p -142.5 174.56 10.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.062 -1.024 . . . . 0.0 110.687 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.485 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 7.9 t -159.99 164.96 32.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.37 -0.831 . . . . 0.0 110.142 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -89.69 -22.85 22.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.306 -0.871 . . . . 0.0 110.213 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.538 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 8.4 mm -68.1 150.71 97.64 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.264 -0.898 . . . . 0.0 109.984 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.538 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 41.0 Cg_endo -66.98 145.05 72.63 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 124.029 1.541 . . . . 0.0 110.598 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.642 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.1 Cg_endo -71.18 -31.99 13.68 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.873 1.459 . . . . 0.0 112.765 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.642 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.1 Cg_endo -69.23 -22.76 34.06 Favored 'Trans proline' 0 C--N 1.318 -1.047 0 N-CA-C 109.988 -0.812 . . . . 0.0 109.988 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.536 ' NE ' ' CB ' ' A' ' 159' ' ' ASN . 52.3 mtp180 -81.79 -43.13 18.75 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.594 ' CD2' ' CG2' ' A' ' 147' ' ' ILE . 0.2 OUTLIER -73.53 -33.78 64.89 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.702 -0.799 . . . . 0.0 108.939 178.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.583 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 59.8 t80 -60.27 -60.51 3.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.511 -0.743 . . . . 0.0 109.765 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.493 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 23.1 mttt -53.77 -38.9 64.92 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.735 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.654 ' CB ' ' CZ ' ' A' ' 158' ' ' TYR . . . -69.17 -36.42 77.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.456 -0.778 . . . . 0.0 110.904 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.577 ' CD1' HD12 ' A' ' 147' ' ' ILE . 0.3 OUTLIER -79.09 -49.21 12.99 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.31 -0.869 . . . . 0.0 110.974 -179.127 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.463 ' HB ' HD13 ' A' ' 24' ' ' LEU . 3.7 t -94.34 -53.97 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.202 -0.936 . . . . 0.0 111.813 -178.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.55 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 7.4 mp -80.03 -1.05 38.06 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.972 -1.08 . . . . 0.0 112.129 -178.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.534 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -147.78 23.46 1.1 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.704 -1.247 . . . . 0.0 110.725 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -65.76 -12.35 53.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.089 -1.007 . . . . 0.0 110.193 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.503 ' HA ' ' CB ' ' A' ' 41' ' ' SER . 92.0 m-20 -80.08 -13.76 59.05 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.205 -0.934 . . . . 0.0 110.443 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -135.46 6.19 3.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.192 -0.943 . . . . 0.0 110.595 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.483 HD23 ' CZ ' ' A' ' 150' ' ' TYR . 0.2 OUTLIER -96.59 -40.56 8.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.214 -0.929 . . . . 0.0 109.888 179.901 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.604 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 4.1 t -82.45 -41.01 0.92 Allowed Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.437 -0.79 . . . . 0.0 111.013 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.7 Cg_endo -78.95 11.43 2.57 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.365 1.192 . . . . 0.0 110.771 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -124.41 -34.04 2.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.065 -1.022 . . . . 0.0 109.438 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.545 HD13 ' CD1' ' A' ' 150' ' ' TYR . 7.5 mt -80.12 -38.75 18.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.489 -0.757 . . . . 0.0 109.399 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.77 96.68 7.43 Favored Pre-proline 0 C--N 1.304 -1.379 0 O-C-N 121.463 -0.773 . . . . 0.0 110.03 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.35 -2.52 11.37 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.003 1.528 . . . . 0.0 110.513 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -88.48 -26.41 22.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.135 -0.978 . . . . 0.0 109.711 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -86.08 -73.43 0.45 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.4 -0.813 . . . . 0.0 109.969 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.522 HG13 ' CG2' ' A' ' 56' ' ' ILE . 2.1 mp -102.6 137.15 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.407 -0.808 . . . . 0.0 110.045 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.2 ttpp -96.18 -32.28 12.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 110.376 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.576 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -167.94 156.68 9.29 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.213 -0.93 . . . . 0.0 110.09 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.503 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 11.0 p -115.83 144.89 43.37 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.273 -0.892 . . . . 0.0 110.266 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.576 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 73.3 tt0 -149.0 97.74 2.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.248 -0.908 . . . . 0.0 110.327 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 19.1 mt -57.52 130.78 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.173 -0.955 . . . . 0.0 110.06 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.523 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 31.0 mt -102.55 -35.25 8.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 110.64 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.505 ' HB2' ' CB ' ' A' ' 53' ' ' ILE . 1.9 m95 -122.91 162.85 21.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.108 -0.995 . . . . 0.0 110.658 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.454 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 41.79 -136.51 2.92 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.418 ' O ' ' CG ' ' A' ' 47' ' ' ASP . 11.1 t0 -154.26 22.41 0.49 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -1.143 . . . . 0.0 109.907 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 122.82 -20.47 7.7 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.819 -1.712 . . . . 0.0 108.819 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.471 ' O ' HG23 ' A' ' 71' ' ' ILE . . . -68.42 -171.92 6.85 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.48 ' HA ' HG23 ' A' ' 71' ' ' ILE . 45.8 Cg_endo -73.81 129.13 13.12 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.051 1.553 . . . . 0.0 110.626 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.84 -9.18 56.66 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -73.49 159.13 33.65 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.523 -0.986 . . . . 0.0 109.94 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.505 ' CB ' ' HB2' ' A' ' 45' ' ' TRP . 78.1 mt -126.85 119.61 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.354 -0.841 . . . . 0.0 109.406 179.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -105.15 135.25 46.84 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 110.451 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.523 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 76.7 tttt -104.22 93.43 4.82 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.364 -0.835 . . . . 0.0 110.05 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.522 ' CG2' HG13 ' A' ' 38' ' ' ILE . 66.3 mt -79.98 134.19 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.206 -0.934 . . . . 0.0 109.942 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.523 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 1.7 p -106.98 155.89 19.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.371 -0.831 . . . . 0.0 110.213 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.43 ' N ' ' O ' ' A' ' 65' ' ' GLY . 22.6 m-85 -111.48 151.24 28.84 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.319 -0.863 . . . . 0.0 110.205 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 58' ' ' PHE . . . -43.44 160.92 0.06 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -46.54 -86.42 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -1.139 . . . . 0.0 110.181 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.54 -94.01 0.22 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 79.2 p -87.49 -140.92 0.11 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.19 -1.182 . . . . 0.0 110.066 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -83.65 -28.65 28.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.182 -0.949 . . . . 0.0 110.115 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -178.44 131.4 0.13 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.233 -0.917 . . . . 0.0 109.934 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.469 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -135.92 133.94 6.92 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.544 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 10.5 p90 -178.16 169.34 1.9 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.335 -1.097 . . . . 0.0 110.181 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.483 HG13 ' CA ' ' A' ' 88' ' ' GLY . 4.1 m -141.92 176.92 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.395 -0.816 . . . . 0.0 110.54 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.474 ' O ' HD22 ' A' ' 85' ' ' LEU . 68.8 tttt -127.69 122.95 34.29 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.363 -0.836 . . . . 0.0 109.792 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.426 ' NE2' ' HG ' ' A' ' 85' ' ' LEU . 9.0 m170 -116.26 126.62 53.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.088 -1.007 . . . . 0.0 110.993 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 52' ' ' THR . 15.2 tttt -102.76 117.23 34.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.295 -0.878 . . . . 0.0 109.403 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.531 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 25.5 mm -60.13 126.61 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.243 -0.911 . . . . 0.0 110.334 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.48 ' N ' ' O ' ' A' ' 82' ' ' SER . 41.9 m-20 -97.95 -36.89 10.0 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.35 -0.844 . . . . 0.0 109.724 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.464 ' OG ' ' HB2' ' A' ' 82' ' ' SER . 35.0 p -178.58 157.33 0.97 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.327 -0.858 . . . . 0.0 109.887 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.461 HD12 ' CG1' ' A' ' 23' ' ' VAL . 1.3 mt -139.67 158.24 27.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.257 -0.902 . . . . 0.0 110.051 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.52 ' HB2' ' HB3' ' A' ' 80' ' ' SER . 0.8 OUTLIER -142.77 82.47 1.77 Allowed 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.537 179.698 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.583 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 48.7 tttm -66.21 -14.62 62.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.309 -0.869 . . . . 0.0 110.214 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -87.69 -29.37 21.17 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.395 -0.816 . . . . 0.0 108.907 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.494 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.2 m-80 -108.07 -5.66 16.9 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.403 0.62 . . . . 0.0 109.358 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.542 ' CB ' ' HB2' ' A' ' 104' ' ' LEU . 50.5 m-85 64.58 53.04 1.65 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.681 -0.637 . . . . 0.0 110.608 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.52 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 11.8 t -125.33 175.75 7.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 110.242 179.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.594 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 20.8 t80 -156.8 145.83 20.21 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.959 -0.697 . . . . 0.0 110.182 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.48 ' O ' ' N ' ' A' ' 72' ' ' ASP . 0.4 OUTLIER -147.34 124.06 11.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.265 -0.897 . . . . 0.0 110.819 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.627 ' N ' ' CD1' ' A' ' 83' ' ' TYR . 2.5 p90 -145.77 -179.92 7.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.37 -0.831 . . . . 0.0 109.708 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.509 ' CG2' ' O ' ' A' ' 98' ' ' ILE . 18.6 m -135.62 146.88 48.34 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.132 -0.98 . . . . 0.0 110.567 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.567 ' CB ' ' HB ' ' A' ' 98' ' ' ILE . 0.2 OUTLIER -102.43 117.82 35.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.29 -0.881 . . . . 0.0 110.257 179.67 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 22.3 pt -113.13 -6.12 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.228 -0.92 . . . . 0.0 110.138 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -145.92 128.29 15.89 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.319 -0.863 . . . . 0.0 110.39 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.483 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . -178.59 120.32 0.7 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -52.56 -27.33 16.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -1.161 . . . . 0.0 110.158 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.07 -20.98 62.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.935 . . . . 0.0 110.154 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' A' ' 92' ' ' GLY . 32.9 mt -69.55 -24.74 63.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.237 -0.914 . . . . 0.0 110.222 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 50.03 -176.87 0.04 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -81.22 6.9 12.62 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -1.143 . . . . 0.0 110.222 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 26.2 p -94.21 -28.72 15.48 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.227 -0.921 . . . . 0.0 110.096 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.567 ' CD2' ' CD1' ' A' ' 128' ' ' ILE . 90.3 mt -110.35 151.66 27.17 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.302 -0.874 . . . . 0.0 110.014 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.42 ' HG3' ' HB2' ' A' ' 123' ' ' LYS . 11.5 mt-10 -133.79 -80.81 0.46 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.172 -0.955 . . . . 0.0 110.281 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.517 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 70.8 mttt -80.36 127.2 32.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.549 -0.719 . . . . 0.0 110.898 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.593 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 13.0 mm -116.98 146.73 21.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 120.722 -1.237 . . . . 0.0 109.664 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.483 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.5 OUTLIER -124.99 124.8 42.78 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.504 -0.879 . . . . 0.0 108.704 178.223 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.593 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 15.3 m-85 -121.15 140.81 51.5 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.366 -0.834 . . . . 0.0 110.454 -178.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.485 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 20.2 tt0 -145.42 136.92 25.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.284 -0.885 . . . . 0.0 110.331 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 60.6 m -135.16 129.69 34.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.32 -0.863 . . . . 0.0 109.635 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.98 144.57 50.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.946 . . . . 0.0 110.691 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.542 ' HB2' ' CB ' ' A' ' 79' ' ' TYR . 7.4 mt -117.52 155.58 29.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.292 -0.88 . . . . 0.0 109.973 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.487 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 1.9 t -151.35 -169.2 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.133 -0.979 . . . . 0.0 110.185 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -121.87 144.07 49.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.37 -0.831 . . . . 0.0 110.234 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.461 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 3.4 p -101.2 169.41 7.81 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.182 -0.949 . . . . 0.0 110.253 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.461 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 47.6 Cg_endo -73.15 -10.91 24.84 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.111 1.585 . . . . 0.0 110.565 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.6 m -99.45 4.29 46.07 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.226 -0.921 . . . . 0.0 110.185 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 102.05 -36.93 3.92 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -56.79 178.17 0.79 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 20.6 p -122.76 130.0 52.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.228 -1.16 . . . . 0.0 110.284 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.523 ' CG1' HG23 ' A' ' 10' ' ' THR . 5.9 mt -80.33 149.41 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.252 -0.905 . . . . 0.0 110.077 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.581 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 6.5 mt -128.59 118.97 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 0.0 110.189 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 38.7 tttt -101.15 128.98 46.99 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.159 -0.963 . . . . 0.0 110.157 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.446 ' HB3' ' HB2' ' A' ' 7' ' ' SER . 0.0 OUTLIER -110.99 152.13 27.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.215 -0.928 . . . . 0.0 110.047 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.585 ' CG2' ' CE1' ' A' ' 119' ' ' HIS . 33.4 m -160.09 125.29 3.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.212 -0.93 . . . . 0.0 110.499 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.505 ' HB3' ' CE1' ' A' ' 100' ' ' TYR . 3.1 m -135.46 142.94 45.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.314 -0.866 . . . . 0.0 109.746 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.585 ' CE1' ' CG2' ' A' ' 117' ' ' THR . 33.1 m-70 -129.49 136.19 49.57 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.082 -1.011 . . . . 0.0 110.293 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.6 ' N ' ' CD1' ' A' ' 120' ' ' TYR . 3.0 m-30 -104.54 151.78 23.19 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.308 -0.87 . . . . 0.0 110.745 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.517 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 82.1 m-70 -129.78 86.97 2.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.297 -0.877 . . . . 0.0 109.43 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.529 ' CG2' HD22 ' A' ' 95' ' ' LEU . 1.4 p -63.23 156.11 26.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.375 -0.828 . . . . 0.0 110.56 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.42 ' HB2' ' HG3' ' A' ' 96' ' ' GLU . 4.3 tttm -103.86 106.52 17.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.399 -0.813 . . . . 0.0 110.07 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 103.45 -123.41 7.78 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -136.62 94.61 3.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.233 -1.157 . . . . 0.0 110.252 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.497 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 14.9 m -141.95 -177.77 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.277 -0.889 . . . . 0.0 110.128 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -134.23 144.5 48.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -0.933 . . . . 0.0 110.48 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.585 HG12 ' CZ ' ' A' ' 3' ' ' PHE . 12.0 mm -64.94 172.54 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 110.154 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 132' ' ' HIS . 18.8 mttt -97.78 127.89 44.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.345 -0.847 . . . . 0.0 109.847 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 129' ' ' LYS . 94.6 mt-10 -44.13 -52.8 6.98 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.131 -0.981 . . . . 0.0 109.937 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.509 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 50.7 tt0 -52.54 -20.53 3.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.203 -0.935 . . . . 0.0 109.706 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.479 ' N ' ' O ' ' A' ' 129' ' ' LYS . 14.0 t-160 -85.31 -61.85 1.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.395 -0.816 . . . . 0.0 110.259 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.653 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 1.8 p -66.37 -20.92 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.306 -0.872 . . . . 0.0 110.285 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -104.42 -72.51 0.7 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.922 . . . . 0.0 110.027 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.509 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -56.57 -22.4 33.28 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 109.77 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -75.46 -27.87 62.67 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -68.83 -33.9 74.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.174 -1.192 . . . . 0.0 110.145 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.419 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 78.4 tt0 -75.95 -24.14 55.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.315 -0.866 . . . . 0.0 110.109 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 67.7 mttt -78.94 -27.98 43.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.335 -0.853 . . . . 0.0 109.991 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -81.85 -36.1 28.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.289 -0.882 . . . . 0.0 110.072 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.8 t -65.25 -46.32 81.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.4 -0.812 . . . . 0.0 110.141 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.419 ' ND2' ' O ' ' A' ' 138' ' ' GLU . 93.5 m-20 -51.69 -47.58 63.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.343 -0.848 . . . . 0.0 110.028 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.473 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 14.0 tp -56.68 -50.03 73.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.903 . . . . 0.0 109.936 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.467 ' CG ' ' CZ ' ' A' ' 9' ' ' PHE . 18.0 m-85 -55.87 -39.26 71.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.334 -0.854 . . . . 0.0 109.708 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -75.97 -11.09 59.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.417 -0.802 . . . . 0.0 110.089 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 143' ' ' LEU . 11.7 mt -83.42 -37.84 22.7 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.211 -0.931 . . . . 0.0 108.804 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.594 ' CG2' ' CD2' ' A' ' 18' ' ' LEU . 63.5 mt -69.06 -48.49 69.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.485 ' CG ' ' OG ' ' A' ' 11' ' ' SER . 96.8 mt-10 -47.27 -38.01 11.69 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.414 -0.804 . . . . 0.0 109.009 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.412 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 11.0 m -79.94 -25.4 40.48 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.318 -0.864 . . . . 0.0 109.237 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.587 ' CD2' ' OH ' ' A' ' 158' ' ' TYR . 64.9 t80 -54.85 -51.8 64.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.583 -0.698 . . . . 0.0 109.824 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.581 HD22 ' CE1' ' A' ' 158' ' ' TYR . 45.0 mt -79.89 -28.97 39.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.479 -0.763 . . . . 0.0 109.994 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.438 ' CA ' HD13 ' A' ' 13' ' ' ILE . 21.1 tttt -64.18 -13.04 45.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.317 -0.864 . . . . 0.0 109.488 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.475 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -124.19 -24.13 1.86 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.58 ' CD2' ' O ' ' A' ' 150' ' ' TYR . 10.4 m-70 -105.53 93.62 7.36 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.147 -1.208 . . . . 0.0 110.165 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.0 Cg_endo -73.43 4.12 4.19 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 124.12 1.589 . . . . 0.0 111.038 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -119.44 -1.53 10.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.023 -1.048 . . . . 0.0 110.126 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.56 ' O ' ' CD1' ' A' ' 158' ' ' TYR . . . -59.76 105.51 0.38 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.339 -0.85 . . . . 0.0 110.159 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.654 ' CZ ' ' CB ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER 35.64 30.53 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.606 -0.684 . . . . 0.0 110.738 -179.754 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.536 ' CB ' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.726 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.591 HG22 ' CD2' ' A' ' 121' ' ' HIS . 2.8 p -80.47 151.56 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.297 -1.119 . . . . 0.0 110.219 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.623 ' CD1' ' CD1' ' A' ' 128' ' ' ILE . 15.9 m-85 -90.14 176.39 6.79 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.276 -0.89 . . . . 0.0 110.046 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.543 HG21 ' CE1' ' A' ' 119' ' ' HIS . 94.9 m -140.88 106.11 5.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.247 -0.908 . . . . 0.0 110.294 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.637 ' CD1' ' CG1' ' A' ' 133' ' ' VAL . 22.2 m-85 -113.36 129.5 56.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -0.895 . . . . 0.0 109.987 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 22.4 pt-20 -130.41 152.99 49.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.233 -0.917 . . . . 0.0 110.569 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.3 m -138.18 147.18 43.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.373 -0.829 . . . . 0.0 109.84 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -131.36 117.12 18.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.132 -0.98 . . . . 0.0 110.556 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.4 p90 -139.21 -176.72 4.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.313 -0.867 . . . . 0.0 110.014 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.474 HG23 HG12 ' A' ' 113' ' ' ILE . 7.6 p -136.05 174.95 10.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.188 -0.945 . . . . 0.0 110.662 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.465 ' HB3' ' OE2' ' A' ' 148' ' ' GLU . 80.5 p -160.02 128.51 4.88 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.392 -0.817 . . . . 0.0 110.288 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.61 -28.86 68.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.195 -0.941 . . . . 0.0 109.924 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.53 ' CD1' ' HB2' ' A' ' 152' ' ' LYS . 1.3 mp -65.89 148.33 98.34 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.334 -0.854 . . . . 0.0 109.828 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.487 ' CG ' ' HD3' ' A' ' 17' ' ' ARG . 40.7 Cg_endo -66.49 141.65 62.09 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.892 1.469 . . . . 0.0 110.491 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.617 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.3 Cg_endo -72.87 -30.88 10.79 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 124.017 1.535 . . . . 0.0 112.886 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.6 Cg_endo -70.68 -22.33 28.0 Favored 'Trans proline' 0 C--N 1.319 -1.001 0 N-CA-C 110.195 -0.733 . . . . 0.0 110.195 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.573 ' NE ' ' CB ' ' A' ' 159' ' ' ASN . 43.4 mtp180 -84.31 -43.28 14.95 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.59 ' CD2' ' CG2' ' A' ' 147' ' ' ILE . 0.2 OUTLIER -72.73 -34.74 67.27 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.018 179.05 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.492 ' HB2' ' O ' ' A' ' 15' ' ' PRO . 52.5 t80 -64.5 -56.21 15.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.333 -0.854 . . . . 0.0 109.573 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 25' ' ' ASP . 28.7 mttt -52.74 -36.41 57.68 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.734 -0.787 . . . . 0.0 109.564 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.647 ' CB ' ' CZ ' ' A' ' 158' ' ' TYR . . . -78.03 -36.58 48.38 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.372 -0.83 . . . . 0.0 111.056 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.64 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 0.3 OUTLIER -73.91 -42.71 60.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.195 -0.94 . . . . 0.0 111.191 -179.057 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.464 HG12 HG12 ' A' ' 74' ' ' ILE . 4.6 t -105.99 -49.97 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.018 -1.051 . . . . 0.0 111.61 -178.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.487 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 7.1 mp -79.84 -9.95 59.72 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.26 -0.9 . . . . 0.0 111.399 -178.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 20' ' ' LYS . 0.9 OUTLIER -149.44 38.82 0.79 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.85 -1.156 . . . . 0.0 110.555 -179.755 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -78.92 -24.97 43.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.333 -0.854 . . . . 0.0 110.504 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.462 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 91.8 m-20 -65.34 -21.15 66.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.154 -0.966 . . . . 0.0 110.221 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.48 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 4.1 p30 -125.4 13.0 8.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.315 -0.866 . . . . 0.0 109.89 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.529 HD11 ' CD1' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -94.28 -52.04 4.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.441 -0.787 . . . . 0.0 110.327 -179.89 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.66 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 3.8 p -75.1 -28.87 0.82 Allowed Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.275 -0.89 . . . . 0.0 112.288 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.66 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 51.9 Cg_endo -79.1 7.58 4.3 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 O-C-N 122.704 0.844 . . . . 0.0 110.581 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -129.66 -29.73 2.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.172 -0.955 . . . . 0.0 110.009 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.57 HG12 ' CD1' ' A' ' 150' ' ' TYR . 75.5 mt -80.04 -44.13 22.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.41 -0.806 . . . . 0.0 109.788 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -160.43 103.21 1.35 Allowed Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.376 -0.827 . . . . 0.0 110.121 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.46 0.29 7.69 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.077 1.567 . . . . 0.0 110.641 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -83.48 -15.57 49.0 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.182 -0.949 . . . . 0.0 109.67 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -92.13 -64.84 1.06 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.414 -0.804 . . . . 0.0 109.993 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.518 ' CD1' HG22 ' A' ' 30' ' ' VAL . 2.1 mp -114.88 131.19 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.426 -0.796 . . . . 0.0 109.941 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 57' ' ' THR . 15.8 ttpt -77.42 -23.43 50.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.203 -0.936 . . . . 0.0 110.48 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.543 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -178.94 161.45 1.18 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.106 -0.996 . . . . 0.0 110.102 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.4 m -134.61 124.34 25.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.329 -0.857 . . . . 0.0 109.977 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.543 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 44.5 tt0 -137.68 110.92 7.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -0.938 . . . . 0.0 110.661 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 33.8 mt -56.25 136.27 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.33 -0.857 . . . . 0.0 109.787 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.462 ' HB2' ' CD ' ' A' ' 55' ' ' LYS . 7.6 tp -108.76 -26.1 10.48 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.174 -0.953 . . . . 0.0 110.575 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.536 ' CG ' HD13 ' A' ' 53' ' ' ILE . 2.0 m95 -128.65 163.3 25.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.123 -0.985 . . . . 0.0 110.845 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.459 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 41.8 -137.72 2.55 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.94 24.13 0.66 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.326 -1.102 . . . . 0.0 110.02 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 119.04 -16.32 10.88 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.463 ' O ' HG23 ' A' ' 71' ' ' ILE . . . -73.66 -170.02 19.66 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.482 ' HA ' HG23 ' A' ' 71' ' ' ILE . 47.1 Cg_endo -73.75 128.85 12.88 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.99 1.521 . . . . 0.0 110.559 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.444 ' HA3' ' HE3' ' A' ' 70' ' ' LYS . . . 102.64 -12.32 56.55 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 108.707 -1.757 . . . . 0.0 108.707 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -71.36 161.6 30.8 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.534 -0.98 . . . . 0.0 109.56 179.674 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.536 HD13 ' CG ' ' A' ' 45' ' ' TRP . 45.0 mt -130.78 119.93 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.329 -0.857 . . . . 0.0 109.959 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.512 ' CE ' HD12 ' A' ' 71' ' ' ILE . 29.3 mttm -103.11 127.17 50.49 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.151 -0.968 . . . . 0.0 110.228 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.462 ' CD ' ' HB2' ' A' ' 44' ' ' LEU . 7.8 mtpt -96.06 92.69 6.57 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.378 -0.826 . . . . 0.0 110.098 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.517 ' CG2' HG12 ' A' ' 38' ' ' ILE . 95.2 mt -79.95 141.87 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 109.914 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 39' ' ' LYS . 2.4 p -116.4 152.07 34.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.3 -0.875 . . . . 0.0 110.582 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.577 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 23.5 m-85 -117.5 145.87 43.92 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.37 -0.832 . . . . 0.0 110.104 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -70.12 122.0 10.92 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -144.94 165.61 27.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -1.161 . . . . 0.0 110.143 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.25 -133.84 0.07 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 92.3 p -60.08 -29.13 68.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.214 -1.168 . . . . 0.0 110.21 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -81.66 142.84 32.35 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.21 -0.932 . . . . 0.0 110.163 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -96.62 145.8 25.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.165 -0.96 . . . . 0.0 110.228 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.577 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -135.53 96.61 0.27 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.546 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 13.6 p90 -136.1 169.13 18.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -1.182 . . . . 0.0 110.197 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.519 HG13 ' CA ' ' A' ' 88' ' ' GLY . 6.5 m -139.54 175.32 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.233 -0.917 . . . . 0.0 110.636 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.522 ' O ' ' CD1' ' A' ' 85' ' ' LEU . 42.7 mttt -133.41 104.63 6.51 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.465 -0.772 . . . . 0.0 109.905 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.547 ' CD2' HD11 ' A' ' 85' ' ' LEU . 13.3 m170 -96.13 129.6 43.38 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.197 -0.94 . . . . 0.0 111.138 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 52' ' ' THR . 21.6 tttp -96.92 116.7 29.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.327 -0.858 . . . . 0.0 109.395 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.523 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 26.8 mm -57.26 128.59 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.172 -0.955 . . . . 0.0 110.346 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 82' ' ' SER . 85.0 m-20 -101.58 -43.79 5.78 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.341 -0.849 . . . . 0.0 110.013 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.42 ' OG ' ' HB2' ' A' ' 82' ' ' SER . 62.0 p -173.67 158.67 3.38 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.434 -0.791 . . . . 0.0 109.946 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.464 HG12 HG12 ' A' ' 23' ' ' VAL . 2.0 mt -139.3 157.4 27.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.229 -0.92 . . . . 0.0 110.228 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 79' ' ' TYR . 4.5 m-20 -135.41 79.2 1.77 Allowed 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.371 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -61.38 -17.74 55.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -0.923 . . . . 0.0 110.174 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -92.48 -30.68 15.59 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.28 -0.887 . . . . 0.0 109.577 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.502 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -104.15 -3.22 24.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.566 -0.709 . . . . 0.0 109.574 179.731 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.605 ' CE1' ' HB3' ' A' ' 16' ' ' PRO . 70.0 m-85 60.18 54.57 3.99 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.599 -0.688 . . . . 0.0 110.756 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.508 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 0.9 OUTLIER -129.47 157.62 41.49 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.278 -0.889 . . . . 0.0 109.689 179.435 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.686 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 45.3 t80 -142.54 138.86 31.18 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.259 -0.901 . . . . 0.0 110.104 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 4.3 m -142.12 132.2 24.65 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.826 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.686 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 21.3 p90 -149.65 170.94 17.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.358 -0.839 . . . . 0.0 110.407 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.505 ' CG2' ' O ' ' A' ' 98' ' ' ILE . 50.4 m -126.72 129.52 48.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.436 -0.79 . . . . 0.0 110.077 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.547 HD11 ' CD2' ' A' ' 69' ' ' HIS . 10.7 tp -95.84 133.55 39.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.084 -1.01 . . . . 0.0 110.378 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.8 pt -111.22 -33.49 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.199 -0.938 . . . . 0.0 110.209 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.454 ' OE1' ' HE3' ' A' ' 68' ' ' LYS . 77.3 tt0 -116.17 155.3 28.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.376 -0.828 . . . . 0.0 110.139 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.519 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 156.29 129.38 1.17 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -60.15 -20.21 57.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -1.161 . . . . 0.0 110.222 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.69 -16.14 60.77 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.276 -0.89 . . . . 0.0 110.252 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.48 HD13 ' N ' ' A' ' 88' ' ' GLY . 75.7 mt -69.1 -25.51 64.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.278 -0.889 . . . . 0.0 110.189 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 49.28 -178.66 0.02 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 55.1 p30 -83.15 10.27 8.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.229 -1.16 . . . . 0.0 110.171 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.508 ' O ' ' CG2' ' A' ' 126' ' ' VAL . 29.7 p -103.08 -33.84 9.1 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.235 -0.916 . . . . 0.0 110.098 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.534 HD23 ' CD1' ' A' ' 128' ' ' ILE . 96.7 mt -103.8 160.6 14.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 110.052 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.471 ' HG2' ' N ' ' A' ' 97' ' ' LYS . 54.4 tt0 -140.05 -82.18 0.26 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.337 -0.852 . . . . 0.0 109.689 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.476 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 42.0 mttm -80.43 135.66 36.2 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.625 -0.672 . . . . 0.0 110.139 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.623 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 4.2 mm -123.1 139.29 50.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 120.866 -1.146 . . . . 0.0 109.982 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.461 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -121.96 129.34 52.41 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.783 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.623 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 9.9 m-85 -123.3 133.66 54.14 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.158 -0.964 . . . . 0.0 110.876 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -135.49 129.95 33.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.444 -0.785 . . . . 0.0 109.711 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 37.4 m -134.14 144.13 48.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.186 -0.946 . . . . 0.0 110.494 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 80' ' ' SER . 5.1 tttt -139.45 144.67 38.14 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.346 -0.846 . . . . 0.0 110.303 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.549 ' HB2' ' HB3' ' A' ' 79' ' ' TYR . 12.7 mt -109.37 155.09 21.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.225 -0.922 . . . . 0.0 110.461 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.493 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -151.17 -168.86 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.359 -0.838 . . . . 0.0 109.608 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.464 ' O ' HD13 ' A' ' 113' ' ' ILE . . . -122.59 154.67 37.63 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.173 -0.955 . . . . 0.0 110.526 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.458 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 55.4 p -114.52 164.56 16.08 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.389 -0.819 . . . . 0.0 110.064 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 47.6 Cg_endo -72.63 -1.77 10.82 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.959 1.505 . . . . 0.0 110.505 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.7 t -97.24 -22.6 16.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.103 -0.998 . . . . 0.0 110.31 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 111' ' ' GLY . . . 125.42 -38.11 2.37 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 110' ' ' GLY . . . -60.29 -147.13 0.01 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 47.5 p -150.43 133.21 15.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.173 -1.193 . . . . 0.0 110.148 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.486 ' HB ' ' HB ' ' A' ' 105' ' ' VAL . 23.4 mt -82.6 149.52 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.246 -0.909 . . . . 0.0 110.241 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.572 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 10.1 mt -129.74 113.47 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.894 . . . . 0.0 110.02 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.424 ' N ' ' O ' ' A' ' 103' ' ' LYS . 15.3 ttpt -94.99 122.26 37.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.088 -1.007 . . . . 0.0 110.216 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.91 147.27 42.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.895 . . . . 0.0 110.293 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 81.6 m -150.22 129.14 12.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.363 -0.836 . . . . 0.0 110.327 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.57 ' OG ' ' CE1' ' A' ' 100' ' ' TYR . 15.4 t -128.4 154.18 46.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.271 -0.893 . . . . 0.0 110.198 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.543 ' CE1' HG21 ' A' ' 4' ' ' THR . 91.5 m-70 -132.87 121.8 23.44 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.348 -0.845 . . . . 0.0 110.3 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.528 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 5.7 m-30 -95.3 119.37 33.69 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.183 -0.948 . . . . 0.0 110.489 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.591 ' CD2' HG22 ' A' ' 2' ' ' VAL . 76.4 m-70 -95.47 107.45 19.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.358 -0.839 . . . . 0.0 109.558 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.504 ' CG2' HD22 ' A' ' 95' ' ' LEU . 1.7 p -77.85 155.79 30.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.107 -0.995 . . . . 0.0 110.387 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.451 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 36.9 tttp -119.6 113.51 20.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.378 -0.826 . . . . 0.0 110.226 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.38 -135.89 12.61 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.406 ' C ' HG11 ' A' ' 126' ' ' VAL . 14.6 t30 -113.2 76.39 0.98 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.258 -1.143 . . . . 0.0 110.235 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.508 ' CG2' ' O ' ' A' ' 94' ' ' THR . 33.5 m -137.09 161.73 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.223 -0.923 . . . . 0.0 110.105 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -141.94 155.69 45.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 110.192 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.623 ' CD1' ' CD1' ' A' ' 3' ' ' PHE . 1.9 mp -84.03 173.43 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.22 -0.925 . . . . 0.0 110.113 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.535 ' N ' ' CG2' ' A' ' 128' ' ' ILE . 9.0 mttt -119.24 142.98 47.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.451 -0.78 . . . . 0.0 109.901 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.431 ' O ' ' HG2' ' A' ' 134' ' ' LYS . 93.6 mt-10 -48.17 -34.47 10.04 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.154 -0.966 . . . . 0.0 110.152 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.498 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 69.1 tt0 -63.84 -32.33 73.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 0.0 109.971 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 13.9 t-160 -77.66 -51.61 10.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.296 -0.877 . . . . 0.0 110.048 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.637 ' CG1' ' CD1' ' A' ' 5' ' ' TYR . 49.6 t -60.69 -38.66 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.39 -0.819 . . . . 0.0 109.979 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' A' ' 130' ' ' GLU . 62.2 mmtt -77.37 -45.01 27.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.316 -0.865 . . . . 0.0 110.122 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.498 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -62.25 -38.31 88.78 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.304 -0.872 . . . . 0.0 110.019 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -63.43 -30.77 78.59 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 77.5 mttt -77.33 -30.93 54.24 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.353 -1.087 . . . . 0.0 110.0 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -75.65 -34.1 60.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.367 -0.833 . . . . 0.0 109.959 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 39.3 mttt -73.36 -37.29 66.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.376 -0.828 . . . . 0.0 109.815 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.512 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -74.76 -32.37 62.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.251 -0.906 . . . . 0.0 109.88 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 137' ' ' LYS . 69.6 m -66.93 -49.33 65.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -0.881 . . . . 0.0 109.904 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -51.56 -47.3 63.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.25 -0.906 . . . . 0.0 109.895 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.431 ' O ' HG13 ' A' ' 147' ' ' ILE . 13.7 tp -57.14 -50.02 74.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -0.899 . . . . 0.0 109.732 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.512 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 21.6 m-85 -52.9 -35.17 57.76 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.388 -0.82 . . . . 0.0 109.673 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 37.2 mttt -78.18 -18.25 55.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.376 -0.828 . . . . 0.0 109.811 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 26.0 mt -82.43 -35.76 27.28 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.255 -0.903 . . . . 0.0 108.778 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.64 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 34.7 mt -69.6 -45.47 77.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.465 ' OE2' ' HB3' ' A' ' 11' ' ' SER . 91.9 mt-10 -53.21 -40.16 64.27 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.353 -0.842 . . . . 0.0 109.428 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.2 m -67.27 -28.23 67.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.309 -0.869 . . . . 0.0 109.447 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.575 ' CE2' ' HB1' ' A' ' 157' ' ' ALA . 80.5 t80 -63.42 -48.08 79.29 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.517 -0.74 . . . . 0.0 109.817 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.572 HD22 ' CE1' ' A' ' 158' ' ' TYR . 81.6 mt -79.91 -37.67 34.17 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.309 -0.87 . . . . 0.0 110.211 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.53 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . 43.5 tptt -60.7 -16.99 45.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.362 -0.836 . . . . 0.0 109.318 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.456 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -116.39 -30.13 2.14 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.573 ' CD2' ' O ' ' A' ' 150' ' ' TYR . 8.2 m-70 -106.05 93.97 8.6 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.222 -1.164 . . . . 0.0 110.223 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.466 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 48.1 Cg_endo -74.02 6.25 3.06 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 124.066 1.561 . . . . 0.0 111.048 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 35.4 p30 -115.77 -5.68 12.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.014 -1.054 . . . . 0.0 109.906 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.575 ' HB1' ' CE2' ' A' ' 150' ' ' TYR . . . -57.76 107.38 0.45 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.379 -0.826 . . . . 0.0 110.112 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.647 ' CZ ' ' CB ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 36.56 29.61 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.654 -0.654 . . . . 0.0 110.573 -179.429 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.573 ' CB ' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.644 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.485 ' CG1' ' O ' ' A' ' 120' ' ' TYR . 94.9 t -118.97 146.54 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.214 -1.168 . . . . 0.0 110.331 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.643 ' CD1' ' CD1' ' A' ' 128' ' ' ILE . 9.8 m-85 -101.03 142.55 32.34 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.285 -0.884 . . . . 0.0 109.518 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 m -118.45 131.88 56.25 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.982 -1.074 . . . . 0.0 110.887 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.646 ' CE2' ' CG2' ' A' ' 133' ' ' VAL . 72.0 m-85 -141.25 124.57 16.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.434 -0.791 . . . . 0.0 109.836 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.59 ' CG ' ' CG2' ' A' ' 117' ' ' THR . 10.2 mt-10 -132.23 136.34 46.92 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 0.0 110.319 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.0 m -125.51 164.08 21.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.235 -0.916 . . . . 0.0 110.093 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.446 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 87.1 mt-10 -146.26 127.18 14.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.298 -0.876 . . . . 0.0 110.445 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.633 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.1 p90 -147.32 -175.17 4.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.308 -0.87 . . . . 0.0 109.818 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.496 ' CG2' ' HA ' ' A' ' 113' ' ' ILE . 5.1 p -142.04 170.78 15.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.097 -1.002 . . . . 0.0 110.64 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.47 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 5.0 t -148.93 164.29 34.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.388 -0.82 . . . . 0.0 110.062 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -85.85 -22.0 27.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.267 -0.895 . . . . 0.0 110.192 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.539 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 8.8 mm -80.9 150.22 68.59 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.316 -0.865 . . . . 0.0 110.07 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.548 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 40.6 Cg_endo -66.17 146.36 81.33 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.044 1.55 . . . . 0.0 110.377 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.647 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.2 Cg_endo -71.18 -31.95 13.75 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.897 1.472 . . . . 0.0 112.912 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.647 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.1 Cg_endo -68.51 -20.59 41.28 Favored 'Trans proline' 0 C--N 1.317 -1.107 0 N-CA-C 110.114 -0.764 . . . . 0.0 110.114 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.529 ' NE ' ' HB2' ' A' ' 159' ' ' ASN . 47.9 mtp180 -85.78 -43.77 13.05 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.517 ' CD2' HD23 ' A' ' 104' ' ' LEU . 1.2 tt -75.21 -34.45 61.49 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.464 ' HB2' ' O ' ' A' ' 15' ' ' PRO . 60.8 t80 -65.75 -55.42 17.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.394 -0.816 . . . . 0.0 109.342 179.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 25' ' ' ASP . 64.3 mttt -53.62 -38.44 64.05 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.884 -0.727 . . . . 0.0 109.558 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.644 ' CB ' ' CZ ' ' A' ' 158' ' ' TYR . . . -74.4 -39.74 62.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.465 -0.772 . . . . 0.0 110.961 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.584 ' CD1' HD12 ' A' ' 147' ' ' ILE . 0.4 OUTLIER -75.21 -38.47 60.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.315 -0.865 . . . . 0.0 111.073 -178.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.448 HG11 ' CE1' ' A' ' 81' ' ' TYR . 4.5 t -105.22 -55.21 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.039 -1.038 . . . . 0.0 111.691 -179.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.463 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 7.3 mp -80.03 -4.64 53.5 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.178 -0.952 . . . . 0.0 111.841 -178.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 20' ' ' LYS . 1.0 OUTLIER -150.7 32.49 0.62 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.706 -1.246 . . . . 0.0 110.724 -179.61 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.508 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -74.44 -20.63 59.96 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.257 -0.902 . . . . 0.0 110.321 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.443 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 94.8 m-20 -67.75 -24.45 65.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.232 -0.918 . . . . 0.0 110.103 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.487 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 4.4 p30 -123.51 12.93 9.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.326 -0.859 . . . . 0.0 109.897 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.522 HD11 ' CD1' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -92.92 -50.33 5.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.356 -0.84 . . . . 0.0 110.184 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.647 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 2.2 m -74.26 -29.44 0.97 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.353 -0.842 . . . . 0.0 112.166 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 53.1 Cg_endo -79.15 3.57 7.33 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 O-C-N 122.785 0.887 . . . . 0.0 110.287 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -124.66 -34.71 2.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.319 -0.863 . . . . 0.0 109.326 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.574 HG12 ' CD1' ' A' ' 150' ' ' TYR . 18.4 mt -79.99 -36.65 17.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.625 -0.672 . . . . 0.0 109.837 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -175.33 102.95 0.26 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.545 -0.722 . . . . 0.0 109.831 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.77 1.57 6.26 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.031 1.543 . . . . 0.0 110.808 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -84.54 0.05 51.33 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.141 -0.974 . . . . 0.0 109.894 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.426 ' HB2' HD11 ' A' ' 38' ' ' ILE . . . -101.03 -51.17 3.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.28 -0.887 . . . . 0.0 110.024 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.518 HG12 ' CG2' ' A' ' 56' ' ' ILE . 1.8 mp -134.45 125.09 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.449 -0.782 . . . . 0.0 109.948 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' A' ' 57' ' ' THR . 21.8 ttpt -61.47 -26.82 68.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.25 -0.906 . . . . 0.0 110.319 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.574 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER 173.24 162.08 0.14 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.153 -0.967 . . . . 0.0 110.107 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.1 m -128.34 125.11 38.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.384 -0.822 . . . . 0.0 110.048 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.574 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 40.5 tt0 -130.16 111.37 12.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.195 -0.94 . . . . 0.0 110.426 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.503 HG22 HD12 ' A' ' 43' ' ' ILE . 36.3 mt -63.35 135.44 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.351 -0.843 . . . . 0.0 110.044 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 16.0 tp -110.45 -27.47 9.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.246 -0.909 . . . . 0.0 110.362 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.488 ' HB2' ' CB ' ' A' ' 53' ' ' ILE . 1.8 m95 -124.14 159.48 29.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -0.958 . . . . 0.0 110.605 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 45' ' ' TRP . . . 42.06 -136.82 3.07 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.419 ' O ' ' CG ' ' A' ' 47' ' ' ASP . 11.9 t0 -152.72 24.75 0.58 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.361 -1.082 . . . . 0.0 109.77 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.466 ' O ' HG22 ' A' ' 71' ' ' ILE . . . 119.97 -21.97 8.73 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.477 ' O ' HG22 ' A' ' 71' ' ' ILE . . . -65.17 -172.82 3.62 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.479 ' HA ' HG23 ' A' ' 71' ' ' ILE . 46.1 Cg_endo -73.44 128.64 12.95 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.997 1.525 . . . . 0.0 110.612 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.32 -13.23 54.98 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -68.61 163.25 24.12 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.569 -0.959 . . . . 0.0 109.663 179.729 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.488 ' CB ' ' HB2' ' A' ' 45' ' ' TRP . 61.6 mt -133.09 120.53 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.305 -0.872 . . . . 0.0 109.748 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.451 ' HG2' HG12 ' A' ' 43' ' ' ILE . 89.8 mttt -109.57 130.52 55.5 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.159 -0.963 . . . . 0.0 110.487 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -96.03 96.3 8.78 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.275 -0.891 . . . . 0.0 109.869 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.518 ' CG2' HG12 ' A' ' 38' ' ' ILE . 73.1 mt -79.87 143.82 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 109.998 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 39' ' ' LYS . 2.4 p -116.67 155.84 28.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 110.863 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.509 ' N ' ' O ' ' A' ' 65' ' ' GLY . 27.2 m-85 -119.07 154.76 32.65 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.473 -0.767 . . . . 0.0 109.917 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -118.62 39.44 2.56 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -57.46 -26.04 60.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.26 -1.141 . . . . 0.0 110.26 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 167.02 -166.04 38.93 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.0 m -52.41 -47.78 66.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -1.134 . . . . 0.0 110.289 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -45.68 150.72 0.48 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.259 -0.9 . . . . 0.0 110.231 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -88.54 124.85 34.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 110.284 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -134.89 113.86 1.19 Allowed Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.634 -1.787 . . . . 0.0 108.634 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.544 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 12.6 p90 -155.93 162.24 40.41 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.113 -1.228 . . . . 0.0 110.208 -179.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.471 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 6.7 m -135.01 172.68 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.301 -0.874 . . . . 0.0 110.542 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.526 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 22.5 mttt -119.07 131.34 55.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.549 -0.719 . . . . 0.0 109.71 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.644 ' CD2' ' CD1' ' A' ' 85' ' ' LEU . 11.6 m170 -116.11 129.99 56.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.17 -0.956 . . . . 0.0 110.758 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 52' ' ' THR . 13.5 ttpt -107.71 108.84 20.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.279 -0.888 . . . . 0.0 109.547 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.527 ' CG2' HD12 ' A' ' 74' ' ' ILE . 27.8 mm -53.03 124.4 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.243 -0.911 . . . . 0.0 110.437 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 82' ' ' SER . 93.4 m-20 -96.71 -43.04 7.72 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.445 -0.784 . . . . 0.0 109.723 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 15.2 m -170.79 157.55 5.58 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.338 -0.851 . . . . 0.0 109.685 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.527 HD12 ' CG2' ' A' ' 71' ' ' ILE . 1.4 mp -135.66 149.66 28.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 110.226 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 79' ' ' TYR . 9.3 m-20 -131.22 77.26 1.77 Allowed 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.711 -0.795 . . . . 0.0 110.677 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.403 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 35.8 mttp -63.71 -16.0 59.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.182 -0.949 . . . . 0.0 109.888 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -93.8 -34.66 13.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.351 -0.843 . . . . 0.0 109.301 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.501 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -99.18 -4.11 32.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.595 -0.691 . . . . 0.0 109.452 179.362 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.589 ' CE1' ' HB3' ' A' ' 16' ' ' PRO . 65.5 m-85 60.11 57.02 3.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.558 -0.714 . . . . 0.0 110.305 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.491 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -130.73 163.08 28.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.383 -0.823 . . . . 0.0 109.595 179.539 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.523 ' OH ' ' CD1' ' A' ' 71' ' ' ILE . 15.2 t80 -144.64 138.33 27.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.921 . . . . 0.0 109.975 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.501 ' O ' ' N ' ' A' ' 72' ' ' ASP . 38.2 m -140.12 121.58 15.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.161 -0.962 . . . . 0.0 111.064 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.595 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 5.3 p90 -139.07 177.69 7.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.457 -0.777 . . . . 0.0 109.556 178.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.463 ' OG1' ' OD2' ' A' ' 72' ' ' ASP . 44.3 m -133.75 137.06 44.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.064 -1.023 . . . . 0.0 110.522 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.644 ' CD1' ' CD2' ' A' ' 69' ' ' HIS . 16.5 tp -93.37 118.31 31.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.236 -0.915 . . . . 0.0 109.831 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.7 pt -107.44 -22.23 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.427 -0.796 . . . . 0.0 110.036 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.526 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 64.9 tt0 -129.59 130.6 45.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.207 -0.933 . . . . 0.0 110.627 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.507 ' N ' HD22 ' A' ' 91' ' ' LEU . . . -176.87 107.94 0.25 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 90' ' ' ALA . 29.4 p-10 -42.34 -25.99 0.09 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.253 -1.145 . . . . 0.0 110.504 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.476 ' N ' ' OD1' ' A' ' 89' ' ' ASP . . . -75.47 -37.93 59.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.083 -1.01 . . . . 0.0 110.445 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.507 HD22 ' N ' ' A' ' 88' ' ' GLY . 1.6 pp -86.99 -25.7 24.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.885 . . . . 0.0 110.537 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.431 ' N ' ' HG ' ' A' ' 91' ' ' LEU . . . -63.11 -36.11 93.0 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.449 ' O ' ' CG2' ' A' ' 94' ' ' THR . 57.1 t0 -44.11 -34.91 1.95 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.174 -1.192 . . . . 0.0 110.403 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.449 ' CG2' ' O ' ' A' ' 93' ' ' ASP . 1.7 p -160.05 -35.07 0.06 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.273 -0.892 . . . . 0.0 110.432 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.596 ' CD2' ' CG1' ' A' ' 128' ' ' ILE . 5.9 mt -79.96 177.71 8.73 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.213 -0.929 . . . . 0.0 110.286 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -148.64 -78.98 0.14 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.363 -0.836 . . . . 0.0 109.479 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.53 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 8.1 mttt -80.14 135.59 36.34 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.63 -0.669 . . . . 0.0 110.486 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.537 ' CG2' ' HB3' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -136.34 132.35 49.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 120.704 -1.247 . . . . 0.0 109.292 178.651 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.518 ' OG ' ' NE2' ' A' ' 121' ' ' HIS . 0.6 OUTLIER -107.37 132.6 52.98 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.383 -0.823 . . . . 0.0 109.909 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.595 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 5.8 m-85 -122.74 132.73 54.37 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.495 -0.753 . . . . 0.0 110.316 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.453 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 9.3 tt0 -135.81 125.31 25.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.205 -0.934 . . . . 0.0 110.295 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.445 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 72.2 m -118.5 154.83 31.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.232 -0.917 . . . . 0.0 109.516 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.449 ' N ' ' O ' ' A' ' 115' ' ' LYS . 31.4 mttt -144.1 132.35 21.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.028 -1.045 . . . . 0.0 110.389 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.517 HD23 ' CD2' ' A' ' 18' ' ' LEU . 2.8 mt -120.01 145.45 46.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.284 -0.885 . . . . 0.0 110.177 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.506 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -153.07 -168.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.378 -0.826 . . . . 0.0 109.891 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -114.76 140.91 48.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.356 -0.84 . . . . 0.0 110.117 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.436 ' HB3' HG13 ' A' ' 113' ' ' ILE . 53.9 p -97.22 162.99 20.84 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.249 -0.907 . . . . 0.0 110.21 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.3 Cg_endo -71.92 -2.99 12.35 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.982 1.517 . . . . 0.0 110.393 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 52.9 p -100.98 2.84 41.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.295 -0.878 . . . . 0.0 110.207 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 101.2 -31.48 8.6 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -70.73 -172.55 12.15 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.524 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 24.5 p -122.03 131.37 53.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.278 -1.131 . . . . 0.0 110.369 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.496 ' HA ' ' CG2' ' A' ' 10' ' ' THR . 21.7 mt -80.07 143.88 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.887 . . . . 0.0 109.742 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.584 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 19.4 mt -131.08 109.78 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.104 -0.997 . . . . 0.0 110.63 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.449 ' O ' ' N ' ' A' ' 103' ' ' LYS . 30.0 tttt -99.33 130.5 45.62 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.277 -0.889 . . . . 0.0 109.825 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.83 151.58 39.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.958 . . . . 0.0 110.53 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.59 ' CG2' ' CG ' ' A' ' 6' ' ' GLU . 25.9 m -146.72 151.84 37.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.35 -0.844 . . . . 0.0 110.302 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 91.3 p -155.84 139.96 16.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.915 . . . . 0.0 110.282 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.501 ' NE2' HG23 ' A' ' 117' ' ' THR . 54.4 m-70 -127.92 157.02 41.7 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.211 -0.931 . . . . 0.0 110.394 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.485 ' O ' ' CG1' ' A' ' 2' ' ' VAL . 7.0 m-85 -120.41 141.62 49.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.197 -0.939 . . . . 0.0 110.733 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.53 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 98.2 m-70 -122.29 96.65 5.13 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.109 -0.994 . . . . 0.0 109.857 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.511 ' CG2' HD22 ' A' ' 95' ' ' LEU . 1.3 p -75.93 156.39 34.26 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.351 -0.843 . . . . 0.0 110.323 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 44.4 tttm -113.17 108.3 17.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.216 -0.927 . . . . 0.0 110.266 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 105.4 -124.07 7.79 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -127.9 75.05 1.58 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.269 -1.136 . . . . 0.0 110.204 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.469 HG21 ' CG2' ' A' ' 122' ' ' THR . 16.4 m -141.49 152.71 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.236 -0.915 . . . . 0.0 110.279 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -127.77 161.78 28.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.298 -0.877 . . . . 0.0 110.098 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.643 ' CD1' ' CD1' ' A' ' 3' ' ' PHE . 5.1 mp -86.66 172.36 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.248 -0.907 . . . . 0.0 110.378 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.477 ' O ' ' N ' ' A' ' 132' ' ' HIS . 10.0 mttp -108.01 127.16 53.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.414 -0.804 . . . . 0.0 109.539 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.492 ' CA ' ' HG3' ' A' ' 134' ' ' LYS . 97.4 mt-10 -42.86 -55.03 3.88 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.214 -0.929 . . . . 0.0 110.069 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.404 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 49.0 tt0 -47.22 -24.24 0.68 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.936 . . . . 0.0 109.751 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.477 ' N ' ' O ' ' A' ' 129' ' ' LYS . 9.7 t-160 -86.19 -64.89 1.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.361 -0.837 . . . . 0.0 110.175 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.646 ' CG2' ' CE2' ' A' ' 5' ' ' TYR . 7.2 p -63.38 -41.46 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.399 -0.813 . . . . 0.0 110.222 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.492 ' HG3' ' CA ' ' A' ' 130' ' ' GLU . 27.5 mttt -63.04 -43.55 98.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.175 -0.953 . . . . 0.0 109.823 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.458 ' O ' ' HG3' ' A' ' 139' ' ' LYS . . . -67.94 -26.15 65.82 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.339 -0.851 . . . . 0.0 109.792 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -71.66 -33.02 63.76 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.478 ' HE2' ' CD1' ' A' ' 5' ' ' TYR . 25.9 mttp -63.37 -34.67 78.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -1.129 . . . . 0.0 109.894 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -79.07 -31.94 44.6 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.366 -0.834 . . . . 0.0 109.936 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 135' ' ' ALA . 83.6 mttt -65.46 -39.36 91.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.347 -0.846 . . . . 0.0 109.857 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.85 -46.6 52.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.875 . . . . 0.0 109.916 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.6 t -55.97 -42.32 76.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.421 -0.799 . . . . 0.0 109.917 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -59.2 -43.03 92.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.922 . . . . 0.0 109.882 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 47.5 mt -60.57 -36.74 79.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.261 -0.899 . . . . 0.0 109.783 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.462 ' HA ' HD11 ' A' ' 147' ' ' ILE . 22.7 m-85 -63.2 -31.93 73.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.377 -0.827 . . . . 0.0 109.823 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -73.64 -18.59 61.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.286 -0.884 . . . . 0.0 109.916 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.496 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 32.2 mt -82.19 -35.57 28.19 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.271 -0.893 . . . . 0.0 108.701 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.584 HD12 ' CD1' ' A' ' 22' ' ' PHE . 26.8 mt -73.0 -47.06 49.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 178.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.481 ' O ' HG13 ' A' ' 13' ' ' ILE . 90.8 mt-10 -57.57 -33.75 68.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.475 -0.766 . . . . 0.0 109.406 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 19.8 m -77.1 -26.19 53.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.206 -0.934 . . . . 0.0 109.267 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.574 ' CD1' HG12 ' A' ' 33' ' ' ILE . 87.9 t80 -62.28 -51.38 67.94 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.605 -0.684 . . . . 0.0 110.03 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.567 ' CD2' ' CE2' ' A' ' 158' ' ' TYR . 71.4 mt -74.53 -29.13 61.27 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.331 -0.856 . . . . 0.0 110.196 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.442 ' HA ' HD13 ' A' ' 13' ' ' ILE . 65.9 tttt -63.19 -17.76 62.76 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.231 -0.918 . . . . 0.0 109.593 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.456 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -122.29 -19.7 3.14 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.573 ' CD2' ' O ' ' A' ' 150' ' ' TYR . 14.4 m-70 -106.91 91.74 6.7 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.128 -1.219 . . . . 0.0 110.3 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 49.1 Cg_endo -73.92 4.76 3.91 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.054 1.555 . . . . 0.0 110.871 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -117.55 -6.12 11.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.095 -1.003 . . . . 0.0 109.809 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.57 ' HB1' ' CE2' ' A' ' 150' ' ' TYR . . . -59.81 104.92 0.33 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.345 -0.847 . . . . 0.0 110.131 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.644 ' CZ ' ' CB ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 35.77 31.12 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.662 -0.649 . . . . 0.0 110.507 -179.492 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.529 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.792 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.491 HG23 ' ND1' ' A' ' 121' ' ' HIS . 39.1 t -124.37 142.84 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.236 -1.155 . . . . 0.0 110.338 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.636 ' CD1' ' CD1' ' A' ' 128' ' ' ILE . 7.9 m-85 -104.62 147.01 28.11 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.339 -0.851 . . . . 0.0 109.667 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.566 HG21 ' CE1' ' A' ' 119' ' ' HIS . 4.0 m -113.28 110.17 19.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.047 -1.033 . . . . 0.0 110.756 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.631 ' CE1' ' CG1' ' A' ' 133' ' ' VAL . 28.8 m-85 -119.58 125.98 50.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.295 -0.878 . . . . 0.0 109.977 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 116' ' ' SER . 22.7 pt-20 -139.99 154.17 47.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.151 -0.968 . . . . 0.0 110.363 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.1 t -127.04 162.93 24.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.312 -0.867 . . . . 0.0 109.992 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -142.82 121.4 12.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.183 -0.948 . . . . 0.0 110.368 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.651 ' CZ ' ' CD2' ' A' ' 144' ' ' PHE . 3.0 p90 -149.24 -172.69 4.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.347 -0.845 . . . . 0.0 109.765 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.476 ' CG2' ' HA ' ' A' ' 113' ' ' ILE . 9.4 p -142.16 173.21 11.73 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.216 -0.928 . . . . 0.0 110.695 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.501 ' HB2' ' CG ' ' A' ' 148' ' ' GLU . 22.9 p -158.03 134.06 9.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.499 -0.75 . . . . 0.0 110.199 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.411 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 97.6 mt-10 -61.11 -39.18 89.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 110.111 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.537 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 3.0 mp -53.99 150.4 14.99 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.43 -0.794 . . . . 0.0 109.998 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.537 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 41.1 Cg_endo -66.89 141.07 57.38 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.958 1.504 . . . . 0.0 110.466 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.601 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.7 Cg_endo -73.44 -30.11 10.41 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 O-C-N 124.04 1.548 . . . . 0.0 112.996 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.2 Cg_endo -71.11 -22.74 25.62 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 O-C-N 122.443 0.707 . . . . 0.0 110.398 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.518 ' NH2' ' HB3' ' A' ' 159' ' ' ASN . 39.7 mtp180 -84.8 -45.58 12.21 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.533 ' HG ' ' CG2' ' A' ' 147' ' ' ILE . 1.0 OUTLIER -66.44 -30.14 70.43 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.663 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.567 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 69.0 t80 -67.19 -59.72 3.2 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.484 -0.76 . . . . 0.0 109.561 178.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.485 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 8.5 mttp -49.34 -29.4 6.09 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.679 ' CB ' ' CZ ' ' A' ' 158' ' ' TYR . . . -75.63 -65.72 0.86 Allowed 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.708 0.765 . . . . 0.0 110.934 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.652 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 0.1 OUTLIER -57.59 -33.57 68.34 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.775 -0.578 . . . . 0.0 111.754 -178.382 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.52 HG12 ' CD1' ' A' ' 81' ' ' TYR . 3.9 t -104.39 -61.46 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.853 -1.154 . . . . 0.0 111.49 -178.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.485 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 7.9 mp -77.01 -0.14 23.39 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.166 -0.959 . . . . 0.0 111.599 -178.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.537 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -142.2 6.88 1.75 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.753 -1.217 . . . . 0.0 110.83 179.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . -47.35 -41.78 20.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.089 -1.007 . . . . 0.0 110.044 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.459 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 86.7 m-20 -64.13 -18.12 64.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -0.893 . . . . 0.0 110.034 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.436 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 81.5 m-20 -127.96 11.13 6.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.875 . . . . 0.0 110.158 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.547 HD13 ' HB2' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -95.95 -46.73 6.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.332 -0.855 . . . . 0.0 110.153 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.662 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 6.8 p -78.09 -26.9 0.53 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.898 . . . . 0.0 112.333 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.662 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.9 Cg_endo -78.14 5.82 5.12 Favored 'Trans proline' 0 C--N 1.318 -1.057 0 O-C-N 122.656 0.819 . . . . 0.0 110.539 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -126.15 -27.62 3.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.194 -0.941 . . . . 0.0 109.815 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.556 HG12 ' CD1' ' A' ' 150' ' ' TYR . 14.1 mt -79.96 -43.06 22.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.427 -0.796 . . . . 0.0 109.734 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -161.37 102.63 1.22 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.436 -0.79 . . . . 0.0 110.142 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.65 -0.51 8.96 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.045 1.55 . . . . 0.0 110.546 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -84.16 -17.04 41.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 0.0 109.712 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.41 -70.45 0.66 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.427 -0.796 . . . . 0.0 109.96 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.524 HG12 ' CG2' ' A' ' 56' ' ' ILE . 1.6 mp -103.96 129.28 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.456 -0.778 . . . . 0.0 109.904 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.499 ' CE ' ' HB2' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -72.65 -27.66 62.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.262 -0.899 . . . . 0.0 110.433 -179.941 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.545 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER 178.0 155.45 0.36 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.069 -1.019 . . . . 0.0 110.198 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.9 m -130.75 123.55 29.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.339 -0.851 . . . . 0.0 109.965 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.523 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 79.6 tt0 -133.98 111.87 10.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.098 -1.001 . . . . 0.0 110.52 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 21.3 mt -54.58 142.64 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.327 -0.858 . . . . 0.0 110.02 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.9 tp -118.56 -25.95 6.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.296 -0.878 . . . . 0.0 110.293 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.515 ' CG ' HD13 ' A' ' 53' ' ' ILE . 1.6 m95 -123.76 158.07 32.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.332 -0.855 . . . . 0.0 110.471 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.455 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 43.21 -139.61 2.98 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -150.17 24.59 0.82 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.4 -1.059 . . . . 0.0 109.896 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 121.43 -18.41 8.79 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.478 ' O ' HG23 ' A' ' 71' ' ' ILE . . . -72.09 -173.33 19.99 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.47 ' HA ' HG21 ' A' ' 71' ' ' ILE . 44.2 Cg_endo -72.57 129.01 14.11 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 124.005 1.529 . . . . 0.0 110.613 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.2 -14.31 48.03 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -69.87 166.3 19.76 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.574 -0.956 . . . . 0.0 109.412 179.565 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.515 HD13 ' CG ' ' A' ' 45' ' ' TRP . 51.6 mt -138.46 119.99 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 110.151 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -104.13 127.26 51.71 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.232 -0.917 . . . . 0.0 110.456 -179.909 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.4 tttt -95.4 90.95 5.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.273 -0.892 . . . . 0.0 109.955 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.524 ' CG2' HG12 ' A' ' 38' ' ' ILE . 94.5 mt -79.97 140.37 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.279 -0.888 . . . . 0.0 110.353 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.487 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 2.4 p -111.1 161.78 15.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.327 -0.858 . . . . 0.0 110.025 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.488 ' CD2' ' N ' ' A' ' 66' ' ' TYR . 22.0 m-85 -116.97 166.07 12.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.194 -0.941 . . . . 0.0 110.344 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 58' ' ' PHE . . . -43.53 137.49 4.25 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.499 ' HB2' ' CE ' ' A' ' 39' ' ' LYS . 73.5 tt0 -89.89 139.39 30.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.235 -1.156 . . . . 0.0 110.165 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -160.37 -132.37 1.34 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.434 ' C ' ' HG3' ' A' ' 63' ' ' GLN . 19.7 m -65.21 -17.33 64.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.171 -1.194 . . . . 0.0 110.178 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.434 ' HG3' ' C ' ' A' ' 62' ' ' SER . 87.1 mt-30 -146.09 152.24 38.99 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.237 -0.915 . . . . 0.0 110.12 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -76.76 143.49 39.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.246 -0.909 . . . . 0.0 110.198 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -133.58 134.22 7.36 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 108.609 -1.797 . . . . 0.0 108.609 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.555 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 11.6 p90 -178.78 162.86 1.37 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.173 -1.192 . . . . 0.0 110.162 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.529 ' CG1' ' HA3' ' A' ' 88' ' ' GLY . 4.4 m -142.62 173.59 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.316 -0.865 . . . . 0.0 110.33 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.467 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 77.7 mttt -125.01 124.37 41.84 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.564 -0.71 . . . . 0.0 109.768 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.57 ' CD2' HD11 ' A' ' 85' ' ' LEU . 15.2 m170 -112.97 122.85 48.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.171 -0.956 . . . . 0.0 110.809 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 52' ' ' THR . 46.7 tttp -101.98 109.72 21.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.323 -0.86 . . . . 0.0 109.549 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.529 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 27.9 mm -48.7 136.64 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.123 -0.986 . . . . 0.0 110.21 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.473 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 14.4 t0 -114.41 -43.02 3.23 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.853 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.46 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 16.7 m -165.4 158.69 16.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.457 -0.777 . . . . 0.0 109.855 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.423 HG12 HG12 ' A' ' 23' ' ' VAL . 1.4 mt -145.77 156.01 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.208 -0.933 . . . . 0.0 110.249 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.539 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 2.7 m-20 -135.56 79.21 1.77 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.547 -0.721 . . . . 0.0 110.086 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.567 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 22.1 tttp -61.78 -13.31 22.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.319 -0.863 . . . . 0.0 110.275 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -94.47 -31.23 14.04 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.237 -0.914 . . . . 0.0 109.724 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.508 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -108.47 -3.42 18.17 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.458 -0.776 . . . . 0.0 109.735 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.517 ' N ' ' O ' ' A' ' 75' ' ' ASP . 7.2 m-30 64.68 50.39 2.1 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.568 -0.707 . . . . 0.0 110.304 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.539 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.6 OUTLIER -118.53 153.44 34.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.316 -0.865 . . . . 0.0 109.25 179.352 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.529 ' OH ' ' CD1' ' A' ' 71' ' ' ILE . 22.0 t80 -141.41 132.46 26.18 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.047 -1.033 . . . . 0.0 110.398 -179.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.453 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 4.3 m -137.6 120.06 15.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.161 -0.962 . . . . 0.0 110.665 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.626 ' CE2' ' CB ' ' A' ' 100' ' ' TYR . 21.2 p90 -135.96 170.88 15.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.142 -0.973 . . . . 0.0 110.349 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 43.5 m -121.31 132.24 54.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.399 -0.813 . . . . 0.0 109.941 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.57 HD11 ' CD2' ' A' ' 69' ' ' HIS . 3.5 tp -98.53 126.03 43.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.177 -0.952 . . . . 0.0 110.153 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 14.3 pt -105.12 -11.22 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.278 -0.889 . . . . 0.0 110.056 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.467 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 4.3 tt0 -134.93 164.23 28.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.196 -0.94 . . . . 0.0 110.25 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.529 ' HA3' ' CG1' ' A' ' 67' ' ' VAL . . . 149.66 116.57 0.81 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -54.89 -20.2 8.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.24 -1.153 . . . . 0.0 110.171 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.575 ' O ' ' CE1' ' A' ' 132' ' ' HIS . . . -73.23 -8.91 57.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.366 -0.834 . . . . 0.0 110.213 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 88' ' ' GLY . 19.4 mt -81.54 -7.03 59.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.301 -0.874 . . . . 0.0 110.088 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 45.61 -170.43 0.02 OUTLIER Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -89.32 24.21 2.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -1.154 . . . . 0.0 109.885 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.419 ' OG1' HD21 ' A' ' 95' ' ' LEU . 11.1 p -118.18 -44.34 2.69 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.395 -0.815 . . . . 0.0 110.402 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.623 ' CD2' ' N ' ' A' ' 95' ' ' LEU . 3.1 mm? -79.93 162.71 24.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.392 -0.817 . . . . 0.0 110.388 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.43 ' CD ' ' HB2' ' A' ' 123' ' ' LYS . 10.5 mt-10 -146.16 -80.99 0.15 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.367 -0.833 . . . . 0.0 109.798 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.533 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 36.8 mttp -80.25 127.28 32.17 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.575 -0.703 . . . . 0.0 110.34 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.635 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 5.1 mm -117.68 137.5 51.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 120.446 -1.409 . . . . 0.0 110.0 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.477 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.3 OUTLIER -114.35 131.02 56.69 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.754 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.635 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 7.6 m-85 -125.42 134.8 51.99 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.317 -0.864 . . . . 0.0 110.576 -178.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 117' ' ' THR . 1.9 tt0 -138.95 131.46 28.73 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.413 -0.805 . . . . 0.0 110.128 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 61.0 m -132.99 142.07 48.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.308 -0.87 . . . . 0.0 109.855 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -134.38 143.2 47.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 0.0 110.527 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.505 ' HB2' ' CB ' ' A' ' 79' ' ' TYR . 14.2 mt -119.0 150.68 39.53 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.396 -0.815 . . . . 0.0 109.916 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.449 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 2.0 t -146.5 -168.99 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.177 -0.952 . . . . 0.0 110.061 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -124.19 160.9 26.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.313 -0.867 . . . . 0.0 110.14 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.452 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.5 p -119.42 170.17 7.14 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.912 . . . . 0.0 110.224 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 45.9 Cg_endo -72.32 -17.13 27.63 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.059 1.557 . . . . 0.0 110.484 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 59.8 p -93.28 -1.09 56.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.232 -0.918 . . . . 0.0 110.27 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.31 -36.98 4.04 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.411 ' HA3' ' HA ' ' A' ' 12' ' ' GLU . . . -54.3 -175.49 0.09 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.466 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 85.7 p -131.41 137.47 48.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.24 -1.153 . . . . 0.0 110.283 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.476 ' HA ' ' CG2' ' A' ' 10' ' ' THR . 16.6 mt -90.61 146.57 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.216 -0.928 . . . . 0.0 110.076 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.582 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 6.7 mt -128.32 127.13 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.283 -0.886 . . . . 0.0 110.134 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -119.77 108.79 14.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -0.912 . . . . 0.0 110.035 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.7 m -95.19 158.72 15.34 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.22 -0.925 . . . . 0.0 110.37 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 101' ' ' GLU . 60.6 m -160.13 122.44 3.31 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.386 -0.821 . . . . 0.0 109.903 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 94.8 p -126.18 171.19 11.09 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.137 -0.977 . . . . 0.0 110.466 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.566 ' CE1' HG21 ' A' ' 4' ' ' THR . 89.2 m-70 -145.27 140.05 27.54 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.334 -0.854 . . . . 0.0 110.288 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.537 ' CD2' HD13 ' A' ' 95' ' ' LEU . 3.2 m-30 -105.84 146.66 29.62 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.322 -0.861 . . . . 0.0 110.634 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.533 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 59.6 m-70 -131.69 96.48 3.97 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.188 -0.945 . . . . 0.0 109.265 178.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.533 ' CG2' HD23 ' A' ' 95' ' ' LEU . 1.1 p -80.04 153.44 28.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.325 -0.859 . . . . 0.0 110.959 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.43 ' HB2' ' CD ' ' A' ' 96' ' ' GLU . 7.9 tttp -96.49 132.85 41.63 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.652 -0.655 . . . . 0.0 110.082 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 87.12 -144.88 19.53 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.42 ' C ' HG11 ' A' ' 126' ' ' VAL . 36.7 t30 -118.65 74.0 0.94 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.296 -1.12 . . . . 0.0 110.17 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.445 HG21 ' HB ' ' A' ' 122' ' ' THR . 21.8 m -131.9 167.19 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.226 -0.921 . . . . 0.0 110.139 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -128.4 152.91 47.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.206 -0.934 . . . . 0.0 110.236 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.636 ' CD1' ' CD1' ' A' ' 3' ' ' PHE . 3.5 mt -77.45 173.09 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.283 -0.886 . . . . 0.0 110.164 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.483 ' N ' HG23 ' A' ' 128' ' ' ILE . 27.1 mttt -104.78 141.63 36.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.406 -0.809 . . . . 0.0 110.025 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' ' 134' ' ' LYS . 97.6 mt-10 -54.52 -42.65 71.1 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.121 -0.987 . . . . 0.0 110.002 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -55.93 -38.28 70.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.245 -0.909 . . . . 0.0 109.897 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.575 ' CE1' ' O ' ' A' ' 90' ' ' ALA . 16.3 t-160 -69.47 -53.88 17.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.244 -0.91 . . . . 0.0 110.099 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.631 ' CG1' ' CE1' ' A' ' 5' ' ' TYR . 97.1 t -60.1 -38.39 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.416 -0.803 . . . . 0.0 109.87 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 130' ' ' GLU . 64.9 mttt -71.06 -38.3 72.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.259 -0.901 . . . . 0.0 109.958 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.97 -20.83 62.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -0.869 . . . . 0.0 110.016 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.15 -25.7 54.51 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 82.7 mttt -77.24 -31.72 55.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.266 -1.138 . . . . 0.0 110.121 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -75.36 -31.74 60.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.334 -0.854 . . . . 0.0 110.028 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -73.88 -31.95 63.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 0.0 109.944 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.573 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -76.16 -35.41 59.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 110.161 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 84.5 p -67.52 -46.73 71.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.299 -0.876 . . . . 0.0 110.02 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -58.71 -46.16 87.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.187 -0.946 . . . . 0.0 110.008 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 19.6 mt -60.63 -36.36 78.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.913 . . . . 0.0 110.033 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.651 ' CD2' ' CZ ' ' A' ' 9' ' ' PHE . 7.2 m-85 -63.35 -40.08 96.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.366 -0.834 . . . . 0.0 109.865 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 145' ' ' LYS . 11.8 tttp -73.43 -9.56 58.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.35 -0.843 . . . . 0.0 110.128 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 13.0 mt -84.72 -39.63 18.28 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.235 -0.915 . . . . 0.0 108.95 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.652 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 4.6 mt -68.61 -45.17 82.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.501 ' CG ' ' HB2' ' A' ' 11' ' ' SER . 84.4 mt-10 -58.59 -45.34 89.31 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.481 -0.762 . . . . 0.0 109.564 179.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 18.9 m -68.24 -32.1 72.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.111 -0.993 . . . . 0.0 109.576 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.57 ' CE2' ' HB1' ' A' ' 157' ' ' ALA . 92.7 t80 -57.26 -47.93 80.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.586 -0.696 . . . . 0.0 109.97 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.591 HD22 ' CZ ' ' A' ' 158' ' ' TYR . 73.3 mt -74.52 -37.73 62.99 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.331 -0.855 . . . . 0.0 110.517 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.46 ' HB2' HD12 ' A' ' 13' ' ' ILE . 14.2 tttm -62.19 -13.62 29.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.248 -0.908 . . . . 0.0 109.59 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.463 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -119.96 -26.2 2.35 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.146 -1.581 . . . . 0.0 109.146 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.568 ' CD2' ' O ' ' A' ' 150' ' ' TYR . 12.8 m-70 -105.97 93.88 8.36 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.338 -1.095 . . . . 0.0 110.109 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.0 Cg_endo -73.23 5.06 3.34 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.111 1.585 . . . . 0.0 111.118 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 32.6 p30 -122.01 -4.8 9.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.006 -1.059 . . . . 0.0 109.833 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.593 ' HB3' ' CZ ' ' A' ' 158' ' ' TYR . . . -47.8 110.85 0.36 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.43 -0.793 . . . . 0.0 110.193 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.679 ' CZ ' ' CB ' ' A' ' 21' ' ' ALA . 0.4 OUTLIER 33.76 33.08 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.766 -0.583 . . . . 0.0 110.872 -179.431 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.518 ' HB3' ' NH2' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 117.98 -1.009 . . . . 0.0 109.769 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 49.0 t -114.71 147.7 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.188 -1.183 . . . . 0.0 110.37 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.566 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 60.8 m-85 -106.72 165.77 11.07 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.336 -0.852 . . . . 0.0 110.336 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 66.5 m -146.85 98.27 3.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.269 -0.894 . . . . 0.0 110.305 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.573 ' CZ ' HG23 ' A' ' 133' ' ' VAL . 87.7 m-85 -111.54 140.92 45.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.197 -0.94 . . . . 0.0 109.876 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 20.6 pt-20 -138.56 151.72 47.55 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.141 -0.975 . . . . 0.0 110.43 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.46 ' OG ' ' HB2' ' A' ' 116' ' ' SER . 88.2 p -123.23 157.12 33.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.328 -0.857 . . . . 0.0 109.782 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -137.28 121.85 18.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.16 -0.962 . . . . 0.0 110.434 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.635 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.3 p90 -148.63 -172.78 4.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.281 -0.887 . . . . 0.0 109.8 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.458 HG23 HG12 ' A' ' 113' ' ' ILE . 17.3 p -141.73 -178.96 5.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.167 -0.958 . . . . 0.0 110.731 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.419 ' HB2' HD13 ' A' ' 114' ' ' ILE . 3.0 t -160.01 160.1 32.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.471 -0.768 . . . . 0.0 110.226 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.44 ' HB2' ' HE2' ' A' ' 152' ' ' LYS . 97.2 mt-10 -84.45 -30.37 25.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.256 -0.903 . . . . 0.0 110.03 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.544 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 11.6 mm -70.58 150.27 95.5 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.46 -0.775 . . . . 0.0 109.942 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.544 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 40.1 Cg_endo -66.2 143.89 72.86 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.022 1.538 . . . . 0.0 110.384 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.64 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.2 Cg_endo -72.27 -31.41 11.76 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.983 1.517 . . . . 0.0 112.849 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.64 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.7 Cg_endo -69.41 -21.47 35.05 Favored 'Trans proline' 0 C--N 1.316 -1.154 0 N-CA-C 110.13 -0.758 . . . . 0.0 110.13 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.527 ' NE ' ' HB2' ' A' ' 159' ' ' ASN . 54.6 mtp180 -84.36 -46.13 12.06 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.505 ' C ' ' CD2' ' A' ' 18' ' ' LEU . 1.1 tt -69.61 -29.31 66.8 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.485 ' HB2' ' O ' ' A' ' 15' ' ' PRO . 76.5 t80 -66.7 -59.55 3.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.51 -0.744 . . . . 0.0 109.328 178.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.484 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 14.9 mttp -50.25 -35.3 26.38 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.199 179.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.653 ' CB ' ' CZ ' ' A' ' 158' ' ' TYR . . . -77.51 -41.01 40.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.394 -0.816 . . . . 0.0 110.703 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.635 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 1.6 t80 -69.56 -43.74 72.3 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.253 -0.904 . . . . 0.0 111.128 -178.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.568 HG12 ' CD1' ' A' ' 81' ' ' TYR . 4.3 t -104.31 -52.41 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.062 -1.024 . . . . 0.0 111.664 -179.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.512 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 7.2 mp -78.34 0.4 25.66 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.11 -0.994 . . . . 0.0 111.304 -178.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.546 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.4 OUTLIER -157.55 39.29 0.28 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.912 -1.118 . . . . 0.0 110.43 179.796 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.466 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -77.48 -24.81 50.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.279 -0.888 . . . . 0.0 110.128 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.461 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 87.3 m-20 -65.54 -16.46 63.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 110.145 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -129.9 13.04 5.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.352 -0.842 . . . . 0.0 110.016 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.527 HD11 ' CD1' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -99.84 -46.64 5.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.273 -0.892 . . . . 0.0 110.042 -179.944 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.598 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 3.5 t -84.92 -41.5 0.67 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.381 -0.824 . . . . 0.0 110.819 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.8 Cg_endo -78.98 9.93 3.13 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 O-C-N 123.47 1.247 . . . . 0.0 110.693 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.9 tptt -126.84 -34.44 2.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.079 -1.013 . . . . 0.0 109.428 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.527 ' CD1' HD11 ' A' ' 29' ' ' LEU . 62.3 mt -80.14 -43.35 22.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.569 -0.707 . . . . 0.0 109.546 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.26 100.4 4.16 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.54 -0.725 . . . . 0.0 109.919 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.37 -0.27 7.89 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 124.108 1.583 . . . . 0.0 110.803 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -84.25 -12.44 54.72 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.097 -1.002 . . . . 0.0 109.627 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.419 ' HB2' HD11 ' A' ' 38' ' ' ILE . . . -99.89 -65.08 0.99 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.491 -0.755 . . . . 0.0 109.987 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.514 HG13 ' CG2' ' A' ' 56' ' ' ILE . 1.9 mp -113.82 117.83 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.428 -0.795 . . . . 0.0 109.86 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' A' ' 57' ' ' THR . 9.1 ttpt -72.02 -30.94 65.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.321 -0.862 . . . . 0.0 110.518 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.548 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -169.02 151.88 4.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.196 -0.94 . . . . 0.0 110.211 -179.674 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.9 m -130.17 123.63 30.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.468 -0.77 . . . . 0.0 109.793 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.507 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 68.6 tt0 -134.25 113.3 11.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.04 -1.037 . . . . 0.0 110.6 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.478 HG22 HD11 ' A' ' 43' ' ' ILE . 44.7 mt -59.15 141.83 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.207 -0.933 . . . . 0.0 109.898 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.484 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 32.4 mt -116.29 -28.21 6.6 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.239 -0.913 . . . . 0.0 110.546 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.512 ' HB2' ' CB ' ' A' ' 53' ' ' ILE . 1.8 m95 -123.7 163.99 20.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.098 -1.001 . . . . 0.0 110.633 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 45' ' ' TRP . . . 42.34 -144.01 1.11 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -146.78 25.7 1.16 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.282 -1.128 . . . . 0.0 110.133 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 117.34 -15.22 13.19 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.126 -1.589 . . . . 0.0 109.126 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.516 ' O ' ' CG2' ' A' ' 71' ' ' ILE . . . -78.15 -167.6 31.04 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.473 ' HA ' HG23 ' A' ' 71' ' ' ILE . 46.2 Cg_endo -73.39 129.48 13.91 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.026 1.54 . . . . 0.0 110.641 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.27 -11.16 54.86 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -72.2 157.47 37.67 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.524 -0.986 . . . . 0.0 109.839 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.512 ' CB ' ' HB2' ' A' ' 45' ' ' TRP . 57.6 mt -129.71 120.06 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.0 109.875 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 93.1 mttt -106.24 132.47 52.26 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.164 -0.96 . . . . 0.0 110.531 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.484 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 77.7 tttt -101.64 92.69 4.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.319 -0.863 . . . . 0.0 109.92 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.514 ' CG2' HG13 ' A' ' 38' ' ' ILE . 91.5 mt -79.95 144.29 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.931 . . . . 0.0 110.289 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 39' ' ' LYS . 2.6 p -117.8 156.07 28.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 110.486 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.572 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 16.1 m-85 -115.49 148.15 39.81 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.352 -0.843 . . . . 0.0 110.039 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.21 35.6 3.96 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -61.44 -28.14 69.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.271 -1.134 . . . . 0.0 110.207 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 62' ' ' SER . . . 77.98 -179.81 51.01 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 61' ' ' GLY . 0.4 OUTLIER 58.96 -89.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.265 -1.138 . . . . 0.0 110.243 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -100.15 128.88 46.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.183 -0.948 . . . . 0.0 110.189 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -50.03 132.19 23.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 110.209 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.572 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -130.08 97.73 0.4 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.538 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 12.8 p90 -138.88 167.13 22.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.145 -1.209 . . . . 0.0 110.112 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.521 ' CG1' ' HA3' ' A' ' 88' ' ' GLY . 6.3 m -139.2 174.88 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.243 -0.911 . . . . 0.0 110.72 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.486 ' NZ ' ' OE1' ' A' ' 87' ' ' GLU . 30.1 mttt -128.85 122.35 30.22 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.516 -0.74 . . . . 0.0 109.743 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.533 ' CD2' ' CD1' ' A' ' 85' ' ' LEU . 13.2 m170 -109.46 126.56 53.62 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.16 -0.962 . . . . 0.0 110.88 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 52' ' ' THR . 54.9 tttt -97.63 121.86 40.03 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.273 -0.892 . . . . 0.0 109.609 179.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.538 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 30.7 mm -64.96 122.37 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.162 -0.961 . . . . 0.0 110.522 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 82' ' ' SER . 27.9 m-20 -98.18 -47.6 5.41 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.427 -0.796 . . . . 0.0 109.968 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 44.7 m -167.8 157.95 10.5 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.349 -0.845 . . . . 0.0 109.751 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.468 HG12 HG12 ' A' ' 23' ' ' VAL . 3.6 mt -135.35 160.52 40.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.228 -0.92 . . . . 0.0 110.355 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.584 ' HB2' ' HB2' ' A' ' 80' ' ' SER . 17.4 m-20 -132.7 83.1 2.04 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.606 -0.684 . . . . 0.0 110.161 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.484 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 45.1 mttm -72.95 -10.1 59.43 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.354 -0.841 . . . . 0.0 110.218 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -93.14 -39.26 11.14 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.317 -0.864 . . . . 0.0 109.315 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.501 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 1.1 p30 -111.78 12.25 20.97 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.466 0.651 . . . . 0.0 110.761 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.508 ' CZ ' ' HB3' ' A' ' 16' ' ' PRO . 7.3 m-85 54.19 60.79 3.37 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.449 -0.782 . . . . 0.0 112.858 178.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.584 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 1.1 m -128.03 156.87 42.07 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.954 -1.091 . . . . 0.0 109.484 177.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.683 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 31.2 t80 -142.13 137.32 30.83 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.158 -0.964 . . . . 0.0 110.444 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 50.7 m -140.74 125.98 18.61 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.447 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.683 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 7.2 p90 -141.69 176.53 8.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.281 -0.887 . . . . 0.0 110.02 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.465 ' OG1' ' OD2' ' A' ' 72' ' ' ASP . 46.0 m -126.8 132.82 50.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.298 -0.876 . . . . 0.0 109.868 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.542 ' HB3' ' HB ' ' A' ' 98' ' ' ILE . 12.4 tp -98.16 121.87 40.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.171 -0.955 . . . . 0.0 110.227 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.467 HG23 HD11 ' A' ' 86' ' ' ILE . 9.7 pt -104.59 -16.63 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.294 -0.879 . . . . 0.0 110.531 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.486 ' OE1' ' NZ ' ' A' ' 68' ' ' LYS . 54.4 tt0 -129.11 165.35 21.41 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.148 -0.97 . . . . 0.0 110.385 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.521 ' HA3' ' CG1' ' A' ' 67' ' ' VAL . . . 149.51 120.96 1.07 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -56.52 -19.31 14.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.299 -1.118 . . . . 0.0 110.183 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.99 -18.18 54.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.295 -0.878 . . . . 0.0 110.228 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 92' ' ' GLY . 77.1 mt -66.98 -27.61 67.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.223 -0.923 . . . . 0.0 110.162 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 50.15 179.51 0.02 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 57.6 p-10 -79.64 5.65 12.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.243 -1.151 . . . . 0.0 110.07 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.449 ' O ' HG21 ' A' ' 122' ' ' THR . 43.0 p -93.65 -34.91 13.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.89 . . . . 0.0 110.099 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.588 ' CD2' ' CG2' ' A' ' 122' ' ' THR . 19.5 mt -104.83 162.05 13.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 110.034 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.42 ' CD ' ' HB2' ' A' ' 123' ' ' LYS . 54.4 mt-10 -142.68 -80.3 0.21 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.297 -0.877 . . . . 0.0 109.978 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.516 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 53.7 mttp -80.14 126.16 30.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.595 -0.691 . . . . 0.0 110.409 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.643 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 5.3 mm -115.52 140.55 36.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 120.615 -1.303 . . . . 0.0 109.826 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.451 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -118.35 128.24 54.46 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.676 -0.81 . . . . 0.0 108.941 178.874 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.643 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 11.0 m-85 -123.53 135.33 53.96 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.313 -0.867 . . . . 0.0 110.533 -178.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.461 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 72.8 tt0 -139.14 136.29 34.96 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.276 -0.89 . . . . 0.0 110.146 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 50.3 m -137.36 138.94 40.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -0.926 . . . . 0.0 110.234 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.8 tttt -133.05 147.01 52.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.196 -0.94 . . . . 0.0 110.391 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.531 ' CD2' HG12 ' A' ' 114' ' ' ILE . 7.8 mt -121.82 153.8 37.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.273 -0.892 . . . . 0.0 110.241 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.455 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -149.49 -168.78 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.19 -0.944 . . . . 0.0 110.061 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -126.01 150.27 48.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.329 -0.857 . . . . 0.0 110.213 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.463 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 2.7 p -108.13 169.65 6.37 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.934 . . . . 0.0 110.345 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.7 Cg_endo -73.11 -11.41 25.2 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 O-C-N 124.106 1.582 . . . . 0.0 110.448 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 58.5 p -96.89 5.74 49.95 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.157 -0.965 . . . . 0.0 110.293 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.08 -38.17 3.2 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -55.61 -172.91 0.12 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.472 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 5.7 p -131.97 138.29 48.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.255 -1.144 . . . . 0.0 110.271 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.461 HD13 ' O ' ' A' ' 106' ' ' ALA . 20.5 mt -89.96 149.81 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.29 -0.881 . . . . 0.0 110.151 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.626 ' CG2' ' CZ ' ' A' ' 9' ' ' PHE . 11.5 mt -131.23 126.73 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.228 -0.92 . . . . 0.0 110.222 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -118.09 110.2 17.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.163 -0.96 . . . . 0.0 110.219 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.46 ' HB2' ' OG ' ' A' ' 7' ' ' SER . 1.6 m -98.57 160.71 14.1 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.236 -0.915 . . . . 0.0 110.44 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 52.9 m -160.03 124.46 3.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.376 -0.827 . . . . 0.0 109.984 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 90.5 p -129.03 157.5 41.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.201 -0.937 . . . . 0.0 110.469 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 47.1 m-70 -134.52 161.45 35.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.263 -0.898 . . . . 0.0 110.037 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.476 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 25.9 m-85 -128.35 142.03 51.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.231 -0.918 . . . . 0.0 110.722 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.516 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 87.8 m-70 -124.56 96.04 4.75 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.214 -0.929 . . . . 0.0 109.124 178.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.588 ' CG2' ' CD2' ' A' ' 95' ' ' LEU . 1.8 p -86.0 153.93 21.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.292 -0.88 . . . . 0.0 111.099 -178.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.42 ' HB2' ' CD ' ' A' ' 96' ' ' GLU . 20.7 tttt -101.92 121.64 42.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.547 -0.721 . . . . 0.0 109.963 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 105.4 -140.7 15.17 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -122.88 76.52 1.37 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.3 -1.117 . . . . 0.0 110.346 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.527 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 21.4 m -136.49 162.36 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.19 -0.944 . . . . 0.0 110.06 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.407 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 87.1 mt-10 -129.93 159.29 37.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.173 -0.955 . . . . 0.0 110.434 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.527 ' CD1' HD22 ' A' ' 95' ' ' LEU . 19.6 mm -66.96 173.1 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.332 -0.855 . . . . 0.0 110.149 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 132' ' ' HIS . 7.4 mtpp -113.02 135.14 54.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.386 -0.821 . . . . 0.0 109.95 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -44.03 -43.14 6.55 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.174 -0.954 . . . . 0.0 110.027 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.5 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 48.7 tt0 -62.92 -24.02 67.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -0.898 . . . . 0.0 109.891 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 129' ' ' LYS . 14.8 t-160 -79.9 -50.91 9.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.379 -0.826 . . . . 0.0 110.113 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.573 HG23 ' CZ ' ' A' ' 5' ' ' TYR . 46.9 t -60.92 -40.03 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.324 -0.86 . . . . 0.0 109.973 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -75.73 -50.43 15.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.399 -0.813 . . . . 0.0 110.149 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.5 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -61.69 -28.17 69.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.214 -0.929 . . . . 0.0 110.049 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.5 -28.81 64.86 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 38.9 mttm -69.53 -31.48 69.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.262 -1.14 . . . . 0.0 110.085 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 142' ' ' ASN . 99.0 mt-10 -77.16 -32.53 56.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.32 -0.862 . . . . 0.0 110.163 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.519 ' O ' ' CD1' ' A' ' 143' ' ' LEU . 35.6 mttt -68.42 -31.62 71.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.313 -0.867 . . . . 0.0 110.22 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.567 ' O ' ' CD1' ' A' ' 144' ' ' PHE . . . -90.28 -41.52 11.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.308 -0.87 . . . . 0.0 110.201 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.3 m -68.98 -47.33 65.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.407 -0.808 . . . . 0.0 110.14 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 138' ' ' GLU . 97.1 m-20 -55.14 -47.68 74.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.183 -0.948 . . . . 0.0 110.035 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.519 ' CD1' ' O ' ' A' ' 139' ' ' LYS . 76.0 mt -57.54 -42.09 82.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.313 -0.867 . . . . 0.0 109.91 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.567 ' CD1' ' O ' ' A' ' 140' ' ' ALA . 4.8 m-85 -58.61 -36.33 73.87 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.304 -0.872 . . . . 0.0 109.774 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 33.8 tttm -64.25 -26.0 68.31 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.319 -0.863 . . . . 0.0 109.777 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.453 ' HB3' HG23 ' A' ' 33' ' ' ILE . 16.6 mt -78.23 -34.27 49.36 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.635 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 47.5 mt -69.22 -51.64 41.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.468 ' O ' ' HG3' ' A' ' 152' ' ' LYS . 94.6 mt-10 -54.56 -42.16 70.63 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.37 -0.831 . . . . 0.0 109.169 178.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.457 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 88.5 m -63.72 -44.4 93.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.369 -0.832 . . . . 0.0 109.375 179.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.584 ' CE2' ' HB1' ' A' ' 157' ' ' ALA . 89.9 t80 -46.32 -44.96 17.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.577 -0.702 . . . . 0.0 109.704 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.584 HD22 ' CE1' ' A' ' 158' ' ' TYR . 77.2 mt -80.02 -31.34 39.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.434 -0.791 . . . . 0.0 110.231 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.528 ' CG ' HG12 ' A' ' 13' ' ' ILE . 45.0 mttt -65.39 -16.4 63.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.187 -0.946 . . . . 0.0 109.602 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.461 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -116.94 -28.17 2.53 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.565 ' CD2' ' O ' ' A' ' 150' ' ' TYR . 7.7 m-70 -106.04 93.2 7.43 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.329 -1.101 . . . . 0.0 110.028 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 46.6 Cg_endo -73.46 4.95 3.52 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.096 1.577 . . . . 0.0 110.951 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -116.25 -8.53 11.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.07 -1.019 . . . . 0.0 109.758 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.584 ' HB1' ' CE2' ' A' ' 150' ' ' TYR . . . -48.48 107.76 0.14 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.407 -0.808 . . . . 0.0 110.059 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.653 ' CZ ' ' CB ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 35.61 30.85 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.599 -0.688 . . . . 0.0 110.644 -179.768 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.527 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.784 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.601 HG22 ' CG ' ' A' ' 121' ' ' HIS . 7.4 p -91.62 154.0 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.262 -1.14 . . . . 0.0 110.386 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.585 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 15.3 m-85 -92.22 173.68 7.7 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.174 -0.953 . . . . 0.0 110.494 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.6 m -152.23 93.37 1.8 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.288 -0.882 . . . . 0.0 110.197 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.639 ' CZ ' ' CG2' ' A' ' 133' ' ' VAL . 81.4 m-85 -116.0 145.84 42.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.172 -0.955 . . . . 0.0 109.905 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 21.4 pt-20 -141.99 152.62 43.6 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.169 -0.957 . . . . 0.0 110.534 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 52.6 m -126.58 146.47 50.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.323 -0.86 . . . . 0.0 109.888 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -121.5 129.04 52.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.166 -0.959 . . . . 0.0 110.485 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.64 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.3 p90 -149.18 -175.57 5.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.35 -0.844 . . . . 0.0 109.802 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.481 HG23 HG12 ' A' ' 113' ' ' ILE . 17.3 p -140.44 177.92 7.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.138 -0.976 . . . . 0.0 110.725 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.524 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 2.5 t -158.14 158.99 35.71 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.479 -0.763 . . . . 0.0 110.069 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -85.4 -15.4 43.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.288 -0.883 . . . . 0.0 110.054 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.538 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 11.4 mm -82.4 149.67 61.98 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.33 -0.856 . . . . 0.0 110.056 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.538 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 41.8 Cg_endo -66.93 145.59 74.8 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.03 1.542 . . . . 0.0 110.306 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.638 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.2 Cg_endo -71.39 -31.96 13.2 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.978 1.514 . . . . 0.0 112.848 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 40.6 Cg_endo -68.31 -22.31 40.07 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 122.51 0.742 . . . . 0.0 110.245 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.534 ' NE ' ' CB ' ' A' ' 159' ' ' ASN . 46.0 mtp180 -85.1 -42.89 14.37 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.505 HD23 ' CD2' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -73.76 -33.37 64.24 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.947 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.567 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 59.5 t80 -65.65 -55.54 16.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.396 -0.815 . . . . 0.0 109.281 178.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 25' ' ' ASP . 12.0 mttt -51.83 -40.17 60.04 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.825 -0.75 . . . . 0.0 109.436 179.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.661 ' CB ' ' CZ ' ' A' ' 158' ' ' TYR . . . -73.96 -38.73 64.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.4 -0.813 . . . . 0.0 111.009 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.623 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 0.3 OUTLIER -75.26 -36.86 61.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.07 -1.019 . . . . 0.0 110.912 -179.231 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.466 HG12 HG12 ' A' ' 74' ' ' ILE . 5.1 t -107.26 -58.56 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.189 -0.944 . . . . 0.0 111.59 -179.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.465 HD11 ' HA ' ' A' ' 20' ' ' LYS . 7.0 mp -76.54 -1.8 29.19 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.138 -0.976 . . . . 0.0 111.534 -178.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.526 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.8 OUTLIER -154.91 49.49 0.58 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.936 -1.103 . . . . 0.0 110.099 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.478 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -87.43 -29.58 21.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.306 -0.871 . . . . 0.0 110.69 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -61.95 -18.0 58.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 0.0 110.425 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.524 ' O ' ' CG ' ' A' ' 32' ' ' LYS . 4.6 p30 -126.08 11.5 7.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 110.065 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.538 HD11 ' CD1' ' A' ' 33' ' ' ILE . 0.4 OUTLIER -97.52 -53.82 3.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -0.859 . . . . 0.0 110.154 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.594 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 2.9 t -71.8 -41.46 9.28 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.273 -0.892 . . . . 0.0 110.876 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 47.5 Cg_endo -76.77 7.44 3.54 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 O-C-N 123.399 1.21 . . . . 0.0 110.968 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.524 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 47.7 mmtm -127.24 -35.46 2.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.086 -1.009 . . . . 0.0 109.403 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.557 HG12 ' CD1' ' A' ' 150' ' ' TYR . 10.1 mt -80.12 -33.73 14.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.583 -0.698 . . . . 0.0 109.382 179.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.43 91.33 4.45 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.583 -0.698 . . . . 0.0 110.068 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.82 2.07 6.34 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.104 1.581 . . . . 0.0 110.797 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -87.34 -15.23 38.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.094 -1.004 . . . . 0.0 109.869 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -107.64 -43.97 4.37 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.3 -0.875 . . . . 0.0 110.188 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.546 HG12 ' CE1' ' A' ' 58' ' ' PHE . 3.4 mt -127.45 142.37 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.392 -0.817 . . . . 0.0 110.116 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.513 ' CE ' ' HA ' ' A' ' 60' ' ' GLU . 8.7 tppt? -119.62 -21.06 7.47 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.282 -0.887 . . . . 0.0 110.689 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.564 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.5 OUTLIER -153.46 152.48 31.05 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.05 -1.031 . . . . 0.0 110.465 -179.671 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.458 ' N ' ' CD2' ' A' ' 40' ' ' HIS . 17.5 m -150.99 118.31 6.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.509 -0.744 . . . . 0.0 109.573 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -133.97 109.3 8.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.181 -0.95 . . . . 0.0 110.788 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.47 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 21.9 mt -54.18 137.62 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.257 -0.902 . . . . 0.0 109.748 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.9 tp -107.07 -30.1 9.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.116 -0.99 . . . . 0.0 110.995 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.571 ' CD2' HD13 ' A' ' 53' ' ' ILE . 2.0 m95 -124.08 164.64 19.0 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.153 -0.967 . . . . 0.0 110.875 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.467 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 41.24 -137.91 2.04 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.429 ' O ' ' CG ' ' A' ' 47' ' ' ASP . 11.5 t0 -154.33 24.25 0.48 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.312 -1.111 . . . . 0.0 109.85 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 120.07 -17.83 9.82 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.467 ' O ' HG22 ' A' ' 71' ' ' ILE . . . -68.29 -174.54 8.73 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.469 ' HA ' HG23 ' A' ' 71' ' ' ILE . 46.0 Cg_endo -73.74 128.34 12.42 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 123.937 1.493 . . . . 0.0 110.639 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.96 -13.12 56.14 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -66.59 162.13 21.63 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.516 -0.99 . . . . 0.0 109.629 179.672 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.571 HD13 ' CD2' ' A' ' 45' ' ' TRP . 48.2 mt -128.56 121.61 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.241 -0.912 . . . . 0.0 109.756 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 98.7 mttt -107.78 134.19 51.09 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.173 -0.955 . . . . 0.0 110.319 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.573 ' HE2' ' CD1' ' A' ' 66' ' ' TYR . 14.5 tptm -105.65 90.32 3.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.266 -0.896 . . . . 0.0 109.802 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.573 HG23 ' CE1' ' A' ' 58' ' ' PHE . 73.0 mt -79.96 145.63 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.32 -0.863 . . . . 0.0 110.339 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.492 ' OG1' ' CD2' ' A' ' 40' ' ' HIS . 0.6 OUTLIER -122.55 144.87 48.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.374 -0.829 . . . . 0.0 109.88 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.609 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 13.5 m-85 -113.26 170.27 8.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.087 -1.008 . . . . 0.0 110.142 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.496 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . 59.15 173.7 0.57 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.513 ' HA ' ' CE ' ' A' ' 39' ' ' LYS . 97.6 mt-10 -72.89 -25.96 61.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.324 -1.103 . . . . 0.0 110.263 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 62' ' ' SER . . . 138.17 -17.73 3.35 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 61' ' ' GLY . 20.3 m -42.86 -42.46 3.67 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.275 -1.132 . . . . 0.0 110.245 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -124.02 176.15 6.53 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.189 -0.945 . . . . 0.0 110.212 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.673 ' CE1' ' CE2' ' A' ' 66' ' ' TYR . 0.1 OUTLIER -88.79 112.41 23.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.909 . . . . 0.0 109.927 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.609 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -145.82 60.98 0.48 Allowed Glycine 0 N--CA 1.483 1.829 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 179.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.673 ' CE2' ' CE1' ' A' ' 64' ' ' TYR . 10.5 p90 -125.12 166.19 16.87 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.206 -1.173 . . . . 0.0 109.894 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.532 HG13 ' CA ' ' A' ' 88' ' ' GLY . 6.3 m -140.54 172.26 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 110.68 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.482 ' HD3' ' CD ' ' A' ' 55' ' ' LYS . 0.8 OUTLIER -120.72 120.46 35.73 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.64 -0.662 . . . . 0.0 109.555 179.507 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.524 ' NE2' HD11 ' A' ' 85' ' ' LEU . 12.6 m170 -110.42 119.36 38.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.126 -0.984 . . . . 0.0 111.106 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 52' ' ' THR . 13.4 tttp -96.69 99.4 11.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.183 -0.948 . . . . 0.0 109.444 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.525 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 30.1 mm -42.38 135.92 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.351 -0.843 . . . . 0.0 110.159 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.473 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 90.2 m-20 -104.2 -39.83 6.36 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.291 -0.881 . . . . 0.0 110.033 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 1.4 m -179.38 162.14 1.13 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.246 -0.909 . . . . 0.0 109.6 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.466 HG12 HG12 ' A' ' 23' ' ' VAL . 0.9 OUTLIER -143.99 153.2 15.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.024 -179.812 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' A' ' 78' ' ' ASN . 5.5 m-20 -134.58 78.49 1.75 Allowed 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.501 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.567 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 20.8 tttt -61.65 -15.74 42.5 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.221 -0.925 . . . . 0.0 110.167 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -92.39 -36.0 13.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.242 -0.912 . . . . 0.0 109.41 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.522 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.8 m-80 -96.52 -5.3 39.71 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.639 -0.663 . . . . 0.0 109.387 179.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.522 ' HB2' ' O ' ' A' ' 78' ' ' ASN . 76.4 m-85 62.08 55.95 2.37 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.566 0.698 . . . . 0.0 110.619 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.467 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 1.3 m -132.33 159.15 40.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.365 -0.834 . . . . 0.0 109.714 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.692 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 64.7 t80 -146.56 146.09 30.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.19 -0.943 . . . . 0.0 109.811 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.533 ' OG ' ' CG ' ' A' ' 101' ' ' GLU . 0.2 OUTLIER -153.48 138.14 16.94 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.167 -0.958 . . . . 0.0 110.861 -179.729 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.692 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 11.5 p90 -150.89 173.43 14.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.427 -0.796 . . . . 0.0 110.2 179.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.471 ' OG1' ' OD2' ' A' ' 72' ' ' ASP . 58.2 m -124.92 131.58 53.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.421 -0.799 . . . . 0.0 109.934 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.524 HD11 ' NE2' ' A' ' 69' ' ' HIS . 2.0 tp -100.1 129.09 46.1 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.201 -0.937 . . . . 0.0 110.044 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.441 HG12 ' HB3' ' A' ' 68' ' ' LYS . 12.8 pt -115.27 -13.56 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -0.891 . . . . 0.0 110.027 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.43 ' O ' HD12 ' A' ' 85' ' ' LEU . 18.1 tt0 -128.68 154.63 46.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.884 . . . . 0.0 110.232 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.532 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 154.8 128.28 1.16 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -64.9 -10.87 32.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.273 -1.133 . . . . 0.0 110.242 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.91 -17.35 41.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.275 -0.891 . . . . 0.0 110.166 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.483 HD23 ' CG1' ' A' ' 98' ' ' ILE . 51.2 mt -69.01 -19.08 64.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.893 . . . . 0.0 110.234 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 49.09 -177.36 0.02 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -84.36 11.88 7.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.259 -1.142 . . . . 0.0 110.173 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 69.7 p -102.84 -38.18 7.52 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.281 -0.887 . . . . 0.0 110.181 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.528 HD22 ' CG2' ' A' ' 122' ' ' THR . 76.5 mt -95.17 166.22 12.02 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.381 -0.824 . . . . 0.0 109.995 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.459 ' HG3' ' HB2' ' A' ' 123' ' ' LYS . 9.9 mt-10 -146.64 -81.36 0.14 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.263 -0.898 . . . . 0.0 109.787 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 49.2 mttt -80.39 130.09 34.94 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.728 -0.607 . . . . 0.0 110.254 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.605 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 5.7 mm -118.0 140.61 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 120.921 -1.112 . . . . 0.0 109.778 178.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.473 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.5 OUTLIER -121.51 128.61 52.24 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.762 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 10.7 m-85 -123.62 134.99 53.7 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.346 -0.846 . . . . 0.0 110.433 -178.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.533 ' CG ' ' OG ' ' A' ' 82' ' ' SER . 7.7 mt-10 -133.61 141.56 47.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.32 -0.863 . . . . 0.0 109.945 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.475 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 18.9 m -138.27 142.88 39.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.092 -1.005 . . . . 0.0 109.975 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.13 138.54 38.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.242 -0.911 . . . . 0.0 110.327 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.519 ' CD2' HG12 ' A' ' 114' ' ' ILE . 5.2 mt -124.86 145.8 49.61 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.259 -0.901 . . . . 0.0 110.227 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.499 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -152.76 -168.54 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.405 -0.81 . . . . 0.0 109.945 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -113.89 141.01 47.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.266 -0.896 . . . . 0.0 110.001 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.536 ' HB3' ' CG1' ' A' ' 113' ' ' ILE . 1.3 p -96.12 170.3 7.77 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.118 -0.989 . . . . 0.0 110.406 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 50.0 Cg_endo -78.81 4.57 6.34 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.105 1.582 . . . . 0.0 110.456 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 51.9 m -110.15 5.22 21.8 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -0.871 . . . . 0.0 110.283 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 99.36 -27.65 19.11 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.463 ' O ' ' OG ' ' A' ' 107' ' ' SER . . . -75.77 -173.94 35.5 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 22.4 p -118.53 132.44 56.21 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.181 -1.188 . . . . 0.0 110.301 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.536 ' CG1' ' HB3' ' A' ' 107' ' ' SER . 23.9 mt -82.84 147.61 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 109.903 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.604 ' CG2' ' CE2' ' A' ' 9' ' ' PHE . 9.7 mt -130.63 122.69 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.305 -0.872 . . . . 0.0 110.566 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.7 tttp -111.93 117.33 32.44 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.383 -0.823 . . . . 0.0 109.762 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 0.5 OUTLIER -110.83 152.69 26.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.246 -0.909 . . . . 0.0 110.69 -179.55 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 53.6 m -149.57 132.57 16.2 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.42 -0.8 . . . . 0.0 110.1 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.4 m -131.12 150.53 52.11 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.198 -0.939 . . . . 0.0 110.321 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.473 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 20.9 m-70 -137.9 135.4 36.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.343 -0.848 . . . . 0.0 110.037 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.544 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 11.5 m-85 -113.27 122.22 46.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.133 -0.979 . . . . 0.0 110.631 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.601 ' CG ' HG22 ' A' ' 2' ' ' VAL . 88.7 m-70 -91.22 121.77 33.27 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.528 ' CG2' HD22 ' A' ' 95' ' ' LEU . 1.2 p -98.11 149.23 22.73 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.059 -1.025 . . . . 0.0 110.974 -178.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.459 ' HB2' ' HG3' ' A' ' 96' ' ' GLU . 20.2 tttt -104.09 108.7 20.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.54 -0.725 . . . . 0.0 110.163 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 108.65 -136.36 13.47 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 26.4 t30 -119.94 54.37 1.03 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.105 -1.232 . . . . 0.0 110.341 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 17.7 m -115.65 170.24 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.311 -0.868 . . . . 0.0 110.113 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.401 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 96.4 mt-10 -134.25 -177.79 4.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.199 -0.938 . . . . 0.0 110.333 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.582 HG12 ' CD1' ' A' ' 3' ' ' PHE . 8.2 mm -84.73 172.25 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.216 -0.928 . . . . 0.0 110.405 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.422 ' N ' HG23 ' A' ' 128' ' ' ILE . 47.5 mttt -94.95 131.03 41.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.437 -0.79 . . . . 0.0 109.825 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.413 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 95.9 mt-10 -48.97 -40.96 32.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.193 -0.942 . . . . 0.0 110.109 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.466 ' HA ' ' HB1' ' A' ' 135' ' ' ALA . 49.0 tt0 -66.67 -8.89 30.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.221 -0.924 . . . . 0.0 109.753 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.465 ' O ' ' HA2' ' A' ' 136' ' ' GLY . 8.4 t-160 -103.24 -55.02 2.49 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.896 . . . . 0.0 110.196 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.639 ' CG2' ' CZ ' ' A' ' 5' ' ' TYR . 2.1 p -61.62 -29.61 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.449 -0.782 . . . . 0.0 110.227 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.456 ' HA ' ' HE3' ' A' ' 137' ' ' LYS . 28.3 tttt -108.91 -71.85 0.75 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.952 . . . . 0.0 110.061 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.466 ' HB1' ' HA ' ' A' ' 131' ' ' GLU . . . -55.79 -21.05 17.34 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 109.68 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 132' ' ' HIS . . . -74.46 -30.91 59.6 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 6.0 mtmp? -66.74 -31.87 72.8 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.25 -1.147 . . . . 0.0 109.949 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -72.96 -34.24 66.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.298 -0.876 . . . . 0.0 109.959 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.457 ' HA ' ' OD1' ' A' ' 142' ' ' ASN . 52.6 mttt -67.91 -38.83 83.43 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.404 -0.81 . . . . 0.0 109.804 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.83 -40.05 91.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.311 -0.868 . . . . 0.0 109.837 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.428 ' O ' ' HG3' ' A' ' 145' ' ' LYS . 22.8 t -56.71 -38.12 71.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.374 -0.829 . . . . 0.0 109.904 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.457 ' OD1' ' HA ' ' A' ' 139' ' ' LYS . 15.7 m120 -56.9 -48.49 78.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.304 -0.872 . . . . 0.0 109.997 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.454 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 1.2 mp -61.68 -34.19 75.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.87 . . . . 0.0 109.962 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.472 ' HA ' HD11 ' A' ' 147' ' ' ILE . 19.8 m-85 -64.68 -38.22 90.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.291 -0.881 . . . . 0.0 109.728 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 141' ' ' SER . 57.7 mttt -71.67 -12.23 61.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 109.946 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.492 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 17.8 mt -81.3 -36.65 29.53 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.233 -0.917 . . . . 0.0 108.882 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.623 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 17.3 mt -69.56 -50.37 51.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.524 ' CG ' ' OG ' ' A' ' 11' ' ' SER . 57.1 mt-10 -58.37 -37.71 75.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.466 -0.771 . . . . 0.0 109.453 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 20.2 m -67.57 -33.76 75.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.166 -0.959 . . . . 0.0 109.511 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.575 ' O ' ' CD2' ' A' ' 154' ' ' HIS . 87.6 t80 -58.91 -45.87 89.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.392 -0.817 . . . . 0.0 109.613 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.584 HD22 ' CE1' ' A' ' 158' ' ' TYR . 70.9 mt -80.0 -28.88 39.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.385 -0.822 . . . . 0.0 110.029 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.451 ' HA ' HD13 ' A' ' 13' ' ' ILE . 82.5 tttt -65.34 -14.91 61.88 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.193 -0.942 . . . . 0.0 109.518 179.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.451 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -119.84 -27.45 2.1 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.591 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 6.1 m-70 -106.44 93.61 8.59 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.22 -1.165 . . . . 0.0 110.301 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.468 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.9 Cg_endo -74.21 4.6 4.19 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 124.07 1.563 . . . . 0.0 110.833 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -115.61 -7.33 12.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.069 -1.019 . . . . 0.0 109.791 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.581 ' O ' ' CD1' ' A' ' 158' ' ' TYR . . . -51.35 108.26 0.24 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.433 -0.792 . . . . 0.0 110.077 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.661 ' CZ ' ' CB ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 35.73 30.7 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.615 -0.678 . . . . 0.0 110.672 -179.637 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.534 ' CB ' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.4 0 O-C-N 121.095 -1.003 . . . . 0.0 109.684 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.568 HG12 ' CE1' ' A' ' 121' ' ' HIS . 58.1 t -122.8 134.25 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.173 -1.193 . . . . 0.0 110.412 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.578 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 32.0 m-85 -89.19 161.11 16.63 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.258 -0.901 . . . . 0.0 110.235 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 92.1 m -144.26 96.57 2.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.229 -0.92 . . . . 0.0 110.079 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.622 ' CE1' ' CG2' ' A' ' 133' ' ' VAL . 77.8 m-85 -115.41 144.66 43.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.15 -0.969 . . . . 0.0 110.172 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 116' ' ' SER . 21.0 pt-20 -138.6 152.41 48.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 0.0 110.218 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 65.2 m -122.37 150.29 42.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.251 -0.906 . . . . 0.0 110.047 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -133.13 120.07 20.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 110.356 -179.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.644 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.7 p90 -149.37 -173.76 4.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.293 -0.879 . . . . 0.0 109.92 179.751 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.53 ' CG2' ' HA ' ' A' ' 113' ' ' ILE . 3.3 p -140.32 171.8 13.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.12 -0.987 . . . . 0.0 110.474 -179.657 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.454 ' HB3' ' OE2' ' A' ' 148' ' ' GLU . 99.7 p -151.46 136.05 17.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.297 -0.877 . . . . 0.0 110.157 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -61.78 -31.91 72.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.172 -0.955 . . . . 0.0 110.244 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.548 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 8.1 mm -70.94 149.21 94.9 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.381 -0.824 . . . . 0.0 109.951 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.548 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 39.9 Cg_endo -65.39 143.59 76.95 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.073 1.565 . . . . 0.0 110.676 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.641 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.9 Cg_endo -71.82 -31.56 12.72 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 124.073 1.565 . . . . 0.0 112.74 -179.37 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.3 Cg_endo -69.02 -21.91 36.25 Favored 'Trans proline' 0 C--N 1.318 -1.051 0 N-CA-C 110.01 -0.804 . . . . 0.0 110.01 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.531 ' NE ' ' CB ' ' A' ' 159' ' ' ASN . 41.5 mtp180 -82.08 -47.45 12.58 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.583 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.591 ' CD2' ' CG2' ' A' ' 147' ' ' ILE . 0.2 OUTLIER -70.38 -35.08 73.28 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.093 178.929 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.486 ' HB2' ' O ' ' A' ' 15' ' ' PRO . 80.4 t80 -61.0 -59.26 5.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.479 -0.763 . . . . 0.0 109.738 179.116 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' A' ' 25' ' ' ASP . 17.6 mttp -51.64 -35.9 43.86 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.724 -0.791 . . . . 0.0 109.503 179.622 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.644 ' CB ' ' CZ ' ' A' ' 158' ' ' TYR . . . -77.55 -32.36 53.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.464 -0.772 . . . . 0.0 111.048 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.629 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 0.1 OUTLIER -80.53 -41.9 23.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.233 -0.917 . . . . 0.0 111.081 -179.099 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.473 HG12 ' CD1' ' A' ' 81' ' ' TYR . 3.7 t -103.91 -51.17 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.118 -0.989 . . . . 0.0 111.386 -179.106 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 7.3 mp -80.14 -9.8 59.73 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.132 -0.98 . . . . 0.0 111.684 -178.878 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 20' ' ' LYS . 1.2 m-20 -148.48 36.57 0.81 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.768 -1.207 . . . . 0.0 110.711 -179.664 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -76.98 -25.7 53.05 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.301 -0.875 . . . . 0.0 110.309 179.676 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -66.16 -15.25 62.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.195 -0.941 . . . . 0.0 109.919 179.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.474 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 4.4 p30 -130.55 11.26 5.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.343 -0.848 . . . . 0.0 109.953 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.53 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -94.42 -48.99 5.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.374 -0.829 . . . . 0.0 110.042 179.689 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.65 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 2.1 m -73.91 -29.65 1.04 Allowed Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.373 -0.829 . . . . 0.0 112.039 -179.826 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 52.9 Cg_endo -78.81 4.06 6.79 Favored 'Trans proline' 0 C--N 1.32 -0.946 0 O-C-N 122.714 0.85 . . . . 0.0 110.128 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -124.34 -36.08 2.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.301 -0.874 . . . . 0.0 109.103 179.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.559 HG12 ' CD1' ' A' ' 150' ' ' TYR . 53.2 mt -79.96 -25.25 11.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 121.622 0.725 . . . . 0.0 109.25 179.19 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.89 91.97 0.52 Allowed Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.702 -0.624 . . . . 0.0 109.738 179.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -70.77 -2.85 11.56 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.0 1.526 . . . . 0.0 110.632 -179.676 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -91.98 10.73 27.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -0.913 . . . . 0.0 109.938 179.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.439 ' HB1' HD11 ' A' ' 38' ' ' ILE . . . -114.65 -49.74 2.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.326 -0.859 . . . . 0.0 109.995 179.854 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.521 ' N ' HD11 ' A' ' 38' ' ' ILE . 1.8 mp -119.87 134.63 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.486 -0.759 . . . . 0.0 109.905 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.1 ttmm -87.59 -24.64 23.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.311 -0.868 . . . . 0.0 110.357 -179.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.546 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -179.32 153.53 0.59 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.2 -0.938 . . . . 0.0 110.172 -179.847 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 m -127.32 124.44 38.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.345 -0.847 . . . . 0.0 109.923 179.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.493 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 49.7 tt0 -136.44 111.81 9.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.173 -0.954 . . . . 0.0 110.46 -179.823 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.472 HG22 HD11 ' A' ' 43' ' ' ILE . 22.2 mt -57.88 134.11 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.22 -0.925 . . . . 0.0 110.052 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.525 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 19.0 mt -103.45 -28.67 11.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.188 -0.945 . . . . 0.0 110.675 -179.79 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.547 ' CD1' HD11 ' A' ' 53' ' ' ILE . 2.0 m95 -129.51 165.18 22.18 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.096 -1.003 . . . . 0.0 110.731 -179.751 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.448 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 41.57 -135.26 3.11 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.658 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -157.2 19.7 0.3 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.299 -1.118 . . . . 0.0 110.099 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.74 -15.82 7.02 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.473 ' O ' HG23 ' A' ' 71' ' ' ILE . . . -76.58 -170.4 31.61 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.48 ' HA ' HG23 ' A' ' 71' ' ' ILE . 47.5 Cg_endo -73.67 129.33 13.48 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.028 1.541 . . . . 0.0 110.662 -179.831 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.98 -9.57 56.64 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 -179.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -73.23 159.04 34.06 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.601 -0.941 . . . . 0.0 109.84 179.835 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.547 HD11 ' CD1' ' A' ' 45' ' ' TRP . 55.5 mt -128.85 121.35 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.382 -0.823 . . . . 0.0 109.79 179.538 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 6.4 mtpm? -104.63 145.03 30.9 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.155 -0.966 . . . . 0.0 110.262 -179.795 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.525 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 13.1 tttt -115.62 89.99 3.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -0.856 . . . . 0.0 110.024 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.572 HG23 ' CE1' ' A' ' 58' ' ' PHE . 64.7 mt -79.98 136.07 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -0.926 . . . . 0.0 110.139 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.465 ' OG1' ' O ' ' A' ' 40' ' ' HIS . 1.4 p -108.98 152.66 24.67 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.211 -0.931 . . . . 0.0 110.396 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.583 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 20.1 m-85 -115.51 152.53 32.81 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.249 -0.907 . . . . 0.0 110.072 179.53 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -106.26 -7.88 34.35 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -107.7 146.68 31.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.275 -1.132 . . . . 0.0 110.298 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.73 -152.66 18.25 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 95.3 p -56.73 177.8 0.07 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.214 -1.168 . . . . 0.0 110.162 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -64.88 -40.22 94.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 110.244 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -110.58 105.4 14.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.215 -0.928 . . . . 0.0 110.299 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.583 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -132.63 84.36 0.29 Allowed Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.679 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.517 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 13.8 p90 -131.09 164.01 26.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.283 -1.127 . . . . 0.0 110.027 -179.795 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.53 HG13 ' CA ' ' A' ' 88' ' ' GLY . 5.7 m -134.08 174.54 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.927 . . . . 0.0 110.583 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.529 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 28.9 mttt -128.17 121.0 28.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.483 -0.76 . . . . 0.0 109.604 179.583 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.521 ' NE2' HD11 ' A' ' 85' ' ' LEU . 15.5 m170 -110.52 122.28 47.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.14 -0.975 . . . . 0.0 110.969 -179.384 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 52' ' ' THR . 81.0 tttt -95.48 117.44 30.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.187 -0.945 . . . . 0.0 109.359 178.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.519 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 23.6 mm -61.98 124.6 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.201 -0.937 . . . . 0.0 110.6 -179.31 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.483 ' HB2' ' O ' ' A' ' 82' ' ' SER . 94.4 m-20 -99.79 -41.88 7.07 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.403 -0.811 . . . . 0.0 109.693 179.512 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.456 ' OG ' ' HB2' ' A' ' 82' ' ' SER . 90.0 p -171.24 158.35 5.4 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.299 -0.875 . . . . 0.0 109.848 179.617 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.446 HG12 HG12 ' A' ' 23' ' ' VAL . 4.9 mt -137.4 158.47 35.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.265 -0.897 . . . . 0.0 110.273 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.58 ' HB2' ' HB2' ' A' ' 80' ' ' SER . 3.2 m-20 -133.68 83.32 2.04 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.579 -0.7 . . . . 0.0 110.166 -179.589 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.477 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 20.8 mttt -73.43 -9.89 59.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.438 -0.789 . . . . 0.0 110.167 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -93.54 -38.97 11.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.249 -0.907 . . . . 0.0 109.289 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.501 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 0.9 OUTLIER -111.3 7.45 21.06 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.466 0.651 . . . . 0.0 110.807 -179.772 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.572 ' CZ ' ' HB3' ' A' ' 16' ' ' PRO . 5.6 m-85 59.03 60.88 2.28 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.379 -0.826 . . . . 0.0 112.859 177.847 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.58 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 1.0 OUTLIER -127.9 156.01 43.28 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.989 -1.069 . . . . 0.0 109.329 177.875 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.691 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 24.7 t80 -140.76 136.55 32.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.14 -0.975 . . . . 0.0 110.49 -179.254 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 1.1 m -139.49 125.69 20.05 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.302 -0.874 . . . . 0.0 110.324 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.691 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 23.7 p90 -147.01 169.92 18.21 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.234 -0.916 . . . . 0.0 110.404 179.558 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.464 ' OG1' ' OD2' ' A' ' 72' ' ' ASP . 60.7 m -122.06 132.04 54.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.449 -0.782 . . . . 0.0 109.998 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.522 ' HB3' ' HB ' ' A' ' 98' ' ' ILE . 2.5 tp -97.41 122.9 41.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.184 -0.947 . . . . 0.0 110.125 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.406 HG23 HD11 ' A' ' 86' ' ' ILE . 13.9 pt -105.15 -15.2 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -0.926 . . . . 0.0 110.293 -179.648 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.529 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 31.6 tt0 -131.14 162.4 29.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.187 -0.946 . . . . 0.0 110.5 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.53 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 152.18 117.46 0.73 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -52.94 -21.16 4.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.174 -1.192 . . . . 0.0 110.3 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.84 -22.96 55.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.896 . . . . 0.0 110.279 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.519 HD23 ' CG1' ' A' ' 98' ' ' ILE . 26.8 mt -66.64 -26.8 67.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.918 . . . . 0.0 110.178 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 49.27 -178.44 0.02 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.431 ' OD1' HG21 ' A' ' 94' ' ' THR . 57.9 p30 -79.05 4.48 14.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -1.167 . . . . 0.0 110.226 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.452 ' O ' HG21 ' A' ' 122' ' ' THR . 43.9 p -90.69 -32.47 16.18 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.269 -0.894 . . . . 0.0 110.114 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.577 ' CD2' ' CG2' ' A' ' 122' ' ' THR . 62.8 mt -111.04 162.76 14.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.373 -0.829 . . . . 0.0 110.089 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.456 ' HG3' ' HB2' ' A' ' 123' ' ' LYS . 71.3 mm-40 -142.63 -80.01 0.22 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.124 -0.985 . . . . 0.0 110.201 -179.726 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.5 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 58.4 mttm -80.21 126.82 31.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.584 -0.698 . . . . 0.0 110.481 -179.823 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.633 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 5.7 mm -117.36 140.57 39.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 120.744 -1.223 . . . . 0.0 109.999 179.149 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.464 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -119.39 129.58 54.88 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.829 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.633 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 10.1 m-85 -124.54 135.55 53.26 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.274 -0.891 . . . . 0.0 110.609 -178.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.462 ' O ' ' N ' ' A' ' 117' ' ' THR . 6.4 mt-10 -138.54 128.79 25.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.335 -0.853 . . . . 0.0 110.039 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 79.3 m -131.25 146.12 52.18 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.135 -0.978 . . . . 0.0 110.202 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 115' ' ' LYS . 4.5 tttt -140.72 145.25 36.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.312 -0.868 . . . . 0.0 110.324 -179.834 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.521 ' CD2' HG12 ' A' ' 114' ' ' ILE . 4.5 mt -124.73 153.8 41.83 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.294 -0.879 . . . . 0.0 110.239 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.495 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -151.45 -168.94 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.177 -0.952 . . . . 0.0 109.982 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -122.76 160.73 25.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.261 -0.899 . . . . 0.0 110.317 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.467 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 2.1 p -117.35 170.26 6.34 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.302 -0.874 . . . . 0.0 110.197 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 47.2 Cg_endo -72.89 -17.11 25.7 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.022 1.538 . . . . 0.0 110.452 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 73.4 m -95.17 9.46 39.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.334 -0.854 . . . . 0.0 110.272 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 94.54 -33.42 5.33 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -55.51 -172.39 0.11 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.46 ' HB3' ' HD3' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -136.53 137.47 40.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -1.148 . . . . 0.0 110.349 -179.998 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.53 ' HA ' ' CG2' ' A' ' 10' ' ' THR . 25.0 mt -90.39 147.74 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.349 -0.844 . . . . 0.0 110.017 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.579 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 23.2 mt -131.48 114.22 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.231 -0.918 . . . . 0.0 110.593 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 103' ' ' LYS . 16.6 tttt -102.9 130.91 50.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.221 -0.924 . . . . 0.0 109.758 179.467 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 3.3 t -123.03 160.09 27.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.096 -1.003 . . . . 0.0 110.558 -179.637 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 29.8 m -156.36 126.98 6.73 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.332 -0.855 . . . . 0.0 110.038 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 83.5 p -130.38 152.58 49.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.114 -0.991 . . . . 0.0 110.489 -179.75 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.464 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 50.4 m-70 -134.93 158.12 45.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.371 -0.831 . . . . 0.0 109.917 179.599 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.479 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 26.8 m-85 -129.59 135.42 48.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.133 -0.979 . . . . 0.0 110.488 -179.624 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.568 ' CE1' HG12 ' A' ' 2' ' ' VAL . 87.5 m-70 -117.25 95.92 5.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.117 -0.99 . . . . 0.0 109.819 179.38 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.577 ' CG2' ' CD2' ' A' ' 95' ' ' LEU . 2.4 p -77.86 158.51 29.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.909 . . . . 0.0 110.616 -179.522 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.456 ' HB2' ' HG3' ' A' ' 96' ' ' GLU . 63.4 tttt -113.12 99.25 7.69 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.372 -0.83 . . . . 0.0 110.191 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 121.84 -128.98 7.47 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -125.9 71.37 1.24 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.336 -1.097 . . . . 0.0 110.173 -179.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.506 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 35.5 m -138.58 155.93 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.188 -0.945 . . . . 0.0 110.092 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -123.51 174.32 7.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.319 -0.863 . . . . 0.0 110.284 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.466 ' CD1' HD22 ' A' ' 95' ' ' LEU . 20.9 mm -76.93 171.77 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.28 -0.888 . . . . 0.0 110.047 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 132' ' ' HIS . 22.3 mttt -99.17 129.9 45.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.191 -0.943 . . . . 0.0 109.986 179.785 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.513 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 93.8 mt-10 -44.05 -43.6 6.9 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.214 -0.929 . . . . 0.0 109.947 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.502 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 47.8 tt0 -58.61 -24.13 60.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.245 -0.909 . . . . 0.0 109.845 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.479 ' N ' ' O ' ' A' ' 129' ' ' LYS . 14.8 t-160 -86.67 -57.05 3.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.328 -0.857 . . . . 0.0 110.135 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.622 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 2.3 p -63.04 -22.31 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.417 -0.802 . . . . 0.0 110.262 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 54.1 mttt -112.0 -73.74 0.66 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.143 -0.973 . . . . 0.0 110.328 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.502 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -53.45 -20.53 4.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.901 . . . . 0.0 109.642 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.55 -29.55 65.62 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.071 -1.611 . . . . 0.0 109.071 179.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.444 ' O ' ' OG ' ' A' ' 141' ' ' SER . 23.7 mttm -64.21 -30.09 71.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.298 -1.119 . . . . 0.0 109.954 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 70.2 tt0 -77.4 -28.32 52.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.379 -0.825 . . . . 0.0 110.156 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.8 mmtp -73.9 -34.8 64.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 110.055 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -80.6 -34.68 34.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.873 . . . . 0.0 110.007 179.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' A' ' 137' ' ' LYS . 33.2 m -63.86 -45.15 90.76 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.401 -0.812 . . . . 0.0 109.943 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -54.94 -42.77 72.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.283 -0.886 . . . . 0.0 110.015 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.45 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 80.8 mt -60.59 -46.1 91.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.294 -0.879 . . . . 0.0 110.083 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -59.31 -37.32 77.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.374 -0.829 . . . . 0.0 109.818 179.793 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -72.15 -12.97 61.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.306 -0.872 . . . . 0.0 110.068 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.45 ' HB2' ' O ' ' A' ' 143' ' ' LEU . 34.4 mt -83.72 -35.58 24.33 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.215 -0.928 . . . . 0.0 108.912 179.25 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.629 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 60.7 mt -68.9 -46.22 79.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.479 ' O ' HG13 ' A' ' 13' ' ' ILE . 84.7 mt-10 -50.43 -35.32 28.06 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.4 -0.812 . . . . 0.0 109.353 179.089 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 3.0 m -75.39 -20.48 58.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.222 -0.924 . . . . 0.0 109.49 179.321 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.567 ' O ' ' CD2' ' A' ' 154' ' ' HIS . 80.1 t80 -69.5 -48.95 58.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.517 -0.739 . . . . 0.0 109.915 179.605 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.573 HD22 ' CE1' ' A' ' 158' ' ' TYR . 48.2 mt -80.03 -31.56 39.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.351 -0.843 . . . . 0.0 110.021 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.524 ' CA ' HD13 ' A' ' 13' ' ' ILE . 7.5 ttpp -64.74 -14.19 57.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.306 -0.872 . . . . 0.0 109.428 179.285 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.439 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -118.35 -30.54 1.7 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 179.708 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.597 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 5.7 m-70 -106.07 94.41 9.3 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.272 -1.134 . . . . 0.0 110.15 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.51 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.9 Cg_endo -73.96 4.58 4.08 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.985 1.519 . . . . 0.0 110.873 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -113.37 -8.8 13.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.972 -1.08 . . . . 0.0 109.819 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.571 ' O ' ' CD1' ' A' ' 158' ' ' TYR . . . -53.65 104.47 0.1 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.374 -0.829 . . . . 0.0 109.979 179.762 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.644 ' CZ ' ' CB ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 35.33 30.96 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.733 -0.604 . . . . 0.0 110.703 -179.663 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.531 ' CB ' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.409 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.745 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.235 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 2.7 p -80.75 149.56 5.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.113 -1.228 . . . . 0.0 110.795 -179.491 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.546 ' CE1' HD11 ' A' ' 128' ' ' ILE . 72.5 m-85 -93.76 169.01 10.63 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.611 -0.681 . . . . 0.0 110.49 -179.579 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.433 ' CG2' ' CE1' ' A' ' 119' ' ' HIS . 86.0 m -139.93 105.06 5.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.345 -0.847 . . . . 0.0 110.126 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.634 ' CD2' ' CG1' ' A' ' 133' ' ' VAL . 65.7 m-85 -114.23 144.68 42.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.909 . . . . 0.0 110.034 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 21.5 pt-20 -134.27 150.5 51.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.173 -0.954 . . . . 0.0 110.254 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.461 ' O ' ' CG ' ' A' ' 8' ' ' GLU . 24.8 p -125.95 169.38 12.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.344 -0.847 . . . . 0.0 109.986 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.461 ' CG ' ' O ' ' A' ' 7' ' ' SER . 80.9 mt-10 -153.95 117.19 4.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.163 -0.961 . . . . 0.0 110.628 -179.852 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.2 p90 -142.58 -178.05 5.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.325 -0.859 . . . . 0.0 109.875 179.562 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 113' ' ' ILE . 16.5 p -136.71 179.78 6.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.182 -0.949 . . . . 0.0 110.544 -179.783 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 112' ' ' SER . 2.2 t -160.05 159.12 31.6 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.297 -0.877 . . . . 0.0 110.55 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -85.55 -12.11 52.44 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.207 -0.933 . . . . 0.0 109.824 179.805 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.532 ' CG1' ' HB2' ' A' ' 152' ' ' LYS . 2.3 mp -88.29 151.02 48.17 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.356 -0.84 . . . . 0.0 109.984 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.531 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 40.9 Cg_endo -66.69 139.9 54.39 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.046 1.55 . . . . 0.0 110.664 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.608 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 41.3 Cg_endo -73.25 -30.03 10.84 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 124.069 1.563 . . . . 0.0 112.843 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.9 Cg_endo -71.72 -23.56 22.61 Favored 'Trans proline' 0 C--N 1.319 -1.002 0 N-CA-C 110.052 -0.788 . . . . 0.0 110.052 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.523 ' CZ ' ' HA ' ' A' ' 159' ' ' ASN . 1.1 mtp85 -82.05 -44.89 16.0 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.008 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.556 ' CD2' ' CG2' ' A' ' 147' ' ' ILE . 0.2 OUTLIER -67.07 -34.0 76.71 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.528 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.605 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 74.9 t80 -59.38 -56.59 20.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.639 -0.663 . . . . 0.0 109.642 178.738 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.493 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 29.6 mttp -52.35 -37.53 56.41 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.721 -0.791 . . . . 0.0 109.421 179.462 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.602 ' HB1' ' CZ ' ' A' ' 158' ' ' TYR . . . -75.63 -43.38 48.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.466 -0.772 . . . . 0.0 110.76 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.575 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 0.3 OUTLIER -65.36 -45.8 82.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.341 -0.849 . . . . 0.0 111.074 -179.065 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.595 ' CG1' ' CD1' ' A' ' 74' ' ' ILE . 10.4 t -104.2 -60.89 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.084 -1.01 . . . . 0.0 111.766 -179.051 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.493 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 7.5 mp -66.13 -11.36 48.66 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.171 -0.956 . . . . 0.0 111.537 -178.64 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 20' ' ' LYS . 1.2 m-20 -148.17 44.18 1.05 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.886 -1.134 . . . . 0.0 110.27 -179.778 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -82.8 -22.14 34.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.297 -0.877 . . . . 0.0 110.47 -179.831 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -68.76 -19.9 64.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.127 -0.983 . . . . 0.0 110.214 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.515 ' O ' ' CB ' ' A' ' 32' ' ' LYS . 4.6 p30 -125.34 13.15 8.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 0.0 109.772 179.836 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.534 HD11 ' CD1' ' A' ' 33' ' ' ILE . 0.4 OUTLIER -97.01 -54.16 3.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.453 -0.779 . . . . 0.0 110.175 -179.939 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.585 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 2.6 t -70.28 -42.78 16.73 Favored Pre-proline 0 C--N 1.299 -1.597 0 O-C-N 121.296 -0.877 . . . . 0.0 110.57 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 50.3 Cg_endo -79.32 8.27 3.98 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.601 1.316 . . . . 0.0 110.617 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.515 ' CB ' ' O ' ' A' ' 28' ' ' ASN . 81.4 tttt -125.41 -31.39 3.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.187 -0.945 . . . . 0.0 109.745 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.566 HG12 ' CD1' ' A' ' 150' ' ' TYR . 22.0 mt -79.76 -35.53 16.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.523 -0.736 . . . . 0.0 109.701 179.578 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -160.66 99.82 1.35 Allowed Pre-proline 0 N--CA 1.487 1.377 0 O-C-N 121.433 -0.792 . . . . 0.0 110.187 179.764 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.96 0.14 8.21 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.201 1.632 . . . . 0.0 110.516 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -86.26 -13.02 47.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.261 -0.899 . . . . 0.0 109.823 179.699 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -98.46 -49.38 4.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.374 -0.829 . . . . 0.0 110.401 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.533 HG12 ' CG2' ' A' ' 56' ' ' ILE . 1.2 mp -130.56 137.93 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.327 -0.858 . . . . 0.0 110.324 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.416 ' O ' ' HB3' ' A' ' 40' ' ' HIS . 7.1 ttmt -70.97 -39.72 72.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.409 -0.807 . . . . 0.0 110.411 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.548 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER 179.03 159.32 0.61 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.277 -0.889 . . . . 0.0 110.284 179.852 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.9 m -121.03 131.61 54.39 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.225 -0.922 . . . . 0.0 110.045 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -135.2 114.28 12.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -0.924 . . . . 0.0 110.428 -179.829 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.421 HG12 ' HG2' ' A' ' 54' ' ' LYS . 28.3 mt -60.37 138.39 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.185 -0.947 . . . . 0.0 110.031 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.524 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 22.8 mt -111.74 -29.28 7.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.917 . . . . 0.0 110.462 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.515 ' CD1' HD11 ' A' ' 53' ' ' ILE . 1.8 m95 -125.33 163.89 21.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.216 -0.927 . . . . 0.0 110.698 -179.773 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.458 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 42.06 -138.23 2.58 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -151.15 21.1 0.76 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -1.154 . . . . 0.0 110.208 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 123.3 -18.93 7.73 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.486 ' O ' HG22 ' A' ' 71' ' ' ILE . . . -72.9 -172.83 23.01 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.491 ' HA ' HG23 ' A' ' 71' ' ' ILE . 43.5 Cg_endo -71.72 128.66 14.52 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.993 1.523 . . . . 0.0 110.683 -179.783 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.09 -14.09 48.59 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 -179.487 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -70.87 161.42 31.04 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.554 -0.968 . . . . 0.0 109.647 179.682 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.515 HD11 ' CD1' ' A' ' 45' ' ' TRP . 56.2 mt -130.7 120.7 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.334 -0.854 . . . . 0.0 109.887 179.599 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 58.6 mttm -105.53 140.98 37.79 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.168 -0.957 . . . . 0.0 110.394 -179.716 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.524 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 78.0 tttt -106.99 88.58 2.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.313 -0.867 . . . . 0.0 110.159 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.533 ' CG2' HG12 ' A' ' 38' ' ' ILE . 79.0 mt -79.86 137.46 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.265 -0.897 . . . . 0.0 110.15 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.506 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 5.6 p -109.29 161.78 14.94 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.18 -0.95 . . . . 0.0 110.658 -179.786 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.552 ' N ' ' O ' ' A' ' 65' ' ' GLY . 31.5 m-85 -115.73 128.64 56.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.47 -0.769 . . . . 0.0 110.211 179.777 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.26 -23.91 77.21 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -94.6 142.52 27.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.295 -1.12 . . . . 0.0 110.238 179.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.32 148.68 4.83 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.3 m -59.87 -35.41 74.75 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.321 -1.105 . . . . 0.0 110.159 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -137.07 -83.6 0.35 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.208 -0.933 . . . . 0.0 110.254 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.9 131.7 49.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.23 -0.918 . . . . 0.0 110.312 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.552 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -137.59 119.12 1.8 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 179.678 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 15.4 p90 -158.01 168.56 26.77 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.038 -1.272 . . . . 0.0 110.072 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.528 HG13 ' CA ' ' A' ' 88' ' ' GLY . 7.1 m -139.49 173.32 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.249 -0.907 . . . . 0.0 110.899 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.509 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 27.8 mttt -125.13 117.78 24.65 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.372 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.564 ' CD2' HD11 ' A' ' 85' ' ' LEU . 17.8 m170 -103.81 125.39 50.22 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.214 -0.929 . . . . 0.0 111.085 -178.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 52' ' ' THR . 25.6 tttt -97.76 106.51 18.83 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.383 -0.823 . . . . 0.0 109.374 179.002 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.527 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 43.3 mm -44.35 133.97 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.09 -1.006 . . . . 0.0 110.153 -179.227 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.522 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 46.3 t0 -107.49 -54.11 2.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.481 -0.762 . . . . 0.0 109.899 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.46 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 5.4 m -172.28 158.25 4.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.453 -0.779 . . . . 0.0 110.277 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.595 ' CD1' ' CG1' ' A' ' 23' ' ' VAL . 4.0 tt -149.77 165.54 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.274 -0.891 . . . . 0.0 110.03 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.6 OUTLIER -133.78 82.06 1.96 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.299 -0.876 . . . . 0.0 110.014 -179.788 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.605 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 90.3 mttt -55.29 -15.14 2.19 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.316 -0.865 . . . . 0.0 110.841 -179.863 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -92.5 -30.4 15.72 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.189 -0.945 . . . . 0.0 109.798 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.512 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -111.34 -1.33 16.05 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.552 -0.717 . . . . 0.0 109.63 179.962 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.577 ' CZ ' ' HB3' ' A' ' 16' ' ' PRO . 10.7 m-85 65.69 48.23 1.98 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.769 -0.582 . . . . 0.0 110.608 -179.864 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.529 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.5 OUTLIER -116.55 148.07 41.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.157 -0.964 . . . . 0.0 109.364 179.386 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.578 ' CD1' HG12 ' A' ' 23' ' ' VAL . 86.9 t80 -148.45 144.63 27.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.122 -0.987 . . . . 0.0 110.414 -179.261 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.466 ' HB3' ' HG3' ' A' ' 101' ' ' GLU . 4.8 p -151.45 145.23 25.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.271 -0.893 . . . . 0.0 110.349 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.586 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 18.0 p90 -148.13 172.02 14.97 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.219 -0.926 . . . . 0.0 110.471 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.411 ' HB ' ' HB3' ' A' ' 70' ' ' LYS . 97.1 m -122.16 123.58 41.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.344 -0.848 . . . . 0.0 109.964 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.564 HD11 ' CD2' ' A' ' 69' ' ' HIS . 0.9 OUTLIER -90.61 129.25 36.76 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.148 -0.97 . . . . 0.0 110.249 -179.827 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 16.7 pt -112.03 0.65 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.279 -0.888 . . . . 0.0 110.298 -179.789 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.509 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 57.3 tt0 -145.66 154.87 42.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.272 -0.892 . . . . 0.0 110.171 -179.922 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.528 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 156.9 126.93 0.95 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -64.26 -25.97 68.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.334 -1.097 . . . . 0.0 110.208 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.552 ' O ' ' CE1' ' A' ' 132' ' ' HIS . . . -70.27 -25.44 63.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -0.916 . . . . 0.0 110.122 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.522 ' CD2' HG13 ' A' ' 98' ' ' ILE . 22.3 mt -64.68 -36.56 84.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.31 -0.868 . . . . 0.0 110.072 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.11 175.69 36.73 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -72.58 -2.29 19.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -1.152 . . . . 0.0 109.967 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.462 ' OG1' HD21 ' A' ' 95' ' ' LEU . 30.3 p -91.42 -38.8 12.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.895 . . . . 0.0 110.455 -179.866 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.567 ' CD2' ' N ' ' A' ' 95' ' ' LEU . 2.4 mm? -79.88 154.92 28.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.262 -0.899 . . . . 0.0 110.964 -179.453 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.462 ' OE1' ' HB2' ' A' ' 123' ' ' LYS . 37.5 tt0 -142.44 -84.21 0.18 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.13 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.519 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 28.5 mttt -80.42 125.14 29.55 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.705 -0.622 . . . . 0.0 110.595 179.076 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.552 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 3.2 mm -118.02 137.96 50.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 120.575 -1.328 . . . . 0.0 109.151 178.199 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.461 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -118.31 129.67 55.58 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.325 -0.859 . . . . 0.0 109.299 179.306 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.586 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 8.8 m-85 -124.13 132.63 53.66 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.42 -0.8 . . . . 0.0 110.236 -179.282 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.466 ' HG3' ' HB3' ' A' ' 82' ' ' SER . 76.9 tt0 -134.5 138.7 44.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.18 -0.95 . . . . 0.0 110.21 179.776 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 90.5 m -141.34 125.51 17.39 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.161 -0.962 . . . . 0.0 110.199 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.443 ' HG3' ' HB3' ' A' ' 80' ' ' SER . 1.0 OUTLIER -116.86 149.42 40.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.881 . . . . 0.0 110.114 179.818 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.525 ' HB2' ' CB ' ' A' ' 79' ' ' TYR . 14.7 mt -123.24 148.86 45.43 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.199 -0.938 . . . . 0.0 110.622 -179.957 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.443 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 2.0 t -149.5 -168.91 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.408 -0.807 . . . . 0.0 109.419 179.546 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -136.92 141.52 42.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.13 -0.981 . . . . 0.0 110.873 179.9 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.533 ' CB ' ' HD2' ' A' ' 108' ' ' PRO . 0.8 OUTLIER -91.79 -179.91 1.22 Allowed Pre-proline 0 C--N 1.302 -1.477 0 O-C-N 121.533 -0.729 . . . . 0.0 109.374 179.183 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.533 ' HD2' ' CB ' ' A' ' 107' ' ' SER . 40.7 Cg_endo -66.54 85.09 0.28 Allowed 'Trans proline' 0 C--N 1.303 -1.861 0 O-C-N 123.649 1.342 . . . . 0.0 109.646 179.376 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 108' ' ' PRO . 4.0 p 44.38 37.41 2.01 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.423 -0.798 . . . . 0.0 109.735 -178.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -125.75 38.16 2.33 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 11' ' ' SER . . . 98.11 -138.75 14.07 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 -179.495 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 11' ' ' SER . 3.7 p -149.43 143.38 25.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.279 -1.13 . . . . 0.0 109.835 179.653 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.477 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 35.9 mt -91.4 147.9 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.24 -0.912 . . . . 0.0 110.307 -179.74 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.578 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 7.6 mt -134.02 111.62 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.186 -0.946 . . . . 0.0 110.208 -179.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 48.4 tttt -97.08 137.67 35.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.231 -0.918 . . . . 0.0 110.239 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 0.8 OUTLIER -134.44 154.55 51.33 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 0.0 110.376 -179.887 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 8.8 m -146.58 158.21 43.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.33 -0.856 . . . . 0.0 110.188 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 99.4 p -151.28 134.96 16.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 110.393 -179.9 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.462 ' O ' HD11 ' A' ' 98' ' ' ILE . 55.4 m-70 -120.78 147.9 44.71 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.287 -0.883 . . . . 0.0 110.384 -179.92 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.585 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 9.3 m-85 -122.4 118.78 29.2 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.268 -0.895 . . . . 0.0 111.161 -179.445 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.576 ' CD2' HG22 ' A' ' 2' ' ' VAL . 90.0 m-70 -104.12 109.69 21.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.073 -1.017 . . . . 0.0 109.353 178.331 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.534 ' HB ' ' CG2' ' A' ' 126' ' ' VAL . 0.6 OUTLIER -88.95 136.5 32.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.294 -0.879 . . . . 0.0 110.866 -179.107 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.462 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 25.3 tttt -109.37 129.49 55.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.484 -0.76 . . . . 0.0 110.1 179.545 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.471 ' O ' ' CB ' ' A' ' 125' ' ' ASN . . . 110.44 15.33 11.47 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 9.1 t30 67.82 54.27 0.64 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.265 -1.138 . . . . 0.0 110.33 179.907 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.534 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 20.3 m -133.4 160.34 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.351 -0.843 . . . . 0.0 109.948 179.744 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -121.3 162.16 20.77 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.225 -0.922 . . . . 0.0 110.576 -179.724 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.548 ' CD1' ' HB3' ' A' ' 120' ' ' TYR . 2.9 mp -83.95 173.45 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.393 -0.817 . . . . 0.0 109.96 179.766 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.507 ' N ' ' CG2' ' A' ' 128' ' ' ILE . 32.4 mttt -108.67 133.79 52.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.413 -0.804 . . . . 0.0 109.894 179.835 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -46.51 -36.26 6.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.183 -0.948 . . . . 0.0 110.198 -179.887 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.432 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 61.7 tt0 -63.31 -29.94 71.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 110.09 179.885 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.552 ' CE1' ' O ' ' A' ' 90' ' ' ALA . 14.5 t-160 -78.18 -51.3 10.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 110.222 179.905 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.634 ' CG1' ' CD2' ' A' ' 5' ' ' TYR . 43.0 t -64.28 -43.45 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.356 -0.84 . . . . 0.0 110.098 179.882 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 7.1 tptm -67.1 -45.87 75.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 110.154 179.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.45 ' O ' ' HG3' ' A' ' 139' ' ' LYS . . . -62.27 -30.06 70.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.212 -0.93 . . . . 0.0 110.035 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.58 -29.39 69.78 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 83.5 mttt -66.99 -33.9 76.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.213 -1.169 . . . . 0.0 110.077 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -81.7 -29.93 32.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.892 . . . . 0.0 110.104 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' ' 135' ' ' ALA . 93.9 mttt -67.29 -41.5 85.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.33 -0.856 . . . . 0.0 110.069 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.16 -41.0 51.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.198 -0.939 . . . . 0.0 110.065 179.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 137' ' ' LYS . 48.8 m -56.99 -48.17 79.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.453 -0.78 . . . . 0.0 110.031 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -55.52 -42.33 74.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.185 -0.947 . . . . 0.0 110.095 179.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.437 ' O ' HG13 ' A' ' 147' ' ' ILE . 61.4 mt -61.52 -40.77 95.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 109.976 179.869 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -60.56 -37.77 82.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.407 -0.808 . . . . 0.0 109.878 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.44 ' HA ' ' OE1' ' A' ' 148' ' ' GLU . 87.8 mttt -71.67 -17.5 62.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.317 -0.864 . . . . 0.0 110.039 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.531 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 34.4 mt -84.11 -35.92 23.34 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.281 -0.887 . . . . 0.0 108.967 179.386 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.575 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 53.4 mt -72.27 -42.46 65.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 119.678 -0.809 . . . . 0.0 108.836 178.735 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.47 ' HB3' HD11 ' A' ' 13' ' ' ILE . 69.4 mt-10 -56.18 -39.11 71.89 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.479 -0.763 . . . . 0.0 109.409 179.03 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.5 m -73.99 -24.43 59.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.944 . . . . 0.0 109.617 179.415 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.579 ' CE2' ' OH ' ' A' ' 158' ' ' TYR . 80.3 t80 -64.68 -49.3 71.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.383 -0.823 . . . . 0.0 110.083 179.822 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.629 ' CD2' ' CE2' ' A' ' 158' ' ' TYR . 84.8 mt -79.94 -29.34 39.67 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.225 -0.922 . . . . 0.0 110.059 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.532 ' HB2' ' CG1' ' A' ' 13' ' ' ILE . 78.3 tttt -70.21 -27.14 64.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.33 -0.856 . . . . 0.0 109.594 179.523 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.452 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -104.04 -33.27 4.07 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.718 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.577 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 5.4 m-70 -107.12 92.34 7.72 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.354 -1.086 . . . . 0.0 109.982 179.734 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 48.4 Cg_endo -74.23 6.35 3.1 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.04 1.547 . . . . 0.0 111.075 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -107.06 -4.94 18.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.999 -1.063 . . . . 0.0 109.756 179.772 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.57 ' HB1' ' CE2' ' A' ' 150' ' ' TYR . . . -75.18 102.44 4.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.411 -0.806 . . . . 0.0 110.019 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.629 ' CE2' ' CD2' ' A' ' 151' ' ' LEU . 0.4 OUTLIER 34.86 32.18 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.69 -0.631 . . . . 0.0 110.572 -179.521 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.523 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.71 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.587 HG22 ' CD2' ' A' ' 121' ' ' HIS . 3.0 p -82.86 153.84 3.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.253 -1.145 . . . . 0.0 110.122 -179.917 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.629 ' CD1' ' CD1' ' A' ' 128' ' ' ILE . 8.4 m-85 -89.23 170.16 10.83 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.329 -0.857 . . . . 0.0 110.014 -179.658 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 50.0 m -137.76 107.56 6.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.111 -0.993 . . . . 0.0 110.364 -179.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.632 ' CD1' ' CG2' ' A' ' 133' ' ' VAL . 47.7 m-85 -112.21 136.67 51.34 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.182 -0.949 . . . . 0.0 110.109 179.804 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 20.8 pt-20 -129.84 152.1 49.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.222 -0.924 . . . . 0.0 110.537 -179.794 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.3 t -139.28 156.22 47.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.401 -0.812 . . . . 0.0 109.902 179.791 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -147.62 124.37 11.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.154 -0.966 . . . . 0.0 110.391 -179.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.637 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.3 p90 -151.6 -176.38 5.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.388 -0.82 . . . . 0.0 109.892 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.486 ' CG2' ' HA ' ' A' ' 113' ' ' ILE . 8.8 p -141.74 174.41 10.6 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.114 -0.991 . . . . 0.0 110.661 -179.642 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.5 t -153.08 159.08 42.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.428 -0.795 . . . . 0.0 110.155 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -81.94 -20.48 38.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.234 -0.916 . . . . 0.0 110.237 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.542 ' CG2' ' HD2' ' A' ' 14' ' ' PRO . 8.1 mm -80.11 150.68 71.88 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.334 -0.854 . . . . 0.0 109.98 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.542 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 40.0 Cg_endo -65.55 143.09 74.07 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.073 1.565 . . . . 0.0 110.789 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.635 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 41.5 Cg_endo -73.34 -30.69 9.99 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 124.109 1.584 . . . . 0.0 113.066 -179.501 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.635 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.3 Cg_endo -69.9 -23.38 30.23 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 O-C-N 122.471 0.722 . . . . 0.0 110.228 -179.899 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.516 ' NH2' ' HA ' ' A' ' 159' ' ' ASN . 2.1 mtp180 -85.16 -43.48 13.8 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.108 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.516 ' CD2' HD23 ' A' ' 104' ' ' LEU . 1.0 OUTLIER -69.89 -30.27 67.66 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.845 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' A' ' 15' ' ' PRO . 50.7 t80 -68.58 -53.7 21.23 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.393 -0.817 . . . . 0.0 109.549 179.126 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.486 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 10.8 mttt -53.41 -33.86 55.54 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.681 -0.807 . . . . 0.0 109.181 179.568 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.606 ' HB1' ' CZ ' ' A' ' 158' ' ' TYR . . . -76.4 -53.65 7.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.485 -0.759 . . . . 0.0 111.158 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.575 ' CE1' HD13 ' A' ' 147' ' ' ILE . 0.5 OUTLIER -60.0 -46.08 90.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.501 -0.749 . . . . 0.0 111.922 -178.429 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.477 HG12 HG12 ' A' ' 74' ' ' ILE . 3.3 t -100.88 -60.6 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.886 -1.134 . . . . 0.0 111.847 -178.665 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.486 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 6.8 mp -67.96 -5.36 16.68 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.172 -0.955 . . . . 0.0 111.647 -178.494 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.486 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 1.1 m-20 -149.04 30.14 0.79 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.669 -1.269 . . . . 0.0 110.946 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -70.05 -23.88 63.17 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.21 -0.931 . . . . 0.0 110.675 179.798 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -69.68 -17.52 63.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.08 -1.013 . . . . 0.0 109.774 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.451 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 7.1 p30 -129.42 13.28 6.03 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.375 -0.828 . . . . 0.0 109.774 179.597 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.551 HD22 ' CZ ' ' A' ' 158' ' ' TYR . 0.3 OUTLIER -94.37 -49.16 5.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.437 -0.789 . . . . 0.0 110.138 179.812 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.648 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 5.8 p -73.2 -28.87 1.01 Allowed Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.141 -0.974 . . . . 0.0 112.051 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.648 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 52.1 Cg_endo -79.56 1.21 9.39 Favored 'Trans proline' 0 C--N 1.319 -1.019 0 O-C-N 122.717 0.851 . . . . 0.0 110.263 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.449 ' HD2' ' O ' ' A' ' 28' ' ' ASN . 51.8 mttm -124.68 -30.0 3.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.292 -0.88 . . . . 0.0 109.869 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.58 HG12 ' CD1' ' A' ' 150' ' ' TYR . 10.8 mt -77.57 -39.14 26.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.482 -0.761 . . . . 0.0 109.76 179.822 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -170.24 102.27 0.44 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.417 -0.802 . . . . 0.0 110.14 179.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.78 1.2 7.27 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.066 1.561 . . . . 0.0 110.647 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -87.27 -8.64 56.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.099 -1.0 . . . . 0.0 110.039 179.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.31 -51.02 3.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.312 -0.868 . . . . 0.0 110.308 -179.929 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.553 ' CD1' HG22 ' A' ' 30' ' ' VAL . 1.1 mp -127.11 138.87 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.426 -0.796 . . . . 0.0 110.11 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.423 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 37.7 ttmt -73.85 -40.53 63.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.318 -0.864 . . . . 0.0 110.098 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.534 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -178.49 156.11 0.9 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.336 -0.852 . . . . 0.0 110.252 179.752 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.4 m -120.0 119.93 34.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.23 -0.919 . . . . 0.0 109.996 179.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.464 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 35.0 tp10 -124.25 114.39 19.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.289 -0.882 . . . . 0.0 110.387 -179.923 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.462 HD11 HG22 ' A' ' 43' ' ' ILE . 21.4 mt -60.04 145.03 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.189 -0.945 . . . . 0.0 110.069 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.49 ' N ' ' O ' ' A' ' 53' ' ' ILE . 4.8 mp -121.77 -27.29 4.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.224 -0.923 . . . . 0.0 110.328 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.574 ' CG ' HD11 ' A' ' 53' ' ' ILE . 1.6 m95 -123.78 163.19 21.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.272 -0.893 . . . . 0.0 110.482 -179.833 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.448 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 43.12 -138.37 3.39 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.81 23.52 0.51 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.309 -1.112 . . . . 0.0 109.994 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 121.73 -13.9 9.23 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.478 ' O ' HG23 ' A' ' 71' ' ' ILE . . . -81.54 -169.61 42.65 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.85 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.49 ' HA ' HG23 ' A' ' 71' ' ' ILE . 45.0 Cg_endo -72.79 129.5 14.53 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 124.086 1.572 . . . . 0.0 110.557 -179.905 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.49 -12.95 51.16 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 -179.569 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -71.52 161.3 31.24 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.589 -0.948 . . . . 0.0 109.374 179.635 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.574 HD11 ' CG ' ' A' ' 45' ' ' TRP . 58.3 mt -134.29 120.37 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.242 -0.911 . . . . 0.0 109.971 179.683 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 96.0 mttt -107.3 128.95 54.91 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.164 -0.96 . . . . 0.0 110.56 -179.595 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -93.01 91.38 7.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -0.881 . . . . 0.0 109.768 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.536 ' CG2' HG12 ' A' ' 38' ' ' ILE . 96.7 mt -80.02 144.11 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.2 -0.937 . . . . 0.0 110.212 -179.753 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.517 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 7.2 p -117.62 163.73 16.01 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.201 -0.937 . . . . 0.0 110.744 -179.649 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.533 ' N ' ' O ' ' A' ' 65' ' ' GLY . 28.6 m-85 -122.4 141.38 51.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.323 -0.861 . . . . 0.0 110.118 179.283 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -88.56 38.14 3.23 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -49.09 -26.59 2.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.287 -1.125 . . . . 0.0 110.148 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.62 -143.06 13.71 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 21.4 m -61.8 -42.93 99.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.182 -1.187 . . . . 0.0 110.201 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -58.87 148.48 29.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.296 -0.878 . . . . 0.0 110.142 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -89.25 125.51 35.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.234 -0.917 . . . . 0.0 110.303 -179.911 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -138.67 102.27 0.35 Allowed Glycine 0 N--CA 1.487 2.096 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 179.669 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.543 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 13.9 p90 -143.44 166.7 24.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.218 -1.166 . . . . 0.0 110.175 -179.685 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.531 HG13 ' CA ' ' A' ' 88' ' ' GLY . 6.1 m -139.35 174.13 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.354 -0.841 . . . . 0.0 110.618 179.78 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.517 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 20.1 mttt -125.56 122.04 35.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.529 -0.732 . . . . 0.0 109.642 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.519 ' NE2' HD12 ' A' ' 85' ' ' LEU . 10.8 m170 -108.56 123.75 49.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.179 -0.951 . . . . 0.0 110.854 -179.436 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 52' ' ' THR . 18.9 tttm -97.65 116.09 29.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.258 -0.901 . . . . 0.0 109.79 179.428 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.523 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 23.6 mm -58.04 132.43 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.994 -1.066 . . . . 0.0 110.365 -179.563 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 82' ' ' SER . 94.1 m-20 -105.34 -42.76 5.16 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.372 -0.83 . . . . 0.0 109.889 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 3.2 m -175.09 159.67 2.63 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.389 -0.82 . . . . 0.0 109.948 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.477 HG12 HG12 ' A' ' 23' ' ' VAL . 2.2 mt -138.62 159.84 30.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.193 -0.942 . . . . 0.0 110.209 179.97 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 79' ' ' TYR . 5.6 m-20 -137.58 80.56 1.81 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.489 -0.757 . . . . 0.0 110.392 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.456 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 22.3 tttt -63.28 -18.9 64.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.133 -0.979 . . . . 0.0 110.259 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -91.6 -32.24 15.58 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.275 -0.89 . . . . 0.0 109.363 179.755 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.507 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -101.25 -4.13 27.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.643 -0.661 . . . . 0.0 109.604 179.619 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.587 ' CE1' ' HB3' ' A' ' 16' ' ' PRO . 85.2 m-85 60.43 55.44 3.49 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.454 0.645 . . . . 0.0 110.581 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.495 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -129.93 165.61 21.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.434 -0.791 . . . . 0.0 109.876 179.495 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.696 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 42.6 t80 -149.71 143.79 25.68 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.219 -0.925 . . . . 0.0 109.903 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 25.9 m -148.76 131.45 15.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.122 -0.986 . . . . 0.0 111.223 -179.724 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.696 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 9.1 p90 -144.36 175.66 9.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.35 -0.844 . . . . 0.0 110.064 179.041 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.478 ' N ' ' O ' ' A' ' 70' ' ' LYS . 27.1 m -127.25 128.42 45.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.348 -0.845 . . . . 0.0 109.824 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.533 ' HB3' ' CG2' ' A' ' 98' ' ' ILE . 7.4 tp -95.39 125.31 39.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.093 -1.004 . . . . 0.0 110.077 -179.85 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.6 pt -109.79 -12.65 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.244 -0.91 . . . . 0.0 110.333 -179.565 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.517 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 18.0 tt0 -124.64 172.84 8.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 0.0 110.191 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.531 ' CA ' HG13 ' A' ' 67' ' ' VAL . . . 137.58 112.08 1.09 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.984 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -56.42 -16.83 6.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.319 -1.106 . . . . 0.0 110.205 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.63 -17.71 57.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 0.0 110.146 179.87 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.454 HD12 ' O ' ' A' ' 87' ' ' GLU . 65.7 mt -66.78 -23.82 66.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.284 -0.885 . . . . 0.0 110.209 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 50.56 -179.69 0.03 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -79.96 6.45 11.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.303 -1.116 . . . . 0.0 110.206 179.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 39.4 p -94.36 -31.55 13.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.236 -0.915 . . . . 0.0 110.238 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.554 HD12 ' CD2' ' A' ' 120' ' ' TYR . 83.6 mt -107.29 163.93 12.61 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.351 -0.843 . . . . 0.0 110.092 179.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.47 ' HG2' ' N ' ' A' ' 97' ' ' LYS . 61.4 tt0 -144.77 -82.85 0.15 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.299 -0.876 . . . . 0.0 109.668 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.494 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 18.7 mttt -80.37 131.57 35.64 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.778 -0.576 . . . . 0.0 110.343 179.683 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.635 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 4.7 mm -119.53 138.67 49.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 120.845 -1.16 . . . . 0.0 109.63 178.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.453 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.3 m -118.85 123.27 44.31 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 119.711 -0.795 . . . . 0.0 108.985 178.786 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.635 ' CE2' ' CG2' ' A' ' 98' ' ' ILE . 13.0 m-85 -119.27 132.61 55.93 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.39 -0.819 . . . . 0.0 110.322 -179.076 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.445 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 85.1 tt0 -132.07 140.26 48.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.263 -0.898 . . . . 0.0 110.061 179.788 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.454 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 32.6 m -133.01 153.95 50.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.924 . . . . 0.0 109.929 179.939 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.449 ' N ' ' O ' ' A' ' 115' ' ' LYS . 7.7 mttt -149.66 133.05 16.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.143 -0.973 . . . . 0.0 110.456 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.534 ' HB2' ' HB3' ' A' ' 79' ' ' TYR . 3.5 mt -115.42 152.49 32.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.196 -0.94 . . . . 0.0 110.03 179.812 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.483 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 1.8 t -151.38 -169.52 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.227 -0.921 . . . . 0.0 110.185 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.471 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -124.52 145.64 49.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.35 -0.844 . . . . 0.0 110.305 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.445 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.3 p -103.8 171.12 5.39 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.281 -0.887 . . . . 0.0 110.2 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.445 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 45.7 Cg_endo -72.54 -13.79 27.53 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.074 1.565 . . . . 0.0 110.585 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 67.8 m -95.84 11.64 32.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.188 -0.945 . . . . 0.0 110.354 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 91.34 -34.93 4.1 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.847 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -55.18 -172.07 0.08 OUTLIER Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.785 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.528 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.4 p -134.98 134.19 40.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.124 -1.221 . . . . 0.0 110.387 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.486 ' HA ' ' CG2' ' A' ' 10' ' ' THR . 15.4 mt -85.74 147.12 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.37 -0.831 . . . . 0.0 109.91 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.574 ' CG2' ' CE2' ' A' ' 9' ' ' PHE . 19.4 mt -131.1 110.8 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.166 -0.959 . . . . 0.0 110.407 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.449 ' O ' ' N ' ' A' ' 103' ' ' LYS . 63.3 tttm -97.93 134.87 40.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.191 -0.943 . . . . 0.0 109.683 179.444 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.67 147.99 51.51 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.219 -0.926 . . . . 0.0 110.354 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 32.9 m -148.54 148.06 29.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.4 -0.812 . . . . 0.0 110.292 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 88.5 p -148.36 155.08 40.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.29 -0.881 . . . . 0.0 110.136 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.453 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 34.1 m-70 -139.14 129.81 26.0 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.168 -0.958 . . . . 0.0 110.373 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.557 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 3.6 m-30 -99.56 120.58 39.88 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.279 -0.888 . . . . 0.0 110.599 -179.555 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.587 ' CD2' HG22 ' A' ' 2' ' ' VAL . 82.4 m-70 -95.51 107.56 19.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.196 -0.94 . . . . 0.0 109.674 179.074 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.531 ' CG2' HD22 ' A' ' 95' ' ' LEU . 1.6 p -77.81 157.39 29.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.917 . . . . 0.0 110.174 -179.854 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 37.6 tttt -114.46 114.0 25.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.193 -0.942 . . . . 0.0 110.237 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 93.26 -132.7 11.35 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.402 ' C ' HG11 ' A' ' 126' ' ' VAL . 4.1 t-20 -115.72 77.19 1.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.215 -1.168 . . . . 0.0 110.147 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.402 HG11 ' C ' ' A' ' 125' ' ' ASN . 32.8 m -142.02 154.39 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.178 -0.951 . . . . 0.0 110.242 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -132.05 164.22 26.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.234 -0.916 . . . . 0.0 110.214 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.629 ' CD1' ' CD1' ' A' ' 3' ' ' PHE . 3.2 mp -92.05 171.83 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.154 -0.966 . . . . 0.0 110.375 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.489 ' N ' ' CG2' ' A' ' 128' ' ' ILE . 60.8 mmtt -113.71 129.98 56.49 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.481 -0.762 . . . . 0.0 109.768 179.742 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.505 ' O ' ' CB ' ' A' ' 134' ' ' LYS . 92.4 mt-10 -43.24 -50.63 6.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.134 -0.979 . . . . 0.0 110.026 -179.841 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -48.28 -23.53 0.92 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.208 -0.933 . . . . 0.0 109.892 179.702 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.456 ' N ' ' O ' ' A' ' 129' ' ' LYS . 12.0 t-80 -87.49 -64.66 1.11 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.302 -0.874 . . . . 0.0 110.322 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.632 ' CG2' ' CD1' ' A' ' 5' ' ' TYR . 2.4 p -65.75 -28.48 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.394 -0.817 . . . . 0.0 110.086 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.505 ' CB ' ' O ' ' A' ' 130' ' ' GLU . 13.6 tptt -72.64 -48.79 36.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.163 -0.961 . . . . 0.0 109.937 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.62 -25.11 67.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.328 -0.858 . . . . 0.0 110.065 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.17 -31.34 69.15 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.412 ' O ' ' OG ' ' A' ' 141' ' ' SER . 82.0 mttt -64.92 -32.72 74.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.264 -1.139 . . . . 0.0 110.106 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -79.67 -40.24 29.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.334 -0.854 . . . . 0.0 110.005 179.81 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -69.71 -34.27 73.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.304 -0.873 . . . . 0.0 109.87 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.01 -35.39 66.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.323 -0.861 . . . . 0.0 109.885 179.718 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 137' ' ' LYS . 48.0 m -66.48 -42.95 86.69 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.276 -0.89 . . . . 0.0 109.939 179.701 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -56.36 -48.96 75.77 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.273 -0.892 . . . . 0.0 109.932 179.81 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.464 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 0.6 OUTLIER -55.8 -44.25 77.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.346 -0.846 . . . . 0.0 109.866 179.817 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.458 ' HA ' HD11 ' A' ' 147' ' ' ILE . 13.7 m-85 -55.81 -39.68 71.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.431 -0.793 . . . . 0.0 109.834 179.715 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.455 ' HA ' ' OE1' ' A' ' 148' ' ' GLU . 95.8 mttt -73.21 -12.46 60.88 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.405 -0.81 . . . . 0.0 110.229 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 143' ' ' LEU . 16.3 mt -83.77 -36.02 23.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.16 -0.962 . . . . 0.0 108.989 179.396 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.575 HD13 ' CE1' ' A' ' 22' ' ' PHE . 19.9 mt -69.66 -45.51 77.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.94 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.475 ' O ' HG13 ' A' ' 13' ' ' ILE . 38.8 mt-10 -58.98 -43.12 91.33 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.702 -0.799 . . . . 0.0 109.471 179.113 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 17.9 m -66.26 -24.49 66.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.291 -0.88 . . . . 0.0 109.564 179.453 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.58 ' CD1' HG12 ' A' ' 33' ' ' ILE . 81.8 t80 -67.02 -46.99 72.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.508 -0.745 . . . . 0.0 109.952 179.794 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.642 ' CD2' ' CE2' ' A' ' 158' ' ' TYR . 68.4 mt -79.74 -30.22 40.8 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.141 -0.975 . . . . 0.0 110.006 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.532 ' HB2' ' CG1' ' A' ' 13' ' ' ILE . 21.0 tttm -71.23 -25.83 62.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.899 . . . . 0.0 109.289 179.062 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -102.9 -33.51 4.34 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.119 -1.593 . . . . 0.0 109.119 179.543 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.58 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 5.4 m-70 -108.61 92.76 10.69 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.277 -1.131 . . . . 0.0 109.933 179.692 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -74.01 6.23 3.07 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.033 1.544 . . . . 0.0 111.168 -179.864 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -108.71 0.09 20.34 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.965 -1.084 . . . . 0.0 109.937 179.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.552 ' C ' ' CG ' ' A' ' 158' ' ' TYR . . . -83.13 102.14 11.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.303 -0.873 . . . . 0.0 110.048 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.642 ' CE2' ' CD2' ' A' ' 151' ' ' LEU . 0.3 OUTLIER 35.67 31.27 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.725 -0.609 . . . . 0.0 110.184 -179.377 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.516 ' HA ' ' NH2' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.714 -179.723 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.588 HG22 ' CD2' ' A' ' 121' ' ' HIS . 3.0 p -79.98 150.87 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.375 -1.073 . . . . 0.0 110.503 -179.795 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.531 ' N ' HG21 ' A' ' 2' ' ' VAL . 3.9 m-85 -87.75 175.41 7.87 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.446 -0.784 . . . . 0.0 110.025 -179.87 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.8 m -147.56 101.97 3.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.115 -0.991 . . . . 0.0 110.463 179.899 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.405 ' CD1' HG11 ' A' ' 133' ' ' VAL . 88.0 m-85 -112.67 127.19 56.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.293 -0.879 . . . . 0.0 109.976 179.811 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.584 ' CG ' ' N ' ' A' ' 7' ' ' SER . 17.2 tt0 -110.66 175.48 5.41 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.265 -0.897 . . . . 0.0 109.95 -179.544 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.584 ' N ' ' CG ' ' A' ' 6' ' ' GLU . 0.2 OUTLIER -156.71 166.76 32.48 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.716 -0.615 . . . . 0.0 109.634 179.756 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -156.53 132.3 9.59 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.983 -1.073 . . . . 0.0 110.955 -179.849 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.625 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 2.9 p90 -155.9 -175.82 5.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.505 -0.747 . . . . 0.0 109.581 179.43 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.46 HG23 HG12 ' A' ' 113' ' ' ILE . 23.4 p -134.7 179.23 6.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.019 -1.051 . . . . 0.0 110.887 -179.559 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.49 ' HB3' ' CD1' ' A' ' 114' ' ' ILE . 87.7 p -159.99 139.08 10.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.572 -0.705 . . . . 0.0 110.06 179.76 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -67.15 -29.85 69.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.129 -0.982 . . . . 0.0 110.287 -179.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.545 ' CD1' ' HB2' ' A' ' 152' ' ' LYS . 1.8 mp -71.7 151.8 93.47 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.291 -0.881 . . . . 0.0 109.793 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.531 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 40.3 Cg_endo -66.44 141.63 62.33 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 124.072 1.564 . . . . 0.0 110.522 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.605 ' CD ' ' CD ' ' A' ' 16' ' ' PRO . 40.9 Cg_endo -73.23 -30.4 10.49 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 124.092 1.575 . . . . 0.0 113.085 -179.256 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.605 ' CD ' ' CD ' ' A' ' 15' ' ' PRO . 43.6 Cg_endo -71.79 -21.65 24.7 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 N-CA-C 110.178 -0.739 . . . . 0.0 110.178 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.482 ' HD3' ' CG ' ' A' ' 14' ' ' PRO . 44.8 mtp180 -84.77 -46.04 11.78 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.084 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.502 ' C ' ' CD2' ' A' ' 18' ' ' LEU . 1.1 tt -67.81 -29.99 69.3 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.755 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.489 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 76.3 t80 -66.84 -57.13 7.61 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.459 -0.776 . . . . 0.0 109.3 178.748 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.494 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 9.8 mttp -48.76 -36.74 17.17 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.266 179.441 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.6 ' HB1' ' CZ ' ' A' ' 158' ' ' TYR . . . -74.69 -43.2 56.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.427 -0.795 . . . . 0.0 110.779 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.642 ' CE1' ' CD1' ' A' ' 147' ' ' ILE . 0.1 OUTLIER -68.45 -48.24 65.06 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.521 -0.737 . . . . 0.0 111.672 -178.45 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.503 HG11 ' CE1' ' A' ' 81' ' ' TYR . 3.5 t -100.3 -51.87 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.835 -1.166 . . . . 0.0 111.603 -178.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.507 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 7.2 mp -77.79 0.02 25.32 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.116 -0.99 . . . . 0.0 111.265 -179.015 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.547 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -154.15 30.92 0.44 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.97 -1.081 . . . . 0.0 110.515 179.881 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 22' ' ' PHE . . . -67.33 -29.57 69.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.233 -0.917 . . . . 0.0 109.999 179.778 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -69.26 -15.6 63.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 0.0 110.069 179.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 78.8 m-20 -125.86 9.81 7.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -0.904 . . . . 0.0 110.196 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -100.34 -48.8 4.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.907 . . . . 0.0 110.245 179.906 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.589 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 2.9 t -74.46 -42.15 5.07 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.43 -0.793 . . . . 0.0 110.974 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 47.7 Cg_endo -78.15 9.01 3.24 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.499 1.263 . . . . 0.0 110.626 -179.919 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 28' ' ' ASN . 33.7 mttt -127.11 -37.27 2.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.185 -0.947 . . . . 0.0 109.464 179.678 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.526 HG12 ' CD1' ' A' ' 150' ' ' TYR . 6.8 mt -80.04 -39.44 19.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.537 -0.727 . . . . 0.0 109.562 179.536 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -155.12 100.33 2.31 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.378 -0.827 . . . . 0.0 110.189 179.819 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.21 -0.85 9.22 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.978 1.515 . . . . 0.0 110.632 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -84.47 -8.0 59.09 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.102 -0.999 . . . . 0.0 109.816 179.75 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.416 ' HB2' HD11 ' A' ' 38' ' ' ILE . . . -98.24 -63.4 1.13 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.303 -0.873 . . . . 0.0 110.234 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.52 ' CD1' HG12 ' A' ' 30' ' ' VAL . 2.0 mp -115.56 137.56 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.378 -0.826 . . . . 0.0 110.191 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 57' ' ' THR . 13.7 ttpt -84.66 -19.2 33.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.381 -0.824 . . . . 0.0 110.207 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.545 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER 178.69 159.85 0.59 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.204 -0.935 . . . . 0.0 109.962 -179.961 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -135.4 126.13 27.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.366 -0.834 . . . . 0.0 109.936 179.798 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.439 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 36.9 tt0 -139.92 113.42 8.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.234 -0.916 . . . . 0.0 110.55 -179.826 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.509 HD11 HG22 ' A' ' 43' ' ' ILE . 43.4 mt -53.87 142.22 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.262 -0.899 . . . . 0.0 109.861 179.535 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.45 HD22 ' CB ' ' A' ' 55' ' ' LYS . 0.4 OUTLIER -114.64 -30.05 6.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.107 -0.996 . . . . 0.0 110.455 -179.862 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.566 ' CD2' HD13 ' A' ' 53' ' ' ILE . 1.7 m95 -126.48 164.97 19.99 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.261 -0.899 . . . . 0.0 110.416 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.46 ' HA2' ' OG1' ' A' ' 52' ' ' THR . . . 41.78 -135.65 3.19 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.745 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.11 22.68 0.5 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.28 -1.13 . . . . 0.0 110.093 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 121.59 -19.14 8.57 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.473 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -71.82 -171.57 15.2 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.479 ' HA ' HG23 ' A' ' 71' ' ' ILE . 45.9 Cg_endo -73.19 129.11 13.65 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 123.939 1.494 . . . . 0.0 110.478 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.74 -14.0 53.35 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.499 -1.84 . . . . 0.0 108.499 -179.392 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -70.48 160.96 31.45 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.613 -0.933 . . . . 0.0 109.381 179.536 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.566 HD13 ' CD2' ' A' ' 45' ' ' TRP . 57.6 mt -128.99 119.54 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.221 -0.924 . . . . 0.0 110.059 179.782 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.472 ' HE3' ' CD1' ' A' ' 71' ' ' ILE . 20.6 mttm -101.2 129.82 47.19 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.292 -0.88 . . . . 0.0 110.134 -179.892 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 34.7 ttpt -100.79 91.84 4.8 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.21 -0.931 . . . . 0.0 110.155 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.468 ' HB ' HG21 ' A' ' 67' ' ' VAL . 88.8 mt -80.07 144.16 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.894 . . . . 0.0 110.208 -179.948 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.499 ' O ' ' N ' ' A' ' 39' ' ' LYS . 1.0 OUTLIER -113.87 150.97 32.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.312 -0.867 . . . . 0.0 110.303 -179.997 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.577 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 20.8 m-85 -115.47 147.55 40.48 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.269 -0.894 . . . . 0.0 110.142 179.744 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -103.71 14.93 53.19 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -129.59 163.26 26.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.167 -1.196 . . . . 0.0 110.26 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 62' ' ' SER . . . 88.95 -152.5 22.97 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.446 ' O ' ' O ' ' A' ' 61' ' ' GLY . 91.8 p -54.03 -168.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.186 -1.184 . . . . 0.0 110.116 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -73.3 -36.19 66.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.22 -0.925 . . . . 0.0 110.196 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -117.79 111.85 19.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.287 -0.883 . . . . 0.0 110.209 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.577 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -131.8 84.88 0.3 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.533 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 11.7 p90 -128.12 163.17 25.22 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.23 -1.159 . . . . 0.0 110.262 -179.658 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.496 HG23 ' CZ ' ' A' ' 58' ' ' PHE . 5.3 m -136.08 175.66 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.369 -0.832 . . . . 0.0 110.251 179.496 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.516 ' O ' ' CD1' ' A' ' 85' ' ' LEU . 26.8 mttm -135.56 104.87 5.97 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.382 -0.824 . . . . 0.0 109.829 179.754 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.529 ' CD2' HD11 ' A' ' 85' ' ' LEU . 14.2 m170 -95.6 130.08 42.58 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.301 -0.874 . . . . 0.0 111.121 -179.317 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 52' ' ' THR . 31.6 tttt -96.88 113.91 25.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.332 -0.855 . . . . 0.0 109.331 179.034 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.507 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 28.9 mm -53.52 131.11 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.197 -0.939 . . . . 0.0 110.313 -179.421 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.473 ' OD2' ' OG1' ' A' ' 84' ' ' THR . 86.1 m-20 -106.09 -46.66 4.03 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.405 -0.809 . . . . 0.0 110.332 -179.799 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 48.0 m -164.94 159.15 17.83 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.324 -0.86 . . . . 0.0 110.039 -179.793 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.464 HG12 HG12 ' A' ' 23' ' ' VAL . 1.7 mt -145.23 157.9 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.189 -0.944 . . . . 0.0 110.655 -179.881 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.537 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 2.2 m-20 -136.93 80.0 1.79 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.611 -0.681 . . . . 0.0 109.938 179.35 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.489 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 44.7 tttt -63.46 -13.27 38.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.189 -0.944 . . . . 0.0 110.431 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -95.79 -30.45 13.69 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.249 -0.907 . . . . 0.0 109.458 179.665 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.5 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -106.52 -7.54 17.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.572 -0.705 . . . . 0.0 109.813 -179.956 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.537 ' CZ ' ' HB3' ' A' ' 16' ' ' PRO . 2.8 m-85 68.62 51.12 0.64 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.558 -0.714 . . . . 0.0 110.177 -179.695 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.537 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -122.68 149.58 43.85 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.256 -0.903 . . . . 0.0 109.409 179.599 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.69 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 31.5 t80 -137.22 149.14 46.98 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.101 -0.999 . . . . 0.0 110.504 -179.204 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.461 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 75.0 m -154.92 129.0 8.84 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.177 -0.952 . . . . 0.0 110.922 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.69 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 26.1 p90 -148.17 169.5 19.9 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.328 -0.858 . . . . 0.0 110.536 179.318 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.473 ' OG1' ' OD2' ' A' ' 72' ' ' ASP . 18.0 m -124.52 129.85 51.38 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.299 -0.876 . . . . 0.0 110.127 -179.8 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.529 HD11 ' CD2' ' A' ' 69' ' ' HIS . 16.0 tp -96.43 136.78 36.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.945 -1.097 . . . . 0.0 110.34 179.735 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.422 HG23 HD11 ' A' ' 86' ' ' ILE . 11.4 pt -118.17 -30.87 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.212 -0.93 . . . . 0.0 110.364 -179.44 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.445 ' OE2' ' OH ' ' A' ' 66' ' ' TYR . 64.3 tt0 -114.53 156.26 24.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.276 -0.89 . . . . 0.0 110.159 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.466 ' HA2' HG13 ' A' ' 67' ' ' VAL . . . 152.69 130.89 1.6 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 89' ' ' ASP . 36.9 p-10 -60.94 -15.31 29.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -1.138 . . . . 0.0 110.09 179.91 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.07 -19.94 53.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 110.166 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.473 ' O ' ' HB2' ' A' ' 95' ' ' LEU . 59.1 mt -70.09 -26.96 64.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.92 . . . . 0.0 110.054 179.909 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 44.74 -169.36 0.02 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -87.36 7.33 29.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.247 -1.149 . . . . 0.0 109.911 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.405 ' O ' HG23 ' A' ' 126' ' ' VAL . 30.1 p -98.84 -28.19 13.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.359 -0.838 . . . . 0.0 109.959 179.91 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.592 ' CD1' ' CD1' ' A' ' 128' ' ' ILE . 41.2 mt -111.91 169.56 8.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.449 -0.782 . . . . 0.0 110.156 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.431 ' HG2' ' C ' ' A' ' 95' ' ' LEU . 66.2 mm-40 -151.2 -81.38 0.1 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.318 -0.864 . . . . 0.0 109.877 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 19.4 mttt -80.33 133.78 35.98 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.727 -0.608 . . . . 0.0 110.564 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.553 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 6.7 mm -123.44 142.01 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.876 -1.14 . . . . 0.0 109.886 179.07 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.471 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.3 OUTLIER -123.42 134.41 53.96 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.39 -0.819 . . . . 0.0 109.021 178.866 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 7.2 m-85 -129.82 132.3 46.44 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.303 -0.873 . . . . 0.0 110.624 -179.021 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -136.41 136.08 39.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.401 -0.812 . . . . 0.0 109.884 179.465 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 39.3 m -136.36 139.6 42.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 110.111 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 115' ' ' LYS . 1.1 tttp -134.52 143.24 47.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.241 -0.912 . . . . 0.0 110.502 -179.87 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.518 ' HB2' ' HB2' ' A' ' 79' ' ' TYR . 7.2 mt -124.52 151.91 44.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.247 -0.908 . . . . 0.0 109.844 179.587 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.481 ' CG2' ' C ' ' A' ' 104' ' ' LEU . 1.9 t -150.06 -169.76 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.176 -0.953 . . . . 0.0 110.288 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 112' ' ' SER . . . -125.34 160.74 28.59 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.399 -0.813 . . . . 0.0 110.21 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.455 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 3.1 p -119.16 169.03 8.73 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.197 -0.939 . . . . 0.0 110.282 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 48.3 Cg_endo -73.37 -4.11 14.85 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.069 1.563 . . . . 0.0 110.7 -179.891 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 39.2 p -105.83 9.93 32.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.085 -1.009 . . . . 0.0 110.298 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 111' ' ' GLY . . . 93.38 -37.84 3.3 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.894 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 110' ' ' GLY . . . -54.27 -172.65 0.06 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.533 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 9.0 p -138.79 136.0 35.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.14 -1.212 . . . . 0.0 110.414 179.937 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.46 HG12 HG23 ' A' ' 10' ' ' THR . 61.4 mt -87.67 149.03 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.346 -0.846 . . . . 0.0 109.944 179.772 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.625 ' CG2' ' CE2' ' A' ' 9' ' ' PHE . 4.6 mt -131.82 116.12 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.224 -0.922 . . . . 0.0 110.389 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 103' ' ' LYS . 39.5 tttt -100.12 148.29 24.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.374 -0.829 . . . . 0.0 110.011 179.708 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.2 t -145.55 155.39 43.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.184 -0.947 . . . . 0.0 110.388 -179.816 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 25.9 m -157.87 126.19 5.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.444 -0.785 . . . . 0.0 109.888 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 3.6 m -121.66 154.85 36.27 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.126 -0.984 . . . . 0.0 110.296 -179.851 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.471 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 56.2 m-70 -137.87 147.27 44.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.276 -0.89 . . . . 0.0 110.392 -179.998 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.6 ' CD2' HG13 ' A' ' 128' ' ' ILE . 58.8 m-85 -126.04 121.95 34.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.299 -0.876 . . . . 0.0 110.208 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.588 ' CD2' HG22 ' A' ' 2' ' ' VAL . 70.4 m-70 -95.55 103.95 15.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.277 -0.889 . . . . 0.0 109.956 179.793 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.519 ' CG2' HG22 ' A' ' 126' ' ' VAL . 0.9 OUTLIER -91.1 142.71 27.46 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.14 -0.975 . . . . 0.0 110.29 -179.792 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.6 tttt -103.73 124.98 49.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.328 -0.858 . . . . 0.0 110.325 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 98.1 -122.51 7.52 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -134.19 67.61 1.51 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.277 -1.131 . . . . 0.0 110.311 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.519 HG22 ' CG2' ' A' ' 122' ' ' THR . 31.0 m -131.5 168.11 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 109.932 179.915 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.434 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 89.7 mt-10 -143.93 157.86 44.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.161 -0.962 . . . . 0.0 110.588 -179.828 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.6 HG13 ' CD2' ' A' ' 120' ' ' TYR . 20.5 mm -61.47 173.41 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.379 -0.826 . . . . 0.0 110.106 179.736 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.49 ' N ' ' CG2' ' A' ' 128' ' ' ILE . 22.9 mttt -96.62 130.8 43.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.334 -0.854 . . . . 0.0 109.66 179.456 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 129' ' ' LYS . 95.5 mt-10 -42.06 -42.9 3.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 110.307 -179.708 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.527 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 31.0 tt0 -55.51 -33.91 64.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.912 . . . . 0.0 109.892 179.636 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.502 ' HB3' ' CG2' ' A' ' 128' ' ' ILE . 5.9 t-160 -75.49 -56.77 4.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.275 -0.891 . . . . 0.0 110.431 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.405 HG11 ' CD1' ' A' ' 5' ' ' TYR . 86.7 t -60.82 -33.03 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.326 -0.858 . . . . 0.0 110.394 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 38.6 mttp -104.04 -71.17 0.74 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.148 -0.97 . . . . 0.0 110.499 -179.688 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -55.93 -19.28 11.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.081 -1.012 . . . . 0.0 109.867 -179.883 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 132' ' ' HIS . . . -76.71 -29.85 57.02 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.819 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 46.4 mttt -68.13 -32.36 72.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.269 -1.136 . . . . 0.0 110.222 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -79.06 -34.21 43.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 110.027 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -66.35 -39.07 88.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.33 -0.856 . . . . 0.0 110.002 179.864 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.87 -42.92 60.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.411 -0.806 . . . . 0.0 110.032 179.76 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.0 t -54.55 -43.11 71.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.323 -0.861 . . . . 0.0 109.905 179.765 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -57.43 -44.82 84.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.349 -0.845 . . . . 0.0 109.919 179.702 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 46.5 mt -58.53 -38.08 77.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.285 -0.884 . . . . 0.0 109.836 179.713 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -62.26 -33.94 75.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.425 -0.797 . . . . 0.0 109.705 179.543 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -72.94 -15.46 61.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.327 -0.858 . . . . 0.0 109.855 179.756 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 14.0 mt -82.34 -37.15 26.13 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.258 -0.901 . . . . 0.0 108.721 179.203 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.642 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 19.1 mt -68.69 -47.35 77.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.751 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.513 ' HB3' ' CD1' ' A' ' 13' ' ' ILE . 88.8 mt-10 -56.18 -43.86 78.82 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.498 -0.751 . . . . 0.0 109.466 179.037 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 42.8 m -65.2 -34.34 78.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.159 -0.963 . . . . 0.0 109.37 179.329 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.596 ' CE2' ' OH ' ' A' ' 158' ' ' TYR . 81.3 t80 -59.15 -47.61 84.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.562 -0.711 . . . . 0.0 109.581 179.341 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.55 HD22 ' CE2' ' A' ' 158' ' ' TYR . 32.8 mt -80.08 -33.37 38.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 110.222 179.655 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.545 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . 27.4 tttt -60.09 -23.21 63.62 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.228 -0.92 . . . . 0.0 109.257 179.364 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.471 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -109.69 -30.5 3.49 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.607 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 5.4 m-70 -105.68 92.22 5.88 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.28 -1.13 . . . . 0.0 110.084 179.817 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 46.3 Cg_endo -72.18 2.93 4.43 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.009 1.531 . . . . 0.0 111.069 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -113.57 -11.5 13.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.067 -1.02 . . . . 0.0 109.764 179.729 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.615 ' C ' ' CG ' ' A' ' 158' ' ' TYR . . . -46.84 102.31 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.412 -0.805 . . . . 0.0 109.688 179.615 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.615 ' CG ' ' C ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER 58.71 -59.12 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.458 0 CA-C-O 121.592 0.71 . . . . 0.0 110.543 -179.33 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.589 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--N 1.293 -1.874 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.169 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 58.5 t -122.31 137.12 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.201 -1.176 . . . . 0.0 110.319 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.66 ' CG ' HD13 ' A' ' 128' ' ' ILE . 11.6 m-85 -95.71 146.88 24.17 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.318 -0.864 . . . . 0.0 109.967 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.814 HG23 ' CE1' ' A' ' 119' ' ' HIS . 7.3 m -127.35 117.26 21.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.179 -0.95 . . . . 0.0 110.597 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 1.085 ' CE2' HG21 ' A' ' 133' ' ' VAL . 67.1 m-85 -129.74 132.86 46.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.381 -0.825 . . . . 0.0 109.655 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 23.1 pt-20 -130.22 153.53 48.49 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.146 -0.971 . . . . 0.0 110.703 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.472 ' O ' ' CG ' ' A' ' 8' ' ' GLU . 5.9 t -131.79 165.93 22.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.459 -0.776 . . . . 0.0 109.574 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.472 ' CG ' ' O ' ' A' ' 7' ' ' SER . 87.5 mt-10 -154.12 121.97 5.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.088 -1.007 . . . . 0.0 110.706 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.618 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.2 p90 -149.53 -178.31 6.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.355 -0.841 . . . . 0.0 109.625 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.864 HG22 ' HA ' ' A' ' 113' ' ' ILE . 8.6 p -142.37 174.57 10.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.196 -0.94 . . . . 0.0 110.651 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.484 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 4.7 t -159.79 162.19 34.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.461 -0.774 . . . . 0.0 110.125 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -83.48 -20.28 34.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.217 -0.927 . . . . 0.0 110.187 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.832 HD11 ' HB2' ' A' ' 152' ' ' LYS . 2.9 mp -74.08 149.66 87.45 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.317 -0.865 . . . . 0.0 110.072 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.804 ' HD2' HG23 ' A' ' 13' ' ' ILE . 41.3 Cg_endo -67.59 142.23 58.08 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.055 1.555 . . . . 0.0 110.473 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.656 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.2 Cg_endo -72.44 -30.95 11.88 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 124.013 1.533 . . . . 0.0 112.804 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.656 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.7 Cg_endo -70.4 -23.79 27.47 Favored 'Trans proline' 0 C--N 1.319 -0.983 0 N-CA-C 110.115 -0.764 . . . . 0.0 110.115 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.801 HH21 ' HB3' ' A' ' 157' ' ' ALA . 58.5 mtp180 -82.24 -44.11 16.75 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.22 -0.925 . . . . 0.0 108.662 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 1.057 HD23 ' CG2' ' A' ' 147' ' ' ILE . 0.2 OUTLIER -70.85 -31.4 68.09 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.04 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.626 ' N ' HD13 ' A' ' 18' ' ' LEU . 70.4 t80 -63.69 -58.82 5.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.478 -0.764 . . . . 0.0 109.509 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.525 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 75.1 mttt -50.23 -41.24 49.64 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.42 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.129 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -70.55 -36.25 73.57 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.406 -0.809 . . . . 0.0 110.928 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 1.052 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -79.18 -40.25 31.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.24 -0.912 . . . . 0.0 111.14 -178.948 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.739 HG13 ' CE1' ' A' ' 81' ' ' TYR . 7.5 t -103.75 -54.85 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.975 -1.078 . . . . 0.0 111.741 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.525 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 5.9 mp -80.02 -1.39 39.55 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.013 -1.054 . . . . 0.0 112.012 -178.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.575 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -146.52 14.49 1.24 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.68 -1.263 . . . . 0.0 110.61 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 1.052 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -60.65 -16.46 39.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.273 -0.892 . . . . 0.0 110.78 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -70.87 -22.11 62.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.065 -1.022 . . . . 0.0 110.556 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.524 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 5.1 p-10 -132.1 3.27 4.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.106 -0.996 . . . . 0.0 110.427 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.966 ' HG ' ' HB1' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -92.27 -39.42 11.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.235 -0.916 . . . . 0.0 109.972 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 1.102 ' CG1' HD13 ' A' ' 38' ' ' ILE . 97.6 t -77.11 -40.77 2.38 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.398 -0.813 . . . . 0.0 110.961 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 30' ' ' VAL . 49.3 Cg_endo -77.85 7.87 3.72 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.32 1.168 . . . . 0.0 110.55 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -121.48 -38.22 2.8 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.159 -0.963 . . . . 0.0 109.078 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.652 HD11 ' CD1' ' A' ' 150' ' ' TYR . 5.6 mt -80.2 -39.13 18.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-O 121.563 0.697 . . . . 0.0 109.271 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.72 80.01 32.67 Favored Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.572 -0.705 . . . . 0.0 109.877 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -73.13 1.14 6.95 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.101 1.579 . . . . 0.0 110.83 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -87.97 -17.44 31.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.139 -0.976 . . . . 0.0 109.919 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -101.19 -56.44 2.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.394 -0.816 . . . . 0.0 110.038 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 1.102 HD13 ' CG1' ' A' ' 30' ' ' VAL . 1.3 mp -107.39 145.53 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.467 -0.771 . . . . 0.0 109.914 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -112.6 -23.46 10.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.891 . . . . 0.0 110.586 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.466 ' O ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -163.02 158.2 21.83 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.097 -1.002 . . . . 0.0 110.223 -179.788 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.8 m -140.87 124.5 16.91 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.295 -0.878 . . . . 0.0 109.917 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 60.3 tt0 -137.56 108.22 6.6 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.107 -0.996 . . . . 0.0 110.452 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.468 HG21 ' HA ' ' A' ' 47' ' ' ASP . 13.6 mt -54.84 131.44 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.191 -0.943 . . . . 0.0 110.008 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.525 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 20.3 mt -97.5 -34.86 10.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.921 . . . . 0.0 110.616 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.722 ' CD1' HD12 ' A' ' 53' ' ' ILE . 1.9 m95 -123.03 161.79 23.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.248 -0.907 . . . . 0.0 110.73 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.45 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 40.18 -133.57 2.39 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.468 ' HA ' HG21 ' A' ' 43' ' ' ILE . 0.5 OUTLIER -157.68 20.14 0.27 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.384 -1.068 . . . . 0.0 110.069 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.457 ' O ' HG21 ' A' ' 71' ' ' ILE . . . 128.57 -21.72 5.34 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.468 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -65.73 -175.91 6.01 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.405 ' HA ' HG22 ' A' ' 71' ' ' ILE . 46.1 Cg_endo -73.23 128.69 13.18 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 124.032 1.543 . . . . 0.0 110.559 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.19 -14.33 55.2 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.643 -1.783 . . . . 0.0 108.643 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.523 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -67.86 164.07 20.53 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.565 -0.962 . . . . 0.0 109.789 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.722 HD12 ' CD1' ' A' ' 45' ' ' TRP . 59.9 mt -131.95 121.59 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.398 -0.813 . . . . 0.0 109.467 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.553 ' NZ ' HD11 ' A' ' 71' ' ' ILE . 66.9 mttt -106.01 135.81 46.79 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.144 -0.972 . . . . 0.0 110.317 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.525 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 21.1 tttp -104.73 89.6 3.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.353 -0.842 . . . . 0.0 110.01 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.542 ' CG2' HG12 ' A' ' 38' ' ' ILE . 61.8 mt -79.91 138.69 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 109.867 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 1.4 p -116.49 152.94 33.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.908 . . . . 0.0 110.589 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.574 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 18.7 m-85 -115.27 169.82 8.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.435 -0.791 . . . . 0.0 110.012 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.951 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.467 ' CD2' ' CD2' ' A' ' 66' ' ' TYR . 1.5 t80 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.313 0.578 . . . . 0.0 110.254 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.574 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -129.6 99.95 0.48 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.488 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 25.8 p90 -140.33 171.69 13.79 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -1.139 . . . . 0.0 110.304 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.874 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.8 m -141.08 173.81 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.335 -0.853 . . . . 0.0 110.563 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.516 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 23.2 mttt -123.2 127.31 48.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.499 -0.751 . . . . 0.0 109.625 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.624 ' CE1' HD13 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -113.74 126.52 55.31 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.102 -0.999 . . . . 0.0 111.049 -179.267 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 52' ' ' THR . 64.8 tttt -104.22 106.63 17.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.326 -0.859 . . . . 0.0 109.533 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.553 HD11 ' NZ ' ' A' ' 54' ' ' LYS . 31.1 mm -49.8 136.02 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.191 -0.943 . . . . 0.0 110.38 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.456 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 8.3 t0 -111.76 -39.86 4.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.359 -0.838 . . . . 0.0 109.55 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.461 ' OG ' ' HB2' ' A' ' 82' ' ' SER . 53.4 p -168.42 160.44 11.2 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.464 -0.773 . . . . 0.0 109.617 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 73' ' ' SER . 1.5 mt -147.52 154.9 10.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.192 -0.942 . . . . 0.0 110.292 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.553 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 4.7 m-20 -135.66 79.09 1.76 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.213 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.506 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 63.5 mttt -63.02 -12.82 28.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.153 -0.967 . . . . 0.0 110.066 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -95.61 -31.78 13.12 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.31 -0.869 . . . . 0.0 109.497 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.5 m120 -106.01 -5.86 19.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.593 -0.692 . . . . 0.0 109.673 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.598 ' O ' HD12 ' A' ' 104' ' ' LEU . 4.6 m-85 66.34 50.22 1.34 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.555 -0.716 . . . . 0.0 110.42 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.553 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -120.42 150.32 40.97 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.241 -0.912 . . . . 0.0 109.227 179.379 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.739 ' CE1' HG13 ' A' ' 23' ' ' VAL . 19.9 t80 -139.09 134.29 32.72 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.14 -0.975 . . . . 0.0 110.299 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.461 ' HB2' ' OG ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -140.6 120.22 13.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.272 -0.892 . . . . 0.0 110.695 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.629 ' CE2' ' CB ' ' A' ' 100' ' ' TYR . 19.5 p90 -138.0 170.97 15.11 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 110.246 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.643 HG23 ' O ' ' A' ' 98' ' ' ILE . 86.7 m -121.64 130.83 53.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.412 -0.805 . . . . 0.0 109.802 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.624 HD13 ' CE1' ' A' ' 69' ' ' HIS . 5.2 tp -95.32 137.88 33.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.091 -1.006 . . . . 0.0 110.124 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.437 HG12 ' HB2' ' A' ' 68' ' ' LYS . 15.1 pt -120.41 -15.04 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.322 -0.862 . . . . 0.0 110.389 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.538 ' O ' HD11 ' A' ' 85' ' ' LEU . 25.3 tt0 -129.37 158.64 38.58 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.134 -0.978 . . . . 0.0 110.262 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.874 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 151.16 115.76 0.7 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -50.44 -20.97 1.27 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.251 -1.146 . . . . 0.0 110.345 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.811 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -72.77 -18.75 61.46 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.19 -0.943 . . . . 0.0 110.41 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 95' ' ' LEU . 74.9 mt -69.33 -7.79 40.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.167 -0.958 . . . . 0.0 110.185 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 46.75 -171.8 0.03 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.439 ' OD1' HG23 ' A' ' 94' ' ' THR . 49.8 p-10 -91.64 34.68 0.97 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.214 -1.168 . . . . 0.0 109.675 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.439 HG23 ' OD1' ' A' ' 93' ' ' ASP . 7.1 p -131.31 -41.64 1.09 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.441 -0.787 . . . . 0.0 110.397 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.696 HD22 HG22 ' A' ' 122' ' ' THR . 3.1 mm? -79.91 157.02 27.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.906 . . . . 0.0 110.352 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.496 ' HG3' ' HB2' ' A' ' 123' ' ' LYS . 48.0 mm-40 -141.08 -80.9 0.25 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.326 -0.859 . . . . 0.0 109.631 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.527 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 36.8 mttp -80.31 126.53 31.27 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.484 -0.76 . . . . 0.0 110.318 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.707 HG21 ' CE2' ' A' ' 100' ' ' TYR . 5.7 mm -116.58 138.93 45.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 120.586 -1.321 . . . . 0.0 109.621 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.483 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -114.76 130.12 56.8 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.465 179.219 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.707 ' CE2' HG21 ' A' ' 98' ' ' ILE . 9.3 m-85 -125.36 134.01 52.34 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.42 -0.8 . . . . 0.0 110.032 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.478 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 78.0 tt0 -136.56 136.12 39.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 0.0 110.478 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.453 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 91.8 m -136.73 137.8 40.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.287 -0.883 . . . . 0.0 109.762 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -135.37 145.56 47.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.063 -1.023 . . . . 0.0 110.49 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.657 HD23 HG12 ' A' ' 114' ' ' ILE . 6.2 mt -126.43 151.79 47.26 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.33 -0.856 . . . . 0.0 110.067 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.708 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -150.97 -169.23 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.247 -0.908 . . . . 0.0 110.247 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.708 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -120.49 151.14 39.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.336 -0.852 . . . . 0.0 110.265 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.473 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 6.1 p -105.08 167.9 9.16 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 110.164 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.3 Cg_endo -72.7 -13.25 27.04 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.059 1.557 . . . . 0.0 110.438 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 74.1 m -97.02 12.45 32.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.184 -0.947 . . . . 0.0 110.252 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 92.29 -32.82 5.24 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -60.36 -175.0 1.11 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 28.8 p -130.57 135.36 47.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -1.16 . . . . 0.0 110.376 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.864 ' HA ' HG22 ' A' ' 10' ' ' THR . 11.0 mt -88.33 151.31 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.294 -0.879 . . . . 0.0 110.065 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.657 HG12 HD23 ' A' ' 104' ' ' LEU . 11.9 mt -131.49 116.67 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -0.936 . . . . 0.0 110.35 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.8 tttm -108.61 124.14 50.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.164 -0.96 . . . . 0.0 109.892 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.7 t -120.46 162.06 20.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.237 -0.914 . . . . 0.0 110.397 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.478 ' HB ' ' HB3' ' A' ' 101' ' ' GLU . 37.5 m -160.02 151.97 20.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.373 -0.829 . . . . 0.0 109.932 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 7.5 m -148.35 157.1 43.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.205 -0.935 . . . . 0.0 110.275 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.814 ' CE1' HG23 ' A' ' 4' ' ' THR . 68.4 m-70 -141.54 162.05 36.42 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.195 -0.94 . . . . 0.0 110.536 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.502 ' N ' ' CD1' ' A' ' 120' ' ' TYR . 11.1 m-85 -127.68 152.36 47.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.358 -0.839 . . . . 0.0 110.302 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.527 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 75.6 m80 -134.99 86.69 2.27 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.201 -0.937 . . . . 0.0 109.518 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.696 HG22 HD22 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -70.79 146.75 49.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.397 -0.814 . . . . 0.0 110.74 -179.341 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.496 ' HB2' ' HG3' ' A' ' 96' ' ' GLU . 2.0 ttpt -92.83 119.1 31.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.373 -0.83 . . . . 0.0 110.057 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 105.58 -125.32 8.2 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -137.43 61.61 1.61 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.328 -1.101 . . . . 0.0 110.231 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.503 HG23 ' CG2' ' A' ' 122' ' ' THR . 35.5 m -124.28 179.32 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.246 -0.909 . . . . 0.0 110.08 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -140.52 158.53 43.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.177 -0.952 . . . . 0.0 110.345 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.683 HD12 ' H ' ' A' ' 128' ' ' ILE . 5.1 mp -78.23 172.98 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.247 -0.908 . . . . 0.0 110.183 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.605 ' N ' HG22 ' A' ' 128' ' ' ILE . 7.3 mttp -107.02 128.02 53.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.363 -0.835 . . . . 0.0 109.888 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.475 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 91.8 mt-10 -42.77 -53.45 4.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.214 -0.928 . . . . 0.0 110.244 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 51.1 tt0 -47.52 -26.19 1.33 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.188 -0.945 . . . . 0.0 109.912 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.811 ' NE2' ' HB1' ' A' ' 90' ' ' ALA . 11.3 t-160 -85.37 -62.39 1.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.297 -0.877 . . . . 0.0 110.137 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 1.085 HG21 ' CE2' ' A' ' 5' ' ' TYR . 7.7 p -62.36 -41.0 89.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.378 -0.826 . . . . 0.0 109.962 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.554 ' N ' HG13 ' A' ' 133' ' ' VAL . 27.6 tttp -64.8 -44.14 90.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.337 -0.852 . . . . 0.0 109.89 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 131' ' ' GLU . . . -63.86 -32.8 74.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.374 -0.829 . . . . 0.0 109.913 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -64.9 -31.86 82.33 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -60.53 -32.66 71.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.273 -1.133 . . . . 0.0 109.955 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 142' ' ' ASN . 99.0 mt-10 -83.6 -33.35 25.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.38 -0.825 . . . . 0.0 109.878 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 24.3 mttt -68.86 -35.06 76.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.34 -0.85 . . . . 0.0 109.881 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.427 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -86.18 -40.89 15.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.297 -0.877 . . . . 0.0 109.934 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.1 m -67.55 -53.45 28.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.419 -0.801 . . . . 0.0 109.846 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 138' ' ' GLU . 98.8 m-20 -49.43 -47.47 48.02 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.226 -0.921 . . . . 0.0 109.924 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.427 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 9.3 tp -55.6 -48.16 75.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.281 -0.887 . . . . 0.0 109.882 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.565 ' CE1' ' CE2' ' A' ' 22' ' ' PHE . 13.6 m-85 -53.31 -36.13 60.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.444 -0.785 . . . . 0.0 109.843 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -74.56 -16.51 60.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.359 -0.838 . . . . 0.0 109.862 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 146' ' ' LEU . 24.0 mt -84.41 -35.63 22.97 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.281 -0.887 . . . . 0.0 109.01 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 1.057 ' CG2' HD23 ' A' ' 18' ' ' LEU . 24.7 mt -68.26 -41.61 83.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.484 ' CG ' ' OG ' ' A' ' 11' ' ' SER . 97.2 mt-10 -48.36 -40.98 27.3 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.158 -0.964 . . . . 0.0 108.794 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.418 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 19.5 m -72.05 -26.74 62.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.28 -0.887 . . . . 0.0 109.351 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.652 ' CD1' HD11 ' A' ' 33' ' ' ILE . 62.7 t80 -57.89 -52.2 66.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.535 -0.728 . . . . 0.0 109.883 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.943 HD21 ' CE1' ' A' ' 158' ' ' TYR . 64.7 mt -80.01 -36.42 35.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.285 -0.884 . . . . 0.0 110.362 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.832 ' HB2' HD11 ' A' ' 13' ' ' ILE . 35.8 tttt -60.05 -19.69 54.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.163 -0.961 . . . . 0.0 109.236 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.48 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -111.1 -32.22 2.66 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.407 ' ND1' ' N ' ' A' ' 154' ' ' HIS . 2.4 m80 -105.97 93.0 7.04 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.324 -1.103 . . . . 0.0 110.039 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.503 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 46.6 Cg_endo -72.94 3.66 4.29 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.018 1.536 . . . . 0.0 110.96 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -114.19 -10.29 12.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.085 -1.009 . . . . 0.0 109.899 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.801 ' HB3' HH21 ' A' ' 17' ' ' ARG . . . -46.92 108.74 0.15 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.333 -0.855 . . . . 0.0 110.053 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 1.129 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 35.46 30.83 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.719 -0.613 . . . . 0.0 110.515 -179.624 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.525 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.701 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.816 HG22 ' CD2' ' A' ' 121' ' ' HIS . 63.6 t -122.93 122.53 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.191 -1.182 . . . . 0.0 110.264 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.579 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 43.1 m-85 -80.2 154.16 28.12 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.28 -0.887 . . . . 0.0 110.302 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.889 HG23 ' CE1' ' A' ' 119' ' ' HIS . 56.5 m -138.35 94.47 2.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.882 . . . . 0.0 110.1 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.592 ' CD1' HG23 ' A' ' 133' ' ' VAL . 75.1 m-85 -116.15 136.41 53.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.889 . . . . 0.0 110.026 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 116' ' ' SER . 21.5 pt-20 -135.92 151.91 50.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.202 -0.936 . . . . 0.0 110.404 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.3 m -121.38 157.83 29.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.337 -0.852 . . . . 0.0 109.92 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -135.44 121.11 19.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.115 -0.99 . . . . 0.0 110.386 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.638 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.9 p90 -146.03 -174.12 4.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.347 -0.846 . . . . 0.0 109.948 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.866 HG22 ' HA ' ' A' ' 113' ' ' ILE . 5.7 p -141.43 173.03 11.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.201 -0.937 . . . . 0.0 110.627 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.479 ' CB ' ' CD ' ' A' ' 148' ' ' GLU . 97.6 p -156.68 135.04 11.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.399 -0.813 . . . . 0.0 110.2 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -62.05 -31.02 71.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.211 -0.931 . . . . 0.0 110.134 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.873 HD11 ' HB2' ' A' ' 152' ' ' LYS . 2.3 mp -64.55 150.62 93.43 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.869 . . . . 0.0 109.944 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.818 ' HD2' HG23 ' A' ' 13' ' ' ILE . 42.0 Cg_endo -68.32 143.15 57.3 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.044 1.549 . . . . 0.0 110.771 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.669 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.5 Cg_endo -72.25 -30.92 12.42 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 O-C-N 124.042 1.549 . . . . 0.0 112.737 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.669 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.1 Cg_endo -69.53 -22.71 32.75 Favored 'Trans proline' 0 N--CA 1.485 0.988 0 N-CA-C 110.07 -0.781 . . . . 0.0 110.07 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.61 ' NH2' ' HB3' ' A' ' 157' ' ' ALA . 42.2 mtp180 -83.5 -42.89 16.37 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 1.039 HD23 HG21 ' A' ' 147' ' ' ILE . 0.3 OUTLIER -71.33 -32.69 68.87 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 178.833 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.581 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 81.4 t80 -63.02 -61.63 2.26 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.538 -0.726 . . . . 0.0 109.577 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.76 ' HG2' HD22 ' A' ' 24' ' ' LEU . 14.9 mttp -53.61 -32.88 53.0 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.383 -0.823 . . . . 0.0 109.351 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.005 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -74.26 -47.45 35.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.363 -0.836 . . . . 0.0 110.568 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 1.049 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -66.67 -46.76 74.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.542 -0.724 . . . . 0.0 111.215 -179.141 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 1.105 HG11 ' CD1' ' A' ' 74' ' ' ILE . 6.1 t -97.45 -60.3 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.109 -0.995 . . . . 0.0 111.914 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.76 HD22 ' HG2' ' A' ' 20' ' ' LYS . 8.5 mp -69.5 -0.19 6.23 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.16 -0.962 . . . . 0.0 111.824 -178.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.548 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -146.16 10.95 1.17 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.692 -1.255 . . . . 0.0 110.811 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 1.049 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -53.38 -19.02 3.0 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.164 -0.96 . . . . 0.0 110.863 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -80.01 -26.87 39.65 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.005 -1.059 . . . . 0.0 110.573 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -127.12 13.05 7.21 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.255 -0.903 . . . . 0.0 110.337 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.765 ' HG ' ' HB1' ' A' ' 21' ' ' ALA . 0.8 OUTLIER -103.9 -45.29 4.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.105 -0.997 . . . . 0.0 110.259 179.921 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.952 HG11 HD13 ' A' ' 38' ' ' ILE . 3.1 t -64.77 -41.83 59.22 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.326 -0.858 . . . . 0.0 110.556 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.0 Cg_endo -78.79 8.87 3.51 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.442 1.233 . . . . 0.0 110.628 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -118.64 -25.47 6.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.153 -0.967 . . . . 0.0 109.263 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.75 HD11 HD11 ' A' ' 29' ' ' LEU . 20.1 mt -80.01 -57.42 5.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 121.612 0.72 . . . . 0.0 109.427 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.422 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . . . -145.06 105.55 4.46 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.541 -0.724 . . . . 0.0 109.818 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 34' ' ' ALA . 44.2 Cg_endo -70.66 -0.77 8.18 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 124.042 1.549 . . . . 0.0 110.824 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -82.87 -10.42 58.84 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.075 -1.016 . . . . 0.0 109.645 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -101.93 -63.31 1.16 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.334 -0.853 . . . . 0.0 110.121 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.952 HD13 HG11 ' A' ' 30' ' ' VAL . 1.3 mp -113.09 154.2 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.446 -0.784 . . . . 0.0 109.985 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.544 ' HG2' ' N ' ' A' ' 59' ' ' GLY . 66.5 mmtt -114.16 -27.5 7.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 0.0 110.457 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.469 ' O ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -159.32 151.72 21.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.955 . . . . 0.0 110.179 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.1 m -138.13 120.71 16.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.393 -0.817 . . . . 0.0 109.677 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -134.09 109.97 9.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.157 -0.964 . . . . 0.0 110.785 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 29.9 mt -55.71 133.81 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.312 -0.868 . . . . 0.0 109.794 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 13.3 tp -105.28 -23.45 12.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.248 -0.908 . . . . 0.0 110.823 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.756 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.8 m95 -129.58 159.37 36.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.043 -1.036 . . . . 0.0 110.855 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.456 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 41.91 -136.23 3.12 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -151.25 21.54 0.75 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.307 -1.114 . . . . 0.0 110.068 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.498 ' O ' HG21 ' A' ' 71' ' ' ILE . . . 122.89 -20.96 7.58 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.517 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -67.8 -173.41 7.03 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -72.81 128.86 13.72 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.071 1.564 . . . . 0.0 110.517 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.45 -13.46 51.13 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 45' ' ' TRP . 1.0 OUTLIER -72.11 165.24 24.73 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.548 -0.972 . . . . 0.0 109.596 179.54 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.756 HD12 ' CG ' ' A' ' 45' ' ' TRP . 63.0 mt -135.35 120.57 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.333 -0.855 . . . . 0.0 109.697 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.665 ' CE ' HD11 ' A' ' 71' ' ' ILE . 39.3 mttm -103.53 128.6 50.72 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.208 -0.932 . . . . 0.0 110.27 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 54.9 tttt -97.6 91.65 5.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.197 -0.939 . . . . 0.0 109.874 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.556 ' CG2' HG12 ' A' ' 38' ' ' ILE . 89.4 mt -79.98 141.6 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.299 -0.876 . . . . 0.0 110.049 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.771 HG22 ' HB3' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -120.12 147.33 45.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 110.471 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.591 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 14.1 m-85 -114.21 162.27 16.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.325 -0.859 . . . . 0.0 110.003 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.544 ' N ' ' HG2' ' A' ' 39' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.576 ' O ' ' CD1' ' A' ' 64' ' ' TYR . 2.3 p90 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 121.317 0.579 . . . . 0.0 110.208 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.591 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -142.48 85.79 0.19 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.771 ' HB3' HG22 ' A' ' 57' ' ' THR . 13.6 p90 -132.74 171.97 13.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.293 -1.122 . . . . 0.0 110.251 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.789 HG12 ' HA2' ' A' ' 88' ' ' GLY . 4.4 m -140.21 176.9 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.917 . . . . 0.0 110.477 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.642 ' O ' HD12 ' A' ' 85' ' ' LEU . 82.3 mttt -133.03 102.9 5.78 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.426 -0.796 . . . . 0.0 109.746 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.979 ' CD2' HD13 ' A' ' 85' ' ' LEU . 15.1 m170 -95.65 127.73 41.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.24 -0.912 . . . . 0.0 111.061 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.536 ' HA ' ' O ' ' A' ' 52' ' ' THR . 17.1 tttt -96.59 114.84 26.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 109.436 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.665 HD11 ' CE ' ' A' ' 54' ' ' LYS . 37.0 mm -52.81 132.07 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.142 -0.974 . . . . 0.0 110.347 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.539 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 23.5 t0 -105.21 -46.86 4.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.487 -0.758 . . . . 0.0 109.982 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.452 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 77.5 p -177.68 160.93 1.61 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.466 -0.771 . . . . 0.0 110.376 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 1.105 ' CD1' HG11 ' A' ' 23' ' ' VAL . 6.6 tt -153.24 170.06 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.375 -0.828 . . . . 0.0 109.703 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.5 m-20 -142.19 84.35 1.87 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.079 -1.013 . . . . 0.0 110.395 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.581 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 18.7 tttm -58.93 -14.26 8.67 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.12 -0.988 . . . . 0.0 110.273 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -92.82 -34.33 13.9 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.349 -0.845 . . . . 0.0 109.517 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.505 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 3.7 m120 -102.71 -3.75 26.04 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.655 0.74 . . . . 0.0 109.267 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.647 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 76.1 m-85 62.39 55.48 2.3 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.338 0.589 . . . . 0.0 110.873 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.489 ' HB3' ' HG3' ' A' ' 103' ' ' LYS . 0.7 OUTLIER -131.09 153.87 48.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.449 -0.782 . . . . 0.0 109.523 179.124 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.614 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 76.0 t80 -151.99 149.48 28.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.183 -0.948 . . . . 0.0 110.352 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.482 ' HB2' ' HA ' ' A' ' 101' ' ' GLU . 13.5 t -157.63 151.14 23.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.249 -0.907 . . . . 0.0 110.386 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.614 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 7.2 p90 -152.18 177.03 10.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.441 -0.787 . . . . 0.0 110.734 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.717 HG23 ' O ' ' A' ' 98' ' ' ILE . 42.0 m -127.38 125.85 41.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.547 -0.721 . . . . 0.0 109.735 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.979 HD13 ' CD2' ' A' ' 69' ' ' HIS . 11.2 tp -95.77 133.63 39.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.006 -1.059 . . . . 0.0 110.407 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.555 ' N ' HD12 ' A' ' 85' ' ' LEU . 10.3 pt -111.53 -34.7 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.238 -0.914 . . . . 0.0 110.408 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.76 ' O ' HD11 ' A' ' 85' ' ' LEU . 76.9 tt0 -115.16 153.27 31.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.326 -0.859 . . . . 0.0 110.18 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.789 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 161.19 127.72 0.9 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -57.54 -20.29 30.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.271 -1.135 . . . . 0.0 110.095 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.83 -19.78 54.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.318 -0.864 . . . . 0.0 110.171 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.622 HD12 ' N ' ' A' ' 88' ' ' GLY . 55.1 mt -67.58 -28.21 67.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.931 . . . . 0.0 110.19 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 49.18 -178.09 0.02 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -81.99 8.23 11.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -1.166 . . . . 0.0 110.166 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.511 ' O ' HG22 ' A' ' 122' ' ' THR . 33.6 p -98.64 -32.71 11.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.206 -0.934 . . . . 0.0 110.144 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.935 HD21 ' CD1' ' A' ' 128' ' ' ILE . 76.5 mt -108.62 158.13 17.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.43 -0.793 . . . . 0.0 110.128 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.1 tp10 -139.35 -79.93 0.31 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.168 -0.957 . . . . 0.0 110.196 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.486 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 29.3 mttp -80.15 127.46 32.35 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.542 -0.724 . . . . 0.0 110.555 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.717 ' O ' HG23 ' A' ' 84' ' ' THR . 6.0 mm -117.83 142.78 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.885 -1.134 . . . . 0.0 110.027 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.473 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -123.64 133.67 53.89 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.409 -0.807 . . . . 0.0 109.112 178.859 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.641 ' HE2' HG21 ' A' ' 98' ' ' ILE . 6.8 m-85 -128.03 131.39 49.17 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.164 -0.96 . . . . 0.0 110.541 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.482 ' HA ' ' HB2' ' A' ' 82' ' ' SER . 85.1 tt0 -135.51 139.4 43.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.277 -0.889 . . . . 0.0 110.066 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.472 ' N ' ' O ' ' A' ' 81' ' ' TYR . 85.7 m -141.52 149.14 40.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 110.217 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.489 ' HG3' ' HB3' ' A' ' 80' ' ' SER . 0.0 OUTLIER -142.32 140.71 32.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.262 -0.899 . . . . 0.0 110.39 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.741 HD23 HG12 ' A' ' 114' ' ' ILE . 2.9 mt -115.37 155.68 26.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 110.063 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.707 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -151.48 -169.49 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.093 -1.005 . . . . 0.0 110.217 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.707 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -123.88 154.4 39.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.411 -0.806 . . . . 0.0 110.247 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.446 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.4 p -113.02 170.96 4.72 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.23 -0.919 . . . . 0.0 110.233 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.3 Cg_endo -72.11 -14.58 28.93 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.048 1.552 . . . . 0.0 110.553 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.2 p -97.82 11.41 37.35 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.224 -0.923 . . . . 0.0 110.174 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 91.92 -31.07 6.13 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -56.64 -172.57 0.17 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.513 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 1.1 p -136.46 135.95 39.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.168 -1.195 . . . . 0.0 110.277 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.866 ' HA ' HG22 ' A' ' 10' ' ' THR . 17.0 mt -89.23 149.47 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.33 -0.856 . . . . 0.0 110.024 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.741 HG12 HD23 ' A' ' 104' ' ' LEU . 23.3 mt -131.29 118.28 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 110.393 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 103' ' ' LYS . 72.2 tttt -105.8 120.75 42.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.945 . . . . 0.0 109.97 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 0.4 OUTLIER -113.04 151.68 30.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.234 -0.916 . . . . 0.0 110.528 -179.719 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.457 ' HB ' ' HB3' ' A' ' 101' ' ' GLU . 81.8 m -154.37 124.31 6.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.373 -0.829 . . . . 0.0 110.252 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.537 ' OG ' ' CE1' ' A' ' 100' ' ' TYR . 2.1 t -125.81 163.14 23.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 110.094 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.889 ' CE1' HG23 ' A' ' 4' ' ' THR . 71.0 m-70 -138.94 154.35 48.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -0.911 . . . . 0.0 110.177 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.531 ' HD1' HD12 ' A' ' 98' ' ' ILE . 21.4 m-85 -124.99 135.94 53.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.896 . . . . 0.0 110.44 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.816 ' CD2' HG22 ' A' ' 2' ' ' VAL . 77.0 m80 -118.79 93.45 4.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.138 -0.976 . . . . 0.0 109.763 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.864 ' CG2' HD23 ' A' ' 95' ' ' LEU . 1.7 p -75.06 155.87 36.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.3 -0.875 . . . . 0.0 110.435 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.4 ttpt -107.94 100.93 10.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.344 -0.847 . . . . 0.0 110.157 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 121.4 -135.91 10.85 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -120.39 67.28 0.84 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.194 -1.18 . . . . 0.0 110.193 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.508 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 32.4 m -135.41 155.66 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.246 -0.909 . . . . 0.0 110.199 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.407 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 92.8 mt-10 -118.78 179.07 4.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.23 -0.919 . . . . 0.0 110.234 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.935 ' CD1' HD21 ' A' ' 95' ' ' LEU . 16.5 mm -80.18 172.69 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.276 -0.89 . . . . 0.0 110.227 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.588 ' N ' HG22 ' A' ' 128' ' ' ILE . 61.9 mttt -96.13 130.61 43.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 109.908 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.469 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 94.7 mt-10 -45.41 -35.17 3.5 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.232 -0.918 . . . . 0.0 110.207 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 1.001 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 59.2 tt0 -68.25 -21.9 64.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.203 -0.935 . . . . 0.0 110.005 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.458 ' N ' ' O ' ' A' ' 129' ' ' LYS . 13.4 t-160 -87.86 -49.41 7.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.247 -0.908 . . . . 0.0 110.176 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.592 HG23 ' CD1' ' A' ' 5' ' ' TYR . 2.6 p -69.47 -28.75 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.454 -0.779 . . . . 0.0 110.132 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -104.95 -69.74 0.8 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.181 -0.949 . . . . 0.0 110.089 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 1.001 ' HB3' ' O ' ' A' ' 131' ' ' GLU . . . -56.56 -19.63 16.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.193 -0.942 . . . . 0.0 109.811 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 132' ' ' HIS . . . -76.21 -30.23 57.36 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.465 ' CE ' ' O ' ' A' ' 133' ' ' VAL . 25.0 mttt -66.68 -30.91 71.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -1.159 . . . . 0.0 110.025 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -81.46 -29.58 33.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.259 -0.9 . . . . 0.0 110.008 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 18.7 mtpp -70.38 -45.99 64.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.9 . . . . 0.0 110.005 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -71.75 -33.28 68.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.318 -0.864 . . . . 0.0 110.067 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.9 t -58.84 -46.27 88.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.354 -0.842 . . . . 0.0 110.001 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -53.02 -43.38 66.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.242 -0.911 . . . . 0.0 109.985 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.622 ' HA ' HD12 ' A' ' 146' ' ' LEU . 14.1 tp -57.3 -50.13 73.9 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.348 -0.845 . . . . 0.0 109.911 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -54.02 -40.1 66.74 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.357 -0.839 . . . . 0.0 109.685 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -73.12 -15.12 61.49 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.295 -0.878 . . . . 0.0 110.089 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.622 HD12 ' HA ' ' A' ' 143' ' ' LEU . 29.9 mt -82.03 -35.4 28.84 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.152 -0.967 . . . . 0.0 108.86 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 1.039 HG21 HD23 ' A' ' 18' ' ' LEU . 23.5 mt -67.96 -47.49 78.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.759 ' HB3' HD13 ' A' ' 13' ' ' ILE . 77.6 mt-10 -47.85 -45.14 29.83 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.334 -0.854 . . . . 0.0 108.822 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.541 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 94.3 m -62.04 -39.58 92.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.269 -0.894 . . . . 0.0 109.313 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.695 ' CE2' HD21 ' A' ' 29' ' ' LEU . 57.5 t80 -47.08 -51.34 17.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.498 -0.751 . . . . 0.0 109.837 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.989 HD21 ' CE1' ' A' ' 158' ' ' TYR . 68.6 mt -80.11 -34.77 37.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.434 -0.792 . . . . 0.0 110.418 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.873 ' HB2' HD11 ' A' ' 13' ' ' ILE . 37.2 tttm -60.72 -14.81 23.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 109.18 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.494 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -120.12 -27.3 2.07 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.429 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 6.1 m80 -106.12 92.58 6.78 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.134 -1.215 . . . . 0.0 110.279 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.498 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 48.3 Cg_endo -73.86 2.23 6.2 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.035 1.545 . . . . 0.0 110.7 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -113.95 -5.14 13.18 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.064 -1.022 . . . . 0.0 110.019 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.61 ' HB3' ' NH2' ' A' ' 17' ' ' ARG . . . -57.78 108.32 0.56 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 109.957 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 1.005 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 0.3 OUTLIER 35.31 31.45 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.702 -0.624 . . . . 0.0 110.689 -179.748 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.539 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.901 -1.047 . . . . 0.0 109.78 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 60.3 t -114.2 126.69 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.232 -1.158 . . . . 0.0 110.274 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.574 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 41.8 m-85 -81.36 158.51 24.66 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.208 -0.932 . . . . 0.0 110.428 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.705 HG23 ' CE1' ' A' ' 119' ' ' HIS . 91.8 m -141.97 94.2 2.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.318 -0.864 . . . . 0.0 109.928 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.628 ' CE1' ' CG2' ' A' ' 133' ' ' VAL . 75.9 m-85 -116.04 138.04 51.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.193 -0.942 . . . . 0.0 110.069 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 116' ' ' SER . 12.5 pt-20 -140.05 154.29 47.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.239 -0.913 . . . . 0.0 110.41 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.7 m -135.64 135.94 40.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.311 -0.868 . . . . 0.0 109.805 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.49 ' HG3' ' HG3' ' A' ' 115' ' ' LYS . 5.5 tt0 -114.42 140.6 48.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.133 -0.979 . . . . 0.0 110.766 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.588 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 4.1 p90 -157.4 -172.73 4.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.541 -0.724 . . . . 0.0 109.581 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.825 HG22 ' HA ' ' A' ' 113' ' ' ILE . 8.8 p -140.0 173.13 11.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.091 -1.006 . . . . 0.0 110.6 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.439 ' HB2' ' CD ' ' A' ' 148' ' ' GLU . 86.0 p -156.04 134.68 11.74 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.44 -0.787 . . . . 0.0 110.094 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -59.73 -39.22 83.96 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.156 -0.965 . . . . 0.0 110.189 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.914 HD11 ' HB2' ' A' ' 152' ' ' LYS . 2.5 mp -59.94 150.62 68.47 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.432 -0.793 . . . . 0.0 109.892 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.811 ' HD2' HG23 ' A' ' 13' ' ' ILE . 41.5 Cg_endo -67.53 142.04 57.71 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.041 1.548 . . . . 0.0 110.559 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.658 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.0 Cg_endo -72.15 -31.08 12.5 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.982 1.517 . . . . 0.0 112.667 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.658 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.4 Cg_endo -70.33 -21.49 30.75 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 N-CA-C 110.086 -0.774 . . . . 0.0 110.086 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.675 ' NH2' ' HB3' ' A' ' 157' ' ' ALA . 36.3 mtp180 -82.94 -46.08 13.37 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.751 HD23 ' C ' ' A' ' 18' ' ' LEU . 0.8 OUTLIER -71.02 -32.53 69.33 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.941 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.595 ' N ' HD23 ' A' ' 18' ' ' LEU . 86.5 t80 -62.84 -59.3 5.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.555 -0.715 . . . . 0.0 109.512 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.521 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 29.5 mttt -50.99 -39.02 54.6 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.629 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.041 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -72.27 -42.53 65.46 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.451 -0.781 . . . . 0.0 110.838 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 1.05 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -72.72 -40.17 66.33 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.317 -0.865 . . . . 0.0 111.17 -178.9 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.807 HG13 ' CE1' ' A' ' 81' ' ' TYR . 4.2 t -103.52 -55.8 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.026 -1.046 . . . . 0.0 111.588 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.729 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.3 mp -79.94 -1.12 38.0 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.06 -1.025 . . . . 0.0 111.889 -178.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.567 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.9 OUTLIER -153.36 30.62 0.48 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.658 -1.276 . . . . 0.0 110.726 -179.9 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 1.05 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -74.5 -23.39 58.84 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.224 -0.922 . . . . 0.0 110.39 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.4 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 94.7 m-20 -67.58 -17.33 64.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -0.936 . . . . 0.0 110.022 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.555 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 8.6 p-10 -128.31 10.5 6.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.306 -0.871 . . . . 0.0 109.977 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.637 ' HG ' ' HB1' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -93.54 -49.8 5.72 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.336 -0.852 . . . . 0.0 110.283 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.837 HG22 ' HD3' ' A' ' 31' ' ' PRO . 2.2 m -74.96 -28.86 0.83 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.373 -0.829 . . . . 0.0 112.171 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.837 ' HD3' HG22 ' A' ' 30' ' ' VAL . 51.7 Cg_endo -78.65 5.6 5.47 Favored 'Trans proline' 0 C--N 1.319 -1.026 0 O-C-N 122.67 0.826 . . . . 0.0 110.5 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -126.91 -34.25 2.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 109.431 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.532 HD11 ' CD1' ' A' ' 29' ' ' LEU . 24.1 mt -80.01 -24.89 11.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 121.653 0.74 . . . . 0.0 109.219 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.419 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . . . -170.89 97.4 0.43 Allowed Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.637 -0.665 . . . . 0.0 109.725 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 34' ' ' ALA . 44.1 Cg_endo -69.89 -3.29 11.79 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.987 1.519 . . . . 0.0 110.664 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -90.52 4.85 49.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 0.0 110.007 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.985 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -109.41 -45.39 3.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.321 -0.862 . . . . 0.0 110.033 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.985 HD12 ' C ' ' A' ' 37' ' ' ALA . 1.9 mp -131.47 126.6 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.371 -0.831 . . . . 0.0 110.049 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.44 ' N ' ' O ' ' A' ' 57' ' ' THR . 18.2 ttpt -78.05 -36.59 48.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.202 -0.936 . . . . 0.0 110.316 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.464 ' O ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -170.97 136.73 1.13 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.278 -0.889 . . . . 0.0 110.027 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.6 m -111.86 124.83 53.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.331 -0.856 . . . . 0.0 110.149 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -133.41 109.32 9.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.213 -0.929 . . . . 0.0 110.32 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 43' ' ' ILE . 19.6 mt -56.29 133.68 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.236 -0.915 . . . . 0.0 110.019 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.453 HD22 ' HD2' ' A' ' 55' ' ' LYS . 14.4 tp -104.69 -27.52 11.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.284 -0.885 . . . . 0.0 110.547 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.592 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.9 m95 -127.6 160.56 31.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 0.0 110.775 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.459 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 42.18 -133.94 4.06 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -156.35 19.7 0.35 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.323 -1.104 . . . . 0.0 110.108 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.91 -17.04 6.81 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.468 ' O ' ' HB ' ' A' ' 71' ' ' ILE . . . -72.27 -172.77 19.65 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.422 ' HA ' HG22 ' A' ' 71' ' ' ILE . 44.9 Cg_endo -73.53 129.1 13.33 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.008 1.53 . . . . 0.0 110.567 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.18 -12.86 55.49 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -70.65 164.57 24.7 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.537 -0.978 . . . . 0.0 109.82 179.705 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.592 HD12 ' CG ' ' A' ' 45' ' ' TRP . 52.7 mt -134.21 121.19 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.388 -0.82 . . . . 0.0 109.79 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.603 ' HE2' HD11 ' A' ' 71' ' ' ILE . 4.9 mtmp? -106.07 138.52 42.11 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.118 -0.989 . . . . 0.0 110.281 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.458 ' HG2' ' HG2' ' A' ' 68' ' ' LYS . 2.1 mtpt -109.98 89.25 2.96 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.321 -0.862 . . . . 0.0 110.15 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.553 ' CG2' HG13 ' A' ' 38' ' ' ILE . 88.9 mt -79.95 141.82 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 110.011 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.529 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 3.5 p -115.06 159.6 20.64 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.268 -0.895 . . . . 0.0 110.517 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.525 ' N ' ' O ' ' A' ' 65' ' ' GLY . 16.4 m-85 -120.29 145.65 46.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.36 -0.838 . . . . 0.0 110.154 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.925 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.207 0.527 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -134.33 87.29 0.26 Allowed Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.532 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 12.5 p90 -133.15 164.08 27.84 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.169 -1.195 . . . . 0.0 110.167 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.911 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.0 m -133.17 175.31 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.358 -0.839 . . . . 0.0 110.583 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.497 ' HB2' HG12 ' A' ' 86' ' ' ILE . 85.2 mttt -129.21 127.21 40.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.523 -0.736 . . . . 0.0 109.5 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.672 ' CE1' HD13 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -115.94 120.01 37.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.138 -0.976 . . . . 0.0 111.079 -179.351 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 52' ' ' THR . 19.9 tttt -96.41 115.81 28.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 0.0 109.459 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.603 HD11 ' HE2' ' A' ' 54' ' ' LYS . 24.6 mm -61.08 129.69 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.206 -0.934 . . . . 0.0 110.491 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 82' ' ' SER . 93.8 m-20 -105.39 -42.95 5.1 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.368 -0.833 . . . . 0.0 110.204 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 35.3 m -166.9 158.65 12.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.367 -0.833 . . . . 0.0 109.946 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.518 HG12 HG11 ' A' ' 23' ' ' VAL . 1.7 mt -144.24 156.74 15.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.225 -0.922 . . . . 0.0 110.321 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.541 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 4.4 m-20 -135.13 78.8 1.75 Allowed 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.238 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.554 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 88.5 mttt -62.23 -12.98 23.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.131 -0.981 . . . . 0.0 110.062 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -95.14 -31.58 13.47 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.268 -0.895 . . . . 0.0 109.585 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.4 m120 -107.4 -4.27 18.71 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.528 -0.732 . . . . 0.0 109.725 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.679 ' O ' HD12 ' A' ' 104' ' ' LEU . 6.7 m-85 64.97 50.63 1.87 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.484 -0.76 . . . . 0.0 110.277 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.541 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -120.75 149.94 41.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.285 -0.885 . . . . 0.0 109.315 179.497 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.807 ' CE1' HG13 ' A' ' 23' ' ' VAL . 30.7 t80 -139.34 133.39 31.07 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.156 -0.965 . . . . 0.0 110.364 -179.077 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 19.2 m -137.06 124.92 22.59 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.29 -0.881 . . . . 0.0 110.486 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.681 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 20.5 p90 -143.24 170.76 15.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.251 -0.905 . . . . 0.0 110.396 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 98' ' ' ILE . 21.4 m -121.34 133.55 55.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.436 -0.79 . . . . 0.0 109.9 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.672 HD13 ' CE1' ' A' ' 69' ' ' HIS . 4.5 tp -100.31 126.62 46.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.826 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.497 HG12 ' HB2' ' A' ' 68' ' ' LYS . 10.6 pt -111.46 -11.95 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.201 -0.937 . . . . 0.0 110.331 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.533 ' O ' HD11 ' A' ' 85' ' ' LEU . 37.4 tp10 -128.67 167.3 17.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.183 -0.948 . . . . 0.0 110.426 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.911 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 140.99 112.84 0.98 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -48.13 -26.22 1.79 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.234 -1.157 . . . . 0.0 110.451 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.42 -19.68 65.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.197 -0.939 . . . . 0.0 110.315 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.462 ' O ' ' O ' ' A' ' 92' ' ' GLY . 64.2 mt -69.77 -31.42 69.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.143 -0.973 . . . . 0.0 110.253 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 48.65 -177.11 0.02 OUTLIER Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -79.16 3.4 17.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.19 -1.182 . . . . 0.0 110.125 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.499 HG22 ' HG ' ' A' ' 95' ' ' LEU . 1.8 m -88.46 -37.13 16.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.265 -0.897 . . . . 0.0 109.812 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.948 HD21 ' CD1' ' A' ' 128' ' ' ILE . 44.7 mt -109.72 167.19 10.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.285 -0.885 . . . . 0.0 109.936 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -147.03 -79.94 0.15 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.131 -0.981 . . . . 0.0 110.026 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.509 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 15.3 mttp -80.26 126.84 31.64 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.567 -0.708 . . . . 0.0 110.441 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.731 HG21 ' CE2' ' A' ' 100' ' ' TYR . 6.5 mm -115.37 141.65 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.775 -1.203 . . . . 0.0 109.978 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.501 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -119.09 129.7 55.21 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.433 -0.792 . . . . 0.0 108.97 178.811 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.731 ' CE2' HG21 ' A' ' 98' ' ' ILE . 10.0 m-85 -124.96 136.11 53.44 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.435 -0.791 . . . . 0.0 110.587 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -139.26 128.89 24.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.331 -0.856 . . . . 0.0 110.04 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 89.8 m -127.47 141.37 51.68 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.15 -0.969 . . . . 0.0 110.135 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 115' ' ' LYS . 2.5 mttt -136.52 139.65 42.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.932 . . . . 0.0 110.317 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.867 HD23 HG12 ' A' ' 114' ' ' ILE . 5.4 mt -123.27 152.63 41.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.237 -0.914 . . . . 0.0 110.093 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.711 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -149.72 -169.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.252 -0.905 . . . . 0.0 110.036 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.711 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -124.87 163.14 22.86 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.348 -0.845 . . . . 0.0 110.204 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.458 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 3.0 p -121.73 169.21 9.67 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.0 110.296 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 47.3 Cg_endo -73.03 -8.76 22.68 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.066 1.561 . . . . 0.0 110.606 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 79.8 p -102.77 9.8 38.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.187 -0.946 . . . . 0.0 110.376 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 111' ' ' GLY . . . 94.2 -36.91 3.56 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 110' ' ' GLY . . . -54.45 -174.5 0.09 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.501 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 13.9 p -135.51 136.61 41.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.161 -1.199 . . . . 0.0 110.372 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.825 ' HA ' HG22 ' A' ' 10' ' ' THR . 21.1 mt -90.38 147.08 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.324 -0.86 . . . . 0.0 110.151 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.867 HG12 HD23 ' A' ' 104' ' ' LEU . 19.3 mt -131.46 127.28 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.208 -0.933 . . . . 0.0 110.443 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.49 ' HG3' ' HG3' ' A' ' 8' ' ' GLU . 44.4 tttp -116.23 120.15 38.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.274 -0.891 . . . . 0.0 109.902 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 2.3 t -114.28 158.7 21.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.144 -0.972 . . . . 0.0 110.56 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.625 HG22 ' NE2' ' A' ' 119' ' ' HIS . 96.6 m -158.77 122.2 3.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.433 -0.792 . . . . 0.0 109.919 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.6 m -122.43 153.16 39.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 0.0 110.266 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.705 ' CE1' HG23 ' A' ' 4' ' ' THR . 28.7 m-70 -133.01 162.72 30.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.267 -0.896 . . . . 0.0 110.265 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.565 ' HD1' HD12 ' A' ' 98' ' ' ILE . 30.3 m-85 -131.68 137.98 48.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.273 -0.892 . . . . 0.0 110.466 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.509 ' HB2' ' HB2' ' A' ' 97' ' ' LYS . 75.2 m80 -117.08 93.07 4.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.231 -0.918 . . . . 0.0 109.342 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.907 ' CG2' HD23 ' A' ' 95' ' ' LEU . 1.4 p -76.96 160.42 29.18 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.375 -0.828 . . . . 0.0 110.85 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 34.2 tttp -137.12 105.76 5.84 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.577 -0.702 . . . . 0.0 109.938 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.455 ' O ' ' CB ' ' A' ' 125' ' ' ASN . . . 126.35 20.62 1.95 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 2.7 t30 67.39 60.42 0.48 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.046 -1.267 . . . . 0.0 110.651 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.54 HG23 ' CG2' ' A' ' 122' ' ' THR . 20.5 m -138.62 145.54 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.176 -0.953 . . . . 0.0 109.739 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.439 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 92.4 mt-10 -104.37 -176.18 3.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.132 -0.98 . . . . 0.0 110.787 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.948 ' CD1' HD21 ' A' ' 95' ' ' LEU . 20.8 mm -86.17 173.39 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.375 -0.828 . . . . 0.0 110.229 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.59 ' N ' HG22 ' A' ' 128' ' ' ILE . 37.9 mttt -97.24 131.27 44.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.282 -0.886 . . . . 0.0 110.027 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.482 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 69.9 mm-40 -45.86 -41.51 11.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.093 -1.004 . . . . 0.0 110.189 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 1.009 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 39.7 tt0 -64.05 -18.01 63.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 109.975 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -93.0 -51.75 4.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 0.0 110.326 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.628 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 2.7 p -67.01 -26.43 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.893 . . . . 0.0 110.19 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -107.72 -70.05 0.82 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -0.918 . . . . 0.0 110.153 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 1.009 ' HB3' ' O ' ' A' ' 131' ' ' GLU . . . -55.55 -19.78 11.11 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.199 -0.938 . . . . 0.0 109.798 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -75.09 -28.88 61.46 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.441 ' HE2' ' O ' ' A' ' 133' ' ' VAL . 29.7 mttm -65.71 -31.66 72.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.285 -1.127 . . . . 0.0 109.951 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -79.86 -28.87 39.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.948 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -69.31 -35.38 75.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 0.0 109.939 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.03 -40.28 39.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.194 -0.941 . . . . 0.0 109.984 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.8 t -58.21 -47.49 83.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.381 -0.825 . . . . 0.0 109.937 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -54.82 -40.54 69.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.917 . . . . 0.0 109.985 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.574 ' HA ' HD12 ' A' ' 146' ' ' LEU . 21.7 mt -65.33 -39.29 92.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.89 . . . . 0.0 109.885 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.692 ' HA ' HD12 ' A' ' 147' ' ' ILE . 26.6 m-85 -62.6 -35.3 79.1 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.343 -0.848 . . . . 0.0 109.801 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 145' ' ' LYS . 21.9 tttm -71.72 -12.63 61.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.356 -0.84 . . . . 0.0 110.039 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.574 HD12 ' HA ' ' A' ' 143' ' ' LEU . 19.2 mt -83.22 -37.35 23.7 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.179 -0.951 . . . . 0.0 108.875 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.792 HD11 ' CE1' ' A' ' 22' ' ' PHE . 15.6 mt -67.57 -46.61 82.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.784 ' HB3' HD13 ' A' ' 13' ' ' ILE . 68.5 mt-10 -56.84 -45.59 82.26 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.459 -0.776 . . . . 0.0 109.516 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 23.3 m -62.84 -36.65 83.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 109.6 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.533 ' CD2' ' OH ' ' A' ' 158' ' ' TYR . 87.7 t80 -54.19 -46.43 72.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.414 -0.804 . . . . 0.0 109.894 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.991 HD21 ' CE1' ' A' ' 158' ' ' TYR . 65.6 mt -79.99 -33.65 39.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.387 -0.821 . . . . 0.0 110.339 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.914 ' HB2' HD11 ' A' ' 13' ' ' ILE . 34.4 tttm -62.68 -16.86 59.16 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.229 -0.919 . . . . 0.0 109.562 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.478 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -115.3 -31.16 2.08 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.417 ' ND1' ' N ' ' A' ' 154' ' ' HIS . 2.1 m80 -105.95 94.2 8.78 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.36 -1.083 . . . . 0.0 110.19 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.511 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.8 Cg_endo -73.68 6.25 2.91 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.099 1.578 . . . . 0.0 111.049 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -115.42 -8.19 12.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.034 -1.041 . . . . 0.0 109.788 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.675 ' HB3' ' NH2' ' A' ' 17' ' ' ARG . . . -53.34 106.55 0.18 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.439 -0.788 . . . . 0.0 110.035 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 1.041 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 36.23 30.27 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.687 -0.633 . . . . 0.0 110.466 -179.617 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.537 ' CB ' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 118.07 -0.967 . . . . 0.0 109.661 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 92.3 t -114.04 135.1 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.288 -1.125 . . . . 0.0 110.179 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.746 ' CE1' HD12 ' A' ' 128' ' ' ILE . 13.2 m-85 -91.76 156.58 17.45 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.278 -0.889 . . . . 0.0 109.972 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.645 HG23 ' CE1' ' A' ' 119' ' ' HIS . 25.3 m -135.81 113.36 10.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.098 -1.001 . . . . 0.0 110.412 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.936 ' CE2' HG21 ' A' ' 133' ' ' VAL . 71.1 m-85 -128.46 145.22 51.17 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.372 -0.83 . . . . 0.0 109.945 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 22.1 pt-20 -140.13 152.62 46.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.139 -0.976 . . . . 0.0 110.676 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.2 p -143.06 136.37 28.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.484 -0.76 . . . . 0.0 109.624 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.415 ' HG3' ' HG3' ' A' ' 115' ' ' LYS . 4.8 tt0 -123.28 141.81 51.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.02 -1.05 . . . . 0.0 110.912 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.595 ' CE2' ' HB ' ' A' ' 114' ' ' ILE . 3.2 p90 -157.8 -178.08 7.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.517 -0.739 . . . . 0.0 109.592 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.948 HG22 ' HA ' ' A' ' 113' ' ' ILE . 11.5 p -141.53 175.42 9.7 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.057 -1.027 . . . . 0.0 110.707 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.424 ' OG ' ' CD ' ' A' ' 148' ' ' GLU . 3.5 t -159.05 161.78 36.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.502 -0.749 . . . . 0.0 110.22 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -81.34 -36.51 29.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.272 -0.893 . . . . 0.0 110.207 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.792 HG23 ' HD2' ' A' ' 14' ' ' PRO . 3.1 mp -60.68 150.4 75.74 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.347 -0.845 . . . . 0.0 109.869 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.792 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.1 Cg_endo -65.1 142.31 73.62 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.878 1.462 . . . . 0.0 110.59 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.627 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.0 Cg_endo -73.01 -30.82 10.46 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 124.042 1.549 . . . . 0.0 113.049 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 45.0 Cg_endo -73.12 -20.27 21.82 Favored 'Trans proline' 0 C--N 1.317 -1.114 0 N-CA-C 110.125 -0.76 . . . . 0.0 110.125 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.72 ' HG2' HD13 ' A' ' 151' ' ' LEU . 39.7 ttm180 -83.53 -50.52 8.18 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.772 HD23 ' C ' ' A' ' 18' ' ' LEU . 1.1 tt -62.14 -25.98 68.05 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.486 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 52.5 t80 -68.76 -55.38 11.47 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.537 0.684 . . . . 0.0 109.449 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.552 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 15.8 mttt -49.55 -33.69 15.52 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.173 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.881 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -78.98 -50.52 10.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.346 -0.846 . . . . 0.0 110.725 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 1.042 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -62.74 -37.41 86.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.496 -0.752 . . . . 0.0 111.47 -178.809 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.728 HG13 ' CE1' ' A' ' 81' ' ' TYR . 3.3 t -109.4 -55.62 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 120.973 -1.079 . . . . 0.0 111.731 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.733 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.3 mp -76.43 0.1 20.92 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.998 -1.064 . . . . 0.0 111.278 -178.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.685 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -152.19 16.52 0.64 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.876 -1.14 . . . . 0.0 110.452 179.729 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 1.042 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -55.66 -41.62 73.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.164 -0.96 . . . . 0.0 109.891 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.451 ' HA ' ' CB ' ' A' ' 41' ' ' SER . 76.5 m-20 -57.26 -24.26 53.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.288 -0.883 . . . . 0.0 110.075 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.496 ' HB3' ' HE3' ' A' ' 32' ' ' LYS . 77.6 m-20 -120.45 13.9 11.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.383 -0.823 . . . . 0.0 110.056 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.736 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -100.78 -46.24 5.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.885 . . . . 0.0 110.094 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 1.016 HG11 HD13 ' A' ' 38' ' ' ILE . 2.8 t -70.22 -42.41 16.28 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.362 -0.836 . . . . 0.0 110.781 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 30' ' ' VAL . 46.9 Cg_endo -76.4 4.54 5.37 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.482 1.254 . . . . 0.0 110.671 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.496 ' HE3' ' HB3' ' A' ' 28' ' ' ASN . 21.1 mttm -120.02 -32.22 4.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.935 . . . . 0.0 109.077 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.607 HG12 ' CD1' ' A' ' 150' ' ' TYR . 6.8 mt -80.05 -35.27 15.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.444 0.64 . . . . 0.0 109.588 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -160.44 98.17 1.42 Allowed Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.442 -0.786 . . . . 0.0 110.17 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.22 0.1 8.4 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.989 1.521 . . . . 0.0 110.678 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -90.57 -19.37 23.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.141 -0.974 . . . . 0.0 110.36 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.92 -42.65 11.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.184 -0.948 . . . . 0.0 110.369 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 1.016 HD13 HG11 ' A' ' 30' ' ' VAL . 1.1 mp -128.81 144.13 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.415 -0.803 . . . . 0.0 110.328 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.467 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 37.9 ttmt -78.97 -41.76 28.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.325 -0.86 . . . . 0.0 109.854 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -178.42 161.57 1.39 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.327 -0.858 . . . . 0.0 110.166 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.451 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 15.5 m -123.3 122.39 38.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.138 -0.976 . . . . 0.0 110.037 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -127.9 111.91 14.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.183 -0.948 . . . . 0.0 110.558 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.447 HG13 ' OD2' ' A' ' 27' ' ' ASP . 24.9 mt -60.05 143.73 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.304 -0.873 . . . . 0.0 109.948 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.539 HD12 ' HB2' ' A' ' 55' ' ' LYS . 1.5 mt -119.26 -26.28 5.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 110.487 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.881 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.6 m95 -123.09 162.03 23.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.162 -0.961 . . . . 0.0 110.496 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.451 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 42.08 -141.95 1.45 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -149.08 24.6 0.92 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -1.13 . . . . 0.0 110.335 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 120.59 -15.59 9.78 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.441 ' O ' ' HB ' ' A' ' 71' ' ' ILE . . . -77.82 -172.87 39.69 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.501 ' HA ' HG22 ' A' ' 71' ' ' ILE . 43.5 Cg_endo -72.04 129.43 15.21 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 O-C-N 123.987 1.519 . . . . 0.0 110.59 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.43 -14.09 47.2 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.564 -1.814 . . . . 0.0 108.564 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -70.63 164.43 24.98 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.51 -0.994 . . . . 0.0 109.581 179.67 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.881 HD12 ' CG ' ' A' ' 45' ' ' TRP . 51.7 mt -135.28 121.23 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 109.997 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 96.2 mttt -107.77 140.72 40.42 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.187 -0.946 . . . . 0.0 110.401 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.539 ' HB2' HD12 ' A' ' 44' ' ' LEU . 25.9 tttt -109.2 90.6 3.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.243 -0.911 . . . . 0.0 110.144 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.562 ' CG2' HG12 ' A' ' 38' ' ' ILE . 82.1 mt -80.04 140.51 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.233 -0.917 . . . . 0.0 110.289 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.516 ' O ' HG23 ' A' ' 38' ' ' ILE . 3.0 p -111.11 158.66 18.62 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.311 -0.868 . . . . 0.0 110.83 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.725 ' HE2' HG13 ' A' ' 67' ' ' VAL . 29.8 m-85 -116.33 133.82 55.58 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.175 -0.953 . . . . 0.0 110.105 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.342 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.876 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.144 0.497 . . . . 0.0 110.24 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -129.61 90.44 0.31 Allowed Glycine 0 N--CA 1.487 2.04 0 N-CA-C 108.29 -1.924 . . . . 0.0 108.29 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.532 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 16.9 p90 -140.36 165.45 27.38 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.055 -1.262 . . . . 0.0 110.304 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.893 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.1 m -131.54 173.48 14.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.459 -0.776 . . . . 0.0 110.321 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.518 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 22.9 mttt -125.49 124.5 41.51 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.62 -0.675 . . . . 0.0 109.656 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.708 ' CE1' HD13 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -112.29 122.01 46.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.191 -0.943 . . . . 0.0 110.777 -179.423 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 52' ' ' THR . 86.6 tttt -98.62 111.23 23.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.184 -0.948 . . . . 0.0 109.516 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.518 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 24.1 mm -52.46 130.19 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.117 -0.989 . . . . 0.0 109.979 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.501 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 11.9 t0 -108.83 -45.86 3.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.354 -0.841 . . . . 0.0 110.377 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.3 m -164.91 157.68 16.4 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.317 -0.865 . . . . 0.0 109.921 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.544 HG12 HG11 ' A' ' 23' ' ' VAL . 1.9 mt -142.96 158.05 17.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.249 -0.907 . . . . 0.0 110.496 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.565 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 3.1 m-20 -132.79 77.81 1.76 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 120.078 -0.649 . . . . 0.0 109.973 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.486 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 84.4 mttt -61.26 -15.65 37.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.133 -0.979 . . . . 0.0 110.413 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -93.33 -31.06 14.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.191 -0.943 . . . . 0.0 109.645 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.483 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.4 m120 -106.69 -5.41 18.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.574 -0.704 . . . . 0.0 109.796 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.562 ' O ' HD12 ' A' ' 104' ' ' LEU . 5.3 m-85 66.02 50.46 1.45 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.504 -0.747 . . . . 0.0 110.292 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.565 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -120.12 154.67 34.39 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 0.0 109.447 179.51 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.728 ' CE1' HG13 ' A' ' 23' ' ' VAL . 24.5 t80 -142.94 129.74 20.45 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.117 -0.99 . . . . 0.0 110.439 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.48 ' OG ' ' HG3' ' A' ' 101' ' ' GLU . 73.8 m -136.41 120.33 17.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.397 -0.814 . . . . 0.0 110.332 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.642 ' CE2' ' CB ' ' A' ' 100' ' ' TYR . 11.8 p90 -135.06 174.92 10.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.272 -0.893 . . . . 0.0 110.207 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 98' ' ' ILE . 29.3 m -123.73 127.35 48.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.371 -0.831 . . . . 0.0 110.104 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.708 HD13 ' CE1' ' A' ' 69' ' ' HIS . 5.1 tp -95.37 136.62 35.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.302 -0.874 . . . . 0.0 109.669 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.4 pt -123.59 -14.61 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.233 -0.917 . . . . 0.0 110.48 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.518 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 20.2 tt0 -129.93 129.25 43.6 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.054 -1.029 . . . . 0.0 110.675 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.893 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 177.68 128.54 1.17 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -59.52 -13.66 9.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -1.134 . . . . 0.0 110.415 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.696 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -83.52 -32.01 26.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 110.299 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.599 HD13 ' O ' ' A' ' 96' ' ' GLU . 1.8 pp -90.99 -27.42 18.68 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.28 -0.888 . . . . 0.0 110.569 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.505 ' N ' ' HG ' ' A' ' 91' ' ' LEU . . . -59.69 -31.89 72.52 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.733 ' O ' HG23 ' A' ' 94' ' ' THR . 87.2 m-20 -45.5 -40.02 7.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -1.168 . . . . 0.0 110.414 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.733 HG23 ' O ' ' A' ' 93' ' ' ASP . 1.3 p -160.03 -33.73 0.06 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.274 -0.891 . . . . 0.0 110.682 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.777 HD21 HG13 ' A' ' 128' ' ' ILE . 1.6 mm? -79.99 167.47 20.42 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.14 -0.975 . . . . 0.0 110.656 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.599 ' O ' HD13 ' A' ' 91' ' ' LEU . 43.6 tt0 -128.36 -77.72 0.56 Allowed 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.489 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 89.4 mttt -80.19 145.13 32.43 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.621 -0.675 . . . . 0.0 109.565 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.732 HG21 ' CE2' ' A' ' 100' ' ' TYR . 8.0 mm -128.45 143.31 41.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 120.733 -1.229 . . . . 0.0 110.11 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.484 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -117.04 128.26 54.98 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.404 -0.81 . . . . 0.0 109.362 179.076 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.732 ' CE2' HG21 ' A' ' 98' ' ' ILE . 8.7 m-85 -124.38 134.05 53.24 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.216 -0.928 . . . . 0.0 110.256 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.48 ' HG3' ' OG ' ' A' ' 82' ' ' SER . 81.6 tt0 -138.58 133.74 32.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.254 -0.904 . . . . 0.0 110.333 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.471 ' N ' ' O ' ' A' ' 81' ' ' TYR . 41.2 m -131.75 152.62 50.8 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.225 -0.922 . . . . 0.0 110.091 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 115' ' ' LYS . 6.8 mttm -146.73 138.14 24.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.2 -0.938 . . . . 0.0 110.507 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.868 HD23 HG12 ' A' ' 114' ' ' ILE . 5.7 mt -120.0 152.09 38.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.205 -0.934 . . . . 0.0 109.831 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.707 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -148.65 -169.45 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.046 -1.034 . . . . 0.0 110.129 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.707 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -123.94 163.52 21.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.332 -0.855 . . . . 0.0 110.195 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.467 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 3.0 p -122.48 169.62 9.36 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.246 -0.909 . . . . 0.0 110.201 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.8 Cg_endo -72.9 -9.01 23.2 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.061 1.559 . . . . 0.0 110.491 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.8 p -103.16 9.6 38.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.24 -0.913 . . . . 0.0 110.274 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 111' ' ' GLY . . . 94.54 -39.43 2.9 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 110' ' ' GLY . . . -51.66 -176.44 0.03 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.507 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.4 p -133.68 135.92 44.4 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -1.163 . . . . 0.0 110.467 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.948 ' HA ' HG22 ' A' ' 10' ' ' THR . 17.2 mt -88.78 148.0 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -0.845 . . . . 0.0 109.716 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.868 HG12 HD23 ' A' ' 104' ' ' LEU . 18.8 mt -131.89 121.87 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.238 -0.914 . . . . 0.0 110.58 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 103' ' ' LYS . 14.4 tttp -109.99 128.63 55.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.0 109.787 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.9 152.41 44.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.094 -1.004 . . . . 0.0 110.444 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.662 HG22 ' NE2' ' A' ' 119' ' ' HIS . 38.6 m -152.56 134.91 15.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 110.094 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.441 ' C ' ' CD2' ' A' ' 119' ' ' HIS . 14.4 m -133.44 156.5 47.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.273 -0.892 . . . . 0.0 110.135 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.662 ' NE2' HG22 ' A' ' 117' ' ' THR . 20.2 m-70 -140.77 170.04 16.51 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.168 -0.957 . . . . 0.0 110.423 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.74 ' CB ' HD11 ' A' ' 128' ' ' ILE . 8.8 m-85 -129.7 156.36 44.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.306 -0.871 . . . . 0.0 110.453 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.489 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 83.6 m-70 -135.13 96.75 3.56 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.211 -0.93 . . . . 0.0 109.545 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.609 HG22 HD13 ' A' ' 95' ' ' LEU . 6.1 p -64.48 160.7 18.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.395 -0.816 . . . . 0.0 110.925 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.411 ' HB2' ' HB2' ' A' ' 96' ' ' GLU . 28.7 tttt -119.57 90.94 3.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.493 -0.754 . . . . 0.0 110.17 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 108.95 -109.22 2.75 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -132.15 79.8 1.88 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.253 -1.145 . . . . 0.0 110.252 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.575 HG23 ' HB ' ' A' ' 122' ' ' THR . 7.9 m -146.63 179.5 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.321 -0.862 . . . . 0.0 110.048 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.508 ' CG ' ' O ' ' A' ' 126' ' ' VAL . 81.7 mt-10 -156.13 167.09 31.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.203 -0.936 . . . . 0.0 110.277 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.777 HG13 HD21 ' A' ' 95' ' ' LEU . 2.8 mp -88.7 172.43 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.231 -0.918 . . . . 0.0 110.16 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.599 ' N ' HG22 ' A' ' 128' ' ' ILE . 8.8 mttm -110.42 127.61 55.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.376 -0.827 . . . . 0.0 109.729 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.487 ' HB3' ' CE ' ' A' ' 134' ' ' LYS . 93.6 mt-10 -44.7 -49.27 10.54 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.112 -0.993 . . . . 0.0 109.904 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.509 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 44.8 tt0 -52.83 -20.6 3.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.646 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.696 ' NE2' ' HB1' ' A' ' 90' ' ' ALA . 12.3 t-160 -87.21 -63.72 1.26 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.456 -0.777 . . . . 0.0 110.031 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.936 HG21 ' CE2' ' A' ' 5' ' ' TYR . 8.3 p -59.86 -38.56 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.339 -0.851 . . . . 0.0 109.834 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.509 ' N ' HG13 ' A' ' 133' ' ' VAL . 55.9 mttm -69.65 -46.51 65.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 0.0 109.743 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.509 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -65.6 -30.79 71.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.295 -0.878 . . . . 0.0 109.801 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.47 -32.79 75.75 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 39.9 mttt -61.87 -33.93 75.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.374 -1.074 . . . . 0.0 109.845 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.504 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 83.0 tt0 -83.89 -33.76 24.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 109.842 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 46.1 mttm -71.06 -34.57 71.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.433 -0.792 . . . . 0.0 109.741 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.98 -40.62 46.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.366 -0.833 . . . . 0.0 109.829 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.0 t -60.92 -39.41 89.27 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.429 -0.795 . . . . 0.0 109.929 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 138' ' ' GLU . 75.9 m-20 -60.46 -45.05 95.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.266 -0.896 . . . . 0.0 109.955 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.437 ' HA ' HD12 ' A' ' 146' ' ' LEU . 46.7 mt -59.68 -40.02 86.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.296 -0.878 . . . . 0.0 110.009 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -61.07 -40.4 93.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.449 -0.782 . . . . 0.0 109.95 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.431 ' HA ' ' OE1' ' A' ' 148' ' ' GLU . 87.6 mttt -70.37 -13.96 62.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.286 -0.884 . . . . 0.0 109.98 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.545 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 35.1 mt -83.84 -36.7 23.27 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.196 -0.94 . . . . 0.0 108.83 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.718 HD11 ' CE1' ' A' ' 22' ' ' PHE . 47.4 mt -68.32 -46.55 80.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.555 ' HB3' HD13 ' A' ' 13' ' ' ILE . 74.1 mt-10 -53.27 -44.57 68.33 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.361 -0.837 . . . . 0.0 109.284 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.428 ' O ' ' C ' ' A' ' 150' ' ' TYR . 42.3 m -70.31 -40.88 73.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.33 -0.856 . . . . 0.0 109.388 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.664 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 86.8 t80 -43.11 -45.32 5.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.444 -0.785 . . . . 0.0 109.73 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.158 HD21 ' CE2' ' A' ' 158' ' ' TYR . 51.3 mt -80.05 -45.62 17.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.37 -0.831 . . . . 0.0 110.459 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.735 ' HB2' HD11 ' A' ' 13' ' ' ILE . 21.7 ttpp -59.72 -15.23 18.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.365 -0.834 . . . . 0.0 109.525 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -112.41 -29.95 3.03 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.464 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 4.5 m80 -114.18 96.01 40.82 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.294 -1.121 . . . . 0.0 110.012 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.423 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.1 Cg_endo -73.52 5.96 3.0 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.161 1.611 . . . . 0.0 111.267 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -108.28 -7.22 15.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.908 -1.12 . . . . 0.0 109.82 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.664 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -75.63 101.72 5.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.435 -0.791 . . . . 0.0 110.147 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 1.158 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.3 OUTLIER 34.71 32.67 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.461 0.648 . . . . 0.0 110.288 -179.417 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.527 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.871 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.657 HG11 ' CE1' ' A' ' 121' ' ' HIS . 22.2 t -124.21 138.24 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -1.139 . . . . 0.0 110.403 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.71 ' CE1' HD12 ' A' ' 128' ' ' ILE . 9.5 m-85 -103.21 156.57 17.62 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.318 -0.864 . . . . 0.0 109.897 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.599 HG23 ' CE1' ' A' ' 119' ' ' HIS . 7.1 m -126.58 112.75 15.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.131 -0.981 . . . . 0.0 110.592 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 1.036 ' CE1' HG11 ' A' ' 133' ' ' VAL . 59.7 m-85 -120.6 143.71 48.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.183 -0.948 . . . . 0.0 110.177 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 21.9 pt-20 -144.7 152.74 40.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.173 -0.954 . . . . 0.0 110.33 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.462 ' O ' ' CG ' ' A' ' 8' ' ' GLU . 2.3 t -128.23 171.1 12.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.334 -0.854 . . . . 0.0 109.989 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.462 ' CG ' ' O ' ' A' ' 7' ' ' SER . 78.7 mt-10 -154.18 115.98 4.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.931 . . . . 0.0 110.422 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.3 p90 -147.93 -174.65 4.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.396 -0.815 . . . . 0.0 109.731 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.867 HG22 ' HA ' ' A' ' 113' ' ' ILE . 7.7 p -141.91 175.66 9.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.091 -1.006 . . . . 0.0 110.527 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.469 ' HB2' ' HG2' ' A' ' 148' ' ' GLU . 85.6 p -157.36 126.91 6.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.543 -0.723 . . . . 0.0 110.23 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.45 ' HA ' ' HA2' ' A' ' 111' ' ' GLY . 98.2 mt-10 -53.64 -35.14 60.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.288 -0.882 . . . . 0.0 110.053 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.824 HG23 ' HD2' ' A' ' 14' ' ' PRO . 2.5 mp -65.18 150.78 95.07 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.309 -0.869 . . . . 0.0 109.881 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.824 ' HD2' HG23 ' A' ' 13' ' ' ILE . 41.8 Cg_endo -67.4 142.72 60.83 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.965 1.508 . . . . 0.0 110.619 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.667 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.6 Cg_endo -72.63 -31.04 11.24 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 124.036 1.545 . . . . 0.0 112.811 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.667 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.1 Cg_endo -70.18 -20.65 32.6 Favored 'Trans proline' 0 N--CA 1.485 1.013 0 N-CA-C 110.145 -0.752 . . . . 0.0 110.145 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.604 ' CZ ' HD22 ' A' ' 151' ' ' LEU . 43.4 mtp180 -84.71 -48.98 8.89 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.773 HD23 ' C ' ' A' ' 18' ' ' LEU . 1.3 tt -67.89 -28.36 67.45 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.571 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 83.5 t80 -68.39 -61.41 1.85 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.435 -0.791 . . . . 0.0 109.067 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.521 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 34.2 mttm -46.6 -32.81 3.69 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.751 -0.78 . . . . 0.0 109.114 179.086 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.047 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -79.85 -40.55 28.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.358 -0.839 . . . . 0.0 110.64 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.982 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -70.98 -42.51 69.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.33 -0.856 . . . . 0.0 111.429 -178.822 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.621 HG13 ' CE1' ' A' ' 81' ' ' TYR . 4.3 t -104.18 -51.53 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.064 -1.023 . . . . 0.0 111.47 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.694 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.4 mp -80.05 0.44 31.83 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.183 -0.948 . . . . 0.0 111.37 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.594 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -155.66 30.44 0.37 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.838 -1.164 . . . . 0.0 110.97 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.982 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -70.27 -28.81 65.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.105 -0.997 . . . . 0.0 109.86 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.491 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 60.9 m-20 -68.18 -12.44 60.94 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.297 -0.877 . . . . 0.0 109.848 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.554 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 79.8 m-20 -131.0 8.86 4.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.351 -0.843 . . . . 0.0 109.948 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.697 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -94.4 -49.99 5.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.356 -0.84 . . . . 0.0 110.466 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.958 HG21 HD13 ' A' ' 38' ' ' ILE . 6.6 p -77.87 -26.94 0.54 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.367 -0.833 . . . . 0.0 112.457 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.795 ' HD3' HG12 ' A' ' 30' ' ' VAL . 50.5 Cg_endo -78.25 7.17 4.22 Favored 'Trans proline' 0 C--N 1.319 -0.994 0 O-C-N 122.592 0.785 . . . . 0.0 110.703 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -135.38 -32.9 0.91 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.23 -0.919 . . . . 0.0 110.066 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.546 HG12 ' CD1' ' A' ' 150' ' ' TYR . 9.6 mt -80.0 -40.05 20.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.363 -0.836 . . . . 0.0 109.993 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -158.96 98.61 1.65 Allowed Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.275 -0.89 . . . . 0.0 110.374 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.04 2.31 6.8 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.032 1.543 . . . . 0.0 110.585 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -88.75 -16.17 32.87 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.186 -0.946 . . . . 0.0 110.129 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.645 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -95.92 -32.7 12.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 110.256 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.958 HD13 HG21 ' A' ' 30' ' ' VAL . 1.1 mp -145.81 133.91 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.338 -0.851 . . . . 0.0 109.883 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 57' ' ' THR . 27.7 ttpp -82.63 -25.98 32.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.886 . . . . 0.0 110.44 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.42 ' O ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -175.31 157.84 2.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.194 -0.941 . . . . 0.0 110.261 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.2 m -135.45 121.29 19.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.421 -0.8 . . . . 0.0 109.565 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -138.88 111.81 7.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.006 -1.059 . . . . 0.0 110.689 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.44 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 27.9 mt -50.63 143.24 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.412 -0.805 . . . . 0.0 109.896 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 11.6 tp -116.83 -21.8 8.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.308 -0.87 . . . . 0.0 110.348 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.733 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.7 m95 -131.5 163.29 28.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.237 -0.915 . . . . 0.0 110.615 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.451 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 42.63 -134.25 4.44 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -155.51 19.12 0.4 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -1.108 . . . . 0.0 110.231 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.69 -16.21 7.0 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.494 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -74.81 -173.73 31.94 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.415 ' HA ' HG22 ' A' ' 71' ' ' ILE . 44.6 Cg_endo -72.97 129.53 14.38 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 124.055 1.555 . . . . 0.0 110.466 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.3 -14.96 47.31 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.52 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -69.86 167.38 17.43 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.521 -0.988 . . . . 0.0 109.463 179.536 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.733 HD12 ' CG ' ' A' ' 45' ' ' TRP . 43.3 mt -134.94 120.75 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.202 -0.936 . . . . 0.0 110.18 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.488 ' HD2' HD11 ' A' ' 71' ' ' ILE . 17.7 mtpt -102.91 130.48 49.97 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.193 -0.942 . . . . 0.0 110.111 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -98.42 91.57 5.25 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.184 -0.948 . . . . 0.0 109.906 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.549 ' CG2' HG12 ' A' ' 38' ' ' ILE . 93.4 mt -80.02 138.73 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.371 -0.831 . . . . 0.0 110.046 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 3.1 p -114.93 155.9 26.02 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.232 -0.918 . . . . 0.0 110.476 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.594 ' CZ ' HG22 ' A' ' 67' ' ' VAL . 20.1 m-85 -117.93 142.46 47.32 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.358 -0.839 . . . . 0.0 110.038 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.98 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.259 0.552 . . . . 0.0 110.27 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -140.74 113.38 0.86 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 15.6 p90 -154.65 170.65 21.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.082 -1.246 . . . . 0.0 110.122 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.897 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.0 m -141.28 174.52 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.27 -0.894 . . . . 0.0 110.764 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.507 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 25.1 mttt -126.21 120.7 30.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.547 -0.72 . . . . 0.0 109.489 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.589 ' CE1' HD13 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -108.76 129.13 55.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.223 -0.923 . . . . 0.0 111.037 -179.294 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 52' ' ' THR . 44.3 tttp -100.43 112.95 25.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.225 -0.922 . . . . 0.0 109.474 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.537 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 31.0 mm -52.08 130.77 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.1 -1.0 . . . . 0.0 110.239 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.458 ' OD2' ' OG1' ' A' ' 84' ' ' THR . 58.8 m-20 -106.45 -36.85 6.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 0.0 110.258 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.647 ' C ' HD12 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -178.55 166.24 1.77 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.178 -0.952 . . . . 0.0 109.635 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.647 HD12 ' C ' ' A' ' 73' ' ' SER . 0.9 OUTLIER -151.82 155.9 6.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 119.016 -1.074 . . . . 0.0 111.386 -179.682 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.508 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 2.3 m-20 -132.78 76.12 1.67 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.303 0.573 . . . . 0.0 109.919 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.571 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 45.9 mttt -60.83 -12.51 11.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.226 -0.921 . . . . 0.0 110.406 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -92.82 -31.97 14.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.298 -0.876 . . . . 0.0 109.483 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.48 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.5 m120 -107.43 -6.16 17.25 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.534 -0.729 . . . . 0.0 109.839 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.774 ' O ' HD12 ' A' ' 104' ' ' LEU . 4.0 m-85 69.11 48.83 0.66 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.558 -0.714 . . . . 0.0 110.183 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.508 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.5 OUTLIER -119.58 147.18 44.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.232 -0.917 . . . . 0.0 109.543 179.626 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.68 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 76.1 t80 -140.35 143.28 35.67 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.093 -1.004 . . . . 0.0 110.6 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.447 ' C ' ' HB2' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -148.69 141.26 24.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -0.877 . . . . 0.0 110.098 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.68 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 10.7 p90 -151.52 175.66 12.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.144 -0.973 . . . . 0.0 110.699 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 98' ' ' ILE . 6.5 m -122.58 127.84 49.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.467 -0.771 . . . . 0.0 109.688 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.589 HD13 ' CE1' ' A' ' 69' ' ' HIS . 2.9 tp -94.98 128.25 41.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.166 -0.959 . . . . 0.0 110.314 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 14.3 pt -114.81 0.51 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.33 -0.856 . . . . 0.0 110.392 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.507 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 72.4 tt0 -149.32 154.42 38.96 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.253 -0.904 . . . . 0.0 110.198 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.897 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 150.94 130.55 1.72 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -57.34 -16.04 7.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.329 -1.1 . . . . 0.0 110.2 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.419 ' O ' ' CE1' ' A' ' 132' ' ' HIS . . . -66.44 -30.28 70.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.225 -0.922 . . . . 0.0 110.201 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 21.1 mt -58.06 -15.57 9.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -0.866 . . . . 0.0 110.036 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.765 ' O ' HG23 ' A' ' 94' ' ' THR . . . 48.12 30.73 7.77 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 92' ' ' GLY . 93.1 m-20 56.56 15.36 2.05 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.251 -1.147 . . . . 0.0 110.379 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.765 HG23 ' O ' ' A' ' 92' ' ' GLY . 65.6 p -108.18 -52.78 2.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.931 . . . . 0.0 109.604 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 1.018 HD21 ' CG1' ' A' ' 128' ' ' ILE . 14.9 mt -80.36 164.1 23.38 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.499 -0.751 . . . . 0.0 109.741 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.444 ' OE1' ' HD3' ' A' ' 123' ' ' LYS . 42.3 tt0 -132.19 -78.35 0.5 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 110.326 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.513 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 54.6 mttt -80.2 128.4 33.48 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.49 -0.756 . . . . 0.0 110.638 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.757 HG21 ' CE2' ' A' ' 100' ' ' TYR . 4.7 mm -120.45 141.53 40.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 120.682 -1.261 . . . . 0.0 109.692 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.491 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -122.38 126.59 48.33 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.429 -0.794 . . . . 0.0 108.986 178.79 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.757 ' CE2' HG21 ' A' ' 98' ' ' ILE . 12.7 m-85 -122.59 133.51 54.54 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.294 -0.879 . . . . 0.0 110.491 -179.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.509 ' N ' ' O ' ' A' ' 117' ' ' THR . 49.6 tt0 -136.24 134.38 38.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.36 -0.837 . . . . 0.0 110.259 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 94.0 m -131.67 140.56 49.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.263 -0.898 . . . . 0.0 110.069 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.76 139.34 50.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.307 -0.871 . . . . 0.0 110.229 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.784 HD23 HG12 ' A' ' 114' ' ' ILE . 11.4 mt -115.51 149.74 37.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.345 -0.847 . . . . 0.0 109.991 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.704 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -150.44 -168.43 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.202 -0.936 . . . . 0.0 110.21 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.704 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -121.37 158.47 28.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.285 -0.884 . . . . 0.0 110.115 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.471 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 9.5 p -114.91 167.04 10.44 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.19 -0.944 . . . . 0.0 110.321 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.9 Cg_endo -72.23 -4.23 14.82 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.074 1.565 . . . . 0.0 110.39 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 65.4 m -107.06 0.7 23.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.238 -0.914 . . . . 0.0 110.245 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.63 -41.07 2.26 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 12' ' ' GLU . . . -54.31 -177.61 0.13 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.517 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 6.7 p -124.61 140.29 53.08 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.226 -1.161 . . . . 0.0 110.321 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.867 ' HA ' HG22 ' A' ' 10' ' ' THR . 19.5 mt -92.9 147.55 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.33 -0.857 . . . . 0.0 110.129 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.784 HG12 HD23 ' A' ' 104' ' ' LEU . 8.7 mt -130.96 126.89 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.283 -0.886 . . . . 0.0 110.144 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -119.72 111.15 17.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.154 -0.966 . . . . 0.0 110.144 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 2.4 m -96.64 159.71 14.78 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.229 -0.919 . . . . 0.0 110.552 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 101' ' ' GLU . 25.4 m -160.11 117.98 2.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.516 -0.74 . . . . 0.0 109.959 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 99' ' ' SER . 96.7 p -125.31 161.78 26.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.09 -1.006 . . . . 0.0 110.453 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.599 ' CE1' HG23 ' A' ' 4' ' ' THR . 62.9 m-70 -140.15 131.84 27.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.307 -0.871 . . . . 0.0 110.225 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.72 ' CD2' HD13 ' A' ' 95' ' ' LEU . 3.2 m-85 -98.16 148.15 23.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.393 -0.817 . . . . 0.0 109.672 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.657 ' CE1' HG11 ' A' ' 2' ' ' VAL . 88.6 m-70 -129.13 93.19 3.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.055 -1.028 . . . . 0.0 110.054 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.661 ' CG2' HD23 ' A' ' 95' ' ' LEU . 2.0 p -66.41 156.93 33.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.249 -0.907 . . . . 0.0 110.228 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.444 ' HD3' ' OE1' ' A' ' 96' ' ' GLU . 17.6 tptt -116.54 115.83 26.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.336 -0.852 . . . . 0.0 110.197 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 99.57 -118.28 6.13 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -132.82 73.11 1.51 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.189 -1.183 . . . . 0.0 110.166 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.544 HG23 ' CG2' ' A' ' 122' ' ' THR . 14.1 m -139.69 153.11 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.262 -0.899 . . . . 0.0 110.154 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -126.37 170.04 12.34 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.215 -0.928 . . . . 0.0 110.28 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 1.018 ' CG1' HD21 ' A' ' 95' ' ' LEU . 3.4 mp -100.01 172.77 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.191 -0.943 . . . . 0.0 110.161 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.602 ' N ' HG22 ' A' ' 128' ' ' ILE . 10.5 mttt -116.32 132.18 56.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.896 . . . . 0.0 109.811 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 129' ' ' LYS . 95.0 mt-10 -42.55 -42.96 3.54 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.266 -0.897 . . . . 0.0 110.185 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -52.4 -37.99 57.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.157 -0.964 . . . . 0.0 109.911 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.419 ' CE1' ' O ' ' A' ' 90' ' ' ALA . 13.7 t-160 -74.54 -57.45 3.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.331 -0.856 . . . . 0.0 110.072 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 1.036 HG11 ' CE1' ' A' ' 5' ' ' TYR . 79.4 t -58.97 -36.35 61.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.421 -0.799 . . . . 0.0 109.891 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 31.0 tttt -71.69 -44.07 64.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.3 -0.875 . . . . 0.0 109.945 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.47 -27.55 68.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.998 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -74.15 -28.64 63.85 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -73.41 -34.04 65.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.294 -1.121 . . . . 0.0 110.006 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -82.1 -31.46 30.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 109.967 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.573 ' O ' HD12 ' A' ' 143' ' ' LEU . 43.3 mttm -72.57 -33.95 67.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.889 . . . . 0.0 110.004 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -80.31 -34.4 36.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 110.123 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 71.4 m -63.66 -41.56 98.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.332 -0.855 . . . . 0.0 110.045 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -58.66 -45.16 89.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.273 -0.892 . . . . 0.0 110.105 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.573 HD12 ' O ' ' A' ' 139' ' ' LYS . 2.6 mt -61.03 -40.25 92.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -0.885 . . . . 0.0 110.104 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.408 ' CE1' ' CE2' ' A' ' 22' ' ' PHE . 17.6 m-85 -62.35 -34.06 75.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.377 -0.827 . . . . 0.0 109.961 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 145' ' ' LYS . 30.3 tttm -76.04 -14.18 60.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.338 -0.851 . . . . 0.0 110.24 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 19.6 mt -84.07 -37.13 22.47 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.059 -1.026 . . . . 0.0 109.023 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.791 HD11 ' CE1' ' A' ' 22' ' ' PHE . 24.5 mt -69.14 -43.32 81.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.581 ' HB3' HD13 ' A' ' 13' ' ' ILE . 83.8 mt-10 -53.04 -44.65 67.56 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.392 -0.818 . . . . 0.0 109.347 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 28.5 m -66.69 -33.13 74.97 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 109.762 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.628 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 89.3 t80 -55.02 -49.65 71.0 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.409 -0.807 . . . . 0.0 110.04 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.021 HD21 ' CE1' ' A' ' 158' ' ' TYR . 74.7 mt -76.17 -36.08 58.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -0.872 . . . . 0.0 110.419 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.754 ' HB2' HD11 ' A' ' 13' ' ' ILE . 8.5 tttp -60.19 -15.35 23.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.253 -0.905 . . . . 0.0 109.308 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.492 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -120.05 -24.12 2.82 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.45 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 7.6 m80 -106.1 92.41 6.57 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.296 -1.12 . . . . 0.0 110.162 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.4 Cg_endo -73.2 4.17 4.02 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.025 1.54 . . . . 0.0 110.937 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -120.33 -6.73 9.83 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.994 -1.066 . . . . 0.0 109.919 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.675 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -53.91 106.11 0.17 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.889 . . . . 0.0 109.826 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 1.047 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 36.23 30.38 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.661 -0.649 . . . . 0.0 110.518 -179.466 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.542 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.802 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.984 HG23 ' C ' ' A' ' 120' ' ' TYR . 2.6 p -79.96 149.54 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.357 -1.084 . . . . 0.0 110.712 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.788 ' CE2' HD12 ' A' ' 128' ' ' ILE . 5.1 m-85 -86.74 169.65 12.45 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.664 -0.647 . . . . 0.0 110.145 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.536 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 3.3 m -123.82 129.82 51.63 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.102 -0.999 . . . . 0.0 110.47 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.584 ' CE2' ' HB2' ' A' ' 3' ' ' PHE . 39.1 m-85 -142.68 133.72 25.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.316 -0.865 . . . . 0.0 110.028 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.608 ' CG ' HG23 ' A' ' 117' ' ' THR . 30.9 mt-10 -143.9 145.22 32.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -0.926 . . . . 0.0 110.515 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.479 ' O ' ' HG2' ' A' ' 8' ' ' GLU . 5.6 t -118.5 169.88 9.4 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.395 -0.815 . . . . 0.0 109.85 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 7' ' ' SER . 60.7 mt-10 -152.53 123.07 7.29 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.14 -0.975 . . . . 0.0 110.643 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.637 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 1.9 p90 -148.93 -176.94 5.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.406 -0.809 . . . . 0.0 109.735 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.726 HG22 ' HA ' ' A' ' 113' ' ' ILE . 11.1 p -139.23 -179.91 6.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.132 -0.98 . . . . 0.0 110.696 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.2 t -159.99 168.65 25.16 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.429 -0.794 . . . . 0.0 110.102 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -92.04 -28.78 16.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.162 -0.961 . . . . 0.0 110.164 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.863 HD13 ' HB3' ' A' ' 148' ' ' GLU . 2.6 mp -70.6 151.04 95.51 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.319 -0.863 . . . . 0.0 110.129 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.836 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.3 Cg_endo -65.92 142.74 70.17 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.965 1.508 . . . . 0.0 110.509 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.646 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.7 Cg_endo -73.31 -30.48 10.26 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 O-C-N 123.992 1.522 . . . . 0.0 113.048 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.646 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.7 Cg_endo -71.13 -24.41 23.59 Favored 'Trans proline' 0 C--N 1.317 -1.084 0 N-CA-C 110.184 -0.737 . . . . 0.0 110.184 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.568 ' CZ ' ' HA ' ' A' ' 159' ' ' ASN . 1.5 mtp85 -83.05 -44.95 14.61 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.942 ' O ' HD22 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -65.59 -30.93 71.72 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.727 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.573 ' N ' HD13 ' A' ' 18' ' ' LEU . 44.7 t80 -66.27 -54.94 18.98 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.413 -0.804 . . . . 0.0 109.685 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.642 ' HG2' HD22 ' A' ' 24' ' ' LEU . 20.1 mttt -51.98 -31.72 30.45 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.107 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.085 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -80.04 -46.44 16.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.612 -0.68 . . . . 0.0 110.87 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 1.046 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -66.44 -40.01 89.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.379 -0.826 . . . . 0.0 111.536 -178.618 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.613 HG13 ' CE1' ' A' ' 81' ' ' TYR . 3.4 t -107.6 -62.6 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.797 -1.19 . . . . 0.0 111.472 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.642 HD22 ' HG2' ' A' ' 20' ' ' LYS . 7.4 mp -62.78 -11.48 18.01 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.143 -0.973 . . . . 0.0 111.324 -178.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.566 ' HB3' HD23 ' A' ' 29' ' ' LEU . 1.2 m-20 -143.76 28.4 1.43 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.829 -1.169 . . . . 0.0 110.59 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 1.046 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -68.27 -21.03 64.82 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.246 -0.909 . . . . 0.0 110.296 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -72.35 -13.73 61.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -0.95 . . . . 0.0 110.173 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.511 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 5.0 p-10 -133.74 8.96 3.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.372 -0.83 . . . . 0.0 110.01 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.908 HD21 ' OH ' ' A' ' 158' ' ' TYR . 0.3 OUTLIER -93.45 -45.72 7.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.325 -0.86 . . . . 0.0 109.913 179.872 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.976 HG11 HD13 ' A' ' 38' ' ' ILE . 2.5 t -73.37 -42.71 6.9 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.448 -0.782 . . . . 0.0 110.777 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.8 Cg_endo -78.01 7.57 3.93 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.448 1.236 . . . . 0.0 110.733 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.5 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 42.8 mmtm -124.32 -32.76 3.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.161 -0.962 . . . . 0.0 109.569 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.578 HD13 ' HA ' ' A' ' 147' ' ' ILE . 12.7 mt -80.04 -33.31 14.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.542 -0.724 . . . . 0.0 109.476 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -156.8 94.87 2.25 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.475 -0.766 . . . . 0.0 110.07 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.26 -1.2 9.77 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.046 1.551 . . . . 0.0 110.614 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -91.88 -6.66 51.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.147 -0.971 . . . . 0.0 110.248 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -99.21 -69.04 0.78 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.224 -0.922 . . . . 0.0 110.25 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.976 HD13 HG11 ' A' ' 30' ' ' VAL . 1.3 mp -103.46 149.1 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.35 -0.844 . . . . 0.0 110.154 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.461 ' O ' ' HB3' ' A' ' 40' ' ' HIS . 8.0 ttmm -86.93 -37.04 17.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 110.26 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.461 ' HB3' ' O ' ' A' ' 39' ' ' LYS . 0.3 OUTLIER 177.71 134.77 0.07 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.186 -0.946 . . . . 0.0 110.502 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.5 m -94.67 135.73 35.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.158 -0.963 . . . . 0.0 109.804 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -140.05 114.38 9.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.182 -0.948 . . . . 0.0 110.446 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 14.2 mt -61.85 138.28 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.164 -0.96 . . . . 0.0 109.962 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 13.3 tp -114.91 -25.86 8.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.23 -0.919 . . . . 0.0 110.468 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.504 ' HB2' ' CB ' ' A' ' 53' ' ' ILE . 1.8 m95 -127.77 163.99 23.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.217 -0.927 . . . . 0.0 110.588 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.46 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 42.23 -132.67 4.4 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.428 ' N ' ' OG1' ' A' ' 52' ' ' THR . 0.6 OUTLIER -156.34 20.23 0.35 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -1.12 . . . . 0.0 110.15 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.04 -22.97 6.65 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.455 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -71.11 -171.96 12.42 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.482 ' HA ' HG22 ' A' ' 71' ' ' ILE . 44.2 Cg_endo -72.12 128.97 14.5 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 124.045 1.55 . . . . 0.0 110.497 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.32 -15.45 42.75 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.55 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.1 m -72.03 161.71 30.51 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.594 -0.945 . . . . 0.0 109.382 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.504 ' CB ' ' HB2' ' A' ' 45' ' ' TRP . 50.0 mt -132.16 119.8 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.292 -0.88 . . . . 0.0 109.993 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 21.7 mtpt -102.29 134.76 45.06 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.151 -0.968 . . . . 0.0 110.339 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 17.9 tttm -102.39 93.7 5.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.32 -0.863 . . . . 0.0 110.008 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.547 ' CG2' HG12 ' A' ' 38' ' ' ILE . 84.7 mt -80.08 138.79 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.233 -0.917 . . . . 0.0 110.052 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.513 ' O ' HG23 ' A' ' 38' ' ' ILE . 1.4 p -113.73 151.75 31.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 0.0 110.446 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.574 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 24.0 m-85 -115.55 150.11 37.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.367 -0.833 . . . . 0.0 110.062 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.936 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.226 0.536 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.574 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -126.56 99.71 0.55 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.545 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 11.6 p90 -138.5 165.58 26.48 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.187 -1.184 . . . . 0.0 110.158 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.898 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.8 m -139.2 175.06 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.252 -0.905 . . . . 0.0 110.567 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 72.8 mttt -129.79 114.98 16.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.525 -0.735 . . . . 0.0 109.928 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.693 ' CE1' HD13 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -103.36 123.16 46.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.343 -0.848 . . . . 0.0 110.742 -179.585 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 52' ' ' THR . 40.3 tttp -94.85 111.95 23.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 0.0 109.664 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.526 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 39.2 mm -47.3 137.13 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.209 -0.932 . . . . 0.0 110.417 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.553 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 11.1 t0 -112.11 -36.77 5.25 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.398 -0.814 . . . . 0.0 109.934 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.428 ' C ' HD12 ' A' ' 74' ' ' ILE . 1.0 OUTLIER 179.92 163.08 1.03 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.319 -0.863 . . . . 0.0 109.657 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.465 HG12 HG11 ' A' ' 23' ' ' VAL . 0.7 OUTLIER -146.75 155.75 11.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.056 -1.028 . . . . 0.0 111.157 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.54 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 2.5 m-20 -132.57 78.2 1.79 Allowed 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.011 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.546 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 34.0 mttp -61.03 -17.97 55.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.228 -0.92 . . . . 0.0 110.346 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -92.32 -31.01 15.53 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.226 -0.921 . . . . 0.0 109.567 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.482 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.6 m120 -103.78 -6.55 21.35 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.571 -0.706 . . . . 0.0 109.893 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.539 ' N ' ' O ' ' A' ' 75' ' ' ASP . 3.8 m-30 66.02 52.11 1.24 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.536 -0.727 . . . . 0.0 110.14 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.54 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.6 OUTLIER -125.18 147.66 48.95 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.246 -0.909 . . . . 0.0 109.672 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.642 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 58.1 t80 -137.26 135.63 37.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.146 -0.971 . . . . 0.0 110.118 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.421 ' O ' ' N ' ' A' ' 72' ' ' ASP . 26.3 m -141.31 127.58 19.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.077 -1.014 . . . . 0.0 110.779 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.642 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 10.9 p90 -138.72 174.52 10.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.373 -0.83 . . . . 0.0 109.966 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 98' ' ' ILE . 69.7 m -125.87 129.19 48.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 0.0 109.738 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.693 HD13 ' CE1' ' A' ' 69' ' ' HIS . 3.5 tp -97.07 132.69 42.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.11 -0.994 . . . . 0.0 110.318 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.3 pt -118.81 -24.25 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.394 -0.816 . . . . 0.0 110.148 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.493 ' O ' HD11 ' A' ' 85' ' ' LEU . 68.0 tt0 -121.73 147.17 46.25 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.262 -0.899 . . . . 0.0 110.159 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.898 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 165.03 124.65 0.72 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -52.05 -25.01 7.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -1.163 . . . . 0.0 110.22 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.32 -24.03 59.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.166 -0.959 . . . . 0.0 110.226 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.687 HD12 ' N ' ' A' ' 88' ' ' GLY . 72.1 mt -63.98 -32.55 74.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.903 . . . . 0.0 110.167 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 46.81 -173.48 0.02 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 52.3 p30 -83.19 7.02 17.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.262 -1.14 . . . . 0.0 110.163 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.709 ' O ' HG21 ' A' ' 126' ' ' VAL . 60.7 p -92.58 -33.72 14.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.319 -0.863 . . . . 0.0 110.137 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.941 HD21 ' CG1' ' A' ' 128' ' ' ILE . 61.9 mt -108.03 172.41 6.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.333 -0.854 . . . . 0.0 110.278 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.517 ' OE1' ' N ' ' A' ' 123' ' ' LYS . 48.5 mp0 -149.9 -82.36 0.11 Allowed 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.772 0.796 . . . . 0.0 109.311 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.509 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 59.7 mttt -80.44 127.57 32.57 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.782 -0.574 . . . . 0.0 110.72 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.753 HG21 ' CE2' ' A' ' 100' ' ' TYR . 5.4 mm -117.8 140.4 41.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 120.563 -1.336 . . . . 0.0 109.293 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.505 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -120.31 126.59 50.92 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.094 179.099 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.753 ' CE2' HG21 ' A' ' 98' ' ' ILE . 11.7 m-85 -122.61 135.55 54.65 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.407 -0.808 . . . . 0.0 110.367 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.527 ' CB ' ' HB ' ' A' ' 117' ' ' THR . 3.5 mt-10 -138.78 131.02 28.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.316 -0.865 . . . . 0.0 110.122 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 34.1 m -128.27 133.91 48.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.323 -0.86 . . . . 0.0 109.853 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.47 145.86 51.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.137 -0.977 . . . . 0.0 110.531 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.641 HD23 HG12 ' A' ' 114' ' ' ILE . 10.9 mt -122.47 153.59 38.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.3 -0.875 . . . . 0.0 110.01 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.701 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -151.12 -168.79 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.183 -0.948 . . . . 0.0 110.125 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.701 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -126.39 147.52 49.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.288 -0.883 . . . . 0.0 110.189 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.458 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 2.6 p -105.87 169.79 6.57 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.14 -0.975 . . . . 0.0 110.273 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 47.3 Cg_endo -73.19 -9.44 23.3 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.004 1.528 . . . . 0.0 110.403 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 63.1 p -97.37 6.63 47.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.305 -0.872 . . . . 0.0 110.326 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 96.18 -37.71 3.34 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -56.67 -172.42 0.17 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.5 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 25.1 p -133.99 137.14 44.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.259 -1.142 . . . . 0.0 110.276 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.726 ' HA ' HG22 ' A' ' 10' ' ' THR . 18.4 mt -86.77 150.31 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.313 -0.867 . . . . 0.0 110.218 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.641 HG12 HD23 ' A' ' 104' ' ' LEU . 16.5 mt -131.45 120.01 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.233 -0.917 . . . . 0.0 110.192 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.4 tttm -106.7 124.72 50.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.134 -0.979 . . . . 0.0 110.093 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -111.56 154.37 24.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.23 -0.919 . . . . 0.0 110.469 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.608 HG23 ' CG ' ' A' ' 6' ' ' GLU . 88.0 m -145.97 145.2 30.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.385 -0.822 . . . . 0.0 110.249 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.462 ' HG ' ' HE1' ' A' ' 100' ' ' TYR . 49.7 m -155.49 120.76 4.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.908 . . . . 0.0 109.857 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.505 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 41.1 m-70 -112.14 157.57 20.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.151 -0.968 . . . . 0.0 110.559 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.984 ' C ' HG23 ' A' ' 2' ' ' VAL . 10.2 m-85 -125.78 119.89 29.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.371 -0.831 . . . . 0.0 110.511 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.729 ' CD2' ' HB ' ' A' ' 2' ' ' VAL . 76.2 m80 -98.79 101.84 13.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.265 -0.897 . . . . 0.0 109.601 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.694 HG23 HD23 ' A' ' 95' ' ' LEU . 0.8 OUTLIER -88.26 142.46 27.73 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.131 -0.981 . . . . 0.0 110.499 -179.507 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.517 ' N ' ' OE1' ' A' ' 96' ' ' GLU . 18.4 tttt -113.32 109.73 19.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.382 -0.824 . . . . 0.0 110.202 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 104.06 -153.26 17.73 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -97.62 77.71 2.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.323 -1.104 . . . . 0.0 110.206 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.709 HG21 ' O ' ' A' ' 94' ' ' THR . 22.3 m -142.76 161.68 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.2 -0.937 . . . . 0.0 110.133 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.404 ' HG3' ' C ' ' A' ' 126' ' ' VAL . 93.1 mt-10 -146.95 153.94 40.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.199 -0.938 . . . . 0.0 110.273 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.941 ' CG1' HD21 ' A' ' 95' ' ' LEU . 3.1 mt -80.18 172.98 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 110.115 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.595 ' N ' HG22 ' A' ' 128' ' ' ILE . 63.2 mttt -96.42 133.67 40.54 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.414 -0.804 . . . . 0.0 109.716 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 97.4 mt-10 -42.87 -36.53 1.53 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.268 -0.895 . . . . 0.0 110.169 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.84 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 81.2 tt0 -57.51 -42.17 82.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 109.922 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.537 ' HB3' ' CG2' ' A' ' 128' ' ' ILE . 6.1 t-160 -65.37 -53.66 40.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.333 -0.854 . . . . 0.0 110.221 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.463 HG13 ' CG ' ' A' ' 5' ' ' TYR . 96.6 t -67.7 -33.87 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.43 -0.794 . . . . 0.0 110.287 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 25.6 mttm -98.11 -69.33 0.76 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.212 -0.93 . . . . 0.0 110.205 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.84 ' HB3' ' O ' ' A' ' 131' ' ' GLU . . . -54.71 -19.61 6.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.18 -0.95 . . . . 0.0 109.626 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.451 ' HA3' ' O ' ' A' ' 132' ' ' HIS . . . -73.17 -30.23 63.25 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.484 ' CE ' ' HB3' ' A' ' 5' ' ' TYR . 66.0 mttm -79.5 -31.45 42.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.335 -1.097 . . . . 0.0 109.932 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -72.45 -52.92 13.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.281 -0.887 . . . . 0.0 109.93 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.52 ' HG3' ' N ' ' A' ' 140' ' ' ALA . 10.1 pttp -56.88 -41.26 77.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.41 -0.806 . . . . 0.0 109.821 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.52 ' N ' ' HG3' ' A' ' 139' ' ' LYS . . . -70.4 -39.73 74.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.349 -0.845 . . . . 0.0 109.853 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 137' ' ' LYS . 16.7 t -55.62 -43.41 76.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.414 -0.804 . . . . 0.0 109.852 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -57.34 -42.47 82.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.347 -0.846 . . . . 0.0 109.873 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.643 ' HA ' HD12 ' A' ' 146' ' ' LEU . 64.3 mt -57.85 -41.82 83.17 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.28 -0.887 . . . . 0.0 109.906 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -59.45 -36.79 76.62 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.422 -0.799 . . . . 0.0 109.845 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.413 ' HA ' ' OE1' ' A' ' 148' ' ' GLU . 95.6 mttt -71.68 -15.07 62.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.322 -0.861 . . . . 0.0 109.878 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.643 HD12 ' HA ' ' A' ' 143' ' ' LEU . 24.2 mt -84.95 -35.34 22.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.28 -0.887 . . . . 0.0 109.045 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.792 ' CG2' HD23 ' A' ' 18' ' ' LEU . 60.0 mt -70.47 -40.75 77.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 119.772 -0.771 . . . . 0.0 108.97 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.863 ' HB3' HD13 ' A' ' 13' ' ' ILE . 52.0 mt-10 -59.46 -44.08 93.06 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.423 -0.798 . . . . 0.0 109.329 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.504 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 33.7 m -67.75 -30.19 69.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.318 -0.864 . . . . 0.0 109.453 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.595 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 73.3 t80 -57.84 -49.72 75.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.463 -0.773 . . . . 0.0 109.802 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.145 HD21 ' CE2' ' A' ' 158' ' ' TYR . 77.5 mt -79.94 -26.61 40.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.209 -0.932 . . . . 0.0 109.983 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.688 ' HB2' HD11 ' A' ' 13' ' ' ILE . 50.8 tttt -72.65 -26.49 61.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.375 -0.828 . . . . 0.0 109.491 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.497 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -105.4 -32.02 4.11 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.453 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 4.6 m80 -106.92 92.31 7.4 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.302 -1.117 . . . . 0.0 109.947 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.6 Cg_endo -73.84 6.9 2.62 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.131 1.595 . . . . 0.0 111.15 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -108.87 -4.49 16.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.936 -1.103 . . . . 0.0 110.008 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.667 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -77.65 101.72 6.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.382 -0.824 . . . . 0.0 110.1 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 1.145 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.3 OUTLIER 35.15 31.8 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.691 -0.63 . . . . 0.0 110.507 -179.49 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.568 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.744 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.575 HG13 ' O ' ' A' ' 120' ' ' TYR . 93.9 t -124.42 137.77 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -1.135 . . . . 0.0 110.206 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.804 ' CE1' HD12 ' A' ' 128' ' ' ILE . 10.1 m-85 -98.89 145.71 26.72 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.248 -0.908 . . . . 0.0 109.843 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.598 HG23 ' CE1' ' A' ' 119' ' ' HIS . 3.2 m -120.89 127.56 51.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.155 -0.966 . . . . 0.0 110.677 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 1.093 ' CE2' HG21 ' A' ' 133' ' ' VAL . 61.5 m-85 -139.92 131.21 26.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.395 -0.815 . . . . 0.0 109.765 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 22.4 pt-20 -131.75 153.3 50.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.043 -1.036 . . . . 0.0 110.774 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.419 ' HB2' ' HB3' ' A' ' 116' ' ' SER . 49.7 m -132.37 144.67 50.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.417 -0.802 . . . . 0.0 109.71 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -135.58 121.99 20.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.162 -0.961 . . . . 0.0 110.719 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.638 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.0 p90 -147.19 -177.03 5.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.363 -0.836 . . . . 0.0 109.691 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.89 HG22 ' HA ' ' A' ' 113' ' ' ILE . 5.7 p -142.52 170.35 15.88 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.115 -0.991 . . . . 0.0 110.739 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.427 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 1.4 t -155.06 157.48 37.61 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.41 -0.807 . . . . 0.0 110.243 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -76.07 -38.34 57.19 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.125 -0.984 . . . . 0.0 109.993 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.835 HD11 ' HB2' ' A' ' 152' ' ' LYS . 3.3 mp -58.37 150.02 56.52 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.44 -0.788 . . . . 0.0 109.98 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.759 ' HD2' HG23 ' A' ' 13' ' ' ILE . 39.6 Cg_endo -66.1 144.71 76.64 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.909 1.478 . . . . 0.0 110.116 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.652 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 38.4 Cg_endo -72.41 -31.46 11.31 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.961 1.506 . . . . 0.0 113.002 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.652 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 44.0 Cg_endo -71.72 -22.0 24.49 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 N-CA-C 109.757 -0.901 . . . . 0.0 109.757 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.803 ' HG2' HD22 ' A' ' 151' ' ' LEU . 42.0 ttm180 -81.89 -47.57 12.61 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.799 ' HA ' HD11 ' A' ' 151' ' ' LEU . 0.7 OUTLIER -66.26 -26.26 67.27 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.645 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.557 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 51.6 t80 -67.88 -50.72 54.76 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.513 0.673 . . . . 0.0 109.798 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.79 ' HG2' HD22 ' A' ' 24' ' ' LEU . 34.7 mttm -58.46 -33.63 69.96 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.624 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.056 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -80.04 -26.22 39.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.449 -0.782 . . . . 0.0 110.749 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.997 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 1.4 t80 -87.18 -46.72 9.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.17 -0.956 . . . . 0.0 111.474 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.704 HG13 ' CE1' ' A' ' 81' ' ' TYR . 3.5 t -98.84 -54.73 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.018 -1.051 . . . . 0.0 111.098 -179.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.79 HD22 ' HG2' ' A' ' 20' ' ' LYS . 8.0 mp -67.81 -5.59 17.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.174 -0.954 . . . . 0.0 110.735 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -144.35 17.82 1.71 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.118 -0.989 . . . . 0.0 110.443 -179.866 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.997 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -56.99 -23.12 43.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.188 -0.945 . . . . 0.0 110.164 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -79.55 -14.34 58.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.309 -0.869 . . . . 0.0 110.335 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.441 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 80.5 m-20 -132.37 9.14 4.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.183 -0.948 . . . . 0.0 110.415 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.654 HD23 ' OH ' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -105.3 -43.61 4.95 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.176 -0.952 . . . . 0.0 110.432 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.624 ' CG1' HD13 ' A' ' 38' ' ' ILE . 3.0 t -74.39 -41.4 4.84 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.339 -0.851 . . . . 0.0 110.956 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.9 Cg_endo -77.8 10.73 2.48 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.313 1.165 . . . . 0.0 110.896 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 28' ' ' ASN . 15.4 mttm -124.87 -34.92 2.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.115 -0.99 . . . . 0.0 109.355 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.663 HG21 ' HB3' ' A' ' 146' ' ' LEU . 6.7 mt -80.12 -44.15 22.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.487 -0.758 . . . . 0.0 109.628 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.87 95.06 14.1 Favored Pre-proline 0 N--CA 1.487 1.398 0 O-C-N 121.407 -0.808 . . . . 0.0 110.189 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.16 -0.41 9.09 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.047 1.551 . . . . 0.0 110.513 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -90.41 -27.42 19.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.218 -0.926 . . . . 0.0 110.039 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -87.53 -47.83 8.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.355 -0.841 . . . . 0.0 110.11 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.624 HD13 ' CG1' ' A' ' 30' ' ' VAL . 1.0 OUTLIER -125.68 130.19 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.495 -0.753 . . . . 0.0 109.926 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -89.17 -26.96 21.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.36 -0.837 . . . . 0.0 110.056 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.454 ' O ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -172.11 150.08 2.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.918 . . . . 0.0 110.197 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.6 m -128.58 123.3 33.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.339 -0.851 . . . . 0.0 109.904 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.415 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 69.5 tt0 -134.13 111.57 10.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.147 -0.97 . . . . 0.0 110.733 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 38.2 mt -53.65 143.61 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.292 -0.88 . . . . 0.0 109.892 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.432 ' HA ' HD12 ' A' ' 44' ' ' LEU . 30.3 tp -120.82 -27.3 5.06 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.224 -0.922 . . . . 0.0 110.447 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.676 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.7 m95 -123.92 162.83 22.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.294 -0.879 . . . . 0.0 110.516 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.45 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 42.84 -135.97 4.07 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.415 ' N ' ' OG1' ' A' ' 52' ' ' THR . 0.2 OUTLIER -152.64 22.95 0.6 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.392 -1.063 . . . . 0.0 110.052 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 120.09 -19.75 9.33 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.494 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -74.16 -169.82 21.43 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.435 ' HA ' HG22 ' A' ' 71' ' ' ILE . 45.3 Cg_endo -72.13 128.12 13.53 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 123.925 1.487 . . . . 0.0 110.649 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.4 -14.57 47.09 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.527 -1.829 . . . . 0.0 108.527 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.545 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.1 m -71.79 160.42 32.63 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.553 -0.969 . . . . 0.0 109.329 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.676 HD12 ' CG ' ' A' ' 45' ' ' TRP . 59.5 mt -132.48 119.36 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 110.276 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.635 ' CE ' HD11 ' A' ' 71' ' ' ILE . 48.6 mttm -102.56 124.8 48.77 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.355 -0.84 . . . . 0.0 110.163 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.4 tttt -92.31 93.9 8.87 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.29 -0.881 . . . . 0.0 110.004 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.548 ' CG2' HG12 ' A' ' 38' ' ' ILE . 70.7 mt -80.1 144.26 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.187 -0.945 . . . . 0.0 110.05 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 40' ' ' HIS . 1.2 p -115.08 153.93 29.82 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.359 -0.838 . . . . 0.0 110.347 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.544 ' CZ ' HG22 ' A' ' 67' ' ' VAL . 19.3 m-85 -114.53 137.87 51.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.158 -0.964 . . . . 0.0 110.107 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.969 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.117 0.484 . . . . 0.0 110.095 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -138.78 116.53 1.28 Allowed Glycine 0 N--CA 1.486 2.033 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.545 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 13.9 p90 -156.4 174.47 15.37 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.088 -1.242 . . . . 0.0 110.208 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.734 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.8 m -144.16 174.97 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.872 . . . . 0.0 110.658 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.671 ' O ' HD12 ' A' ' 85' ' ' LEU . 22.7 mttm -132.22 104.36 6.72 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.515 -0.741 . . . . 0.0 109.687 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.981 ' CD2' HD13 ' A' ' 85' ' ' LEU . 12.5 m170 -95.57 126.09 40.62 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.26 -0.9 . . . . 0.0 111.103 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.545 ' HA ' ' O ' ' A' ' 52' ' ' THR . 23.8 tttt -98.48 108.67 21.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.351 -0.843 . . . . 0.0 109.434 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.635 HD11 ' CE ' ' A' ' 54' ' ' LYS . 30.2 mm -42.38 139.78 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.222 -0.924 . . . . 0.0 110.15 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.542 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 13.1 t0 -116.55 -41.22 3.11 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.187 -0.945 . . . . 0.0 110.46 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.485 ' C ' HD12 ' A' ' 74' ' ' ILE . 22.9 m -168.94 158.86 9.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 109.917 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.485 HD12 ' C ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -148.93 154.33 9.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 C-N-CA 119.142 -1.023 . . . . 0.0 111.131 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 79' ' ' TYR . 2.4 m-20 -133.91 77.82 1.73 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 120.269 -0.573 . . . . 0.0 110.092 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.557 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 36.7 tttm -61.6 -15.66 41.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.099 -1.001 . . . . 0.0 110.199 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -92.93 -30.53 15.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.259 -0.9 . . . . 0.0 109.593 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 2.0 m120 -105.04 -9.15 18.04 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.69 -0.632 . . . . 0.0 109.882 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.578 ' CZ ' ' HB3' ' A' ' 16' ' ' PRO . 2.9 m-85 70.13 51.31 0.4 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.62 -0.675 . . . . 0.0 110.277 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.487 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -125.17 149.01 48.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.908 . . . . 0.0 109.669 179.711 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.704 ' CE1' HG13 ' A' ' 23' ' ' VAL . 58.5 t80 -138.86 139.96 38.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.162 -0.961 . . . . 0.0 110.235 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.434 ' O ' ' HB3' ' A' ' 72' ' ' ASP . 3.3 m -148.52 121.37 8.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.208 -0.932 . . . . 0.0 110.439 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.676 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 8.8 p90 -131.41 175.12 9.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.291 -0.881 . . . . 0.0 110.42 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 98' ' ' ILE . 19.7 m -127.82 126.06 40.96 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.346 -0.846 . . . . 0.0 109.948 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.981 HD13 ' CD2' ' A' ' 69' ' ' HIS . 14.0 tp -97.57 135.5 39.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.018 -1.051 . . . . 0.0 110.277 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.519 ' H ' HD12 ' A' ' 85' ' ' LEU . 9.5 pt -115.81 -31.27 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.219 -0.926 . . . . 0.0 110.255 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.489 ' C ' ' CD1' ' A' ' 91' ' ' LEU . 39.4 tt0 -107.86 165.65 11.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.28 -0.887 . . . . 0.0 110.09 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.734 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 151.55 140.17 3.1 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -60.04 -31.93 70.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.276 -1.132 . . . . 0.0 110.228 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.786 ' HB1' ' CE1' ' A' ' 132' ' ' HIS . . . -67.02 -39.61 87.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.29 -0.881 . . . . 0.0 110.213 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.654 ' CD2' HD21 ' A' ' 95' ' ' LEU . 11.4 mt -42.31 -51.96 4.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.367 -0.833 . . . . 0.0 110.135 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 43.54 -167.4 0.02 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.409 ' C ' ' OD1' ' A' ' 93' ' ' ASP . 55.8 p-10 -79.43 3.22 19.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -1.146 . . . . 0.0 110.176 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.514 ' O ' HG22 ' A' ' 122' ' ' THR . 0.1 OUTLIER -92.32 -51.93 4.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.231 -0.918 . . . . 0.0 110.185 -179.907 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.874 HD12 ' H ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -107.56 159.59 16.32 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.406 -0.809 . . . . 0.0 109.416 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.874 ' H ' HD12 ' A' ' 95' ' ' LEU . 62.9 tt0 -134.88 -80.33 0.44 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.306 -0.871 . . . . 0.0 110.182 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 46.8 mttt -80.27 152.74 28.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.633 -0.667 . . . . 0.0 110.78 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.726 HG21 ' CE2' ' A' ' 100' ' ' TYR . 4.7 mm -138.66 142.99 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.175 -0.953 . . . . 0.0 109.701 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.482 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.8 OUTLIER -121.38 127.39 51.16 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.356 -0.84 . . . . 0.0 109.151 178.887 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.726 ' CE2' HG21 ' A' ' 98' ' ' ILE . 10.3 m-85 -122.52 135.19 54.59 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 110.517 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.466 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 74.4 tt0 -138.14 141.38 40.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.312 -0.867 . . . . 0.0 110.356 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.53 ' N ' ' O ' ' A' ' 81' ' ' TYR . 32.7 m -137.66 149.94 46.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.412 -0.805 . . . . 0.0 109.732 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 115' ' ' LYS . 7.9 mttt -145.54 138.14 25.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.114 -0.991 . . . . 0.0 110.725 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.828 HD23 HG12 ' A' ' 114' ' ' ILE . 5.9 mt -118.75 151.69 37.56 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.298 -0.876 . . . . 0.0 109.497 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.701 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -150.23 -169.85 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.042 -1.036 . . . . 0.0 110.371 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.701 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -121.44 141.87 50.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.42 -0.8 . . . . 0.0 110.141 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.479 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 7.9 p -99.25 167.51 11.12 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.209 -0.932 . . . . 0.0 110.29 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.7 Cg_endo -72.32 -1.12 9.68 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.013 1.533 . . . . 0.0 110.596 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 52.0 p -106.65 4.14 27.58 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.248 -0.907 . . . . 0.0 110.303 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 100.21 -32.83 6.86 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -61.97 -172.11 1.27 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.508 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.0 OUTLIER -131.56 128.77 39.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.217 -1.167 . . . . 0.0 110.413 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.89 ' HA ' HG22 ' A' ' 10' ' ' THR . 10.3 mt -82.19 152.14 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.321 -0.862 . . . . 0.0 110.039 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.828 HG12 HD23 ' A' ' 104' ' ' LEU . 15.7 mt -132.31 119.03 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.2 -0.938 . . . . 0.0 110.436 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.486 ' O ' ' N ' ' A' ' 103' ' ' LYS . 26.6 tttt -108.63 119.04 38.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 110.075 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 2.0 t -110.87 158.16 19.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 110.306 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.466 ' HB ' ' HB3' ' A' ' 101' ' ' GLU . 43.1 m -160.01 139.74 11.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.21 -0.931 . . . . 0.0 110.3 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 41.9 t -143.58 159.67 42.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.214 -0.929 . . . . 0.0 110.116 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.598 ' CE1' HG23 ' A' ' 4' ' ' THR . 69.8 m-70 -142.34 159.1 42.9 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.157 -0.964 . . . . 0.0 110.527 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.596 ' HA ' HD13 ' A' ' 98' ' ' ILE . 8.7 m-85 -117.86 150.78 38.61 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.36 -0.837 . . . . 0.0 110.279 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.476 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 95.2 m-70 -128.39 82.76 2.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.138 -0.976 . . . . 0.0 109.896 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 94' ' ' THR . 1.2 p -71.74 152.13 43.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.347 -0.845 . . . . 0.0 110.082 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.419 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 7.3 ttpt -109.89 118.29 36.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.255 -0.903 . . . . 0.0 110.335 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 101.59 -143.44 16.07 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -112.72 73.41 0.81 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.302 -1.116 . . . . 0.0 110.207 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 5.9 m -140.67 156.49 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.273 -0.892 . . . . 0.0 110.147 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -128.2 154.7 45.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.266 -0.896 . . . . 0.0 110.261 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.804 HD12 ' CE1' ' A' ' 3' ' ' PHE . 3.0 mt -74.9 172.74 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.337 -0.852 . . . . 0.0 110.2 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.61 ' N ' HG22 ' A' ' 128' ' ' ILE . 40.9 mmtm -104.07 125.9 50.78 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.347 -0.846 . . . . 0.0 110.053 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 129' ' ' LYS . 96.0 mt-10 -43.65 -54.05 5.31 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.223 -0.923 . . . . 0.0 110.038 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 42.9 tt0 -46.32 -25.04 0.56 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.207 -0.933 . . . . 0.0 109.797 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.786 ' CE1' ' HB1' ' A' ' 90' ' ' ALA . 12.1 t-160 -81.54 -64.56 1.16 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.435 -0.791 . . . . 0.0 110.071 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 1.093 HG21 ' CE2' ' A' ' 5' ' ' TYR . 8.8 p -66.14 -39.47 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.359 -0.838 . . . . 0.0 110.031 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.519 ' N ' HG13 ' A' ' 133' ' ' VAL . 38.0 tttp -63.59 -42.46 98.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 109.968 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 131' ' ' GLU . . . -66.77 -32.27 73.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.353 -0.842 . . . . 0.0 109.883 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.64 -26.98 74.13 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.564 ' NZ ' HG22 ' A' ' 133' ' ' VAL . 45.1 mttp -65.11 -35.43 81.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.336 -1.096 . . . . 0.0 110.021 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -82.69 -36.48 25.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.32 -0.862 . . . . 0.0 109.868 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 41.0 mttt -73.29 -26.93 61.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.387 -0.821 . . . . 0.0 109.854 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.407 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -81.54 -38.77 25.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.368 -0.833 . . . . 0.0 109.92 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.9 t -64.01 -47.15 81.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.335 -0.853 . . . . 0.0 109.947 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -54.86 -44.68 74.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.247 -0.908 . . . . 0.0 109.867 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.474 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 9.4 tp -57.2 -45.88 83.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 0.0 109.859 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.557 ' HA ' HD12 ' A' ' 147' ' ' ILE . 28.0 m-85 -54.44 -41.32 69.26 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.234 -0.916 . . . . 0.0 109.507 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 18.7 mttp -72.82 -12.98 61.19 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.438 -0.789 . . . . 0.0 110.035 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.663 ' HB3' HG21 ' A' ' 33' ' ' ILE . 16.1 mt -83.75 -36.2 23.82 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.177 -0.952 . . . . 0.0 108.921 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.699 HD11 ' CE1' ' A' ' 22' ' ' PHE . 25.8 mt -68.05 -44.31 84.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.538 ' OE2' HD13 ' A' ' 18' ' ' LEU . 60.8 mm-40 -53.66 -46.22 70.53 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.533 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 25.7 m -65.83 -39.11 90.51 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.354 -0.841 . . . . 0.0 109.351 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.611 ' CD1' HD11 ' A' ' 33' ' ' ILE . 58.0 t80 -43.64 -56.85 3.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.435 -0.791 . . . . 0.0 109.829 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.803 HD22 ' HG2' ' A' ' 17' ' ' ARG . 12.4 mt -75.16 -39.72 60.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.541 -0.724 . . . . 0.0 110.432 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.835 ' HB2' HD11 ' A' ' 13' ' ' ILE . 25.1 tttm -60.83 -17.77 51.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.122 -0.986 . . . . 0.0 109.364 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.498 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -113.46 -29.59 2.9 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.453 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 8.0 m80 -105.82 89.84 3.87 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.285 -1.126 . . . . 0.0 110.009 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.554 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 45.6 Cg_endo -71.12 1.85 4.9 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.052 1.554 . . . . 0.0 110.989 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -108.33 -16.31 14.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.049 -1.032 . . . . 0.0 110.107 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.607 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -71.41 99.56 2.01 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.2 -0.937 . . . . 0.0 109.848 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 1.056 ' CE1' ' HB2' ' A' ' 21' ' ' ALA . 0.1 OUTLIER 35.06 32.54 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 CA-C-O 121.564 0.697 . . . . 0.0 109.569 -179.24 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.554 ' ND2' ' HA ' ' A' ' 155' ' ' PRO . 0.1 OUTLIER . . . . . 0 C--N 1.303 -1.451 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.94 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.456 ' O ' ' OG1' ' A' ' 122' ' ' THR . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.929 HG13 ' O ' ' A' ' 120' ' ' TYR . 77.4 t -125.29 138.57 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -1.157 . . . . 0.0 110.2 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.697 ' CE1' HD12 ' A' ' 128' ' ' ILE . 11.7 m-85 -98.02 136.13 38.72 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.205 -0.934 . . . . 0.0 109.624 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.681 HG23 ' ND1' ' A' ' 119' ' ' HIS . 8.5 m -119.19 136.81 54.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.093 -1.004 . . . . 0.0 110.815 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 1.006 ' CE2' HG21 ' A' ' 133' ' ' VAL . 57.0 m-85 -147.18 124.83 11.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.474 -0.766 . . . . 0.0 109.83 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 1.004 ' CG ' HG23 ' A' ' 117' ' ' THR . 5.0 mt-10 -123.54 132.77 53.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.277 -0.889 . . . . 0.0 110.494 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.444 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 50.7 m -119.01 157.8 27.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.325 -0.86 . . . . 0.0 109.898 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 7' ' ' SER . 50.5 mp0 -146.37 123.98 11.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.111 -0.993 . . . . 0.0 110.804 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.635 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.0 p90 -141.71 -175.88 4.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.886 . . . . 0.0 109.632 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.81 HG22 ' HA ' ' A' ' 113' ' ' ILE . 8.6 p -142.5 169.84 16.83 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.009 -1.057 . . . . 0.0 110.794 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 112' ' ' SER . 4.0 t -153.83 162.15 41.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.422 -0.799 . . . . 0.0 110.174 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -85.1 -28.47 25.57 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.127 -0.983 . . . . 0.0 110.164 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.79 HG23 ' HD2' ' A' ' 14' ' ' PRO . 9.1 mm -67.9 150.79 97.63 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 0.0 109.891 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.79 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.4 Cg_endo -66.12 143.35 71.3 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.932 1.491 . . . . 0.0 110.325 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.658 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.2 Cg_endo -72.55 -31.13 11.35 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 124.023 1.539 . . . . 0.0 112.888 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.658 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.6 Cg_endo -70.1 -23.83 28.83 Favored 'Trans proline' 0 C--N 1.316 -1.147 0 N-CA-C 110.177 -0.74 . . . . 0.0 110.177 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.731 HH21 ' HB3' ' A' ' 157' ' ' ALA . 46.2 mtp180 -83.68 -42.47 16.6 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.741 HD23 ' C ' ' A' ' 18' ' ' LEU . 0.6 OUTLIER -71.85 -31.56 66.62 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.958 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.619 ' N ' HD23 ' A' ' 18' ' ' LEU . 54.3 t80 -65.39 -54.93 21.56 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.461 -0.774 . . . . 0.0 109.042 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.533 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 70.1 mttt -48.63 -48.54 39.43 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.724 -0.79 . . . . 0.0 109.355 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.17 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -67.75 -28.77 67.91 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.334 -0.854 . . . . 0.0 111.135 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 1.066 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.9 OUTLIER -80.92 -46.54 15.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 111.411 -178.814 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.701 HG13 ' CE1' ' A' ' 81' ' ' TYR . 3.4 t -104.44 -51.36 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.942 -1.099 . . . . 0.0 111.761 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.678 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.2 mp -79.97 -4.61 53.22 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.097 -1.002 . . . . 0.0 111.966 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.571 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 1.0 OUTLIER -149.17 23.95 0.93 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.717 -1.239 . . . . 0.0 110.643 -179.632 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 1.066 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -67.01 -32.94 74.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.17 -0.956 . . . . 0.0 110.301 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.427 ' HA ' ' OG ' ' A' ' 41' ' ' SER . 81.4 m-20 -56.54 -17.68 9.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.357 -0.839 . . . . 0.0 110.559 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.539 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 4.2 p-10 -128.94 -0.93 5.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.15 -0.969 . . . . 0.0 110.523 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.758 ' HG ' ' HB1' ' A' ' 21' ' ' ALA . 1.1 tm? -88.57 -43.76 11.14 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.112 -0.992 . . . . 0.0 110.17 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 1.067 HG11 HD13 ' A' ' 38' ' ' ILE . 5.0 t -74.59 -40.86 4.36 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.437 -0.79 . . . . 0.0 111.319 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.0 Cg_endo -77.54 10.91 2.33 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 123.448 1.236 . . . . 0.0 111.005 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.486 ' CD ' ' O ' ' A' ' 28' ' ' ASN . 31.9 mtpt -120.65 -34.65 3.54 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.029 -1.044 . . . . 0.0 109.031 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.971 HG21 ' HB3' ' A' ' 146' ' ' LEU . 10.6 mt -80.19 -32.58 13.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 121.53 0.681 . . . . 0.0 109.657 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -159.65 98.35 1.54 Allowed Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.412 -0.805 . . . . 0.0 110.097 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.8 -0.75 8.86 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.034 1.544 . . . . 0.0 110.809 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -85.03 -19.08 32.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 109.788 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -85.76 -86.05 0.14 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.415 -0.803 . . . . 0.0 110.082 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 1.067 HD13 HG11 ' A' ' 30' ' ' VAL . 1.9 mp -90.75 139.94 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.279 -0.888 . . . . 0.0 110.112 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.425 ' O ' ' CB ' ' A' ' 40' ' ' HIS . 4.8 ttmm -87.81 -26.74 22.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.353 -0.842 . . . . 0.0 110.18 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.675 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER 177.03 157.19 0.31 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.177 -0.952 . . . . 0.0 110.193 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.427 ' OG ' ' HA ' ' A' ' 27' ' ' ASP . 79.4 p -117.3 134.21 55.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.356 -0.84 . . . . 0.0 110.023 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.675 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 29.0 tp10 -138.69 106.87 5.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.091 -1.005 . . . . 0.0 110.246 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 20.0 mt -62.59 137.16 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 110.098 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.899 HD22 ' CE ' ' A' ' 55' ' ' LYS . 13.0 tp -114.08 -23.51 9.49 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.239 -0.913 . . . . 0.0 110.534 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.701 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.7 m95 -127.06 161.61 28.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.049 -1.032 . . . . 0.0 110.63 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.446 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 41.76 -132.09 3.97 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -157.24 19.78 0.3 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.296 -1.12 . . . . 0.0 110.154 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.91 -18.22 7.09 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.472 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -74.51 -171.64 26.87 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.432 ' HA ' HG22 ' A' ' 71' ' ' ILE . 46.0 Cg_endo -73.38 129.54 13.99 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.103 1.581 . . . . 0.0 110.665 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.34 -9.44 49.55 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.509 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.1 m -76.88 167.17 22.29 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.567 -0.96 . . . . 0.0 109.921 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.701 HD12 ' CG ' ' A' ' 45' ' ' TRP . 65.6 mt -137.35 120.24 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.322 -0.861 . . . . 0.0 109.871 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 70.7 mttt -106.03 138.37 42.34 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.211 -0.93 . . . . 0.0 110.411 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.899 ' CE ' HD22 ' A' ' 44' ' ' LEU . 43.5 mttt -102.53 95.86 6.52 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.308 -0.87 . . . . 0.0 110.06 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.545 ' HB ' HG23 ' A' ' 67' ' ' VAL . 52.1 mt -80.05 135.41 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 109.846 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 1.6 p -104.77 155.8 18.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.374 -0.828 . . . . 0.0 110.452 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.741 ' HE2' HG13 ' A' ' 67' ' ' VAL . 23.9 m-85 -118.73 169.89 9.45 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.316 -0.865 . . . . 0.0 110.083 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.919 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.515 ' CE2' ' CD2' ' A' ' 66' ' ' TYR . 8.5 t80 . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.19 0.519 . . . . 0.0 110.075 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -129.31 136.18 8.84 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.562 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 11.7 p90 -179.49 161.38 1.04 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.349 -1.089 . . . . 0.0 109.952 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.844 HG12 ' HA2' ' A' ' 88' ' ' GLY . 7.1 m -141.95 171.83 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.681 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.513 ' O ' HD23 ' A' ' 85' ' ' LEU . 50.9 mttt -123.31 115.03 21.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.597 -0.689 . . . . 0.0 109.801 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.455 ' CE1' ' HG ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -106.29 126.19 51.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.141 -0.974 . . . . 0.0 110.633 -179.608 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 52' ' ' THR . 27.2 ttpp -97.43 126.58 42.77 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.322 -0.861 . . . . 0.0 109.77 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.508 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 26.1 mm -66.22 122.02 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 0.0 110.219 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -98.14 -43.34 7.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.359 -0.838 . . . . 0.0 110.118 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.8 m -169.0 159.42 9.28 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.382 -0.824 . . . . 0.0 109.616 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.5 mt -144.19 158.22 15.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.141 -0.975 . . . . 0.0 110.386 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.551 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 4.3 m-20 -134.39 78.76 1.77 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.088 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.432 ' HB2' ' HE3' ' A' ' 76' ' ' LYS . 38.1 mtmt -62.52 -14.03 37.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.195 -0.94 . . . . 0.0 110.233 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -93.68 -33.06 13.81 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.266 -0.896 . . . . 0.0 109.521 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.469 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.6 m120 -104.65 -8.18 19.1 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.605 -0.685 . . . . 0.0 109.841 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.636 ' O ' HD12 ' A' ' 104' ' ' LEU . 3.2 m-85 68.95 50.86 0.58 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.447 -0.783 . . . . 0.0 110.12 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.551 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -120.96 155.3 34.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.318 -0.864 . . . . 0.0 109.405 179.638 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.701 ' CE1' HG13 ' A' ' 23' ' ' VAL . 26.8 t80 -143.21 133.17 24.14 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.177 -0.952 . . . . 0.0 110.216 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 37.9 m -136.75 122.73 20.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 110.488 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.612 ' N ' ' CD1' ' A' ' 83' ' ' TYR . 3.1 p90 -139.42 179.98 6.23 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.179 -0.951 . . . . 0.0 110.039 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . 1.001 HG23 ' O ' ' A' ' 98' ' ' ILE . 39.3 m -132.02 142.46 49.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 110.332 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.664 HD22 ' O ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -98.04 119.35 36.52 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.261 -0.9 . . . . 0.0 110.278 179.911 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.473 ' CG1' ' HB2' ' A' ' 68' ' ' LYS . 31.2 pt -102.64 -12.85 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.2 -0.938 . . . . 0.0 110.062 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.664 ' O ' HD22 ' A' ' 85' ' ' LEU . 47.8 tp10 -141.82 166.7 24.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.311 -0.868 . . . . 0.0 110.214 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.844 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 148.87 120.33 1.07 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -50.15 -24.39 2.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.341 -1.094 . . . . 0.0 110.229 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 1.039 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -74.09 -22.61 59.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.926 . . . . 0.0 110.27 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.465 ' O ' ' O ' ' A' ' 92' ' ' GLY . 37.7 mt -66.86 -27.09 67.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.229 -0.919 . . . . 0.0 110.307 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 48.91 -178.04 0.01 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 93' ' ' ASP . 38.1 p30 -81.61 8.67 9.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -1.16 . . . . 0.0 110.267 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.616 ' O ' HG21 ' A' ' 126' ' ' VAL . 71.2 p -96.3 -39.62 9.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -0.906 . . . . 0.0 110.182 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.915 HD21 ' CG1' ' A' ' 128' ' ' ILE . 47.3 mt -98.8 153.59 18.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.389 -0.819 . . . . 0.0 110.193 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.509 ' HG3' ' HB2' ' A' ' 123' ' ' LYS . 41.9 mm-40 -131.91 -80.31 0.51 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.242 -0.911 . . . . 0.0 110.253 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.507 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 17.6 mttt -80.19 128.73 33.86 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.595 -0.691 . . . . 0.0 110.756 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 1.001 ' O ' HG23 ' A' ' 84' ' ' THR . 11.3 mm -115.65 146.76 19.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 120.777 -1.202 . . . . 0.0 109.582 178.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.503 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.0 OUTLIER -123.41 123.77 41.41 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.258 -0.901 . . . . 0.0 109.046 178.564 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.806 ' CE2' HG21 ' A' ' 98' ' ' ILE . 15.0 m-85 -121.34 133.13 55.1 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.457 -0.777 . . . . 0.0 109.732 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.486 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 21.1 tt0 -142.07 144.05 33.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.09 -1.006 . . . . 0.0 110.782 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 62.1 m -140.13 146.03 38.32 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.455 -0.778 . . . . 0.0 109.594 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -139.52 138.38 36.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.096 -1.002 . . . . 0.0 110.658 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.826 HD23 HG12 ' A' ' 114' ' ' ILE . 7.1 mt -118.6 150.3 39.92 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.4 -0.813 . . . . 0.0 109.965 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.679 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.8 t -147.72 -171.38 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.188 -0.945 . . . . 0.0 110.212 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.679 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -122.75 138.19 54.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.419 -0.801 . . . . 0.0 110.171 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.44 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 4.2 p -99.2 167.74 10.77 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.289 -0.882 . . . . 0.0 110.22 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.44 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.1 Cg_endo -72.27 -4.27 14.9 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.12 1.59 . . . . 0.0 110.349 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 36.5 m -93.82 -18.73 21.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 110.309 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 118.18 -30.37 6.08 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.485 ' HA3' ' O ' ' A' ' 11' ' ' SER . . . -64.72 -142.96 0.03 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 11' ' ' SER . 26.4 p -155.71 128.57 7.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.287 -1.125 . . . . 0.0 109.968 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.81 ' HA ' HG22 ' A' ' 10' ' ' THR . 15.2 mt -79.96 149.14 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -0.908 . . . . 0.0 110.085 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.826 HG12 HD23 ' A' ' 104' ' ' LEU . 15.6 mt -131.36 119.45 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.414 -0.804 . . . . 0.0 110.25 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -104.83 121.35 43.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.098 -1.001 . . . . 0.0 110.072 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.411 ' C ' ' HG1' ' A' ' 117' ' ' THR . 0.0 OUTLIER -104.12 152.65 21.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -0.868 . . . . 0.0 110.216 -179.861 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . 1.004 HG23 ' CG ' ' A' ' 6' ' ' GLU . 12.1 m -159.97 122.39 3.37 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.316 -0.865 . . . . 0.0 110.568 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.506 ' C ' ' CG ' ' A' ' 119' ' ' HIS . 15.0 t -133.55 160.13 38.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.361 -0.837 . . . . 0.0 109.669 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.681 ' ND1' HG23 ' A' ' 4' ' ' THR . 33.7 m-70 -147.19 164.2 33.89 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.061 -1.025 . . . . 0.0 110.642 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.929 ' O ' HG13 ' A' ' 2' ' ' VAL . 6.3 m-85 -126.93 150.53 49.29 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.253 -0.904 . . . . 0.0 110.443 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.507 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 93.6 m-70 -129.78 84.71 2.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.255 -0.903 . . . . 0.0 109.723 178.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.709 ' CG2' HD23 ' A' ' 95' ' ' LEU . 1.2 p -63.64 154.8 31.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.302 -0.874 . . . . 0.0 110.179 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.509 ' HB2' ' HG3' ' A' ' 96' ' ' GLU . 43.4 tttt -113.73 117.56 31.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 110.048 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 99.25 -115.95 5.45 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.476 ' O ' ' ND2' ' A' ' 125' ' ' ASN . 0.7 OUTLIER -138.27 67.4 1.41 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.301 -1.117 . . . . 0.0 110.138 179.854 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.616 HG21 ' O ' ' A' ' 94' ' ' THR . 27.9 m -131.92 167.23 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.886 . . . . 0.0 110.085 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -140.76 161.41 37.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 110.255 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.915 ' CG1' HD21 ' A' ' 95' ' ' LEU . 3.5 mp -84.17 172.8 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.252 -0.905 . . . . 0.0 110.127 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.614 ' N ' HG22 ' A' ' 128' ' ' ILE . 16.2 mttm -108.25 129.92 55.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.384 -0.823 . . . . 0.0 109.683 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.459 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 73.1 mm-40 -43.86 -49.69 8.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.079 -1.013 . . . . 0.0 109.885 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.506 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 51.6 tt0 -48.54 -23.09 0.87 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.154 -0.966 . . . . 0.0 109.651 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 1.039 ' NE2' ' HB1' ' A' ' 90' ' ' ALA . 13.5 t-160 -88.48 -66.42 0.92 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.372 -0.83 . . . . 0.0 110.142 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 1.006 HG21 ' CE2' ' A' ' 5' ' ' TYR . 7.3 p -59.91 -40.21 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.345 -0.847 . . . . 0.0 109.84 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.533 ' N ' HG13 ' A' ' 133' ' ' VAL . 31.5 tptt -66.69 -47.39 72.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.285 -0.884 . . . . 0.0 109.795 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.506 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -63.32 -34.18 77.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.74 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.86 -33.89 85.47 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.658 ' NZ ' HG22 ' A' ' 133' ' ' VAL . 21.9 mttp -62.87 -37.87 88.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.366 -1.079 . . . . 0.0 109.78 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -78.81 -37.54 40.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.491 -0.756 . . . . 0.0 109.826 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 135' ' ' ALA . 20.9 mttm -66.89 -33.24 75.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.411 -0.805 . . . . 0.0 109.801 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.1 -45.71 26.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.311 -0.868 . . . . 0.0 109.829 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.0 m -59.13 -42.8 91.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.425 -0.797 . . . . 0.0 109.798 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -59.88 -46.26 89.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.31 -0.869 . . . . 0.0 109.816 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.5 HD23 ' HA ' ' A' ' 143' ' ' LEU . 18.9 mt -58.13 -35.63 71.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.373 -0.829 . . . . 0.0 109.722 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.578 ' HA ' HD12 ' A' ' 147' ' ' ILE . 22.6 m-85 -64.27 -34.33 77.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.372 -0.83 . . . . 0.0 109.774 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -71.95 -16.9 62.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.332 -0.855 . . . . 0.0 109.848 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.971 ' HB3' HG21 ' A' ' 33' ' ' ILE . 19.5 mt -81.23 -36.65 29.73 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.231 -0.918 . . . . 0.0 108.728 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.661 HG21 ' HG ' ' A' ' 18' ' ' LEU . 27.8 mt -70.43 -49.03 56.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.504 ' O ' HG13 ' A' ' 13' ' ' ILE . 97.9 mt-10 -53.07 -38.83 62.84 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.379 -0.825 . . . . 0.0 109.056 178.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.477 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 35.2 m -76.49 -30.18 57.13 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.271 -0.893 . . . . 0.0 109.011 178.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.593 ' CD1' HD11 ' A' ' 33' ' ' ILE . 54.0 t80 -50.52 -52.95 33.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.591 -0.693 . . . . 0.0 109.566 179.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.964 HD21 ' CE1' ' A' ' 158' ' ' TYR . 40.6 mt -80.15 -25.0 40.01 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.457 -0.777 . . . . 0.0 109.812 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.545 ' HA ' HD11 ' A' ' 13' ' ' ILE . 14.4 tttp -63.38 -17.42 62.6 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.329 -0.857 . . . . 0.0 109.311 179.133 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.49 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -120.3 -27.14 2.07 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.427 ' ND1' ' N ' ' A' ' 154' ' ' HIS . 1.3 m80 -106.38 91.24 5.56 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.191 -1.182 . . . . 0.0 110.285 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.8 Cg_endo -73.38 2.51 5.6 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.022 1.538 . . . . 0.0 110.82 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -113.17 -9.58 13.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.12 -0.987 . . . . 0.0 109.879 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.731 ' HB3' HH21 ' A' ' 17' ' ' ARG . . . -47.8 111.08 0.38 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.386 -0.821 . . . . 0.0 110.176 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 1.17 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 35.13 31.56 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.695 -0.628 . . . . 0.0 110.658 -179.804 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.533 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.65 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 93.5 t -128.04 126.57 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -1.161 . . . . 0.0 110.226 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.604 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 38.9 m-85 -87.18 161.36 18.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 0.0 110.415 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.856 HG23 ' CE1' ' A' ' 119' ' ' HIS . 33.8 m -138.63 92.18 2.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.886 . . . . 0.0 110.272 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.651 ' CD1' HG11 ' A' ' 133' ' ' VAL . 72.5 m-85 -110.43 126.61 54.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.245 -0.909 . . . . 0.0 109.643 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 116' ' ' SER . 21.2 pt-20 -132.47 152.2 51.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -0.916 . . . . 0.0 110.699 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 61.6 m -129.87 138.86 51.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.367 -0.833 . . . . 0.0 109.581 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -112.99 139.92 48.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.117 -0.989 . . . . 0.0 110.816 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.598 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.8 p90 -155.97 -175.23 5.32 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.431 -0.793 . . . . 0.0 109.511 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.803 HG22 ' HA ' ' A' ' 113' ' ' ILE . 8.1 p -139.9 174.57 10.38 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.99 -1.069 . . . . 0.0 110.814 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.46 ' HB3' ' OE2' ' A' ' 148' ' ' GLU . 54.1 p -158.59 127.41 5.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.447 -0.783 . . . . 0.0 110.124 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -55.1 -38.24 67.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.231 -0.918 . . . . 0.0 110.036 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.836 HG21 HD12 ' A' ' 151' ' ' LEU . 3.1 mp -59.07 150.36 62.26 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.416 -0.803 . . . . 0.0 110.015 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.797 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.9 Cg_endo -66.41 142.29 65.19 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.938 1.493 . . . . 0.0 110.37 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.633 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.0 Cg_endo -72.4 -31.2 11.68 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.874 1.46 . . . . 0.0 112.881 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 44.2 Cg_endo -72.78 -19.85 23.41 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 N-CA-C 109.984 -0.814 . . . . 0.0 109.984 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.903 ' HG2' HD13 ' A' ' 151' ' ' LEU . 36.7 ttm180 -83.55 -47.62 11.11 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.773 HD23 ' C ' ' A' ' 18' ' ' LEU . 1.1 tt -67.51 -32.42 73.21 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.55 ' N ' HD23 ' A' ' 18' ' ' LEU . 57.2 t80 -64.17 -53.99 40.66 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.479 -0.763 . . . . 0.0 109.402 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.546 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 17.8 mttm -49.6 -41.43 42.09 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.801 -0.76 . . . . 0.0 109.326 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.036 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -76.65 -33.54 58.32 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.398 -0.814 . . . . 0.0 111.04 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.817 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.6 OUTLIER -71.49 -49.08 44.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.036 -1.04 . . . . 0.0 111.323 -178.803 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.58 ' HB ' HD12 ' A' ' 24' ' ' LEU . 4.9 t -104.75 -49.25 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.015 -1.053 . . . . 0.0 111.437 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.674 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.2 mp -76.99 -5.42 48.61 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.088 -1.007 . . . . 0.0 111.218 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.573 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -157.2 54.98 0.51 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.861 -1.15 . . . . 0.0 110.418 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.817 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -92.04 -10.07 40.47 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.341 -0.849 . . . . 0.0 110.05 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.514 ' O ' ' CG ' ' A' ' 31' ' ' PRO . 41.8 t0 -73.26 -20.32 60.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.326 -0.859 . . . . 0.0 109.919 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -128.46 14.02 6.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.353 -0.842 . . . . 0.0 109.888 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.873 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 0.4 OUTLIER -98.23 -46.19 5.92 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.363 -0.836 . . . . 0.0 110.321 -179.876 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.657 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.4 m -89.16 -33.35 0.4 Allowed Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.369 -0.832 . . . . 0.0 111.074 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.3 Cg_endo -80.22 7.59 4.62 Favored 'Trans proline' 0 C--N 1.317 -1.097 0 O-C-N 123.06 1.032 . . . . 0.0 110.318 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 51.6 tttt -131.99 -33.24 1.37 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.298 -0.876 . . . . 0.0 109.972 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.575 HG12 ' CD1' ' A' ' 150' ' ' TYR . 11.9 mt -80.02 -43.0 22.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.386 -0.821 . . . . 0.0 109.876 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.717 ' HB2' HD13 ' A' ' 146' ' ' LEU . . . -152.2 95.47 3.16 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.298 -0.876 . . . . 0.0 110.233 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -76.92 6.2 4.38 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.125 1.592 . . . . 0.0 110.774 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -89.59 -9.44 49.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.077 -1.014 . . . . 0.0 110.214 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.733 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -104.12 -41.78 5.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 110.23 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.733 HD12 ' C ' ' A' ' 37' ' ' ALA . 1.4 mp -136.43 121.07 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.429 -0.794 . . . . 0.0 109.88 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 57' ' ' THR . 6.7 ttpp -56.79 -29.94 63.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -0.914 . . . . 0.0 110.249 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.524 ' CG ' ' N ' ' A' ' 41' ' ' SER . 0.0 OUTLIER 173.53 179.38 0.1 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.245 -0.91 . . . . 0.0 110.004 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.524 ' N ' ' CG ' ' A' ' 40' ' ' HIS . 56.3 m -139.97 148.46 41.94 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.234 -0.916 . . . . 0.0 110.245 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.4 tp10 -152.85 111.2 3.69 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.155 -0.965 . . . . 0.0 110.601 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 29.8 mt -60.51 133.1 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.198 -0.939 . . . . 0.0 109.895 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.54 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 18.2 mt -107.27 -27.06 10.75 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.176 -0.952 . . . . 0.0 110.686 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.716 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.8 m95 -126.18 161.19 28.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.118 -0.989 . . . . 0.0 110.826 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.454 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 41.95 -133.81 3.86 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.431 ' O ' ' CG ' ' A' ' 47' ' ' ASP . 9.5 t0 -154.67 19.17 0.46 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.309 -1.112 . . . . 0.0 110.011 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.01 -17.29 7.63 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.577 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -70.31 -172.55 11.15 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -73.62 129.08 13.23 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 O-C-N 124.093 1.575 . . . . 0.0 110.589 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.38 -11.66 56.82 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.528 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -71.71 164.75 25.37 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.522 -0.987 . . . . 0.0 109.699 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.716 HD12 ' CG ' ' A' ' 45' ' ' TRP . 47.3 mt -133.35 120.9 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.345 -0.847 . . . . 0.0 109.725 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.471 ' CE ' HD11 ' A' ' 71' ' ' ILE . 28.4 mttm -104.36 131.4 51.75 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.205 -0.935 . . . . 0.0 110.291 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.54 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 73.0 tttt -101.81 93.26 5.22 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.215 -0.928 . . . . 0.0 110.05 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.55 ' CG2' HG12 ' A' ' 38' ' ' ILE . 74.6 mt -80.0 147.34 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.216 -0.927 . . . . 0.0 110.065 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.576 ' O ' HG23 ' A' ' 38' ' ' ILE . 2.2 p -116.69 150.59 37.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.29 -0.881 . . . . 0.0 110.729 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.703 ' HE2' HG13 ' A' ' 67' ' ' VAL . 22.3 m-85 -113.79 126.84 55.66 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.411 -0.806 . . . . 0.0 110.037 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.437 ' N ' ' HB2' ' A' ' 39' ' ' LYS . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.256 0.551 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.576 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -120.98 94.49 0.55 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.537 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 11.8 p90 -131.17 169.13 16.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -1.182 . . . . 0.0 110.217 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.792 HG12 ' HA2' ' A' ' 88' ' ' GLY . 4.1 m -135.25 177.9 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.233 -0.917 . . . . 0.0 110.345 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.656 ' O ' HD12 ' A' ' 85' ' ' LEU . 83.2 mttt -134.91 106.8 7.02 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.377 -0.827 . . . . 0.0 109.872 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.983 ' CD2' HD13 ' A' ' 85' ' ' LEU . 14.5 m170 -98.32 125.78 43.57 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.217 -0.927 . . . . 0.0 111.247 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.577 ' CE ' ' CG2' ' A' ' 86' ' ' ILE . 5.8 mtmp? -93.3 119.13 32.09 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.29 -0.881 . . . . 0.0 109.496 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.577 HG21 ' O ' ' A' ' 49' ' ' GLY . 37.8 mm -58.36 128.39 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.128 -0.983 . . . . 0.0 110.519 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.483 ' HB2' ' OG ' ' A' ' 82' ' ' SER . 94.3 m-20 -101.81 -43.82 5.71 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.382 -0.824 . . . . 0.0 109.939 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.498 ' N ' ' OG ' ' A' ' 82' ' ' SER . 22.7 m -169.49 158.89 8.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.407 -0.808 . . . . 0.0 109.736 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.6 mt -142.99 158.27 17.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.175 -0.953 . . . . 0.0 110.465 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.552 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 4.4 m-20 -134.32 77.81 1.72 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.682 -0.636 . . . . 0.0 109.927 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.53 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 14.7 ttpp -61.14 -16.25 42.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.088 -1.008 . . . . 0.0 110.238 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -93.15 -30.34 15.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.287 -0.883 . . . . 0.0 109.623 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.5 m120 -106.38 -7.28 17.73 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.481 -0.762 . . . . 0.0 109.958 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.575 ' O ' HD12 ' A' ' 104' ' ' LEU . 2.7 m-85 67.59 51.19 0.85 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.49 -0.756 . . . . 0.0 110.008 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.552 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -123.41 151.2 42.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.305 -0.872 . . . . 0.0 109.324 179.618 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.684 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 31.1 t80 -137.93 141.07 40.58 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.174 -0.954 . . . . 0.0 110.414 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.498 ' OG ' ' N ' ' A' ' 73' ' ' SER . 1.2 p -143.38 126.48 16.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.243 -0.911 . . . . 0.0 110.56 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.684 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 26.8 p90 -149.17 170.86 17.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.33 -0.856 . . . . 0.0 110.233 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.857 HG23 ' O ' ' A' ' 98' ' ' ILE . 40.7 m -127.05 150.51 49.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.308 -0.87 . . . . 0.0 109.88 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.983 HD13 ' CD2' ' A' ' 69' ' ' HIS . 8.0 tp -111.42 124.79 52.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.0 -1.063 . . . . 0.0 110.354 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.577 ' CG2' ' CE ' ' A' ' 70' ' ' LYS . 14.4 pt -105.21 -27.08 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.382 -0.824 . . . . 0.0 110.23 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.611 ' O ' HD11 ' A' ' 85' ' ' LEU . 81.7 tt0 -123.38 155.73 36.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -0.86 . . . . 0.0 110.227 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.792 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 162.26 137.99 2.32 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -65.07 -19.21 65.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.22 -1.164 . . . . 0.0 110.16 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.93 -17.8 45.83 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.288 -0.882 . . . . 0.0 110.278 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.635 HD22 HD12 ' A' ' 98' ' ' ILE . 14.1 mt -61.38 -29.02 69.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.269 -0.894 . . . . 0.0 110.03 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 47.27 -175.61 0.01 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.575 ' OD1' HG23 ' A' ' 94' ' ' THR . 54.6 p30 -83.85 6.76 20.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.192 -1.181 . . . . 0.0 109.773 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.575 HG23 ' OD1' ' A' ' 93' ' ' ASP . 50.0 p -98.93 -42.42 7.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.366 -0.834 . . . . 0.0 110.225 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.921 HD21 HD11 ' A' ' 128' ' ' ILE . 74.6 mt -100.44 161.67 13.45 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.39 -0.819 . . . . 0.0 110.137 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -142.46 -81.27 0.21 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.307 -0.871 . . . . 0.0 109.609 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 7.8 mtpp -80.2 143.74 33.54 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.688 -0.632 . . . . 0.0 110.352 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.857 ' O ' HG23 ' A' ' 84' ' ' THR . 0.6 OUTLIER -138.06 134.86 45.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.049 -1.032 . . . . 0.0 109.489 179.092 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.499 ' CB ' ' HB2' ' A' ' 119' ' ' HIS . 0.1 OUTLIER -109.9 141.06 43.16 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.467 -0.771 . . . . 0.0 109.875 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.611 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 2.8 m-85 -127.8 143.16 51.14 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.319 -0.863 . . . . 0.0 110.341 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.476 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 68.2 tt0 -149.79 119.43 6.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.317 -0.864 . . . . 0.0 110.193 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 64.4 m -119.66 150.76 39.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.166 -0.959 . . . . 0.0 109.923 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 115' ' ' LYS . 20.8 mttt -142.65 133.71 25.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.237 -0.915 . . . . 0.0 110.515 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.927 HD23 HG12 ' A' ' 114' ' ' ILE . 5.4 mt -116.74 147.35 42.11 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.193 -0.942 . . . . 0.0 109.799 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.69 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -150.69 -168.75 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.195 -0.941 . . . . 0.0 110.107 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.69 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -112.75 156.15 23.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.356 -0.84 . . . . 0.0 109.973 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.452 ' HB3' HG13 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -114.42 170.21 5.71 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.257 -0.902 . . . . 0.0 110.36 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -76.04 0.77 8.95 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.069 1.563 . . . . 0.0 110.471 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 59.0 p -109.9 8.96 24.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.236 -0.915 . . . . 0.0 110.268 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 93.41 -26.39 15.91 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.428 ' C ' ' OG ' ' A' ' 107' ' ' SER . . . -70.24 -172.41 10.81 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.509 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 5.2 p -124.78 127.2 46.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.124 -1.221 . . . . 0.0 110.428 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.803 ' HA ' HG22 ' A' ' 10' ' ' THR . 73.9 mt -79.9 148.28 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.303 -0.873 . . . . 0.0 110.199 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.927 HG12 HD23 ' A' ' 104' ' ' LEU . 18.0 mt -132.45 127.48 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.188 -0.945 . . . . 0.0 110.563 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 103' ' ' LYS . 38.1 tttp -118.08 118.59 32.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.255 -0.903 . . . . 0.0 109.797 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.1 t -113.9 155.17 26.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.114 -0.991 . . . . 0.0 110.656 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.476 ' HB ' ' HB3' ' A' ' 101' ' ' GLU . 78.6 m -149.87 133.37 16.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.365 -0.834 . . . . 0.0 110.192 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 28.0 p -126.47 142.99 51.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.237 -0.914 . . . . 0.0 110.238 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.856 ' CE1' HG23 ' A' ' 4' ' ' THR . 85.5 m-70 -122.67 157.37 32.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.152 -0.967 . . . . 0.0 110.436 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.526 ' CD2' HG13 ' A' ' 128' ' ' ILE . 28.5 m-85 -128.32 137.34 51.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.248 -0.908 . . . . 0.0 110.354 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.487 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 47.4 m-70 -117.71 88.79 2.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.095 -1.003 . . . . 0.0 109.491 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.809 ' CG2' HD23 ' A' ' 95' ' ' LEU . 1.1 p -72.92 160.16 32.57 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.46 -0.775 . . . . 0.0 110.411 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 15.5 tttt -113.9 111.85 22.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.372 -0.83 . . . . 0.0 110.214 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 113.64 -133.87 11.49 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -123.5 64.33 1.02 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.217 -1.166 . . . . 0.0 110.255 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.452 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 24.2 m -130.73 162.52 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.258 -0.901 . . . . 0.0 110.142 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.423 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 93.0 mt-10 -134.67 161.62 34.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 0.0 110.307 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.921 HD11 HD21 ' A' ' 95' ' ' LEU . 20.6 mm -67.29 173.12 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 0.0 110.056 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.591 ' N ' HG22 ' A' ' 128' ' ' ILE . 12.5 mttt -111.75 132.8 54.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.0 110.029 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.434 ' OE1' ' HA ' ' A' ' 130' ' ' GLU . 69.4 mm-40 -44.61 -35.16 2.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.195 -0.941 . . . . 0.0 110.133 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -67.81 -23.81 65.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 109.967 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.472 ' N ' ' O ' ' A' ' 129' ' ' LYS . 16.4 t-160 -83.16 -49.33 9.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.297 -0.877 . . . . 0.0 110.217 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.651 HG11 ' CD1' ' A' ' 5' ' ' TYR . 98.8 t -59.61 -34.29 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.388 -0.82 . . . . 0.0 110.076 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -73.87 -51.14 17.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.893 . . . . 0.0 110.037 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.426 ' O ' ' HG3' ' A' ' 139' ' ' LYS . . . -59.29 -32.95 70.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.251 -0.905 . . . . 0.0 110.016 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.34 -27.93 73.11 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 81.0 mttt -78.9 -31.71 45.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.246 -1.15 . . . . 0.0 110.125 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -88.72 -30.03 19.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 0.0 109.92 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.426 ' HG3' ' O ' ' A' ' 135' ' ' ALA . 25.9 mttm -72.17 -31.11 65.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.349 -0.845 . . . . 0.0 109.94 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -86.64 -41.64 14.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.258 -0.901 . . . . 0.0 109.961 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 36.0 t -53.22 -43.25 67.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.338 -0.851 . . . . 0.0 110.088 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -57.38 -42.87 83.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -0.847 . . . . 0.0 110.005 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.463 HD23 HD12 ' A' ' 146' ' ' LEU . 52.7 mt -63.9 -37.75 88.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -0.914 . . . . 0.0 109.941 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -63.14 -35.15 79.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.433 -0.792 . . . . 0.0 109.857 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -75.15 -10.68 59.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.289 -0.882 . . . . 0.0 110.278 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.717 HD13 ' HB2' ' A' ' 34' ' ' ALA . 24.0 mt -85.18 -36.67 20.87 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.11 -0.994 . . . . 0.0 109.099 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.701 HD11 ' CE1' ' A' ' 22' ' ' PHE . 32.3 mt -71.2 -44.12 74.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.618 ' HB3' HD13 ' A' ' 13' ' ' ILE . 85.2 mt-10 -58.08 -42.22 85.14 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.446 -0.784 . . . . 0.0 109.614 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 28.2 m -70.19 -39.97 74.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.191 -0.943 . . . . 0.0 109.54 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.615 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 93.1 t80 -49.37 -42.44 42.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.437 -0.789 . . . . 0.0 109.995 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.903 HD13 ' HG2' ' A' ' 17' ' ' ARG . 42.6 mt -80.16 -44.72 19.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.322 -0.862 . . . . 0.0 110.33 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.745 ' HB2' HD11 ' A' ' 13' ' ' ILE . 29.9 tttt -61.03 -14.45 23.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.337 -0.852 . . . . 0.0 109.629 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -113.31 -30.05 2.8 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.46 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 5.5 m80 -112.64 96.09 35.35 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.357 -1.084 . . . . 0.0 110.025 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.48 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.9 Cg_endo -73.78 7.68 2.28 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.155 1.608 . . . . 0.0 111.279 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 157' ' ' ALA . 39.3 p30 -109.84 -9.56 14.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.952 -1.093 . . . . 0.0 109.582 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.615 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -66.01 101.14 0.65 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.548 -0.72 . . . . 0.0 110.182 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 1.036 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 0.3 OUTLIER 35.05 32.63 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.218 0 CA-C-O 121.406 0.622 . . . . 0.0 110.164 -179.602 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.533 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.305 -1.365 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.935 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 1.043 HG23 ' C ' ' A' ' 120' ' ' TYR . 3.4 p -88.11 148.13 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.332 -1.099 . . . . 0.0 110.538 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -83.95 172.25 12.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.403 -0.811 . . . . 0.0 110.118 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . 1.0 HG23 ' CE1' ' A' ' 119' ' ' HIS . 92.8 m -141.1 124.83 16.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.289 -0.882 . . . . 0.0 110.46 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.639 ' CZ ' HG11 ' A' ' 133' ' ' VAL . 74.4 m-85 -126.04 144.63 50.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.321 -0.862 . . . . 0.0 109.932 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.454 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 20.5 pt-20 -139.34 149.54 44.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.208 -0.932 . . . . 0.0 110.581 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -135.44 144.54 46.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.453 -0.779 . . . . 0.0 109.595 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -130.33 119.48 22.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.113 -0.992 . . . . 0.0 110.634 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.641 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.0 p90 -144.61 -177.89 5.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.393 -0.817 . . . . 0.0 109.793 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.89 HG22 ' HA ' ' A' ' 113' ' ' ILE . 9.4 p -141.9 171.89 13.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.175 -0.953 . . . . 0.0 110.678 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -152.36 154.99 36.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.46 -0.775 . . . . 0.0 110.247 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -77.01 -27.88 54.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.293 -0.88 . . . . 0.0 109.928 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.818 HG23 ' HD2' ' A' ' 14' ' ' PRO . 1.8 mp -71.39 150.54 94.07 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.351 -0.843 . . . . 0.0 109.849 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.818 ' HD2' HG23 ' A' ' 13' ' ' ILE . 41.0 Cg_endo -66.43 141.49 61.82 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.99 1.521 . . . . 0.0 110.498 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.636 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 41.2 Cg_endo -73.64 -30.21 9.94 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 124.068 1.562 . . . . 0.0 113.125 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 44.6 Cg_endo -71.56 -28.3 17.69 Favored 'Trans proline' 0 C--N 1.318 -1.034 0 N-CA-C 110.288 -0.697 . . . . 0.0 110.288 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.563 ' CZ ' ' HA ' ' A' ' 159' ' ' ASN . 6.3 mtp180 -79.92 -42.91 23.12 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.029 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.722 HD23 ' C ' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -66.51 -30.07 70.32 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.575 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.608 ' N ' HD23 ' A' ' 18' ' ' LEU . 52.0 t80 -63.83 -51.99 62.16 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.51 0.671 . . . . 0.0 109.851 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.54 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 22.9 mttt -55.94 -40.04 72.59 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.525 -0.734 . . . . 0.0 109.94 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.068 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -77.86 -26.8 49.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.263 -0.898 . . . . 0.0 110.946 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 1.002 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 3.4 t80 -81.8 -49.12 10.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.095 -1.003 . . . . 0.0 111.579 -178.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.702 HG13 ' CE1' ' A' ' 81' ' ' TYR . 5.5 t -102.03 -53.71 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.098 -1.001 . . . . 0.0 111.462 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.622 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.6 mp -66.0 -8.7 24.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.137 -0.977 . . . . 0.0 111.016 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.564 ' OD2' ' CE2' ' A' ' 158' ' ' TYR . 2.7 m-20 -145.0 21.79 1.58 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.963 -1.086 . . . . 0.0 110.524 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 1.002 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -59.73 -14.85 16.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.201 -0.937 . . . . 0.0 110.414 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -80.08 -25.03 40.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -0.914 . . . . 0.0 110.483 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.494 ' HB2' ' HE3' ' A' ' 32' ' ' LYS . 6.9 p30 -126.8 14.39 7.46 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.128 -0.982 . . . . 0.0 110.606 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.766 HD23 ' OH ' ' A' ' 158' ' ' TYR . 1.2 tm? -100.71 -43.09 6.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.239 -0.913 . . . . 0.0 109.858 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.93 HG11 HD13 ' A' ' 38' ' ' ILE . 4.8 t -77.41 -40.81 2.26 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.464 -0.772 . . . . 0.0 111.193 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 47.6 Cg_endo -77.6 10.65 2.45 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.444 1.234 . . . . 0.0 111.051 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.494 ' HE3' ' HB2' ' A' ' 28' ' ' ASN . 16.6 mttm -122.27 -30.74 3.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.985 -1.072 . . . . 0.0 109.496 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.93 HG21 ' HB3' ' A' ' 146' ' ' LEU . 7.5 mt -80.13 -55.48 8.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.579 -0.701 . . . . 0.0 109.821 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.51 103.96 5.02 Favored Pre-proline 0 C--N 1.304 -1.409 0 O-C-N 121.404 -0.81 . . . . 0.0 110.238 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.33 0.34 7.54 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.015 1.534 . . . . 0.0 110.526 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -81.62 -20.59 39.42 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.116 -0.99 . . . . 0.0 109.475 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -91.5 -42.32 10.33 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.467 -0.771 . . . . 0.0 109.927 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.93 HD13 HG11 ' A' ' 30' ' ' VAL . 1.1 mp -137.7 140.1 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.43 -0.794 . . . . 0.0 109.944 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.3 ttmm -82.25 -36.37 27.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 110.208 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -176.44 154.98 1.36 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.262 -0.898 . . . . 0.0 110.192 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.5 m -124.2 116.8 23.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.287 -0.883 . . . . 0.0 109.975 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.8 tp10 -122.79 113.27 18.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.193 -0.942 . . . . 0.0 110.449 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.482 HG12 ' HG2' ' A' ' 54' ' ' LYS . 23.2 mt -60.67 133.94 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.322 -0.861 . . . . 0.0 109.98 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.537 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 26.7 mt -106.97 -23.5 12.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.247 -0.908 . . . . 0.0 110.517 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.576 ' CD1' HD12 ' A' ' 53' ' ' ILE . 1.6 m95 -130.94 161.25 32.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.127 -0.983 . . . . 0.0 110.559 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.454 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 41.98 -133.56 3.95 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -157.7 20.65 0.27 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -1.104 . . . . 0.0 110.059 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.465 ' O ' HG21 ' A' ' 71' ' ' ILE . . . 125.49 -19.92 6.61 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.484 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -67.79 -175.21 8.48 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.426 ' HA ' HG22 ' A' ' 71' ' ' ILE . 47.1 Cg_endo -73.92 129.54 13.47 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 123.932 1.49 . . . . 0.0 110.66 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.94 -13.99 52.66 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -68.0 166.38 15.95 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.516 -0.991 . . . . 0.0 109.907 179.751 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.576 HD12 ' CD1' ' A' ' 45' ' ' TRP . 40.7 mt -133.27 121.68 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.315 -0.865 . . . . 0.0 109.662 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.52 ' HE3' HD11 ' A' ' 71' ' ' ILE . 20.7 mttm -111.15 132.29 54.41 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.144 -0.973 . . . . 0.0 110.411 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.537 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 17.7 tttt -101.36 89.93 3.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 109.904 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.551 ' CG2' HG12 ' A' ' 38' ' ' ILE . 83.0 mt -79.98 144.4 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.296 -0.877 . . . . 0.0 110.168 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.516 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 4.8 p -117.31 159.11 23.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.295 -0.878 . . . . 0.0 110.603 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' A' ' 65' ' ' GLY . 22.5 m-85 -119.61 149.54 41.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.381 -0.824 . . . . 0.0 110.076 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.964 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.306 0.574 . . . . 0.0 110.342 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -134.1 91.61 0.25 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.538 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 15.2 p90 -129.92 166.7 19.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.137 -1.213 . . . . 0.0 110.276 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.794 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.4 m -142.92 172.27 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 110.696 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.523 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 23.3 mttm -125.19 124.48 41.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.621 -0.675 . . . . 0.0 109.543 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.698 ' NE2' HD13 ' A' ' 85' ' ' LEU . 11.3 m170 -113.41 126.1 54.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.143 -0.973 . . . . 0.0 111.157 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 1.03 ' HE3' HD13 ' A' ' 86' ' ' ILE . 48.3 mttt -97.82 117.15 31.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.373 -0.829 . . . . 0.0 109.509 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.522 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 22.4 mm -60.07 128.64 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.082 -1.011 . . . . 0.0 110.311 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 82' ' ' SER . 89.4 m-20 -102.5 -45.34 5.09 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.314 -0.867 . . . . 0.0 110.179 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 19.1 m -168.08 159.07 10.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.385 -0.822 . . . . 0.0 110.094 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.483 HG12 HG11 ' A' ' 23' ' ' VAL . 2.0 mt -141.26 158.79 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.292 -0.88 . . . . 0.0 110.118 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.551 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 4.5 m-20 -135.37 80.02 1.81 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.502 -0.749 . . . . 0.0 110.116 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.564 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 17.8 mttt -62.39 -18.16 60.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.135 -0.978 . . . . 0.0 110.4 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -91.91 -31.79 15.53 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.133 -0.979 . . . . 0.0 109.633 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.476 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.5 m120 -103.58 -6.63 21.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.591 -0.693 . . . . 0.0 109.799 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.569 ' CZ ' ' HB3' ' A' ' 16' ' ' PRO . 4.1 m-85 65.91 51.8 1.32 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.494 -0.754 . . . . 0.0 110.056 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.551 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -123.38 157.9 32.33 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.081 -1.012 . . . . 0.0 109.595 179.812 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.702 ' CE1' HG13 ' A' ' 23' ' ' VAL . 32.3 t80 -144.56 141.01 29.16 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.196 -0.94 . . . . 0.0 110.259 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.6 OUTLIER -145.89 127.02 14.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.208 -0.932 . . . . 0.0 110.929 -179.799 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.688 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 20.0 p90 -146.6 170.67 16.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.436 -0.79 . . . . 0.0 109.796 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.606 HG23 ' O ' ' A' ' 98' ' ' ILE . 35.2 m -124.44 135.43 53.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.159 -0.963 . . . . 0.0 110.427 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.698 HD13 ' NE2' ' A' ' 69' ' ' HIS . 6.3 tp -99.49 124.35 44.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.283 -0.886 . . . . 0.0 109.702 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 1.03 HD13 ' HE3' ' A' ' 70' ' ' LYS . 14.3 pt -106.41 -15.77 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.387 -0.821 . . . . 0.0 110.459 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.523 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 24.9 tt0 -121.3 176.11 5.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.147 -0.97 . . . . 0.0 110.339 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.794 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 137.09 123.58 2.24 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -57.78 -15.37 7.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -1.142 . . . . 0.0 110.205 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.929 ' HB1' ' CE1' ' A' ' 132' ' ' HIS . . . -73.92 -40.48 63.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -0.88 . . . . 0.0 110.167 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.669 ' CD2' HD21 ' A' ' 95' ' ' LEU . 10.1 mt -42.17 -48.05 4.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.406 -0.809 . . . . 0.0 110.119 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 43.23 -164.72 0.03 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -81.19 2.57 27.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -1.142 . . . . 0.0 110.172 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 52.2 p -92.62 -42.51 9.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.287 -0.883 . . . . 0.0 110.17 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.873 HD12 ' H ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -119.55 159.91 23.43 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.367 -0.833 . . . . 0.0 109.339 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.873 ' H ' HD12 ' A' ' 95' ' ' LEU . 53.9 tt0 -136.32 -82.02 0.39 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.344 -0.848 . . . . 0.0 110.178 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.499 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 5.3 mttt -80.24 139.36 36.73 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.768 -0.583 . . . . 0.0 110.558 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.752 HG21 ' CE2' ' A' ' 100' ' ' TYR . 3.6 mm -123.06 139.97 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.963 -1.086 . . . . 0.0 109.887 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.513 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -117.48 126.77 53.19 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.279 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.752 ' CE2' HG21 ' A' ' 98' ' ' ILE . 8.7 m-85 -119.56 137.63 53.72 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.237 -0.914 . . . . 0.0 110.722 -178.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.469 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 80.9 tt0 -143.2 134.57 26.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.353 -0.842 . . . . 0.0 110.143 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.417 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 85.6 m -133.77 145.11 49.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -0.917 . . . . 0.0 110.18 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.6 mttt -140.53 140.72 35.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 0.0 110.671 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.794 HD23 HG12 ' A' ' 114' ' ' ILE . 10.1 mt -121.05 149.57 42.51 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.236 -0.915 . . . . 0.0 110.142 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.7 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -146.05 -169.71 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.207 -0.933 . . . . 0.0 110.03 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.7 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -126.68 160.56 30.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.256 -0.902 . . . . 0.0 110.275 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.423 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.2 p -119.32 170.55 6.54 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.225 -0.922 . . . . 0.0 110.144 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.423 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 45.7 Cg_endo -72.8 -14.8 26.89 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 124.11 1.584 . . . . 0.0 110.575 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 24.8 p -94.7 7.15 46.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -0.903 . . . . 0.0 110.273 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 94.46 -31.16 6.99 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -58.26 -172.41 0.34 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 10.4 p -137.25 137.63 39.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.194 -1.18 . . . . 0.0 110.39 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.89 ' HA ' HG22 ' A' ' 10' ' ' THR . 16.2 mt -92.58 149.59 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.402 -0.811 . . . . 0.0 110.088 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.794 HG12 HD23 ' A' ' 104' ' ' LEU . 18.5 mt -131.23 128.63 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.22 -0.925 . . . . 0.0 110.228 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.1 tttp -118.11 108.73 15.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.084 -1.01 . . . . 0.0 110.209 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.434 ' OG ' ' CZ ' ' A' ' 9' ' ' PHE . 0.9 OUTLIER -103.25 157.33 17.08 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.238 -0.914 . . . . 0.0 110.441 -179.854 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.704 HG22 ' NE2' ' A' ' 119' ' ' HIS . 24.8 m -154.87 119.56 4.83 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.337 -0.852 . . . . 0.0 110.438 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 86.5 p -119.01 148.1 43.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.403 -0.811 . . . . 0.0 110.041 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 1.0 ' CE1' HG23 ' A' ' 4' ' ' THR . 24.6 m-70 -132.42 152.93 51.29 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.201 -0.937 . . . . 0.0 110.668 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 1.043 ' C ' HG23 ' A' ' 2' ' ' VAL . 9.8 m-85 -121.82 119.92 33.05 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.271 -0.893 . . . . 0.0 110.614 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.566 ' N ' HG23 ' A' ' 2' ' ' VAL . 80.4 m-70 -92.62 104.1 16.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.558 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.468 HG21 ' HA ' ' A' ' 127' ' ' GLU . 0.8 OUTLIER -77.96 144.75 36.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.141 -0.975 . . . . 0.0 110.374 -179.593 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.418 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 31.5 tttp -105.57 126.93 52.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.278 -0.889 . . . . 0.0 110.207 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.37 -138.92 21.14 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -113.87 59.64 0.67 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -1.142 . . . . 0.0 110.274 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 26.2 m -131.28 161.7 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.319 -0.863 . . . . 0.0 110.194 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.468 ' HA ' HG21 ' A' ' 122' ' ' THR . 85.3 mt-10 -137.6 139.7 40.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.266 -0.896 . . . . 0.0 110.25 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.598 HG22 ' N ' ' A' ' 129' ' ' LYS . 2.7 mp -59.77 173.25 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.191 -0.943 . . . . 0.0 110.148 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.598 ' N ' HG22 ' A' ' 128' ' ' ILE . 21.4 mttm -92.45 127.41 37.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 110.089 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -45.39 -44.72 12.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.149 -0.969 . . . . 0.0 110.136 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 29.0 tp10 -53.29 -30.26 37.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.194 -0.941 . . . . 0.0 110.04 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.929 ' CE1' ' HB1' ' A' ' 90' ' ' ALA . 11.1 t-160 -76.35 -57.82 3.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -0.932 . . . . 0.0 110.239 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.639 HG11 ' CZ ' ' A' ' 5' ' ' TYR . 72.3 t -59.19 -34.22 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.377 -0.827 . . . . 0.0 110.063 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -72.41 -49.1 36.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.332 -0.855 . . . . 0.0 110.111 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.87 -29.66 69.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.095 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.72 -32.08 80.29 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.429 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 17.3 mttp -65.04 -36.84 85.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.251 -1.146 . . . . 0.0 110.036 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -75.35 -35.44 61.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.307 -0.87 . . . . 0.0 110.041 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -70.12 -30.84 68.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.363 -0.836 . . . . 0.0 109.92 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.482 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -74.61 -41.28 60.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.287 -0.883 . . . . 0.0 110.134 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 61.3 p -64.68 -39.36 93.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.371 -0.831 . . . . 0.0 109.991 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -60.87 -48.11 83.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 110.004 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 27.6 mt -57.87 -38.54 75.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.271 -0.893 . . . . 0.0 109.957 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.498 ' HA ' HD12 ' A' ' 147' ' ' ILE . 19.7 m-85 -62.87 -33.79 76.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.448 -0.783 . . . . 0.0 109.905 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.409 ' HA ' ' OE1' ' A' ' 148' ' ' GLU . 92.8 mttt -74.85 -15.03 60.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -0.904 . . . . 0.0 110.202 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.93 ' HB3' HG21 ' A' ' 33' ' ' ILE . 28.2 mt -85.25 -36.69 20.76 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.222 -0.923 . . . . 0.0 109.043 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.626 HD13 ' CD1' ' A' ' 22' ' ' PHE . 16.1 mt -72.09 -41.41 67.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.538 ' HB3' HD13 ' A' ' 13' ' ' ILE . 86.5 mt-10 -59.13 -42.81 91.5 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.49 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 15.5 m -74.12 -27.96 61.11 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.64 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 50.2 t80 -52.07 -61.85 2.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.563 -0.71 . . . . 0.0 109.836 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.548 HD21 ' CE1' ' A' ' 158' ' ' TYR . 36.0 mt -72.24 -30.08 64.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.346 -0.846 . . . . 0.0 109.71 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.554 ' HB2' HD11 ' A' ' 13' ' ' ILE . 27.8 tttp -65.27 -33.84 76.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.343 -0.848 . . . . 0.0 109.253 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.487 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -99.0 -30.74 6.56 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -107.26 87.2 3.02 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.327 -1.101 . . . . 0.0 109.796 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 46.1 Cg_endo -72.08 2.62 4.71 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.068 1.562 . . . . 0.0 110.955 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -108.24 -12.61 15.05 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.96 -1.087 . . . . 0.0 110.197 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.64 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -69.2 99.71 1.19 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.253 -0.905 . . . . 0.0 109.846 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 1.068 ' CE1' ' HB2' ' A' ' 21' ' ' ALA . 0.1 OUTLIER 34.77 32.33 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 CA-C-O 121.518 0.675 . . . . 0.0 109.871 -179.21 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.563 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.446 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.826 -179.021 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.679 HG13 ' O ' ' A' ' 120' ' ' TYR . 40.4 t -126.85 139.95 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -1.135 . . . . 0.0 110.239 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.75 ' CE1' HD12 ' A' ' 128' ' ' ILE . 16.2 m-85 -101.94 160.6 14.35 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.213 -0.93 . . . . 0.0 109.728 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.596 HG23 ' CD2' ' A' ' 119' ' ' HIS . 5.1 m -124.42 108.32 12.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.118 -0.989 . . . . 0.0 110.508 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.759 ' CE1' HG11 ' A' ' 133' ' ' VAL . 25.3 m-85 -120.47 126.18 49.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.26 -0.9 . . . . 0.0 109.969 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.604 ' HB3' HG23 ' A' ' 117' ' ' THR . 25.8 pt-20 -139.37 159.66 41.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.924 . . . . 0.0 110.394 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.2 t -138.65 148.93 44.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.862 . . . . 0.0 110.012 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -131.81 123.28 27.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.195 -0.941 . . . . 0.0 110.257 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.638 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.0 p90 -145.94 -174.07 4.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.194 -0.941 . . . . 0.0 109.952 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.722 HG22 ' HA ' ' A' ' 113' ' ' ILE . 8.7 p -139.28 175.52 9.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.134 -0.979 . . . . 0.0 110.496 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.477 ' CB ' ' CD ' ' A' ' 148' ' ' GLU . 79.8 p -158.08 139.4 13.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.306 -0.871 . . . . 0.0 110.229 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -64.74 -28.71 69.77 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 0.0 109.888 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.805 HG23 ' HD2' ' A' ' 14' ' ' PRO . 8.3 mm -68.96 149.88 97.74 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.365 -0.835 . . . . 0.0 109.904 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.805 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.5 Cg_endo -65.6 146.47 84.57 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.971 1.511 . . . . 0.0 110.44 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.672 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.1 Cg_endo -71.51 -31.73 13.26 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.969 1.51 . . . . 0.0 112.828 -179.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.672 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 40.8 Cg_endo -69.41 -21.38 35.2 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 N-CA-C 110.059 -0.785 . . . . 0.0 110.059 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.753 ' HB3' HD13 ' A' ' 151' ' ' LEU . 52.7 mtp180 -85.68 -44.87 12.2 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.883 ' HG ' HG21 ' A' ' 147' ' ' ILE . 1.1 tt -71.34 -30.07 65.74 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.627 ' CZ ' HD11 ' A' ' 74' ' ' ILE . 71.4 t80 -66.88 -61.76 1.78 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.521 -0.737 . . . . 0.0 109.13 178.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.585 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 52.6 mttt -52.78 -34.33 52.84 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.338 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.95 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -72.21 -53.75 11.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.33 -0.856 . . . . 0.0 110.749 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.99 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.3 OUTLIER -59.86 -53.2 60.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.507 -0.745 . . . . 0.0 111.425 -178.897 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 1.004 HG11 HD12 ' A' ' 74' ' ' ILE . 11.1 t -91.26 -63.86 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.992 -1.068 . . . . 0.0 111.767 -178.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.585 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 4.7 mp -65.12 -3.57 3.9 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.22 -0.925 . . . . 0.0 111.793 -178.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.581 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.8 OUTLIER -140.46 9.54 2.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.658 -1.276 . . . . 0.0 110.788 179.882 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.99 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -51.57 -26.83 9.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.176 -0.953 . . . . 0.0 110.31 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -76.63 -13.95 60.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.947 . . . . 0.0 110.502 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.424 ' O ' ' HD2' ' A' ' 32' ' ' LYS . 72.0 m-80 -134.97 10.64 3.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.211 -0.93 . . . . 0.0 110.345 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.54 ' HG ' ' HB1' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -104.24 -40.97 5.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.185 -0.947 . . . . 0.0 110.38 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.848 ' CG1' HD13 ' A' ' 38' ' ' ILE . 2.8 t -81.08 -41.55 1.13 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.28 -0.888 . . . . 0.0 111.178 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.3 Cg_endo -77.17 11.17 2.14 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.387 1.204 . . . . 0.0 111.074 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.424 ' HD2' ' O ' ' A' ' 28' ' ' ASN . 17.1 mttm -123.25 -31.51 3.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.943 -1.098 . . . . 0.0 109.471 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.86 ' CG2' HD22 ' A' ' 146' ' ' LEU . 9.3 mt -80.12 -44.96 22.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.52 -0.737 . . . . 0.0 109.611 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.437 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . . . -141.07 99.11 6.66 Favored Pre-proline 0 C--N 1.304 -1.39 0 O-C-N 121.371 -0.831 . . . . 0.0 110.115 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 34' ' ' ALA . 44.9 Cg_endo -71.12 -2.82 11.71 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.951 1.501 . . . . 0.0 110.524 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -89.02 -23.15 22.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 109.949 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 58' ' ' PHE . . . -85.54 -70.39 0.59 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.323 -0.86 . . . . 0.0 110.06 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.848 HD13 ' CG1' ' A' ' 30' ' ' VAL . 1.8 mp -101.11 122.08 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.449 -0.782 . . . . 0.0 110.01 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 57' ' ' THR . 10.7 ttmt -75.2 -32.11 61.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.154 -0.966 . . . . 0.0 110.487 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -176.25 148.41 0.78 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.162 -0.961 . . . . 0.0 110.171 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.3 m -122.31 118.43 28.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.35 -0.844 . . . . 0.0 109.718 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -129.18 110.37 11.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.149 -0.969 . . . . 0.0 110.422 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.413 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 38.3 mt -53.06 144.91 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.372 -0.83 . . . . 0.0 110.046 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.0 tp -119.72 -25.13 5.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.237 -0.914 . . . . 0.0 110.544 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.825 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.7 m95 -127.81 162.97 25.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.113 -0.992 . . . . 0.0 110.646 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.446 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 42.56 -140.3 2.21 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -149.2 24.79 0.91 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.285 -1.126 . . . . 0.0 110.017 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 118.4 -12.19 12.51 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.546 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -81.97 -168.95 42.27 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.402 ' HA ' HG22 ' A' ' 71' ' ' ILE . 44.2 Cg_endo -72.54 128.28 13.37 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.042 1.548 . . . . 0.0 110.694 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.88 -12.45 49.66 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.1 m -72.85 162.28 29.68 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.616 -0.931 . . . . 0.0 109.47 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.825 HD12 ' CG ' ' A' ' 45' ' ' TRP . 66.1 mt -133.84 119.4 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.235 -0.916 . . . . 0.0 110.103 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.701 ' HE3' HD11 ' A' ' 71' ' ' ILE . 52.5 mttt -102.59 130.72 49.55 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.2 -0.938 . . . . 0.0 110.179 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.526 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 53.6 tttm -102.24 92.42 4.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.242 -0.911 . . . . 0.0 110.164 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.432 ' HB ' HG23 ' A' ' 67' ' ' VAL . 97.5 mt -80.45 140.61 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.142 -0.974 . . . . 0.0 110.394 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 1.4 p -110.16 150.94 27.91 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.351 -0.843 . . . . 0.0 110.267 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.675 ' HE2' HG13 ' A' ' 67' ' ' VAL . 24.7 m-85 -113.83 149.08 35.53 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.221 -0.924 . . . . 0.0 110.077 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.859 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.213 0.53 . . . . 0.0 110.228 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.571 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -130.26 88.69 0.3 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 13.7 p90 -133.77 166.68 22.07 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.192 -1.181 . . . . 0.0 110.292 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.855 HG12 ' HA2' ' A' ' 88' ' ' GLY . 4.4 m -133.93 175.74 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.384 -0.823 . . . . 0.0 110.253 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.711 ' O ' HD12 ' A' ' 85' ' ' LEU . 33.3 mttt -135.52 103.96 5.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.426 -0.797 . . . . 0.0 109.834 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.945 ' CD2' HD13 ' A' ' 85' ' ' LEU . 15.4 m170 -94.19 129.18 40.9 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.292 -0.88 . . . . 0.0 111.073 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 52' ' ' THR . 70.0 tttt -97.21 111.55 23.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.458 -0.776 . . . . 0.0 109.18 178.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.701 HD11 ' HE3' ' A' ' 54' ' ' LYS . 27.3 mm -52.91 125.61 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.093 -1.005 . . . . 0.0 110.354 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 82' ' ' SER . 95.0 m-20 -99.37 -48.6 4.74 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.374 -0.829 . . . . 0.0 109.666 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.4 m 177.8 160.68 0.51 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.544 -0.722 . . . . 0.0 110.054 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 1.004 HD12 HG11 ' A' ' 23' ' ' VAL . 3.2 tt -145.31 165.92 10.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.392 -0.817 . . . . 0.0 109.785 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.8 m-20 -128.95 76.89 1.75 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.099 -1.0 . . . . 0.0 110.132 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.59 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 65.3 mttm -55.43 -16.66 3.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.16 -0.962 . . . . 0.0 110.367 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -92.8 -30.67 15.35 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.348 -0.845 . . . . 0.0 109.705 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.516 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 2.4 m120 -106.61 -0.13 24.01 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.561 -0.712 . . . . 0.0 109.475 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.608 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 72.8 m-85 62.06 52.84 3.15 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.297 0.57 . . . . 0.0 110.863 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.478 ' HB3' ' HG3' ' A' ' 103' ' ' LYS . 0.7 OUTLIER -130.56 152.01 50.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 109.84 179.305 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.677 ' CE1' HG13 ' A' ' 23' ' ' VAL . 74.5 t80 -149.46 133.86 17.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.022 -1.049 . . . . 0.0 110.368 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 36.1 m -139.66 147.08 40.52 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.176 -0.952 . . . . 0.0 110.525 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.668 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 7.8 p90 -148.47 177.88 9.08 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.346 -0.846 . . . . 0.0 110.666 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 98' ' ' ILE . 15.6 m -127.88 123.32 34.76 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.441 -0.787 . . . . 0.0 109.924 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.945 HD13 ' CD2' ' A' ' 69' ' ' HIS . 12.2 tp -94.34 134.0 37.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.021 -1.05 . . . . 0.0 110.292 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.548 ' H ' HD12 ' A' ' 85' ' ' LEU . 13.6 pt -114.89 -33.32 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 110.334 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.641 ' O ' HD11 ' A' ' 85' ' ' LEU . 29.3 tt0 -114.11 134.07 55.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 110.38 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.855 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . -176.92 122.38 0.84 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -55.77 -17.07 5.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.16 -1.2 . . . . 0.0 110.235 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -91.35 -34.15 15.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.934 . . . . 0.0 110.469 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.622 HD12 ' C ' ' A' ' 91' ' ' LEU . 1.9 pp -84.9 -16.97 39.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.256 -0.903 . . . . 0.0 110.404 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.87 -23.8 75.62 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -49.45 -65.56 0.55 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.288 -1.125 . . . . 0.0 110.358 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 80.5 p -137.28 8.4 2.91 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.463 -0.773 . . . . 0.0 110.175 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 1.048 HD21 ' CG1' ' A' ' 128' ' ' ILE . 11.4 mt -119.41 177.73 4.81 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.3 -0.875 . . . . 0.0 110.051 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.517 ' O ' HD13 ' A' ' 91' ' ' LEU . 39.4 tt0 -146.29 -78.73 0.17 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.332 -0.855 . . . . 0.0 109.772 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.499 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 16.1 mttm -80.16 142.57 34.63 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.87 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.732 HG21 ' HE2' ' A' ' 100' ' ' TYR . 5.2 mm -135.39 140.97 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.924 -1.11 . . . . 0.0 110.548 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.55 137.15 53.42 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.59 -0.694 . . . . 0.0 109.235 178.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.732 ' HE2' HG21 ' A' ' 98' ' ' ILE . 8.4 m-85 -131.99 131.52 42.62 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.124 -0.985 . . . . 0.0 110.872 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.468 ' HG2' ' OG ' ' A' ' 82' ' ' SER . 7.1 mt-10 -129.52 133.47 47.26 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.409 -0.807 . . . . 0.0 109.91 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.51 ' N ' ' O ' ' A' ' 81' ' ' TYR . 43.4 m -127.41 144.9 50.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.925 . . . . 0.0 110.023 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.478 ' HG3' ' HB3' ' A' ' 80' ' ' SER . 2.2 mttt -141.94 136.49 30.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.944 . . . . 0.0 110.256 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.753 HD23 HG12 ' A' ' 114' ' ' ILE . 3.7 mt -120.91 151.01 40.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 110.102 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.713 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -151.62 -169.14 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.306 -0.872 . . . . 0.0 110.063 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.713 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -119.39 138.6 52.98 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.308 -0.87 . . . . 0.0 110.115 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.456 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 28.8 p -94.67 164.9 18.46 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.177 -0.952 . . . . 0.0 110.245 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.456 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.5 Cg_endo -72.5 -2.68 12.15 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.057 1.556 . . . . 0.0 110.59 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 81.8 p -102.14 0.86 35.4 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.225 -0.922 . . . . 0.0 110.263 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.73 -31.83 8.25 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -67.87 -173.98 7.59 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 1.1 p -126.29 131.42 51.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.235 -1.156 . . . . 0.0 110.237 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.722 ' HA ' HG22 ' A' ' 10' ' ' THR . 11.1 mt -82.3 150.26 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.415 -0.803 . . . . 0.0 110.196 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.753 HG12 HD23 ' A' ' 104' ' ' LEU . 15.4 mt -130.34 110.43 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 110.4 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.42 ' O ' ' N ' ' A' ' 103' ' ' LYS . 51.6 tttt -99.34 128.34 45.45 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.201 -0.937 . . . . 0.0 109.923 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 0.7 OUTLIER -123.02 153.39 39.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.182 -0.949 . . . . 0.0 110.537 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.604 HG23 ' HB3' ' A' ' 6' ' ' GLU . 28.7 m -159.99 127.71 4.67 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.396 -0.815 . . . . 0.0 110.286 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.486 ' HB2' ' CD1' ' A' ' 100' ' ' TYR . 24.6 p -132.13 160.16 36.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.242 -0.911 . . . . 0.0 110.225 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.596 ' CD2' HG23 ' A' ' 4' ' ' THR . 41.4 m80 -132.3 135.76 46.44 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.11 -0.994 . . . . 0.0 110.625 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.679 ' O ' HG13 ' A' ' 2' ' ' VAL . 4.4 m-30 -97.66 146.84 24.93 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.293 -0.879 . . . . 0.0 110.108 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.499 ' HB2' ' HB2' ' A' ' 97' ' ' LYS . 94.0 m-70 -126.73 92.11 3.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.074 -1.016 . . . . 0.0 109.86 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.657 HG21 ' O ' ' A' ' 126' ' ' VAL . 1.8 p -66.62 164.38 16.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.449 -0.782 . . . . 0.0 110.311 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.431 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 34.4 tptt -147.48 114.81 6.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.368 -0.832 . . . . 0.0 110.257 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 125' ' ' ASN . . . 111.26 25.61 4.94 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 2.9 t30 65.1 62.45 0.71 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.198 -1.178 . . . . 0.0 110.179 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.657 ' O ' HG21 ' A' ' 122' ' ' THR . 20.2 m -140.35 143.44 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.244 -0.91 . . . . 0.0 110.316 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.469 ' N ' ' OE1' ' A' ' 127' ' ' GLU . 47.0 mp0 -114.03 165.99 12.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 110.257 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 1.048 ' CG1' HD21 ' A' ' 95' ' ' LEU . 3.1 mt -89.42 173.15 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.259 -0.901 . . . . 0.0 110.134 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.617 ' N ' HG22 ' A' ' 128' ' ' ILE . 8.1 mttm -111.55 152.66 27.28 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.361 -0.837 . . . . 0.0 110.009 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -58.57 -34.98 71.67 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.222 -0.924 . . . . 0.0 109.979 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.507 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 46.5 tt0 -62.57 -33.09 74.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.279 -0.888 . . . . 0.0 109.91 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 18.3 t-160 -76.45 -52.31 10.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -0.883 . . . . 0.0 110.104 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.759 HG11 ' CE1' ' A' ' 5' ' ' TYR . 57.8 t -62.28 -41.07 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.394 -0.816 . . . . 0.0 109.889 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -71.97 -47.26 53.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.268 -0.895 . . . . 0.0 109.854 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.507 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -61.57 -33.87 74.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.262 -0.899 . . . . 0.0 109.902 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.13 -29.7 66.29 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 37.1 mttm -74.15 -33.0 63.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.205 -1.174 . . . . 0.0 109.921 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -79.25 -35.73 41.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.354 -0.841 . . . . 0.0 109.933 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -70.2 -33.2 71.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.352 -0.842 . . . . 0.0 109.779 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.426 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -76.49 -41.04 48.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.348 -0.845 . . . . 0.0 109.957 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 35.3 t -59.87 -43.81 94.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.385 -0.822 . . . . 0.0 109.848 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -59.28 -42.41 91.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.299 -0.875 . . . . 0.0 109.881 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.91 ' HA ' HD12 ' A' ' 146' ' ' LEU . 18.7 mt -61.75 -36.36 80.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 109.946 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.786 ' HA ' HD12 ' A' ' 147' ' ' ILE . 30.1 m-85 -64.41 -37.12 86.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.348 -0.845 . . . . 0.0 109.568 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 25.9 mttm -70.28 -12.9 61.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.418 -0.801 . . . . 0.0 109.977 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.91 HD12 ' HA ' ' A' ' 143' ' ' LEU . 9.2 mt -81.57 -36.43 29.06 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.138 -0.976 . . . . 0.0 108.855 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.903 HD11 ' CE1' ' A' ' 22' ' ' PHE . 8.2 mt -68.39 -49.41 66.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.501 ' O ' HG13 ' A' ' 13' ' ' ILE . 69.9 mt-10 -52.62 -42.54 64.7 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.566 -0.709 . . . . 0.0 109.675 179.064 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.504 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 54.1 m -70.81 -34.66 71.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.065 -1.022 . . . . 0.0 109.526 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.575 ' CD2' ' OH ' ' A' ' 158' ' ' TYR . 51.9 t80 -51.24 -60.85 2.66 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.519 -0.738 . . . . 0.0 109.924 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.06 HD21 ' CE1' ' A' ' 158' ' ' TYR . 38.1 mt -73.07 -27.9 62.0 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.393 -0.817 . . . . 0.0 109.995 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.632 ' HA ' HD11 ' A' ' 13' ' ' ILE . 60.1 tttm -57.2 -19.96 23.97 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.201 -0.937 . . . . 0.0 108.486 178.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -128.08 -4.09 5.62 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.572 ' CG ' ' O ' ' A' ' 150' ' ' TYR . 63.6 m170 -113.39 86.52 10.08 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.171 -1.193 . . . . 0.0 110.235 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -73.59 2.21 6.05 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.038 1.546 . . . . 0.0 110.859 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -124.04 4.38 8.64 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.122 -0.987 . . . . 0.0 110.005 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.758 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -69.13 108.81 3.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.296 -0.877 . . . . 0.0 110.053 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 1.06 ' CE1' HD21 ' A' ' 151' ' ' LEU . 0.3 OUTLIER 35.3 35.14 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.633 -0.667 . . . . 0.0 110.952 -179.363 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.565 ' CB ' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.417 0 CA-C-O 117.953 -1.023 . . . . 0.0 109.824 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 1.045 HG23 ' C ' ' A' ' 120' ' ' TYR . 5.0 p -85.79 153.68 3.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 121.27 -1.135 . . . . 0.0 110.064 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.55 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 16.2 m-85 -89.92 167.36 12.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.309 -0.87 . . . . 0.0 110.433 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.913 HG23 ' CE1' ' A' ' 119' ' ' HIS . 55.1 m -145.67 102.26 3.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.302 -0.874 . . . . 0.0 110.221 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.915 ' CZ ' HG22 ' A' ' 133' ' ' VAL . 84.8 m-85 -116.09 151.76 34.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.316 -0.865 . . . . 0.0 109.936 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 19.6 pt-20 -143.01 151.63 41.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.142 -0.974 . . . . 0.0 110.366 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.4 t -128.6 151.77 49.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.41 -0.806 . . . . 0.0 109.839 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.477 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 92.8 mt-10 -134.3 116.05 14.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.947 . . . . 0.0 110.488 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.2 p90 -142.66 -175.12 4.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -0.852 . . . . 0.0 109.778 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.775 HG22 ' HA ' ' A' ' 113' ' ' ILE . 6.6 p -137.75 173.35 11.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.144 -0.973 . . . . 0.0 110.634 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.511 ' HB3' HD11 ' A' ' 114' ' ' ILE . 84.0 p -149.56 144.22 26.09 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.397 -0.815 . . . . 0.0 110.23 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -72.57 -32.37 65.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.226 -0.921 . . . . 0.0 109.958 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.813 HG23 ' HD2' ' A' ' 14' ' ' PRO . 6.5 mm -72.51 151.35 91.66 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.517 -0.739 . . . . 0.0 109.653 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.813 ' HD2' HG23 ' A' ' 13' ' ' ILE . 39.1 Cg_endo -64.61 140.58 69.16 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.889 1.468 . . . . 0.0 110.692 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.656 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 41.9 Cg_endo -73.08 -30.49 10.69 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 124.145 1.603 . . . . 0.0 112.871 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.656 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.3 Cg_endo -69.84 -23.57 30.31 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 O-C-N 122.448 0.71 . . . . 0.0 110.357 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.515 ' NH2' ' HD2' ' A' ' 20' ' ' LYS . 1.6 mmp_? -83.42 -46.8 12.11 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.774 HD23 ' C ' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -65.54 -31.05 71.9 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.601 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.519 ' N ' HD23 ' A' ' 18' ' ' LEU . 59.4 t80 -64.66 -54.49 30.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.56 -0.712 . . . . 0.0 109.26 178.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.54 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 25.2 mttt -47.99 -42.84 28.91 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.796 -0.761 . . . . 0.0 109.459 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.969 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -73.07 -35.61 66.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.469 -0.77 . . . . 0.0 110.927 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 1.033 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -74.57 -42.85 58.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 111.42 -178.659 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.629 HG13 ' CE1' ' A' ' 81' ' ' TYR . 5.7 t -107.5 -50.36 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.956 -1.09 . . . . 0.0 111.74 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.766 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.3 mp -79.44 -5.64 55.14 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.077 -1.014 . . . . 0.0 111.483 -178.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.557 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 1.1 m-20 -151.2 30.36 0.62 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.796 -1.19 . . . . 0.0 110.651 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 1.033 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -72.87 -21.23 60.96 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.243 -0.91 . . . . 0.0 110.615 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.477 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 39.2 t0 -66.63 -24.14 66.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.014 -1.054 . . . . 0.0 110.201 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.558 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 7.1 p-10 -124.55 12.81 8.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.33 -0.856 . . . . 0.0 110.078 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.767 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -94.08 -48.45 6.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.364 -0.835 . . . . 0.0 110.221 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 1.032 HG21 HD13 ' A' ' 38' ' ' ILE . 3.7 p -76.89 -28.37 0.66 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.305 -0.872 . . . . 0.0 112.231 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.855 ' HD3' HG12 ' A' ' 30' ' ' VAL . 52.5 Cg_endo -79.23 5.31 5.87 Favored 'Trans proline' 0 C--N 1.319 -1.026 0 O-C-N 122.672 0.827 . . . . 0.0 110.272 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -128.78 -37.38 1.75 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 109.346 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.55 HG12 ' CD1' ' A' ' 150' ' ' TYR . 11.3 mt -79.97 -25.9 11.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-O 121.646 0.736 . . . . 0.0 109.151 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -157.22 77.32 3.93 Favored Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 121.628 -0.67 . . . . 0.0 109.841 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.29 -5.49 16.65 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.984 1.518 . . . . 0.0 110.565 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -87.65 -15.74 36.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.0 109.8 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -93.71 -69.27 0.76 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.38 -0.825 . . . . 0.0 110.151 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 1.032 HD13 HG21 ' A' ' 30' ' ' VAL . 1.7 mp -99.86 126.96 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.315 -0.866 . . . . 0.0 110.086 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.522 ' HB2' ' N ' ' A' ' 59' ' ' GLY . 27.7 ttpt -76.3 -25.41 54.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.357 -0.839 . . . . 0.0 110.639 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.51 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER 179.75 164.67 1.1 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.065 -1.022 . . . . 0.0 110.497 -179.75 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.454 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 18.5 m -137.53 128.6 27.57 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.466 -0.771 . . . . 0.0 109.81 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.51 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 48.5 tt0 -135.54 111.55 9.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.149 -0.969 . . . . 0.0 110.596 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.443 HG12 ' HG2' ' A' ' 54' ' ' LYS . 21.2 mt -59.54 140.26 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 109.859 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.729 HD11 ' HB2' ' A' ' 55' ' ' LYS . 39.0 mt -115.68 -27.91 6.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.145 -0.972 . . . . 0.0 110.268 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.683 ' CD1' HD12 ' A' ' 53' ' ' ILE . 1.4 m95 -123.58 157.95 32.54 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.246 -0.908 . . . . 0.0 110.418 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.412 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 43.53 -134.08 5.56 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.58 20.67 0.4 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.302 -1.117 . . . . 0.0 109.995 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.432 ' O ' HG21 ' A' ' 71' ' ' ILE . . . 125.56 -20.31 6.53 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.024 -1.631 . . . . 0.0 109.024 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.489 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -69.98 -172.47 10.27 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.429 ' HA ' HG22 ' A' ' 71' ' ' ILE . 45.5 Cg_endo -73.47 129.61 13.99 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.991 1.522 . . . . 0.0 110.653 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.79 -11.4 53.08 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.654 -1.778 . . . . 0.0 108.654 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 45' ' ' TRP . 1.0 OUTLIER -72.73 164.83 25.93 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.519 -0.989 . . . . 0.0 109.958 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.683 HD12 ' CD1' ' A' ' 45' ' ' TRP . 59.3 mt -135.49 120.09 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.4 -0.812 . . . . 0.0 109.698 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.443 ' HG2' HG12 ' A' ' 43' ' ' ILE . 93.8 mttt -108.49 134.85 50.7 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.195 -0.941 . . . . 0.0 110.624 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.729 ' HB2' HD11 ' A' ' 44' ' ' LEU . 32.9 tttt -101.53 92.68 5.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.262 -0.899 . . . . 0.0 110.084 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.524 ' CG2' HG12 ' A' ' 38' ' ' ILE . 84.2 mt -79.92 141.26 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.179 -0.951 . . . . 0.0 110.197 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 2.1 p -115.12 158.77 21.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 110.412 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.613 ' HE2' HG13 ' A' ' 67' ' ' VAL . 28.6 m-85 -119.31 135.94 54.48 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.368 -0.832 . . . . 0.0 110.12 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.522 ' N ' ' HB2' ' A' ' 39' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.22 0.533 . . . . 0.0 110.402 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.545 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -136.36 94.71 0.23 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.533 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 17.2 p90 -139.43 168.8 19.01 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.163 -1.199 . . . . 0.0 110.336 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.975 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.2 m -139.38 173.29 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.375 -0.828 . . . . 0.0 110.507 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.516 ' CE ' ' OE1' ' A' ' 87' ' ' GLU . 22.1 mttm -124.01 126.28 46.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.554 -0.716 . . . . 0.0 109.629 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.698 ' CE1' HD13 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -110.56 134.39 52.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.167 -0.958 . . . . 0.0 110.788 -179.549 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 52' ' ' THR . 29.6 ttpt -108.2 115.72 30.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.288 -0.883 . . . . 0.0 109.436 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.528 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 28.6 mm -62.95 120.67 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.3 -0.875 . . . . 0.0 110.561 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 82' ' ' SER . 83.8 m-20 -93.7 -42.58 9.08 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.521 -0.737 . . . . 0.0 109.717 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.469 ' OG ' ' HB2' ' A' ' 82' ' ' SER . 90.6 p -169.66 159.25 8.12 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.436 -0.79 . . . . 0.0 109.744 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.551 HG12 HG11 ' A' ' 23' ' ' VAL . 1.9 mt -142.34 156.36 19.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.213 -0.93 . . . . 0.0 110.354 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.548 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 5.1 m-20 -134.59 79.11 1.78 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.623 -0.673 . . . . 0.0 110.143 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.457 ' HZ2' HD21 ' A' ' 24' ' ' LEU . 67.5 mttm -62.83 -14.33 44.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.128 -0.982 . . . . 0.0 110.224 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -94.24 -32.29 13.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.241 -0.912 . . . . 0.0 109.592 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.5 m120 -104.75 -6.85 19.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.517 -0.739 . . . . 0.0 109.665 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.557 ' CZ ' ' HB3' ' A' ' 16' ' ' PRO . 4.1 m-85 67.21 50.62 0.98 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.571 -0.706 . . . . 0.0 110.224 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.548 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -121.11 151.53 39.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -0.922 . . . . 0.0 109.304 179.441 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.629 ' CE1' HG13 ' A' ' 23' ' ' VAL . 22.5 t80 -139.91 136.7 34.15 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.207 -0.933 . . . . 0.0 110.191 -178.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 4.8 m -139.45 121.55 15.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.93 . . . . 0.0 110.942 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.6 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 8.6 p90 -141.15 175.44 9.64 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.342 -0.849 . . . . 0.0 109.737 179.178 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.755 HG23 ' O ' ' A' ' 98' ' ' ILE . 82.1 m -131.77 143.11 49.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.912 . . . . 0.0 110.23 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.698 HD13 ' CE1' ' A' ' 69' ' ' HIS . 19.1 tp -96.67 121.01 38.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 110.126 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 20.3 pt -105.86 -17.95 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.392 -0.818 . . . . 0.0 109.982 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.516 ' OE1' ' CE ' ' A' ' 68' ' ' LYS . 83.1 tt0 -138.18 151.49 47.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -0.889 . . . . 0.0 110.374 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.975 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 164.94 133.5 1.51 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -64.18 -15.3 59.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.297 -1.119 . . . . 0.0 110.245 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.13 -18.59 45.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.302 -0.874 . . . . 0.0 110.207 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.647 HD22 ' CD1' ' A' ' 98' ' ' ILE . 16.4 mt -63.82 -19.8 65.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.225 -0.922 . . . . 0.0 110.073 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 46.29 -173.29 0.02 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.555 ' OD1' HG23 ' A' ' 94' ' ' THR . 59.5 p30 -87.93 12.36 13.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.133 -1.216 . . . . 0.0 109.823 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.734 HG22 HG11 ' A' ' 126' ' ' VAL . 23.2 p -107.07 -29.88 9.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.366 -0.834 . . . . 0.0 110.173 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.604 HD11 ' CD1' ' A' ' 128' ' ' ILE . 67.5 mt -107.95 161.29 15.07 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.269 -0.894 . . . . 0.0 110.405 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.401 ' OE2' ' HD2' ' A' ' 123' ' ' LYS . 55.9 mt-10 -142.28 -82.96 0.19 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.335 -0.853 . . . . 0.0 109.994 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.521 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 62.2 mttt -80.37 140.26 36.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.687 -0.633 . . . . 0.0 110.763 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.755 ' O ' HG23 ' A' ' 84' ' ' THR . 0.1 OUTLIER -135.0 135.55 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.967 -1.083 . . . . 0.0 109.602 178.98 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.485 ' HB2' ' CD2' ' A' ' 119' ' ' HIS . 0.5 OUTLIER -108.96 133.36 53.06 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.315 -0.866 . . . . 0.0 109.956 179.626 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.6 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 5.6 m-85 -122.78 132.3 54.16 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.312 -0.867 . . . . 0.0 110.252 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 117' ' ' THR . 2.9 mt-10 -134.65 130.43 36.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 0.0 110.242 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.475 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 26.0 m -129.41 135.94 49.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.222 -0.924 . . . . 0.0 109.858 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.4 mttm -134.18 135.78 43.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.156 -0.965 . . . . 0.0 110.599 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.887 HD23 HG12 ' A' ' 114' ' ' ILE . 7.1 mt -115.72 151.16 35.63 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.29 -0.882 . . . . 0.0 109.932 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.704 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -148.04 -169.04 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.133 -0.98 . . . . 0.0 110.0 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.704 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -124.37 154.09 40.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.288 -0.882 . . . . 0.0 110.137 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.457 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 5.1 p -113.7 168.1 8.39 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.896 . . . . 0.0 110.195 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 48.1 Cg_endo -72.92 -4.24 15.04 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.021 1.537 . . . . 0.0 110.474 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 34.3 p -104.89 8.71 34.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.284 -0.885 . . . . 0.0 110.279 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 94.5 -34.43 4.74 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -59.09 -171.78 0.4 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 3.1 p -134.82 136.05 42.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -1.167 . . . . 0.0 110.359 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.775 ' HA ' HG22 ' A' ' 10' ' ' THR . 22.4 mt -88.89 148.82 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.325 -0.859 . . . . 0.0 110.078 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.887 HG12 HD23 ' A' ' 104' ' ' LEU . 18.2 mt -132.3 124.51 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.205 -0.934 . . . . 0.0 110.46 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.477 ' HG3' ' HG2' ' A' ' 8' ' ' GLU . 75.3 tttt -113.59 109.82 19.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.2 -0.938 . . . . 0.0 110.014 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.447 ' OG ' ' CZ ' ' A' ' 9' ' ' PHE . 1.2 m -101.01 159.35 15.29 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.251 -0.906 . . . . 0.0 110.643 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.707 HG22 ' NE2' ' A' ' 119' ' ' HIS . 60.8 m -154.16 133.61 12.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.327 -0.858 . . . . 0.0 110.045 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.8 m -136.25 144.53 44.87 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.13 -0.981 . . . . 0.0 110.478 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.913 ' CE1' HG23 ' A' ' 4' ' ' THR . 20.8 m-70 -132.05 146.74 52.26 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.295 -0.878 . . . . 0.0 110.325 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 1.045 ' C ' HG23 ' A' ' 2' ' ' VAL . 40.2 m-85 -121.59 120.53 35.06 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.18 -0.95 . . . . 0.0 110.542 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.58 ' N ' HG23 ' A' ' 2' ' ' VAL . 87.2 m-70 -92.85 103.72 16.03 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.4 -0.812 . . . . 0.0 109.368 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.564 ' OG1' HG23 ' A' ' 126' ' ' VAL . 1.6 t -88.39 173.71 8.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.014 -1.054 . . . . 0.0 110.856 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.401 ' HD2' ' OE2' ' A' ' 96' ' ' GLU . 40.0 tttm -141.8 117.1 10.12 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 120.284 -0.567 . . . . 0.0 110.221 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 113.2 -123.98 6.4 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -133.25 62.03 1.66 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.313 -1.11 . . . . 0.0 110.204 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.734 HG11 HG22 ' A' ' 94' ' ' THR . 34.8 m -137.54 153.46 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.22 -0.925 . . . . 0.0 110.203 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.464 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 90.4 mt-10 -127.05 169.57 13.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.188 -0.945 . . . . 0.0 110.29 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.604 ' CD1' HD11 ' A' ' 95' ' ' LEU . 15.8 mm -67.77 173.09 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.884 . . . . 0.0 110.244 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.586 ' N ' HG22 ' A' ' 128' ' ' ILE . 17.5 mttp -99.08 149.53 22.94 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.265 -0.897 . . . . 0.0 110.041 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.12 -20.09 16.02 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.091 -1.006 . . . . 0.0 109.841 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.786 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 94.3 mt-10 -71.63 -39.91 70.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.369 -0.832 . . . . 0.0 109.904 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.486 ' HB2' ' CG2' ' A' ' 128' ' ' ILE . 6.3 m170 -65.18 -45.72 83.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.297 -0.877 . . . . 0.0 109.949 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.915 HG22 ' CZ ' ' A' ' 5' ' ' TYR . 58.3 t -64.95 -42.79 95.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.506 -0.746 . . . . 0.0 110.264 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 33.1 tttm -102.87 -63.57 1.15 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.283 -0.886 . . . . 0.0 110.31 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.786 ' HB3' ' O ' ' A' ' 131' ' ' GLU . . . -56.78 -19.54 17.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.122 -0.986 . . . . 0.0 110.025 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 131' ' ' GLU . . . -76.91 -31.16 54.39 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.221 -1.551 . . . . 0.0 109.221 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.491 ' CE ' ' O ' ' A' ' 133' ' ' VAL . 27.4 mttt -72.85 -30.07 63.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.324 -1.103 . . . . 0.0 110.18 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -82.91 -32.23 27.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.315 -0.866 . . . . 0.0 110.044 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 50.5 mttt -70.45 -38.46 74.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.391 -0.818 . . . . 0.0 110.028 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.402 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -78.74 -30.83 46.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.321 -0.862 . . . . 0.0 109.88 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.1 m -66.67 -45.29 79.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.35 -0.844 . . . . 0.0 110.011 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -50.99 -51.2 55.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.303 -0.873 . . . . 0.0 109.947 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.662 ' HA ' HD12 ' A' ' 146' ' ' LEU . 10.6 tp -55.47 -49.31 72.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.258 -0.901 . . . . 0.0 109.742 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.402 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 17.7 m-85 -53.62 -38.84 64.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.44 -0.788 . . . . 0.0 109.746 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -73.38 -16.72 61.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.273 -0.892 . . . . 0.0 109.852 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.662 HD12 ' HA ' ' A' ' 143' ' ' LEU . 17.7 mt -81.98 -35.68 28.69 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.234 -0.917 . . . . 0.0 108.706 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.662 HD11 ' CE1' ' A' ' 22' ' ' PHE . 53.5 mt -66.66 -47.17 84.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.498 ' O ' HG13 ' A' ' 13' ' ' ILE . 84.1 mt-10 -52.26 -45.42 65.39 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.307 -0.87 . . . . 0.0 109.324 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 36.4 m -64.68 -30.97 72.0 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.152 -0.968 . . . . 0.0 109.535 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.694 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 71.1 t80 -60.94 -50.48 73.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.474 -0.766 . . . . 0.0 109.815 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.143 HD21 ' CE1' ' A' ' 158' ' ' TYR . 92.5 mt -80.03 -36.92 35.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.223 -0.923 . . . . 0.0 110.03 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.594 ' HG3' HD11 ' A' ' 13' ' ' ILE . 16.6 tttt -64.03 -20.29 65.81 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.392 -0.817 . . . . 0.0 109.516 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -110.67 -32.78 2.6 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.45 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 3.7 m80 -109.6 94.3 16.21 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.267 -1.137 . . . . 0.0 110.203 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.71 6.25 3.38 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.08 1.569 . . . . 0.0 111.046 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -109.8 -2.37 17.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.994 -1.066 . . . . 0.0 109.966 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.694 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -74.39 104.61 5.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.368 -0.832 . . . . 0.0 110.199 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 1.143 ' CE1' HD21 ' A' ' 151' ' ' LEU . 1.5 p90 34.65 37.28 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.726 -0.609 . . . . 0.0 110.842 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.498 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.69 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.501 HG22 ' ND1' ' A' ' 121' ' ' HIS . 98.7 t -128.02 132.07 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.208 -1.172 . . . . 0.0 110.205 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.708 ' CE1' HD12 ' A' ' 128' ' ' ILE . 12.3 m-85 -93.19 148.21 22.22 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.205 -0.934 . . . . 0.0 110.117 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.778 HG23 ' CE1' ' A' ' 119' ' ' HIS . 10.3 m -128.1 111.48 13.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.173 -0.955 . . . . 0.0 110.344 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.983 ' CE2' HG21 ' A' ' 133' ' ' VAL . 69.1 m-85 -123.38 140.25 53.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.341 -0.85 . . . . 0.0 110.16 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -140.28 151.33 45.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.224 -0.923 . . . . 0.0 110.359 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.7 t -138.77 160.97 38.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.386 -0.821 . . . . 0.0 109.918 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.431 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 85.8 mt-10 -142.14 115.77 9.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.102 -0.999 . . . . 0.0 110.368 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.6 p90 -140.42 -175.04 4.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.311 -0.868 . . . . 0.0 109.843 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.778 HG22 ' HA ' ' A' ' 113' ' ' ILE . 2.4 p -137.52 167.38 21.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.118 -0.989 . . . . 0.0 110.493 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.445 ' HB3' HD11 ' A' ' 114' ' ' ILE . 75.5 p -138.93 147.93 42.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.38 -0.825 . . . . 0.0 110.168 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -69.96 -32.96 71.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.236 -0.915 . . . . 0.0 110.254 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.756 HD13 ' CB ' ' A' ' 148' ' ' GLU . 2.6 mp -79.58 148.56 69.93 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.378 -0.826 . . . . 0.0 109.915 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.755 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.0 Cg_endo -64.99 152.72 81.4 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.937 1.493 . . . . 0.0 110.722 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.695 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 36.7 Cg_endo -63.35 -35.87 59.34 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.793 1.418 . . . . 0.0 113.035 -178.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.695 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 38.0 Cg_endo -63.89 -21.3 68.99 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 N-CA-C 109.811 -0.88 . . . . 0.0 109.811 178.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.761 ' HB3' HD13 ' A' ' 151' ' ' LEU . 6.6 mmp_? -80.28 -45.25 18.23 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.682 HD12 ' N ' ' A' ' 18' ' ' LEU . 9.3 mp -73.31 -40.87 64.16 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.251 -0.98 . . . . 0.0 108.576 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.617 ' CD1' ' HA ' ' A' ' 79' ' ' TYR . 36.9 t80 -52.72 -59.95 3.86 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 119.869 -0.733 . . . . 0.0 110.155 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.536 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 40.4 mttp -56.03 -38.27 70.33 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.404 -0.81 . . . . 0.0 110.18 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.056 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -78.56 -62.76 1.58 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.125 -0.984 . . . . 0.0 110.878 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 1.055 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.3 OUTLIER -49.2 -41.49 37.17 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.65 -0.656 . . . . 0.0 112.006 -178.847 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 1.047 HG11 HD12 ' A' ' 74' ' ' ILE . 11.5 t -106.32 -62.93 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.767 -1.208 . . . . 0.0 111.813 -178.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.649 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.4 mp -68.5 -1.07 5.84 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.243 -0.911 . . . . 0.0 111.69 -178.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.9 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -149.63 15.7 0.88 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.704 -1.248 . . . . 0.0 110.756 179.743 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 1.055 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -57.45 -40.68 78.99 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.142 -0.974 . . . . 0.0 110.12 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.508 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 14.0 t70 -62.75 -11.42 17.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.268 -0.895 . . . . 0.0 109.901 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.514 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 84.7 m-20 -132.89 10.07 4.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.42 -0.8 . . . . 0.0 109.701 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.931 HD21 ' CZ ' ' A' ' 158' ' ' TYR . 0.2 OUTLIER -95.57 -49.06 5.56 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.396 -0.815 . . . . 0.0 110.387 -179.764 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.786 HG22 ' HD3' ' A' ' 31' ' ' PRO . 3.5 m -83.48 -26.22 0.39 Allowed Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.396 -0.815 . . . . 0.0 112.707 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.786 ' HD3' HG22 ' A' ' 30' ' ' VAL . 47.0 Cg_endo -76.88 2.93 7.01 Favored 'Trans proline' 0 C--N 1.318 -1.039 0 O-C-N 122.511 0.743 . . . . 0.0 110.476 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.7 tttm -128.95 -35.15 1.88 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.29 -0.882 . . . . 0.0 109.541 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.607 HG12 ' CD1' ' A' ' 150' ' ' TYR . 40.1 mt -80.03 -35.27 15.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.599 -0.688 . . . . 0.0 109.596 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -161.9 97.5 1.22 Allowed Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.582 -0.699 . . . . 0.0 109.833 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.57 2.21 6.05 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.069 1.563 . . . . 0.0 110.793 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -84.11 -10.09 58.07 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.146 -0.971 . . . . 0.0 109.812 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.94 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -97.88 -47.19 5.65 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.392 -0.817 . . . . 0.0 109.912 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.94 HD12 ' C ' ' A' ' 37' ' ' ALA . 2.1 mp -134.75 108.01 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.463 -0.773 . . . . 0.0 109.899 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 57' ' ' THR . 39.3 ttpt -55.29 -16.99 3.89 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.223 -0.923 . . . . 0.0 110.298 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.546 ' CD2' ' H ' ' A' ' 41' ' ' SER . 0.0 OUTLIER 173.03 175.16 0.11 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.081 -1.012 . . . . 0.0 110.11 -179.739 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.546 ' H ' ' CD2' ' A' ' 40' ' ' HIS . 25.2 m -152.11 149.77 29.17 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.361 -0.837 . . . . 0.0 109.827 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -155.56 112.15 3.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.163 -0.961 . . . . 0.0 110.711 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 41.1 mt -62.55 136.5 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.306 -0.871 . . . . 0.0 109.808 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.803 HD22 ' CE ' ' A' ' 55' ' ' LYS . 4.9 tp -114.19 -24.47 8.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.156 -0.965 . . . . 0.0 110.717 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.527 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.8 m95 -124.93 161.35 26.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.116 -0.99 . . . . 0.0 110.782 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.442 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 42.23 -139.73 2.19 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -147.85 24.79 1.06 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.368 -1.078 . . . . 0.0 109.878 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 117.88 -18.9 11.39 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.559 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -72.87 -169.27 14.09 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.21 128.9 13.39 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.093 1.575 . . . . 0.0 110.724 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.81 -11.55 49.52 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.519 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.1 m -75.08 163.84 27.15 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.643 -0.916 . . . . 0.0 109.78 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.986 HG21 ' HE2' ' A' ' 68' ' ' LYS . 85.6 mt -134.13 118.87 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 0.0 109.942 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.455 ' HE2' HD11 ' A' ' 71' ' ' ILE . 1.0 OUTLIER -106.55 124.11 49.11 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.322 -0.861 . . . . 0.0 110.567 -179.565 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.803 ' CE ' HD22 ' A' ' 44' ' ' LEU . 75.8 mttt -90.53 95.2 10.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.258 -0.901 . . . . 0.0 109.826 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.529 ' CG2' HG12 ' A' ' 38' ' ' ILE . 99.6 mt -79.98 139.97 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.142 -0.974 . . . . 0.0 110.083 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -112.99 146.65 38.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.315 -0.865 . . . . 0.0 110.434 -179.736 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.571 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 21.7 m-85 -110.04 154.8 22.7 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.289 -0.882 . . . . 0.0 110.052 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.876 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.499 ' HE1' HG22 ' A' ' 57' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.312 0.577 . . . . 0.0 110.321 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.571 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -132.61 90.25 0.27 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.991 -1.643 . . . . 0.0 108.991 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.538 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 12.1 p90 -130.29 166.57 20.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.081 -1.246 . . . . 0.0 110.158 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.628 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.3 m -140.02 175.64 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.337 -0.852 . . . . 0.0 110.579 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.986 ' HE2' HG21 ' A' ' 53' ' ' ILE . 69.6 tttt -131.17 103.09 6.29 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.506 -0.746 . . . . 0.0 109.875 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 1.008 ' CD2' HD13 ' A' ' 85' ' ' LEU . 13.4 m170 -98.15 121.77 40.48 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.207 -0.933 . . . . 0.0 111.036 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 52' ' ' THR . 82.8 tttt -91.45 120.35 32.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.301 -0.874 . . . . 0.0 109.348 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.559 HG21 ' O ' ' A' ' 49' ' ' GLY . 26.2 mm -58.62 126.88 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.165 -0.959 . . . . 0.0 110.229 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.473 ' O ' ' HB3' ' A' ' 73' ' ' SER . 90.9 m-20 -98.36 -51.1 4.09 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.447 -0.783 . . . . 0.0 109.769 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.473 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 91.3 p -178.45 159.2 1.16 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.5 -0.75 . . . . 0.0 110.316 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 1.047 HD12 HG11 ' A' ' 23' ' ' VAL . 3.5 tt -144.41 167.33 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.502 -0.749 . . . . 0.0 109.236 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -131.13 81.05 1.97 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.944 -1.098 . . . . 0.0 110.523 -179.376 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.593 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 82.1 tttt -55.99 -14.56 2.62 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.29 -0.881 . . . . 0.0 110.604 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -90.76 -30.44 17.04 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.24 -0.912 . . . . 0.0 109.658 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.494 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.9 m120 -113.3 -1.44 14.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.486 -0.759 . . . . 0.0 109.731 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.919 ' O ' HD12 ' A' ' 104' ' ' LEU . 56.1 m-85 64.87 50.04 2.05 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.389 0.614 . . . . 0.0 110.369 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.517 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.6 OUTLIER -118.51 152.57 35.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 109.524 179.394 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.643 ' CE1' HG13 ' A' ' 23' ' ' VAL . 82.5 t80 -151.04 140.85 21.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.066 -1.021 . . . . 0.0 110.262 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 74.3 m -147.81 147.61 30.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.259 -0.901 . . . . 0.0 110.442 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.622 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 8.8 p90 -149.82 175.59 11.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.344 -0.848 . . . . 0.0 110.361 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.585 HG23 ' O ' ' A' ' 98' ' ' ILE . 44.3 m -125.58 128.16 47.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.404 -0.81 . . . . 0.0 109.888 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 1.008 HD13 ' CD2' ' A' ' 69' ' ' HIS . 8.6 tp -98.77 131.64 44.75 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.216 -0.993 . . . . 0.0 110.284 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.888 HD11 ' HD3' ' A' ' 68' ' ' LYS . 9.1 pt -117.19 -29.51 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.199 -0.938 . . . . 0.0 110.419 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.613 ' O ' HD11 ' A' ' 85' ' ' LEU . 43.1 tt0 -110.39 138.77 46.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -0.888 . . . . 0.0 110.19 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.628 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 175.82 134.25 1.9 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -53.38 -31.22 43.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -1.112 . . . . 0.0 110.305 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.495 ' HB1' ' CE1' ' A' ' 132' ' ' HIS . . . -69.73 -38.73 76.98 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.297 -0.877 . . . . 0.0 110.243 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.625 HD23 ' CD2' ' A' ' 95' ' ' LEU . 15.5 mt -41.19 -61.71 0.97 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.503 -0.748 . . . . 0.0 110.284 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 49.14 -178.01 0.02 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -67.01 -7.5 23.02 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.25 -1.147 . . . . 0.0 110.213 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.446 ' O ' HG22 ' A' ' 122' ' ' THR . 61.2 p -79.98 -60.97 2.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 110.213 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.867 HD12 ' H ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -102.25 159.39 15.44 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.352 -0.843 . . . . 0.0 109.387 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.867 ' H ' HD12 ' A' ' 95' ' ' LEU . 61.1 tt0 -137.74 -79.7 0.37 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.208 -0.932 . . . . 0.0 110.576 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.488 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 10.1 mttt -80.24 144.81 32.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.592 -0.692 . . . . 0.0 111.023 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.715 HG21 ' HE2' ' A' ' 100' ' ' TYR . 4.6 mm -133.1 144.7 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.208 -0.932 . . . . 0.0 109.487 178.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.482 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.1 m -123.9 127.72 48.41 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.28 -0.887 . . . . 0.0 109.377 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.715 ' HE2' HG21 ' A' ' 98' ' ' ILE . 12.0 m-85 -123.54 133.4 53.99 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.194 -0.941 . . . . 0.0 110.581 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.462 ' HG3' ' OG ' ' A' ' 82' ' ' SER . 62.9 tt0 -135.59 137.41 41.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.279 -0.888 . . . . 0.0 110.109 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.508 ' N ' ' O ' ' A' ' 81' ' ' TYR . 23.4 m -135.24 146.41 48.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.165 -0.959 . . . . 0.0 110.281 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 115' ' ' LYS . 12.1 mttt -138.94 139.53 38.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.328 -0.858 . . . . 0.0 110.131 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.989 HD23 HG12 ' A' ' 114' ' ' ILE . 2.7 mt -118.66 154.21 33.07 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.215 -0.928 . . . . 0.0 110.542 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.713 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -152.34 -169.35 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.332 -0.855 . . . . 0.0 109.925 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.713 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -121.45 158.47 28.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.329 -0.857 . . . . 0.0 110.215 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.462 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 5.8 p -118.01 168.08 10.06 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.235 -0.916 . . . . 0.0 110.176 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.6 Cg_endo -72.41 -12.66 27.48 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.003 1.528 . . . . 0.0 110.378 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 95.8 p -95.84 2.61 53.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.245 -0.909 . . . . 0.0 110.176 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 99.35 -29.04 12.7 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.08 -172.53 1.91 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 2.1 m -133.3 133.68 42.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -1.109 . . . . 0.0 110.378 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.778 ' HA ' HG22 ' A' ' 10' ' ' THR . 20.8 mt -86.05 144.67 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.358 -0.838 . . . . 0.0 109.939 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.989 HG12 HD23 ' A' ' 104' ' ' LEU . 20.6 mt -131.03 114.01 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.173 -0.954 . . . . 0.0 110.441 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 103' ' ' LYS . 35.2 tttt -100.48 120.77 40.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.914 . . . . 0.0 109.837 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.1 t -115.99 154.87 29.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.205 -0.935 . . . . 0.0 110.53 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.45 HG22 ' NE2' ' A' ' 119' ' ' HIS . 38.5 m -156.73 131.64 8.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.352 -0.842 . . . . 0.0 110.133 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 91.7 p -132.72 155.81 48.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.137 -0.977 . . . . 0.0 110.319 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.778 ' CE1' HG23 ' A' ' 4' ' ' THR . 32.3 m-70 -135.83 164.28 28.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.331 -0.856 . . . . 0.0 110.182 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.653 ' HA ' HD13 ' A' ' 98' ' ' ILE . 11.0 m-85 -124.77 148.54 48.06 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.292 -0.88 . . . . 0.0 110.196 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.501 ' ND1' HG22 ' A' ' 2' ' ' VAL . 97.1 m-70 -129.21 85.37 2.31 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.135 -0.978 . . . . 0.0 109.698 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.712 HG22 ' HA ' ' A' ' 95' ' ' LEU . 1.4 p -81.77 157.73 24.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.326 -0.859 . . . . 0.0 110.427 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.2 tttm -113.6 127.06 55.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.435 -0.791 . . . . 0.0 110.202 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 99.45 -153.24 19.62 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -102.97 64.17 0.84 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.219 -1.166 . . . . 0.0 110.182 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.531 HG23 ' HB ' ' A' ' 122' ' ' THR . 20.1 m -130.62 154.36 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.186 -0.946 . . . . 0.0 110.214 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -133.6 159.37 40.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.261 -0.899 . . . . 0.0 110.195 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.708 HD12 ' CE1' ' A' ' 3' ' ' PHE . 4.3 mp -80.86 173.24 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.27 -0.894 . . . . 0.0 110.211 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.588 ' N ' HG22 ' A' ' 128' ' ' ILE . 10.6 mttp -108.26 132.89 53.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.321 -0.862 . . . . 0.0 110.124 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.42 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 94.6 mt-10 -47.1 -47.73 23.1 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.191 -0.943 . . . . 0.0 110.169 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.503 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 54.7 tt0 -50.97 -28.59 10.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.202 -0.936 . . . . 0.0 109.973 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.495 ' CE1' ' HB1' ' A' ' 90' ' ' ALA . 14.2 t-160 -79.74 -60.63 2.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.268 -0.895 . . . . 0.0 110.114 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.983 HG21 ' CE2' ' A' ' 5' ' ' TYR . 7.3 p -65.55 -38.49 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.428 -0.795 . . . . 0.0 110.185 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.496 ' N ' HG13 ' A' ' 133' ' ' VAL . 26.1 tttp -68.77 -47.33 66.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.233 -0.917 . . . . 0.0 110.238 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.503 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -61.43 -27.02 68.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.91 . . . . 0.0 110.226 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.41 -28.09 71.74 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 49.0 mttt -69.58 -39.99 76.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.221 -1.164 . . . . 0.0 110.211 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -75.18 -34.82 61.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.407 -0.808 . . . . 0.0 110.054 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.449 ' O ' ' HG ' ' A' ' 143' ' ' LEU . 28.5 mttt -67.85 -32.85 73.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.33 -0.856 . . . . 0.0 109.925 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.7 -45.03 47.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.295 -0.878 . . . . 0.0 110.014 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 36.8 m -59.5 -38.62 81.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.444 -0.785 . . . . 0.0 110.049 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -61.52 -41.85 97.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.208 -0.932 . . . . 0.0 109.898 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 139' ' ' LYS . 38.1 mt -60.07 -41.73 93.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.269 -0.894 . . . . 0.0 109.859 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.448 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 24.7 m-85 -56.83 -37.3 71.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.441 -0.787 . . . . 0.0 109.982 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 55.9 mttt -66.5 -25.05 66.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.334 -0.854 . . . . 0.0 109.904 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.537 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 15.9 mt -83.02 -34.69 26.22 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.276 -0.89 . . . . 0.0 108.952 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.583 HD11 ' HE1' ' A' ' 22' ' ' PHE . 79.8 mt -69.54 -34.91 63.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.538 -0.726 . . . . 0.0 109.451 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.756 ' CB ' HD13 ' A' ' 13' ' ' ILE . 97.0 mt-10 -62.84 -39.06 93.2 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.494 -0.754 . . . . 0.0 109.869 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 86.1 m -72.15 -40.0 68.35 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.299 -0.875 . . . . 0.0 109.96 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.608 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 68.6 t80 -55.82 -50.54 70.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.479 -0.763 . . . . 0.0 110.023 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.933 HD21 ' CE1' ' A' ' 158' ' ' TYR . 33.6 mt -79.88 -40.2 28.86 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.331 -0.856 . . . . 0.0 110.464 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.634 ' HB2' HD11 ' A' ' 13' ' ' ILE . 40.5 tttp -66.12 -22.84 66.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.267 -0.896 . . . . 0.0 109.456 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -103.09 -35.97 3.52 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.454 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 2.4 m80 -110.77 93.94 18.45 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.397 -1.061 . . . . 0.0 109.978 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.48 5.64 3.62 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.06 1.558 . . . . 0.0 111.022 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 41.6 p30 -107.54 -2.92 19.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.05 -1.031 . . . . 0.0 109.84 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.608 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -70.5 102.58 2.25 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.413 -0.804 . . . . 0.0 110.126 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 1.056 ' CE1' ' HB2' ' A' ' 21' ' ' ALA . 1.4 p90 33.72 36.67 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.737 -0.602 . . . . 0.0 110.729 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.526 ' HB2' ' CD ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.776 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.93 HG13 ' O ' ' A' ' 120' ' ' TYR . 82.3 t -135.78 144.92 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -1.161 . . . . 0.0 110.358 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.785 ' CE1' HD12 ' A' ' 128' ' ' ILE . 9.8 m-85 -107.71 134.23 50.98 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.238 -0.914 . . . . 0.0 110.031 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.731 HG23 ' CE1' ' A' ' 119' ' ' HIS . 16.6 m -101.8 111.09 23.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.233 -0.917 . . . . 0.0 110.328 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.832 ' CE1' HG11 ' A' ' 133' ' ' VAL . 28.7 m-85 -115.26 126.01 54.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.137 -0.977 . . . . 0.0 109.795 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 116' ' ' SER . 23.1 pt-20 -140.29 154.77 46.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.183 -0.948 . . . . 0.0 110.524 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.458 ' O ' ' HB3' ' A' ' 116' ' ' SER . 49.4 m -139.53 135.61 33.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.336 -0.853 . . . . 0.0 109.729 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.454 ' HG3' ' HG3' ' A' ' 115' ' ' LYS . 2.4 tt0 -116.15 138.86 50.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.1 -1.0 . . . . 0.0 110.72 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.631 ' CZ ' ' CG2' ' A' ' 114' ' ' ILE . 5.8 p90 -158.98 -173.04 4.04 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.506 -0.746 . . . . 0.0 109.814 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.891 HG22 ' HA ' ' A' ' 113' ' ' ILE . 7.4 p -141.57 172.02 13.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.137 -0.977 . . . . 0.0 110.519 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.452 ' HB3' ' CD ' ' A' ' 148' ' ' GLU . 89.9 p -159.95 140.2 11.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.282 -0.886 . . . . 0.0 110.264 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.524 ' HA ' ' HA2' ' A' ' 111' ' ' GLY . 97.2 mt-10 -64.32 -39.08 93.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.28 -0.887 . . . . 0.0 110.106 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 1.049 HD13 ' HB3' ' A' ' 148' ' ' GLU . 2.7 mp -51.37 150.2 6.62 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.313 -0.867 . . . . 0.0 109.791 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.824 ' HD2' HG23 ' A' ' 13' ' ' ILE . 41.7 Cg_endo -67.99 137.1 40.16 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.974 1.513 . . . . 0.0 110.505 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.614 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 41.8 Cg_endo -73.68 -28.95 11.18 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 124.072 1.564 . . . . 0.0 112.933 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 15' ' ' PRO . 43.4 Cg_endo -73.68 -21.33 19.2 Favored 'Trans proline' 0 C--N 1.319 -1.001 0 O-C-N 122.408 0.688 . . . . 0.0 110.534 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.958 ' NE ' HD22 ' A' ' 151' ' ' LEU . 57.6 ttt180 -85.7 -50.9 6.82 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.794 HD23 ' C ' ' A' ' 18' ' ' LEU . 1.7 tt -57.13 -27.66 62.03 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.262 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.555 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 64.9 t80 -69.57 -54.65 13.04 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.488 0.661 . . . . 0.0 109.477 178.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.605 ' HG2' HD22 ' A' ' 24' ' ' LEU . 49.5 mttt -55.31 -29.65 58.68 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 122.158 0.98 . . . . 0.0 108.376 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.002 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -77.36 -63.46 1.37 Allowed 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.647 0.737 . . . . 0.0 110.797 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 1.015 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -60.72 -28.92 69.02 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.612 -0.68 . . . . 0.0 111.401 -178.599 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.743 HG13 ' CD1' ' A' ' 81' ' ' TYR . 4.3 t -108.63 -66.39 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.046 -1.034 . . . . 0.0 111.406 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.678 ' N ' HD12 ' A' ' 24' ' ' LEU . 8.6 mp -68.91 -10.97 60.04 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.162 -0.961 . . . . 0.0 111.205 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.534 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -138.2 16.89 2.79 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.889 -1.132 . . . . 0.0 110.075 179.721 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 1.015 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -51.76 -44.91 63.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 110.177 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.479 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 61.8 m-20 -62.07 -12.41 19.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.181 -0.949 . . . . 0.0 110.157 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.531 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 77.8 m-20 -124.2 -7.71 7.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 110.42 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.747 HD12 ' N ' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -85.0 -46.04 11.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.201 -0.937 . . . . 0.0 110.37 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.948 ' CG1' HD13 ' A' ' 38' ' ' ILE . 2.9 t -69.51 -41.86 18.2 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.35 -0.844 . . . . 0.0 111.002 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.1 Cg_endo -78.55 9.72 3.08 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.54 1.284 . . . . 0.0 110.792 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.449 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 21.7 mttm -121.17 -29.43 4.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.174 -0.954 . . . . 0.0 109.307 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.75 HG21 ' HB3' ' A' ' 146' ' ' LEU . 14.9 mt -80.21 -64.99 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-O 121.607 0.718 . . . . 0.0 109.388 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.457 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . . . -136.01 106.51 9.61 Favored Pre-proline 0 C--N 1.303 -1.451 0 O-C-N 121.708 -0.62 . . . . 0.0 109.876 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.457 ' HD2' ' HA ' ' A' ' 34' ' ' ALA . 44.1 Cg_endo -70.3 0.49 5.97 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.078 1.567 . . . . 0.0 111.035 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -81.13 -13.3 58.81 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.032 -1.042 . . . . 0.0 109.418 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.591 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -96.95 -67.66 0.84 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.393 -0.817 . . . . 0.0 110.15 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.948 HD13 ' CG1' ' A' ' 30' ' ' VAL . 2.3 mp -109.6 127.82 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.491 -0.756 . . . . 0.0 110.158 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 57' ' ' THR . 22.2 ttpt -85.8 -27.68 24.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.272 -0.893 . . . . 0.0 110.366 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.453 ' O ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -163.39 148.83 11.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.122 -0.986 . . . . 0.0 110.037 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.468 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 4.2 m -131.54 122.97 27.02 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.314 -0.866 . . . . 0.0 109.953 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -138.15 111.25 7.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.14 -0.975 . . . . 0.0 110.661 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 28.5 mt -56.87 133.5 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.336 -0.852 . . . . 0.0 109.837 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.539 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 25.3 mt -104.67 -29.78 10.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.913 . . . . 0.0 110.605 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.651 ' CG ' HD12 ' A' ' 53' ' ' ILE . 2.0 m95 -122.46 160.43 25.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.208 -0.932 . . . . 0.0 110.706 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.451 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 41.39 -138.74 1.91 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -152.33 22.2 0.64 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -1.197 . . . . 0.0 110.15 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 126.35 -22.94 5.84 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.536 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -68.43 -174.35 8.79 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -72.33 128.8 14.11 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 123.986 1.519 . . . . 0.0 110.593 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.488 ' HA2' ' HE2' ' A' ' 70' ' ' LYS . . . 105.19 -13.54 48.45 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.504 -1.838 . . . . 0.0 108.504 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -71.74 160.73 32.11 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.616 -0.932 . . . . 0.0 109.327 179.589 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.651 HD12 ' CG ' ' A' ' 45' ' ' TRP . 80.6 mt -131.71 119.37 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 110.215 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 0.4 OUTLIER -101.54 126.47 48.36 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.276 -0.89 . . . . 0.0 110.03 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.539 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 22.2 tttm -96.97 90.68 5.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 110.101 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.588 ' CG2' ' CG1' ' A' ' 38' ' ' ILE . 94.1 mt -80.11 139.41 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.299 -0.876 . . . . 0.0 110.065 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.594 HG22 ' HB3' ' A' ' 66' ' ' TYR . 1.2 p -115.17 153.14 31.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.888 . . . . 0.0 110.301 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.581 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 14.7 m-85 -114.27 176.06 5.21 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.314 -0.866 . . . . 0.0 110.168 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 58' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.562 ' O ' ' CD1' ' A' ' 64' ' ' TYR . 5.4 p90 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.242 0.544 . . . . 0.0 110.171 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.581 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -137.71 85.75 0.23 Allowed Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.594 ' HB3' HG22 ' A' ' 57' ' ' THR . 12.4 p90 -133.52 171.65 13.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -1.166 . . . . 0.0 110.249 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.842 HG12 ' HA2' ' A' ' 88' ' ' GLY . 4.0 m -140.3 177.66 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.332 -0.855 . . . . 0.0 110.35 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.664 ' O ' HD12 ' A' ' 85' ' ' LEU . 23.7 mttm -134.81 104.76 6.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.412 -0.805 . . . . 0.0 109.804 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 1.001 ' CD2' HD13 ' A' ' 85' ' ' LEU . 14.8 m170 -96.9 127.54 42.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.196 -0.94 . . . . 0.0 110.862 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 52' ' ' THR . 77.8 tttt -98.2 113.74 25.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.91 . . . . 0.0 109.414 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.536 HG21 ' O ' ' A' ' 49' ' ' GLY . 33.0 mm -44.53 136.19 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.101 -1.0 . . . . 0.0 110.162 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.547 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 23.8 t0 -109.89 -43.57 3.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.419 -0.801 . . . . 0.0 109.969 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.665 ' C ' HD12 ' A' ' 74' ' ' ILE . 62.3 p -170.81 161.2 7.17 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.484 -0.886 . . . . 0.0 109.947 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.665 HD12 ' C ' ' A' ' 73' ' ' SER . 0.9 OUTLIER -149.44 154.36 9.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 119.277 -0.969 . . . . 0.0 111.005 -179.754 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.548 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 2.3 m-20 -136.1 79.96 1.8 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.809 -0.557 . . . . 0.0 110.288 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.555 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 22.2 mttp -59.94 -14.85 17.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.246 -0.909 . . . . 0.0 110.365 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -93.65 -30.88 14.7 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.22 -0.925 . . . . 0.0 109.753 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.493 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.5 m120 -108.25 -3.82 18.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.533 -0.729 . . . . 0.0 109.723 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.712 ' O ' HD12 ' A' ' 104' ' ' LEU . 5.5 m-85 65.36 47.24 2.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.469 -0.77 . . . . 0.0 110.361 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.548 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.6 OUTLIER -116.62 147.41 41.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -0.896 . . . . 0.0 109.289 179.534 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.743 ' CD1' HG13 ' A' ' 23' ' ' VAL . 90.3 t80 -141.88 139.89 32.72 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.07 -1.019 . . . . 0.0 110.344 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 72' ' ' ASP . 1.3 m -143.72 135.41 26.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.255 -0.903 . . . . 0.0 110.348 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.615 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 20.2 p90 -142.86 170.25 16.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.343 -0.848 . . . . 0.0 110.3 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.795 HG23 ' O ' ' A' ' 98' ' ' ILE . 93.5 m -127.31 125.58 41.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.33 -0.856 . . . . 0.0 109.763 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 1.001 HD13 ' CD2' ' A' ' 69' ' ' HIS . 10.8 tp -95.09 129.86 42.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.068 -1.02 . . . . 0.0 110.444 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.463 ' N ' HD12 ' A' ' 85' ' ' LEU . 11.0 pt -106.25 -32.89 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.323 -0.861 . . . . 0.0 110.175 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.717 ' O ' HD11 ' A' ' 85' ' ' LEU . 86.9 tt0 -118.5 160.72 21.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.337 -0.852 . . . . 0.0 110.107 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.842 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 151.86 151.65 5.69 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -73.27 -25.28 60.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -1.155 . . . . 0.0 110.185 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.19 -20.04 63.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.302 -0.874 . . . . 0.0 110.157 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 92' ' ' GLY . 77.0 mt -69.36 -33.57 73.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.269 -0.894 . . . . 0.0 110.137 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 49.77 -179.71 0.02 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -78.14 3.17 15.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.215 -1.168 . . . . 0.0 109.984 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.412 HG22 ' HG ' ' A' ' 95' ' ' LEU . 1.8 m -93.89 -49.81 5.64 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.204 -0.935 . . . . 0.0 109.849 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.83 HD23 ' CG2' ' A' ' 122' ' ' THR . 42.1 mt -93.6 163.16 13.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.443 -0.786 . . . . 0.0 109.914 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.416 ' CD ' ' HB2' ' A' ' 123' ' ' LYS . 12.3 mt-10 -140.38 -79.85 0.28 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.216 -0.928 . . . . 0.0 109.982 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.498 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 29.2 mtmt -80.14 141.24 35.91 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.586 -0.696 . . . . 0.0 109.999 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.795 ' O ' HG23 ' A' ' 84' ' ' THR . 6.3 mm -130.38 140.87 47.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 120.85 -1.157 . . . . 0.0 110.149 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.516 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -123.81 130.04 51.99 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.642 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.696 ' HE2' HG21 ' A' ' 98' ' ' ILE . 11.6 m-85 -125.35 134.72 52.1 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.21 -0.931 . . . . 0.0 110.603 -178.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.423 ' HG3' ' HB3' ' A' ' 82' ' ' SER . 6.3 mt-10 -134.52 131.15 37.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.436 -0.79 . . . . 0.0 110.211 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 32.3 m -130.26 140.71 50.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -0.894 . . . . 0.0 109.911 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.471 ' HB2' ' HB3' ' A' ' 115' ' ' LYS . 8.9 mttp -131.79 137.55 48.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.181 -0.95 . . . . 0.0 110.763 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.891 HD23 HG12 ' A' ' 114' ' ' ILE . 7.3 mt -116.5 150.66 37.54 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.277 -0.89 . . . . 0.0 109.839 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.705 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -150.91 -169.45 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.11 -0.993 . . . . 0.0 110.064 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.705 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -126.83 155.98 42.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.368 -0.833 . . . . 0.0 110.091 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.443 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.7 p -114.6 169.43 6.63 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.279 -0.888 . . . . 0.0 110.309 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.443 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.2 Cg_endo -72.62 -10.69 25.49 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.14 1.6 . . . . 0.0 110.49 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 95.5 p -98.19 5.53 48.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.273 -0.892 . . . . 0.0 110.37 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.1 -34.89 4.76 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' A' ' 12' ' ' GLU . . . -57.65 -173.86 0.33 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 54.0 p -133.76 138.41 45.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.198 -1.178 . . . . 0.0 110.434 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.891 ' HA ' HG22 ' A' ' 10' ' ' THR . 23.0 mt -91.36 147.26 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.367 -0.833 . . . . 0.0 110.085 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.891 HG12 HD23 ' A' ' 104' ' ' LEU . 22.8 mt -133.58 123.26 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.215 -0.928 . . . . 0.0 110.328 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.471 ' HB3' ' HB2' ' A' ' 103' ' ' LYS . 72.4 tttt -107.96 121.66 45.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.233 -0.917 . . . . 0.0 110.089 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.458 ' HB3' ' O ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -104.32 154.68 19.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.187 -0.946 . . . . 0.0 110.419 -179.854 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 20.9 m -158.76 148.82 19.52 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.432 -0.793 . . . . 0.0 110.2 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.428 ' OG ' ' HB2' ' A' ' 5' ' ' TYR . 86.2 p -157.03 156.28 32.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.297 -0.877 . . . . 0.0 110.154 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.731 ' CE1' HG23 ' A' ' 4' ' ' THR . 85.7 m-70 -134.9 137.95 43.66 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.162 -0.961 . . . . 0.0 110.51 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.93 ' O ' HG13 ' A' ' 2' ' ' VAL . 3.9 m-30 -104.01 139.29 39.33 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.345 -0.847 . . . . 0.0 110.262 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.498 ' HB2' ' HB2' ' A' ' 97' ' ' LYS . 92.1 m-70 -121.96 90.49 3.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.981 -1.074 . . . . 0.0 109.565 179.003 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.83 ' CG2' HD23 ' A' ' 95' ' ' LEU . 1.8 p -72.22 156.69 38.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.28 -0.888 . . . . 0.0 110.66 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.482 ' HG2' ' N ' ' A' ' 124' ' ' GLY . 42.4 tttt -100.31 149.01 24.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.461 -0.775 . . . . 0.0 109.946 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.482 ' N ' ' HG2' ' A' ' 123' ' ' LYS . . . 69.4 -122.88 13.04 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -138.69 70.28 1.38 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -1.195 . . . . 0.0 110.244 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.538 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 32.5 m -122.9 164.21 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 0.0 109.972 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -131.86 152.39 51.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.098 -1.001 . . . . 0.0 110.406 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.785 HD12 ' CE1' ' A' ' 3' ' ' PHE . 2.8 mp -84.35 172.4 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.269 -0.895 . . . . 0.0 110.205 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.594 ' N ' HG22 ' A' ' 128' ' ' ILE . 5.8 tttp -112.31 179.03 4.11 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.323 -0.86 . . . . 0.0 109.853 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -82.39 5.46 20.33 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.172 -0.955 . . . . 0.0 108.822 178.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -93.83 -31.56 14.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.386 -0.821 . . . . 0.0 109.906 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -85.93 -36.16 20.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.29 -0.881 . . . . 0.0 110.083 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.832 HG11 ' CE1' ' A' ' 5' ' ' TYR . 37.0 t -77.56 -43.21 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.351 -0.843 . . . . 0.0 110.095 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 57.5 tttm -65.51 -44.21 87.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 0.0 110.114 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.44 -37.23 85.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.24 -0.913 . . . . 0.0 110.027 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -64.09 -30.72 78.57 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 81.0 mttt -61.9 -31.67 71.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.366 -1.079 . . . . 0.0 109.998 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.483 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 70.0 mm-40 -82.29 -36.92 26.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.319 -0.863 . . . . 0.0 109.962 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -70.48 -30.52 67.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.337 -0.852 . . . . 0.0 109.975 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.57 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -88.43 -37.74 15.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.894 . . . . 0.0 110.094 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.419 ' O ' ' HB2' ' A' ' 144' ' ' PHE . 66.3 m -71.24 -52.58 18.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.416 -0.802 . . . . 0.0 109.97 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.483 ' ND2' ' O ' ' A' ' 138' ' ' GLU . 92.3 m-20 -54.62 -43.41 72.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.275 -0.891 . . . . 0.0 109.971 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.623 ' HA ' HD12 ' A' ' 146' ' ' LEU . 13.0 tp -59.7 -42.74 93.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.895 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.717 ' HA ' HD12 ' A' ' 147' ' ' ILE . 7.7 m-85 -55.17 -39.1 69.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.331 -0.856 . . . . 0.0 109.587 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.46 ' O ' ' HG2' ' A' ' 145' ' ' LYS . 51.0 tttt -74.53 -15.02 60.88 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.419 -0.801 . . . . 0.0 109.859 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.75 ' HB3' HG21 ' A' ' 33' ' ' ILE . 29.2 mt -80.86 -35.15 33.11 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.178 -0.951 . . . . 0.0 108.712 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.78 HD11 ' CE1' ' A' ' 22' ' ' PHE . 17.4 mt -68.83 -51.59 43.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 1.049 ' HB3' HD13 ' A' ' 13' ' ' ILE . 52.6 mt-10 -56.46 -40.9 75.64 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.543 -0.723 . . . . 0.0 109.764 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 98.0 m -66.97 -41.81 86.2 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.144 -0.973 . . . . 0.0 109.811 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.619 ' CD1' HG12 ' A' ' 33' ' ' ILE . 87.1 t80 -56.19 -46.18 79.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.344 -0.847 . . . . 0.0 109.997 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.958 HD22 ' NE ' ' A' ' 17' ' ' ARG . 33.2 mt -80.15 -28.98 38.78 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.227 -0.921 . . . . 0.0 110.344 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.775 ' HB2' HD11 ' A' ' 13' ' ' ILE . 21.4 tttt -72.23 -28.06 62.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.327 -0.858 . . . . 0.0 109.822 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.493 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -101.47 -33.61 4.75 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.525 ' O ' ' NH2' ' A' ' 17' ' ' ARG . 4.4 m80 -106.94 92.4 7.54 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.339 -1.095 . . . . 0.0 109.71 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 48.5 Cg_endo -73.68 8.22 2.02 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.288 1.678 . . . . 0.0 111.439 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -112.5 1.47 15.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.915 -1.116 . . . . 0.0 109.817 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.615 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -73.4 100.98 3.35 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.367 -0.833 . . . . 0.0 110.421 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 1.002 ' CE1' ' HB2' ' A' ' 21' ' ' ALA . 0.3 OUTLIER 34.53 39.55 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.747 -0.596 . . . . 0.0 110.691 -179.737 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.589 ' CB ' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.416 0 CA-C-O 118.007 -0.996 . . . . 0.0 109.722 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.911 HG13 ' O ' ' A' ' 120' ' ' TYR . 70.9 t -140.21 125.32 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.197 -1.178 . . . . 0.0 110.169 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.619 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 66.0 m-85 -88.93 126.09 35.24 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.141 -0.974 . . . . 0.0 110.108 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.71 HG23 ' CE1' ' A' ' 119' ' ' HIS . 3.0 m -117.38 107.24 14.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.235 -0.916 . . . . 0.0 110.431 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.69 ' CE1' HG23 ' A' ' 133' ' ' VAL . 69.5 m-85 -111.49 126.11 54.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.184 -0.948 . . . . 0.0 110.164 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.468 ' HG2' ' OG1' ' A' ' 117' ' ' THR . 2.4 mt-10 -117.6 144.79 44.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.295 -0.878 . . . . 0.0 110.564 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.477 ' O ' ' HG2' ' A' ' 8' ' ' GLU . 20.0 m -128.0 164.64 21.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.331 -0.856 . . . . 0.0 109.842 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 7' ' ' SER . 68.4 mt-10 -153.12 124.65 7.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.064 -1.022 . . . . 0.0 110.757 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.636 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.0 p90 -145.24 -176.22 5.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.308 -0.87 . . . . 0.0 109.728 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.785 HG22 ' HA ' ' A' ' 113' ' ' ILE . 6.8 p -142.5 174.56 10.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.062 -1.024 . . . . 0.0 110.687 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.485 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 7.9 t -159.99 164.96 32.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.37 -0.831 . . . . 0.0 110.142 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -89.69 -22.85 22.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.306 -0.871 . . . . 0.0 110.213 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.844 HG21 HD12 ' A' ' 151' ' ' LEU . 8.4 mm -68.1 150.71 97.64 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.264 -0.898 . . . . 0.0 109.984 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.825 ' HD2' HG23 ' A' ' 13' ' ' ILE . 41.0 Cg_endo -66.98 145.05 72.63 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 124.029 1.541 . . . . 0.0 110.598 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.669 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.1 Cg_endo -71.18 -31.99 13.68 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.873 1.459 . . . . 0.0 112.765 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.669 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.1 Cg_endo -69.23 -22.76 34.06 Favored 'Trans proline' 0 C--N 1.318 -1.047 0 N-CA-C 109.988 -0.812 . . . . 0.0 109.988 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.726 HH21 ' HB3' ' A' ' 157' ' ' ALA . 52.3 mtp180 -81.79 -43.13 18.75 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 1.095 HD23 ' CG2' ' A' ' 147' ' ' ILE . 0.2 OUTLIER -73.53 -33.78 64.89 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.702 -0.799 . . . . 0.0 108.939 178.971 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.649 ' N ' HD13 ' A' ' 18' ' ' LEU . 59.8 t80 -60.27 -60.51 3.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.511 -0.743 . . . . 0.0 109.765 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.645 ' HG2' HD22 ' A' ' 24' ' ' LEU . 23.1 mttt -53.77 -38.9 64.92 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.735 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.058 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -69.17 -36.42 77.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.456 -0.778 . . . . 0.0 110.904 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 1.047 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.3 OUTLIER -79.09 -49.21 12.99 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.31 -0.869 . . . . 0.0 110.974 -179.127 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.608 ' HB ' HD12 ' A' ' 24' ' ' LEU . 3.7 t -94.34 -53.97 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.202 -0.936 . . . . 0.0 111.813 -178.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.765 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.4 mp -80.03 -1.05 38.06 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.972 -1.08 . . . . 0.0 112.129 -178.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.587 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -147.78 23.46 1.1 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.704 -1.247 . . . . 0.0 110.725 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 1.047 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -65.76 -12.35 53.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.089 -1.007 . . . . 0.0 110.193 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.514 ' HA ' ' CB ' ' A' ' 41' ' ' SER . 92.0 m-20 -80.08 -13.76 59.05 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.205 -0.934 . . . . 0.0 110.443 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.402 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 4.6 p30 -135.46 6.19 3.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.192 -0.943 . . . . 0.0 110.595 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.682 ' HG ' ' HB1' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -96.59 -40.56 8.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.214 -0.929 . . . . 0.0 109.888 179.901 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.871 ' CG1' HD13 ' A' ' 38' ' ' ILE . 4.1 t -82.45 -41.01 0.92 Allowed Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.437 -0.79 . . . . 0.0 111.013 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.7 Cg_endo -78.95 11.43 2.57 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.365 1.192 . . . . 0.0 110.771 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -124.41 -34.04 2.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.065 -1.022 . . . . 0.0 109.438 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.617 HG21 ' HB3' ' A' ' 146' ' ' LEU . 7.5 mt -80.12 -38.75 18.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.489 -0.757 . . . . 0.0 109.399 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.77 96.68 7.43 Favored Pre-proline 0 C--N 1.304 -1.379 0 O-C-N 121.463 -0.773 . . . . 0.0 110.03 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.35 -2.52 11.37 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.003 1.528 . . . . 0.0 110.513 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -88.48 -26.41 22.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.135 -0.978 . . . . 0.0 109.711 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -86.08 -73.43 0.45 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.4 -0.813 . . . . 0.0 109.969 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.871 HD13 ' CG1' ' A' ' 30' ' ' VAL . 2.1 mp -102.6 137.15 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.407 -0.808 . . . . 0.0 110.045 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.2 ttpp -96.18 -32.28 12.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 110.376 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.47 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -167.94 156.68 9.29 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.213 -0.93 . . . . 0.0 110.09 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.514 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 11.0 p -115.83 144.89 43.37 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.273 -0.892 . . . . 0.0 110.266 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.47 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 73.3 tt0 -149.0 97.74 2.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.248 -0.908 . . . . 0.0 110.327 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.403 HG21 ' HA ' ' A' ' 47' ' ' ASP . 19.1 mt -57.52 130.78 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.173 -0.955 . . . . 0.0 110.06 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.532 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 31.0 mt -102.55 -35.25 8.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 110.64 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.807 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.9 m95 -122.91 162.85 21.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.108 -0.995 . . . . 0.0 110.658 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.446 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 41.79 -136.51 2.92 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.418 ' O ' ' CG ' ' A' ' 47' ' ' ASP . 11.1 t0 -154.26 22.41 0.49 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -1.143 . . . . 0.0 109.907 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 122.82 -20.47 7.7 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.819 -1.712 . . . . 0.0 108.819 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.454 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -68.42 -171.92 6.85 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.81 129.13 13.12 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.051 1.553 . . . . 0.0 110.626 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.84 -9.18 56.66 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.509 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -73.49 159.13 33.65 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.523 -0.986 . . . . 0.0 109.94 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.807 HD12 ' CG ' ' A' ' 45' ' ' TRP . 78.1 mt -126.85 119.61 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.354 -0.841 . . . . 0.0 109.406 179.266 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -105.15 135.25 46.84 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 110.451 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.532 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 76.7 tttt -104.22 93.43 4.82 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.364 -0.835 . . . . 0.0 110.05 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.549 ' HB ' HG23 ' A' ' 67' ' ' VAL . 66.3 mt -79.98 134.19 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.206 -0.934 . . . . 0.0 109.942 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.526 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 1.7 p -106.98 155.89 19.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.371 -0.831 . . . . 0.0 110.213 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.484 ' CE2' HG13 ' A' ' 67' ' ' VAL . 22.6 m-85 -111.48 151.24 28.84 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.319 -0.863 . . . . 0.0 110.205 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 58' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.117 0.484 . . . . 0.0 109.934 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -135.92 133.94 6.92 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.544 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 10.5 p90 -178.16 169.34 1.9 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.335 -1.097 . . . . 0.0 110.181 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.865 HG12 ' HA2' ' A' ' 88' ' ' GLY . 4.1 m -141.92 176.92 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.395 -0.816 . . . . 0.0 110.54 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.705 ' HE2' HG21 ' A' ' 53' ' ' ILE . 68.8 tttt -127.69 122.95 34.29 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.363 -0.836 . . . . 0.0 109.792 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.425 ' NE2' ' HG ' ' A' ' 85' ' ' LEU . 9.0 m170 -116.26 126.62 53.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.088 -1.007 . . . . 0.0 110.993 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 52' ' ' THR . 15.2 tttt -102.76 117.23 34.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.295 -0.878 . . . . 0.0 109.403 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.531 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 25.5 mm -60.13 126.61 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.243 -0.911 . . . . 0.0 110.334 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.433 ' HB2' ' C ' ' A' ' 82' ' ' SER . 41.9 m-20 -97.95 -36.89 10.0 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.35 -0.844 . . . . 0.0 109.724 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.487 ' OG ' ' HB2' ' A' ' 82' ' ' SER . 35.0 p -178.58 157.33 0.97 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.327 -0.858 . . . . 0.0 109.887 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.401 HG12 HG11 ' A' ' 23' ' ' VAL . 1.3 mt -139.67 158.24 27.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.257 -0.902 . . . . 0.0 110.051 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.551 ' HB2' ' HB3' ' A' ' 80' ' ' SER . 0.8 OUTLIER -142.77 82.47 1.77 Allowed 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.537 179.698 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.549 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 48.7 tttm -66.21 -14.62 62.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.309 -0.869 . . . . 0.0 110.214 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -87.69 -29.37 21.17 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.395 -0.816 . . . . 0.0 108.907 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.489 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 2.3 m120 -108.07 -5.66 16.9 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.403 0.62 . . . . 0.0 109.358 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.569 ' HA ' ' CD1' ' A' ' 19' ' ' PHE . 50.5 m-85 64.58 53.04 1.65 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.681 -0.637 . . . . 0.0 110.608 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.551 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 11.8 t -125.33 175.75 7.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 110.242 179.24 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.594 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 20.8 t80 -156.8 145.83 20.21 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.959 -0.697 . . . . 0.0 110.182 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.487 ' HB2' ' OG ' ' A' ' 73' ' ' SER . 0.4 OUTLIER -147.34 124.06 11.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.265 -0.897 . . . . 0.0 110.819 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.627 ' N ' ' CD1' ' A' ' 83' ' ' TYR . 2.5 p90 -145.77 -179.92 7.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.37 -0.831 . . . . 0.0 109.708 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' THR . . . . . 1.013 HG23 ' O ' ' A' ' 98' ' ' ILE . 18.6 m -135.62 146.88 48.34 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.132 -0.98 . . . . 0.0 110.567 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.65 HD12 ' HE2' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -102.43 117.82 35.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.29 -0.881 . . . . 0.0 110.257 179.67 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.606 HD11 ' HD3' ' A' ' 68' ' ' LYS . 22.3 pt -113.13 -6.12 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.228 -0.92 . . . . 0.0 110.138 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -145.92 128.29 15.89 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.319 -0.863 . . . . 0.0 110.39 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.865 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . -178.59 120.32 0.7 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -52.56 -27.33 16.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -1.161 . . . . 0.0 110.158 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.07 -20.98 62.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.935 . . . . 0.0 110.154 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.707 HD12 ' N ' ' A' ' 88' ' ' GLY . 32.9 mt -69.55 -24.74 63.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.237 -0.914 . . . . 0.0 110.222 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 50.03 -176.87 0.04 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -81.22 6.9 12.62 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -1.143 . . . . 0.0 110.222 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.423 ' O ' HG22 ' A' ' 122' ' ' THR . 26.2 p -94.21 -28.72 15.48 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.227 -0.921 . . . . 0.0 110.096 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 1.083 HD21 ' CD1' ' A' ' 128' ' ' ILE . 90.3 mt -110.35 151.66 27.17 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.302 -0.874 . . . . 0.0 110.014 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.427 ' HG3' ' HB2' ' A' ' 123' ' ' LYS . 11.5 mt-10 -133.79 -80.81 0.46 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.172 -0.955 . . . . 0.0 110.281 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.512 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 70.8 mttt -80.36 127.2 32.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.549 -0.719 . . . . 0.0 110.898 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 1.013 ' O ' HG23 ' A' ' 84' ' ' THR . 13.0 mm -116.98 146.73 21.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 120.722 -1.237 . . . . 0.0 109.664 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.511 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.5 OUTLIER -124.99 124.8 42.78 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.504 -0.879 . . . . 0.0 108.704 178.223 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.829 ' CE2' HG21 ' A' ' 98' ' ' ILE . 15.3 m-85 -121.15 140.81 51.5 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.366 -0.834 . . . . 0.0 110.454 -178.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.514 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 20.2 tt0 -145.42 136.92 25.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.284 -0.885 . . . . 0.0 110.331 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.478 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 60.6 m -135.16 129.69 34.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.32 -0.863 . . . . 0.0 109.635 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 80' ' ' SER . 0.0 OUTLIER -125.98 144.57 50.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.946 . . . . 0.0 110.691 -179.487 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.566 HD12 ' O ' ' A' ' 79' ' ' TYR . 7.4 mt -117.52 155.58 29.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.292 -0.88 . . . . 0.0 109.973 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.688 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -151.35 -169.2 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.133 -0.979 . . . . 0.0 110.185 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.688 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -121.87 144.07 49.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.37 -0.831 . . . . 0.0 110.234 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.458 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 3.4 p -101.2 169.41 7.81 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.182 -0.949 . . . . 0.0 110.253 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 47.6 Cg_endo -73.15 -10.91 24.84 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.111 1.585 . . . . 0.0 110.565 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.6 m -99.45 4.29 46.07 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.226 -0.921 . . . . 0.0 110.185 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 102.05 -36.93 3.92 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -56.79 178.17 0.79 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 20.6 p -122.76 130.0 52.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.228 -1.16 . . . . 0.0 110.284 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.785 ' HA ' HG22 ' A' ' 10' ' ' THR . 5.9 mt -80.33 149.41 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.252 -0.905 . . . . 0.0 110.077 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.586 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 6.5 mt -128.59 118.97 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 0.0 110.189 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 38.7 tttt -101.15 128.98 46.99 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.159 -0.963 . . . . 0.0 110.157 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.449 ' HB3' ' HB2' ' A' ' 7' ' ' SER . 0.0 OUTLIER -110.99 152.13 27.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.215 -0.928 . . . . 0.0 110.047 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.585 ' CG2' ' CE1' ' A' ' 119' ' ' HIS . 33.4 m -160.09 125.29 3.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.212 -0.93 . . . . 0.0 110.499 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.504 ' HB3' ' CE1' ' A' ' 100' ' ' TYR . 3.1 m -135.46 142.94 45.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.314 -0.866 . . . . 0.0 109.746 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.71 ' CE1' HG23 ' A' ' 4' ' ' THR . 33.1 m-70 -129.49 136.19 49.57 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.082 -1.011 . . . . 0.0 110.293 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.911 ' O ' HG13 ' A' ' 2' ' ' VAL . 3.0 m-30 -104.54 151.78 23.19 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.308 -0.87 . . . . 0.0 110.745 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.512 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 82.1 m-70 -129.78 86.97 2.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.297 -0.877 . . . . 0.0 109.43 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.685 ' CG2' HD23 ' A' ' 95' ' ' LEU . 1.4 p -63.23 156.11 26.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.375 -0.828 . . . . 0.0 110.56 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.427 ' HB2' ' HG3' ' A' ' 96' ' ' GLU . 4.3 tttm -103.86 106.52 17.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.399 -0.813 . . . . 0.0 110.07 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 103.45 -123.41 7.78 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -136.62 94.61 3.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.233 -1.157 . . . . 0.0 110.252 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.503 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 14.9 m -141.95 -177.77 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.277 -0.889 . . . . 0.0 110.128 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -134.23 144.5 48.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -0.933 . . . . 0.0 110.48 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 1.083 ' CD1' HD21 ' A' ' 95' ' ' LEU . 12.0 mm -64.94 172.54 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 110.154 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.596 ' N ' HG22 ' A' ' 128' ' ' ILE . 18.8 mttt -97.78 127.89 44.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.345 -0.847 . . . . 0.0 109.847 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 129' ' ' LYS . 94.6 mt-10 -44.13 -52.8 6.98 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.131 -0.981 . . . . 0.0 109.937 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.99 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 50.7 tt0 -52.54 -20.53 3.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.203 -0.935 . . . . 0.0 109.706 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.479 ' N ' ' O ' ' A' ' 129' ' ' LYS . 14.0 t-160 -85.31 -61.85 1.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.395 -0.816 . . . . 0.0 110.259 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.69 HG23 ' CE1' ' A' ' 5' ' ' TYR . 1.8 p -66.37 -20.92 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.306 -0.872 . . . . 0.0 110.285 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.532 ' HG3' HG13 ' A' ' 133' ' ' VAL . 26.3 mttt -104.42 -72.51 0.7 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.922 . . . . 0.0 110.027 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.99 ' HB3' ' O ' ' A' ' 131' ' ' GLU . . . -56.57 -22.4 33.28 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 109.77 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -75.46 -27.87 62.67 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -68.83 -33.9 74.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.174 -1.192 . . . . 0.0 110.145 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.419 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 78.4 tt0 -75.95 -24.14 55.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.315 -0.866 . . . . 0.0 110.109 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 67.7 mttt -78.94 -27.98 43.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.335 -0.853 . . . . 0.0 109.991 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -81.85 -36.1 28.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.289 -0.882 . . . . 0.0 110.072 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.8 t -65.25 -46.32 81.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.4 -0.812 . . . . 0.0 110.141 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.419 ' ND2' ' O ' ' A' ' 138' ' ' GLU . 93.5 m-20 -51.69 -47.58 63.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.343 -0.848 . . . . 0.0 110.028 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.744 ' HA ' HD12 ' A' ' 146' ' ' LEU . 14.0 tp -56.68 -50.03 73.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.903 . . . . 0.0 109.936 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.467 ' CG ' ' CZ ' ' A' ' 9' ' ' PHE . 18.0 m-85 -55.87 -39.26 71.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.334 -0.854 . . . . 0.0 109.708 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -75.97 -11.09 59.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.417 -0.802 . . . . 0.0 110.089 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.744 HD12 ' HA ' ' A' ' 143' ' ' LEU . 11.7 mt -83.42 -37.84 22.7 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.211 -0.931 . . . . 0.0 108.804 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 1.095 ' CG2' HD23 ' A' ' 18' ' ' LEU . 63.5 mt -69.06 -48.49 69.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.513 ' O ' HG13 ' A' ' 13' ' ' ILE . 96.8 mt-10 -47.27 -38.01 11.69 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.414 -0.804 . . . . 0.0 109.009 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.482 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 11.0 m -79.94 -25.4 40.48 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.318 -0.864 . . . . 0.0 109.237 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.575 ' CD1' HD11 ' A' ' 33' ' ' ILE . 64.9 t80 -54.85 -51.8 64.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.583 -0.698 . . . . 0.0 109.824 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.002 HD21 ' CE1' ' A' ' 158' ' ' TYR . 45.0 mt -79.89 -28.97 39.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.479 -0.763 . . . . 0.0 109.994 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.49 ' HA ' HD11 ' A' ' 13' ' ' ILE . 21.1 tttt -64.18 -13.04 45.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.317 -0.864 . . . . 0.0 109.488 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.502 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -124.19 -24.13 1.86 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -105.53 93.62 7.36 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.147 -1.208 . . . . 0.0 110.165 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.0 Cg_endo -73.43 4.12 4.19 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 124.12 1.589 . . . . 0.0 111.038 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -119.44 -1.53 10.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.023 -1.048 . . . . 0.0 110.126 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.726 ' HB3' HH21 ' A' ' 17' ' ' ARG . . . -59.76 105.51 0.38 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.339 -0.85 . . . . 0.0 110.159 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 1.058 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 0.3 OUTLIER 35.64 30.53 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.606 -0.684 . . . . 0.0 110.738 -179.754 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.536 ' CB ' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.726 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 1.026 HG23 ' C ' ' A' ' 120' ' ' TYR . 2.8 p -80.47 151.56 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.297 -1.119 . . . . 0.0 110.219 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.677 ' CE1' HD12 ' A' ' 128' ' ' ILE . 15.9 m-85 -90.14 176.39 6.79 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.276 -0.89 . . . . 0.0 110.046 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.826 HG23 ' CE1' ' A' ' 119' ' ' HIS . 94.9 m -140.88 106.11 5.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.247 -0.908 . . . . 0.0 110.294 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.657 ' CD1' HG13 ' A' ' 133' ' ' VAL . 22.2 m-85 -113.36 129.5 56.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -0.895 . . . . 0.0 109.987 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 22.4 pt-20 -130.41 152.99 49.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.233 -0.917 . . . . 0.0 110.569 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.3 m -138.18 147.18 43.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.373 -0.829 . . . . 0.0 109.84 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -131.36 117.12 18.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.132 -0.98 . . . . 0.0 110.556 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.4 p90 -139.21 -176.72 4.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.313 -0.867 . . . . 0.0 110.014 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.548 HG22 HG12 ' A' ' 113' ' ' ILE . 7.6 p -136.05 174.95 10.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.188 -0.945 . . . . 0.0 110.662 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.49 ' HB3' ' OE2' ' A' ' 148' ' ' GLU . 80.5 p -160.02 128.51 4.88 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.392 -0.817 . . . . 0.0 110.288 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.428 ' HA ' ' CA ' ' A' ' 111' ' ' GLY . 96.6 mt-10 -60.61 -28.86 68.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.195 -0.941 . . . . 0.0 109.924 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.939 HD13 ' HB3' ' A' ' 148' ' ' GLU . 1.3 mp -65.89 148.33 98.34 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.334 -0.854 . . . . 0.0 109.828 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.654 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.7 Cg_endo -66.49 141.65 62.09 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.892 1.469 . . . . 0.0 110.491 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.646 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.3 Cg_endo -72.87 -30.88 10.79 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 124.017 1.535 . . . . 0.0 112.886 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.646 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.6 Cg_endo -70.68 -22.33 28.0 Favored 'Trans proline' 0 C--N 1.319 -1.001 0 N-CA-C 110.195 -0.733 . . . . 0.0 110.195 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.638 HH21 ' HB3' ' A' ' 157' ' ' ALA . 43.4 mtp180 -84.31 -43.28 14.95 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.011 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 1.049 HD23 ' CG2' ' A' ' 147' ' ' ILE . 0.2 OUTLIER -72.73 -34.74 67.27 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.018 179.05 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.624 ' N ' HD13 ' A' ' 18' ' ' LEU . 52.5 t80 -64.5 -56.21 15.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.333 -0.854 . . . . 0.0 109.573 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.539 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 28.7 mttt -52.74 -36.41 57.68 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.734 -0.787 . . . . 0.0 109.564 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.007 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -78.03 -36.58 48.38 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.372 -0.83 . . . . 0.0 111.056 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 1.03 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.3 OUTLIER -73.91 -42.71 60.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.195 -0.94 . . . . 0.0 111.191 -179.057 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.628 ' HB ' HD12 ' A' ' 24' ' ' LEU . 4.6 t -105.99 -49.97 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.018 -1.051 . . . . 0.0 111.61 -178.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.676 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.1 mp -79.84 -9.95 59.72 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.26 -0.9 . . . . 0.0 111.399 -178.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.559 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.9 OUTLIER -149.44 38.82 0.79 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.85 -1.156 . . . . 0.0 110.555 -179.755 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 1.03 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -78.92 -24.97 43.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.333 -0.854 . . . . 0.0 110.504 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.484 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 91.8 m-20 -65.34 -21.15 66.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.154 -0.966 . . . . 0.0 110.221 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.554 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 7.6 p-10 -125.4 13.0 8.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.315 -0.866 . . . . 0.0 109.89 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.752 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -94.28 -52.04 4.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.441 -0.787 . . . . 0.0 110.327 -179.89 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 1.112 HG21 HD13 ' A' ' 38' ' ' ILE . 3.8 p -75.1 -28.87 0.82 Allowed Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.275 -0.89 . . . . 0.0 112.288 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.844 ' HD3' HG12 ' A' ' 30' ' ' VAL . 51.9 Cg_endo -79.1 7.58 4.3 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 O-C-N 122.704 0.844 . . . . 0.0 110.581 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -129.66 -29.73 2.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.172 -0.955 . . . . 0.0 110.009 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.698 HD11 HD13 ' A' ' 29' ' ' LEU . 75.5 mt -80.04 -44.13 22.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.41 -0.806 . . . . 0.0 109.788 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -160.43 103.21 1.35 Allowed Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.376 -0.827 . . . . 0.0 110.121 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.46 0.29 7.69 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.077 1.567 . . . . 0.0 110.641 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -83.48 -15.57 49.0 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.182 -0.949 . . . . 0.0 109.67 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -92.13 -64.84 1.06 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.414 -0.804 . . . . 0.0 109.993 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 1.112 HD13 HG21 ' A' ' 30' ' ' VAL . 2.1 mp -114.88 131.19 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.426 -0.796 . . . . 0.0 109.941 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 57' ' ' THR . 15.8 ttpt -77.42 -23.43 50.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.203 -0.936 . . . . 0.0 110.48 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.451 ' O ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -178.94 161.45 1.18 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.106 -0.996 . . . . 0.0 110.102 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.4 m -134.61 124.34 25.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.329 -0.857 . . . . 0.0 109.977 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -137.68 110.92 7.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -0.938 . . . . 0.0 110.661 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.416 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 33.8 mt -56.25 136.27 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.33 -0.857 . . . . 0.0 109.787 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.727 HD13 ' HD2' ' A' ' 55' ' ' LYS . 7.6 tp -108.76 -26.1 10.48 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.174 -0.953 . . . . 0.0 110.575 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.483 ' HB2' ' CB ' ' A' ' 53' ' ' ILE . 2.0 m95 -128.65 163.3 25.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.123 -0.985 . . . . 0.0 110.845 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.448 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 41.8 -137.72 2.55 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.94 24.13 0.66 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.326 -1.102 . . . . 0.0 110.02 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 119.04 -16.32 10.88 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.519 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -73.66 -170.02 19.66 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.75 128.85 12.88 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.99 1.521 . . . . 0.0 110.559 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.465 ' HA2' ' HE3' ' A' ' 70' ' ' LYS . . . 102.64 -12.32 56.55 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 108.707 -1.757 . . . . 0.0 108.707 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.539 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -71.36 161.6 30.8 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.534 -0.98 . . . . 0.0 109.56 179.674 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.483 ' CB ' ' HB2' ' A' ' 45' ' ' TRP . 45.0 mt -130.78 119.93 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.329 -0.857 . . . . 0.0 109.959 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.784 ' CE ' HD11 ' A' ' 71' ' ' ILE . 29.3 mttm -103.11 127.17 50.49 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.151 -0.968 . . . . 0.0 110.228 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.727 ' HD2' HD13 ' A' ' 44' ' ' LEU . 7.8 mtpt -96.06 92.69 6.57 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.378 -0.826 . . . . 0.0 110.098 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.542 ' CG2' HG12 ' A' ' 38' ' ' ILE . 95.2 mt -79.95 141.87 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 109.914 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 2.4 p -116.4 152.07 34.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.3 -0.875 . . . . 0.0 110.582 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.594 ' HE2' HG13 ' A' ' 67' ' ' VAL . 23.5 m-85 -117.5 145.87 43.92 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.37 -0.832 . . . . 0.0 110.104 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.901 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.3 t80 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.324 0.583 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.577 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -135.53 96.61 0.27 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.546 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 13.6 p90 -136.1 169.13 18.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -1.182 . . . . 0.0 110.197 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.72 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.5 m -139.54 175.32 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.233 -0.917 . . . . 0.0 110.636 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.68 ' O ' HD12 ' A' ' 85' ' ' LEU . 42.7 mttt -133.41 104.63 6.51 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.465 -0.772 . . . . 0.0 109.905 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.971 ' CD2' HD13 ' A' ' 85' ' ' LEU . 13.3 m170 -96.13 129.6 43.38 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.197 -0.94 . . . . 0.0 111.138 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 52' ' ' THR . 21.6 tttp -96.92 116.7 29.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.327 -0.858 . . . . 0.0 109.395 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.784 HD11 ' CE ' ' A' ' 54' ' ' LYS . 26.8 mm -57.26 128.59 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.172 -0.955 . . . . 0.0 110.346 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 82' ' ' SER . 85.0 m-20 -101.58 -43.79 5.78 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.341 -0.849 . . . . 0.0 110.013 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.423 ' OG ' ' HB2' ' A' ' 82' ' ' SER . 62.0 p -173.67 158.67 3.38 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.434 -0.791 . . . . 0.0 109.946 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.48 HG12 HG11 ' A' ' 23' ' ' VAL . 2.0 mt -139.3 157.4 27.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.229 -0.92 . . . . 0.0 110.228 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 79' ' ' TYR . 4.5 m-20 -135.41 79.2 1.77 Allowed 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.371 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -61.38 -17.74 55.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -0.923 . . . . 0.0 110.174 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -92.48 -30.68 15.59 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.28 -0.887 . . . . 0.0 109.577 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.497 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.6 m120 -104.15 -3.22 24.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.566 -0.709 . . . . 0.0 109.574 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.716 ' HB3' HD12 ' A' ' 104' ' ' LEU . 70.0 m-85 60.18 54.57 3.99 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.599 -0.688 . . . . 0.0 110.756 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.508 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 0.9 OUTLIER -129.47 157.62 41.49 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.278 -0.889 . . . . 0.0 109.689 179.435 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.686 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 45.3 t80 -142.54 138.86 31.18 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.259 -0.901 . . . . 0.0 110.104 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 4.3 m -142.12 132.2 24.65 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.826 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.686 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 21.3 p90 -149.65 170.94 17.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.358 -0.839 . . . . 0.0 110.407 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.858 HG23 ' O ' ' A' ' 98' ' ' ILE . 50.4 m -126.72 129.52 48.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.436 -0.79 . . . . 0.0 110.077 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.971 HD13 ' CD2' ' A' ' 69' ' ' HIS . 10.7 tp -95.84 133.55 39.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.084 -1.01 . . . . 0.0 110.378 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.529 ' H ' HD12 ' A' ' 85' ' ' LEU . 9.8 pt -111.22 -33.49 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.199 -0.938 . . . . 0.0 110.209 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.685 ' O ' HD11 ' A' ' 85' ' ' LEU . 77.3 tt0 -116.17 155.3 28.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.376 -0.828 . . . . 0.0 110.139 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.72 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 156.29 129.38 1.17 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -60.15 -20.21 57.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -1.161 . . . . 0.0 110.222 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.69 -16.14 60.77 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.276 -0.89 . . . . 0.0 110.252 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.46 ' O ' ' HB2' ' A' ' 95' ' ' LEU . 75.7 mt -69.1 -25.51 64.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.278 -0.889 . . . . 0.0 110.189 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 49.28 -178.66 0.02 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.544 ' OD1' HG23 ' A' ' 94' ' ' THR . 55.1 p30 -83.15 10.27 8.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.229 -1.16 . . . . 0.0 110.171 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.728 ' O ' HG21 ' A' ' 126' ' ' VAL . 29.7 p -103.08 -33.84 9.1 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.235 -0.916 . . . . 0.0 110.098 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.902 HD21 HD11 ' A' ' 128' ' ' ILE . 96.7 mt -103.8 160.6 14.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 110.052 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.46 ' HG2' ' N ' ' A' ' 97' ' ' LYS . 54.4 tt0 -140.05 -82.18 0.26 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.337 -0.852 . . . . 0.0 109.689 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.5 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 42.0 mttm -80.43 135.66 36.2 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.625 -0.672 . . . . 0.0 110.139 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.858 ' O ' HG23 ' A' ' 84' ' ' THR . 4.2 mm -123.1 139.29 50.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 120.866 -1.146 . . . . 0.0 109.982 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.496 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -121.96 129.34 52.41 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.783 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.699 ' HE2' HG21 ' A' ' 98' ' ' ILE . 9.9 m-85 -123.3 133.66 54.14 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.158 -0.964 . . . . 0.0 110.876 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -135.49 129.95 33.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.444 -0.785 . . . . 0.0 109.711 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 37.4 m -134.14 144.13 48.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.186 -0.946 . . . . 0.0 110.494 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.491 ' HG3' ' HB3' ' A' ' 80' ' ' SER . 5.1 tttt -139.45 144.67 38.14 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.346 -0.846 . . . . 0.0 110.303 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.716 HD12 ' HB3' ' A' ' 79' ' ' TYR . 12.7 mt -109.37 155.09 21.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.225 -0.922 . . . . 0.0 110.461 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.693 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -151.17 -168.86 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.359 -0.838 . . . . 0.0 109.608 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.693 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -122.59 154.67 37.63 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.173 -0.955 . . . . 0.0 110.526 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.457 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 55.4 p -114.52 164.56 16.08 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.389 -0.819 . . . . 0.0 110.064 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 47.6 Cg_endo -72.63 -1.77 10.82 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.959 1.505 . . . . 0.0 110.505 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.7 t -97.24 -22.6 16.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.103 -0.998 . . . . 0.0 110.31 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 111' ' ' GLY . . . 125.42 -38.11 2.37 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 110' ' ' GLY . . . -60.29 -147.13 0.01 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 47.5 p -150.43 133.21 15.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.173 -1.193 . . . . 0.0 110.148 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.548 HG12 HG22 ' A' ' 10' ' ' THR . 23.4 mt -82.6 149.52 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.246 -0.909 . . . . 0.0 110.241 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.694 HG23 HD23 ' A' ' 104' ' ' LEU . 10.1 mt -129.74 113.47 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.894 . . . . 0.0 110.02 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.424 ' N ' ' O ' ' A' ' 103' ' ' LYS . 15.3 ttpt -94.99 122.26 37.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.088 -1.007 . . . . 0.0 110.216 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.91 147.27 42.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.895 . . . . 0.0 110.293 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 81.6 m -150.22 129.14 12.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.363 -0.836 . . . . 0.0 110.327 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.471 ' OG ' ' CE1' ' A' ' 100' ' ' TYR . 15.4 t -128.4 154.18 46.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.271 -0.893 . . . . 0.0 110.198 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.826 ' CE1' HG23 ' A' ' 4' ' ' THR . 91.5 m-70 -132.87 121.8 23.44 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.348 -0.845 . . . . 0.0 110.3 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 1.026 ' C ' HG23 ' A' ' 2' ' ' VAL . 5.7 m-30 -95.3 119.37 33.69 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.183 -0.948 . . . . 0.0 110.489 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.553 ' CE1' HG21 ' A' ' 2' ' ' VAL . 76.4 m-70 -95.47 107.45 19.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.358 -0.839 . . . . 0.0 109.558 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.7 p -77.85 155.79 30.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.107 -0.995 . . . . 0.0 110.387 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.448 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 36.9 tttp -119.6 113.51 20.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.378 -0.826 . . . . 0.0 110.226 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.38 -135.89 12.61 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -113.2 76.39 0.98 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.258 -1.143 . . . . 0.0 110.235 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.728 HG21 ' O ' ' A' ' 94' ' ' THR . 33.5 m -137.09 161.73 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.223 -0.923 . . . . 0.0 110.105 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -141.94 155.69 45.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 110.192 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.902 HD11 HD21 ' A' ' 95' ' ' LEU . 1.9 mp -84.03 173.43 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.22 -0.925 . . . . 0.0 110.113 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.608 ' N ' HG22 ' A' ' 128' ' ' ILE . 9.0 mttt -119.24 142.98 47.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.451 -0.78 . . . . 0.0 109.901 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' A' ' 134' ' ' LYS . 93.6 mt-10 -48.17 -34.47 10.04 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.154 -0.966 . . . . 0.0 110.152 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.498 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 69.1 tt0 -63.84 -32.33 73.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 0.0 109.971 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 13.9 t-160 -77.66 -51.61 10.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.296 -0.877 . . . . 0.0 110.048 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.657 HG13 ' CD1' ' A' ' 5' ' ' TYR . 49.6 t -60.69 -38.66 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.39 -0.819 . . . . 0.0 109.979 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 130' ' ' GLU . 62.2 mmtt -77.37 -45.01 27.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.316 -0.865 . . . . 0.0 110.122 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.498 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -62.25 -38.31 88.78 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.304 -0.872 . . . . 0.0 110.019 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -63.43 -30.77 78.59 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 77.5 mttt -77.33 -30.93 54.24 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.353 -1.087 . . . . 0.0 110.0 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -75.65 -34.1 60.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.367 -0.833 . . . . 0.0 109.959 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 39.3 mttt -73.36 -37.29 66.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.376 -0.828 . . . . 0.0 109.815 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.512 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -74.76 -32.37 62.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.251 -0.906 . . . . 0.0 109.88 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.6 m -66.93 -49.33 65.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -0.881 . . . . 0.0 109.904 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -51.56 -47.3 63.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.25 -0.906 . . . . 0.0 109.895 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.433 ' O ' HG13 ' A' ' 147' ' ' ILE . 13.7 tp -57.14 -50.02 74.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -0.899 . . . . 0.0 109.732 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.512 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 21.6 m-85 -52.9 -35.17 57.76 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.388 -0.82 . . . . 0.0 109.673 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 37.2 mttt -78.18 -18.25 55.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.376 -0.828 . . . . 0.0 109.811 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 143' ' ' LEU . 26.0 mt -82.43 -35.76 27.28 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.255 -0.903 . . . . 0.0 108.778 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 1.049 ' CG2' HD23 ' A' ' 18' ' ' LEU . 34.7 mt -69.6 -45.47 77.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.939 ' HB3' HD13 ' A' ' 13' ' ' ILE . 91.9 mt-10 -53.21 -40.16 64.27 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.353 -0.842 . . . . 0.0 109.428 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.2 m -67.27 -28.23 67.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.309 -0.869 . . . . 0.0 109.447 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.591 ' CD1' HG12 ' A' ' 33' ' ' ILE . 80.5 t80 -63.42 -48.08 79.29 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.517 -0.74 . . . . 0.0 109.817 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.014 HD21 ' CE1' ' A' ' 158' ' ' TYR . 81.6 mt -79.91 -37.67 34.17 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.309 -0.87 . . . . 0.0 110.211 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.928 ' HB2' HD11 ' A' ' 13' ' ' ILE . 43.5 tptt -60.7 -16.99 45.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.362 -0.836 . . . . 0.0 109.318 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.484 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -116.39 -30.13 2.14 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.449 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 4.4 m80 -106.05 93.97 8.6 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.222 -1.164 . . . . 0.0 110.223 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 48.1 Cg_endo -74.02 6.25 3.06 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 124.066 1.561 . . . . 0.0 111.048 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 35.4 p30 -115.77 -5.68 12.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.014 -1.054 . . . . 0.0 109.906 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.638 ' HB3' HH21 ' A' ' 17' ' ' ARG . . . -57.76 107.38 0.45 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.379 -0.826 . . . . 0.0 110.112 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 1.014 ' CE1' HD21 ' A' ' 151' ' ' LEU . 0.2 OUTLIER 36.56 29.61 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.654 -0.654 . . . . 0.0 110.573 -179.429 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.573 ' CB ' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.644 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.923 HG13 ' O ' ' A' ' 120' ' ' TYR . 94.9 t -118.97 146.54 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.214 -1.168 . . . . 0.0 110.331 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.654 ' CE1' HD12 ' A' ' 128' ' ' ILE . 9.8 m-85 -101.03 142.55 32.34 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.285 -0.884 . . . . 0.0 109.518 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 m -118.45 131.88 56.25 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.982 -1.074 . . . . 0.0 110.887 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 1.138 ' CE2' HG21 ' A' ' 133' ' ' VAL . 72.0 m-85 -141.25 124.57 16.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.434 -0.791 . . . . 0.0 109.836 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.994 ' CG ' HG23 ' A' ' 117' ' ' THR . 10.2 mt-10 -132.23 136.34 46.92 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 0.0 110.319 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.414 ' C ' ' HG3' ' A' ' 8' ' ' GLU . 50.0 m -125.51 164.08 21.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.235 -0.916 . . . . 0.0 110.093 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.459 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 87.1 mt-10 -146.26 127.18 14.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.298 -0.876 . . . . 0.0 110.445 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.633 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.1 p90 -147.32 -175.17 4.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.308 -0.87 . . . . 0.0 109.818 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.85 HG22 ' HA ' ' A' ' 113' ' ' ILE . 5.1 p -142.04 170.78 15.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.097 -1.002 . . . . 0.0 110.64 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.47 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 5.0 t -148.93 164.29 34.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.388 -0.82 . . . . 0.0 110.062 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -85.85 -22.0 27.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.267 -0.895 . . . . 0.0 110.192 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.816 HG23 ' HD2' ' A' ' 14' ' ' PRO . 8.8 mm -80.9 150.22 68.59 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.316 -0.865 . . . . 0.0 110.07 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.816 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.6 Cg_endo -66.17 146.36 81.33 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.044 1.55 . . . . 0.0 110.377 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.68 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.2 Cg_endo -71.18 -31.95 13.75 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.897 1.472 . . . . 0.0 112.912 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.68 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.1 Cg_endo -68.51 -20.59 41.28 Favored 'Trans proline' 0 C--N 1.317 -1.107 0 N-CA-C 110.114 -0.764 . . . . 0.0 110.114 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.775 ' HB3' HD13 ' A' ' 151' ' ' LEU . 47.9 mtp180 -85.78 -43.77 13.05 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.132 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.779 HD23 ' C ' ' A' ' 18' ' ' LEU . 1.2 tt -75.21 -34.45 61.49 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.567 ' N ' HD23 ' A' ' 18' ' ' LEU . 60.8 t80 -65.75 -55.42 17.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.394 -0.816 . . . . 0.0 109.342 179.04 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.522 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 64.3 mttt -53.62 -38.44 64.05 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.884 -0.727 . . . . 0.0 109.558 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.019 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -74.4 -39.74 62.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.465 -0.772 . . . . 0.0 110.961 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.96 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -75.21 -38.47 60.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.315 -0.865 . . . . 0.0 111.073 -178.99 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.668 HG13 ' CE1' ' A' ' 81' ' ' TYR . 4.5 t -105.22 -55.21 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.039 -1.038 . . . . 0.0 111.691 -179.104 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.676 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.3 mp -80.03 -4.64 53.5 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.178 -0.952 . . . . 0.0 111.841 -178.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.533 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 1.0 OUTLIER -150.7 32.49 0.62 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.706 -1.246 . . . . 0.0 110.724 -179.61 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.96 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -74.44 -20.63 59.96 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.257 -0.902 . . . . 0.0 110.321 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.46 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 94.8 m-20 -67.75 -24.45 65.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.232 -0.918 . . . . 0.0 110.103 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.572 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 4.4 p30 -123.51 12.93 9.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.326 -0.859 . . . . 0.0 109.897 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.691 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -92.92 -50.33 5.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.356 -0.84 . . . . 0.0 110.184 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.87 HG22 ' HD3' ' A' ' 31' ' ' PRO . 2.2 m -74.26 -29.44 0.97 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.353 -0.842 . . . . 0.0 112.166 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.87 ' HD3' HG22 ' A' ' 30' ' ' VAL . 53.1 Cg_endo -79.15 3.57 7.33 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 O-C-N 122.785 0.887 . . . . 0.0 110.287 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -124.66 -34.71 2.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.319 -0.863 . . . . 0.0 109.326 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.593 HG12 ' CD1' ' A' ' 150' ' ' TYR . 18.4 mt -79.99 -36.65 17.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.625 -0.672 . . . . 0.0 109.837 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -175.33 102.95 0.26 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.545 -0.722 . . . . 0.0 109.831 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.77 1.57 6.26 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.031 1.543 . . . . 0.0 110.808 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -84.54 0.05 51.33 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.141 -0.974 . . . . 0.0 109.894 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.858 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -101.03 -51.17 3.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.28 -0.887 . . . . 0.0 110.024 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.858 HD12 ' C ' ' A' ' 37' ' ' ALA . 1.8 mp -134.45 125.09 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.449 -0.782 . . . . 0.0 109.948 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' A' ' 57' ' ' THR . 21.8 ttpt -61.47 -26.82 68.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.25 -0.906 . . . . 0.0 110.319 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.512 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER 173.24 162.08 0.14 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.153 -0.967 . . . . 0.0 110.107 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.1 m -128.34 125.11 38.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.384 -0.822 . . . . 0.0 110.048 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.512 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 40.5 tt0 -130.16 111.37 12.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.195 -0.94 . . . . 0.0 110.426 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.447 HG12 ' HG2' ' A' ' 54' ' ' LYS . 36.3 mt -63.35 135.44 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.351 -0.843 . . . . 0.0 110.044 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 16.0 tp -110.45 -27.47 9.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.246 -0.909 . . . . 0.0 110.362 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.75 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.8 m95 -124.14 159.48 29.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -0.958 . . . . 0.0 110.605 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 45' ' ' TRP . . . 42.06 -136.82 3.07 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.419 ' O ' ' CG ' ' A' ' 47' ' ' ASP . 11.9 t0 -152.72 24.75 0.58 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.361 -1.082 . . . . 0.0 109.77 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.47 ' O ' HG21 ' A' ' 71' ' ' ILE . . . 119.97 -21.97 8.73 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.494 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -65.17 -172.82 3.62 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.454 ' HA ' HG22 ' A' ' 71' ' ' ILE . 46.1 Cg_endo -73.44 128.64 12.95 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.997 1.525 . . . . 0.0 110.612 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.32 -13.23 54.98 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.524 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -68.61 163.25 24.12 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.569 -0.959 . . . . 0.0 109.663 179.729 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.75 HD12 ' CG ' ' A' ' 45' ' ' TRP . 61.6 mt -133.09 120.53 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.305 -0.872 . . . . 0.0 109.748 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.447 ' HG2' HG12 ' A' ' 43' ' ' ILE . 89.8 mttt -109.57 130.52 55.5 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.159 -0.963 . . . . 0.0 110.487 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -96.03 96.3 8.78 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.275 -0.891 . . . . 0.0 109.869 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.54 ' CG2' HG12 ' A' ' 38' ' ' ILE . 73.1 mt -79.87 143.82 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 109.998 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 39' ' ' LYS . 2.4 p -116.67 155.84 28.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 110.863 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.675 ' HE2' HG13 ' A' ' 67' ' ' VAL . 27.2 m-85 -119.07 154.76 32.65 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.473 -0.767 . . . . 0.0 109.917 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.836 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.168 0.508 . . . . 0.0 110.284 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -134.89 113.86 1.19 Allowed Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.634 -1.787 . . . . 0.0 108.634 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.544 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 12.6 p90 -155.93 162.24 40.41 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.113 -1.228 . . . . 0.0 110.208 -179.444 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.815 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.7 m -135.01 172.68 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.301 -0.874 . . . . 0.0 110.542 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.526 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 22.5 mttt -119.07 131.34 55.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.549 -0.719 . . . . 0.0 109.71 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.644 ' CD2' ' CD1' ' A' ' 85' ' ' LEU . 11.6 m170 -116.11 129.99 56.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.17 -0.956 . . . . 0.0 110.758 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 52' ' ' THR . 13.5 ttpt -107.71 108.84 20.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.279 -0.888 . . . . 0.0 109.547 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.722 HG23 HD11 ' A' ' 74' ' ' ILE . 27.8 mm -53.03 124.4 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.243 -0.911 . . . . 0.0 110.437 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 82' ' ' SER . 93.4 m-20 -96.71 -43.04 7.72 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.445 -0.784 . . . . 0.0 109.723 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.873 ' C ' HD12 ' A' ' 74' ' ' ILE . 15.2 m -170.79 157.55 5.58 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.338 -0.851 . . . . 0.0 109.685 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.873 HD12 ' C ' ' A' ' 73' ' ' SER . 1.4 mp -135.66 149.66 28.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 110.226 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 79' ' ' TYR . 9.3 m-20 -131.22 77.26 1.77 Allowed 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.711 -0.795 . . . . 0.0 110.677 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 35.8 mttp -63.71 -16.0 59.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.182 -0.949 . . . . 0.0 109.888 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -93.8 -34.66 13.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.351 -0.843 . . . . 0.0 109.301 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.507 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.6 m120 -99.18 -4.11 32.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.595 -0.691 . . . . 0.0 109.452 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.582 ' CE1' ' HB3' ' A' ' 16' ' ' PRO . 65.5 m-85 60.11 57.02 3.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.558 -0.714 . . . . 0.0 110.305 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.487 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -130.73 163.08 28.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.383 -0.823 . . . . 0.0 109.595 179.539 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.668 ' CE1' HG13 ' A' ' 23' ' ' VAL . 15.2 t80 -144.64 138.33 27.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.921 . . . . 0.0 109.975 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 38.2 m -140.12 121.58 15.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.161 -0.962 . . . . 0.0 111.064 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.614 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 5.3 p90 -139.07 177.69 7.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.457 -0.777 . . . . 0.0 109.556 178.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 98' ' ' ILE . 44.3 m -133.75 137.06 44.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.064 -1.023 . . . . 0.0 110.522 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.644 ' CD1' ' CD2' ' A' ' 69' ' ' HIS . 16.5 tp -93.37 118.31 31.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.236 -0.915 . . . . 0.0 109.831 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.7 pt -107.44 -22.23 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.427 -0.796 . . . . 0.0 110.036 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.526 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 64.9 tt0 -129.59 130.6 45.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.207 -0.933 . . . . 0.0 110.627 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.815 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . -176.87 107.94 0.25 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 90' ' ' ALA . 29.4 p-10 -42.34 -25.99 0.09 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.253 -1.145 . . . . 0.0 110.504 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.476 ' N ' ' OD1' ' A' ' 89' ' ' ASP . . . -75.47 -37.93 59.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.083 -1.01 . . . . 0.0 110.445 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.496 HD12 ' C ' ' A' ' 91' ' ' LEU . 1.6 pp -86.99 -25.7 24.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.885 . . . . 0.0 110.537 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.435 ' N ' ' HG ' ' A' ' 91' ' ' LEU . . . -63.11 -36.11 93.0 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.724 ' O ' HG23 ' A' ' 94' ' ' THR . 57.1 t0 -44.11 -34.91 1.95 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.174 -1.192 . . . . 0.0 110.403 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.724 HG23 ' O ' ' A' ' 93' ' ' ASP . 1.7 p -160.05 -35.07 0.06 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.273 -0.892 . . . . 0.0 110.432 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 1.044 HD21 ' CG1' ' A' ' 128' ' ' ILE . 5.9 mt -79.96 177.71 8.73 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.213 -0.929 . . . . 0.0 110.286 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.454 ' O ' HD13 ' A' ' 91' ' ' LEU . 45.5 tt0 -148.64 -78.98 0.14 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.363 -0.836 . . . . 0.0 109.479 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.526 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 8.1 mttt -80.14 135.59 36.34 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.63 -0.669 . . . . 0.0 110.486 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.584 ' O ' HG23 ' A' ' 84' ' ' THR . 0.3 OUTLIER -136.34 132.35 49.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 120.704 -1.247 . . . . 0.0 109.292 178.651 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.434 ' HG ' ' HE2' ' A' ' 121' ' ' HIS . 0.6 OUTLIER -107.37 132.6 52.98 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.383 -0.823 . . . . 0.0 109.909 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.614 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 5.8 m-85 -122.74 132.73 54.37 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.495 -0.753 . . . . 0.0 110.316 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.477 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 9.3 tt0 -135.81 125.31 25.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.205 -0.934 . . . . 0.0 110.295 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.471 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 72.2 m -118.5 154.83 31.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.232 -0.917 . . . . 0.0 109.516 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.449 ' N ' ' O ' ' A' ' 115' ' ' LYS . 31.4 mttt -144.1 132.35 21.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.028 -1.045 . . . . 0.0 110.389 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.847 HD23 HG12 ' A' ' 114' ' ' ILE . 2.8 mt -120.01 145.45 46.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.284 -0.885 . . . . 0.0 110.177 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.702 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -153.07 -168.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.378 -0.826 . . . . 0.0 109.891 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.702 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -114.76 140.91 48.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.356 -0.84 . . . . 0.0 110.117 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.488 ' HA ' HD11 ' A' ' 113' ' ' ILE . 53.9 p -97.22 162.99 20.84 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.249 -0.907 . . . . 0.0 110.21 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.425 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.3 Cg_endo -71.92 -2.99 12.35 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.982 1.517 . . . . 0.0 110.393 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 52.9 p -100.98 2.84 41.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.295 -0.878 . . . . 0.0 110.207 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 101.2 -31.48 8.6 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -70.73 -172.55 12.15 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.511 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 24.5 p -122.03 131.37 53.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.278 -1.131 . . . . 0.0 110.369 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.85 ' HA ' HG22 ' A' ' 10' ' ' THR . 21.7 mt -80.07 143.88 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.887 . . . . 0.0 109.742 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.847 HG12 HD23 ' A' ' 104' ' ' LEU . 19.4 mt -131.08 109.78 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.104 -0.997 . . . . 0.0 110.63 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.459 ' HG3' ' HG2' ' A' ' 8' ' ' GLU . 30.0 tttt -99.33 130.5 45.62 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.277 -0.889 . . . . 0.0 109.825 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.83 151.58 39.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.958 . . . . 0.0 110.53 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.994 HG23 ' CG ' ' A' ' 6' ' ' GLU . 25.9 m -146.72 151.84 37.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.35 -0.844 . . . . 0.0 110.302 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 91.3 p -155.84 139.96 16.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.915 . . . . 0.0 110.282 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.455 ' CE1' HG22 ' A' ' 117' ' ' THR . 54.4 m-70 -127.92 157.02 41.7 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.211 -0.931 . . . . 0.0 110.394 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.923 ' O ' HG13 ' A' ' 2' ' ' VAL . 7.0 m-85 -120.41 141.62 49.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.197 -0.939 . . . . 0.0 110.733 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.526 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 98.2 m-70 -122.29 96.65 5.13 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.109 -0.994 . . . . 0.0 109.857 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.835 HG23 HD23 ' A' ' 95' ' ' LEU . 1.3 p -75.93 156.39 34.26 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.351 -0.843 . . . . 0.0 110.323 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 44.4 tttm -113.17 108.3 17.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.216 -0.927 . . . . 0.0 110.266 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 105.4 -124.07 7.79 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -127.9 75.05 1.58 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.269 -1.136 . . . . 0.0 110.204 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.466 HG23 ' CG2' ' A' ' 122' ' ' THR . 16.4 m -141.49 152.71 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.236 -0.915 . . . . 0.0 110.279 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -127.77 161.78 28.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.298 -0.877 . . . . 0.0 110.098 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 1.044 ' CG1' HD21 ' A' ' 95' ' ' LEU . 5.1 mp -86.66 172.36 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.248 -0.907 . . . . 0.0 110.378 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.602 ' N ' HG22 ' A' ' 128' ' ' ILE . 10.0 mttp -108.01 127.16 53.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.414 -0.804 . . . . 0.0 109.539 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.493 ' CA ' ' HG3' ' A' ' 134' ' ' LYS . 97.4 mt-10 -42.86 -55.03 3.88 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.214 -0.929 . . . . 0.0 110.069 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.404 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 49.0 tt0 -47.22 -24.24 0.68 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.936 . . . . 0.0 109.751 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.477 ' N ' ' O ' ' A' ' 129' ' ' LYS . 9.7 t-160 -86.19 -64.89 1.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.361 -0.837 . . . . 0.0 110.175 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 1.138 HG21 ' CE2' ' A' ' 5' ' ' TYR . 7.2 p -63.38 -41.46 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.399 -0.813 . . . . 0.0 110.222 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.531 ' N ' HG13 ' A' ' 133' ' ' VAL . 27.5 mttt -63.04 -43.55 98.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.175 -0.953 . . . . 0.0 109.823 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.451 ' O ' ' HG3' ' A' ' 139' ' ' LYS . . . -67.94 -26.15 65.82 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.339 -0.851 . . . . 0.0 109.792 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -71.66 -33.02 63.76 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.499 ' HE2' ' CD1' ' A' ' 5' ' ' TYR . 25.9 mttp -63.37 -34.67 78.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -1.129 . . . . 0.0 109.894 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -79.07 -31.94 44.6 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.366 -0.834 . . . . 0.0 109.936 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 135' ' ' ALA . 83.6 mttt -65.46 -39.36 91.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.347 -0.846 . . . . 0.0 109.857 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.85 -46.6 52.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.875 . . . . 0.0 109.916 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.6 t -55.97 -42.32 76.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.421 -0.799 . . . . 0.0 109.917 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -59.2 -43.03 92.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.922 . . . . 0.0 109.882 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 47.5 mt -60.57 -36.74 79.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.261 -0.899 . . . . 0.0 109.783 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.539 ' HA ' HD12 ' A' ' 147' ' ' ILE . 22.7 m-85 -63.2 -31.93 73.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.377 -0.827 . . . . 0.0 109.823 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -73.64 -18.59 61.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.286 -0.884 . . . . 0.0 109.916 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.504 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 32.2 mt -82.19 -35.57 28.19 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.271 -0.893 . . . . 0.0 108.701 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.727 HD11 ' CE1' ' A' ' 22' ' ' PHE . 26.8 mt -73.0 -47.06 49.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 178.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.509 ' O ' HG13 ' A' ' 13' ' ' ILE . 90.8 mt-10 -57.57 -33.75 68.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.475 -0.766 . . . . 0.0 109.406 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 19.8 m -77.1 -26.19 53.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.206 -0.934 . . . . 0.0 109.267 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.597 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 87.9 t80 -62.28 -51.38 67.94 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.605 -0.684 . . . . 0.0 110.03 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.058 HD21 ' CE2' ' A' ' 158' ' ' TYR . 71.4 mt -74.53 -29.13 61.27 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.331 -0.856 . . . . 0.0 110.196 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.599 ' HA ' HD11 ' A' ' 13' ' ' ILE . 65.9 tttt -63.19 -17.76 62.76 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.231 -0.918 . . . . 0.0 109.593 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.484 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -122.29 -19.7 3.14 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.417 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 10.5 m80 -106.91 91.74 6.7 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.128 -1.219 . . . . 0.0 110.3 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 49.1 Cg_endo -73.92 4.76 3.91 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.054 1.555 . . . . 0.0 110.871 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -117.55 -6.12 11.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.095 -1.003 . . . . 0.0 109.809 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.64 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -59.81 104.92 0.33 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.345 -0.847 . . . . 0.0 110.131 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 1.058 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.2 OUTLIER 35.77 31.12 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.662 -0.649 . . . . 0.0 110.507 -179.492 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.546 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.792 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.765 HG13 ' O ' ' A' ' 120' ' ' TYR . 39.1 t -124.37 142.84 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.236 -1.155 . . . . 0.0 110.338 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.798 ' CE1' HD12 ' A' ' 128' ' ' ILE . 7.9 m-85 -104.62 147.01 28.11 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.339 -0.851 . . . . 0.0 109.667 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.61 HG23 ' CE1' ' A' ' 119' ' ' HIS . 4.0 m -113.28 110.17 19.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.047 -1.033 . . . . 0.0 110.756 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.918 ' CE1' HG11 ' A' ' 133' ' ' VAL . 28.8 m-85 -119.58 125.98 50.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.295 -0.878 . . . . 0.0 109.977 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 116' ' ' SER . 22.7 pt-20 -139.99 154.17 47.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.151 -0.968 . . . . 0.0 110.363 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.1 t -127.04 162.93 24.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.312 -0.867 . . . . 0.0 109.992 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -142.82 121.4 12.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.183 -0.948 . . . . 0.0 110.368 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.651 ' CZ ' ' CD2' ' A' ' 144' ' ' PHE . 3.0 p90 -149.24 -172.69 4.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.347 -0.845 . . . . 0.0 109.765 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.861 HG22 ' HA ' ' A' ' 113' ' ' ILE . 9.4 p -142.16 173.21 11.73 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.216 -0.928 . . . . 0.0 110.695 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.521 ' HB2' ' CG ' ' A' ' 148' ' ' GLU . 22.9 p -158.03 134.06 9.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.499 -0.75 . . . . 0.0 110.199 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.489 ' HA ' ' HA2' ' A' ' 111' ' ' GLY . 97.6 mt-10 -61.11 -39.18 89.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 110.111 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.809 HG23 ' HD2' ' A' ' 14' ' ' PRO . 3.0 mp -53.99 150.4 14.99 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.43 -0.794 . . . . 0.0 109.998 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.809 ' HD2' HG23 ' A' ' 13' ' ' ILE . 41.1 Cg_endo -66.89 141.07 57.38 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.958 1.504 . . . . 0.0 110.466 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.633 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.7 Cg_endo -73.44 -30.11 10.41 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 O-C-N 124.04 1.548 . . . . 0.0 112.996 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.2 Cg_endo -71.11 -22.74 25.62 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 O-C-N 122.443 0.707 . . . . 0.0 110.398 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.613 ' NH2' ' HB3' ' A' ' 157' ' ' ALA . 39.7 mtp180 -84.8 -45.58 12.21 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.774 HD23 ' C ' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -66.44 -30.14 70.43 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.663 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.543 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 69.0 t80 -67.19 -59.72 3.2 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.484 -0.76 . . . . 0.0 109.561 178.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.544 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 8.5 mttp -49.34 -29.4 6.09 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.056 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.04 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -75.63 -65.72 0.86 Allowed 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.708 0.765 . . . . 0.0 110.934 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.849 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -57.59 -33.57 68.34 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.775 -0.578 . . . . 0.0 111.754 -178.382 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.794 HG13 ' CE1' ' A' ' 81' ' ' TYR . 3.9 t -104.39 -61.46 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.853 -1.154 . . . . 0.0 111.49 -178.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.688 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.9 mp -77.01 -0.14 23.39 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.166 -0.959 . . . . 0.0 111.599 -178.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.593 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -142.2 6.88 1.75 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.753 -1.217 . . . . 0.0 110.83 179.945 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.849 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -47.35 -41.78 20.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.089 -1.007 . . . . 0.0 110.044 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.479 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 86.7 m-20 -64.13 -18.12 64.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -0.893 . . . . 0.0 110.034 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.511 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 81.5 m-20 -127.96 11.13 6.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.875 . . . . 0.0 110.158 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.793 HD12 ' C ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -95.95 -46.73 6.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.332 -0.855 . . . . 0.0 110.153 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 1.069 HG21 HD13 ' A' ' 38' ' ' ILE . 6.8 p -78.09 -26.9 0.53 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.898 . . . . 0.0 112.333 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.807 ' HD3' HG12 ' A' ' 30' ' ' VAL . 49.9 Cg_endo -78.14 5.82 5.12 Favored 'Trans proline' 0 C--N 1.318 -1.057 0 O-C-N 122.656 0.819 . . . . 0.0 110.539 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -126.15 -27.62 3.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.194 -0.941 . . . . 0.0 109.815 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.575 HG12 ' CD1' ' A' ' 150' ' ' TYR . 14.1 mt -79.96 -43.06 22.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.427 -0.796 . . . . 0.0 109.734 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -161.37 102.63 1.22 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.436 -0.79 . . . . 0.0 110.142 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.65 -0.51 8.96 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.045 1.55 . . . . 0.0 110.546 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -84.16 -17.04 41.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 0.0 109.712 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.41 -70.45 0.66 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.427 -0.796 . . . . 0.0 109.96 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 1.069 HD13 HG21 ' A' ' 30' ' ' VAL . 1.6 mp -103.96 129.28 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.456 -0.778 . . . . 0.0 109.904 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.439 ' HZ3' ' HB ' ' A' ' 57' ' ' THR . 0.1 OUTLIER -72.65 -27.66 62.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.262 -0.899 . . . . 0.0 110.433 -179.941 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.447 ' N ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER 178.0 155.45 0.36 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.069 -1.019 . . . . 0.0 110.198 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.9 m -130.75 123.55 29.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.339 -0.851 . . . . 0.0 109.965 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -133.98 111.87 10.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.098 -1.001 . . . . 0.0 110.52 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.457 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 21.3 mt -54.58 142.64 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.327 -0.858 . . . . 0.0 110.02 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.9 tp -118.56 -25.95 6.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.296 -0.878 . . . . 0.0 110.293 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.533 ' HB2' ' N ' ' A' ' 53' ' ' ILE . 1.6 m95 -123.76 158.07 32.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.332 -0.855 . . . . 0.0 110.471 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.439 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 43.21 -139.61 2.98 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -150.17 24.59 0.82 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.4 -1.059 . . . . 0.0 109.896 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 121.43 -18.41 8.79 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.456 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -72.09 -173.33 19.99 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.482 ' HA ' HG22 ' A' ' 71' ' ' ILE . 44.2 Cg_endo -72.57 129.01 14.11 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 124.005 1.529 . . . . 0.0 110.613 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.2 -14.31 48.03 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.538 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -69.87 166.3 19.76 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.574 -0.956 . . . . 0.0 109.412 179.565 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.533 ' N ' ' HB2' ' A' ' 45' ' ' TRP . 51.6 mt -138.46 119.99 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 110.151 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -104.13 127.26 51.71 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.232 -0.917 . . . . 0.0 110.456 -179.909 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.4 tttt -95.4 90.95 5.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.273 -0.892 . . . . 0.0 109.955 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.547 ' CG2' HG12 ' A' ' 38' ' ' ILE . 94.5 mt -79.97 140.37 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.279 -0.888 . . . . 0.0 110.353 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 2.4 p -111.1 161.78 15.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.327 -0.858 . . . . 0.0 110.025 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.689 ' HE2' HG13 ' A' ' 67' ' ' VAL . 22.0 m-85 -116.97 166.07 12.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.194 -0.941 . . . . 0.0 110.344 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 58' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.316 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.1 t80 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.194 0.521 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.482 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -133.58 134.22 7.36 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 108.609 -1.797 . . . . 0.0 108.609 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.555 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 11.6 p90 -178.78 162.86 1.37 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.173 -1.192 . . . . 0.0 110.162 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.945 HG12 ' HA2' ' A' ' 88' ' ' GLY . 4.4 m -142.62 173.59 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.316 -0.865 . . . . 0.0 110.33 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.467 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 77.7 mttt -125.01 124.37 41.84 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.564 -0.71 . . . . 0.0 109.768 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.614 ' CE1' HD13 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -112.97 122.85 48.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.171 -0.956 . . . . 0.0 110.809 -179.541 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 52' ' ' THR . 46.7 tttp -101.98 109.72 21.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.323 -0.86 . . . . 0.0 109.549 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.529 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 27.9 mm -48.7 136.64 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.123 -0.986 . . . . 0.0 110.21 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.493 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 14.4 t0 -114.41 -43.02 3.23 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.853 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.451 ' HB2' ' HB2' ' A' ' 82' ' ' SER . 16.7 m -165.4 158.69 16.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.457 -0.777 . . . . 0.0 109.855 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.421 HG12 HG11 ' A' ' 23' ' ' VAL . 1.4 mt -145.77 156.01 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.208 -0.933 . . . . 0.0 110.249 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.563 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 2.7 m-20 -135.56 79.21 1.77 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.547 -0.721 . . . . 0.0 110.086 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.543 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 22.1 tttp -61.78 -13.31 22.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.319 -0.863 . . . . 0.0 110.275 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -94.47 -31.23 14.04 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.237 -0.914 . . . . 0.0 109.724 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.498 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.4 m120 -108.47 -3.42 18.17 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.458 -0.776 . . . . 0.0 109.735 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.577 ' O ' HD12 ' A' ' 104' ' ' LEU . 7.2 m-30 64.68 50.39 2.1 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.568 -0.707 . . . . 0.0 110.304 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.563 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.6 OUTLIER -118.53 153.44 34.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.316 -0.865 . . . . 0.0 109.25 179.352 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.794 ' CE1' HG13 ' A' ' 23' ' ' VAL . 22.0 t80 -141.41 132.46 26.18 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.047 -1.033 . . . . 0.0 110.398 -179.065 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.451 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 4.3 m -137.6 120.06 15.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.161 -0.962 . . . . 0.0 110.665 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.626 ' CE2' ' CB ' ' A' ' 100' ' ' TYR . 21.2 p90 -135.96 170.88 15.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.142 -0.973 . . . . 0.0 110.349 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 98' ' ' ILE . 43.5 m -121.31 132.24 54.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.399 -0.813 . . . . 0.0 109.941 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.614 HD13 ' CE1' ' A' ' 69' ' ' HIS . 3.5 tp -98.53 126.03 43.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.177 -0.952 . . . . 0.0 110.153 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 86' ' ' ILE . 14.3 pt -105.12 -11.22 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.278 -0.889 . . . . 0.0 110.056 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.572 ' O ' HD11 ' A' ' 85' ' ' LEU . 4.3 tt0 -134.93 164.23 28.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.196 -0.94 . . . . 0.0 110.25 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.945 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 149.66 116.57 0.81 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -54.89 -20.2 8.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.24 -1.153 . . . . 0.0 110.171 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.575 ' O ' ' CE1' ' A' ' 132' ' ' HIS . . . -73.23 -8.91 57.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.366 -0.834 . . . . 0.0 110.213 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 88' ' ' GLY . 19.4 mt -81.54 -7.03 59.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.301 -0.874 . . . . 0.0 110.088 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 45.61 -170.43 0.02 OUTLIER Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -89.32 24.21 2.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -1.154 . . . . 0.0 109.885 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.1 p -118.18 -44.34 2.69 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.395 -0.815 . . . . 0.0 110.402 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.771 HD22 HG22 ' A' ' 122' ' ' THR . 3.1 mm? -79.93 162.71 24.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.392 -0.817 . . . . 0.0 110.388 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.443 ' CD ' ' HB2' ' A' ' 123' ' ' LYS . 10.5 mt-10 -146.16 -80.99 0.15 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.367 -0.833 . . . . 0.0 109.798 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.531 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 36.8 mttp -80.25 127.28 32.17 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.575 -0.703 . . . . 0.0 110.34 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.726 HG21 ' CE2' ' A' ' 100' ' ' TYR . 5.1 mm -117.68 137.5 51.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 120.446 -1.409 . . . . 0.0 110.0 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.513 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.3 OUTLIER -114.35 131.02 56.69 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.754 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.726 ' CE2' HG21 ' A' ' 98' ' ' ILE . 7.6 m-85 -125.42 134.8 51.99 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.317 -0.864 . . . . 0.0 110.576 -178.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 117' ' ' THR . 1.9 tt0 -138.95 131.46 28.73 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.413 -0.805 . . . . 0.0 110.128 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 61.0 m -132.99 142.07 48.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.308 -0.87 . . . . 0.0 109.855 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -134.38 143.2 47.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 0.0 110.527 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.66 HD23 HG12 ' A' ' 114' ' ' ILE . 14.2 mt -119.0 150.68 39.53 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.396 -0.815 . . . . 0.0 109.916 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.715 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -146.5 -168.99 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.177 -0.952 . . . . 0.0 110.061 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.715 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -124.19 160.9 26.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.313 -0.867 . . . . 0.0 110.14 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.45 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.5 p -119.42 170.17 7.14 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.912 . . . . 0.0 110.224 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.45 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 45.9 Cg_endo -72.32 -17.13 27.63 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.059 1.557 . . . . 0.0 110.484 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 59.8 p -93.28 -1.09 56.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.232 -0.918 . . . . 0.0 110.27 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.31 -36.98 4.04 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.489 ' HA2' ' HA ' ' A' ' 12' ' ' GLU . . . -54.3 -175.49 0.09 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.506 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 85.7 p -131.41 137.47 48.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.24 -1.153 . . . . 0.0 110.283 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.861 ' HA ' HG22 ' A' ' 10' ' ' THR . 16.6 mt -90.61 146.57 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.216 -0.928 . . . . 0.0 110.076 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.66 HG12 HD23 ' A' ' 104' ' ' LEU . 6.7 mt -128.32 127.13 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.283 -0.886 . . . . 0.0 110.134 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -119.77 108.79 14.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -0.912 . . . . 0.0 110.035 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.7 m -95.19 158.72 15.34 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.22 -0.925 . . . . 0.0 110.37 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 101' ' ' GLU . 60.6 m -160.13 122.44 3.31 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.386 -0.821 . . . . 0.0 109.903 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 94.8 p -126.18 171.19 11.09 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.137 -0.977 . . . . 0.0 110.466 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.61 ' CE1' HG23 ' A' ' 4' ' ' THR . 89.2 m-70 -145.27 140.05 27.54 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.334 -0.854 . . . . 0.0 110.288 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.765 ' O ' HG13 ' A' ' 2' ' ' VAL . 3.2 m-30 -105.84 146.66 29.62 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.322 -0.861 . . . . 0.0 110.634 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.531 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 66.2 m80 -131.69 96.48 3.97 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.188 -0.945 . . . . 0.0 109.265 178.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.771 HG22 HD22 ' A' ' 95' ' ' LEU . 1.1 p -80.04 153.44 28.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.325 -0.859 . . . . 0.0 110.959 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.443 ' HB2' ' CD ' ' A' ' 96' ' ' GLU . 7.9 tttp -96.49 132.85 41.63 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.652 -0.655 . . . . 0.0 110.082 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 87.12 -144.88 19.53 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -118.65 74.0 0.94 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.296 -1.12 . . . . 0.0 110.17 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.431 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 21.8 m -131.9 167.19 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.226 -0.921 . . . . 0.0 110.139 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -128.4 152.91 47.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.206 -0.934 . . . . 0.0 110.236 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.798 HD12 ' CE1' ' A' ' 3' ' ' PHE . 3.5 mt -77.45 173.09 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.283 -0.886 . . . . 0.0 110.164 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.617 ' N ' HG22 ' A' ' 128' ' ' ILE . 27.1 mttt -104.78 141.63 36.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.406 -0.809 . . . . 0.0 110.025 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -54.52 -42.65 71.1 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.121 -0.987 . . . . 0.0 110.002 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -55.93 -38.28 70.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.245 -0.909 . . . . 0.0 109.897 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.575 ' CE1' ' O ' ' A' ' 90' ' ' ALA . 16.3 t-160 -69.47 -53.88 17.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.244 -0.91 . . . . 0.0 110.099 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.918 HG11 ' CE1' ' A' ' 5' ' ' TYR . 97.1 t -60.1 -38.39 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.416 -0.803 . . . . 0.0 109.87 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -71.06 -38.3 72.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.259 -0.901 . . . . 0.0 109.958 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.97 -20.83 62.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -0.869 . . . . 0.0 110.016 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.15 -25.7 54.51 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.492 ' HE3' HG12 ' A' ' 133' ' ' VAL . 82.7 mttt -77.24 -31.72 55.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.266 -1.138 . . . . 0.0 110.121 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -75.36 -31.74 60.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.334 -0.854 . . . . 0.0 110.028 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -73.88 -31.95 63.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 0.0 109.944 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.573 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -76.16 -35.41 59.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 110.161 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 84.5 p -67.52 -46.73 71.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.299 -0.876 . . . . 0.0 110.02 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -58.71 -46.16 87.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.187 -0.946 . . . . 0.0 110.008 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.6 HD23 HD12 ' A' ' 146' ' ' LEU . 19.6 mt -60.63 -36.36 78.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.913 . . . . 0.0 110.033 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.671 ' HA ' HD12 ' A' ' 147' ' ' ILE . 7.2 m-85 -63.35 -40.08 96.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.366 -0.834 . . . . 0.0 109.865 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 145' ' ' LYS . 11.8 tttp -73.43 -9.56 58.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.35 -0.843 . . . . 0.0 110.128 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.6 HD12 HD23 ' A' ' 143' ' ' LEU . 13.0 mt -84.72 -39.63 18.28 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.235 -0.915 . . . . 0.0 108.95 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.843 HD11 ' CE1' ' A' ' 22' ' ' PHE . 4.6 mt -68.61 -45.17 82.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.521 ' CG ' ' HB2' ' A' ' 11' ' ' SER . 84.4 mt-10 -58.59 -45.34 89.31 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.481 -0.762 . . . . 0.0 109.564 179.166 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 18.9 m -68.24 -32.1 72.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.111 -0.993 . . . . 0.0 109.576 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.671 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 92.7 t80 -57.26 -47.93 80.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.586 -0.696 . . . . 0.0 109.97 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.001 HD21 ' CE1' ' A' ' 158' ' ' TYR . 73.3 mt -74.52 -37.73 62.99 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.331 -0.855 . . . . 0.0 110.517 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.687 ' HB2' HD11 ' A' ' 13' ' ' ILE . 14.2 tttm -62.19 -13.62 29.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.248 -0.908 . . . . 0.0 109.59 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.492 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -119.96 -26.2 2.35 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.146 -1.581 . . . . 0.0 109.146 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.439 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 8.2 m80 -105.97 93.88 8.36 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.338 -1.095 . . . . 0.0 110.109 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.0 Cg_endo -73.23 5.06 3.34 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.111 1.585 . . . . 0.0 111.118 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 32.6 p30 -122.01 -4.8 9.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.006 -1.059 . . . . 0.0 109.833 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.671 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -47.8 110.85 0.36 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.43 -0.793 . . . . 0.0 110.193 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 1.04 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 0.4 OUTLIER 33.76 33.08 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.766 -0.583 . . . . 0.0 110.872 -179.431 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.537 ' HB3' ' NH2' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 117.98 -1.009 . . . . 0.0 109.769 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.637 HG13 ' O ' ' A' ' 120' ' ' TYR . 49.0 t -114.71 147.7 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.188 -1.183 . . . . 0.0 110.37 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.587 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 60.8 m-85 -106.72 165.77 11.07 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.336 -0.852 . . . . 0.0 110.336 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.923 HG23 ' CE1' ' A' ' 119' ' ' HIS . 66.5 m -146.85 98.27 3.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.269 -0.894 . . . . 0.0 110.305 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.617 ' CE1' HG11 ' A' ' 133' ' ' VAL . 87.7 m-85 -111.54 140.92 45.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.197 -0.94 . . . . 0.0 109.876 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 20.6 pt-20 -138.56 151.72 47.55 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.141 -0.975 . . . . 0.0 110.43 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.455 ' OG ' ' HB2' ' A' ' 116' ' ' SER . 88.2 p -123.23 157.12 33.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.328 -0.857 . . . . 0.0 109.782 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -137.28 121.85 18.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.16 -0.962 . . . . 0.0 110.434 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.635 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.3 p90 -148.63 -172.78 4.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.281 -0.887 . . . . 0.0 109.8 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.683 HG22 ' HA ' ' A' ' 113' ' ' ILE . 17.3 p -141.73 -178.96 5.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.167 -0.958 . . . . 0.0 110.731 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.402 ' OG ' ' CD ' ' A' ' 148' ' ' GLU . 3.0 t -160.01 160.1 32.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.471 -0.768 . . . . 0.0 110.226 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.433 ' HB2' ' HE2' ' A' ' 152' ' ' LYS . 97.2 mt-10 -84.45 -30.37 25.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.256 -0.903 . . . . 0.0 110.03 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.804 HG23 ' HD2' ' A' ' 14' ' ' PRO . 11.6 mm -70.58 150.27 95.5 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.46 -0.775 . . . . 0.0 109.942 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.804 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.1 Cg_endo -66.2 143.89 72.86 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.022 1.538 . . . . 0.0 110.384 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.672 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.2 Cg_endo -72.27 -31.41 11.76 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.983 1.517 . . . . 0.0 112.849 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.672 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.7 Cg_endo -69.41 -21.47 35.05 Favored 'Trans proline' 0 C--N 1.316 -1.154 0 N-CA-C 110.13 -0.758 . . . . 0.0 110.13 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.544 ' NE ' ' HB2' ' A' ' 159' ' ' ASN . 54.6 mtp180 -84.36 -46.13 12.06 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.78 HD23 ' C ' ' A' ' 18' ' ' LEU . 1.1 tt -69.61 -29.31 66.8 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.506 ' HB2' ' O ' ' A' ' 15' ' ' PRO . 76.5 t80 -66.7 -59.55 3.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.51 -0.744 . . . . 0.0 109.328 178.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.536 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 14.9 mttp -50.25 -35.3 26.38 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.199 179.281 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.031 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -77.51 -41.01 40.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.394 -0.816 . . . . 0.0 110.703 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.947 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 1.6 t80 -69.56 -43.74 72.3 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.253 -0.904 . . . . 0.0 111.128 -178.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.672 HG13 ' CE1' ' A' ' 81' ' ' TYR . 4.3 t -104.31 -52.41 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.062 -1.024 . . . . 0.0 111.664 -179.139 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.728 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.2 mp -78.34 0.4 25.66 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.11 -0.994 . . . . 0.0 111.304 -178.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.586 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.4 OUTLIER -157.55 39.29 0.28 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.912 -1.118 . . . . 0.0 110.43 179.796 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.947 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -77.48 -24.81 50.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.279 -0.888 . . . . 0.0 110.128 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.488 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 87.3 m-20 -65.54 -16.46 63.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 110.145 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -129.9 13.04 5.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.352 -0.842 . . . . 0.0 110.016 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.675 HD13 HD11 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -99.84 -46.64 5.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.273 -0.892 . . . . 0.0 110.042 -179.944 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.793 HG11 HD13 ' A' ' 38' ' ' ILE . 3.5 t -84.92 -41.5 0.67 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.381 -0.824 . . . . 0.0 110.819 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.8 Cg_endo -78.98 9.93 3.13 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 O-C-N 123.47 1.247 . . . . 0.0 110.693 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.9 tptt -126.84 -34.44 2.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.079 -1.013 . . . . 0.0 109.428 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.675 HD11 HD13 ' A' ' 29' ' ' LEU . 62.3 mt -80.14 -43.35 22.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.569 -0.707 . . . . 0.0 109.546 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.441 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . . . -146.26 100.4 4.16 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.54 -0.725 . . . . 0.0 109.919 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 34' ' ' ALA . 44.3 Cg_endo -71.37 -0.27 7.89 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 124.108 1.583 . . . . 0.0 110.803 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -84.25 -12.44 54.72 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.097 -1.002 . . . . 0.0 109.627 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.764 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -99.89 -65.08 0.99 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.491 -0.755 . . . . 0.0 109.987 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.793 HD13 HG11 ' A' ' 30' ' ' VAL . 1.9 mp -113.82 117.83 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.428 -0.795 . . . . 0.0 109.86 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' A' ' 57' ' ' THR . 9.1 ttpt -72.02 -30.94 65.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.321 -0.862 . . . . 0.0 110.518 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.427 ' O ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -169.02 151.88 4.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.196 -0.94 . . . . 0.0 110.211 -179.674 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.9 m -130.17 123.63 30.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.468 -0.77 . . . . 0.0 109.793 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 68.6 tt0 -134.25 113.3 11.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.04 -1.037 . . . . 0.0 110.6 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.43 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 44.7 mt -59.15 141.83 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.207 -0.933 . . . . 0.0 109.898 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.505 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 32.4 mt -116.29 -28.21 6.6 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.239 -0.913 . . . . 0.0 110.546 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.713 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.8 m95 -123.7 163.99 20.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.098 -1.001 . . . . 0.0 110.633 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 45' ' ' TRP . . . 42.34 -144.01 1.11 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -146.78 25.7 1.16 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.282 -1.128 . . . . 0.0 110.133 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 117.34 -15.22 13.19 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.126 -1.589 . . . . 0.0 109.126 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.573 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -78.15 -167.6 31.04 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.39 129.48 13.91 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.026 1.54 . . . . 0.0 110.641 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.27 -11.16 54.86 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.523 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -72.2 157.47 37.67 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.524 -0.986 . . . . 0.0 109.839 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.713 HD12 ' CG ' ' A' ' 45' ' ' TRP . 57.6 mt -129.71 120.06 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.0 109.875 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 93.1 mttt -106.24 132.47 52.26 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.164 -0.96 . . . . 0.0 110.531 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.505 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 77.7 tttt -101.64 92.69 4.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.319 -0.863 . . . . 0.0 109.92 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.54 ' CG2' HG13 ' A' ' 38' ' ' ILE . 91.5 mt -79.95 144.29 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.931 . . . . 0.0 110.289 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 39' ' ' LYS . 2.6 p -117.8 156.07 28.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 110.486 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.572 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 16.1 m-85 -115.49 148.15 39.81 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.352 -0.843 . . . . 0.0 110.039 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.912 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.235 0.541 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.572 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -130.08 97.73 0.4 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.538 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 12.8 p90 -138.88 167.13 22.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.145 -1.209 . . . . 0.0 110.112 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.927 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.3 m -139.2 174.88 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.243 -0.911 . . . . 0.0 110.72 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 30.1 mttt -128.85 122.35 30.22 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.516 -0.74 . . . . 0.0 109.743 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.827 ' CE1' HD13 ' A' ' 85' ' ' LEU . 0.6 OUTLIER -109.46 126.56 53.62 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.16 -0.962 . . . . 0.0 110.88 -179.463 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 52' ' ' THR . 54.9 tttt -97.63 121.86 40.03 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.273 -0.892 . . . . 0.0 109.609 179.196 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.573 HG21 ' O ' ' A' ' 49' ' ' GLY . 30.7 mm -64.96 122.37 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.162 -0.961 . . . . 0.0 110.522 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 82' ' ' SER . 27.9 m-20 -98.18 -47.6 5.41 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.427 -0.796 . . . . 0.0 109.968 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 44.7 m -167.8 157.95 10.5 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.349 -0.845 . . . . 0.0 109.751 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.596 HG12 HG11 ' A' ' 23' ' ' VAL . 3.6 mt -135.35 160.52 40.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.228 -0.92 . . . . 0.0 110.355 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.597 ' HB2' ' HB2' ' A' ' 80' ' ' SER . 17.4 m-20 -132.7 83.1 2.04 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.606 -0.684 . . . . 0.0 110.161 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.663 ' NZ ' HD21 ' A' ' 24' ' ' LEU . 45.1 mttm -72.95 -10.1 59.43 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.354 -0.841 . . . . 0.0 110.218 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -93.14 -39.26 11.14 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.317 -0.864 . . . . 0.0 109.315 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.529 ' ND2' ' H ' ' A' ' 78' ' ' ASN . 1.1 p30 -111.78 12.25 20.97 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.466 0.651 . . . . 0.0 110.761 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.504 ' CZ ' ' HB3' ' A' ' 16' ' ' PRO . 7.3 m-85 54.19 60.79 3.37 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.449 -0.782 . . . . 0.0 112.858 178.034 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.597 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 1.1 m -128.03 156.87 42.07 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.954 -1.091 . . . . 0.0 109.484 177.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.683 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 31.2 t80 -142.13 137.32 30.83 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.158 -0.964 . . . . 0.0 110.444 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 50.7 m -140.74 125.98 18.61 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.447 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.683 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 7.2 p90 -141.69 176.53 8.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.281 -0.887 . . . . 0.0 110.02 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.555 HG23 ' O ' ' A' ' 98' ' ' ILE . 46.0 m -126.8 132.82 50.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.298 -0.876 . . . . 0.0 109.868 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.827 HD13 ' CE1' ' A' ' 69' ' ' HIS . 12.4 tp -98.16 121.87 40.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.171 -0.955 . . . . 0.0 110.227 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.7 pt -104.59 -16.63 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.294 -0.879 . . . . 0.0 110.531 -179.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.475 ' OE1' ' NZ ' ' A' ' 68' ' ' LYS . 54.4 tt0 -129.11 165.35 21.41 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.148 -0.97 . . . . 0.0 110.385 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.927 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 149.51 120.96 1.07 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -56.52 -19.31 14.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.299 -1.118 . . . . 0.0 110.183 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.99 -18.18 54.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.295 -0.878 . . . . 0.0 110.228 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 92' ' ' GLY . 77.1 mt -66.98 -27.61 67.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.223 -0.923 . . . . 0.0 110.162 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 50.15 179.51 0.02 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.445 ' OD1' HG23 ' A' ' 94' ' ' THR . 57.6 p-10 -79.64 5.65 12.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.243 -1.151 . . . . 0.0 110.07 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.536 ' O ' HG22 ' A' ' 122' ' ' THR . 43.0 p -93.65 -34.91 13.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.89 . . . . 0.0 110.099 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 1.026 HD23 HG23 ' A' ' 122' ' ' THR . 19.5 mt -104.83 162.05 13.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 110.034 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.438 ' CD ' ' HB2' ' A' ' 123' ' ' LYS . 54.4 mt-10 -142.68 -80.3 0.21 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.297 -0.877 . . . . 0.0 109.978 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.515 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 53.7 mttp -80.14 126.16 30.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.595 -0.691 . . . . 0.0 110.409 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.761 HG21 ' CE2' ' A' ' 100' ' ' TYR . 5.3 mm -115.52 140.55 36.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 120.615 -1.303 . . . . 0.0 109.826 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.482 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -118.35 128.24 54.46 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.676 -0.81 . . . . 0.0 108.941 178.874 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.761 ' CE2' HG21 ' A' ' 98' ' ' ILE . 11.0 m-85 -123.53 135.33 53.96 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.313 -0.867 . . . . 0.0 110.533 -178.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.481 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 72.8 tt0 -139.14 136.29 34.96 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.276 -0.89 . . . . 0.0 110.146 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 50.3 m -137.36 138.94 40.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -0.926 . . . . 0.0 110.234 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.8 tttt -133.05 147.01 52.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.196 -0.94 . . . . 0.0 110.391 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.754 HD23 HG12 ' A' ' 114' ' ' ILE . 7.8 mt -121.82 153.8 37.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.273 -0.892 . . . . 0.0 110.241 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.711 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -149.49 -168.78 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.19 -0.944 . . . . 0.0 110.061 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.711 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -126.01 150.27 48.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.329 -0.857 . . . . 0.0 110.213 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.461 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 2.7 p -108.13 169.65 6.37 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.934 . . . . 0.0 110.345 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.461 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.7 Cg_endo -73.11 -11.41 25.2 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 O-C-N 124.106 1.582 . . . . 0.0 110.448 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 58.5 p -96.89 5.74 49.95 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.157 -0.965 . . . . 0.0 110.293 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.08 -38.17 3.2 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -55.61 -172.91 0.12 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.5 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 5.7 p -131.97 138.29 48.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.255 -1.144 . . . . 0.0 110.271 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.683 ' HA ' HG22 ' A' ' 10' ' ' THR . 20.5 mt -89.96 149.81 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.29 -0.881 . . . . 0.0 110.151 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.754 HG12 HD23 ' A' ' 104' ' ' LEU . 11.5 mt -131.23 126.73 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.228 -0.92 . . . . 0.0 110.222 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -118.09 110.2 17.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.163 -0.96 . . . . 0.0 110.219 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.455 ' HB2' ' OG ' ' A' ' 7' ' ' SER . 1.6 m -98.57 160.71 14.1 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.236 -0.915 . . . . 0.0 110.44 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' A' ' 101' ' ' GLU . 52.9 m -160.03 124.46 3.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.376 -0.827 . . . . 0.0 109.984 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 90.5 p -129.03 157.5 41.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.201 -0.937 . . . . 0.0 110.469 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.923 ' CE1' HG23 ' A' ' 4' ' ' THR . 47.1 m-70 -134.52 161.45 35.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.263 -0.898 . . . . 0.0 110.037 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.637 ' O ' HG13 ' A' ' 2' ' ' VAL . 25.9 m-85 -128.35 142.03 51.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.231 -0.918 . . . . 0.0 110.722 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.559 ' CD2' HG22 ' A' ' 2' ' ' VAL . 80.5 m80 -124.56 96.04 4.75 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.214 -0.929 . . . . 0.0 109.124 178.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' THR . . . . . 1.026 HG23 HD23 ' A' ' 95' ' ' LEU . 1.8 p -86.0 153.93 21.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.292 -0.88 . . . . 0.0 111.099 -178.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.438 ' HB2' ' CD ' ' A' ' 96' ' ' GLU . 20.7 tttt -101.92 121.64 42.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.547 -0.721 . . . . 0.0 109.963 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 105.4 -140.7 15.17 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -122.88 76.52 1.37 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.3 -1.117 . . . . 0.0 110.346 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.535 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 21.4 m -136.49 162.36 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.19 -0.944 . . . . 0.0 110.06 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.427 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 87.1 mt-10 -129.93 159.29 37.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.173 -0.955 . . . . 0.0 110.434 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.934 HD11 HD21 ' A' ' 95' ' ' LEU . 19.6 mm -66.96 173.1 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.332 -0.855 . . . . 0.0 110.149 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.586 ' N ' HG22 ' A' ' 128' ' ' ILE . 7.4 mtpp -113.02 135.14 54.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.386 -0.821 . . . . 0.0 109.95 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -44.03 -43.14 6.55 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.174 -0.954 . . . . 0.0 110.027 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.5 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 48.7 tt0 -62.92 -24.02 67.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -0.898 . . . . 0.0 109.891 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 129' ' ' LYS . 14.8 t-160 -79.9 -50.91 9.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.379 -0.826 . . . . 0.0 110.113 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.617 HG11 ' CE1' ' A' ' 5' ' ' TYR . 46.9 t -60.92 -40.03 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.324 -0.86 . . . . 0.0 109.973 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -75.73 -50.43 15.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.399 -0.813 . . . . 0.0 110.149 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.5 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -61.69 -28.17 69.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.214 -0.929 . . . . 0.0 110.049 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.5 -28.81 64.86 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 38.9 mttm -69.53 -31.48 69.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.262 -1.14 . . . . 0.0 110.085 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 142' ' ' ASN . 99.0 mt-10 -77.16 -32.53 56.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.32 -0.862 . . . . 0.0 110.163 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.693 ' O ' HD12 ' A' ' 143' ' ' LEU . 35.6 mttt -68.42 -31.62 71.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.313 -0.867 . . . . 0.0 110.22 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.567 ' O ' ' CD1' ' A' ' 144' ' ' PHE . . . -90.28 -41.52 11.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.308 -0.87 . . . . 0.0 110.201 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.3 m -68.98 -47.33 65.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.407 -0.808 . . . . 0.0 110.14 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 138' ' ' GLU . 97.1 m-20 -55.14 -47.68 74.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.183 -0.948 . . . . 0.0 110.035 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.693 HD12 ' O ' ' A' ' 139' ' ' LYS . 76.0 mt -57.54 -42.09 82.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.313 -0.867 . . . . 0.0 109.91 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.567 ' CD1' ' O ' ' A' ' 140' ' ' ALA . 4.8 m-85 -58.61 -36.33 73.87 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.304 -0.872 . . . . 0.0 109.774 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 33.8 tttm -64.25 -26.0 68.31 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.319 -0.863 . . . . 0.0 109.777 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.456 ' HB3' HG21 ' A' ' 33' ' ' ILE . 16.6 mt -78.23 -34.27 49.36 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.635 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 47.5 mt -69.22 -51.64 41.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.47 ' O ' ' HG3' ' A' ' 152' ' ' LYS . 94.6 mt-10 -54.56 -42.16 70.63 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.37 -0.831 . . . . 0.0 109.169 178.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.516 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 88.5 m -63.72 -44.4 93.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.369 -0.832 . . . . 0.0 109.375 179.286 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.491 ' CD2' ' OH ' ' A' ' 158' ' ' TYR . 89.9 t80 -46.32 -44.96 17.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.577 -0.702 . . . . 0.0 109.704 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.957 HD21 ' CE1' ' A' ' 158' ' ' TYR . 77.2 mt -80.02 -31.34 39.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.434 -0.791 . . . . 0.0 110.231 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.55 ' HA ' HD11 ' A' ' 13' ' ' ILE . 45.0 mttt -65.39 -16.4 63.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.187 -0.946 . . . . 0.0 109.602 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.489 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -116.94 -28.17 2.53 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -106.04 93.2 7.43 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.329 -1.101 . . . . 0.0 110.028 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 46.6 Cg_endo -73.46 4.95 3.52 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.096 1.577 . . . . 0.0 110.951 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -116.25 -8.53 11.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.07 -1.019 . . . . 0.0 109.758 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.623 ' HB1' ' CZ ' ' A' ' 158' ' ' TYR . . . -48.48 107.76 0.14 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.407 -0.808 . . . . 0.0 110.059 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 1.031 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 35.61 30.85 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.599 -0.688 . . . . 0.0 110.644 -179.768 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.544 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.784 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 1.045 HG23 ' C ' ' A' ' 120' ' ' TYR . 7.4 p -91.62 154.0 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.262 -1.14 . . . . 0.0 110.386 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.602 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 15.3 m-85 -92.22 173.68 7.7 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.174 -0.953 . . . . 0.0 110.494 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.83 HG23 ' CE1' ' A' ' 119' ' ' HIS . 5.6 m -152.23 93.37 1.8 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.288 -0.882 . . . . 0.0 110.197 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.639 ' CZ ' ' CG2' ' A' ' 133' ' ' VAL . 81.4 m-85 -116.0 145.84 42.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.172 -0.955 . . . . 0.0 109.905 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.508 ' HB3' HG23 ' A' ' 117' ' ' THR . 21.4 pt-20 -141.99 152.62 43.6 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.169 -0.957 . . . . 0.0 110.534 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 52.6 m -126.58 146.47 50.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.323 -0.86 . . . . 0.0 109.888 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -121.5 129.04 52.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.166 -0.959 . . . . 0.0 110.485 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.64 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.3 p90 -149.18 -175.57 5.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.35 -0.844 . . . . 0.0 109.802 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.677 HG22 ' HA ' ' A' ' 113' ' ' ILE . 17.3 p -140.44 177.92 7.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.138 -0.976 . . . . 0.0 110.725 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.524 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 2.5 t -158.14 158.99 35.71 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.479 -0.763 . . . . 0.0 110.069 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -85.4 -15.4 43.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.288 -0.883 . . . . 0.0 110.054 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.781 HG23 ' HD2' ' A' ' 14' ' ' PRO . 11.4 mm -82.4 149.67 61.98 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.33 -0.856 . . . . 0.0 110.056 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.781 ' HD2' HG23 ' A' ' 13' ' ' ILE . 41.8 Cg_endo -66.93 145.59 74.8 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.03 1.542 . . . . 0.0 110.306 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.67 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.2 Cg_endo -71.39 -31.96 13.2 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.978 1.514 . . . . 0.0 112.848 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.67 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 40.6 Cg_endo -68.31 -22.31 40.07 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 122.51 0.742 . . . . 0.0 110.245 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.613 ' NH2' ' HB3' ' A' ' 157' ' ' ALA . 46.0 mtp180 -85.1 -42.89 14.37 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.75 HD23 ' C ' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -73.76 -33.37 64.24 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.947 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.583 ' N ' HD23 ' A' ' 18' ' ' LEU . 59.5 t80 -65.65 -55.54 16.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.396 -0.815 . . . . 0.0 109.281 178.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 25' ' ' ASP . 12.0 mttt -51.83 -40.17 60.04 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.825 -0.75 . . . . 0.0 109.436 179.404 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.063 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -73.96 -38.73 64.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.4 -0.813 . . . . 0.0 111.009 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.704 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.3 OUTLIER -75.26 -36.86 61.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.07 -1.019 . . . . 0.0 110.912 -179.231 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.671 HG13 ' CE1' ' A' ' 81' ' ' TYR . 5.1 t -107.26 -58.56 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.189 -0.944 . . . . 0.0 111.59 -179.247 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.64 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.0 mp -76.54 -1.8 29.19 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.138 -0.976 . . . . 0.0 111.534 -178.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.594 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.8 OUTLIER -154.91 49.49 0.58 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.936 -1.103 . . . . 0.0 110.099 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.704 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -87.43 -29.58 21.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.306 -0.871 . . . . 0.0 110.69 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -61.95 -18.0 58.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 0.0 110.425 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.524 ' O ' ' CG ' ' A' ' 32' ' ' LYS . 7.0 p-10 -126.08 11.5 7.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 110.065 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.631 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 0.4 OUTLIER -97.52 -53.82 3.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -0.859 . . . . 0.0 110.154 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.66 HG11 HD12 ' A' ' 38' ' ' ILE . 2.9 t -71.8 -41.46 9.28 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.273 -0.892 . . . . 0.0 110.876 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 30' ' ' VAL . 47.5 Cg_endo -76.77 7.44 3.54 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 O-C-N 123.399 1.21 . . . . 0.0 110.968 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.524 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 47.7 mmtm -127.24 -35.46 2.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.086 -1.009 . . . . 0.0 109.403 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.574 HD13 ' HB2' ' A' ' 150' ' ' TYR . 10.1 mt -80.12 -33.73 14.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.583 -0.698 . . . . 0.0 109.382 179.359 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.662 ' HB2' HD13 ' A' ' 146' ' ' LEU . . . -149.43 91.33 4.45 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.583 -0.698 . . . . 0.0 110.068 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.82 2.07 6.34 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.104 1.581 . . . . 0.0 110.797 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -87.34 -15.23 38.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.094 -1.004 . . . . 0.0 109.869 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -107.64 -43.97 4.37 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.3 -0.875 . . . . 0.0 110.188 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.66 HD12 HG11 ' A' ' 30' ' ' VAL . 3.4 mt -127.45 142.37 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.392 -0.817 . . . . 0.0 110.116 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.496 ' CB ' ' O ' ' A' ' 59' ' ' GLY . 8.7 tppt? -119.62 -21.06 7.47 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.282 -0.887 . . . . 0.0 110.689 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.472 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 0.3 OUTLIER -153.46 152.48 31.05 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.05 -1.031 . . . . 0.0 110.465 -179.671 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.5 m -150.99 118.31 6.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.509 -0.744 . . . . 0.0 109.573 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -133.97 109.3 8.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.181 -0.95 . . . . 0.0 110.788 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 21.9 mt -54.18 137.62 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.257 -0.902 . . . . 0.0 109.748 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.508 HD22 ' HE3' ' A' ' 68' ' ' LYS . 14.9 tp -107.07 -30.1 9.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.116 -0.99 . . . . 0.0 110.995 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.839 ' CG ' HD12 ' A' ' 53' ' ' ILE . 2.0 m95 -124.08 164.64 19.0 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.153 -0.967 . . . . 0.0 110.875 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.46 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 41.24 -137.91 2.04 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.429 ' O ' ' CG ' ' A' ' 47' ' ' ASP . 11.5 t0 -154.33 24.25 0.48 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.312 -1.111 . . . . 0.0 109.85 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 120.07 -17.83 9.82 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.498 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -68.29 -174.54 8.73 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.434 ' HA ' HG22 ' A' ' 71' ' ' ILE . 46.0 Cg_endo -73.74 128.34 12.42 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 123.937 1.493 . . . . 0.0 110.639 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.96 -13.12 56.14 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -66.59 162.13 21.63 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.516 -0.99 . . . . 0.0 109.629 179.672 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.839 HD12 ' CG ' ' A' ' 45' ' ' TRP . 48.2 mt -128.56 121.61 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.241 -0.912 . . . . 0.0 109.756 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 98.7 mttt -107.78 134.19 51.09 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.173 -0.955 . . . . 0.0 110.319 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.605 ' HE2' ' CD1' ' A' ' 66' ' ' TYR . 14.5 tptm -105.65 90.32 3.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.266 -0.896 . . . . 0.0 109.802 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.629 ' CG2' HD13 ' A' ' 38' ' ' ILE . 73.0 mt -79.96 145.63 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.32 -0.863 . . . . 0.0 110.339 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.578 HG22 ' HB3' ' A' ' 66' ' ' TYR . 0.6 OUTLIER -122.55 144.87 48.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.374 -0.829 . . . . 0.0 109.88 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.609 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 13.5 m-85 -113.26 170.27 8.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.087 -1.008 . . . . 0.0 110.142 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.496 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.673 ' CE1' ' CE2' ' A' ' 66' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.308 0.575 . . . . 0.0 109.927 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.609 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -145.82 60.98 0.48 Allowed Glycine 0 N--CA 1.483 1.829 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 179.289 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.673 ' CE2' ' CE1' ' A' ' 64' ' ' TYR . 10.5 p90 -125.12 166.19 16.87 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.206 -1.173 . . . . 0.0 109.894 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.929 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.3 m -140.54 172.26 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 110.68 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.508 ' HE3' HD22 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -120.72 120.46 35.73 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.64 -0.662 . . . . 0.0 109.555 179.507 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.649 ' CE1' HD13 ' A' ' 85' ' ' LEU . 0.5 OUTLIER -110.42 119.36 38.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.126 -0.984 . . . . 0.0 111.106 -179.31 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 52' ' ' THR . 13.4 tttp -96.69 99.4 11.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.183 -0.948 . . . . 0.0 109.444 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.525 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 30.1 mm -42.38 135.92 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.351 -0.843 . . . . 0.0 110.159 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.46 ' OD2' ' OG1' ' A' ' 84' ' ' THR . 90.2 m-20 -104.2 -39.83 6.36 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.291 -0.881 . . . . 0.0 110.033 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.531 ' C ' HD12 ' A' ' 74' ' ' ILE . 1.4 m -179.38 162.14 1.13 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.246 -0.909 . . . . 0.0 109.6 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.531 HD12 ' C ' ' A' ' 73' ' ' SER . 0.9 OUTLIER -143.99 153.2 15.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.024 -179.812 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.497 ' HB3' ' HB2' ' A' ' 78' ' ' ASN . 5.5 m-20 -134.58 78.49 1.75 Allowed 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.501 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.546 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 20.8 tttt -61.65 -15.74 42.5 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.221 -0.925 . . . . 0.0 110.167 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -92.39 -36.0 13.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.242 -0.912 . . . . 0.0 109.41 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.517 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 2.6 m120 -96.52 -5.3 39.71 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.639 -0.663 . . . . 0.0 109.387 179.319 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.549 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 76.4 m-85 62.08 55.95 2.37 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.566 0.698 . . . . 0.0 110.619 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.477 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 1.3 m -132.33 159.15 40.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.365 -0.834 . . . . 0.0 109.714 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.692 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 64.7 t80 -146.56 146.09 30.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.19 -0.943 . . . . 0.0 109.811 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.533 ' OG ' ' CG ' ' A' ' 101' ' ' GLU . 0.2 OUTLIER -153.48 138.14 16.94 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.167 -0.958 . . . . 0.0 110.861 -179.729 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.692 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 11.5 p90 -150.89 173.43 14.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.427 -0.796 . . . . 0.0 110.2 179.107 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 98' ' ' ILE . 58.2 m -124.92 131.58 53.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.421 -0.799 . . . . 0.0 109.934 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.654 HD23 HG13 ' A' ' 98' ' ' ILE . 2.0 tp -100.1 129.09 46.1 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.201 -0.937 . . . . 0.0 110.044 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.466 HG12 ' HB3' ' A' ' 68' ' ' LYS . 12.8 pt -115.27 -13.56 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -0.891 . . . . 0.0 110.027 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.554 ' O ' HD11 ' A' ' 85' ' ' LEU . 18.1 tt0 -128.68 154.63 46.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.884 . . . . 0.0 110.232 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.929 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 154.8 128.28 1.16 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -64.9 -10.87 32.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.273 -1.133 . . . . 0.0 110.242 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.91 -17.35 41.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.275 -0.891 . . . . 0.0 110.166 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.478 HD21 HD23 ' A' ' 85' ' ' LEU . 51.2 mt -69.01 -19.08 64.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.893 . . . . 0.0 110.234 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 49.09 -177.36 0.02 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.488 ' OD1' HG23 ' A' ' 94' ' ' THR . 54.2 p-10 -84.36 11.88 7.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.259 -1.142 . . . . 0.0 110.173 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.488 HG23 ' OD1' ' A' ' 93' ' ' ASP . 69.7 p -102.84 -38.18 7.52 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.281 -0.887 . . . . 0.0 110.181 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.906 HD21 ' CD1' ' A' ' 128' ' ' ILE . 76.5 mt -95.17 166.22 12.02 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.381 -0.824 . . . . 0.0 109.995 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.472 ' HG3' ' HB2' ' A' ' 123' ' ' LYS . 9.9 mt-10 -146.64 -81.36 0.14 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.263 -0.898 . . . . 0.0 109.787 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 49.2 mttt -80.39 130.09 34.94 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.728 -0.607 . . . . 0.0 110.254 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.707 HG21 ' CE2' ' A' ' 100' ' ' TYR . 5.7 mm -118.0 140.61 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 120.921 -1.112 . . . . 0.0 109.778 178.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.5 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.5 OUTLIER -121.51 128.61 52.24 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.762 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.707 ' CE2' HG21 ' A' ' 98' ' ' ILE . 10.7 m-85 -123.62 134.99 53.7 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.346 -0.846 . . . . 0.0 110.433 -178.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.533 ' CG ' ' OG ' ' A' ' 82' ' ' SER . 7.7 mt-10 -133.61 141.56 47.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.32 -0.863 . . . . 0.0 109.945 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.487 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 18.9 m -138.27 142.88 39.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.092 -1.005 . . . . 0.0 109.975 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.13 138.54 38.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.242 -0.911 . . . . 0.0 110.327 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.728 HD23 HG12 ' A' ' 114' ' ' ILE . 5.2 mt -124.86 145.8 49.61 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.259 -0.901 . . . . 0.0 110.227 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.697 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -152.76 -168.54 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.405 -0.81 . . . . 0.0 109.945 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.697 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -113.89 141.01 47.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.266 -0.896 . . . . 0.0 110.001 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.743 ' HA ' HD11 ' A' ' 113' ' ' ILE . 1.3 p -96.12 170.3 7.77 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.118 -0.989 . . . . 0.0 110.406 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.474 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 50.0 Cg_endo -78.81 4.57 6.34 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.105 1.582 . . . . 0.0 110.456 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 51.9 m -110.15 5.22 21.8 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -0.871 . . . . 0.0 110.283 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 99.36 -27.65 19.11 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.453 ' O ' ' OG ' ' A' ' 107' ' ' SER . . . -75.77 -173.94 35.5 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 22.4 p -118.53 132.44 56.21 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.181 -1.188 . . . . 0.0 110.301 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.743 HD11 ' HA ' ' A' ' 107' ' ' SER . 23.9 mt -82.84 147.61 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 109.903 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.728 HG12 HD23 ' A' ' 104' ' ' LEU . 9.7 mt -130.63 122.69 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.305 -0.872 . . . . 0.0 110.566 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.7 tttp -111.93 117.33 32.44 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.383 -0.823 . . . . 0.0 109.762 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 0.5 OUTLIER -110.83 152.69 26.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.246 -0.909 . . . . 0.0 110.69 -179.55 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.763 HG22 ' NE2' ' A' ' 119' ' ' HIS . 53.6 m -149.57 132.57 16.2 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.42 -0.8 . . . . 0.0 110.1 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.4 m -131.12 150.53 52.11 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.198 -0.939 . . . . 0.0 110.321 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.83 ' CE1' HG23 ' A' ' 4' ' ' THR . 20.9 m-70 -137.9 135.4 36.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.343 -0.848 . . . . 0.0 110.037 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 1.045 ' C ' HG23 ' A' ' 2' ' ' VAL . 11.5 m-85 -113.27 122.22 46.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.133 -0.979 . . . . 0.0 110.631 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.614 ' N ' HG23 ' A' ' 2' ' ' VAL . 88.7 m-70 -91.22 121.77 33.27 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.2 p -98.11 149.23 22.73 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.059 -1.025 . . . . 0.0 110.974 -178.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.472 ' HB2' ' HG3' ' A' ' 96' ' ' GLU . 20.2 tttt -104.09 108.7 20.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.54 -0.725 . . . . 0.0 110.163 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 108.65 -136.36 13.47 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 26.4 t30 -119.94 54.37 1.03 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.105 -1.232 . . . . 0.0 110.341 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 17.7 m -115.65 170.24 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.311 -0.868 . . . . 0.0 110.113 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.428 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 96.4 mt-10 -134.25 -177.79 4.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.199 -0.938 . . . . 0.0 110.333 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.906 ' CD1' HD21 ' A' ' 95' ' ' LEU . 8.2 mm -84.73 172.25 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.216 -0.928 . . . . 0.0 110.405 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.586 ' N ' HG22 ' A' ' 128' ' ' ILE . 47.5 mttt -94.95 131.03 41.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.437 -0.79 . . . . 0.0 109.825 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.444 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 95.9 mt-10 -48.97 -40.96 32.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.193 -0.942 . . . . 0.0 110.109 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.753 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 49.0 tt0 -66.67 -8.89 30.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.221 -0.924 . . . . 0.0 109.753 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.454 ' O ' ' HA3' ' A' ' 136' ' ' GLY . 8.4 t-160 -103.24 -55.02 2.49 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.896 . . . . 0.0 110.196 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.639 ' CG2' ' CZ ' ' A' ' 5' ' ' TYR . 2.1 p -61.62 -29.61 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.449 -0.782 . . . . 0.0 110.227 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.538 ' HA ' ' HE3' ' A' ' 137' ' ' LYS . 28.3 tttt -108.91 -71.85 0.75 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.952 . . . . 0.0 110.061 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.753 ' HB3' ' O ' ' A' ' 131' ' ' GLU . . . -55.79 -21.05 17.34 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 109.68 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' A' ' 132' ' ' HIS . . . -74.46 -30.91 59.6 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.538 ' HE3' ' HA ' ' A' ' 134' ' ' LYS . 6.0 mtmp? -66.74 -31.87 72.8 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.25 -1.147 . . . . 0.0 109.949 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -72.96 -34.24 66.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.298 -0.876 . . . . 0.0 109.959 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.484 ' O ' HD12 ' A' ' 143' ' ' LEU . 52.6 mttt -67.91 -38.83 83.43 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.404 -0.81 . . . . 0.0 109.804 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.83 -40.05 91.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.311 -0.868 . . . . 0.0 109.837 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.429 ' O ' ' HG3' ' A' ' 145' ' ' LYS . 22.8 t -56.71 -38.12 71.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.374 -0.829 . . . . 0.0 109.904 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.482 ' OD1' ' HA ' ' A' ' 139' ' ' LYS . 15.7 m120 -56.9 -48.49 78.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.304 -0.872 . . . . 0.0 109.997 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.484 HD12 ' O ' ' A' ' 139' ' ' LYS . 1.2 mp -61.68 -34.19 75.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.87 . . . . 0.0 109.962 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.577 ' HA ' HD12 ' A' ' 147' ' ' ILE . 19.8 m-85 -64.68 -38.22 90.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.291 -0.881 . . . . 0.0 109.728 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.429 ' HG3' ' O ' ' A' ' 141' ' ' SER . 57.7 mttt -71.67 -12.23 61.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 109.946 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.662 HD13 ' HB2' ' A' ' 34' ' ' ALA . 17.8 mt -81.3 -36.65 29.53 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.233 -0.917 . . . . 0.0 108.882 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.649 HD11 ' CE1' ' A' ' 22' ' ' PHE . 17.3 mt -69.56 -50.37 51.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.524 ' CG ' ' OG ' ' A' ' 11' ' ' SER . 57.1 mt-10 -58.37 -37.71 75.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.466 -0.771 . . . . 0.0 109.453 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 20.2 m -67.57 -33.76 75.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.166 -0.959 . . . . 0.0 109.511 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.574 ' HB2' HD13 ' A' ' 33' ' ' ILE . 87.6 t80 -58.91 -45.87 89.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.392 -0.817 . . . . 0.0 109.613 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.967 HD21 ' CE1' ' A' ' 158' ' ' TYR . 70.9 mt -80.0 -28.88 39.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.385 -0.822 . . . . 0.0 110.029 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.706 ' HA ' HD11 ' A' ' 13' ' ' ILE . 82.5 tttt -65.34 -14.91 61.88 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.193 -0.942 . . . . 0.0 109.518 179.281 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.479 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -119.84 -27.45 2.1 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.402 ' ND1' ' N ' ' A' ' 154' ' ' HIS . 2.4 m80 -106.44 93.61 8.59 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.22 -1.165 . . . . 0.0 110.301 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.9 Cg_endo -74.21 4.6 4.19 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 124.07 1.563 . . . . 0.0 110.833 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -115.61 -7.33 12.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.069 -1.019 . . . . 0.0 109.791 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.613 ' HB3' ' NH2' ' A' ' 17' ' ' ARG . . . -51.35 108.26 0.24 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.433 -0.792 . . . . 0.0 110.077 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 1.063 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 35.73 30.7 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.615 -0.678 . . . . 0.0 110.672 -179.637 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.54 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.4 0 O-C-N 121.095 -1.003 . . . . 0.0 109.684 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.617 HG11 ' CE1' ' A' ' 121' ' ' HIS . 58.1 t -122.8 134.25 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.173 -1.193 . . . . 0.0 110.412 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.597 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 32.0 m-85 -89.19 161.11 16.63 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.258 -0.901 . . . . 0.0 110.235 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.831 HG23 ' CE1' ' A' ' 119' ' ' HIS . 92.1 m -144.26 96.57 2.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.229 -0.92 . . . . 0.0 110.079 179.822 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.622 ' CE1' ' CG2' ' A' ' 133' ' ' VAL . 77.8 m-85 -115.41 144.66 43.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.15 -0.969 . . . . 0.0 110.172 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 116' ' ' SER . 21.0 pt-20 -138.6 152.41 48.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 0.0 110.218 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 65.2 m -122.37 150.29 42.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.251 -0.906 . . . . 0.0 110.047 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -133.13 120.07 20.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 110.356 -179.842 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.644 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.7 p90 -149.37 -173.76 4.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.293 -0.879 . . . . 0.0 109.92 179.751 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.863 HG22 ' HA ' ' A' ' 113' ' ' ILE . 3.3 p -140.32 171.8 13.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.12 -0.987 . . . . 0.0 110.474 -179.657 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.475 ' HB3' ' OE2' ' A' ' 148' ' ' GLU . 99.7 p -151.46 136.05 17.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.297 -0.877 . . . . 0.0 110.157 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -61.78 -31.91 72.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.172 -0.955 . . . . 0.0 110.244 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.809 HG21 HD12 ' A' ' 151' ' ' LEU . 8.1 mm -70.94 149.21 94.9 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.381 -0.824 . . . . 0.0 109.951 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.774 ' HD2' HG23 ' A' ' 13' ' ' ILE . 39.9 Cg_endo -65.39 143.59 76.95 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.073 1.565 . . . . 0.0 110.676 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.673 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.9 Cg_endo -71.82 -31.56 12.72 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 124.073 1.565 . . . . 0.0 112.74 -179.37 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.673 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.3 Cg_endo -69.02 -21.91 36.25 Favored 'Trans proline' 0 C--N 1.318 -1.051 0 N-CA-C 110.01 -0.804 . . . . 0.0 110.01 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.904 ' HB3' HD13 ' A' ' 151' ' ' LEU . 41.5 mtp180 -82.08 -47.45 12.58 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.583 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 1.111 HD23 ' CG2' ' A' ' 147' ' ' ILE . 0.2 OUTLIER -70.38 -35.08 73.28 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.093 178.929 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.645 ' N ' HD13 ' A' ' 18' ' ' LEU . 80.4 t80 -61.0 -59.26 5.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.479 -0.763 . . . . 0.0 109.738 179.116 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.53 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 17.6 mttp -51.64 -35.9 43.86 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.724 -0.791 . . . . 0.0 109.503 179.622 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.997 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -77.55 -32.36 53.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.464 -0.772 . . . . 0.0 111.048 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 1.058 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -80.53 -41.9 23.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.233 -0.917 . . . . 0.0 111.081 -179.099 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.742 HG13 ' CE1' ' A' ' 81' ' ' TYR . 3.7 t -103.91 -51.17 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.118 -0.989 . . . . 0.0 111.386 -179.106 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.674 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.3 mp -80.14 -9.8 59.73 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.132 -0.98 . . . . 0.0 111.684 -178.878 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 20' ' ' LYS . 1.2 m-20 -148.48 36.57 0.81 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.768 -1.207 . . . . 0.0 110.711 -179.664 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 1.058 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -76.98 -25.7 53.05 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.301 -0.875 . . . . 0.0 110.309 179.676 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -66.16 -15.25 62.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.195 -0.941 . . . . 0.0 109.919 179.783 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.56 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 7.4 p-10 -130.55 11.26 5.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.343 -0.848 . . . . 0.0 109.953 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.703 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -94.42 -48.99 5.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.374 -0.829 . . . . 0.0 110.042 179.689 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.863 HG22 ' HD3' ' A' ' 31' ' ' PRO . 2.1 m -73.91 -29.65 1.04 Allowed Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.373 -0.829 . . . . 0.0 112.039 -179.826 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.863 ' HD3' HG22 ' A' ' 30' ' ' VAL . 52.9 Cg_endo -78.81 4.06 6.79 Favored 'Trans proline' 0 C--N 1.32 -0.946 0 O-C-N 122.714 0.85 . . . . 0.0 110.128 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -124.34 -36.08 2.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.301 -0.874 . . . . 0.0 109.103 179.62 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.622 HD11 ' CD1' ' A' ' 29' ' ' LEU . 53.2 mt -79.96 -25.25 11.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 121.622 0.725 . . . . 0.0 109.25 179.19 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.407 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . . . -169.89 91.97 0.52 Allowed Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.702 -0.624 . . . . 0.0 109.738 179.705 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 34' ' ' ALA . 44.6 Cg_endo -70.77 -2.85 11.56 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.0 1.526 . . . . 0.0 110.632 -179.676 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -91.98 10.73 27.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -0.913 . . . . 0.0 109.938 179.789 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.913 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -114.65 -49.74 2.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.326 -0.859 . . . . 0.0 109.995 179.854 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.913 HD12 ' C ' ' A' ' 37' ' ' ALA . 1.8 mp -119.87 134.63 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.486 -0.759 . . . . 0.0 109.905 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' A' ' 57' ' ' THR . 6.1 ttmm -87.59 -24.64 23.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.311 -0.868 . . . . 0.0 110.357 -179.804 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.465 ' O ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -179.32 153.53 0.59 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.2 -0.938 . . . . 0.0 110.172 -179.847 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 m -127.32 124.44 38.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.345 -0.847 . . . . 0.0 109.923 179.702 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -136.44 111.81 9.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.173 -0.954 . . . . 0.0 110.46 -179.823 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 22.2 mt -57.88 134.11 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.22 -0.925 . . . . 0.0 110.052 179.789 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.54 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 19.0 mt -103.45 -28.67 11.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.188 -0.945 . . . . 0.0 110.675 -179.79 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.666 ' CG ' HD12 ' A' ' 53' ' ' ILE . 2.0 m95 -129.51 165.18 22.18 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.096 -1.003 . . . . 0.0 110.731 -179.751 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 45' ' ' TRP . . . 41.57 -135.26 3.11 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.658 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -157.2 19.7 0.3 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.299 -1.118 . . . . 0.0 110.099 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.74 -15.82 7.02 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.798 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.505 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -76.58 -170.4 31.61 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.67 129.33 13.48 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.028 1.541 . . . . 0.0 110.662 -179.831 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.98 -9.57 56.64 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 -179.643 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -73.23 159.04 34.06 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.601 -0.941 . . . . 0.0 109.84 179.835 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.666 HD12 ' CG ' ' A' ' 45' ' ' TRP . 55.5 mt -128.85 121.35 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.382 -0.823 . . . . 0.0 109.79 179.538 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 6.4 mtpm? -104.63 145.03 30.9 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.155 -0.966 . . . . 0.0 110.262 -179.795 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.54 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 13.1 tttt -115.62 89.99 3.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -0.856 . . . . 0.0 110.024 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.453 ' CG2' HG13 ' A' ' 38' ' ' ILE . 64.7 mt -79.98 136.07 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -0.926 . . . . 0.0 110.139 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.513 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 1.4 p -108.98 152.66 24.67 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.211 -0.931 . . . . 0.0 110.396 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.583 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 20.1 m-85 -115.51 152.53 32.81 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.249 -0.907 . . . . 0.0 110.072 179.53 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.953 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.192 0.52 . . . . 0.0 110.299 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.583 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -132.63 84.36 0.29 Allowed Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.679 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.517 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 13.8 p90 -131.09 164.01 26.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.283 -1.127 . . . . 0.0 110.027 -179.795 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.942 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.7 m -134.08 174.54 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.927 . . . . 0.0 110.583 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.529 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 28.9 mttt -128.17 121.0 28.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.483 -0.76 . . . . 0.0 109.604 179.583 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.626 ' CE1' HD13 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -110.52 122.28 47.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.14 -0.975 . . . . 0.0 110.969 -179.384 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 52' ' ' THR . 81.0 tttt -95.48 117.44 30.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.187 -0.945 . . . . 0.0 109.359 178.989 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.519 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 23.6 mm -61.98 124.6 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.201 -0.937 . . . . 0.0 110.6 -179.31 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 82' ' ' SER . 94.4 m-20 -99.79 -41.88 7.07 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.403 -0.811 . . . . 0.0 109.693 179.512 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.458 ' OG ' ' HB2' ' A' ' 82' ' ' SER . 90.0 p -171.24 158.35 5.4 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.299 -0.875 . . . . 0.0 109.848 179.617 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.488 HG12 HG11 ' A' ' 23' ' ' VAL . 4.9 mt -137.4 158.47 35.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.265 -0.897 . . . . 0.0 110.273 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.59 ' HB2' ' HB2' ' A' ' 80' ' ' SER . 3.2 m-20 -133.68 83.32 2.04 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.579 -0.7 . . . . 0.0 110.166 -179.589 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.458 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 20.8 mttt -73.43 -9.89 59.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.438 -0.789 . . . . 0.0 110.167 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -93.54 -38.97 11.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.249 -0.907 . . . . 0.0 109.289 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.517 ' ND2' ' H ' ' A' ' 78' ' ' ASN . 0.9 OUTLIER -111.3 7.45 21.06 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.466 0.651 . . . . 0.0 110.807 -179.772 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.568 ' CZ ' ' HB3' ' A' ' 16' ' ' PRO . 5.6 m-85 59.03 60.88 2.28 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.379 -0.826 . . . . 0.0 112.859 177.847 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.59 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 1.0 OUTLIER -127.9 156.01 43.28 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.989 -1.069 . . . . 0.0 109.329 177.875 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.742 ' CE1' HG13 ' A' ' 23' ' ' VAL . 24.7 t80 -140.76 136.55 32.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.14 -0.975 . . . . 0.0 110.49 -179.254 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 1.1 m -139.49 125.69 20.05 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.302 -0.874 . . . . 0.0 110.324 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.691 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 23.7 p90 -147.01 169.92 18.21 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.234 -0.916 . . . . 0.0 110.404 179.558 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.674 HG23 ' O ' ' A' ' 98' ' ' ILE . 60.7 m -122.06 132.04 54.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.449 -0.782 . . . . 0.0 109.998 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.626 HD13 ' CE1' ' A' ' 69' ' ' HIS . 2.5 tp -97.41 122.9 41.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.184 -0.947 . . . . 0.0 110.125 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 86' ' ' ILE . 13.9 pt -105.15 -15.2 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -0.926 . . . . 0.0 110.293 -179.648 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.58 ' O ' HD11 ' A' ' 85' ' ' LEU . 31.6 tt0 -131.14 162.4 29.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.187 -0.946 . . . . 0.0 110.5 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.942 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 152.18 117.46 0.73 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -52.94 -21.16 4.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.174 -1.192 . . . . 0.0 110.3 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.84 -22.96 55.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.896 . . . . 0.0 110.279 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.599 HD21 HD23 ' A' ' 85' ' ' LEU . 26.8 mt -66.64 -26.8 67.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.918 . . . . 0.0 110.178 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 49.27 -178.44 0.02 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 57.9 p30 -79.05 4.48 14.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -1.167 . . . . 0.0 110.226 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.494 ' O ' HG22 ' A' ' 122' ' ' THR . 43.9 p -90.69 -32.47 16.18 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.269 -0.894 . . . . 0.0 110.114 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.871 HD23 ' CG2' ' A' ' 122' ' ' THR . 62.8 mt -111.04 162.76 14.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.373 -0.829 . . . . 0.0 110.089 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.499 ' HG3' ' HB2' ' A' ' 123' ' ' LYS . 71.3 mm-40 -142.63 -80.01 0.22 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.124 -0.985 . . . . 0.0 110.201 -179.726 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 58.4 mttm -80.21 126.82 31.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.584 -0.698 . . . . 0.0 110.481 -179.823 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.731 HG21 ' CE2' ' A' ' 100' ' ' TYR . 5.7 mm -117.36 140.57 39.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 120.744 -1.223 . . . . 0.0 109.999 179.149 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.498 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -119.39 129.58 54.88 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.829 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.731 ' CE2' HG21 ' A' ' 98' ' ' ILE . 10.1 m-85 -124.54 135.55 53.26 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.274 -0.891 . . . . 0.0 110.609 -178.986 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.462 ' O ' ' N ' ' A' ' 117' ' ' THR . 6.4 mt-10 -138.54 128.79 25.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.335 -0.853 . . . . 0.0 110.039 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 79.3 m -131.25 146.12 52.18 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.135 -0.978 . . . . 0.0 110.202 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 115' ' ' LYS . 4.5 tttt -140.72 145.25 36.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.312 -0.868 . . . . 0.0 110.324 -179.834 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.863 HD23 HG12 ' A' ' 114' ' ' ILE . 4.5 mt -124.73 153.8 41.83 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.294 -0.879 . . . . 0.0 110.239 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.698 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -151.45 -168.94 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.177 -0.952 . . . . 0.0 109.982 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.698 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -122.76 160.73 25.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.261 -0.899 . . . . 0.0 110.317 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.463 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 2.1 p -117.35 170.26 6.34 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.302 -0.874 . . . . 0.0 110.197 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 47.2 Cg_endo -72.89 -17.11 25.7 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.022 1.538 . . . . 0.0 110.452 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 73.4 m -95.17 9.46 39.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.334 -0.854 . . . . 0.0 110.272 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 94.54 -33.42 5.33 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -55.51 -172.39 0.11 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 0.7 OUTLIER -136.53 137.47 40.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -1.148 . . . . 0.0 110.349 -179.998 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.863 ' HA ' HG22 ' A' ' 10' ' ' THR . 25.0 mt -90.39 147.74 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.349 -0.844 . . . . 0.0 110.017 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.863 HG12 HD23 ' A' ' 104' ' ' LEU . 23.2 mt -131.48 114.22 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.231 -0.918 . . . . 0.0 110.593 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 103' ' ' LYS . 16.6 tttt -102.9 130.91 50.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.221 -0.924 . . . . 0.0 109.758 179.467 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 3.3 t -123.03 160.09 27.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.096 -1.003 . . . . 0.0 110.558 -179.637 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.462 ' N ' ' O ' ' A' ' 101' ' ' GLU . 29.8 m -156.36 126.98 6.73 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.332 -0.855 . . . . 0.0 110.038 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 83.5 p -130.38 152.58 49.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.114 -0.991 . . . . 0.0 110.489 -179.75 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.831 ' CE1' HG23 ' A' ' 4' ' ' THR . 50.4 m-70 -134.93 158.12 45.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.371 -0.831 . . . . 0.0 109.917 179.599 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.629 ' HD1' HD12 ' A' ' 98' ' ' ILE . 26.8 m-85 -129.59 135.42 48.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.133 -0.979 . . . . 0.0 110.488 -179.624 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.617 ' CE1' HG11 ' A' ' 2' ' ' VAL . 87.5 m-70 -117.25 95.92 5.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.117 -0.99 . . . . 0.0 109.819 179.38 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.871 ' CG2' HD23 ' A' ' 95' ' ' LEU . 2.4 p -77.86 158.51 29.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.909 . . . . 0.0 110.616 -179.522 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.499 ' HB2' ' HG3' ' A' ' 96' ' ' GLU . 63.4 tttt -113.12 99.25 7.69 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.372 -0.83 . . . . 0.0 110.191 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 121.84 -128.98 7.47 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.865 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -125.9 71.37 1.24 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.336 -1.097 . . . . 0.0 110.173 -179.859 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.514 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 35.5 m -138.58 155.93 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.188 -0.945 . . . . 0.0 110.092 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -123.51 174.32 7.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.319 -0.863 . . . . 0.0 110.284 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.823 ' CD1' HD21 ' A' ' 95' ' ' LEU . 20.9 mm -76.93 171.77 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.28 -0.888 . . . . 0.0 110.047 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.546 ' N ' HG22 ' A' ' 128' ' ' ILE . 22.3 mttt -99.17 129.9 45.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.191 -0.943 . . . . 0.0 109.986 179.785 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.546 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 93.8 mt-10 -44.05 -43.6 6.9 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.214 -0.929 . . . . 0.0 109.947 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.974 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 47.8 tt0 -58.61 -24.13 60.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.245 -0.909 . . . . 0.0 109.845 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.479 ' N ' ' O ' ' A' ' 129' ' ' LYS . 14.8 t-160 -86.67 -57.05 3.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.328 -0.857 . . . . 0.0 110.135 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.636 HG13 ' HG3' ' A' ' 134' ' ' LYS . 2.3 p -63.04 -22.31 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.417 -0.802 . . . . 0.0 110.262 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.636 ' HG3' HG13 ' A' ' 133' ' ' VAL . 54.1 mttt -112.0 -73.74 0.66 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.143 -0.973 . . . . 0.0 110.328 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.974 ' HB3' ' O ' ' A' ' 131' ' ' GLU . . . -53.45 -20.53 4.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.901 . . . . 0.0 109.642 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.55 -29.55 65.62 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.071 -1.611 . . . . 0.0 109.071 179.728 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 23.7 mttm -64.21 -30.09 71.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.298 -1.119 . . . . 0.0 109.954 179.8 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 70.2 tt0 -77.4 -28.32 52.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.379 -0.825 . . . . 0.0 110.156 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.8 mmtp -73.9 -34.8 64.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 110.055 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -80.6 -34.68 34.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.873 . . . . 0.0 110.007 179.809 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 33.2 m -63.86 -45.15 90.76 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.401 -0.812 . . . . 0.0 109.943 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -54.94 -42.77 72.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.283 -0.886 . . . . 0.0 110.015 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.632 ' HA ' HD12 ' A' ' 146' ' ' LEU . 80.8 mt -60.59 -46.1 91.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.294 -0.879 . . . . 0.0 110.083 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -59.31 -37.32 77.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.374 -0.829 . . . . 0.0 109.818 179.793 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -72.15 -12.97 61.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.306 -0.872 . . . . 0.0 110.068 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.632 HD12 ' HA ' ' A' ' 143' ' ' LEU . 34.4 mt -83.72 -35.58 24.33 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.215 -0.928 . . . . 0.0 108.912 179.25 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 1.111 ' CG2' HD23 ' A' ' 18' ' ' LEU . 60.7 mt -68.9 -46.22 79.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.926 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.503 ' O ' HG13 ' A' ' 13' ' ' ILE . 84.7 mt-10 -50.43 -35.32 28.06 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.4 -0.812 . . . . 0.0 109.353 179.089 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 3.0 m -75.39 -20.48 58.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.222 -0.924 . . . . 0.0 109.49 179.321 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.579 ' CD1' HG12 ' A' ' 33' ' ' ILE . 80.1 t80 -69.5 -48.95 58.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.517 -0.739 . . . . 0.0 109.915 179.605 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.904 HD13 ' HB3' ' A' ' 17' ' ' ARG . 48.2 mt -80.03 -31.56 39.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.351 -0.843 . . . . 0.0 110.021 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.464 ' CA ' HD11 ' A' ' 13' ' ' ILE . 7.5 ttpp -64.74 -14.19 57.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.306 -0.872 . . . . 0.0 109.428 179.285 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.464 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -118.35 -30.54 1.7 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 179.708 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.405 ' ND1' ' N ' ' A' ' 154' ' ' HIS . 2.3 m80 -106.07 94.41 9.3 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.272 -1.134 . . . . 0.0 110.15 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.51 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.9 Cg_endo -73.96 4.58 4.08 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.985 1.519 . . . . 0.0 110.873 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -113.37 -8.8 13.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.972 -1.08 . . . . 0.0 109.819 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.597 ' HB3' ' NH2' ' A' ' 17' ' ' ARG . . . -53.65 104.47 0.1 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.374 -0.829 . . . . 0.0 109.979 179.762 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.997 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 35.33 30.96 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.733 -0.604 . . . . 0.0 110.703 -179.663 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.538 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.409 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.745 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.235 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.955 HG11 ' CE1' ' A' ' 121' ' ' HIS . 2.7 p -80.75 149.56 5.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.113 -1.228 . . . . 0.0 110.795 -179.491 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 5' ' ' TYR . 72.5 m-85 -93.76 169.01 10.63 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.611 -0.681 . . . . 0.0 110.49 -179.579 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.959 HG23 ' CE1' ' A' ' 119' ' ' HIS . 86.0 m -139.93 105.06 5.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.345 -0.847 . . . . 0.0 110.126 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.784 ' CE2' HG11 ' A' ' 133' ' ' VAL . 65.7 m-85 -114.23 144.68 42.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.909 . . . . 0.0 110.034 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 21.5 pt-20 -134.27 150.5 51.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.173 -0.954 . . . . 0.0 110.254 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.461 ' O ' ' CG ' ' A' ' 8' ' ' GLU . 24.8 p -125.95 169.38 12.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.344 -0.847 . . . . 0.0 109.986 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.461 ' CG ' ' O ' ' A' ' 7' ' ' SER . 80.9 mt-10 -153.95 117.19 4.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.163 -0.961 . . . . 0.0 110.628 -179.852 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.2 p90 -142.58 -178.05 5.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.325 -0.859 . . . . 0.0 109.875 179.562 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.558 HG22 HG12 ' A' ' 113' ' ' ILE . 16.5 p -136.71 179.78 6.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.182 -0.949 . . . . 0.0 110.544 -179.783 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 112' ' ' SER . 2.2 t -160.05 159.12 31.6 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.297 -0.877 . . . . 0.0 110.55 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -85.55 -12.11 52.44 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.207 -0.933 . . . . 0.0 109.824 179.805 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.815 HG23 ' HD2' ' A' ' 14' ' ' PRO . 2.3 mp -88.29 151.02 48.17 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.356 -0.84 . . . . 0.0 109.984 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.815 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.9 Cg_endo -66.69 139.9 54.39 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.046 1.55 . . . . 0.0 110.664 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.64 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 41.3 Cg_endo -73.25 -30.03 10.84 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 124.069 1.563 . . . . 0.0 112.843 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.64 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.9 Cg_endo -71.72 -23.56 22.61 Favored 'Trans proline' 0 C--N 1.319 -1.002 0 N-CA-C 110.052 -0.788 . . . . 0.0 110.052 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.565 ' CZ ' ' HA ' ' A' ' 159' ' ' ASN . 1.1 mtp85 -82.05 -44.89 16.0 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.008 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.96 HD23 ' CG2' ' A' ' 147' ' ' ILE . 0.2 OUTLIER -67.07 -34.0 76.71 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.528 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.626 ' N ' HD13 ' A' ' 18' ' ' LEU . 74.9 t80 -59.38 -56.59 20.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.639 -0.663 . . . . 0.0 109.642 178.738 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.551 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 29.6 mttp -52.35 -37.53 56.41 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.721 -0.791 . . . . 0.0 109.421 179.462 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.007 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -75.63 -43.38 48.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.466 -0.772 . . . . 0.0 110.76 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 1.051 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.3 OUTLIER -65.36 -45.8 82.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.341 -0.849 . . . . 0.0 111.074 -179.065 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 1.126 HG11 ' CD1' ' A' ' 74' ' ' ILE . 10.4 t -104.2 -60.89 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.084 -1.01 . . . . 0.0 111.766 -179.051 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.616 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.5 mp -66.13 -11.36 48.66 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.171 -0.956 . . . . 0.0 111.537 -178.64 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.612 ' O ' HD23 ' A' ' 29' ' ' LEU . 1.2 m-20 -148.17 44.18 1.05 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.886 -1.134 . . . . 0.0 110.27 -179.778 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 1.051 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -82.8 -22.14 34.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.297 -0.877 . . . . 0.0 110.47 -179.831 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -68.76 -19.9 64.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.127 -0.983 . . . . 0.0 110.214 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.515 ' O ' ' CB ' ' A' ' 32' ' ' LYS . 7.2 p-10 -125.34 13.15 8.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 0.0 109.772 179.836 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.612 HD23 ' O ' ' A' ' 25' ' ' ASP . 0.4 OUTLIER -97.01 -54.16 3.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.453 -0.779 . . . . 0.0 110.175 -179.939 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.984 HG11 HD13 ' A' ' 38' ' ' ILE . 2.6 t -70.28 -42.78 16.73 Favored Pre-proline 0 C--N 1.299 -1.597 0 O-C-N 121.296 -0.877 . . . . 0.0 110.57 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 50.3 Cg_endo -79.32 8.27 3.98 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.601 1.316 . . . . 0.0 110.617 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.515 ' CB ' ' O ' ' A' ' 28' ' ' ASN . 81.4 tttt -125.41 -31.39 3.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.187 -0.945 . . . . 0.0 109.745 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.669 HD13 ' HA ' ' A' ' 147' ' ' ILE . 22.0 mt -79.76 -35.53 16.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.523 -0.736 . . . . 0.0 109.701 179.578 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.404 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . . . -160.66 99.82 1.35 Allowed Pre-proline 0 N--CA 1.487 1.377 0 O-C-N 121.433 -0.792 . . . . 0.0 110.187 179.764 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 34' ' ' ALA . 47.0 Cg_endo -72.96 0.14 8.21 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.201 1.632 . . . . 0.0 110.516 179.907 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -86.26 -13.02 47.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.261 -0.899 . . . . 0.0 109.823 179.699 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -98.46 -49.38 4.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.374 -0.829 . . . . 0.0 110.401 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.984 HD13 HG11 ' A' ' 30' ' ' VAL . 1.2 mp -130.56 137.93 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.327 -0.858 . . . . 0.0 110.324 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.426 ' O ' ' HB3' ' A' ' 40' ' ' HIS . 7.1 ttmt -70.97 -39.72 72.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.409 -0.807 . . . . 0.0 110.411 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.453 ' HA ' ' HB3' ' A' ' 31' ' ' PRO . 0.0 OUTLIER 179.03 159.32 0.61 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.277 -0.889 . . . . 0.0 110.284 179.852 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.9 m -121.03 131.61 54.39 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.225 -0.922 . . . . 0.0 110.045 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -135.2 114.28 12.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -0.924 . . . . 0.0 110.428 -179.829 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.426 HG12 ' HG2' ' A' ' 54' ' ' LYS . 28.3 mt -60.37 138.39 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.185 -0.947 . . . . 0.0 110.031 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.577 HD11 ' HB2' ' A' ' 55' ' ' LYS . 22.8 mt -111.74 -29.28 7.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.917 . . . . 0.0 110.462 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.635 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.8 m95 -125.33 163.89 21.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.216 -0.927 . . . . 0.0 110.698 -179.773 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.447 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 42.06 -138.23 2.58 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -151.15 21.1 0.76 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -1.154 . . . . 0.0 110.208 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 123.3 -18.93 7.73 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.541 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -72.9 -172.83 23.01 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.412 ' HA ' HG22 ' A' ' 71' ' ' ILE . 43.5 Cg_endo -71.72 128.66 14.52 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.993 1.523 . . . . 0.0 110.683 -179.783 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.09 -14.09 48.59 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 -179.487 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -70.87 161.42 31.04 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.554 -0.968 . . . . 0.0 109.647 179.682 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.635 HD12 ' CG ' ' A' ' 45' ' ' TRP . 56.2 mt -130.7 120.7 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.334 -0.854 . . . . 0.0 109.887 179.599 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.891 ' CE ' HD11 ' A' ' 71' ' ' ILE . 58.6 mttm -105.53 140.98 37.79 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.168 -0.957 . . . . 0.0 110.394 -179.716 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.577 ' HB2' HD11 ' A' ' 44' ' ' LEU . 78.0 tttt -106.99 88.58 2.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.313 -0.867 . . . . 0.0 110.159 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.547 ' CG2' HG12 ' A' ' 38' ' ' ILE . 79.0 mt -79.86 137.46 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.265 -0.897 . . . . 0.0 110.15 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.743 ' O ' HG23 ' A' ' 38' ' ' ILE . 5.6 p -109.29 161.78 14.94 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.18 -0.95 . . . . 0.0 110.658 -179.786 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.584 ' HE2' HG13 ' A' ' 67' ' ' VAL . 31.5 m-85 -115.73 128.64 56.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.47 -0.769 . . . . 0.0 110.211 179.777 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.979 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.266 0.555 . . . . 0.0 110.312 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.552 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -137.59 119.12 1.8 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 179.678 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 15.4 p90 -158.01 168.56 26.77 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.038 -1.272 . . . . 0.0 110.072 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.934 HG12 ' HA2' ' A' ' 88' ' ' GLY . 7.1 m -139.49 173.32 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.249 -0.907 . . . . 0.0 110.899 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 27.8 mttt -125.13 117.78 24.65 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.372 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.616 ' ND1' HD12 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -103.81 125.39 50.22 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.214 -0.929 . . . . 0.0 111.085 -178.949 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 52' ' ' THR . 25.6 tttt -97.76 106.51 18.83 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.383 -0.823 . . . . 0.0 109.374 179.002 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.891 HD11 ' CE ' ' A' ' 54' ' ' LYS . 43.3 mm -44.35 133.97 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.09 -1.006 . . . . 0.0 110.153 -179.227 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.51 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 46.3 t0 -107.49 -54.11 2.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.481 -0.762 . . . . 0.0 109.899 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.424 ' O ' ' N ' ' A' ' 82' ' ' SER . 5.4 m -172.28 158.25 4.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.453 -0.779 . . . . 0.0 110.277 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 1.126 ' CD1' HG11 ' A' ' 23' ' ' VAL . 4.0 tt -149.77 165.54 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.274 -0.891 . . . . 0.0 110.03 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.549 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 0.6 OUTLIER -133.78 82.06 1.96 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.299 -0.876 . . . . 0.0 110.014 -179.788 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.604 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 90.3 mttt -55.29 -15.14 2.19 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.316 -0.865 . . . . 0.0 110.841 -179.863 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -92.5 -30.4 15.72 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.189 -0.945 . . . . 0.0 109.798 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.502 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 2.0 m120 -111.34 -1.33 16.05 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.552 -0.717 . . . . 0.0 109.63 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.648 ' O ' HD12 ' A' ' 104' ' ' LEU . 10.7 m-85 65.69 48.23 1.98 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.769 -0.582 . . . . 0.0 110.608 -179.864 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.549 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.5 OUTLIER -116.55 148.07 41.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.157 -0.964 . . . . 0.0 109.364 179.386 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.535 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 86.9 t80 -148.45 144.63 27.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.122 -0.987 . . . . 0.0 110.414 -179.261 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.504 ' HB3' ' HG3' ' A' ' 101' ' ' GLU . 4.8 p -151.45 145.23 25.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.271 -0.893 . . . . 0.0 110.349 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.608 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 18.0 p90 -148.13 172.02 14.97 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.219 -0.926 . . . . 0.0 110.471 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.626 HG23 ' O ' ' A' ' 98' ' ' ILE . 97.1 m -122.16 123.58 41.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.344 -0.848 . . . . 0.0 109.964 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.937 HD21 HD11 ' A' ' 91' ' ' LEU . 0.9 OUTLIER -90.61 129.25 36.76 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.148 -0.97 . . . . 0.0 110.249 -179.827 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 16.7 pt -112.03 0.65 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.279 -0.888 . . . . 0.0 110.298 -179.789 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.509 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 57.3 tt0 -145.66 154.87 42.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.272 -0.892 . . . . 0.0 110.171 -179.922 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.934 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 156.9 126.93 0.95 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -64.26 -25.97 68.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.334 -1.097 . . . . 0.0 110.208 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.552 ' O ' ' CE1' ' A' ' 132' ' ' HIS . . . -70.27 -25.44 63.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -0.916 . . . . 0.0 110.122 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.937 HD11 HD21 ' A' ' 85' ' ' LEU . 22.3 mt -64.68 -36.56 84.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.31 -0.868 . . . . 0.0 110.072 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.11 175.69 36.73 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -72.58 -2.29 19.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -1.152 . . . . 0.0 109.967 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 122' ' ' THR . 30.3 p -91.42 -38.8 12.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.895 . . . . 0.0 110.455 -179.866 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.681 HD21 HG13 ' A' ' 128' ' ' ILE . 2.4 mm? -79.88 154.92 28.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.262 -0.899 . . . . 0.0 110.964 -179.453 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.47 ' OE1' ' HB2' ' A' ' 123' ' ' LYS . 37.5 tt0 -142.44 -84.21 0.18 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.13 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.517 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 28.5 mttt -80.42 125.14 29.55 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.705 -0.622 . . . . 0.0 110.595 179.076 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.626 ' O ' HG23 ' A' ' 84' ' ' THR . 3.2 mm -118.02 137.96 50.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 120.575 -1.328 . . . . 0.0 109.151 178.199 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.489 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -118.31 129.67 55.58 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.325 -0.859 . . . . 0.0 109.299 179.306 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.613 ' CE2' HG21 ' A' ' 98' ' ' ILE . 8.8 m-85 -124.13 132.63 53.66 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.42 -0.8 . . . . 0.0 110.236 -179.282 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.504 ' HG3' ' HB3' ' A' ' 82' ' ' SER . 76.9 tt0 -134.5 138.7 44.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.18 -0.95 . . . . 0.0 110.21 179.776 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 90.5 m -141.34 125.51 17.39 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.161 -0.962 . . . . 0.0 110.199 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.468 ' HG3' ' HB3' ' A' ' 80' ' ' SER . 1.0 OUTLIER -116.86 149.42 40.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.881 . . . . 0.0 110.114 179.818 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.648 HD12 ' O ' ' A' ' 79' ' ' TYR . 14.7 mt -123.24 148.86 45.43 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.199 -0.938 . . . . 0.0 110.622 -179.957 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.685 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -149.5 -168.91 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.408 -0.807 . . . . 0.0 109.419 179.546 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.685 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -136.92 141.52 42.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.13 -0.981 . . . . 0.0 110.873 179.9 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.537 ' CB ' ' HD2' ' A' ' 108' ' ' PRO . 0.8 OUTLIER -91.79 -179.91 1.22 Allowed Pre-proline 0 C--N 1.302 -1.477 0 O-C-N 121.533 -0.729 . . . . 0.0 109.374 179.183 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.537 ' HD2' ' CB ' ' A' ' 107' ' ' SER . 40.7 Cg_endo -66.54 85.09 0.28 Allowed 'Trans proline' 0 C--N 1.303 -1.861 0 O-C-N 123.649 1.342 . . . . 0.0 109.646 179.376 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 108' ' ' PRO . 4.0 p 44.38 37.41 2.01 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.423 -0.798 . . . . 0.0 109.735 -178.994 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -125.75 38.16 2.33 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 11' ' ' SER . . . 98.11 -138.75 14.07 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 -179.495 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.531 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 3.7 p -149.43 143.38 25.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.279 -1.13 . . . . 0.0 109.835 179.653 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.558 HG12 HG22 ' A' ' 10' ' ' THR . 35.9 mt -91.4 147.9 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.24 -0.912 . . . . 0.0 110.307 -179.74 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.583 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 7.6 mt -134.02 111.62 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.186 -0.946 . . . . 0.0 110.208 -179.912 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 48.4 tttt -97.08 137.67 35.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.231 -0.918 . . . . 0.0 110.239 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 0.8 OUTLIER -134.44 154.55 51.33 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 0.0 110.376 -179.887 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.473 ' HB ' ' HB3' ' A' ' 101' ' ' GLU . 8.8 m -146.58 158.21 43.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.33 -0.856 . . . . 0.0 110.188 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 99.4 p -151.28 134.96 16.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 110.393 -179.9 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.959 ' CE1' HG23 ' A' ' 4' ' ' THR . 55.4 m-70 -120.78 147.9 44.71 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.287 -0.883 . . . . 0.0 110.384 -179.92 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.931 ' C ' HG23 ' A' ' 2' ' ' VAL . 9.3 m-85 -122.4 118.78 29.2 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.268 -0.895 . . . . 0.0 111.161 -179.445 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.955 ' CE1' HG11 ' A' ' 2' ' ' VAL . 90.0 m-70 -104.12 109.69 21.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.073 -1.017 . . . . 0.0 109.353 178.331 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.552 ' CG2' HG23 ' A' ' 126' ' ' VAL . 0.6 OUTLIER -88.95 136.5 32.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.294 -0.879 . . . . 0.0 110.866 -179.107 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.47 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 25.3 tttt -109.37 129.49 55.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.484 -0.76 . . . . 0.0 110.1 179.545 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.471 ' O ' ' CB ' ' A' ' 125' ' ' ASN . . . 110.44 15.33 11.47 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 9.1 t30 67.82 54.27 0.64 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.265 -1.138 . . . . 0.0 110.33 179.907 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.552 HG23 ' CG2' ' A' ' 122' ' ' THR . 20.3 m -133.4 160.34 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.351 -0.843 . . . . 0.0 109.948 179.744 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -121.3 162.16 20.77 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.225 -0.922 . . . . 0.0 110.576 -179.724 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.681 HG13 HD21 ' A' ' 95' ' ' LEU . 2.9 mp -83.95 173.45 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.393 -0.817 . . . . 0.0 109.96 179.766 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.604 ' N ' HG22 ' A' ' 128' ' ' ILE . 32.4 mttt -108.67 133.79 52.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.413 -0.804 . . . . 0.0 109.894 179.835 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -46.51 -36.26 6.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.183 -0.948 . . . . 0.0 110.198 -179.887 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -63.31 -29.94 71.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 110.09 179.885 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.552 ' CE1' ' O ' ' A' ' 90' ' ' ALA . 14.5 t-160 -78.18 -51.3 10.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 110.222 179.905 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.784 HG11 ' CE2' ' A' ' 5' ' ' TYR . 43.0 t -64.28 -43.45 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.356 -0.84 . . . . 0.0 110.098 179.882 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 7.1 tptm -67.1 -45.87 75.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 110.154 179.888 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.439 ' O ' ' HG3' ' A' ' 139' ' ' LYS . . . -62.27 -30.06 70.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.212 -0.93 . . . . 0.0 110.035 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.58 -29.39 69.78 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 83.5 mttt -66.99 -33.9 76.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.213 -1.169 . . . . 0.0 110.077 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -81.7 -29.93 32.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.892 . . . . 0.0 110.104 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.439 ' HG3' ' O ' ' A' ' 135' ' ' ALA . 93.9 mttt -67.29 -41.5 85.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.33 -0.856 . . . . 0.0 110.069 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.16 -41.0 51.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.198 -0.939 . . . . 0.0 110.065 179.847 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 137' ' ' LYS . 48.8 m -56.99 -48.17 79.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.453 -0.78 . . . . 0.0 110.031 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -55.52 -42.33 74.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.185 -0.947 . . . . 0.0 110.095 179.793 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.436 ' O ' HG13 ' A' ' 147' ' ' ILE . 61.4 mt -61.52 -40.77 95.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 109.976 179.869 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -60.56 -37.77 82.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.407 -0.808 . . . . 0.0 109.878 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.431 ' HA ' ' OE1' ' A' ' 148' ' ' GLU . 87.8 mttt -71.67 -17.5 62.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.317 -0.864 . . . . 0.0 110.039 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.542 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 34.4 mt -84.11 -35.92 23.34 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.281 -0.887 . . . . 0.0 108.967 179.386 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.96 ' CG2' HD23 ' A' ' 18' ' ' LEU . 53.4 mt -72.27 -42.46 65.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 119.678 -0.809 . . . . 0.0 108.836 178.735 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.753 ' HB3' HD13 ' A' ' 13' ' ' ILE . 69.4 mt-10 -56.18 -39.11 71.89 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.479 -0.763 . . . . 0.0 109.409 179.03 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.5 m -73.99 -24.43 59.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.944 . . . . 0.0 109.617 179.415 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.648 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 80.3 t80 -64.68 -49.3 71.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.383 -0.823 . . . . 0.0 110.083 179.822 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.12 HD21 ' CE2' ' A' ' 158' ' ' TYR . 84.8 mt -79.94 -29.34 39.67 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.225 -0.922 . . . . 0.0 110.059 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.683 ' HB2' HD11 ' A' ' 13' ' ' ILE . 78.3 tttt -70.21 -27.14 64.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.33 -0.856 . . . . 0.0 109.594 179.523 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.483 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -104.04 -33.27 4.07 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.718 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.451 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 3.7 m80 -107.12 92.34 7.72 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.354 -1.086 . . . . 0.0 109.982 179.734 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 48.4 Cg_endo -74.23 6.35 3.1 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.04 1.547 . . . . 0.0 111.075 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -107.06 -4.94 18.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.999 -1.063 . . . . 0.0 109.756 179.772 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.67 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -75.18 102.44 4.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.411 -0.806 . . . . 0.0 110.019 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 1.12 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.4 OUTLIER 34.86 32.18 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.69 -0.631 . . . . 0.0 110.572 -179.521 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.565 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.71 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 1.043 HG23 ' C ' ' A' ' 120' ' ' TYR . 3.0 p -82.86 153.84 3.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.253 -1.145 . . . . 0.0 110.122 -179.917 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.791 ' CE1' HD12 ' A' ' 128' ' ' ILE . 8.4 m-85 -89.23 170.16 10.83 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.329 -0.857 . . . . 0.0 110.014 -179.658 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.815 HG23 ' CE1' ' A' ' 119' ' ' HIS . 50.0 m -137.76 107.56 6.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.111 -0.993 . . . . 0.0 110.364 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 1.185 ' CE1' HG21 ' A' ' 133' ' ' VAL . 47.7 m-85 -112.21 136.67 51.34 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.182 -0.949 . . . . 0.0 110.109 179.804 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 20.8 pt-20 -129.84 152.1 49.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.222 -0.924 . . . . 0.0 110.537 -179.794 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.3 t -139.28 156.22 47.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.401 -0.812 . . . . 0.0 109.902 179.791 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -147.62 124.37 11.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.154 -0.966 . . . . 0.0 110.391 -179.873 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.637 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.3 p90 -151.6 -176.38 5.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.388 -0.82 . . . . 0.0 109.892 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.849 HG22 ' HA ' ' A' ' 113' ' ' ILE . 8.8 p -141.74 174.41 10.6 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.114 -0.991 . . . . 0.0 110.661 -179.642 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.5 t -153.08 159.08 42.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.428 -0.795 . . . . 0.0 110.155 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -81.94 -20.48 38.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.234 -0.916 . . . . 0.0 110.237 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.834 HG23 ' HD2' ' A' ' 14' ' ' PRO . 8.1 mm -80.11 150.68 71.88 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.334 -0.854 . . . . 0.0 109.98 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.834 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.0 Cg_endo -65.55 143.09 74.07 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.073 1.565 . . . . 0.0 110.789 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.666 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 41.5 Cg_endo -73.34 -30.69 9.99 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 124.109 1.584 . . . . 0.0 113.066 -179.501 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.666 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.3 Cg_endo -69.9 -23.38 30.23 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 O-C-N 122.471 0.722 . . . . 0.0 110.228 -179.899 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.579 ' NH2' ' HA ' ' A' ' 159' ' ' ASN . 2.1 mtp180 -85.16 -43.48 13.8 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.108 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.749 HD23 ' C ' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -69.89 -30.27 67.66 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.845 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.54 ' N ' HD23 ' A' ' 18' ' ' LEU . 50.7 t80 -68.58 -53.7 21.23 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.393 -0.817 . . . . 0.0 109.549 179.126 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.55 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 10.8 mttt -53.41 -33.86 55.54 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.681 -0.807 . . . . 0.0 109.181 179.568 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.063 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -76.4 -53.65 7.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.485 -0.759 . . . . 0.0 111.158 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 1.072 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -60.0 -46.08 90.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.501 -0.749 . . . . 0.0 111.922 -178.429 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.642 HG13 ' CE1' ' A' ' 81' ' ' TYR . 3.3 t -100.88 -60.6 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.886 -1.134 . . . . 0.0 111.847 -178.665 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.614 ' N ' HD12 ' A' ' 24' ' ' LEU . 6.8 mp -67.96 -5.36 16.68 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.172 -0.955 . . . . 0.0 111.647 -178.494 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.68 ' HB3' HD23 ' A' ' 29' ' ' LEU . 1.1 m-20 -149.04 30.14 0.79 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.669 -1.269 . . . . 0.0 110.946 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 1.072 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -70.05 -23.88 63.17 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.21 -0.931 . . . . 0.0 110.675 179.798 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -69.68 -17.52 63.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.08 -1.013 . . . . 0.0 109.774 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.533 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 4.1 p-10 -129.42 13.28 6.03 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.375 -0.828 . . . . 0.0 109.774 179.597 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.695 HD21 ' CZ ' ' A' ' 158' ' ' TYR . 0.3 OUTLIER -94.37 -49.16 5.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.437 -0.789 . . . . 0.0 110.138 179.812 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.974 HG21 HD13 ' A' ' 38' ' ' ILE . 5.8 p -73.2 -28.87 1.01 Allowed Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.141 -0.974 . . . . 0.0 112.051 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.848 ' HD3' HG12 ' A' ' 30' ' ' VAL . 52.1 Cg_endo -79.56 1.21 9.39 Favored 'Trans proline' 0 C--N 1.319 -1.019 0 O-C-N 122.717 0.851 . . . . 0.0 110.263 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.437 ' HD2' ' O ' ' A' ' 28' ' ' ASN . 51.8 mttm -124.68 -30.0 3.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.292 -0.88 . . . . 0.0 109.869 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.617 HD11 ' CD1' ' A' ' 29' ' ' LEU . 10.8 mt -77.57 -39.14 26.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.482 -0.761 . . . . 0.0 109.76 179.822 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -170.24 102.27 0.44 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.417 -0.802 . . . . 0.0 110.14 179.871 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.78 1.2 7.27 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.066 1.561 . . . . 0.0 110.647 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -87.27 -8.64 56.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.099 -1.0 . . . . 0.0 110.039 179.916 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.31 -51.02 3.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.312 -0.868 . . . . 0.0 110.308 -179.929 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.974 HD13 HG21 ' A' ' 30' ' ' VAL . 1.1 mp -127.11 138.87 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.426 -0.796 . . . . 0.0 110.11 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.43 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 37.7 ttmt -73.85 -40.53 63.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.318 -0.864 . . . . 0.0 110.098 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -178.49 156.11 0.9 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.336 -0.852 . . . . 0.0 110.252 179.752 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.4 m -120.0 119.93 34.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.23 -0.919 . . . . 0.0 109.996 179.889 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.518 ' O ' HD12 ' A' ' 44' ' ' LEU . 35.0 tp10 -124.25 114.39 19.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.289 -0.882 . . . . 0.0 110.387 -179.923 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.467 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 21.4 mt -60.04 145.03 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.189 -0.945 . . . . 0.0 110.069 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.518 HD12 ' O ' ' A' ' 42' ' ' GLU . 4.8 mp -121.77 -27.29 4.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.224 -0.923 . . . . 0.0 110.328 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.627 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.6 m95 -123.78 163.19 21.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.272 -0.893 . . . . 0.0 110.482 -179.833 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.431 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 43.12 -138.37 3.39 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.81 23.52 0.51 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.309 -1.112 . . . . 0.0 109.994 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 121.73 -13.9 9.23 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.481 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -81.54 -169.61 42.65 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.85 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.436 ' HA ' HG22 ' A' ' 71' ' ' ILE . 45.0 Cg_endo -72.79 129.5 14.53 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 124.086 1.572 . . . . 0.0 110.557 -179.905 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.49 -12.95 51.16 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 -179.569 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.544 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -71.52 161.3 31.24 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.589 -0.948 . . . . 0.0 109.374 179.635 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.627 HD12 ' CG ' ' A' ' 45' ' ' TRP . 58.3 mt -134.29 120.37 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.242 -0.911 . . . . 0.0 109.971 179.683 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 96.0 mttt -107.3 128.95 54.91 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.164 -0.96 . . . . 0.0 110.56 -179.595 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -93.01 91.38 7.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -0.881 . . . . 0.0 109.768 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.555 ' CG2' HG12 ' A' ' 38' ' ' ILE . 96.7 mt -80.02 144.11 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.2 -0.937 . . . . 0.0 110.212 -179.753 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.515 ' O ' HG23 ' A' ' 38' ' ' ILE . 7.2 p -117.62 163.73 16.01 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.201 -0.937 . . . . 0.0 110.744 -179.649 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.568 ' HE2' HG13 ' A' ' 67' ' ' VAL . 28.6 m-85 -122.4 141.38 51.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.323 -0.861 . . . . 0.0 110.118 179.283 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.343 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.953 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.181 0.515 . . . . 0.0 110.303 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -138.67 102.27 0.35 Allowed Glycine 0 N--CA 1.487 2.096 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 179.669 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.543 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 13.9 p90 -143.44 166.7 24.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.218 -1.166 . . . . 0.0 110.175 -179.685 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.885 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.1 m -139.35 174.13 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.354 -0.841 . . . . 0.0 110.618 179.78 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.517 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 20.1 mttt -125.56 122.04 35.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.529 -0.732 . . . . 0.0 109.642 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.773 ' CE1' HD13 ' A' ' 85' ' ' LEU . 0.5 OUTLIER -108.56 123.75 49.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.179 -0.951 . . . . 0.0 110.854 -179.436 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 52' ' ' THR . 18.9 tttm -97.65 116.09 29.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.258 -0.901 . . . . 0.0 109.79 179.428 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.523 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 23.6 mm -58.04 132.43 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.994 -1.066 . . . . 0.0 110.365 -179.563 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 82' ' ' SER . 94.1 m-20 -105.34 -42.76 5.16 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.372 -0.83 . . . . 0.0 109.889 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.2 m -175.09 159.67 2.63 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.389 -0.82 . . . . 0.0 109.948 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.492 HG12 HG11 ' A' ' 23' ' ' VAL . 2.2 mt -138.62 159.84 30.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.193 -0.942 . . . . 0.0 110.209 179.97 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 79' ' ' TYR . 5.6 m-20 -137.58 80.56 1.81 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.489 -0.757 . . . . 0.0 110.392 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.433 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 22.3 tttt -63.28 -18.9 64.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.133 -0.979 . . . . 0.0 110.259 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -91.6 -32.24 15.58 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.275 -0.89 . . . . 0.0 109.363 179.755 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.503 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.5 m120 -101.25 -4.13 27.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.643 -0.661 . . . . 0.0 109.604 179.619 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.588 ' CE1' ' HB3' ' A' ' 16' ' ' PRO . 85.2 m-85 60.43 55.44 3.49 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.454 0.645 . . . . 0.0 110.581 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.487 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -129.93 165.61 21.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.434 -0.791 . . . . 0.0 109.876 179.495 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.696 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 42.6 t80 -149.71 143.79 25.68 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.219 -0.925 . . . . 0.0 109.903 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.464 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 25.9 m -148.76 131.45 15.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.122 -0.986 . . . . 0.0 111.223 -179.724 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.696 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 9.1 p90 -144.36 175.66 9.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.35 -0.844 . . . . 0.0 110.064 179.041 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 98' ' ' ILE . 27.1 m -127.25 128.42 45.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.348 -0.845 . . . . 0.0 109.824 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.773 HD13 ' CE1' ' A' ' 69' ' ' HIS . 7.4 tp -95.39 125.31 39.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.093 -1.004 . . . . 0.0 110.077 -179.85 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.6 pt -109.79 -12.65 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.244 -0.91 . . . . 0.0 110.333 -179.565 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.566 ' O ' HD11 ' A' ' 91' ' ' LEU . 18.0 tt0 -124.64 172.84 8.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 0.0 110.191 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.885 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 137.58 112.08 1.09 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.984 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -56.42 -16.83 6.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.319 -1.106 . . . . 0.0 110.205 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.63 -17.71 57.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 0.0 110.146 179.87 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.566 HD11 ' O ' ' A' ' 87' ' ' GLU . 65.7 mt -66.78 -23.82 66.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.284 -0.885 . . . . 0.0 110.209 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 50.56 -179.69 0.03 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -79.96 6.45 11.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.303 -1.116 . . . . 0.0 110.206 179.897 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.498 ' O ' HG21 ' A' ' 126' ' ' VAL . 39.4 p -94.36 -31.55 13.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.236 -0.915 . . . . 0.0 110.238 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.86 HD21 HD11 ' A' ' 128' ' ' ILE . 83.6 mt -107.29 163.93 12.61 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.351 -0.843 . . . . 0.0 110.092 179.929 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.466 ' HG2' ' N ' ' A' ' 97' ' ' LYS . 61.4 tt0 -144.77 -82.85 0.15 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.299 -0.876 . . . . 0.0 109.668 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.495 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 18.7 mttt -80.37 131.57 35.64 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.778 -0.576 . . . . 0.0 110.343 179.683 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.791 HG21 ' CE2' ' A' ' 100' ' ' TYR . 4.7 mm -119.53 138.67 49.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 120.845 -1.16 . . . . 0.0 109.63 178.93 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.476 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.3 m -118.85 123.27 44.31 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 119.711 -0.795 . . . . 0.0 108.985 178.786 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.791 ' CE2' HG21 ' A' ' 98' ' ' ILE . 13.0 m-85 -119.27 132.61 55.93 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.39 -0.819 . . . . 0.0 110.322 -179.076 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.467 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 85.1 tt0 -132.07 140.26 48.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.263 -0.898 . . . . 0.0 110.061 179.788 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.468 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 32.6 m -133.01 153.95 50.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.924 . . . . 0.0 109.929 179.939 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.477 ' O ' ' N ' ' A' ' 115' ' ' LYS . 7.7 mttt -149.66 133.05 16.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.143 -0.973 . . . . 0.0 110.456 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.87 HD23 HG12 ' A' ' 114' ' ' ILE . 3.5 mt -115.42 152.49 32.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.196 -0.94 . . . . 0.0 110.03 179.812 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.696 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.8 t -151.38 -169.52 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.227 -0.921 . . . . 0.0 110.185 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.696 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -124.52 145.64 49.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.35 -0.844 . . . . 0.0 110.305 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.443 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.3 p -103.8 171.12 5.39 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.281 -0.887 . . . . 0.0 110.2 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.443 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 45.7 Cg_endo -72.54 -13.79 27.53 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.074 1.565 . . . . 0.0 110.585 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 67.8 m -95.84 11.64 32.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.188 -0.945 . . . . 0.0 110.354 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 91.34 -34.93 4.1 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.847 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -55.18 -172.07 0.08 OUTLIER Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.785 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.52 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 1.4 p -134.98 134.19 40.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.124 -1.221 . . . . 0.0 110.387 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.849 ' HA ' HG22 ' A' ' 10' ' ' THR . 15.4 mt -85.74 147.12 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.37 -0.831 . . . . 0.0 109.91 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.87 HG12 HD23 ' A' ' 104' ' ' LEU . 19.4 mt -131.1 110.8 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.166 -0.959 . . . . 0.0 110.407 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 103' ' ' LYS . 63.3 tttm -97.93 134.87 40.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.191 -0.943 . . . . 0.0 109.683 179.444 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.67 147.99 51.51 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.219 -0.926 . . . . 0.0 110.354 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' A' ' 101' ' ' GLU . 32.9 m -148.54 148.06 29.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.4 -0.812 . . . . 0.0 110.292 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 88.5 p -148.36 155.08 40.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.29 -0.881 . . . . 0.0 110.136 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.815 ' CE1' HG23 ' A' ' 4' ' ' THR . 34.1 m-70 -139.14 129.81 26.0 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.168 -0.958 . . . . 0.0 110.373 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 1.043 ' C ' HG23 ' A' ' 2' ' ' VAL . 3.6 m-30 -99.56 120.58 39.88 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.279 -0.888 . . . . 0.0 110.599 -179.555 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.565 ' CE1' HG21 ' A' ' 2' ' ' VAL . 82.4 m-70 -95.51 107.56 19.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.196 -0.94 . . . . 0.0 109.674 179.074 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.6 p -77.81 157.39 29.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.917 . . . . 0.0 110.174 -179.854 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 37.6 tttt -114.46 114.0 25.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.193 -0.942 . . . . 0.0 110.237 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 93.26 -132.7 11.35 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -115.72 77.19 1.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.215 -1.168 . . . . 0.0 110.147 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.498 HG21 ' O ' ' A' ' 94' ' ' THR . 32.8 m -142.02 154.39 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.178 -0.951 . . . . 0.0 110.242 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -132.05 164.22 26.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.234 -0.916 . . . . 0.0 110.214 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.86 HD11 HD21 ' A' ' 95' ' ' LEU . 3.2 mp -92.05 171.83 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.154 -0.966 . . . . 0.0 110.375 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.623 ' N ' HG22 ' A' ' 128' ' ' ILE . 60.8 mmtt -113.71 129.98 56.49 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.481 -0.762 . . . . 0.0 109.768 179.742 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.505 ' O ' ' CB ' ' A' ' 134' ' ' LYS . 92.4 mt-10 -43.24 -50.63 6.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.134 -0.979 . . . . 0.0 110.026 -179.841 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -48.28 -23.53 0.92 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.208 -0.933 . . . . 0.0 109.892 179.702 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -87.49 -64.66 1.11 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.302 -0.874 . . . . 0.0 110.322 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 1.185 HG21 ' CE1' ' A' ' 5' ' ' TYR . 2.4 p -65.75 -28.48 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.394 -0.817 . . . . 0.0 110.086 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.505 ' CB ' ' O ' ' A' ' 130' ' ' GLU . 13.6 tptt -72.64 -48.79 36.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.163 -0.961 . . . . 0.0 109.937 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.62 -25.11 67.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.328 -0.858 . . . . 0.0 110.065 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.17 -31.34 69.15 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.843 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -64.92 -32.72 74.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.264 -1.139 . . . . 0.0 110.106 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -79.67 -40.24 29.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.334 -0.854 . . . . 0.0 110.005 179.81 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -69.71 -34.27 73.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.304 -0.873 . . . . 0.0 109.87 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.01 -35.39 66.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.323 -0.861 . . . . 0.0 109.885 179.718 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 48.0 m -66.48 -42.95 86.69 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.276 -0.89 . . . . 0.0 109.939 179.701 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -56.36 -48.96 75.77 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.273 -0.892 . . . . 0.0 109.932 179.81 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.611 HD13 ' O ' ' A' ' 143' ' ' LEU . 0.6 OUTLIER -55.8 -44.25 77.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.346 -0.846 . . . . 0.0 109.866 179.817 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.519 ' HA ' HD12 ' A' ' 147' ' ' ILE . 13.7 m-85 -55.81 -39.68 71.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.431 -0.793 . . . . 0.0 109.834 179.715 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.452 ' HA ' ' OE1' ' A' ' 148' ' ' GLU . 95.8 mttt -73.21 -12.46 60.88 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.405 -0.81 . . . . 0.0 110.229 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.481 HD12 HD22 ' A' ' 143' ' ' LEU . 16.3 mt -83.77 -36.02 23.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.16 -0.962 . . . . 0.0 108.989 179.396 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.623 HD11 ' CE1' ' A' ' 22' ' ' PHE . 19.9 mt -69.66 -45.51 77.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.94 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.491 ' O ' HG13 ' A' ' 13' ' ' ILE . 38.8 mt-10 -58.98 -43.12 91.33 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.702 -0.799 . . . . 0.0 109.471 179.113 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 17.9 m -66.26 -24.49 66.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.291 -0.88 . . . . 0.0 109.564 179.453 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.602 ' CD1' HG12 ' A' ' 33' ' ' ILE . 81.8 t80 -67.02 -46.99 72.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.508 -0.745 . . . . 0.0 109.952 179.794 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.171 HD21 ' CE2' ' A' ' 158' ' ' TYR . 68.4 mt -79.74 -30.22 40.8 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.141 -0.975 . . . . 0.0 110.006 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.538 ' HB2' ' CG1' ' A' ' 13' ' ' ILE . 21.0 tttm -71.23 -25.83 62.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.899 . . . . 0.0 109.289 179.062 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.422 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -102.9 -33.51 4.34 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.119 -1.593 . . . . 0.0 109.119 179.543 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.447 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 3.3 m80 -108.61 92.76 10.69 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.277 -1.131 . . . . 0.0 109.933 179.692 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 46.9 Cg_endo -74.01 6.23 3.07 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.033 1.544 . . . . 0.0 111.168 -179.864 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -108.71 0.09 20.34 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.965 -1.084 . . . . 0.0 109.937 179.782 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.68 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -83.13 102.14 11.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.303 -0.873 . . . . 0.0 110.048 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 1.171 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.3 OUTLIER 35.67 31.27 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.725 -0.609 . . . . 0.0 110.184 -179.377 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.579 ' HA ' ' NH2' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.714 -179.723 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.997 HG23 ' C ' ' A' ' 120' ' ' TYR . 3.0 p -79.98 150.87 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.375 -1.073 . . . . 0.0 110.503 -179.795 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.517 ' CE2' HG12 ' A' ' 128' ' ' ILE . 3.9 m-85 -87.75 175.41 7.87 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.446 -0.784 . . . . 0.0 110.025 -179.87 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.881 HG23 ' CE1' ' A' ' 119' ' ' HIS . 44.8 m -147.56 101.97 3.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.115 -0.991 . . . . 0.0 110.463 179.899 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.427 ' CD1' HG13 ' A' ' 133' ' ' VAL . 88.0 m-85 -112.67 127.19 56.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.293 -0.879 . . . . 0.0 109.976 179.811 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.584 ' CG ' ' N ' ' A' ' 7' ' ' SER . 17.2 tt0 -110.66 175.48 5.41 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.265 -0.897 . . . . 0.0 109.95 -179.544 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.584 ' N ' ' CG ' ' A' ' 6' ' ' GLU . 0.2 OUTLIER -156.71 166.76 32.48 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.716 -0.615 . . . . 0.0 109.634 179.756 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.421 ' HG3' ' HG3' ' A' ' 115' ' ' LYS . 1.4 tt0 -156.53 132.3 9.59 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.983 -1.073 . . . . 0.0 110.955 -179.849 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.625 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 2.9 p90 -155.9 -175.82 5.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.505 -0.747 . . . . 0.0 109.581 179.43 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.511 HG22 ' HA ' ' A' ' 113' ' ' ILE . 23.4 p -134.7 179.23 6.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.019 -1.051 . . . . 0.0 110.887 -179.559 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.654 ' OG ' HD11 ' A' ' 114' ' ' ILE . 87.7 p -159.99 139.08 10.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.572 -0.705 . . . . 0.0 110.06 179.76 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -67.15 -29.85 69.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.129 -0.982 . . . . 0.0 110.287 -179.815 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 1.026 HD13 ' HB3' ' A' ' 148' ' ' GLU . 1.8 mp -71.7 151.8 93.47 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.291 -0.881 . . . . 0.0 109.793 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.825 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.3 Cg_endo -66.44 141.63 62.33 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 124.072 1.564 . . . . 0.0 110.522 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.633 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.9 Cg_endo -73.23 -30.4 10.49 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 124.092 1.575 . . . . 0.0 113.085 -179.256 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.6 Cg_endo -71.79 -21.65 24.7 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 N-CA-C 110.178 -0.739 . . . . 0.0 110.178 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.484 ' HD3' ' CG ' ' A' ' 14' ' ' PRO . 44.8 mtp180 -84.77 -46.04 11.78 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.084 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.771 HD23 ' C ' ' A' ' 18' ' ' LEU . 1.1 tt -67.81 -29.99 69.3 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.755 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.489 ' N ' HD23 ' A' ' 18' ' ' LEU . 76.3 t80 -66.84 -57.13 7.61 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.459 -0.776 . . . . 0.0 109.3 178.748 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.554 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 9.8 mttp -48.76 -36.74 17.17 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.266 179.441 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.046 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -74.69 -43.2 56.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.427 -0.795 . . . . 0.0 110.779 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.983 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -68.45 -48.24 65.06 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.521 -0.737 . . . . 0.0 111.672 -178.45 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.62 HG13 ' CE1' ' A' ' 81' ' ' TYR . 3.5 t -100.3 -51.87 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.835 -1.166 . . . . 0.0 111.603 -178.944 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.725 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.2 mp -77.79 0.02 25.32 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.116 -0.99 . . . . 0.0 111.265 -179.015 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.597 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -154.15 30.92 0.44 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.97 -1.081 . . . . 0.0 110.515 179.881 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.983 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -67.33 -29.57 69.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.233 -0.917 . . . . 0.0 109.999 179.778 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -69.26 -15.6 63.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 0.0 110.069 179.98 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.482 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 78.8 m-20 -125.86 9.81 7.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -0.904 . . . . 0.0 110.196 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.798 HD21 ' CZ ' ' A' ' 158' ' ' TYR . 0.5 OUTLIER -100.34 -48.8 4.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.907 . . . . 0.0 110.245 179.906 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 1.128 HG11 HD13 ' A' ' 38' ' ' ILE . 2.9 t -74.46 -42.15 5.07 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.43 -0.793 . . . . 0.0 110.974 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 47.7 Cg_endo -78.15 9.01 3.24 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.499 1.263 . . . . 0.0 110.626 -179.919 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 28' ' ' ASN . 33.7 mttt -127.11 -37.27 2.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.185 -0.947 . . . . 0.0 109.464 179.678 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.54 HG12 ' CD1' ' A' ' 150' ' ' TYR . 6.8 mt -80.04 -39.44 19.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.537 -0.727 . . . . 0.0 109.562 179.536 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.422 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . . . -155.12 100.33 2.31 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.378 -0.827 . . . . 0.0 110.189 179.819 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 34' ' ' ALA . 46.3 Cg_endo -72.21 -0.85 9.22 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.978 1.515 . . . . 0.0 110.632 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -84.47 -8.0 59.09 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.102 -0.999 . . . . 0.0 109.816 179.75 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.662 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -98.24 -63.4 1.13 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.303 -0.873 . . . . 0.0 110.234 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 1.128 HD13 HG11 ' A' ' 30' ' ' VAL . 2.0 mp -115.56 137.56 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.378 -0.826 . . . . 0.0 110.191 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 57' ' ' THR . 13.7 ttpt -84.66 -19.2 33.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.381 -0.824 . . . . 0.0 110.207 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.456 ' O ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER 178.69 159.85 0.59 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.204 -0.935 . . . . 0.0 109.962 -179.961 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -135.4 126.13 27.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.366 -0.834 . . . . 0.0 109.936 179.798 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.428 ' HB3' ' HE1' ' A' ' 40' ' ' HIS . 36.9 tt0 -139.92 113.42 8.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.234 -0.916 . . . . 0.0 110.55 -179.826 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.4 mt -53.87 142.22 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.262 -0.899 . . . . 0.0 109.861 179.535 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.607 HD23 ' CB ' ' A' ' 55' ' ' LYS . 0.4 OUTLIER -114.64 -30.05 6.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.107 -0.996 . . . . 0.0 110.455 -179.862 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.876 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.7 m95 -126.48 164.97 19.99 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.261 -0.899 . . . . 0.0 110.416 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.445 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 41.78 -135.65 3.19 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.745 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.11 22.68 0.5 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.28 -1.13 . . . . 0.0 110.093 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 121.59 -19.14 8.57 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.964 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.475 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -71.82 -171.57 15.2 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.416 ' HA ' HG22 ' A' ' 71' ' ' ILE . 45.9 Cg_endo -73.19 129.11 13.65 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 123.939 1.494 . . . . 0.0 110.478 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.74 -14.0 53.35 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.499 -1.84 . . . . 0.0 108.499 -179.392 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.548 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -70.48 160.96 31.45 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.613 -0.933 . . . . 0.0 109.381 179.536 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.876 HD12 ' CG ' ' A' ' 45' ' ' TRP . 57.6 mt -128.99 119.54 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.221 -0.924 . . . . 0.0 110.059 179.782 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.926 ' HE3' HD11 ' A' ' 71' ' ' ILE . 20.6 mttm -101.2 129.82 47.19 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.292 -0.88 . . . . 0.0 110.134 -179.892 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.607 ' CB ' HD23 ' A' ' 44' ' ' LEU . 34.7 ttpt -100.79 91.84 4.8 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.21 -0.931 . . . . 0.0 110.155 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.474 ' HB ' HG23 ' A' ' 67' ' ' VAL . 88.8 mt -80.07 144.16 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.894 . . . . 0.0 110.208 -179.948 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.499 ' O ' ' N ' ' A' ' 39' ' ' LYS . 1.0 OUTLIER -113.87 150.97 32.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.312 -0.867 . . . . 0.0 110.303 -179.997 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.609 ' HE2' HG13 ' A' ' 67' ' ' VAL . 20.8 m-85 -115.47 147.55 40.48 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.269 -0.894 . . . . 0.0 110.142 179.744 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.887 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.208 0.528 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.577 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -131.8 84.88 0.3 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.533 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 11.7 p90 -128.12 163.17 25.22 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.23 -1.159 . . . . 0.0 110.262 -179.658 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.627 HG12 ' CA ' ' A' ' 88' ' ' GLY . 5.3 m -136.08 175.66 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.369 -0.832 . . . . 0.0 110.251 179.496 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.711 ' O ' HD12 ' A' ' 85' ' ' LEU . 26.8 mttm -135.56 104.87 5.97 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.382 -0.824 . . . . 0.0 109.829 179.754 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.994 ' CD2' HD13 ' A' ' 85' ' ' LEU . 14.2 m170 -95.6 130.08 42.58 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.301 -0.874 . . . . 0.0 111.121 -179.317 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 52' ' ' THR . 31.6 tttt -96.88 113.91 25.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.332 -0.855 . . . . 0.0 109.331 179.034 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.926 HD11 ' HE3' ' A' ' 54' ' ' LYS . 28.9 mm -53.52 131.11 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.197 -0.939 . . . . 0.0 110.313 -179.421 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 82' ' ' SER . 86.1 m-20 -106.09 -46.66 4.03 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.405 -0.809 . . . . 0.0 110.332 -179.799 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 48.0 m -164.94 159.15 17.83 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.324 -0.86 . . . . 0.0 110.039 -179.793 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.468 HG12 HG11 ' A' ' 23' ' ' VAL . 1.7 mt -145.23 157.9 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.189 -0.944 . . . . 0.0 110.655 -179.881 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.559 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 2.2 m-20 -136.93 80.0 1.79 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.611 -0.681 . . . . 0.0 109.938 179.35 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.48 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 44.7 tttt -63.46 -13.27 38.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.189 -0.944 . . . . 0.0 110.431 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -95.79 -30.45 13.69 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.249 -0.907 . . . . 0.0 109.458 179.665 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.7 m120 -106.52 -7.54 17.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.572 -0.705 . . . . 0.0 109.813 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.562 ' HB2' ' HB2' ' A' ' 104' ' ' LEU . 2.8 m-85 68.62 51.12 0.64 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.558 -0.714 . . . . 0.0 110.177 -179.695 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.559 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -122.68 149.58 43.85 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.256 -0.903 . . . . 0.0 109.409 179.599 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.69 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 31.5 t80 -137.22 149.14 46.98 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.101 -0.999 . . . . 0.0 110.504 -179.204 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.458 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 75.0 m -154.92 129.0 8.84 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.177 -0.952 . . . . 0.0 110.922 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.69 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 26.1 p90 -148.17 169.5 19.9 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.328 -0.858 . . . . 0.0 110.536 179.318 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.805 HG23 ' O ' ' A' ' 98' ' ' ILE . 18.0 m -124.52 129.85 51.38 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.299 -0.876 . . . . 0.0 110.127 -179.8 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.994 HD13 ' CD2' ' A' ' 69' ' ' HIS . 16.0 tp -96.43 136.78 36.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.945 -1.097 . . . . 0.0 110.34 179.735 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.533 ' H ' HD12 ' A' ' 85' ' ' LEU . 11.4 pt -118.17 -30.87 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.212 -0.93 . . . . 0.0 110.364 -179.44 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.621 ' O ' HD11 ' A' ' 85' ' ' LEU . 64.3 tt0 -114.53 156.26 24.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.276 -0.89 . . . . 0.0 110.159 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.627 ' CA ' HG12 ' A' ' 67' ' ' VAL . . . 152.69 130.89 1.6 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 89' ' ' ASP . 36.9 p-10 -60.94 -15.31 29.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -1.138 . . . . 0.0 110.09 179.91 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.07 -19.94 53.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 110.166 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.473 ' O ' ' HB2' ' A' ' 95' ' ' LEU . 59.1 mt -70.09 -26.96 64.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.92 . . . . 0.0 110.054 179.909 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 44.74 -169.36 0.02 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -87.36 7.33 29.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.247 -1.149 . . . . 0.0 109.911 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.577 ' O ' HG21 ' A' ' 126' ' ' VAL . 30.1 p -98.84 -28.19 13.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.359 -0.838 . . . . 0.0 109.959 179.91 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 1.012 HD11 ' CD1' ' A' ' 128' ' ' ILE . 41.2 mt -111.91 169.56 8.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.449 -0.782 . . . . 0.0 110.156 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.416 ' HG2' ' C ' ' A' ' 95' ' ' LEU . 66.2 mm-40 -151.2 -81.38 0.1 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.318 -0.864 . . . . 0.0 109.877 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.48 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 19.4 mttt -80.33 133.78 35.98 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.727 -0.608 . . . . 0.0 110.564 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.805 ' O ' HG23 ' A' ' 84' ' ' THR . 6.7 mm -123.44 142.01 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.876 -1.14 . . . . 0.0 109.886 179.07 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.509 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.3 OUTLIER -123.42 134.41 53.96 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.39 -0.819 . . . . 0.0 109.021 178.866 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.664 ' HE2' HG21 ' A' ' 98' ' ' ILE . 7.2 m-85 -129.82 132.3 46.44 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.303 -0.873 . . . . 0.0 110.624 -179.021 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.405 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 70.4 tt0 -136.41 136.08 39.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.401 -0.812 . . . . 0.0 109.884 179.465 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 39.3 m -136.36 139.6 42.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 110.111 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 115' ' ' LYS . 1.1 tttp -134.52 143.24 47.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.241 -0.912 . . . . 0.0 110.502 -179.87 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.608 HD23 HG12 ' A' ' 114' ' ' ILE . 7.2 mt -124.52 151.91 44.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.247 -0.908 . . . . 0.0 109.844 179.587 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.699 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -150.06 -169.76 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.176 -0.953 . . . . 0.0 110.288 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.699 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -125.34 160.74 28.59 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.399 -0.813 . . . . 0.0 110.21 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.452 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 3.1 p -119.16 169.03 8.73 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.197 -0.939 . . . . 0.0 110.282 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 48.3 Cg_endo -73.37 -4.11 14.85 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.069 1.563 . . . . 0.0 110.7 -179.891 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 39.2 p -105.83 9.93 32.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.085 -1.009 . . . . 0.0 110.298 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 111' ' ' GLY . . . 93.38 -37.84 3.3 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.894 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 110' ' ' GLY . . . -54.27 -172.65 0.06 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.523 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 9.0 p -138.79 136.0 35.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.14 -1.212 . . . . 0.0 110.414 179.937 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.511 ' HA ' HG22 ' A' ' 10' ' ' THR . 61.4 mt -87.67 149.03 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.346 -0.846 . . . . 0.0 109.944 179.772 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.654 HD11 ' OG ' ' A' ' 11' ' ' SER . 4.6 mt -131.82 116.12 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.224 -0.922 . . . . 0.0 110.389 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 103' ' ' LYS . 39.5 tttt -100.12 148.29 24.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.374 -0.829 . . . . 0.0 110.011 179.708 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.2 t -145.55 155.39 43.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.184 -0.947 . . . . 0.0 110.388 -179.816 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.526 HG22 ' NE2' ' A' ' 119' ' ' HIS . 25.9 m -157.87 126.19 5.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.444 -0.785 . . . . 0.0 109.888 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 3.6 m -121.66 154.85 36.27 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.126 -0.984 . . . . 0.0 110.296 -179.851 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.881 ' CE1' HG23 ' A' ' 4' ' ' THR . 56.2 m-70 -137.87 147.27 44.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.276 -0.89 . . . . 0.0 110.392 -179.998 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.997 ' C ' HG23 ' A' ' 2' ' ' VAL . 58.8 m-85 -126.04 121.95 34.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.299 -0.876 . . . . 0.0 110.208 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.736 ' CD2' ' HB ' ' A' ' 2' ' ' VAL . 76.2 m80 -95.55 103.95 15.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.277 -0.889 . . . . 0.0 109.956 179.793 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.582 HG23 HD23 ' A' ' 95' ' ' LEU . 0.9 OUTLIER -91.1 142.71 27.46 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.14 -0.975 . . . . 0.0 110.29 -179.792 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.6 tttt -103.73 124.98 49.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.328 -0.858 . . . . 0.0 110.325 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 98.1 -122.51 7.52 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -134.19 67.61 1.51 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.277 -1.131 . . . . 0.0 110.311 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.577 HG21 ' O ' ' A' ' 94' ' ' THR . 31.0 m -131.5 168.11 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 109.932 179.915 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.433 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 89.7 mt-10 -143.93 157.86 44.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.161 -0.962 . . . . 0.0 110.588 -179.828 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 1.012 ' CD1' HD11 ' A' ' 95' ' ' LEU . 20.5 mm -61.47 173.41 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.379 -0.826 . . . . 0.0 110.106 179.736 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.625 ' N ' HG22 ' A' ' 128' ' ' ILE . 22.9 mttt -96.62 130.8 43.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.334 -0.854 . . . . 0.0 109.66 179.456 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 129' ' ' LYS . 95.5 mt-10 -42.06 -42.9 3.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 110.307 -179.708 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.91 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 31.0 tt0 -55.51 -33.91 64.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.912 . . . . 0.0 109.892 179.636 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.519 ' HB3' ' CG2' ' A' ' 128' ' ' ILE . 5.9 t-160 -75.49 -56.77 4.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.275 -0.891 . . . . 0.0 110.431 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.517 HG23 ' CG2' ' A' ' 128' ' ' ILE . 86.7 t -60.82 -33.03 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.326 -0.858 . . . . 0.0 110.394 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 38.6 mttp -104.04 -71.17 0.74 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.148 -0.97 . . . . 0.0 110.499 -179.688 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.91 ' HB3' ' O ' ' A' ' 131' ' ' GLU . . . -55.93 -19.28 11.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.081 -1.012 . . . . 0.0 109.867 -179.883 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' A' ' 132' ' ' HIS . . . -76.71 -29.85 57.02 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.819 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 46.4 mttt -68.13 -32.36 72.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.269 -1.136 . . . . 0.0 110.222 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -79.06 -34.21 43.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 110.027 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -66.35 -39.07 88.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.33 -0.856 . . . . 0.0 110.002 179.864 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.87 -42.92 60.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.411 -0.806 . . . . 0.0 110.032 179.76 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 144' ' ' PHE . 23.0 t -54.55 -43.11 71.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.323 -0.861 . . . . 0.0 109.905 179.765 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -57.43 -44.82 84.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.349 -0.845 . . . . 0.0 109.919 179.702 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 46.5 mt -58.53 -38.08 77.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.285 -0.884 . . . . 0.0 109.836 179.713 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.4 ' HB2' ' O ' ' A' ' 141' ' ' SER . 16.2 m-85 -62.26 -33.94 75.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.425 -0.797 . . . . 0.0 109.705 179.543 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -72.94 -15.46 61.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.327 -0.858 . . . . 0.0 109.855 179.756 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' A' ' 146' ' ' LEU . 14.0 mt -82.34 -37.15 26.13 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.258 -0.901 . . . . 0.0 108.721 179.203 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.729 HD11 ' CE1' ' A' ' 22' ' ' PHE . 19.1 mt -68.69 -47.35 77.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.751 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 1.026 ' HB3' HD13 ' A' ' 13' ' ' ILE . 88.8 mt-10 -56.18 -43.86 78.82 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.498 -0.751 . . . . 0.0 109.466 179.037 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 42.8 m -65.2 -34.34 78.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.159 -0.963 . . . . 0.0 109.37 179.329 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.596 ' CE2' ' OH ' ' A' ' 158' ' ' TYR . 81.3 t80 -59.15 -47.61 84.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.562 -0.711 . . . . 0.0 109.581 179.341 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.915 HD21 ' CE2' ' A' ' 158' ' ' TYR . 32.8 mt -80.08 -33.37 38.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 110.222 179.655 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.87 ' HB2' HD11 ' A' ' 13' ' ' ILE . 27.4 tttt -60.09 -23.21 63.62 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.228 -0.92 . . . . 0.0 109.257 179.364 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.5 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -109.69 -30.5 3.49 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.417 ' ND1' ' N ' ' A' ' 154' ' ' HIS . 1.8 m80 -105.68 92.22 5.88 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.28 -1.13 . . . . 0.0 110.084 179.817 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 46.3 Cg_endo -72.18 2.93 4.43 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.009 1.531 . . . . 0.0 111.069 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -113.57 -11.5 13.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.067 -1.02 . . . . 0.0 109.764 179.729 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.664 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -46.84 102.31 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.412 -0.805 . . . . 0.0 109.688 179.615 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 1.046 ' CE2' ' HB2' ' A' ' 21' ' ' ALA . 0.0 OUTLIER 58.71 -59.12 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.458 0 CA-C-O 121.592 0.71 . . . . 0.0 110.543 -179.33 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.589 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--N 1.293 -1.874 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.169 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 58.5 t -122.31 137.12 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.201 -1.176 . . . . 0.0 110.319 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.66 ' CG ' HD13 ' A' ' 128' ' ' ILE . 11.6 m-85 -95.71 146.88 24.17 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.318 -0.864 . . . . 0.0 109.967 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.814 HG23 ' CE1' ' A' ' 119' ' ' HIS . 7.3 m -127.35 117.26 21.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.179 -0.95 . . . . 0.0 110.597 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.085 ' CE2' HG21 ' A' ' 133' ' ' VAL . 67.1 m-85 -129.74 132.86 46.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.381 -0.825 . . . . 0.0 109.655 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 23.1 pt-20 -130.22 153.53 48.49 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.146 -0.971 . . . . 0.0 110.703 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.472 ' O ' ' CG ' ' A' ' 8' ' ' GLU . 5.9 t -131.79 165.93 22.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.459 -0.776 . . . . 0.0 109.574 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.472 ' CG ' ' O ' ' A' ' 7' ' ' SER . 87.5 mt-10 -154.12 121.97 5.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.088 -1.007 . . . . 0.0 110.706 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.618 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.2 p90 -149.53 -178.31 6.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.355 -0.841 . . . . 0.0 109.625 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.864 HG22 ' HA ' ' A' ' 113' ' ' ILE . 8.6 p -142.37 174.57 10.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.196 -0.94 . . . . 0.0 110.651 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.484 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 4.7 t -159.79 162.19 34.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.461 -0.774 . . . . 0.0 110.125 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -83.48 -20.28 34.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.217 -0.927 . . . . 0.0 110.187 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.832 HD11 ' HB2' ' A' ' 152' ' ' LYS . 2.9 mp -74.08 149.66 87.45 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.317 -0.865 . . . . 0.0 110.072 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.804 ' HD2' HG23 ' A' ' 13' ' ' ILE . 41.3 Cg_endo -67.59 142.23 58.08 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.055 1.555 . . . . 0.0 110.473 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.656 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.2 Cg_endo -72.44 -30.95 11.88 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 124.013 1.533 . . . . 0.0 112.804 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.656 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.7 Cg_endo -70.4 -23.79 27.47 Favored 'Trans proline' 0 C--N 1.319 -0.983 0 N-CA-C 110.115 -0.764 . . . . 0.0 110.115 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.801 HH21 ' HB3' ' A' ' 157' ' ' ALA . 58.5 mtp180 -82.24 -44.11 16.75 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.22 -0.925 . . . . 0.0 108.662 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 1.057 HD23 ' CG2' ' A' ' 147' ' ' ILE . 0.2 OUTLIER -70.85 -31.4 68.09 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.04 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.626 ' N ' HD13 ' A' ' 18' ' ' LEU . 70.4 t80 -63.69 -58.82 5.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.478 -0.764 . . . . 0.0 109.509 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.525 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 75.1 mttt -50.23 -41.24 49.64 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.42 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.129 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -70.55 -36.25 73.57 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.406 -0.809 . . . . 0.0 110.928 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 1.052 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -79.18 -40.25 31.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.24 -0.912 . . . . 0.0 111.14 -178.948 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.739 HG13 ' CE1' ' A' ' 81' ' ' TYR . 7.5 t -103.75 -54.85 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.975 -1.078 . . . . 0.0 111.741 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.525 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 5.9 mp -80.02 -1.39 39.55 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.013 -1.054 . . . . 0.0 112.012 -178.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.575 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -146.52 14.49 1.24 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.68 -1.263 . . . . 0.0 110.61 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 1.052 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -60.65 -16.46 39.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.273 -0.892 . . . . 0.0 110.78 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -70.87 -22.11 62.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.065 -1.022 . . . . 0.0 110.556 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.524 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 5.1 p-10 -132.1 3.27 4.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.106 -0.996 . . . . 0.0 110.427 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.966 ' HG ' ' HB1' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -92.27 -39.42 11.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.235 -0.916 . . . . 0.0 109.972 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 1.102 ' CG1' HD13 ' A' ' 38' ' ' ILE . 97.6 t -77.11 -40.77 2.38 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.398 -0.813 . . . . 0.0 110.961 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 30' ' ' VAL . 49.3 Cg_endo -77.85 7.87 3.72 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.32 1.168 . . . . 0.0 110.55 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -121.48 -38.22 2.8 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.159 -0.963 . . . . 0.0 109.078 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.652 HD11 ' CD1' ' A' ' 150' ' ' TYR . 5.6 mt -80.2 -39.13 18.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-O 121.563 0.697 . . . . 0.0 109.271 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.72 80.01 32.67 Favored Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.572 -0.705 . . . . 0.0 109.877 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -73.13 1.14 6.95 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.101 1.579 . . . . 0.0 110.83 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -87.97 -17.44 31.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.139 -0.976 . . . . 0.0 109.919 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -101.19 -56.44 2.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.394 -0.816 . . . . 0.0 110.038 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 1.102 HD13 ' CG1' ' A' ' 30' ' ' VAL . 1.3 mp -107.39 145.53 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.467 -0.771 . . . . 0.0 109.914 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -112.6 -23.46 10.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.891 . . . . 0.0 110.586 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.466 ' O ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -163.02 158.2 21.83 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.097 -1.002 . . . . 0.0 110.223 -179.788 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.8 m -140.87 124.5 16.91 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.295 -0.878 . . . . 0.0 109.917 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 60.3 tt0 -137.56 108.22 6.6 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.107 -0.996 . . . . 0.0 110.452 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.468 HG21 ' HA ' ' A' ' 47' ' ' ASP . 13.6 mt -54.84 131.44 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.191 -0.943 . . . . 0.0 110.008 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.525 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 20.3 mt -97.5 -34.86 10.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.921 . . . . 0.0 110.616 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.722 ' CD1' HD12 ' A' ' 53' ' ' ILE . 1.9 m95 -123.03 161.79 23.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.248 -0.907 . . . . 0.0 110.73 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.45 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 40.18 -133.57 2.39 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.468 ' HA ' HG21 ' A' ' 43' ' ' ILE . 0.5 OUTLIER -157.68 20.14 0.27 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.384 -1.068 . . . . 0.0 110.069 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.457 ' O ' HG21 ' A' ' 71' ' ' ILE . . . 128.57 -21.72 5.34 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.468 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -65.73 -175.91 6.01 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.405 ' HA ' HG22 ' A' ' 71' ' ' ILE . 46.1 Cg_endo -73.23 128.69 13.18 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 124.032 1.543 . . . . 0.0 110.559 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.19 -14.33 55.2 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.643 -1.783 . . . . 0.0 108.643 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.523 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -67.86 164.07 20.53 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.565 -0.962 . . . . 0.0 109.789 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.722 HD12 ' CD1' ' A' ' 45' ' ' TRP . 59.9 mt -131.95 121.59 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.398 -0.813 . . . . 0.0 109.467 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.553 ' NZ ' HD11 ' A' ' 71' ' ' ILE . 66.9 mttt -106.01 135.81 46.79 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.144 -0.972 . . . . 0.0 110.317 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.525 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 21.1 tttp -104.73 89.6 3.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.353 -0.842 . . . . 0.0 110.01 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.542 ' CG2' HG12 ' A' ' 38' ' ' ILE . 61.8 mt -79.91 138.69 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 109.867 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 1.4 p -116.49 152.94 33.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.908 . . . . 0.0 110.589 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.574 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 18.7 m-85 -115.27 169.82 8.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.435 -0.791 . . . . 0.0 110.012 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -136.05 29.93 2.78 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -54.08 -23.52 14.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.277 -1.131 . . . . 0.0 110.302 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -176.38 -166.87 34.28 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.2 p -64.58 -45.71 85.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.248 -1.148 . . . . 0.0 110.172 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -46.89 135.53 9.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 0.0 110.149 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.467 ' CD2' ' CD2' ' A' ' 66' ' ' TYR . 1.5 t80 -69.45 122.1 18.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 0.0 110.254 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.574 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -129.6 99.95 0.48 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.488 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 25.8 p90 -140.33 171.69 13.79 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -1.139 . . . . 0.0 110.304 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.874 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.8 m -141.08 173.81 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.335 -0.853 . . . . 0.0 110.563 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.516 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 23.2 mttt -123.2 127.31 48.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.499 -0.751 . . . . 0.0 109.625 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.624 ' CE1' HD13 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -113.74 126.52 55.31 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.102 -0.999 . . . . 0.0 111.049 -179.267 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 52' ' ' THR . 64.8 tttt -104.22 106.63 17.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.326 -0.859 . . . . 0.0 109.533 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.553 HD11 ' NZ ' ' A' ' 54' ' ' LYS . 31.1 mm -49.8 136.02 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.191 -0.943 . . . . 0.0 110.38 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.456 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 8.3 t0 -111.76 -39.86 4.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.359 -0.838 . . . . 0.0 109.55 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.461 ' OG ' ' HB2' ' A' ' 82' ' ' SER . 53.4 p -168.42 160.44 11.2 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.464 -0.773 . . . . 0.0 109.617 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 73' ' ' SER . 1.5 mt -147.52 154.9 10.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.192 -0.942 . . . . 0.0 110.292 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.553 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 4.7 m-20 -135.66 79.09 1.76 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.213 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.506 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 63.5 mttt -63.02 -12.82 28.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.153 -0.967 . . . . 0.0 110.066 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -95.61 -31.78 13.12 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.31 -0.869 . . . . 0.0 109.497 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.5 m120 -106.01 -5.86 19.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.593 -0.692 . . . . 0.0 109.673 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.598 ' O ' HD12 ' A' ' 104' ' ' LEU . 4.6 m-85 66.34 50.22 1.34 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.555 -0.716 . . . . 0.0 110.42 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.553 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -120.42 150.32 40.97 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.241 -0.912 . . . . 0.0 109.227 179.379 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.739 ' CE1' HG13 ' A' ' 23' ' ' VAL . 19.9 t80 -139.09 134.29 32.72 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.14 -0.975 . . . . 0.0 110.299 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.461 ' HB2' ' OG ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -140.6 120.22 13.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.272 -0.892 . . . . 0.0 110.695 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.629 ' CE2' ' CB ' ' A' ' 100' ' ' TYR . 19.5 p90 -138.0 170.97 15.11 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 110.246 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.643 HG23 ' O ' ' A' ' 98' ' ' ILE . 86.7 m -121.64 130.83 53.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.412 -0.805 . . . . 0.0 109.802 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.624 HD13 ' CE1' ' A' ' 69' ' ' HIS . 5.2 tp -95.32 137.88 33.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.091 -1.006 . . . . 0.0 110.124 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.437 HG12 ' HB2' ' A' ' 68' ' ' LYS . 15.1 pt -120.41 -15.04 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.322 -0.862 . . . . 0.0 110.389 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.538 ' O ' HD11 ' A' ' 85' ' ' LEU . 25.3 tt0 -129.37 158.64 38.58 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.134 -0.978 . . . . 0.0 110.262 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.874 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 151.16 115.76 0.7 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -50.44 -20.97 1.27 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.251 -1.146 . . . . 0.0 110.345 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.811 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -72.77 -18.75 61.46 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.19 -0.943 . . . . 0.0 110.41 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 95' ' ' LEU . 74.9 mt -69.33 -7.79 40.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.167 -0.958 . . . . 0.0 110.185 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 46.75 -171.8 0.03 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.439 ' OD1' HG23 ' A' ' 94' ' ' THR . 49.8 p-10 -91.64 34.68 0.97 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.214 -1.168 . . . . 0.0 109.675 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.439 HG23 ' OD1' ' A' ' 93' ' ' ASP . 7.1 p -131.31 -41.64 1.09 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.441 -0.787 . . . . 0.0 110.397 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.696 HD22 HG22 ' A' ' 122' ' ' THR . 3.1 mm? -79.91 157.02 27.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.906 . . . . 0.0 110.352 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.496 ' HG3' ' HB2' ' A' ' 123' ' ' LYS . 48.0 mm-40 -141.08 -80.9 0.25 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.326 -0.859 . . . . 0.0 109.631 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.527 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 36.8 mttp -80.31 126.53 31.27 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.484 -0.76 . . . . 0.0 110.318 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.707 HG21 ' CE2' ' A' ' 100' ' ' TYR . 5.7 mm -116.58 138.93 45.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 120.586 -1.321 . . . . 0.0 109.621 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.483 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -114.76 130.12 56.8 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.465 179.219 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.707 ' CE2' HG21 ' A' ' 98' ' ' ILE . 9.3 m-85 -125.36 134.01 52.34 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.42 -0.8 . . . . 0.0 110.032 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.478 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 78.0 tt0 -136.56 136.12 39.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 0.0 110.478 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.453 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 91.8 m -136.73 137.8 40.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.287 -0.883 . . . . 0.0 109.762 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -135.37 145.56 47.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.063 -1.023 . . . . 0.0 110.49 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.657 HD23 HG12 ' A' ' 114' ' ' ILE . 6.2 mt -126.43 151.79 47.26 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.33 -0.856 . . . . 0.0 110.067 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.708 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -150.97 -169.23 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.247 -0.908 . . . . 0.0 110.247 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.708 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -120.49 151.14 39.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.336 -0.852 . . . . 0.0 110.265 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.473 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 6.1 p -105.08 167.9 9.16 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 110.164 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.3 Cg_endo -72.7 -13.25 27.04 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.059 1.557 . . . . 0.0 110.438 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 74.1 m -97.02 12.45 32.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.184 -0.947 . . . . 0.0 110.252 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 92.29 -32.82 5.24 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -60.36 -175.0 1.11 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 28.8 p -130.57 135.36 47.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -1.16 . . . . 0.0 110.376 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.864 ' HA ' HG22 ' A' ' 10' ' ' THR . 11.0 mt -88.33 151.31 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.294 -0.879 . . . . 0.0 110.065 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.657 HG12 HD23 ' A' ' 104' ' ' LEU . 11.9 mt -131.49 116.67 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -0.936 . . . . 0.0 110.35 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.8 tttm -108.61 124.14 50.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.164 -0.96 . . . . 0.0 109.892 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.7 t -120.46 162.06 20.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.237 -0.914 . . . . 0.0 110.397 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.478 ' HB ' ' HB3' ' A' ' 101' ' ' GLU . 37.5 m -160.02 151.97 20.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.373 -0.829 . . . . 0.0 109.932 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 7.5 m -148.35 157.1 43.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.205 -0.935 . . . . 0.0 110.275 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.814 ' CE1' HG23 ' A' ' 4' ' ' THR . 68.4 m-70 -141.54 162.05 36.42 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.195 -0.94 . . . . 0.0 110.536 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.502 ' N ' ' CD1' ' A' ' 120' ' ' TYR . 11.1 m-85 -127.68 152.36 47.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.358 -0.839 . . . . 0.0 110.302 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.527 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 75.6 m80 -134.99 86.69 2.27 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.201 -0.937 . . . . 0.0 109.518 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.696 HG22 HD22 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -70.79 146.75 49.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.397 -0.814 . . . . 0.0 110.74 -179.341 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.496 ' HB2' ' HG3' ' A' ' 96' ' ' GLU . 2.0 ttpt -92.83 119.1 31.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.373 -0.83 . . . . 0.0 110.057 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 105.58 -125.32 8.2 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -137.43 61.61 1.61 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.328 -1.101 . . . . 0.0 110.231 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.503 HG23 ' CG2' ' A' ' 122' ' ' THR . 35.5 m -124.28 179.32 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.246 -0.909 . . . . 0.0 110.08 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -140.52 158.53 43.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.177 -0.952 . . . . 0.0 110.345 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.683 HD12 ' H ' ' A' ' 128' ' ' ILE . 5.1 mp -78.23 172.98 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.247 -0.908 . . . . 0.0 110.183 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.605 ' N ' HG22 ' A' ' 128' ' ' ILE . 7.3 mttp -107.02 128.02 53.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.363 -0.835 . . . . 0.0 109.888 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.475 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 91.8 mt-10 -42.77 -53.45 4.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.214 -0.928 . . . . 0.0 110.244 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 51.1 tt0 -47.52 -26.19 1.33 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.188 -0.945 . . . . 0.0 109.912 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.811 ' NE2' ' HB1' ' A' ' 90' ' ' ALA . 11.3 t-160 -85.37 -62.39 1.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.297 -0.877 . . . . 0.0 110.137 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 1.085 HG21 ' CE2' ' A' ' 5' ' ' TYR . 7.7 p -62.36 -41.0 89.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.378 -0.826 . . . . 0.0 109.962 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.554 ' N ' HG13 ' A' ' 133' ' ' VAL . 27.6 tttp -64.8 -44.14 90.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.337 -0.852 . . . . 0.0 109.89 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 131' ' ' GLU . . . -63.86 -32.8 74.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.374 -0.829 . . . . 0.0 109.913 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -64.9 -31.86 82.33 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -60.53 -32.66 71.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.273 -1.133 . . . . 0.0 109.955 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 142' ' ' ASN . 99.0 mt-10 -83.6 -33.35 25.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.38 -0.825 . . . . 0.0 109.878 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 24.3 mttt -68.86 -35.06 76.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.34 -0.85 . . . . 0.0 109.881 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.427 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -86.18 -40.89 15.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.297 -0.877 . . . . 0.0 109.934 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.1 m -67.55 -53.45 28.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.419 -0.801 . . . . 0.0 109.846 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 138' ' ' GLU . 98.8 m-20 -49.43 -47.47 48.02 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.226 -0.921 . . . . 0.0 109.924 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.427 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 9.3 tp -55.6 -48.16 75.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.281 -0.887 . . . . 0.0 109.882 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.565 ' CE1' ' CE2' ' A' ' 22' ' ' PHE . 13.6 m-85 -53.31 -36.13 60.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.444 -0.785 . . . . 0.0 109.843 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -74.56 -16.51 60.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.359 -0.838 . . . . 0.0 109.862 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 146' ' ' LEU . 24.0 mt -84.41 -35.63 22.97 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.281 -0.887 . . . . 0.0 109.01 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 1.057 ' CG2' HD23 ' A' ' 18' ' ' LEU . 24.7 mt -68.26 -41.61 83.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.484 ' CG ' ' OG ' ' A' ' 11' ' ' SER . 97.2 mt-10 -48.36 -40.98 27.3 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.158 -0.964 . . . . 0.0 108.794 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.418 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 19.5 m -72.05 -26.74 62.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.28 -0.887 . . . . 0.0 109.351 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.652 ' CD1' HD11 ' A' ' 33' ' ' ILE . 62.7 t80 -57.89 -52.2 66.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.535 -0.728 . . . . 0.0 109.883 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.943 HD21 ' CE1' ' A' ' 158' ' ' TYR . 64.7 mt -80.01 -36.42 35.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.285 -0.884 . . . . 0.0 110.362 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.832 ' HB2' HD11 ' A' ' 13' ' ' ILE . 35.8 tttt -60.05 -19.69 54.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.163 -0.961 . . . . 0.0 109.236 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.48 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -111.1 -32.22 2.66 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.407 ' ND1' ' N ' ' A' ' 154' ' ' HIS . 2.4 m80 -105.97 93.0 7.04 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.324 -1.103 . . . . 0.0 110.039 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.503 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 46.6 Cg_endo -72.94 3.66 4.29 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.018 1.536 . . . . 0.0 110.96 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -114.19 -10.29 12.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.085 -1.009 . . . . 0.0 109.899 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.801 ' HB3' HH21 ' A' ' 17' ' ' ARG . . . -46.92 108.74 0.15 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.333 -0.855 . . . . 0.0 110.053 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 1.129 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 35.46 30.83 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.719 -0.613 . . . . 0.0 110.515 -179.624 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.525 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.701 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.816 HG22 ' CD2' ' A' ' 121' ' ' HIS . 63.6 t -122.93 122.53 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.191 -1.182 . . . . 0.0 110.264 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.579 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 43.1 m-85 -80.2 154.16 28.12 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.28 -0.887 . . . . 0.0 110.302 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.889 HG23 ' CE1' ' A' ' 119' ' ' HIS . 56.5 m -138.35 94.47 2.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.882 . . . . 0.0 110.1 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.592 ' CD1' HG23 ' A' ' 133' ' ' VAL . 75.1 m-85 -116.15 136.41 53.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.889 . . . . 0.0 110.026 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 116' ' ' SER . 21.5 pt-20 -135.92 151.91 50.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.202 -0.936 . . . . 0.0 110.404 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.3 m -121.38 157.83 29.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.337 -0.852 . . . . 0.0 109.92 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -135.44 121.11 19.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.115 -0.99 . . . . 0.0 110.386 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.638 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.9 p90 -146.03 -174.12 4.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.347 -0.846 . . . . 0.0 109.948 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.866 HG22 ' HA ' ' A' ' 113' ' ' ILE . 5.7 p -141.43 173.03 11.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.201 -0.937 . . . . 0.0 110.627 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.479 ' CB ' ' CD ' ' A' ' 148' ' ' GLU . 97.6 p -156.68 135.04 11.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.399 -0.813 . . . . 0.0 110.2 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -62.05 -31.02 71.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.211 -0.931 . . . . 0.0 110.134 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.873 HD11 ' HB2' ' A' ' 152' ' ' LYS . 2.3 mp -64.55 150.62 93.43 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.869 . . . . 0.0 109.944 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.818 ' HD2' HG23 ' A' ' 13' ' ' ILE . 42.0 Cg_endo -68.32 143.15 57.3 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.044 1.549 . . . . 0.0 110.771 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.669 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.5 Cg_endo -72.25 -30.92 12.42 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 O-C-N 124.042 1.549 . . . . 0.0 112.737 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.669 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.1 Cg_endo -69.53 -22.71 32.75 Favored 'Trans proline' 0 N--CA 1.485 0.988 0 N-CA-C 110.07 -0.781 . . . . 0.0 110.07 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.61 ' NH2' ' HB3' ' A' ' 157' ' ' ALA . 42.2 mtp180 -83.5 -42.89 16.37 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 1.039 HD23 HG21 ' A' ' 147' ' ' ILE . 0.3 OUTLIER -71.33 -32.69 68.87 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 178.833 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.581 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 81.4 t80 -63.02 -61.63 2.26 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.538 -0.726 . . . . 0.0 109.577 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.76 ' HG2' HD22 ' A' ' 24' ' ' LEU . 14.9 mttp -53.61 -32.88 53.0 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.383 -0.823 . . . . 0.0 109.351 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.005 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -74.26 -47.45 35.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.363 -0.836 . . . . 0.0 110.568 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 1.049 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -66.67 -46.76 74.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.542 -0.724 . . . . 0.0 111.215 -179.141 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 1.105 HG11 ' CD1' ' A' ' 74' ' ' ILE . 6.1 t -97.45 -60.3 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.109 -0.995 . . . . 0.0 111.914 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.76 HD22 ' HG2' ' A' ' 20' ' ' LYS . 8.5 mp -69.5 -0.19 6.23 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.16 -0.962 . . . . 0.0 111.824 -178.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.548 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -146.16 10.95 1.17 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.692 -1.255 . . . . 0.0 110.811 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 1.049 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -53.38 -19.02 3.0 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.164 -0.96 . . . . 0.0 110.863 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -80.01 -26.87 39.65 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.005 -1.059 . . . . 0.0 110.573 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -127.12 13.05 7.21 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.255 -0.903 . . . . 0.0 110.337 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.765 ' HG ' ' HB1' ' A' ' 21' ' ' ALA . 0.8 OUTLIER -103.9 -45.29 4.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.105 -0.997 . . . . 0.0 110.259 179.921 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.952 HG11 HD13 ' A' ' 38' ' ' ILE . 3.1 t -64.77 -41.83 59.22 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.326 -0.858 . . . . 0.0 110.556 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.0 Cg_endo -78.79 8.87 3.51 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.442 1.233 . . . . 0.0 110.628 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -118.64 -25.47 6.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.153 -0.967 . . . . 0.0 109.263 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.75 HD11 HD11 ' A' ' 29' ' ' LEU . 20.1 mt -80.01 -57.42 5.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 121.612 0.72 . . . . 0.0 109.427 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.422 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . . . -145.06 105.55 4.46 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.541 -0.724 . . . . 0.0 109.818 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 34' ' ' ALA . 44.2 Cg_endo -70.66 -0.77 8.18 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 124.042 1.549 . . . . 0.0 110.824 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -82.87 -10.42 58.84 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.075 -1.016 . . . . 0.0 109.645 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -101.93 -63.31 1.16 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.334 -0.853 . . . . 0.0 110.121 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.952 HD13 HG11 ' A' ' 30' ' ' VAL . 1.3 mp -113.09 154.2 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.446 -0.784 . . . . 0.0 109.985 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.544 ' HG2' ' N ' ' A' ' 59' ' ' GLY . 66.5 mmtt -114.16 -27.5 7.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 0.0 110.457 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.469 ' O ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -159.32 151.72 21.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.955 . . . . 0.0 110.179 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.1 m -138.13 120.71 16.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.393 -0.817 . . . . 0.0 109.677 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -134.09 109.97 9.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.157 -0.964 . . . . 0.0 110.785 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 29.9 mt -55.71 133.81 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.312 -0.868 . . . . 0.0 109.794 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 13.3 tp -105.28 -23.45 12.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.248 -0.908 . . . . 0.0 110.823 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.756 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.8 m95 -129.58 159.37 36.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.043 -1.036 . . . . 0.0 110.855 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.456 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 41.91 -136.23 3.12 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -151.25 21.54 0.75 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.307 -1.114 . . . . 0.0 110.068 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.498 ' O ' HG21 ' A' ' 71' ' ' ILE . . . 122.89 -20.96 7.58 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.517 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -67.8 -173.41 7.03 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -72.81 128.86 13.72 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.071 1.564 . . . . 0.0 110.517 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.45 -13.46 51.13 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 45' ' ' TRP . 1.0 OUTLIER -72.11 165.24 24.73 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.548 -0.972 . . . . 0.0 109.596 179.54 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.756 HD12 ' CG ' ' A' ' 45' ' ' TRP . 63.0 mt -135.35 120.57 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.333 -0.855 . . . . 0.0 109.697 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.665 ' CE ' HD11 ' A' ' 71' ' ' ILE . 39.3 mttm -103.53 128.6 50.72 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.208 -0.932 . . . . 0.0 110.27 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 54.9 tttt -97.6 91.65 5.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.197 -0.939 . . . . 0.0 109.874 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.556 ' CG2' HG12 ' A' ' 38' ' ' ILE . 89.4 mt -79.98 141.6 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.299 -0.876 . . . . 0.0 110.049 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.771 HG22 ' HB3' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -120.12 147.33 45.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 110.471 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.591 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 14.1 m-85 -114.21 162.27 16.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.325 -0.859 . . . . 0.0 110.003 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.544 ' N ' ' HG2' ' A' ' 39' ' ' LYS . . . -110.61 8.71 30.23 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -120.5 179.01 4.45 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.229 -1.159 . . . . 0.0 110.223 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 62' ' ' SER . . . 74.54 -165.58 54.77 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 61' ' ' GLY . 13.2 m -46.67 174.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -1.143 . . . . 0.0 110.239 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' A' ' 62' ' ' SER . 86.8 mt-30 -43.48 -84.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.921 . . . . 0.0 110.156 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.576 ' O ' ' CD1' ' A' ' 64' ' ' TYR . 2.3 p90 -80.93 131.16 35.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.344 -0.847 . . . . 0.0 110.208 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.591 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -142.48 85.79 0.19 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.771 ' HB3' HG22 ' A' ' 57' ' ' THR . 13.6 p90 -132.74 171.97 13.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.293 -1.122 . . . . 0.0 110.251 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.789 HG12 ' HA2' ' A' ' 88' ' ' GLY . 4.4 m -140.21 176.9 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.917 . . . . 0.0 110.477 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.642 ' O ' HD12 ' A' ' 85' ' ' LEU . 82.3 mttt -133.03 102.9 5.78 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.426 -0.796 . . . . 0.0 109.746 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.979 ' CD2' HD13 ' A' ' 85' ' ' LEU . 15.1 m170 -95.65 127.73 41.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.24 -0.912 . . . . 0.0 111.061 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.536 ' HA ' ' O ' ' A' ' 52' ' ' THR . 17.1 tttt -96.59 114.84 26.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 109.436 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.665 HD11 ' CE ' ' A' ' 54' ' ' LYS . 37.0 mm -52.81 132.07 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.142 -0.974 . . . . 0.0 110.347 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.539 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 23.5 t0 -105.21 -46.86 4.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.487 -0.758 . . . . 0.0 109.982 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.452 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 77.5 p -177.68 160.93 1.61 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.466 -0.771 . . . . 0.0 110.376 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 1.105 ' CD1' HG11 ' A' ' 23' ' ' VAL . 6.6 tt -153.24 170.06 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.375 -0.828 . . . . 0.0 109.703 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.5 m-20 -142.19 84.35 1.87 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.079 -1.013 . . . . 0.0 110.395 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.581 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 18.7 tttm -58.93 -14.26 8.67 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.12 -0.988 . . . . 0.0 110.273 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -92.82 -34.33 13.9 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.349 -0.845 . . . . 0.0 109.517 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.505 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 3.7 m120 -102.71 -3.75 26.04 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.655 0.74 . . . . 0.0 109.267 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.647 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 76.1 m-85 62.39 55.48 2.3 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.338 0.589 . . . . 0.0 110.873 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.489 ' HB3' ' HG3' ' A' ' 103' ' ' LYS . 0.7 OUTLIER -131.09 153.87 48.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.449 -0.782 . . . . 0.0 109.523 179.124 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.614 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 76.0 t80 -151.99 149.48 28.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.183 -0.948 . . . . 0.0 110.352 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.482 ' HB2' ' HA ' ' A' ' 101' ' ' GLU . 13.5 t -157.63 151.14 23.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.249 -0.907 . . . . 0.0 110.386 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.614 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 7.2 p90 -152.18 177.03 10.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.441 -0.787 . . . . 0.0 110.734 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.717 HG23 ' O ' ' A' ' 98' ' ' ILE . 42.0 m -127.38 125.85 41.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.547 -0.721 . . . . 0.0 109.735 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.979 HD13 ' CD2' ' A' ' 69' ' ' HIS . 11.2 tp -95.77 133.63 39.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.006 -1.059 . . . . 0.0 110.407 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.555 ' N ' HD12 ' A' ' 85' ' ' LEU . 10.3 pt -111.53 -34.7 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.238 -0.914 . . . . 0.0 110.408 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.76 ' O ' HD11 ' A' ' 85' ' ' LEU . 76.9 tt0 -115.16 153.27 31.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.326 -0.859 . . . . 0.0 110.18 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.789 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 161.19 127.72 0.9 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -57.54 -20.29 30.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.271 -1.135 . . . . 0.0 110.095 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.83 -19.78 54.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.318 -0.864 . . . . 0.0 110.171 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.622 HD12 ' N ' ' A' ' 88' ' ' GLY . 55.1 mt -67.58 -28.21 67.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.931 . . . . 0.0 110.19 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 49.18 -178.09 0.02 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -81.99 8.23 11.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -1.166 . . . . 0.0 110.166 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.511 ' O ' HG22 ' A' ' 122' ' ' THR . 33.6 p -98.64 -32.71 11.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.206 -0.934 . . . . 0.0 110.144 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.935 HD21 ' CD1' ' A' ' 128' ' ' ILE . 76.5 mt -108.62 158.13 17.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.43 -0.793 . . . . 0.0 110.128 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.1 tp10 -139.35 -79.93 0.31 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.168 -0.957 . . . . 0.0 110.196 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.486 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 29.3 mttp -80.15 127.46 32.35 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.542 -0.724 . . . . 0.0 110.555 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.717 ' O ' HG23 ' A' ' 84' ' ' THR . 6.0 mm -117.83 142.78 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.885 -1.134 . . . . 0.0 110.027 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.473 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -123.64 133.67 53.89 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.409 -0.807 . . . . 0.0 109.112 178.859 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.641 ' HE2' HG21 ' A' ' 98' ' ' ILE . 6.8 m-85 -128.03 131.39 49.17 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.164 -0.96 . . . . 0.0 110.541 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.482 ' HA ' ' HB2' ' A' ' 82' ' ' SER . 85.1 tt0 -135.51 139.4 43.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.277 -0.889 . . . . 0.0 110.066 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.472 ' N ' ' O ' ' A' ' 81' ' ' TYR . 85.7 m -141.52 149.14 40.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 110.217 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.489 ' HG3' ' HB3' ' A' ' 80' ' ' SER . 0.0 OUTLIER -142.32 140.71 32.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.262 -0.899 . . . . 0.0 110.39 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.741 HD23 HG12 ' A' ' 114' ' ' ILE . 2.9 mt -115.37 155.68 26.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 110.063 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.707 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -151.48 -169.49 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.093 -1.005 . . . . 0.0 110.217 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.707 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -123.88 154.4 39.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.411 -0.806 . . . . 0.0 110.247 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.446 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.4 p -113.02 170.96 4.72 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.23 -0.919 . . . . 0.0 110.233 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.3 Cg_endo -72.11 -14.58 28.93 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.048 1.552 . . . . 0.0 110.553 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.2 p -97.82 11.41 37.35 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.224 -0.923 . . . . 0.0 110.174 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 91.92 -31.07 6.13 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -56.64 -172.57 0.17 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.513 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 1.1 p -136.46 135.95 39.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.168 -1.195 . . . . 0.0 110.277 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.866 ' HA ' HG22 ' A' ' 10' ' ' THR . 17.0 mt -89.23 149.47 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.33 -0.856 . . . . 0.0 110.024 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.741 HG12 HD23 ' A' ' 104' ' ' LEU . 23.3 mt -131.29 118.28 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 110.393 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 103' ' ' LYS . 72.2 tttt -105.8 120.75 42.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.945 . . . . 0.0 109.97 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 0.4 OUTLIER -113.04 151.68 30.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.234 -0.916 . . . . 0.0 110.528 -179.719 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.457 ' HB ' ' HB3' ' A' ' 101' ' ' GLU . 81.8 m -154.37 124.31 6.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.373 -0.829 . . . . 0.0 110.252 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.537 ' OG ' ' CE1' ' A' ' 100' ' ' TYR . 2.1 t -125.81 163.14 23.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 110.094 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.889 ' CE1' HG23 ' A' ' 4' ' ' THR . 71.0 m-70 -138.94 154.35 48.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -0.911 . . . . 0.0 110.177 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.531 ' HD1' HD12 ' A' ' 98' ' ' ILE . 21.4 m-85 -124.99 135.94 53.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.896 . . . . 0.0 110.44 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.816 ' CD2' HG22 ' A' ' 2' ' ' VAL . 77.0 m80 -118.79 93.45 4.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.138 -0.976 . . . . 0.0 109.763 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.864 ' CG2' HD23 ' A' ' 95' ' ' LEU . 1.7 p -75.06 155.87 36.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.3 -0.875 . . . . 0.0 110.435 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.4 ttpt -107.94 100.93 10.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.344 -0.847 . . . . 0.0 110.157 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 121.4 -135.91 10.85 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -120.39 67.28 0.84 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.194 -1.18 . . . . 0.0 110.193 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.508 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 32.4 m -135.41 155.66 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.246 -0.909 . . . . 0.0 110.199 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.407 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 92.8 mt-10 -118.78 179.07 4.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.23 -0.919 . . . . 0.0 110.234 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.935 ' CD1' HD21 ' A' ' 95' ' ' LEU . 16.5 mm -80.18 172.69 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.276 -0.89 . . . . 0.0 110.227 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.588 ' N ' HG22 ' A' ' 128' ' ' ILE . 61.9 mttt -96.13 130.61 43.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 109.908 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.469 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 94.7 mt-10 -45.41 -35.17 3.5 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.232 -0.918 . . . . 0.0 110.207 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 1.001 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 59.2 tt0 -68.25 -21.9 64.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.203 -0.935 . . . . 0.0 110.005 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.458 ' N ' ' O ' ' A' ' 129' ' ' LYS . 13.4 t-160 -87.86 -49.41 7.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.247 -0.908 . . . . 0.0 110.176 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.592 HG23 ' CD1' ' A' ' 5' ' ' TYR . 2.6 p -69.47 -28.75 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.454 -0.779 . . . . 0.0 110.132 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -104.95 -69.74 0.8 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.181 -0.949 . . . . 0.0 110.089 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 1.001 ' HB3' ' O ' ' A' ' 131' ' ' GLU . . . -56.56 -19.63 16.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.193 -0.942 . . . . 0.0 109.811 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 132' ' ' HIS . . . -76.21 -30.23 57.36 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.465 ' CE ' ' O ' ' A' ' 133' ' ' VAL . 25.0 mttt -66.68 -30.91 71.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -1.159 . . . . 0.0 110.025 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -81.46 -29.58 33.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.259 -0.9 . . . . 0.0 110.008 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 18.7 mtpp -70.38 -45.99 64.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.9 . . . . 0.0 110.005 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -71.75 -33.28 68.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.318 -0.864 . . . . 0.0 110.067 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.9 t -58.84 -46.27 88.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.354 -0.842 . . . . 0.0 110.001 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -53.02 -43.38 66.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.242 -0.911 . . . . 0.0 109.985 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.622 ' HA ' HD12 ' A' ' 146' ' ' LEU . 14.1 tp -57.3 -50.13 73.9 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.348 -0.845 . . . . 0.0 109.911 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -54.02 -40.1 66.74 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.357 -0.839 . . . . 0.0 109.685 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -73.12 -15.12 61.49 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.295 -0.878 . . . . 0.0 110.089 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.622 HD12 ' HA ' ' A' ' 143' ' ' LEU . 29.9 mt -82.03 -35.4 28.84 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.152 -0.967 . . . . 0.0 108.86 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 1.039 HG21 HD23 ' A' ' 18' ' ' LEU . 23.5 mt -67.96 -47.49 78.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.759 ' HB3' HD13 ' A' ' 13' ' ' ILE . 77.6 mt-10 -47.85 -45.14 29.83 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.334 -0.854 . . . . 0.0 108.822 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.541 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 94.3 m -62.04 -39.58 92.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.269 -0.894 . . . . 0.0 109.313 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.695 ' CE2' HD21 ' A' ' 29' ' ' LEU . 57.5 t80 -47.08 -51.34 17.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.498 -0.751 . . . . 0.0 109.837 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.989 HD21 ' CE1' ' A' ' 158' ' ' TYR . 68.6 mt -80.11 -34.77 37.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.434 -0.792 . . . . 0.0 110.418 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.873 ' HB2' HD11 ' A' ' 13' ' ' ILE . 37.2 tttm -60.72 -14.81 23.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 109.18 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.494 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -120.12 -27.3 2.07 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.429 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 6.1 m80 -106.12 92.58 6.78 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.134 -1.215 . . . . 0.0 110.279 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.498 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 48.3 Cg_endo -73.86 2.23 6.2 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.035 1.545 . . . . 0.0 110.7 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -113.95 -5.14 13.18 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.064 -1.022 . . . . 0.0 110.019 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.61 ' HB3' ' NH2' ' A' ' 17' ' ' ARG . . . -57.78 108.32 0.56 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 109.957 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 1.005 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 0.3 OUTLIER 35.31 31.45 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.702 -0.624 . . . . 0.0 110.689 -179.748 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.539 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.901 -1.047 . . . . 0.0 109.78 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 60.3 t -114.2 126.69 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.232 -1.158 . . . . 0.0 110.274 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.574 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 41.8 m-85 -81.36 158.51 24.66 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.208 -0.932 . . . . 0.0 110.428 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.705 HG23 ' CE1' ' A' ' 119' ' ' HIS . 91.8 m -141.97 94.2 2.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.318 -0.864 . . . . 0.0 109.928 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.628 ' CE1' ' CG2' ' A' ' 133' ' ' VAL . 75.9 m-85 -116.04 138.04 51.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.193 -0.942 . . . . 0.0 110.069 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 116' ' ' SER . 12.5 pt-20 -140.05 154.29 47.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.239 -0.913 . . . . 0.0 110.41 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.7 m -135.64 135.94 40.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.311 -0.868 . . . . 0.0 109.805 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.49 ' HG3' ' HG3' ' A' ' 115' ' ' LYS . 5.5 tt0 -114.42 140.6 48.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.133 -0.979 . . . . 0.0 110.766 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.588 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 4.1 p90 -157.4 -172.73 4.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.541 -0.724 . . . . 0.0 109.581 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.825 HG22 ' HA ' ' A' ' 113' ' ' ILE . 8.8 p -140.0 173.13 11.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.091 -1.006 . . . . 0.0 110.6 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.439 ' HB2' ' CD ' ' A' ' 148' ' ' GLU . 86.0 p -156.04 134.68 11.74 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.44 -0.787 . . . . 0.0 110.094 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -59.73 -39.22 83.96 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.156 -0.965 . . . . 0.0 110.189 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.914 HD11 ' HB2' ' A' ' 152' ' ' LYS . 2.5 mp -59.94 150.62 68.47 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.432 -0.793 . . . . 0.0 109.892 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.811 ' HD2' HG23 ' A' ' 13' ' ' ILE . 41.5 Cg_endo -67.53 142.04 57.71 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.041 1.548 . . . . 0.0 110.559 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.658 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.0 Cg_endo -72.15 -31.08 12.5 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.982 1.517 . . . . 0.0 112.667 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.658 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.4 Cg_endo -70.33 -21.49 30.75 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 N-CA-C 110.086 -0.774 . . . . 0.0 110.086 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.675 ' NH2' ' HB3' ' A' ' 157' ' ' ALA . 36.3 mtp180 -82.94 -46.08 13.37 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.751 HD23 ' C ' ' A' ' 18' ' ' LEU . 0.8 OUTLIER -71.02 -32.53 69.33 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.941 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.595 ' N ' HD23 ' A' ' 18' ' ' LEU . 86.5 t80 -62.84 -59.3 5.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.555 -0.715 . . . . 0.0 109.512 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.521 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 29.5 mttt -50.99 -39.02 54.6 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.629 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.041 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -72.27 -42.53 65.46 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.451 -0.781 . . . . 0.0 110.838 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 1.05 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -72.72 -40.17 66.33 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.317 -0.865 . . . . 0.0 111.17 -178.9 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.807 HG13 ' CE1' ' A' ' 81' ' ' TYR . 4.2 t -103.52 -55.8 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.026 -1.046 . . . . 0.0 111.588 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.729 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.3 mp -79.94 -1.12 38.0 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.06 -1.025 . . . . 0.0 111.889 -178.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.567 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.9 OUTLIER -153.36 30.62 0.48 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.658 -1.276 . . . . 0.0 110.726 -179.9 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 1.05 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -74.5 -23.39 58.84 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.224 -0.922 . . . . 0.0 110.39 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.4 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 94.7 m-20 -67.58 -17.33 64.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -0.936 . . . . 0.0 110.022 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.555 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 8.6 p-10 -128.31 10.5 6.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.306 -0.871 . . . . 0.0 109.977 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.637 ' HG ' ' HB1' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -93.54 -49.8 5.72 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.336 -0.852 . . . . 0.0 110.283 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.837 HG22 ' HD3' ' A' ' 31' ' ' PRO . 2.2 m -74.96 -28.86 0.83 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.373 -0.829 . . . . 0.0 112.171 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.837 ' HD3' HG22 ' A' ' 30' ' ' VAL . 51.7 Cg_endo -78.65 5.6 5.47 Favored 'Trans proline' 0 C--N 1.319 -1.026 0 O-C-N 122.67 0.826 . . . . 0.0 110.5 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -126.91 -34.25 2.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 109.431 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.532 HD11 ' CD1' ' A' ' 29' ' ' LEU . 24.1 mt -80.01 -24.89 11.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 121.653 0.74 . . . . 0.0 109.219 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.419 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . . . -170.89 97.4 0.43 Allowed Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.637 -0.665 . . . . 0.0 109.725 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 34' ' ' ALA . 44.1 Cg_endo -69.89 -3.29 11.79 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.987 1.519 . . . . 0.0 110.664 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.448 ' HB2' ' OE2' ' A' ' 60' ' ' GLU . 12.0 pt20 -90.52 4.85 49.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 0.0 110.007 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.985 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -109.41 -45.39 3.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.321 -0.862 . . . . 0.0 110.033 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.985 HD12 ' C ' ' A' ' 37' ' ' ALA . 1.9 mp -131.47 126.6 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.371 -0.831 . . . . 0.0 110.049 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.44 ' N ' ' O ' ' A' ' 57' ' ' THR . 18.2 ttpt -78.05 -36.59 48.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.202 -0.936 . . . . 0.0 110.316 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.464 ' O ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -170.97 136.73 1.13 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.278 -0.889 . . . . 0.0 110.027 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.6 m -111.86 124.83 53.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.331 -0.856 . . . . 0.0 110.149 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -133.41 109.32 9.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.213 -0.929 . . . . 0.0 110.32 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 43' ' ' ILE . 19.6 mt -56.29 133.68 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.236 -0.915 . . . . 0.0 110.019 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.453 HD22 ' HD2' ' A' ' 55' ' ' LYS . 14.4 tp -104.69 -27.52 11.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.284 -0.885 . . . . 0.0 110.547 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.592 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.9 m95 -127.6 160.56 31.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 0.0 110.775 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.459 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 42.18 -133.94 4.06 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -156.35 19.7 0.35 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.323 -1.104 . . . . 0.0 110.108 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.91 -17.04 6.81 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.468 ' O ' ' HB ' ' A' ' 71' ' ' ILE . . . -72.27 -172.77 19.65 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.422 ' HA ' HG22 ' A' ' 71' ' ' ILE . 44.9 Cg_endo -73.53 129.1 13.33 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.008 1.53 . . . . 0.0 110.567 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.18 -12.86 55.49 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -70.65 164.57 24.7 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.537 -0.978 . . . . 0.0 109.82 179.705 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.592 HD12 ' CG ' ' A' ' 45' ' ' TRP . 52.7 mt -134.21 121.19 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.388 -0.82 . . . . 0.0 109.79 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.603 ' HE2' HD11 ' A' ' 71' ' ' ILE . 4.9 mtmp? -106.07 138.52 42.11 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.118 -0.989 . . . . 0.0 110.281 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.458 ' HG2' ' HG2' ' A' ' 68' ' ' LYS . 2.1 mtpt -109.98 89.25 2.96 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.321 -0.862 . . . . 0.0 110.15 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.553 ' CG2' HG13 ' A' ' 38' ' ' ILE . 88.9 mt -79.95 141.82 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 110.011 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.529 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 3.5 p -115.06 159.6 20.64 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.268 -0.895 . . . . 0.0 110.517 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.525 ' N ' ' O ' ' A' ' 65' ' ' GLY . 16.4 m-85 -120.29 145.65 46.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.36 -0.838 . . . . 0.0 110.154 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -98.28 11.62 63.56 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.448 ' OE2' ' HB2' ' A' ' 36' ' ' GLN . 94.0 mt-10 -128.67 156.65 43.11 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.284 -1.127 . . . . 0.0 110.165 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 62' ' ' SER . . . 99.1 -155.77 19.99 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.417 ' O ' ' O ' ' A' ' 61' ' ' GLY . 83.1 p -55.0 -169.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.164 -1.198 . . . . 0.0 110.152 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -71.55 -25.71 62.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.187 -0.945 . . . . 0.0 110.198 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -129.13 111.18 12.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.231 -0.918 . . . . 0.0 110.16 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -134.33 87.29 0.26 Allowed Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.532 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 12.5 p90 -133.15 164.08 27.84 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.169 -1.195 . . . . 0.0 110.167 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.911 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.0 m -133.17 175.31 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.358 -0.839 . . . . 0.0 110.583 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.497 ' HB2' HG12 ' A' ' 86' ' ' ILE . 85.2 mttt -129.21 127.21 40.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.523 -0.736 . . . . 0.0 109.5 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.672 ' CE1' HD13 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -115.94 120.01 37.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.138 -0.976 . . . . 0.0 111.079 -179.351 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 52' ' ' THR . 19.9 tttt -96.41 115.81 28.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 0.0 109.459 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.603 HD11 ' HE2' ' A' ' 54' ' ' LYS . 24.6 mm -61.08 129.69 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.206 -0.934 . . . . 0.0 110.491 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 82' ' ' SER . 93.8 m-20 -105.39 -42.95 5.1 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.368 -0.833 . . . . 0.0 110.204 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 35.3 m -166.9 158.65 12.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.367 -0.833 . . . . 0.0 109.946 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.518 HG12 HG11 ' A' ' 23' ' ' VAL . 1.7 mt -144.24 156.74 15.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.225 -0.922 . . . . 0.0 110.321 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.541 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 4.4 m-20 -135.13 78.8 1.75 Allowed 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.238 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.554 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 88.5 mttt -62.23 -12.98 23.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.131 -0.981 . . . . 0.0 110.062 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -95.14 -31.58 13.47 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.268 -0.895 . . . . 0.0 109.585 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.4 m120 -107.4 -4.27 18.71 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.528 -0.732 . . . . 0.0 109.725 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.679 ' O ' HD12 ' A' ' 104' ' ' LEU . 6.7 m-85 64.97 50.63 1.87 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.484 -0.76 . . . . 0.0 110.277 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.541 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -120.75 149.94 41.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.285 -0.885 . . . . 0.0 109.315 179.497 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.807 ' CE1' HG13 ' A' ' 23' ' ' VAL . 30.7 t80 -139.34 133.39 31.07 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.156 -0.965 . . . . 0.0 110.364 -179.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 19.2 m -137.06 124.92 22.59 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.29 -0.881 . . . . 0.0 110.486 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.681 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 20.5 p90 -143.24 170.76 15.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.251 -0.905 . . . . 0.0 110.396 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 98' ' ' ILE . 21.4 m -121.34 133.55 55.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.436 -0.79 . . . . 0.0 109.9 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.672 HD13 ' CE1' ' A' ' 69' ' ' HIS . 4.5 tp -100.31 126.62 46.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.826 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.497 HG12 ' HB2' ' A' ' 68' ' ' LYS . 10.6 pt -111.46 -11.95 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.201 -0.937 . . . . 0.0 110.331 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.533 ' O ' HD11 ' A' ' 85' ' ' LEU . 37.4 tp10 -128.67 167.3 17.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.183 -0.948 . . . . 0.0 110.426 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.911 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 140.99 112.84 0.98 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -48.13 -26.22 1.79 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.234 -1.157 . . . . 0.0 110.451 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.42 -19.68 65.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.197 -0.939 . . . . 0.0 110.315 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.462 ' O ' ' O ' ' A' ' 92' ' ' GLY . 64.2 mt -69.77 -31.42 69.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.143 -0.973 . . . . 0.0 110.253 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 48.65 -177.11 0.02 OUTLIER Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -79.16 3.4 17.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.19 -1.182 . . . . 0.0 110.125 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.499 HG22 ' HG ' ' A' ' 95' ' ' LEU . 1.8 m -88.46 -37.13 16.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.265 -0.897 . . . . 0.0 109.812 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.948 HD21 ' CD1' ' A' ' 128' ' ' ILE . 44.7 mt -109.72 167.19 10.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.285 -0.885 . . . . 0.0 109.936 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -147.03 -79.94 0.15 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.131 -0.981 . . . . 0.0 110.026 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.509 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 15.3 mttp -80.26 126.84 31.64 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.567 -0.708 . . . . 0.0 110.441 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.731 HG21 ' CE2' ' A' ' 100' ' ' TYR . 6.5 mm -115.37 141.65 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.775 -1.203 . . . . 0.0 109.978 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.501 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -119.09 129.7 55.21 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.433 -0.792 . . . . 0.0 108.97 178.811 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.731 ' CE2' HG21 ' A' ' 98' ' ' ILE . 10.0 m-85 -124.96 136.11 53.44 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.435 -0.791 . . . . 0.0 110.587 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -139.26 128.89 24.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.331 -0.856 . . . . 0.0 110.04 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 89.8 m -127.47 141.37 51.68 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.15 -0.969 . . . . 0.0 110.135 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 115' ' ' LYS . 2.5 mttt -136.52 139.65 42.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.932 . . . . 0.0 110.317 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.867 HD23 HG12 ' A' ' 114' ' ' ILE . 5.4 mt -123.27 152.63 41.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.237 -0.914 . . . . 0.0 110.093 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.711 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -149.72 -169.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.252 -0.905 . . . . 0.0 110.036 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.711 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -124.87 163.14 22.86 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.348 -0.845 . . . . 0.0 110.204 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.458 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 3.0 p -121.73 169.21 9.67 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.0 110.296 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 47.3 Cg_endo -73.03 -8.76 22.68 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.066 1.561 . . . . 0.0 110.606 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 79.8 p -102.77 9.8 38.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.187 -0.946 . . . . 0.0 110.376 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 111' ' ' GLY . . . 94.2 -36.91 3.56 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 110' ' ' GLY . . . -54.45 -174.5 0.09 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.501 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 13.9 p -135.51 136.61 41.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.161 -1.199 . . . . 0.0 110.372 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.825 ' HA ' HG22 ' A' ' 10' ' ' THR . 21.1 mt -90.38 147.08 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.324 -0.86 . . . . 0.0 110.151 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.867 HG12 HD23 ' A' ' 104' ' ' LEU . 19.3 mt -131.46 127.28 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.208 -0.933 . . . . 0.0 110.443 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.49 ' HG3' ' HG3' ' A' ' 8' ' ' GLU . 44.4 tttp -116.23 120.15 38.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.274 -0.891 . . . . 0.0 109.902 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 2.3 t -114.28 158.7 21.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.144 -0.972 . . . . 0.0 110.56 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.625 HG22 ' NE2' ' A' ' 119' ' ' HIS . 96.6 m -158.77 122.2 3.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.433 -0.792 . . . . 0.0 109.919 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.6 m -122.43 153.16 39.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 0.0 110.266 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.705 ' CE1' HG23 ' A' ' 4' ' ' THR . 28.7 m-70 -133.01 162.72 30.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.267 -0.896 . . . . 0.0 110.265 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.565 ' HD1' HD12 ' A' ' 98' ' ' ILE . 30.3 m-85 -131.68 137.98 48.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.273 -0.892 . . . . 0.0 110.466 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.509 ' HB2' ' HB2' ' A' ' 97' ' ' LYS . 75.2 m80 -117.08 93.07 4.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.231 -0.918 . . . . 0.0 109.342 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.907 ' CG2' HD23 ' A' ' 95' ' ' LEU . 1.4 p -76.96 160.42 29.18 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.375 -0.828 . . . . 0.0 110.85 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 34.2 tttp -137.12 105.76 5.84 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.577 -0.702 . . . . 0.0 109.938 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.455 ' O ' ' CB ' ' A' ' 125' ' ' ASN . . . 126.35 20.62 1.95 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 2.7 t30 67.39 60.42 0.48 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.046 -1.267 . . . . 0.0 110.651 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.54 HG23 ' CG2' ' A' ' 122' ' ' THR . 20.5 m -138.62 145.54 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.176 -0.953 . . . . 0.0 109.739 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.439 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 92.4 mt-10 -104.37 -176.18 3.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.132 -0.98 . . . . 0.0 110.787 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.948 ' CD1' HD21 ' A' ' 95' ' ' LEU . 20.8 mm -86.17 173.39 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.375 -0.828 . . . . 0.0 110.229 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.59 ' N ' HG22 ' A' ' 128' ' ' ILE . 37.9 mttt -97.24 131.27 44.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.282 -0.886 . . . . 0.0 110.027 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.482 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 69.9 mm-40 -45.86 -41.51 11.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.093 -1.004 . . . . 0.0 110.189 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 1.009 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 39.7 tt0 -64.05 -18.01 63.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 109.975 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -93.0 -51.75 4.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 0.0 110.326 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.628 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 2.7 p -67.01 -26.43 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.893 . . . . 0.0 110.19 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -107.72 -70.05 0.82 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -0.918 . . . . 0.0 110.153 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 1.009 ' HB3' ' O ' ' A' ' 131' ' ' GLU . . . -55.55 -19.78 11.11 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.199 -0.938 . . . . 0.0 109.798 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -75.09 -28.88 61.46 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.441 ' HE2' ' O ' ' A' ' 133' ' ' VAL . 29.7 mttm -65.71 -31.66 72.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.285 -1.127 . . . . 0.0 109.951 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -79.86 -28.87 39.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.948 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -69.31 -35.38 75.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 0.0 109.939 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.03 -40.28 39.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.194 -0.941 . . . . 0.0 109.984 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.8 t -58.21 -47.49 83.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.381 -0.825 . . . . 0.0 109.937 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -54.82 -40.54 69.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.917 . . . . 0.0 109.985 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.574 ' HA ' HD12 ' A' ' 146' ' ' LEU . 21.7 mt -65.33 -39.29 92.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.89 . . . . 0.0 109.885 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.692 ' HA ' HD12 ' A' ' 147' ' ' ILE . 26.6 m-85 -62.6 -35.3 79.1 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.343 -0.848 . . . . 0.0 109.801 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 145' ' ' LYS . 21.9 tttm -71.72 -12.63 61.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.356 -0.84 . . . . 0.0 110.039 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.574 HD12 ' HA ' ' A' ' 143' ' ' LEU . 19.2 mt -83.22 -37.35 23.7 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.179 -0.951 . . . . 0.0 108.875 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.792 HD11 ' CE1' ' A' ' 22' ' ' PHE . 15.6 mt -67.57 -46.61 82.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.784 ' HB3' HD13 ' A' ' 13' ' ' ILE . 68.5 mt-10 -56.84 -45.59 82.26 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.459 -0.776 . . . . 0.0 109.516 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 23.3 m -62.84 -36.65 83.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 109.6 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.533 ' CD2' ' OH ' ' A' ' 158' ' ' TYR . 87.7 t80 -54.19 -46.43 72.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.414 -0.804 . . . . 0.0 109.894 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.991 HD21 ' CE1' ' A' ' 158' ' ' TYR . 65.6 mt -79.99 -33.65 39.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.387 -0.821 . . . . 0.0 110.339 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.914 ' HB2' HD11 ' A' ' 13' ' ' ILE . 34.4 tttm -62.68 -16.86 59.16 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.229 -0.919 . . . . 0.0 109.562 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.478 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -115.3 -31.16 2.08 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.417 ' ND1' ' N ' ' A' ' 154' ' ' HIS . 2.1 m80 -105.95 94.2 8.78 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.36 -1.083 . . . . 0.0 110.19 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.511 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.8 Cg_endo -73.68 6.25 2.91 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.099 1.578 . . . . 0.0 111.049 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -115.42 -8.19 12.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.034 -1.041 . . . . 0.0 109.788 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.675 ' HB3' ' NH2' ' A' ' 17' ' ' ARG . . . -53.34 106.55 0.18 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.439 -0.788 . . . . 0.0 110.035 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 1.041 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 36.23 30.27 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.687 -0.633 . . . . 0.0 110.466 -179.617 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.537 ' CB ' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 118.07 -0.967 . . . . 0.0 109.661 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 92.3 t -114.04 135.1 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.288 -1.125 . . . . 0.0 110.179 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.746 ' CE1' HD12 ' A' ' 128' ' ' ILE . 13.2 m-85 -91.76 156.58 17.45 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.278 -0.889 . . . . 0.0 109.972 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.645 HG23 ' CE1' ' A' ' 119' ' ' HIS . 25.3 m -135.81 113.36 10.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.098 -1.001 . . . . 0.0 110.412 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.936 ' CE2' HG21 ' A' ' 133' ' ' VAL . 71.1 m-85 -128.46 145.22 51.17 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.372 -0.83 . . . . 0.0 109.945 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 22.1 pt-20 -140.13 152.62 46.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.139 -0.976 . . . . 0.0 110.676 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.2 p -143.06 136.37 28.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.484 -0.76 . . . . 0.0 109.624 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.415 ' HG3' ' HG3' ' A' ' 115' ' ' LYS . 4.8 tt0 -123.28 141.81 51.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.02 -1.05 . . . . 0.0 110.912 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.595 ' CE2' ' HB ' ' A' ' 114' ' ' ILE . 3.2 p90 -157.8 -178.08 7.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.517 -0.739 . . . . 0.0 109.592 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.948 HG22 ' HA ' ' A' ' 113' ' ' ILE . 11.5 p -141.53 175.42 9.7 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.057 -1.027 . . . . 0.0 110.707 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.424 ' OG ' ' CD ' ' A' ' 148' ' ' GLU . 3.5 t -159.05 161.78 36.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.502 -0.749 . . . . 0.0 110.22 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -81.34 -36.51 29.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.272 -0.893 . . . . 0.0 110.207 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.792 HG23 ' HD2' ' A' ' 14' ' ' PRO . 3.1 mp -60.68 150.4 75.74 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.347 -0.845 . . . . 0.0 109.869 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.792 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.1 Cg_endo -65.1 142.31 73.62 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.878 1.462 . . . . 0.0 110.59 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.627 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.0 Cg_endo -73.01 -30.82 10.46 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 124.042 1.549 . . . . 0.0 113.049 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 45.0 Cg_endo -73.12 -20.27 21.82 Favored 'Trans proline' 0 C--N 1.317 -1.114 0 N-CA-C 110.125 -0.76 . . . . 0.0 110.125 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.72 ' HG2' HD13 ' A' ' 151' ' ' LEU . 39.7 ttm180 -83.53 -50.52 8.18 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.772 HD23 ' C ' ' A' ' 18' ' ' LEU . 1.1 tt -62.14 -25.98 68.05 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.486 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 52.5 t80 -68.76 -55.38 11.47 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.537 0.684 . . . . 0.0 109.449 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.552 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 15.8 mttt -49.55 -33.69 15.52 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.173 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.881 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -78.98 -50.52 10.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.346 -0.846 . . . . 0.0 110.725 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 1.042 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -62.74 -37.41 86.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.496 -0.752 . . . . 0.0 111.47 -178.809 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.728 HG13 ' CE1' ' A' ' 81' ' ' TYR . 3.3 t -109.4 -55.62 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 120.973 -1.079 . . . . 0.0 111.731 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.733 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.3 mp -76.43 0.1 20.92 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.998 -1.064 . . . . 0.0 111.278 -178.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.685 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -152.19 16.52 0.64 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.876 -1.14 . . . . 0.0 110.452 179.729 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 1.042 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -55.66 -41.62 73.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.164 -0.96 . . . . 0.0 109.891 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.451 ' HA ' ' CB ' ' A' ' 41' ' ' SER . 76.5 m-20 -57.26 -24.26 53.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.288 -0.883 . . . . 0.0 110.075 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.496 ' HB3' ' HE3' ' A' ' 32' ' ' LYS . 77.6 m-20 -120.45 13.9 11.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.383 -0.823 . . . . 0.0 110.056 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.736 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -100.78 -46.24 5.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.885 . . . . 0.0 110.094 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 1.016 HG11 HD13 ' A' ' 38' ' ' ILE . 2.8 t -70.22 -42.41 16.28 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.362 -0.836 . . . . 0.0 110.781 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 30' ' ' VAL . 46.9 Cg_endo -76.4 4.54 5.37 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.482 1.254 . . . . 0.0 110.671 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.496 ' HE3' ' HB3' ' A' ' 28' ' ' ASN . 21.1 mttm -120.02 -32.22 4.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.935 . . . . 0.0 109.077 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.607 HG12 ' CD1' ' A' ' 150' ' ' TYR . 6.8 mt -80.05 -35.27 15.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.444 0.64 . . . . 0.0 109.588 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -160.44 98.17 1.42 Allowed Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.442 -0.786 . . . . 0.0 110.17 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.22 0.1 8.4 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.989 1.521 . . . . 0.0 110.678 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -90.57 -19.37 23.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.141 -0.974 . . . . 0.0 110.36 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.92 -42.65 11.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.184 -0.948 . . . . 0.0 110.369 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 1.016 HD13 HG11 ' A' ' 30' ' ' VAL . 1.1 mp -128.81 144.13 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.415 -0.803 . . . . 0.0 110.328 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.467 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 37.9 ttmt -78.97 -41.76 28.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.325 -0.86 . . . . 0.0 109.854 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -178.42 161.57 1.39 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.327 -0.858 . . . . 0.0 110.166 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.451 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 15.5 m -123.3 122.39 38.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.138 -0.976 . . . . 0.0 110.037 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -127.9 111.91 14.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.183 -0.948 . . . . 0.0 110.558 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.447 HG13 ' OD2' ' A' ' 27' ' ' ASP . 24.9 mt -60.05 143.73 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.304 -0.873 . . . . 0.0 109.948 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.539 HD12 ' HB2' ' A' ' 55' ' ' LYS . 1.5 mt -119.26 -26.28 5.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 110.487 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.881 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.6 m95 -123.09 162.03 23.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.162 -0.961 . . . . 0.0 110.496 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.451 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 42.08 -141.95 1.45 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -149.08 24.6 0.92 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -1.13 . . . . 0.0 110.335 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 120.59 -15.59 9.78 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.441 ' O ' ' HB ' ' A' ' 71' ' ' ILE . . . -77.82 -172.87 39.69 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.501 ' HA ' HG22 ' A' ' 71' ' ' ILE . 43.5 Cg_endo -72.04 129.43 15.21 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 O-C-N 123.987 1.519 . . . . 0.0 110.59 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.43 -14.09 47.2 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.564 -1.814 . . . . 0.0 108.564 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -70.63 164.43 24.98 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.51 -0.994 . . . . 0.0 109.581 179.67 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.881 HD12 ' CG ' ' A' ' 45' ' ' TRP . 51.7 mt -135.28 121.23 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 109.997 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 96.2 mttt -107.77 140.72 40.42 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.187 -0.946 . . . . 0.0 110.401 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.539 ' HB2' HD12 ' A' ' 44' ' ' LEU . 25.9 tttt -109.2 90.6 3.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.243 -0.911 . . . . 0.0 110.144 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.562 ' CG2' HG12 ' A' ' 38' ' ' ILE . 82.1 mt -80.04 140.51 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.233 -0.917 . . . . 0.0 110.289 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.516 ' O ' HG23 ' A' ' 38' ' ' ILE . 3.0 p -111.11 158.66 18.62 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.311 -0.868 . . . . 0.0 110.83 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.725 ' HE2' HG13 ' A' ' 67' ' ' VAL . 29.8 m-85 -116.33 133.82 55.58 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.175 -0.953 . . . . 0.0 110.105 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.08 -32.25 83.49 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -60.11 161.03 7.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.202 -1.175 . . . . 0.0 110.229 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 62' ' ' SER . . . 49.74 71.41 0.62 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 61' ' ' GLY . 23.4 m -42.69 -27.76 0.19 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.28 -1.129 . . . . 0.0 110.272 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.404 ' N ' ' O ' ' A' ' 61' ' ' GLY . 69.6 mt-30 -51.54 -72.51 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.183 -0.948 . . . . 0.0 110.119 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -173.18 100.75 0.12 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.242 -0.911 . . . . 0.0 110.24 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -129.61 90.44 0.31 Allowed Glycine 0 N--CA 1.487 2.04 0 N-CA-C 108.29 -1.924 . . . . 0.0 108.29 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.532 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 16.9 p90 -140.36 165.45 27.38 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.055 -1.262 . . . . 0.0 110.304 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.893 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.1 m -131.54 173.48 14.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.459 -0.776 . . . . 0.0 110.321 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.518 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 22.9 mttt -125.49 124.5 41.51 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.62 -0.675 . . . . 0.0 109.656 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.708 ' CE1' HD13 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -112.29 122.01 46.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.191 -0.943 . . . . 0.0 110.777 -179.423 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 52' ' ' THR . 86.6 tttt -98.62 111.23 23.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.184 -0.948 . . . . 0.0 109.516 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.518 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 24.1 mm -52.46 130.19 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.117 -0.989 . . . . 0.0 109.979 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.501 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 11.9 t0 -108.83 -45.86 3.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.354 -0.841 . . . . 0.0 110.377 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.3 m -164.91 157.68 16.4 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.317 -0.865 . . . . 0.0 109.921 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.544 HG12 HG11 ' A' ' 23' ' ' VAL . 1.9 mt -142.96 158.05 17.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.249 -0.907 . . . . 0.0 110.496 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.565 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 3.1 m-20 -132.79 77.81 1.76 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 120.078 -0.649 . . . . 0.0 109.973 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.486 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 84.4 mttt -61.26 -15.65 37.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.133 -0.979 . . . . 0.0 110.413 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -93.33 -31.06 14.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.191 -0.943 . . . . 0.0 109.645 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.483 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.4 m120 -106.69 -5.41 18.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.574 -0.704 . . . . 0.0 109.796 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.562 ' O ' HD12 ' A' ' 104' ' ' LEU . 5.3 m-85 66.02 50.46 1.45 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.504 -0.747 . . . . 0.0 110.292 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.565 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -120.12 154.67 34.39 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 0.0 109.447 179.51 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.728 ' CE1' HG13 ' A' ' 23' ' ' VAL . 24.5 t80 -142.94 129.74 20.45 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.117 -0.99 . . . . 0.0 110.439 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.48 ' OG ' ' HG3' ' A' ' 101' ' ' GLU . 73.8 m -136.41 120.33 17.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.397 -0.814 . . . . 0.0 110.332 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.642 ' CE2' ' CB ' ' A' ' 100' ' ' TYR . 11.8 p90 -135.06 174.92 10.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.272 -0.893 . . . . 0.0 110.207 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 98' ' ' ILE . 29.3 m -123.73 127.35 48.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.371 -0.831 . . . . 0.0 110.104 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.708 HD13 ' CE1' ' A' ' 69' ' ' HIS . 5.1 tp -95.37 136.62 35.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.302 -0.874 . . . . 0.0 109.669 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.4 pt -123.59 -14.61 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.233 -0.917 . . . . 0.0 110.48 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.518 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 20.2 tt0 -129.93 129.25 43.6 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.054 -1.029 . . . . 0.0 110.675 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.893 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 177.68 128.54 1.17 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -59.52 -13.66 9.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -1.134 . . . . 0.0 110.415 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.696 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -83.52 -32.01 26.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 110.299 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.599 HD13 ' O ' ' A' ' 96' ' ' GLU . 1.8 pp -90.99 -27.42 18.68 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.28 -0.888 . . . . 0.0 110.569 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.505 ' N ' ' HG ' ' A' ' 91' ' ' LEU . . . -59.69 -31.89 72.52 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.733 ' O ' HG23 ' A' ' 94' ' ' THR . 87.2 m-20 -45.5 -40.02 7.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -1.168 . . . . 0.0 110.414 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.733 HG23 ' O ' ' A' ' 93' ' ' ASP . 1.3 p -160.03 -33.73 0.06 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.274 -0.891 . . . . 0.0 110.682 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.777 HD21 HG13 ' A' ' 128' ' ' ILE . 1.6 mm? -79.99 167.47 20.42 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.14 -0.975 . . . . 0.0 110.656 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.599 ' O ' HD13 ' A' ' 91' ' ' LEU . 43.6 tt0 -128.36 -77.72 0.56 Allowed 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.489 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 89.4 mttt -80.19 145.13 32.43 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.621 -0.675 . . . . 0.0 109.565 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.732 HG21 ' CE2' ' A' ' 100' ' ' TYR . 8.0 mm -128.45 143.31 41.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 120.733 -1.229 . . . . 0.0 110.11 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.484 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -117.04 128.26 54.98 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.404 -0.81 . . . . 0.0 109.362 179.076 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.732 ' CE2' HG21 ' A' ' 98' ' ' ILE . 8.7 m-85 -124.38 134.05 53.24 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.216 -0.928 . . . . 0.0 110.256 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.48 ' HG3' ' OG ' ' A' ' 82' ' ' SER . 81.6 tt0 -138.58 133.74 32.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.254 -0.904 . . . . 0.0 110.333 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.471 ' N ' ' O ' ' A' ' 81' ' ' TYR . 41.2 m -131.75 152.62 50.8 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.225 -0.922 . . . . 0.0 110.091 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 115' ' ' LYS . 6.8 mttm -146.73 138.14 24.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.2 -0.938 . . . . 0.0 110.507 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.868 HD23 HG12 ' A' ' 114' ' ' ILE . 5.7 mt -120.0 152.09 38.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.205 -0.934 . . . . 0.0 109.831 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.707 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -148.65 -169.45 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.046 -1.034 . . . . 0.0 110.129 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.707 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -123.94 163.52 21.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.332 -0.855 . . . . 0.0 110.195 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.467 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 3.0 p -122.48 169.62 9.36 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.246 -0.909 . . . . 0.0 110.201 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.8 Cg_endo -72.9 -9.01 23.2 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.061 1.559 . . . . 0.0 110.491 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.8 p -103.16 9.6 38.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.24 -0.913 . . . . 0.0 110.274 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 111' ' ' GLY . . . 94.54 -39.43 2.9 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 110' ' ' GLY . . . -51.66 -176.44 0.03 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.507 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.4 p -133.68 135.92 44.4 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -1.163 . . . . 0.0 110.467 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.948 ' HA ' HG22 ' A' ' 10' ' ' THR . 17.2 mt -88.78 148.0 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -0.845 . . . . 0.0 109.716 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.868 HG12 HD23 ' A' ' 104' ' ' LEU . 18.8 mt -131.89 121.87 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.238 -0.914 . . . . 0.0 110.58 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 103' ' ' LYS . 14.4 tttp -109.99 128.63 55.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.0 109.787 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.9 152.41 44.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.094 -1.004 . . . . 0.0 110.444 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.662 HG22 ' NE2' ' A' ' 119' ' ' HIS . 38.6 m -152.56 134.91 15.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 110.094 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.441 ' C ' ' CD2' ' A' ' 119' ' ' HIS . 14.4 m -133.44 156.5 47.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.273 -0.892 . . . . 0.0 110.135 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.662 ' NE2' HG22 ' A' ' 117' ' ' THR . 20.2 m-70 -140.77 170.04 16.51 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.168 -0.957 . . . . 0.0 110.423 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.74 ' CB ' HD11 ' A' ' 128' ' ' ILE . 8.8 m-85 -129.7 156.36 44.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.306 -0.871 . . . . 0.0 110.453 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.489 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 83.6 m-70 -135.13 96.75 3.56 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.211 -0.93 . . . . 0.0 109.545 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.609 HG22 HD13 ' A' ' 95' ' ' LEU . 6.1 p -64.48 160.7 18.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.395 -0.816 . . . . 0.0 110.925 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.411 ' HB2' ' HB2' ' A' ' 96' ' ' GLU . 28.7 tttt -119.57 90.94 3.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.493 -0.754 . . . . 0.0 110.17 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 108.95 -109.22 2.75 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -132.15 79.8 1.88 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.253 -1.145 . . . . 0.0 110.252 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.575 HG23 ' HB ' ' A' ' 122' ' ' THR . 7.9 m -146.63 179.5 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.321 -0.862 . . . . 0.0 110.048 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.508 ' CG ' ' O ' ' A' ' 126' ' ' VAL . 81.7 mt-10 -156.13 167.09 31.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.203 -0.936 . . . . 0.0 110.277 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.777 HG13 HD21 ' A' ' 95' ' ' LEU . 2.8 mp -88.7 172.43 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.231 -0.918 . . . . 0.0 110.16 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.599 ' N ' HG22 ' A' ' 128' ' ' ILE . 8.8 mttm -110.42 127.61 55.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.376 -0.827 . . . . 0.0 109.729 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.487 ' HB3' ' CE ' ' A' ' 134' ' ' LYS . 93.6 mt-10 -44.7 -49.27 10.54 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.112 -0.993 . . . . 0.0 109.904 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.509 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 44.8 tt0 -52.83 -20.6 3.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.646 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.696 ' NE2' ' HB1' ' A' ' 90' ' ' ALA . 12.3 t-160 -87.21 -63.72 1.26 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.456 -0.777 . . . . 0.0 110.031 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.936 HG21 ' CE2' ' A' ' 5' ' ' TYR . 8.3 p -59.86 -38.56 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.339 -0.851 . . . . 0.0 109.834 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.509 ' N ' HG13 ' A' ' 133' ' ' VAL . 55.9 mttm -69.65 -46.51 65.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 0.0 109.743 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.509 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -65.6 -30.79 71.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.295 -0.878 . . . . 0.0 109.801 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.47 -32.79 75.75 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 39.9 mttt -61.87 -33.93 75.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.374 -1.074 . . . . 0.0 109.845 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.504 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 83.0 tt0 -83.89 -33.76 24.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 109.842 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 46.1 mttm -71.06 -34.57 71.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.433 -0.792 . . . . 0.0 109.741 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.98 -40.62 46.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.366 -0.833 . . . . 0.0 109.829 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.0 t -60.92 -39.41 89.27 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.429 -0.795 . . . . 0.0 109.929 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 138' ' ' GLU . 75.9 m-20 -60.46 -45.05 95.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.266 -0.896 . . . . 0.0 109.955 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.437 ' HA ' HD12 ' A' ' 146' ' ' LEU . 46.7 mt -59.68 -40.02 86.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.296 -0.878 . . . . 0.0 110.009 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -61.07 -40.4 93.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.449 -0.782 . . . . 0.0 109.95 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.431 ' HA ' ' OE1' ' A' ' 148' ' ' GLU . 87.6 mttt -70.37 -13.96 62.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.286 -0.884 . . . . 0.0 109.98 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.545 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 35.1 mt -83.84 -36.7 23.27 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.196 -0.94 . . . . 0.0 108.83 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.718 HD11 ' CE1' ' A' ' 22' ' ' PHE . 47.4 mt -68.32 -46.55 80.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.555 ' HB3' HD13 ' A' ' 13' ' ' ILE . 74.1 mt-10 -53.27 -44.57 68.33 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.361 -0.837 . . . . 0.0 109.284 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.428 ' O ' ' C ' ' A' ' 150' ' ' TYR . 42.3 m -70.31 -40.88 73.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.33 -0.856 . . . . 0.0 109.388 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.664 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 86.8 t80 -43.11 -45.32 5.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.444 -0.785 . . . . 0.0 109.73 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.158 HD21 ' CE2' ' A' ' 158' ' ' TYR . 51.3 mt -80.05 -45.62 17.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.37 -0.831 . . . . 0.0 110.459 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.735 ' HB2' HD11 ' A' ' 13' ' ' ILE . 21.7 ttpp -59.72 -15.23 18.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.365 -0.834 . . . . 0.0 109.525 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -112.41 -29.95 3.03 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.464 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 4.5 m80 -114.18 96.01 40.82 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.294 -1.121 . . . . 0.0 110.012 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.423 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.1 Cg_endo -73.52 5.96 3.0 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.161 1.611 . . . . 0.0 111.267 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -108.28 -7.22 15.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.908 -1.12 . . . . 0.0 109.82 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.664 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -75.63 101.72 5.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.435 -0.791 . . . . 0.0 110.147 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 1.158 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.3 OUTLIER 34.71 32.67 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.461 0.648 . . . . 0.0 110.288 -179.417 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.527 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.871 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.657 HG11 ' CE1' ' A' ' 121' ' ' HIS . 22.2 t -124.21 138.24 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -1.139 . . . . 0.0 110.403 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.71 ' CE1' HD12 ' A' ' 128' ' ' ILE . 9.5 m-85 -103.21 156.57 17.62 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.318 -0.864 . . . . 0.0 109.897 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.599 HG23 ' CE1' ' A' ' 119' ' ' HIS . 7.1 m -126.58 112.75 15.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.131 -0.981 . . . . 0.0 110.592 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.036 ' CE1' HG11 ' A' ' 133' ' ' VAL . 59.7 m-85 -120.6 143.71 48.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.183 -0.948 . . . . 0.0 110.177 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 21.9 pt-20 -144.7 152.74 40.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.173 -0.954 . . . . 0.0 110.33 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.462 ' O ' ' CG ' ' A' ' 8' ' ' GLU . 2.3 t -128.23 171.1 12.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.334 -0.854 . . . . 0.0 109.989 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.462 ' CG ' ' O ' ' A' ' 7' ' ' SER . 78.7 mt-10 -154.18 115.98 4.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.931 . . . . 0.0 110.422 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.3 p90 -147.93 -174.65 4.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.396 -0.815 . . . . 0.0 109.731 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.867 HG22 ' HA ' ' A' ' 113' ' ' ILE . 7.7 p -141.91 175.66 9.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.091 -1.006 . . . . 0.0 110.527 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.469 ' HB2' ' HG2' ' A' ' 148' ' ' GLU . 85.6 p -157.36 126.91 6.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.543 -0.723 . . . . 0.0 110.23 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.45 ' HA ' ' HA2' ' A' ' 111' ' ' GLY . 98.2 mt-10 -53.64 -35.14 60.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.288 -0.882 . . . . 0.0 110.053 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.824 HG23 ' HD2' ' A' ' 14' ' ' PRO . 2.5 mp -65.18 150.78 95.07 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.309 -0.869 . . . . 0.0 109.881 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.824 ' HD2' HG23 ' A' ' 13' ' ' ILE . 41.8 Cg_endo -67.4 142.72 60.83 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.965 1.508 . . . . 0.0 110.619 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.667 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.6 Cg_endo -72.63 -31.04 11.24 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 124.036 1.545 . . . . 0.0 112.811 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.667 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.1 Cg_endo -70.18 -20.65 32.6 Favored 'Trans proline' 0 N--CA 1.485 1.013 0 N-CA-C 110.145 -0.752 . . . . 0.0 110.145 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.604 ' CZ ' HD22 ' A' ' 151' ' ' LEU . 43.4 mtp180 -84.71 -48.98 8.89 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.773 HD23 ' C ' ' A' ' 18' ' ' LEU . 1.3 tt -67.89 -28.36 67.45 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.571 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 83.5 t80 -68.39 -61.41 1.85 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.435 -0.791 . . . . 0.0 109.067 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.521 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 34.2 mttm -46.6 -32.81 3.69 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.751 -0.78 . . . . 0.0 109.114 179.086 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.047 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -79.85 -40.55 28.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.358 -0.839 . . . . 0.0 110.64 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.982 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -70.98 -42.51 69.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.33 -0.856 . . . . 0.0 111.429 -178.822 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.621 HG13 ' CE1' ' A' ' 81' ' ' TYR . 4.3 t -104.18 -51.53 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.064 -1.023 . . . . 0.0 111.47 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.694 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.4 mp -80.05 0.44 31.83 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.183 -0.948 . . . . 0.0 111.37 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.594 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -155.66 30.44 0.37 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.838 -1.164 . . . . 0.0 110.97 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.982 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -70.27 -28.81 65.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.105 -0.997 . . . . 0.0 109.86 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.491 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 60.9 m-20 -68.18 -12.44 60.94 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.297 -0.877 . . . . 0.0 109.848 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.554 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 79.8 m-20 -131.0 8.86 4.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.351 -0.843 . . . . 0.0 109.948 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.697 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -94.4 -49.99 5.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.356 -0.84 . . . . 0.0 110.466 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.958 HG21 HD13 ' A' ' 38' ' ' ILE . 6.6 p -77.87 -26.94 0.54 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.367 -0.833 . . . . 0.0 112.457 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.795 ' HD3' HG12 ' A' ' 30' ' ' VAL . 50.5 Cg_endo -78.25 7.17 4.22 Favored 'Trans proline' 0 C--N 1.319 -0.994 0 O-C-N 122.592 0.785 . . . . 0.0 110.703 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -135.38 -32.9 0.91 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.23 -0.919 . . . . 0.0 110.066 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.546 HG12 ' CD1' ' A' ' 150' ' ' TYR . 9.6 mt -80.0 -40.05 20.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.363 -0.836 . . . . 0.0 109.993 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -158.96 98.61 1.65 Allowed Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.275 -0.89 . . . . 0.0 110.374 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.04 2.31 6.8 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.032 1.543 . . . . 0.0 110.585 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -88.75 -16.17 32.87 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.186 -0.946 . . . . 0.0 110.129 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.645 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -95.92 -32.7 12.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 110.256 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.958 HD13 HG21 ' A' ' 30' ' ' VAL . 1.1 mp -145.81 133.91 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.338 -0.851 . . . . 0.0 109.883 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 57' ' ' THR . 27.7 ttpp -82.63 -25.98 32.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.886 . . . . 0.0 110.44 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.42 ' O ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -175.31 157.84 2.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.194 -0.941 . . . . 0.0 110.261 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.2 m -135.45 121.29 19.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.421 -0.8 . . . . 0.0 109.565 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -138.88 111.81 7.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.006 -1.059 . . . . 0.0 110.689 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.44 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 27.9 mt -50.63 143.24 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.412 -0.805 . . . . 0.0 109.896 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 11.6 tp -116.83 -21.8 8.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.308 -0.87 . . . . 0.0 110.348 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.733 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.7 m95 -131.5 163.29 28.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.237 -0.915 . . . . 0.0 110.615 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.451 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 42.63 -134.25 4.44 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -155.51 19.12 0.4 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -1.108 . . . . 0.0 110.231 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.69 -16.21 7.0 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.494 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -74.81 -173.73 31.94 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.415 ' HA ' HG22 ' A' ' 71' ' ' ILE . 44.6 Cg_endo -72.97 129.53 14.38 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 124.055 1.555 . . . . 0.0 110.466 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.3 -14.96 47.31 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.52 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -69.86 167.38 17.43 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.521 -0.988 . . . . 0.0 109.463 179.536 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.733 HD12 ' CG ' ' A' ' 45' ' ' TRP . 43.3 mt -134.94 120.75 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.202 -0.936 . . . . 0.0 110.18 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.488 ' HD2' HD11 ' A' ' 71' ' ' ILE . 17.7 mtpt -102.91 130.48 49.97 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.193 -0.942 . . . . 0.0 110.111 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -98.42 91.57 5.25 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.184 -0.948 . . . . 0.0 109.906 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.549 ' CG2' HG12 ' A' ' 38' ' ' ILE . 93.4 mt -80.02 138.73 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.371 -0.831 . . . . 0.0 110.046 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 3.1 p -114.93 155.9 26.02 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.232 -0.918 . . . . 0.0 110.476 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.594 ' CZ ' HG22 ' A' ' 67' ' ' VAL . 20.1 m-85 -117.93 142.46 47.32 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.358 -0.839 . . . . 0.0 110.038 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -113.93 34.22 5.08 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.4 -24.38 44.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.356 -1.085 . . . . 0.0 110.373 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 177.78 -163.88 32.5 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 65.7 m -63.7 -45.73 88.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -1.105 . . . . 0.0 110.196 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -46.47 134.06 9.48 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.264 -0.898 . . . . 0.0 110.146 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -72.09 127.21 31.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.291 -0.88 . . . . 0.0 110.27 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -140.74 113.38 0.86 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 15.6 p90 -154.65 170.65 21.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.082 -1.246 . . . . 0.0 110.122 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.897 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.0 m -141.28 174.52 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.27 -0.894 . . . . 0.0 110.764 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.507 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 25.1 mttt -126.21 120.7 30.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.547 -0.72 . . . . 0.0 109.489 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.589 ' CE1' HD13 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -108.76 129.13 55.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.223 -0.923 . . . . 0.0 111.037 -179.294 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 52' ' ' THR . 44.3 tttp -100.43 112.95 25.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.225 -0.922 . . . . 0.0 109.474 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.537 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 31.0 mm -52.08 130.77 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.1 -1.0 . . . . 0.0 110.239 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.458 ' OD2' ' OG1' ' A' ' 84' ' ' THR . 58.8 m-20 -106.45 -36.85 6.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 0.0 110.258 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.647 ' C ' HD12 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -178.55 166.24 1.77 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.178 -0.952 . . . . 0.0 109.635 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.647 HD12 ' C ' ' A' ' 73' ' ' SER . 0.9 OUTLIER -151.82 155.9 6.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 119.016 -1.074 . . . . 0.0 111.386 -179.682 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.508 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 2.3 m-20 -132.78 76.12 1.67 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.303 0.573 . . . . 0.0 109.919 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.571 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 45.9 mttt -60.83 -12.51 11.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.226 -0.921 . . . . 0.0 110.406 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -92.82 -31.97 14.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.298 -0.876 . . . . 0.0 109.483 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.48 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.5 m120 -107.43 -6.16 17.25 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.534 -0.729 . . . . 0.0 109.839 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.774 ' O ' HD12 ' A' ' 104' ' ' LEU . 4.0 m-85 69.11 48.83 0.66 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.558 -0.714 . . . . 0.0 110.183 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.508 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.5 OUTLIER -119.58 147.18 44.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.232 -0.917 . . . . 0.0 109.543 179.626 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.68 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 76.1 t80 -140.35 143.28 35.67 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.093 -1.004 . . . . 0.0 110.6 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.447 ' C ' ' HB2' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -148.69 141.26 24.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -0.877 . . . . 0.0 110.098 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.68 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 10.7 p90 -151.52 175.66 12.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.144 -0.973 . . . . 0.0 110.699 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 98' ' ' ILE . 6.5 m -122.58 127.84 49.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.467 -0.771 . . . . 0.0 109.688 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.589 HD13 ' CE1' ' A' ' 69' ' ' HIS . 2.9 tp -94.98 128.25 41.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.166 -0.959 . . . . 0.0 110.314 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 14.3 pt -114.81 0.51 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.33 -0.856 . . . . 0.0 110.392 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.507 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 72.4 tt0 -149.32 154.42 38.96 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.253 -0.904 . . . . 0.0 110.198 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.897 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 150.94 130.55 1.72 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -57.34 -16.04 7.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.329 -1.1 . . . . 0.0 110.2 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.419 ' O ' ' CE1' ' A' ' 132' ' ' HIS . . . -66.44 -30.28 70.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.225 -0.922 . . . . 0.0 110.201 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 21.1 mt -58.06 -15.57 9.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -0.866 . . . . 0.0 110.036 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.765 ' O ' HG23 ' A' ' 94' ' ' THR . . . 48.12 30.73 7.77 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 92' ' ' GLY . 93.1 m-20 56.56 15.36 2.05 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.251 -1.147 . . . . 0.0 110.379 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.765 HG23 ' O ' ' A' ' 92' ' ' GLY . 65.6 p -108.18 -52.78 2.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.931 . . . . 0.0 109.604 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 1.018 HD21 ' CG1' ' A' ' 128' ' ' ILE . 14.9 mt -80.36 164.1 23.38 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.499 -0.751 . . . . 0.0 109.741 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.444 ' OE1' ' HD3' ' A' ' 123' ' ' LYS . 42.3 tt0 -132.19 -78.35 0.5 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 110.326 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.513 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 54.6 mttt -80.2 128.4 33.48 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.49 -0.756 . . . . 0.0 110.638 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.757 HG21 ' CE2' ' A' ' 100' ' ' TYR . 4.7 mm -120.45 141.53 40.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 120.682 -1.261 . . . . 0.0 109.692 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.491 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -122.38 126.59 48.33 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.429 -0.794 . . . . 0.0 108.986 178.79 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.757 ' CE2' HG21 ' A' ' 98' ' ' ILE . 12.7 m-85 -122.59 133.51 54.54 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.294 -0.879 . . . . 0.0 110.491 -179.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.509 ' N ' ' O ' ' A' ' 117' ' ' THR . 49.6 tt0 -136.24 134.38 38.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.36 -0.837 . . . . 0.0 110.259 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 94.0 m -131.67 140.56 49.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.263 -0.898 . . . . 0.0 110.069 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.76 139.34 50.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.307 -0.871 . . . . 0.0 110.229 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.784 HD23 HG12 ' A' ' 114' ' ' ILE . 11.4 mt -115.51 149.74 37.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.345 -0.847 . . . . 0.0 109.991 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.704 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -150.44 -168.43 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.202 -0.936 . . . . 0.0 110.21 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.704 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -121.37 158.47 28.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.285 -0.884 . . . . 0.0 110.115 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.471 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 9.5 p -114.91 167.04 10.44 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.19 -0.944 . . . . 0.0 110.321 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.9 Cg_endo -72.23 -4.23 14.82 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.074 1.565 . . . . 0.0 110.39 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 65.4 m -107.06 0.7 23.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.238 -0.914 . . . . 0.0 110.245 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.63 -41.07 2.26 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 12' ' ' GLU . . . -54.31 -177.61 0.13 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.517 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 6.7 p -124.61 140.29 53.08 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.226 -1.161 . . . . 0.0 110.321 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.867 ' HA ' HG22 ' A' ' 10' ' ' THR . 19.5 mt -92.9 147.55 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.33 -0.857 . . . . 0.0 110.129 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.784 HG12 HD23 ' A' ' 104' ' ' LEU . 8.7 mt -130.96 126.89 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.283 -0.886 . . . . 0.0 110.144 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -119.72 111.15 17.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.154 -0.966 . . . . 0.0 110.144 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 2.4 m -96.64 159.71 14.78 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.229 -0.919 . . . . 0.0 110.552 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 101' ' ' GLU . 25.4 m -160.11 117.98 2.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.516 -0.74 . . . . 0.0 109.959 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 99' ' ' SER . 96.7 p -125.31 161.78 26.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.09 -1.006 . . . . 0.0 110.453 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.599 ' CE1' HG23 ' A' ' 4' ' ' THR . 62.9 m-70 -140.15 131.84 27.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.307 -0.871 . . . . 0.0 110.225 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.72 ' CD2' HD13 ' A' ' 95' ' ' LEU . 3.2 m-85 -98.16 148.15 23.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.393 -0.817 . . . . 0.0 109.672 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.657 ' CE1' HG11 ' A' ' 2' ' ' VAL . 88.6 m-70 -129.13 93.19 3.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.055 -1.028 . . . . 0.0 110.054 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.661 ' CG2' HD23 ' A' ' 95' ' ' LEU . 2.0 p -66.41 156.93 33.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.249 -0.907 . . . . 0.0 110.228 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.444 ' HD3' ' OE1' ' A' ' 96' ' ' GLU . 17.6 tptt -116.54 115.83 26.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.336 -0.852 . . . . 0.0 110.197 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 99.57 -118.28 6.13 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -132.82 73.11 1.51 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.189 -1.183 . . . . 0.0 110.166 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.544 HG23 ' CG2' ' A' ' 122' ' ' THR . 14.1 m -139.69 153.11 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.262 -0.899 . . . . 0.0 110.154 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -126.37 170.04 12.34 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.215 -0.928 . . . . 0.0 110.28 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 1.018 ' CG1' HD21 ' A' ' 95' ' ' LEU . 3.4 mp -100.01 172.77 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.191 -0.943 . . . . 0.0 110.161 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.602 ' N ' HG22 ' A' ' 128' ' ' ILE . 10.5 mttt -116.32 132.18 56.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.896 . . . . 0.0 109.811 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 129' ' ' LYS . 95.0 mt-10 -42.55 -42.96 3.54 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.266 -0.897 . . . . 0.0 110.185 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -52.4 -37.99 57.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.157 -0.964 . . . . 0.0 109.911 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.419 ' CE1' ' O ' ' A' ' 90' ' ' ALA . 13.7 t-160 -74.54 -57.45 3.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.331 -0.856 . . . . 0.0 110.072 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 1.036 HG11 ' CE1' ' A' ' 5' ' ' TYR . 79.4 t -58.97 -36.35 61.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.421 -0.799 . . . . 0.0 109.891 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 31.0 tttt -71.69 -44.07 64.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.3 -0.875 . . . . 0.0 109.945 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.47 -27.55 68.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.998 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -74.15 -28.64 63.85 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -73.41 -34.04 65.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.294 -1.121 . . . . 0.0 110.006 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -82.1 -31.46 30.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 109.967 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.573 ' O ' HD12 ' A' ' 143' ' ' LEU . 43.3 mttm -72.57 -33.95 67.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.889 . . . . 0.0 110.004 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -80.31 -34.4 36.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 110.123 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 71.4 m -63.66 -41.56 98.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.332 -0.855 . . . . 0.0 110.045 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -58.66 -45.16 89.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.273 -0.892 . . . . 0.0 110.105 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.573 HD12 ' O ' ' A' ' 139' ' ' LYS . 2.6 mt -61.03 -40.25 92.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -0.885 . . . . 0.0 110.104 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.408 ' CE1' ' CE2' ' A' ' 22' ' ' PHE . 17.6 m-85 -62.35 -34.06 75.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.377 -0.827 . . . . 0.0 109.961 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 145' ' ' LYS . 30.3 tttm -76.04 -14.18 60.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.338 -0.851 . . . . 0.0 110.24 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 19.6 mt -84.07 -37.13 22.47 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.059 -1.026 . . . . 0.0 109.023 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.791 HD11 ' CE1' ' A' ' 22' ' ' PHE . 24.5 mt -69.14 -43.32 81.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.581 ' HB3' HD13 ' A' ' 13' ' ' ILE . 83.8 mt-10 -53.04 -44.65 67.56 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.392 -0.818 . . . . 0.0 109.347 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 28.5 m -66.69 -33.13 74.97 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 109.762 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.628 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 89.3 t80 -55.02 -49.65 71.0 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.409 -0.807 . . . . 0.0 110.04 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.021 HD21 ' CE1' ' A' ' 158' ' ' TYR . 74.7 mt -76.17 -36.08 58.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -0.872 . . . . 0.0 110.419 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.754 ' HB2' HD11 ' A' ' 13' ' ' ILE . 8.5 tttp -60.19 -15.35 23.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.253 -0.905 . . . . 0.0 109.308 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.492 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -120.05 -24.12 2.82 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.45 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 7.6 m80 -106.1 92.41 6.57 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.296 -1.12 . . . . 0.0 110.162 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.4 Cg_endo -73.2 4.17 4.02 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.025 1.54 . . . . 0.0 110.937 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -120.33 -6.73 9.83 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.994 -1.066 . . . . 0.0 109.919 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.675 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -53.91 106.11 0.17 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.889 . . . . 0.0 109.826 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 1.047 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 36.23 30.38 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.661 -0.649 . . . . 0.0 110.518 -179.466 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.542 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.802 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.984 HG23 ' C ' ' A' ' 120' ' ' TYR . 2.6 p -79.96 149.54 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.357 -1.084 . . . . 0.0 110.712 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.788 ' CE2' HD12 ' A' ' 128' ' ' ILE . 5.1 m-85 -86.74 169.65 12.45 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.664 -0.647 . . . . 0.0 110.145 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.536 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 3.3 m -123.82 129.82 51.63 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.102 -0.999 . . . . 0.0 110.47 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.584 ' CE2' ' HB2' ' A' ' 3' ' ' PHE . 39.1 m-85 -142.68 133.72 25.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.316 -0.865 . . . . 0.0 110.028 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.608 ' CG ' HG23 ' A' ' 117' ' ' THR . 30.9 mt-10 -143.9 145.22 32.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -0.926 . . . . 0.0 110.515 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.479 ' O ' ' HG2' ' A' ' 8' ' ' GLU . 5.6 t -118.5 169.88 9.4 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.395 -0.815 . . . . 0.0 109.85 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 7' ' ' SER . 60.7 mt-10 -152.53 123.07 7.29 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.14 -0.975 . . . . 0.0 110.643 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.637 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 1.9 p90 -148.93 -176.94 5.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.406 -0.809 . . . . 0.0 109.735 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.726 HG22 ' HA ' ' A' ' 113' ' ' ILE . 11.1 p -139.23 -179.91 6.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.132 -0.98 . . . . 0.0 110.696 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.2 t -159.99 168.65 25.16 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.429 -0.794 . . . . 0.0 110.102 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -92.04 -28.78 16.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.162 -0.961 . . . . 0.0 110.164 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.863 HD13 ' HB3' ' A' ' 148' ' ' GLU . 2.6 mp -70.6 151.04 95.51 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.319 -0.863 . . . . 0.0 110.129 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.836 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.3 Cg_endo -65.92 142.74 70.17 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.965 1.508 . . . . 0.0 110.509 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.646 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.7 Cg_endo -73.31 -30.48 10.26 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 O-C-N 123.992 1.522 . . . . 0.0 113.048 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.646 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.7 Cg_endo -71.13 -24.41 23.59 Favored 'Trans proline' 0 C--N 1.317 -1.084 0 N-CA-C 110.184 -0.737 . . . . 0.0 110.184 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.568 ' CZ ' ' HA ' ' A' ' 159' ' ' ASN . 1.5 mtp85 -83.05 -44.95 14.61 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.942 ' O ' HD22 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -65.59 -30.93 71.72 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.727 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.573 ' N ' HD13 ' A' ' 18' ' ' LEU . 44.7 t80 -66.27 -54.94 18.98 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.413 -0.804 . . . . 0.0 109.685 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.642 ' HG2' HD22 ' A' ' 24' ' ' LEU . 20.1 mttt -51.98 -31.72 30.45 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.107 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.085 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -80.04 -46.44 16.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.612 -0.68 . . . . 0.0 110.87 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 1.046 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -66.44 -40.01 89.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.379 -0.826 . . . . 0.0 111.536 -178.618 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.613 HG13 ' CE1' ' A' ' 81' ' ' TYR . 3.4 t -107.6 -62.6 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.797 -1.19 . . . . 0.0 111.472 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.642 HD22 ' HG2' ' A' ' 20' ' ' LYS . 7.4 mp -62.78 -11.48 18.01 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.143 -0.973 . . . . 0.0 111.324 -178.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.566 ' HB3' HD23 ' A' ' 29' ' ' LEU . 1.2 m-20 -143.76 28.4 1.43 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.829 -1.169 . . . . 0.0 110.59 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 1.046 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -68.27 -21.03 64.82 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.246 -0.909 . . . . 0.0 110.296 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -72.35 -13.73 61.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -0.95 . . . . 0.0 110.173 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.511 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 5.0 p-10 -133.74 8.96 3.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.372 -0.83 . . . . 0.0 110.01 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.908 HD21 ' OH ' ' A' ' 158' ' ' TYR . 0.3 OUTLIER -93.45 -45.72 7.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.325 -0.86 . . . . 0.0 109.913 179.872 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.976 HG11 HD13 ' A' ' 38' ' ' ILE . 2.5 t -73.37 -42.71 6.9 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.448 -0.782 . . . . 0.0 110.777 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.8 Cg_endo -78.01 7.57 3.93 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.448 1.236 . . . . 0.0 110.733 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.5 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 42.8 mmtm -124.32 -32.76 3.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.161 -0.962 . . . . 0.0 109.569 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.578 HD13 ' HA ' ' A' ' 147' ' ' ILE . 12.7 mt -80.04 -33.31 14.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.542 -0.724 . . . . 0.0 109.476 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -156.8 94.87 2.25 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.475 -0.766 . . . . 0.0 110.07 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.26 -1.2 9.77 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.046 1.551 . . . . 0.0 110.614 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -91.88 -6.66 51.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.147 -0.971 . . . . 0.0 110.248 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -99.21 -69.04 0.78 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.224 -0.922 . . . . 0.0 110.25 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.976 HD13 HG11 ' A' ' 30' ' ' VAL . 1.3 mp -103.46 149.1 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.35 -0.844 . . . . 0.0 110.154 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.461 ' O ' ' HB3' ' A' ' 40' ' ' HIS . 8.0 ttmm -86.93 -37.04 17.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 110.26 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.461 ' HB3' ' O ' ' A' ' 39' ' ' LYS . 0.3 OUTLIER 177.71 134.77 0.07 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.186 -0.946 . . . . 0.0 110.502 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.5 m -94.67 135.73 35.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.158 -0.963 . . . . 0.0 109.804 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -140.05 114.38 9.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.182 -0.948 . . . . 0.0 110.446 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 14.2 mt -61.85 138.28 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.164 -0.96 . . . . 0.0 109.962 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 13.3 tp -114.91 -25.86 8.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.23 -0.919 . . . . 0.0 110.468 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.504 ' HB2' ' CB ' ' A' ' 53' ' ' ILE . 1.8 m95 -127.77 163.99 23.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.217 -0.927 . . . . 0.0 110.588 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.46 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 42.23 -132.67 4.4 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.428 ' N ' ' OG1' ' A' ' 52' ' ' THR . 0.6 OUTLIER -156.34 20.23 0.35 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -1.12 . . . . 0.0 110.15 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.04 -22.97 6.65 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.455 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -71.11 -171.96 12.42 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.482 ' HA ' HG22 ' A' ' 71' ' ' ILE . 44.2 Cg_endo -72.12 128.97 14.5 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 124.045 1.55 . . . . 0.0 110.497 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.32 -15.45 42.75 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.55 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.1 m -72.03 161.71 30.51 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.594 -0.945 . . . . 0.0 109.382 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.504 ' CB ' ' HB2' ' A' ' 45' ' ' TRP . 50.0 mt -132.16 119.8 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.292 -0.88 . . . . 0.0 109.993 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 21.7 mtpt -102.29 134.76 45.06 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.151 -0.968 . . . . 0.0 110.339 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 17.9 tttm -102.39 93.7 5.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.32 -0.863 . . . . 0.0 110.008 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.547 ' CG2' HG12 ' A' ' 38' ' ' ILE . 84.7 mt -80.08 138.79 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.233 -0.917 . . . . 0.0 110.052 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.513 ' O ' HG23 ' A' ' 38' ' ' ILE . 1.4 p -113.73 151.75 31.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 0.0 110.446 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.574 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 24.0 m-85 -115.55 150.11 37.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.367 -0.833 . . . . 0.0 110.062 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -125.09 44.28 1.28 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -73.6 -23.66 59.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.342 -1.093 . . . . 0.0 110.336 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -165.11 -170.45 30.09 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 91.4 p -66.54 -40.59 89.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -1.155 . . . . 0.0 110.202 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -49.72 147.13 3.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.31 -0.869 . . . . 0.0 110.126 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -82.39 117.83 22.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.304 -0.872 . . . . 0.0 110.146 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.574 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -126.56 99.71 0.55 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.545 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 11.6 p90 -138.5 165.58 26.48 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.187 -1.184 . . . . 0.0 110.158 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.898 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.8 m -139.2 175.06 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.252 -0.905 . . . . 0.0 110.567 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 72.8 mttt -129.79 114.98 16.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.525 -0.735 . . . . 0.0 109.928 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.693 ' CE1' HD13 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -103.36 123.16 46.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.343 -0.848 . . . . 0.0 110.742 -179.585 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 52' ' ' THR . 40.3 tttp -94.85 111.95 23.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 0.0 109.664 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.526 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 39.2 mm -47.3 137.13 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.209 -0.932 . . . . 0.0 110.417 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.553 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 11.1 t0 -112.11 -36.77 5.25 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.398 -0.814 . . . . 0.0 109.934 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.428 ' C ' HD12 ' A' ' 74' ' ' ILE . 1.0 OUTLIER 179.92 163.08 1.03 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.319 -0.863 . . . . 0.0 109.657 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.465 HG12 HG11 ' A' ' 23' ' ' VAL . 0.7 OUTLIER -146.75 155.75 11.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.056 -1.028 . . . . 0.0 111.157 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.54 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 2.5 m-20 -132.57 78.2 1.79 Allowed 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.011 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.546 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 34.0 mttp -61.03 -17.97 55.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.228 -0.92 . . . . 0.0 110.346 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -92.32 -31.01 15.53 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.226 -0.921 . . . . 0.0 109.567 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.482 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.6 m120 -103.78 -6.55 21.35 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.571 -0.706 . . . . 0.0 109.893 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.539 ' N ' ' O ' ' A' ' 75' ' ' ASP . 3.8 m-30 66.02 52.11 1.24 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.536 -0.727 . . . . 0.0 110.14 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.54 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.6 OUTLIER -125.18 147.66 48.95 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.246 -0.909 . . . . 0.0 109.672 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.642 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 58.1 t80 -137.26 135.63 37.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.146 -0.971 . . . . 0.0 110.118 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.421 ' O ' ' N ' ' A' ' 72' ' ' ASP . 26.3 m -141.31 127.58 19.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.077 -1.014 . . . . 0.0 110.779 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.642 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 10.9 p90 -138.72 174.52 10.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.373 -0.83 . . . . 0.0 109.966 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 98' ' ' ILE . 69.7 m -125.87 129.19 48.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 0.0 109.738 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.693 HD13 ' CE1' ' A' ' 69' ' ' HIS . 3.5 tp -97.07 132.69 42.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.11 -0.994 . . . . 0.0 110.318 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.3 pt -118.81 -24.25 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.394 -0.816 . . . . 0.0 110.148 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.493 ' O ' HD11 ' A' ' 85' ' ' LEU . 68.0 tt0 -121.73 147.17 46.25 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.262 -0.899 . . . . 0.0 110.159 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.898 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 165.03 124.65 0.72 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -52.05 -25.01 7.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -1.163 . . . . 0.0 110.22 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.32 -24.03 59.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.166 -0.959 . . . . 0.0 110.226 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.687 HD12 ' N ' ' A' ' 88' ' ' GLY . 72.1 mt -63.98 -32.55 74.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.903 . . . . 0.0 110.167 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 46.81 -173.48 0.02 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 52.3 p30 -83.19 7.02 17.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.262 -1.14 . . . . 0.0 110.163 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.709 ' O ' HG21 ' A' ' 126' ' ' VAL . 60.7 p -92.58 -33.72 14.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.319 -0.863 . . . . 0.0 110.137 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.941 HD21 ' CG1' ' A' ' 128' ' ' ILE . 61.9 mt -108.03 172.41 6.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.333 -0.854 . . . . 0.0 110.278 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.517 ' OE1' ' N ' ' A' ' 123' ' ' LYS . 48.5 mp0 -149.9 -82.36 0.11 Allowed 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.772 0.796 . . . . 0.0 109.311 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.509 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 59.7 mttt -80.44 127.57 32.57 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.782 -0.574 . . . . 0.0 110.72 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.753 HG21 ' CE2' ' A' ' 100' ' ' TYR . 5.4 mm -117.8 140.4 41.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 120.563 -1.336 . . . . 0.0 109.293 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.505 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -120.31 126.59 50.92 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.094 179.099 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.753 ' CE2' HG21 ' A' ' 98' ' ' ILE . 11.7 m-85 -122.61 135.55 54.65 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.407 -0.808 . . . . 0.0 110.367 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.527 ' CB ' ' HB ' ' A' ' 117' ' ' THR . 3.5 mt-10 -138.78 131.02 28.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.316 -0.865 . . . . 0.0 110.122 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 34.1 m -128.27 133.91 48.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.323 -0.86 . . . . 0.0 109.853 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.47 145.86 51.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.137 -0.977 . . . . 0.0 110.531 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.641 HD23 HG12 ' A' ' 114' ' ' ILE . 10.9 mt -122.47 153.59 38.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.3 -0.875 . . . . 0.0 110.01 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.701 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -151.12 -168.79 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.183 -0.948 . . . . 0.0 110.125 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.701 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -126.39 147.52 49.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.288 -0.883 . . . . 0.0 110.189 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.458 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 2.6 p -105.87 169.79 6.57 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.14 -0.975 . . . . 0.0 110.273 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 47.3 Cg_endo -73.19 -9.44 23.3 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.004 1.528 . . . . 0.0 110.403 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 63.1 p -97.37 6.63 47.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.305 -0.872 . . . . 0.0 110.326 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 96.18 -37.71 3.34 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -56.67 -172.42 0.17 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.5 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 25.1 p -133.99 137.14 44.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.259 -1.142 . . . . 0.0 110.276 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.726 ' HA ' HG22 ' A' ' 10' ' ' THR . 18.4 mt -86.77 150.31 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.313 -0.867 . . . . 0.0 110.218 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.641 HG12 HD23 ' A' ' 104' ' ' LEU . 16.5 mt -131.45 120.01 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.233 -0.917 . . . . 0.0 110.192 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.4 tttm -106.7 124.72 50.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.134 -0.979 . . . . 0.0 110.093 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -111.56 154.37 24.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.23 -0.919 . . . . 0.0 110.469 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.608 HG23 ' CG ' ' A' ' 6' ' ' GLU . 88.0 m -145.97 145.2 30.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.385 -0.822 . . . . 0.0 110.249 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.462 ' HG ' ' HE1' ' A' ' 100' ' ' TYR . 49.7 m -155.49 120.76 4.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.908 . . . . 0.0 109.857 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.505 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 41.1 m-70 -112.14 157.57 20.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.151 -0.968 . . . . 0.0 110.559 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.984 ' C ' HG23 ' A' ' 2' ' ' VAL . 10.2 m-85 -125.78 119.89 29.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.371 -0.831 . . . . 0.0 110.511 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.729 ' CD2' ' HB ' ' A' ' 2' ' ' VAL . 76.2 m80 -98.79 101.84 13.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.265 -0.897 . . . . 0.0 109.601 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.694 HG23 HD23 ' A' ' 95' ' ' LEU . 0.8 OUTLIER -88.26 142.46 27.73 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.131 -0.981 . . . . 0.0 110.499 -179.507 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.517 ' N ' ' OE1' ' A' ' 96' ' ' GLU . 18.4 tttt -113.32 109.73 19.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.382 -0.824 . . . . 0.0 110.202 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 104.06 -153.26 17.73 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -97.62 77.71 2.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.323 -1.104 . . . . 0.0 110.206 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.709 HG21 ' O ' ' A' ' 94' ' ' THR . 22.3 m -142.76 161.68 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.2 -0.937 . . . . 0.0 110.133 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.404 ' HG3' ' C ' ' A' ' 126' ' ' VAL . 93.1 mt-10 -146.95 153.94 40.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.199 -0.938 . . . . 0.0 110.273 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.941 ' CG1' HD21 ' A' ' 95' ' ' LEU . 3.1 mt -80.18 172.98 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 110.115 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.595 ' N ' HG22 ' A' ' 128' ' ' ILE . 63.2 mttt -96.42 133.67 40.54 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.414 -0.804 . . . . 0.0 109.716 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 97.4 mt-10 -42.87 -36.53 1.53 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.268 -0.895 . . . . 0.0 110.169 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.84 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 81.2 tt0 -57.51 -42.17 82.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 109.922 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.537 ' HB3' ' CG2' ' A' ' 128' ' ' ILE . 6.1 t-160 -65.37 -53.66 40.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.333 -0.854 . . . . 0.0 110.221 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.463 HG13 ' CG ' ' A' ' 5' ' ' TYR . 96.6 t -67.7 -33.87 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.43 -0.794 . . . . 0.0 110.287 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 25.6 mttm -98.11 -69.33 0.76 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.212 -0.93 . . . . 0.0 110.205 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.84 ' HB3' ' O ' ' A' ' 131' ' ' GLU . . . -54.71 -19.61 6.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.18 -0.95 . . . . 0.0 109.626 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.451 ' HA3' ' O ' ' A' ' 132' ' ' HIS . . . -73.17 -30.23 63.25 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.484 ' CE ' ' HB3' ' A' ' 5' ' ' TYR . 66.0 mttm -79.5 -31.45 42.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.335 -1.097 . . . . 0.0 109.932 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -72.45 -52.92 13.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.281 -0.887 . . . . 0.0 109.93 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.52 ' HG3' ' N ' ' A' ' 140' ' ' ALA . 10.1 pttp -56.88 -41.26 77.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.41 -0.806 . . . . 0.0 109.821 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.52 ' N ' ' HG3' ' A' ' 139' ' ' LYS . . . -70.4 -39.73 74.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.349 -0.845 . . . . 0.0 109.853 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 137' ' ' LYS . 16.7 t -55.62 -43.41 76.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.414 -0.804 . . . . 0.0 109.852 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -57.34 -42.47 82.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.347 -0.846 . . . . 0.0 109.873 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.643 ' HA ' HD12 ' A' ' 146' ' ' LEU . 64.3 mt -57.85 -41.82 83.17 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.28 -0.887 . . . . 0.0 109.906 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -59.45 -36.79 76.62 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.422 -0.799 . . . . 0.0 109.845 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.413 ' HA ' ' OE1' ' A' ' 148' ' ' GLU . 95.6 mttt -71.68 -15.07 62.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.322 -0.861 . . . . 0.0 109.878 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.643 HD12 ' HA ' ' A' ' 143' ' ' LEU . 24.2 mt -84.95 -35.34 22.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.28 -0.887 . . . . 0.0 109.045 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.792 ' CG2' HD23 ' A' ' 18' ' ' LEU . 60.0 mt -70.47 -40.75 77.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 119.772 -0.771 . . . . 0.0 108.97 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.863 ' HB3' HD13 ' A' ' 13' ' ' ILE . 52.0 mt-10 -59.46 -44.08 93.06 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.423 -0.798 . . . . 0.0 109.329 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.504 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 33.7 m -67.75 -30.19 69.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.318 -0.864 . . . . 0.0 109.453 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.595 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 73.3 t80 -57.84 -49.72 75.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.463 -0.773 . . . . 0.0 109.802 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.145 HD21 ' CE2' ' A' ' 158' ' ' TYR . 77.5 mt -79.94 -26.61 40.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.209 -0.932 . . . . 0.0 109.983 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.688 ' HB2' HD11 ' A' ' 13' ' ' ILE . 50.8 tttt -72.65 -26.49 61.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.375 -0.828 . . . . 0.0 109.491 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.497 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -105.4 -32.02 4.11 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.453 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 4.6 m80 -106.92 92.31 7.4 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.302 -1.117 . . . . 0.0 109.947 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.6 Cg_endo -73.84 6.9 2.62 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.131 1.595 . . . . 0.0 111.15 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -108.87 -4.49 16.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.936 -1.103 . . . . 0.0 110.008 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.667 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -77.65 101.72 6.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.382 -0.824 . . . . 0.0 110.1 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 1.145 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.3 OUTLIER 35.15 31.8 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.691 -0.63 . . . . 0.0 110.507 -179.49 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.568 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.744 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.575 HG13 ' O ' ' A' ' 120' ' ' TYR . 93.9 t -124.42 137.77 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -1.135 . . . . 0.0 110.206 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.804 ' CE1' HD12 ' A' ' 128' ' ' ILE . 10.1 m-85 -98.89 145.71 26.72 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.248 -0.908 . . . . 0.0 109.843 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.598 HG23 ' CE1' ' A' ' 119' ' ' HIS . 3.2 m -120.89 127.56 51.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.155 -0.966 . . . . 0.0 110.677 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.093 ' CE2' HG21 ' A' ' 133' ' ' VAL . 61.5 m-85 -139.92 131.21 26.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.395 -0.815 . . . . 0.0 109.765 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 22.4 pt-20 -131.75 153.3 50.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.043 -1.036 . . . . 0.0 110.774 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.419 ' HB2' ' HB3' ' A' ' 116' ' ' SER . 49.7 m -132.37 144.67 50.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.417 -0.802 . . . . 0.0 109.71 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -135.58 121.99 20.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.162 -0.961 . . . . 0.0 110.719 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.638 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.0 p90 -147.19 -177.03 5.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.363 -0.836 . . . . 0.0 109.691 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.89 HG22 ' HA ' ' A' ' 113' ' ' ILE . 5.7 p -142.52 170.35 15.88 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.115 -0.991 . . . . 0.0 110.739 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.427 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 1.4 t -155.06 157.48 37.61 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.41 -0.807 . . . . 0.0 110.243 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -76.07 -38.34 57.19 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.125 -0.984 . . . . 0.0 109.993 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.835 HD11 ' HB2' ' A' ' 152' ' ' LYS . 3.3 mp -58.37 150.02 56.52 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.44 -0.788 . . . . 0.0 109.98 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.759 ' HD2' HG23 ' A' ' 13' ' ' ILE . 39.6 Cg_endo -66.1 144.71 76.64 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.909 1.478 . . . . 0.0 110.116 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.652 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 38.4 Cg_endo -72.41 -31.46 11.31 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.961 1.506 . . . . 0.0 113.002 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.652 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 44.0 Cg_endo -71.72 -22.0 24.49 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 N-CA-C 109.757 -0.901 . . . . 0.0 109.757 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.803 ' HG2' HD22 ' A' ' 151' ' ' LEU . 42.0 ttm180 -81.89 -47.57 12.61 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.799 ' HA ' HD11 ' A' ' 151' ' ' LEU . 0.7 OUTLIER -66.26 -26.26 67.27 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.645 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.557 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 51.6 t80 -67.88 -50.72 54.76 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.513 0.673 . . . . 0.0 109.798 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.79 ' HG2' HD22 ' A' ' 24' ' ' LEU . 34.7 mttm -58.46 -33.63 69.96 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.624 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.056 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -80.04 -26.22 39.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.449 -0.782 . . . . 0.0 110.749 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.997 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 1.4 t80 -87.18 -46.72 9.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.17 -0.956 . . . . 0.0 111.474 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.704 HG13 ' CE1' ' A' ' 81' ' ' TYR . 3.5 t -98.84 -54.73 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.018 -1.051 . . . . 0.0 111.098 -179.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.79 HD22 ' HG2' ' A' ' 20' ' ' LYS . 8.0 mp -67.81 -5.59 17.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.174 -0.954 . . . . 0.0 110.735 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -144.35 17.82 1.71 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.118 -0.989 . . . . 0.0 110.443 -179.866 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.997 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -56.99 -23.12 43.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.188 -0.945 . . . . 0.0 110.164 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -79.55 -14.34 58.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.309 -0.869 . . . . 0.0 110.335 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.441 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 80.5 m-20 -132.37 9.14 4.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.183 -0.948 . . . . 0.0 110.415 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.654 HD23 ' OH ' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -105.3 -43.61 4.95 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.176 -0.952 . . . . 0.0 110.432 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.624 ' CG1' HD13 ' A' ' 38' ' ' ILE . 3.0 t -74.39 -41.4 4.84 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.339 -0.851 . . . . 0.0 110.956 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.9 Cg_endo -77.8 10.73 2.48 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.313 1.165 . . . . 0.0 110.896 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 28' ' ' ASN . 15.4 mttm -124.87 -34.92 2.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.115 -0.99 . . . . 0.0 109.355 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.663 HG21 ' HB3' ' A' ' 146' ' ' LEU . 6.7 mt -80.12 -44.15 22.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.487 -0.758 . . . . 0.0 109.628 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.87 95.06 14.1 Favored Pre-proline 0 N--CA 1.487 1.398 0 O-C-N 121.407 -0.808 . . . . 0.0 110.189 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.16 -0.41 9.09 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.047 1.551 . . . . 0.0 110.513 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -90.41 -27.42 19.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.218 -0.926 . . . . 0.0 110.039 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -87.53 -47.83 8.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.355 -0.841 . . . . 0.0 110.11 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.624 HD13 ' CG1' ' A' ' 30' ' ' VAL . 1.0 OUTLIER -125.68 130.19 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.495 -0.753 . . . . 0.0 109.926 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -89.17 -26.96 21.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.36 -0.837 . . . . 0.0 110.056 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.454 ' O ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -172.11 150.08 2.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.918 . . . . 0.0 110.197 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.6 m -128.58 123.3 33.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.339 -0.851 . . . . 0.0 109.904 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.415 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 69.5 tt0 -134.13 111.57 10.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.147 -0.97 . . . . 0.0 110.733 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 38.2 mt -53.65 143.61 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.292 -0.88 . . . . 0.0 109.892 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.432 ' HA ' HD12 ' A' ' 44' ' ' LEU . 30.3 tp -120.82 -27.3 5.06 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.224 -0.922 . . . . 0.0 110.447 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.676 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.7 m95 -123.92 162.83 22.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.294 -0.879 . . . . 0.0 110.516 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.45 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 42.84 -135.97 4.07 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.415 ' N ' ' OG1' ' A' ' 52' ' ' THR . 0.2 OUTLIER -152.64 22.95 0.6 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.392 -1.063 . . . . 0.0 110.052 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 120.09 -19.75 9.33 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.494 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -74.16 -169.82 21.43 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.435 ' HA ' HG22 ' A' ' 71' ' ' ILE . 45.3 Cg_endo -72.13 128.12 13.53 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 123.925 1.487 . . . . 0.0 110.649 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.4 -14.57 47.09 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.527 -1.829 . . . . 0.0 108.527 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.545 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.1 m -71.79 160.42 32.63 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.553 -0.969 . . . . 0.0 109.329 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.676 HD12 ' CG ' ' A' ' 45' ' ' TRP . 59.5 mt -132.48 119.36 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 110.276 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.635 ' CE ' HD11 ' A' ' 71' ' ' ILE . 48.6 mttm -102.56 124.8 48.77 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.355 -0.84 . . . . 0.0 110.163 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.4 tttt -92.31 93.9 8.87 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.29 -0.881 . . . . 0.0 110.004 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.548 ' CG2' HG12 ' A' ' 38' ' ' ILE . 70.7 mt -80.1 144.26 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.187 -0.945 . . . . 0.0 110.05 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 40' ' ' HIS . 1.2 p -115.08 153.93 29.82 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.359 -0.838 . . . . 0.0 110.347 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.544 ' CZ ' HG22 ' A' ' 67' ' ' VAL . 19.3 m-85 -114.53 137.87 51.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.158 -0.964 . . . . 0.0 110.107 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.9 29.3 8.14 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.424 ' HG3' ' HB3' ' A' ' 58' ' ' PHE . 95.2 mt-10 -48.35 -29.45 3.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.182 -1.187 . . . . 0.0 110.201 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 118.64 -119.29 4.3 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.415 ' O ' ' HB2' ' A' ' 63' ' ' GLN . 55.7 p -60.27 165.42 3.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.288 -1.125 . . . . 0.0 110.316 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' A' ' 62' ' ' SER . 98.8 mt-30 54.42 97.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.29 -0.881 . . . . 0.0 110.349 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.403 ' C ' ' O ' ' A' ' 63' ' ' GLN . 0.7 OUTLIER -44.13 140.81 1.97 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.9 . . . . 0.0 110.095 179.869 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -138.78 116.53 1.28 Allowed Glycine 0 N--CA 1.486 2.033 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.545 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 13.9 p90 -156.4 174.47 15.37 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.088 -1.242 . . . . 0.0 110.208 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.734 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.8 m -144.16 174.97 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.872 . . . . 0.0 110.658 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.671 ' O ' HD12 ' A' ' 85' ' ' LEU . 22.7 mttm -132.22 104.36 6.72 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.515 -0.741 . . . . 0.0 109.687 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.981 ' CD2' HD13 ' A' ' 85' ' ' LEU . 12.5 m170 -95.57 126.09 40.62 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.26 -0.9 . . . . 0.0 111.103 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.545 ' HA ' ' O ' ' A' ' 52' ' ' THR . 23.8 tttt -98.48 108.67 21.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.351 -0.843 . . . . 0.0 109.434 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.635 HD11 ' CE ' ' A' ' 54' ' ' LYS . 30.2 mm -42.38 139.78 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.222 -0.924 . . . . 0.0 110.15 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.542 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 13.1 t0 -116.55 -41.22 3.11 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.187 -0.945 . . . . 0.0 110.46 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.485 ' C ' HD12 ' A' ' 74' ' ' ILE . 22.9 m -168.94 158.86 9.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 109.917 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.485 HD12 ' C ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -148.93 154.33 9.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 C-N-CA 119.142 -1.023 . . . . 0.0 111.131 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 79' ' ' TYR . 2.4 m-20 -133.91 77.82 1.73 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 120.269 -0.573 . . . . 0.0 110.092 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.557 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 36.7 tttm -61.6 -15.66 41.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.099 -1.001 . . . . 0.0 110.199 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -92.93 -30.53 15.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.259 -0.9 . . . . 0.0 109.593 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 2.0 m120 -105.04 -9.15 18.04 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.69 -0.632 . . . . 0.0 109.882 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.578 ' CZ ' ' HB3' ' A' ' 16' ' ' PRO . 2.9 m-85 70.13 51.31 0.4 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.62 -0.675 . . . . 0.0 110.277 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.487 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -125.17 149.01 48.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.908 . . . . 0.0 109.669 179.711 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.704 ' CE1' HG13 ' A' ' 23' ' ' VAL . 58.5 t80 -138.86 139.96 38.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.162 -0.961 . . . . 0.0 110.235 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.434 ' O ' ' HB3' ' A' ' 72' ' ' ASP . 3.3 m -148.52 121.37 8.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.208 -0.932 . . . . 0.0 110.439 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.676 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 8.8 p90 -131.41 175.12 9.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.291 -0.881 . . . . 0.0 110.42 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 98' ' ' ILE . 19.7 m -127.82 126.06 40.96 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.346 -0.846 . . . . 0.0 109.948 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.981 HD13 ' CD2' ' A' ' 69' ' ' HIS . 14.0 tp -97.57 135.5 39.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.018 -1.051 . . . . 0.0 110.277 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.519 ' H ' HD12 ' A' ' 85' ' ' LEU . 9.5 pt -115.81 -31.27 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.219 -0.926 . . . . 0.0 110.255 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.489 ' C ' ' CD1' ' A' ' 91' ' ' LEU . 39.4 tt0 -107.86 165.65 11.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.28 -0.887 . . . . 0.0 110.09 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.734 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 151.55 140.17 3.1 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -60.04 -31.93 70.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.276 -1.132 . . . . 0.0 110.228 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.786 ' HB1' ' CE1' ' A' ' 132' ' ' HIS . . . -67.02 -39.61 87.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.29 -0.881 . . . . 0.0 110.213 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.654 ' CD2' HD21 ' A' ' 95' ' ' LEU . 11.4 mt -42.31 -51.96 4.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.367 -0.833 . . . . 0.0 110.135 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 43.54 -167.4 0.02 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.409 ' C ' ' OD1' ' A' ' 93' ' ' ASP . 55.8 p-10 -79.43 3.22 19.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -1.146 . . . . 0.0 110.176 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.514 ' O ' HG22 ' A' ' 122' ' ' THR . 0.1 OUTLIER -92.32 -51.93 4.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.231 -0.918 . . . . 0.0 110.185 -179.907 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.874 HD12 ' H ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -107.56 159.59 16.32 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.406 -0.809 . . . . 0.0 109.416 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.874 ' H ' HD12 ' A' ' 95' ' ' LEU . 62.9 tt0 -134.88 -80.33 0.44 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.306 -0.871 . . . . 0.0 110.182 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 46.8 mttt -80.27 152.74 28.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.633 -0.667 . . . . 0.0 110.78 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.726 HG21 ' CE2' ' A' ' 100' ' ' TYR . 4.7 mm -138.66 142.99 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.175 -0.953 . . . . 0.0 109.701 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.482 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.8 OUTLIER -121.38 127.39 51.16 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.356 -0.84 . . . . 0.0 109.151 178.887 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.726 ' CE2' HG21 ' A' ' 98' ' ' ILE . 10.3 m-85 -122.52 135.19 54.59 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 110.517 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.466 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 74.4 tt0 -138.14 141.38 40.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.312 -0.867 . . . . 0.0 110.356 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.53 ' N ' ' O ' ' A' ' 81' ' ' TYR . 32.7 m -137.66 149.94 46.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.412 -0.805 . . . . 0.0 109.732 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 115' ' ' LYS . 7.9 mttt -145.54 138.14 25.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.114 -0.991 . . . . 0.0 110.725 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.828 HD23 HG12 ' A' ' 114' ' ' ILE . 5.9 mt -118.75 151.69 37.56 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.298 -0.876 . . . . 0.0 109.497 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.701 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -150.23 -169.85 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.042 -1.036 . . . . 0.0 110.371 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.701 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -121.44 141.87 50.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.42 -0.8 . . . . 0.0 110.141 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.479 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 7.9 p -99.25 167.51 11.12 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.209 -0.932 . . . . 0.0 110.29 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.7 Cg_endo -72.32 -1.12 9.68 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.013 1.533 . . . . 0.0 110.596 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 52.0 p -106.65 4.14 27.58 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.248 -0.907 . . . . 0.0 110.303 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 100.21 -32.83 6.86 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -61.97 -172.11 1.27 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.508 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.0 OUTLIER -131.56 128.77 39.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.217 -1.167 . . . . 0.0 110.413 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.89 ' HA ' HG22 ' A' ' 10' ' ' THR . 10.3 mt -82.19 152.14 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.321 -0.862 . . . . 0.0 110.039 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.828 HG12 HD23 ' A' ' 104' ' ' LEU . 15.7 mt -132.31 119.03 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.2 -0.938 . . . . 0.0 110.436 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.486 ' O ' ' N ' ' A' ' 103' ' ' LYS . 26.6 tttt -108.63 119.04 38.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 110.075 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 2.0 t -110.87 158.16 19.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 110.306 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.466 ' HB ' ' HB3' ' A' ' 101' ' ' GLU . 43.1 m -160.01 139.74 11.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.21 -0.931 . . . . 0.0 110.3 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 41.9 t -143.58 159.67 42.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.214 -0.929 . . . . 0.0 110.116 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.598 ' CE1' HG23 ' A' ' 4' ' ' THR . 69.8 m-70 -142.34 159.1 42.9 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.157 -0.964 . . . . 0.0 110.527 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.596 ' HA ' HD13 ' A' ' 98' ' ' ILE . 8.7 m-85 -117.86 150.78 38.61 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.36 -0.837 . . . . 0.0 110.279 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.476 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 95.2 m-70 -128.39 82.76 2.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.138 -0.976 . . . . 0.0 109.896 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 94' ' ' THR . 1.2 p -71.74 152.13 43.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.347 -0.845 . . . . 0.0 110.082 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.419 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 7.3 ttpt -109.89 118.29 36.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.255 -0.903 . . . . 0.0 110.335 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 101.59 -143.44 16.07 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -112.72 73.41 0.81 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.302 -1.116 . . . . 0.0 110.207 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 5.9 m -140.67 156.49 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.273 -0.892 . . . . 0.0 110.147 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -128.2 154.7 45.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.266 -0.896 . . . . 0.0 110.261 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.804 HD12 ' CE1' ' A' ' 3' ' ' PHE . 3.0 mt -74.9 172.74 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.337 -0.852 . . . . 0.0 110.2 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.61 ' N ' HG22 ' A' ' 128' ' ' ILE . 40.9 mmtm -104.07 125.9 50.78 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.347 -0.846 . . . . 0.0 110.053 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 129' ' ' LYS . 96.0 mt-10 -43.65 -54.05 5.31 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.223 -0.923 . . . . 0.0 110.038 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 42.9 tt0 -46.32 -25.04 0.56 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.207 -0.933 . . . . 0.0 109.797 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.786 ' CE1' ' HB1' ' A' ' 90' ' ' ALA . 12.1 t-160 -81.54 -64.56 1.16 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.435 -0.791 . . . . 0.0 110.071 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 1.093 HG21 ' CE2' ' A' ' 5' ' ' TYR . 8.8 p -66.14 -39.47 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.359 -0.838 . . . . 0.0 110.031 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.519 ' N ' HG13 ' A' ' 133' ' ' VAL . 38.0 tttp -63.59 -42.46 98.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 109.968 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 131' ' ' GLU . . . -66.77 -32.27 73.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.353 -0.842 . . . . 0.0 109.883 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.64 -26.98 74.13 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.564 ' NZ ' HG22 ' A' ' 133' ' ' VAL . 45.1 mttp -65.11 -35.43 81.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.336 -1.096 . . . . 0.0 110.021 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -82.69 -36.48 25.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.32 -0.862 . . . . 0.0 109.868 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 41.0 mttt -73.29 -26.93 61.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.387 -0.821 . . . . 0.0 109.854 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.407 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -81.54 -38.77 25.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.368 -0.833 . . . . 0.0 109.92 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.9 t -64.01 -47.15 81.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.335 -0.853 . . . . 0.0 109.947 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -54.86 -44.68 74.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.247 -0.908 . . . . 0.0 109.867 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.474 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 9.4 tp -57.2 -45.88 83.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 0.0 109.859 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.557 ' HA ' HD12 ' A' ' 147' ' ' ILE . 28.0 m-85 -54.44 -41.32 69.26 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.234 -0.916 . . . . 0.0 109.507 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 18.7 mttp -72.82 -12.98 61.19 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.438 -0.789 . . . . 0.0 110.035 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.663 ' HB3' HG21 ' A' ' 33' ' ' ILE . 16.1 mt -83.75 -36.2 23.82 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.177 -0.952 . . . . 0.0 108.921 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.699 HD11 ' CE1' ' A' ' 22' ' ' PHE . 25.8 mt -68.05 -44.31 84.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.538 ' OE2' HD13 ' A' ' 18' ' ' LEU . 60.8 mm-40 -53.66 -46.22 70.53 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.533 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 25.7 m -65.83 -39.11 90.51 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.354 -0.841 . . . . 0.0 109.351 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.611 ' CD1' HD11 ' A' ' 33' ' ' ILE . 58.0 t80 -43.64 -56.85 3.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.435 -0.791 . . . . 0.0 109.829 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.803 HD22 ' HG2' ' A' ' 17' ' ' ARG . 12.4 mt -75.16 -39.72 60.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.541 -0.724 . . . . 0.0 110.432 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.835 ' HB2' HD11 ' A' ' 13' ' ' ILE . 25.1 tttm -60.83 -17.77 51.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.122 -0.986 . . . . 0.0 109.364 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.498 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -113.46 -29.59 2.9 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.453 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 8.0 m80 -105.82 89.84 3.87 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.285 -1.126 . . . . 0.0 110.009 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.554 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 45.6 Cg_endo -71.12 1.85 4.9 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.052 1.554 . . . . 0.0 110.989 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -108.33 -16.31 14.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.049 -1.032 . . . . 0.0 110.107 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.607 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -71.41 99.56 2.01 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.2 -0.937 . . . . 0.0 109.848 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 1.056 ' CE1' ' HB2' ' A' ' 21' ' ' ALA . 0.1 OUTLIER 35.06 32.54 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 CA-C-O 121.564 0.697 . . . . 0.0 109.569 -179.24 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.554 ' ND2' ' HA ' ' A' ' 155' ' ' PRO . 0.1 OUTLIER . . . . . 0 C--N 1.303 -1.451 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.94 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.456 ' O ' ' OG1' ' A' ' 122' ' ' THR . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.929 HG13 ' O ' ' A' ' 120' ' ' TYR . 77.4 t -125.29 138.57 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -1.157 . . . . 0.0 110.2 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.697 ' CE1' HD12 ' A' ' 128' ' ' ILE . 11.7 m-85 -98.02 136.13 38.72 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.205 -0.934 . . . . 0.0 109.624 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.681 HG23 ' ND1' ' A' ' 119' ' ' HIS . 8.5 m -119.19 136.81 54.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.093 -1.004 . . . . 0.0 110.815 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.006 ' CE2' HG21 ' A' ' 133' ' ' VAL . 57.0 m-85 -147.18 124.83 11.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.474 -0.766 . . . . 0.0 109.83 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 1.004 ' CG ' HG23 ' A' ' 117' ' ' THR . 5.0 mt-10 -123.54 132.77 53.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.277 -0.889 . . . . 0.0 110.494 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.444 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 50.7 m -119.01 157.8 27.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.325 -0.86 . . . . 0.0 109.898 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 7' ' ' SER . 50.5 mp0 -146.37 123.98 11.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.111 -0.993 . . . . 0.0 110.804 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.635 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.0 p90 -141.71 -175.88 4.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.886 . . . . 0.0 109.632 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.81 HG22 ' HA ' ' A' ' 113' ' ' ILE . 8.6 p -142.5 169.84 16.83 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.009 -1.057 . . . . 0.0 110.794 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 112' ' ' SER . 4.0 t -153.83 162.15 41.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.422 -0.799 . . . . 0.0 110.174 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -85.1 -28.47 25.57 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.127 -0.983 . . . . 0.0 110.164 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.79 HG23 ' HD2' ' A' ' 14' ' ' PRO . 9.1 mm -67.9 150.79 97.63 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 0.0 109.891 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.79 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.4 Cg_endo -66.12 143.35 71.3 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.932 1.491 . . . . 0.0 110.325 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.658 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.2 Cg_endo -72.55 -31.13 11.35 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 124.023 1.539 . . . . 0.0 112.888 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.658 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.6 Cg_endo -70.1 -23.83 28.83 Favored 'Trans proline' 0 C--N 1.316 -1.147 0 N-CA-C 110.177 -0.74 . . . . 0.0 110.177 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.731 HH21 ' HB3' ' A' ' 157' ' ' ALA . 46.2 mtp180 -83.68 -42.47 16.6 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.741 HD23 ' C ' ' A' ' 18' ' ' LEU . 0.6 OUTLIER -71.85 -31.56 66.62 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.958 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.619 ' N ' HD23 ' A' ' 18' ' ' LEU . 54.3 t80 -65.39 -54.93 21.56 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.461 -0.774 . . . . 0.0 109.042 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.533 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 70.1 mttt -48.63 -48.54 39.43 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.724 -0.79 . . . . 0.0 109.355 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.17 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -67.75 -28.77 67.91 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.334 -0.854 . . . . 0.0 111.135 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 1.066 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.9 OUTLIER -80.92 -46.54 15.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 111.411 -178.814 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.701 HG13 ' CE1' ' A' ' 81' ' ' TYR . 3.4 t -104.44 -51.36 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.942 -1.099 . . . . 0.0 111.761 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.678 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.2 mp -79.97 -4.61 53.22 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.097 -1.002 . . . . 0.0 111.966 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.571 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 1.0 OUTLIER -149.17 23.95 0.93 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.717 -1.239 . . . . 0.0 110.643 -179.632 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 1.066 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -67.01 -32.94 74.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.17 -0.956 . . . . 0.0 110.301 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.427 ' HA ' ' OG ' ' A' ' 41' ' ' SER . 81.4 m-20 -56.54 -17.68 9.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.357 -0.839 . . . . 0.0 110.559 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.539 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 4.2 p-10 -128.94 -0.93 5.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.15 -0.969 . . . . 0.0 110.523 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.758 ' HG ' ' HB1' ' A' ' 21' ' ' ALA . 1.1 tm? -88.57 -43.76 11.14 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.112 -0.992 . . . . 0.0 110.17 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 1.067 HG11 HD13 ' A' ' 38' ' ' ILE . 5.0 t -74.59 -40.86 4.36 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.437 -0.79 . . . . 0.0 111.319 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.0 Cg_endo -77.54 10.91 2.33 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 123.448 1.236 . . . . 0.0 111.005 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.486 ' CD ' ' O ' ' A' ' 28' ' ' ASN . 31.9 mtpt -120.65 -34.65 3.54 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.029 -1.044 . . . . 0.0 109.031 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.971 HG21 ' HB3' ' A' ' 146' ' ' LEU . 10.6 mt -80.19 -32.58 13.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 121.53 0.681 . . . . 0.0 109.657 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -159.65 98.35 1.54 Allowed Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.412 -0.805 . . . . 0.0 110.097 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.8 -0.75 8.86 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.034 1.544 . . . . 0.0 110.809 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -85.03 -19.08 32.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 109.788 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -85.76 -86.05 0.14 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.415 -0.803 . . . . 0.0 110.082 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 1.067 HD13 HG11 ' A' ' 30' ' ' VAL . 1.9 mp -90.75 139.94 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.279 -0.888 . . . . 0.0 110.112 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.425 ' O ' ' CB ' ' A' ' 40' ' ' HIS . 4.8 ttmm -87.81 -26.74 22.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.353 -0.842 . . . . 0.0 110.18 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.675 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER 177.03 157.19 0.31 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.177 -0.952 . . . . 0.0 110.193 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.427 ' OG ' ' HA ' ' A' ' 27' ' ' ASP . 79.4 p -117.3 134.21 55.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.356 -0.84 . . . . 0.0 110.023 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.675 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 29.0 tp10 -138.69 106.87 5.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.091 -1.005 . . . . 0.0 110.246 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 20.0 mt -62.59 137.16 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 110.098 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.899 HD22 ' CE ' ' A' ' 55' ' ' LYS . 13.0 tp -114.08 -23.51 9.49 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.239 -0.913 . . . . 0.0 110.534 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.701 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.7 m95 -127.06 161.61 28.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.049 -1.032 . . . . 0.0 110.63 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.446 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 41.76 -132.09 3.97 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -157.24 19.78 0.3 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.296 -1.12 . . . . 0.0 110.154 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.91 -18.22 7.09 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.472 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -74.51 -171.64 26.87 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.432 ' HA ' HG22 ' A' ' 71' ' ' ILE . 46.0 Cg_endo -73.38 129.54 13.99 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.103 1.581 . . . . 0.0 110.665 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.34 -9.44 49.55 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.509 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.1 m -76.88 167.17 22.29 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.567 -0.96 . . . . 0.0 109.921 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.701 HD12 ' CG ' ' A' ' 45' ' ' TRP . 65.6 mt -137.35 120.24 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.322 -0.861 . . . . 0.0 109.871 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 70.7 mttt -106.03 138.37 42.34 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.211 -0.93 . . . . 0.0 110.411 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.899 ' CE ' HD22 ' A' ' 44' ' ' LEU . 43.5 mttt -102.53 95.86 6.52 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.308 -0.87 . . . . 0.0 110.06 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.545 ' HB ' HG23 ' A' ' 67' ' ' VAL . 52.1 mt -80.05 135.41 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 109.846 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 1.6 p -104.77 155.8 18.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.374 -0.828 . . . . 0.0 110.452 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.741 ' HE2' HG13 ' A' ' 67' ' ' VAL . 23.9 m-85 -118.73 169.89 9.45 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.316 -0.865 . . . . 0.0 110.083 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -46.85 150.95 1.8 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 61' ' ' GLY . 79.8 tt0 -57.97 -40.25 80.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -1.177 . . . . 0.0 110.262 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' A' ' 60' ' ' GLU . . . 42.99 -163.61 0.03 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.8 m -67.21 -40.82 86.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -1.126 . . . . 0.0 110.032 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.416 ' O ' ' C ' ' A' ' 64' ' ' TYR . 95.3 mt-30 -123.7 140.91 52.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.343 -0.848 . . . . 0.0 110.018 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.515 ' CE2' ' CD2' ' A' ' 66' ' ' TYR . 8.5 t80 -43.32 141.04 1.4 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.172 -0.955 . . . . 0.0 110.075 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -129.31 136.18 8.84 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.562 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 11.7 p90 -179.49 161.38 1.04 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.349 -1.089 . . . . 0.0 109.952 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.844 HG12 ' HA2' ' A' ' 88' ' ' GLY . 7.1 m -141.95 171.83 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.681 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.513 ' O ' HD23 ' A' ' 85' ' ' LEU . 50.9 mttt -123.31 115.03 21.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.597 -0.689 . . . . 0.0 109.801 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.455 ' CE1' ' HG ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -106.29 126.19 51.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.141 -0.974 . . . . 0.0 110.633 -179.608 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 52' ' ' THR . 27.2 ttpp -97.43 126.58 42.77 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.322 -0.861 . . . . 0.0 109.77 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.508 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 26.1 mm -66.22 122.02 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 0.0 110.219 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -98.14 -43.34 7.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.359 -0.838 . . . . 0.0 110.118 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.8 m -169.0 159.42 9.28 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.382 -0.824 . . . . 0.0 109.616 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.5 mt -144.19 158.22 15.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.141 -0.975 . . . . 0.0 110.386 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.551 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 4.3 m-20 -134.39 78.76 1.77 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.088 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.432 ' HB2' ' HE3' ' A' ' 76' ' ' LYS . 38.1 mtmt -62.52 -14.03 37.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.195 -0.94 . . . . 0.0 110.233 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -93.68 -33.06 13.81 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.266 -0.896 . . . . 0.0 109.521 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.469 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.6 m120 -104.65 -8.18 19.1 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.605 -0.685 . . . . 0.0 109.841 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.636 ' O ' HD12 ' A' ' 104' ' ' LEU . 3.2 m-85 68.95 50.86 0.58 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.447 -0.783 . . . . 0.0 110.12 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.551 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -120.96 155.3 34.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.318 -0.864 . . . . 0.0 109.405 179.638 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.701 ' CE1' HG13 ' A' ' 23' ' ' VAL . 26.8 t80 -143.21 133.17 24.14 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.177 -0.952 . . . . 0.0 110.216 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 37.9 m -136.75 122.73 20.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 110.488 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.612 ' N ' ' CD1' ' A' ' 83' ' ' TYR . 3.1 p90 -139.42 179.98 6.23 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.179 -0.951 . . . . 0.0 110.039 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . 1.001 HG23 ' O ' ' A' ' 98' ' ' ILE . 39.3 m -132.02 142.46 49.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 110.332 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.664 HD22 ' O ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -98.04 119.35 36.52 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.261 -0.9 . . . . 0.0 110.278 179.911 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.473 ' CG1' ' HB2' ' A' ' 68' ' ' LYS . 31.2 pt -102.64 -12.85 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.2 -0.938 . . . . 0.0 110.062 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.664 ' O ' HD22 ' A' ' 85' ' ' LEU . 47.8 tp10 -141.82 166.7 24.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.311 -0.868 . . . . 0.0 110.214 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.844 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 148.87 120.33 1.07 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -50.15 -24.39 2.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.341 -1.094 . . . . 0.0 110.229 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 1.039 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -74.09 -22.61 59.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.926 . . . . 0.0 110.27 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.465 ' O ' ' O ' ' A' ' 92' ' ' GLY . 37.7 mt -66.86 -27.09 67.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.229 -0.919 . . . . 0.0 110.307 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 48.91 -178.04 0.01 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 93' ' ' ASP . 38.1 p30 -81.61 8.67 9.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -1.16 . . . . 0.0 110.267 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.616 ' O ' HG21 ' A' ' 126' ' ' VAL . 71.2 p -96.3 -39.62 9.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -0.906 . . . . 0.0 110.182 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.915 HD21 ' CG1' ' A' ' 128' ' ' ILE . 47.3 mt -98.8 153.59 18.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.389 -0.819 . . . . 0.0 110.193 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.509 ' HG3' ' HB2' ' A' ' 123' ' ' LYS . 41.9 mm-40 -131.91 -80.31 0.51 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.242 -0.911 . . . . 0.0 110.253 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.507 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 17.6 mttt -80.19 128.73 33.86 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.595 -0.691 . . . . 0.0 110.756 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 1.001 ' O ' HG23 ' A' ' 84' ' ' THR . 11.3 mm -115.65 146.76 19.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 120.777 -1.202 . . . . 0.0 109.582 178.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.503 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.0 OUTLIER -123.41 123.77 41.41 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.258 -0.901 . . . . 0.0 109.046 178.564 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.806 ' CE2' HG21 ' A' ' 98' ' ' ILE . 15.0 m-85 -121.34 133.13 55.1 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.457 -0.777 . . . . 0.0 109.732 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.486 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 21.1 tt0 -142.07 144.05 33.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.09 -1.006 . . . . 0.0 110.782 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 62.1 m -140.13 146.03 38.32 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.455 -0.778 . . . . 0.0 109.594 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -139.52 138.38 36.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.096 -1.002 . . . . 0.0 110.658 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.826 HD23 HG12 ' A' ' 114' ' ' ILE . 7.1 mt -118.6 150.3 39.92 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.4 -0.813 . . . . 0.0 109.965 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.679 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.8 t -147.72 -171.38 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.188 -0.945 . . . . 0.0 110.212 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.679 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -122.75 138.19 54.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.419 -0.801 . . . . 0.0 110.171 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.44 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 4.2 p -99.2 167.74 10.77 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.289 -0.882 . . . . 0.0 110.22 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.44 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.1 Cg_endo -72.27 -4.27 14.9 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.12 1.59 . . . . 0.0 110.349 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 36.5 m -93.82 -18.73 21.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 110.309 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 118.18 -30.37 6.08 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.485 ' HA3' ' O ' ' A' ' 11' ' ' SER . . . -64.72 -142.96 0.03 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 11' ' ' SER . 26.4 p -155.71 128.57 7.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.287 -1.125 . . . . 0.0 109.968 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.81 ' HA ' HG22 ' A' ' 10' ' ' THR . 15.2 mt -79.96 149.14 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -0.908 . . . . 0.0 110.085 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.826 HG12 HD23 ' A' ' 104' ' ' LEU . 15.6 mt -131.36 119.45 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.414 -0.804 . . . . 0.0 110.25 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -104.83 121.35 43.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.098 -1.001 . . . . 0.0 110.072 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.411 ' C ' ' HG1' ' A' ' 117' ' ' THR . 0.0 OUTLIER -104.12 152.65 21.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -0.868 . . . . 0.0 110.216 -179.861 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . 1.004 HG23 ' CG ' ' A' ' 6' ' ' GLU . 12.1 m -159.97 122.39 3.37 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.316 -0.865 . . . . 0.0 110.568 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.506 ' C ' ' CG ' ' A' ' 119' ' ' HIS . 15.0 t -133.55 160.13 38.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.361 -0.837 . . . . 0.0 109.669 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.681 ' ND1' HG23 ' A' ' 4' ' ' THR . 33.7 m-70 -147.19 164.2 33.89 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.061 -1.025 . . . . 0.0 110.642 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.929 ' O ' HG13 ' A' ' 2' ' ' VAL . 6.3 m-85 -126.93 150.53 49.29 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.253 -0.904 . . . . 0.0 110.443 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.507 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 93.6 m-70 -129.78 84.71 2.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.255 -0.903 . . . . 0.0 109.723 178.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.709 ' CG2' HD23 ' A' ' 95' ' ' LEU . 1.2 p -63.64 154.8 31.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.302 -0.874 . . . . 0.0 110.179 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.509 ' HB2' ' HG3' ' A' ' 96' ' ' GLU . 43.4 tttt -113.73 117.56 31.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 110.048 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 99.25 -115.95 5.45 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.476 ' O ' ' ND2' ' A' ' 125' ' ' ASN . 0.7 OUTLIER -138.27 67.4 1.41 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.301 -1.117 . . . . 0.0 110.138 179.854 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.616 HG21 ' O ' ' A' ' 94' ' ' THR . 27.9 m -131.92 167.23 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.886 . . . . 0.0 110.085 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -140.76 161.41 37.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 110.255 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.915 ' CG1' HD21 ' A' ' 95' ' ' LEU . 3.5 mp -84.17 172.8 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.252 -0.905 . . . . 0.0 110.127 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.614 ' N ' HG22 ' A' ' 128' ' ' ILE . 16.2 mttm -108.25 129.92 55.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.384 -0.823 . . . . 0.0 109.683 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.459 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 73.1 mm-40 -43.86 -49.69 8.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.079 -1.013 . . . . 0.0 109.885 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.506 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 51.6 tt0 -48.54 -23.09 0.87 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.154 -0.966 . . . . 0.0 109.651 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 1.039 ' NE2' ' HB1' ' A' ' 90' ' ' ALA . 13.5 t-160 -88.48 -66.42 0.92 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.372 -0.83 . . . . 0.0 110.142 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 1.006 HG21 ' CE2' ' A' ' 5' ' ' TYR . 7.3 p -59.91 -40.21 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.345 -0.847 . . . . 0.0 109.84 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.533 ' N ' HG13 ' A' ' 133' ' ' VAL . 31.5 tptt -66.69 -47.39 72.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.285 -0.884 . . . . 0.0 109.795 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.506 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -63.32 -34.18 77.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.74 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.86 -33.89 85.47 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.658 ' NZ ' HG22 ' A' ' 133' ' ' VAL . 21.9 mttp -62.87 -37.87 88.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.366 -1.079 . . . . 0.0 109.78 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -78.81 -37.54 40.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.491 -0.756 . . . . 0.0 109.826 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 135' ' ' ALA . 20.9 mttm -66.89 -33.24 75.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.411 -0.805 . . . . 0.0 109.801 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.1 -45.71 26.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.311 -0.868 . . . . 0.0 109.829 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.0 m -59.13 -42.8 91.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.425 -0.797 . . . . 0.0 109.798 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -59.88 -46.26 89.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.31 -0.869 . . . . 0.0 109.816 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.5 HD23 ' HA ' ' A' ' 143' ' ' LEU . 18.9 mt -58.13 -35.63 71.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.373 -0.829 . . . . 0.0 109.722 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.578 ' HA ' HD12 ' A' ' 147' ' ' ILE . 22.6 m-85 -64.27 -34.33 77.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.372 -0.83 . . . . 0.0 109.774 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -71.95 -16.9 62.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.332 -0.855 . . . . 0.0 109.848 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.971 ' HB3' HG21 ' A' ' 33' ' ' ILE . 19.5 mt -81.23 -36.65 29.73 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.231 -0.918 . . . . 0.0 108.728 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.661 HG21 ' HG ' ' A' ' 18' ' ' LEU . 27.8 mt -70.43 -49.03 56.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.504 ' O ' HG13 ' A' ' 13' ' ' ILE . 97.9 mt-10 -53.07 -38.83 62.84 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.379 -0.825 . . . . 0.0 109.056 178.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.477 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 35.2 m -76.49 -30.18 57.13 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.271 -0.893 . . . . 0.0 109.011 178.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.593 ' CD1' HD11 ' A' ' 33' ' ' ILE . 54.0 t80 -50.52 -52.95 33.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.591 -0.693 . . . . 0.0 109.566 179.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.964 HD21 ' CE1' ' A' ' 158' ' ' TYR . 40.6 mt -80.15 -25.0 40.01 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.457 -0.777 . . . . 0.0 109.812 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.545 ' HA ' HD11 ' A' ' 13' ' ' ILE . 14.4 tttp -63.38 -17.42 62.6 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.329 -0.857 . . . . 0.0 109.311 179.133 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.49 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -120.3 -27.14 2.07 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.427 ' ND1' ' N ' ' A' ' 154' ' ' HIS . 1.3 m80 -106.38 91.24 5.56 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.191 -1.182 . . . . 0.0 110.285 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.8 Cg_endo -73.38 2.51 5.6 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.022 1.538 . . . . 0.0 110.82 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -113.17 -9.58 13.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.12 -0.987 . . . . 0.0 109.879 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.731 ' HB3' HH21 ' A' ' 17' ' ' ARG . . . -47.8 111.08 0.38 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.386 -0.821 . . . . 0.0 110.176 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 1.17 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 35.13 31.56 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.695 -0.628 . . . . 0.0 110.658 -179.804 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.533 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.65 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 93.5 t -128.04 126.57 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -1.161 . . . . 0.0 110.226 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.604 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 38.9 m-85 -87.18 161.36 18.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 0.0 110.415 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.856 HG23 ' CE1' ' A' ' 119' ' ' HIS . 33.8 m -138.63 92.18 2.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.886 . . . . 0.0 110.272 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.651 ' CD1' HG11 ' A' ' 133' ' ' VAL . 72.5 m-85 -110.43 126.61 54.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.245 -0.909 . . . . 0.0 109.643 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 116' ' ' SER . 21.2 pt-20 -132.47 152.2 51.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -0.916 . . . . 0.0 110.699 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 61.6 m -129.87 138.86 51.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.367 -0.833 . . . . 0.0 109.581 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -112.99 139.92 48.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.117 -0.989 . . . . 0.0 110.816 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.598 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.8 p90 -155.97 -175.23 5.32 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.431 -0.793 . . . . 0.0 109.511 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.803 HG22 ' HA ' ' A' ' 113' ' ' ILE . 8.1 p -139.9 174.57 10.38 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.99 -1.069 . . . . 0.0 110.814 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.46 ' HB3' ' OE2' ' A' ' 148' ' ' GLU . 54.1 p -158.59 127.41 5.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.447 -0.783 . . . . 0.0 110.124 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -55.1 -38.24 67.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.231 -0.918 . . . . 0.0 110.036 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.836 HG21 HD12 ' A' ' 151' ' ' LEU . 3.1 mp -59.07 150.36 62.26 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.416 -0.803 . . . . 0.0 110.015 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.797 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.9 Cg_endo -66.41 142.29 65.19 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.938 1.493 . . . . 0.0 110.37 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.633 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.0 Cg_endo -72.4 -31.2 11.68 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.874 1.46 . . . . 0.0 112.881 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 44.2 Cg_endo -72.78 -19.85 23.41 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 N-CA-C 109.984 -0.814 . . . . 0.0 109.984 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.903 ' HG2' HD13 ' A' ' 151' ' ' LEU . 36.7 ttm180 -83.55 -47.62 11.11 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.773 HD23 ' C ' ' A' ' 18' ' ' LEU . 1.1 tt -67.51 -32.42 73.21 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.55 ' N ' HD23 ' A' ' 18' ' ' LEU . 57.2 t80 -64.17 -53.99 40.66 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.479 -0.763 . . . . 0.0 109.402 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.546 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 17.8 mttm -49.6 -41.43 42.09 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.801 -0.76 . . . . 0.0 109.326 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.036 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -76.65 -33.54 58.32 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.398 -0.814 . . . . 0.0 111.04 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.817 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.6 OUTLIER -71.49 -49.08 44.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.036 -1.04 . . . . 0.0 111.323 -178.803 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.58 ' HB ' HD12 ' A' ' 24' ' ' LEU . 4.9 t -104.75 -49.25 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.015 -1.053 . . . . 0.0 111.437 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.674 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.2 mp -76.99 -5.42 48.61 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.088 -1.007 . . . . 0.0 111.218 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.573 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -157.2 54.98 0.51 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.861 -1.15 . . . . 0.0 110.418 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.817 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -92.04 -10.07 40.47 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.341 -0.849 . . . . 0.0 110.05 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.514 ' O ' ' CG ' ' A' ' 31' ' ' PRO . 41.8 t0 -73.26 -20.32 60.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.326 -0.859 . . . . 0.0 109.919 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -128.46 14.02 6.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.353 -0.842 . . . . 0.0 109.888 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.873 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 0.4 OUTLIER -98.23 -46.19 5.92 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.363 -0.836 . . . . 0.0 110.321 -179.876 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.657 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.4 m -89.16 -33.35 0.4 Allowed Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.369 -0.832 . . . . 0.0 111.074 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.3 Cg_endo -80.22 7.59 4.62 Favored 'Trans proline' 0 C--N 1.317 -1.097 0 O-C-N 123.06 1.032 . . . . 0.0 110.318 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 51.6 tttt -131.99 -33.24 1.37 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.298 -0.876 . . . . 0.0 109.972 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.575 HG12 ' CD1' ' A' ' 150' ' ' TYR . 11.9 mt -80.02 -43.0 22.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.386 -0.821 . . . . 0.0 109.876 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.717 ' HB2' HD13 ' A' ' 146' ' ' LEU . . . -152.2 95.47 3.16 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.298 -0.876 . . . . 0.0 110.233 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -76.92 6.2 4.38 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.125 1.592 . . . . 0.0 110.774 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -89.59 -9.44 49.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.077 -1.014 . . . . 0.0 110.214 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.733 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -104.12 -41.78 5.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 110.23 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.733 HD12 ' C ' ' A' ' 37' ' ' ALA . 1.4 mp -136.43 121.07 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.429 -0.794 . . . . 0.0 109.88 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 57' ' ' THR . 6.7 ttpp -56.79 -29.94 63.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -0.914 . . . . 0.0 110.249 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.524 ' CG ' ' N ' ' A' ' 41' ' ' SER . 0.0 OUTLIER 173.53 179.38 0.1 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.245 -0.91 . . . . 0.0 110.004 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.524 ' N ' ' CG ' ' A' ' 40' ' ' HIS . 56.3 m -139.97 148.46 41.94 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.234 -0.916 . . . . 0.0 110.245 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.4 tp10 -152.85 111.2 3.69 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.155 -0.965 . . . . 0.0 110.601 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 29.8 mt -60.51 133.1 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.198 -0.939 . . . . 0.0 109.895 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.54 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 18.2 mt -107.27 -27.06 10.75 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.176 -0.952 . . . . 0.0 110.686 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.716 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.8 m95 -126.18 161.19 28.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.118 -0.989 . . . . 0.0 110.826 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.454 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 41.95 -133.81 3.86 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.431 ' O ' ' CG ' ' A' ' 47' ' ' ASP . 9.5 t0 -154.67 19.17 0.46 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.309 -1.112 . . . . 0.0 110.011 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.01 -17.29 7.63 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.577 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -70.31 -172.55 11.15 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -73.62 129.08 13.23 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 O-C-N 124.093 1.575 . . . . 0.0 110.589 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.38 -11.66 56.82 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.528 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -71.71 164.75 25.37 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.522 -0.987 . . . . 0.0 109.699 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.716 HD12 ' CG ' ' A' ' 45' ' ' TRP . 47.3 mt -133.35 120.9 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.345 -0.847 . . . . 0.0 109.725 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.471 ' CE ' HD11 ' A' ' 71' ' ' ILE . 28.4 mttm -104.36 131.4 51.75 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.205 -0.935 . . . . 0.0 110.291 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.54 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 73.0 tttt -101.81 93.26 5.22 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.215 -0.928 . . . . 0.0 110.05 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.55 ' CG2' HG12 ' A' ' 38' ' ' ILE . 74.6 mt -80.0 147.34 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.216 -0.927 . . . . 0.0 110.065 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.576 ' O ' HG23 ' A' ' 38' ' ' ILE . 2.2 p -116.69 150.59 37.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.29 -0.881 . . . . 0.0 110.729 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.703 ' HE2' HG13 ' A' ' 67' ' ' VAL . 22.3 m-85 -113.79 126.84 55.66 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.411 -0.806 . . . . 0.0 110.037 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.437 ' N ' ' HB2' ' A' ' 39' ' ' LYS . . . -91.49 50.39 2.96 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -71.78 -25.1 61.88 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.336 -1.097 . . . . 0.0 110.294 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 173.07 -160.66 31.49 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 63' ' ' GLN . 8.7 t -61.16 -52.12 66.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -1.136 . . . . 0.0 110.205 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 62' ' ' SER . 92.4 mt-30 -42.81 147.61 0.29 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.251 -0.906 . . . . 0.0 110.154 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.86 113.8 23.86 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.24 -0.912 . . . . 0.0 110.175 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.576 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -120.98 94.49 0.55 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.537 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 11.8 p90 -131.17 169.13 16.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -1.182 . . . . 0.0 110.217 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.792 HG12 ' HA2' ' A' ' 88' ' ' GLY . 4.1 m -135.25 177.9 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.233 -0.917 . . . . 0.0 110.345 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.656 ' O ' HD12 ' A' ' 85' ' ' LEU . 83.2 mttt -134.91 106.8 7.02 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.377 -0.827 . . . . 0.0 109.872 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.983 ' CD2' HD13 ' A' ' 85' ' ' LEU . 14.5 m170 -98.32 125.78 43.57 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.217 -0.927 . . . . 0.0 111.247 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.577 ' CE ' ' CG2' ' A' ' 86' ' ' ILE . 5.8 mtmp? -93.3 119.13 32.09 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.29 -0.881 . . . . 0.0 109.496 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.577 HG21 ' O ' ' A' ' 49' ' ' GLY . 37.8 mm -58.36 128.39 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.128 -0.983 . . . . 0.0 110.519 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.483 ' HB2' ' OG ' ' A' ' 82' ' ' SER . 94.3 m-20 -101.81 -43.82 5.71 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.382 -0.824 . . . . 0.0 109.939 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.498 ' N ' ' OG ' ' A' ' 82' ' ' SER . 22.7 m -169.49 158.89 8.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.407 -0.808 . . . . 0.0 109.736 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.6 mt -142.99 158.27 17.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.175 -0.953 . . . . 0.0 110.465 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.552 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 4.4 m-20 -134.32 77.81 1.72 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.682 -0.636 . . . . 0.0 109.927 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.53 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 14.7 ttpp -61.14 -16.25 42.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.088 -1.008 . . . . 0.0 110.238 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -93.15 -30.34 15.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.287 -0.883 . . . . 0.0 109.623 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.5 m120 -106.38 -7.28 17.73 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.481 -0.762 . . . . 0.0 109.958 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.575 ' O ' HD12 ' A' ' 104' ' ' LEU . 2.7 m-85 67.59 51.19 0.85 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.49 -0.756 . . . . 0.0 110.008 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.552 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -123.41 151.2 42.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.305 -0.872 . . . . 0.0 109.324 179.618 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.684 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 31.1 t80 -137.93 141.07 40.58 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.174 -0.954 . . . . 0.0 110.414 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.498 ' OG ' ' N ' ' A' ' 73' ' ' SER . 1.2 p -143.38 126.48 16.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.243 -0.911 . . . . 0.0 110.56 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.684 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 26.8 p90 -149.17 170.86 17.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.33 -0.856 . . . . 0.0 110.233 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.857 HG23 ' O ' ' A' ' 98' ' ' ILE . 40.7 m -127.05 150.51 49.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.308 -0.87 . . . . 0.0 109.88 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.983 HD13 ' CD2' ' A' ' 69' ' ' HIS . 8.0 tp -111.42 124.79 52.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.0 -1.063 . . . . 0.0 110.354 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.577 ' CG2' ' CE ' ' A' ' 70' ' ' LYS . 14.4 pt -105.21 -27.08 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.382 -0.824 . . . . 0.0 110.23 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.611 ' O ' HD11 ' A' ' 85' ' ' LEU . 81.7 tt0 -123.38 155.73 36.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -0.86 . . . . 0.0 110.227 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.792 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 162.26 137.99 2.32 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -65.07 -19.21 65.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.22 -1.164 . . . . 0.0 110.16 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.93 -17.8 45.83 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.288 -0.882 . . . . 0.0 110.278 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.635 HD22 HD12 ' A' ' 98' ' ' ILE . 14.1 mt -61.38 -29.02 69.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.269 -0.894 . . . . 0.0 110.03 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 47.27 -175.61 0.01 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.575 ' OD1' HG23 ' A' ' 94' ' ' THR . 54.6 p30 -83.85 6.76 20.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.192 -1.181 . . . . 0.0 109.773 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.575 HG23 ' OD1' ' A' ' 93' ' ' ASP . 50.0 p -98.93 -42.42 7.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.366 -0.834 . . . . 0.0 110.225 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.921 HD21 HD11 ' A' ' 128' ' ' ILE . 74.6 mt -100.44 161.67 13.45 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.39 -0.819 . . . . 0.0 110.137 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -142.46 -81.27 0.21 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.307 -0.871 . . . . 0.0 109.609 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 7.8 mtpp -80.2 143.74 33.54 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.688 -0.632 . . . . 0.0 110.352 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.857 ' O ' HG23 ' A' ' 84' ' ' THR . 0.6 OUTLIER -138.06 134.86 45.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.049 -1.032 . . . . 0.0 109.489 179.092 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.499 ' CB ' ' HB2' ' A' ' 119' ' ' HIS . 0.1 OUTLIER -109.9 141.06 43.16 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.467 -0.771 . . . . 0.0 109.875 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.611 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 2.8 m-85 -127.8 143.16 51.14 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.319 -0.863 . . . . 0.0 110.341 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.476 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 68.2 tt0 -149.79 119.43 6.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.317 -0.864 . . . . 0.0 110.193 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 64.4 m -119.66 150.76 39.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.166 -0.959 . . . . 0.0 109.923 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 115' ' ' LYS . 20.8 mttt -142.65 133.71 25.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.237 -0.915 . . . . 0.0 110.515 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.927 HD23 HG12 ' A' ' 114' ' ' ILE . 5.4 mt -116.74 147.35 42.11 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.193 -0.942 . . . . 0.0 109.799 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.69 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -150.69 -168.75 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.195 -0.941 . . . . 0.0 110.107 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.69 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -112.75 156.15 23.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.356 -0.84 . . . . 0.0 109.973 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.452 ' HB3' HG13 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -114.42 170.21 5.71 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.257 -0.902 . . . . 0.0 110.36 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -76.04 0.77 8.95 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.069 1.563 . . . . 0.0 110.471 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 59.0 p -109.9 8.96 24.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.236 -0.915 . . . . 0.0 110.268 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 93.41 -26.39 15.91 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.428 ' C ' ' OG ' ' A' ' 107' ' ' SER . . . -70.24 -172.41 10.81 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.509 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 5.2 p -124.78 127.2 46.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.124 -1.221 . . . . 0.0 110.428 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.803 ' HA ' HG22 ' A' ' 10' ' ' THR . 73.9 mt -79.9 148.28 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.303 -0.873 . . . . 0.0 110.199 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.927 HG12 HD23 ' A' ' 104' ' ' LEU . 18.0 mt -132.45 127.48 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.188 -0.945 . . . . 0.0 110.563 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 103' ' ' LYS . 38.1 tttp -118.08 118.59 32.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.255 -0.903 . . . . 0.0 109.797 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.1 t -113.9 155.17 26.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.114 -0.991 . . . . 0.0 110.656 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.476 ' HB ' ' HB3' ' A' ' 101' ' ' GLU . 78.6 m -149.87 133.37 16.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.365 -0.834 . . . . 0.0 110.192 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 28.0 p -126.47 142.99 51.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.237 -0.914 . . . . 0.0 110.238 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.856 ' CE1' HG23 ' A' ' 4' ' ' THR . 85.5 m-70 -122.67 157.37 32.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.152 -0.967 . . . . 0.0 110.436 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.526 ' CD2' HG13 ' A' ' 128' ' ' ILE . 28.5 m-85 -128.32 137.34 51.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.248 -0.908 . . . . 0.0 110.354 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.487 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 47.4 m-70 -117.71 88.79 2.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.095 -1.003 . . . . 0.0 109.491 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.809 ' CG2' HD23 ' A' ' 95' ' ' LEU . 1.1 p -72.92 160.16 32.57 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.46 -0.775 . . . . 0.0 110.411 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 15.5 tttt -113.9 111.85 22.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.372 -0.83 . . . . 0.0 110.214 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 113.64 -133.87 11.49 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -123.5 64.33 1.02 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.217 -1.166 . . . . 0.0 110.255 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.452 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 24.2 m -130.73 162.52 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.258 -0.901 . . . . 0.0 110.142 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.423 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 93.0 mt-10 -134.67 161.62 34.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 0.0 110.307 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.921 HD11 HD21 ' A' ' 95' ' ' LEU . 20.6 mm -67.29 173.12 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 0.0 110.056 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.591 ' N ' HG22 ' A' ' 128' ' ' ILE . 12.5 mttt -111.75 132.8 54.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.0 110.029 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.434 ' OE1' ' HA ' ' A' ' 130' ' ' GLU . 69.4 mm-40 -44.61 -35.16 2.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.195 -0.941 . . . . 0.0 110.133 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -67.81 -23.81 65.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 109.967 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.472 ' N ' ' O ' ' A' ' 129' ' ' LYS . 16.4 t-160 -83.16 -49.33 9.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.297 -0.877 . . . . 0.0 110.217 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.651 HG11 ' CD1' ' A' ' 5' ' ' TYR . 98.8 t -59.61 -34.29 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.388 -0.82 . . . . 0.0 110.076 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -73.87 -51.14 17.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.893 . . . . 0.0 110.037 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.426 ' O ' ' HG3' ' A' ' 139' ' ' LYS . . . -59.29 -32.95 70.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.251 -0.905 . . . . 0.0 110.016 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.34 -27.93 73.11 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 81.0 mttt -78.9 -31.71 45.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.246 -1.15 . . . . 0.0 110.125 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -88.72 -30.03 19.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 0.0 109.92 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.426 ' HG3' ' O ' ' A' ' 135' ' ' ALA . 25.9 mttm -72.17 -31.11 65.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.349 -0.845 . . . . 0.0 109.94 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -86.64 -41.64 14.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.258 -0.901 . . . . 0.0 109.961 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 36.0 t -53.22 -43.25 67.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.338 -0.851 . . . . 0.0 110.088 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -57.38 -42.87 83.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -0.847 . . . . 0.0 110.005 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.463 HD23 HD12 ' A' ' 146' ' ' LEU . 52.7 mt -63.9 -37.75 88.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -0.914 . . . . 0.0 109.941 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -63.14 -35.15 79.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.433 -0.792 . . . . 0.0 109.857 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -75.15 -10.68 59.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.289 -0.882 . . . . 0.0 110.278 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.717 HD13 ' HB2' ' A' ' 34' ' ' ALA . 24.0 mt -85.18 -36.67 20.87 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.11 -0.994 . . . . 0.0 109.099 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.701 HD11 ' CE1' ' A' ' 22' ' ' PHE . 32.3 mt -71.2 -44.12 74.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.618 ' HB3' HD13 ' A' ' 13' ' ' ILE . 85.2 mt-10 -58.08 -42.22 85.14 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.446 -0.784 . . . . 0.0 109.614 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 28.2 m -70.19 -39.97 74.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.191 -0.943 . . . . 0.0 109.54 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.615 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 93.1 t80 -49.37 -42.44 42.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.437 -0.789 . . . . 0.0 109.995 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.903 HD13 ' HG2' ' A' ' 17' ' ' ARG . 42.6 mt -80.16 -44.72 19.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.322 -0.862 . . . . 0.0 110.33 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.745 ' HB2' HD11 ' A' ' 13' ' ' ILE . 29.9 tttt -61.03 -14.45 23.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.337 -0.852 . . . . 0.0 109.629 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -113.31 -30.05 2.8 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.46 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 5.5 m80 -112.64 96.09 35.35 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.357 -1.084 . . . . 0.0 110.025 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.48 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.9 Cg_endo -73.78 7.68 2.28 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.155 1.608 . . . . 0.0 111.279 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 157' ' ' ALA . 39.3 p30 -109.84 -9.56 14.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.952 -1.093 . . . . 0.0 109.582 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.615 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -66.01 101.14 0.65 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.548 -0.72 . . . . 0.0 110.182 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 1.036 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 0.3 OUTLIER 35.05 32.63 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.218 0 CA-C-O 121.406 0.622 . . . . 0.0 110.164 -179.602 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.533 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.305 -1.365 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.935 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 1.043 HG23 ' C ' ' A' ' 120' ' ' TYR . 3.4 p -88.11 148.13 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.332 -1.099 . . . . 0.0 110.538 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -83.95 172.25 12.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.403 -0.811 . . . . 0.0 110.118 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . 1.0 HG23 ' CE1' ' A' ' 119' ' ' HIS . 92.8 m -141.1 124.83 16.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.289 -0.882 . . . . 0.0 110.46 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.639 ' CZ ' HG11 ' A' ' 133' ' ' VAL . 74.4 m-85 -126.04 144.63 50.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.321 -0.862 . . . . 0.0 109.932 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.454 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 20.5 pt-20 -139.34 149.54 44.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.208 -0.932 . . . . 0.0 110.581 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -135.44 144.54 46.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.453 -0.779 . . . . 0.0 109.595 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -130.33 119.48 22.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.113 -0.992 . . . . 0.0 110.634 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.641 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.0 p90 -144.61 -177.89 5.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.393 -0.817 . . . . 0.0 109.793 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.89 HG22 ' HA ' ' A' ' 113' ' ' ILE . 9.4 p -141.9 171.89 13.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.175 -0.953 . . . . 0.0 110.678 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -152.36 154.99 36.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.46 -0.775 . . . . 0.0 110.247 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -77.01 -27.88 54.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.293 -0.88 . . . . 0.0 109.928 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.818 HG23 ' HD2' ' A' ' 14' ' ' PRO . 1.8 mp -71.39 150.54 94.07 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.351 -0.843 . . . . 0.0 109.849 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.818 ' HD2' HG23 ' A' ' 13' ' ' ILE . 41.0 Cg_endo -66.43 141.49 61.82 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.99 1.521 . . . . 0.0 110.498 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.636 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 41.2 Cg_endo -73.64 -30.21 9.94 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 124.068 1.562 . . . . 0.0 113.125 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 44.6 Cg_endo -71.56 -28.3 17.69 Favored 'Trans proline' 0 C--N 1.318 -1.034 0 N-CA-C 110.288 -0.697 . . . . 0.0 110.288 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.563 ' CZ ' ' HA ' ' A' ' 159' ' ' ASN . 6.3 mtp180 -79.92 -42.91 23.12 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.029 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.722 HD23 ' C ' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -66.51 -30.07 70.32 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.575 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.608 ' N ' HD23 ' A' ' 18' ' ' LEU . 52.0 t80 -63.83 -51.99 62.16 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.51 0.671 . . . . 0.0 109.851 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.54 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 22.9 mttt -55.94 -40.04 72.59 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.525 -0.734 . . . . 0.0 109.94 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.068 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -77.86 -26.8 49.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.263 -0.898 . . . . 0.0 110.946 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 1.002 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 3.4 t80 -81.8 -49.12 10.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.095 -1.003 . . . . 0.0 111.579 -178.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.702 HG13 ' CE1' ' A' ' 81' ' ' TYR . 5.5 t -102.03 -53.71 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.098 -1.001 . . . . 0.0 111.462 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.622 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.6 mp -66.0 -8.7 24.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.137 -0.977 . . . . 0.0 111.016 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.564 ' OD2' ' CE2' ' A' ' 158' ' ' TYR . 2.7 m-20 -145.0 21.79 1.58 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.963 -1.086 . . . . 0.0 110.524 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 1.002 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -59.73 -14.85 16.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.201 -0.937 . . . . 0.0 110.414 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -80.08 -25.03 40.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -0.914 . . . . 0.0 110.483 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.494 ' HB2' ' HE3' ' A' ' 32' ' ' LYS . 6.9 p30 -126.8 14.39 7.46 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.128 -0.982 . . . . 0.0 110.606 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.766 HD23 ' OH ' ' A' ' 158' ' ' TYR . 1.2 tm? -100.71 -43.09 6.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.239 -0.913 . . . . 0.0 109.858 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.93 HG11 HD13 ' A' ' 38' ' ' ILE . 4.8 t -77.41 -40.81 2.26 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.464 -0.772 . . . . 0.0 111.193 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 47.6 Cg_endo -77.6 10.65 2.45 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.444 1.234 . . . . 0.0 111.051 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.494 ' HE3' ' HB2' ' A' ' 28' ' ' ASN . 16.6 mttm -122.27 -30.74 3.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.985 -1.072 . . . . 0.0 109.496 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.93 HG21 ' HB3' ' A' ' 146' ' ' LEU . 7.5 mt -80.13 -55.48 8.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.579 -0.701 . . . . 0.0 109.821 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.51 103.96 5.02 Favored Pre-proline 0 C--N 1.304 -1.409 0 O-C-N 121.404 -0.81 . . . . 0.0 110.238 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.33 0.34 7.54 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.015 1.534 . . . . 0.0 110.526 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -81.62 -20.59 39.42 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.116 -0.99 . . . . 0.0 109.475 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -91.5 -42.32 10.33 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.467 -0.771 . . . . 0.0 109.927 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.93 HD13 HG11 ' A' ' 30' ' ' VAL . 1.1 mp -137.7 140.1 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.43 -0.794 . . . . 0.0 109.944 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.3 ttmm -82.25 -36.37 27.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 110.208 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -176.44 154.98 1.36 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.262 -0.898 . . . . 0.0 110.192 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.5 m -124.2 116.8 23.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.287 -0.883 . . . . 0.0 109.975 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.8 tp10 -122.79 113.27 18.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.193 -0.942 . . . . 0.0 110.449 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.482 HG12 ' HG2' ' A' ' 54' ' ' LYS . 23.2 mt -60.67 133.94 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.322 -0.861 . . . . 0.0 109.98 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.537 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 26.7 mt -106.97 -23.5 12.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.247 -0.908 . . . . 0.0 110.517 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.576 ' CD1' HD12 ' A' ' 53' ' ' ILE . 1.6 m95 -130.94 161.25 32.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.127 -0.983 . . . . 0.0 110.559 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.454 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 41.98 -133.56 3.95 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -157.7 20.65 0.27 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -1.104 . . . . 0.0 110.059 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.465 ' O ' HG21 ' A' ' 71' ' ' ILE . . . 125.49 -19.92 6.61 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.484 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -67.79 -175.21 8.48 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.426 ' HA ' HG22 ' A' ' 71' ' ' ILE . 47.1 Cg_endo -73.92 129.54 13.47 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 123.932 1.49 . . . . 0.0 110.66 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.94 -13.99 52.66 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -68.0 166.38 15.95 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.516 -0.991 . . . . 0.0 109.907 179.751 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.576 HD12 ' CD1' ' A' ' 45' ' ' TRP . 40.7 mt -133.27 121.68 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.315 -0.865 . . . . 0.0 109.662 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.52 ' HE3' HD11 ' A' ' 71' ' ' ILE . 20.7 mttm -111.15 132.29 54.41 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.144 -0.973 . . . . 0.0 110.411 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.537 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 17.7 tttt -101.36 89.93 3.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 109.904 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.551 ' CG2' HG12 ' A' ' 38' ' ' ILE . 83.0 mt -79.98 144.4 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.296 -0.877 . . . . 0.0 110.168 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.516 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 4.8 p -117.31 159.11 23.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.295 -0.878 . . . . 0.0 110.603 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' A' ' 65' ' ' GLY . 22.5 m-85 -119.61 149.54 41.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.381 -0.824 . . . . 0.0 110.076 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -111.91 30.69 7.55 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -48.74 -26.55 2.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.305 -1.115 . . . . 0.0 110.274 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 171.94 -160.85 32.68 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.6 m -63.05 -41.01 99.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.263 -1.139 . . . . 0.0 110.224 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -49.94 149.5 2.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.168 -0.957 . . . . 0.0 110.09 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -85.1 123.15 30.29 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.2 -0.938 . . . . 0.0 110.342 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -134.1 91.61 0.25 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.538 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 15.2 p90 -129.92 166.7 19.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.137 -1.213 . . . . 0.0 110.276 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.794 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.4 m -142.92 172.27 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 110.696 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.523 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 23.3 mttm -125.19 124.48 41.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.621 -0.675 . . . . 0.0 109.543 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.698 ' NE2' HD13 ' A' ' 85' ' ' LEU . 11.3 m170 -113.41 126.1 54.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.143 -0.973 . . . . 0.0 111.157 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 1.03 ' HE3' HD13 ' A' ' 86' ' ' ILE . 48.3 mttt -97.82 117.15 31.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.373 -0.829 . . . . 0.0 109.509 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.522 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 22.4 mm -60.07 128.64 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.082 -1.011 . . . . 0.0 110.311 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 82' ' ' SER . 89.4 m-20 -102.5 -45.34 5.09 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.314 -0.867 . . . . 0.0 110.179 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 19.1 m -168.08 159.07 10.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.385 -0.822 . . . . 0.0 110.094 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.483 HG12 HG11 ' A' ' 23' ' ' VAL . 2.0 mt -141.26 158.79 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.292 -0.88 . . . . 0.0 110.118 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.551 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 4.5 m-20 -135.37 80.02 1.81 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.502 -0.749 . . . . 0.0 110.116 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.564 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 17.8 mttt -62.39 -18.16 60.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.135 -0.978 . . . . 0.0 110.4 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -91.91 -31.79 15.53 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.133 -0.979 . . . . 0.0 109.633 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.476 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.5 m120 -103.58 -6.63 21.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.591 -0.693 . . . . 0.0 109.799 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.569 ' CZ ' ' HB3' ' A' ' 16' ' ' PRO . 4.1 m-85 65.91 51.8 1.32 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.494 -0.754 . . . . 0.0 110.056 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.551 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -123.38 157.9 32.33 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.081 -1.012 . . . . 0.0 109.595 179.812 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.702 ' CE1' HG13 ' A' ' 23' ' ' VAL . 32.3 t80 -144.56 141.01 29.16 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.196 -0.94 . . . . 0.0 110.259 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.6 OUTLIER -145.89 127.02 14.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.208 -0.932 . . . . 0.0 110.929 -179.799 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.688 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 20.0 p90 -146.6 170.67 16.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.436 -0.79 . . . . 0.0 109.796 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.606 HG23 ' O ' ' A' ' 98' ' ' ILE . 35.2 m -124.44 135.43 53.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.159 -0.963 . . . . 0.0 110.427 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.698 HD13 ' NE2' ' A' ' 69' ' ' HIS . 6.3 tp -99.49 124.35 44.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.283 -0.886 . . . . 0.0 109.702 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 1.03 HD13 ' HE3' ' A' ' 70' ' ' LYS . 14.3 pt -106.41 -15.77 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.387 -0.821 . . . . 0.0 110.459 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.523 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 24.9 tt0 -121.3 176.11 5.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.147 -0.97 . . . . 0.0 110.339 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.794 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 137.09 123.58 2.24 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -57.78 -15.37 7.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -1.142 . . . . 0.0 110.205 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.929 ' HB1' ' CE1' ' A' ' 132' ' ' HIS . . . -73.92 -40.48 63.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -0.88 . . . . 0.0 110.167 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.669 ' CD2' HD21 ' A' ' 95' ' ' LEU . 10.1 mt -42.17 -48.05 4.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.406 -0.809 . . . . 0.0 110.119 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 43.23 -164.72 0.03 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -81.19 2.57 27.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -1.142 . . . . 0.0 110.172 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 52.2 p -92.62 -42.51 9.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.287 -0.883 . . . . 0.0 110.17 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.873 HD12 ' H ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -119.55 159.91 23.43 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.367 -0.833 . . . . 0.0 109.339 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.873 ' H ' HD12 ' A' ' 95' ' ' LEU . 53.9 tt0 -136.32 -82.02 0.39 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.344 -0.848 . . . . 0.0 110.178 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.499 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 5.3 mttt -80.24 139.36 36.73 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.768 -0.583 . . . . 0.0 110.558 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.752 HG21 ' CE2' ' A' ' 100' ' ' TYR . 3.6 mm -123.06 139.97 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.963 -1.086 . . . . 0.0 109.887 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.513 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -117.48 126.77 53.19 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.279 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.752 ' CE2' HG21 ' A' ' 98' ' ' ILE . 8.7 m-85 -119.56 137.63 53.72 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.237 -0.914 . . . . 0.0 110.722 -178.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.469 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 80.9 tt0 -143.2 134.57 26.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.353 -0.842 . . . . 0.0 110.143 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.417 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 85.6 m -133.77 145.11 49.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -0.917 . . . . 0.0 110.18 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.6 mttt -140.53 140.72 35.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 0.0 110.671 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.794 HD23 HG12 ' A' ' 114' ' ' ILE . 10.1 mt -121.05 149.57 42.51 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.236 -0.915 . . . . 0.0 110.142 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.7 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -146.05 -169.71 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.207 -0.933 . . . . 0.0 110.03 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.7 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -126.68 160.56 30.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.256 -0.902 . . . . 0.0 110.275 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.423 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.2 p -119.32 170.55 6.54 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.225 -0.922 . . . . 0.0 110.144 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.423 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 45.7 Cg_endo -72.8 -14.8 26.89 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 124.11 1.584 . . . . 0.0 110.575 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 24.8 p -94.7 7.15 46.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -0.903 . . . . 0.0 110.273 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 94.46 -31.16 6.99 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -58.26 -172.41 0.34 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 10.4 p -137.25 137.63 39.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.194 -1.18 . . . . 0.0 110.39 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.89 ' HA ' HG22 ' A' ' 10' ' ' THR . 16.2 mt -92.58 149.59 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.402 -0.811 . . . . 0.0 110.088 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.794 HG12 HD23 ' A' ' 104' ' ' LEU . 18.5 mt -131.23 128.63 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.22 -0.925 . . . . 0.0 110.228 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.1 tttp -118.11 108.73 15.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.084 -1.01 . . . . 0.0 110.209 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.434 ' OG ' ' CZ ' ' A' ' 9' ' ' PHE . 0.9 OUTLIER -103.25 157.33 17.08 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.238 -0.914 . . . . 0.0 110.441 -179.854 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.704 HG22 ' NE2' ' A' ' 119' ' ' HIS . 24.8 m -154.87 119.56 4.83 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.337 -0.852 . . . . 0.0 110.438 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 86.5 p -119.01 148.1 43.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.403 -0.811 . . . . 0.0 110.041 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 1.0 ' CE1' HG23 ' A' ' 4' ' ' THR . 24.6 m-70 -132.42 152.93 51.29 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.201 -0.937 . . . . 0.0 110.668 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 1.043 ' C ' HG23 ' A' ' 2' ' ' VAL . 9.8 m-85 -121.82 119.92 33.05 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.271 -0.893 . . . . 0.0 110.614 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.566 ' N ' HG23 ' A' ' 2' ' ' VAL . 80.4 m-70 -92.62 104.1 16.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.558 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.468 HG21 ' HA ' ' A' ' 127' ' ' GLU . 0.8 OUTLIER -77.96 144.75 36.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.141 -0.975 . . . . 0.0 110.374 -179.593 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.418 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 31.5 tttp -105.57 126.93 52.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.278 -0.889 . . . . 0.0 110.207 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.37 -138.92 21.14 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -113.87 59.64 0.67 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -1.142 . . . . 0.0 110.274 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 26.2 m -131.28 161.7 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.319 -0.863 . . . . 0.0 110.194 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.468 ' HA ' HG21 ' A' ' 122' ' ' THR . 85.3 mt-10 -137.6 139.7 40.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.266 -0.896 . . . . 0.0 110.25 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.598 HG22 ' N ' ' A' ' 129' ' ' LYS . 2.7 mp -59.77 173.25 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.191 -0.943 . . . . 0.0 110.148 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.598 ' N ' HG22 ' A' ' 128' ' ' ILE . 21.4 mttm -92.45 127.41 37.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 110.089 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -45.39 -44.72 12.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.149 -0.969 . . . . 0.0 110.136 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 29.0 tp10 -53.29 -30.26 37.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.194 -0.941 . . . . 0.0 110.04 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.929 ' CE1' ' HB1' ' A' ' 90' ' ' ALA . 11.1 t-160 -76.35 -57.82 3.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -0.932 . . . . 0.0 110.239 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.639 HG11 ' CZ ' ' A' ' 5' ' ' TYR . 72.3 t -59.19 -34.22 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.377 -0.827 . . . . 0.0 110.063 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -72.41 -49.1 36.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.332 -0.855 . . . . 0.0 110.111 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.87 -29.66 69.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.095 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.72 -32.08 80.29 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.429 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 17.3 mttp -65.04 -36.84 85.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.251 -1.146 . . . . 0.0 110.036 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -75.35 -35.44 61.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.307 -0.87 . . . . 0.0 110.041 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -70.12 -30.84 68.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.363 -0.836 . . . . 0.0 109.92 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.482 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -74.61 -41.28 60.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.287 -0.883 . . . . 0.0 110.134 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 61.3 p -64.68 -39.36 93.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.371 -0.831 . . . . 0.0 109.991 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -60.87 -48.11 83.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 110.004 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 27.6 mt -57.87 -38.54 75.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.271 -0.893 . . . . 0.0 109.957 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.498 ' HA ' HD12 ' A' ' 147' ' ' ILE . 19.7 m-85 -62.87 -33.79 76.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.448 -0.783 . . . . 0.0 109.905 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.409 ' HA ' ' OE1' ' A' ' 148' ' ' GLU . 92.8 mttt -74.85 -15.03 60.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -0.904 . . . . 0.0 110.202 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.93 ' HB3' HG21 ' A' ' 33' ' ' ILE . 28.2 mt -85.25 -36.69 20.76 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.222 -0.923 . . . . 0.0 109.043 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.626 HD13 ' CD1' ' A' ' 22' ' ' PHE . 16.1 mt -72.09 -41.41 67.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.538 ' HB3' HD13 ' A' ' 13' ' ' ILE . 86.5 mt-10 -59.13 -42.81 91.5 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.49 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 15.5 m -74.12 -27.96 61.11 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.64 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 50.2 t80 -52.07 -61.85 2.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.563 -0.71 . . . . 0.0 109.836 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.548 HD21 ' CE1' ' A' ' 158' ' ' TYR . 36.0 mt -72.24 -30.08 64.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.346 -0.846 . . . . 0.0 109.71 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.554 ' HB2' HD11 ' A' ' 13' ' ' ILE . 27.8 tttp -65.27 -33.84 76.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.343 -0.848 . . . . 0.0 109.253 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.487 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -99.0 -30.74 6.56 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -107.26 87.2 3.02 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.327 -1.101 . . . . 0.0 109.796 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 46.1 Cg_endo -72.08 2.62 4.71 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.068 1.562 . . . . 0.0 110.955 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -108.24 -12.61 15.05 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.96 -1.087 . . . . 0.0 110.197 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.64 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -69.2 99.71 1.19 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.253 -0.905 . . . . 0.0 109.846 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 1.068 ' CE1' ' HB2' ' A' ' 21' ' ' ALA . 0.1 OUTLIER 34.77 32.33 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 CA-C-O 121.518 0.675 . . . . 0.0 109.871 -179.21 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.563 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.446 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.826 -179.021 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.679 HG13 ' O ' ' A' ' 120' ' ' TYR . 40.4 t -126.85 139.95 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -1.135 . . . . 0.0 110.239 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.75 ' CE1' HD12 ' A' ' 128' ' ' ILE . 16.2 m-85 -101.94 160.6 14.35 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.213 -0.93 . . . . 0.0 109.728 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.596 HG23 ' CD2' ' A' ' 119' ' ' HIS . 5.1 m -124.42 108.32 12.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.118 -0.989 . . . . 0.0 110.508 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.759 ' CE1' HG11 ' A' ' 133' ' ' VAL . 25.3 m-85 -120.47 126.18 49.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.26 -0.9 . . . . 0.0 109.969 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.604 ' HB3' HG23 ' A' ' 117' ' ' THR . 25.8 pt-20 -139.37 159.66 41.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.924 . . . . 0.0 110.394 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.2 t -138.65 148.93 44.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.862 . . . . 0.0 110.012 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -131.81 123.28 27.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.195 -0.941 . . . . 0.0 110.257 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.638 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.0 p90 -145.94 -174.07 4.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.194 -0.941 . . . . 0.0 109.952 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.722 HG22 ' HA ' ' A' ' 113' ' ' ILE . 8.7 p -139.28 175.52 9.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.134 -0.979 . . . . 0.0 110.496 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.477 ' CB ' ' CD ' ' A' ' 148' ' ' GLU . 79.8 p -158.08 139.4 13.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.306 -0.871 . . . . 0.0 110.229 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -64.74 -28.71 69.77 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 0.0 109.888 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.805 HG23 ' HD2' ' A' ' 14' ' ' PRO . 8.3 mm -68.96 149.88 97.74 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.365 -0.835 . . . . 0.0 109.904 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.805 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.5 Cg_endo -65.6 146.47 84.57 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.971 1.511 . . . . 0.0 110.44 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.672 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.1 Cg_endo -71.51 -31.73 13.26 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.969 1.51 . . . . 0.0 112.828 -179.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.672 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 40.8 Cg_endo -69.41 -21.38 35.2 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 N-CA-C 110.059 -0.785 . . . . 0.0 110.059 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.753 ' HB3' HD13 ' A' ' 151' ' ' LEU . 52.7 mtp180 -85.68 -44.87 12.2 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.883 ' HG ' HG21 ' A' ' 147' ' ' ILE . 1.1 tt -71.34 -30.07 65.74 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.627 ' CZ ' HD11 ' A' ' 74' ' ' ILE . 71.4 t80 -66.88 -61.76 1.78 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.521 -0.737 . . . . 0.0 109.13 178.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.585 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 52.6 mttt -52.78 -34.33 52.84 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.338 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.95 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -72.21 -53.75 11.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.33 -0.856 . . . . 0.0 110.749 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.99 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.3 OUTLIER -59.86 -53.2 60.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.507 -0.745 . . . . 0.0 111.425 -178.897 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 1.004 HG11 HD12 ' A' ' 74' ' ' ILE . 11.1 t -91.26 -63.86 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.992 -1.068 . . . . 0.0 111.767 -178.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.585 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 4.7 mp -65.12 -3.57 3.9 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.22 -0.925 . . . . 0.0 111.793 -178.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.581 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.8 OUTLIER -140.46 9.54 2.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.658 -1.276 . . . . 0.0 110.788 179.882 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.99 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -51.57 -26.83 9.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.176 -0.953 . . . . 0.0 110.31 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -76.63 -13.95 60.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.947 . . . . 0.0 110.502 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.424 ' O ' ' HD2' ' A' ' 32' ' ' LYS . 72.0 m-80 -134.97 10.64 3.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.211 -0.93 . . . . 0.0 110.345 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.54 ' HG ' ' HB1' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -104.24 -40.97 5.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.185 -0.947 . . . . 0.0 110.38 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.848 ' CG1' HD13 ' A' ' 38' ' ' ILE . 2.8 t -81.08 -41.55 1.13 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.28 -0.888 . . . . 0.0 111.178 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.3 Cg_endo -77.17 11.17 2.14 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.387 1.204 . . . . 0.0 111.074 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.424 ' HD2' ' O ' ' A' ' 28' ' ' ASN . 17.1 mttm -123.25 -31.51 3.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.943 -1.098 . . . . 0.0 109.471 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.86 ' CG2' HD22 ' A' ' 146' ' ' LEU . 9.3 mt -80.12 -44.96 22.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.52 -0.737 . . . . 0.0 109.611 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.437 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . . . -141.07 99.11 6.66 Favored Pre-proline 0 C--N 1.304 -1.39 0 O-C-N 121.371 -0.831 . . . . 0.0 110.115 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 34' ' ' ALA . 44.9 Cg_endo -71.12 -2.82 11.71 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.951 1.501 . . . . 0.0 110.524 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.448 ' O ' ' HG3' ' A' ' 60' ' ' GLU . 13.5 pt20 -89.02 -23.15 22.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 109.949 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 58' ' ' PHE . . . -85.54 -70.39 0.59 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.323 -0.86 . . . . 0.0 110.06 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.848 HD13 ' CG1' ' A' ' 30' ' ' VAL . 1.8 mp -101.11 122.08 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.449 -0.782 . . . . 0.0 110.01 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 57' ' ' THR . 10.7 ttmt -75.2 -32.11 61.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.154 -0.966 . . . . 0.0 110.487 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -176.25 148.41 0.78 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.162 -0.961 . . . . 0.0 110.171 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.3 m -122.31 118.43 28.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.35 -0.844 . . . . 0.0 109.718 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -129.18 110.37 11.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.149 -0.969 . . . . 0.0 110.422 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.413 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 38.3 mt -53.06 144.91 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.372 -0.83 . . . . 0.0 110.046 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.0 tp -119.72 -25.13 5.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.237 -0.914 . . . . 0.0 110.544 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.825 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.7 m95 -127.81 162.97 25.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.113 -0.992 . . . . 0.0 110.646 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.446 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 42.56 -140.3 2.21 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -149.2 24.79 0.91 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.285 -1.126 . . . . 0.0 110.017 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 118.4 -12.19 12.51 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.546 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -81.97 -168.95 42.27 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.402 ' HA ' HG22 ' A' ' 71' ' ' ILE . 44.2 Cg_endo -72.54 128.28 13.37 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.042 1.548 . . . . 0.0 110.694 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.88 -12.45 49.66 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.1 m -72.85 162.28 29.68 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.616 -0.931 . . . . 0.0 109.47 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.825 HD12 ' CG ' ' A' ' 45' ' ' TRP . 66.1 mt -133.84 119.4 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.235 -0.916 . . . . 0.0 110.103 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.701 ' HE3' HD11 ' A' ' 71' ' ' ILE . 52.5 mttt -102.59 130.72 49.55 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.2 -0.938 . . . . 0.0 110.179 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.526 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 53.6 tttm -102.24 92.42 4.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.242 -0.911 . . . . 0.0 110.164 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.432 ' HB ' HG23 ' A' ' 67' ' ' VAL . 97.5 mt -80.45 140.61 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.142 -0.974 . . . . 0.0 110.394 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 1.4 p -110.16 150.94 27.91 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.351 -0.843 . . . . 0.0 110.267 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.675 ' HE2' HG13 ' A' ' 67' ' ' VAL . 24.7 m-85 -113.83 149.08 35.53 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.221 -0.924 . . . . 0.0 110.077 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -101.79 6.95 54.98 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.448 ' HG3' ' O ' ' A' ' 36' ' ' GLN . 97.4 mt-10 -119.91 155.35 32.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -1.151 . . . . 0.0 110.225 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.91 -153.41 21.17 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 84.5 p -56.34 -172.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.2 -1.176 . . . . 0.0 110.25 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -73.66 -27.94 61.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.907 . . . . 0.0 110.204 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -120.53 101.59 7.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.289 -0.882 . . . . 0.0 110.228 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.571 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -130.26 88.69 0.3 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 13.7 p90 -133.77 166.68 22.07 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.192 -1.181 . . . . 0.0 110.292 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.855 HG12 ' HA2' ' A' ' 88' ' ' GLY . 4.4 m -133.93 175.74 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.384 -0.823 . . . . 0.0 110.253 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.711 ' O ' HD12 ' A' ' 85' ' ' LEU . 33.3 mttt -135.52 103.96 5.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.426 -0.797 . . . . 0.0 109.834 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.945 ' CD2' HD13 ' A' ' 85' ' ' LEU . 15.4 m170 -94.19 129.18 40.9 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.292 -0.88 . . . . 0.0 111.073 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 52' ' ' THR . 70.0 tttt -97.21 111.55 23.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.458 -0.776 . . . . 0.0 109.18 178.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.701 HD11 ' HE3' ' A' ' 54' ' ' LYS . 27.3 mm -52.91 125.61 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.093 -1.005 . . . . 0.0 110.354 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 82' ' ' SER . 95.0 m-20 -99.37 -48.6 4.74 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.374 -0.829 . . . . 0.0 109.666 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.4 m 177.8 160.68 0.51 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.544 -0.722 . . . . 0.0 110.054 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 1.004 HD12 HG11 ' A' ' 23' ' ' VAL . 3.2 tt -145.31 165.92 10.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.392 -0.817 . . . . 0.0 109.785 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.8 m-20 -128.95 76.89 1.75 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.099 -1.0 . . . . 0.0 110.132 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.59 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 65.3 mttm -55.43 -16.66 3.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.16 -0.962 . . . . 0.0 110.367 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -92.8 -30.67 15.35 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.348 -0.845 . . . . 0.0 109.705 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.516 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 2.4 m120 -106.61 -0.13 24.01 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.561 -0.712 . . . . 0.0 109.475 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.608 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 72.8 m-85 62.06 52.84 3.15 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.297 0.57 . . . . 0.0 110.863 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.478 ' HB3' ' HG3' ' A' ' 103' ' ' LYS . 0.7 OUTLIER -130.56 152.01 50.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 109.84 179.305 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.677 ' CE1' HG13 ' A' ' 23' ' ' VAL . 74.5 t80 -149.46 133.86 17.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.022 -1.049 . . . . 0.0 110.368 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 36.1 m -139.66 147.08 40.52 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.176 -0.952 . . . . 0.0 110.525 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.668 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 7.8 p90 -148.47 177.88 9.08 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.346 -0.846 . . . . 0.0 110.666 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 98' ' ' ILE . 15.6 m -127.88 123.32 34.76 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.441 -0.787 . . . . 0.0 109.924 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.945 HD13 ' CD2' ' A' ' 69' ' ' HIS . 12.2 tp -94.34 134.0 37.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.021 -1.05 . . . . 0.0 110.292 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.548 ' H ' HD12 ' A' ' 85' ' ' LEU . 13.6 pt -114.89 -33.32 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 110.334 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.641 ' O ' HD11 ' A' ' 85' ' ' LEU . 29.3 tt0 -114.11 134.07 55.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 110.38 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.855 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . -176.92 122.38 0.84 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -55.77 -17.07 5.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.16 -1.2 . . . . 0.0 110.235 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -91.35 -34.15 15.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.934 . . . . 0.0 110.469 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.622 HD12 ' C ' ' A' ' 91' ' ' LEU . 1.9 pp -84.9 -16.97 39.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.256 -0.903 . . . . 0.0 110.404 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.87 -23.8 75.62 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -49.45 -65.56 0.55 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.288 -1.125 . . . . 0.0 110.358 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 80.5 p -137.28 8.4 2.91 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.463 -0.773 . . . . 0.0 110.175 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 1.048 HD21 ' CG1' ' A' ' 128' ' ' ILE . 11.4 mt -119.41 177.73 4.81 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.3 -0.875 . . . . 0.0 110.051 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.517 ' O ' HD13 ' A' ' 91' ' ' LEU . 39.4 tt0 -146.29 -78.73 0.17 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.332 -0.855 . . . . 0.0 109.772 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.499 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 16.1 mttm -80.16 142.57 34.63 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.87 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.732 HG21 ' HE2' ' A' ' 100' ' ' TYR . 5.2 mm -135.39 140.97 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.924 -1.11 . . . . 0.0 110.548 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.55 137.15 53.42 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.59 -0.694 . . . . 0.0 109.235 178.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.732 ' HE2' HG21 ' A' ' 98' ' ' ILE . 8.4 m-85 -131.99 131.52 42.62 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.124 -0.985 . . . . 0.0 110.872 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.468 ' HG2' ' OG ' ' A' ' 82' ' ' SER . 7.1 mt-10 -129.52 133.47 47.26 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.409 -0.807 . . . . 0.0 109.91 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.51 ' N ' ' O ' ' A' ' 81' ' ' TYR . 43.4 m -127.41 144.9 50.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.925 . . . . 0.0 110.023 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.478 ' HG3' ' HB3' ' A' ' 80' ' ' SER . 2.2 mttt -141.94 136.49 30.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.944 . . . . 0.0 110.256 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.753 HD23 HG12 ' A' ' 114' ' ' ILE . 3.7 mt -120.91 151.01 40.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 110.102 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.713 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -151.62 -169.14 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.306 -0.872 . . . . 0.0 110.063 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.713 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -119.39 138.6 52.98 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.308 -0.87 . . . . 0.0 110.115 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.456 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 28.8 p -94.67 164.9 18.46 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.177 -0.952 . . . . 0.0 110.245 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.456 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.5 Cg_endo -72.5 -2.68 12.15 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.057 1.556 . . . . 0.0 110.59 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 81.8 p -102.14 0.86 35.4 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.225 -0.922 . . . . 0.0 110.263 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.73 -31.83 8.25 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -67.87 -173.98 7.59 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 1.1 p -126.29 131.42 51.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.235 -1.156 . . . . 0.0 110.237 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.722 ' HA ' HG22 ' A' ' 10' ' ' THR . 11.1 mt -82.3 150.26 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.415 -0.803 . . . . 0.0 110.196 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.753 HG12 HD23 ' A' ' 104' ' ' LEU . 15.4 mt -130.34 110.43 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 110.4 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.42 ' O ' ' N ' ' A' ' 103' ' ' LYS . 51.6 tttt -99.34 128.34 45.45 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.201 -0.937 . . . . 0.0 109.923 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 0.7 OUTLIER -123.02 153.39 39.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.182 -0.949 . . . . 0.0 110.537 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.604 HG23 ' HB3' ' A' ' 6' ' ' GLU . 28.7 m -159.99 127.71 4.67 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.396 -0.815 . . . . 0.0 110.286 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.486 ' HB2' ' CD1' ' A' ' 100' ' ' TYR . 24.6 p -132.13 160.16 36.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.242 -0.911 . . . . 0.0 110.225 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.596 ' CD2' HG23 ' A' ' 4' ' ' THR . 41.4 m80 -132.3 135.76 46.44 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.11 -0.994 . . . . 0.0 110.625 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.679 ' O ' HG13 ' A' ' 2' ' ' VAL . 4.4 m-30 -97.66 146.84 24.93 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.293 -0.879 . . . . 0.0 110.108 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.499 ' HB2' ' HB2' ' A' ' 97' ' ' LYS . 94.0 m-70 -126.73 92.11 3.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.074 -1.016 . . . . 0.0 109.86 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.657 HG21 ' O ' ' A' ' 126' ' ' VAL . 1.8 p -66.62 164.38 16.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.449 -0.782 . . . . 0.0 110.311 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.431 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 34.4 tptt -147.48 114.81 6.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.368 -0.832 . . . . 0.0 110.257 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 125' ' ' ASN . . . 111.26 25.61 4.94 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 2.9 t30 65.1 62.45 0.71 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.198 -1.178 . . . . 0.0 110.179 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.657 ' O ' HG21 ' A' ' 122' ' ' THR . 20.2 m -140.35 143.44 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.244 -0.91 . . . . 0.0 110.316 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.469 ' N ' ' OE1' ' A' ' 127' ' ' GLU . 47.0 mp0 -114.03 165.99 12.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 110.257 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 1.048 ' CG1' HD21 ' A' ' 95' ' ' LEU . 3.1 mt -89.42 173.15 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.259 -0.901 . . . . 0.0 110.134 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.617 ' N ' HG22 ' A' ' 128' ' ' ILE . 8.1 mttm -111.55 152.66 27.28 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.361 -0.837 . . . . 0.0 110.009 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -58.57 -34.98 71.67 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.222 -0.924 . . . . 0.0 109.979 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.507 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 46.5 tt0 -62.57 -33.09 74.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.279 -0.888 . . . . 0.0 109.91 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 18.3 t-160 -76.45 -52.31 10.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -0.883 . . . . 0.0 110.104 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.759 HG11 ' CE1' ' A' ' 5' ' ' TYR . 57.8 t -62.28 -41.07 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.394 -0.816 . . . . 0.0 109.889 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -71.97 -47.26 53.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.268 -0.895 . . . . 0.0 109.854 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.507 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -61.57 -33.87 74.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.262 -0.899 . . . . 0.0 109.902 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.13 -29.7 66.29 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 37.1 mttm -74.15 -33.0 63.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.205 -1.174 . . . . 0.0 109.921 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -79.25 -35.73 41.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.354 -0.841 . . . . 0.0 109.933 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -70.2 -33.2 71.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.352 -0.842 . . . . 0.0 109.779 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.426 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -76.49 -41.04 48.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.348 -0.845 . . . . 0.0 109.957 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 35.3 t -59.87 -43.81 94.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.385 -0.822 . . . . 0.0 109.848 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -59.28 -42.41 91.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.299 -0.875 . . . . 0.0 109.881 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.91 ' HA ' HD12 ' A' ' 146' ' ' LEU . 18.7 mt -61.75 -36.36 80.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 109.946 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.786 ' HA ' HD12 ' A' ' 147' ' ' ILE . 30.1 m-85 -64.41 -37.12 86.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.348 -0.845 . . . . 0.0 109.568 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 25.9 mttm -70.28 -12.9 61.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.418 -0.801 . . . . 0.0 109.977 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.91 HD12 ' HA ' ' A' ' 143' ' ' LEU . 9.2 mt -81.57 -36.43 29.06 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.138 -0.976 . . . . 0.0 108.855 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.903 HD11 ' CE1' ' A' ' 22' ' ' PHE . 8.2 mt -68.39 -49.41 66.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.501 ' O ' HG13 ' A' ' 13' ' ' ILE . 69.9 mt-10 -52.62 -42.54 64.7 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.566 -0.709 . . . . 0.0 109.675 179.064 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.504 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 54.1 m -70.81 -34.66 71.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.065 -1.022 . . . . 0.0 109.526 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.575 ' CD2' ' OH ' ' A' ' 158' ' ' TYR . 51.9 t80 -51.24 -60.85 2.66 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.519 -0.738 . . . . 0.0 109.924 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.06 HD21 ' CE1' ' A' ' 158' ' ' TYR . 38.1 mt -73.07 -27.9 62.0 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.393 -0.817 . . . . 0.0 109.995 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.632 ' HA ' HD11 ' A' ' 13' ' ' ILE . 60.1 tttm -57.2 -19.96 23.97 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.201 -0.937 . . . . 0.0 108.486 178.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -128.08 -4.09 5.62 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.572 ' CG ' ' O ' ' A' ' 150' ' ' TYR . 63.6 m170 -113.39 86.52 10.08 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.171 -1.193 . . . . 0.0 110.235 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -73.59 2.21 6.05 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.038 1.546 . . . . 0.0 110.859 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -124.04 4.38 8.64 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.122 -0.987 . . . . 0.0 110.005 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.758 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -69.13 108.81 3.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.296 -0.877 . . . . 0.0 110.053 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 1.06 ' CE1' HD21 ' A' ' 151' ' ' LEU . 0.3 OUTLIER 35.3 35.14 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.633 -0.667 . . . . 0.0 110.952 -179.363 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.565 ' CB ' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.417 0 CA-C-O 117.953 -1.023 . . . . 0.0 109.824 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 1.045 HG23 ' C ' ' A' ' 120' ' ' TYR . 5.0 p -85.79 153.68 3.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 121.27 -1.135 . . . . 0.0 110.064 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.55 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 16.2 m-85 -89.92 167.36 12.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.309 -0.87 . . . . 0.0 110.433 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.913 HG23 ' CE1' ' A' ' 119' ' ' HIS . 55.1 m -145.67 102.26 3.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.302 -0.874 . . . . 0.0 110.221 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.915 ' CZ ' HG22 ' A' ' 133' ' ' VAL . 84.8 m-85 -116.09 151.76 34.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.316 -0.865 . . . . 0.0 109.936 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 19.6 pt-20 -143.01 151.63 41.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.142 -0.974 . . . . 0.0 110.366 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.4 t -128.6 151.77 49.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.41 -0.806 . . . . 0.0 109.839 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.477 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 92.8 mt-10 -134.3 116.05 14.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.947 . . . . 0.0 110.488 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.2 p90 -142.66 -175.12 4.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -0.852 . . . . 0.0 109.778 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.775 HG22 ' HA ' ' A' ' 113' ' ' ILE . 6.6 p -137.75 173.35 11.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.144 -0.973 . . . . 0.0 110.634 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.511 ' HB3' HD11 ' A' ' 114' ' ' ILE . 84.0 p -149.56 144.22 26.09 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.397 -0.815 . . . . 0.0 110.23 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -72.57 -32.37 65.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.226 -0.921 . . . . 0.0 109.958 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.813 HG23 ' HD2' ' A' ' 14' ' ' PRO . 6.5 mm -72.51 151.35 91.66 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.517 -0.739 . . . . 0.0 109.653 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.813 ' HD2' HG23 ' A' ' 13' ' ' ILE . 39.1 Cg_endo -64.61 140.58 69.16 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.889 1.468 . . . . 0.0 110.692 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.656 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 41.9 Cg_endo -73.08 -30.49 10.69 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 124.145 1.603 . . . . 0.0 112.871 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.656 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.3 Cg_endo -69.84 -23.57 30.31 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 O-C-N 122.448 0.71 . . . . 0.0 110.357 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.515 ' NH2' ' HD2' ' A' ' 20' ' ' LYS . 1.6 mmp_? -83.42 -46.8 12.11 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.774 HD23 ' C ' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -65.54 -31.05 71.9 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.601 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.519 ' N ' HD23 ' A' ' 18' ' ' LEU . 59.4 t80 -64.66 -54.49 30.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.56 -0.712 . . . . 0.0 109.26 178.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.54 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 25.2 mttt -47.99 -42.84 28.91 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.796 -0.761 . . . . 0.0 109.459 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.969 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -73.07 -35.61 66.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.469 -0.77 . . . . 0.0 110.927 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 1.033 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -74.57 -42.85 58.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 111.42 -178.659 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.629 HG13 ' CE1' ' A' ' 81' ' ' TYR . 5.7 t -107.5 -50.36 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.956 -1.09 . . . . 0.0 111.74 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.766 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.3 mp -79.44 -5.64 55.14 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.077 -1.014 . . . . 0.0 111.483 -178.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.557 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 1.1 m-20 -151.2 30.36 0.62 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.796 -1.19 . . . . 0.0 110.651 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 1.033 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -72.87 -21.23 60.96 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.243 -0.91 . . . . 0.0 110.615 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.477 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 39.2 t0 -66.63 -24.14 66.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.014 -1.054 . . . . 0.0 110.201 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.558 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 7.1 p-10 -124.55 12.81 8.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.33 -0.856 . . . . 0.0 110.078 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.767 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -94.08 -48.45 6.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.364 -0.835 . . . . 0.0 110.221 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 1.032 HG21 HD13 ' A' ' 38' ' ' ILE . 3.7 p -76.89 -28.37 0.66 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.305 -0.872 . . . . 0.0 112.231 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.855 ' HD3' HG12 ' A' ' 30' ' ' VAL . 52.5 Cg_endo -79.23 5.31 5.87 Favored 'Trans proline' 0 C--N 1.319 -1.026 0 O-C-N 122.672 0.827 . . . . 0.0 110.272 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -128.78 -37.38 1.75 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 109.346 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.55 HG12 ' CD1' ' A' ' 150' ' ' TYR . 11.3 mt -79.97 -25.9 11.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-O 121.646 0.736 . . . . 0.0 109.151 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -157.22 77.32 3.93 Favored Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 121.628 -0.67 . . . . 0.0 109.841 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.29 -5.49 16.65 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.984 1.518 . . . . 0.0 110.565 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -87.65 -15.74 36.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.0 109.8 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -93.71 -69.27 0.76 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.38 -0.825 . . . . 0.0 110.151 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 1.032 HD13 HG21 ' A' ' 30' ' ' VAL . 1.7 mp -99.86 126.96 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.315 -0.866 . . . . 0.0 110.086 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.522 ' HB2' ' N ' ' A' ' 59' ' ' GLY . 27.7 ttpt -76.3 -25.41 54.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.357 -0.839 . . . . 0.0 110.639 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.51 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER 179.75 164.67 1.1 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.065 -1.022 . . . . 0.0 110.497 -179.75 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.454 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 18.5 m -137.53 128.6 27.57 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.466 -0.771 . . . . 0.0 109.81 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.51 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 48.5 tt0 -135.54 111.55 9.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.149 -0.969 . . . . 0.0 110.596 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.443 HG12 ' HG2' ' A' ' 54' ' ' LYS . 21.2 mt -59.54 140.26 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 109.859 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.729 HD11 ' HB2' ' A' ' 55' ' ' LYS . 39.0 mt -115.68 -27.91 6.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.145 -0.972 . . . . 0.0 110.268 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.683 ' CD1' HD12 ' A' ' 53' ' ' ILE . 1.4 m95 -123.58 157.95 32.54 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.246 -0.908 . . . . 0.0 110.418 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.412 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 43.53 -134.08 5.56 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.58 20.67 0.4 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.302 -1.117 . . . . 0.0 109.995 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.432 ' O ' HG21 ' A' ' 71' ' ' ILE . . . 125.56 -20.31 6.53 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.024 -1.631 . . . . 0.0 109.024 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.489 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -69.98 -172.47 10.27 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.429 ' HA ' HG22 ' A' ' 71' ' ' ILE . 45.5 Cg_endo -73.47 129.61 13.99 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.991 1.522 . . . . 0.0 110.653 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.79 -11.4 53.08 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.654 -1.778 . . . . 0.0 108.654 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 45' ' ' TRP . 1.0 OUTLIER -72.73 164.83 25.93 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.519 -0.989 . . . . 0.0 109.958 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.683 HD12 ' CD1' ' A' ' 45' ' ' TRP . 59.3 mt -135.49 120.09 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.4 -0.812 . . . . 0.0 109.698 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.443 ' HG2' HG12 ' A' ' 43' ' ' ILE . 93.8 mttt -108.49 134.85 50.7 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.195 -0.941 . . . . 0.0 110.624 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.729 ' HB2' HD11 ' A' ' 44' ' ' LEU . 32.9 tttt -101.53 92.68 5.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.262 -0.899 . . . . 0.0 110.084 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.524 ' CG2' HG12 ' A' ' 38' ' ' ILE . 84.2 mt -79.92 141.26 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.179 -0.951 . . . . 0.0 110.197 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 2.1 p -115.12 158.77 21.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 110.412 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.613 ' HE2' HG13 ' A' ' 67' ' ' VAL . 28.6 m-85 -119.31 135.94 54.48 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.368 -0.832 . . . . 0.0 110.12 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.522 ' N ' ' HB2' ' A' ' 39' ' ' LYS . . . -92.66 -2.87 66.93 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -113.75 140.72 48.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.187 -1.184 . . . . 0.0 110.226 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 112.21 -153.12 17.57 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 60.5 p -56.15 -168.46 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.261 -1.141 . . . . 0.0 110.145 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -76.76 -29.48 56.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.201 -0.937 . . . . 0.0 110.24 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -125.91 105.86 9.23 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.102 -0.999 . . . . 0.0 110.402 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.545 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -136.36 94.71 0.23 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.533 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 17.2 p90 -139.43 168.8 19.01 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.163 -1.199 . . . . 0.0 110.336 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.975 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.2 m -139.38 173.29 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.375 -0.828 . . . . 0.0 110.507 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.516 ' CE ' ' OE1' ' A' ' 87' ' ' GLU . 22.1 mttm -124.01 126.28 46.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.554 -0.716 . . . . 0.0 109.629 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.698 ' CE1' HD13 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -110.56 134.39 52.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.167 -0.958 . . . . 0.0 110.788 -179.549 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 52' ' ' THR . 29.6 ttpt -108.2 115.72 30.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.288 -0.883 . . . . 0.0 109.436 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.528 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 28.6 mm -62.95 120.67 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.3 -0.875 . . . . 0.0 110.561 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 82' ' ' SER . 83.8 m-20 -93.7 -42.58 9.08 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.521 -0.737 . . . . 0.0 109.717 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.469 ' OG ' ' HB2' ' A' ' 82' ' ' SER . 90.6 p -169.66 159.25 8.12 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.436 -0.79 . . . . 0.0 109.744 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.551 HG12 HG11 ' A' ' 23' ' ' VAL . 1.9 mt -142.34 156.36 19.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.213 -0.93 . . . . 0.0 110.354 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.548 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 5.1 m-20 -134.59 79.11 1.78 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.623 -0.673 . . . . 0.0 110.143 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.457 ' HZ2' HD21 ' A' ' 24' ' ' LEU . 67.5 mttm -62.83 -14.33 44.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.128 -0.982 . . . . 0.0 110.224 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -94.24 -32.29 13.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.241 -0.912 . . . . 0.0 109.592 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.5 m120 -104.75 -6.85 19.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.517 -0.739 . . . . 0.0 109.665 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.557 ' CZ ' ' HB3' ' A' ' 16' ' ' PRO . 4.1 m-85 67.21 50.62 0.98 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.571 -0.706 . . . . 0.0 110.224 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.548 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -121.11 151.53 39.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -0.922 . . . . 0.0 109.304 179.441 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.629 ' CE1' HG13 ' A' ' 23' ' ' VAL . 22.5 t80 -139.91 136.7 34.15 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.207 -0.933 . . . . 0.0 110.191 -178.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 4.8 m -139.45 121.55 15.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.93 . . . . 0.0 110.942 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.6 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 8.6 p90 -141.15 175.44 9.64 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.342 -0.849 . . . . 0.0 109.737 179.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.755 HG23 ' O ' ' A' ' 98' ' ' ILE . 82.1 m -131.77 143.11 49.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.912 . . . . 0.0 110.23 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.698 HD13 ' CE1' ' A' ' 69' ' ' HIS . 19.1 tp -96.67 121.01 38.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 110.126 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 20.3 pt -105.86 -17.95 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.392 -0.818 . . . . 0.0 109.982 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.516 ' OE1' ' CE ' ' A' ' 68' ' ' LYS . 83.1 tt0 -138.18 151.49 47.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -0.889 . . . . 0.0 110.374 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.975 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 164.94 133.5 1.51 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -64.18 -15.3 59.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.297 -1.119 . . . . 0.0 110.245 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.13 -18.59 45.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.302 -0.874 . . . . 0.0 110.207 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.647 HD22 ' CD1' ' A' ' 98' ' ' ILE . 16.4 mt -63.82 -19.8 65.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.225 -0.922 . . . . 0.0 110.073 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 46.29 -173.29 0.02 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.555 ' OD1' HG23 ' A' ' 94' ' ' THR . 59.5 p30 -87.93 12.36 13.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.133 -1.216 . . . . 0.0 109.823 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.734 HG22 HG11 ' A' ' 126' ' ' VAL . 23.2 p -107.07 -29.88 9.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.366 -0.834 . . . . 0.0 110.173 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.604 HD11 ' CD1' ' A' ' 128' ' ' ILE . 67.5 mt -107.95 161.29 15.07 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.269 -0.894 . . . . 0.0 110.405 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.401 ' OE2' ' HD2' ' A' ' 123' ' ' LYS . 55.9 mt-10 -142.28 -82.96 0.19 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.335 -0.853 . . . . 0.0 109.994 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.521 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 62.2 mttt -80.37 140.26 36.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.687 -0.633 . . . . 0.0 110.763 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.755 ' O ' HG23 ' A' ' 84' ' ' THR . 0.1 OUTLIER -135.0 135.55 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.967 -1.083 . . . . 0.0 109.602 178.98 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.485 ' HB2' ' CD2' ' A' ' 119' ' ' HIS . 0.5 OUTLIER -108.96 133.36 53.06 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.315 -0.866 . . . . 0.0 109.956 179.626 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.6 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 5.6 m-85 -122.78 132.3 54.16 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.312 -0.867 . . . . 0.0 110.252 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 117' ' ' THR . 2.9 mt-10 -134.65 130.43 36.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 0.0 110.242 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.475 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 26.0 m -129.41 135.94 49.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.222 -0.924 . . . . 0.0 109.858 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.4 mttm -134.18 135.78 43.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.156 -0.965 . . . . 0.0 110.599 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.887 HD23 HG12 ' A' ' 114' ' ' ILE . 7.1 mt -115.72 151.16 35.63 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.29 -0.882 . . . . 0.0 109.932 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.704 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -148.04 -169.04 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.133 -0.98 . . . . 0.0 110.0 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.704 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -124.37 154.09 40.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.288 -0.882 . . . . 0.0 110.137 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.457 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 5.1 p -113.7 168.1 8.39 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.896 . . . . 0.0 110.195 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 48.1 Cg_endo -72.92 -4.24 15.04 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.021 1.537 . . . . 0.0 110.474 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 34.3 p -104.89 8.71 34.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.284 -0.885 . . . . 0.0 110.279 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 94.5 -34.43 4.74 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -59.09 -171.78 0.4 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 3.1 p -134.82 136.05 42.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -1.167 . . . . 0.0 110.359 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.775 ' HA ' HG22 ' A' ' 10' ' ' THR . 22.4 mt -88.89 148.82 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.325 -0.859 . . . . 0.0 110.078 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.887 HG12 HD23 ' A' ' 104' ' ' LEU . 18.2 mt -132.3 124.51 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.205 -0.934 . . . . 0.0 110.46 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.477 ' HG3' ' HG2' ' A' ' 8' ' ' GLU . 75.3 tttt -113.59 109.82 19.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.2 -0.938 . . . . 0.0 110.014 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.447 ' OG ' ' CZ ' ' A' ' 9' ' ' PHE . 1.2 m -101.01 159.35 15.29 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.251 -0.906 . . . . 0.0 110.643 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.707 HG22 ' NE2' ' A' ' 119' ' ' HIS . 60.8 m -154.16 133.61 12.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.327 -0.858 . . . . 0.0 110.045 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.8 m -136.25 144.53 44.87 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.13 -0.981 . . . . 0.0 110.478 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.913 ' CE1' HG23 ' A' ' 4' ' ' THR . 20.8 m-70 -132.05 146.74 52.26 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.295 -0.878 . . . . 0.0 110.325 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 1.045 ' C ' HG23 ' A' ' 2' ' ' VAL . 40.2 m-85 -121.59 120.53 35.06 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.18 -0.95 . . . . 0.0 110.542 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.58 ' N ' HG23 ' A' ' 2' ' ' VAL . 87.2 m-70 -92.85 103.72 16.03 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.4 -0.812 . . . . 0.0 109.368 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.564 ' OG1' HG23 ' A' ' 126' ' ' VAL . 1.6 t -88.39 173.71 8.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.014 -1.054 . . . . 0.0 110.856 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.401 ' HD2' ' OE2' ' A' ' 96' ' ' GLU . 40.0 tttm -141.8 117.1 10.12 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 120.284 -0.567 . . . . 0.0 110.221 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 113.2 -123.98 6.4 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -133.25 62.03 1.66 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.313 -1.11 . . . . 0.0 110.204 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.734 HG11 HG22 ' A' ' 94' ' ' THR . 34.8 m -137.54 153.46 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.22 -0.925 . . . . 0.0 110.203 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.464 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 90.4 mt-10 -127.05 169.57 13.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.188 -0.945 . . . . 0.0 110.29 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.604 ' CD1' HD11 ' A' ' 95' ' ' LEU . 15.8 mm -67.77 173.09 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.884 . . . . 0.0 110.244 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.586 ' N ' HG22 ' A' ' 128' ' ' ILE . 17.5 mttp -99.08 149.53 22.94 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.265 -0.897 . . . . 0.0 110.041 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.12 -20.09 16.02 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.091 -1.006 . . . . 0.0 109.841 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.786 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 94.3 mt-10 -71.63 -39.91 70.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.369 -0.832 . . . . 0.0 109.904 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.486 ' HB2' ' CG2' ' A' ' 128' ' ' ILE . 6.3 m170 -65.18 -45.72 83.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.297 -0.877 . . . . 0.0 109.949 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.915 HG22 ' CZ ' ' A' ' 5' ' ' TYR . 58.3 t -64.95 -42.79 95.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.506 -0.746 . . . . 0.0 110.264 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 33.1 tttm -102.87 -63.57 1.15 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.283 -0.886 . . . . 0.0 110.31 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.786 ' HB3' ' O ' ' A' ' 131' ' ' GLU . . . -56.78 -19.54 17.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.122 -0.986 . . . . 0.0 110.025 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 131' ' ' GLU . . . -76.91 -31.16 54.39 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.221 -1.551 . . . . 0.0 109.221 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.491 ' CE ' ' O ' ' A' ' 133' ' ' VAL . 27.4 mttt -72.85 -30.07 63.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.324 -1.103 . . . . 0.0 110.18 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -82.91 -32.23 27.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.315 -0.866 . . . . 0.0 110.044 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 50.5 mttt -70.45 -38.46 74.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.391 -0.818 . . . . 0.0 110.028 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.402 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -78.74 -30.83 46.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.321 -0.862 . . . . 0.0 109.88 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.1 m -66.67 -45.29 79.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.35 -0.844 . . . . 0.0 110.011 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -50.99 -51.2 55.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.303 -0.873 . . . . 0.0 109.947 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.662 ' HA ' HD12 ' A' ' 146' ' ' LEU . 10.6 tp -55.47 -49.31 72.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.258 -0.901 . . . . 0.0 109.742 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.402 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 17.7 m-85 -53.62 -38.84 64.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.44 -0.788 . . . . 0.0 109.746 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -73.38 -16.72 61.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.273 -0.892 . . . . 0.0 109.852 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.662 HD12 ' HA ' ' A' ' 143' ' ' LEU . 17.7 mt -81.98 -35.68 28.69 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.234 -0.917 . . . . 0.0 108.706 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.662 HD11 ' CE1' ' A' ' 22' ' ' PHE . 53.5 mt -66.66 -47.17 84.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.498 ' O ' HG13 ' A' ' 13' ' ' ILE . 84.1 mt-10 -52.26 -45.42 65.39 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.307 -0.87 . . . . 0.0 109.324 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 36.4 m -64.68 -30.97 72.0 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.152 -0.968 . . . . 0.0 109.535 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.694 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 71.1 t80 -60.94 -50.48 73.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.474 -0.766 . . . . 0.0 109.815 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.143 HD21 ' CE1' ' A' ' 158' ' ' TYR . 92.5 mt -80.03 -36.92 35.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.223 -0.923 . . . . 0.0 110.03 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.594 ' HG3' HD11 ' A' ' 13' ' ' ILE . 16.6 tttt -64.03 -20.29 65.81 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.392 -0.817 . . . . 0.0 109.516 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -110.67 -32.78 2.6 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.45 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 3.7 m80 -109.6 94.3 16.21 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.267 -1.137 . . . . 0.0 110.203 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.71 6.25 3.38 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.08 1.569 . . . . 0.0 111.046 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -109.8 -2.37 17.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.994 -1.066 . . . . 0.0 109.966 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.694 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -74.39 104.61 5.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.368 -0.832 . . . . 0.0 110.199 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 1.143 ' CE1' HD21 ' A' ' 151' ' ' LEU . 1.5 p90 34.65 37.28 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.726 -0.609 . . . . 0.0 110.842 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.498 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.69 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.501 HG22 ' ND1' ' A' ' 121' ' ' HIS . 98.7 t -128.02 132.07 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.208 -1.172 . . . . 0.0 110.205 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.708 ' CE1' HD12 ' A' ' 128' ' ' ILE . 12.3 m-85 -93.19 148.21 22.22 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.205 -0.934 . . . . 0.0 110.117 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.778 HG23 ' CE1' ' A' ' 119' ' ' HIS . 10.3 m -128.1 111.48 13.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.173 -0.955 . . . . 0.0 110.344 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.983 ' CE2' HG21 ' A' ' 133' ' ' VAL . 69.1 m-85 -123.38 140.25 53.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.341 -0.85 . . . . 0.0 110.16 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -140.28 151.33 45.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.224 -0.923 . . . . 0.0 110.359 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.7 t -138.77 160.97 38.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.386 -0.821 . . . . 0.0 109.918 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.431 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 85.8 mt-10 -142.14 115.77 9.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.102 -0.999 . . . . 0.0 110.368 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.6 p90 -140.42 -175.04 4.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.311 -0.868 . . . . 0.0 109.843 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.778 HG22 ' HA ' ' A' ' 113' ' ' ILE . 2.4 p -137.52 167.38 21.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.118 -0.989 . . . . 0.0 110.493 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.445 ' HB3' HD11 ' A' ' 114' ' ' ILE . 75.5 p -138.93 147.93 42.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.38 -0.825 . . . . 0.0 110.168 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -69.96 -32.96 71.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.236 -0.915 . . . . 0.0 110.254 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.756 HD13 ' CB ' ' A' ' 148' ' ' GLU . 2.6 mp -79.58 148.56 69.93 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.378 -0.826 . . . . 0.0 109.915 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.755 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.0 Cg_endo -64.99 152.72 81.4 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.937 1.493 . . . . 0.0 110.722 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.695 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 36.7 Cg_endo -63.35 -35.87 59.34 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.793 1.418 . . . . 0.0 113.035 -178.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.695 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 38.0 Cg_endo -63.89 -21.3 68.99 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 N-CA-C 109.811 -0.88 . . . . 0.0 109.811 178.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.761 ' HB3' HD13 ' A' ' 151' ' ' LEU . 6.6 mmp_? -80.28 -45.25 18.23 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.682 HD12 ' N ' ' A' ' 18' ' ' LEU . 9.3 mp -73.31 -40.87 64.16 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.251 -0.98 . . . . 0.0 108.576 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.617 ' CD1' ' HA ' ' A' ' 79' ' ' TYR . 36.9 t80 -52.72 -59.95 3.86 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 119.869 -0.733 . . . . 0.0 110.155 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.536 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 40.4 mttp -56.03 -38.27 70.33 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.404 -0.81 . . . . 0.0 110.18 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.056 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -78.56 -62.76 1.58 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.125 -0.984 . . . . 0.0 110.878 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 1.055 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.3 OUTLIER -49.2 -41.49 37.17 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.65 -0.656 . . . . 0.0 112.006 -178.847 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 1.047 HG11 HD12 ' A' ' 74' ' ' ILE . 11.5 t -106.32 -62.93 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.767 -1.208 . . . . 0.0 111.813 -178.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.649 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.4 mp -68.5 -1.07 5.84 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.243 -0.911 . . . . 0.0 111.69 -178.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.9 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -149.63 15.7 0.88 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.704 -1.248 . . . . 0.0 110.756 179.743 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 1.055 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -57.45 -40.68 78.99 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.142 -0.974 . . . . 0.0 110.12 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.508 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 14.0 t70 -62.75 -11.42 17.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.268 -0.895 . . . . 0.0 109.901 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.514 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 84.7 m-20 -132.89 10.07 4.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.42 -0.8 . . . . 0.0 109.701 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.931 HD21 ' CZ ' ' A' ' 158' ' ' TYR . 0.2 OUTLIER -95.57 -49.06 5.56 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.396 -0.815 . . . . 0.0 110.387 -179.764 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.786 HG22 ' HD3' ' A' ' 31' ' ' PRO . 3.5 m -83.48 -26.22 0.39 Allowed Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.396 -0.815 . . . . 0.0 112.707 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.786 ' HD3' HG22 ' A' ' 30' ' ' VAL . 47.0 Cg_endo -76.88 2.93 7.01 Favored 'Trans proline' 0 C--N 1.318 -1.039 0 O-C-N 122.511 0.743 . . . . 0.0 110.476 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.7 tttm -128.95 -35.15 1.88 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.29 -0.882 . . . . 0.0 109.541 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.607 HG12 ' CD1' ' A' ' 150' ' ' TYR . 40.1 mt -80.03 -35.27 15.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.599 -0.688 . . . . 0.0 109.596 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -161.9 97.5 1.22 Allowed Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.582 -0.699 . . . . 0.0 109.833 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.57 2.21 6.05 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.069 1.563 . . . . 0.0 110.793 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -84.11 -10.09 58.07 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.146 -0.971 . . . . 0.0 109.812 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.94 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -97.88 -47.19 5.65 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.392 -0.817 . . . . 0.0 109.912 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.94 HD12 ' C ' ' A' ' 37' ' ' ALA . 2.1 mp -134.75 108.01 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.463 -0.773 . . . . 0.0 109.899 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 57' ' ' THR . 39.3 ttpt -55.29 -16.99 3.89 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.223 -0.923 . . . . 0.0 110.298 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.546 ' CD2' ' H ' ' A' ' 41' ' ' SER . 0.0 OUTLIER 173.03 175.16 0.11 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.081 -1.012 . . . . 0.0 110.11 -179.739 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.546 ' H ' ' CD2' ' A' ' 40' ' ' HIS . 25.2 m -152.11 149.77 29.17 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.361 -0.837 . . . . 0.0 109.827 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -155.56 112.15 3.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.163 -0.961 . . . . 0.0 110.711 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 41.1 mt -62.55 136.5 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.306 -0.871 . . . . 0.0 109.808 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.803 HD22 ' CE ' ' A' ' 55' ' ' LYS . 4.9 tp -114.19 -24.47 8.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.156 -0.965 . . . . 0.0 110.717 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.527 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.8 m95 -124.93 161.35 26.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.116 -0.99 . . . . 0.0 110.782 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.442 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 42.23 -139.73 2.19 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -147.85 24.79 1.06 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.368 -1.078 . . . . 0.0 109.878 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 117.88 -18.9 11.39 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.559 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -72.87 -169.27 14.09 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.21 128.9 13.39 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.093 1.575 . . . . 0.0 110.724 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.81 -11.55 49.52 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.519 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.1 m -75.08 163.84 27.15 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.643 -0.916 . . . . 0.0 109.78 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.986 HG21 ' HE2' ' A' ' 68' ' ' LYS . 85.6 mt -134.13 118.87 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 0.0 109.942 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.455 ' HE2' HD11 ' A' ' 71' ' ' ILE . 1.0 OUTLIER -106.55 124.11 49.11 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.322 -0.861 . . . . 0.0 110.567 -179.565 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.803 ' CE ' HD22 ' A' ' 44' ' ' LEU . 75.8 mttt -90.53 95.2 10.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.258 -0.901 . . . . 0.0 109.826 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.529 ' CG2' HG12 ' A' ' 38' ' ' ILE . 99.6 mt -79.98 139.97 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.142 -0.974 . . . . 0.0 110.083 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -112.99 146.65 38.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.315 -0.865 . . . . 0.0 110.434 -179.736 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.571 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 21.7 m-85 -110.04 154.8 22.7 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.289 -0.882 . . . . 0.0 110.052 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -103.62 -4.95 45.84 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -101.11 145.24 29.02 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.224 -1.163 . . . . 0.0 110.248 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.22 128.93 4.95 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.0 t -54.21 -43.88 71.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.21 -1.17 . . . . 0.0 110.178 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.409 ' O ' ' C ' ' A' ' 64' ' ' TYR . 91.1 mt-30 -96.12 157.86 15.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.27 -0.894 . . . . 0.0 110.183 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.499 ' HE1' HG22 ' A' ' 57' ' ' THR . 0.7 OUTLIER -43.71 140.96 1.66 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.28 -0.888 . . . . 0.0 110.321 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.571 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -132.61 90.25 0.27 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.991 -1.643 . . . . 0.0 108.991 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.538 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 12.1 p90 -130.29 166.57 20.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.081 -1.246 . . . . 0.0 110.158 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.628 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.3 m -140.02 175.64 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.337 -0.852 . . . . 0.0 110.579 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.986 ' HE2' HG21 ' A' ' 53' ' ' ILE . 69.6 tttt -131.17 103.09 6.29 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.506 -0.746 . . . . 0.0 109.875 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 1.008 ' CD2' HD13 ' A' ' 85' ' ' LEU . 13.4 m170 -98.15 121.77 40.48 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.207 -0.933 . . . . 0.0 111.036 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 52' ' ' THR . 82.8 tttt -91.45 120.35 32.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.301 -0.874 . . . . 0.0 109.348 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.559 HG21 ' O ' ' A' ' 49' ' ' GLY . 26.2 mm -58.62 126.88 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.165 -0.959 . . . . 0.0 110.229 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.473 ' O ' ' HB3' ' A' ' 73' ' ' SER . 90.9 m-20 -98.36 -51.1 4.09 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.447 -0.783 . . . . 0.0 109.769 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.473 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 91.3 p -178.45 159.2 1.16 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.5 -0.75 . . . . 0.0 110.316 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 1.047 HD12 HG11 ' A' ' 23' ' ' VAL . 3.5 tt -144.41 167.33 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.502 -0.749 . . . . 0.0 109.236 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -131.13 81.05 1.97 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.944 -1.098 . . . . 0.0 110.523 -179.376 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.593 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 82.1 tttt -55.99 -14.56 2.62 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.29 -0.881 . . . . 0.0 110.604 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -90.76 -30.44 17.04 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.24 -0.912 . . . . 0.0 109.658 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.494 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.9 m120 -113.3 -1.44 14.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.486 -0.759 . . . . 0.0 109.731 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.919 ' O ' HD12 ' A' ' 104' ' ' LEU . 56.1 m-85 64.87 50.04 2.05 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.389 0.614 . . . . 0.0 110.369 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.517 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.6 OUTLIER -118.51 152.57 35.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 109.524 179.394 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.643 ' CE1' HG13 ' A' ' 23' ' ' VAL . 82.5 t80 -151.04 140.85 21.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.066 -1.021 . . . . 0.0 110.262 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 74.3 m -147.81 147.61 30.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.259 -0.901 . . . . 0.0 110.442 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.622 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 8.8 p90 -149.82 175.59 11.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.344 -0.848 . . . . 0.0 110.361 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.585 HG23 ' O ' ' A' ' 98' ' ' ILE . 44.3 m -125.58 128.16 47.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.404 -0.81 . . . . 0.0 109.888 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 1.008 HD13 ' CD2' ' A' ' 69' ' ' HIS . 8.6 tp -98.77 131.64 44.75 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.216 -0.993 . . . . 0.0 110.284 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.888 HD11 ' HD3' ' A' ' 68' ' ' LYS . 9.1 pt -117.19 -29.51 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.199 -0.938 . . . . 0.0 110.419 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.613 ' O ' HD11 ' A' ' 85' ' ' LEU . 43.1 tt0 -110.39 138.77 46.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -0.888 . . . . 0.0 110.19 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.628 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 175.82 134.25 1.9 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -53.38 -31.22 43.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -1.112 . . . . 0.0 110.305 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.495 ' HB1' ' CE1' ' A' ' 132' ' ' HIS . . . -69.73 -38.73 76.98 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.297 -0.877 . . . . 0.0 110.243 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.625 HD23 ' CD2' ' A' ' 95' ' ' LEU . 15.5 mt -41.19 -61.71 0.97 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.503 -0.748 . . . . 0.0 110.284 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 49.14 -178.01 0.02 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -67.01 -7.5 23.02 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.25 -1.147 . . . . 0.0 110.213 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.446 ' O ' HG22 ' A' ' 122' ' ' THR . 61.2 p -79.98 -60.97 2.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 110.213 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.867 HD12 ' H ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -102.25 159.39 15.44 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.352 -0.843 . . . . 0.0 109.387 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.867 ' H ' HD12 ' A' ' 95' ' ' LEU . 61.1 tt0 -137.74 -79.7 0.37 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.208 -0.932 . . . . 0.0 110.576 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.488 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 10.1 mttt -80.24 144.81 32.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.592 -0.692 . . . . 0.0 111.023 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.715 HG21 ' HE2' ' A' ' 100' ' ' TYR . 4.6 mm -133.1 144.7 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.208 -0.932 . . . . 0.0 109.487 178.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.482 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.1 m -123.9 127.72 48.41 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.28 -0.887 . . . . 0.0 109.377 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.715 ' HE2' HG21 ' A' ' 98' ' ' ILE . 12.0 m-85 -123.54 133.4 53.99 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.194 -0.941 . . . . 0.0 110.581 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.462 ' HG3' ' OG ' ' A' ' 82' ' ' SER . 62.9 tt0 -135.59 137.41 41.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.279 -0.888 . . . . 0.0 110.109 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.508 ' N ' ' O ' ' A' ' 81' ' ' TYR . 23.4 m -135.24 146.41 48.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.165 -0.959 . . . . 0.0 110.281 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 115' ' ' LYS . 12.1 mttt -138.94 139.53 38.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.328 -0.858 . . . . 0.0 110.131 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.989 HD23 HG12 ' A' ' 114' ' ' ILE . 2.7 mt -118.66 154.21 33.07 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.215 -0.928 . . . . 0.0 110.542 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.713 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -152.34 -169.35 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.332 -0.855 . . . . 0.0 109.925 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.713 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -121.45 158.47 28.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.329 -0.857 . . . . 0.0 110.215 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.462 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 5.8 p -118.01 168.08 10.06 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.235 -0.916 . . . . 0.0 110.176 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.6 Cg_endo -72.41 -12.66 27.48 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.003 1.528 . . . . 0.0 110.378 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 95.8 p -95.84 2.61 53.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.245 -0.909 . . . . 0.0 110.176 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 99.35 -29.04 12.7 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.08 -172.53 1.91 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 2.1 m -133.3 133.68 42.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -1.109 . . . . 0.0 110.378 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.778 ' HA ' HG22 ' A' ' 10' ' ' THR . 20.8 mt -86.05 144.67 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.358 -0.838 . . . . 0.0 109.939 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.989 HG12 HD23 ' A' ' 104' ' ' LEU . 20.6 mt -131.03 114.01 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.173 -0.954 . . . . 0.0 110.441 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 103' ' ' LYS . 35.2 tttt -100.48 120.77 40.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.914 . . . . 0.0 109.837 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.1 t -115.99 154.87 29.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.205 -0.935 . . . . 0.0 110.53 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.45 HG22 ' NE2' ' A' ' 119' ' ' HIS . 38.5 m -156.73 131.64 8.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.352 -0.842 . . . . 0.0 110.133 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 91.7 p -132.72 155.81 48.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.137 -0.977 . . . . 0.0 110.319 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.778 ' CE1' HG23 ' A' ' 4' ' ' THR . 32.3 m-70 -135.83 164.28 28.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.331 -0.856 . . . . 0.0 110.182 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.653 ' HA ' HD13 ' A' ' 98' ' ' ILE . 11.0 m-85 -124.77 148.54 48.06 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.292 -0.88 . . . . 0.0 110.196 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.501 ' ND1' HG22 ' A' ' 2' ' ' VAL . 97.1 m-70 -129.21 85.37 2.31 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.135 -0.978 . . . . 0.0 109.698 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.712 HG22 ' HA ' ' A' ' 95' ' ' LEU . 1.4 p -81.77 157.73 24.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.326 -0.859 . . . . 0.0 110.427 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.2 tttm -113.6 127.06 55.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.435 -0.791 . . . . 0.0 110.202 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 99.45 -153.24 19.62 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -102.97 64.17 0.84 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.219 -1.166 . . . . 0.0 110.182 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.531 HG23 ' HB ' ' A' ' 122' ' ' THR . 20.1 m -130.62 154.36 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.186 -0.946 . . . . 0.0 110.214 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -133.6 159.37 40.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.261 -0.899 . . . . 0.0 110.195 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.708 HD12 ' CE1' ' A' ' 3' ' ' PHE . 4.3 mp -80.86 173.24 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.27 -0.894 . . . . 0.0 110.211 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.588 ' N ' HG22 ' A' ' 128' ' ' ILE . 10.6 mttp -108.26 132.89 53.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.321 -0.862 . . . . 0.0 110.124 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.42 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 94.6 mt-10 -47.1 -47.73 23.1 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.191 -0.943 . . . . 0.0 110.169 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.503 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 54.7 tt0 -50.97 -28.59 10.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.202 -0.936 . . . . 0.0 109.973 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.495 ' CE1' ' HB1' ' A' ' 90' ' ' ALA . 14.2 t-160 -79.74 -60.63 2.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.268 -0.895 . . . . 0.0 110.114 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.983 HG21 ' CE2' ' A' ' 5' ' ' TYR . 7.3 p -65.55 -38.49 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.428 -0.795 . . . . 0.0 110.185 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.496 ' N ' HG13 ' A' ' 133' ' ' VAL . 26.1 tttp -68.77 -47.33 66.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.233 -0.917 . . . . 0.0 110.238 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.503 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -61.43 -27.02 68.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.91 . . . . 0.0 110.226 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.41 -28.09 71.74 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 49.0 mttt -69.58 -39.99 76.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.221 -1.164 . . . . 0.0 110.211 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -75.18 -34.82 61.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.407 -0.808 . . . . 0.0 110.054 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.449 ' O ' ' HG ' ' A' ' 143' ' ' LEU . 28.5 mttt -67.85 -32.85 73.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.33 -0.856 . . . . 0.0 109.925 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.7 -45.03 47.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.295 -0.878 . . . . 0.0 110.014 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 36.8 m -59.5 -38.62 81.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.444 -0.785 . . . . 0.0 110.049 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -61.52 -41.85 97.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.208 -0.932 . . . . 0.0 109.898 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 139' ' ' LYS . 38.1 mt -60.07 -41.73 93.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.269 -0.894 . . . . 0.0 109.859 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.448 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 24.7 m-85 -56.83 -37.3 71.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.441 -0.787 . . . . 0.0 109.982 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 55.9 mttt -66.5 -25.05 66.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.334 -0.854 . . . . 0.0 109.904 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.537 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 15.9 mt -83.02 -34.69 26.22 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.276 -0.89 . . . . 0.0 108.952 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.583 HD11 ' HE1' ' A' ' 22' ' ' PHE . 79.8 mt -69.54 -34.91 63.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.538 -0.726 . . . . 0.0 109.451 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.756 ' CB ' HD13 ' A' ' 13' ' ' ILE . 97.0 mt-10 -62.84 -39.06 93.2 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.494 -0.754 . . . . 0.0 109.869 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 86.1 m -72.15 -40.0 68.35 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.299 -0.875 . . . . 0.0 109.96 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.608 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 68.6 t80 -55.82 -50.54 70.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.479 -0.763 . . . . 0.0 110.023 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.933 HD21 ' CE1' ' A' ' 158' ' ' TYR . 33.6 mt -79.88 -40.2 28.86 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.331 -0.856 . . . . 0.0 110.464 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.634 ' HB2' HD11 ' A' ' 13' ' ' ILE . 40.5 tttp -66.12 -22.84 66.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.267 -0.896 . . . . 0.0 109.456 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -103.09 -35.97 3.52 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.454 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 2.4 m80 -110.77 93.94 18.45 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.397 -1.061 . . . . 0.0 109.978 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.48 5.64 3.62 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.06 1.558 . . . . 0.0 111.022 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 41.6 p30 -107.54 -2.92 19.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.05 -1.031 . . . . 0.0 109.84 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.608 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -70.5 102.58 2.25 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.413 -0.804 . . . . 0.0 110.126 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 1.056 ' CE1' ' HB2' ' A' ' 21' ' ' ALA . 1.4 p90 33.72 36.67 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.737 -0.602 . . . . 0.0 110.729 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.526 ' HB2' ' CD ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.776 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.93 HG13 ' O ' ' A' ' 120' ' ' TYR . 82.3 t -135.78 144.92 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -1.161 . . . . 0.0 110.358 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.785 ' CE1' HD12 ' A' ' 128' ' ' ILE . 9.8 m-85 -107.71 134.23 50.98 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.238 -0.914 . . . . 0.0 110.031 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.731 HG23 ' CE1' ' A' ' 119' ' ' HIS . 16.6 m -101.8 111.09 23.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.233 -0.917 . . . . 0.0 110.328 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.832 ' CE1' HG11 ' A' ' 133' ' ' VAL . 28.7 m-85 -115.26 126.01 54.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.137 -0.977 . . . . 0.0 109.795 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 116' ' ' SER . 23.1 pt-20 -140.29 154.77 46.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.183 -0.948 . . . . 0.0 110.524 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.458 ' O ' ' HB3' ' A' ' 116' ' ' SER . 49.4 m -139.53 135.61 33.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.336 -0.853 . . . . 0.0 109.729 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.454 ' HG3' ' HG3' ' A' ' 115' ' ' LYS . 2.4 tt0 -116.15 138.86 50.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.1 -1.0 . . . . 0.0 110.72 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.631 ' CZ ' ' CG2' ' A' ' 114' ' ' ILE . 5.8 p90 -158.98 -173.04 4.04 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.506 -0.746 . . . . 0.0 109.814 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.891 HG22 ' HA ' ' A' ' 113' ' ' ILE . 7.4 p -141.57 172.02 13.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.137 -0.977 . . . . 0.0 110.519 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.452 ' HB3' ' CD ' ' A' ' 148' ' ' GLU . 89.9 p -159.95 140.2 11.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.282 -0.886 . . . . 0.0 110.264 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.524 ' HA ' ' HA2' ' A' ' 111' ' ' GLY . 97.2 mt-10 -64.32 -39.08 93.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.28 -0.887 . . . . 0.0 110.106 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 1.049 HD13 ' HB3' ' A' ' 148' ' ' GLU . 2.7 mp -51.37 150.2 6.62 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.313 -0.867 . . . . 0.0 109.791 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.824 ' HD2' HG23 ' A' ' 13' ' ' ILE . 41.7 Cg_endo -67.99 137.1 40.16 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.974 1.513 . . . . 0.0 110.505 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.614 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 41.8 Cg_endo -73.68 -28.95 11.18 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 124.072 1.564 . . . . 0.0 112.933 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 15' ' ' PRO . 43.4 Cg_endo -73.68 -21.33 19.2 Favored 'Trans proline' 0 C--N 1.319 -1.001 0 O-C-N 122.408 0.688 . . . . 0.0 110.534 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.958 ' NE ' HD22 ' A' ' 151' ' ' LEU . 57.6 ttt180 -85.7 -50.9 6.82 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.794 HD23 ' C ' ' A' ' 18' ' ' LEU . 1.7 tt -57.13 -27.66 62.03 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.262 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.555 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 64.9 t80 -69.57 -54.65 13.04 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.488 0.661 . . . . 0.0 109.477 178.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.605 ' HG2' HD22 ' A' ' 24' ' ' LEU . 49.5 mttt -55.31 -29.65 58.68 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 122.158 0.98 . . . . 0.0 108.376 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.002 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -77.36 -63.46 1.37 Allowed 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.647 0.737 . . . . 0.0 110.797 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 1.015 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -60.72 -28.92 69.02 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.612 -0.68 . . . . 0.0 111.401 -178.599 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.743 HG13 ' CD1' ' A' ' 81' ' ' TYR . 4.3 t -108.63 -66.39 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.046 -1.034 . . . . 0.0 111.406 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.678 ' N ' HD12 ' A' ' 24' ' ' LEU . 8.6 mp -68.91 -10.97 60.04 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.162 -0.961 . . . . 0.0 111.205 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.534 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -138.2 16.89 2.79 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.889 -1.132 . . . . 0.0 110.075 179.721 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 1.015 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -51.76 -44.91 63.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 110.177 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.479 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 61.8 m-20 -62.07 -12.41 19.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.181 -0.949 . . . . 0.0 110.157 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.531 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 77.8 m-20 -124.2 -7.71 7.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 110.42 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.747 HD12 ' N ' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -85.0 -46.04 11.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.201 -0.937 . . . . 0.0 110.37 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.948 ' CG1' HD13 ' A' ' 38' ' ' ILE . 2.9 t -69.51 -41.86 18.2 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.35 -0.844 . . . . 0.0 111.002 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.1 Cg_endo -78.55 9.72 3.08 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.54 1.284 . . . . 0.0 110.792 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.449 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 21.7 mttm -121.17 -29.43 4.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.174 -0.954 . . . . 0.0 109.307 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.75 HG21 ' HB3' ' A' ' 146' ' ' LEU . 14.9 mt -80.21 -64.99 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-O 121.607 0.718 . . . . 0.0 109.388 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.457 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . . . -136.01 106.51 9.61 Favored Pre-proline 0 C--N 1.303 -1.451 0 O-C-N 121.708 -0.62 . . . . 0.0 109.876 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.457 ' HD2' ' HA ' ' A' ' 34' ' ' ALA . 44.1 Cg_endo -70.3 0.49 5.97 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.078 1.567 . . . . 0.0 111.035 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -81.13 -13.3 58.81 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.032 -1.042 . . . . 0.0 109.418 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.591 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -96.95 -67.66 0.84 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.393 -0.817 . . . . 0.0 110.15 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.948 HD13 ' CG1' ' A' ' 30' ' ' VAL . 2.3 mp -109.6 127.82 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.491 -0.756 . . . . 0.0 110.158 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 57' ' ' THR . 22.2 ttpt -85.8 -27.68 24.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.272 -0.893 . . . . 0.0 110.366 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.453 ' O ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -163.39 148.83 11.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.122 -0.986 . . . . 0.0 110.037 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.468 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 4.2 m -131.54 122.97 27.02 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.314 -0.866 . . . . 0.0 109.953 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -138.15 111.25 7.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.14 -0.975 . . . . 0.0 110.661 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 28.5 mt -56.87 133.5 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.336 -0.852 . . . . 0.0 109.837 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.539 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 25.3 mt -104.67 -29.78 10.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.913 . . . . 0.0 110.605 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.651 ' CG ' HD12 ' A' ' 53' ' ' ILE . 2.0 m95 -122.46 160.43 25.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.208 -0.932 . . . . 0.0 110.706 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.451 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 41.39 -138.74 1.91 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -152.33 22.2 0.64 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -1.197 . . . . 0.0 110.15 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 126.35 -22.94 5.84 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.536 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -68.43 -174.35 8.79 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -72.33 128.8 14.11 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 123.986 1.519 . . . . 0.0 110.593 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.488 ' HA2' ' HE2' ' A' ' 70' ' ' LYS . . . 105.19 -13.54 48.45 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.504 -1.838 . . . . 0.0 108.504 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -71.74 160.73 32.11 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.616 -0.932 . . . . 0.0 109.327 179.589 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.651 HD12 ' CG ' ' A' ' 45' ' ' TRP . 80.6 mt -131.71 119.37 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 110.215 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 0.4 OUTLIER -101.54 126.47 48.36 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.276 -0.89 . . . . 0.0 110.03 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.539 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 22.2 tttm -96.97 90.68 5.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 110.101 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.588 ' CG2' ' CG1' ' A' ' 38' ' ' ILE . 94.1 mt -80.11 139.41 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.299 -0.876 . . . . 0.0 110.065 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.594 HG22 ' HB3' ' A' ' 66' ' ' TYR . 1.2 p -115.17 153.14 31.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.888 . . . . 0.0 110.301 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.581 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 14.7 m-85 -114.27 176.06 5.21 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.314 -0.866 . . . . 0.0 110.168 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 58' ' ' PHE . . . -43.68 141.82 2.57 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' A' ' 61' ' ' GLY . 80.9 tt0 -53.63 -34.83 59.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -1.179 . . . . 0.0 110.209 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 60' ' ' GLU . . . 43.43 -157.88 0.11 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.48 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 29.6 m -72.27 -29.28 63.75 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.341 -1.093 . . . . 0.0 110.193 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.48 ' NE2' ' O ' ' A' ' 62' ' ' SER . 76.0 mm-40 -140.02 158.41 44.1 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.267 -0.896 . . . . 0.0 110.177 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.562 ' O ' ' CD1' ' A' ' 64' ' ' TYR . 5.4 p90 -50.51 138.6 17.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.267 -0.896 . . . . 0.0 110.171 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.581 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -137.71 85.75 0.23 Allowed Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.594 ' HB3' HG22 ' A' ' 57' ' ' THR . 12.4 p90 -133.52 171.65 13.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -1.166 . . . . 0.0 110.249 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.842 HG12 ' HA2' ' A' ' 88' ' ' GLY . 4.0 m -140.3 177.66 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.332 -0.855 . . . . 0.0 110.35 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.664 ' O ' HD12 ' A' ' 85' ' ' LEU . 23.7 mttm -134.81 104.76 6.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.412 -0.805 . . . . 0.0 109.804 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 1.001 ' CD2' HD13 ' A' ' 85' ' ' LEU . 14.8 m170 -96.9 127.54 42.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.196 -0.94 . . . . 0.0 110.862 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 52' ' ' THR . 77.8 tttt -98.2 113.74 25.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.91 . . . . 0.0 109.414 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.536 HG21 ' O ' ' A' ' 49' ' ' GLY . 33.0 mm -44.53 136.19 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.101 -1.0 . . . . 0.0 110.162 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.547 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 23.8 t0 -109.89 -43.57 3.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.419 -0.801 . . . . 0.0 109.969 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.665 ' C ' HD12 ' A' ' 74' ' ' ILE . 62.3 p -170.81 161.2 7.17 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.484 -0.886 . . . . 0.0 109.947 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.665 HD12 ' C ' ' A' ' 73' ' ' SER . 0.9 OUTLIER -149.44 154.36 9.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 119.277 -0.969 . . . . 0.0 111.005 -179.754 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.548 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 2.3 m-20 -136.1 79.96 1.8 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.809 -0.557 . . . . 0.0 110.288 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.555 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 22.2 mttp -59.94 -14.85 17.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.246 -0.909 . . . . 0.0 110.365 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -93.65 -30.88 14.7 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.22 -0.925 . . . . 0.0 109.753 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.493 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.5 m120 -108.25 -3.82 18.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.533 -0.729 . . . . 0.0 109.723 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.712 ' O ' HD12 ' A' ' 104' ' ' LEU . 5.5 m-85 65.36 47.24 2.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.469 -0.77 . . . . 0.0 110.361 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.548 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.6 OUTLIER -116.62 147.41 41.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -0.896 . . . . 0.0 109.289 179.534 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.743 ' CD1' HG13 ' A' ' 23' ' ' VAL . 90.3 t80 -141.88 139.89 32.72 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.07 -1.019 . . . . 0.0 110.344 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 72' ' ' ASP . 1.3 m -143.72 135.41 26.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.255 -0.903 . . . . 0.0 110.348 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.615 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 20.2 p90 -142.86 170.25 16.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.343 -0.848 . . . . 0.0 110.3 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.795 HG23 ' O ' ' A' ' 98' ' ' ILE . 93.5 m -127.31 125.58 41.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.33 -0.856 . . . . 0.0 109.763 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 1.001 HD13 ' CD2' ' A' ' 69' ' ' HIS . 10.8 tp -95.09 129.86 42.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.068 -1.02 . . . . 0.0 110.444 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.463 ' N ' HD12 ' A' ' 85' ' ' LEU . 11.0 pt -106.25 -32.89 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.323 -0.861 . . . . 0.0 110.175 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.717 ' O ' HD11 ' A' ' 85' ' ' LEU . 86.9 tt0 -118.5 160.72 21.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.337 -0.852 . . . . 0.0 110.107 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.842 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 151.86 151.65 5.69 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -73.27 -25.28 60.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -1.155 . . . . 0.0 110.185 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.19 -20.04 63.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.302 -0.874 . . . . 0.0 110.157 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 92' ' ' GLY . 77.0 mt -69.36 -33.57 73.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.269 -0.894 . . . . 0.0 110.137 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 49.77 -179.71 0.02 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -78.14 3.17 15.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.215 -1.168 . . . . 0.0 109.984 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.412 HG22 ' HG ' ' A' ' 95' ' ' LEU . 1.8 m -93.89 -49.81 5.64 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.204 -0.935 . . . . 0.0 109.849 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.83 HD23 ' CG2' ' A' ' 122' ' ' THR . 42.1 mt -93.6 163.16 13.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.443 -0.786 . . . . 0.0 109.914 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.416 ' CD ' ' HB2' ' A' ' 123' ' ' LYS . 12.3 mt-10 -140.38 -79.85 0.28 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.216 -0.928 . . . . 0.0 109.982 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.498 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 29.2 mtmt -80.14 141.24 35.91 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.586 -0.696 . . . . 0.0 109.999 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.795 ' O ' HG23 ' A' ' 84' ' ' THR . 6.3 mm -130.38 140.87 47.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 120.85 -1.157 . . . . 0.0 110.149 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.516 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -123.81 130.04 51.99 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.642 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.696 ' HE2' HG21 ' A' ' 98' ' ' ILE . 11.6 m-85 -125.35 134.72 52.1 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.21 -0.931 . . . . 0.0 110.603 -178.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.423 ' HG3' ' HB3' ' A' ' 82' ' ' SER . 6.3 mt-10 -134.52 131.15 37.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.436 -0.79 . . . . 0.0 110.211 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 32.3 m -130.26 140.71 50.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -0.894 . . . . 0.0 109.911 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.471 ' HB2' ' HB3' ' A' ' 115' ' ' LYS . 8.9 mttp -131.79 137.55 48.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.181 -0.95 . . . . 0.0 110.763 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.891 HD23 HG12 ' A' ' 114' ' ' ILE . 7.3 mt -116.5 150.66 37.54 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.277 -0.89 . . . . 0.0 109.839 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.705 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -150.91 -169.45 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.11 -0.993 . . . . 0.0 110.064 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.705 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -126.83 155.98 42.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.368 -0.833 . . . . 0.0 110.091 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.443 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.7 p -114.6 169.43 6.63 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.279 -0.888 . . . . 0.0 110.309 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.443 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.2 Cg_endo -72.62 -10.69 25.49 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.14 1.6 . . . . 0.0 110.49 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 95.5 p -98.19 5.53 48.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.273 -0.892 . . . . 0.0 110.37 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.1 -34.89 4.76 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' A' ' 12' ' ' GLU . . . -57.65 -173.86 0.33 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 54.0 p -133.76 138.41 45.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.198 -1.178 . . . . 0.0 110.434 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.891 ' HA ' HG22 ' A' ' 10' ' ' THR . 23.0 mt -91.36 147.26 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.367 -0.833 . . . . 0.0 110.085 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.891 HG12 HD23 ' A' ' 104' ' ' LEU . 22.8 mt -133.58 123.26 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.215 -0.928 . . . . 0.0 110.328 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.471 ' HB3' ' HB2' ' A' ' 103' ' ' LYS . 72.4 tttt -107.96 121.66 45.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.233 -0.917 . . . . 0.0 110.089 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.458 ' HB3' ' O ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -104.32 154.68 19.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.187 -0.946 . . . . 0.0 110.419 -179.854 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 20.9 m -158.76 148.82 19.52 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.432 -0.793 . . . . 0.0 110.2 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.428 ' OG ' ' HB2' ' A' ' 5' ' ' TYR . 86.2 p -157.03 156.28 32.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.297 -0.877 . . . . 0.0 110.154 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.731 ' CE1' HG23 ' A' ' 4' ' ' THR . 85.7 m-70 -134.9 137.95 43.66 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.162 -0.961 . . . . 0.0 110.51 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.93 ' O ' HG13 ' A' ' 2' ' ' VAL . 3.9 m-30 -104.01 139.29 39.33 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.345 -0.847 . . . . 0.0 110.262 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.498 ' HB2' ' HB2' ' A' ' 97' ' ' LYS . 92.1 m-70 -121.96 90.49 3.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.981 -1.074 . . . . 0.0 109.565 179.003 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.83 ' CG2' HD23 ' A' ' 95' ' ' LEU . 1.8 p -72.22 156.69 38.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.28 -0.888 . . . . 0.0 110.66 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.482 ' HG2' ' N ' ' A' ' 124' ' ' GLY . 42.4 tttt -100.31 149.01 24.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.461 -0.775 . . . . 0.0 109.946 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.482 ' N ' ' HG2' ' A' ' 123' ' ' LYS . . . 69.4 -122.88 13.04 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -138.69 70.28 1.38 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -1.195 . . . . 0.0 110.244 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.538 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 32.5 m -122.9 164.21 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 0.0 109.972 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -131.86 152.39 51.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.098 -1.001 . . . . 0.0 110.406 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.785 HD12 ' CE1' ' A' ' 3' ' ' PHE . 2.8 mp -84.35 172.4 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.269 -0.895 . . . . 0.0 110.205 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.594 ' N ' HG22 ' A' ' 128' ' ' ILE . 5.8 tttp -112.31 179.03 4.11 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.323 -0.86 . . . . 0.0 109.853 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -82.39 5.46 20.33 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.172 -0.955 . . . . 0.0 108.822 178.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -93.83 -31.56 14.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.386 -0.821 . . . . 0.0 109.906 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -85.93 -36.16 20.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.29 -0.881 . . . . 0.0 110.083 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.832 HG11 ' CE1' ' A' ' 5' ' ' TYR . 37.0 t -77.56 -43.21 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.351 -0.843 . . . . 0.0 110.095 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 57.5 tttm -65.51 -44.21 87.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 0.0 110.114 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.44 -37.23 85.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.24 -0.913 . . . . 0.0 110.027 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -64.09 -30.72 78.57 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 81.0 mttt -61.9 -31.67 71.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.366 -1.079 . . . . 0.0 109.998 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.483 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 70.0 mm-40 -82.29 -36.92 26.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.319 -0.863 . . . . 0.0 109.962 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -70.48 -30.52 67.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.337 -0.852 . . . . 0.0 109.975 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.57 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -88.43 -37.74 15.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.894 . . . . 0.0 110.094 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.419 ' O ' ' HB2' ' A' ' 144' ' ' PHE . 66.3 m -71.24 -52.58 18.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.416 -0.802 . . . . 0.0 109.97 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.483 ' ND2' ' O ' ' A' ' 138' ' ' GLU . 92.3 m-20 -54.62 -43.41 72.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.275 -0.891 . . . . 0.0 109.971 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.623 ' HA ' HD12 ' A' ' 146' ' ' LEU . 13.0 tp -59.7 -42.74 93.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.895 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.717 ' HA ' HD12 ' A' ' 147' ' ' ILE . 7.7 m-85 -55.17 -39.1 69.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.331 -0.856 . . . . 0.0 109.587 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.46 ' O ' ' HG2' ' A' ' 145' ' ' LYS . 51.0 tttt -74.53 -15.02 60.88 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.419 -0.801 . . . . 0.0 109.859 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.75 ' HB3' HG21 ' A' ' 33' ' ' ILE . 29.2 mt -80.86 -35.15 33.11 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.178 -0.951 . . . . 0.0 108.712 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.78 HD11 ' CE1' ' A' ' 22' ' ' PHE . 17.4 mt -68.83 -51.59 43.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 1.049 ' HB3' HD13 ' A' ' 13' ' ' ILE . 52.6 mt-10 -56.46 -40.9 75.64 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.543 -0.723 . . . . 0.0 109.764 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 98.0 m -66.97 -41.81 86.2 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.144 -0.973 . . . . 0.0 109.811 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.619 ' CD1' HG12 ' A' ' 33' ' ' ILE . 87.1 t80 -56.19 -46.18 79.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.344 -0.847 . . . . 0.0 109.997 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.958 HD22 ' NE ' ' A' ' 17' ' ' ARG . 33.2 mt -80.15 -28.98 38.78 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.227 -0.921 . . . . 0.0 110.344 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.775 ' HB2' HD11 ' A' ' 13' ' ' ILE . 21.4 tttt -72.23 -28.06 62.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.327 -0.858 . . . . 0.0 109.822 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.493 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -101.47 -33.61 4.75 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.525 ' O ' ' NH2' ' A' ' 17' ' ' ARG . 4.4 m80 -106.94 92.4 7.54 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.339 -1.095 . . . . 0.0 109.71 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 48.5 Cg_endo -73.68 8.22 2.02 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.288 1.678 . . . . 0.0 111.439 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -112.5 1.47 15.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.915 -1.116 . . . . 0.0 109.817 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.615 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -73.4 100.98 3.35 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.367 -0.833 . . . . 0.0 110.421 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 1.002 ' CE1' ' HB2' ' A' ' 21' ' ' ALA . 0.3 OUTLIER 34.53 39.55 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.747 -0.596 . . . . 0.0 110.691 -179.737 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.589 ' CB ' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.416 0 CA-C-O 118.007 -0.996 . . . . 0.0 109.722 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.911 HG13 ' O ' ' A' ' 120' ' ' TYR . 70.9 t -140.21 125.32 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.197 -1.178 . . . . 0.0 110.169 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.619 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 66.0 m-85 -88.93 126.09 35.24 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.141 -0.974 . . . . 0.0 110.108 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.71 HG23 ' CE1' ' A' ' 119' ' ' HIS . 3.0 m -117.38 107.24 14.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.235 -0.916 . . . . 0.0 110.431 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.69 ' CE1' HG23 ' A' ' 133' ' ' VAL . 69.5 m-85 -111.49 126.11 54.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.184 -0.948 . . . . 0.0 110.164 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.468 ' HG2' ' OG1' ' A' ' 117' ' ' THR . 2.4 mt-10 -117.6 144.79 44.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.295 -0.878 . . . . 0.0 110.564 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.477 ' O ' ' HG2' ' A' ' 8' ' ' GLU . 20.0 m -128.0 164.64 21.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.331 -0.856 . . . . 0.0 109.842 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 7' ' ' SER . 68.4 mt-10 -153.12 124.65 7.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.064 -1.022 . . . . 0.0 110.757 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.636 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.0 p90 -145.24 -176.22 5.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.308 -0.87 . . . . 0.0 109.728 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.785 HG22 ' HA ' ' A' ' 113' ' ' ILE . 6.8 p -142.5 174.56 10.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.062 -1.024 . . . . 0.0 110.687 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.485 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 7.9 t -159.99 164.96 32.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.37 -0.831 . . . . 0.0 110.142 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -89.69 -22.85 22.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.306 -0.871 . . . . 0.0 110.213 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.844 HG21 HD12 ' A' ' 151' ' ' LEU . 8.4 mm -68.1 150.71 97.64 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.264 -0.898 . . . . 0.0 109.984 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.825 ' HD2' HG23 ' A' ' 13' ' ' ILE . 41.0 Cg_endo -66.98 145.05 72.63 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 124.029 1.541 . . . . 0.0 110.598 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.669 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.1 Cg_endo -71.18 -31.99 13.68 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.873 1.459 . . . . 0.0 112.765 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.669 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.1 Cg_endo -69.23 -22.76 34.06 Favored 'Trans proline' 0 C--N 1.318 -1.047 0 N-CA-C 109.988 -0.812 . . . . 0.0 109.988 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.726 HH21 ' HB3' ' A' ' 157' ' ' ALA . 52.3 mtp180 -81.79 -43.13 18.75 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 1.095 HD23 ' CG2' ' A' ' 147' ' ' ILE . 0.2 OUTLIER -73.53 -33.78 64.89 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.702 -0.799 . . . . 0.0 108.939 178.971 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.649 ' N ' HD13 ' A' ' 18' ' ' LEU . 59.8 t80 -60.27 -60.51 3.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.511 -0.743 . . . . 0.0 109.765 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.645 ' HG2' HD22 ' A' ' 24' ' ' LEU . 23.1 mttt -53.77 -38.9 64.92 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.735 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.058 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -69.17 -36.42 77.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.456 -0.778 . . . . 0.0 110.904 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 1.047 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.3 OUTLIER -79.09 -49.21 12.99 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.31 -0.869 . . . . 0.0 110.974 -179.127 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.608 ' HB ' HD12 ' A' ' 24' ' ' LEU . 3.7 t -94.34 -53.97 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.202 -0.936 . . . . 0.0 111.813 -178.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.765 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.4 mp -80.03 -1.05 38.06 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.972 -1.08 . . . . 0.0 112.129 -178.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.587 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -147.78 23.46 1.1 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.704 -1.247 . . . . 0.0 110.725 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 1.047 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -65.76 -12.35 53.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.089 -1.007 . . . . 0.0 110.193 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.514 ' HA ' ' CB ' ' A' ' 41' ' ' SER . 92.0 m-20 -80.08 -13.76 59.05 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.205 -0.934 . . . . 0.0 110.443 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.402 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 4.6 p30 -135.46 6.19 3.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.192 -0.943 . . . . 0.0 110.595 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.682 ' HG ' ' HB1' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -96.59 -40.56 8.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.214 -0.929 . . . . 0.0 109.888 179.901 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.871 ' CG1' HD13 ' A' ' 38' ' ' ILE . 4.1 t -82.45 -41.01 0.92 Allowed Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.437 -0.79 . . . . 0.0 111.013 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.7 Cg_endo -78.95 11.43 2.57 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.365 1.192 . . . . 0.0 110.771 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -124.41 -34.04 2.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.065 -1.022 . . . . 0.0 109.438 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.617 HG21 ' HB3' ' A' ' 146' ' ' LEU . 7.5 mt -80.12 -38.75 18.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.489 -0.757 . . . . 0.0 109.399 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.77 96.68 7.43 Favored Pre-proline 0 C--N 1.304 -1.379 0 O-C-N 121.463 -0.773 . . . . 0.0 110.03 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.35 -2.52 11.37 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.003 1.528 . . . . 0.0 110.513 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -88.48 -26.41 22.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.135 -0.978 . . . . 0.0 109.711 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -86.08 -73.43 0.45 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.4 -0.813 . . . . 0.0 109.969 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.871 HD13 ' CG1' ' A' ' 30' ' ' VAL . 2.1 mp -102.6 137.15 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.407 -0.808 . . . . 0.0 110.045 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.2 ttpp -96.18 -32.28 12.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 110.376 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.47 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -167.94 156.68 9.29 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.213 -0.93 . . . . 0.0 110.09 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.514 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 11.0 p -115.83 144.89 43.37 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.273 -0.892 . . . . 0.0 110.266 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.47 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 73.3 tt0 -149.0 97.74 2.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.248 -0.908 . . . . 0.0 110.327 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.403 HG21 ' HA ' ' A' ' 47' ' ' ASP . 19.1 mt -57.52 130.78 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.173 -0.955 . . . . 0.0 110.06 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.532 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 31.0 mt -102.55 -35.25 8.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 110.64 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.807 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.9 m95 -122.91 162.85 21.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.108 -0.995 . . . . 0.0 110.658 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.446 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 41.79 -136.51 2.92 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.418 ' O ' ' CG ' ' A' ' 47' ' ' ASP . 11.1 t0 -154.26 22.41 0.49 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -1.143 . . . . 0.0 109.907 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 122.82 -20.47 7.7 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.819 -1.712 . . . . 0.0 108.819 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.454 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -68.42 -171.92 6.85 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.81 129.13 13.12 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.051 1.553 . . . . 0.0 110.626 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.84 -9.18 56.66 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.509 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -73.49 159.13 33.65 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.523 -0.986 . . . . 0.0 109.94 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.807 HD12 ' CG ' ' A' ' 45' ' ' TRP . 78.1 mt -126.85 119.61 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.354 -0.841 . . . . 0.0 109.406 179.266 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -105.15 135.25 46.84 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 110.451 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.532 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 76.7 tttt -104.22 93.43 4.82 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.364 -0.835 . . . . 0.0 110.05 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.549 ' HB ' HG23 ' A' ' 67' ' ' VAL . 66.3 mt -79.98 134.19 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.206 -0.934 . . . . 0.0 109.942 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.526 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 1.7 p -106.98 155.89 19.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.371 -0.831 . . . . 0.0 110.213 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.484 ' CE2' HG13 ' A' ' 67' ' ' VAL . 22.6 m-85 -111.48 151.24 28.84 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.319 -0.863 . . . . 0.0 110.205 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 58' ' ' PHE . . . -43.44 160.92 0.06 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -46.54 -86.42 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -1.139 . . . . 0.0 110.181 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.54 -94.01 0.22 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 79.2 p -87.49 -140.92 0.11 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.19 -1.182 . . . . 0.0 110.066 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -83.65 -28.65 28.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.182 -0.949 . . . . 0.0 110.115 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -178.44 131.4 0.13 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.233 -0.917 . . . . 0.0 109.934 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -135.92 133.94 6.92 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.544 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 10.5 p90 -178.16 169.34 1.9 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.335 -1.097 . . . . 0.0 110.181 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.865 HG12 ' HA2' ' A' ' 88' ' ' GLY . 4.1 m -141.92 176.92 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.395 -0.816 . . . . 0.0 110.54 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.705 ' HE2' HG21 ' A' ' 53' ' ' ILE . 68.8 tttt -127.69 122.95 34.29 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.363 -0.836 . . . . 0.0 109.792 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.425 ' NE2' ' HG ' ' A' ' 85' ' ' LEU . 9.0 m170 -116.26 126.62 53.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.088 -1.007 . . . . 0.0 110.993 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 52' ' ' THR . 15.2 tttt -102.76 117.23 34.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.295 -0.878 . . . . 0.0 109.403 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.531 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 25.5 mm -60.13 126.61 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.243 -0.911 . . . . 0.0 110.334 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.433 ' HB2' ' C ' ' A' ' 82' ' ' SER . 41.9 m-20 -97.95 -36.89 10.0 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.35 -0.844 . . . . 0.0 109.724 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.487 ' OG ' ' HB2' ' A' ' 82' ' ' SER . 35.0 p -178.58 157.33 0.97 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.327 -0.858 . . . . 0.0 109.887 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.401 HG12 HG11 ' A' ' 23' ' ' VAL . 1.3 mt -139.67 158.24 27.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.257 -0.902 . . . . 0.0 110.051 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.551 ' HB2' ' HB3' ' A' ' 80' ' ' SER . 0.8 OUTLIER -142.77 82.47 1.77 Allowed 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.537 179.698 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.549 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 48.7 tttm -66.21 -14.62 62.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.309 -0.869 . . . . 0.0 110.214 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -87.69 -29.37 21.17 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.395 -0.816 . . . . 0.0 108.907 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.489 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 2.3 m120 -108.07 -5.66 16.9 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.403 0.62 . . . . 0.0 109.358 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.569 ' HA ' ' CD1' ' A' ' 19' ' ' PHE . 50.5 m-85 64.58 53.04 1.65 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.681 -0.637 . . . . 0.0 110.608 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.551 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 11.8 t -125.33 175.75 7.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 110.242 179.24 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.594 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 20.8 t80 -156.8 145.83 20.21 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.959 -0.697 . . . . 0.0 110.182 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.487 ' HB2' ' OG ' ' A' ' 73' ' ' SER . 0.4 OUTLIER -147.34 124.06 11.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.265 -0.897 . . . . 0.0 110.819 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.627 ' N ' ' CD1' ' A' ' 83' ' ' TYR . 2.5 p90 -145.77 -179.92 7.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.37 -0.831 . . . . 0.0 109.708 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . 1.013 HG23 ' O ' ' A' ' 98' ' ' ILE . 18.6 m -135.62 146.88 48.34 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.132 -0.98 . . . . 0.0 110.567 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.65 HD12 ' HE2' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -102.43 117.82 35.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.29 -0.881 . . . . 0.0 110.257 179.67 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.606 HD11 ' HD3' ' A' ' 68' ' ' LYS . 22.3 pt -113.13 -6.12 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.228 -0.92 . . . . 0.0 110.138 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -145.92 128.29 15.89 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.319 -0.863 . . . . 0.0 110.39 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.865 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . -178.59 120.32 0.7 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -52.56 -27.33 16.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -1.161 . . . . 0.0 110.158 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.07 -20.98 62.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.935 . . . . 0.0 110.154 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.707 HD12 ' N ' ' A' ' 88' ' ' GLY . 32.9 mt -69.55 -24.74 63.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.237 -0.914 . . . . 0.0 110.222 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 50.03 -176.87 0.04 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -81.22 6.9 12.62 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -1.143 . . . . 0.0 110.222 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.423 ' O ' HG22 ' A' ' 122' ' ' THR . 26.2 p -94.21 -28.72 15.48 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.227 -0.921 . . . . 0.0 110.096 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 1.083 HD21 ' CD1' ' A' ' 128' ' ' ILE . 90.3 mt -110.35 151.66 27.17 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.302 -0.874 . . . . 0.0 110.014 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.427 ' HG3' ' HB2' ' A' ' 123' ' ' LYS . 11.5 mt-10 -133.79 -80.81 0.46 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.172 -0.955 . . . . 0.0 110.281 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.512 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 70.8 mttt -80.36 127.2 32.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.549 -0.719 . . . . 0.0 110.898 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 1.013 ' O ' HG23 ' A' ' 84' ' ' THR . 13.0 mm -116.98 146.73 21.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 120.722 -1.237 . . . . 0.0 109.664 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.511 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.5 OUTLIER -124.99 124.8 42.78 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.504 -0.879 . . . . 0.0 108.704 178.223 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.829 ' CE2' HG21 ' A' ' 98' ' ' ILE . 15.3 m-85 -121.15 140.81 51.5 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.366 -0.834 . . . . 0.0 110.454 -178.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.514 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 20.2 tt0 -145.42 136.92 25.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.284 -0.885 . . . . 0.0 110.331 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.478 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 60.6 m -135.16 129.69 34.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.32 -0.863 . . . . 0.0 109.635 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 80' ' ' SER . 0.0 OUTLIER -125.98 144.57 50.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.946 . . . . 0.0 110.691 -179.487 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.566 HD12 ' O ' ' A' ' 79' ' ' TYR . 7.4 mt -117.52 155.58 29.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.292 -0.88 . . . . 0.0 109.973 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.688 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -151.35 -169.2 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.133 -0.979 . . . . 0.0 110.185 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.688 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -121.87 144.07 49.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.37 -0.831 . . . . 0.0 110.234 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.458 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 3.4 p -101.2 169.41 7.81 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.182 -0.949 . . . . 0.0 110.253 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 47.6 Cg_endo -73.15 -10.91 24.84 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.111 1.585 . . . . 0.0 110.565 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.6 m -99.45 4.29 46.07 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.226 -0.921 . . . . 0.0 110.185 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 102.05 -36.93 3.92 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -56.79 178.17 0.79 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 20.6 p -122.76 130.0 52.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.228 -1.16 . . . . 0.0 110.284 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.785 ' HA ' HG22 ' A' ' 10' ' ' THR . 5.9 mt -80.33 149.41 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.252 -0.905 . . . . 0.0 110.077 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.586 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 6.5 mt -128.59 118.97 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 0.0 110.189 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 38.7 tttt -101.15 128.98 46.99 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.159 -0.963 . . . . 0.0 110.157 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.449 ' HB3' ' HB2' ' A' ' 7' ' ' SER . 0.0 OUTLIER -110.99 152.13 27.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.215 -0.928 . . . . 0.0 110.047 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.585 ' CG2' ' CE1' ' A' ' 119' ' ' HIS . 33.4 m -160.09 125.29 3.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.212 -0.93 . . . . 0.0 110.499 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.504 ' HB3' ' CE1' ' A' ' 100' ' ' TYR . 3.1 m -135.46 142.94 45.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.314 -0.866 . . . . 0.0 109.746 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.71 ' CE1' HG23 ' A' ' 4' ' ' THR . 33.1 m-70 -129.49 136.19 49.57 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.082 -1.011 . . . . 0.0 110.293 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.911 ' O ' HG13 ' A' ' 2' ' ' VAL . 3.0 m-30 -104.54 151.78 23.19 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.308 -0.87 . . . . 0.0 110.745 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.512 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 82.1 m-70 -129.78 86.97 2.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.297 -0.877 . . . . 0.0 109.43 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.685 ' CG2' HD23 ' A' ' 95' ' ' LEU . 1.4 p -63.23 156.11 26.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.375 -0.828 . . . . 0.0 110.56 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.427 ' HB2' ' HG3' ' A' ' 96' ' ' GLU . 4.3 tttm -103.86 106.52 17.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.399 -0.813 . . . . 0.0 110.07 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 103.45 -123.41 7.78 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -136.62 94.61 3.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.233 -1.157 . . . . 0.0 110.252 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.503 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 14.9 m -141.95 -177.77 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.277 -0.889 . . . . 0.0 110.128 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -134.23 144.5 48.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -0.933 . . . . 0.0 110.48 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 1.083 ' CD1' HD21 ' A' ' 95' ' ' LEU . 12.0 mm -64.94 172.54 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 110.154 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.596 ' N ' HG22 ' A' ' 128' ' ' ILE . 18.8 mttt -97.78 127.89 44.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.345 -0.847 . . . . 0.0 109.847 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 129' ' ' LYS . 94.6 mt-10 -44.13 -52.8 6.98 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.131 -0.981 . . . . 0.0 109.937 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.99 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 50.7 tt0 -52.54 -20.53 3.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.203 -0.935 . . . . 0.0 109.706 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.479 ' N ' ' O ' ' A' ' 129' ' ' LYS . 14.0 t-160 -85.31 -61.85 1.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.395 -0.816 . . . . 0.0 110.259 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.69 HG23 ' CE1' ' A' ' 5' ' ' TYR . 1.8 p -66.37 -20.92 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.306 -0.872 . . . . 0.0 110.285 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.532 ' HG3' HG13 ' A' ' 133' ' ' VAL . 26.3 mttt -104.42 -72.51 0.7 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.922 . . . . 0.0 110.027 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.99 ' HB3' ' O ' ' A' ' 131' ' ' GLU . . . -56.57 -22.4 33.28 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 109.77 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -75.46 -27.87 62.67 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -68.83 -33.9 74.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.174 -1.192 . . . . 0.0 110.145 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.419 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 78.4 tt0 -75.95 -24.14 55.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.315 -0.866 . . . . 0.0 110.109 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 67.7 mttt -78.94 -27.98 43.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.335 -0.853 . . . . 0.0 109.991 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -81.85 -36.1 28.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.289 -0.882 . . . . 0.0 110.072 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.8 t -65.25 -46.32 81.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.4 -0.812 . . . . 0.0 110.141 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.419 ' ND2' ' O ' ' A' ' 138' ' ' GLU . 93.5 m-20 -51.69 -47.58 63.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.343 -0.848 . . . . 0.0 110.028 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.744 ' HA ' HD12 ' A' ' 146' ' ' LEU . 14.0 tp -56.68 -50.03 73.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.903 . . . . 0.0 109.936 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.467 ' CG ' ' CZ ' ' A' ' 9' ' ' PHE . 18.0 m-85 -55.87 -39.26 71.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.334 -0.854 . . . . 0.0 109.708 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -75.97 -11.09 59.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.417 -0.802 . . . . 0.0 110.089 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.744 HD12 ' HA ' ' A' ' 143' ' ' LEU . 11.7 mt -83.42 -37.84 22.7 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.211 -0.931 . . . . 0.0 108.804 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 1.095 ' CG2' HD23 ' A' ' 18' ' ' LEU . 63.5 mt -69.06 -48.49 69.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.513 ' O ' HG13 ' A' ' 13' ' ' ILE . 96.8 mt-10 -47.27 -38.01 11.69 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.414 -0.804 . . . . 0.0 109.009 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.482 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 11.0 m -79.94 -25.4 40.48 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.318 -0.864 . . . . 0.0 109.237 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.575 ' CD1' HD11 ' A' ' 33' ' ' ILE . 64.9 t80 -54.85 -51.8 64.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.583 -0.698 . . . . 0.0 109.824 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.002 HD21 ' CE1' ' A' ' 158' ' ' TYR . 45.0 mt -79.89 -28.97 39.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.479 -0.763 . . . . 0.0 109.994 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.49 ' HA ' HD11 ' A' ' 13' ' ' ILE . 21.1 tttt -64.18 -13.04 45.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.317 -0.864 . . . . 0.0 109.488 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.502 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -124.19 -24.13 1.86 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -105.53 93.62 7.36 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.147 -1.208 . . . . 0.0 110.165 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.0 Cg_endo -73.43 4.12 4.19 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 124.12 1.589 . . . . 0.0 111.038 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -119.44 -1.53 10.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.023 -1.048 . . . . 0.0 110.126 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.726 ' HB3' HH21 ' A' ' 17' ' ' ARG . . . -59.76 105.51 0.38 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.339 -0.85 . . . . 0.0 110.159 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 1.058 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 0.3 OUTLIER 35.64 30.53 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.606 -0.684 . . . . 0.0 110.738 -179.754 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.536 ' CB ' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.726 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 1.026 HG23 ' C ' ' A' ' 120' ' ' TYR . 2.8 p -80.47 151.56 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.297 -1.119 . . . . 0.0 110.219 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.677 ' CE1' HD12 ' A' ' 128' ' ' ILE . 15.9 m-85 -90.14 176.39 6.79 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.276 -0.89 . . . . 0.0 110.046 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.826 HG23 ' CE1' ' A' ' 119' ' ' HIS . 94.9 m -140.88 106.11 5.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.247 -0.908 . . . . 0.0 110.294 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.657 ' CD1' HG13 ' A' ' 133' ' ' VAL . 22.2 m-85 -113.36 129.5 56.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -0.895 . . . . 0.0 109.987 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 22.4 pt-20 -130.41 152.99 49.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.233 -0.917 . . . . 0.0 110.569 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.3 m -138.18 147.18 43.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.373 -0.829 . . . . 0.0 109.84 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -131.36 117.12 18.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.132 -0.98 . . . . 0.0 110.556 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.4 p90 -139.21 -176.72 4.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.313 -0.867 . . . . 0.0 110.014 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.548 HG22 HG12 ' A' ' 113' ' ' ILE . 7.6 p -136.05 174.95 10.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.188 -0.945 . . . . 0.0 110.662 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.49 ' HB3' ' OE2' ' A' ' 148' ' ' GLU . 80.5 p -160.02 128.51 4.88 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.392 -0.817 . . . . 0.0 110.288 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.428 ' HA ' ' CA ' ' A' ' 111' ' ' GLY . 96.6 mt-10 -60.61 -28.86 68.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.195 -0.941 . . . . 0.0 109.924 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.939 HD13 ' HB3' ' A' ' 148' ' ' GLU . 1.3 mp -65.89 148.33 98.34 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.334 -0.854 . . . . 0.0 109.828 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.654 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.7 Cg_endo -66.49 141.65 62.09 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.892 1.469 . . . . 0.0 110.491 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.646 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.3 Cg_endo -72.87 -30.88 10.79 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 124.017 1.535 . . . . 0.0 112.886 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.646 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.6 Cg_endo -70.68 -22.33 28.0 Favored 'Trans proline' 0 C--N 1.319 -1.001 0 N-CA-C 110.195 -0.733 . . . . 0.0 110.195 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.638 HH21 ' HB3' ' A' ' 157' ' ' ALA . 43.4 mtp180 -84.31 -43.28 14.95 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.011 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 1.049 HD23 ' CG2' ' A' ' 147' ' ' ILE . 0.2 OUTLIER -72.73 -34.74 67.27 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.018 179.05 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.624 ' N ' HD13 ' A' ' 18' ' ' LEU . 52.5 t80 -64.5 -56.21 15.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.333 -0.854 . . . . 0.0 109.573 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.539 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 28.7 mttt -52.74 -36.41 57.68 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.734 -0.787 . . . . 0.0 109.564 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.007 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -78.03 -36.58 48.38 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.372 -0.83 . . . . 0.0 111.056 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 1.03 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.3 OUTLIER -73.91 -42.71 60.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.195 -0.94 . . . . 0.0 111.191 -179.057 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.628 ' HB ' HD12 ' A' ' 24' ' ' LEU . 4.6 t -105.99 -49.97 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.018 -1.051 . . . . 0.0 111.61 -178.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.676 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.1 mp -79.84 -9.95 59.72 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.26 -0.9 . . . . 0.0 111.399 -178.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.559 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.9 OUTLIER -149.44 38.82 0.79 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.85 -1.156 . . . . 0.0 110.555 -179.755 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 1.03 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -78.92 -24.97 43.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.333 -0.854 . . . . 0.0 110.504 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.484 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 91.8 m-20 -65.34 -21.15 66.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.154 -0.966 . . . . 0.0 110.221 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.554 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 7.6 p-10 -125.4 13.0 8.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.315 -0.866 . . . . 0.0 109.89 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.752 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -94.28 -52.04 4.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.441 -0.787 . . . . 0.0 110.327 -179.89 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 1.112 HG21 HD13 ' A' ' 38' ' ' ILE . 3.8 p -75.1 -28.87 0.82 Allowed Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.275 -0.89 . . . . 0.0 112.288 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.844 ' HD3' HG12 ' A' ' 30' ' ' VAL . 51.9 Cg_endo -79.1 7.58 4.3 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 O-C-N 122.704 0.844 . . . . 0.0 110.581 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -129.66 -29.73 2.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.172 -0.955 . . . . 0.0 110.009 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.698 HD11 HD13 ' A' ' 29' ' ' LEU . 75.5 mt -80.04 -44.13 22.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.41 -0.806 . . . . 0.0 109.788 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -160.43 103.21 1.35 Allowed Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.376 -0.827 . . . . 0.0 110.121 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.46 0.29 7.69 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.077 1.567 . . . . 0.0 110.641 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -83.48 -15.57 49.0 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.182 -0.949 . . . . 0.0 109.67 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -92.13 -64.84 1.06 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.414 -0.804 . . . . 0.0 109.993 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 1.112 HD13 HG21 ' A' ' 30' ' ' VAL . 2.1 mp -114.88 131.19 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.426 -0.796 . . . . 0.0 109.941 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 57' ' ' THR . 15.8 ttpt -77.42 -23.43 50.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.203 -0.936 . . . . 0.0 110.48 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.451 ' O ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -178.94 161.45 1.18 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.106 -0.996 . . . . 0.0 110.102 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.4 m -134.61 124.34 25.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.329 -0.857 . . . . 0.0 109.977 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -137.68 110.92 7.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -0.938 . . . . 0.0 110.661 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.416 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 33.8 mt -56.25 136.27 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.33 -0.857 . . . . 0.0 109.787 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.727 HD13 ' HD2' ' A' ' 55' ' ' LYS . 7.6 tp -108.76 -26.1 10.48 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.174 -0.953 . . . . 0.0 110.575 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.483 ' HB2' ' CB ' ' A' ' 53' ' ' ILE . 2.0 m95 -128.65 163.3 25.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.123 -0.985 . . . . 0.0 110.845 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.448 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 41.8 -137.72 2.55 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.94 24.13 0.66 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.326 -1.102 . . . . 0.0 110.02 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 119.04 -16.32 10.88 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.519 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -73.66 -170.02 19.66 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.75 128.85 12.88 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.99 1.521 . . . . 0.0 110.559 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.465 ' HA2' ' HE3' ' A' ' 70' ' ' LYS . . . 102.64 -12.32 56.55 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 108.707 -1.757 . . . . 0.0 108.707 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.539 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -71.36 161.6 30.8 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.534 -0.98 . . . . 0.0 109.56 179.674 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.483 ' CB ' ' HB2' ' A' ' 45' ' ' TRP . 45.0 mt -130.78 119.93 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.329 -0.857 . . . . 0.0 109.959 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.784 ' CE ' HD11 ' A' ' 71' ' ' ILE . 29.3 mttm -103.11 127.17 50.49 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.151 -0.968 . . . . 0.0 110.228 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.727 ' HD2' HD13 ' A' ' 44' ' ' LEU . 7.8 mtpt -96.06 92.69 6.57 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.378 -0.826 . . . . 0.0 110.098 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.542 ' CG2' HG12 ' A' ' 38' ' ' ILE . 95.2 mt -79.95 141.87 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 109.914 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 2.4 p -116.4 152.07 34.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.3 -0.875 . . . . 0.0 110.582 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.594 ' HE2' HG13 ' A' ' 67' ' ' VAL . 23.5 m-85 -117.5 145.87 43.92 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.37 -0.832 . . . . 0.0 110.104 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -70.12 122.0 10.92 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -144.94 165.61 27.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -1.161 . . . . 0.0 110.143 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.25 -133.84 0.07 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 92.3 p -60.08 -29.13 68.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.214 -1.168 . . . . 0.0 110.21 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -81.66 142.84 32.35 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.21 -0.932 . . . . 0.0 110.163 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -96.62 145.8 25.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.165 -0.96 . . . . 0.0 110.228 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.577 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -135.53 96.61 0.27 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.546 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 13.6 p90 -136.1 169.13 18.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -1.182 . . . . 0.0 110.197 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.72 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.5 m -139.54 175.32 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.233 -0.917 . . . . 0.0 110.636 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.68 ' O ' HD12 ' A' ' 85' ' ' LEU . 42.7 mttt -133.41 104.63 6.51 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.465 -0.772 . . . . 0.0 109.905 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.971 ' CD2' HD13 ' A' ' 85' ' ' LEU . 13.3 m170 -96.13 129.6 43.38 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.197 -0.94 . . . . 0.0 111.138 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 52' ' ' THR . 21.6 tttp -96.92 116.7 29.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.327 -0.858 . . . . 0.0 109.395 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.784 HD11 ' CE ' ' A' ' 54' ' ' LYS . 26.8 mm -57.26 128.59 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.172 -0.955 . . . . 0.0 110.346 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 82' ' ' SER . 85.0 m-20 -101.58 -43.79 5.78 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.341 -0.849 . . . . 0.0 110.013 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.423 ' OG ' ' HB2' ' A' ' 82' ' ' SER . 62.0 p -173.67 158.67 3.38 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.434 -0.791 . . . . 0.0 109.946 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.48 HG12 HG11 ' A' ' 23' ' ' VAL . 2.0 mt -139.3 157.4 27.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.229 -0.92 . . . . 0.0 110.228 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 79' ' ' TYR . 4.5 m-20 -135.41 79.2 1.77 Allowed 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.371 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -61.38 -17.74 55.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -0.923 . . . . 0.0 110.174 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -92.48 -30.68 15.59 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.28 -0.887 . . . . 0.0 109.577 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.497 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.6 m120 -104.15 -3.22 24.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.566 -0.709 . . . . 0.0 109.574 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.716 ' HB3' HD12 ' A' ' 104' ' ' LEU . 70.0 m-85 60.18 54.57 3.99 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.599 -0.688 . . . . 0.0 110.756 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.508 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 0.9 OUTLIER -129.47 157.62 41.49 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.278 -0.889 . . . . 0.0 109.689 179.435 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.686 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 45.3 t80 -142.54 138.86 31.18 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.259 -0.901 . . . . 0.0 110.104 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 4.3 m -142.12 132.2 24.65 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.826 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.686 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 21.3 p90 -149.65 170.94 17.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.358 -0.839 . . . . 0.0 110.407 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.858 HG23 ' O ' ' A' ' 98' ' ' ILE . 50.4 m -126.72 129.52 48.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.436 -0.79 . . . . 0.0 110.077 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.971 HD13 ' CD2' ' A' ' 69' ' ' HIS . 10.7 tp -95.84 133.55 39.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.084 -1.01 . . . . 0.0 110.378 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.529 ' H ' HD12 ' A' ' 85' ' ' LEU . 9.8 pt -111.22 -33.49 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.199 -0.938 . . . . 0.0 110.209 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.685 ' O ' HD11 ' A' ' 85' ' ' LEU . 77.3 tt0 -116.17 155.3 28.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.376 -0.828 . . . . 0.0 110.139 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.72 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 156.29 129.38 1.17 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -60.15 -20.21 57.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -1.161 . . . . 0.0 110.222 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.69 -16.14 60.77 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.276 -0.89 . . . . 0.0 110.252 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.46 ' O ' ' HB2' ' A' ' 95' ' ' LEU . 75.7 mt -69.1 -25.51 64.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.278 -0.889 . . . . 0.0 110.189 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 49.28 -178.66 0.02 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.544 ' OD1' HG23 ' A' ' 94' ' ' THR . 55.1 p30 -83.15 10.27 8.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.229 -1.16 . . . . 0.0 110.171 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.728 ' O ' HG21 ' A' ' 126' ' ' VAL . 29.7 p -103.08 -33.84 9.1 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.235 -0.916 . . . . 0.0 110.098 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.902 HD21 HD11 ' A' ' 128' ' ' ILE . 96.7 mt -103.8 160.6 14.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 110.052 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.46 ' HG2' ' N ' ' A' ' 97' ' ' LYS . 54.4 tt0 -140.05 -82.18 0.26 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.337 -0.852 . . . . 0.0 109.689 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.5 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 42.0 mttm -80.43 135.66 36.2 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.625 -0.672 . . . . 0.0 110.139 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.858 ' O ' HG23 ' A' ' 84' ' ' THR . 4.2 mm -123.1 139.29 50.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 120.866 -1.146 . . . . 0.0 109.982 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.496 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -121.96 129.34 52.41 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.783 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.699 ' HE2' HG21 ' A' ' 98' ' ' ILE . 9.9 m-85 -123.3 133.66 54.14 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.158 -0.964 . . . . 0.0 110.876 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -135.49 129.95 33.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.444 -0.785 . . . . 0.0 109.711 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 37.4 m -134.14 144.13 48.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.186 -0.946 . . . . 0.0 110.494 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.491 ' HG3' ' HB3' ' A' ' 80' ' ' SER . 5.1 tttt -139.45 144.67 38.14 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.346 -0.846 . . . . 0.0 110.303 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.716 HD12 ' HB3' ' A' ' 79' ' ' TYR . 12.7 mt -109.37 155.09 21.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.225 -0.922 . . . . 0.0 110.461 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.693 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -151.17 -168.86 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.359 -0.838 . . . . 0.0 109.608 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.693 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -122.59 154.67 37.63 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.173 -0.955 . . . . 0.0 110.526 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.457 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 55.4 p -114.52 164.56 16.08 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.389 -0.819 . . . . 0.0 110.064 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 47.6 Cg_endo -72.63 -1.77 10.82 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.959 1.505 . . . . 0.0 110.505 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.7 t -97.24 -22.6 16.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.103 -0.998 . . . . 0.0 110.31 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 111' ' ' GLY . . . 125.42 -38.11 2.37 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 110' ' ' GLY . . . -60.29 -147.13 0.01 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 47.5 p -150.43 133.21 15.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.173 -1.193 . . . . 0.0 110.148 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.548 HG12 HG22 ' A' ' 10' ' ' THR . 23.4 mt -82.6 149.52 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.246 -0.909 . . . . 0.0 110.241 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.694 HG23 HD23 ' A' ' 104' ' ' LEU . 10.1 mt -129.74 113.47 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.894 . . . . 0.0 110.02 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.424 ' N ' ' O ' ' A' ' 103' ' ' LYS . 15.3 ttpt -94.99 122.26 37.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.088 -1.007 . . . . 0.0 110.216 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.91 147.27 42.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.895 . . . . 0.0 110.293 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 81.6 m -150.22 129.14 12.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.363 -0.836 . . . . 0.0 110.327 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.471 ' OG ' ' CE1' ' A' ' 100' ' ' TYR . 15.4 t -128.4 154.18 46.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.271 -0.893 . . . . 0.0 110.198 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.826 ' CE1' HG23 ' A' ' 4' ' ' THR . 91.5 m-70 -132.87 121.8 23.44 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.348 -0.845 . . . . 0.0 110.3 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 1.026 ' C ' HG23 ' A' ' 2' ' ' VAL . 5.7 m-30 -95.3 119.37 33.69 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.183 -0.948 . . . . 0.0 110.489 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.553 ' CE1' HG21 ' A' ' 2' ' ' VAL . 76.4 m-70 -95.47 107.45 19.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.358 -0.839 . . . . 0.0 109.558 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.7 p -77.85 155.79 30.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.107 -0.995 . . . . 0.0 110.387 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.448 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 36.9 tttp -119.6 113.51 20.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.378 -0.826 . . . . 0.0 110.226 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.38 -135.89 12.61 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -113.2 76.39 0.98 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.258 -1.143 . . . . 0.0 110.235 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.728 HG21 ' O ' ' A' ' 94' ' ' THR . 33.5 m -137.09 161.73 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.223 -0.923 . . . . 0.0 110.105 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -141.94 155.69 45.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 110.192 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.902 HD11 HD21 ' A' ' 95' ' ' LEU . 1.9 mp -84.03 173.43 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.22 -0.925 . . . . 0.0 110.113 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.608 ' N ' HG22 ' A' ' 128' ' ' ILE . 9.0 mttt -119.24 142.98 47.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.451 -0.78 . . . . 0.0 109.901 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' A' ' 134' ' ' LYS . 93.6 mt-10 -48.17 -34.47 10.04 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.154 -0.966 . . . . 0.0 110.152 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.498 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 69.1 tt0 -63.84 -32.33 73.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 0.0 109.971 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 13.9 t-160 -77.66 -51.61 10.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.296 -0.877 . . . . 0.0 110.048 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.657 HG13 ' CD1' ' A' ' 5' ' ' TYR . 49.6 t -60.69 -38.66 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.39 -0.819 . . . . 0.0 109.979 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 130' ' ' GLU . 62.2 mmtt -77.37 -45.01 27.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.316 -0.865 . . . . 0.0 110.122 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.498 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -62.25 -38.31 88.78 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.304 -0.872 . . . . 0.0 110.019 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -63.43 -30.77 78.59 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 77.5 mttt -77.33 -30.93 54.24 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.353 -1.087 . . . . 0.0 110.0 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -75.65 -34.1 60.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.367 -0.833 . . . . 0.0 109.959 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 39.3 mttt -73.36 -37.29 66.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.376 -0.828 . . . . 0.0 109.815 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.512 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -74.76 -32.37 62.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.251 -0.906 . . . . 0.0 109.88 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.6 m -66.93 -49.33 65.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -0.881 . . . . 0.0 109.904 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -51.56 -47.3 63.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.25 -0.906 . . . . 0.0 109.895 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.433 ' O ' HG13 ' A' ' 147' ' ' ILE . 13.7 tp -57.14 -50.02 74.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -0.899 . . . . 0.0 109.732 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.512 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 21.6 m-85 -52.9 -35.17 57.76 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.388 -0.82 . . . . 0.0 109.673 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 37.2 mttt -78.18 -18.25 55.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.376 -0.828 . . . . 0.0 109.811 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 143' ' ' LEU . 26.0 mt -82.43 -35.76 27.28 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.255 -0.903 . . . . 0.0 108.778 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 1.049 ' CG2' HD23 ' A' ' 18' ' ' LEU . 34.7 mt -69.6 -45.47 77.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.939 ' HB3' HD13 ' A' ' 13' ' ' ILE . 91.9 mt-10 -53.21 -40.16 64.27 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.353 -0.842 . . . . 0.0 109.428 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.2 m -67.27 -28.23 67.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.309 -0.869 . . . . 0.0 109.447 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.591 ' CD1' HG12 ' A' ' 33' ' ' ILE . 80.5 t80 -63.42 -48.08 79.29 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.517 -0.74 . . . . 0.0 109.817 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.014 HD21 ' CE1' ' A' ' 158' ' ' TYR . 81.6 mt -79.91 -37.67 34.17 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.309 -0.87 . . . . 0.0 110.211 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.928 ' HB2' HD11 ' A' ' 13' ' ' ILE . 43.5 tptt -60.7 -16.99 45.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.362 -0.836 . . . . 0.0 109.318 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.484 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -116.39 -30.13 2.14 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.449 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 4.4 m80 -106.05 93.97 8.6 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.222 -1.164 . . . . 0.0 110.223 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 48.1 Cg_endo -74.02 6.25 3.06 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 124.066 1.561 . . . . 0.0 111.048 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 35.4 p30 -115.77 -5.68 12.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.014 -1.054 . . . . 0.0 109.906 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.638 ' HB3' HH21 ' A' ' 17' ' ' ARG . . . -57.76 107.38 0.45 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.379 -0.826 . . . . 0.0 110.112 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 1.014 ' CE1' HD21 ' A' ' 151' ' ' LEU . 0.2 OUTLIER 36.56 29.61 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.654 -0.654 . . . . 0.0 110.573 -179.429 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.573 ' CB ' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.644 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.923 HG13 ' O ' ' A' ' 120' ' ' TYR . 94.9 t -118.97 146.54 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.214 -1.168 . . . . 0.0 110.331 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.654 ' CE1' HD12 ' A' ' 128' ' ' ILE . 9.8 m-85 -101.03 142.55 32.34 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.285 -0.884 . . . . 0.0 109.518 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 m -118.45 131.88 56.25 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.982 -1.074 . . . . 0.0 110.887 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.138 ' CE2' HG21 ' A' ' 133' ' ' VAL . 72.0 m-85 -141.25 124.57 16.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.434 -0.791 . . . . 0.0 109.836 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.994 ' CG ' HG23 ' A' ' 117' ' ' THR . 10.2 mt-10 -132.23 136.34 46.92 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 0.0 110.319 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.414 ' C ' ' HG3' ' A' ' 8' ' ' GLU . 50.0 m -125.51 164.08 21.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.235 -0.916 . . . . 0.0 110.093 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.459 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 87.1 mt-10 -146.26 127.18 14.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.298 -0.876 . . . . 0.0 110.445 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.633 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.1 p90 -147.32 -175.17 4.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.308 -0.87 . . . . 0.0 109.818 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.85 HG22 ' HA ' ' A' ' 113' ' ' ILE . 5.1 p -142.04 170.78 15.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.097 -1.002 . . . . 0.0 110.64 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.47 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 5.0 t -148.93 164.29 34.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.388 -0.82 . . . . 0.0 110.062 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -85.85 -22.0 27.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.267 -0.895 . . . . 0.0 110.192 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.816 HG23 ' HD2' ' A' ' 14' ' ' PRO . 8.8 mm -80.9 150.22 68.59 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.316 -0.865 . . . . 0.0 110.07 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.816 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.6 Cg_endo -66.17 146.36 81.33 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.044 1.55 . . . . 0.0 110.377 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.68 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.2 Cg_endo -71.18 -31.95 13.75 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.897 1.472 . . . . 0.0 112.912 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.68 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.1 Cg_endo -68.51 -20.59 41.28 Favored 'Trans proline' 0 C--N 1.317 -1.107 0 N-CA-C 110.114 -0.764 . . . . 0.0 110.114 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.775 ' HB3' HD13 ' A' ' 151' ' ' LEU . 47.9 mtp180 -85.78 -43.77 13.05 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.132 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.779 HD23 ' C ' ' A' ' 18' ' ' LEU . 1.2 tt -75.21 -34.45 61.49 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.567 ' N ' HD23 ' A' ' 18' ' ' LEU . 60.8 t80 -65.75 -55.42 17.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.394 -0.816 . . . . 0.0 109.342 179.04 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.522 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 64.3 mttt -53.62 -38.44 64.05 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.884 -0.727 . . . . 0.0 109.558 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.019 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -74.4 -39.74 62.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.465 -0.772 . . . . 0.0 110.961 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.96 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -75.21 -38.47 60.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.315 -0.865 . . . . 0.0 111.073 -178.99 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.668 HG13 ' CE1' ' A' ' 81' ' ' TYR . 4.5 t -105.22 -55.21 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.039 -1.038 . . . . 0.0 111.691 -179.104 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.676 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.3 mp -80.03 -4.64 53.5 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.178 -0.952 . . . . 0.0 111.841 -178.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.533 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 1.0 OUTLIER -150.7 32.49 0.62 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.706 -1.246 . . . . 0.0 110.724 -179.61 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.96 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -74.44 -20.63 59.96 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.257 -0.902 . . . . 0.0 110.321 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.46 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 94.8 m-20 -67.75 -24.45 65.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.232 -0.918 . . . . 0.0 110.103 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.572 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 4.4 p30 -123.51 12.93 9.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.326 -0.859 . . . . 0.0 109.897 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.691 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -92.92 -50.33 5.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.356 -0.84 . . . . 0.0 110.184 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.87 HG22 ' HD3' ' A' ' 31' ' ' PRO . 2.2 m -74.26 -29.44 0.97 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.353 -0.842 . . . . 0.0 112.166 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.87 ' HD3' HG22 ' A' ' 30' ' ' VAL . 53.1 Cg_endo -79.15 3.57 7.33 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 O-C-N 122.785 0.887 . . . . 0.0 110.287 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -124.66 -34.71 2.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.319 -0.863 . . . . 0.0 109.326 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.593 HG12 ' CD1' ' A' ' 150' ' ' TYR . 18.4 mt -79.99 -36.65 17.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.625 -0.672 . . . . 0.0 109.837 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -175.33 102.95 0.26 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.545 -0.722 . . . . 0.0 109.831 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.77 1.57 6.26 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.031 1.543 . . . . 0.0 110.808 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -84.54 0.05 51.33 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.141 -0.974 . . . . 0.0 109.894 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.858 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -101.03 -51.17 3.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.28 -0.887 . . . . 0.0 110.024 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.858 HD12 ' C ' ' A' ' 37' ' ' ALA . 1.8 mp -134.45 125.09 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.449 -0.782 . . . . 0.0 109.948 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' A' ' 57' ' ' THR . 21.8 ttpt -61.47 -26.82 68.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.25 -0.906 . . . . 0.0 110.319 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.512 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER 173.24 162.08 0.14 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.153 -0.967 . . . . 0.0 110.107 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.1 m -128.34 125.11 38.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.384 -0.822 . . . . 0.0 110.048 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.512 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 40.5 tt0 -130.16 111.37 12.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.195 -0.94 . . . . 0.0 110.426 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.447 HG12 ' HG2' ' A' ' 54' ' ' LYS . 36.3 mt -63.35 135.44 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.351 -0.843 . . . . 0.0 110.044 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 16.0 tp -110.45 -27.47 9.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.246 -0.909 . . . . 0.0 110.362 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.75 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.8 m95 -124.14 159.48 29.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -0.958 . . . . 0.0 110.605 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 45' ' ' TRP . . . 42.06 -136.82 3.07 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.419 ' O ' ' CG ' ' A' ' 47' ' ' ASP . 11.9 t0 -152.72 24.75 0.58 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.361 -1.082 . . . . 0.0 109.77 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.47 ' O ' HG21 ' A' ' 71' ' ' ILE . . . 119.97 -21.97 8.73 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.494 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -65.17 -172.82 3.62 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.454 ' HA ' HG22 ' A' ' 71' ' ' ILE . 46.1 Cg_endo -73.44 128.64 12.95 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.997 1.525 . . . . 0.0 110.612 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.32 -13.23 54.98 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.524 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -68.61 163.25 24.12 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.569 -0.959 . . . . 0.0 109.663 179.729 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.75 HD12 ' CG ' ' A' ' 45' ' ' TRP . 61.6 mt -133.09 120.53 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.305 -0.872 . . . . 0.0 109.748 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.447 ' HG2' HG12 ' A' ' 43' ' ' ILE . 89.8 mttt -109.57 130.52 55.5 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.159 -0.963 . . . . 0.0 110.487 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -96.03 96.3 8.78 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.275 -0.891 . . . . 0.0 109.869 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.54 ' CG2' HG12 ' A' ' 38' ' ' ILE . 73.1 mt -79.87 143.82 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 109.998 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 39' ' ' LYS . 2.4 p -116.67 155.84 28.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 110.863 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.675 ' HE2' HG13 ' A' ' 67' ' ' VAL . 27.2 m-85 -119.07 154.76 32.65 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.473 -0.767 . . . . 0.0 109.917 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -118.62 39.44 2.56 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -57.46 -26.04 60.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.26 -1.141 . . . . 0.0 110.26 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 167.02 -166.04 38.93 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.0 m -52.41 -47.78 66.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -1.134 . . . . 0.0 110.289 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -45.68 150.72 0.48 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.259 -0.9 . . . . 0.0 110.231 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -88.54 124.85 34.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 110.284 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -134.89 113.86 1.19 Allowed Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.634 -1.787 . . . . 0.0 108.634 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.544 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 12.6 p90 -155.93 162.24 40.41 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.113 -1.228 . . . . 0.0 110.208 -179.444 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.815 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.7 m -135.01 172.68 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.301 -0.874 . . . . 0.0 110.542 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.526 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 22.5 mttt -119.07 131.34 55.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.549 -0.719 . . . . 0.0 109.71 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.644 ' CD2' ' CD1' ' A' ' 85' ' ' LEU . 11.6 m170 -116.11 129.99 56.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.17 -0.956 . . . . 0.0 110.758 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 52' ' ' THR . 13.5 ttpt -107.71 108.84 20.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.279 -0.888 . . . . 0.0 109.547 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.722 HG23 HD11 ' A' ' 74' ' ' ILE . 27.8 mm -53.03 124.4 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.243 -0.911 . . . . 0.0 110.437 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 82' ' ' SER . 93.4 m-20 -96.71 -43.04 7.72 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.445 -0.784 . . . . 0.0 109.723 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.873 ' C ' HD12 ' A' ' 74' ' ' ILE . 15.2 m -170.79 157.55 5.58 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.338 -0.851 . . . . 0.0 109.685 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.873 HD12 ' C ' ' A' ' 73' ' ' SER . 1.4 mp -135.66 149.66 28.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 110.226 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 79' ' ' TYR . 9.3 m-20 -131.22 77.26 1.77 Allowed 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.711 -0.795 . . . . 0.0 110.677 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 35.8 mttp -63.71 -16.0 59.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.182 -0.949 . . . . 0.0 109.888 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -93.8 -34.66 13.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.351 -0.843 . . . . 0.0 109.301 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.507 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.6 m120 -99.18 -4.11 32.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.595 -0.691 . . . . 0.0 109.452 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.582 ' CE1' ' HB3' ' A' ' 16' ' ' PRO . 65.5 m-85 60.11 57.02 3.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.558 -0.714 . . . . 0.0 110.305 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.487 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -130.73 163.08 28.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.383 -0.823 . . . . 0.0 109.595 179.539 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.668 ' CE1' HG13 ' A' ' 23' ' ' VAL . 15.2 t80 -144.64 138.33 27.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.921 . . . . 0.0 109.975 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 38.2 m -140.12 121.58 15.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.161 -0.962 . . . . 0.0 111.064 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.614 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 5.3 p90 -139.07 177.69 7.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.457 -0.777 . . . . 0.0 109.556 178.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 98' ' ' ILE . 44.3 m -133.75 137.06 44.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.064 -1.023 . . . . 0.0 110.522 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.644 ' CD1' ' CD2' ' A' ' 69' ' ' HIS . 16.5 tp -93.37 118.31 31.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.236 -0.915 . . . . 0.0 109.831 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.7 pt -107.44 -22.23 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.427 -0.796 . . . . 0.0 110.036 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.526 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 64.9 tt0 -129.59 130.6 45.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.207 -0.933 . . . . 0.0 110.627 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.815 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . -176.87 107.94 0.25 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 90' ' ' ALA . 29.4 p-10 -42.34 -25.99 0.09 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.253 -1.145 . . . . 0.0 110.504 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.476 ' N ' ' OD1' ' A' ' 89' ' ' ASP . . . -75.47 -37.93 59.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.083 -1.01 . . . . 0.0 110.445 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.496 HD12 ' C ' ' A' ' 91' ' ' LEU . 1.6 pp -86.99 -25.7 24.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.885 . . . . 0.0 110.537 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.435 ' N ' ' HG ' ' A' ' 91' ' ' LEU . . . -63.11 -36.11 93.0 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.724 ' O ' HG23 ' A' ' 94' ' ' THR . 57.1 t0 -44.11 -34.91 1.95 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.174 -1.192 . . . . 0.0 110.403 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.724 HG23 ' O ' ' A' ' 93' ' ' ASP . 1.7 p -160.05 -35.07 0.06 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.273 -0.892 . . . . 0.0 110.432 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 1.044 HD21 ' CG1' ' A' ' 128' ' ' ILE . 5.9 mt -79.96 177.71 8.73 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.213 -0.929 . . . . 0.0 110.286 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.454 ' O ' HD13 ' A' ' 91' ' ' LEU . 45.5 tt0 -148.64 -78.98 0.14 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.363 -0.836 . . . . 0.0 109.479 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.526 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 8.1 mttt -80.14 135.59 36.34 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.63 -0.669 . . . . 0.0 110.486 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.584 ' O ' HG23 ' A' ' 84' ' ' THR . 0.3 OUTLIER -136.34 132.35 49.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 120.704 -1.247 . . . . 0.0 109.292 178.651 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.434 ' HG ' ' HE2' ' A' ' 121' ' ' HIS . 0.6 OUTLIER -107.37 132.6 52.98 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.383 -0.823 . . . . 0.0 109.909 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.614 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 5.8 m-85 -122.74 132.73 54.37 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.495 -0.753 . . . . 0.0 110.316 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.477 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 9.3 tt0 -135.81 125.31 25.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.205 -0.934 . . . . 0.0 110.295 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.471 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 72.2 m -118.5 154.83 31.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.232 -0.917 . . . . 0.0 109.516 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.449 ' N ' ' O ' ' A' ' 115' ' ' LYS . 31.4 mttt -144.1 132.35 21.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.028 -1.045 . . . . 0.0 110.389 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.847 HD23 HG12 ' A' ' 114' ' ' ILE . 2.8 mt -120.01 145.45 46.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.284 -0.885 . . . . 0.0 110.177 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.702 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -153.07 -168.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.378 -0.826 . . . . 0.0 109.891 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.702 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -114.76 140.91 48.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.356 -0.84 . . . . 0.0 110.117 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.488 ' HA ' HD11 ' A' ' 113' ' ' ILE . 53.9 p -97.22 162.99 20.84 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.249 -0.907 . . . . 0.0 110.21 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.425 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.3 Cg_endo -71.92 -2.99 12.35 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.982 1.517 . . . . 0.0 110.393 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 52.9 p -100.98 2.84 41.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.295 -0.878 . . . . 0.0 110.207 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 101.2 -31.48 8.6 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -70.73 -172.55 12.15 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.511 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 24.5 p -122.03 131.37 53.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.278 -1.131 . . . . 0.0 110.369 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.85 ' HA ' HG22 ' A' ' 10' ' ' THR . 21.7 mt -80.07 143.88 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.887 . . . . 0.0 109.742 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.847 HG12 HD23 ' A' ' 104' ' ' LEU . 19.4 mt -131.08 109.78 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.104 -0.997 . . . . 0.0 110.63 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.459 ' HG3' ' HG2' ' A' ' 8' ' ' GLU . 30.0 tttt -99.33 130.5 45.62 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.277 -0.889 . . . . 0.0 109.825 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.83 151.58 39.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.958 . . . . 0.0 110.53 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.994 HG23 ' CG ' ' A' ' 6' ' ' GLU . 25.9 m -146.72 151.84 37.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.35 -0.844 . . . . 0.0 110.302 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 91.3 p -155.84 139.96 16.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.915 . . . . 0.0 110.282 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.455 ' CE1' HG22 ' A' ' 117' ' ' THR . 54.4 m-70 -127.92 157.02 41.7 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.211 -0.931 . . . . 0.0 110.394 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.923 ' O ' HG13 ' A' ' 2' ' ' VAL . 7.0 m-85 -120.41 141.62 49.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.197 -0.939 . . . . 0.0 110.733 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.526 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 98.2 m-70 -122.29 96.65 5.13 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.109 -0.994 . . . . 0.0 109.857 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.835 HG23 HD23 ' A' ' 95' ' ' LEU . 1.3 p -75.93 156.39 34.26 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.351 -0.843 . . . . 0.0 110.323 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 44.4 tttm -113.17 108.3 17.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.216 -0.927 . . . . 0.0 110.266 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 105.4 -124.07 7.79 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -127.9 75.05 1.58 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.269 -1.136 . . . . 0.0 110.204 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.466 HG23 ' CG2' ' A' ' 122' ' ' THR . 16.4 m -141.49 152.71 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.236 -0.915 . . . . 0.0 110.279 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -127.77 161.78 28.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.298 -0.877 . . . . 0.0 110.098 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 1.044 ' CG1' HD21 ' A' ' 95' ' ' LEU . 5.1 mp -86.66 172.36 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.248 -0.907 . . . . 0.0 110.378 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.602 ' N ' HG22 ' A' ' 128' ' ' ILE . 10.0 mttp -108.01 127.16 53.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.414 -0.804 . . . . 0.0 109.539 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.493 ' CA ' ' HG3' ' A' ' 134' ' ' LYS . 97.4 mt-10 -42.86 -55.03 3.88 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.214 -0.929 . . . . 0.0 110.069 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.404 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 49.0 tt0 -47.22 -24.24 0.68 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.936 . . . . 0.0 109.751 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.477 ' N ' ' O ' ' A' ' 129' ' ' LYS . 9.7 t-160 -86.19 -64.89 1.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.361 -0.837 . . . . 0.0 110.175 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 1.138 HG21 ' CE2' ' A' ' 5' ' ' TYR . 7.2 p -63.38 -41.46 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.399 -0.813 . . . . 0.0 110.222 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.531 ' N ' HG13 ' A' ' 133' ' ' VAL . 27.5 mttt -63.04 -43.55 98.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.175 -0.953 . . . . 0.0 109.823 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.451 ' O ' ' HG3' ' A' ' 139' ' ' LYS . . . -67.94 -26.15 65.82 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.339 -0.851 . . . . 0.0 109.792 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -71.66 -33.02 63.76 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.499 ' HE2' ' CD1' ' A' ' 5' ' ' TYR . 25.9 mttp -63.37 -34.67 78.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -1.129 . . . . 0.0 109.894 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -79.07 -31.94 44.6 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.366 -0.834 . . . . 0.0 109.936 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 135' ' ' ALA . 83.6 mttt -65.46 -39.36 91.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.347 -0.846 . . . . 0.0 109.857 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.85 -46.6 52.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.875 . . . . 0.0 109.916 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.6 t -55.97 -42.32 76.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.421 -0.799 . . . . 0.0 109.917 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -59.2 -43.03 92.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.922 . . . . 0.0 109.882 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 47.5 mt -60.57 -36.74 79.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.261 -0.899 . . . . 0.0 109.783 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.539 ' HA ' HD12 ' A' ' 147' ' ' ILE . 22.7 m-85 -63.2 -31.93 73.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.377 -0.827 . . . . 0.0 109.823 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -73.64 -18.59 61.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.286 -0.884 . . . . 0.0 109.916 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.504 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 32.2 mt -82.19 -35.57 28.19 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.271 -0.893 . . . . 0.0 108.701 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.727 HD11 ' CE1' ' A' ' 22' ' ' PHE . 26.8 mt -73.0 -47.06 49.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 178.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.509 ' O ' HG13 ' A' ' 13' ' ' ILE . 90.8 mt-10 -57.57 -33.75 68.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.475 -0.766 . . . . 0.0 109.406 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 19.8 m -77.1 -26.19 53.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.206 -0.934 . . . . 0.0 109.267 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.597 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 87.9 t80 -62.28 -51.38 67.94 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.605 -0.684 . . . . 0.0 110.03 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.058 HD21 ' CE2' ' A' ' 158' ' ' TYR . 71.4 mt -74.53 -29.13 61.27 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.331 -0.856 . . . . 0.0 110.196 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.599 ' HA ' HD11 ' A' ' 13' ' ' ILE . 65.9 tttt -63.19 -17.76 62.76 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.231 -0.918 . . . . 0.0 109.593 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.484 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -122.29 -19.7 3.14 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.417 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 10.5 m80 -106.91 91.74 6.7 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.128 -1.219 . . . . 0.0 110.3 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 49.1 Cg_endo -73.92 4.76 3.91 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.054 1.555 . . . . 0.0 110.871 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -117.55 -6.12 11.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.095 -1.003 . . . . 0.0 109.809 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.64 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -59.81 104.92 0.33 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.345 -0.847 . . . . 0.0 110.131 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 1.058 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.2 OUTLIER 35.77 31.12 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.662 -0.649 . . . . 0.0 110.507 -179.492 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.546 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.792 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.765 HG13 ' O ' ' A' ' 120' ' ' TYR . 39.1 t -124.37 142.84 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.236 -1.155 . . . . 0.0 110.338 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.798 ' CE1' HD12 ' A' ' 128' ' ' ILE . 7.9 m-85 -104.62 147.01 28.11 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.339 -0.851 . . . . 0.0 109.667 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.61 HG23 ' CE1' ' A' ' 119' ' ' HIS . 4.0 m -113.28 110.17 19.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.047 -1.033 . . . . 0.0 110.756 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.918 ' CE1' HG11 ' A' ' 133' ' ' VAL . 28.8 m-85 -119.58 125.98 50.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.295 -0.878 . . . . 0.0 109.977 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 116' ' ' SER . 22.7 pt-20 -139.99 154.17 47.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.151 -0.968 . . . . 0.0 110.363 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.1 t -127.04 162.93 24.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.312 -0.867 . . . . 0.0 109.992 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -142.82 121.4 12.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.183 -0.948 . . . . 0.0 110.368 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.651 ' CZ ' ' CD2' ' A' ' 144' ' ' PHE . 3.0 p90 -149.24 -172.69 4.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.347 -0.845 . . . . 0.0 109.765 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.861 HG22 ' HA ' ' A' ' 113' ' ' ILE . 9.4 p -142.16 173.21 11.73 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.216 -0.928 . . . . 0.0 110.695 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.521 ' HB2' ' CG ' ' A' ' 148' ' ' GLU . 22.9 p -158.03 134.06 9.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.499 -0.75 . . . . 0.0 110.199 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.489 ' HA ' ' HA2' ' A' ' 111' ' ' GLY . 97.6 mt-10 -61.11 -39.18 89.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 110.111 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.809 HG23 ' HD2' ' A' ' 14' ' ' PRO . 3.0 mp -53.99 150.4 14.99 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.43 -0.794 . . . . 0.0 109.998 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.809 ' HD2' HG23 ' A' ' 13' ' ' ILE . 41.1 Cg_endo -66.89 141.07 57.38 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.958 1.504 . . . . 0.0 110.466 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.633 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.7 Cg_endo -73.44 -30.11 10.41 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 O-C-N 124.04 1.548 . . . . 0.0 112.996 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.2 Cg_endo -71.11 -22.74 25.62 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 O-C-N 122.443 0.707 . . . . 0.0 110.398 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.613 ' NH2' ' HB3' ' A' ' 157' ' ' ALA . 39.7 mtp180 -84.8 -45.58 12.21 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.774 HD23 ' C ' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -66.44 -30.14 70.43 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.663 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.543 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 69.0 t80 -67.19 -59.72 3.2 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.484 -0.76 . . . . 0.0 109.561 178.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.544 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 8.5 mttp -49.34 -29.4 6.09 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.056 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.04 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -75.63 -65.72 0.86 Allowed 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.708 0.765 . . . . 0.0 110.934 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.849 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -57.59 -33.57 68.34 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.775 -0.578 . . . . 0.0 111.754 -178.382 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.794 HG13 ' CE1' ' A' ' 81' ' ' TYR . 3.9 t -104.39 -61.46 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.853 -1.154 . . . . 0.0 111.49 -178.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.688 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.9 mp -77.01 -0.14 23.39 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.166 -0.959 . . . . 0.0 111.599 -178.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.593 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -142.2 6.88 1.75 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.753 -1.217 . . . . 0.0 110.83 179.945 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.849 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -47.35 -41.78 20.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.089 -1.007 . . . . 0.0 110.044 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.479 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 86.7 m-20 -64.13 -18.12 64.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -0.893 . . . . 0.0 110.034 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.511 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 81.5 m-20 -127.96 11.13 6.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.875 . . . . 0.0 110.158 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.793 HD12 ' C ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -95.95 -46.73 6.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.332 -0.855 . . . . 0.0 110.153 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 1.069 HG21 HD13 ' A' ' 38' ' ' ILE . 6.8 p -78.09 -26.9 0.53 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.898 . . . . 0.0 112.333 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.807 ' HD3' HG12 ' A' ' 30' ' ' VAL . 49.9 Cg_endo -78.14 5.82 5.12 Favored 'Trans proline' 0 C--N 1.318 -1.057 0 O-C-N 122.656 0.819 . . . . 0.0 110.539 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -126.15 -27.62 3.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.194 -0.941 . . . . 0.0 109.815 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.575 HG12 ' CD1' ' A' ' 150' ' ' TYR . 14.1 mt -79.96 -43.06 22.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.427 -0.796 . . . . 0.0 109.734 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -161.37 102.63 1.22 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.436 -0.79 . . . . 0.0 110.142 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.65 -0.51 8.96 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.045 1.55 . . . . 0.0 110.546 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -84.16 -17.04 41.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 0.0 109.712 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.41 -70.45 0.66 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.427 -0.796 . . . . 0.0 109.96 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 1.069 HD13 HG21 ' A' ' 30' ' ' VAL . 1.6 mp -103.96 129.28 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.456 -0.778 . . . . 0.0 109.904 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.508 ' CE ' ' HB2' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -72.65 -27.66 62.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.262 -0.899 . . . . 0.0 110.433 -179.941 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.447 ' N ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER 178.0 155.45 0.36 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.069 -1.019 . . . . 0.0 110.198 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.9 m -130.75 123.55 29.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.339 -0.851 . . . . 0.0 109.965 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -133.98 111.87 10.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.098 -1.001 . . . . 0.0 110.52 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.457 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 21.3 mt -54.58 142.64 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.327 -0.858 . . . . 0.0 110.02 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.9 tp -118.56 -25.95 6.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.296 -0.878 . . . . 0.0 110.293 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.533 ' HB2' ' N ' ' A' ' 53' ' ' ILE . 1.6 m95 -123.76 158.07 32.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.332 -0.855 . . . . 0.0 110.471 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.439 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 43.21 -139.61 2.98 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -150.17 24.59 0.82 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.4 -1.059 . . . . 0.0 109.896 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 121.43 -18.41 8.79 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.456 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -72.09 -173.33 19.99 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.482 ' HA ' HG22 ' A' ' 71' ' ' ILE . 44.2 Cg_endo -72.57 129.01 14.11 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 124.005 1.529 . . . . 0.0 110.613 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.2 -14.31 48.03 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.538 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -69.87 166.3 19.76 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.574 -0.956 . . . . 0.0 109.412 179.565 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.533 ' N ' ' HB2' ' A' ' 45' ' ' TRP . 51.6 mt -138.46 119.99 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 110.151 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -104.13 127.26 51.71 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.232 -0.917 . . . . 0.0 110.456 -179.909 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.4 tttt -95.4 90.95 5.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.273 -0.892 . . . . 0.0 109.955 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.547 ' CG2' HG12 ' A' ' 38' ' ' ILE . 94.5 mt -79.97 140.37 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.279 -0.888 . . . . 0.0 110.353 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 2.4 p -111.1 161.78 15.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.327 -0.858 . . . . 0.0 110.025 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.689 ' HE2' HG13 ' A' ' 67' ' ' VAL . 22.0 m-85 -116.97 166.07 12.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.194 -0.941 . . . . 0.0 110.344 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 58' ' ' PHE . . . -43.53 137.49 4.25 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.508 ' HB2' ' CE ' ' A' ' 39' ' ' LYS . 73.5 tt0 -89.89 139.39 30.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.235 -1.156 . . . . 0.0 110.165 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -160.37 -132.37 1.34 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.45 ' C ' ' HG3' ' A' ' 63' ' ' GLN . 19.7 m -65.21 -17.33 64.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.171 -1.194 . . . . 0.0 110.178 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.45 ' HG3' ' C ' ' A' ' 62' ' ' SER . 87.1 mt-30 -146.09 152.24 38.99 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.237 -0.915 . . . . 0.0 110.12 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -76.76 143.49 39.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.246 -0.909 . . . . 0.0 110.198 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.482 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -133.58 134.22 7.36 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 108.609 -1.797 . . . . 0.0 108.609 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.555 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 11.6 p90 -178.78 162.86 1.37 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.173 -1.192 . . . . 0.0 110.162 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.945 HG12 ' HA2' ' A' ' 88' ' ' GLY . 4.4 m -142.62 173.59 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.316 -0.865 . . . . 0.0 110.33 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.467 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 77.7 mttt -125.01 124.37 41.84 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.564 -0.71 . . . . 0.0 109.768 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.614 ' CE1' HD13 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -112.97 122.85 48.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.171 -0.956 . . . . 0.0 110.809 -179.541 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 52' ' ' THR . 46.7 tttp -101.98 109.72 21.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.323 -0.86 . . . . 0.0 109.549 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.529 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 27.9 mm -48.7 136.64 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.123 -0.986 . . . . 0.0 110.21 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.493 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 14.4 t0 -114.41 -43.02 3.23 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.853 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.451 ' HB2' ' HB2' ' A' ' 82' ' ' SER . 16.7 m -165.4 158.69 16.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.457 -0.777 . . . . 0.0 109.855 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.421 HG12 HG11 ' A' ' 23' ' ' VAL . 1.4 mt -145.77 156.01 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.208 -0.933 . . . . 0.0 110.249 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.563 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 2.7 m-20 -135.56 79.21 1.77 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.547 -0.721 . . . . 0.0 110.086 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.543 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 22.1 tttp -61.78 -13.31 22.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.319 -0.863 . . . . 0.0 110.275 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -94.47 -31.23 14.04 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.237 -0.914 . . . . 0.0 109.724 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.498 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.4 m120 -108.47 -3.42 18.17 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.458 -0.776 . . . . 0.0 109.735 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.577 ' O ' HD12 ' A' ' 104' ' ' LEU . 7.2 m-30 64.68 50.39 2.1 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.568 -0.707 . . . . 0.0 110.304 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.563 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.6 OUTLIER -118.53 153.44 34.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.316 -0.865 . . . . 0.0 109.25 179.352 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.794 ' CE1' HG13 ' A' ' 23' ' ' VAL . 22.0 t80 -141.41 132.46 26.18 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.047 -1.033 . . . . 0.0 110.398 -179.065 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.451 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 4.3 m -137.6 120.06 15.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.161 -0.962 . . . . 0.0 110.665 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.626 ' CE2' ' CB ' ' A' ' 100' ' ' TYR . 21.2 p90 -135.96 170.88 15.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.142 -0.973 . . . . 0.0 110.349 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 98' ' ' ILE . 43.5 m -121.31 132.24 54.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.399 -0.813 . . . . 0.0 109.941 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.614 HD13 ' CE1' ' A' ' 69' ' ' HIS . 3.5 tp -98.53 126.03 43.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.177 -0.952 . . . . 0.0 110.153 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 86' ' ' ILE . 14.3 pt -105.12 -11.22 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.278 -0.889 . . . . 0.0 110.056 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.572 ' O ' HD11 ' A' ' 85' ' ' LEU . 4.3 tt0 -134.93 164.23 28.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.196 -0.94 . . . . 0.0 110.25 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.945 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 149.66 116.57 0.81 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -54.89 -20.2 8.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.24 -1.153 . . . . 0.0 110.171 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.575 ' O ' ' CE1' ' A' ' 132' ' ' HIS . . . -73.23 -8.91 57.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.366 -0.834 . . . . 0.0 110.213 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 88' ' ' GLY . 19.4 mt -81.54 -7.03 59.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.301 -0.874 . . . . 0.0 110.088 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 45.61 -170.43 0.02 OUTLIER Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -89.32 24.21 2.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -1.154 . . . . 0.0 109.885 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.1 p -118.18 -44.34 2.69 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.395 -0.815 . . . . 0.0 110.402 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.771 HD22 HG22 ' A' ' 122' ' ' THR . 3.1 mm? -79.93 162.71 24.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.392 -0.817 . . . . 0.0 110.388 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.443 ' CD ' ' HB2' ' A' ' 123' ' ' LYS . 10.5 mt-10 -146.16 -80.99 0.15 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.367 -0.833 . . . . 0.0 109.798 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.531 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 36.8 mttp -80.25 127.28 32.17 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.575 -0.703 . . . . 0.0 110.34 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.726 HG21 ' CE2' ' A' ' 100' ' ' TYR . 5.1 mm -117.68 137.5 51.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 120.446 -1.409 . . . . 0.0 110.0 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.513 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.3 OUTLIER -114.35 131.02 56.69 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.754 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.726 ' CE2' HG21 ' A' ' 98' ' ' ILE . 7.6 m-85 -125.42 134.8 51.99 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.317 -0.864 . . . . 0.0 110.576 -178.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 117' ' ' THR . 1.9 tt0 -138.95 131.46 28.73 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.413 -0.805 . . . . 0.0 110.128 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 61.0 m -132.99 142.07 48.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.308 -0.87 . . . . 0.0 109.855 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -134.38 143.2 47.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 0.0 110.527 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.66 HD23 HG12 ' A' ' 114' ' ' ILE . 14.2 mt -119.0 150.68 39.53 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.396 -0.815 . . . . 0.0 109.916 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.715 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -146.5 -168.99 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.177 -0.952 . . . . 0.0 110.061 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.715 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -124.19 160.9 26.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.313 -0.867 . . . . 0.0 110.14 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.45 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.5 p -119.42 170.17 7.14 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.912 . . . . 0.0 110.224 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.45 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 45.9 Cg_endo -72.32 -17.13 27.63 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.059 1.557 . . . . 0.0 110.484 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 59.8 p -93.28 -1.09 56.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.232 -0.918 . . . . 0.0 110.27 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.31 -36.98 4.04 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.489 ' HA2' ' HA ' ' A' ' 12' ' ' GLU . . . -54.3 -175.49 0.09 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.506 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 85.7 p -131.41 137.47 48.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.24 -1.153 . . . . 0.0 110.283 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.861 ' HA ' HG22 ' A' ' 10' ' ' THR . 16.6 mt -90.61 146.57 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.216 -0.928 . . . . 0.0 110.076 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.66 HG12 HD23 ' A' ' 104' ' ' LEU . 6.7 mt -128.32 127.13 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.283 -0.886 . . . . 0.0 110.134 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -119.77 108.79 14.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -0.912 . . . . 0.0 110.035 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.7 m -95.19 158.72 15.34 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.22 -0.925 . . . . 0.0 110.37 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 101' ' ' GLU . 60.6 m -160.13 122.44 3.31 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.386 -0.821 . . . . 0.0 109.903 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 94.8 p -126.18 171.19 11.09 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.137 -0.977 . . . . 0.0 110.466 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.61 ' CE1' HG23 ' A' ' 4' ' ' THR . 89.2 m-70 -145.27 140.05 27.54 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.334 -0.854 . . . . 0.0 110.288 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.765 ' O ' HG13 ' A' ' 2' ' ' VAL . 3.2 m-30 -105.84 146.66 29.62 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.322 -0.861 . . . . 0.0 110.634 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.531 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 66.2 m80 -131.69 96.48 3.97 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.188 -0.945 . . . . 0.0 109.265 178.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.771 HG22 HD22 ' A' ' 95' ' ' LEU . 1.1 p -80.04 153.44 28.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.325 -0.859 . . . . 0.0 110.959 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.443 ' HB2' ' CD ' ' A' ' 96' ' ' GLU . 7.9 tttp -96.49 132.85 41.63 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.652 -0.655 . . . . 0.0 110.082 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 87.12 -144.88 19.53 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -118.65 74.0 0.94 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.296 -1.12 . . . . 0.0 110.17 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.431 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 21.8 m -131.9 167.19 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.226 -0.921 . . . . 0.0 110.139 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -128.4 152.91 47.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.206 -0.934 . . . . 0.0 110.236 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.798 HD12 ' CE1' ' A' ' 3' ' ' PHE . 3.5 mt -77.45 173.09 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.283 -0.886 . . . . 0.0 110.164 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.617 ' N ' HG22 ' A' ' 128' ' ' ILE . 27.1 mttt -104.78 141.63 36.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.406 -0.809 . . . . 0.0 110.025 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -54.52 -42.65 71.1 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.121 -0.987 . . . . 0.0 110.002 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -55.93 -38.28 70.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.245 -0.909 . . . . 0.0 109.897 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.575 ' CE1' ' O ' ' A' ' 90' ' ' ALA . 16.3 t-160 -69.47 -53.88 17.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.244 -0.91 . . . . 0.0 110.099 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.918 HG11 ' CE1' ' A' ' 5' ' ' TYR . 97.1 t -60.1 -38.39 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.416 -0.803 . . . . 0.0 109.87 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -71.06 -38.3 72.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.259 -0.901 . . . . 0.0 109.958 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.97 -20.83 62.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -0.869 . . . . 0.0 110.016 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.15 -25.7 54.51 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.492 ' HE3' HG12 ' A' ' 133' ' ' VAL . 82.7 mttt -77.24 -31.72 55.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.266 -1.138 . . . . 0.0 110.121 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -75.36 -31.74 60.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.334 -0.854 . . . . 0.0 110.028 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -73.88 -31.95 63.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 0.0 109.944 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.573 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -76.16 -35.41 59.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 110.161 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 84.5 p -67.52 -46.73 71.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.299 -0.876 . . . . 0.0 110.02 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -58.71 -46.16 87.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.187 -0.946 . . . . 0.0 110.008 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.6 HD23 HD12 ' A' ' 146' ' ' LEU . 19.6 mt -60.63 -36.36 78.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.913 . . . . 0.0 110.033 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.671 ' HA ' HD12 ' A' ' 147' ' ' ILE . 7.2 m-85 -63.35 -40.08 96.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.366 -0.834 . . . . 0.0 109.865 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 145' ' ' LYS . 11.8 tttp -73.43 -9.56 58.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.35 -0.843 . . . . 0.0 110.128 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.6 HD12 HD23 ' A' ' 143' ' ' LEU . 13.0 mt -84.72 -39.63 18.28 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.235 -0.915 . . . . 0.0 108.95 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.843 HD11 ' CE1' ' A' ' 22' ' ' PHE . 4.6 mt -68.61 -45.17 82.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.521 ' CG ' ' HB2' ' A' ' 11' ' ' SER . 84.4 mt-10 -58.59 -45.34 89.31 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.481 -0.762 . . . . 0.0 109.564 179.166 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 18.9 m -68.24 -32.1 72.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.111 -0.993 . . . . 0.0 109.576 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.671 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 92.7 t80 -57.26 -47.93 80.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.586 -0.696 . . . . 0.0 109.97 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.001 HD21 ' CE1' ' A' ' 158' ' ' TYR . 73.3 mt -74.52 -37.73 62.99 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.331 -0.855 . . . . 0.0 110.517 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.687 ' HB2' HD11 ' A' ' 13' ' ' ILE . 14.2 tttm -62.19 -13.62 29.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.248 -0.908 . . . . 0.0 109.59 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.492 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -119.96 -26.2 2.35 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.146 -1.581 . . . . 0.0 109.146 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.439 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 8.2 m80 -105.97 93.88 8.36 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.338 -1.095 . . . . 0.0 110.109 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.0 Cg_endo -73.23 5.06 3.34 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.111 1.585 . . . . 0.0 111.118 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 32.6 p30 -122.01 -4.8 9.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.006 -1.059 . . . . 0.0 109.833 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.671 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -47.8 110.85 0.36 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.43 -0.793 . . . . 0.0 110.193 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 1.04 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 0.4 OUTLIER 33.76 33.08 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.766 -0.583 . . . . 0.0 110.872 -179.431 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.537 ' HB3' ' NH2' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 117.98 -1.009 . . . . 0.0 109.769 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.637 HG13 ' O ' ' A' ' 120' ' ' TYR . 49.0 t -114.71 147.7 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.188 -1.183 . . . . 0.0 110.37 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.587 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 60.8 m-85 -106.72 165.77 11.07 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.336 -0.852 . . . . 0.0 110.336 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.923 HG23 ' CE1' ' A' ' 119' ' ' HIS . 66.5 m -146.85 98.27 3.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.269 -0.894 . . . . 0.0 110.305 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.617 ' CE1' HG11 ' A' ' 133' ' ' VAL . 87.7 m-85 -111.54 140.92 45.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.197 -0.94 . . . . 0.0 109.876 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 20.6 pt-20 -138.56 151.72 47.55 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.141 -0.975 . . . . 0.0 110.43 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.455 ' OG ' ' HB2' ' A' ' 116' ' ' SER . 88.2 p -123.23 157.12 33.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.328 -0.857 . . . . 0.0 109.782 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -137.28 121.85 18.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.16 -0.962 . . . . 0.0 110.434 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.635 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.3 p90 -148.63 -172.78 4.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.281 -0.887 . . . . 0.0 109.8 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.683 HG22 ' HA ' ' A' ' 113' ' ' ILE . 17.3 p -141.73 -178.96 5.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.167 -0.958 . . . . 0.0 110.731 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.402 ' OG ' ' CD ' ' A' ' 148' ' ' GLU . 3.0 t -160.01 160.1 32.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.471 -0.768 . . . . 0.0 110.226 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.433 ' HB2' ' HE2' ' A' ' 152' ' ' LYS . 97.2 mt-10 -84.45 -30.37 25.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.256 -0.903 . . . . 0.0 110.03 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.804 HG23 ' HD2' ' A' ' 14' ' ' PRO . 11.6 mm -70.58 150.27 95.5 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.46 -0.775 . . . . 0.0 109.942 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.804 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.1 Cg_endo -66.2 143.89 72.86 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.022 1.538 . . . . 0.0 110.384 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.672 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.2 Cg_endo -72.27 -31.41 11.76 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.983 1.517 . . . . 0.0 112.849 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.672 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.7 Cg_endo -69.41 -21.47 35.05 Favored 'Trans proline' 0 C--N 1.316 -1.154 0 N-CA-C 110.13 -0.758 . . . . 0.0 110.13 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.544 ' NE ' ' HB2' ' A' ' 159' ' ' ASN . 54.6 mtp180 -84.36 -46.13 12.06 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.78 HD23 ' C ' ' A' ' 18' ' ' LEU . 1.1 tt -69.61 -29.31 66.8 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.506 ' HB2' ' O ' ' A' ' 15' ' ' PRO . 76.5 t80 -66.7 -59.55 3.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.51 -0.744 . . . . 0.0 109.328 178.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.536 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 14.9 mttp -50.25 -35.3 26.38 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.199 179.281 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.031 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -77.51 -41.01 40.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.394 -0.816 . . . . 0.0 110.703 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.947 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 1.6 t80 -69.56 -43.74 72.3 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.253 -0.904 . . . . 0.0 111.128 -178.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.672 HG13 ' CE1' ' A' ' 81' ' ' TYR . 4.3 t -104.31 -52.41 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.062 -1.024 . . . . 0.0 111.664 -179.139 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.728 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.2 mp -78.34 0.4 25.66 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.11 -0.994 . . . . 0.0 111.304 -178.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.586 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.4 OUTLIER -157.55 39.29 0.28 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.912 -1.118 . . . . 0.0 110.43 179.796 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.947 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -77.48 -24.81 50.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.279 -0.888 . . . . 0.0 110.128 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.488 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 87.3 m-20 -65.54 -16.46 63.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 110.145 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -129.9 13.04 5.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.352 -0.842 . . . . 0.0 110.016 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.675 HD13 HD11 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -99.84 -46.64 5.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.273 -0.892 . . . . 0.0 110.042 -179.944 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.793 HG11 HD13 ' A' ' 38' ' ' ILE . 3.5 t -84.92 -41.5 0.67 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.381 -0.824 . . . . 0.0 110.819 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.8 Cg_endo -78.98 9.93 3.13 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 O-C-N 123.47 1.247 . . . . 0.0 110.693 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.9 tptt -126.84 -34.44 2.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.079 -1.013 . . . . 0.0 109.428 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.675 HD11 HD13 ' A' ' 29' ' ' LEU . 62.3 mt -80.14 -43.35 22.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.569 -0.707 . . . . 0.0 109.546 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.441 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . . . -146.26 100.4 4.16 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.54 -0.725 . . . . 0.0 109.919 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 34' ' ' ALA . 44.3 Cg_endo -71.37 -0.27 7.89 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 124.108 1.583 . . . . 0.0 110.803 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -84.25 -12.44 54.72 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.097 -1.002 . . . . 0.0 109.627 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.764 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -99.89 -65.08 0.99 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.491 -0.755 . . . . 0.0 109.987 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.793 HD13 HG11 ' A' ' 30' ' ' VAL . 1.9 mp -113.82 117.83 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.428 -0.795 . . . . 0.0 109.86 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' A' ' 57' ' ' THR . 9.1 ttpt -72.02 -30.94 65.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.321 -0.862 . . . . 0.0 110.518 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.427 ' O ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -169.02 151.88 4.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.196 -0.94 . . . . 0.0 110.211 -179.674 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.9 m -130.17 123.63 30.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.468 -0.77 . . . . 0.0 109.793 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 68.6 tt0 -134.25 113.3 11.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.04 -1.037 . . . . 0.0 110.6 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.43 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 44.7 mt -59.15 141.83 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.207 -0.933 . . . . 0.0 109.898 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.505 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 32.4 mt -116.29 -28.21 6.6 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.239 -0.913 . . . . 0.0 110.546 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.713 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.8 m95 -123.7 163.99 20.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.098 -1.001 . . . . 0.0 110.633 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 45' ' ' TRP . . . 42.34 -144.01 1.11 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -146.78 25.7 1.16 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.282 -1.128 . . . . 0.0 110.133 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 117.34 -15.22 13.19 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.126 -1.589 . . . . 0.0 109.126 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.573 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -78.15 -167.6 31.04 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.39 129.48 13.91 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.026 1.54 . . . . 0.0 110.641 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.27 -11.16 54.86 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.523 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -72.2 157.47 37.67 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.524 -0.986 . . . . 0.0 109.839 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.713 HD12 ' CG ' ' A' ' 45' ' ' TRP . 57.6 mt -129.71 120.06 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.0 109.875 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 93.1 mttt -106.24 132.47 52.26 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.164 -0.96 . . . . 0.0 110.531 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.505 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 77.7 tttt -101.64 92.69 4.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.319 -0.863 . . . . 0.0 109.92 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.54 ' CG2' HG13 ' A' ' 38' ' ' ILE . 91.5 mt -79.95 144.29 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.931 . . . . 0.0 110.289 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 39' ' ' LYS . 2.6 p -117.8 156.07 28.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 110.486 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.572 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 16.1 m-85 -115.49 148.15 39.81 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.352 -0.843 . . . . 0.0 110.039 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.21 35.6 3.96 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -61.44 -28.14 69.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.271 -1.134 . . . . 0.0 110.207 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 62' ' ' SER . . . 77.98 -179.81 51.01 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 61' ' ' GLY . 0.4 OUTLIER 58.96 -89.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.265 -1.138 . . . . 0.0 110.243 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -100.15 128.88 46.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.183 -0.948 . . . . 0.0 110.189 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -50.03 132.19 23.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 110.209 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.572 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -130.08 97.73 0.4 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.538 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 12.8 p90 -138.88 167.13 22.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.145 -1.209 . . . . 0.0 110.112 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.927 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.3 m -139.2 174.88 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.243 -0.911 . . . . 0.0 110.72 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 30.1 mttt -128.85 122.35 30.22 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.516 -0.74 . . . . 0.0 109.743 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.827 ' CE1' HD13 ' A' ' 85' ' ' LEU . 0.6 OUTLIER -109.46 126.56 53.62 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.16 -0.962 . . . . 0.0 110.88 -179.463 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 52' ' ' THR . 54.9 tttt -97.63 121.86 40.03 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.273 -0.892 . . . . 0.0 109.609 179.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.573 HG21 ' O ' ' A' ' 49' ' ' GLY . 30.7 mm -64.96 122.37 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.162 -0.961 . . . . 0.0 110.522 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 82' ' ' SER . 27.9 m-20 -98.18 -47.6 5.41 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.427 -0.796 . . . . 0.0 109.968 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 44.7 m -167.8 157.95 10.5 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.349 -0.845 . . . . 0.0 109.751 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.596 HG12 HG11 ' A' ' 23' ' ' VAL . 3.6 mt -135.35 160.52 40.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.228 -0.92 . . . . 0.0 110.355 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.597 ' HB2' ' HB2' ' A' ' 80' ' ' SER . 17.4 m-20 -132.7 83.1 2.04 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.606 -0.684 . . . . 0.0 110.161 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.663 ' NZ ' HD21 ' A' ' 24' ' ' LEU . 45.1 mttm -72.95 -10.1 59.43 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.354 -0.841 . . . . 0.0 110.218 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -93.14 -39.26 11.14 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.317 -0.864 . . . . 0.0 109.315 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.529 ' ND2' ' H ' ' A' ' 78' ' ' ASN . 1.1 p30 -111.78 12.25 20.97 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.466 0.651 . . . . 0.0 110.761 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.504 ' CZ ' ' HB3' ' A' ' 16' ' ' PRO . 7.3 m-85 54.19 60.79 3.37 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.449 -0.782 . . . . 0.0 112.858 178.034 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.597 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 1.1 m -128.03 156.87 42.07 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.954 -1.091 . . . . 0.0 109.484 177.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.683 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 31.2 t80 -142.13 137.32 30.83 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.158 -0.964 . . . . 0.0 110.444 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 50.7 m -140.74 125.98 18.61 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.447 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.683 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 7.2 p90 -141.69 176.53 8.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.281 -0.887 . . . . 0.0 110.02 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.555 HG23 ' O ' ' A' ' 98' ' ' ILE . 46.0 m -126.8 132.82 50.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.298 -0.876 . . . . 0.0 109.868 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.827 HD13 ' CE1' ' A' ' 69' ' ' HIS . 12.4 tp -98.16 121.87 40.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.171 -0.955 . . . . 0.0 110.227 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.7 pt -104.59 -16.63 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.294 -0.879 . . . . 0.0 110.531 -179.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.475 ' OE1' ' NZ ' ' A' ' 68' ' ' LYS . 54.4 tt0 -129.11 165.35 21.41 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.148 -0.97 . . . . 0.0 110.385 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.927 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 149.51 120.96 1.07 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -56.52 -19.31 14.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.299 -1.118 . . . . 0.0 110.183 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.99 -18.18 54.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.295 -0.878 . . . . 0.0 110.228 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 92' ' ' GLY . 77.1 mt -66.98 -27.61 67.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.223 -0.923 . . . . 0.0 110.162 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 50.15 179.51 0.02 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.445 ' OD1' HG23 ' A' ' 94' ' ' THR . 57.6 p-10 -79.64 5.65 12.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.243 -1.151 . . . . 0.0 110.07 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.536 ' O ' HG22 ' A' ' 122' ' ' THR . 43.0 p -93.65 -34.91 13.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.89 . . . . 0.0 110.099 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 1.026 HD23 HG23 ' A' ' 122' ' ' THR . 19.5 mt -104.83 162.05 13.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 110.034 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.438 ' CD ' ' HB2' ' A' ' 123' ' ' LYS . 54.4 mt-10 -142.68 -80.3 0.21 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.297 -0.877 . . . . 0.0 109.978 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.515 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 53.7 mttp -80.14 126.16 30.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.595 -0.691 . . . . 0.0 110.409 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.761 HG21 ' CE2' ' A' ' 100' ' ' TYR . 5.3 mm -115.52 140.55 36.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 120.615 -1.303 . . . . 0.0 109.826 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.482 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -118.35 128.24 54.46 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.676 -0.81 . . . . 0.0 108.941 178.874 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.761 ' CE2' HG21 ' A' ' 98' ' ' ILE . 11.0 m-85 -123.53 135.33 53.96 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.313 -0.867 . . . . 0.0 110.533 -178.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.481 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 72.8 tt0 -139.14 136.29 34.96 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.276 -0.89 . . . . 0.0 110.146 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 50.3 m -137.36 138.94 40.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -0.926 . . . . 0.0 110.234 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.8 tttt -133.05 147.01 52.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.196 -0.94 . . . . 0.0 110.391 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.754 HD23 HG12 ' A' ' 114' ' ' ILE . 7.8 mt -121.82 153.8 37.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.273 -0.892 . . . . 0.0 110.241 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.711 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -149.49 -168.78 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.19 -0.944 . . . . 0.0 110.061 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.711 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -126.01 150.27 48.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.329 -0.857 . . . . 0.0 110.213 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.461 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 2.7 p -108.13 169.65 6.37 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.934 . . . . 0.0 110.345 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.461 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.7 Cg_endo -73.11 -11.41 25.2 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 O-C-N 124.106 1.582 . . . . 0.0 110.448 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 58.5 p -96.89 5.74 49.95 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.157 -0.965 . . . . 0.0 110.293 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.08 -38.17 3.2 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -55.61 -172.91 0.12 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.5 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 5.7 p -131.97 138.29 48.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.255 -1.144 . . . . 0.0 110.271 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.683 ' HA ' HG22 ' A' ' 10' ' ' THR . 20.5 mt -89.96 149.81 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.29 -0.881 . . . . 0.0 110.151 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.754 HG12 HD23 ' A' ' 104' ' ' LEU . 11.5 mt -131.23 126.73 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.228 -0.92 . . . . 0.0 110.222 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -118.09 110.2 17.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.163 -0.96 . . . . 0.0 110.219 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.455 ' HB2' ' OG ' ' A' ' 7' ' ' SER . 1.6 m -98.57 160.71 14.1 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.236 -0.915 . . . . 0.0 110.44 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' A' ' 101' ' ' GLU . 52.9 m -160.03 124.46 3.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.376 -0.827 . . . . 0.0 109.984 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 90.5 p -129.03 157.5 41.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.201 -0.937 . . . . 0.0 110.469 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.923 ' CE1' HG23 ' A' ' 4' ' ' THR . 47.1 m-70 -134.52 161.45 35.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.263 -0.898 . . . . 0.0 110.037 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.637 ' O ' HG13 ' A' ' 2' ' ' VAL . 25.9 m-85 -128.35 142.03 51.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.231 -0.918 . . . . 0.0 110.722 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.559 ' CD2' HG22 ' A' ' 2' ' ' VAL . 80.5 m80 -124.56 96.04 4.75 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.214 -0.929 . . . . 0.0 109.124 178.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' THR . . . . . 1.026 HG23 HD23 ' A' ' 95' ' ' LEU . 1.8 p -86.0 153.93 21.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.292 -0.88 . . . . 0.0 111.099 -178.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.438 ' HB2' ' CD ' ' A' ' 96' ' ' GLU . 20.7 tttt -101.92 121.64 42.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.547 -0.721 . . . . 0.0 109.963 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 105.4 -140.7 15.17 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -122.88 76.52 1.37 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.3 -1.117 . . . . 0.0 110.346 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.535 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 21.4 m -136.49 162.36 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.19 -0.944 . . . . 0.0 110.06 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.427 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 87.1 mt-10 -129.93 159.29 37.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.173 -0.955 . . . . 0.0 110.434 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.934 HD11 HD21 ' A' ' 95' ' ' LEU . 19.6 mm -66.96 173.1 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.332 -0.855 . . . . 0.0 110.149 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.586 ' N ' HG22 ' A' ' 128' ' ' ILE . 7.4 mtpp -113.02 135.14 54.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.386 -0.821 . . . . 0.0 109.95 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -44.03 -43.14 6.55 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.174 -0.954 . . . . 0.0 110.027 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.5 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 48.7 tt0 -62.92 -24.02 67.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -0.898 . . . . 0.0 109.891 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 129' ' ' LYS . 14.8 t-160 -79.9 -50.91 9.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.379 -0.826 . . . . 0.0 110.113 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.617 HG11 ' CE1' ' A' ' 5' ' ' TYR . 46.9 t -60.92 -40.03 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.324 -0.86 . . . . 0.0 109.973 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -75.73 -50.43 15.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.399 -0.813 . . . . 0.0 110.149 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.5 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -61.69 -28.17 69.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.214 -0.929 . . . . 0.0 110.049 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.5 -28.81 64.86 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 38.9 mttm -69.53 -31.48 69.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.262 -1.14 . . . . 0.0 110.085 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 142' ' ' ASN . 99.0 mt-10 -77.16 -32.53 56.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.32 -0.862 . . . . 0.0 110.163 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.693 ' O ' HD12 ' A' ' 143' ' ' LEU . 35.6 mttt -68.42 -31.62 71.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.313 -0.867 . . . . 0.0 110.22 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.567 ' O ' ' CD1' ' A' ' 144' ' ' PHE . . . -90.28 -41.52 11.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.308 -0.87 . . . . 0.0 110.201 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.3 m -68.98 -47.33 65.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.407 -0.808 . . . . 0.0 110.14 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 138' ' ' GLU . 97.1 m-20 -55.14 -47.68 74.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.183 -0.948 . . . . 0.0 110.035 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.693 HD12 ' O ' ' A' ' 139' ' ' LYS . 76.0 mt -57.54 -42.09 82.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.313 -0.867 . . . . 0.0 109.91 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.567 ' CD1' ' O ' ' A' ' 140' ' ' ALA . 4.8 m-85 -58.61 -36.33 73.87 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.304 -0.872 . . . . 0.0 109.774 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 33.8 tttm -64.25 -26.0 68.31 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.319 -0.863 . . . . 0.0 109.777 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.456 ' HB3' HG21 ' A' ' 33' ' ' ILE . 16.6 mt -78.23 -34.27 49.36 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.635 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 47.5 mt -69.22 -51.64 41.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.47 ' O ' ' HG3' ' A' ' 152' ' ' LYS . 94.6 mt-10 -54.56 -42.16 70.63 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.37 -0.831 . . . . 0.0 109.169 178.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.516 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 88.5 m -63.72 -44.4 93.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.369 -0.832 . . . . 0.0 109.375 179.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.491 ' CD2' ' OH ' ' A' ' 158' ' ' TYR . 89.9 t80 -46.32 -44.96 17.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.577 -0.702 . . . . 0.0 109.704 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.957 HD21 ' CE1' ' A' ' 158' ' ' TYR . 77.2 mt -80.02 -31.34 39.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.434 -0.791 . . . . 0.0 110.231 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.55 ' HA ' HD11 ' A' ' 13' ' ' ILE . 45.0 mttt -65.39 -16.4 63.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.187 -0.946 . . . . 0.0 109.602 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.489 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -116.94 -28.17 2.53 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -106.04 93.2 7.43 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.329 -1.101 . . . . 0.0 110.028 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 46.6 Cg_endo -73.46 4.95 3.52 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.096 1.577 . . . . 0.0 110.951 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -116.25 -8.53 11.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.07 -1.019 . . . . 0.0 109.758 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.623 ' HB1' ' CZ ' ' A' ' 158' ' ' TYR . . . -48.48 107.76 0.14 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.407 -0.808 . . . . 0.0 110.059 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 1.031 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 35.61 30.85 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.599 -0.688 . . . . 0.0 110.644 -179.768 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.544 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.784 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 1.045 HG23 ' C ' ' A' ' 120' ' ' TYR . 7.4 p -91.62 154.0 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.262 -1.14 . . . . 0.0 110.386 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.602 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 15.3 m-85 -92.22 173.68 7.7 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.174 -0.953 . . . . 0.0 110.494 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.83 HG23 ' CE1' ' A' ' 119' ' ' HIS . 5.6 m -152.23 93.37 1.8 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.288 -0.882 . . . . 0.0 110.197 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.639 ' CZ ' ' CG2' ' A' ' 133' ' ' VAL . 81.4 m-85 -116.0 145.84 42.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.172 -0.955 . . . . 0.0 109.905 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.508 ' HB3' HG23 ' A' ' 117' ' ' THR . 21.4 pt-20 -141.99 152.62 43.6 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.169 -0.957 . . . . 0.0 110.534 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 52.6 m -126.58 146.47 50.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.323 -0.86 . . . . 0.0 109.888 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -121.5 129.04 52.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.166 -0.959 . . . . 0.0 110.485 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.64 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.3 p90 -149.18 -175.57 5.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.35 -0.844 . . . . 0.0 109.802 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.677 HG22 ' HA ' ' A' ' 113' ' ' ILE . 17.3 p -140.44 177.92 7.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.138 -0.976 . . . . 0.0 110.725 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.524 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 2.5 t -158.14 158.99 35.71 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.479 -0.763 . . . . 0.0 110.069 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -85.4 -15.4 43.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.288 -0.883 . . . . 0.0 110.054 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.781 HG23 ' HD2' ' A' ' 14' ' ' PRO . 11.4 mm -82.4 149.67 61.98 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.33 -0.856 . . . . 0.0 110.056 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.781 ' HD2' HG23 ' A' ' 13' ' ' ILE . 41.8 Cg_endo -66.93 145.59 74.8 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.03 1.542 . . . . 0.0 110.306 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.67 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.2 Cg_endo -71.39 -31.96 13.2 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.978 1.514 . . . . 0.0 112.848 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.67 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 40.6 Cg_endo -68.31 -22.31 40.07 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 122.51 0.742 . . . . 0.0 110.245 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.613 ' NH2' ' HB3' ' A' ' 157' ' ' ALA . 46.0 mtp180 -85.1 -42.89 14.37 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.75 HD23 ' C ' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -73.76 -33.37 64.24 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.947 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.583 ' N ' HD23 ' A' ' 18' ' ' LEU . 59.5 t80 -65.65 -55.54 16.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.396 -0.815 . . . . 0.0 109.281 178.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 25' ' ' ASP . 12.0 mttt -51.83 -40.17 60.04 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.825 -0.75 . . . . 0.0 109.436 179.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.063 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -73.96 -38.73 64.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.4 -0.813 . . . . 0.0 111.009 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.704 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.3 OUTLIER -75.26 -36.86 61.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.07 -1.019 . . . . 0.0 110.912 -179.231 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.671 HG13 ' CE1' ' A' ' 81' ' ' TYR . 5.1 t -107.26 -58.56 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.189 -0.944 . . . . 0.0 111.59 -179.247 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.64 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.0 mp -76.54 -1.8 29.19 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.138 -0.976 . . . . 0.0 111.534 -178.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.594 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.8 OUTLIER -154.91 49.49 0.58 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.936 -1.103 . . . . 0.0 110.099 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.704 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -87.43 -29.58 21.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.306 -0.871 . . . . 0.0 110.69 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -61.95 -18.0 58.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 0.0 110.425 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.524 ' O ' ' CG ' ' A' ' 32' ' ' LYS . 7.0 p-10 -126.08 11.5 7.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 110.065 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.631 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 0.4 OUTLIER -97.52 -53.82 3.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -0.859 . . . . 0.0 110.154 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.66 HG11 HD12 ' A' ' 38' ' ' ILE . 2.9 t -71.8 -41.46 9.28 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.273 -0.892 . . . . 0.0 110.876 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 30' ' ' VAL . 47.5 Cg_endo -76.77 7.44 3.54 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 O-C-N 123.399 1.21 . . . . 0.0 110.968 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.524 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 47.7 mmtm -127.24 -35.46 2.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.086 -1.009 . . . . 0.0 109.403 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.574 HD13 ' HB2' ' A' ' 150' ' ' TYR . 10.1 mt -80.12 -33.73 14.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.583 -0.698 . . . . 0.0 109.382 179.359 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.662 ' HB2' HD13 ' A' ' 146' ' ' LEU . . . -149.43 91.33 4.45 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.583 -0.698 . . . . 0.0 110.068 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.82 2.07 6.34 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.104 1.581 . . . . 0.0 110.797 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -87.34 -15.23 38.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.094 -1.004 . . . . 0.0 109.869 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -107.64 -43.97 4.37 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.3 -0.875 . . . . 0.0 110.188 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.66 HD12 HG11 ' A' ' 30' ' ' VAL . 3.4 mt -127.45 142.37 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.392 -0.817 . . . . 0.0 110.116 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.496 ' CB ' ' O ' ' A' ' 59' ' ' GLY . 8.7 tppt? -119.62 -21.06 7.47 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.282 -0.887 . . . . 0.0 110.689 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.472 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 0.3 OUTLIER -153.46 152.48 31.05 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.05 -1.031 . . . . 0.0 110.465 -179.671 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.5 m -150.99 118.31 6.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.509 -0.744 . . . . 0.0 109.573 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -133.97 109.3 8.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.181 -0.95 . . . . 0.0 110.788 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 21.9 mt -54.18 137.62 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.257 -0.902 . . . . 0.0 109.748 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.508 HD22 ' HE3' ' A' ' 68' ' ' LYS . 14.9 tp -107.07 -30.1 9.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.116 -0.99 . . . . 0.0 110.995 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.839 ' CG ' HD12 ' A' ' 53' ' ' ILE . 2.0 m95 -124.08 164.64 19.0 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.153 -0.967 . . . . 0.0 110.875 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.46 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 41.24 -137.91 2.04 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.429 ' O ' ' CG ' ' A' ' 47' ' ' ASP . 11.5 t0 -154.33 24.25 0.48 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.312 -1.111 . . . . 0.0 109.85 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 120.07 -17.83 9.82 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.498 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -68.29 -174.54 8.73 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.434 ' HA ' HG22 ' A' ' 71' ' ' ILE . 46.0 Cg_endo -73.74 128.34 12.42 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 123.937 1.493 . . . . 0.0 110.639 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.96 -13.12 56.14 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -66.59 162.13 21.63 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.516 -0.99 . . . . 0.0 109.629 179.672 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.839 HD12 ' CG ' ' A' ' 45' ' ' TRP . 48.2 mt -128.56 121.61 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.241 -0.912 . . . . 0.0 109.756 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 98.7 mttt -107.78 134.19 51.09 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.173 -0.955 . . . . 0.0 110.319 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.605 ' HE2' ' CD1' ' A' ' 66' ' ' TYR . 14.5 tptm -105.65 90.32 3.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.266 -0.896 . . . . 0.0 109.802 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.629 ' CG2' HD13 ' A' ' 38' ' ' ILE . 73.0 mt -79.96 145.63 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.32 -0.863 . . . . 0.0 110.339 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.578 HG22 ' HB3' ' A' ' 66' ' ' TYR . 0.6 OUTLIER -122.55 144.87 48.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.374 -0.829 . . . . 0.0 109.88 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.609 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 13.5 m-85 -113.26 170.27 8.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.087 -1.008 . . . . 0.0 110.142 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.496 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . 59.15 173.7 0.57 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.488 ' HA ' ' CE ' ' A' ' 39' ' ' LYS . 97.6 mt-10 -72.89 -25.96 61.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.324 -1.103 . . . . 0.0 110.263 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 62' ' ' SER . . . 138.17 -17.73 3.35 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 61' ' ' GLY . 20.3 m -42.86 -42.46 3.67 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.275 -1.132 . . . . 0.0 110.245 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -124.02 176.15 6.53 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.189 -0.945 . . . . 0.0 110.212 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.673 ' CE1' ' CE2' ' A' ' 66' ' ' TYR . 0.1 OUTLIER -88.79 112.41 23.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.909 . . . . 0.0 109.927 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.609 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -145.82 60.98 0.48 Allowed Glycine 0 N--CA 1.483 1.829 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 179.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.673 ' CE2' ' CE1' ' A' ' 64' ' ' TYR . 10.5 p90 -125.12 166.19 16.87 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.206 -1.173 . . . . 0.0 109.894 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.929 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.3 m -140.54 172.26 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 110.68 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.508 ' HE3' HD22 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -120.72 120.46 35.73 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.64 -0.662 . . . . 0.0 109.555 179.507 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.649 ' CE1' HD13 ' A' ' 85' ' ' LEU . 0.5 OUTLIER -110.42 119.36 38.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.126 -0.984 . . . . 0.0 111.106 -179.31 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 52' ' ' THR . 13.4 tttp -96.69 99.4 11.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.183 -0.948 . . . . 0.0 109.444 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.525 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 30.1 mm -42.38 135.92 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.351 -0.843 . . . . 0.0 110.159 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.46 ' OD2' ' OG1' ' A' ' 84' ' ' THR . 90.2 m-20 -104.2 -39.83 6.36 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.291 -0.881 . . . . 0.0 110.033 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.531 ' C ' HD12 ' A' ' 74' ' ' ILE . 1.4 m -179.38 162.14 1.13 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.246 -0.909 . . . . 0.0 109.6 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.531 HD12 ' C ' ' A' ' 73' ' ' SER . 0.9 OUTLIER -143.99 153.2 15.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.024 -179.812 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.497 ' HB3' ' HB2' ' A' ' 78' ' ' ASN . 5.5 m-20 -134.58 78.49 1.75 Allowed 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.501 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.546 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 20.8 tttt -61.65 -15.74 42.5 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.221 -0.925 . . . . 0.0 110.167 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -92.39 -36.0 13.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.242 -0.912 . . . . 0.0 109.41 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.517 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 2.6 m120 -96.52 -5.3 39.71 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.639 -0.663 . . . . 0.0 109.387 179.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.549 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 76.4 m-85 62.08 55.95 2.37 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.566 0.698 . . . . 0.0 110.619 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.477 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 1.3 m -132.33 159.15 40.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.365 -0.834 . . . . 0.0 109.714 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.692 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 64.7 t80 -146.56 146.09 30.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.19 -0.943 . . . . 0.0 109.811 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.533 ' OG ' ' CG ' ' A' ' 101' ' ' GLU . 0.2 OUTLIER -153.48 138.14 16.94 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.167 -0.958 . . . . 0.0 110.861 -179.729 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.692 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 11.5 p90 -150.89 173.43 14.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.427 -0.796 . . . . 0.0 110.2 179.107 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 98' ' ' ILE . 58.2 m -124.92 131.58 53.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.421 -0.799 . . . . 0.0 109.934 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.654 HD23 HG13 ' A' ' 98' ' ' ILE . 2.0 tp -100.1 129.09 46.1 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.201 -0.937 . . . . 0.0 110.044 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.466 HG12 ' HB3' ' A' ' 68' ' ' LYS . 12.8 pt -115.27 -13.56 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -0.891 . . . . 0.0 110.027 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.554 ' O ' HD11 ' A' ' 85' ' ' LEU . 18.1 tt0 -128.68 154.63 46.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.884 . . . . 0.0 110.232 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.929 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 154.8 128.28 1.16 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -64.9 -10.87 32.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.273 -1.133 . . . . 0.0 110.242 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.91 -17.35 41.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.275 -0.891 . . . . 0.0 110.166 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.478 HD21 HD23 ' A' ' 85' ' ' LEU . 51.2 mt -69.01 -19.08 64.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.893 . . . . 0.0 110.234 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 49.09 -177.36 0.02 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.488 ' OD1' HG23 ' A' ' 94' ' ' THR . 54.2 p-10 -84.36 11.88 7.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.259 -1.142 . . . . 0.0 110.173 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.488 HG23 ' OD1' ' A' ' 93' ' ' ASP . 69.7 p -102.84 -38.18 7.52 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.281 -0.887 . . . . 0.0 110.181 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.906 HD21 ' CD1' ' A' ' 128' ' ' ILE . 76.5 mt -95.17 166.22 12.02 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.381 -0.824 . . . . 0.0 109.995 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.472 ' HG3' ' HB2' ' A' ' 123' ' ' LYS . 9.9 mt-10 -146.64 -81.36 0.14 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.263 -0.898 . . . . 0.0 109.787 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 49.2 mttt -80.39 130.09 34.94 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.728 -0.607 . . . . 0.0 110.254 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.707 HG21 ' CE2' ' A' ' 100' ' ' TYR . 5.7 mm -118.0 140.61 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 120.921 -1.112 . . . . 0.0 109.778 178.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.5 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.5 OUTLIER -121.51 128.61 52.24 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.762 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.707 ' CE2' HG21 ' A' ' 98' ' ' ILE . 10.7 m-85 -123.62 134.99 53.7 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.346 -0.846 . . . . 0.0 110.433 -178.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.533 ' CG ' ' OG ' ' A' ' 82' ' ' SER . 7.7 mt-10 -133.61 141.56 47.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.32 -0.863 . . . . 0.0 109.945 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.487 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 18.9 m -138.27 142.88 39.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.092 -1.005 . . . . 0.0 109.975 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.13 138.54 38.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.242 -0.911 . . . . 0.0 110.327 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.728 HD23 HG12 ' A' ' 114' ' ' ILE . 5.2 mt -124.86 145.8 49.61 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.259 -0.901 . . . . 0.0 110.227 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.697 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -152.76 -168.54 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.405 -0.81 . . . . 0.0 109.945 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.697 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -113.89 141.01 47.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.266 -0.896 . . . . 0.0 110.001 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.743 ' HA ' HD11 ' A' ' 113' ' ' ILE . 1.3 p -96.12 170.3 7.77 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.118 -0.989 . . . . 0.0 110.406 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.474 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 50.0 Cg_endo -78.81 4.57 6.34 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.105 1.582 . . . . 0.0 110.456 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 51.9 m -110.15 5.22 21.8 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -0.871 . . . . 0.0 110.283 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 99.36 -27.65 19.11 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.453 ' O ' ' OG ' ' A' ' 107' ' ' SER . . . -75.77 -173.94 35.5 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 22.4 p -118.53 132.44 56.21 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.181 -1.188 . . . . 0.0 110.301 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.743 HD11 ' HA ' ' A' ' 107' ' ' SER . 23.9 mt -82.84 147.61 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 109.903 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.728 HG12 HD23 ' A' ' 104' ' ' LEU . 9.7 mt -130.63 122.69 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.305 -0.872 . . . . 0.0 110.566 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.7 tttp -111.93 117.33 32.44 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.383 -0.823 . . . . 0.0 109.762 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 0.5 OUTLIER -110.83 152.69 26.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.246 -0.909 . . . . 0.0 110.69 -179.55 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.763 HG22 ' NE2' ' A' ' 119' ' ' HIS . 53.6 m -149.57 132.57 16.2 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.42 -0.8 . . . . 0.0 110.1 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.4 m -131.12 150.53 52.11 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.198 -0.939 . . . . 0.0 110.321 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.83 ' CE1' HG23 ' A' ' 4' ' ' THR . 20.9 m-70 -137.9 135.4 36.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.343 -0.848 . . . . 0.0 110.037 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 1.045 ' C ' HG23 ' A' ' 2' ' ' VAL . 11.5 m-85 -113.27 122.22 46.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.133 -0.979 . . . . 0.0 110.631 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.614 ' N ' HG23 ' A' ' 2' ' ' VAL . 88.7 m-70 -91.22 121.77 33.27 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.2 p -98.11 149.23 22.73 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.059 -1.025 . . . . 0.0 110.974 -178.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.472 ' HB2' ' HG3' ' A' ' 96' ' ' GLU . 20.2 tttt -104.09 108.7 20.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.54 -0.725 . . . . 0.0 110.163 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 108.65 -136.36 13.47 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 26.4 t30 -119.94 54.37 1.03 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.105 -1.232 . . . . 0.0 110.341 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 17.7 m -115.65 170.24 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.311 -0.868 . . . . 0.0 110.113 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.428 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 96.4 mt-10 -134.25 -177.79 4.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.199 -0.938 . . . . 0.0 110.333 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.906 ' CD1' HD21 ' A' ' 95' ' ' LEU . 8.2 mm -84.73 172.25 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.216 -0.928 . . . . 0.0 110.405 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.586 ' N ' HG22 ' A' ' 128' ' ' ILE . 47.5 mttt -94.95 131.03 41.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.437 -0.79 . . . . 0.0 109.825 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.444 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 95.9 mt-10 -48.97 -40.96 32.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.193 -0.942 . . . . 0.0 110.109 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.753 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 49.0 tt0 -66.67 -8.89 30.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.221 -0.924 . . . . 0.0 109.753 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.454 ' O ' ' HA3' ' A' ' 136' ' ' GLY . 8.4 t-160 -103.24 -55.02 2.49 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.896 . . . . 0.0 110.196 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.639 ' CG2' ' CZ ' ' A' ' 5' ' ' TYR . 2.1 p -61.62 -29.61 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.449 -0.782 . . . . 0.0 110.227 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.538 ' HA ' ' HE3' ' A' ' 137' ' ' LYS . 28.3 tttt -108.91 -71.85 0.75 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.952 . . . . 0.0 110.061 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.753 ' HB3' ' O ' ' A' ' 131' ' ' GLU . . . -55.79 -21.05 17.34 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 109.68 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' A' ' 132' ' ' HIS . . . -74.46 -30.91 59.6 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.538 ' HE3' ' HA ' ' A' ' 134' ' ' LYS . 6.0 mtmp? -66.74 -31.87 72.8 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.25 -1.147 . . . . 0.0 109.949 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -72.96 -34.24 66.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.298 -0.876 . . . . 0.0 109.959 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.484 ' O ' HD12 ' A' ' 143' ' ' LEU . 52.6 mttt -67.91 -38.83 83.43 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.404 -0.81 . . . . 0.0 109.804 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.83 -40.05 91.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.311 -0.868 . . . . 0.0 109.837 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.429 ' O ' ' HG3' ' A' ' 145' ' ' LYS . 22.8 t -56.71 -38.12 71.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.374 -0.829 . . . . 0.0 109.904 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.482 ' OD1' ' HA ' ' A' ' 139' ' ' LYS . 15.7 m120 -56.9 -48.49 78.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.304 -0.872 . . . . 0.0 109.997 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.484 HD12 ' O ' ' A' ' 139' ' ' LYS . 1.2 mp -61.68 -34.19 75.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.87 . . . . 0.0 109.962 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.577 ' HA ' HD12 ' A' ' 147' ' ' ILE . 19.8 m-85 -64.68 -38.22 90.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.291 -0.881 . . . . 0.0 109.728 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.429 ' HG3' ' O ' ' A' ' 141' ' ' SER . 57.7 mttt -71.67 -12.23 61.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 109.946 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.662 HD13 ' HB2' ' A' ' 34' ' ' ALA . 17.8 mt -81.3 -36.65 29.53 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.233 -0.917 . . . . 0.0 108.882 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.649 HD11 ' CE1' ' A' ' 22' ' ' PHE . 17.3 mt -69.56 -50.37 51.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.524 ' CG ' ' OG ' ' A' ' 11' ' ' SER . 57.1 mt-10 -58.37 -37.71 75.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.466 -0.771 . . . . 0.0 109.453 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 20.2 m -67.57 -33.76 75.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.166 -0.959 . . . . 0.0 109.511 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.574 ' HB2' HD13 ' A' ' 33' ' ' ILE . 87.6 t80 -58.91 -45.87 89.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.392 -0.817 . . . . 0.0 109.613 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.967 HD21 ' CE1' ' A' ' 158' ' ' TYR . 70.9 mt -80.0 -28.88 39.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.385 -0.822 . . . . 0.0 110.029 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.706 ' HA ' HD11 ' A' ' 13' ' ' ILE . 82.5 tttt -65.34 -14.91 61.88 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.193 -0.942 . . . . 0.0 109.518 179.281 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.479 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -119.84 -27.45 2.1 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.402 ' ND1' ' N ' ' A' ' 154' ' ' HIS . 2.4 m80 -106.44 93.61 8.59 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.22 -1.165 . . . . 0.0 110.301 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.9 Cg_endo -74.21 4.6 4.19 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 124.07 1.563 . . . . 0.0 110.833 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -115.61 -7.33 12.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.069 -1.019 . . . . 0.0 109.791 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.613 ' HB3' ' NH2' ' A' ' 17' ' ' ARG . . . -51.35 108.26 0.24 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.433 -0.792 . . . . 0.0 110.077 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 1.063 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 35.73 30.7 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.615 -0.678 . . . . 0.0 110.672 -179.637 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.54 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.4 0 O-C-N 121.095 -1.003 . . . . 0.0 109.684 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.617 HG11 ' CE1' ' A' ' 121' ' ' HIS . 58.1 t -122.8 134.25 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.173 -1.193 . . . . 0.0 110.412 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.597 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 32.0 m-85 -89.19 161.11 16.63 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.258 -0.901 . . . . 0.0 110.235 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.831 HG23 ' CE1' ' A' ' 119' ' ' HIS . 92.1 m -144.26 96.57 2.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.229 -0.92 . . . . 0.0 110.079 179.822 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.622 ' CE1' ' CG2' ' A' ' 133' ' ' VAL . 77.8 m-85 -115.41 144.66 43.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.15 -0.969 . . . . 0.0 110.172 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 116' ' ' SER . 21.0 pt-20 -138.6 152.41 48.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 0.0 110.218 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 65.2 m -122.37 150.29 42.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.251 -0.906 . . . . 0.0 110.047 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -133.13 120.07 20.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 110.356 -179.842 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.644 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.7 p90 -149.37 -173.76 4.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.293 -0.879 . . . . 0.0 109.92 179.751 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.863 HG22 ' HA ' ' A' ' 113' ' ' ILE . 3.3 p -140.32 171.8 13.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.12 -0.987 . . . . 0.0 110.474 -179.657 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.475 ' HB3' ' OE2' ' A' ' 148' ' ' GLU . 99.7 p -151.46 136.05 17.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.297 -0.877 . . . . 0.0 110.157 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -61.78 -31.91 72.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.172 -0.955 . . . . 0.0 110.244 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.809 HG21 HD12 ' A' ' 151' ' ' LEU . 8.1 mm -70.94 149.21 94.9 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.381 -0.824 . . . . 0.0 109.951 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.774 ' HD2' HG23 ' A' ' 13' ' ' ILE . 39.9 Cg_endo -65.39 143.59 76.95 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.073 1.565 . . . . 0.0 110.676 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.673 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.9 Cg_endo -71.82 -31.56 12.72 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 124.073 1.565 . . . . 0.0 112.74 -179.37 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.673 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.3 Cg_endo -69.02 -21.91 36.25 Favored 'Trans proline' 0 C--N 1.318 -1.051 0 N-CA-C 110.01 -0.804 . . . . 0.0 110.01 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.904 ' HB3' HD13 ' A' ' 151' ' ' LEU . 41.5 mtp180 -82.08 -47.45 12.58 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.583 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 1.111 HD23 ' CG2' ' A' ' 147' ' ' ILE . 0.2 OUTLIER -70.38 -35.08 73.28 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.093 178.929 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.645 ' N ' HD13 ' A' ' 18' ' ' LEU . 80.4 t80 -61.0 -59.26 5.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.479 -0.763 . . . . 0.0 109.738 179.116 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.53 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 17.6 mttp -51.64 -35.9 43.86 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.724 -0.791 . . . . 0.0 109.503 179.622 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.997 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -77.55 -32.36 53.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.464 -0.772 . . . . 0.0 111.048 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 1.058 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -80.53 -41.9 23.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.233 -0.917 . . . . 0.0 111.081 -179.099 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.742 HG13 ' CE1' ' A' ' 81' ' ' TYR . 3.7 t -103.91 -51.17 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.118 -0.989 . . . . 0.0 111.386 -179.106 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.674 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.3 mp -80.14 -9.8 59.73 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.132 -0.98 . . . . 0.0 111.684 -178.878 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 20' ' ' LYS . 1.2 m-20 -148.48 36.57 0.81 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.768 -1.207 . . . . 0.0 110.711 -179.664 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 1.058 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -76.98 -25.7 53.05 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.301 -0.875 . . . . 0.0 110.309 179.676 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -66.16 -15.25 62.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.195 -0.941 . . . . 0.0 109.919 179.783 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.56 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 7.4 p-10 -130.55 11.26 5.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.343 -0.848 . . . . 0.0 109.953 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.703 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -94.42 -48.99 5.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.374 -0.829 . . . . 0.0 110.042 179.689 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.863 HG22 ' HD3' ' A' ' 31' ' ' PRO . 2.1 m -73.91 -29.65 1.04 Allowed Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.373 -0.829 . . . . 0.0 112.039 -179.826 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.863 ' HD3' HG22 ' A' ' 30' ' ' VAL . 52.9 Cg_endo -78.81 4.06 6.79 Favored 'Trans proline' 0 C--N 1.32 -0.946 0 O-C-N 122.714 0.85 . . . . 0.0 110.128 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -124.34 -36.08 2.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.301 -0.874 . . . . 0.0 109.103 179.62 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.622 HD11 ' CD1' ' A' ' 29' ' ' LEU . 53.2 mt -79.96 -25.25 11.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 121.622 0.725 . . . . 0.0 109.25 179.19 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.407 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . . . -169.89 91.97 0.52 Allowed Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.702 -0.624 . . . . 0.0 109.738 179.705 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 34' ' ' ALA . 44.6 Cg_endo -70.77 -2.85 11.56 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.0 1.526 . . . . 0.0 110.632 -179.676 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -91.98 10.73 27.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -0.913 . . . . 0.0 109.938 179.789 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.913 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -114.65 -49.74 2.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.326 -0.859 . . . . 0.0 109.995 179.854 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.913 HD12 ' C ' ' A' ' 37' ' ' ALA . 1.8 mp -119.87 134.63 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.486 -0.759 . . . . 0.0 109.905 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' A' ' 57' ' ' THR . 6.1 ttmm -87.59 -24.64 23.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.311 -0.868 . . . . 0.0 110.357 -179.804 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.465 ' O ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -179.32 153.53 0.59 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.2 -0.938 . . . . 0.0 110.172 -179.847 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 m -127.32 124.44 38.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.345 -0.847 . . . . 0.0 109.923 179.702 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -136.44 111.81 9.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.173 -0.954 . . . . 0.0 110.46 -179.823 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 22.2 mt -57.88 134.11 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.22 -0.925 . . . . 0.0 110.052 179.789 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.54 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 19.0 mt -103.45 -28.67 11.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.188 -0.945 . . . . 0.0 110.675 -179.79 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.666 ' CG ' HD12 ' A' ' 53' ' ' ILE . 2.0 m95 -129.51 165.18 22.18 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.096 -1.003 . . . . 0.0 110.731 -179.751 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 45' ' ' TRP . . . 41.57 -135.26 3.11 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.658 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -157.2 19.7 0.3 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.299 -1.118 . . . . 0.0 110.099 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.74 -15.82 7.02 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.798 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.505 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -76.58 -170.4 31.61 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.67 129.33 13.48 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.028 1.541 . . . . 0.0 110.662 -179.831 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.98 -9.57 56.64 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 -179.643 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -73.23 159.04 34.06 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.601 -0.941 . . . . 0.0 109.84 179.835 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.666 HD12 ' CG ' ' A' ' 45' ' ' TRP . 55.5 mt -128.85 121.35 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.382 -0.823 . . . . 0.0 109.79 179.538 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 6.4 mtpm? -104.63 145.03 30.9 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.155 -0.966 . . . . 0.0 110.262 -179.795 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.54 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 13.1 tttt -115.62 89.99 3.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -0.856 . . . . 0.0 110.024 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.453 ' CG2' HG13 ' A' ' 38' ' ' ILE . 64.7 mt -79.98 136.07 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -0.926 . . . . 0.0 110.139 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.513 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 1.4 p -108.98 152.66 24.67 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.211 -0.931 . . . . 0.0 110.396 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.583 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 20.1 m-85 -115.51 152.53 32.81 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.249 -0.907 . . . . 0.0 110.072 179.53 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -106.26 -7.88 34.35 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -107.7 146.68 31.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.275 -1.132 . . . . 0.0 110.298 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.73 -152.66 18.25 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 95.3 p -56.73 177.8 0.07 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.214 -1.168 . . . . 0.0 110.162 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -64.88 -40.22 94.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 110.244 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -110.58 105.4 14.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.215 -0.928 . . . . 0.0 110.299 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.583 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -132.63 84.36 0.29 Allowed Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.679 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.517 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 13.8 p90 -131.09 164.01 26.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.283 -1.127 . . . . 0.0 110.027 -179.795 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.942 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.7 m -134.08 174.54 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.927 . . . . 0.0 110.583 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.529 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 28.9 mttt -128.17 121.0 28.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.483 -0.76 . . . . 0.0 109.604 179.583 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.626 ' CE1' HD13 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -110.52 122.28 47.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.14 -0.975 . . . . 0.0 110.969 -179.384 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 52' ' ' THR . 81.0 tttt -95.48 117.44 30.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.187 -0.945 . . . . 0.0 109.359 178.989 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.519 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 23.6 mm -61.98 124.6 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.201 -0.937 . . . . 0.0 110.6 -179.31 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 82' ' ' SER . 94.4 m-20 -99.79 -41.88 7.07 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.403 -0.811 . . . . 0.0 109.693 179.512 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.458 ' OG ' ' HB2' ' A' ' 82' ' ' SER . 90.0 p -171.24 158.35 5.4 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.299 -0.875 . . . . 0.0 109.848 179.617 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.488 HG12 HG11 ' A' ' 23' ' ' VAL . 4.9 mt -137.4 158.47 35.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.265 -0.897 . . . . 0.0 110.273 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.59 ' HB2' ' HB2' ' A' ' 80' ' ' SER . 3.2 m-20 -133.68 83.32 2.04 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.579 -0.7 . . . . 0.0 110.166 -179.589 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.458 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 20.8 mttt -73.43 -9.89 59.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.438 -0.789 . . . . 0.0 110.167 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -93.54 -38.97 11.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.249 -0.907 . . . . 0.0 109.289 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.517 ' ND2' ' H ' ' A' ' 78' ' ' ASN . 0.9 OUTLIER -111.3 7.45 21.06 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.466 0.651 . . . . 0.0 110.807 -179.772 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.568 ' CZ ' ' HB3' ' A' ' 16' ' ' PRO . 5.6 m-85 59.03 60.88 2.28 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.379 -0.826 . . . . 0.0 112.859 177.847 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.59 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 1.0 OUTLIER -127.9 156.01 43.28 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.989 -1.069 . . . . 0.0 109.329 177.875 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.742 ' CE1' HG13 ' A' ' 23' ' ' VAL . 24.7 t80 -140.76 136.55 32.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.14 -0.975 . . . . 0.0 110.49 -179.254 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 1.1 m -139.49 125.69 20.05 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.302 -0.874 . . . . 0.0 110.324 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.691 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 23.7 p90 -147.01 169.92 18.21 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.234 -0.916 . . . . 0.0 110.404 179.558 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.674 HG23 ' O ' ' A' ' 98' ' ' ILE . 60.7 m -122.06 132.04 54.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.449 -0.782 . . . . 0.0 109.998 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.626 HD13 ' CE1' ' A' ' 69' ' ' HIS . 2.5 tp -97.41 122.9 41.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.184 -0.947 . . . . 0.0 110.125 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 86' ' ' ILE . 13.9 pt -105.15 -15.2 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -0.926 . . . . 0.0 110.293 -179.648 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.58 ' O ' HD11 ' A' ' 85' ' ' LEU . 31.6 tt0 -131.14 162.4 29.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.187 -0.946 . . . . 0.0 110.5 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.942 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 152.18 117.46 0.73 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -52.94 -21.16 4.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.174 -1.192 . . . . 0.0 110.3 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.84 -22.96 55.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.896 . . . . 0.0 110.279 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.599 HD21 HD23 ' A' ' 85' ' ' LEU . 26.8 mt -66.64 -26.8 67.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.918 . . . . 0.0 110.178 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 49.27 -178.44 0.02 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 57.9 p30 -79.05 4.48 14.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -1.167 . . . . 0.0 110.226 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.494 ' O ' HG22 ' A' ' 122' ' ' THR . 43.9 p -90.69 -32.47 16.18 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.269 -0.894 . . . . 0.0 110.114 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.871 HD23 ' CG2' ' A' ' 122' ' ' THR . 62.8 mt -111.04 162.76 14.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.373 -0.829 . . . . 0.0 110.089 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.499 ' HG3' ' HB2' ' A' ' 123' ' ' LYS . 71.3 mm-40 -142.63 -80.01 0.22 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.124 -0.985 . . . . 0.0 110.201 -179.726 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 58.4 mttm -80.21 126.82 31.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.584 -0.698 . . . . 0.0 110.481 -179.823 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.731 HG21 ' CE2' ' A' ' 100' ' ' TYR . 5.7 mm -117.36 140.57 39.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 120.744 -1.223 . . . . 0.0 109.999 179.149 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.498 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -119.39 129.58 54.88 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.829 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.731 ' CE2' HG21 ' A' ' 98' ' ' ILE . 10.1 m-85 -124.54 135.55 53.26 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.274 -0.891 . . . . 0.0 110.609 -178.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.462 ' O ' ' N ' ' A' ' 117' ' ' THR . 6.4 mt-10 -138.54 128.79 25.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.335 -0.853 . . . . 0.0 110.039 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 79.3 m -131.25 146.12 52.18 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.135 -0.978 . . . . 0.0 110.202 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 115' ' ' LYS . 4.5 tttt -140.72 145.25 36.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.312 -0.868 . . . . 0.0 110.324 -179.834 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.863 HD23 HG12 ' A' ' 114' ' ' ILE . 4.5 mt -124.73 153.8 41.83 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.294 -0.879 . . . . 0.0 110.239 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.698 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -151.45 -168.94 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.177 -0.952 . . . . 0.0 109.982 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.698 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -122.76 160.73 25.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.261 -0.899 . . . . 0.0 110.317 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.463 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 2.1 p -117.35 170.26 6.34 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.302 -0.874 . . . . 0.0 110.197 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 47.2 Cg_endo -72.89 -17.11 25.7 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.022 1.538 . . . . 0.0 110.452 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 73.4 m -95.17 9.46 39.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.334 -0.854 . . . . 0.0 110.272 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 94.54 -33.42 5.33 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -55.51 -172.39 0.11 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 0.7 OUTLIER -136.53 137.47 40.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -1.148 . . . . 0.0 110.349 -179.998 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.863 ' HA ' HG22 ' A' ' 10' ' ' THR . 25.0 mt -90.39 147.74 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.349 -0.844 . . . . 0.0 110.017 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.863 HG12 HD23 ' A' ' 104' ' ' LEU . 23.2 mt -131.48 114.22 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.231 -0.918 . . . . 0.0 110.593 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 103' ' ' LYS . 16.6 tttt -102.9 130.91 50.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.221 -0.924 . . . . 0.0 109.758 179.467 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 3.3 t -123.03 160.09 27.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.096 -1.003 . . . . 0.0 110.558 -179.637 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.462 ' N ' ' O ' ' A' ' 101' ' ' GLU . 29.8 m -156.36 126.98 6.73 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.332 -0.855 . . . . 0.0 110.038 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 83.5 p -130.38 152.58 49.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.114 -0.991 . . . . 0.0 110.489 -179.75 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.831 ' CE1' HG23 ' A' ' 4' ' ' THR . 50.4 m-70 -134.93 158.12 45.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.371 -0.831 . . . . 0.0 109.917 179.599 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.629 ' HD1' HD12 ' A' ' 98' ' ' ILE . 26.8 m-85 -129.59 135.42 48.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.133 -0.979 . . . . 0.0 110.488 -179.624 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.617 ' CE1' HG11 ' A' ' 2' ' ' VAL . 87.5 m-70 -117.25 95.92 5.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.117 -0.99 . . . . 0.0 109.819 179.38 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.871 ' CG2' HD23 ' A' ' 95' ' ' LEU . 2.4 p -77.86 158.51 29.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.909 . . . . 0.0 110.616 -179.522 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.499 ' HB2' ' HG3' ' A' ' 96' ' ' GLU . 63.4 tttt -113.12 99.25 7.69 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.372 -0.83 . . . . 0.0 110.191 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 121.84 -128.98 7.47 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.865 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -125.9 71.37 1.24 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.336 -1.097 . . . . 0.0 110.173 -179.859 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.514 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 35.5 m -138.58 155.93 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.188 -0.945 . . . . 0.0 110.092 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -123.51 174.32 7.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.319 -0.863 . . . . 0.0 110.284 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.823 ' CD1' HD21 ' A' ' 95' ' ' LEU . 20.9 mm -76.93 171.77 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.28 -0.888 . . . . 0.0 110.047 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.546 ' N ' HG22 ' A' ' 128' ' ' ILE . 22.3 mttt -99.17 129.9 45.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.191 -0.943 . . . . 0.0 109.986 179.785 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.546 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 93.8 mt-10 -44.05 -43.6 6.9 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.214 -0.929 . . . . 0.0 109.947 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.974 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 47.8 tt0 -58.61 -24.13 60.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.245 -0.909 . . . . 0.0 109.845 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.479 ' N ' ' O ' ' A' ' 129' ' ' LYS . 14.8 t-160 -86.67 -57.05 3.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.328 -0.857 . . . . 0.0 110.135 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.636 HG13 ' HG3' ' A' ' 134' ' ' LYS . 2.3 p -63.04 -22.31 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.417 -0.802 . . . . 0.0 110.262 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.636 ' HG3' HG13 ' A' ' 133' ' ' VAL . 54.1 mttt -112.0 -73.74 0.66 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.143 -0.973 . . . . 0.0 110.328 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.974 ' HB3' ' O ' ' A' ' 131' ' ' GLU . . . -53.45 -20.53 4.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.901 . . . . 0.0 109.642 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.55 -29.55 65.62 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.071 -1.611 . . . . 0.0 109.071 179.728 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 23.7 mttm -64.21 -30.09 71.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.298 -1.119 . . . . 0.0 109.954 179.8 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 70.2 tt0 -77.4 -28.32 52.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.379 -0.825 . . . . 0.0 110.156 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.8 mmtp -73.9 -34.8 64.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 110.055 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -80.6 -34.68 34.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.873 . . . . 0.0 110.007 179.809 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 33.2 m -63.86 -45.15 90.76 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.401 -0.812 . . . . 0.0 109.943 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -54.94 -42.77 72.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.283 -0.886 . . . . 0.0 110.015 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.632 ' HA ' HD12 ' A' ' 146' ' ' LEU . 80.8 mt -60.59 -46.1 91.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.294 -0.879 . . . . 0.0 110.083 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -59.31 -37.32 77.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.374 -0.829 . . . . 0.0 109.818 179.793 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -72.15 -12.97 61.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.306 -0.872 . . . . 0.0 110.068 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.632 HD12 ' HA ' ' A' ' 143' ' ' LEU . 34.4 mt -83.72 -35.58 24.33 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.215 -0.928 . . . . 0.0 108.912 179.25 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 1.111 ' CG2' HD23 ' A' ' 18' ' ' LEU . 60.7 mt -68.9 -46.22 79.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.926 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.503 ' O ' HG13 ' A' ' 13' ' ' ILE . 84.7 mt-10 -50.43 -35.32 28.06 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.4 -0.812 . . . . 0.0 109.353 179.089 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 3.0 m -75.39 -20.48 58.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.222 -0.924 . . . . 0.0 109.49 179.321 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.579 ' CD1' HG12 ' A' ' 33' ' ' ILE . 80.1 t80 -69.5 -48.95 58.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.517 -0.739 . . . . 0.0 109.915 179.605 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.904 HD13 ' HB3' ' A' ' 17' ' ' ARG . 48.2 mt -80.03 -31.56 39.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.351 -0.843 . . . . 0.0 110.021 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.464 ' CA ' HD11 ' A' ' 13' ' ' ILE . 7.5 ttpp -64.74 -14.19 57.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.306 -0.872 . . . . 0.0 109.428 179.285 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.464 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -118.35 -30.54 1.7 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 179.708 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.405 ' ND1' ' N ' ' A' ' 154' ' ' HIS . 2.3 m80 -106.07 94.41 9.3 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.272 -1.134 . . . . 0.0 110.15 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.51 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.9 Cg_endo -73.96 4.58 4.08 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.985 1.519 . . . . 0.0 110.873 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -113.37 -8.8 13.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.972 -1.08 . . . . 0.0 109.819 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.597 ' HB3' ' NH2' ' A' ' 17' ' ' ARG . . . -53.65 104.47 0.1 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.374 -0.829 . . . . 0.0 109.979 179.762 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.997 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 35.33 30.96 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.733 -0.604 . . . . 0.0 110.703 -179.663 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.538 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.409 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.745 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.235 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.955 HG11 ' CE1' ' A' ' 121' ' ' HIS . 2.7 p -80.75 149.56 5.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.113 -1.228 . . . . 0.0 110.795 -179.491 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 5' ' ' TYR . 72.5 m-85 -93.76 169.01 10.63 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.611 -0.681 . . . . 0.0 110.49 -179.579 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.959 HG23 ' CE1' ' A' ' 119' ' ' HIS . 86.0 m -139.93 105.06 5.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.345 -0.847 . . . . 0.0 110.126 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.784 ' CE2' HG11 ' A' ' 133' ' ' VAL . 65.7 m-85 -114.23 144.68 42.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.909 . . . . 0.0 110.034 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 21.5 pt-20 -134.27 150.5 51.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.173 -0.954 . . . . 0.0 110.254 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.461 ' O ' ' CG ' ' A' ' 8' ' ' GLU . 24.8 p -125.95 169.38 12.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.344 -0.847 . . . . 0.0 109.986 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.461 ' CG ' ' O ' ' A' ' 7' ' ' SER . 80.9 mt-10 -153.95 117.19 4.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.163 -0.961 . . . . 0.0 110.628 -179.852 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.2 p90 -142.58 -178.05 5.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.325 -0.859 . . . . 0.0 109.875 179.562 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.558 HG22 HG12 ' A' ' 113' ' ' ILE . 16.5 p -136.71 179.78 6.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.182 -0.949 . . . . 0.0 110.544 -179.783 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 112' ' ' SER . 2.2 t -160.05 159.12 31.6 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.297 -0.877 . . . . 0.0 110.55 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -85.55 -12.11 52.44 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.207 -0.933 . . . . 0.0 109.824 179.805 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.815 HG23 ' HD2' ' A' ' 14' ' ' PRO . 2.3 mp -88.29 151.02 48.17 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.356 -0.84 . . . . 0.0 109.984 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.815 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.9 Cg_endo -66.69 139.9 54.39 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.046 1.55 . . . . 0.0 110.664 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.64 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 41.3 Cg_endo -73.25 -30.03 10.84 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 124.069 1.563 . . . . 0.0 112.843 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.64 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.9 Cg_endo -71.72 -23.56 22.61 Favored 'Trans proline' 0 C--N 1.319 -1.002 0 N-CA-C 110.052 -0.788 . . . . 0.0 110.052 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.565 ' CZ ' ' HA ' ' A' ' 159' ' ' ASN . 1.1 mtp85 -82.05 -44.89 16.0 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.008 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.96 HD23 ' CG2' ' A' ' 147' ' ' ILE . 0.2 OUTLIER -67.07 -34.0 76.71 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.528 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.626 ' N ' HD13 ' A' ' 18' ' ' LEU . 74.9 t80 -59.38 -56.59 20.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.639 -0.663 . . . . 0.0 109.642 178.738 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.551 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 29.6 mttp -52.35 -37.53 56.41 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.721 -0.791 . . . . 0.0 109.421 179.462 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.007 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -75.63 -43.38 48.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.466 -0.772 . . . . 0.0 110.76 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 1.051 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.3 OUTLIER -65.36 -45.8 82.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.341 -0.849 . . . . 0.0 111.074 -179.065 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 1.126 HG11 ' CD1' ' A' ' 74' ' ' ILE . 10.4 t -104.2 -60.89 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.084 -1.01 . . . . 0.0 111.766 -179.051 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.616 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.5 mp -66.13 -11.36 48.66 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.171 -0.956 . . . . 0.0 111.537 -178.64 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.612 ' O ' HD23 ' A' ' 29' ' ' LEU . 1.2 m-20 -148.17 44.18 1.05 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.886 -1.134 . . . . 0.0 110.27 -179.778 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 1.051 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -82.8 -22.14 34.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.297 -0.877 . . . . 0.0 110.47 -179.831 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -68.76 -19.9 64.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.127 -0.983 . . . . 0.0 110.214 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.515 ' O ' ' CB ' ' A' ' 32' ' ' LYS . 7.2 p-10 -125.34 13.15 8.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 0.0 109.772 179.836 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.612 HD23 ' O ' ' A' ' 25' ' ' ASP . 0.4 OUTLIER -97.01 -54.16 3.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.453 -0.779 . . . . 0.0 110.175 -179.939 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.984 HG11 HD13 ' A' ' 38' ' ' ILE . 2.6 t -70.28 -42.78 16.73 Favored Pre-proline 0 C--N 1.299 -1.597 0 O-C-N 121.296 -0.877 . . . . 0.0 110.57 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 50.3 Cg_endo -79.32 8.27 3.98 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.601 1.316 . . . . 0.0 110.617 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.515 ' CB ' ' O ' ' A' ' 28' ' ' ASN . 81.4 tttt -125.41 -31.39 3.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.187 -0.945 . . . . 0.0 109.745 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.669 HD13 ' HA ' ' A' ' 147' ' ' ILE . 22.0 mt -79.76 -35.53 16.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.523 -0.736 . . . . 0.0 109.701 179.578 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.404 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . . . -160.66 99.82 1.35 Allowed Pre-proline 0 N--CA 1.487 1.377 0 O-C-N 121.433 -0.792 . . . . 0.0 110.187 179.764 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 34' ' ' ALA . 47.0 Cg_endo -72.96 0.14 8.21 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.201 1.632 . . . . 0.0 110.516 179.907 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -86.26 -13.02 47.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.261 -0.899 . . . . 0.0 109.823 179.699 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -98.46 -49.38 4.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.374 -0.829 . . . . 0.0 110.401 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.984 HD13 HG11 ' A' ' 30' ' ' VAL . 1.2 mp -130.56 137.93 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.327 -0.858 . . . . 0.0 110.324 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.426 ' O ' ' HB3' ' A' ' 40' ' ' HIS . 7.1 ttmt -70.97 -39.72 72.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.409 -0.807 . . . . 0.0 110.411 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.453 ' HA ' ' HB3' ' A' ' 31' ' ' PRO . 0.0 OUTLIER 179.03 159.32 0.61 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.277 -0.889 . . . . 0.0 110.284 179.852 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.9 m -121.03 131.61 54.39 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.225 -0.922 . . . . 0.0 110.045 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -135.2 114.28 12.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -0.924 . . . . 0.0 110.428 -179.829 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.426 HG12 ' HG2' ' A' ' 54' ' ' LYS . 28.3 mt -60.37 138.39 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.185 -0.947 . . . . 0.0 110.031 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.577 HD11 ' HB2' ' A' ' 55' ' ' LYS . 22.8 mt -111.74 -29.28 7.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.917 . . . . 0.0 110.462 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.635 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.8 m95 -125.33 163.89 21.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.216 -0.927 . . . . 0.0 110.698 -179.773 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.447 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 42.06 -138.23 2.58 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -151.15 21.1 0.76 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -1.154 . . . . 0.0 110.208 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 123.3 -18.93 7.73 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.541 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -72.9 -172.83 23.01 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.412 ' HA ' HG22 ' A' ' 71' ' ' ILE . 43.5 Cg_endo -71.72 128.66 14.52 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.993 1.523 . . . . 0.0 110.683 -179.783 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.09 -14.09 48.59 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 -179.487 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -70.87 161.42 31.04 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.554 -0.968 . . . . 0.0 109.647 179.682 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.635 HD12 ' CG ' ' A' ' 45' ' ' TRP . 56.2 mt -130.7 120.7 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.334 -0.854 . . . . 0.0 109.887 179.599 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.891 ' CE ' HD11 ' A' ' 71' ' ' ILE . 58.6 mttm -105.53 140.98 37.79 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.168 -0.957 . . . . 0.0 110.394 -179.716 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.577 ' HB2' HD11 ' A' ' 44' ' ' LEU . 78.0 tttt -106.99 88.58 2.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.313 -0.867 . . . . 0.0 110.159 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.547 ' CG2' HG12 ' A' ' 38' ' ' ILE . 79.0 mt -79.86 137.46 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.265 -0.897 . . . . 0.0 110.15 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.743 ' O ' HG23 ' A' ' 38' ' ' ILE . 5.6 p -109.29 161.78 14.94 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.18 -0.95 . . . . 0.0 110.658 -179.786 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.584 ' HE2' HG13 ' A' ' 67' ' ' VAL . 31.5 m-85 -115.73 128.64 56.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.47 -0.769 . . . . 0.0 110.211 179.777 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.26 -23.91 77.21 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.979 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -94.6 142.52 27.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.295 -1.12 . . . . 0.0 110.238 179.924 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.32 148.68 4.83 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.3 m -59.87 -35.41 74.75 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.321 -1.105 . . . . 0.0 110.159 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -137.07 -83.6 0.35 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.208 -0.933 . . . . 0.0 110.254 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.9 131.7 49.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.23 -0.918 . . . . 0.0 110.312 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.552 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -137.59 119.12 1.8 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 179.678 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 15.4 p90 -158.01 168.56 26.77 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.038 -1.272 . . . . 0.0 110.072 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.934 HG12 ' HA2' ' A' ' 88' ' ' GLY . 7.1 m -139.49 173.32 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.249 -0.907 . . . . 0.0 110.899 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 27.8 mttt -125.13 117.78 24.65 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.372 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.616 ' ND1' HD12 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -103.81 125.39 50.22 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.214 -0.929 . . . . 0.0 111.085 -178.949 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 52' ' ' THR . 25.6 tttt -97.76 106.51 18.83 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.383 -0.823 . . . . 0.0 109.374 179.002 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.891 HD11 ' CE ' ' A' ' 54' ' ' LYS . 43.3 mm -44.35 133.97 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.09 -1.006 . . . . 0.0 110.153 -179.227 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.51 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 46.3 t0 -107.49 -54.11 2.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.481 -0.762 . . . . 0.0 109.899 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.424 ' O ' ' N ' ' A' ' 82' ' ' SER . 5.4 m -172.28 158.25 4.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.453 -0.779 . . . . 0.0 110.277 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 1.126 ' CD1' HG11 ' A' ' 23' ' ' VAL . 4.0 tt -149.77 165.54 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.274 -0.891 . . . . 0.0 110.03 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.549 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 0.6 OUTLIER -133.78 82.06 1.96 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.299 -0.876 . . . . 0.0 110.014 -179.788 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.604 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 90.3 mttt -55.29 -15.14 2.19 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.316 -0.865 . . . . 0.0 110.841 -179.863 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -92.5 -30.4 15.72 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.189 -0.945 . . . . 0.0 109.798 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.502 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 2.0 m120 -111.34 -1.33 16.05 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.552 -0.717 . . . . 0.0 109.63 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.648 ' O ' HD12 ' A' ' 104' ' ' LEU . 10.7 m-85 65.69 48.23 1.98 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.769 -0.582 . . . . 0.0 110.608 -179.864 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.549 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.5 OUTLIER -116.55 148.07 41.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.157 -0.964 . . . . 0.0 109.364 179.386 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.535 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 86.9 t80 -148.45 144.63 27.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.122 -0.987 . . . . 0.0 110.414 -179.261 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.504 ' HB3' ' HG3' ' A' ' 101' ' ' GLU . 4.8 p -151.45 145.23 25.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.271 -0.893 . . . . 0.0 110.349 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.608 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 18.0 p90 -148.13 172.02 14.97 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.219 -0.926 . . . . 0.0 110.471 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.626 HG23 ' O ' ' A' ' 98' ' ' ILE . 97.1 m -122.16 123.58 41.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.344 -0.848 . . . . 0.0 109.964 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.937 HD21 HD11 ' A' ' 91' ' ' LEU . 0.9 OUTLIER -90.61 129.25 36.76 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.148 -0.97 . . . . 0.0 110.249 -179.827 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 16.7 pt -112.03 0.65 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.279 -0.888 . . . . 0.0 110.298 -179.789 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.509 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 57.3 tt0 -145.66 154.87 42.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.272 -0.892 . . . . 0.0 110.171 -179.922 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.934 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 156.9 126.93 0.95 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -64.26 -25.97 68.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.334 -1.097 . . . . 0.0 110.208 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.552 ' O ' ' CE1' ' A' ' 132' ' ' HIS . . . -70.27 -25.44 63.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -0.916 . . . . 0.0 110.122 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.937 HD11 HD21 ' A' ' 85' ' ' LEU . 22.3 mt -64.68 -36.56 84.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.31 -0.868 . . . . 0.0 110.072 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.11 175.69 36.73 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -72.58 -2.29 19.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -1.152 . . . . 0.0 109.967 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 122' ' ' THR . 30.3 p -91.42 -38.8 12.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.895 . . . . 0.0 110.455 -179.866 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.681 HD21 HG13 ' A' ' 128' ' ' ILE . 2.4 mm? -79.88 154.92 28.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.262 -0.899 . . . . 0.0 110.964 -179.453 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.47 ' OE1' ' HB2' ' A' ' 123' ' ' LYS . 37.5 tt0 -142.44 -84.21 0.18 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.13 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.517 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 28.5 mttt -80.42 125.14 29.55 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.705 -0.622 . . . . 0.0 110.595 179.076 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.626 ' O ' HG23 ' A' ' 84' ' ' THR . 3.2 mm -118.02 137.96 50.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 120.575 -1.328 . . . . 0.0 109.151 178.199 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.489 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -118.31 129.67 55.58 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.325 -0.859 . . . . 0.0 109.299 179.306 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.613 ' CE2' HG21 ' A' ' 98' ' ' ILE . 8.8 m-85 -124.13 132.63 53.66 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.42 -0.8 . . . . 0.0 110.236 -179.282 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.504 ' HG3' ' HB3' ' A' ' 82' ' ' SER . 76.9 tt0 -134.5 138.7 44.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.18 -0.95 . . . . 0.0 110.21 179.776 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 90.5 m -141.34 125.51 17.39 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.161 -0.962 . . . . 0.0 110.199 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.468 ' HG3' ' HB3' ' A' ' 80' ' ' SER . 1.0 OUTLIER -116.86 149.42 40.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.881 . . . . 0.0 110.114 179.818 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.648 HD12 ' O ' ' A' ' 79' ' ' TYR . 14.7 mt -123.24 148.86 45.43 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.199 -0.938 . . . . 0.0 110.622 -179.957 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.685 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -149.5 -168.91 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.408 -0.807 . . . . 0.0 109.419 179.546 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.685 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -136.92 141.52 42.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.13 -0.981 . . . . 0.0 110.873 179.9 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.537 ' CB ' ' HD2' ' A' ' 108' ' ' PRO . 0.8 OUTLIER -91.79 -179.91 1.22 Allowed Pre-proline 0 C--N 1.302 -1.477 0 O-C-N 121.533 -0.729 . . . . 0.0 109.374 179.183 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.537 ' HD2' ' CB ' ' A' ' 107' ' ' SER . 40.7 Cg_endo -66.54 85.09 0.28 Allowed 'Trans proline' 0 C--N 1.303 -1.861 0 O-C-N 123.649 1.342 . . . . 0.0 109.646 179.376 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 108' ' ' PRO . 4.0 p 44.38 37.41 2.01 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.423 -0.798 . . . . 0.0 109.735 -178.994 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -125.75 38.16 2.33 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 11' ' ' SER . . . 98.11 -138.75 14.07 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 -179.495 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.531 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 3.7 p -149.43 143.38 25.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.279 -1.13 . . . . 0.0 109.835 179.653 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.558 HG12 HG22 ' A' ' 10' ' ' THR . 35.9 mt -91.4 147.9 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.24 -0.912 . . . . 0.0 110.307 -179.74 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.583 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 7.6 mt -134.02 111.62 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.186 -0.946 . . . . 0.0 110.208 -179.912 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 48.4 tttt -97.08 137.67 35.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.231 -0.918 . . . . 0.0 110.239 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 0.8 OUTLIER -134.44 154.55 51.33 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 0.0 110.376 -179.887 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.473 ' HB ' ' HB3' ' A' ' 101' ' ' GLU . 8.8 m -146.58 158.21 43.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.33 -0.856 . . . . 0.0 110.188 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 99.4 p -151.28 134.96 16.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 110.393 -179.9 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.959 ' CE1' HG23 ' A' ' 4' ' ' THR . 55.4 m-70 -120.78 147.9 44.71 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.287 -0.883 . . . . 0.0 110.384 -179.92 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.931 ' C ' HG23 ' A' ' 2' ' ' VAL . 9.3 m-85 -122.4 118.78 29.2 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.268 -0.895 . . . . 0.0 111.161 -179.445 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.955 ' CE1' HG11 ' A' ' 2' ' ' VAL . 90.0 m-70 -104.12 109.69 21.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.073 -1.017 . . . . 0.0 109.353 178.331 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.552 ' CG2' HG23 ' A' ' 126' ' ' VAL . 0.6 OUTLIER -88.95 136.5 32.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.294 -0.879 . . . . 0.0 110.866 -179.107 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.47 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 25.3 tttt -109.37 129.49 55.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.484 -0.76 . . . . 0.0 110.1 179.545 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.471 ' O ' ' CB ' ' A' ' 125' ' ' ASN . . . 110.44 15.33 11.47 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 9.1 t30 67.82 54.27 0.64 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.265 -1.138 . . . . 0.0 110.33 179.907 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.552 HG23 ' CG2' ' A' ' 122' ' ' THR . 20.3 m -133.4 160.34 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.351 -0.843 . . . . 0.0 109.948 179.744 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -121.3 162.16 20.77 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.225 -0.922 . . . . 0.0 110.576 -179.724 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.681 HG13 HD21 ' A' ' 95' ' ' LEU . 2.9 mp -83.95 173.45 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.393 -0.817 . . . . 0.0 109.96 179.766 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.604 ' N ' HG22 ' A' ' 128' ' ' ILE . 32.4 mttt -108.67 133.79 52.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.413 -0.804 . . . . 0.0 109.894 179.835 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -46.51 -36.26 6.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.183 -0.948 . . . . 0.0 110.198 -179.887 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -63.31 -29.94 71.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 110.09 179.885 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.552 ' CE1' ' O ' ' A' ' 90' ' ' ALA . 14.5 t-160 -78.18 -51.3 10.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 110.222 179.905 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.784 HG11 ' CE2' ' A' ' 5' ' ' TYR . 43.0 t -64.28 -43.45 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.356 -0.84 . . . . 0.0 110.098 179.882 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 7.1 tptm -67.1 -45.87 75.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 110.154 179.888 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.439 ' O ' ' HG3' ' A' ' 139' ' ' LYS . . . -62.27 -30.06 70.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.212 -0.93 . . . . 0.0 110.035 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.58 -29.39 69.78 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 83.5 mttt -66.99 -33.9 76.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.213 -1.169 . . . . 0.0 110.077 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -81.7 -29.93 32.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.892 . . . . 0.0 110.104 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.439 ' HG3' ' O ' ' A' ' 135' ' ' ALA . 93.9 mttt -67.29 -41.5 85.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.33 -0.856 . . . . 0.0 110.069 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.16 -41.0 51.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.198 -0.939 . . . . 0.0 110.065 179.847 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 137' ' ' LYS . 48.8 m -56.99 -48.17 79.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.453 -0.78 . . . . 0.0 110.031 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -55.52 -42.33 74.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.185 -0.947 . . . . 0.0 110.095 179.793 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.436 ' O ' HG13 ' A' ' 147' ' ' ILE . 61.4 mt -61.52 -40.77 95.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 109.976 179.869 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -60.56 -37.77 82.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.407 -0.808 . . . . 0.0 109.878 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.431 ' HA ' ' OE1' ' A' ' 148' ' ' GLU . 87.8 mttt -71.67 -17.5 62.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.317 -0.864 . . . . 0.0 110.039 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.542 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 34.4 mt -84.11 -35.92 23.34 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.281 -0.887 . . . . 0.0 108.967 179.386 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.96 ' CG2' HD23 ' A' ' 18' ' ' LEU . 53.4 mt -72.27 -42.46 65.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 119.678 -0.809 . . . . 0.0 108.836 178.735 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.753 ' HB3' HD13 ' A' ' 13' ' ' ILE . 69.4 mt-10 -56.18 -39.11 71.89 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.479 -0.763 . . . . 0.0 109.409 179.03 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.5 m -73.99 -24.43 59.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.944 . . . . 0.0 109.617 179.415 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.648 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 80.3 t80 -64.68 -49.3 71.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.383 -0.823 . . . . 0.0 110.083 179.822 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.12 HD21 ' CE2' ' A' ' 158' ' ' TYR . 84.8 mt -79.94 -29.34 39.67 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.225 -0.922 . . . . 0.0 110.059 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.683 ' HB2' HD11 ' A' ' 13' ' ' ILE . 78.3 tttt -70.21 -27.14 64.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.33 -0.856 . . . . 0.0 109.594 179.523 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.483 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -104.04 -33.27 4.07 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.718 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.451 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 3.7 m80 -107.12 92.34 7.72 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.354 -1.086 . . . . 0.0 109.982 179.734 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 48.4 Cg_endo -74.23 6.35 3.1 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.04 1.547 . . . . 0.0 111.075 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -107.06 -4.94 18.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.999 -1.063 . . . . 0.0 109.756 179.772 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.67 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -75.18 102.44 4.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.411 -0.806 . . . . 0.0 110.019 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 1.12 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.4 OUTLIER 34.86 32.18 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.69 -0.631 . . . . 0.0 110.572 -179.521 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.565 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.71 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 1.043 HG23 ' C ' ' A' ' 120' ' ' TYR . 3.0 p -82.86 153.84 3.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.253 -1.145 . . . . 0.0 110.122 -179.917 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.791 ' CE1' HD12 ' A' ' 128' ' ' ILE . 8.4 m-85 -89.23 170.16 10.83 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.329 -0.857 . . . . 0.0 110.014 -179.658 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.815 HG23 ' CE1' ' A' ' 119' ' ' HIS . 50.0 m -137.76 107.56 6.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.111 -0.993 . . . . 0.0 110.364 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.185 ' CE1' HG21 ' A' ' 133' ' ' VAL . 47.7 m-85 -112.21 136.67 51.34 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.182 -0.949 . . . . 0.0 110.109 179.804 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 20.8 pt-20 -129.84 152.1 49.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.222 -0.924 . . . . 0.0 110.537 -179.794 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.3 t -139.28 156.22 47.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.401 -0.812 . . . . 0.0 109.902 179.791 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -147.62 124.37 11.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.154 -0.966 . . . . 0.0 110.391 -179.873 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.637 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.3 p90 -151.6 -176.38 5.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.388 -0.82 . . . . 0.0 109.892 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.849 HG22 ' HA ' ' A' ' 113' ' ' ILE . 8.8 p -141.74 174.41 10.6 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.114 -0.991 . . . . 0.0 110.661 -179.642 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.5 t -153.08 159.08 42.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.428 -0.795 . . . . 0.0 110.155 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -81.94 -20.48 38.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.234 -0.916 . . . . 0.0 110.237 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.834 HG23 ' HD2' ' A' ' 14' ' ' PRO . 8.1 mm -80.11 150.68 71.88 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.334 -0.854 . . . . 0.0 109.98 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.834 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.0 Cg_endo -65.55 143.09 74.07 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.073 1.565 . . . . 0.0 110.789 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.666 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 41.5 Cg_endo -73.34 -30.69 9.99 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 124.109 1.584 . . . . 0.0 113.066 -179.501 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.666 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.3 Cg_endo -69.9 -23.38 30.23 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 O-C-N 122.471 0.722 . . . . 0.0 110.228 -179.899 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.579 ' NH2' ' HA ' ' A' ' 159' ' ' ASN . 2.1 mtp180 -85.16 -43.48 13.8 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.108 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.749 HD23 ' C ' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -69.89 -30.27 67.66 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.845 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.54 ' N ' HD23 ' A' ' 18' ' ' LEU . 50.7 t80 -68.58 -53.7 21.23 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.393 -0.817 . . . . 0.0 109.549 179.126 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.55 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 10.8 mttt -53.41 -33.86 55.54 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.681 -0.807 . . . . 0.0 109.181 179.568 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.063 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -76.4 -53.65 7.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.485 -0.759 . . . . 0.0 111.158 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 1.072 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -60.0 -46.08 90.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.501 -0.749 . . . . 0.0 111.922 -178.429 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.642 HG13 ' CE1' ' A' ' 81' ' ' TYR . 3.3 t -100.88 -60.6 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.886 -1.134 . . . . 0.0 111.847 -178.665 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.614 ' N ' HD12 ' A' ' 24' ' ' LEU . 6.8 mp -67.96 -5.36 16.68 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.172 -0.955 . . . . 0.0 111.647 -178.494 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.68 ' HB3' HD23 ' A' ' 29' ' ' LEU . 1.1 m-20 -149.04 30.14 0.79 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.669 -1.269 . . . . 0.0 110.946 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 1.072 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -70.05 -23.88 63.17 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.21 -0.931 . . . . 0.0 110.675 179.798 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -69.68 -17.52 63.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.08 -1.013 . . . . 0.0 109.774 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.533 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 4.1 p-10 -129.42 13.28 6.03 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.375 -0.828 . . . . 0.0 109.774 179.597 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.695 HD21 ' CZ ' ' A' ' 158' ' ' TYR . 0.3 OUTLIER -94.37 -49.16 5.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.437 -0.789 . . . . 0.0 110.138 179.812 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.974 HG21 HD13 ' A' ' 38' ' ' ILE . 5.8 p -73.2 -28.87 1.01 Allowed Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.141 -0.974 . . . . 0.0 112.051 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.848 ' HD3' HG12 ' A' ' 30' ' ' VAL . 52.1 Cg_endo -79.56 1.21 9.39 Favored 'Trans proline' 0 C--N 1.319 -1.019 0 O-C-N 122.717 0.851 . . . . 0.0 110.263 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.437 ' HD2' ' O ' ' A' ' 28' ' ' ASN . 51.8 mttm -124.68 -30.0 3.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.292 -0.88 . . . . 0.0 109.869 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.617 HD11 ' CD1' ' A' ' 29' ' ' LEU . 10.8 mt -77.57 -39.14 26.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.482 -0.761 . . . . 0.0 109.76 179.822 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -170.24 102.27 0.44 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.417 -0.802 . . . . 0.0 110.14 179.871 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.78 1.2 7.27 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.066 1.561 . . . . 0.0 110.647 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -87.27 -8.64 56.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.099 -1.0 . . . . 0.0 110.039 179.916 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.31 -51.02 3.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.312 -0.868 . . . . 0.0 110.308 -179.929 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.974 HD13 HG21 ' A' ' 30' ' ' VAL . 1.1 mp -127.11 138.87 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.426 -0.796 . . . . 0.0 110.11 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.43 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 37.7 ttmt -73.85 -40.53 63.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.318 -0.864 . . . . 0.0 110.098 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -178.49 156.11 0.9 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.336 -0.852 . . . . 0.0 110.252 179.752 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.4 m -120.0 119.93 34.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.23 -0.919 . . . . 0.0 109.996 179.889 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.518 ' O ' HD12 ' A' ' 44' ' ' LEU . 35.0 tp10 -124.25 114.39 19.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.289 -0.882 . . . . 0.0 110.387 -179.923 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.467 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 21.4 mt -60.04 145.03 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.189 -0.945 . . . . 0.0 110.069 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.518 HD12 ' O ' ' A' ' 42' ' ' GLU . 4.8 mp -121.77 -27.29 4.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.224 -0.923 . . . . 0.0 110.328 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.627 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.6 m95 -123.78 163.19 21.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.272 -0.893 . . . . 0.0 110.482 -179.833 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.431 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 43.12 -138.37 3.39 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.81 23.52 0.51 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.309 -1.112 . . . . 0.0 109.994 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 121.73 -13.9 9.23 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.481 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -81.54 -169.61 42.65 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.85 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.436 ' HA ' HG22 ' A' ' 71' ' ' ILE . 45.0 Cg_endo -72.79 129.5 14.53 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 124.086 1.572 . . . . 0.0 110.557 -179.905 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.49 -12.95 51.16 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 -179.569 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.544 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -71.52 161.3 31.24 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.589 -0.948 . . . . 0.0 109.374 179.635 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.627 HD12 ' CG ' ' A' ' 45' ' ' TRP . 58.3 mt -134.29 120.37 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.242 -0.911 . . . . 0.0 109.971 179.683 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 96.0 mttt -107.3 128.95 54.91 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.164 -0.96 . . . . 0.0 110.56 -179.595 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -93.01 91.38 7.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -0.881 . . . . 0.0 109.768 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.555 ' CG2' HG12 ' A' ' 38' ' ' ILE . 96.7 mt -80.02 144.11 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.2 -0.937 . . . . 0.0 110.212 -179.753 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.515 ' O ' HG23 ' A' ' 38' ' ' ILE . 7.2 p -117.62 163.73 16.01 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.201 -0.937 . . . . 0.0 110.744 -179.649 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.568 ' HE2' HG13 ' A' ' 67' ' ' VAL . 28.6 m-85 -122.4 141.38 51.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.323 -0.861 . . . . 0.0 110.118 179.283 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -88.56 38.14 3.23 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -49.09 -26.59 2.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.287 -1.125 . . . . 0.0 110.148 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.62 -143.06 13.71 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.98 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 21.4 m -61.8 -42.93 99.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.182 -1.187 . . . . 0.0 110.201 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -58.87 148.48 29.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.296 -0.878 . . . . 0.0 110.142 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -89.25 125.51 35.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.234 -0.917 . . . . 0.0 110.303 -179.911 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -138.67 102.27 0.35 Allowed Glycine 0 N--CA 1.487 2.096 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 179.669 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.543 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 13.9 p90 -143.44 166.7 24.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.218 -1.166 . . . . 0.0 110.175 -179.685 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.885 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.1 m -139.35 174.13 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.354 -0.841 . . . . 0.0 110.618 179.78 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.517 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 20.1 mttt -125.56 122.04 35.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.529 -0.732 . . . . 0.0 109.642 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.773 ' CE1' HD13 ' A' ' 85' ' ' LEU . 0.5 OUTLIER -108.56 123.75 49.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.179 -0.951 . . . . 0.0 110.854 -179.436 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 52' ' ' THR . 18.9 tttm -97.65 116.09 29.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.258 -0.901 . . . . 0.0 109.79 179.428 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.523 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 23.6 mm -58.04 132.43 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.994 -1.066 . . . . 0.0 110.365 -179.563 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 82' ' ' SER . 94.1 m-20 -105.34 -42.76 5.16 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.372 -0.83 . . . . 0.0 109.889 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.2 m -175.09 159.67 2.63 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.389 -0.82 . . . . 0.0 109.948 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.492 HG12 HG11 ' A' ' 23' ' ' VAL . 2.2 mt -138.62 159.84 30.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.193 -0.942 . . . . 0.0 110.209 179.97 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 79' ' ' TYR . 5.6 m-20 -137.58 80.56 1.81 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.489 -0.757 . . . . 0.0 110.392 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.433 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 22.3 tttt -63.28 -18.9 64.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.133 -0.979 . . . . 0.0 110.259 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -91.6 -32.24 15.58 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.275 -0.89 . . . . 0.0 109.363 179.755 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.503 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.5 m120 -101.25 -4.13 27.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.643 -0.661 . . . . 0.0 109.604 179.619 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.588 ' CE1' ' HB3' ' A' ' 16' ' ' PRO . 85.2 m-85 60.43 55.44 3.49 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.454 0.645 . . . . 0.0 110.581 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.487 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -129.93 165.61 21.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.434 -0.791 . . . . 0.0 109.876 179.495 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.696 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 42.6 t80 -149.71 143.79 25.68 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.219 -0.925 . . . . 0.0 109.903 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.464 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 25.9 m -148.76 131.45 15.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.122 -0.986 . . . . 0.0 111.223 -179.724 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.696 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 9.1 p90 -144.36 175.66 9.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.35 -0.844 . . . . 0.0 110.064 179.041 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 98' ' ' ILE . 27.1 m -127.25 128.42 45.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.348 -0.845 . . . . 0.0 109.824 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.773 HD13 ' CE1' ' A' ' 69' ' ' HIS . 7.4 tp -95.39 125.31 39.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.093 -1.004 . . . . 0.0 110.077 -179.85 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.6 pt -109.79 -12.65 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.244 -0.91 . . . . 0.0 110.333 -179.565 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.566 ' O ' HD11 ' A' ' 91' ' ' LEU . 18.0 tt0 -124.64 172.84 8.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 0.0 110.191 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.885 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 137.58 112.08 1.09 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.984 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -56.42 -16.83 6.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.319 -1.106 . . . . 0.0 110.205 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.63 -17.71 57.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 0.0 110.146 179.87 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.566 HD11 ' O ' ' A' ' 87' ' ' GLU . 65.7 mt -66.78 -23.82 66.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.284 -0.885 . . . . 0.0 110.209 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 50.56 -179.69 0.03 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -79.96 6.45 11.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.303 -1.116 . . . . 0.0 110.206 179.897 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.498 ' O ' HG21 ' A' ' 126' ' ' VAL . 39.4 p -94.36 -31.55 13.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.236 -0.915 . . . . 0.0 110.238 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.86 HD21 HD11 ' A' ' 128' ' ' ILE . 83.6 mt -107.29 163.93 12.61 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.351 -0.843 . . . . 0.0 110.092 179.929 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.466 ' HG2' ' N ' ' A' ' 97' ' ' LYS . 61.4 tt0 -144.77 -82.85 0.15 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.299 -0.876 . . . . 0.0 109.668 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.495 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 18.7 mttt -80.37 131.57 35.64 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.778 -0.576 . . . . 0.0 110.343 179.683 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.791 HG21 ' CE2' ' A' ' 100' ' ' TYR . 4.7 mm -119.53 138.67 49.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 120.845 -1.16 . . . . 0.0 109.63 178.93 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.476 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.3 m -118.85 123.27 44.31 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 119.711 -0.795 . . . . 0.0 108.985 178.786 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.791 ' CE2' HG21 ' A' ' 98' ' ' ILE . 13.0 m-85 -119.27 132.61 55.93 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.39 -0.819 . . . . 0.0 110.322 -179.076 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.467 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 85.1 tt0 -132.07 140.26 48.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.263 -0.898 . . . . 0.0 110.061 179.788 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.468 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 32.6 m -133.01 153.95 50.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.924 . . . . 0.0 109.929 179.939 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.477 ' O ' ' N ' ' A' ' 115' ' ' LYS . 7.7 mttt -149.66 133.05 16.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.143 -0.973 . . . . 0.0 110.456 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.87 HD23 HG12 ' A' ' 114' ' ' ILE . 3.5 mt -115.42 152.49 32.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.196 -0.94 . . . . 0.0 110.03 179.812 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.696 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.8 t -151.38 -169.52 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.227 -0.921 . . . . 0.0 110.185 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.696 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -124.52 145.64 49.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.35 -0.844 . . . . 0.0 110.305 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.443 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.3 p -103.8 171.12 5.39 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.281 -0.887 . . . . 0.0 110.2 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.443 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 45.7 Cg_endo -72.54 -13.79 27.53 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.074 1.565 . . . . 0.0 110.585 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 67.8 m -95.84 11.64 32.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.188 -0.945 . . . . 0.0 110.354 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 91.34 -34.93 4.1 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.847 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -55.18 -172.07 0.08 OUTLIER Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.785 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.52 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 1.4 p -134.98 134.19 40.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.124 -1.221 . . . . 0.0 110.387 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.849 ' HA ' HG22 ' A' ' 10' ' ' THR . 15.4 mt -85.74 147.12 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.37 -0.831 . . . . 0.0 109.91 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.87 HG12 HD23 ' A' ' 104' ' ' LEU . 19.4 mt -131.1 110.8 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.166 -0.959 . . . . 0.0 110.407 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 103' ' ' LYS . 63.3 tttm -97.93 134.87 40.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.191 -0.943 . . . . 0.0 109.683 179.444 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.67 147.99 51.51 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.219 -0.926 . . . . 0.0 110.354 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' A' ' 101' ' ' GLU . 32.9 m -148.54 148.06 29.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.4 -0.812 . . . . 0.0 110.292 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 88.5 p -148.36 155.08 40.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.29 -0.881 . . . . 0.0 110.136 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.815 ' CE1' HG23 ' A' ' 4' ' ' THR . 34.1 m-70 -139.14 129.81 26.0 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.168 -0.958 . . . . 0.0 110.373 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 1.043 ' C ' HG23 ' A' ' 2' ' ' VAL . 3.6 m-30 -99.56 120.58 39.88 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.279 -0.888 . . . . 0.0 110.599 -179.555 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.565 ' CE1' HG21 ' A' ' 2' ' ' VAL . 82.4 m-70 -95.51 107.56 19.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.196 -0.94 . . . . 0.0 109.674 179.074 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.6 p -77.81 157.39 29.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.917 . . . . 0.0 110.174 -179.854 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 37.6 tttt -114.46 114.0 25.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.193 -0.942 . . . . 0.0 110.237 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 93.26 -132.7 11.35 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -115.72 77.19 1.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.215 -1.168 . . . . 0.0 110.147 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.498 HG21 ' O ' ' A' ' 94' ' ' THR . 32.8 m -142.02 154.39 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.178 -0.951 . . . . 0.0 110.242 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -132.05 164.22 26.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.234 -0.916 . . . . 0.0 110.214 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.86 HD11 HD21 ' A' ' 95' ' ' LEU . 3.2 mp -92.05 171.83 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.154 -0.966 . . . . 0.0 110.375 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.623 ' N ' HG22 ' A' ' 128' ' ' ILE . 60.8 mmtt -113.71 129.98 56.49 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.481 -0.762 . . . . 0.0 109.768 179.742 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.505 ' O ' ' CB ' ' A' ' 134' ' ' LYS . 92.4 mt-10 -43.24 -50.63 6.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.134 -0.979 . . . . 0.0 110.026 -179.841 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -48.28 -23.53 0.92 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.208 -0.933 . . . . 0.0 109.892 179.702 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -87.49 -64.66 1.11 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.302 -0.874 . . . . 0.0 110.322 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 1.185 HG21 ' CE1' ' A' ' 5' ' ' TYR . 2.4 p -65.75 -28.48 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.394 -0.817 . . . . 0.0 110.086 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.505 ' CB ' ' O ' ' A' ' 130' ' ' GLU . 13.6 tptt -72.64 -48.79 36.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.163 -0.961 . . . . 0.0 109.937 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.62 -25.11 67.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.328 -0.858 . . . . 0.0 110.065 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.17 -31.34 69.15 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.843 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -64.92 -32.72 74.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.264 -1.139 . . . . 0.0 110.106 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -79.67 -40.24 29.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.334 -0.854 . . . . 0.0 110.005 179.81 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -69.71 -34.27 73.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.304 -0.873 . . . . 0.0 109.87 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.01 -35.39 66.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.323 -0.861 . . . . 0.0 109.885 179.718 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 48.0 m -66.48 -42.95 86.69 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.276 -0.89 . . . . 0.0 109.939 179.701 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -56.36 -48.96 75.77 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.273 -0.892 . . . . 0.0 109.932 179.81 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.611 HD13 ' O ' ' A' ' 143' ' ' LEU . 0.6 OUTLIER -55.8 -44.25 77.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.346 -0.846 . . . . 0.0 109.866 179.817 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.519 ' HA ' HD12 ' A' ' 147' ' ' ILE . 13.7 m-85 -55.81 -39.68 71.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.431 -0.793 . . . . 0.0 109.834 179.715 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.452 ' HA ' ' OE1' ' A' ' 148' ' ' GLU . 95.8 mttt -73.21 -12.46 60.88 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.405 -0.81 . . . . 0.0 110.229 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.481 HD12 HD22 ' A' ' 143' ' ' LEU . 16.3 mt -83.77 -36.02 23.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.16 -0.962 . . . . 0.0 108.989 179.396 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.623 HD11 ' CE1' ' A' ' 22' ' ' PHE . 19.9 mt -69.66 -45.51 77.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.94 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.491 ' O ' HG13 ' A' ' 13' ' ' ILE . 38.8 mt-10 -58.98 -43.12 91.33 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.702 -0.799 . . . . 0.0 109.471 179.113 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 17.9 m -66.26 -24.49 66.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.291 -0.88 . . . . 0.0 109.564 179.453 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.602 ' CD1' HG12 ' A' ' 33' ' ' ILE . 81.8 t80 -67.02 -46.99 72.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.508 -0.745 . . . . 0.0 109.952 179.794 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.171 HD21 ' CE2' ' A' ' 158' ' ' TYR . 68.4 mt -79.74 -30.22 40.8 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.141 -0.975 . . . . 0.0 110.006 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.538 ' HB2' ' CG1' ' A' ' 13' ' ' ILE . 21.0 tttm -71.23 -25.83 62.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.899 . . . . 0.0 109.289 179.062 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.422 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -102.9 -33.51 4.34 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.119 -1.593 . . . . 0.0 109.119 179.543 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.447 ' HB2' ' O ' ' A' ' 150' ' ' TYR . 3.3 m80 -108.61 92.76 10.69 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.277 -1.131 . . . . 0.0 109.933 179.692 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 46.9 Cg_endo -74.01 6.23 3.07 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.033 1.544 . . . . 0.0 111.168 -179.864 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -108.71 0.09 20.34 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.965 -1.084 . . . . 0.0 109.937 179.782 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.68 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -83.13 102.14 11.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.303 -0.873 . . . . 0.0 110.048 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 1.171 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.3 OUTLIER 35.67 31.27 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.725 -0.609 . . . . 0.0 110.184 -179.377 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.579 ' HA ' ' NH2' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.714 -179.723 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.997 HG23 ' C ' ' A' ' 120' ' ' TYR . 3.0 p -79.98 150.87 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.375 -1.073 . . . . 0.0 110.503 -179.795 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.517 ' CE2' HG12 ' A' ' 128' ' ' ILE . 3.9 m-85 -87.75 175.41 7.87 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.446 -0.784 . . . . 0.0 110.025 -179.87 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.881 HG23 ' CE1' ' A' ' 119' ' ' HIS . 44.8 m -147.56 101.97 3.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.115 -0.991 . . . . 0.0 110.463 179.899 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.427 ' CD1' HG13 ' A' ' 133' ' ' VAL . 88.0 m-85 -112.67 127.19 56.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.293 -0.879 . . . . 0.0 109.976 179.811 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.584 ' CG ' ' N ' ' A' ' 7' ' ' SER . 17.2 tt0 -110.66 175.48 5.41 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.265 -0.897 . . . . 0.0 109.95 -179.544 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.584 ' N ' ' CG ' ' A' ' 6' ' ' GLU . 0.2 OUTLIER -156.71 166.76 32.48 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.716 -0.615 . . . . 0.0 109.634 179.756 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.421 ' HG3' ' HG3' ' A' ' 115' ' ' LYS . 1.4 tt0 -156.53 132.3 9.59 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.983 -1.073 . . . . 0.0 110.955 -179.849 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.625 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 2.9 p90 -155.9 -175.82 5.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.505 -0.747 . . . . 0.0 109.581 179.43 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.511 HG22 ' HA ' ' A' ' 113' ' ' ILE . 23.4 p -134.7 179.23 6.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.019 -1.051 . . . . 0.0 110.887 -179.559 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.654 ' OG ' HD11 ' A' ' 114' ' ' ILE . 87.7 p -159.99 139.08 10.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.572 -0.705 . . . . 0.0 110.06 179.76 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -67.15 -29.85 69.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.129 -0.982 . . . . 0.0 110.287 -179.815 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 1.026 HD13 ' HB3' ' A' ' 148' ' ' GLU . 1.8 mp -71.7 151.8 93.47 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.291 -0.881 . . . . 0.0 109.793 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.825 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.3 Cg_endo -66.44 141.63 62.33 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 124.072 1.564 . . . . 0.0 110.522 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.633 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.9 Cg_endo -73.23 -30.4 10.49 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 124.092 1.575 . . . . 0.0 113.085 -179.256 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.6 Cg_endo -71.79 -21.65 24.7 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 N-CA-C 110.178 -0.739 . . . . 0.0 110.178 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.484 ' HD3' ' CG ' ' A' ' 14' ' ' PRO . 44.8 mtp180 -84.77 -46.04 11.78 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.084 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.771 HD23 ' C ' ' A' ' 18' ' ' LEU . 1.1 tt -67.81 -29.99 69.3 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.755 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.489 ' N ' HD23 ' A' ' 18' ' ' LEU . 76.3 t80 -66.84 -57.13 7.61 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.459 -0.776 . . . . 0.0 109.3 178.748 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.554 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 9.8 mttp -48.76 -36.74 17.17 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.266 179.441 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.046 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -74.69 -43.2 56.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.427 -0.795 . . . . 0.0 110.779 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.983 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -68.45 -48.24 65.06 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.521 -0.737 . . . . 0.0 111.672 -178.45 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.62 HG13 ' CE1' ' A' ' 81' ' ' TYR . 3.5 t -100.3 -51.87 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.835 -1.166 . . . . 0.0 111.603 -178.944 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.725 ' N ' HD12 ' A' ' 24' ' ' LEU . 7.2 mp -77.79 0.02 25.32 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.116 -0.99 . . . . 0.0 111.265 -179.015 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.597 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -154.15 30.92 0.44 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.97 -1.081 . . . . 0.0 110.515 179.881 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.983 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -67.33 -29.57 69.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.233 -0.917 . . . . 0.0 109.999 179.778 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -69.26 -15.6 63.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 0.0 110.069 179.98 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.482 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 78.8 m-20 -125.86 9.81 7.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -0.904 . . . . 0.0 110.196 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.798 HD21 ' CZ ' ' A' ' 158' ' ' TYR . 0.5 OUTLIER -100.34 -48.8 4.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.907 . . . . 0.0 110.245 179.906 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 1.128 HG11 HD13 ' A' ' 38' ' ' ILE . 2.9 t -74.46 -42.15 5.07 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.43 -0.793 . . . . 0.0 110.974 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 47.7 Cg_endo -78.15 9.01 3.24 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.499 1.263 . . . . 0.0 110.626 -179.919 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 28' ' ' ASN . 33.7 mttt -127.11 -37.27 2.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.185 -0.947 . . . . 0.0 109.464 179.678 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.54 HG12 ' CD1' ' A' ' 150' ' ' TYR . 6.8 mt -80.04 -39.44 19.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.537 -0.727 . . . . 0.0 109.562 179.536 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.422 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . . . -155.12 100.33 2.31 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.378 -0.827 . . . . 0.0 110.189 179.819 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 34' ' ' ALA . 46.3 Cg_endo -72.21 -0.85 9.22 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.978 1.515 . . . . 0.0 110.632 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -84.47 -8.0 59.09 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.102 -0.999 . . . . 0.0 109.816 179.75 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.662 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -98.24 -63.4 1.13 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.303 -0.873 . . . . 0.0 110.234 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 1.128 HD13 HG11 ' A' ' 30' ' ' VAL . 2.0 mp -115.56 137.56 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.378 -0.826 . . . . 0.0 110.191 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 57' ' ' THR . 13.7 ttpt -84.66 -19.2 33.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.381 -0.824 . . . . 0.0 110.207 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.456 ' O ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER 178.69 159.85 0.59 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.204 -0.935 . . . . 0.0 109.962 -179.961 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -135.4 126.13 27.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.366 -0.834 . . . . 0.0 109.936 179.798 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.428 ' HB3' ' HE1' ' A' ' 40' ' ' HIS . 36.9 tt0 -139.92 113.42 8.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.234 -0.916 . . . . 0.0 110.55 -179.826 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.4 mt -53.87 142.22 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.262 -0.899 . . . . 0.0 109.861 179.535 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.607 HD23 ' CB ' ' A' ' 55' ' ' LYS . 0.4 OUTLIER -114.64 -30.05 6.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.107 -0.996 . . . . 0.0 110.455 -179.862 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.876 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.7 m95 -126.48 164.97 19.99 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.261 -0.899 . . . . 0.0 110.416 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.445 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 41.78 -135.65 3.19 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.745 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.11 22.68 0.5 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.28 -1.13 . . . . 0.0 110.093 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 121.59 -19.14 8.57 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.964 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.475 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -71.82 -171.57 15.2 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.416 ' HA ' HG22 ' A' ' 71' ' ' ILE . 45.9 Cg_endo -73.19 129.11 13.65 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 123.939 1.494 . . . . 0.0 110.478 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.74 -14.0 53.35 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.499 -1.84 . . . . 0.0 108.499 -179.392 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.548 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -70.48 160.96 31.45 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.613 -0.933 . . . . 0.0 109.381 179.536 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.876 HD12 ' CG ' ' A' ' 45' ' ' TRP . 57.6 mt -128.99 119.54 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.221 -0.924 . . . . 0.0 110.059 179.782 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.926 ' HE3' HD11 ' A' ' 71' ' ' ILE . 20.6 mttm -101.2 129.82 47.19 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.292 -0.88 . . . . 0.0 110.134 -179.892 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.607 ' CB ' HD23 ' A' ' 44' ' ' LEU . 34.7 ttpt -100.79 91.84 4.8 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.21 -0.931 . . . . 0.0 110.155 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.474 ' HB ' HG23 ' A' ' 67' ' ' VAL . 88.8 mt -80.07 144.16 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.894 . . . . 0.0 110.208 -179.948 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.499 ' O ' ' N ' ' A' ' 39' ' ' LYS . 1.0 OUTLIER -113.87 150.97 32.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.312 -0.867 . . . . 0.0 110.303 -179.997 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.609 ' HE2' HG13 ' A' ' 67' ' ' VAL . 20.8 m-85 -115.47 147.55 40.48 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.269 -0.894 . . . . 0.0 110.142 179.744 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -103.71 14.93 53.19 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -129.59 163.26 26.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.167 -1.196 . . . . 0.0 110.26 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 62' ' ' SER . . . 88.95 -152.5 22.97 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.446 ' O ' ' O ' ' A' ' 61' ' ' GLY . 91.8 p -54.03 -168.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.186 -1.184 . . . . 0.0 110.116 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -73.3 -36.19 66.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.22 -0.925 . . . . 0.0 110.196 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -117.79 111.85 19.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.287 -0.883 . . . . 0.0 110.209 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.577 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -131.8 84.88 0.3 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.533 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 11.7 p90 -128.12 163.17 25.22 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.23 -1.159 . . . . 0.0 110.262 -179.658 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.627 HG12 ' CA ' ' A' ' 88' ' ' GLY . 5.3 m -136.08 175.66 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.369 -0.832 . . . . 0.0 110.251 179.496 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.711 ' O ' HD12 ' A' ' 85' ' ' LEU . 26.8 mttm -135.56 104.87 5.97 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.382 -0.824 . . . . 0.0 109.829 179.754 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.994 ' CD2' HD13 ' A' ' 85' ' ' LEU . 14.2 m170 -95.6 130.08 42.58 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.301 -0.874 . . . . 0.0 111.121 -179.317 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 52' ' ' THR . 31.6 tttt -96.88 113.91 25.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.332 -0.855 . . . . 0.0 109.331 179.034 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.926 HD11 ' HE3' ' A' ' 54' ' ' LYS . 28.9 mm -53.52 131.11 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.197 -0.939 . . . . 0.0 110.313 -179.421 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 82' ' ' SER . 86.1 m-20 -106.09 -46.66 4.03 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.405 -0.809 . . . . 0.0 110.332 -179.799 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 48.0 m -164.94 159.15 17.83 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.324 -0.86 . . . . 0.0 110.039 -179.793 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.468 HG12 HG11 ' A' ' 23' ' ' VAL . 1.7 mt -145.23 157.9 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.189 -0.944 . . . . 0.0 110.655 -179.881 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.559 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 2.2 m-20 -136.93 80.0 1.79 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.611 -0.681 . . . . 0.0 109.938 179.35 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.48 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 44.7 tttt -63.46 -13.27 38.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.189 -0.944 . . . . 0.0 110.431 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -95.79 -30.45 13.69 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.249 -0.907 . . . . 0.0 109.458 179.665 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.7 m120 -106.52 -7.54 17.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.572 -0.705 . . . . 0.0 109.813 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.562 ' HB2' ' HB2' ' A' ' 104' ' ' LEU . 2.8 m-85 68.62 51.12 0.64 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.558 -0.714 . . . . 0.0 110.177 -179.695 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.559 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -122.68 149.58 43.85 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.256 -0.903 . . . . 0.0 109.409 179.599 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.69 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 31.5 t80 -137.22 149.14 46.98 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.101 -0.999 . . . . 0.0 110.504 -179.204 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.458 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 75.0 m -154.92 129.0 8.84 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.177 -0.952 . . . . 0.0 110.922 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.69 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 26.1 p90 -148.17 169.5 19.9 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.328 -0.858 . . . . 0.0 110.536 179.318 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.805 HG23 ' O ' ' A' ' 98' ' ' ILE . 18.0 m -124.52 129.85 51.38 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.299 -0.876 . . . . 0.0 110.127 -179.8 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.994 HD13 ' CD2' ' A' ' 69' ' ' HIS . 16.0 tp -96.43 136.78 36.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.945 -1.097 . . . . 0.0 110.34 179.735 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.533 ' H ' HD12 ' A' ' 85' ' ' LEU . 11.4 pt -118.17 -30.87 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.212 -0.93 . . . . 0.0 110.364 -179.44 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.621 ' O ' HD11 ' A' ' 85' ' ' LEU . 64.3 tt0 -114.53 156.26 24.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.276 -0.89 . . . . 0.0 110.159 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.627 ' CA ' HG12 ' A' ' 67' ' ' VAL . . . 152.69 130.89 1.6 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 89' ' ' ASP . 36.9 p-10 -60.94 -15.31 29.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -1.138 . . . . 0.0 110.09 179.91 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.07 -19.94 53.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 110.166 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.473 ' O ' ' HB2' ' A' ' 95' ' ' LEU . 59.1 mt -70.09 -26.96 64.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.92 . . . . 0.0 110.054 179.909 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 44.74 -169.36 0.02 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -87.36 7.33 29.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.247 -1.149 . . . . 0.0 109.911 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.577 ' O ' HG21 ' A' ' 126' ' ' VAL . 30.1 p -98.84 -28.19 13.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.359 -0.838 . . . . 0.0 109.959 179.91 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 1.012 HD11 ' CD1' ' A' ' 128' ' ' ILE . 41.2 mt -111.91 169.56 8.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.449 -0.782 . . . . 0.0 110.156 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.416 ' HG2' ' C ' ' A' ' 95' ' ' LEU . 66.2 mm-40 -151.2 -81.38 0.1 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.318 -0.864 . . . . 0.0 109.877 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.48 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 19.4 mttt -80.33 133.78 35.98 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.727 -0.608 . . . . 0.0 110.564 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.805 ' O ' HG23 ' A' ' 84' ' ' THR . 6.7 mm -123.44 142.01 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.876 -1.14 . . . . 0.0 109.886 179.07 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.509 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.3 OUTLIER -123.42 134.41 53.96 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.39 -0.819 . . . . 0.0 109.021 178.866 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.664 ' HE2' HG21 ' A' ' 98' ' ' ILE . 7.2 m-85 -129.82 132.3 46.44 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.303 -0.873 . . . . 0.0 110.624 -179.021 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.405 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 70.4 tt0 -136.41 136.08 39.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.401 -0.812 . . . . 0.0 109.884 179.465 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 39.3 m -136.36 139.6 42.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 110.111 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 115' ' ' LYS . 1.1 tttp -134.52 143.24 47.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.241 -0.912 . . . . 0.0 110.502 -179.87 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.608 HD23 HG12 ' A' ' 114' ' ' ILE . 7.2 mt -124.52 151.91 44.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.247 -0.908 . . . . 0.0 109.844 179.587 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.699 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -150.06 -169.76 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.176 -0.953 . . . . 0.0 110.288 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.699 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -125.34 160.74 28.59 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.399 -0.813 . . . . 0.0 110.21 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.452 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 3.1 p -119.16 169.03 8.73 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.197 -0.939 . . . . 0.0 110.282 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 48.3 Cg_endo -73.37 -4.11 14.85 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.069 1.563 . . . . 0.0 110.7 -179.891 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 39.2 p -105.83 9.93 32.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.085 -1.009 . . . . 0.0 110.298 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 111' ' ' GLY . . . 93.38 -37.84 3.3 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.894 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 110' ' ' GLY . . . -54.27 -172.65 0.06 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.523 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 9.0 p -138.79 136.0 35.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.14 -1.212 . . . . 0.0 110.414 179.937 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.511 ' HA ' HG22 ' A' ' 10' ' ' THR . 61.4 mt -87.67 149.03 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.346 -0.846 . . . . 0.0 109.944 179.772 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.654 HD11 ' OG ' ' A' ' 11' ' ' SER . 4.6 mt -131.82 116.12 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.224 -0.922 . . . . 0.0 110.389 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 103' ' ' LYS . 39.5 tttt -100.12 148.29 24.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.374 -0.829 . . . . 0.0 110.011 179.708 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.2 t -145.55 155.39 43.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.184 -0.947 . . . . 0.0 110.388 -179.816 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.526 HG22 ' NE2' ' A' ' 119' ' ' HIS . 25.9 m -157.87 126.19 5.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.444 -0.785 . . . . 0.0 109.888 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 3.6 m -121.66 154.85 36.27 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.126 -0.984 . . . . 0.0 110.296 -179.851 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.881 ' CE1' HG23 ' A' ' 4' ' ' THR . 56.2 m-70 -137.87 147.27 44.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.276 -0.89 . . . . 0.0 110.392 -179.998 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.997 ' C ' HG23 ' A' ' 2' ' ' VAL . 58.8 m-85 -126.04 121.95 34.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.299 -0.876 . . . . 0.0 110.208 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.736 ' CD2' ' HB ' ' A' ' 2' ' ' VAL . 76.2 m80 -95.55 103.95 15.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.277 -0.889 . . . . 0.0 109.956 179.793 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.582 HG23 HD23 ' A' ' 95' ' ' LEU . 0.9 OUTLIER -91.1 142.71 27.46 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.14 -0.975 . . . . 0.0 110.29 -179.792 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.6 tttt -103.73 124.98 49.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.328 -0.858 . . . . 0.0 110.325 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 98.1 -122.51 7.52 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -134.19 67.61 1.51 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.277 -1.131 . . . . 0.0 110.311 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.577 HG21 ' O ' ' A' ' 94' ' ' THR . 31.0 m -131.5 168.11 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 109.932 179.915 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.433 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 89.7 mt-10 -143.93 157.86 44.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.161 -0.962 . . . . 0.0 110.588 -179.828 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 1.012 ' CD1' HD11 ' A' ' 95' ' ' LEU . 20.5 mm -61.47 173.41 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.379 -0.826 . . . . 0.0 110.106 179.736 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.625 ' N ' HG22 ' A' ' 128' ' ' ILE . 22.9 mttt -96.62 130.8 43.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.334 -0.854 . . . . 0.0 109.66 179.456 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 129' ' ' LYS . 95.5 mt-10 -42.06 -42.9 3.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 110.307 -179.708 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.91 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 31.0 tt0 -55.51 -33.91 64.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.912 . . . . 0.0 109.892 179.636 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.519 ' HB3' ' CG2' ' A' ' 128' ' ' ILE . 5.9 t-160 -75.49 -56.77 4.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.275 -0.891 . . . . 0.0 110.431 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.517 HG23 ' CG2' ' A' ' 128' ' ' ILE . 86.7 t -60.82 -33.03 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.326 -0.858 . . . . 0.0 110.394 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 38.6 mttp -104.04 -71.17 0.74 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.148 -0.97 . . . . 0.0 110.499 -179.688 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.91 ' HB3' ' O ' ' A' ' 131' ' ' GLU . . . -55.93 -19.28 11.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.081 -1.012 . . . . 0.0 109.867 -179.883 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' A' ' 132' ' ' HIS . . . -76.71 -29.85 57.02 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.819 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 46.4 mttt -68.13 -32.36 72.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.269 -1.136 . . . . 0.0 110.222 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -79.06 -34.21 43.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 110.027 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -66.35 -39.07 88.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.33 -0.856 . . . . 0.0 110.002 179.864 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.87 -42.92 60.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.411 -0.806 . . . . 0.0 110.032 179.76 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 144' ' ' PHE . 23.0 t -54.55 -43.11 71.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.323 -0.861 . . . . 0.0 109.905 179.765 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -57.43 -44.82 84.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.349 -0.845 . . . . 0.0 109.919 179.702 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 46.5 mt -58.53 -38.08 77.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.285 -0.884 . . . . 0.0 109.836 179.713 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.4 ' HB2' ' O ' ' A' ' 141' ' ' SER . 16.2 m-85 -62.26 -33.94 75.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.425 -0.797 . . . . 0.0 109.705 179.543 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -72.94 -15.46 61.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.327 -0.858 . . . . 0.0 109.855 179.756 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' A' ' 146' ' ' LEU . 14.0 mt -82.34 -37.15 26.13 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.258 -0.901 . . . . 0.0 108.721 179.203 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.729 HD11 ' CE1' ' A' ' 22' ' ' PHE . 19.1 mt -68.69 -47.35 77.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.751 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 1.026 ' HB3' HD13 ' A' ' 13' ' ' ILE . 88.8 mt-10 -56.18 -43.86 78.82 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.498 -0.751 . . . . 0.0 109.466 179.037 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 42.8 m -65.2 -34.34 78.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.159 -0.963 . . . . 0.0 109.37 179.329 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.596 ' CE2' ' OH ' ' A' ' 158' ' ' TYR . 81.3 t80 -59.15 -47.61 84.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.562 -0.711 . . . . 0.0 109.581 179.341 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.915 HD21 ' CE2' ' A' ' 158' ' ' TYR . 32.8 mt -80.08 -33.37 38.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 110.222 179.655 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.87 ' HB2' HD11 ' A' ' 13' ' ' ILE . 27.4 tttt -60.09 -23.21 63.62 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.228 -0.92 . . . . 0.0 109.257 179.364 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.5 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -109.69 -30.5 3.49 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.417 ' ND1' ' N ' ' A' ' 154' ' ' HIS . 1.8 m80 -105.68 92.22 5.88 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.28 -1.13 . . . . 0.0 110.084 179.817 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 46.3 Cg_endo -72.18 2.93 4.43 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.009 1.531 . . . . 0.0 111.069 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -113.57 -11.5 13.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.067 -1.02 . . . . 0.0 109.764 179.729 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.664 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -46.84 102.31 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.412 -0.805 . . . . 0.0 109.688 179.615 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 1.046 ' CE2' ' HB2' ' A' ' 21' ' ' ALA . 0.0 OUTLIER 58.71 -59.12 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.458 0 CA-C-O 121.592 0.71 . . . . 0.0 110.543 -179.33 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.589 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--N 1.293 -1.874 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.169 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 58.5 t -122.31 137.12 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.201 -1.176 . . . . 0.0 110.319 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.66 ' CG ' HD13 ' A' ' 128' ' ' ILE . 11.6 m-85 -95.71 146.88 24.17 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.318 -0.864 . . . . 0.0 109.967 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.814 HG23 ' CE1' ' A' ' 119' ' ' HIS . 7.3 m -127.35 117.26 21.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.179 -0.95 . . . . 0.0 110.597 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 1.085 ' CE2' HG21 ' A' ' 133' ' ' VAL . 67.1 m-85 -129.74 132.86 46.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.381 -0.825 . . . . 0.0 109.655 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 23.1 pt-20 -130.22 153.53 48.49 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.146 -0.971 . . . . 0.0 110.703 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.472 ' O ' ' CG ' ' A' ' 8' ' ' GLU . 5.9 t -131.79 165.93 22.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.459 -0.776 . . . . 0.0 109.574 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.472 ' CG ' ' O ' ' A' ' 7' ' ' SER . 87.5 mt-10 -154.12 121.97 5.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.088 -1.007 . . . . 0.0 110.706 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.618 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.2 p90 -149.53 -178.31 6.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.355 -0.841 . . . . 0.0 109.625 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.864 HG22 ' HA ' ' A' ' 113' ' ' ILE . 8.6 p -142.37 174.57 10.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.196 -0.94 . . . . 0.0 110.651 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.484 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 4.7 t -159.79 162.19 34.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.461 -0.774 . . . . 0.0 110.125 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -83.48 -20.28 34.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.217 -0.927 . . . . 0.0 110.187 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.832 HD11 ' HB2' ' A' ' 152' ' ' LYS . 2.9 mp -74.08 149.66 87.45 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.317 -0.865 . . . . 0.0 110.072 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.804 ' HD2' HG23 ' A' ' 13' ' ' ILE . 41.3 Cg_endo -67.59 142.23 58.08 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.055 1.555 . . . . 0.0 110.473 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.656 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.2 Cg_endo -72.44 -30.95 11.88 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 124.013 1.533 . . . . 0.0 112.804 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.656 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.7 Cg_endo -70.4 -23.79 27.47 Favored 'Trans proline' 0 C--N 1.319 -0.983 0 N-CA-C 110.115 -0.764 . . . . 0.0 110.115 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.801 HH21 ' HB3' ' A' ' 157' ' ' ALA . 58.5 mtp180 -82.24 -44.11 16.75 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.22 -0.925 . . . . 0.0 108.662 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 1.057 HD23 ' CG2' ' A' ' 147' ' ' ILE . 0.2 OUTLIER -70.85 -31.4 68.09 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.04 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.626 ' N ' HD13 ' A' ' 18' ' ' LEU . 70.4 t80 -63.69 -58.82 5.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.478 -0.764 . . . . 0.0 109.509 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.525 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 75.1 mttt -50.23 -41.24 49.64 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.42 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.129 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -70.55 -36.25 73.57 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.406 -0.809 . . . . 0.0 110.928 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 1.052 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -79.18 -40.25 31.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.24 -0.912 . . . . 0.0 111.14 -178.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.739 HG13 ' CE1' ' A' ' 81' ' ' TYR . 7.5 t -103.75 -54.85 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.975 -1.078 . . . . 0.0 111.741 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.525 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 5.9 mp -80.02 -1.39 39.55 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.013 -1.054 . . . . 0.0 112.012 -178.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.575 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -146.52 14.49 1.24 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.68 -1.263 . . . . 0.0 110.61 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 1.052 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -60.65 -16.46 39.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.273 -0.892 . . . . 0.0 110.78 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -70.87 -22.11 62.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.065 -1.022 . . . . 0.0 110.556 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.524 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 6.9 p30 -132.1 3.27 4.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.106 -0.996 . . . . 0.0 110.427 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.966 ' HG ' ' HB1' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -92.27 -39.42 11.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.235 -0.916 . . . . 0.0 109.972 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 1.102 ' CG1' HD13 ' A' ' 38' ' ' ILE . 97.6 t -77.11 -40.77 2.38 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.398 -0.813 . . . . 0.0 110.961 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 30' ' ' VAL . 49.3 Cg_endo -77.85 7.87 3.72 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.32 1.168 . . . . 0.0 110.55 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -121.48 -38.22 2.8 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.159 -0.963 . . . . 0.0 109.078 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.652 HD11 ' CD1' ' A' ' 150' ' ' TYR . 5.6 mt -80.2 -39.13 18.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-O 121.563 0.697 . . . . 0.0 109.271 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.72 80.01 32.67 Favored Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.572 -0.705 . . . . 0.0 109.877 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -73.13 1.14 6.95 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.101 1.579 . . . . 0.0 110.83 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -87.97 -17.44 31.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.139 -0.976 . . . . 0.0 109.919 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -101.19 -56.44 2.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.394 -0.816 . . . . 0.0 110.038 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 1.102 HD13 ' CG1' ' A' ' 30' ' ' VAL . 1.3 mp -107.39 145.53 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.467 -0.771 . . . . 0.0 109.914 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -112.6 -23.46 10.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.891 . . . . 0.0 110.586 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.551 ' C ' ' CD2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -163.02 158.2 21.83 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.097 -1.002 . . . . 0.0 110.223 -179.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.8 m -140.87 124.5 16.91 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.295 -0.878 . . . . 0.0 109.917 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 60.3 tt0 -137.56 108.22 6.6 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.107 -0.996 . . . . 0.0 110.452 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.468 HG21 ' HA ' ' A' ' 47' ' ' ASP . 13.6 mt -54.84 131.44 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.191 -0.943 . . . . 0.0 110.008 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.525 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 20.3 mt -97.5 -34.86 10.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.921 . . . . 0.0 110.616 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.722 ' CD1' HD12 ' A' ' 53' ' ' ILE . 1.9 m95 -123.03 161.79 23.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.248 -0.907 . . . . 0.0 110.73 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.45 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 40.18 -133.57 2.39 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.468 ' HA ' HG21 ' A' ' 43' ' ' ILE . 0.5 OUTLIER -157.68 20.14 0.27 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.384 -1.068 . . . . 0.0 110.069 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.457 ' O ' HG21 ' A' ' 71' ' ' ILE . . . 128.57 -21.72 5.34 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.468 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -65.73 -175.91 6.01 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.405 ' HA ' HG22 ' A' ' 71' ' ' ILE . 46.1 Cg_endo -73.23 128.69 13.18 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 124.032 1.543 . . . . 0.0 110.559 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.19 -14.33 55.2 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.643 -1.783 . . . . 0.0 108.643 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.523 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -67.86 164.07 20.53 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.565 -0.962 . . . . 0.0 109.789 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.722 HD12 ' CD1' ' A' ' 45' ' ' TRP . 59.9 mt -131.95 121.59 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.398 -0.813 . . . . 0.0 109.467 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.553 ' NZ ' HD11 ' A' ' 71' ' ' ILE . 66.9 mttt -106.01 135.81 46.79 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.144 -0.972 . . . . 0.0 110.317 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.525 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 21.1 tttp -104.73 89.6 3.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.353 -0.842 . . . . 0.0 110.01 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.542 ' CG2' HG12 ' A' ' 38' ' ' ILE . 61.8 mt -79.91 138.69 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 109.867 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 1.4 p -116.49 152.94 33.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.908 . . . . 0.0 110.589 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.574 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 18.7 m-85 -115.27 169.82 8.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.435 -0.791 . . . . 0.0 110.012 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.951 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.467 ' CD2' ' CD2' ' A' ' 66' ' ' TYR . 1.5 t80 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.313 0.578 . . . . 0.0 110.254 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.574 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -129.6 99.95 0.48 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.488 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 25.8 p90 -140.33 171.69 13.79 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -1.139 . . . . 0.0 110.304 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.874 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.8 m -141.08 173.81 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.335 -0.853 . . . . 0.0 110.563 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.516 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 23.2 mttt -123.2 127.31 48.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.499 -0.751 . . . . 0.0 109.625 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.511 ' O ' ' HA ' ' A' ' 53' ' ' ILE . 16.5 m170 -113.74 126.52 55.31 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.102 -0.999 . . . . 0.0 111.049 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 52' ' ' THR . 64.8 tttt -104.22 106.63 17.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.326 -0.859 . . . . 0.0 109.533 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.553 HD11 ' NZ ' ' A' ' 54' ' ' LYS . 31.1 mm -49.8 136.02 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.191 -0.943 . . . . 0.0 110.38 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.456 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 8.3 t0 -111.76 -39.86 4.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.359 -0.838 . . . . 0.0 109.55 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.461 ' OG ' ' HB2' ' A' ' 82' ' ' SER . 53.4 p -168.42 160.44 11.2 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.464 -0.773 . . . . 0.0 109.617 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 73' ' ' SER . 1.5 mt -147.52 154.9 10.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.192 -0.942 . . . . 0.0 110.292 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.553 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 4.7 m-20 -135.66 79.09 1.76 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.213 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.506 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 63.5 mttt -63.02 -12.82 28.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.153 -0.967 . . . . 0.0 110.066 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -95.61 -31.78 13.12 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.31 -0.869 . . . . 0.0 109.497 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -106.01 -5.86 19.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.593 -0.692 . . . . 0.0 109.673 179.825 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.598 ' O ' HD12 ' A' ' 104' ' ' LEU . 4.6 m-85 66.34 50.22 1.34 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.555 -0.716 . . . . 0.0 110.42 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.553 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -120.42 150.32 40.97 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.241 -0.912 . . . . 0.0 109.227 179.379 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.739 ' CE1' HG13 ' A' ' 23' ' ' VAL . 19.9 t80 -139.09 134.29 32.72 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.14 -0.975 . . . . 0.0 110.299 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.461 ' HB2' ' OG ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -140.6 120.22 13.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.272 -0.892 . . . . 0.0 110.695 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.629 ' CE2' ' CB ' ' A' ' 100' ' ' TYR . 19.5 p90 -138.0 170.97 15.11 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 110.246 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.643 HG23 ' O ' ' A' ' 98' ' ' ILE . 86.7 m -121.64 130.83 53.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.412 -0.805 . . . . 0.0 109.802 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.569 ' HB3' ' CG2' ' A' ' 98' ' ' ILE . 5.2 tp -95.32 137.88 33.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.091 -1.006 . . . . 0.0 110.124 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.437 HG12 ' HB2' ' A' ' 68' ' ' LYS . 15.1 pt -120.41 -15.04 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.322 -0.862 . . . . 0.0 110.389 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.538 ' O ' HD11 ' A' ' 85' ' ' LEU . 25.3 tt0 -129.37 158.64 38.58 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.134 -0.978 . . . . 0.0 110.262 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.874 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 151.16 115.76 0.7 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -50.44 -20.97 1.27 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.251 -1.146 . . . . 0.0 110.345 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.811 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -72.77 -18.75 61.46 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.19 -0.943 . . . . 0.0 110.41 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 95' ' ' LEU . 74.9 mt -69.33 -7.79 40.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.167 -0.958 . . . . 0.0 110.185 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 46.75 -171.8 0.03 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.439 ' OD1' HG23 ' A' ' 94' ' ' THR . 49.8 p-10 -91.64 34.68 0.97 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.214 -1.168 . . . . 0.0 109.675 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.439 HG23 ' OD1' ' A' ' 93' ' ' ASP . 7.1 p -131.31 -41.64 1.09 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.441 -0.787 . . . . 0.0 110.397 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.696 HD22 HG22 ' A' ' 122' ' ' THR . 3.1 mm? -79.91 157.02 27.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.906 . . . . 0.0 110.352 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.496 ' HG3' ' HB2' ' A' ' 123' ' ' LYS . 48.0 mm-40 -141.08 -80.9 0.25 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.326 -0.859 . . . . 0.0 109.631 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.527 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 36.8 mttp -80.31 126.53 31.27 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.484 -0.76 . . . . 0.0 110.318 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.707 HG21 ' CE2' ' A' ' 100' ' ' TYR . 5.7 mm -116.58 138.93 45.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 120.586 -1.321 . . . . 0.0 109.621 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.483 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -114.76 130.12 56.8 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.465 179.219 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.707 ' CE2' HG21 ' A' ' 98' ' ' ILE . 9.3 m-85 -125.36 134.01 52.34 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.42 -0.8 . . . . 0.0 110.032 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.478 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 78.0 tt0 -136.56 136.12 39.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 0.0 110.478 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.453 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 91.8 m -136.73 137.8 40.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.287 -0.883 . . . . 0.0 109.762 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -135.37 145.56 47.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.063 -1.023 . . . . 0.0 110.49 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.657 HD23 HG12 ' A' ' 114' ' ' ILE . 6.2 mt -126.43 151.79 47.26 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.33 -0.856 . . . . 0.0 110.067 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.708 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -150.97 -169.23 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.247 -0.908 . . . . 0.0 110.247 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.708 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -120.49 151.14 39.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.336 -0.852 . . . . 0.0 110.265 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.473 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 6.1 p -105.08 167.9 9.16 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 110.164 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.3 Cg_endo -72.7 -13.25 27.04 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.059 1.557 . . . . 0.0 110.438 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 74.1 m -97.02 12.45 32.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.184 -0.947 . . . . 0.0 110.252 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 92.29 -32.82 5.24 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -60.36 -175.0 1.11 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 28.8 p -130.57 135.36 47.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -1.16 . . . . 0.0 110.376 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.864 ' HA ' HG22 ' A' ' 10' ' ' THR . 11.0 mt -88.33 151.31 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.294 -0.879 . . . . 0.0 110.065 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.657 HG12 HD23 ' A' ' 104' ' ' LEU . 11.9 mt -131.49 116.67 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -0.936 . . . . 0.0 110.35 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.8 tttm -108.61 124.14 50.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.164 -0.96 . . . . 0.0 109.892 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.7 t -120.46 162.06 20.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.237 -0.914 . . . . 0.0 110.397 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.478 ' HB ' ' HB3' ' A' ' 101' ' ' GLU . 37.5 m -160.02 151.97 20.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.373 -0.829 . . . . 0.0 109.932 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 7.5 m -148.35 157.1 43.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.205 -0.935 . . . . 0.0 110.275 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.814 ' CE1' HG23 ' A' ' 4' ' ' THR . 68.4 m-70 -141.54 162.05 36.42 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.195 -0.94 . . . . 0.0 110.536 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.502 ' CD1' ' N ' ' A' ' 120' ' ' TYR . 11.1 m-85 -127.68 152.36 47.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.358 -0.839 . . . . 0.0 110.302 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.527 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 74.2 m-70 -134.99 86.69 2.27 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.201 -0.937 . . . . 0.0 109.518 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.696 HG22 HD22 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -70.79 146.75 49.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.397 -0.814 . . . . 0.0 110.74 -179.341 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.496 ' HB2' ' HG3' ' A' ' 96' ' ' GLU . 2.0 ttpt -92.83 119.1 31.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.373 -0.83 . . . . 0.0 110.057 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 105.58 -125.32 8.2 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -137.43 61.61 1.61 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.328 -1.101 . . . . 0.0 110.231 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.503 HG23 ' CG2' ' A' ' 122' ' ' THR . 35.5 m -124.28 179.32 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.246 -0.909 . . . . 0.0 110.08 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -140.52 158.53 43.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.177 -0.952 . . . . 0.0 110.345 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.683 HD12 ' H ' ' A' ' 128' ' ' ILE . 5.1 mp -78.23 172.98 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.247 -0.908 . . . . 0.0 110.183 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.605 ' N ' HG22 ' A' ' 128' ' ' ILE . 7.3 mttp -107.02 128.02 53.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.363 -0.835 . . . . 0.0 109.888 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.475 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 91.8 mt-10 -42.77 -53.45 4.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.214 -0.928 . . . . 0.0 110.244 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 51.1 tt0 -47.52 -26.19 1.33 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.188 -0.945 . . . . 0.0 109.912 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.811 ' NE2' ' HB1' ' A' ' 90' ' ' ALA . 11.3 t-160 -85.37 -62.39 1.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.297 -0.877 . . . . 0.0 110.137 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 1.085 HG21 ' CE2' ' A' ' 5' ' ' TYR . 7.7 p -62.36 -41.0 89.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.378 -0.826 . . . . 0.0 109.962 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.554 ' N ' HG13 ' A' ' 133' ' ' VAL . 27.6 tttp -64.8 -44.14 90.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.337 -0.852 . . . . 0.0 109.89 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 131' ' ' GLU . . . -63.86 -32.8 74.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.374 -0.829 . . . . 0.0 109.913 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -64.9 -31.86 82.33 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -60.53 -32.66 71.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.273 -1.133 . . . . 0.0 109.955 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 142' ' ' ASN . 99.0 mt-10 -83.6 -33.35 25.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.38 -0.825 . . . . 0.0 109.878 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 24.3 mttt -68.86 -35.06 76.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.34 -0.85 . . . . 0.0 109.881 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.427 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -86.18 -40.89 15.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.297 -0.877 . . . . 0.0 109.934 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.1 m -67.55 -53.45 28.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.419 -0.801 . . . . 0.0 109.846 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 138' ' ' GLU . 98.8 m-20 -49.43 -47.47 48.02 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.226 -0.921 . . . . 0.0 109.924 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.427 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 9.3 tp -55.6 -48.16 75.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.281 -0.887 . . . . 0.0 109.882 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.565 ' CE1' ' CE2' ' A' ' 22' ' ' PHE . 13.6 m-85 -53.31 -36.13 60.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.444 -0.785 . . . . 0.0 109.843 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -74.56 -16.51 60.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.359 -0.838 . . . . 0.0 109.862 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 146' ' ' LEU . 24.0 mt -84.41 -35.63 22.97 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.281 -0.887 . . . . 0.0 109.01 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 1.057 ' CG2' HD23 ' A' ' 18' ' ' LEU . 24.7 mt -68.26 -41.61 83.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.484 ' CG ' ' OG ' ' A' ' 11' ' ' SER . 97.2 mt-10 -48.36 -40.98 27.3 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.158 -0.964 . . . . 0.0 108.794 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.418 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 19.5 m -72.05 -26.74 62.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.28 -0.887 . . . . 0.0 109.351 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.652 ' CD1' HD11 ' A' ' 33' ' ' ILE . 62.7 t80 -57.89 -52.2 66.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.535 -0.728 . . . . 0.0 109.883 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.943 HD21 ' CE1' ' A' ' 158' ' ' TYR . 64.7 mt -80.01 -36.42 35.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.285 -0.884 . . . . 0.0 110.362 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.832 ' HB2' HD11 ' A' ' 13' ' ' ILE . 35.8 tttt -60.05 -19.69 54.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.163 -0.961 . . . . 0.0 109.236 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.48 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -111.1 -32.22 2.66 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.6 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 5.8 m-70 -105.97 93.0 7.04 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.324 -1.103 . . . . 0.0 110.039 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.503 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 46.6 Cg_endo -72.94 3.66 4.29 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.018 1.536 . . . . 0.0 110.96 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -114.19 -10.29 12.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.085 -1.009 . . . . 0.0 109.899 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.801 ' HB3' HH21 ' A' ' 17' ' ' ARG . . . -46.92 108.74 0.15 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.333 -0.855 . . . . 0.0 110.053 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 1.129 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 35.46 30.83 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.719 -0.613 . . . . 0.0 110.515 -179.624 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.525 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.701 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.616 HG22 ' ND1' ' A' ' 121' ' ' HIS . 63.6 t -122.93 122.53 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.191 -1.182 . . . . 0.0 110.264 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.579 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 43.1 m-85 -80.2 154.16 28.12 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.28 -0.887 . . . . 0.0 110.302 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.889 HG23 ' CE1' ' A' ' 119' ' ' HIS . 56.5 m -138.35 94.47 2.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.882 . . . . 0.0 110.1 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.592 ' CD1' HG23 ' A' ' 133' ' ' VAL . 75.1 m-85 -116.15 136.41 53.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.889 . . . . 0.0 110.026 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 116' ' ' SER . 21.5 pt-20 -135.92 151.91 50.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.202 -0.936 . . . . 0.0 110.404 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.3 m -121.38 157.83 29.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.337 -0.852 . . . . 0.0 109.92 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -135.44 121.11 19.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.115 -0.99 . . . . 0.0 110.386 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.638 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.9 p90 -146.03 -174.12 4.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.347 -0.846 . . . . 0.0 109.948 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.866 HG22 ' HA ' ' A' ' 113' ' ' ILE . 5.7 p -141.43 173.03 11.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.201 -0.937 . . . . 0.0 110.627 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.479 ' CB ' ' CD ' ' A' ' 148' ' ' GLU . 97.6 p -156.68 135.04 11.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.399 -0.813 . . . . 0.0 110.2 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -62.05 -31.02 71.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.211 -0.931 . . . . 0.0 110.134 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.873 HD11 ' HB2' ' A' ' 152' ' ' LYS . 2.3 mp -64.55 150.62 93.43 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.869 . . . . 0.0 109.944 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.818 ' HD2' HG23 ' A' ' 13' ' ' ILE . 42.0 Cg_endo -68.32 143.15 57.3 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.044 1.549 . . . . 0.0 110.771 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.669 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.5 Cg_endo -72.25 -30.92 12.42 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 O-C-N 124.042 1.549 . . . . 0.0 112.737 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.669 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.1 Cg_endo -69.53 -22.71 32.75 Favored 'Trans proline' 0 N--CA 1.485 0.988 0 N-CA-C 110.07 -0.781 . . . . 0.0 110.07 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.61 ' NH2' ' HB3' ' A' ' 157' ' ' ALA . 42.2 mtp180 -83.5 -42.89 16.37 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 1.039 HD23 HG21 ' A' ' 147' ' ' ILE . 0.3 OUTLIER -71.33 -32.69 68.87 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 178.833 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.581 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 81.4 t80 -63.02 -61.63 2.26 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.538 -0.726 . . . . 0.0 109.577 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.76 ' HG2' HD22 ' A' ' 24' ' ' LEU . 14.9 mttp -53.61 -32.88 53.0 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.383 -0.823 . . . . 0.0 109.351 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.005 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -74.26 -47.45 35.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.363 -0.836 . . . . 0.0 110.568 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 1.049 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -66.67 -46.76 74.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.542 -0.724 . . . . 0.0 111.215 -179.141 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 1.105 HG11 ' CD1' ' A' ' 74' ' ' ILE . 6.1 t -97.45 -60.3 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.109 -0.995 . . . . 0.0 111.914 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.76 HD22 ' HG2' ' A' ' 20' ' ' LYS . 8.5 mp -69.5 -0.19 6.23 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.16 -0.962 . . . . 0.0 111.824 -178.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.548 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -146.16 10.95 1.17 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.692 -1.255 . . . . 0.0 110.811 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 1.049 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -53.38 -19.02 3.0 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.164 -0.96 . . . . 0.0 110.863 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -80.01 -26.87 39.65 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.005 -1.059 . . . . 0.0 110.573 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -127.12 13.05 7.21 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.255 -0.903 . . . . 0.0 110.337 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.765 ' HG ' ' HB1' ' A' ' 21' ' ' ALA . 0.8 OUTLIER -103.9 -45.29 4.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.105 -0.997 . . . . 0.0 110.259 179.921 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.952 HG11 HD13 ' A' ' 38' ' ' ILE . 3.1 t -64.77 -41.83 59.22 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.326 -0.858 . . . . 0.0 110.556 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.0 Cg_endo -78.79 8.87 3.51 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.442 1.233 . . . . 0.0 110.628 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -118.64 -25.47 6.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.153 -0.967 . . . . 0.0 109.263 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.75 HD11 HD11 ' A' ' 29' ' ' LEU . 20.1 mt -80.01 -57.42 5.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 121.612 0.72 . . . . 0.0 109.427 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.422 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . . . -145.06 105.55 4.46 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.541 -0.724 . . . . 0.0 109.818 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 34' ' ' ALA . 44.2 Cg_endo -70.66 -0.77 8.18 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 124.042 1.549 . . . . 0.0 110.824 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -82.87 -10.42 58.84 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.075 -1.016 . . . . 0.0 109.645 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -101.93 -63.31 1.16 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.334 -0.853 . . . . 0.0 110.121 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.952 HD13 HG11 ' A' ' 30' ' ' VAL . 1.3 mp -113.09 154.2 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.446 -0.784 . . . . 0.0 109.985 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.544 ' HG2' ' N ' ' A' ' 59' ' ' GLY . 66.5 mmtt -114.16 -27.5 7.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 0.0 110.457 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.574 ' C ' ' CD2' ' A' ' 40' ' ' HIS . 0.1 OUTLIER -159.32 151.72 21.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.955 . . . . 0.0 110.179 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.1 m -138.13 120.71 16.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.393 -0.817 . . . . 0.0 109.677 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -134.09 109.97 9.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.157 -0.964 . . . . 0.0 110.785 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 29.9 mt -55.71 133.81 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.312 -0.868 . . . . 0.0 109.794 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 13.3 tp -105.28 -23.45 12.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.248 -0.908 . . . . 0.0 110.823 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.756 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.8 m95 -129.58 159.37 36.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.043 -1.036 . . . . 0.0 110.855 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.456 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 41.91 -136.23 3.12 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -151.25 21.54 0.75 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.307 -1.114 . . . . 0.0 110.068 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.498 ' O ' HG21 ' A' ' 71' ' ' ILE . . . 122.89 -20.96 7.58 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.517 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -67.8 -173.41 7.03 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -72.81 128.86 13.72 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.071 1.564 . . . . 0.0 110.517 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.45 -13.46 51.13 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 45' ' ' TRP . 1.0 OUTLIER -72.11 165.24 24.73 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.548 -0.972 . . . . 0.0 109.596 179.54 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.756 HD12 ' CG ' ' A' ' 45' ' ' TRP . 63.0 mt -135.35 120.57 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.333 -0.855 . . . . 0.0 109.697 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.665 ' CE ' HD11 ' A' ' 71' ' ' ILE . 39.3 mttm -103.53 128.6 50.72 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.208 -0.932 . . . . 0.0 110.27 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 54.9 tttt -97.6 91.65 5.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.197 -0.939 . . . . 0.0 109.874 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.556 ' CG2' HG12 ' A' ' 38' ' ' ILE . 89.4 mt -79.98 141.6 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.299 -0.876 . . . . 0.0 110.049 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.771 HG22 ' HB3' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -120.12 147.33 45.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 110.471 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.591 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 14.1 m-85 -114.21 162.27 16.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.325 -0.859 . . . . 0.0 110.003 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.544 ' N ' ' HG2' ' A' ' 39' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.576 ' O ' ' CD1' ' A' ' 64' ' ' TYR . 2.3 p90 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 121.317 0.579 . . . . 0.0 110.208 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.591 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -142.48 85.79 0.19 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.771 ' HB3' HG22 ' A' ' 57' ' ' THR . 13.6 p90 -132.74 171.97 13.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.293 -1.122 . . . . 0.0 110.251 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.789 HG12 ' HA2' ' A' ' 88' ' ' GLY . 4.4 m -140.21 176.9 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.917 . . . . 0.0 110.477 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.642 ' O ' HD12 ' A' ' 85' ' ' LEU . 82.3 mttt -133.03 102.9 5.78 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.426 -0.796 . . . . 0.0 109.746 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.979 ' CD2' HD13 ' A' ' 85' ' ' LEU . 15.1 m170 -95.65 127.73 41.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.24 -0.912 . . . . 0.0 111.061 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.536 ' HA ' ' O ' ' A' ' 52' ' ' THR . 17.1 tttt -96.59 114.84 26.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 109.436 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.665 HD11 ' CE ' ' A' ' 54' ' ' LYS . 37.0 mm -52.81 132.07 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.142 -0.974 . . . . 0.0 110.347 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.539 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 23.5 t0 -105.21 -46.86 4.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.487 -0.758 . . . . 0.0 109.982 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.452 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 77.5 p -177.68 160.93 1.61 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.466 -0.771 . . . . 0.0 110.376 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 1.105 ' CD1' HG11 ' A' ' 23' ' ' VAL . 6.6 tt -153.24 170.06 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.375 -0.828 . . . . 0.0 109.703 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.5 m-20 -142.19 84.35 1.87 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.079 -1.013 . . . . 0.0 110.395 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.581 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 18.7 tttm -58.93 -14.26 8.67 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.12 -0.988 . . . . 0.0 110.273 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -92.82 -34.33 13.9 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.349 -0.845 . . . . 0.0 109.517 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.505 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 2.3 m-80 -102.71 -3.75 26.04 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.655 0.74 . . . . 0.0 109.267 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.647 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 76.1 m-85 62.39 55.48 2.3 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.338 0.589 . . . . 0.0 110.873 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.489 ' HB3' ' HG3' ' A' ' 103' ' ' LYS . 0.7 OUTLIER -131.09 153.87 48.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.449 -0.782 . . . . 0.0 109.523 179.124 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.614 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 76.0 t80 -151.99 149.48 28.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.183 -0.948 . . . . 0.0 110.352 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.482 ' HB2' ' HA ' ' A' ' 101' ' ' GLU . 13.5 t -157.63 151.14 23.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.249 -0.907 . . . . 0.0 110.386 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.614 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 7.2 p90 -152.18 177.03 10.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.441 -0.787 . . . . 0.0 110.734 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.717 HG23 ' O ' ' A' ' 98' ' ' ILE . 42.0 m -127.38 125.85 41.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.547 -0.721 . . . . 0.0 109.735 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.979 HD13 ' CD2' ' A' ' 69' ' ' HIS . 11.2 tp -95.77 133.63 39.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.006 -1.059 . . . . 0.0 110.407 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.555 ' N ' HD12 ' A' ' 85' ' ' LEU . 10.3 pt -111.53 -34.7 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.238 -0.914 . . . . 0.0 110.408 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.76 ' O ' HD11 ' A' ' 85' ' ' LEU . 76.9 tt0 -115.16 153.27 31.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.326 -0.859 . . . . 0.0 110.18 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.789 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 161.19 127.72 0.9 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -57.54 -20.29 30.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.271 -1.135 . . . . 0.0 110.095 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.83 -19.78 54.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.318 -0.864 . . . . 0.0 110.171 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.622 HD12 ' N ' ' A' ' 88' ' ' GLY . 55.1 mt -67.58 -28.21 67.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.931 . . . . 0.0 110.19 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 49.18 -178.09 0.02 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -81.99 8.23 11.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -1.166 . . . . 0.0 110.166 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.511 ' O ' HG22 ' A' ' 122' ' ' THR . 33.6 p -98.64 -32.71 11.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.206 -0.934 . . . . 0.0 110.144 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.935 HD21 ' CD1' ' A' ' 128' ' ' ILE . 76.5 mt -108.62 158.13 17.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.43 -0.793 . . . . 0.0 110.128 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.1 tp10 -139.35 -79.93 0.31 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.168 -0.957 . . . . 0.0 110.196 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.486 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 29.3 mttp -80.15 127.46 32.35 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.542 -0.724 . . . . 0.0 110.555 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.717 ' O ' HG23 ' A' ' 84' ' ' THR . 6.0 mm -117.83 142.78 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.885 -1.134 . . . . 0.0 110.027 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.473 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -123.64 133.67 53.89 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.409 -0.807 . . . . 0.0 109.112 178.859 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.641 ' HE2' HG21 ' A' ' 98' ' ' ILE . 6.8 m-85 -128.03 131.39 49.17 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.164 -0.96 . . . . 0.0 110.541 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.482 ' HA ' ' HB2' ' A' ' 82' ' ' SER . 85.1 tt0 -135.51 139.4 43.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.277 -0.889 . . . . 0.0 110.066 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.472 ' N ' ' O ' ' A' ' 81' ' ' TYR . 85.7 m -141.52 149.14 40.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 110.217 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.489 ' HG3' ' HB3' ' A' ' 80' ' ' SER . 0.0 OUTLIER -142.32 140.71 32.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.262 -0.899 . . . . 0.0 110.39 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.741 HD23 HG12 ' A' ' 114' ' ' ILE . 2.9 mt -115.37 155.68 26.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 110.063 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.707 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -151.48 -169.49 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.093 -1.005 . . . . 0.0 110.217 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.707 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -123.88 154.4 39.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.411 -0.806 . . . . 0.0 110.247 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.446 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.4 p -113.02 170.96 4.72 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.23 -0.919 . . . . 0.0 110.233 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.3 Cg_endo -72.11 -14.58 28.93 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.048 1.552 . . . . 0.0 110.553 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.2 p -97.82 11.41 37.35 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.224 -0.923 . . . . 0.0 110.174 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 91.92 -31.07 6.13 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -56.64 -172.57 0.17 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.513 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 1.1 p -136.46 135.95 39.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.168 -1.195 . . . . 0.0 110.277 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.866 ' HA ' HG22 ' A' ' 10' ' ' THR . 17.0 mt -89.23 149.47 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.33 -0.856 . . . . 0.0 110.024 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.741 HG12 HD23 ' A' ' 104' ' ' LEU . 23.3 mt -131.29 118.28 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 110.393 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 103' ' ' LYS . 72.2 tttt -105.8 120.75 42.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.945 . . . . 0.0 109.97 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 0.4 OUTLIER -113.04 151.68 30.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.234 -0.916 . . . . 0.0 110.528 -179.719 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.457 ' HB ' ' HB3' ' A' ' 101' ' ' GLU . 81.8 m -154.37 124.31 6.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.373 -0.829 . . . . 0.0 110.252 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.537 ' OG ' ' CE1' ' A' ' 100' ' ' TYR . 2.1 t -125.81 163.14 23.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 110.094 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.889 ' CE1' HG23 ' A' ' 4' ' ' THR . 71.0 m-70 -138.94 154.35 48.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -0.911 . . . . 0.0 110.177 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.531 ' HD1' HD12 ' A' ' 98' ' ' ILE . 21.4 m-85 -124.99 135.94 53.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.896 . . . . 0.0 110.44 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.616 ' ND1' HG22 ' A' ' 2' ' ' VAL . 73.6 m-70 -118.79 93.45 4.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.138 -0.976 . . . . 0.0 109.763 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.864 ' CG2' HD23 ' A' ' 95' ' ' LEU . 1.7 p -75.06 155.87 36.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.3 -0.875 . . . . 0.0 110.435 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.4 ttpt -107.94 100.93 10.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.344 -0.847 . . . . 0.0 110.157 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 121.4 -135.91 10.85 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -120.39 67.28 0.84 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.194 -1.18 . . . . 0.0 110.193 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.508 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 32.4 m -135.41 155.66 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.246 -0.909 . . . . 0.0 110.199 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.407 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 92.8 mt-10 -118.78 179.07 4.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.23 -0.919 . . . . 0.0 110.234 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.935 ' CD1' HD21 ' A' ' 95' ' ' LEU . 16.5 mm -80.18 172.69 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.276 -0.89 . . . . 0.0 110.227 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.588 ' N ' HG22 ' A' ' 128' ' ' ILE . 61.9 mttt -96.13 130.61 43.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 109.908 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.469 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 94.7 mt-10 -45.41 -35.17 3.5 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.232 -0.918 . . . . 0.0 110.207 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 1.001 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 59.2 tt0 -68.25 -21.9 64.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.203 -0.935 . . . . 0.0 110.005 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.458 ' N ' ' O ' ' A' ' 129' ' ' LYS . 13.4 t-160 -87.86 -49.41 7.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.247 -0.908 . . . . 0.0 110.176 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.592 HG23 ' CD1' ' A' ' 5' ' ' TYR . 2.6 p -69.47 -28.75 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.454 -0.779 . . . . 0.0 110.132 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -104.95 -69.74 0.8 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.181 -0.949 . . . . 0.0 110.089 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 1.001 ' HB3' ' O ' ' A' ' 131' ' ' GLU . . . -56.56 -19.63 16.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.193 -0.942 . . . . 0.0 109.811 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 132' ' ' HIS . . . -76.21 -30.23 57.36 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.465 ' CE ' ' O ' ' A' ' 133' ' ' VAL . 25.0 mttt -66.68 -30.91 71.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -1.159 . . . . 0.0 110.025 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -81.46 -29.58 33.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.259 -0.9 . . . . 0.0 110.008 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 18.7 mtpp -70.38 -45.99 64.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.9 . . . . 0.0 110.005 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -71.75 -33.28 68.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.318 -0.864 . . . . 0.0 110.067 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.9 t -58.84 -46.27 88.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.354 -0.842 . . . . 0.0 110.001 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -53.02 -43.38 66.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.242 -0.911 . . . . 0.0 109.985 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.622 ' HA ' HD12 ' A' ' 146' ' ' LEU . 14.1 tp -57.3 -50.13 73.9 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.348 -0.845 . . . . 0.0 109.911 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -54.02 -40.1 66.74 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.357 -0.839 . . . . 0.0 109.685 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -73.12 -15.12 61.49 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.295 -0.878 . . . . 0.0 110.089 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.622 HD12 ' HA ' ' A' ' 143' ' ' LEU . 29.9 mt -82.03 -35.4 28.84 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.152 -0.967 . . . . 0.0 108.86 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 1.039 HG21 HD23 ' A' ' 18' ' ' LEU . 23.5 mt -67.96 -47.49 78.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.759 ' HB3' HD13 ' A' ' 13' ' ' ILE . 77.6 mt-10 -47.85 -45.14 29.83 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.334 -0.854 . . . . 0.0 108.822 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.541 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 94.3 m -62.04 -39.58 92.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.269 -0.894 . . . . 0.0 109.313 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.695 ' CE2' HD21 ' A' ' 29' ' ' LEU . 57.5 t80 -47.08 -51.34 17.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.498 -0.751 . . . . 0.0 109.837 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.989 HD21 ' CE1' ' A' ' 158' ' ' TYR . 68.6 mt -80.11 -34.77 37.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.434 -0.792 . . . . 0.0 110.418 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.873 ' HB2' HD11 ' A' ' 13' ' ' ILE . 37.2 tttm -60.72 -14.81 23.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 109.18 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.494 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -120.12 -27.3 2.07 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.576 ' CD2' ' O ' ' A' ' 150' ' ' TYR . 10.3 m-70 -106.12 92.58 6.78 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.134 -1.215 . . . . 0.0 110.279 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.498 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 48.3 Cg_endo -73.86 2.23 6.2 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.035 1.545 . . . . 0.0 110.7 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -113.95 -5.14 13.18 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.064 -1.022 . . . . 0.0 110.019 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.61 ' HB3' ' NH2' ' A' ' 17' ' ' ARG . . . -57.78 108.32 0.56 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 109.957 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 1.005 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 0.3 OUTLIER 35.31 31.45 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.702 -0.624 . . . . 0.0 110.689 -179.748 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.539 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.901 -1.047 . . . . 0.0 109.78 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 60.3 t -114.2 126.69 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.232 -1.158 . . . . 0.0 110.274 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.574 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 41.8 m-85 -81.36 158.51 24.66 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.208 -0.932 . . . . 0.0 110.428 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.705 HG23 ' CE1' ' A' ' 119' ' ' HIS . 91.8 m -141.97 94.2 2.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.318 -0.864 . . . . 0.0 109.928 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.628 ' CE1' ' CG2' ' A' ' 133' ' ' VAL . 75.9 m-85 -116.04 138.04 51.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.193 -0.942 . . . . 0.0 110.069 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 116' ' ' SER . 12.5 pt-20 -140.05 154.29 47.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.239 -0.913 . . . . 0.0 110.41 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.7 m -135.64 135.94 40.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.311 -0.868 . . . . 0.0 109.805 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.49 ' HG3' ' HG3' ' A' ' 115' ' ' LYS . 5.5 tt0 -114.42 140.6 48.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.133 -0.979 . . . . 0.0 110.766 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.588 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 4.1 p90 -157.4 -172.73 4.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.541 -0.724 . . . . 0.0 109.581 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.825 HG22 ' HA ' ' A' ' 113' ' ' ILE . 8.8 p -140.0 173.13 11.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.091 -1.006 . . . . 0.0 110.6 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.439 ' HB2' ' CD ' ' A' ' 148' ' ' GLU . 86.0 p -156.04 134.68 11.74 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.44 -0.787 . . . . 0.0 110.094 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -59.73 -39.22 83.96 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.156 -0.965 . . . . 0.0 110.189 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.914 HD11 ' HB2' ' A' ' 152' ' ' LYS . 2.5 mp -59.94 150.62 68.47 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.432 -0.793 . . . . 0.0 109.892 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.811 ' HD2' HG23 ' A' ' 13' ' ' ILE . 41.5 Cg_endo -67.53 142.04 57.71 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.041 1.548 . . . . 0.0 110.559 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.658 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.0 Cg_endo -72.15 -31.08 12.5 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.982 1.517 . . . . 0.0 112.667 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.658 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.4 Cg_endo -70.33 -21.49 30.75 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 N-CA-C 110.086 -0.774 . . . . 0.0 110.086 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.675 ' NH2' ' HB3' ' A' ' 157' ' ' ALA . 36.3 mtp180 -82.94 -46.08 13.37 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.751 ' C ' HD23 ' A' ' 18' ' ' LEU . 0.8 OUTLIER -71.02 -32.53 69.33 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.595 ' N ' HD23 ' A' ' 18' ' ' LEU . 86.5 t80 -62.84 -59.3 5.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.555 -0.715 . . . . 0.0 109.512 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.521 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 29.5 mttt -50.99 -39.02 54.6 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.629 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.041 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -72.27 -42.53 65.46 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.451 -0.781 . . . . 0.0 110.838 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 1.05 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -72.72 -40.17 66.33 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.317 -0.865 . . . . 0.0 111.17 -178.9 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.807 HG13 ' CE1' ' A' ' 81' ' ' TYR . 4.2 t -103.52 -55.8 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.026 -1.046 . . . . 0.0 111.588 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.729 HD12 ' N ' ' A' ' 24' ' ' LEU . 7.3 mp -79.94 -1.12 38.0 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.06 -1.025 . . . . 0.0 111.889 -178.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.567 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.9 OUTLIER -153.36 30.62 0.48 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.658 -1.276 . . . . 0.0 110.726 -179.9 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 1.05 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -74.5 -23.39 58.84 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.224 -0.922 . . . . 0.0 110.39 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.4 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 94.7 m-20 -67.58 -17.33 64.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -0.936 . . . . 0.0 110.022 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.555 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 3.4 p30 -128.31 10.5 6.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.306 -0.871 . . . . 0.0 109.977 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.637 ' HG ' ' HB1' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -93.54 -49.8 5.72 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.336 -0.852 . . . . 0.0 110.283 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.837 HG22 ' HD3' ' A' ' 31' ' ' PRO . 2.2 m -74.96 -28.86 0.83 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.373 -0.829 . . . . 0.0 112.171 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.837 ' HD3' HG22 ' A' ' 30' ' ' VAL . 51.7 Cg_endo -78.65 5.6 5.47 Favored 'Trans proline' 0 C--N 1.319 -1.026 0 O-C-N 122.67 0.826 . . . . 0.0 110.5 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -126.91 -34.25 2.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 109.431 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.532 HD11 ' CD1' ' A' ' 29' ' ' LEU . 24.1 mt -80.01 -24.89 11.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 121.653 0.74 . . . . 0.0 109.219 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.419 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . . . -170.89 97.4 0.43 Allowed Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.637 -0.665 . . . . 0.0 109.725 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 34' ' ' ALA . 44.1 Cg_endo -69.89 -3.29 11.79 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.987 1.519 . . . . 0.0 110.664 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -90.52 4.85 49.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 0.0 110.007 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.985 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -109.41 -45.39 3.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.321 -0.862 . . . . 0.0 110.033 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.985 HD12 ' C ' ' A' ' 37' ' ' ALA . 1.9 mp -131.47 126.6 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.371 -0.831 . . . . 0.0 110.049 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.44 ' N ' ' O ' ' A' ' 57' ' ' THR . 18.2 ttpt -78.05 -36.59 48.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.202 -0.936 . . . . 0.0 110.316 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.516 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -170.97 136.73 1.13 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.278 -0.889 . . . . 0.0 110.027 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.6 m -111.86 124.83 53.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.331 -0.856 . . . . 0.0 110.149 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.516 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 42.2 tt0 -133.41 109.32 9.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.213 -0.929 . . . . 0.0 110.32 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 43' ' ' ILE . 19.6 mt -56.29 133.68 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.236 -0.915 . . . . 0.0 110.019 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.453 HD22 ' HD2' ' A' ' 55' ' ' LYS . 14.4 tp -104.69 -27.52 11.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.284 -0.885 . . . . 0.0 110.547 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.592 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.9 m95 -127.6 160.56 31.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 0.0 110.775 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.459 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 42.18 -133.94 4.06 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -156.35 19.7 0.35 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.323 -1.104 . . . . 0.0 110.108 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.91 -17.04 6.81 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.468 ' O ' ' HB ' ' A' ' 71' ' ' ILE . . . -72.27 -172.77 19.65 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.422 ' HA ' HG22 ' A' ' 71' ' ' ILE . 44.9 Cg_endo -73.53 129.1 13.33 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.008 1.53 . . . . 0.0 110.567 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.18 -12.86 55.49 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -70.65 164.57 24.7 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.537 -0.978 . . . . 0.0 109.82 179.705 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.592 HD12 ' CG ' ' A' ' 45' ' ' TRP . 52.7 mt -134.21 121.19 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.388 -0.82 . . . . 0.0 109.79 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.603 ' HE2' HD11 ' A' ' 71' ' ' ILE . 4.9 mtmp? -106.07 138.52 42.11 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.118 -0.989 . . . . 0.0 110.281 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.458 ' HG2' ' HG2' ' A' ' 68' ' ' LYS . 2.1 mtpt -109.98 89.25 2.96 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.321 -0.862 . . . . 0.0 110.15 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.553 ' CG2' HG13 ' A' ' 38' ' ' ILE . 88.9 mt -79.95 141.82 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 110.011 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.529 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 3.5 p -115.06 159.6 20.64 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.268 -0.895 . . . . 0.0 110.517 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.525 ' N ' ' O ' ' A' ' 65' ' ' GLY . 16.4 m-85 -120.29 145.65 46.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.36 -0.838 . . . . 0.0 110.154 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.925 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.207 0.527 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -134.33 87.29 0.26 Allowed Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.532 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 12.5 p90 -133.15 164.08 27.84 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.169 -1.195 . . . . 0.0 110.167 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.911 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.0 m -133.17 175.31 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.358 -0.839 . . . . 0.0 110.583 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.497 ' HB2' HG12 ' A' ' 86' ' ' ILE . 85.2 mttt -129.21 127.21 40.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.523 -0.736 . . . . 0.0 109.5 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.474 ' NE2' HD13 ' A' ' 85' ' ' LEU . 12.6 m170 -115.94 120.01 37.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.138 -0.976 . . . . 0.0 111.079 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 52' ' ' THR . 19.9 tttt -96.41 115.81 28.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 0.0 109.459 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.603 HD11 ' HE2' ' A' ' 54' ' ' LYS . 24.6 mm -61.08 129.69 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.206 -0.934 . . . . 0.0 110.491 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 82' ' ' SER . 93.8 m-20 -105.39 -42.95 5.1 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.368 -0.833 . . . . 0.0 110.204 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 35.3 m -166.9 158.65 12.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.367 -0.833 . . . . 0.0 109.946 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.518 HG12 HG11 ' A' ' 23' ' ' VAL . 1.7 mt -144.24 156.74 15.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.225 -0.922 . . . . 0.0 110.321 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.541 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 4.4 m-20 -135.13 78.8 1.75 Allowed 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.238 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.554 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 88.5 mttt -62.23 -12.98 23.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.131 -0.981 . . . . 0.0 110.062 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -95.14 -31.58 13.47 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.268 -0.895 . . . . 0.0 109.585 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -107.4 -4.27 18.71 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.528 -0.732 . . . . 0.0 109.725 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.679 ' O ' HD12 ' A' ' 104' ' ' LEU . 6.7 m-85 64.97 50.63 1.87 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.484 -0.76 . . . . 0.0 110.277 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.541 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -120.75 149.94 41.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.285 -0.885 . . . . 0.0 109.315 179.497 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.807 ' CE1' HG13 ' A' ' 23' ' ' VAL . 30.7 t80 -139.34 133.39 31.07 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.156 -0.965 . . . . 0.0 110.364 -179.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 19.2 m -137.06 124.92 22.59 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.29 -0.881 . . . . 0.0 110.486 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.681 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 20.5 p90 -143.24 170.76 15.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.251 -0.905 . . . . 0.0 110.396 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 98' ' ' ILE . 21.4 m -121.34 133.55 55.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.436 -0.79 . . . . 0.0 109.9 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.64 HD23 HG13 ' A' ' 98' ' ' ILE . 4.5 tp -100.31 126.62 46.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.826 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.497 HG12 ' HB2' ' A' ' 68' ' ' LYS . 10.6 pt -111.46 -11.95 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.201 -0.937 . . . . 0.0 110.331 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.533 ' O ' HD11 ' A' ' 85' ' ' LEU . 37.4 tp10 -128.67 167.3 17.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.183 -0.948 . . . . 0.0 110.426 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.911 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 140.99 112.84 0.98 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -48.13 -26.22 1.79 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.234 -1.157 . . . . 0.0 110.451 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.42 -19.68 65.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.197 -0.939 . . . . 0.0 110.315 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.462 ' O ' ' O ' ' A' ' 92' ' ' GLY . 64.2 mt -69.77 -31.42 69.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.143 -0.973 . . . . 0.0 110.253 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 48.65 -177.11 0.02 OUTLIER Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -79.16 3.4 17.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.19 -1.182 . . . . 0.0 110.125 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.499 HG22 ' HG ' ' A' ' 95' ' ' LEU . 1.8 m -88.46 -37.13 16.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.265 -0.897 . . . . 0.0 109.812 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.948 HD21 ' CD1' ' A' ' 128' ' ' ILE . 44.7 mt -109.72 167.19 10.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.285 -0.885 . . . . 0.0 109.936 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -147.03 -79.94 0.15 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.131 -0.981 . . . . 0.0 110.026 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.509 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 15.3 mttp -80.26 126.84 31.64 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.567 -0.708 . . . . 0.0 110.441 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.731 HG21 ' CE2' ' A' ' 100' ' ' TYR . 6.5 mm -115.37 141.65 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.775 -1.203 . . . . 0.0 109.978 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.501 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -119.09 129.7 55.21 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.433 -0.792 . . . . 0.0 108.97 178.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.731 ' CE2' HG21 ' A' ' 98' ' ' ILE . 10.0 m-85 -124.96 136.11 53.44 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.435 -0.791 . . . . 0.0 110.587 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -139.26 128.89 24.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.331 -0.856 . . . . 0.0 110.04 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 89.8 m -127.47 141.37 51.68 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.15 -0.969 . . . . 0.0 110.135 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 115' ' ' LYS . 2.5 mttt -136.52 139.65 42.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.932 . . . . 0.0 110.317 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.867 HD23 HG12 ' A' ' 114' ' ' ILE . 5.4 mt -123.27 152.63 41.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.237 -0.914 . . . . 0.0 110.093 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.711 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -149.72 -169.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.252 -0.905 . . . . 0.0 110.036 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.711 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -124.87 163.14 22.86 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.348 -0.845 . . . . 0.0 110.204 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.458 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 3.0 p -121.73 169.21 9.67 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.0 110.296 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 47.3 Cg_endo -73.03 -8.76 22.68 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.066 1.561 . . . . 0.0 110.606 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 79.8 p -102.77 9.8 38.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.187 -0.946 . . . . 0.0 110.376 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 111' ' ' GLY . . . 94.2 -36.91 3.56 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 110' ' ' GLY . . . -54.45 -174.5 0.09 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.501 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 13.9 p -135.51 136.61 41.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.161 -1.199 . . . . 0.0 110.372 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.825 ' HA ' HG22 ' A' ' 10' ' ' THR . 21.1 mt -90.38 147.08 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.324 -0.86 . . . . 0.0 110.151 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.867 HG12 HD23 ' A' ' 104' ' ' LEU . 19.3 mt -131.46 127.28 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.208 -0.933 . . . . 0.0 110.443 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.49 ' HG3' ' HG3' ' A' ' 8' ' ' GLU . 44.4 tttp -116.23 120.15 38.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.274 -0.891 . . . . 0.0 109.902 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 2.3 t -114.28 158.7 21.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.144 -0.972 . . . . 0.0 110.56 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.625 HG22 ' NE2' ' A' ' 119' ' ' HIS . 96.6 m -158.77 122.2 3.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.433 -0.792 . . . . 0.0 109.919 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.6 m -122.43 153.16 39.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 0.0 110.266 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.705 ' CE1' HG23 ' A' ' 4' ' ' THR . 28.7 m-70 -133.01 162.72 30.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.267 -0.896 . . . . 0.0 110.265 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.565 ' HD1' HD12 ' A' ' 98' ' ' ILE . 30.3 m-85 -131.68 137.98 48.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.273 -0.892 . . . . 0.0 110.466 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.509 ' HB2' ' HB2' ' A' ' 97' ' ' LYS . 69.5 m-70 -117.08 93.07 4.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.231 -0.918 . . . . 0.0 109.342 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.907 ' CG2' HD23 ' A' ' 95' ' ' LEU . 1.4 p -76.96 160.42 29.18 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.375 -0.828 . . . . 0.0 110.85 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 34.2 tttp -137.12 105.76 5.84 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.577 -0.702 . . . . 0.0 109.938 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.455 ' O ' ' CB ' ' A' ' 125' ' ' ASN . . . 126.35 20.62 1.95 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 2.7 t30 67.39 60.42 0.48 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.046 -1.267 . . . . 0.0 110.651 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.54 HG23 ' CG2' ' A' ' 122' ' ' THR . 20.5 m -138.62 145.54 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.176 -0.953 . . . . 0.0 109.739 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.439 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 92.4 mt-10 -104.37 -176.18 3.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.132 -0.98 . . . . 0.0 110.787 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.948 ' CD1' HD21 ' A' ' 95' ' ' LEU . 20.8 mm -86.17 173.39 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.375 -0.828 . . . . 0.0 110.229 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.59 ' N ' HG22 ' A' ' 128' ' ' ILE . 37.9 mttt -97.24 131.27 44.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.282 -0.886 . . . . 0.0 110.027 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.482 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 69.9 mm-40 -45.86 -41.51 11.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.093 -1.004 . . . . 0.0 110.189 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 1.009 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 39.7 tt0 -64.05 -18.01 63.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 109.975 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -93.0 -51.75 4.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 0.0 110.326 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.628 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 2.7 p -67.01 -26.43 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.893 . . . . 0.0 110.19 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -107.72 -70.05 0.82 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -0.918 . . . . 0.0 110.153 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 1.009 ' HB3' ' O ' ' A' ' 131' ' ' GLU . . . -55.55 -19.78 11.11 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.199 -0.938 . . . . 0.0 109.798 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -75.09 -28.88 61.46 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.441 ' HE2' ' O ' ' A' ' 133' ' ' VAL . 29.7 mttm -65.71 -31.66 72.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.285 -1.127 . . . . 0.0 109.951 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -79.86 -28.87 39.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.948 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -69.31 -35.38 75.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 0.0 109.939 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.03 -40.28 39.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.194 -0.941 . . . . 0.0 109.984 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.8 t -58.21 -47.49 83.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.381 -0.825 . . . . 0.0 109.937 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -54.82 -40.54 69.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.917 . . . . 0.0 109.985 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.574 ' HA ' HD12 ' A' ' 146' ' ' LEU . 21.7 mt -65.33 -39.29 92.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.89 . . . . 0.0 109.885 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.692 ' HA ' HD12 ' A' ' 147' ' ' ILE . 26.6 m-85 -62.6 -35.3 79.1 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.343 -0.848 . . . . 0.0 109.801 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 145' ' ' LYS . 21.9 tttm -71.72 -12.63 61.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.356 -0.84 . . . . 0.0 110.039 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.574 HD12 ' HA ' ' A' ' 143' ' ' LEU . 19.2 mt -83.22 -37.35 23.7 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.179 -0.951 . . . . 0.0 108.875 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.792 HD11 ' CE1' ' A' ' 22' ' ' PHE . 15.6 mt -67.57 -46.61 82.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.784 ' HB3' HD13 ' A' ' 13' ' ' ILE . 68.5 mt-10 -56.84 -45.59 82.26 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.459 -0.776 . . . . 0.0 109.516 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 23.3 m -62.84 -36.65 83.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 109.6 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.572 ' O ' ' CD2' ' A' ' 154' ' ' HIS . 87.7 t80 -54.19 -46.43 72.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.414 -0.804 . . . . 0.0 109.894 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.991 HD21 ' CE1' ' A' ' 158' ' ' TYR . 65.6 mt -79.99 -33.65 39.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.387 -0.821 . . . . 0.0 110.339 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.914 ' HB2' HD11 ' A' ' 13' ' ' ILE . 34.4 tttm -62.68 -16.86 59.16 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.229 -0.919 . . . . 0.0 109.562 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.478 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -115.3 -31.16 2.08 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.615 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 5.1 m-70 -105.95 94.2 8.78 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.36 -1.083 . . . . 0.0 110.19 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.511 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.8 Cg_endo -73.68 6.25 2.91 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.099 1.578 . . . . 0.0 111.049 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -115.42 -8.19 12.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.034 -1.041 . . . . 0.0 109.788 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.675 ' HB3' ' NH2' ' A' ' 17' ' ' ARG . . . -53.34 106.55 0.18 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.439 -0.788 . . . . 0.0 110.035 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 1.041 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 36.23 30.27 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.687 -0.633 . . . . 0.0 110.466 -179.617 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.537 ' CB ' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 118.07 -0.967 . . . . 0.0 109.661 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 92.3 t -114.04 135.1 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.288 -1.125 . . . . 0.0 110.179 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.746 ' CE1' HD12 ' A' ' 128' ' ' ILE . 13.2 m-85 -91.76 156.58 17.45 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.278 -0.889 . . . . 0.0 109.972 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.645 HG23 ' CE1' ' A' ' 119' ' ' HIS . 25.3 m -135.81 113.36 10.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.098 -1.001 . . . . 0.0 110.412 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.936 ' CE2' HG21 ' A' ' 133' ' ' VAL . 71.1 m-85 -128.46 145.22 51.17 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.372 -0.83 . . . . 0.0 109.945 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 22.1 pt-20 -140.13 152.62 46.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.139 -0.976 . . . . 0.0 110.676 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.2 p -143.06 136.37 28.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.484 -0.76 . . . . 0.0 109.624 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.415 ' HG3' ' HG3' ' A' ' 115' ' ' LYS . 4.8 tt0 -123.28 141.81 51.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.02 -1.05 . . . . 0.0 110.912 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.595 ' CE2' ' HB ' ' A' ' 114' ' ' ILE . 3.2 p90 -157.8 -178.08 7.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.517 -0.739 . . . . 0.0 109.592 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.948 HG22 ' HA ' ' A' ' 113' ' ' ILE . 11.5 p -141.53 175.42 9.7 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.057 -1.027 . . . . 0.0 110.707 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.424 ' OG ' ' CD ' ' A' ' 148' ' ' GLU . 3.5 t -159.05 161.78 36.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.502 -0.749 . . . . 0.0 110.22 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -81.34 -36.51 29.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.272 -0.893 . . . . 0.0 110.207 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.792 HG23 ' HD2' ' A' ' 14' ' ' PRO . 3.1 mp -60.68 150.4 75.74 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.347 -0.845 . . . . 0.0 109.869 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.792 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.1 Cg_endo -65.1 142.31 73.62 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.878 1.462 . . . . 0.0 110.59 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.627 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.0 Cg_endo -73.01 -30.82 10.46 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 124.042 1.549 . . . . 0.0 113.049 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 45.0 Cg_endo -73.12 -20.27 21.82 Favored 'Trans proline' 0 C--N 1.317 -1.114 0 N-CA-C 110.125 -0.76 . . . . 0.0 110.125 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.72 ' HG2' HD13 ' A' ' 151' ' ' LEU . 39.7 ttm180 -83.53 -50.52 8.18 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.772 ' C ' HD23 ' A' ' 18' ' ' LEU . 1.1 tt -62.14 -25.98 68.05 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.486 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 52.5 t80 -68.76 -55.38 11.47 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.537 0.684 . . . . 0.0 109.449 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.552 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 15.8 mttt -49.55 -33.69 15.52 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.173 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.881 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -78.98 -50.52 10.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.346 -0.846 . . . . 0.0 110.725 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 1.042 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -62.74 -37.41 86.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.496 -0.752 . . . . 0.0 111.47 -178.809 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.728 HG13 ' CE1' ' A' ' 81' ' ' TYR . 3.3 t -109.4 -55.62 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 120.973 -1.079 . . . . 0.0 111.731 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.733 HD12 ' N ' ' A' ' 24' ' ' LEU . 7.3 mp -76.43 0.1 20.92 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.998 -1.064 . . . . 0.0 111.278 -178.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.685 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -152.19 16.52 0.64 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.876 -1.14 . . . . 0.0 110.452 179.729 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 1.042 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -55.66 -41.62 73.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.164 -0.96 . . . . 0.0 109.891 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.451 ' HA ' ' CB ' ' A' ' 41' ' ' SER . 76.5 m-20 -57.26 -24.26 53.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.288 -0.883 . . . . 0.0 110.075 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.496 ' HB3' ' HE3' ' A' ' 32' ' ' LYS . 77.6 m-20 -120.45 13.9 11.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.383 -0.823 . . . . 0.0 110.056 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.736 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -100.78 -46.24 5.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.885 . . . . 0.0 110.094 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 1.016 HG11 HD13 ' A' ' 38' ' ' ILE . 2.8 t -70.22 -42.41 16.28 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.362 -0.836 . . . . 0.0 110.781 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 30' ' ' VAL . 46.9 Cg_endo -76.4 4.54 5.37 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.482 1.254 . . . . 0.0 110.671 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.496 ' HE3' ' HB3' ' A' ' 28' ' ' ASN . 21.1 mttm -120.02 -32.22 4.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.935 . . . . 0.0 109.077 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.607 HG12 ' CD1' ' A' ' 150' ' ' TYR . 6.8 mt -80.05 -35.27 15.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.444 0.64 . . . . 0.0 109.588 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -160.44 98.17 1.42 Allowed Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.442 -0.786 . . . . 0.0 110.17 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.22 0.1 8.4 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.989 1.521 . . . . 0.0 110.678 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -90.57 -19.37 23.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.141 -0.974 . . . . 0.0 110.36 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.92 -42.65 11.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.184 -0.948 . . . . 0.0 110.369 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 1.016 HD13 HG11 ' A' ' 30' ' ' VAL . 1.1 mp -128.81 144.13 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.415 -0.803 . . . . 0.0 110.328 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.467 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 37.9 ttmt -78.97 -41.76 28.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.325 -0.86 . . . . 0.0 109.854 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.545 ' C ' ' CD2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -178.42 161.57 1.39 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.327 -0.858 . . . . 0.0 110.166 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.451 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 15.5 m -123.3 122.39 38.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.138 -0.976 . . . . 0.0 110.037 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -127.9 111.91 14.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.183 -0.948 . . . . 0.0 110.558 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.447 HG13 ' OD2' ' A' ' 27' ' ' ASP . 24.9 mt -60.05 143.73 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.304 -0.873 . . . . 0.0 109.948 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.539 HD12 ' HB2' ' A' ' 55' ' ' LYS . 1.5 mt -119.26 -26.28 5.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 110.487 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.881 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.6 m95 -123.09 162.03 23.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.162 -0.961 . . . . 0.0 110.496 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.451 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 42.08 -141.95 1.45 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -149.08 24.6 0.92 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -1.13 . . . . 0.0 110.335 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 120.59 -15.59 9.78 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.441 ' O ' ' HB ' ' A' ' 71' ' ' ILE . . . -77.82 -172.87 39.69 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.501 ' HA ' HG22 ' A' ' 71' ' ' ILE . 43.5 Cg_endo -72.04 129.43 15.21 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 O-C-N 123.987 1.519 . . . . 0.0 110.59 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.43 -14.09 47.2 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.564 -1.814 . . . . 0.0 108.564 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -70.63 164.43 24.98 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.51 -0.994 . . . . 0.0 109.581 179.67 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.881 HD12 ' CG ' ' A' ' 45' ' ' TRP . 51.7 mt -135.28 121.23 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 109.997 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 96.2 mttt -107.77 140.72 40.42 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.187 -0.946 . . . . 0.0 110.401 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.539 ' HB2' HD12 ' A' ' 44' ' ' LEU . 25.9 tttt -109.2 90.6 3.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.243 -0.911 . . . . 0.0 110.144 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.562 ' CG2' HG12 ' A' ' 38' ' ' ILE . 82.1 mt -80.04 140.51 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.233 -0.917 . . . . 0.0 110.289 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.516 ' O ' HG23 ' A' ' 38' ' ' ILE . 3.0 p -111.11 158.66 18.62 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.311 -0.868 . . . . 0.0 110.83 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.725 ' HE2' HG13 ' A' ' 67' ' ' VAL . 29.8 m-85 -116.33 133.82 55.58 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.175 -0.953 . . . . 0.0 110.105 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.342 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.876 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.144 0.497 . . . . 0.0 110.24 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -129.61 90.44 0.31 Allowed Glycine 0 N--CA 1.487 2.04 0 N-CA-C 108.29 -1.924 . . . . 0.0 108.29 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.532 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 16.9 p90 -140.36 165.45 27.38 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.055 -1.262 . . . . 0.0 110.304 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.893 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.1 m -131.54 173.48 14.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.459 -0.776 . . . . 0.0 110.321 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.518 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 22.9 mttt -125.49 124.5 41.51 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.62 -0.675 . . . . 0.0 109.656 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.508 ' NE2' HD13 ' A' ' 85' ' ' LEU . 14.7 m170 -112.29 122.01 46.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.191 -0.943 . . . . 0.0 110.777 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 52' ' ' THR . 86.6 tttt -98.62 111.23 23.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.184 -0.948 . . . . 0.0 109.516 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.518 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 24.1 mm -52.46 130.19 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.117 -0.989 . . . . 0.0 109.979 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.501 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 11.9 t0 -108.83 -45.86 3.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.354 -0.841 . . . . 0.0 110.377 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.3 m -164.91 157.68 16.4 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.317 -0.865 . . . . 0.0 109.921 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.544 HG12 HG11 ' A' ' 23' ' ' VAL . 1.9 mt -142.96 158.05 17.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.249 -0.907 . . . . 0.0 110.496 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.565 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 3.1 m-20 -132.79 77.81 1.76 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 120.078 -0.649 . . . . 0.0 109.973 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.486 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 84.4 mttt -61.26 -15.65 37.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.133 -0.979 . . . . 0.0 110.413 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -93.33 -31.06 14.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.191 -0.943 . . . . 0.0 109.645 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.483 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -106.69 -5.41 18.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.574 -0.704 . . . . 0.0 109.796 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.562 ' O ' HD12 ' A' ' 104' ' ' LEU . 5.3 m-85 66.02 50.46 1.45 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.504 -0.747 . . . . 0.0 110.292 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.565 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -120.12 154.67 34.39 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 0.0 109.447 179.51 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.728 ' CE1' HG13 ' A' ' 23' ' ' VAL . 24.5 t80 -142.94 129.74 20.45 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.117 -0.99 . . . . 0.0 110.439 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.48 ' OG ' ' HG3' ' A' ' 101' ' ' GLU . 73.8 m -136.41 120.33 17.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.397 -0.814 . . . . 0.0 110.332 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.642 ' CE2' ' CB ' ' A' ' 100' ' ' TYR . 11.8 p90 -135.06 174.92 10.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.272 -0.893 . . . . 0.0 110.207 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 98' ' ' ILE . 29.3 m -123.73 127.35 48.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.371 -0.831 . . . . 0.0 110.104 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.686 HD23 HG13 ' A' ' 98' ' ' ILE . 5.1 tp -95.37 136.62 35.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.302 -0.874 . . . . 0.0 109.669 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.4 pt -123.59 -14.61 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.233 -0.917 . . . . 0.0 110.48 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.518 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 20.2 tt0 -129.93 129.25 43.6 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.054 -1.029 . . . . 0.0 110.675 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.893 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 177.68 128.54 1.17 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -59.52 -13.66 9.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -1.134 . . . . 0.0 110.415 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.696 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -83.52 -32.01 26.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 110.299 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.599 HD13 ' O ' ' A' ' 96' ' ' GLU . 1.8 pp -90.99 -27.42 18.68 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.28 -0.888 . . . . 0.0 110.569 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.505 ' N ' ' HG ' ' A' ' 91' ' ' LEU . . . -59.69 -31.89 72.52 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.733 ' O ' HG23 ' A' ' 94' ' ' THR . 87.2 m-20 -45.5 -40.02 7.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -1.168 . . . . 0.0 110.414 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.733 HG23 ' O ' ' A' ' 93' ' ' ASP . 1.3 p -160.03 -33.73 0.06 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.274 -0.891 . . . . 0.0 110.682 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.777 HD21 HG13 ' A' ' 128' ' ' ILE . 1.6 mm? -79.99 167.47 20.42 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.14 -0.975 . . . . 0.0 110.656 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.599 ' O ' HD13 ' A' ' 91' ' ' LEU . 43.6 tt0 -128.36 -77.72 0.56 Allowed 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.489 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 89.4 mttt -80.19 145.13 32.43 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.621 -0.675 . . . . 0.0 109.565 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.732 HG21 ' CE2' ' A' ' 100' ' ' TYR . 8.0 mm -128.45 143.31 41.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 120.733 -1.229 . . . . 0.0 110.11 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.484 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -117.04 128.26 54.98 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.404 -0.81 . . . . 0.0 109.362 179.076 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.732 ' CE2' HG21 ' A' ' 98' ' ' ILE . 8.7 m-85 -124.38 134.05 53.24 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.216 -0.928 . . . . 0.0 110.256 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.48 ' HG3' ' OG ' ' A' ' 82' ' ' SER . 81.6 tt0 -138.58 133.74 32.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.254 -0.904 . . . . 0.0 110.333 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.471 ' N ' ' O ' ' A' ' 81' ' ' TYR . 41.2 m -131.75 152.62 50.8 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.225 -0.922 . . . . 0.0 110.091 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 115' ' ' LYS . 6.8 mttm -146.73 138.14 24.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.2 -0.938 . . . . 0.0 110.507 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.868 HD23 HG12 ' A' ' 114' ' ' ILE . 5.7 mt -120.0 152.09 38.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.205 -0.934 . . . . 0.0 109.831 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.707 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -148.65 -169.45 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.046 -1.034 . . . . 0.0 110.129 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.707 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -123.94 163.52 21.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.332 -0.855 . . . . 0.0 110.195 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.467 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 3.0 p -122.48 169.62 9.36 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.246 -0.909 . . . . 0.0 110.201 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.8 Cg_endo -72.9 -9.01 23.2 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.061 1.559 . . . . 0.0 110.491 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.8 p -103.16 9.6 38.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.24 -0.913 . . . . 0.0 110.274 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 111' ' ' GLY . . . 94.54 -39.43 2.9 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 110' ' ' GLY . . . -51.66 -176.44 0.03 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.507 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.4 p -133.68 135.92 44.4 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -1.163 . . . . 0.0 110.467 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.948 ' HA ' HG22 ' A' ' 10' ' ' THR . 17.2 mt -88.78 148.0 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -0.845 . . . . 0.0 109.716 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.868 HG12 HD23 ' A' ' 104' ' ' LEU . 18.8 mt -131.89 121.87 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.238 -0.914 . . . . 0.0 110.58 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 103' ' ' LYS . 14.4 tttp -109.99 128.63 55.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.0 109.787 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.9 152.41 44.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.094 -1.004 . . . . 0.0 110.444 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.662 HG22 ' NE2' ' A' ' 119' ' ' HIS . 38.6 m -152.56 134.91 15.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 110.094 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.441 ' C ' ' CD2' ' A' ' 119' ' ' HIS . 14.4 m -133.44 156.5 47.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.273 -0.892 . . . . 0.0 110.135 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.662 ' NE2' HG22 ' A' ' 117' ' ' THR . 20.2 m-70 -140.77 170.04 16.51 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.168 -0.957 . . . . 0.0 110.423 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.74 ' CB ' HD11 ' A' ' 128' ' ' ILE . 8.8 m-85 -129.7 156.36 44.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.306 -0.871 . . . . 0.0 110.453 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.489 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 83.6 m-70 -135.13 96.75 3.56 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.211 -0.93 . . . . 0.0 109.545 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.609 HG22 HD13 ' A' ' 95' ' ' LEU . 6.1 p -64.48 160.7 18.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.395 -0.816 . . . . 0.0 110.925 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.411 ' HB2' ' HB2' ' A' ' 96' ' ' GLU . 28.7 tttt -119.57 90.94 3.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.493 -0.754 . . . . 0.0 110.17 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 108.95 -109.22 2.75 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -132.15 79.8 1.88 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.253 -1.145 . . . . 0.0 110.252 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.575 HG23 ' HB ' ' A' ' 122' ' ' THR . 7.9 m -146.63 179.5 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.321 -0.862 . . . . 0.0 110.048 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.508 ' CG ' ' O ' ' A' ' 126' ' ' VAL . 81.7 mt-10 -156.13 167.09 31.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.203 -0.936 . . . . 0.0 110.277 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.777 HG13 HD21 ' A' ' 95' ' ' LEU . 2.8 mp -88.7 172.43 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.231 -0.918 . . . . 0.0 110.16 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.599 ' N ' HG22 ' A' ' 128' ' ' ILE . 8.8 mttm -110.42 127.61 55.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.376 -0.827 . . . . 0.0 109.729 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.487 ' HB3' ' CE ' ' A' ' 134' ' ' LYS . 93.6 mt-10 -44.7 -49.27 10.54 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.112 -0.993 . . . . 0.0 109.904 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.509 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 44.8 tt0 -52.83 -20.6 3.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.646 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.696 ' NE2' ' HB1' ' A' ' 90' ' ' ALA . 12.3 t-160 -87.21 -63.72 1.26 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.456 -0.777 . . . . 0.0 110.031 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.936 HG21 ' CE2' ' A' ' 5' ' ' TYR . 8.3 p -59.86 -38.56 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.339 -0.851 . . . . 0.0 109.834 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.509 ' N ' HG13 ' A' ' 133' ' ' VAL . 55.9 mttm -69.65 -46.51 65.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 0.0 109.743 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.509 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -65.6 -30.79 71.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.295 -0.878 . . . . 0.0 109.801 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.47 -32.79 75.75 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 39.9 mttt -61.87 -33.93 75.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.374 -1.074 . . . . 0.0 109.845 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.504 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 83.0 tt0 -83.89 -33.76 24.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 109.842 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 46.1 mttm -71.06 -34.57 71.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.433 -0.792 . . . . 0.0 109.741 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.98 -40.62 46.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.366 -0.833 . . . . 0.0 109.829 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.0 t -60.92 -39.41 89.27 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.429 -0.795 . . . . 0.0 109.929 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 138' ' ' GLU . 75.9 m-20 -60.46 -45.05 95.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.266 -0.896 . . . . 0.0 109.955 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.437 ' HA ' HD12 ' A' ' 146' ' ' LEU . 46.7 mt -59.68 -40.02 86.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.296 -0.878 . . . . 0.0 110.009 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -61.07 -40.4 93.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.449 -0.782 . . . . 0.0 109.95 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.431 ' HA ' ' OE1' ' A' ' 148' ' ' GLU . 87.6 mttt -70.37 -13.96 62.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.286 -0.884 . . . . 0.0 109.98 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.545 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 35.1 mt -83.84 -36.7 23.27 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.196 -0.94 . . . . 0.0 108.83 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.718 HD11 ' CE1' ' A' ' 22' ' ' PHE . 47.4 mt -68.32 -46.55 80.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.555 ' HB3' HD13 ' A' ' 13' ' ' ILE . 74.1 mt-10 -53.27 -44.57 68.33 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.361 -0.837 . . . . 0.0 109.284 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.428 ' O ' ' C ' ' A' ' 150' ' ' TYR . 42.3 m -70.31 -40.88 73.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.33 -0.856 . . . . 0.0 109.388 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.664 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 86.8 t80 -43.11 -45.32 5.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.444 -0.785 . . . . 0.0 109.73 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.158 HD21 ' CE2' ' A' ' 158' ' ' TYR . 51.3 mt -80.05 -45.62 17.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.37 -0.831 . . . . 0.0 110.459 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.735 ' HB2' HD11 ' A' ' 13' ' ' ILE . 21.7 ttpp -59.72 -15.23 18.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.365 -0.834 . . . . 0.0 109.525 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -112.41 -29.95 3.03 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.56 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 7.1 m-70 -114.18 96.01 40.82 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.294 -1.121 . . . . 0.0 110.012 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.423 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.1 Cg_endo -73.52 5.96 3.0 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.161 1.611 . . . . 0.0 111.267 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -108.28 -7.22 15.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.908 -1.12 . . . . 0.0 109.82 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.664 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -75.63 101.72 5.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.435 -0.791 . . . . 0.0 110.147 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 1.158 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.3 OUTLIER 34.71 32.67 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.461 0.648 . . . . 0.0 110.288 -179.417 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.527 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.871 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.657 HG11 ' CE1' ' A' ' 121' ' ' HIS . 22.2 t -124.21 138.24 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -1.139 . . . . 0.0 110.403 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.71 ' CE1' HD12 ' A' ' 128' ' ' ILE . 9.5 m-85 -103.21 156.57 17.62 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.318 -0.864 . . . . 0.0 109.897 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.599 HG23 ' CE1' ' A' ' 119' ' ' HIS . 7.1 m -126.58 112.75 15.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.131 -0.981 . . . . 0.0 110.592 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 1.036 ' CE1' HG11 ' A' ' 133' ' ' VAL . 59.7 m-85 -120.6 143.71 48.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.183 -0.948 . . . . 0.0 110.177 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 21.9 pt-20 -144.7 152.74 40.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.173 -0.954 . . . . 0.0 110.33 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.462 ' O ' ' CG ' ' A' ' 8' ' ' GLU . 2.3 t -128.23 171.1 12.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.334 -0.854 . . . . 0.0 109.989 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.462 ' CG ' ' O ' ' A' ' 7' ' ' SER . 78.7 mt-10 -154.18 115.98 4.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.931 . . . . 0.0 110.422 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.3 p90 -147.93 -174.65 4.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.396 -0.815 . . . . 0.0 109.731 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.867 HG22 ' HA ' ' A' ' 113' ' ' ILE . 7.7 p -141.91 175.66 9.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.091 -1.006 . . . . 0.0 110.527 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.469 ' HB2' ' HG2' ' A' ' 148' ' ' GLU . 85.6 p -157.36 126.91 6.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.543 -0.723 . . . . 0.0 110.23 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.45 ' HA ' ' HA2' ' A' ' 111' ' ' GLY . 98.2 mt-10 -53.64 -35.14 60.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.288 -0.882 . . . . 0.0 110.053 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.824 HG23 ' HD2' ' A' ' 14' ' ' PRO . 2.5 mp -65.18 150.78 95.07 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.309 -0.869 . . . . 0.0 109.881 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.824 ' HD2' HG23 ' A' ' 13' ' ' ILE . 41.8 Cg_endo -67.4 142.72 60.83 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.965 1.508 . . . . 0.0 110.619 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.667 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.6 Cg_endo -72.63 -31.04 11.24 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 124.036 1.545 . . . . 0.0 112.811 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.667 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.1 Cg_endo -70.18 -20.65 32.6 Favored 'Trans proline' 0 N--CA 1.485 1.013 0 N-CA-C 110.145 -0.752 . . . . 0.0 110.145 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.604 ' CZ ' HD22 ' A' ' 151' ' ' LEU . 43.4 mtp180 -84.71 -48.98 8.89 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.773 ' C ' HD23 ' A' ' 18' ' ' LEU . 1.3 tt -67.89 -28.36 67.45 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.571 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 83.5 t80 -68.39 -61.41 1.85 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.435 -0.791 . . . . 0.0 109.067 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.521 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 34.2 mttm -46.6 -32.81 3.69 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.751 -0.78 . . . . 0.0 109.114 179.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.047 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -79.85 -40.55 28.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.358 -0.839 . . . . 0.0 110.64 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.982 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -70.98 -42.51 69.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.33 -0.856 . . . . 0.0 111.429 -178.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.621 HG13 ' CE1' ' A' ' 81' ' ' TYR . 4.3 t -104.18 -51.53 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.064 -1.023 . . . . 0.0 111.47 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.694 HD12 ' N ' ' A' ' 24' ' ' LEU . 7.4 mp -80.05 0.44 31.83 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.183 -0.948 . . . . 0.0 111.37 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.594 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -155.66 30.44 0.37 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.838 -1.164 . . . . 0.0 110.97 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.982 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -70.27 -28.81 65.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.105 -0.997 . . . . 0.0 109.86 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.491 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 60.9 m-20 -68.18 -12.44 60.94 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.297 -0.877 . . . . 0.0 109.848 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.554 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 79.8 m-20 -131.0 8.86 4.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.351 -0.843 . . . . 0.0 109.948 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.697 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -94.4 -49.99 5.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.356 -0.84 . . . . 0.0 110.466 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.958 HG21 HD13 ' A' ' 38' ' ' ILE . 6.6 p -77.87 -26.94 0.54 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.367 -0.833 . . . . 0.0 112.457 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.795 ' HD3' HG12 ' A' ' 30' ' ' VAL . 50.5 Cg_endo -78.25 7.17 4.22 Favored 'Trans proline' 0 C--N 1.319 -0.994 0 O-C-N 122.592 0.785 . . . . 0.0 110.703 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -135.38 -32.9 0.91 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.23 -0.919 . . . . 0.0 110.066 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.546 HG12 ' CD1' ' A' ' 150' ' ' TYR . 9.6 mt -80.0 -40.05 20.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.363 -0.836 . . . . 0.0 109.993 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -158.96 98.61 1.65 Allowed Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.275 -0.89 . . . . 0.0 110.374 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.04 2.31 6.8 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.032 1.543 . . . . 0.0 110.585 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -88.75 -16.17 32.87 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.186 -0.946 . . . . 0.0 110.129 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.645 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -95.92 -32.7 12.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 110.256 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.958 HD13 HG21 ' A' ' 30' ' ' VAL . 1.1 mp -145.81 133.91 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.338 -0.851 . . . . 0.0 109.883 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 57' ' ' THR . 27.7 ttpp -82.63 -25.98 32.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.886 . . . . 0.0 110.44 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.539 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -175.31 157.84 2.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.194 -0.941 . . . . 0.0 110.261 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.2 m -135.45 121.29 19.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.421 -0.8 . . . . 0.0 109.565 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.539 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 48.3 tt0 -138.88 111.81 7.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.006 -1.059 . . . . 0.0 110.689 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.44 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 27.9 mt -50.63 143.24 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.412 -0.805 . . . . 0.0 109.896 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 11.6 tp -116.83 -21.8 8.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.308 -0.87 . . . . 0.0 110.348 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.733 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.7 m95 -131.5 163.29 28.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.237 -0.915 . . . . 0.0 110.615 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.451 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 42.63 -134.25 4.44 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -155.51 19.12 0.4 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -1.108 . . . . 0.0 110.231 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.69 -16.21 7.0 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.494 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -74.81 -173.73 31.94 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.415 ' HA ' HG22 ' A' ' 71' ' ' ILE . 44.6 Cg_endo -72.97 129.53 14.38 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 124.055 1.555 . . . . 0.0 110.466 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.3 -14.96 47.31 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.52 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -69.86 167.38 17.43 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.521 -0.988 . . . . 0.0 109.463 179.536 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.733 HD12 ' CG ' ' A' ' 45' ' ' TRP . 43.3 mt -134.94 120.75 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.202 -0.936 . . . . 0.0 110.18 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.488 ' HD2' HD11 ' A' ' 71' ' ' ILE . 17.7 mtpt -102.91 130.48 49.97 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.193 -0.942 . . . . 0.0 110.111 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -98.42 91.57 5.25 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.184 -0.948 . . . . 0.0 109.906 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.549 ' CG2' HG12 ' A' ' 38' ' ' ILE . 93.4 mt -80.02 138.73 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.371 -0.831 . . . . 0.0 110.046 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 3.1 p -114.93 155.9 26.02 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.232 -0.918 . . . . 0.0 110.476 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.594 ' CZ ' HG22 ' A' ' 67' ' ' VAL . 20.1 m-85 -117.93 142.46 47.32 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.358 -0.839 . . . . 0.0 110.038 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.98 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.259 0.552 . . . . 0.0 110.27 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -140.74 113.38 0.86 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.539 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 15.6 p90 -154.65 170.65 21.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.082 -1.246 . . . . 0.0 110.122 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.897 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.0 m -141.28 174.52 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.27 -0.894 . . . . 0.0 110.764 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.507 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 25.1 mttt -126.21 120.7 30.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.547 -0.72 . . . . 0.0 109.489 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.729 ' CD2' HD12 ' A' ' 85' ' ' LEU . 18.3 m170 -108.76 129.13 55.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.223 -0.923 . . . . 0.0 111.037 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 52' ' ' THR . 44.3 tttp -100.43 112.95 25.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.225 -0.922 . . . . 0.0 109.474 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.537 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 31.0 mm -52.08 130.77 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.1 -1.0 . . . . 0.0 110.239 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.458 ' OD2' ' OG1' ' A' ' 84' ' ' THR . 58.8 m-20 -106.45 -36.85 6.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 0.0 110.258 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.647 ' C ' HD12 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -178.55 166.24 1.77 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.178 -0.952 . . . . 0.0 109.635 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.647 HD12 ' C ' ' A' ' 73' ' ' SER . 0.9 OUTLIER -151.82 155.9 6.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 119.016 -1.074 . . . . 0.0 111.386 -179.682 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.508 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 2.3 m-20 -132.78 76.12 1.67 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.303 0.573 . . . . 0.0 109.919 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.571 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 45.9 mttt -60.83 -12.51 11.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.226 -0.921 . . . . 0.0 110.406 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -92.82 -31.97 14.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.298 -0.876 . . . . 0.0 109.483 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.48 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -107.43 -6.16 17.25 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.534 -0.729 . . . . 0.0 109.839 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.774 ' O ' HD12 ' A' ' 104' ' ' LEU . 4.0 m-85 69.11 48.83 0.66 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.558 -0.714 . . . . 0.0 110.183 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.508 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.5 OUTLIER -119.58 147.18 44.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.232 -0.917 . . . . 0.0 109.543 179.626 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.68 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 76.1 t80 -140.35 143.28 35.67 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.093 -1.004 . . . . 0.0 110.6 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.447 ' C ' ' HB2' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -148.69 141.26 24.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -0.877 . . . . 0.0 110.098 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.68 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 10.7 p90 -151.52 175.66 12.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.144 -0.973 . . . . 0.0 110.699 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 98' ' ' ILE . 6.5 m -122.58 127.84 49.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.467 -0.771 . . . . 0.0 109.688 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.729 HD12 ' CD2' ' A' ' 69' ' ' HIS . 2.9 tp -94.98 128.25 41.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.166 -0.959 . . . . 0.0 110.314 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 14.3 pt -114.81 0.51 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.33 -0.856 . . . . 0.0 110.392 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.507 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 72.4 tt0 -149.32 154.42 38.96 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.253 -0.904 . . . . 0.0 110.198 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.897 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 150.94 130.55 1.72 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -57.34 -16.04 7.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.329 -1.1 . . . . 0.0 110.2 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.419 ' O ' ' CE1' ' A' ' 132' ' ' HIS . . . -66.44 -30.28 70.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.225 -0.922 . . . . 0.0 110.201 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 21.1 mt -58.06 -15.57 9.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -0.866 . . . . 0.0 110.036 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.765 ' O ' HG23 ' A' ' 94' ' ' THR . . . 48.12 30.73 7.77 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 92' ' ' GLY . 93.1 m-20 56.56 15.36 2.05 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.251 -1.147 . . . . 0.0 110.379 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.765 HG23 ' O ' ' A' ' 92' ' ' GLY . 65.6 p -108.18 -52.78 2.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.931 . . . . 0.0 109.604 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 1.018 HD21 ' CG1' ' A' ' 128' ' ' ILE . 14.9 mt -80.36 164.1 23.38 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.499 -0.751 . . . . 0.0 109.741 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.444 ' OE1' ' HD3' ' A' ' 123' ' ' LYS . 42.3 tt0 -132.19 -78.35 0.5 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 110.326 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.513 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 54.6 mttt -80.2 128.4 33.48 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.49 -0.756 . . . . 0.0 110.638 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.757 HG21 ' CE2' ' A' ' 100' ' ' TYR . 4.7 mm -120.45 141.53 40.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 120.682 -1.261 . . . . 0.0 109.692 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.491 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -122.38 126.59 48.33 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.429 -0.794 . . . . 0.0 108.986 178.79 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.757 ' CE2' HG21 ' A' ' 98' ' ' ILE . 12.7 m-85 -122.59 133.51 54.54 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.294 -0.879 . . . . 0.0 110.491 -179.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.509 ' N ' ' O ' ' A' ' 117' ' ' THR . 49.6 tt0 -136.24 134.38 38.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.36 -0.837 . . . . 0.0 110.259 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 94.0 m -131.67 140.56 49.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.263 -0.898 . . . . 0.0 110.069 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.76 139.34 50.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.307 -0.871 . . . . 0.0 110.229 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.784 HD23 HG12 ' A' ' 114' ' ' ILE . 11.4 mt -115.51 149.74 37.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.345 -0.847 . . . . 0.0 109.991 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.704 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -150.44 -168.43 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.202 -0.936 . . . . 0.0 110.21 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.704 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -121.37 158.47 28.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.285 -0.884 . . . . 0.0 110.115 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.471 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 9.5 p -114.91 167.04 10.44 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.19 -0.944 . . . . 0.0 110.321 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.9 Cg_endo -72.23 -4.23 14.82 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.074 1.565 . . . . 0.0 110.39 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 65.4 m -107.06 0.7 23.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.238 -0.914 . . . . 0.0 110.245 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.63 -41.07 2.26 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 12' ' ' GLU . . . -54.31 -177.61 0.13 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.517 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 6.7 p -124.61 140.29 53.08 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.226 -1.161 . . . . 0.0 110.321 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.867 ' HA ' HG22 ' A' ' 10' ' ' THR . 19.5 mt -92.9 147.55 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.33 -0.857 . . . . 0.0 110.129 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.784 HG12 HD23 ' A' ' 104' ' ' LEU . 8.7 mt -130.96 126.89 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.283 -0.886 . . . . 0.0 110.144 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -119.72 111.15 17.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.154 -0.966 . . . . 0.0 110.144 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 2.4 m -96.64 159.71 14.78 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.229 -0.919 . . . . 0.0 110.552 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 101' ' ' GLU . 25.4 m -160.11 117.98 2.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.516 -0.74 . . . . 0.0 109.959 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 99' ' ' SER . 96.7 p -125.31 161.78 26.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.09 -1.006 . . . . 0.0 110.453 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.599 ' CE1' HG23 ' A' ' 4' ' ' THR . 62.9 m-70 -140.15 131.84 27.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.307 -0.871 . . . . 0.0 110.225 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.72 ' CD2' HD13 ' A' ' 95' ' ' LEU . 3.2 m-85 -98.16 148.15 23.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.393 -0.817 . . . . 0.0 109.672 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.657 ' CE1' HG11 ' A' ' 2' ' ' VAL . 88.6 m-70 -129.13 93.19 3.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.055 -1.028 . . . . 0.0 110.054 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.661 ' CG2' HD23 ' A' ' 95' ' ' LEU . 2.0 p -66.41 156.93 33.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.249 -0.907 . . . . 0.0 110.228 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.444 ' HD3' ' OE1' ' A' ' 96' ' ' GLU . 17.6 tptt -116.54 115.83 26.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.336 -0.852 . . . . 0.0 110.197 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 99.57 -118.28 6.13 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -132.82 73.11 1.51 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.189 -1.183 . . . . 0.0 110.166 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.544 HG23 ' CG2' ' A' ' 122' ' ' THR . 14.1 m -139.69 153.11 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.262 -0.899 . . . . 0.0 110.154 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -126.37 170.04 12.34 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.215 -0.928 . . . . 0.0 110.28 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 1.018 ' CG1' HD21 ' A' ' 95' ' ' LEU . 3.4 mp -100.01 172.77 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.191 -0.943 . . . . 0.0 110.161 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.602 ' N ' HG22 ' A' ' 128' ' ' ILE . 10.5 mttt -116.32 132.18 56.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.896 . . . . 0.0 109.811 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 129' ' ' LYS . 95.0 mt-10 -42.55 -42.96 3.54 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.266 -0.897 . . . . 0.0 110.185 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -52.4 -37.99 57.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.157 -0.964 . . . . 0.0 109.911 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.419 ' CE1' ' O ' ' A' ' 90' ' ' ALA . 13.7 t-160 -74.54 -57.45 3.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.331 -0.856 . . . . 0.0 110.072 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 1.036 HG11 ' CE1' ' A' ' 5' ' ' TYR . 79.4 t -58.97 -36.35 61.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.421 -0.799 . . . . 0.0 109.891 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 31.0 tttt -71.69 -44.07 64.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.3 -0.875 . . . . 0.0 109.945 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.47 -27.55 68.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.998 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -74.15 -28.64 63.85 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -73.41 -34.04 65.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.294 -1.121 . . . . 0.0 110.006 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -82.1 -31.46 30.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 109.967 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.573 ' O ' HD12 ' A' ' 143' ' ' LEU . 43.3 mttm -72.57 -33.95 67.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.889 . . . . 0.0 110.004 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -80.31 -34.4 36.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 110.123 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 71.4 m -63.66 -41.56 98.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.332 -0.855 . . . . 0.0 110.045 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -58.66 -45.16 89.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.273 -0.892 . . . . 0.0 110.105 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.573 HD12 ' O ' ' A' ' 139' ' ' LYS . 2.6 mt -61.03 -40.25 92.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -0.885 . . . . 0.0 110.104 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.408 ' CE1' ' CE2' ' A' ' 22' ' ' PHE . 17.6 m-85 -62.35 -34.06 75.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.377 -0.827 . . . . 0.0 109.961 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 145' ' ' LYS . 30.3 tttm -76.04 -14.18 60.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.338 -0.851 . . . . 0.0 110.24 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 19.6 mt -84.07 -37.13 22.47 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.059 -1.026 . . . . 0.0 109.023 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.791 HD11 ' CE1' ' A' ' 22' ' ' PHE . 24.5 mt -69.14 -43.32 81.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.581 ' HB3' HD13 ' A' ' 13' ' ' ILE . 83.8 mt-10 -53.04 -44.65 67.56 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.392 -0.818 . . . . 0.0 109.347 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 28.5 m -66.69 -33.13 74.97 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 109.762 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.628 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 89.3 t80 -55.02 -49.65 71.0 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.409 -0.807 . . . . 0.0 110.04 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.021 HD21 ' CE1' ' A' ' 158' ' ' TYR . 74.7 mt -76.17 -36.08 58.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -0.872 . . . . 0.0 110.419 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.754 ' HB2' HD11 ' A' ' 13' ' ' ILE . 8.5 tttp -60.19 -15.35 23.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.253 -0.905 . . . . 0.0 109.308 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.492 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -120.05 -24.12 2.82 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.577 ' CD2' ' O ' ' A' ' 150' ' ' TYR . 12.9 m-70 -106.1 92.41 6.57 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.296 -1.12 . . . . 0.0 110.162 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.4 Cg_endo -73.2 4.17 4.02 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.025 1.54 . . . . 0.0 110.937 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -120.33 -6.73 9.83 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.994 -1.066 . . . . 0.0 109.919 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.675 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -53.91 106.11 0.17 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.889 . . . . 0.0 109.826 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 1.047 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 36.23 30.38 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.661 -0.649 . . . . 0.0 110.518 -179.466 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.542 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.802 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.984 HG23 ' C ' ' A' ' 120' ' ' TYR . 2.6 p -79.96 149.54 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.357 -1.084 . . . . 0.0 110.712 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.788 ' CE2' HD12 ' A' ' 128' ' ' ILE . 5.1 m-85 -86.74 169.65 12.45 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.664 -0.647 . . . . 0.0 110.145 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.536 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 3.3 m -123.82 129.82 51.63 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.102 -0.999 . . . . 0.0 110.47 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.584 ' CE2' ' HB2' ' A' ' 3' ' ' PHE . 39.1 m-85 -142.68 133.72 25.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.316 -0.865 . . . . 0.0 110.028 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.608 ' CG ' HG23 ' A' ' 117' ' ' THR . 30.9 mt-10 -143.9 145.22 32.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -0.926 . . . . 0.0 110.515 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.479 ' O ' ' HG2' ' A' ' 8' ' ' GLU . 5.6 t -118.5 169.88 9.4 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.395 -0.815 . . . . 0.0 109.85 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 7' ' ' SER . 60.7 mt-10 -152.53 123.07 7.29 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.14 -0.975 . . . . 0.0 110.643 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.637 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 1.9 p90 -148.93 -176.94 5.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.406 -0.809 . . . . 0.0 109.735 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.726 HG22 ' HA ' ' A' ' 113' ' ' ILE . 11.1 p -139.23 -179.91 6.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.132 -0.98 . . . . 0.0 110.696 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.2 t -159.99 168.65 25.16 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.429 -0.794 . . . . 0.0 110.102 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -92.04 -28.78 16.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.162 -0.961 . . . . 0.0 110.164 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.863 HD13 ' HB3' ' A' ' 148' ' ' GLU . 2.6 mp -70.6 151.04 95.51 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.319 -0.863 . . . . 0.0 110.129 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.836 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.3 Cg_endo -65.92 142.74 70.17 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.965 1.508 . . . . 0.0 110.509 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.646 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.7 Cg_endo -73.31 -30.48 10.26 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 O-C-N 123.992 1.522 . . . . 0.0 113.048 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.646 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.7 Cg_endo -71.13 -24.41 23.59 Favored 'Trans proline' 0 C--N 1.317 -1.084 0 N-CA-C 110.184 -0.737 . . . . 0.0 110.184 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.568 ' CZ ' ' HA ' ' A' ' 159' ' ' ASN . 1.5 mtp85 -83.05 -44.95 14.61 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.942 HD22 ' O ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -65.59 -30.93 71.72 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.727 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.573 ' N ' HD13 ' A' ' 18' ' ' LEU . 44.7 t80 -66.27 -54.94 18.98 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.413 -0.804 . . . . 0.0 109.685 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.642 ' HG2' HD22 ' A' ' 24' ' ' LEU . 20.1 mttt -51.98 -31.72 30.45 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.107 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.085 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -80.04 -46.44 16.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.612 -0.68 . . . . 0.0 110.87 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 1.046 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -66.44 -40.01 89.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.379 -0.826 . . . . 0.0 111.536 -178.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.613 HG13 ' CE1' ' A' ' 81' ' ' TYR . 3.4 t -107.6 -62.6 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.797 -1.19 . . . . 0.0 111.472 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.642 HD22 ' HG2' ' A' ' 20' ' ' LYS . 7.4 mp -62.78 -11.48 18.01 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.143 -0.973 . . . . 0.0 111.324 -178.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.566 ' HB3' HD23 ' A' ' 29' ' ' LEU . 1.2 m-20 -143.76 28.4 1.43 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.829 -1.169 . . . . 0.0 110.59 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 1.046 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -68.27 -21.03 64.82 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.246 -0.909 . . . . 0.0 110.296 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -72.35 -13.73 61.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -0.95 . . . . 0.0 110.173 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.511 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 5.5 p30 -133.74 8.96 3.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.372 -0.83 . . . . 0.0 110.01 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.908 HD21 ' OH ' ' A' ' 158' ' ' TYR . 0.3 OUTLIER -93.45 -45.72 7.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.325 -0.86 . . . . 0.0 109.913 179.872 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.976 HG11 HD13 ' A' ' 38' ' ' ILE . 2.5 t -73.37 -42.71 6.9 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.448 -0.782 . . . . 0.0 110.777 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.8 Cg_endo -78.01 7.57 3.93 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.448 1.236 . . . . 0.0 110.733 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.5 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 42.8 mmtm -124.32 -32.76 3.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.161 -0.962 . . . . 0.0 109.569 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.578 HD13 ' HA ' ' A' ' 147' ' ' ILE . 12.7 mt -80.04 -33.31 14.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.542 -0.724 . . . . 0.0 109.476 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -156.8 94.87 2.25 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.475 -0.766 . . . . 0.0 110.07 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.26 -1.2 9.77 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.046 1.551 . . . . 0.0 110.614 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -91.88 -6.66 51.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.147 -0.971 . . . . 0.0 110.248 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -99.21 -69.04 0.78 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.224 -0.922 . . . . 0.0 110.25 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.976 HD13 HG11 ' A' ' 30' ' ' VAL . 1.3 mp -103.46 149.1 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.35 -0.844 . . . . 0.0 110.154 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.461 ' O ' ' HB3' ' A' ' 40' ' ' HIS . 8.0 ttmm -86.93 -37.04 17.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 110.26 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.542 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER 177.71 134.77 0.07 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.186 -0.946 . . . . 0.0 110.502 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.5 m -94.67 135.73 35.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.158 -0.963 . . . . 0.0 109.804 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.542 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 42.4 tt0 -140.05 114.38 9.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.182 -0.948 . . . . 0.0 110.446 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 14.2 mt -61.85 138.28 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.164 -0.96 . . . . 0.0 109.962 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 13.3 tp -114.91 -25.86 8.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.23 -0.919 . . . . 0.0 110.468 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.504 ' HB2' ' CB ' ' A' ' 53' ' ' ILE . 1.8 m95 -127.77 163.99 23.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.217 -0.927 . . . . 0.0 110.588 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.46 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 42.23 -132.67 4.4 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.428 ' N ' ' OG1' ' A' ' 52' ' ' THR . 0.6 OUTLIER -156.34 20.23 0.35 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -1.12 . . . . 0.0 110.15 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.04 -22.97 6.65 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.455 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -71.11 -171.96 12.42 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.482 ' HA ' HG22 ' A' ' 71' ' ' ILE . 44.2 Cg_endo -72.12 128.97 14.5 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 124.045 1.55 . . . . 0.0 110.497 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.32 -15.45 42.75 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.55 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.1 m -72.03 161.71 30.51 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.594 -0.945 . . . . 0.0 109.382 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.504 ' CB ' ' HB2' ' A' ' 45' ' ' TRP . 50.0 mt -132.16 119.8 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.292 -0.88 . . . . 0.0 109.993 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 21.7 mtpt -102.29 134.76 45.06 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.151 -0.968 . . . . 0.0 110.339 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 17.9 tttm -102.39 93.7 5.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.32 -0.863 . . . . 0.0 110.008 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.547 ' CG2' HG12 ' A' ' 38' ' ' ILE . 84.7 mt -80.08 138.79 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.233 -0.917 . . . . 0.0 110.052 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.513 ' O ' HG23 ' A' ' 38' ' ' ILE . 1.4 p -113.73 151.75 31.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 0.0 110.446 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.574 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 24.0 m-85 -115.55 150.11 37.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.367 -0.833 . . . . 0.0 110.062 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.936 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.226 0.536 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.574 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -126.56 99.71 0.55 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.545 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 11.6 p90 -138.5 165.58 26.48 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.187 -1.184 . . . . 0.0 110.158 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.898 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.8 m -139.2 175.06 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.252 -0.905 . . . . 0.0 110.567 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 72.8 mttt -129.79 114.98 16.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.525 -0.735 . . . . 0.0 109.928 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.493 ' NE2' HD13 ' A' ' 85' ' ' LEU . 20.1 m170 -103.36 123.16 46.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.343 -0.848 . . . . 0.0 110.742 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 52' ' ' THR . 40.3 tttp -94.85 111.95 23.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 0.0 109.664 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.526 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 39.2 mm -47.3 137.13 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.209 -0.932 . . . . 0.0 110.417 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.553 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 11.1 t0 -112.11 -36.77 5.25 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.398 -0.814 . . . . 0.0 109.934 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.428 ' C ' HD12 ' A' ' 74' ' ' ILE . 1.0 OUTLIER 179.92 163.08 1.03 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.319 -0.863 . . . . 0.0 109.657 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.465 HG12 HG11 ' A' ' 23' ' ' VAL . 0.7 OUTLIER -146.75 155.75 11.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.056 -1.028 . . . . 0.0 111.157 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.54 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 2.5 m-20 -132.57 78.2 1.79 Allowed 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.011 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.546 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 34.0 mttp -61.03 -17.97 55.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.228 -0.92 . . . . 0.0 110.346 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -92.32 -31.01 15.53 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.226 -0.921 . . . . 0.0 109.567 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.482 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -103.78 -6.55 21.35 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.571 -0.706 . . . . 0.0 109.893 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.539 ' N ' ' O ' ' A' ' 75' ' ' ASP . 3.8 m-30 66.02 52.11 1.24 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.536 -0.727 . . . . 0.0 110.14 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.54 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.6 OUTLIER -125.18 147.66 48.95 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.246 -0.909 . . . . 0.0 109.672 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.642 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 58.1 t80 -137.26 135.63 37.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.146 -0.971 . . . . 0.0 110.118 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.421 ' O ' ' N ' ' A' ' 72' ' ' ASP . 26.3 m -141.31 127.58 19.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.077 -1.014 . . . . 0.0 110.779 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.642 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 10.9 p90 -138.72 174.52 10.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.373 -0.83 . . . . 0.0 109.966 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 98' ' ' ILE . 69.7 m -125.87 129.19 48.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 0.0 109.738 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.675 HD23 HG13 ' A' ' 98' ' ' ILE . 3.5 tp -97.07 132.69 42.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.11 -0.994 . . . . 0.0 110.318 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.3 pt -118.81 -24.25 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.394 -0.816 . . . . 0.0 110.148 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.493 ' O ' HD11 ' A' ' 85' ' ' LEU . 68.0 tt0 -121.73 147.17 46.25 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.262 -0.899 . . . . 0.0 110.159 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.898 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 165.03 124.65 0.72 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -52.05 -25.01 7.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -1.163 . . . . 0.0 110.22 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.32 -24.03 59.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.166 -0.959 . . . . 0.0 110.226 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.687 HD12 ' N ' ' A' ' 88' ' ' GLY . 72.1 mt -63.98 -32.55 74.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.903 . . . . 0.0 110.167 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 46.81 -173.48 0.02 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 52.3 p30 -83.19 7.02 17.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.262 -1.14 . . . . 0.0 110.163 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.709 ' O ' HG21 ' A' ' 126' ' ' VAL . 60.7 p -92.58 -33.72 14.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.319 -0.863 . . . . 0.0 110.137 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.941 HD21 ' CG1' ' A' ' 128' ' ' ILE . 61.9 mt -108.03 172.41 6.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.333 -0.854 . . . . 0.0 110.278 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.517 ' OE1' ' N ' ' A' ' 123' ' ' LYS . 48.5 mp0 -149.9 -82.36 0.11 Allowed 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.772 0.796 . . . . 0.0 109.311 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.509 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 59.7 mttt -80.44 127.57 32.57 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.782 -0.574 . . . . 0.0 110.72 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.753 HG21 ' CE2' ' A' ' 100' ' ' TYR . 5.4 mm -117.8 140.4 41.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 120.563 -1.336 . . . . 0.0 109.293 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.505 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -120.31 126.59 50.92 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.094 179.099 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.753 ' CE2' HG21 ' A' ' 98' ' ' ILE . 11.7 m-85 -122.61 135.55 54.65 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.407 -0.808 . . . . 0.0 110.367 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.527 ' CB ' ' HB ' ' A' ' 117' ' ' THR . 3.5 mt-10 -138.78 131.02 28.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.316 -0.865 . . . . 0.0 110.122 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 34.1 m -128.27 133.91 48.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.323 -0.86 . . . . 0.0 109.853 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.47 145.86 51.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.137 -0.977 . . . . 0.0 110.531 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.641 HD23 HG12 ' A' ' 114' ' ' ILE . 10.9 mt -122.47 153.59 38.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.3 -0.875 . . . . 0.0 110.01 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.701 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -151.12 -168.79 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.183 -0.948 . . . . 0.0 110.125 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.701 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -126.39 147.52 49.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.288 -0.883 . . . . 0.0 110.189 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.458 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 2.6 p -105.87 169.79 6.57 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.14 -0.975 . . . . 0.0 110.273 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 47.3 Cg_endo -73.19 -9.44 23.3 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.004 1.528 . . . . 0.0 110.403 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 63.1 p -97.37 6.63 47.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.305 -0.872 . . . . 0.0 110.326 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 96.18 -37.71 3.34 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -56.67 -172.42 0.17 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.5 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 25.1 p -133.99 137.14 44.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.259 -1.142 . . . . 0.0 110.276 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.726 ' HA ' HG22 ' A' ' 10' ' ' THR . 18.4 mt -86.77 150.31 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.313 -0.867 . . . . 0.0 110.218 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.641 HG12 HD23 ' A' ' 104' ' ' LEU . 16.5 mt -131.45 120.01 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.233 -0.917 . . . . 0.0 110.192 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.4 tttm -106.7 124.72 50.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.134 -0.979 . . . . 0.0 110.093 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -111.56 154.37 24.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.23 -0.919 . . . . 0.0 110.469 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.608 HG23 ' CG ' ' A' ' 6' ' ' GLU . 88.0 m -145.97 145.2 30.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.385 -0.822 . . . . 0.0 110.249 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.462 ' HG ' ' HE1' ' A' ' 100' ' ' TYR . 49.7 m -155.49 120.76 4.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.908 . . . . 0.0 109.857 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.505 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 41.1 m-70 -112.14 157.57 20.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.151 -0.968 . . . . 0.0 110.559 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.984 ' C ' HG23 ' A' ' 2' ' ' VAL . 10.2 m-85 -125.78 119.89 29.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.371 -0.831 . . . . 0.0 110.511 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.697 ' CE1' HG11 ' A' ' 2' ' ' VAL . 69.9 m-70 -98.79 101.84 13.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.265 -0.897 . . . . 0.0 109.601 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.694 HG23 HD23 ' A' ' 95' ' ' LEU . 0.8 OUTLIER -88.26 142.46 27.73 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.131 -0.981 . . . . 0.0 110.499 -179.507 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.517 ' N ' ' OE1' ' A' ' 96' ' ' GLU . 18.4 tttt -113.32 109.73 19.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.382 -0.824 . . . . 0.0 110.202 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 104.06 -153.26 17.73 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -97.62 77.71 2.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.323 -1.104 . . . . 0.0 110.206 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.709 HG21 ' O ' ' A' ' 94' ' ' THR . 22.3 m -142.76 161.68 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.2 -0.937 . . . . 0.0 110.133 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.404 ' HG3' ' C ' ' A' ' 126' ' ' VAL . 93.1 mt-10 -146.95 153.94 40.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.199 -0.938 . . . . 0.0 110.273 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.941 ' CG1' HD21 ' A' ' 95' ' ' LEU . 3.1 mt -80.18 172.98 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 110.115 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.595 ' N ' HG22 ' A' ' 128' ' ' ILE . 63.2 mttt -96.42 133.67 40.54 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.414 -0.804 . . . . 0.0 109.716 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 97.4 mt-10 -42.87 -36.53 1.53 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.268 -0.895 . . . . 0.0 110.169 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.84 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 81.2 tt0 -57.51 -42.17 82.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 109.922 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.537 ' HB3' ' CG2' ' A' ' 128' ' ' ILE . 6.1 t-160 -65.37 -53.66 40.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.333 -0.854 . . . . 0.0 110.221 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.463 HG13 ' CG ' ' A' ' 5' ' ' TYR . 96.6 t -67.7 -33.87 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.43 -0.794 . . . . 0.0 110.287 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 25.6 mttm -98.11 -69.33 0.76 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.212 -0.93 . . . . 0.0 110.205 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.84 ' HB3' ' O ' ' A' ' 131' ' ' GLU . . . -54.71 -19.61 6.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.18 -0.95 . . . . 0.0 109.626 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.451 ' HA3' ' O ' ' A' ' 132' ' ' HIS . . . -73.17 -30.23 63.25 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.484 ' CE ' ' HB3' ' A' ' 5' ' ' TYR . 66.0 mttm -79.5 -31.45 42.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.335 -1.097 . . . . 0.0 109.932 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -72.45 -52.92 13.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.281 -0.887 . . . . 0.0 109.93 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.52 ' HG3' ' N ' ' A' ' 140' ' ' ALA . 10.1 pttp -56.88 -41.26 77.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.41 -0.806 . . . . 0.0 109.821 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.52 ' N ' ' HG3' ' A' ' 139' ' ' LYS . . . -70.4 -39.73 74.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.349 -0.845 . . . . 0.0 109.853 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 137' ' ' LYS . 16.7 t -55.62 -43.41 76.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.414 -0.804 . . . . 0.0 109.852 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -57.34 -42.47 82.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.347 -0.846 . . . . 0.0 109.873 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.643 ' HA ' HD12 ' A' ' 146' ' ' LEU . 64.3 mt -57.85 -41.82 83.17 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.28 -0.887 . . . . 0.0 109.906 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -59.45 -36.79 76.62 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.422 -0.799 . . . . 0.0 109.845 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.413 ' HA ' ' OE1' ' A' ' 148' ' ' GLU . 95.6 mttt -71.68 -15.07 62.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.322 -0.861 . . . . 0.0 109.878 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.643 HD12 ' HA ' ' A' ' 143' ' ' LEU . 24.2 mt -84.95 -35.34 22.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.28 -0.887 . . . . 0.0 109.045 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.792 ' CG2' HD23 ' A' ' 18' ' ' LEU . 60.0 mt -70.47 -40.75 77.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 119.772 -0.771 . . . . 0.0 108.97 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.863 ' HB3' HD13 ' A' ' 13' ' ' ILE . 52.0 mt-10 -59.46 -44.08 93.06 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.423 -0.798 . . . . 0.0 109.329 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.504 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 33.7 m -67.75 -30.19 69.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.318 -0.864 . . . . 0.0 109.453 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.595 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 73.3 t80 -57.84 -49.72 75.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.463 -0.773 . . . . 0.0 109.802 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.145 HD21 ' CE2' ' A' ' 158' ' ' TYR . 77.5 mt -79.94 -26.61 40.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.209 -0.932 . . . . 0.0 109.983 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.688 ' HB2' HD11 ' A' ' 13' ' ' ILE . 50.8 tttt -72.65 -26.49 61.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.375 -0.828 . . . . 0.0 109.491 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.497 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -105.4 -32.02 4.11 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.553 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 6.6 m-70 -106.92 92.31 7.4 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.302 -1.117 . . . . 0.0 109.947 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.6 Cg_endo -73.84 6.9 2.62 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.131 1.595 . . . . 0.0 111.15 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -108.87 -4.49 16.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.936 -1.103 . . . . 0.0 110.008 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.667 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -77.65 101.72 6.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.382 -0.824 . . . . 0.0 110.1 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 1.145 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.3 OUTLIER 35.15 31.8 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.691 -0.63 . . . . 0.0 110.507 -179.49 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.568 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.744 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.575 HG13 ' O ' ' A' ' 120' ' ' TYR . 93.9 t -124.42 137.77 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -1.135 . . . . 0.0 110.206 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.804 ' CE1' HD12 ' A' ' 128' ' ' ILE . 10.1 m-85 -98.89 145.71 26.72 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.248 -0.908 . . . . 0.0 109.843 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.598 HG23 ' CE1' ' A' ' 119' ' ' HIS . 3.2 m -120.89 127.56 51.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.155 -0.966 . . . . 0.0 110.677 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 1.093 ' CE2' HG21 ' A' ' 133' ' ' VAL . 61.5 m-85 -139.92 131.21 26.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.395 -0.815 . . . . 0.0 109.765 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 22.4 pt-20 -131.75 153.3 50.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.043 -1.036 . . . . 0.0 110.774 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.419 ' HB2' ' HB3' ' A' ' 116' ' ' SER . 49.7 m -132.37 144.67 50.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.417 -0.802 . . . . 0.0 109.71 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -135.58 121.99 20.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.162 -0.961 . . . . 0.0 110.719 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.638 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.0 p90 -147.19 -177.03 5.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.363 -0.836 . . . . 0.0 109.691 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.89 HG22 ' HA ' ' A' ' 113' ' ' ILE . 5.7 p -142.52 170.35 15.88 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.115 -0.991 . . . . 0.0 110.739 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.427 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 1.4 t -155.06 157.48 37.61 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.41 -0.807 . . . . 0.0 110.243 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -76.07 -38.34 57.19 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.125 -0.984 . . . . 0.0 109.993 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.835 HD11 ' HB2' ' A' ' 152' ' ' LYS . 3.3 mp -58.37 150.02 56.52 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.44 -0.788 . . . . 0.0 109.98 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.759 ' HD2' HG23 ' A' ' 13' ' ' ILE . 39.6 Cg_endo -66.1 144.71 76.64 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.909 1.478 . . . . 0.0 110.116 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.652 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 38.4 Cg_endo -72.41 -31.46 11.31 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.961 1.506 . . . . 0.0 113.002 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.652 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 44.0 Cg_endo -71.72 -22.0 24.49 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 N-CA-C 109.757 -0.901 . . . . 0.0 109.757 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.803 ' HG2' HD22 ' A' ' 151' ' ' LEU . 42.0 ttm180 -81.89 -47.57 12.61 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.799 ' HA ' HD11 ' A' ' 151' ' ' LEU . 0.7 OUTLIER -66.26 -26.26 67.27 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.645 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.557 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 51.6 t80 -67.88 -50.72 54.76 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.513 0.673 . . . . 0.0 109.798 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.79 ' HG2' HD22 ' A' ' 24' ' ' LEU . 34.7 mttm -58.46 -33.63 69.96 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.624 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.056 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -80.04 -26.22 39.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.449 -0.782 . . . . 0.0 110.749 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.997 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 1.4 t80 -87.18 -46.72 9.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.17 -0.956 . . . . 0.0 111.474 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.704 HG13 ' CE1' ' A' ' 81' ' ' TYR . 3.5 t -98.84 -54.73 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.018 -1.051 . . . . 0.0 111.098 -179.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.79 HD22 ' HG2' ' A' ' 20' ' ' LYS . 8.0 mp -67.81 -5.59 17.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.174 -0.954 . . . . 0.0 110.735 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -144.35 17.82 1.71 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.118 -0.989 . . . . 0.0 110.443 -179.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.997 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -56.99 -23.12 43.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.188 -0.945 . . . . 0.0 110.164 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -79.55 -14.34 58.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.309 -0.869 . . . . 0.0 110.335 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.441 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 80.5 m-20 -132.37 9.14 4.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.183 -0.948 . . . . 0.0 110.415 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.654 HD23 ' OH ' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -105.3 -43.61 4.95 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.176 -0.952 . . . . 0.0 110.432 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.624 ' CG1' HD13 ' A' ' 38' ' ' ILE . 3.0 t -74.39 -41.4 4.84 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.339 -0.851 . . . . 0.0 110.956 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.9 Cg_endo -77.8 10.73 2.48 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.313 1.165 . . . . 0.0 110.896 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 28' ' ' ASN . 15.4 mttm -124.87 -34.92 2.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.115 -0.99 . . . . 0.0 109.355 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.663 HG21 ' HB3' ' A' ' 146' ' ' LEU . 6.7 mt -80.12 -44.15 22.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.487 -0.758 . . . . 0.0 109.628 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.87 95.06 14.1 Favored Pre-proline 0 N--CA 1.487 1.398 0 O-C-N 121.407 -0.808 . . . . 0.0 110.189 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.16 -0.41 9.09 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.047 1.551 . . . . 0.0 110.513 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -90.41 -27.42 19.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.218 -0.926 . . . . 0.0 110.039 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -87.53 -47.83 8.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.355 -0.841 . . . . 0.0 110.11 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.624 HD13 ' CG1' ' A' ' 30' ' ' VAL . 1.0 OUTLIER -125.68 130.19 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.495 -0.753 . . . . 0.0 109.926 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -89.17 -26.96 21.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.36 -0.837 . . . . 0.0 110.056 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.548 ' C ' ' CD2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -172.11 150.08 2.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.918 . . . . 0.0 110.197 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.6 m -128.58 123.3 33.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.339 -0.851 . . . . 0.0 109.904 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.548 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 69.5 tt0 -134.13 111.57 10.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.147 -0.97 . . . . 0.0 110.733 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 38.2 mt -53.65 143.61 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.292 -0.88 . . . . 0.0 109.892 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.432 ' HA ' HD12 ' A' ' 44' ' ' LEU . 30.3 tp -120.82 -27.3 5.06 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.224 -0.922 . . . . 0.0 110.447 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.676 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.7 m95 -123.92 162.83 22.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.294 -0.879 . . . . 0.0 110.516 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.45 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 42.84 -135.97 4.07 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.415 ' N ' ' OG1' ' A' ' 52' ' ' THR . 0.2 OUTLIER -152.64 22.95 0.6 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.392 -1.063 . . . . 0.0 110.052 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 120.09 -19.75 9.33 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.494 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -74.16 -169.82 21.43 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.435 ' HA ' HG22 ' A' ' 71' ' ' ILE . 45.3 Cg_endo -72.13 128.12 13.53 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 123.925 1.487 . . . . 0.0 110.649 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.4 -14.57 47.09 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.527 -1.829 . . . . 0.0 108.527 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.545 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.1 m -71.79 160.42 32.63 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.553 -0.969 . . . . 0.0 109.329 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.676 HD12 ' CG ' ' A' ' 45' ' ' TRP . 59.5 mt -132.48 119.36 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 110.276 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.635 ' CE ' HD11 ' A' ' 71' ' ' ILE . 48.6 mttm -102.56 124.8 48.77 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.355 -0.84 . . . . 0.0 110.163 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.4 tttt -92.31 93.9 8.87 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.29 -0.881 . . . . 0.0 110.004 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.548 ' CG2' HG12 ' A' ' 38' ' ' ILE . 70.7 mt -80.1 144.26 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.187 -0.945 . . . . 0.0 110.05 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.44 ' H ' ' HG1' ' A' ' 57' ' ' THR . 1.2 p -115.08 153.93 29.82 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.359 -0.838 . . . . 0.0 110.347 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.544 ' CZ ' HG22 ' A' ' 67' ' ' VAL . 19.3 m-85 -114.53 137.87 51.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.158 -0.964 . . . . 0.0 110.107 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.969 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.117 0.484 . . . . 0.0 110.095 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -138.78 116.53 1.28 Allowed Glycine 0 N--CA 1.486 2.033 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.545 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 13.9 p90 -156.4 174.47 15.37 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.088 -1.242 . . . . 0.0 110.208 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.734 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.8 m -144.16 174.97 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.872 . . . . 0.0 110.658 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.671 ' O ' HD12 ' A' ' 85' ' ' LEU . 22.7 mttm -132.22 104.36 6.72 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.515 -0.741 . . . . 0.0 109.687 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.981 ' CD2' HD13 ' A' ' 85' ' ' LEU . 12.5 m170 -95.57 126.09 40.62 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.26 -0.9 . . . . 0.0 111.103 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.545 ' HA ' ' O ' ' A' ' 52' ' ' THR . 23.8 tttt -98.48 108.67 21.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.351 -0.843 . . . . 0.0 109.434 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.635 HD11 ' CE ' ' A' ' 54' ' ' LYS . 30.2 mm -42.38 139.78 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.222 -0.924 . . . . 0.0 110.15 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.542 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 13.1 t0 -116.55 -41.22 3.11 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.187 -0.945 . . . . 0.0 110.46 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.485 ' C ' HD12 ' A' ' 74' ' ' ILE . 22.9 m -168.94 158.86 9.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 109.917 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.485 HD12 ' C ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -148.93 154.33 9.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 C-N-CA 119.142 -1.023 . . . . 0.0 111.131 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 79' ' ' TYR . 2.4 m-20 -133.91 77.82 1.73 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 120.269 -0.573 . . . . 0.0 110.092 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.557 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 36.7 tttm -61.6 -15.66 41.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.099 -1.001 . . . . 0.0 110.199 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -92.93 -30.53 15.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.259 -0.9 . . . . 0.0 109.593 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.2 m-80 -105.04 -9.15 18.04 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.69 -0.632 . . . . 0.0 109.882 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.578 ' CZ ' ' HB3' ' A' ' 16' ' ' PRO . 2.9 m-85 70.13 51.31 0.4 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.62 -0.675 . . . . 0.0 110.277 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.487 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -125.17 149.01 48.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.908 . . . . 0.0 109.669 179.711 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.704 ' CE1' HG13 ' A' ' 23' ' ' VAL . 58.5 t80 -138.86 139.96 38.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.162 -0.961 . . . . 0.0 110.235 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.434 ' O ' ' HB3' ' A' ' 72' ' ' ASP . 3.3 m -148.52 121.37 8.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.208 -0.932 . . . . 0.0 110.439 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.676 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 8.8 p90 -131.41 175.12 9.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.291 -0.881 . . . . 0.0 110.42 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 98' ' ' ILE . 19.7 m -127.82 126.06 40.96 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.346 -0.846 . . . . 0.0 109.948 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.981 HD13 ' CD2' ' A' ' 69' ' ' HIS . 14.0 tp -97.57 135.5 39.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.018 -1.051 . . . . 0.0 110.277 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.519 ' H ' HD12 ' A' ' 85' ' ' LEU . 9.5 pt -115.81 -31.27 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.219 -0.926 . . . . 0.0 110.255 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.489 ' C ' ' CD1' ' A' ' 91' ' ' LEU . 39.4 tt0 -107.86 165.65 11.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.28 -0.887 . . . . 0.0 110.09 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.734 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 151.55 140.17 3.1 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -60.04 -31.93 70.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.276 -1.132 . . . . 0.0 110.228 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.786 ' HB1' ' CE1' ' A' ' 132' ' ' HIS . . . -67.02 -39.61 87.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.29 -0.881 . . . . 0.0 110.213 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.654 ' CD2' HD21 ' A' ' 95' ' ' LEU . 11.4 mt -42.31 -51.96 4.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.367 -0.833 . . . . 0.0 110.135 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 43.54 -167.4 0.02 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.409 ' C ' ' OD1' ' A' ' 93' ' ' ASP . 55.8 p-10 -79.43 3.22 19.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -1.146 . . . . 0.0 110.176 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.514 ' O ' HG22 ' A' ' 122' ' ' THR . 0.1 OUTLIER -92.32 -51.93 4.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.231 -0.918 . . . . 0.0 110.185 -179.907 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.874 HD12 ' H ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -107.56 159.59 16.32 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.406 -0.809 . . . . 0.0 109.416 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.874 ' H ' HD12 ' A' ' 95' ' ' LEU . 62.9 tt0 -134.88 -80.33 0.44 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.306 -0.871 . . . . 0.0 110.182 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 46.8 mttt -80.27 152.74 28.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.633 -0.667 . . . . 0.0 110.78 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.726 HG21 ' CE2' ' A' ' 100' ' ' TYR . 4.7 mm -138.66 142.99 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.175 -0.953 . . . . 0.0 109.701 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.482 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.8 OUTLIER -121.38 127.39 51.16 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.356 -0.84 . . . . 0.0 109.151 178.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.726 ' CE2' HG21 ' A' ' 98' ' ' ILE . 10.3 m-85 -122.52 135.19 54.59 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 110.517 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.466 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 74.4 tt0 -138.14 141.38 40.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.312 -0.867 . . . . 0.0 110.356 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.53 ' N ' ' O ' ' A' ' 81' ' ' TYR . 32.7 m -137.66 149.94 46.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.412 -0.805 . . . . 0.0 109.732 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 115' ' ' LYS . 7.9 mttt -145.54 138.14 25.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.114 -0.991 . . . . 0.0 110.725 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.828 HD23 HG12 ' A' ' 114' ' ' ILE . 5.9 mt -118.75 151.69 37.56 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.298 -0.876 . . . . 0.0 109.497 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.701 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -150.23 -169.85 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.042 -1.036 . . . . 0.0 110.371 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.701 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -121.44 141.87 50.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.42 -0.8 . . . . 0.0 110.141 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.479 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 7.9 p -99.25 167.51 11.12 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.209 -0.932 . . . . 0.0 110.29 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.7 Cg_endo -72.32 -1.12 9.68 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.013 1.533 . . . . 0.0 110.596 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 52.0 p -106.65 4.14 27.58 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.248 -0.907 . . . . 0.0 110.303 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 100.21 -32.83 6.86 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -61.97 -172.11 1.27 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.508 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.0 OUTLIER -131.56 128.77 39.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.217 -1.167 . . . . 0.0 110.413 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.89 ' HA ' HG22 ' A' ' 10' ' ' THR . 10.3 mt -82.19 152.14 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.321 -0.862 . . . . 0.0 110.039 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.828 HG12 HD23 ' A' ' 104' ' ' LEU . 15.7 mt -132.31 119.03 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.2 -0.938 . . . . 0.0 110.436 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.486 ' O ' ' N ' ' A' ' 103' ' ' LYS . 26.6 tttt -108.63 119.04 38.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 110.075 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 2.0 t -110.87 158.16 19.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 110.306 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.466 ' HB ' ' HB3' ' A' ' 101' ' ' GLU . 43.1 m -160.01 139.74 11.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.21 -0.931 . . . . 0.0 110.3 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 41.9 t -143.58 159.67 42.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.214 -0.929 . . . . 0.0 110.116 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.598 ' CE1' HG23 ' A' ' 4' ' ' THR . 69.8 m-70 -142.34 159.1 42.9 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.157 -0.964 . . . . 0.0 110.527 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.596 ' HA ' HD13 ' A' ' 98' ' ' ILE . 8.7 m-85 -117.86 150.78 38.61 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.36 -0.837 . . . . 0.0 110.279 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.476 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 95.2 m-70 -128.39 82.76 2.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.138 -0.976 . . . . 0.0 109.896 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 94' ' ' THR . 1.2 p -71.74 152.13 43.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.347 -0.845 . . . . 0.0 110.082 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.419 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 7.3 ttpt -109.89 118.29 36.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.255 -0.903 . . . . 0.0 110.335 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 101.59 -143.44 16.07 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -112.72 73.41 0.81 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.302 -1.116 . . . . 0.0 110.207 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 5.9 m -140.67 156.49 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.273 -0.892 . . . . 0.0 110.147 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -128.2 154.7 45.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.266 -0.896 . . . . 0.0 110.261 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.804 HD12 ' CE1' ' A' ' 3' ' ' PHE . 3.0 mt -74.9 172.74 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.337 -0.852 . . . . 0.0 110.2 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.61 ' N ' HG22 ' A' ' 128' ' ' ILE . 40.9 mmtm -104.07 125.9 50.78 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.347 -0.846 . . . . 0.0 110.053 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 129' ' ' LYS . 96.0 mt-10 -43.65 -54.05 5.31 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.223 -0.923 . . . . 0.0 110.038 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 42.9 tt0 -46.32 -25.04 0.56 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.207 -0.933 . . . . 0.0 109.797 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.786 ' CE1' ' HB1' ' A' ' 90' ' ' ALA . 12.1 t-160 -81.54 -64.56 1.16 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.435 -0.791 . . . . 0.0 110.071 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 1.093 HG21 ' CE2' ' A' ' 5' ' ' TYR . 8.8 p -66.14 -39.47 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.359 -0.838 . . . . 0.0 110.031 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.519 ' N ' HG13 ' A' ' 133' ' ' VAL . 38.0 tttp -63.59 -42.46 98.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 109.968 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 131' ' ' GLU . . . -66.77 -32.27 73.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.353 -0.842 . . . . 0.0 109.883 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.64 -26.98 74.13 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.564 ' NZ ' HG22 ' A' ' 133' ' ' VAL . 45.1 mttp -65.11 -35.43 81.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.336 -1.096 . . . . 0.0 110.021 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -82.69 -36.48 25.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.32 -0.862 . . . . 0.0 109.868 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 41.0 mttt -73.29 -26.93 61.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.387 -0.821 . . . . 0.0 109.854 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.407 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -81.54 -38.77 25.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.368 -0.833 . . . . 0.0 109.92 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.9 t -64.01 -47.15 81.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.335 -0.853 . . . . 0.0 109.947 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -54.86 -44.68 74.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.247 -0.908 . . . . 0.0 109.867 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.474 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 9.4 tp -57.2 -45.88 83.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 0.0 109.859 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.557 ' HA ' HD12 ' A' ' 147' ' ' ILE . 28.0 m-85 -54.44 -41.32 69.26 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.234 -0.916 . . . . 0.0 109.507 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 18.7 mttp -72.82 -12.98 61.19 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.438 -0.789 . . . . 0.0 110.035 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.663 ' HB3' HG21 ' A' ' 33' ' ' ILE . 16.1 mt -83.75 -36.2 23.82 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.177 -0.952 . . . . 0.0 108.921 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.699 HD11 ' CE1' ' A' ' 22' ' ' PHE . 25.8 mt -68.05 -44.31 84.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.538 ' OE2' HD13 ' A' ' 18' ' ' LEU . 60.8 mm-40 -53.66 -46.22 70.53 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.533 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 25.7 m -65.83 -39.11 90.51 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.354 -0.841 . . . . 0.0 109.351 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.611 ' CD1' HD11 ' A' ' 33' ' ' ILE . 58.0 t80 -43.64 -56.85 3.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.435 -0.791 . . . . 0.0 109.829 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.803 HD22 ' HG2' ' A' ' 17' ' ' ARG . 12.4 mt -75.16 -39.72 60.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.541 -0.724 . . . . 0.0 110.432 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.835 ' HB2' HD11 ' A' ' 13' ' ' ILE . 25.1 tttm -60.83 -17.77 51.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.122 -0.986 . . . . 0.0 109.364 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.498 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -113.46 -29.59 2.9 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.538 ' CD2' ' O ' ' A' ' 150' ' ' TYR . 12.2 m-70 -105.82 89.84 3.87 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.285 -1.126 . . . . 0.0 110.009 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.554 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 45.6 Cg_endo -71.12 1.85 4.9 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.052 1.554 . . . . 0.0 110.989 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -108.33 -16.31 14.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.049 -1.032 . . . . 0.0 110.107 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.607 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -71.41 99.56 2.01 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.2 -0.937 . . . . 0.0 109.848 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 1.056 ' CE1' ' HB2' ' A' ' 21' ' ' ALA . 0.1 OUTLIER 35.06 32.54 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 CA-C-O 121.564 0.697 . . . . 0.0 109.569 -179.24 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.554 ' ND2' ' HA ' ' A' ' 155' ' ' PRO . 0.1 OUTLIER . . . . . 0 C--N 1.303 -1.451 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.94 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.456 ' O ' ' OG1' ' A' ' 122' ' ' THR . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.929 HG13 ' O ' ' A' ' 120' ' ' TYR . 77.4 t -125.29 138.57 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -1.157 . . . . 0.0 110.2 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.697 ' CE1' HD12 ' A' ' 128' ' ' ILE . 11.7 m-85 -98.02 136.13 38.72 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.205 -0.934 . . . . 0.0 109.624 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.681 HG23 ' ND1' ' A' ' 119' ' ' HIS . 8.5 m -119.19 136.81 54.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.093 -1.004 . . . . 0.0 110.815 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 1.006 ' CE2' HG21 ' A' ' 133' ' ' VAL . 57.0 m-85 -147.18 124.83 11.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.474 -0.766 . . . . 0.0 109.83 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 1.004 ' CG ' HG23 ' A' ' 117' ' ' THR . 5.0 mt-10 -123.54 132.77 53.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.277 -0.889 . . . . 0.0 110.494 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.444 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 50.7 m -119.01 157.8 27.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.325 -0.86 . . . . 0.0 109.898 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 7' ' ' SER . 50.5 mp0 -146.37 123.98 11.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.111 -0.993 . . . . 0.0 110.804 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.635 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.0 p90 -141.71 -175.88 4.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.886 . . . . 0.0 109.632 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.81 HG22 ' HA ' ' A' ' 113' ' ' ILE . 8.6 p -142.5 169.84 16.83 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.009 -1.057 . . . . 0.0 110.794 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 112' ' ' SER . 4.0 t -153.83 162.15 41.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.422 -0.799 . . . . 0.0 110.174 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -85.1 -28.47 25.57 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.127 -0.983 . . . . 0.0 110.164 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.79 HG23 ' HD2' ' A' ' 14' ' ' PRO . 9.1 mm -67.9 150.79 97.63 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 0.0 109.891 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.79 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.4 Cg_endo -66.12 143.35 71.3 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.932 1.491 . . . . 0.0 110.325 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.658 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.2 Cg_endo -72.55 -31.13 11.35 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 124.023 1.539 . . . . 0.0 112.888 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.658 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.6 Cg_endo -70.1 -23.83 28.83 Favored 'Trans proline' 0 C--N 1.316 -1.147 0 N-CA-C 110.177 -0.74 . . . . 0.0 110.177 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.731 HH21 ' HB3' ' A' ' 157' ' ' ALA . 46.2 mtp180 -83.68 -42.47 16.6 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.741 ' C ' HD23 ' A' ' 18' ' ' LEU . 0.6 OUTLIER -71.85 -31.56 66.62 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.619 ' N ' HD23 ' A' ' 18' ' ' LEU . 54.3 t80 -65.39 -54.93 21.56 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.461 -0.774 . . . . 0.0 109.042 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.533 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 70.1 mttt -48.63 -48.54 39.43 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.724 -0.79 . . . . 0.0 109.355 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.17 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -67.75 -28.77 67.91 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.334 -0.854 . . . . 0.0 111.135 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 1.066 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.9 OUTLIER -80.92 -46.54 15.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 111.411 -178.814 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.701 HG13 ' CE1' ' A' ' 81' ' ' TYR . 3.4 t -104.44 -51.36 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.942 -1.099 . . . . 0.0 111.761 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.678 HD12 ' N ' ' A' ' 24' ' ' LEU . 7.2 mp -79.97 -4.61 53.22 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.097 -1.002 . . . . 0.0 111.966 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.571 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 1.0 OUTLIER -149.17 23.95 0.93 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.717 -1.239 . . . . 0.0 110.643 -179.632 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 1.066 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -67.01 -32.94 74.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.17 -0.956 . . . . 0.0 110.301 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.427 ' HA ' ' OG ' ' A' ' 41' ' ' SER . 81.4 m-20 -56.54 -17.68 9.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.357 -0.839 . . . . 0.0 110.559 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.539 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 4.2 p30 -128.94 -0.93 5.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.15 -0.969 . . . . 0.0 110.523 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.758 ' HG ' ' HB1' ' A' ' 21' ' ' ALA . 1.1 tm? -88.57 -43.76 11.14 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.112 -0.992 . . . . 0.0 110.17 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 1.067 HG11 HD13 ' A' ' 38' ' ' ILE . 5.0 t -74.59 -40.86 4.36 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.437 -0.79 . . . . 0.0 111.319 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.0 Cg_endo -77.54 10.91 2.33 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 123.448 1.236 . . . . 0.0 111.005 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.486 ' CD ' ' O ' ' A' ' 28' ' ' ASN . 31.9 mtpt -120.65 -34.65 3.54 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.029 -1.044 . . . . 0.0 109.031 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.971 HG21 ' HB3' ' A' ' 146' ' ' LEU . 10.6 mt -80.19 -32.58 13.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 121.53 0.681 . . . . 0.0 109.657 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -159.65 98.35 1.54 Allowed Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.412 -0.805 . . . . 0.0 110.097 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.8 -0.75 8.86 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.034 1.544 . . . . 0.0 110.809 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -85.03 -19.08 32.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 109.788 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -85.76 -86.05 0.14 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.415 -0.803 . . . . 0.0 110.082 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 1.067 HD13 HG11 ' A' ' 30' ' ' VAL . 1.9 mp -90.75 139.94 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.279 -0.888 . . . . 0.0 110.112 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.425 ' O ' ' CB ' ' A' ' 40' ' ' HIS . 4.8 ttmm -87.81 -26.74 22.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.353 -0.842 . . . . 0.0 110.18 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.575 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER 177.03 157.19 0.31 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.177 -0.952 . . . . 0.0 110.193 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.427 ' OG ' ' HA ' ' A' ' 27' ' ' ASP . 79.4 p -117.3 134.21 55.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.356 -0.84 . . . . 0.0 110.023 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.575 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 29.0 tp10 -138.69 106.87 5.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.091 -1.005 . . . . 0.0 110.246 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 20.0 mt -62.59 137.16 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 110.098 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.899 HD22 ' CE ' ' A' ' 55' ' ' LYS . 13.0 tp -114.08 -23.51 9.49 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.239 -0.913 . . . . 0.0 110.534 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.701 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.7 m95 -127.06 161.61 28.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.049 -1.032 . . . . 0.0 110.63 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.446 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 41.76 -132.09 3.97 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -157.24 19.78 0.3 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.296 -1.12 . . . . 0.0 110.154 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.91 -18.22 7.09 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.472 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -74.51 -171.64 26.87 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.432 ' HA ' HG22 ' A' ' 71' ' ' ILE . 46.0 Cg_endo -73.38 129.54 13.99 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.103 1.581 . . . . 0.0 110.665 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.34 -9.44 49.55 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.509 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.1 m -76.88 167.17 22.29 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.567 -0.96 . . . . 0.0 109.921 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.701 HD12 ' CG ' ' A' ' 45' ' ' TRP . 65.6 mt -137.35 120.24 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.322 -0.861 . . . . 0.0 109.871 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 70.7 mttt -106.03 138.37 42.34 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.211 -0.93 . . . . 0.0 110.411 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.899 ' CE ' HD22 ' A' ' 44' ' ' LEU . 43.5 mttt -102.53 95.86 6.52 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.308 -0.87 . . . . 0.0 110.06 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.545 ' HB ' HG23 ' A' ' 67' ' ' VAL . 52.1 mt -80.05 135.41 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 109.846 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 1.6 p -104.77 155.8 18.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.374 -0.828 . . . . 0.0 110.452 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.741 ' HE2' HG13 ' A' ' 67' ' ' VAL . 23.9 m-85 -118.73 169.89 9.45 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.316 -0.865 . . . . 0.0 110.083 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.919 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.515 ' CE2' ' CD2' ' A' ' 66' ' ' TYR . 8.5 t80 . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.19 0.519 . . . . 0.0 110.075 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -129.31 136.18 8.84 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.562 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 11.7 p90 -179.49 161.38 1.04 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.349 -1.089 . . . . 0.0 109.952 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.844 HG12 ' HA2' ' A' ' 88' ' ' GLY . 7.1 m -141.95 171.83 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.681 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.513 ' O ' HD23 ' A' ' 85' ' ' LEU . 50.9 mttt -123.31 115.03 21.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.597 -0.689 . . . . 0.0 109.801 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -106.29 126.19 51.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.141 -0.974 . . . . 0.0 110.633 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 52' ' ' THR . 27.2 ttpp -97.43 126.58 42.77 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.322 -0.861 . . . . 0.0 109.77 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.508 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 26.1 mm -66.22 122.02 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 0.0 110.219 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -98.14 -43.34 7.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.359 -0.838 . . . . 0.0 110.118 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.8 m -169.0 159.42 9.28 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.382 -0.824 . . . . 0.0 109.616 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.5 mt -144.19 158.22 15.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.141 -0.975 . . . . 0.0 110.386 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.551 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 4.3 m-20 -134.39 78.76 1.77 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.088 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.432 ' HB2' ' HE3' ' A' ' 76' ' ' LYS . 38.1 mtmt -62.52 -14.03 37.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.195 -0.94 . . . . 0.0 110.233 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -93.68 -33.06 13.81 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.266 -0.896 . . . . 0.0 109.521 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.469 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -104.65 -8.18 19.1 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.605 -0.685 . . . . 0.0 109.841 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.636 ' O ' HD12 ' A' ' 104' ' ' LEU . 3.2 m-85 68.95 50.86 0.58 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.447 -0.783 . . . . 0.0 110.12 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.551 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -120.96 155.3 34.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.318 -0.864 . . . . 0.0 109.405 179.638 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.701 ' CE1' HG13 ' A' ' 23' ' ' VAL . 26.8 t80 -143.21 133.17 24.14 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.177 -0.952 . . . . 0.0 110.216 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 37.9 m -136.75 122.73 20.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 110.488 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.612 ' CD1' ' N ' ' A' ' 83' ' ' TYR . 3.1 p90 -139.42 179.98 6.23 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.179 -0.951 . . . . 0.0 110.039 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 1.001 HG23 ' O ' ' A' ' 98' ' ' ILE . 39.3 m -132.02 142.46 49.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 110.332 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.664 HD22 ' O ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -98.04 119.35 36.52 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.261 -0.9 . . . . 0.0 110.278 179.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.473 ' CG1' ' HB2' ' A' ' 68' ' ' LYS . 31.2 pt -102.64 -12.85 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.2 -0.938 . . . . 0.0 110.062 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.664 ' O ' HD22 ' A' ' 85' ' ' LEU . 47.8 tp10 -141.82 166.7 24.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.311 -0.868 . . . . 0.0 110.214 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.844 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 148.87 120.33 1.07 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -50.15 -24.39 2.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.341 -1.094 . . . . 0.0 110.229 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 1.039 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -74.09 -22.61 59.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.926 . . . . 0.0 110.27 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.465 ' O ' ' O ' ' A' ' 92' ' ' GLY . 37.7 mt -66.86 -27.09 67.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.229 -0.919 . . . . 0.0 110.307 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 48.91 -178.04 0.01 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 93' ' ' ASP . 38.1 p30 -81.61 8.67 9.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -1.16 . . . . 0.0 110.267 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.616 ' O ' HG21 ' A' ' 126' ' ' VAL . 71.2 p -96.3 -39.62 9.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -0.906 . . . . 0.0 110.182 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.915 HD21 ' CG1' ' A' ' 128' ' ' ILE . 47.3 mt -98.8 153.59 18.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.389 -0.819 . . . . 0.0 110.193 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.509 ' HG3' ' HB2' ' A' ' 123' ' ' LYS . 41.9 mm-40 -131.91 -80.31 0.51 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.242 -0.911 . . . . 0.0 110.253 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.507 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 17.6 mttt -80.19 128.73 33.86 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.595 -0.691 . . . . 0.0 110.756 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 1.001 ' O ' HG23 ' A' ' 84' ' ' THR . 11.3 mm -115.65 146.76 19.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 120.777 -1.202 . . . . 0.0 109.582 178.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.503 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.0 OUTLIER -123.41 123.77 41.41 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.258 -0.901 . . . . 0.0 109.046 178.564 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.806 ' CE2' HG21 ' A' ' 98' ' ' ILE . 15.0 m-85 -121.34 133.13 55.1 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.457 -0.777 . . . . 0.0 109.732 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.486 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 21.1 tt0 -142.07 144.05 33.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.09 -1.006 . . . . 0.0 110.782 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 62.1 m -140.13 146.03 38.32 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.455 -0.778 . . . . 0.0 109.594 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -139.52 138.38 36.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.096 -1.002 . . . . 0.0 110.658 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.826 HD23 HG12 ' A' ' 114' ' ' ILE . 7.1 mt -118.6 150.3 39.92 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.4 -0.813 . . . . 0.0 109.965 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.679 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.8 t -147.72 -171.38 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.188 -0.945 . . . . 0.0 110.212 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.679 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -122.75 138.19 54.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.419 -0.801 . . . . 0.0 110.171 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.44 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 4.2 p -99.2 167.74 10.77 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.289 -0.882 . . . . 0.0 110.22 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.44 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.1 Cg_endo -72.27 -4.27 14.9 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.12 1.59 . . . . 0.0 110.349 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 36.5 m -93.82 -18.73 21.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 110.309 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 118.18 -30.37 6.08 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.485 ' HA3' ' O ' ' A' ' 11' ' ' SER . . . -64.72 -142.96 0.03 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 11' ' ' SER . 26.4 p -155.71 128.57 7.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.287 -1.125 . . . . 0.0 109.968 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.81 ' HA ' HG22 ' A' ' 10' ' ' THR . 15.2 mt -79.96 149.14 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -0.908 . . . . 0.0 110.085 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.826 HG12 HD23 ' A' ' 104' ' ' LEU . 15.6 mt -131.36 119.45 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.414 -0.804 . . . . 0.0 110.25 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -104.83 121.35 43.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.098 -1.001 . . . . 0.0 110.072 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.411 ' C ' ' HG1' ' A' ' 117' ' ' THR . 0.0 OUTLIER -104.12 152.65 21.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -0.868 . . . . 0.0 110.216 -179.861 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 1.004 HG23 ' CG ' ' A' ' 6' ' ' GLU . 12.1 m -159.97 122.39 3.37 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.316 -0.865 . . . . 0.0 110.568 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.506 ' C ' ' CG ' ' A' ' 119' ' ' HIS . 15.0 t -133.55 160.13 38.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.361 -0.837 . . . . 0.0 109.669 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.681 ' ND1' HG23 ' A' ' 4' ' ' THR . 33.7 m-70 -147.19 164.2 33.89 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.061 -1.025 . . . . 0.0 110.642 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.929 ' O ' HG13 ' A' ' 2' ' ' VAL . 6.3 m-85 -126.93 150.53 49.29 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.253 -0.904 . . . . 0.0 110.443 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.507 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 93.6 m-70 -129.78 84.71 2.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.255 -0.903 . . . . 0.0 109.723 178.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.709 ' CG2' HD23 ' A' ' 95' ' ' LEU . 1.2 p -63.64 154.8 31.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.302 -0.874 . . . . 0.0 110.179 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.509 ' HB2' ' HG3' ' A' ' 96' ' ' GLU . 43.4 tttt -113.73 117.56 31.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 110.048 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 99.25 -115.95 5.45 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.476 ' O ' ' ND2' ' A' ' 125' ' ' ASN . 0.7 OUTLIER -138.27 67.4 1.41 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.301 -1.117 . . . . 0.0 110.138 179.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.616 HG21 ' O ' ' A' ' 94' ' ' THR . 27.9 m -131.92 167.23 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.886 . . . . 0.0 110.085 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -140.76 161.41 37.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 110.255 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.915 ' CG1' HD21 ' A' ' 95' ' ' LEU . 3.5 mp -84.17 172.8 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.252 -0.905 . . . . 0.0 110.127 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.614 ' N ' HG22 ' A' ' 128' ' ' ILE . 16.2 mttm -108.25 129.92 55.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.384 -0.823 . . . . 0.0 109.683 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.459 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 73.1 mm-40 -43.86 -49.69 8.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.079 -1.013 . . . . 0.0 109.885 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.506 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 51.6 tt0 -48.54 -23.09 0.87 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.154 -0.966 . . . . 0.0 109.651 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 1.039 ' NE2' ' HB1' ' A' ' 90' ' ' ALA . 13.5 t-160 -88.48 -66.42 0.92 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.372 -0.83 . . . . 0.0 110.142 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 1.006 HG21 ' CE2' ' A' ' 5' ' ' TYR . 7.3 p -59.91 -40.21 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.345 -0.847 . . . . 0.0 109.84 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.533 ' N ' HG13 ' A' ' 133' ' ' VAL . 31.5 tptt -66.69 -47.39 72.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.285 -0.884 . . . . 0.0 109.795 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.506 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -63.32 -34.18 77.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.74 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.86 -33.89 85.47 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.658 ' NZ ' HG22 ' A' ' 133' ' ' VAL . 21.9 mttp -62.87 -37.87 88.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.366 -1.079 . . . . 0.0 109.78 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -78.81 -37.54 40.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.491 -0.756 . . . . 0.0 109.826 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 135' ' ' ALA . 20.9 mttm -66.89 -33.24 75.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.411 -0.805 . . . . 0.0 109.801 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.1 -45.71 26.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.311 -0.868 . . . . 0.0 109.829 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.0 m -59.13 -42.8 91.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.425 -0.797 . . . . 0.0 109.798 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -59.88 -46.26 89.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.31 -0.869 . . . . 0.0 109.816 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.5 ' HA ' HD23 ' A' ' 143' ' ' LEU . 18.9 mt -58.13 -35.63 71.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.373 -0.829 . . . . 0.0 109.722 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.578 ' HA ' HD12 ' A' ' 147' ' ' ILE . 22.6 m-85 -64.27 -34.33 77.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.372 -0.83 . . . . 0.0 109.774 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -71.95 -16.9 62.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.332 -0.855 . . . . 0.0 109.848 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.971 ' HB3' HG21 ' A' ' 33' ' ' ILE . 19.5 mt -81.23 -36.65 29.73 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.231 -0.918 . . . . 0.0 108.728 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.661 HG21 ' HG ' ' A' ' 18' ' ' LEU . 27.8 mt -70.43 -49.03 56.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.504 ' O ' HG13 ' A' ' 13' ' ' ILE . 97.9 mt-10 -53.07 -38.83 62.84 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.379 -0.825 . . . . 0.0 109.056 178.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.477 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 35.2 m -76.49 -30.18 57.13 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.271 -0.893 . . . . 0.0 109.011 178.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.593 ' CD1' HD11 ' A' ' 33' ' ' ILE . 54.0 t80 -50.52 -52.95 33.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.591 -0.693 . . . . 0.0 109.566 179.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.964 HD21 ' CE1' ' A' ' 158' ' ' TYR . 40.6 mt -80.15 -25.0 40.01 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.457 -0.777 . . . . 0.0 109.812 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.545 ' HA ' HD11 ' A' ' 13' ' ' ILE . 14.4 tttp -63.38 -17.42 62.6 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.329 -0.857 . . . . 0.0 109.311 179.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.49 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -120.3 -27.14 2.07 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.626 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 4.0 m-70 -106.38 91.24 5.56 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.191 -1.182 . . . . 0.0 110.285 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.8 Cg_endo -73.38 2.51 5.6 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.022 1.538 . . . . 0.0 110.82 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -113.17 -9.58 13.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.12 -0.987 . . . . 0.0 109.879 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.731 ' HB3' HH21 ' A' ' 17' ' ' ARG . . . -47.8 111.08 0.38 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.386 -0.821 . . . . 0.0 110.176 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 1.17 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 35.13 31.56 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.695 -0.628 . . . . 0.0 110.658 -179.804 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.533 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.65 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 93.5 t -128.04 126.57 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -1.161 . . . . 0.0 110.226 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.604 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 38.9 m-85 -87.18 161.36 18.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 0.0 110.415 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.856 HG23 ' CE1' ' A' ' 119' ' ' HIS . 33.8 m -138.63 92.18 2.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.886 . . . . 0.0 110.272 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.651 ' CD1' HG11 ' A' ' 133' ' ' VAL . 72.5 m-85 -110.43 126.61 54.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.245 -0.909 . . . . 0.0 109.643 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 116' ' ' SER . 21.2 pt-20 -132.47 152.2 51.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -0.916 . . . . 0.0 110.699 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 61.6 m -129.87 138.86 51.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.367 -0.833 . . . . 0.0 109.581 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -112.99 139.92 48.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.117 -0.989 . . . . 0.0 110.816 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.598 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.8 p90 -155.97 -175.23 5.32 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.431 -0.793 . . . . 0.0 109.511 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.803 HG22 ' HA ' ' A' ' 113' ' ' ILE . 8.1 p -139.9 174.57 10.38 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.99 -1.069 . . . . 0.0 110.814 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.46 ' HB3' ' OE2' ' A' ' 148' ' ' GLU . 54.1 p -158.59 127.41 5.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.447 -0.783 . . . . 0.0 110.124 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -55.1 -38.24 67.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.231 -0.918 . . . . 0.0 110.036 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.836 HG21 HD12 ' A' ' 151' ' ' LEU . 3.1 mp -59.07 150.36 62.26 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.416 -0.803 . . . . 0.0 110.015 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.797 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.9 Cg_endo -66.41 142.29 65.19 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.938 1.493 . . . . 0.0 110.37 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.633 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.0 Cg_endo -72.4 -31.2 11.68 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.874 1.46 . . . . 0.0 112.881 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 44.2 Cg_endo -72.78 -19.85 23.41 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 N-CA-C 109.984 -0.814 . . . . 0.0 109.984 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.903 ' HG2' HD13 ' A' ' 151' ' ' LEU . 36.7 ttm180 -83.55 -47.62 11.11 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.773 ' C ' HD23 ' A' ' 18' ' ' LEU . 1.1 tt -67.51 -32.42 73.21 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.55 ' N ' HD23 ' A' ' 18' ' ' LEU . 57.2 t80 -64.17 -53.99 40.66 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.479 -0.763 . . . . 0.0 109.402 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.546 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 17.8 mttm -49.6 -41.43 42.09 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.801 -0.76 . . . . 0.0 109.326 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.036 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -76.65 -33.54 58.32 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.398 -0.814 . . . . 0.0 111.04 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.817 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.6 OUTLIER -71.49 -49.08 44.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.036 -1.04 . . . . 0.0 111.323 -178.803 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.58 ' HB ' HD12 ' A' ' 24' ' ' LEU . 4.9 t -104.75 -49.25 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.015 -1.053 . . . . 0.0 111.437 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.674 HD12 ' N ' ' A' ' 24' ' ' LEU . 7.2 mp -76.99 -5.42 48.61 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.088 -1.007 . . . . 0.0 111.218 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.573 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -157.2 54.98 0.51 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.861 -1.15 . . . . 0.0 110.418 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.817 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -92.04 -10.07 40.47 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.341 -0.849 . . . . 0.0 110.05 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.514 ' O ' ' CG ' ' A' ' 31' ' ' PRO . 41.8 t0 -73.26 -20.32 60.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.326 -0.859 . . . . 0.0 109.919 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -128.46 14.02 6.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.353 -0.842 . . . . 0.0 109.888 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.873 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 0.4 OUTLIER -98.23 -46.19 5.92 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.363 -0.836 . . . . 0.0 110.321 -179.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.657 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.4 m -89.16 -33.35 0.4 Allowed Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.369 -0.832 . . . . 0.0 111.074 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.3 Cg_endo -80.22 7.59 4.62 Favored 'Trans proline' 0 C--N 1.317 -1.097 0 O-C-N 123.06 1.032 . . . . 0.0 110.318 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 51.6 tttt -131.99 -33.24 1.37 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.298 -0.876 . . . . 0.0 109.972 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.575 HG12 ' CD1' ' A' ' 150' ' ' TYR . 11.9 mt -80.02 -43.0 22.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.386 -0.821 . . . . 0.0 109.876 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.717 ' HB2' HD13 ' A' ' 146' ' ' LEU . . . -152.2 95.47 3.16 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.298 -0.876 . . . . 0.0 110.233 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -76.92 6.2 4.38 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.125 1.592 . . . . 0.0 110.774 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -89.59 -9.44 49.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.077 -1.014 . . . . 0.0 110.214 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.733 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -104.12 -41.78 5.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 110.23 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.733 HD12 ' C ' ' A' ' 37' ' ' ALA . 1.4 mp -136.43 121.07 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.429 -0.794 . . . . 0.0 109.88 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 57' ' ' THR . 6.7 ttpp -56.79 -29.94 63.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -0.914 . . . . 0.0 110.249 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.548 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER 173.53 179.38 0.1 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.245 -0.91 . . . . 0.0 110.004 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.524 ' N ' ' CG ' ' A' ' 40' ' ' HIS . 56.3 m -139.97 148.46 41.94 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.234 -0.916 . . . . 0.0 110.245 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.548 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 36.4 tp10 -152.85 111.2 3.69 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.155 -0.965 . . . . 0.0 110.601 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 29.8 mt -60.51 133.1 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.198 -0.939 . . . . 0.0 109.895 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.54 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 18.2 mt -107.27 -27.06 10.75 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.176 -0.952 . . . . 0.0 110.686 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.716 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.8 m95 -126.18 161.19 28.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.118 -0.989 . . . . 0.0 110.826 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.454 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 41.95 -133.81 3.86 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.431 ' CG ' ' O ' ' A' ' 47' ' ' ASP . 9.5 t0 -154.67 19.17 0.46 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.309 -1.112 . . . . 0.0 110.011 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.01 -17.29 7.63 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.577 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -70.31 -172.55 11.15 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -73.62 129.08 13.23 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 O-C-N 124.093 1.575 . . . . 0.0 110.589 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.38 -11.66 56.82 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.528 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -71.71 164.75 25.37 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.522 -0.987 . . . . 0.0 109.699 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.716 HD12 ' CG ' ' A' ' 45' ' ' TRP . 47.3 mt -133.35 120.9 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.345 -0.847 . . . . 0.0 109.725 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.471 ' CE ' HD11 ' A' ' 71' ' ' ILE . 28.4 mttm -104.36 131.4 51.75 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.205 -0.935 . . . . 0.0 110.291 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.54 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 73.0 tttt -101.81 93.26 5.22 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.215 -0.928 . . . . 0.0 110.05 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.55 ' CG2' HG12 ' A' ' 38' ' ' ILE . 74.6 mt -80.0 147.34 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.216 -0.927 . . . . 0.0 110.065 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.576 ' O ' HG23 ' A' ' 38' ' ' ILE . 2.2 p -116.69 150.59 37.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.29 -0.881 . . . . 0.0 110.729 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.703 ' HE2' HG13 ' A' ' 67' ' ' VAL . 22.3 m-85 -113.79 126.84 55.66 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.411 -0.806 . . . . 0.0 110.037 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.437 ' N ' ' HB2' ' A' ' 39' ' ' LYS . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.256 0.551 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.576 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -120.98 94.49 0.55 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.537 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 11.8 p90 -131.17 169.13 16.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -1.182 . . . . 0.0 110.217 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.792 HG12 ' HA2' ' A' ' 88' ' ' GLY . 4.1 m -135.25 177.9 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.233 -0.917 . . . . 0.0 110.345 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.656 ' O ' HD12 ' A' ' 85' ' ' LEU . 83.2 mttt -134.91 106.8 7.02 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.377 -0.827 . . . . 0.0 109.872 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.983 ' CD2' HD13 ' A' ' 85' ' ' LEU . 14.5 m170 -98.32 125.78 43.57 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.217 -0.927 . . . . 0.0 111.247 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.577 ' CE ' ' CG2' ' A' ' 86' ' ' ILE . 5.8 mtmp? -93.3 119.13 32.09 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.29 -0.881 . . . . 0.0 109.496 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.577 HG21 ' O ' ' A' ' 49' ' ' GLY . 37.8 mm -58.36 128.39 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.128 -0.983 . . . . 0.0 110.519 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.483 ' HB2' ' OG ' ' A' ' 82' ' ' SER . 94.3 m-20 -101.81 -43.82 5.71 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.382 -0.824 . . . . 0.0 109.939 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.498 ' N ' ' OG ' ' A' ' 82' ' ' SER . 22.7 m -169.49 158.89 8.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.407 -0.808 . . . . 0.0 109.736 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.6 mt -142.99 158.27 17.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.175 -0.953 . . . . 0.0 110.465 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.552 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 4.4 m-20 -134.32 77.81 1.72 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.682 -0.636 . . . . 0.0 109.927 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.53 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 14.7 ttpp -61.14 -16.25 42.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.088 -1.008 . . . . 0.0 110.238 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -93.15 -30.34 15.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.287 -0.883 . . . . 0.0 109.623 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -106.38 -7.28 17.73 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.481 -0.762 . . . . 0.0 109.958 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.575 ' O ' HD12 ' A' ' 104' ' ' LEU . 2.7 m-85 67.59 51.19 0.85 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.49 -0.756 . . . . 0.0 110.008 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.552 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -123.41 151.2 42.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.305 -0.872 . . . . 0.0 109.324 179.618 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.684 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 31.1 t80 -137.93 141.07 40.58 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.174 -0.954 . . . . 0.0 110.414 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.498 ' OG ' ' N ' ' A' ' 73' ' ' SER . 1.2 p -143.38 126.48 16.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.243 -0.911 . . . . 0.0 110.56 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.684 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 26.8 p90 -149.17 170.86 17.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.33 -0.856 . . . . 0.0 110.233 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.857 HG23 ' O ' ' A' ' 98' ' ' ILE . 40.7 m -127.05 150.51 49.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.308 -0.87 . . . . 0.0 109.88 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.983 HD13 ' CD2' ' A' ' 69' ' ' HIS . 8.0 tp -111.42 124.79 52.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.0 -1.063 . . . . 0.0 110.354 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.577 ' CG2' ' CE ' ' A' ' 70' ' ' LYS . 14.4 pt -105.21 -27.08 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.382 -0.824 . . . . 0.0 110.23 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.611 ' O ' HD11 ' A' ' 85' ' ' LEU . 81.7 tt0 -123.38 155.73 36.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -0.86 . . . . 0.0 110.227 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.792 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 162.26 137.99 2.32 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -65.07 -19.21 65.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.22 -1.164 . . . . 0.0 110.16 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.93 -17.8 45.83 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.288 -0.882 . . . . 0.0 110.278 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.635 HD22 HD12 ' A' ' 98' ' ' ILE . 14.1 mt -61.38 -29.02 69.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.269 -0.894 . . . . 0.0 110.03 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 47.27 -175.61 0.01 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.575 ' OD1' HG23 ' A' ' 94' ' ' THR . 54.6 p30 -83.85 6.76 20.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.192 -1.181 . . . . 0.0 109.773 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.575 HG23 ' OD1' ' A' ' 93' ' ' ASP . 50.0 p -98.93 -42.42 7.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.366 -0.834 . . . . 0.0 110.225 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.921 HD21 HD11 ' A' ' 128' ' ' ILE . 74.6 mt -100.44 161.67 13.45 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.39 -0.819 . . . . 0.0 110.137 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -142.46 -81.27 0.21 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.307 -0.871 . . . . 0.0 109.609 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 7.8 mtpp -80.2 143.74 33.54 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.688 -0.632 . . . . 0.0 110.352 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.857 ' O ' HG23 ' A' ' 84' ' ' THR . 0.6 OUTLIER -138.06 134.86 45.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.049 -1.032 . . . . 0.0 109.489 179.092 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.499 ' CB ' ' HB2' ' A' ' 119' ' ' HIS . 0.1 OUTLIER -109.9 141.06 43.16 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.467 -0.771 . . . . 0.0 109.875 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.611 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 2.8 m-85 -127.8 143.16 51.14 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.319 -0.863 . . . . 0.0 110.341 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.476 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 68.2 tt0 -149.79 119.43 6.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.317 -0.864 . . . . 0.0 110.193 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 64.4 m -119.66 150.76 39.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.166 -0.959 . . . . 0.0 109.923 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 115' ' ' LYS . 20.8 mttt -142.65 133.71 25.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.237 -0.915 . . . . 0.0 110.515 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.927 HD23 HG12 ' A' ' 114' ' ' ILE . 5.4 mt -116.74 147.35 42.11 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.193 -0.942 . . . . 0.0 109.799 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.69 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -150.69 -168.75 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.195 -0.941 . . . . 0.0 110.107 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.69 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -112.75 156.15 23.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.356 -0.84 . . . . 0.0 109.973 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.452 ' HB3' HG13 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -114.42 170.21 5.71 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.257 -0.902 . . . . 0.0 110.36 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -76.04 0.77 8.95 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.069 1.563 . . . . 0.0 110.471 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 59.0 p -109.9 8.96 24.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.236 -0.915 . . . . 0.0 110.268 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 93.41 -26.39 15.91 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.428 ' C ' ' OG ' ' A' ' 107' ' ' SER . . . -70.24 -172.41 10.81 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.509 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 5.2 p -124.78 127.2 46.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.124 -1.221 . . . . 0.0 110.428 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.803 ' HA ' HG22 ' A' ' 10' ' ' THR . 73.9 mt -79.9 148.28 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.303 -0.873 . . . . 0.0 110.199 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.927 HG12 HD23 ' A' ' 104' ' ' LEU . 18.0 mt -132.45 127.48 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.188 -0.945 . . . . 0.0 110.563 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 103' ' ' LYS . 38.1 tttp -118.08 118.59 32.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.255 -0.903 . . . . 0.0 109.797 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.1 t -113.9 155.17 26.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.114 -0.991 . . . . 0.0 110.656 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.476 ' HB ' ' HB3' ' A' ' 101' ' ' GLU . 78.6 m -149.87 133.37 16.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.365 -0.834 . . . . 0.0 110.192 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 28.0 p -126.47 142.99 51.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.237 -0.914 . . . . 0.0 110.238 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.856 ' CE1' HG23 ' A' ' 4' ' ' THR . 85.5 m-70 -122.67 157.37 32.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.152 -0.967 . . . . 0.0 110.436 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.526 ' CD2' HG13 ' A' ' 128' ' ' ILE . 28.5 m-85 -128.32 137.34 51.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.248 -0.908 . . . . 0.0 110.354 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.487 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 47.4 m-70 -117.71 88.79 2.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.095 -1.003 . . . . 0.0 109.491 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.809 ' CG2' HD23 ' A' ' 95' ' ' LEU . 1.1 p -72.92 160.16 32.57 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.46 -0.775 . . . . 0.0 110.411 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 15.5 tttt -113.9 111.85 22.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.372 -0.83 . . . . 0.0 110.214 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 113.64 -133.87 11.49 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -123.5 64.33 1.02 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.217 -1.166 . . . . 0.0 110.255 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.452 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 24.2 m -130.73 162.52 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.258 -0.901 . . . . 0.0 110.142 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.423 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 93.0 mt-10 -134.67 161.62 34.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 0.0 110.307 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.921 HD11 HD21 ' A' ' 95' ' ' LEU . 20.6 mm -67.29 173.12 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 0.0 110.056 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.591 ' N ' HG22 ' A' ' 128' ' ' ILE . 12.5 mttt -111.75 132.8 54.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.0 110.029 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.434 ' OE1' ' HA ' ' A' ' 130' ' ' GLU . 69.4 mm-40 -44.61 -35.16 2.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.195 -0.941 . . . . 0.0 110.133 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -67.81 -23.81 65.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 109.967 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.472 ' N ' ' O ' ' A' ' 129' ' ' LYS . 16.4 t-160 -83.16 -49.33 9.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.297 -0.877 . . . . 0.0 110.217 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.651 HG11 ' CD1' ' A' ' 5' ' ' TYR . 98.8 t -59.61 -34.29 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.388 -0.82 . . . . 0.0 110.076 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -73.87 -51.14 17.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.893 . . . . 0.0 110.037 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.426 ' O ' ' HG3' ' A' ' 139' ' ' LYS . . . -59.29 -32.95 70.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.251 -0.905 . . . . 0.0 110.016 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.34 -27.93 73.11 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 81.0 mttt -78.9 -31.71 45.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.246 -1.15 . . . . 0.0 110.125 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -88.72 -30.03 19.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 0.0 109.92 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.426 ' HG3' ' O ' ' A' ' 135' ' ' ALA . 25.9 mttm -72.17 -31.11 65.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.349 -0.845 . . . . 0.0 109.94 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -86.64 -41.64 14.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.258 -0.901 . . . . 0.0 109.961 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 36.0 t -53.22 -43.25 67.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.338 -0.851 . . . . 0.0 110.088 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -57.38 -42.87 83.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -0.847 . . . . 0.0 110.005 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.463 HD23 HD12 ' A' ' 146' ' ' LEU . 52.7 mt -63.9 -37.75 88.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -0.914 . . . . 0.0 109.941 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -63.14 -35.15 79.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.433 -0.792 . . . . 0.0 109.857 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -75.15 -10.68 59.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.289 -0.882 . . . . 0.0 110.278 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.717 HD13 ' HB2' ' A' ' 34' ' ' ALA . 24.0 mt -85.18 -36.67 20.87 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.11 -0.994 . . . . 0.0 109.099 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.701 HD11 ' CE1' ' A' ' 22' ' ' PHE . 32.3 mt -71.2 -44.12 74.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.618 ' HB3' HD13 ' A' ' 13' ' ' ILE . 85.2 mt-10 -58.08 -42.22 85.14 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.446 -0.784 . . . . 0.0 109.614 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 28.2 m -70.19 -39.97 74.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.191 -0.943 . . . . 0.0 109.54 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.615 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 93.1 t80 -49.37 -42.44 42.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.437 -0.789 . . . . 0.0 109.995 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.903 HD13 ' HG2' ' A' ' 17' ' ' ARG . 42.6 mt -80.16 -44.72 19.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.322 -0.862 . . . . 0.0 110.33 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.745 ' HB2' HD11 ' A' ' 13' ' ' ILE . 29.9 tttt -61.03 -14.45 23.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.337 -0.852 . . . . 0.0 109.629 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -113.31 -30.05 2.8 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.56 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 8.0 m-70 -112.64 96.09 35.35 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.357 -1.084 . . . . 0.0 110.025 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.48 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.9 Cg_endo -73.78 7.68 2.28 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.155 1.608 . . . . 0.0 111.279 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 157' ' ' ALA . 39.3 p30 -109.84 -9.56 14.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.952 -1.093 . . . . 0.0 109.582 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.615 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -66.01 101.14 0.65 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.548 -0.72 . . . . 0.0 110.182 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 1.036 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 0.3 OUTLIER 35.05 32.63 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.218 0 CA-C-O 121.406 0.622 . . . . 0.0 110.164 -179.602 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.533 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.305 -1.365 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.935 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 1.043 HG23 ' C ' ' A' ' 120' ' ' TYR . 3.4 p -88.11 148.13 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.332 -1.099 . . . . 0.0 110.538 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -83.95 172.25 12.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.403 -0.811 . . . . 0.0 110.118 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 1.0 HG23 ' CE1' ' A' ' 119' ' ' HIS . 92.8 m -141.1 124.83 16.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.289 -0.882 . . . . 0.0 110.46 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.639 ' CZ ' HG11 ' A' ' 133' ' ' VAL . 74.4 m-85 -126.04 144.63 50.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.321 -0.862 . . . . 0.0 109.932 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.454 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 20.5 pt-20 -139.34 149.54 44.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.208 -0.932 . . . . 0.0 110.581 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -135.44 144.54 46.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.453 -0.779 . . . . 0.0 109.595 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -130.33 119.48 22.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.113 -0.992 . . . . 0.0 110.634 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.641 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.0 p90 -144.61 -177.89 5.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.393 -0.817 . . . . 0.0 109.793 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.89 HG22 ' HA ' ' A' ' 113' ' ' ILE . 9.4 p -141.9 171.89 13.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.175 -0.953 . . . . 0.0 110.678 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -152.36 154.99 36.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.46 -0.775 . . . . 0.0 110.247 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -77.01 -27.88 54.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.293 -0.88 . . . . 0.0 109.928 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.818 HG23 ' HD2' ' A' ' 14' ' ' PRO . 1.8 mp -71.39 150.54 94.07 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.351 -0.843 . . . . 0.0 109.849 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.818 ' HD2' HG23 ' A' ' 13' ' ' ILE . 41.0 Cg_endo -66.43 141.49 61.82 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.99 1.521 . . . . 0.0 110.498 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.636 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 41.2 Cg_endo -73.64 -30.21 9.94 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 124.068 1.562 . . . . 0.0 113.125 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 44.6 Cg_endo -71.56 -28.3 17.69 Favored 'Trans proline' 0 C--N 1.318 -1.034 0 N-CA-C 110.288 -0.697 . . . . 0.0 110.288 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.563 ' CZ ' ' HA ' ' A' ' 159' ' ' ASN . 6.3 mtp180 -79.92 -42.91 23.12 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.722 ' C ' HD23 ' A' ' 18' ' ' LEU . 0.4 OUTLIER -66.51 -30.07 70.32 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.575 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.608 ' N ' HD23 ' A' ' 18' ' ' LEU . 52.0 t80 -63.83 -51.99 62.16 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.51 0.671 . . . . 0.0 109.851 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.54 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 22.9 mttt -55.94 -40.04 72.59 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.525 -0.734 . . . . 0.0 109.94 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.068 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -77.86 -26.8 49.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.263 -0.898 . . . . 0.0 110.946 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 1.002 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 3.4 t80 -81.8 -49.12 10.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.095 -1.003 . . . . 0.0 111.579 -178.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.702 HG13 ' CE1' ' A' ' 81' ' ' TYR . 5.5 t -102.03 -53.71 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.098 -1.001 . . . . 0.0 111.462 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.622 HD12 ' N ' ' A' ' 24' ' ' LEU . 7.6 mp -66.0 -8.7 24.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.137 -0.977 . . . . 0.0 111.016 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.564 ' OD2' ' CE2' ' A' ' 158' ' ' TYR . 2.7 m-20 -145.0 21.79 1.58 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.963 -1.086 . . . . 0.0 110.524 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 1.002 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -59.73 -14.85 16.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.201 -0.937 . . . . 0.0 110.414 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -80.08 -25.03 40.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -0.914 . . . . 0.0 110.483 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.494 ' HB2' ' HE3' ' A' ' 32' ' ' LYS . 6.9 p30 -126.8 14.39 7.46 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.128 -0.982 . . . . 0.0 110.606 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.766 HD23 ' OH ' ' A' ' 158' ' ' TYR . 1.2 tm? -100.71 -43.09 6.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.239 -0.913 . . . . 0.0 109.858 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.93 HG11 HD13 ' A' ' 38' ' ' ILE . 4.8 t -77.41 -40.81 2.26 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.464 -0.772 . . . . 0.0 111.193 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 47.6 Cg_endo -77.6 10.65 2.45 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.444 1.234 . . . . 0.0 111.051 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.494 ' HE3' ' HB2' ' A' ' 28' ' ' ASN . 16.6 mttm -122.27 -30.74 3.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.985 -1.072 . . . . 0.0 109.496 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.93 HG21 ' HB3' ' A' ' 146' ' ' LEU . 7.5 mt -80.13 -55.48 8.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.579 -0.701 . . . . 0.0 109.821 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.51 103.96 5.02 Favored Pre-proline 0 C--N 1.304 -1.409 0 O-C-N 121.404 -0.81 . . . . 0.0 110.238 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.33 0.34 7.54 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.015 1.534 . . . . 0.0 110.526 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -81.62 -20.59 39.42 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.116 -0.99 . . . . 0.0 109.475 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -91.5 -42.32 10.33 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.467 -0.771 . . . . 0.0 109.927 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.93 HD13 HG11 ' A' ' 30' ' ' VAL . 1.1 mp -137.7 140.1 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.43 -0.794 . . . . 0.0 109.944 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.3 ttmm -82.25 -36.37 27.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 110.208 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.562 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -176.44 154.98 1.36 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.262 -0.898 . . . . 0.0 110.192 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.5 m -124.2 116.8 23.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.287 -0.883 . . . . 0.0 109.975 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.562 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 35.8 tp10 -122.79 113.27 18.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.193 -0.942 . . . . 0.0 110.449 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.482 HG12 ' HG2' ' A' ' 54' ' ' LYS . 23.2 mt -60.67 133.94 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.322 -0.861 . . . . 0.0 109.98 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.537 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 26.7 mt -106.97 -23.5 12.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.247 -0.908 . . . . 0.0 110.517 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.576 ' CD1' HD12 ' A' ' 53' ' ' ILE . 1.6 m95 -130.94 161.25 32.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.127 -0.983 . . . . 0.0 110.559 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.454 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 41.98 -133.56 3.95 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -157.7 20.65 0.27 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -1.104 . . . . 0.0 110.059 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.465 ' O ' HG21 ' A' ' 71' ' ' ILE . . . 125.49 -19.92 6.61 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.484 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -67.79 -175.21 8.48 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.426 ' HA ' HG22 ' A' ' 71' ' ' ILE . 47.1 Cg_endo -73.92 129.54 13.47 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 123.932 1.49 . . . . 0.0 110.66 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.94 -13.99 52.66 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -68.0 166.38 15.95 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.516 -0.991 . . . . 0.0 109.907 179.751 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.576 HD12 ' CD1' ' A' ' 45' ' ' TRP . 40.7 mt -133.27 121.68 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.315 -0.865 . . . . 0.0 109.662 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.52 ' HE3' HD11 ' A' ' 71' ' ' ILE . 20.7 mttm -111.15 132.29 54.41 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.144 -0.973 . . . . 0.0 110.411 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.537 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 17.7 tttt -101.36 89.93 3.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 109.904 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.551 ' CG2' HG12 ' A' ' 38' ' ' ILE . 83.0 mt -79.98 144.4 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.296 -0.877 . . . . 0.0 110.168 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.516 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 4.8 p -117.31 159.11 23.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.295 -0.878 . . . . 0.0 110.603 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' A' ' 65' ' ' GLY . 22.5 m-85 -119.61 149.54 41.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.381 -0.824 . . . . 0.0 110.076 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.964 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.306 0.574 . . . . 0.0 110.342 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -134.1 91.61 0.25 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.538 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 15.2 p90 -129.92 166.7 19.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.137 -1.213 . . . . 0.0 110.276 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.794 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.4 m -142.92 172.27 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 110.696 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.523 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 23.3 mttm -125.19 124.48 41.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.621 -0.675 . . . . 0.0 109.543 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.698 ' NE2' HD13 ' A' ' 85' ' ' LEU . 11.3 m170 -113.41 126.1 54.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.143 -0.973 . . . . 0.0 111.157 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 1.03 ' HE3' HD13 ' A' ' 86' ' ' ILE . 48.3 mttt -97.82 117.15 31.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.373 -0.829 . . . . 0.0 109.509 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.522 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 22.4 mm -60.07 128.64 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.082 -1.011 . . . . 0.0 110.311 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 82' ' ' SER . 89.4 m-20 -102.5 -45.34 5.09 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.314 -0.867 . . . . 0.0 110.179 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 19.1 m -168.08 159.07 10.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.385 -0.822 . . . . 0.0 110.094 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.483 HG12 HG11 ' A' ' 23' ' ' VAL . 2.0 mt -141.26 158.79 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.292 -0.88 . . . . 0.0 110.118 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.551 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 4.5 m-20 -135.37 80.02 1.81 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.502 -0.749 . . . . 0.0 110.116 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.564 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 17.8 mttt -62.39 -18.16 60.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.135 -0.978 . . . . 0.0 110.4 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -91.91 -31.79 15.53 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.133 -0.979 . . . . 0.0 109.633 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.476 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -103.58 -6.63 21.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.591 -0.693 . . . . 0.0 109.799 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.569 ' CZ ' ' HB3' ' A' ' 16' ' ' PRO . 4.1 m-85 65.91 51.8 1.32 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.494 -0.754 . . . . 0.0 110.056 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.551 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -123.38 157.9 32.33 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.081 -1.012 . . . . 0.0 109.595 179.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.702 ' CE1' HG13 ' A' ' 23' ' ' VAL . 32.3 t80 -144.56 141.01 29.16 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.196 -0.94 . . . . 0.0 110.259 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.6 OUTLIER -145.89 127.02 14.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.208 -0.932 . . . . 0.0 110.929 -179.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.688 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 20.0 p90 -146.6 170.67 16.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.436 -0.79 . . . . 0.0 109.796 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.606 HG23 ' O ' ' A' ' 98' ' ' ILE . 35.2 m -124.44 135.43 53.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.159 -0.963 . . . . 0.0 110.427 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.698 HD13 ' NE2' ' A' ' 69' ' ' HIS . 6.3 tp -99.49 124.35 44.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.283 -0.886 . . . . 0.0 109.702 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 1.03 HD13 ' HE3' ' A' ' 70' ' ' LYS . 14.3 pt -106.41 -15.77 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.387 -0.821 . . . . 0.0 110.459 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.523 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 24.9 tt0 -121.3 176.11 5.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.147 -0.97 . . . . 0.0 110.339 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.794 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 137.09 123.58 2.24 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -57.78 -15.37 7.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -1.142 . . . . 0.0 110.205 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.929 ' HB1' ' CE1' ' A' ' 132' ' ' HIS . . . -73.92 -40.48 63.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -0.88 . . . . 0.0 110.167 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.669 ' CD2' HD21 ' A' ' 95' ' ' LEU . 10.1 mt -42.17 -48.05 4.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.406 -0.809 . . . . 0.0 110.119 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 43.23 -164.72 0.03 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -81.19 2.57 27.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -1.142 . . . . 0.0 110.172 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 52.2 p -92.62 -42.51 9.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.287 -0.883 . . . . 0.0 110.17 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.873 HD12 ' H ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -119.55 159.91 23.43 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.367 -0.833 . . . . 0.0 109.339 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.873 ' H ' HD12 ' A' ' 95' ' ' LEU . 53.9 tt0 -136.32 -82.02 0.39 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.344 -0.848 . . . . 0.0 110.178 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.499 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 5.3 mttt -80.24 139.36 36.73 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.768 -0.583 . . . . 0.0 110.558 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.752 HG21 ' CE2' ' A' ' 100' ' ' TYR . 3.6 mm -123.06 139.97 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.963 -1.086 . . . . 0.0 109.887 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.513 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -117.48 126.77 53.19 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.279 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.752 ' CE2' HG21 ' A' ' 98' ' ' ILE . 8.7 m-85 -119.56 137.63 53.72 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.237 -0.914 . . . . 0.0 110.722 -178.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.469 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 80.9 tt0 -143.2 134.57 26.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.353 -0.842 . . . . 0.0 110.143 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.417 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 85.6 m -133.77 145.11 49.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -0.917 . . . . 0.0 110.18 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.6 mttt -140.53 140.72 35.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 0.0 110.671 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.794 HD23 HG12 ' A' ' 114' ' ' ILE . 10.1 mt -121.05 149.57 42.51 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.236 -0.915 . . . . 0.0 110.142 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.7 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -146.05 -169.71 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.207 -0.933 . . . . 0.0 110.03 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.7 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -126.68 160.56 30.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.256 -0.902 . . . . 0.0 110.275 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.423 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.2 p -119.32 170.55 6.54 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.225 -0.922 . . . . 0.0 110.144 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.423 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 45.7 Cg_endo -72.8 -14.8 26.89 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 124.11 1.584 . . . . 0.0 110.575 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 24.8 p -94.7 7.15 46.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -0.903 . . . . 0.0 110.273 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 94.46 -31.16 6.99 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -58.26 -172.41 0.34 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 10.4 p -137.25 137.63 39.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.194 -1.18 . . . . 0.0 110.39 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.89 ' HA ' HG22 ' A' ' 10' ' ' THR . 16.2 mt -92.58 149.59 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.402 -0.811 . . . . 0.0 110.088 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.794 HG12 HD23 ' A' ' 104' ' ' LEU . 18.5 mt -131.23 128.63 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.22 -0.925 . . . . 0.0 110.228 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.1 tttp -118.11 108.73 15.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.084 -1.01 . . . . 0.0 110.209 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.434 ' OG ' ' CZ ' ' A' ' 9' ' ' PHE . 0.9 OUTLIER -103.25 157.33 17.08 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.238 -0.914 . . . . 0.0 110.441 -179.854 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.704 HG22 ' NE2' ' A' ' 119' ' ' HIS . 24.8 m -154.87 119.56 4.83 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.337 -0.852 . . . . 0.0 110.438 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 86.5 p -119.01 148.1 43.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.403 -0.811 . . . . 0.0 110.041 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 1.0 ' CE1' HG23 ' A' ' 4' ' ' THR . 24.6 m-70 -132.42 152.93 51.29 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.201 -0.937 . . . . 0.0 110.668 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 1.043 ' C ' HG23 ' A' ' 2' ' ' VAL . 9.8 m-85 -121.82 119.92 33.05 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.271 -0.893 . . . . 0.0 110.614 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.566 ' N ' HG23 ' A' ' 2' ' ' VAL . 80.4 m-70 -92.62 104.1 16.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.558 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.468 HG21 ' HA ' ' A' ' 127' ' ' GLU . 0.8 OUTLIER -77.96 144.75 36.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.141 -0.975 . . . . 0.0 110.374 -179.593 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.418 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 31.5 tttp -105.57 126.93 52.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.278 -0.889 . . . . 0.0 110.207 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.37 -138.92 21.14 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -113.87 59.64 0.67 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -1.142 . . . . 0.0 110.274 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 26.2 m -131.28 161.7 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.319 -0.863 . . . . 0.0 110.194 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.468 ' HA ' HG21 ' A' ' 122' ' ' THR . 85.3 mt-10 -137.6 139.7 40.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.266 -0.896 . . . . 0.0 110.25 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.598 HG22 ' N ' ' A' ' 129' ' ' LYS . 2.7 mp -59.77 173.25 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.191 -0.943 . . . . 0.0 110.148 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.598 ' N ' HG22 ' A' ' 128' ' ' ILE . 21.4 mttm -92.45 127.41 37.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 110.089 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -45.39 -44.72 12.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.149 -0.969 . . . . 0.0 110.136 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 29.0 tp10 -53.29 -30.26 37.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.194 -0.941 . . . . 0.0 110.04 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.929 ' CE1' ' HB1' ' A' ' 90' ' ' ALA . 11.1 t-160 -76.35 -57.82 3.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -0.932 . . . . 0.0 110.239 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.639 HG11 ' CZ ' ' A' ' 5' ' ' TYR . 72.3 t -59.19 -34.22 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.377 -0.827 . . . . 0.0 110.063 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -72.41 -49.1 36.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.332 -0.855 . . . . 0.0 110.111 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.87 -29.66 69.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.095 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.72 -32.08 80.29 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.429 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 17.3 mttp -65.04 -36.84 85.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.251 -1.146 . . . . 0.0 110.036 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -75.35 -35.44 61.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.307 -0.87 . . . . 0.0 110.041 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -70.12 -30.84 68.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.363 -0.836 . . . . 0.0 109.92 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.482 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -74.61 -41.28 60.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.287 -0.883 . . . . 0.0 110.134 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 61.3 p -64.68 -39.36 93.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.371 -0.831 . . . . 0.0 109.991 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -60.87 -48.11 83.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 110.004 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 27.6 mt -57.87 -38.54 75.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.271 -0.893 . . . . 0.0 109.957 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.498 ' HA ' HD12 ' A' ' 147' ' ' ILE . 19.7 m-85 -62.87 -33.79 76.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.448 -0.783 . . . . 0.0 109.905 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.409 ' HA ' ' OE1' ' A' ' 148' ' ' GLU . 92.8 mttt -74.85 -15.03 60.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -0.904 . . . . 0.0 110.202 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.93 ' HB3' HG21 ' A' ' 33' ' ' ILE . 28.2 mt -85.25 -36.69 20.76 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.222 -0.923 . . . . 0.0 109.043 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.626 HD13 ' CD1' ' A' ' 22' ' ' PHE . 16.1 mt -72.09 -41.41 67.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.538 ' HB3' HD13 ' A' ' 13' ' ' ILE . 86.5 mt-10 -59.13 -42.81 91.5 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.49 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 15.5 m -74.12 -27.96 61.11 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.64 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 50.2 t80 -52.07 -61.85 2.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.563 -0.71 . . . . 0.0 109.836 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.548 HD21 ' CE1' ' A' ' 158' ' ' TYR . 36.0 mt -72.24 -30.08 64.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.346 -0.846 . . . . 0.0 109.71 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.554 ' HB2' HD11 ' A' ' 13' ' ' ILE . 27.8 tttp -65.27 -33.84 76.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.343 -0.848 . . . . 0.0 109.253 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.487 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -99.0 -30.74 6.56 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.59 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 5.4 m-70 -107.26 87.2 3.02 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.327 -1.101 . . . . 0.0 109.796 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 46.1 Cg_endo -72.08 2.62 4.71 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.068 1.562 . . . . 0.0 110.955 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -108.24 -12.61 15.05 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.96 -1.087 . . . . 0.0 110.197 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.64 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -69.2 99.71 1.19 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.253 -0.905 . . . . 0.0 109.846 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 1.068 ' CE1' ' HB2' ' A' ' 21' ' ' ALA . 0.1 OUTLIER 34.77 32.33 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 CA-C-O 121.518 0.675 . . . . 0.0 109.871 -179.21 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.563 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.446 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.826 -179.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.679 HG13 ' O ' ' A' ' 120' ' ' TYR . 40.4 t -126.85 139.95 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -1.135 . . . . 0.0 110.239 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.75 ' CE1' HD12 ' A' ' 128' ' ' ILE . 16.2 m-85 -101.94 160.6 14.35 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.213 -0.93 . . . . 0.0 109.728 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.785 HG23 ' CE1' ' A' ' 119' ' ' HIS . 5.1 m -124.42 108.32 12.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.118 -0.989 . . . . 0.0 110.508 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.759 ' CE1' HG11 ' A' ' 133' ' ' VAL . 25.3 m-85 -120.47 126.18 49.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.26 -0.9 . . . . 0.0 109.969 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.604 ' HB3' HG23 ' A' ' 117' ' ' THR . 25.8 pt-20 -139.37 159.66 41.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.924 . . . . 0.0 110.394 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.2 t -138.65 148.93 44.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.862 . . . . 0.0 110.012 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -131.81 123.28 27.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.195 -0.941 . . . . 0.0 110.257 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.638 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.0 p90 -145.94 -174.07 4.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.194 -0.941 . . . . 0.0 109.952 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.722 HG22 ' HA ' ' A' ' 113' ' ' ILE . 8.7 p -139.28 175.52 9.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.134 -0.979 . . . . 0.0 110.496 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.477 ' CB ' ' CD ' ' A' ' 148' ' ' GLU . 79.8 p -158.08 139.4 13.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.306 -0.871 . . . . 0.0 110.229 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -64.74 -28.71 69.77 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 0.0 109.888 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.805 HG23 ' HD2' ' A' ' 14' ' ' PRO . 8.3 mm -68.96 149.88 97.74 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.365 -0.835 . . . . 0.0 109.904 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.805 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.5 Cg_endo -65.6 146.47 84.57 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.971 1.511 . . . . 0.0 110.44 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.672 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.1 Cg_endo -71.51 -31.73 13.26 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.969 1.51 . . . . 0.0 112.828 -179.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.672 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 40.8 Cg_endo -69.41 -21.38 35.2 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 N-CA-C 110.059 -0.785 . . . . 0.0 110.059 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.753 ' HB3' HD13 ' A' ' 151' ' ' LEU . 52.7 mtp180 -85.68 -44.87 12.2 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.883 ' HG ' HG21 ' A' ' 147' ' ' ILE . 1.1 tt -71.34 -30.07 65.74 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.627 ' CZ ' HD11 ' A' ' 74' ' ' ILE . 71.4 t80 -66.88 -61.76 1.78 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.521 -0.737 . . . . 0.0 109.13 178.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.585 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 52.6 mttt -52.78 -34.33 52.84 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.338 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.95 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -72.21 -53.75 11.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.33 -0.856 . . . . 0.0 110.749 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.99 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.3 OUTLIER -59.86 -53.2 60.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.507 -0.745 . . . . 0.0 111.425 -178.897 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 1.004 HG11 HD12 ' A' ' 74' ' ' ILE . 11.1 t -91.26 -63.86 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.992 -1.068 . . . . 0.0 111.767 -178.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.585 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 4.7 mp -65.12 -3.57 3.9 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.22 -0.925 . . . . 0.0 111.793 -178.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.581 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.8 OUTLIER -140.46 9.54 2.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.658 -1.276 . . . . 0.0 110.788 179.882 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.99 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -51.57 -26.83 9.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.176 -0.953 . . . . 0.0 110.31 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -76.63 -13.95 60.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.947 . . . . 0.0 110.502 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.424 ' O ' ' HD2' ' A' ' 32' ' ' LYS . 72.0 m-80 -134.97 10.64 3.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.211 -0.93 . . . . 0.0 110.345 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.54 ' HG ' ' HB1' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -104.24 -40.97 5.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.185 -0.947 . . . . 0.0 110.38 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.848 ' CG1' HD13 ' A' ' 38' ' ' ILE . 2.8 t -81.08 -41.55 1.13 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.28 -0.888 . . . . 0.0 111.178 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.3 Cg_endo -77.17 11.17 2.14 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.387 1.204 . . . . 0.0 111.074 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.424 ' HD2' ' O ' ' A' ' 28' ' ' ASN . 17.1 mttm -123.25 -31.51 3.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.943 -1.098 . . . . 0.0 109.471 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.86 ' CG2' HD22 ' A' ' 146' ' ' LEU . 9.3 mt -80.12 -44.96 22.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.52 -0.737 . . . . 0.0 109.611 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.437 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . . . -141.07 99.11 6.66 Favored Pre-proline 0 C--N 1.304 -1.39 0 O-C-N 121.371 -0.831 . . . . 0.0 110.115 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 34' ' ' ALA . 44.9 Cg_endo -71.12 -2.82 11.71 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.951 1.501 . . . . 0.0 110.524 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -89.02 -23.15 22.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 109.949 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 58' ' ' PHE . . . -85.54 -70.39 0.59 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.323 -0.86 . . . . 0.0 110.06 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.848 HD13 ' CG1' ' A' ' 30' ' ' VAL . 1.8 mp -101.11 122.08 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.449 -0.782 . . . . 0.0 110.01 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 57' ' ' THR . 10.7 ttmt -75.2 -32.11 61.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.154 -0.966 . . . . 0.0 110.487 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.53 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -176.25 148.41 0.78 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.162 -0.961 . . . . 0.0 110.171 -179.882 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.3 m -122.31 118.43 28.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.35 -0.844 . . . . 0.0 109.718 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.524 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 42.4 tt0 -129.18 110.37 11.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.149 -0.969 . . . . 0.0 110.422 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.413 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 38.3 mt -53.06 144.91 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.372 -0.83 . . . . 0.0 110.046 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.0 tp -119.72 -25.13 5.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.237 -0.914 . . . . 0.0 110.544 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.825 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.7 m95 -127.81 162.97 25.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.113 -0.992 . . . . 0.0 110.646 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.446 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 42.56 -140.3 2.21 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -149.2 24.79 0.91 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.285 -1.126 . . . . 0.0 110.017 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 118.4 -12.19 12.51 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.546 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -81.97 -168.95 42.27 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.402 ' HA ' HG22 ' A' ' 71' ' ' ILE . 44.2 Cg_endo -72.54 128.28 13.37 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.042 1.548 . . . . 0.0 110.694 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.88 -12.45 49.66 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.1 m -72.85 162.28 29.68 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.616 -0.931 . . . . 0.0 109.47 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.825 HD12 ' CG ' ' A' ' 45' ' ' TRP . 66.1 mt -133.84 119.4 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.235 -0.916 . . . . 0.0 110.103 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.701 ' HE3' HD11 ' A' ' 71' ' ' ILE . 52.5 mttt -102.59 130.72 49.55 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.2 -0.938 . . . . 0.0 110.179 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.526 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 53.6 tttm -102.24 92.42 4.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.242 -0.911 . . . . 0.0 110.164 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.432 ' HB ' HG23 ' A' ' 67' ' ' VAL . 97.5 mt -80.45 140.61 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.142 -0.974 . . . . 0.0 110.394 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 1.4 p -110.16 150.94 27.91 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.351 -0.843 . . . . 0.0 110.267 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.675 ' HE2' HG13 ' A' ' 67' ' ' VAL . 24.7 m-85 -113.83 149.08 35.53 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.221 -0.924 . . . . 0.0 110.077 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.859 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.213 0.53 . . . . 0.0 110.228 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.571 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -130.26 88.69 0.3 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.539 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 13.7 p90 -133.77 166.68 22.07 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.192 -1.181 . . . . 0.0 110.292 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.855 HG12 ' HA2' ' A' ' 88' ' ' GLY . 4.4 m -133.93 175.74 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.384 -0.823 . . . . 0.0 110.253 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.711 ' O ' HD12 ' A' ' 85' ' ' LEU . 33.3 mttt -135.52 103.96 5.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.426 -0.797 . . . . 0.0 109.834 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.945 ' CD2' HD13 ' A' ' 85' ' ' LEU . 15.4 m170 -94.19 129.18 40.9 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.292 -0.88 . . . . 0.0 111.073 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 52' ' ' THR . 70.0 tttt -97.21 111.55 23.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.458 -0.776 . . . . 0.0 109.18 178.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.701 HD11 ' HE3' ' A' ' 54' ' ' LYS . 27.3 mm -52.91 125.61 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.093 -1.005 . . . . 0.0 110.354 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 82' ' ' SER . 95.0 m-20 -99.37 -48.6 4.74 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.374 -0.829 . . . . 0.0 109.666 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.4 m 177.8 160.68 0.51 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.544 -0.722 . . . . 0.0 110.054 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 1.004 HD12 HG11 ' A' ' 23' ' ' VAL . 3.2 tt -145.31 165.92 10.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.392 -0.817 . . . . 0.0 109.785 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.8 m-20 -128.95 76.89 1.75 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.099 -1.0 . . . . 0.0 110.132 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.59 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 65.3 mttm -55.43 -16.66 3.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.16 -0.962 . . . . 0.0 110.367 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -92.8 -30.67 15.35 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.348 -0.845 . . . . 0.0 109.705 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.516 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.2 m-80 -106.61 -0.13 24.01 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.561 -0.712 . . . . 0.0 109.475 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.608 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 72.8 m-85 62.06 52.84 3.15 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.297 0.57 . . . . 0.0 110.863 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.478 ' HB3' ' HG3' ' A' ' 103' ' ' LYS . 0.7 OUTLIER -130.56 152.01 50.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 109.84 179.305 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.677 ' CE1' HG13 ' A' ' 23' ' ' VAL . 74.5 t80 -149.46 133.86 17.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.022 -1.049 . . . . 0.0 110.368 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 36.1 m -139.66 147.08 40.52 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.176 -0.952 . . . . 0.0 110.525 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.668 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 7.8 p90 -148.47 177.88 9.08 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.346 -0.846 . . . . 0.0 110.666 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 98' ' ' ILE . 15.6 m -127.88 123.32 34.76 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.441 -0.787 . . . . 0.0 109.924 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.945 HD13 ' CD2' ' A' ' 69' ' ' HIS . 12.2 tp -94.34 134.0 37.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.021 -1.05 . . . . 0.0 110.292 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.548 ' H ' HD12 ' A' ' 85' ' ' LEU . 13.6 pt -114.89 -33.32 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 110.334 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.641 ' O ' HD11 ' A' ' 85' ' ' LEU . 29.3 tt0 -114.11 134.07 55.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 110.38 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.855 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . -176.92 122.38 0.84 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -55.77 -17.07 5.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.16 -1.2 . . . . 0.0 110.235 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -91.35 -34.15 15.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.934 . . . . 0.0 110.469 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.622 HD12 ' C ' ' A' ' 91' ' ' LEU . 1.9 pp -84.9 -16.97 39.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.256 -0.903 . . . . 0.0 110.404 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.87 -23.8 75.62 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -49.45 -65.56 0.55 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.288 -1.125 . . . . 0.0 110.358 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 80.5 p -137.28 8.4 2.91 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.463 -0.773 . . . . 0.0 110.175 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 1.048 HD21 ' CG1' ' A' ' 128' ' ' ILE . 11.4 mt -119.41 177.73 4.81 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.3 -0.875 . . . . 0.0 110.051 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.517 ' O ' HD13 ' A' ' 91' ' ' LEU . 39.4 tt0 -146.29 -78.73 0.17 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.332 -0.855 . . . . 0.0 109.772 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.499 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 16.1 mttm -80.16 142.57 34.63 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.87 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.732 HG21 ' HE2' ' A' ' 100' ' ' TYR . 5.2 mm -135.39 140.97 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.924 -1.11 . . . . 0.0 110.548 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.423 ' OG ' ' HD2' ' A' ' 119' ' ' HIS . 0.1 OUTLIER -118.55 137.15 53.42 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.59 -0.694 . . . . 0.0 109.235 178.434 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.732 ' HE2' HG21 ' A' ' 98' ' ' ILE . 8.4 m-85 -131.99 131.52 42.62 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.124 -0.985 . . . . 0.0 110.872 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.468 ' HG2' ' OG ' ' A' ' 82' ' ' SER . 7.1 mt-10 -129.52 133.47 47.26 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.409 -0.807 . . . . 0.0 109.91 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.51 ' N ' ' O ' ' A' ' 81' ' ' TYR . 43.4 m -127.41 144.9 50.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.925 . . . . 0.0 110.023 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.478 ' HG3' ' HB3' ' A' ' 80' ' ' SER . 2.2 mttt -141.94 136.49 30.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.944 . . . . 0.0 110.256 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.753 HD23 HG12 ' A' ' 114' ' ' ILE . 3.7 mt -120.91 151.01 40.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 110.102 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.713 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -151.62 -169.14 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.306 -0.872 . . . . 0.0 110.063 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.713 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -119.39 138.6 52.98 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.308 -0.87 . . . . 0.0 110.115 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.456 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 28.8 p -94.67 164.9 18.46 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.177 -0.952 . . . . 0.0 110.245 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.456 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.5 Cg_endo -72.5 -2.68 12.15 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.057 1.556 . . . . 0.0 110.59 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 81.8 p -102.14 0.86 35.4 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.225 -0.922 . . . . 0.0 110.263 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.73 -31.83 8.25 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -67.87 -173.98 7.59 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 1.1 p -126.29 131.42 51.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.235 -1.156 . . . . 0.0 110.237 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.722 ' HA ' HG22 ' A' ' 10' ' ' THR . 11.1 mt -82.3 150.26 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.415 -0.803 . . . . 0.0 110.196 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.753 HG12 HD23 ' A' ' 104' ' ' LEU . 15.4 mt -130.34 110.43 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 110.4 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.42 ' O ' ' N ' ' A' ' 103' ' ' LYS . 51.6 tttt -99.34 128.34 45.45 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.201 -0.937 . . . . 0.0 109.923 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 0.7 OUTLIER -123.02 153.39 39.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.182 -0.949 . . . . 0.0 110.537 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.604 HG23 ' HB3' ' A' ' 6' ' ' GLU . 28.7 m -159.99 127.71 4.67 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.396 -0.815 . . . . 0.0 110.286 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.486 ' HB2' ' CD1' ' A' ' 100' ' ' TYR . 24.6 p -132.13 160.16 36.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.242 -0.911 . . . . 0.0 110.225 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.785 ' CE1' HG23 ' A' ' 4' ' ' THR . 94.9 m-70 -132.3 135.76 46.44 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.11 -0.994 . . . . 0.0 110.625 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.679 ' O ' HG13 ' A' ' 2' ' ' VAL . 4.4 m-30 -97.66 146.84 24.93 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.293 -0.879 . . . . 0.0 110.108 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.499 ' HB2' ' HB2' ' A' ' 97' ' ' LYS . 94.0 m-70 -126.73 92.11 3.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.074 -1.016 . . . . 0.0 109.86 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.657 HG21 ' O ' ' A' ' 126' ' ' VAL . 1.8 p -66.62 164.38 16.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.449 -0.782 . . . . 0.0 110.311 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.431 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 34.4 tptt -147.48 114.81 6.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.368 -0.832 . . . . 0.0 110.257 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 125' ' ' ASN . . . 111.26 25.61 4.94 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 2.9 t30 65.1 62.45 0.71 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.198 -1.178 . . . . 0.0 110.179 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.657 ' O ' HG21 ' A' ' 122' ' ' THR . 20.2 m -140.35 143.44 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.244 -0.91 . . . . 0.0 110.316 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.469 ' N ' ' OE1' ' A' ' 127' ' ' GLU . 47.0 mp0 -114.03 165.99 12.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 110.257 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 1.048 ' CG1' HD21 ' A' ' 95' ' ' LEU . 3.1 mt -89.42 173.15 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.259 -0.901 . . . . 0.0 110.134 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.617 ' N ' HG22 ' A' ' 128' ' ' ILE . 8.1 mttm -111.55 152.66 27.28 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.361 -0.837 . . . . 0.0 110.009 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -58.57 -34.98 71.67 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.222 -0.924 . . . . 0.0 109.979 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.507 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 46.5 tt0 -62.57 -33.09 74.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.279 -0.888 . . . . 0.0 109.91 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 18.3 t-160 -76.45 -52.31 10.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -0.883 . . . . 0.0 110.104 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.759 HG11 ' CE1' ' A' ' 5' ' ' TYR . 57.8 t -62.28 -41.07 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.394 -0.816 . . . . 0.0 109.889 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -71.97 -47.26 53.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.268 -0.895 . . . . 0.0 109.854 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.507 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -61.57 -33.87 74.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.262 -0.899 . . . . 0.0 109.902 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.13 -29.7 66.29 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 37.1 mttm -74.15 -33.0 63.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.205 -1.174 . . . . 0.0 109.921 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -79.25 -35.73 41.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.354 -0.841 . . . . 0.0 109.933 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -70.2 -33.2 71.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.352 -0.842 . . . . 0.0 109.779 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.426 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -76.49 -41.04 48.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.348 -0.845 . . . . 0.0 109.957 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 35.3 t -59.87 -43.81 94.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.385 -0.822 . . . . 0.0 109.848 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -59.28 -42.41 91.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.299 -0.875 . . . . 0.0 109.881 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.91 ' HA ' HD12 ' A' ' 146' ' ' LEU . 18.7 mt -61.75 -36.36 80.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 109.946 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.786 ' HA ' HD12 ' A' ' 147' ' ' ILE . 30.1 m-85 -64.41 -37.12 86.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.348 -0.845 . . . . 0.0 109.568 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 25.9 mttm -70.28 -12.9 61.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.418 -0.801 . . . . 0.0 109.977 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.91 HD12 ' HA ' ' A' ' 143' ' ' LEU . 9.2 mt -81.57 -36.43 29.06 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.138 -0.976 . . . . 0.0 108.855 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.903 HD11 ' CE1' ' A' ' 22' ' ' PHE . 8.2 mt -68.39 -49.41 66.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.501 ' O ' HG13 ' A' ' 13' ' ' ILE . 69.9 mt-10 -52.62 -42.54 64.7 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.566 -0.709 . . . . 0.0 109.675 179.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.504 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 54.1 m -70.81 -34.66 71.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.065 -1.022 . . . . 0.0 109.526 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.575 ' CD2' ' OH ' ' A' ' 158' ' ' TYR . 51.9 t80 -51.24 -60.85 2.66 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.519 -0.738 . . . . 0.0 109.924 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.06 HD21 ' CE1' ' A' ' 158' ' ' TYR . 38.1 mt -73.07 -27.9 62.0 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.393 -0.817 . . . . 0.0 109.995 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.632 ' HA ' HD11 ' A' ' 13' ' ' ILE . 60.1 tttm -57.2 -19.96 23.97 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.201 -0.937 . . . . 0.0 108.486 178.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -128.08 -4.09 5.62 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.572 ' CG ' ' O ' ' A' ' 150' ' ' TYR . 63.6 m170 -113.39 86.52 10.08 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.171 -1.193 . . . . 0.0 110.235 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -73.59 2.21 6.05 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.038 1.546 . . . . 0.0 110.859 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -124.04 4.38 8.64 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.122 -0.987 . . . . 0.0 110.005 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.758 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -69.13 108.81 3.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.296 -0.877 . . . . 0.0 110.053 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 1.06 ' CE1' HD21 ' A' ' 151' ' ' LEU . 0.3 OUTLIER 35.3 35.14 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.633 -0.667 . . . . 0.0 110.952 -179.363 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.565 ' CB ' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.417 0 CA-C-O 117.953 -1.023 . . . . 0.0 109.824 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 1.045 HG23 ' C ' ' A' ' 120' ' ' TYR . 5.0 p -85.79 153.68 3.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 121.27 -1.135 . . . . 0.0 110.064 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.55 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 16.2 m-85 -89.92 167.36 12.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.309 -0.87 . . . . 0.0 110.433 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.913 HG23 ' CE1' ' A' ' 119' ' ' HIS . 55.1 m -145.67 102.26 3.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.302 -0.874 . . . . 0.0 110.221 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.915 ' CZ ' HG22 ' A' ' 133' ' ' VAL . 84.8 m-85 -116.09 151.76 34.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.316 -0.865 . . . . 0.0 109.936 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 19.6 pt-20 -143.01 151.63 41.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.142 -0.974 . . . . 0.0 110.366 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.4 t -128.6 151.77 49.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.41 -0.806 . . . . 0.0 109.839 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.477 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 92.8 mt-10 -134.3 116.05 14.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.947 . . . . 0.0 110.488 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.2 p90 -142.66 -175.12 4.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -0.852 . . . . 0.0 109.778 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.775 HG22 ' HA ' ' A' ' 113' ' ' ILE . 6.6 p -137.75 173.35 11.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.144 -0.973 . . . . 0.0 110.634 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.511 ' HB3' HD11 ' A' ' 114' ' ' ILE . 84.0 p -149.56 144.22 26.09 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.397 -0.815 . . . . 0.0 110.23 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -72.57 -32.37 65.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.226 -0.921 . . . . 0.0 109.958 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.813 HG23 ' HD2' ' A' ' 14' ' ' PRO . 6.5 mm -72.51 151.35 91.66 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.517 -0.739 . . . . 0.0 109.653 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.813 ' HD2' HG23 ' A' ' 13' ' ' ILE . 39.1 Cg_endo -64.61 140.58 69.16 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.889 1.468 . . . . 0.0 110.692 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.656 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 41.9 Cg_endo -73.08 -30.49 10.69 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 124.145 1.603 . . . . 0.0 112.871 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.656 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.3 Cg_endo -69.84 -23.57 30.31 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 O-C-N 122.448 0.71 . . . . 0.0 110.357 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.515 ' NH2' ' HD2' ' A' ' 20' ' ' LYS . 1.6 mmp_? -83.42 -46.8 12.11 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.774 ' C ' HD23 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -65.54 -31.05 71.9 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.601 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.519 ' N ' HD23 ' A' ' 18' ' ' LEU . 59.4 t80 -64.66 -54.49 30.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.56 -0.712 . . . . 0.0 109.26 178.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.54 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 25.2 mttt -47.99 -42.84 28.91 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.796 -0.761 . . . . 0.0 109.459 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.969 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -73.07 -35.61 66.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.469 -0.77 . . . . 0.0 110.927 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 1.033 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -74.57 -42.85 58.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 111.42 -178.659 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.629 HG13 ' CE1' ' A' ' 81' ' ' TYR . 5.7 t -107.5 -50.36 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.956 -1.09 . . . . 0.0 111.74 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.766 HD12 ' N ' ' A' ' 24' ' ' LEU . 7.3 mp -79.44 -5.64 55.14 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.077 -1.014 . . . . 0.0 111.483 -178.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.557 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 1.1 m-20 -151.2 30.36 0.62 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.796 -1.19 . . . . 0.0 110.651 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 1.033 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -72.87 -21.23 60.96 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.243 -0.91 . . . . 0.0 110.615 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.477 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 39.2 t0 -66.63 -24.14 66.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.014 -1.054 . . . . 0.0 110.201 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.558 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 4.4 p30 -124.55 12.81 8.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.33 -0.856 . . . . 0.0 110.078 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.767 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -94.08 -48.45 6.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.364 -0.835 . . . . 0.0 110.221 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 1.032 HG21 HD13 ' A' ' 38' ' ' ILE . 3.7 p -76.89 -28.37 0.66 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.305 -0.872 . . . . 0.0 112.231 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.855 ' HD3' HG12 ' A' ' 30' ' ' VAL . 52.5 Cg_endo -79.23 5.31 5.87 Favored 'Trans proline' 0 C--N 1.319 -1.026 0 O-C-N 122.672 0.827 . . . . 0.0 110.272 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -128.78 -37.38 1.75 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 109.346 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.55 HG12 ' CD1' ' A' ' 150' ' ' TYR . 11.3 mt -79.97 -25.9 11.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-O 121.646 0.736 . . . . 0.0 109.151 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -157.22 77.32 3.93 Favored Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 121.628 -0.67 . . . . 0.0 109.841 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.29 -5.49 16.65 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.984 1.518 . . . . 0.0 110.565 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -87.65 -15.74 36.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.0 109.8 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -93.71 -69.27 0.76 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.38 -0.825 . . . . 0.0 110.151 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 1.032 HD13 HG21 ' A' ' 30' ' ' VAL . 1.7 mp -99.86 126.96 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.315 -0.866 . . . . 0.0 110.086 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.522 ' HB2' ' N ' ' A' ' 59' ' ' GLY . 27.7 ttpt -76.3 -25.41 54.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.357 -0.839 . . . . 0.0 110.639 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.545 ' C ' ' CD2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER 179.75 164.67 1.1 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.065 -1.022 . . . . 0.0 110.497 -179.75 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.454 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 18.5 m -137.53 128.6 27.57 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.466 -0.771 . . . . 0.0 109.81 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.545 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 48.5 tt0 -135.54 111.55 9.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.149 -0.969 . . . . 0.0 110.596 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.443 HG12 ' HG2' ' A' ' 54' ' ' LYS . 21.2 mt -59.54 140.26 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 109.859 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.729 HD11 ' HB2' ' A' ' 55' ' ' LYS . 39.0 mt -115.68 -27.91 6.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.145 -0.972 . . . . 0.0 110.268 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.683 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.4 m95 -123.58 157.95 32.54 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.246 -0.908 . . . . 0.0 110.418 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.412 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 43.53 -134.08 5.56 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.58 20.67 0.4 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.302 -1.117 . . . . 0.0 109.995 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.432 ' O ' HG21 ' A' ' 71' ' ' ILE . . . 125.56 -20.31 6.53 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.024 -1.631 . . . . 0.0 109.024 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.489 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -69.98 -172.47 10.27 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.429 ' HA ' HG22 ' A' ' 71' ' ' ILE . 45.5 Cg_endo -73.47 129.61 13.99 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.991 1.522 . . . . 0.0 110.653 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.79 -11.4 53.08 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.654 -1.778 . . . . 0.0 108.654 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 45' ' ' TRP . 1.0 OUTLIER -72.73 164.83 25.93 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.519 -0.989 . . . . 0.0 109.958 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.683 HD12 ' CG ' ' A' ' 45' ' ' TRP . 59.3 mt -135.49 120.09 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.4 -0.812 . . . . 0.0 109.698 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.443 ' HG2' HG12 ' A' ' 43' ' ' ILE . 93.8 mttt -108.49 134.85 50.7 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.195 -0.941 . . . . 0.0 110.624 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.729 ' HB2' HD11 ' A' ' 44' ' ' LEU . 32.9 tttt -101.53 92.68 5.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.262 -0.899 . . . . 0.0 110.084 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.524 ' CG2' HG12 ' A' ' 38' ' ' ILE . 84.2 mt -79.92 141.26 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.179 -0.951 . . . . 0.0 110.197 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 2.1 p -115.12 158.77 21.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 110.412 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.613 ' HE2' HG13 ' A' ' 67' ' ' VAL . 28.6 m-85 -119.31 135.94 54.48 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.368 -0.832 . . . . 0.0 110.12 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.522 ' N ' ' HB2' ' A' ' 39' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.22 0.533 . . . . 0.0 110.402 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.545 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -136.36 94.71 0.23 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.533 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 17.2 p90 -139.43 168.8 19.01 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.163 -1.199 . . . . 0.0 110.336 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.975 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.2 m -139.38 173.29 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.375 -0.828 . . . . 0.0 110.507 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.516 ' CE ' ' OE1' ' A' ' 87' ' ' GLU . 22.1 mttm -124.01 126.28 46.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.554 -0.716 . . . . 0.0 109.629 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.645 ' CD2' ' CD1' ' A' ' 85' ' ' LEU . 16.4 m170 -110.56 134.39 52.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.167 -0.958 . . . . 0.0 110.788 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 52' ' ' THR . 29.6 ttpt -108.2 115.72 30.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.288 -0.883 . . . . 0.0 109.436 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.528 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 28.6 mm -62.95 120.67 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.3 -0.875 . . . . 0.0 110.561 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 82' ' ' SER . 83.8 m-20 -93.7 -42.58 9.08 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.521 -0.737 . . . . 0.0 109.717 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.469 ' OG ' ' HB2' ' A' ' 82' ' ' SER . 90.6 p -169.66 159.25 8.12 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.436 -0.79 . . . . 0.0 109.744 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.551 HG12 HG11 ' A' ' 23' ' ' VAL . 1.9 mt -142.34 156.36 19.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.213 -0.93 . . . . 0.0 110.354 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.548 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 5.1 m-20 -134.59 79.11 1.78 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.623 -0.673 . . . . 0.0 110.143 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.457 ' HZ2' HD21 ' A' ' 24' ' ' LEU . 67.5 mttm -62.83 -14.33 44.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.128 -0.982 . . . . 0.0 110.224 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -94.24 -32.29 13.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.241 -0.912 . . . . 0.0 109.592 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -104.75 -6.85 19.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.517 -0.739 . . . . 0.0 109.665 179.771 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.557 ' CZ ' ' HB3' ' A' ' 16' ' ' PRO . 4.1 m-85 67.21 50.62 0.98 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.571 -0.706 . . . . 0.0 110.224 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.548 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -121.11 151.53 39.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -0.922 . . . . 0.0 109.304 179.441 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.629 ' CE1' HG13 ' A' ' 23' ' ' VAL . 22.5 t80 -139.91 136.7 34.15 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.207 -0.933 . . . . 0.0 110.191 -178.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 4.8 m -139.45 121.55 15.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.93 . . . . 0.0 110.942 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.6 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 8.6 p90 -141.15 175.44 9.64 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.342 -0.849 . . . . 0.0 109.737 179.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.755 HG23 ' O ' ' A' ' 98' ' ' ILE . 82.1 m -131.77 143.11 49.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.912 . . . . 0.0 110.23 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.645 ' CD1' ' CD2' ' A' ' 69' ' ' HIS . 19.1 tp -96.67 121.01 38.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 110.126 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 20.3 pt -105.86 -17.95 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.392 -0.818 . . . . 0.0 109.982 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.516 ' OE1' ' CE ' ' A' ' 68' ' ' LYS . 83.1 tt0 -138.18 151.49 47.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -0.889 . . . . 0.0 110.374 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.975 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 164.94 133.5 1.51 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -64.18 -15.3 59.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.297 -1.119 . . . . 0.0 110.245 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.13 -18.59 45.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.302 -0.874 . . . . 0.0 110.207 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.647 HD22 ' CD1' ' A' ' 98' ' ' ILE . 16.4 mt -63.82 -19.8 65.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.225 -0.922 . . . . 0.0 110.073 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 46.29 -173.29 0.02 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.555 ' OD1' HG23 ' A' ' 94' ' ' THR . 59.5 p30 -87.93 12.36 13.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.133 -1.216 . . . . 0.0 109.823 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.734 HG22 HG11 ' A' ' 126' ' ' VAL . 23.2 p -107.07 -29.88 9.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.366 -0.834 . . . . 0.0 110.173 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.604 HD11 ' CD1' ' A' ' 128' ' ' ILE . 67.5 mt -107.95 161.29 15.07 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.269 -0.894 . . . . 0.0 110.405 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.401 ' OE2' ' HD2' ' A' ' 123' ' ' LYS . 55.9 mt-10 -142.28 -82.96 0.19 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.335 -0.853 . . . . 0.0 109.994 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.521 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 62.2 mttt -80.37 140.26 36.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.687 -0.633 . . . . 0.0 110.763 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.755 ' O ' HG23 ' A' ' 84' ' ' THR . 0.1 OUTLIER -135.0 135.55 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.967 -1.083 . . . . 0.0 109.602 178.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.485 ' HB2' ' CD2' ' A' ' 119' ' ' HIS . 0.5 OUTLIER -108.96 133.36 53.06 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.315 -0.866 . . . . 0.0 109.956 179.626 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.6 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 5.6 m-85 -122.78 132.3 54.16 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.312 -0.867 . . . . 0.0 110.252 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 117' ' ' THR . 2.9 mt-10 -134.65 130.43 36.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 0.0 110.242 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.475 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 26.0 m -129.41 135.94 49.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.222 -0.924 . . . . 0.0 109.858 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.4 mttm -134.18 135.78 43.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.156 -0.965 . . . . 0.0 110.599 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.887 HD23 HG12 ' A' ' 114' ' ' ILE . 7.1 mt -115.72 151.16 35.63 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.29 -0.882 . . . . 0.0 109.932 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.704 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -148.04 -169.04 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.133 -0.98 . . . . 0.0 110.0 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.704 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -124.37 154.09 40.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.288 -0.882 . . . . 0.0 110.137 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.457 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 5.1 p -113.7 168.1 8.39 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.896 . . . . 0.0 110.195 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 48.1 Cg_endo -72.92 -4.24 15.04 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.021 1.537 . . . . 0.0 110.474 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 34.3 p -104.89 8.71 34.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.284 -0.885 . . . . 0.0 110.279 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 94.5 -34.43 4.74 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -59.09 -171.78 0.4 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 3.1 p -134.82 136.05 42.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -1.167 . . . . 0.0 110.359 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.775 ' HA ' HG22 ' A' ' 10' ' ' THR . 22.4 mt -88.89 148.82 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.325 -0.859 . . . . 0.0 110.078 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.887 HG12 HD23 ' A' ' 104' ' ' LEU . 18.2 mt -132.3 124.51 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.205 -0.934 . . . . 0.0 110.46 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.477 ' HG3' ' HG2' ' A' ' 8' ' ' GLU . 75.3 tttt -113.59 109.82 19.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.2 -0.938 . . . . 0.0 110.014 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.447 ' OG ' ' CZ ' ' A' ' 9' ' ' PHE . 1.2 m -101.01 159.35 15.29 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.251 -0.906 . . . . 0.0 110.643 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.707 HG22 ' NE2' ' A' ' 119' ' ' HIS . 60.8 m -154.16 133.61 12.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.327 -0.858 . . . . 0.0 110.045 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.8 m -136.25 144.53 44.87 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.13 -0.981 . . . . 0.0 110.478 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.913 ' CE1' HG23 ' A' ' 4' ' ' THR . 20.8 m-70 -132.05 146.74 52.26 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.295 -0.878 . . . . 0.0 110.325 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 1.045 ' C ' HG23 ' A' ' 2' ' ' VAL . 40.2 m-85 -121.59 120.53 35.06 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.18 -0.95 . . . . 0.0 110.542 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.58 ' N ' HG23 ' A' ' 2' ' ' VAL . 87.2 m-70 -92.85 103.72 16.03 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.4 -0.812 . . . . 0.0 109.368 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.564 ' OG1' HG23 ' A' ' 126' ' ' VAL . 1.6 t -88.39 173.71 8.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.014 -1.054 . . . . 0.0 110.856 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.401 ' HD2' ' OE2' ' A' ' 96' ' ' GLU . 40.0 tttm -141.8 117.1 10.12 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 120.284 -0.567 . . . . 0.0 110.221 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 113.2 -123.98 6.4 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -133.25 62.03 1.66 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.313 -1.11 . . . . 0.0 110.204 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.734 HG11 HG22 ' A' ' 94' ' ' THR . 34.8 m -137.54 153.46 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.22 -0.925 . . . . 0.0 110.203 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.464 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 90.4 mt-10 -127.05 169.57 13.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.188 -0.945 . . . . 0.0 110.29 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.604 ' CD1' HD11 ' A' ' 95' ' ' LEU . 15.8 mm -67.77 173.09 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.884 . . . . 0.0 110.244 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.586 ' N ' HG22 ' A' ' 128' ' ' ILE . 17.5 mttp -99.08 149.53 22.94 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.265 -0.897 . . . . 0.0 110.041 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.12 -20.09 16.02 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.091 -1.006 . . . . 0.0 109.841 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.786 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 94.3 mt-10 -71.63 -39.91 70.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.369 -0.832 . . . . 0.0 109.904 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.486 ' HB2' ' CG2' ' A' ' 128' ' ' ILE . 6.3 m170 -65.18 -45.72 83.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.297 -0.877 . . . . 0.0 109.949 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.915 HG22 ' CZ ' ' A' ' 5' ' ' TYR . 58.3 t -64.95 -42.79 95.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.506 -0.746 . . . . 0.0 110.264 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 33.1 tttm -102.87 -63.57 1.15 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.283 -0.886 . . . . 0.0 110.31 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.786 ' HB3' ' O ' ' A' ' 131' ' ' GLU . . . -56.78 -19.54 17.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.122 -0.986 . . . . 0.0 110.025 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 131' ' ' GLU . . . -76.91 -31.16 54.39 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.221 -1.551 . . . . 0.0 109.221 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.491 ' CE ' ' O ' ' A' ' 133' ' ' VAL . 27.4 mttt -72.85 -30.07 63.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.324 -1.103 . . . . 0.0 110.18 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -82.91 -32.23 27.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.315 -0.866 . . . . 0.0 110.044 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 50.5 mttt -70.45 -38.46 74.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.391 -0.818 . . . . 0.0 110.028 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.402 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -78.74 -30.83 46.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.321 -0.862 . . . . 0.0 109.88 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.1 m -66.67 -45.29 79.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.35 -0.844 . . . . 0.0 110.011 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -50.99 -51.2 55.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.303 -0.873 . . . . 0.0 109.947 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.662 ' HA ' HD12 ' A' ' 146' ' ' LEU . 10.6 tp -55.47 -49.31 72.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.258 -0.901 . . . . 0.0 109.742 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.402 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 17.7 m-85 -53.62 -38.84 64.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.44 -0.788 . . . . 0.0 109.746 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -73.38 -16.72 61.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.273 -0.892 . . . . 0.0 109.852 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.662 HD12 ' HA ' ' A' ' 143' ' ' LEU . 17.7 mt -81.98 -35.68 28.69 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.234 -0.917 . . . . 0.0 108.706 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.662 HD11 ' CE1' ' A' ' 22' ' ' PHE . 53.5 mt -66.66 -47.17 84.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.498 ' O ' HG13 ' A' ' 13' ' ' ILE . 84.1 mt-10 -52.26 -45.42 65.39 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.307 -0.87 . . . . 0.0 109.324 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 36.4 m -64.68 -30.97 72.0 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.152 -0.968 . . . . 0.0 109.535 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.694 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 71.1 t80 -60.94 -50.48 73.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.474 -0.766 . . . . 0.0 109.815 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.143 HD21 ' CE1' ' A' ' 158' ' ' TYR . 92.5 mt -80.03 -36.92 35.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.223 -0.923 . . . . 0.0 110.03 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.594 ' HG3' HD11 ' A' ' 13' ' ' ILE . 16.6 tttt -64.03 -20.29 65.81 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.392 -0.817 . . . . 0.0 109.516 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -110.67 -32.78 2.6 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.581 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 5.8 m-70 -109.6 94.3 16.21 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.267 -1.137 . . . . 0.0 110.203 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.71 6.25 3.38 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.08 1.569 . . . . 0.0 111.046 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -109.8 -2.37 17.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.994 -1.066 . . . . 0.0 109.966 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.694 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -74.39 104.61 5.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.368 -0.832 . . . . 0.0 110.199 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 1.143 ' CE1' HD21 ' A' ' 151' ' ' LEU . 1.5 p90 34.65 37.28 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.726 -0.609 . . . . 0.0 110.842 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.498 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.69 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.501 HG22 ' ND1' ' A' ' 121' ' ' HIS . 98.7 t -128.02 132.07 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.208 -1.172 . . . . 0.0 110.205 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.708 ' CE1' HD12 ' A' ' 128' ' ' ILE . 12.3 m-85 -93.19 148.21 22.22 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.205 -0.934 . . . . 0.0 110.117 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.778 HG23 ' CE1' ' A' ' 119' ' ' HIS . 10.3 m -128.1 111.48 13.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.173 -0.955 . . . . 0.0 110.344 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.983 ' CE2' HG21 ' A' ' 133' ' ' VAL . 69.1 m-85 -123.38 140.25 53.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.341 -0.85 . . . . 0.0 110.16 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -140.28 151.33 45.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.224 -0.923 . . . . 0.0 110.359 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.7 t -138.77 160.97 38.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.386 -0.821 . . . . 0.0 109.918 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.431 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 85.8 mt-10 -142.14 115.77 9.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.102 -0.999 . . . . 0.0 110.368 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.6 p90 -140.42 -175.04 4.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.311 -0.868 . . . . 0.0 109.843 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.778 HG22 ' HA ' ' A' ' 113' ' ' ILE . 2.4 p -137.52 167.38 21.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.118 -0.989 . . . . 0.0 110.493 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.445 ' HB3' HD11 ' A' ' 114' ' ' ILE . 75.5 p -138.93 147.93 42.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.38 -0.825 . . . . 0.0 110.168 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -69.96 -32.96 71.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.236 -0.915 . . . . 0.0 110.254 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.756 HD13 ' CB ' ' A' ' 148' ' ' GLU . 2.6 mp -79.58 148.56 69.93 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.378 -0.826 . . . . 0.0 109.915 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.755 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.0 Cg_endo -64.99 152.72 81.4 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.937 1.493 . . . . 0.0 110.722 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.695 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 36.7 Cg_endo -63.35 -35.87 59.34 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.793 1.418 . . . . 0.0 113.035 -178.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.695 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 38.0 Cg_endo -63.89 -21.3 68.99 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 N-CA-C 109.811 -0.88 . . . . 0.0 109.811 178.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.761 ' HB3' HD13 ' A' ' 151' ' ' LEU . 6.6 mmp_? -80.28 -45.25 18.23 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.682 HD12 ' N ' ' A' ' 18' ' ' LEU . 9.3 mp -73.31 -40.87 64.16 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.251 -0.98 . . . . 0.0 108.576 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.617 ' CD1' ' HA ' ' A' ' 79' ' ' TYR . 36.9 t80 -52.72 -59.95 3.86 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 119.869 -0.733 . . . . 0.0 110.155 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.536 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 40.4 mttp -56.03 -38.27 70.33 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.404 -0.81 . . . . 0.0 110.18 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.056 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -78.56 -62.76 1.58 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.125 -0.984 . . . . 0.0 110.878 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 1.055 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.3 OUTLIER -49.2 -41.49 37.17 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.65 -0.656 . . . . 0.0 112.006 -178.847 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 1.047 HG11 HD12 ' A' ' 74' ' ' ILE . 11.5 t -106.32 -62.93 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.767 -1.208 . . . . 0.0 111.813 -178.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.649 HD12 ' N ' ' A' ' 24' ' ' LEU . 7.4 mp -68.5 -1.07 5.84 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.243 -0.911 . . . . 0.0 111.69 -178.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.9 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -149.63 15.7 0.88 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.704 -1.248 . . . . 0.0 110.756 179.743 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 1.055 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -57.45 -40.68 78.99 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.142 -0.974 . . . . 0.0 110.12 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.508 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 14.0 t70 -62.75 -11.42 17.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.268 -0.895 . . . . 0.0 109.901 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.514 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 84.7 m-20 -132.89 10.07 4.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.42 -0.8 . . . . 0.0 109.701 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.931 HD21 ' CZ ' ' A' ' 158' ' ' TYR . 0.2 OUTLIER -95.57 -49.06 5.56 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.396 -0.815 . . . . 0.0 110.387 -179.764 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.786 HG22 ' HD3' ' A' ' 31' ' ' PRO . 3.5 m -83.48 -26.22 0.39 Allowed Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.396 -0.815 . . . . 0.0 112.707 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.786 ' HD3' HG22 ' A' ' 30' ' ' VAL . 47.0 Cg_endo -76.88 2.93 7.01 Favored 'Trans proline' 0 C--N 1.318 -1.039 0 O-C-N 122.511 0.743 . . . . 0.0 110.476 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.7 tttm -128.95 -35.15 1.88 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.29 -0.882 . . . . 0.0 109.541 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.607 HG12 ' CD1' ' A' ' 150' ' ' TYR . 40.1 mt -80.03 -35.27 15.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.599 -0.688 . . . . 0.0 109.596 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -161.9 97.5 1.22 Allowed Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.582 -0.699 . . . . 0.0 109.833 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.57 2.21 6.05 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.069 1.563 . . . . 0.0 110.793 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -84.11 -10.09 58.07 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.146 -0.971 . . . . 0.0 109.812 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.94 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -97.88 -47.19 5.65 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.392 -0.817 . . . . 0.0 109.912 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.94 HD12 ' C ' ' A' ' 37' ' ' ALA . 2.1 mp -134.75 108.01 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.463 -0.773 . . . . 0.0 109.899 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 57' ' ' THR . 39.3 ttpt -55.29 -16.99 3.89 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.223 -0.923 . . . . 0.0 110.298 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.545 ' CG ' ' N ' ' A' ' 41' ' ' SER . 0.2 OUTLIER 173.03 175.16 0.11 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.081 -1.012 . . . . 0.0 110.11 -179.739 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.545 ' N ' ' CG ' ' A' ' 40' ' ' HIS . 25.2 m -152.11 149.77 29.17 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.361 -0.837 . . . . 0.0 109.827 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -155.56 112.15 3.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.163 -0.961 . . . . 0.0 110.711 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 41.1 mt -62.55 136.5 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.306 -0.871 . . . . 0.0 109.808 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.803 HD22 ' CE ' ' A' ' 55' ' ' LYS . 4.9 tp -114.19 -24.47 8.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.156 -0.965 . . . . 0.0 110.717 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.527 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.8 m95 -124.93 161.35 26.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.116 -0.99 . . . . 0.0 110.782 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.442 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 42.23 -139.73 2.19 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -147.85 24.79 1.06 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.368 -1.078 . . . . 0.0 109.878 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 117.88 -18.9 11.39 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.559 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -72.87 -169.27 14.09 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.21 128.9 13.39 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.093 1.575 . . . . 0.0 110.724 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.81 -11.55 49.52 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.519 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.1 m -75.08 163.84 27.15 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.643 -0.916 . . . . 0.0 109.78 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.986 HG21 ' HE2' ' A' ' 68' ' ' LYS . 85.6 mt -134.13 118.87 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 0.0 109.942 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.455 ' HE2' HD11 ' A' ' 71' ' ' ILE . 1.0 OUTLIER -106.55 124.11 49.11 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.322 -0.861 . . . . 0.0 110.567 -179.565 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.803 ' CE ' HD22 ' A' ' 44' ' ' LEU . 75.8 mttt -90.53 95.2 10.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.258 -0.901 . . . . 0.0 109.826 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.529 ' CG2' HG12 ' A' ' 38' ' ' ILE . 99.6 mt -79.98 139.97 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.142 -0.974 . . . . 0.0 110.083 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -112.99 146.65 38.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.315 -0.865 . . . . 0.0 110.434 -179.736 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.571 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 21.7 m-85 -110.04 154.8 22.7 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.289 -0.882 . . . . 0.0 110.052 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.876 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.499 ' HE1' HG22 ' A' ' 57' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.312 0.577 . . . . 0.0 110.321 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.571 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -132.61 90.25 0.27 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.991 -1.643 . . . . 0.0 108.991 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.538 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 12.1 p90 -130.29 166.57 20.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.081 -1.246 . . . . 0.0 110.158 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.628 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.3 m -140.02 175.64 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.337 -0.852 . . . . 0.0 110.579 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.986 ' HE2' HG21 ' A' ' 53' ' ' ILE . 69.6 tttt -131.17 103.09 6.29 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.506 -0.746 . . . . 0.0 109.875 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 1.008 ' CD2' HD13 ' A' ' 85' ' ' LEU . 13.4 m170 -98.15 121.77 40.48 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.207 -0.933 . . . . 0.0 111.036 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 52' ' ' THR . 82.8 tttt -91.45 120.35 32.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.301 -0.874 . . . . 0.0 109.348 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.559 HG21 ' O ' ' A' ' 49' ' ' GLY . 26.2 mm -58.62 126.88 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.165 -0.959 . . . . 0.0 110.229 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.473 ' O ' ' HB3' ' A' ' 73' ' ' SER . 90.9 m-20 -98.36 -51.1 4.09 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.447 -0.783 . . . . 0.0 109.769 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.473 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 91.3 p -178.45 159.2 1.16 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.5 -0.75 . . . . 0.0 110.316 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 1.047 HD12 HG11 ' A' ' 23' ' ' VAL . 3.5 tt -144.41 167.33 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.502 -0.749 . . . . 0.0 109.236 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -131.13 81.05 1.97 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.944 -1.098 . . . . 0.0 110.523 -179.376 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.593 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 82.1 tttt -55.99 -14.56 2.62 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.29 -0.881 . . . . 0.0 110.604 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -90.76 -30.44 17.04 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.24 -0.912 . . . . 0.0 109.658 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.494 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -113.3 -1.44 14.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.486 -0.759 . . . . 0.0 109.731 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.919 ' O ' HD12 ' A' ' 104' ' ' LEU . 56.1 m-85 64.87 50.04 2.05 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.389 0.614 . . . . 0.0 110.369 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.517 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.6 OUTLIER -118.51 152.57 35.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 109.524 179.394 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.643 ' CE1' HG13 ' A' ' 23' ' ' VAL . 82.5 t80 -151.04 140.85 21.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.066 -1.021 . . . . 0.0 110.262 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 74.3 m -147.81 147.61 30.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.259 -0.901 . . . . 0.0 110.442 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.622 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 8.8 p90 -149.82 175.59 11.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.344 -0.848 . . . . 0.0 110.361 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.585 HG23 ' O ' ' A' ' 98' ' ' ILE . 44.3 m -125.58 128.16 47.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.404 -0.81 . . . . 0.0 109.888 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 1.008 HD13 ' CD2' ' A' ' 69' ' ' HIS . 8.6 tp -98.77 131.64 44.75 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.216 -0.993 . . . . 0.0 110.284 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.888 HD11 ' HD3' ' A' ' 68' ' ' LYS . 9.1 pt -117.19 -29.51 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.199 -0.938 . . . . 0.0 110.419 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.613 ' O ' HD11 ' A' ' 85' ' ' LEU . 43.1 tt0 -110.39 138.77 46.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -0.888 . . . . 0.0 110.19 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.628 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 175.82 134.25 1.9 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -53.38 -31.22 43.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -1.112 . . . . 0.0 110.305 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.495 ' HB1' ' CE1' ' A' ' 132' ' ' HIS . . . -69.73 -38.73 76.98 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.297 -0.877 . . . . 0.0 110.243 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.625 HD23 ' CD2' ' A' ' 95' ' ' LEU . 15.5 mt -41.19 -61.71 0.97 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.503 -0.748 . . . . 0.0 110.284 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 49.14 -178.01 0.02 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -67.01 -7.5 23.02 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.25 -1.147 . . . . 0.0 110.213 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.446 ' O ' HG22 ' A' ' 122' ' ' THR . 61.2 p -79.98 -60.97 2.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 110.213 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.867 HD12 ' H ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -102.25 159.39 15.44 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.352 -0.843 . . . . 0.0 109.387 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.867 ' H ' HD12 ' A' ' 95' ' ' LEU . 61.1 tt0 -137.74 -79.7 0.37 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.208 -0.932 . . . . 0.0 110.576 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.488 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 10.1 mttt -80.24 144.81 32.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.592 -0.692 . . . . 0.0 111.023 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.715 HG21 ' HE2' ' A' ' 100' ' ' TYR . 4.6 mm -133.1 144.7 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.208 -0.932 . . . . 0.0 109.487 178.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.482 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.1 m -123.9 127.72 48.41 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.28 -0.887 . . . . 0.0 109.377 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.715 ' HE2' HG21 ' A' ' 98' ' ' ILE . 12.0 m-85 -123.54 133.4 53.99 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.194 -0.941 . . . . 0.0 110.581 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.462 ' HG3' ' OG ' ' A' ' 82' ' ' SER . 62.9 tt0 -135.59 137.41 41.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.279 -0.888 . . . . 0.0 110.109 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.508 ' N ' ' O ' ' A' ' 81' ' ' TYR . 23.4 m -135.24 146.41 48.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.165 -0.959 . . . . 0.0 110.281 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 115' ' ' LYS . 12.1 mttt -138.94 139.53 38.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.328 -0.858 . . . . 0.0 110.131 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.989 HD23 HG12 ' A' ' 114' ' ' ILE . 2.7 mt -118.66 154.21 33.07 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.215 -0.928 . . . . 0.0 110.542 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.713 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -152.34 -169.35 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.332 -0.855 . . . . 0.0 109.925 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.713 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -121.45 158.47 28.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.329 -0.857 . . . . 0.0 110.215 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.462 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 5.8 p -118.01 168.08 10.06 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.235 -0.916 . . . . 0.0 110.176 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.6 Cg_endo -72.41 -12.66 27.48 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.003 1.528 . . . . 0.0 110.378 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 95.8 p -95.84 2.61 53.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.245 -0.909 . . . . 0.0 110.176 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 99.35 -29.04 12.7 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.08 -172.53 1.91 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 2.1 m -133.3 133.68 42.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -1.109 . . . . 0.0 110.378 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.778 ' HA ' HG22 ' A' ' 10' ' ' THR . 20.8 mt -86.05 144.67 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.358 -0.838 . . . . 0.0 109.939 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.989 HG12 HD23 ' A' ' 104' ' ' LEU . 20.6 mt -131.03 114.01 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.173 -0.954 . . . . 0.0 110.441 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 103' ' ' LYS . 35.2 tttt -100.48 120.77 40.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.914 . . . . 0.0 109.837 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.1 t -115.99 154.87 29.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.205 -0.935 . . . . 0.0 110.53 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.45 HG22 ' NE2' ' A' ' 119' ' ' HIS . 38.5 m -156.73 131.64 8.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.352 -0.842 . . . . 0.0 110.133 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 91.7 p -132.72 155.81 48.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.137 -0.977 . . . . 0.0 110.319 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.778 ' CE1' HG23 ' A' ' 4' ' ' THR . 32.3 m-70 -135.83 164.28 28.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.331 -0.856 . . . . 0.0 110.182 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.653 ' HA ' HD13 ' A' ' 98' ' ' ILE . 11.0 m-85 -124.77 148.54 48.06 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.292 -0.88 . . . . 0.0 110.196 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.501 ' ND1' HG22 ' A' ' 2' ' ' VAL . 97.1 m-70 -129.21 85.37 2.31 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.135 -0.978 . . . . 0.0 109.698 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.712 HG22 ' HA ' ' A' ' 95' ' ' LEU . 1.4 p -81.77 157.73 24.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.326 -0.859 . . . . 0.0 110.427 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.2 tttm -113.6 127.06 55.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.435 -0.791 . . . . 0.0 110.202 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 99.45 -153.24 19.62 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -102.97 64.17 0.84 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.219 -1.166 . . . . 0.0 110.182 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.531 HG23 ' HB ' ' A' ' 122' ' ' THR . 20.1 m -130.62 154.36 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.186 -0.946 . . . . 0.0 110.214 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -133.6 159.37 40.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.261 -0.899 . . . . 0.0 110.195 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.708 HD12 ' CE1' ' A' ' 3' ' ' PHE . 4.3 mp -80.86 173.24 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.27 -0.894 . . . . 0.0 110.211 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.588 ' N ' HG22 ' A' ' 128' ' ' ILE . 10.6 mttp -108.26 132.89 53.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.321 -0.862 . . . . 0.0 110.124 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.42 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 94.6 mt-10 -47.1 -47.73 23.1 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.191 -0.943 . . . . 0.0 110.169 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.503 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 54.7 tt0 -50.97 -28.59 10.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.202 -0.936 . . . . 0.0 109.973 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.495 ' CE1' ' HB1' ' A' ' 90' ' ' ALA . 14.2 t-160 -79.74 -60.63 2.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.268 -0.895 . . . . 0.0 110.114 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.983 HG21 ' CE2' ' A' ' 5' ' ' TYR . 7.3 p -65.55 -38.49 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.428 -0.795 . . . . 0.0 110.185 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.496 ' N ' HG13 ' A' ' 133' ' ' VAL . 26.1 tttp -68.77 -47.33 66.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.233 -0.917 . . . . 0.0 110.238 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.503 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -61.43 -27.02 68.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.91 . . . . 0.0 110.226 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.41 -28.09 71.74 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 49.0 mttt -69.58 -39.99 76.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.221 -1.164 . . . . 0.0 110.211 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -75.18 -34.82 61.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.407 -0.808 . . . . 0.0 110.054 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.449 ' O ' ' HG ' ' A' ' 143' ' ' LEU . 28.5 mttt -67.85 -32.85 73.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.33 -0.856 . . . . 0.0 109.925 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.7 -45.03 47.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.295 -0.878 . . . . 0.0 110.014 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 36.8 m -59.5 -38.62 81.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.444 -0.785 . . . . 0.0 110.049 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -61.52 -41.85 97.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.208 -0.932 . . . . 0.0 109.898 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 139' ' ' LYS . 38.1 mt -60.07 -41.73 93.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.269 -0.894 . . . . 0.0 109.859 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.448 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 24.7 m-85 -56.83 -37.3 71.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.441 -0.787 . . . . 0.0 109.982 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 55.9 mttt -66.5 -25.05 66.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.334 -0.854 . . . . 0.0 109.904 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.537 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 15.9 mt -83.02 -34.69 26.22 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.276 -0.89 . . . . 0.0 108.952 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.583 HD11 ' HE1' ' A' ' 22' ' ' PHE . 79.8 mt -69.54 -34.91 63.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.538 -0.726 . . . . 0.0 109.451 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.756 ' CB ' HD13 ' A' ' 13' ' ' ILE . 97.0 mt-10 -62.84 -39.06 93.2 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.494 -0.754 . . . . 0.0 109.869 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 86.1 m -72.15 -40.0 68.35 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.299 -0.875 . . . . 0.0 109.96 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.608 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 68.6 t80 -55.82 -50.54 70.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.479 -0.763 . . . . 0.0 110.023 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.933 HD21 ' CE1' ' A' ' 158' ' ' TYR . 33.6 mt -79.88 -40.2 28.86 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.331 -0.856 . . . . 0.0 110.464 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.634 ' HB2' HD11 ' A' ' 13' ' ' ILE . 40.5 tttp -66.12 -22.84 66.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.267 -0.896 . . . . 0.0 109.456 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -103.09 -35.97 3.52 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.613 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 3.8 m-70 -110.77 93.94 18.45 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.397 -1.061 . . . . 0.0 109.978 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.48 5.64 3.62 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.06 1.558 . . . . 0.0 111.022 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 41.6 p30 -107.54 -2.92 19.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.05 -1.031 . . . . 0.0 109.84 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.608 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -70.5 102.58 2.25 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.413 -0.804 . . . . 0.0 110.126 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 1.056 ' CE1' ' HB2' ' A' ' 21' ' ' ALA . 1.4 p90 33.72 36.67 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.737 -0.602 . . . . 0.0 110.729 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.526 ' HB2' ' CD ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.776 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.93 HG13 ' O ' ' A' ' 120' ' ' TYR . 82.3 t -135.78 144.92 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -1.161 . . . . 0.0 110.358 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.785 ' CE1' HD12 ' A' ' 128' ' ' ILE . 9.8 m-85 -107.71 134.23 50.98 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.238 -0.914 . . . . 0.0 110.031 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.731 HG23 ' CE1' ' A' ' 119' ' ' HIS . 16.6 m -101.8 111.09 23.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.233 -0.917 . . . . 0.0 110.328 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.832 ' CE1' HG11 ' A' ' 133' ' ' VAL . 28.7 m-85 -115.26 126.01 54.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.137 -0.977 . . . . 0.0 109.795 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 116' ' ' SER . 23.1 pt-20 -140.29 154.77 46.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.183 -0.948 . . . . 0.0 110.524 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.458 ' O ' ' HB3' ' A' ' 116' ' ' SER . 49.4 m -139.53 135.61 33.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.336 -0.853 . . . . 0.0 109.729 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.454 ' HG3' ' HG3' ' A' ' 115' ' ' LYS . 2.4 tt0 -116.15 138.86 50.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.1 -1.0 . . . . 0.0 110.72 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.631 ' CZ ' ' CG2' ' A' ' 114' ' ' ILE . 5.8 p90 -158.98 -173.04 4.04 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.506 -0.746 . . . . 0.0 109.814 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.891 HG22 ' HA ' ' A' ' 113' ' ' ILE . 7.4 p -141.57 172.02 13.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.137 -0.977 . . . . 0.0 110.519 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.452 ' HB3' ' CD ' ' A' ' 148' ' ' GLU . 89.9 p -159.95 140.2 11.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.282 -0.886 . . . . 0.0 110.264 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.524 ' HA ' ' HA2' ' A' ' 111' ' ' GLY . 97.2 mt-10 -64.32 -39.08 93.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.28 -0.887 . . . . 0.0 110.106 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 1.049 HD13 ' HB3' ' A' ' 148' ' ' GLU . 2.7 mp -51.37 150.2 6.62 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.313 -0.867 . . . . 0.0 109.791 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.824 ' HD2' HG23 ' A' ' 13' ' ' ILE . 41.7 Cg_endo -67.99 137.1 40.16 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.974 1.513 . . . . 0.0 110.505 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.614 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 41.8 Cg_endo -73.68 -28.95 11.18 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 124.072 1.564 . . . . 0.0 112.933 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 15' ' ' PRO . 43.4 Cg_endo -73.68 -21.33 19.2 Favored 'Trans proline' 0 C--N 1.319 -1.001 0 O-C-N 122.408 0.688 . . . . 0.0 110.534 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.958 ' NE ' HD22 ' A' ' 151' ' ' LEU . 57.6 ttt180 -85.7 -50.9 6.82 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.794 ' C ' HD23 ' A' ' 18' ' ' LEU . 1.7 tt -57.13 -27.66 62.03 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.555 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 64.9 t80 -69.57 -54.65 13.04 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.488 0.661 . . . . 0.0 109.477 178.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.605 ' HG2' HD22 ' A' ' 24' ' ' LEU . 49.5 mttt -55.31 -29.65 58.68 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 122.158 0.98 . . . . 0.0 108.376 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.002 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -77.36 -63.46 1.37 Allowed 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.647 0.737 . . . . 0.0 110.797 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 1.015 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -60.72 -28.92 69.02 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.612 -0.68 . . . . 0.0 111.401 -178.599 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.743 HG13 ' CD1' ' A' ' 81' ' ' TYR . 4.3 t -108.63 -66.39 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.046 -1.034 . . . . 0.0 111.406 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.678 HD12 ' N ' ' A' ' 24' ' ' LEU . 8.6 mp -68.91 -10.97 60.04 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.162 -0.961 . . . . 0.0 111.205 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.534 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -138.2 16.89 2.79 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.889 -1.132 . . . . 0.0 110.075 179.721 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 1.015 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -51.76 -44.91 63.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 110.177 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.479 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 61.8 m-20 -62.07 -12.41 19.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.181 -0.949 . . . . 0.0 110.157 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.531 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 77.8 m-20 -124.2 -7.71 7.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 110.42 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.747 HD12 ' N ' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -85.0 -46.04 11.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.201 -0.937 . . . . 0.0 110.37 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.948 ' CG1' HD13 ' A' ' 38' ' ' ILE . 2.9 t -69.51 -41.86 18.2 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.35 -0.844 . . . . 0.0 111.002 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.1 Cg_endo -78.55 9.72 3.08 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.54 1.284 . . . . 0.0 110.792 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.449 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 21.7 mttm -121.17 -29.43 4.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.174 -0.954 . . . . 0.0 109.307 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.75 HG21 ' HB3' ' A' ' 146' ' ' LEU . 14.9 mt -80.21 -64.99 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-O 121.607 0.718 . . . . 0.0 109.388 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.457 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . . . -136.01 106.51 9.61 Favored Pre-proline 0 C--N 1.303 -1.451 0 O-C-N 121.708 -0.62 . . . . 0.0 109.876 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.457 ' HD2' ' HA ' ' A' ' 34' ' ' ALA . 44.1 Cg_endo -70.3 0.49 5.97 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.078 1.567 . . . . 0.0 111.035 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -81.13 -13.3 58.81 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.032 -1.042 . . . . 0.0 109.418 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.591 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -96.95 -67.66 0.84 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.393 -0.817 . . . . 0.0 110.15 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.948 HD13 ' CG1' ' A' ' 30' ' ' VAL . 2.3 mp -109.6 127.82 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.491 -0.756 . . . . 0.0 110.158 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 57' ' ' THR . 22.2 ttpt -85.8 -27.68 24.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.272 -0.893 . . . . 0.0 110.366 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.554 ' C ' ' CD2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -163.39 148.83 11.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.122 -0.986 . . . . 0.0 110.037 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.468 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 4.2 m -131.54 122.97 27.02 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.314 -0.866 . . . . 0.0 109.953 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -138.15 111.25 7.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.14 -0.975 . . . . 0.0 110.661 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 28.5 mt -56.87 133.5 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.336 -0.852 . . . . 0.0 109.837 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.539 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 25.3 mt -104.67 -29.78 10.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.913 . . . . 0.0 110.605 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.651 ' CG ' HD12 ' A' ' 53' ' ' ILE . 2.0 m95 -122.46 160.43 25.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.208 -0.932 . . . . 0.0 110.706 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.451 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 41.39 -138.74 1.91 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -152.33 22.2 0.64 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -1.197 . . . . 0.0 110.15 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 126.35 -22.94 5.84 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.536 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -68.43 -174.35 8.79 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -72.33 128.8 14.11 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 123.986 1.519 . . . . 0.0 110.593 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.488 ' HA2' ' HE2' ' A' ' 70' ' ' LYS . . . 105.19 -13.54 48.45 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.504 -1.838 . . . . 0.0 108.504 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -71.74 160.73 32.11 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.616 -0.932 . . . . 0.0 109.327 179.589 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.651 HD12 ' CG ' ' A' ' 45' ' ' TRP . 80.6 mt -131.71 119.37 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 110.215 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 0.4 OUTLIER -101.54 126.47 48.36 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.276 -0.89 . . . . 0.0 110.03 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.539 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 22.2 tttm -96.97 90.68 5.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 110.101 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.588 ' CG2' ' CG1' ' A' ' 38' ' ' ILE . 94.1 mt -80.11 139.41 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.299 -0.876 . . . . 0.0 110.065 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.594 HG22 ' HB3' ' A' ' 66' ' ' TYR . 1.2 p -115.17 153.14 31.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.888 . . . . 0.0 110.301 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.581 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 14.7 m-85 -114.27 176.06 5.21 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.314 -0.866 . . . . 0.0 110.168 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 58' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.562 ' O ' ' CD1' ' A' ' 64' ' ' TYR . 5.4 p90 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.242 0.544 . . . . 0.0 110.171 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.581 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -137.71 85.75 0.23 Allowed Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.594 ' HB3' HG22 ' A' ' 57' ' ' THR . 12.4 p90 -133.52 171.65 13.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -1.166 . . . . 0.0 110.249 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.842 HG12 ' HA2' ' A' ' 88' ' ' GLY . 4.0 m -140.3 177.66 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.332 -0.855 . . . . 0.0 110.35 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.664 ' O ' HD12 ' A' ' 85' ' ' LEU . 23.7 mttm -134.81 104.76 6.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.412 -0.805 . . . . 0.0 109.804 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 1.001 ' CD2' HD13 ' A' ' 85' ' ' LEU . 14.8 m170 -96.9 127.54 42.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.196 -0.94 . . . . 0.0 110.862 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 52' ' ' THR . 77.8 tttt -98.2 113.74 25.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.91 . . . . 0.0 109.414 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.536 HG21 ' O ' ' A' ' 49' ' ' GLY . 33.0 mm -44.53 136.19 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.101 -1.0 . . . . 0.0 110.162 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.547 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 23.8 t0 -109.89 -43.57 3.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.419 -0.801 . . . . 0.0 109.969 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.665 ' C ' HD12 ' A' ' 74' ' ' ILE . 62.3 p -170.81 161.2 7.17 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.484 -0.886 . . . . 0.0 109.947 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.665 HD12 ' C ' ' A' ' 73' ' ' SER . 0.9 OUTLIER -149.44 154.36 9.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 119.277 -0.969 . . . . 0.0 111.005 -179.754 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.548 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 2.3 m-20 -136.1 79.96 1.8 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.809 -0.557 . . . . 0.0 110.288 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.555 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 22.2 mttp -59.94 -14.85 17.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.246 -0.909 . . . . 0.0 110.365 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -93.65 -30.88 14.7 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.22 -0.925 . . . . 0.0 109.753 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.493 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -108.25 -3.82 18.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.533 -0.729 . . . . 0.0 109.723 -179.947 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.712 ' O ' HD12 ' A' ' 104' ' ' LEU . 5.5 m-85 65.36 47.24 2.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.469 -0.77 . . . . 0.0 110.361 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.548 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.6 OUTLIER -116.62 147.41 41.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -0.896 . . . . 0.0 109.289 179.534 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.743 ' CD1' HG13 ' A' ' 23' ' ' VAL . 90.3 t80 -141.88 139.89 32.72 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.07 -1.019 . . . . 0.0 110.344 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 72' ' ' ASP . 1.3 m -143.72 135.41 26.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.255 -0.903 . . . . 0.0 110.348 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.615 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 20.2 p90 -142.86 170.25 16.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.343 -0.848 . . . . 0.0 110.3 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.795 HG23 ' O ' ' A' ' 98' ' ' ILE . 93.5 m -127.31 125.58 41.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.33 -0.856 . . . . 0.0 109.763 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 1.001 HD13 ' CD2' ' A' ' 69' ' ' HIS . 10.8 tp -95.09 129.86 42.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.068 -1.02 . . . . 0.0 110.444 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.463 ' N ' HD12 ' A' ' 85' ' ' LEU . 11.0 pt -106.25 -32.89 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.323 -0.861 . . . . 0.0 110.175 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.717 ' O ' HD11 ' A' ' 85' ' ' LEU . 86.9 tt0 -118.5 160.72 21.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.337 -0.852 . . . . 0.0 110.107 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.842 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 151.86 151.65 5.69 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -73.27 -25.28 60.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -1.155 . . . . 0.0 110.185 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.19 -20.04 63.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.302 -0.874 . . . . 0.0 110.157 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 92' ' ' GLY . 77.0 mt -69.36 -33.57 73.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.269 -0.894 . . . . 0.0 110.137 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 49.77 -179.71 0.02 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -78.14 3.17 15.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.215 -1.168 . . . . 0.0 109.984 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.412 HG22 ' HG ' ' A' ' 95' ' ' LEU . 1.8 m -93.89 -49.81 5.64 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.204 -0.935 . . . . 0.0 109.849 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.83 HD23 ' CG2' ' A' ' 122' ' ' THR . 42.1 mt -93.6 163.16 13.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.443 -0.786 . . . . 0.0 109.914 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.416 ' CD ' ' HB2' ' A' ' 123' ' ' LYS . 12.3 mt-10 -140.38 -79.85 0.28 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.216 -0.928 . . . . 0.0 109.982 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.498 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 29.2 mtmt -80.14 141.24 35.91 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.586 -0.696 . . . . 0.0 109.999 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.795 ' O ' HG23 ' A' ' 84' ' ' THR . 6.3 mm -130.38 140.87 47.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 120.85 -1.157 . . . . 0.0 110.149 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.516 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -123.81 130.04 51.99 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.642 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.696 ' HE2' HG21 ' A' ' 98' ' ' ILE . 11.6 m-85 -125.35 134.72 52.1 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.21 -0.931 . . . . 0.0 110.603 -178.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.423 ' HG3' ' HB3' ' A' ' 82' ' ' SER . 6.3 mt-10 -134.52 131.15 37.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.436 -0.79 . . . . 0.0 110.211 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 32.3 m -130.26 140.71 50.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -0.894 . . . . 0.0 109.911 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.471 ' HB2' ' HB3' ' A' ' 115' ' ' LYS . 8.9 mttp -131.79 137.55 48.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.181 -0.95 . . . . 0.0 110.763 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.891 HD23 HG12 ' A' ' 114' ' ' ILE . 7.3 mt -116.5 150.66 37.54 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.277 -0.89 . . . . 0.0 109.839 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.705 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -150.91 -169.45 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.11 -0.993 . . . . 0.0 110.064 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.705 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -126.83 155.98 42.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.368 -0.833 . . . . 0.0 110.091 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.443 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.7 p -114.6 169.43 6.63 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.279 -0.888 . . . . 0.0 110.309 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.443 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.2 Cg_endo -72.62 -10.69 25.49 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.14 1.6 . . . . 0.0 110.49 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 95.5 p -98.19 5.53 48.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.273 -0.892 . . . . 0.0 110.37 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.1 -34.89 4.76 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' A' ' 12' ' ' GLU . . . -57.65 -173.86 0.33 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 54.0 p -133.76 138.41 45.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.198 -1.178 . . . . 0.0 110.434 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.891 ' HA ' HG22 ' A' ' 10' ' ' THR . 23.0 mt -91.36 147.26 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.367 -0.833 . . . . 0.0 110.085 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.891 HG12 HD23 ' A' ' 104' ' ' LEU . 22.8 mt -133.58 123.26 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.215 -0.928 . . . . 0.0 110.328 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.471 ' HB3' ' HB2' ' A' ' 103' ' ' LYS . 72.4 tttt -107.96 121.66 45.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.233 -0.917 . . . . 0.0 110.089 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.458 ' HB3' ' O ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -104.32 154.68 19.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.187 -0.946 . . . . 0.0 110.419 -179.854 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 20.9 m -158.76 148.82 19.52 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.432 -0.793 . . . . 0.0 110.2 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.428 ' OG ' ' HB2' ' A' ' 5' ' ' TYR . 86.2 p -157.03 156.28 32.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.297 -0.877 . . . . 0.0 110.154 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.731 ' CE1' HG23 ' A' ' 4' ' ' THR . 85.7 m-70 -134.9 137.95 43.66 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.162 -0.961 . . . . 0.0 110.51 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.93 ' O ' HG13 ' A' ' 2' ' ' VAL . 3.9 m-30 -104.01 139.29 39.33 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.345 -0.847 . . . . 0.0 110.262 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.498 ' HB2' ' HB2' ' A' ' 97' ' ' LYS . 92.1 m-70 -121.96 90.49 3.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.981 -1.074 . . . . 0.0 109.565 179.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.83 ' CG2' HD23 ' A' ' 95' ' ' LEU . 1.8 p -72.22 156.69 38.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.28 -0.888 . . . . 0.0 110.66 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.482 ' HG2' ' N ' ' A' ' 124' ' ' GLY . 42.4 tttt -100.31 149.01 24.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.461 -0.775 . . . . 0.0 109.946 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.482 ' N ' ' HG2' ' A' ' 123' ' ' LYS . . . 69.4 -122.88 13.04 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -138.69 70.28 1.38 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -1.195 . . . . 0.0 110.244 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.538 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 32.5 m -122.9 164.21 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 0.0 109.972 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -131.86 152.39 51.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.098 -1.001 . . . . 0.0 110.406 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.785 HD12 ' CE1' ' A' ' 3' ' ' PHE . 2.8 mp -84.35 172.4 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.269 -0.895 . . . . 0.0 110.205 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.594 ' N ' HG22 ' A' ' 128' ' ' ILE . 5.8 tttp -112.31 179.03 4.11 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.323 -0.86 . . . . 0.0 109.853 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -82.39 5.46 20.33 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.172 -0.955 . . . . 0.0 108.822 178.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -93.83 -31.56 14.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.386 -0.821 . . . . 0.0 109.906 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.406 ' HE1' HD12 ' A' ' 95' ' ' LEU . 15.8 t-160 -85.93 -36.16 20.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.29 -0.881 . . . . 0.0 110.083 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.832 HG11 ' CE1' ' A' ' 5' ' ' TYR . 37.0 t -77.56 -43.21 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.351 -0.843 . . . . 0.0 110.095 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 57.5 tttm -65.51 -44.21 87.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 0.0 110.114 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.44 -37.23 85.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.24 -0.913 . . . . 0.0 110.027 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -64.09 -30.72 78.57 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 81.0 mttt -61.9 -31.67 71.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.366 -1.079 . . . . 0.0 109.998 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.483 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 70.0 mm-40 -82.29 -36.92 26.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.319 -0.863 . . . . 0.0 109.962 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -70.48 -30.52 67.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.337 -0.852 . . . . 0.0 109.975 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.57 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -88.43 -37.74 15.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.894 . . . . 0.0 110.094 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.419 ' O ' ' HB2' ' A' ' 144' ' ' PHE . 66.3 m -71.24 -52.58 18.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.416 -0.802 . . . . 0.0 109.97 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.483 ' ND2' ' O ' ' A' ' 138' ' ' GLU . 92.3 m-20 -54.62 -43.41 72.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.275 -0.891 . . . . 0.0 109.971 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.623 ' HA ' HD12 ' A' ' 146' ' ' LEU . 13.0 tp -59.7 -42.74 93.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.895 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.717 ' HA ' HD12 ' A' ' 147' ' ' ILE . 7.7 m-85 -55.17 -39.1 69.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.331 -0.856 . . . . 0.0 109.587 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.46 ' O ' ' HG2' ' A' ' 145' ' ' LYS . 51.0 tttt -74.53 -15.02 60.88 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.419 -0.801 . . . . 0.0 109.859 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.75 ' HB3' HG21 ' A' ' 33' ' ' ILE . 29.2 mt -80.86 -35.15 33.11 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.178 -0.951 . . . . 0.0 108.712 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.78 HD11 ' CE1' ' A' ' 22' ' ' PHE . 17.4 mt -68.83 -51.59 43.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 1.049 ' HB3' HD13 ' A' ' 13' ' ' ILE . 52.6 mt-10 -56.46 -40.9 75.64 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.543 -0.723 . . . . 0.0 109.764 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 98.0 m -66.97 -41.81 86.2 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.144 -0.973 . . . . 0.0 109.811 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.619 ' CD1' HG12 ' A' ' 33' ' ' ILE . 87.1 t80 -56.19 -46.18 79.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.344 -0.847 . . . . 0.0 109.997 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.958 HD22 ' NE ' ' A' ' 17' ' ' ARG . 33.2 mt -80.15 -28.98 38.78 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.227 -0.921 . . . . 0.0 110.344 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.775 ' HB2' HD11 ' A' ' 13' ' ' ILE . 21.4 tttt -72.23 -28.06 62.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.327 -0.858 . . . . 0.0 109.822 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.493 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -101.47 -33.61 4.75 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.56 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 5.9 m-70 -106.94 92.4 7.54 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.339 -1.095 . . . . 0.0 109.71 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 48.5 Cg_endo -73.68 8.22 2.02 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.288 1.678 . . . . 0.0 111.439 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -112.5 1.47 15.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.915 -1.116 . . . . 0.0 109.817 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.615 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -73.4 100.98 3.35 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.367 -0.833 . . . . 0.0 110.421 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 1.002 ' CE1' ' HB2' ' A' ' 21' ' ' ALA . 0.3 OUTLIER 34.53 39.55 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.747 -0.596 . . . . 0.0 110.691 -179.737 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.589 ' CB ' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.416 0 CA-C-O 118.007 -0.996 . . . . 0.0 109.722 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.911 HG13 ' O ' ' A' ' 120' ' ' TYR . 70.9 t -140.21 125.32 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.197 -1.178 . . . . 0.0 110.169 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.619 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 66.0 m-85 -88.93 126.09 35.24 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.141 -0.974 . . . . 0.0 110.108 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.71 HG23 ' CE1' ' A' ' 119' ' ' HIS . 3.0 m -117.38 107.24 14.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.235 -0.916 . . . . 0.0 110.431 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.69 ' CE1' HG23 ' A' ' 133' ' ' VAL . 69.5 m-85 -111.49 126.11 54.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.184 -0.948 . . . . 0.0 110.164 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.468 ' HG2' ' OG1' ' A' ' 117' ' ' THR . 2.4 mt-10 -117.6 144.79 44.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.295 -0.878 . . . . 0.0 110.564 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.477 ' O ' ' HG2' ' A' ' 8' ' ' GLU . 20.0 m -128.0 164.64 21.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.331 -0.856 . . . . 0.0 109.842 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 7' ' ' SER . 68.4 mt-10 -153.12 124.65 7.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.064 -1.022 . . . . 0.0 110.757 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.636 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.0 p90 -145.24 -176.22 5.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.308 -0.87 . . . . 0.0 109.728 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.785 HG22 ' HA ' ' A' ' 113' ' ' ILE . 6.8 p -142.5 174.56 10.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.062 -1.024 . . . . 0.0 110.687 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.485 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 7.9 t -159.99 164.96 32.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.37 -0.831 . . . . 0.0 110.142 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -89.69 -22.85 22.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.306 -0.871 . . . . 0.0 110.213 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.844 HG21 HD12 ' A' ' 151' ' ' LEU . 8.4 mm -68.1 150.71 97.64 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.264 -0.898 . . . . 0.0 109.984 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.825 ' HD2' HG23 ' A' ' 13' ' ' ILE . 41.0 Cg_endo -66.98 145.05 72.63 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 124.029 1.541 . . . . 0.0 110.598 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.669 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.1 Cg_endo -71.18 -31.99 13.68 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.873 1.459 . . . . 0.0 112.765 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.669 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.1 Cg_endo -69.23 -22.76 34.06 Favored 'Trans proline' 0 C--N 1.318 -1.047 0 N-CA-C 109.988 -0.812 . . . . 0.0 109.988 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.726 HH21 ' HB3' ' A' ' 157' ' ' ALA . 52.3 mtp180 -81.79 -43.13 18.75 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 1.095 HD23 ' CG2' ' A' ' 147' ' ' ILE . 0.2 OUTLIER -73.53 -33.78 64.89 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.702 -0.799 . . . . 0.0 108.939 178.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.649 ' N ' HD13 ' A' ' 18' ' ' LEU . 59.8 t80 -60.27 -60.51 3.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.511 -0.743 . . . . 0.0 109.765 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.645 ' HG2' HD22 ' A' ' 24' ' ' LEU . 23.1 mttt -53.77 -38.9 64.92 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.735 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.058 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -69.17 -36.42 77.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.456 -0.778 . . . . 0.0 110.904 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 1.047 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.3 OUTLIER -79.09 -49.21 12.99 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.31 -0.869 . . . . 0.0 110.974 -179.127 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.608 ' HB ' HD12 ' A' ' 24' ' ' LEU . 3.7 t -94.34 -53.97 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.202 -0.936 . . . . 0.0 111.813 -178.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.765 HD12 ' N ' ' A' ' 24' ' ' LEU . 7.4 mp -80.03 -1.05 38.06 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.972 -1.08 . . . . 0.0 112.129 -178.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.587 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -147.78 23.46 1.1 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.704 -1.247 . . . . 0.0 110.725 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 1.047 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -65.76 -12.35 53.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.089 -1.007 . . . . 0.0 110.193 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.514 ' HA ' ' CB ' ' A' ' 41' ' ' SER . 92.0 m-20 -80.08 -13.76 59.05 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.205 -0.934 . . . . 0.0 110.443 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.402 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 4.6 p30 -135.46 6.19 3.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.192 -0.943 . . . . 0.0 110.595 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.682 ' HG ' ' HB1' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -96.59 -40.56 8.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.214 -0.929 . . . . 0.0 109.888 179.901 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.871 ' CG1' HD13 ' A' ' 38' ' ' ILE . 4.1 t -82.45 -41.01 0.92 Allowed Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.437 -0.79 . . . . 0.0 111.013 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.7 Cg_endo -78.95 11.43 2.57 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.365 1.192 . . . . 0.0 110.771 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -124.41 -34.04 2.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.065 -1.022 . . . . 0.0 109.438 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.617 HG21 ' HB3' ' A' ' 146' ' ' LEU . 7.5 mt -80.12 -38.75 18.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.489 -0.757 . . . . 0.0 109.399 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.77 96.68 7.43 Favored Pre-proline 0 C--N 1.304 -1.379 0 O-C-N 121.463 -0.773 . . . . 0.0 110.03 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.35 -2.52 11.37 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.003 1.528 . . . . 0.0 110.513 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -88.48 -26.41 22.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.135 -0.978 . . . . 0.0 109.711 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -86.08 -73.43 0.45 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.4 -0.813 . . . . 0.0 109.969 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.871 HD13 ' CG1' ' A' ' 30' ' ' VAL . 2.1 mp -102.6 137.15 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.407 -0.808 . . . . 0.0 110.045 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.2 ttpp -96.18 -32.28 12.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 110.376 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.593 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -167.94 156.68 9.29 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.213 -0.93 . . . . 0.0 110.09 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.514 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 11.0 p -115.83 144.89 43.37 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.273 -0.892 . . . . 0.0 110.266 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.593 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 73.3 tt0 -149.0 97.74 2.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.248 -0.908 . . . . 0.0 110.327 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.403 HG21 ' HA ' ' A' ' 47' ' ' ASP . 19.1 mt -57.52 130.78 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.173 -0.955 . . . . 0.0 110.06 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.532 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 31.0 mt -102.55 -35.25 8.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 110.64 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.807 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.9 m95 -122.91 162.85 21.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.108 -0.995 . . . . 0.0 110.658 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.446 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 41.79 -136.51 2.92 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.418 ' O ' ' CG ' ' A' ' 47' ' ' ASP . 11.1 t0 -154.26 22.41 0.49 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -1.143 . . . . 0.0 109.907 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 122.82 -20.47 7.7 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.819 -1.712 . . . . 0.0 108.819 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.454 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -68.42 -171.92 6.85 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.81 129.13 13.12 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.051 1.553 . . . . 0.0 110.626 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.84 -9.18 56.66 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.509 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -73.49 159.13 33.65 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.523 -0.986 . . . . 0.0 109.94 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.807 HD12 ' CG ' ' A' ' 45' ' ' TRP . 78.1 mt -126.85 119.61 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.354 -0.841 . . . . 0.0 109.406 179.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -105.15 135.25 46.84 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 110.451 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.532 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 76.7 tttt -104.22 93.43 4.82 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.364 -0.835 . . . . 0.0 110.05 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.549 ' HB ' HG23 ' A' ' 67' ' ' VAL . 66.3 mt -79.98 134.19 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.206 -0.934 . . . . 0.0 109.942 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.526 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 1.7 p -106.98 155.89 19.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.371 -0.831 . . . . 0.0 110.213 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.484 ' CE2' HG13 ' A' ' 67' ' ' VAL . 22.6 m-85 -111.48 151.24 28.84 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.319 -0.863 . . . . 0.0 110.205 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 58' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.117 0.484 . . . . 0.0 109.934 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -135.92 133.94 6.92 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.544 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 10.5 p90 -178.16 169.34 1.9 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.335 -1.097 . . . . 0.0 110.181 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.865 HG12 ' HA2' ' A' ' 88' ' ' GLY . 4.1 m -141.92 176.92 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.395 -0.816 . . . . 0.0 110.54 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.705 ' HE2' HG21 ' A' ' 53' ' ' ILE . 68.8 tttt -127.69 122.95 34.29 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.363 -0.836 . . . . 0.0 109.792 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.425 ' NE2' ' HG ' ' A' ' 85' ' ' LEU . 9.0 m170 -116.26 126.62 53.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.088 -1.007 . . . . 0.0 110.993 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 52' ' ' THR . 15.2 tttt -102.76 117.23 34.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.295 -0.878 . . . . 0.0 109.403 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.531 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 25.5 mm -60.13 126.61 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.243 -0.911 . . . . 0.0 110.334 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.433 ' HB2' ' C ' ' A' ' 82' ' ' SER . 41.9 m-20 -97.95 -36.89 10.0 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.35 -0.844 . . . . 0.0 109.724 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.487 ' OG ' ' HB2' ' A' ' 82' ' ' SER . 35.0 p -178.58 157.33 0.97 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.327 -0.858 . . . . 0.0 109.887 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.401 HG12 HG11 ' A' ' 23' ' ' VAL . 1.3 mt -139.67 158.24 27.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.257 -0.902 . . . . 0.0 110.051 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.551 ' HB2' ' HB3' ' A' ' 80' ' ' SER . 0.8 OUTLIER -142.77 82.47 1.77 Allowed 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.537 179.698 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.549 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 48.7 tttm -66.21 -14.62 62.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.309 -0.869 . . . . 0.0 110.214 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -87.69 -29.37 21.17 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.395 -0.816 . . . . 0.0 108.907 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.489 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.2 m-80 -108.07 -5.66 16.9 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.403 0.62 . . . . 0.0 109.358 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.569 ' HA ' ' CD1' ' A' ' 19' ' ' PHE . 50.5 m-85 64.58 53.04 1.65 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.681 -0.637 . . . . 0.0 110.608 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.551 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 11.8 t -125.33 175.75 7.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 110.242 179.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.594 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 20.8 t80 -156.8 145.83 20.21 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.959 -0.697 . . . . 0.0 110.182 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.487 ' HB2' ' OG ' ' A' ' 73' ' ' SER . 0.4 OUTLIER -147.34 124.06 11.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.265 -0.897 . . . . 0.0 110.819 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.627 ' CD1' ' N ' ' A' ' 83' ' ' TYR . 2.5 p90 -145.77 -179.92 7.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.37 -0.831 . . . . 0.0 109.708 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 1.013 HG23 ' O ' ' A' ' 98' ' ' ILE . 18.6 m -135.62 146.88 48.34 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.132 -0.98 . . . . 0.0 110.567 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.65 HD12 ' HE2' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -102.43 117.82 35.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.29 -0.881 . . . . 0.0 110.257 179.67 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.606 HD11 ' HD3' ' A' ' 68' ' ' LYS . 22.3 pt -113.13 -6.12 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.228 -0.92 . . . . 0.0 110.138 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -145.92 128.29 15.89 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.319 -0.863 . . . . 0.0 110.39 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.865 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . -178.59 120.32 0.7 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -52.56 -27.33 16.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -1.161 . . . . 0.0 110.158 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.07 -20.98 62.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.935 . . . . 0.0 110.154 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.707 HD12 ' N ' ' A' ' 88' ' ' GLY . 32.9 mt -69.55 -24.74 63.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.237 -0.914 . . . . 0.0 110.222 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 50.03 -176.87 0.04 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -81.22 6.9 12.62 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -1.143 . . . . 0.0 110.222 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.423 ' O ' HG22 ' A' ' 122' ' ' THR . 26.2 p -94.21 -28.72 15.48 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.227 -0.921 . . . . 0.0 110.096 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 1.083 HD21 ' CD1' ' A' ' 128' ' ' ILE . 90.3 mt -110.35 151.66 27.17 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.302 -0.874 . . . . 0.0 110.014 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.427 ' HG3' ' HB2' ' A' ' 123' ' ' LYS . 11.5 mt-10 -133.79 -80.81 0.46 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.172 -0.955 . . . . 0.0 110.281 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.512 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 70.8 mttt -80.36 127.2 32.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.549 -0.719 . . . . 0.0 110.898 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 1.013 ' O ' HG23 ' A' ' 84' ' ' THR . 13.0 mm -116.98 146.73 21.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 120.722 -1.237 . . . . 0.0 109.664 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.511 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.5 OUTLIER -124.99 124.8 42.78 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.504 -0.879 . . . . 0.0 108.704 178.223 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.829 ' CE2' HG21 ' A' ' 98' ' ' ILE . 15.3 m-85 -121.15 140.81 51.5 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.366 -0.834 . . . . 0.0 110.454 -178.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.514 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 20.2 tt0 -145.42 136.92 25.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.284 -0.885 . . . . 0.0 110.331 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.478 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 60.6 m -135.16 129.69 34.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.32 -0.863 . . . . 0.0 109.635 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 80' ' ' SER . 0.0 OUTLIER -125.98 144.57 50.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.946 . . . . 0.0 110.691 -179.487 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.566 HD12 ' O ' ' A' ' 79' ' ' TYR . 7.4 mt -117.52 155.58 29.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.292 -0.88 . . . . 0.0 109.973 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.688 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -151.35 -169.2 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.133 -0.979 . . . . 0.0 110.185 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.688 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -121.87 144.07 49.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.37 -0.831 . . . . 0.0 110.234 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.458 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 3.4 p -101.2 169.41 7.81 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.182 -0.949 . . . . 0.0 110.253 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 47.6 Cg_endo -73.15 -10.91 24.84 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.111 1.585 . . . . 0.0 110.565 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.6 m -99.45 4.29 46.07 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.226 -0.921 . . . . 0.0 110.185 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 102.05 -36.93 3.92 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -56.79 178.17 0.79 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 20.6 p -122.76 130.0 52.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.228 -1.16 . . . . 0.0 110.284 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.785 ' HA ' HG22 ' A' ' 10' ' ' THR . 5.9 mt -80.33 149.41 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.252 -0.905 . . . . 0.0 110.077 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.586 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 6.5 mt -128.59 118.97 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 0.0 110.189 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 38.7 tttt -101.15 128.98 46.99 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.159 -0.963 . . . . 0.0 110.157 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.449 ' HB3' ' HB2' ' A' ' 7' ' ' SER . 0.0 OUTLIER -110.99 152.13 27.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.215 -0.928 . . . . 0.0 110.047 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.585 ' CG2' ' CE1' ' A' ' 119' ' ' HIS . 33.4 m -160.09 125.29 3.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.212 -0.93 . . . . 0.0 110.499 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.504 ' HB3' ' CE1' ' A' ' 100' ' ' TYR . 3.1 m -135.46 142.94 45.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.314 -0.866 . . . . 0.0 109.746 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.71 ' CE1' HG23 ' A' ' 4' ' ' THR . 33.1 m-70 -129.49 136.19 49.57 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.082 -1.011 . . . . 0.0 110.293 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.911 ' O ' HG13 ' A' ' 2' ' ' VAL . 3.0 m-30 -104.54 151.78 23.19 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.308 -0.87 . . . . 0.0 110.745 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.512 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 82.1 m-70 -129.78 86.97 2.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.297 -0.877 . . . . 0.0 109.43 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.685 ' CG2' HD23 ' A' ' 95' ' ' LEU . 1.4 p -63.23 156.11 26.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.375 -0.828 . . . . 0.0 110.56 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.427 ' HB2' ' HG3' ' A' ' 96' ' ' GLU . 4.3 tttm -103.86 106.52 17.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.399 -0.813 . . . . 0.0 110.07 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 103.45 -123.41 7.78 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -136.62 94.61 3.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.233 -1.157 . . . . 0.0 110.252 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.503 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 14.9 m -141.95 -177.77 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.277 -0.889 . . . . 0.0 110.128 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -134.23 144.5 48.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -0.933 . . . . 0.0 110.48 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 1.083 ' CD1' HD21 ' A' ' 95' ' ' LEU . 12.0 mm -64.94 172.54 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 110.154 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.596 ' N ' HG22 ' A' ' 128' ' ' ILE . 18.8 mttt -97.78 127.89 44.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.345 -0.847 . . . . 0.0 109.847 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 129' ' ' LYS . 94.6 mt-10 -44.13 -52.8 6.98 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.131 -0.981 . . . . 0.0 109.937 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.99 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 50.7 tt0 -52.54 -20.53 3.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.203 -0.935 . . . . 0.0 109.706 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.479 ' N ' ' O ' ' A' ' 129' ' ' LYS . 14.0 t-160 -85.31 -61.85 1.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.395 -0.816 . . . . 0.0 110.259 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.69 HG23 ' CE1' ' A' ' 5' ' ' TYR . 1.8 p -66.37 -20.92 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.306 -0.872 . . . . 0.0 110.285 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.532 ' HG3' HG13 ' A' ' 133' ' ' VAL . 26.3 mttt -104.42 -72.51 0.7 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.922 . . . . 0.0 110.027 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.99 ' HB3' ' O ' ' A' ' 131' ' ' GLU . . . -56.57 -22.4 33.28 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 109.77 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -75.46 -27.87 62.67 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -68.83 -33.9 74.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.174 -1.192 . . . . 0.0 110.145 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.419 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 78.4 tt0 -75.95 -24.14 55.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.315 -0.866 . . . . 0.0 110.109 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 67.7 mttt -78.94 -27.98 43.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.335 -0.853 . . . . 0.0 109.991 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -81.85 -36.1 28.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.289 -0.882 . . . . 0.0 110.072 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.8 t -65.25 -46.32 81.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.4 -0.812 . . . . 0.0 110.141 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.419 ' ND2' ' O ' ' A' ' 138' ' ' GLU . 93.5 m-20 -51.69 -47.58 63.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.343 -0.848 . . . . 0.0 110.028 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.744 ' HA ' HD12 ' A' ' 146' ' ' LEU . 14.0 tp -56.68 -50.03 73.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.903 . . . . 0.0 109.936 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.467 ' CG ' ' CZ ' ' A' ' 9' ' ' PHE . 18.0 m-85 -55.87 -39.26 71.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.334 -0.854 . . . . 0.0 109.708 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -75.97 -11.09 59.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.417 -0.802 . . . . 0.0 110.089 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.744 HD12 ' HA ' ' A' ' 143' ' ' LEU . 11.7 mt -83.42 -37.84 22.7 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.211 -0.931 . . . . 0.0 108.804 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 1.095 ' CG2' HD23 ' A' ' 18' ' ' LEU . 63.5 mt -69.06 -48.49 69.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.513 ' O ' HG13 ' A' ' 13' ' ' ILE . 96.8 mt-10 -47.27 -38.01 11.69 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.414 -0.804 . . . . 0.0 109.009 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.482 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 11.0 m -79.94 -25.4 40.48 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.318 -0.864 . . . . 0.0 109.237 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.58 ' O ' ' CD2' ' A' ' 154' ' ' HIS . 64.9 t80 -54.85 -51.8 64.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.583 -0.698 . . . . 0.0 109.824 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.002 HD21 ' CE1' ' A' ' 158' ' ' TYR . 45.0 mt -79.89 -28.97 39.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.479 -0.763 . . . . 0.0 109.994 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.49 ' HA ' HD11 ' A' ' 13' ' ' ILE . 21.1 tttt -64.18 -13.04 45.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.317 -0.864 . . . . 0.0 109.488 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.502 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -124.19 -24.13 1.86 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.58 ' CD2' ' O ' ' A' ' 150' ' ' TYR . 10.4 m-70 -105.53 93.62 7.36 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.147 -1.208 . . . . 0.0 110.165 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.0 Cg_endo -73.43 4.12 4.19 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 124.12 1.589 . . . . 0.0 111.038 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -119.44 -1.53 10.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.023 -1.048 . . . . 0.0 110.126 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.726 ' HB3' HH21 ' A' ' 17' ' ' ARG . . . -59.76 105.51 0.38 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.339 -0.85 . . . . 0.0 110.159 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 1.058 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 0.3 OUTLIER 35.64 30.53 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.606 -0.684 . . . . 0.0 110.738 -179.754 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.536 ' CB ' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.726 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 1.026 HG23 ' C ' ' A' ' 120' ' ' TYR . 2.8 p -80.47 151.56 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.297 -1.119 . . . . 0.0 110.219 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.677 ' CE1' HD12 ' A' ' 128' ' ' ILE . 15.9 m-85 -90.14 176.39 6.79 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.276 -0.89 . . . . 0.0 110.046 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.826 HG23 ' CE1' ' A' ' 119' ' ' HIS . 94.9 m -140.88 106.11 5.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.247 -0.908 . . . . 0.0 110.294 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.657 ' CD1' HG13 ' A' ' 133' ' ' VAL . 22.2 m-85 -113.36 129.5 56.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -0.895 . . . . 0.0 109.987 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 22.4 pt-20 -130.41 152.99 49.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.233 -0.917 . . . . 0.0 110.569 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.3 m -138.18 147.18 43.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.373 -0.829 . . . . 0.0 109.84 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -131.36 117.12 18.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.132 -0.98 . . . . 0.0 110.556 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.4 p90 -139.21 -176.72 4.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.313 -0.867 . . . . 0.0 110.014 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.548 HG22 HG12 ' A' ' 113' ' ' ILE . 7.6 p -136.05 174.95 10.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.188 -0.945 . . . . 0.0 110.662 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.49 ' HB3' ' OE2' ' A' ' 148' ' ' GLU . 80.5 p -160.02 128.51 4.88 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.392 -0.817 . . . . 0.0 110.288 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.428 ' HA ' ' CA ' ' A' ' 111' ' ' GLY . 96.6 mt-10 -60.61 -28.86 68.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.195 -0.941 . . . . 0.0 109.924 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.939 HD13 ' HB3' ' A' ' 148' ' ' GLU . 1.3 mp -65.89 148.33 98.34 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.334 -0.854 . . . . 0.0 109.828 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.654 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.7 Cg_endo -66.49 141.65 62.09 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.892 1.469 . . . . 0.0 110.491 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.646 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.3 Cg_endo -72.87 -30.88 10.79 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 124.017 1.535 . . . . 0.0 112.886 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.646 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.6 Cg_endo -70.68 -22.33 28.0 Favored 'Trans proline' 0 C--N 1.319 -1.001 0 N-CA-C 110.195 -0.733 . . . . 0.0 110.195 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.638 HH21 ' HB3' ' A' ' 157' ' ' ALA . 43.4 mtp180 -84.31 -43.28 14.95 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 1.049 HD23 ' CG2' ' A' ' 147' ' ' ILE . 0.2 OUTLIER -72.73 -34.74 67.27 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.018 179.05 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.624 ' N ' HD13 ' A' ' 18' ' ' LEU . 52.5 t80 -64.5 -56.21 15.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.333 -0.854 . . . . 0.0 109.573 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.539 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 28.7 mttt -52.74 -36.41 57.68 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.734 -0.787 . . . . 0.0 109.564 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.007 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -78.03 -36.58 48.38 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.372 -0.83 . . . . 0.0 111.056 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 1.03 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.3 OUTLIER -73.91 -42.71 60.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.195 -0.94 . . . . 0.0 111.191 -179.057 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.628 ' HB ' HD12 ' A' ' 24' ' ' LEU . 4.6 t -105.99 -49.97 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.018 -1.051 . . . . 0.0 111.61 -178.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.676 HD12 ' N ' ' A' ' 24' ' ' LEU . 7.1 mp -79.84 -9.95 59.72 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.26 -0.9 . . . . 0.0 111.399 -178.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.559 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.9 OUTLIER -149.44 38.82 0.79 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.85 -1.156 . . . . 0.0 110.555 -179.755 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 1.03 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -78.92 -24.97 43.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.333 -0.854 . . . . 0.0 110.504 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.484 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 91.8 m-20 -65.34 -21.15 66.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.154 -0.966 . . . . 0.0 110.221 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.554 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 4.1 p30 -125.4 13.0 8.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.315 -0.866 . . . . 0.0 109.89 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.752 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -94.28 -52.04 4.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.441 -0.787 . . . . 0.0 110.327 -179.89 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 1.112 HG21 HD13 ' A' ' 38' ' ' ILE . 3.8 p -75.1 -28.87 0.82 Allowed Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.275 -0.89 . . . . 0.0 112.288 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.844 ' HD3' HG12 ' A' ' 30' ' ' VAL . 51.9 Cg_endo -79.1 7.58 4.3 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 O-C-N 122.704 0.844 . . . . 0.0 110.581 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -129.66 -29.73 2.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.172 -0.955 . . . . 0.0 110.009 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.698 HD11 HD13 ' A' ' 29' ' ' LEU . 75.5 mt -80.04 -44.13 22.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.41 -0.806 . . . . 0.0 109.788 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -160.43 103.21 1.35 Allowed Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.376 -0.827 . . . . 0.0 110.121 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.46 0.29 7.69 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.077 1.567 . . . . 0.0 110.641 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -83.48 -15.57 49.0 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.182 -0.949 . . . . 0.0 109.67 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -92.13 -64.84 1.06 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.414 -0.804 . . . . 0.0 109.993 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 1.112 HD13 HG21 ' A' ' 30' ' ' VAL . 2.1 mp -114.88 131.19 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.426 -0.796 . . . . 0.0 109.941 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 57' ' ' THR . 15.8 ttpt -77.42 -23.43 50.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.203 -0.936 . . . . 0.0 110.48 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.566 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -178.94 161.45 1.18 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.106 -0.996 . . . . 0.0 110.102 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.4 m -134.61 124.34 25.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.329 -0.857 . . . . 0.0 109.977 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.566 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 44.5 tt0 -137.68 110.92 7.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -0.938 . . . . 0.0 110.661 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.416 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 33.8 mt -56.25 136.27 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.33 -0.857 . . . . 0.0 109.787 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.727 HD13 ' HD2' ' A' ' 55' ' ' LYS . 7.6 tp -108.76 -26.1 10.48 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.174 -0.953 . . . . 0.0 110.575 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.483 ' HB2' ' CB ' ' A' ' 53' ' ' ILE . 2.0 m95 -128.65 163.3 25.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.123 -0.985 . . . . 0.0 110.845 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.448 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 41.8 -137.72 2.55 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.94 24.13 0.66 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.326 -1.102 . . . . 0.0 110.02 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 119.04 -16.32 10.88 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.519 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -73.66 -170.02 19.66 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.75 128.85 12.88 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.99 1.521 . . . . 0.0 110.559 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.465 ' HA2' ' HE3' ' A' ' 70' ' ' LYS . . . 102.64 -12.32 56.55 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 108.707 -1.757 . . . . 0.0 108.707 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.539 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -71.36 161.6 30.8 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.534 -0.98 . . . . 0.0 109.56 179.674 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.483 ' CB ' ' HB2' ' A' ' 45' ' ' TRP . 45.0 mt -130.78 119.93 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.329 -0.857 . . . . 0.0 109.959 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.784 ' CE ' HD11 ' A' ' 71' ' ' ILE . 29.3 mttm -103.11 127.17 50.49 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.151 -0.968 . . . . 0.0 110.228 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.727 ' HD2' HD13 ' A' ' 44' ' ' LEU . 7.8 mtpt -96.06 92.69 6.57 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.378 -0.826 . . . . 0.0 110.098 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.542 ' CG2' HG12 ' A' ' 38' ' ' ILE . 95.2 mt -79.95 141.87 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 109.914 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 2.4 p -116.4 152.07 34.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.3 -0.875 . . . . 0.0 110.582 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.594 ' HE2' HG13 ' A' ' 67' ' ' VAL . 23.5 m-85 -117.5 145.87 43.92 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.37 -0.832 . . . . 0.0 110.104 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.901 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.3 t80 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.324 0.583 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.577 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -135.53 96.61 0.27 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.546 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 13.6 p90 -136.1 169.13 18.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -1.182 . . . . 0.0 110.197 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.72 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.5 m -139.54 175.32 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.233 -0.917 . . . . 0.0 110.636 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.68 ' O ' HD12 ' A' ' 85' ' ' LEU . 42.7 mttt -133.41 104.63 6.51 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.465 -0.772 . . . . 0.0 109.905 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.971 ' CD2' HD13 ' A' ' 85' ' ' LEU . 13.3 m170 -96.13 129.6 43.38 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.197 -0.94 . . . . 0.0 111.138 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 52' ' ' THR . 21.6 tttp -96.92 116.7 29.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.327 -0.858 . . . . 0.0 109.395 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.784 HD11 ' CE ' ' A' ' 54' ' ' LYS . 26.8 mm -57.26 128.59 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.172 -0.955 . . . . 0.0 110.346 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 82' ' ' SER . 85.0 m-20 -101.58 -43.79 5.78 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.341 -0.849 . . . . 0.0 110.013 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.423 ' OG ' ' HB2' ' A' ' 82' ' ' SER . 62.0 p -173.67 158.67 3.38 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.434 -0.791 . . . . 0.0 109.946 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.48 HG12 HG11 ' A' ' 23' ' ' VAL . 2.0 mt -139.3 157.4 27.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.229 -0.92 . . . . 0.0 110.228 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 79' ' ' TYR . 4.5 m-20 -135.41 79.2 1.77 Allowed 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.371 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -61.38 -17.74 55.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -0.923 . . . . 0.0 110.174 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -92.48 -30.68 15.59 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.28 -0.887 . . . . 0.0 109.577 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.497 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -104.15 -3.22 24.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.566 -0.709 . . . . 0.0 109.574 179.731 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.716 ' HB3' HD12 ' A' ' 104' ' ' LEU . 70.0 m-85 60.18 54.57 3.99 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.599 -0.688 . . . . 0.0 110.756 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.508 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 0.9 OUTLIER -129.47 157.62 41.49 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.278 -0.889 . . . . 0.0 109.689 179.435 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.686 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 45.3 t80 -142.54 138.86 31.18 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.259 -0.901 . . . . 0.0 110.104 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 4.3 m -142.12 132.2 24.65 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.826 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.686 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 21.3 p90 -149.65 170.94 17.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.358 -0.839 . . . . 0.0 110.407 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.858 HG23 ' O ' ' A' ' 98' ' ' ILE . 50.4 m -126.72 129.52 48.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.436 -0.79 . . . . 0.0 110.077 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.971 HD13 ' CD2' ' A' ' 69' ' ' HIS . 10.7 tp -95.84 133.55 39.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.084 -1.01 . . . . 0.0 110.378 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.529 ' H ' HD12 ' A' ' 85' ' ' LEU . 9.8 pt -111.22 -33.49 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.199 -0.938 . . . . 0.0 110.209 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.685 ' O ' HD11 ' A' ' 85' ' ' LEU . 77.3 tt0 -116.17 155.3 28.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.376 -0.828 . . . . 0.0 110.139 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.72 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 156.29 129.38 1.17 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -60.15 -20.21 57.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -1.161 . . . . 0.0 110.222 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.69 -16.14 60.77 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.276 -0.89 . . . . 0.0 110.252 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.46 ' O ' ' HB2' ' A' ' 95' ' ' LEU . 75.7 mt -69.1 -25.51 64.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.278 -0.889 . . . . 0.0 110.189 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 49.28 -178.66 0.02 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.544 ' OD1' HG23 ' A' ' 94' ' ' THR . 55.1 p30 -83.15 10.27 8.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.229 -1.16 . . . . 0.0 110.171 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.728 ' O ' HG21 ' A' ' 126' ' ' VAL . 29.7 p -103.08 -33.84 9.1 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.235 -0.916 . . . . 0.0 110.098 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.902 HD21 HD11 ' A' ' 128' ' ' ILE . 96.7 mt -103.8 160.6 14.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 110.052 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.46 ' HG2' ' N ' ' A' ' 97' ' ' LYS . 54.4 tt0 -140.05 -82.18 0.26 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.337 -0.852 . . . . 0.0 109.689 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.5 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 42.0 mttm -80.43 135.66 36.2 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.625 -0.672 . . . . 0.0 110.139 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.858 ' O ' HG23 ' A' ' 84' ' ' THR . 4.2 mm -123.1 139.29 50.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 120.866 -1.146 . . . . 0.0 109.982 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.496 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -121.96 129.34 52.41 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.783 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.699 ' HE2' HG21 ' A' ' 98' ' ' ILE . 9.9 m-85 -123.3 133.66 54.14 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.158 -0.964 . . . . 0.0 110.876 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -135.49 129.95 33.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.444 -0.785 . . . . 0.0 109.711 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 37.4 m -134.14 144.13 48.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.186 -0.946 . . . . 0.0 110.494 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.491 ' HG3' ' HB3' ' A' ' 80' ' ' SER . 5.1 tttt -139.45 144.67 38.14 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.346 -0.846 . . . . 0.0 110.303 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.716 HD12 ' HB3' ' A' ' 79' ' ' TYR . 12.7 mt -109.37 155.09 21.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.225 -0.922 . . . . 0.0 110.461 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.693 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -151.17 -168.86 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.359 -0.838 . . . . 0.0 109.608 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.693 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -122.59 154.67 37.63 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.173 -0.955 . . . . 0.0 110.526 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.457 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 55.4 p -114.52 164.56 16.08 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.389 -0.819 . . . . 0.0 110.064 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 47.6 Cg_endo -72.63 -1.77 10.82 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.959 1.505 . . . . 0.0 110.505 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.7 t -97.24 -22.6 16.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.103 -0.998 . . . . 0.0 110.31 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 111' ' ' GLY . . . 125.42 -38.11 2.37 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 110' ' ' GLY . . . -60.29 -147.13 0.01 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 47.5 p -150.43 133.21 15.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.173 -1.193 . . . . 0.0 110.148 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.548 HG12 HG22 ' A' ' 10' ' ' THR . 23.4 mt -82.6 149.52 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.246 -0.909 . . . . 0.0 110.241 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.694 HG23 HD23 ' A' ' 104' ' ' LEU . 10.1 mt -129.74 113.47 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.894 . . . . 0.0 110.02 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.424 ' N ' ' O ' ' A' ' 103' ' ' LYS . 15.3 ttpt -94.99 122.26 37.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.088 -1.007 . . . . 0.0 110.216 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.91 147.27 42.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.895 . . . . 0.0 110.293 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 81.6 m -150.22 129.14 12.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.363 -0.836 . . . . 0.0 110.327 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.471 ' OG ' ' CE1' ' A' ' 100' ' ' TYR . 15.4 t -128.4 154.18 46.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.271 -0.893 . . . . 0.0 110.198 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.826 ' CE1' HG23 ' A' ' 4' ' ' THR . 91.5 m-70 -132.87 121.8 23.44 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.348 -0.845 . . . . 0.0 110.3 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 1.026 ' C ' HG23 ' A' ' 2' ' ' VAL . 5.7 m-30 -95.3 119.37 33.69 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.183 -0.948 . . . . 0.0 110.489 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.553 ' CE1' HG21 ' A' ' 2' ' ' VAL . 76.4 m-70 -95.47 107.45 19.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.358 -0.839 . . . . 0.0 109.558 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.7 p -77.85 155.79 30.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.107 -0.995 . . . . 0.0 110.387 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.448 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 36.9 tttp -119.6 113.51 20.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.378 -0.826 . . . . 0.0 110.226 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.38 -135.89 12.61 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -113.2 76.39 0.98 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.258 -1.143 . . . . 0.0 110.235 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.728 HG21 ' O ' ' A' ' 94' ' ' THR . 33.5 m -137.09 161.73 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.223 -0.923 . . . . 0.0 110.105 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -141.94 155.69 45.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 110.192 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.902 HD11 HD21 ' A' ' 95' ' ' LEU . 1.9 mp -84.03 173.43 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.22 -0.925 . . . . 0.0 110.113 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.608 ' N ' HG22 ' A' ' 128' ' ' ILE . 9.0 mttt -119.24 142.98 47.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.451 -0.78 . . . . 0.0 109.901 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' A' ' 134' ' ' LYS . 93.6 mt-10 -48.17 -34.47 10.04 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.154 -0.966 . . . . 0.0 110.152 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.498 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 69.1 tt0 -63.84 -32.33 73.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 0.0 109.971 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 13.9 t-160 -77.66 -51.61 10.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.296 -0.877 . . . . 0.0 110.048 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.657 HG13 ' CD1' ' A' ' 5' ' ' TYR . 49.6 t -60.69 -38.66 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.39 -0.819 . . . . 0.0 109.979 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 130' ' ' GLU . 62.2 mmtt -77.37 -45.01 27.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.316 -0.865 . . . . 0.0 110.122 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.498 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -62.25 -38.31 88.78 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.304 -0.872 . . . . 0.0 110.019 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -63.43 -30.77 78.59 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 77.5 mttt -77.33 -30.93 54.24 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.353 -1.087 . . . . 0.0 110.0 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -75.65 -34.1 60.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.367 -0.833 . . . . 0.0 109.959 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 39.3 mttt -73.36 -37.29 66.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.376 -0.828 . . . . 0.0 109.815 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.512 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -74.76 -32.37 62.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.251 -0.906 . . . . 0.0 109.88 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.6 m -66.93 -49.33 65.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -0.881 . . . . 0.0 109.904 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -51.56 -47.3 63.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.25 -0.906 . . . . 0.0 109.895 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.433 ' O ' HG13 ' A' ' 147' ' ' ILE . 13.7 tp -57.14 -50.02 74.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -0.899 . . . . 0.0 109.732 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.512 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 21.6 m-85 -52.9 -35.17 57.76 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.388 -0.82 . . . . 0.0 109.673 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 37.2 mttt -78.18 -18.25 55.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.376 -0.828 . . . . 0.0 109.811 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 143' ' ' LEU . 26.0 mt -82.43 -35.76 27.28 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.255 -0.903 . . . . 0.0 108.778 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 1.049 ' CG2' HD23 ' A' ' 18' ' ' LEU . 34.7 mt -69.6 -45.47 77.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.939 ' HB3' HD13 ' A' ' 13' ' ' ILE . 91.9 mt-10 -53.21 -40.16 64.27 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.353 -0.842 . . . . 0.0 109.428 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.2 m -67.27 -28.23 67.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.309 -0.869 . . . . 0.0 109.447 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.591 ' CD1' HG12 ' A' ' 33' ' ' ILE . 80.5 t80 -63.42 -48.08 79.29 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.517 -0.74 . . . . 0.0 109.817 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.014 HD21 ' CE1' ' A' ' 158' ' ' TYR . 81.6 mt -79.91 -37.67 34.17 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.309 -0.87 . . . . 0.0 110.211 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.928 ' HB2' HD11 ' A' ' 13' ' ' ILE . 43.5 tptt -60.7 -16.99 45.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.362 -0.836 . . . . 0.0 109.318 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.484 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -116.39 -30.13 2.14 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.573 ' CD2' ' O ' ' A' ' 150' ' ' TYR . 8.2 m-70 -106.05 93.97 8.6 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.222 -1.164 . . . . 0.0 110.223 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 48.1 Cg_endo -74.02 6.25 3.06 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 124.066 1.561 . . . . 0.0 111.048 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 35.4 p30 -115.77 -5.68 12.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.014 -1.054 . . . . 0.0 109.906 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.638 ' HB3' HH21 ' A' ' 17' ' ' ARG . . . -57.76 107.38 0.45 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.379 -0.826 . . . . 0.0 110.112 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 1.014 ' CE1' HD21 ' A' ' 151' ' ' LEU . 0.2 OUTLIER 36.56 29.61 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.654 -0.654 . . . . 0.0 110.573 -179.429 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.573 ' CB ' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.644 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.923 HG13 ' O ' ' A' ' 120' ' ' TYR . 94.9 t -118.97 146.54 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.214 -1.168 . . . . 0.0 110.331 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.654 ' CE1' HD12 ' A' ' 128' ' ' ILE . 9.8 m-85 -101.03 142.55 32.34 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.285 -0.884 . . . . 0.0 109.518 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 m -118.45 131.88 56.25 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.982 -1.074 . . . . 0.0 110.887 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 1.138 ' CE2' HG21 ' A' ' 133' ' ' VAL . 72.0 m-85 -141.25 124.57 16.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.434 -0.791 . . . . 0.0 109.836 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.994 ' CG ' HG23 ' A' ' 117' ' ' THR . 10.2 mt-10 -132.23 136.34 46.92 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 0.0 110.319 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.414 ' C ' ' HG3' ' A' ' 8' ' ' GLU . 50.0 m -125.51 164.08 21.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.235 -0.916 . . . . 0.0 110.093 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.459 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 87.1 mt-10 -146.26 127.18 14.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.298 -0.876 . . . . 0.0 110.445 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.633 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.1 p90 -147.32 -175.17 4.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.308 -0.87 . . . . 0.0 109.818 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.85 HG22 ' HA ' ' A' ' 113' ' ' ILE . 5.1 p -142.04 170.78 15.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.097 -1.002 . . . . 0.0 110.64 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.47 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 5.0 t -148.93 164.29 34.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.388 -0.82 . . . . 0.0 110.062 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -85.85 -22.0 27.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.267 -0.895 . . . . 0.0 110.192 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.816 HG23 ' HD2' ' A' ' 14' ' ' PRO . 8.8 mm -80.9 150.22 68.59 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.316 -0.865 . . . . 0.0 110.07 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.816 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.6 Cg_endo -66.17 146.36 81.33 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.044 1.55 . . . . 0.0 110.377 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.68 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.2 Cg_endo -71.18 -31.95 13.75 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.897 1.472 . . . . 0.0 112.912 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.68 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.1 Cg_endo -68.51 -20.59 41.28 Favored 'Trans proline' 0 C--N 1.317 -1.107 0 N-CA-C 110.114 -0.764 . . . . 0.0 110.114 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.775 ' HB3' HD13 ' A' ' 151' ' ' LEU . 47.9 mtp180 -85.78 -43.77 13.05 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.779 ' C ' HD23 ' A' ' 18' ' ' LEU . 1.2 tt -75.21 -34.45 61.49 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.567 ' N ' HD23 ' A' ' 18' ' ' LEU . 60.8 t80 -65.75 -55.42 17.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.394 -0.816 . . . . 0.0 109.342 179.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.522 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 64.3 mttt -53.62 -38.44 64.05 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.884 -0.727 . . . . 0.0 109.558 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.019 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -74.4 -39.74 62.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.465 -0.772 . . . . 0.0 110.961 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.96 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -75.21 -38.47 60.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.315 -0.865 . . . . 0.0 111.073 -178.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.668 HG13 ' CE1' ' A' ' 81' ' ' TYR . 4.5 t -105.22 -55.21 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.039 -1.038 . . . . 0.0 111.691 -179.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.676 HD12 ' N ' ' A' ' 24' ' ' LEU . 7.3 mp -80.03 -4.64 53.5 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.178 -0.952 . . . . 0.0 111.841 -178.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.533 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 1.0 OUTLIER -150.7 32.49 0.62 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.706 -1.246 . . . . 0.0 110.724 -179.61 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.96 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -74.44 -20.63 59.96 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.257 -0.902 . . . . 0.0 110.321 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.46 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 94.8 m-20 -67.75 -24.45 65.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.232 -0.918 . . . . 0.0 110.103 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.572 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 4.4 p30 -123.51 12.93 9.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.326 -0.859 . . . . 0.0 109.897 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.691 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -92.92 -50.33 5.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.356 -0.84 . . . . 0.0 110.184 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.87 HG22 ' HD3' ' A' ' 31' ' ' PRO . 2.2 m -74.26 -29.44 0.97 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.353 -0.842 . . . . 0.0 112.166 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.87 ' HD3' HG22 ' A' ' 30' ' ' VAL . 53.1 Cg_endo -79.15 3.57 7.33 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 O-C-N 122.785 0.887 . . . . 0.0 110.287 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -124.66 -34.71 2.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.319 -0.863 . . . . 0.0 109.326 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.593 HG12 ' CD1' ' A' ' 150' ' ' TYR . 18.4 mt -79.99 -36.65 17.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.625 -0.672 . . . . 0.0 109.837 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -175.33 102.95 0.26 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.545 -0.722 . . . . 0.0 109.831 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.77 1.57 6.26 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.031 1.543 . . . . 0.0 110.808 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -84.54 0.05 51.33 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.141 -0.974 . . . . 0.0 109.894 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.858 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -101.03 -51.17 3.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.28 -0.887 . . . . 0.0 110.024 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.858 HD12 ' C ' ' A' ' 37' ' ' ALA . 1.8 mp -134.45 125.09 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.449 -0.782 . . . . 0.0 109.948 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' A' ' 57' ' ' THR . 21.8 ttpt -61.47 -26.82 68.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.25 -0.906 . . . . 0.0 110.319 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.595 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER 173.24 162.08 0.14 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.153 -0.967 . . . . 0.0 110.107 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.1 m -128.34 125.11 38.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.384 -0.822 . . . . 0.0 110.048 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.595 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 40.5 tt0 -130.16 111.37 12.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.195 -0.94 . . . . 0.0 110.426 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.447 HG12 ' HG2' ' A' ' 54' ' ' LYS . 36.3 mt -63.35 135.44 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.351 -0.843 . . . . 0.0 110.044 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 16.0 tp -110.45 -27.47 9.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.246 -0.909 . . . . 0.0 110.362 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.75 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.8 m95 -124.14 159.48 29.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -0.958 . . . . 0.0 110.605 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 45' ' ' TRP . . . 42.06 -136.82 3.07 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.419 ' O ' ' CG ' ' A' ' 47' ' ' ASP . 11.9 t0 -152.72 24.75 0.58 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.361 -1.082 . . . . 0.0 109.77 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.47 ' O ' HG21 ' A' ' 71' ' ' ILE . . . 119.97 -21.97 8.73 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.494 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -65.17 -172.82 3.62 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.454 ' HA ' HG22 ' A' ' 71' ' ' ILE . 46.1 Cg_endo -73.44 128.64 12.95 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.997 1.525 . . . . 0.0 110.612 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.32 -13.23 54.98 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.524 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -68.61 163.25 24.12 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.569 -0.959 . . . . 0.0 109.663 179.729 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.75 HD12 ' CG ' ' A' ' 45' ' ' TRP . 61.6 mt -133.09 120.53 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.305 -0.872 . . . . 0.0 109.748 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.447 ' HG2' HG12 ' A' ' 43' ' ' ILE . 89.8 mttt -109.57 130.52 55.5 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.159 -0.963 . . . . 0.0 110.487 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -96.03 96.3 8.78 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.275 -0.891 . . . . 0.0 109.869 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.54 ' CG2' HG12 ' A' ' 38' ' ' ILE . 73.1 mt -79.87 143.82 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 109.998 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 39' ' ' LYS . 2.4 p -116.67 155.84 28.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 110.863 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.675 ' HE2' HG13 ' A' ' 67' ' ' VAL . 27.2 m-85 -119.07 154.76 32.65 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.473 -0.767 . . . . 0.0 109.917 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.836 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.168 0.508 . . . . 0.0 110.284 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -134.89 113.86 1.19 Allowed Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.634 -1.787 . . . . 0.0 108.634 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.544 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 12.6 p90 -155.93 162.24 40.41 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.113 -1.228 . . . . 0.0 110.208 -179.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.815 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.7 m -135.01 172.68 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.301 -0.874 . . . . 0.0 110.542 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.526 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 22.5 mttt -119.07 131.34 55.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.549 -0.719 . . . . 0.0 109.71 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.644 ' CD2' ' CD1' ' A' ' 85' ' ' LEU . 11.6 m170 -116.11 129.99 56.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.17 -0.956 . . . . 0.0 110.758 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 52' ' ' THR . 13.5 ttpt -107.71 108.84 20.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.279 -0.888 . . . . 0.0 109.547 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.722 HG23 HD11 ' A' ' 74' ' ' ILE . 27.8 mm -53.03 124.4 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.243 -0.911 . . . . 0.0 110.437 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 82' ' ' SER . 93.4 m-20 -96.71 -43.04 7.72 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.445 -0.784 . . . . 0.0 109.723 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.873 ' C ' HD12 ' A' ' 74' ' ' ILE . 15.2 m -170.79 157.55 5.58 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.338 -0.851 . . . . 0.0 109.685 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.873 HD12 ' C ' ' A' ' 73' ' ' SER . 1.4 mp -135.66 149.66 28.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 110.226 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 79' ' ' TYR . 9.3 m-20 -131.22 77.26 1.77 Allowed 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.711 -0.795 . . . . 0.0 110.677 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 35.8 mttp -63.71 -16.0 59.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.182 -0.949 . . . . 0.0 109.888 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -93.8 -34.66 13.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.351 -0.843 . . . . 0.0 109.301 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.507 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -99.18 -4.11 32.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.595 -0.691 . . . . 0.0 109.452 179.362 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.582 ' CE1' ' HB3' ' A' ' 16' ' ' PRO . 65.5 m-85 60.11 57.02 3.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.558 -0.714 . . . . 0.0 110.305 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.487 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -130.73 163.08 28.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.383 -0.823 . . . . 0.0 109.595 179.539 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.668 ' CE1' HG13 ' A' ' 23' ' ' VAL . 15.2 t80 -144.64 138.33 27.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.921 . . . . 0.0 109.975 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 38.2 m -140.12 121.58 15.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.161 -0.962 . . . . 0.0 111.064 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.614 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 5.3 p90 -139.07 177.69 7.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.457 -0.777 . . . . 0.0 109.556 178.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 98' ' ' ILE . 44.3 m -133.75 137.06 44.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.064 -1.023 . . . . 0.0 110.522 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.644 ' CD1' ' CD2' ' A' ' 69' ' ' HIS . 16.5 tp -93.37 118.31 31.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.236 -0.915 . . . . 0.0 109.831 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.7 pt -107.44 -22.23 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.427 -0.796 . . . . 0.0 110.036 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.526 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 64.9 tt0 -129.59 130.6 45.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.207 -0.933 . . . . 0.0 110.627 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.815 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . -176.87 107.94 0.25 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 90' ' ' ALA . 29.4 p-10 -42.34 -25.99 0.09 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.253 -1.145 . . . . 0.0 110.504 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.476 ' N ' ' OD1' ' A' ' 89' ' ' ASP . . . -75.47 -37.93 59.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.083 -1.01 . . . . 0.0 110.445 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.496 HD12 ' C ' ' A' ' 91' ' ' LEU . 1.6 pp -86.99 -25.7 24.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.885 . . . . 0.0 110.537 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.435 ' N ' ' HG ' ' A' ' 91' ' ' LEU . . . -63.11 -36.11 93.0 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.724 ' O ' HG23 ' A' ' 94' ' ' THR . 57.1 t0 -44.11 -34.91 1.95 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.174 -1.192 . . . . 0.0 110.403 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.724 HG23 ' O ' ' A' ' 93' ' ' ASP . 1.7 p -160.05 -35.07 0.06 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.273 -0.892 . . . . 0.0 110.432 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 1.044 HD21 ' CG1' ' A' ' 128' ' ' ILE . 5.9 mt -79.96 177.71 8.73 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.213 -0.929 . . . . 0.0 110.286 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.454 ' O ' HD13 ' A' ' 91' ' ' LEU . 45.5 tt0 -148.64 -78.98 0.14 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.363 -0.836 . . . . 0.0 109.479 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.526 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 8.1 mttt -80.14 135.59 36.34 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.63 -0.669 . . . . 0.0 110.486 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.584 ' O ' HG23 ' A' ' 84' ' ' THR . 0.3 OUTLIER -136.34 132.35 49.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 120.704 -1.247 . . . . 0.0 109.292 178.651 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.434 ' HG ' ' HE2' ' A' ' 121' ' ' HIS . 0.6 OUTLIER -107.37 132.6 52.98 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.383 -0.823 . . . . 0.0 109.909 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.614 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 5.8 m-85 -122.74 132.73 54.37 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.495 -0.753 . . . . 0.0 110.316 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.477 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 9.3 tt0 -135.81 125.31 25.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.205 -0.934 . . . . 0.0 110.295 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.471 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 72.2 m -118.5 154.83 31.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.232 -0.917 . . . . 0.0 109.516 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.449 ' N ' ' O ' ' A' ' 115' ' ' LYS . 31.4 mttt -144.1 132.35 21.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.028 -1.045 . . . . 0.0 110.389 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.847 HD23 HG12 ' A' ' 114' ' ' ILE . 2.8 mt -120.01 145.45 46.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.284 -0.885 . . . . 0.0 110.177 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.702 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -153.07 -168.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.378 -0.826 . . . . 0.0 109.891 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.702 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -114.76 140.91 48.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.356 -0.84 . . . . 0.0 110.117 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.488 ' HA ' HD11 ' A' ' 113' ' ' ILE . 53.9 p -97.22 162.99 20.84 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.249 -0.907 . . . . 0.0 110.21 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.425 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.3 Cg_endo -71.92 -2.99 12.35 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.982 1.517 . . . . 0.0 110.393 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 52.9 p -100.98 2.84 41.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.295 -0.878 . . . . 0.0 110.207 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 101.2 -31.48 8.6 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -70.73 -172.55 12.15 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.511 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 24.5 p -122.03 131.37 53.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.278 -1.131 . . . . 0.0 110.369 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.85 ' HA ' HG22 ' A' ' 10' ' ' THR . 21.7 mt -80.07 143.88 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.887 . . . . 0.0 109.742 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.847 HG12 HD23 ' A' ' 104' ' ' LEU . 19.4 mt -131.08 109.78 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.104 -0.997 . . . . 0.0 110.63 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.459 ' HG3' ' HG2' ' A' ' 8' ' ' GLU . 30.0 tttt -99.33 130.5 45.62 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.277 -0.889 . . . . 0.0 109.825 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.83 151.58 39.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.958 . . . . 0.0 110.53 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.994 HG23 ' CG ' ' A' ' 6' ' ' GLU . 25.9 m -146.72 151.84 37.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.35 -0.844 . . . . 0.0 110.302 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 91.3 p -155.84 139.96 16.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.915 . . . . 0.0 110.282 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.455 ' CE1' HG22 ' A' ' 117' ' ' THR . 54.4 m-70 -127.92 157.02 41.7 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.211 -0.931 . . . . 0.0 110.394 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.923 ' O ' HG13 ' A' ' 2' ' ' VAL . 7.0 m-85 -120.41 141.62 49.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.197 -0.939 . . . . 0.0 110.733 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.526 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 98.2 m-70 -122.29 96.65 5.13 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.109 -0.994 . . . . 0.0 109.857 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.835 HG23 HD23 ' A' ' 95' ' ' LEU . 1.3 p -75.93 156.39 34.26 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.351 -0.843 . . . . 0.0 110.323 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 44.4 tttm -113.17 108.3 17.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.216 -0.927 . . . . 0.0 110.266 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 105.4 -124.07 7.79 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -127.9 75.05 1.58 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.269 -1.136 . . . . 0.0 110.204 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.466 HG23 ' CG2' ' A' ' 122' ' ' THR . 16.4 m -141.49 152.71 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.236 -0.915 . . . . 0.0 110.279 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -127.77 161.78 28.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.298 -0.877 . . . . 0.0 110.098 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 1.044 ' CG1' HD21 ' A' ' 95' ' ' LEU . 5.1 mp -86.66 172.36 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.248 -0.907 . . . . 0.0 110.378 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.602 ' N ' HG22 ' A' ' 128' ' ' ILE . 10.0 mttp -108.01 127.16 53.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.414 -0.804 . . . . 0.0 109.539 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.493 ' CA ' ' HG3' ' A' ' 134' ' ' LYS . 97.4 mt-10 -42.86 -55.03 3.88 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.214 -0.929 . . . . 0.0 110.069 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.404 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 49.0 tt0 -47.22 -24.24 0.68 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.936 . . . . 0.0 109.751 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.477 ' N ' ' O ' ' A' ' 129' ' ' LYS . 9.7 t-160 -86.19 -64.89 1.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.361 -0.837 . . . . 0.0 110.175 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 1.138 HG21 ' CE2' ' A' ' 5' ' ' TYR . 7.2 p -63.38 -41.46 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.399 -0.813 . . . . 0.0 110.222 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.531 ' N ' HG13 ' A' ' 133' ' ' VAL . 27.5 mttt -63.04 -43.55 98.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.175 -0.953 . . . . 0.0 109.823 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.451 ' O ' ' HG3' ' A' ' 139' ' ' LYS . . . -67.94 -26.15 65.82 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.339 -0.851 . . . . 0.0 109.792 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -71.66 -33.02 63.76 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.499 ' HE2' ' CD1' ' A' ' 5' ' ' TYR . 25.9 mttp -63.37 -34.67 78.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -1.129 . . . . 0.0 109.894 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -79.07 -31.94 44.6 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.366 -0.834 . . . . 0.0 109.936 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 135' ' ' ALA . 83.6 mttt -65.46 -39.36 91.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.347 -0.846 . . . . 0.0 109.857 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.85 -46.6 52.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.875 . . . . 0.0 109.916 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.6 t -55.97 -42.32 76.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.421 -0.799 . . . . 0.0 109.917 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -59.2 -43.03 92.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.922 . . . . 0.0 109.882 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 47.5 mt -60.57 -36.74 79.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.261 -0.899 . . . . 0.0 109.783 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.539 ' HA ' HD12 ' A' ' 147' ' ' ILE . 22.7 m-85 -63.2 -31.93 73.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.377 -0.827 . . . . 0.0 109.823 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -73.64 -18.59 61.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.286 -0.884 . . . . 0.0 109.916 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.504 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 32.2 mt -82.19 -35.57 28.19 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.271 -0.893 . . . . 0.0 108.701 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.727 HD11 ' CE1' ' A' ' 22' ' ' PHE . 26.8 mt -73.0 -47.06 49.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 178.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.509 ' O ' HG13 ' A' ' 13' ' ' ILE . 90.8 mt-10 -57.57 -33.75 68.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.475 -0.766 . . . . 0.0 109.406 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 19.8 m -77.1 -26.19 53.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.206 -0.934 . . . . 0.0 109.267 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.597 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 87.9 t80 -62.28 -51.38 67.94 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.605 -0.684 . . . . 0.0 110.03 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.058 HD21 ' CE2' ' A' ' 158' ' ' TYR . 71.4 mt -74.53 -29.13 61.27 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.331 -0.856 . . . . 0.0 110.196 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.599 ' HA ' HD11 ' A' ' 13' ' ' ILE . 65.9 tttt -63.19 -17.76 62.76 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.231 -0.918 . . . . 0.0 109.593 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.484 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -122.29 -19.7 3.14 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.573 ' CD2' ' O ' ' A' ' 150' ' ' TYR . 14.4 m-70 -106.91 91.74 6.7 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.128 -1.219 . . . . 0.0 110.3 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 49.1 Cg_endo -73.92 4.76 3.91 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.054 1.555 . . . . 0.0 110.871 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -117.55 -6.12 11.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.095 -1.003 . . . . 0.0 109.809 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.64 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -59.81 104.92 0.33 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.345 -0.847 . . . . 0.0 110.131 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 1.058 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.2 OUTLIER 35.77 31.12 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.662 -0.649 . . . . 0.0 110.507 -179.492 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.546 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.792 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.765 HG13 ' O ' ' A' ' 120' ' ' TYR . 39.1 t -124.37 142.84 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.236 -1.155 . . . . 0.0 110.338 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.798 ' CE1' HD12 ' A' ' 128' ' ' ILE . 7.9 m-85 -104.62 147.01 28.11 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.339 -0.851 . . . . 0.0 109.667 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.61 HG23 ' CE1' ' A' ' 119' ' ' HIS . 4.0 m -113.28 110.17 19.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.047 -1.033 . . . . 0.0 110.756 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.918 ' CE1' HG11 ' A' ' 133' ' ' VAL . 28.8 m-85 -119.58 125.98 50.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.295 -0.878 . . . . 0.0 109.977 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.452 ' HB2' ' HG1' ' A' ' 117' ' ' THR . 22.7 pt-20 -139.99 154.17 47.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.151 -0.968 . . . . 0.0 110.363 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.1 t -127.04 162.93 24.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.312 -0.867 . . . . 0.0 109.992 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -142.82 121.4 12.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.183 -0.948 . . . . 0.0 110.368 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.651 ' CZ ' ' CD2' ' A' ' 144' ' ' PHE . 3.0 p90 -149.24 -172.69 4.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.347 -0.845 . . . . 0.0 109.765 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.861 HG22 ' HA ' ' A' ' 113' ' ' ILE . 9.4 p -142.16 173.21 11.73 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.216 -0.928 . . . . 0.0 110.695 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.521 ' HB2' ' CG ' ' A' ' 148' ' ' GLU . 22.9 p -158.03 134.06 9.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.499 -0.75 . . . . 0.0 110.199 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.489 ' HA ' ' HA2' ' A' ' 111' ' ' GLY . 97.6 mt-10 -61.11 -39.18 89.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 110.111 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.809 HG23 ' HD2' ' A' ' 14' ' ' PRO . 3.0 mp -53.99 150.4 14.99 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.43 -0.794 . . . . 0.0 109.998 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.809 ' HD2' HG23 ' A' ' 13' ' ' ILE . 41.1 Cg_endo -66.89 141.07 57.38 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.958 1.504 . . . . 0.0 110.466 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.633 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.7 Cg_endo -73.44 -30.11 10.41 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 O-C-N 124.04 1.548 . . . . 0.0 112.996 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.2 Cg_endo -71.11 -22.74 25.62 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 O-C-N 122.443 0.707 . . . . 0.0 110.398 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.613 ' NH2' ' HB3' ' A' ' 157' ' ' ALA . 39.7 mtp180 -84.8 -45.58 12.21 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.774 ' C ' HD23 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -66.44 -30.14 70.43 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.663 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.543 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 69.0 t80 -67.19 -59.72 3.2 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.484 -0.76 . . . . 0.0 109.561 178.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.544 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 8.5 mttp -49.34 -29.4 6.09 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.04 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -75.63 -65.72 0.86 Allowed 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.708 0.765 . . . . 0.0 110.934 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.849 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -57.59 -33.57 68.34 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.775 -0.578 . . . . 0.0 111.754 -178.382 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.794 HG13 ' CE1' ' A' ' 81' ' ' TYR . 3.9 t -104.39 -61.46 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.853 -1.154 . . . . 0.0 111.49 -178.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.688 HD12 ' N ' ' A' ' 24' ' ' LEU . 7.9 mp -77.01 -0.14 23.39 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.166 -0.959 . . . . 0.0 111.599 -178.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.593 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -142.2 6.88 1.75 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.753 -1.217 . . . . 0.0 110.83 179.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.849 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -47.35 -41.78 20.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.089 -1.007 . . . . 0.0 110.044 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.479 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 86.7 m-20 -64.13 -18.12 64.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -0.893 . . . . 0.0 110.034 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.511 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 81.5 m-20 -127.96 11.13 6.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.875 . . . . 0.0 110.158 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.793 HD12 ' C ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -95.95 -46.73 6.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.332 -0.855 . . . . 0.0 110.153 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 1.069 HG21 HD13 ' A' ' 38' ' ' ILE . 6.8 p -78.09 -26.9 0.53 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.898 . . . . 0.0 112.333 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.807 ' HD3' HG12 ' A' ' 30' ' ' VAL . 49.9 Cg_endo -78.14 5.82 5.12 Favored 'Trans proline' 0 C--N 1.318 -1.057 0 O-C-N 122.656 0.819 . . . . 0.0 110.539 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -126.15 -27.62 3.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.194 -0.941 . . . . 0.0 109.815 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.575 HG12 ' CD1' ' A' ' 150' ' ' TYR . 14.1 mt -79.96 -43.06 22.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.427 -0.796 . . . . 0.0 109.734 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -161.37 102.63 1.22 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.436 -0.79 . . . . 0.0 110.142 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.65 -0.51 8.96 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.045 1.55 . . . . 0.0 110.546 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -84.16 -17.04 41.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 0.0 109.712 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.41 -70.45 0.66 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.427 -0.796 . . . . 0.0 109.96 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 1.069 HD13 HG21 ' A' ' 30' ' ' VAL . 1.6 mp -103.96 129.28 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.456 -0.778 . . . . 0.0 109.904 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.439 ' HZ3' ' HB ' ' A' ' 57' ' ' THR . 0.1 OUTLIER -72.65 -27.66 62.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.262 -0.899 . . . . 0.0 110.433 -179.941 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.545 ' C ' ' CD2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER 178.0 155.45 0.36 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.069 -1.019 . . . . 0.0 110.198 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.9 m -130.75 123.55 29.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.339 -0.851 . . . . 0.0 109.965 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.545 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 79.6 tt0 -133.98 111.87 10.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.098 -1.001 . . . . 0.0 110.52 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.457 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 21.3 mt -54.58 142.64 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.327 -0.858 . . . . 0.0 110.02 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.9 tp -118.56 -25.95 6.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.296 -0.878 . . . . 0.0 110.293 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.533 ' HB2' ' N ' ' A' ' 53' ' ' ILE . 1.6 m95 -123.76 158.07 32.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.332 -0.855 . . . . 0.0 110.471 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.439 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 43.21 -139.61 2.98 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -150.17 24.59 0.82 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.4 -1.059 . . . . 0.0 109.896 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 121.43 -18.41 8.79 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.456 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -72.09 -173.33 19.99 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.482 ' HA ' HG22 ' A' ' 71' ' ' ILE . 44.2 Cg_endo -72.57 129.01 14.11 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 124.005 1.529 . . . . 0.0 110.613 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.2 -14.31 48.03 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.538 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -69.87 166.3 19.76 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.574 -0.956 . . . . 0.0 109.412 179.565 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.533 ' N ' ' HB2' ' A' ' 45' ' ' TRP . 51.6 mt -138.46 119.99 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 110.151 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -104.13 127.26 51.71 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.232 -0.917 . . . . 0.0 110.456 -179.909 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.4 tttt -95.4 90.95 5.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.273 -0.892 . . . . 0.0 109.955 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.547 ' CG2' HG12 ' A' ' 38' ' ' ILE . 94.5 mt -79.97 140.37 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.279 -0.888 . . . . 0.0 110.353 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 2.4 p -111.1 161.78 15.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.327 -0.858 . . . . 0.0 110.025 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.689 ' HE2' HG13 ' A' ' 67' ' ' VAL . 22.0 m-85 -116.97 166.07 12.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.194 -0.941 . . . . 0.0 110.344 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 58' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.316 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.1 t80 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.194 0.521 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.482 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -133.58 134.22 7.36 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 108.609 -1.797 . . . . 0.0 108.609 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.555 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 11.6 p90 -178.78 162.86 1.37 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.173 -1.192 . . . . 0.0 110.162 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.945 HG12 ' HA2' ' A' ' 88' ' ' GLY . 4.4 m -142.62 173.59 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.316 -0.865 . . . . 0.0 110.33 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.467 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 77.7 mttt -125.01 124.37 41.84 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.564 -0.71 . . . . 0.0 109.768 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.516 ' CD2' HD12 ' A' ' 85' ' ' LEU . 15.2 m170 -112.97 122.85 48.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.171 -0.956 . . . . 0.0 110.809 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 52' ' ' THR . 46.7 tttp -101.98 109.72 21.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.323 -0.86 . . . . 0.0 109.549 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.529 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 27.9 mm -48.7 136.64 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.123 -0.986 . . . . 0.0 110.21 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.493 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 14.4 t0 -114.41 -43.02 3.23 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.853 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.451 ' HB2' ' HB2' ' A' ' 82' ' ' SER . 16.7 m -165.4 158.69 16.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.457 -0.777 . . . . 0.0 109.855 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.421 HG12 HG11 ' A' ' 23' ' ' VAL . 1.4 mt -145.77 156.01 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.208 -0.933 . . . . 0.0 110.249 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.563 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 2.7 m-20 -135.56 79.21 1.77 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.547 -0.721 . . . . 0.0 110.086 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.543 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 22.1 tttp -61.78 -13.31 22.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.319 -0.863 . . . . 0.0 110.275 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -94.47 -31.23 14.04 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.237 -0.914 . . . . 0.0 109.724 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.498 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -108.47 -3.42 18.17 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.458 -0.776 . . . . 0.0 109.735 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.577 ' O ' HD12 ' A' ' 104' ' ' LEU . 7.2 m-30 64.68 50.39 2.1 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.568 -0.707 . . . . 0.0 110.304 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.563 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.6 OUTLIER -118.53 153.44 34.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.316 -0.865 . . . . 0.0 109.25 179.352 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.794 ' CE1' HG13 ' A' ' 23' ' ' VAL . 22.0 t80 -141.41 132.46 26.18 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.047 -1.033 . . . . 0.0 110.398 -179.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.451 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 4.3 m -137.6 120.06 15.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.161 -0.962 . . . . 0.0 110.665 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.626 ' CE2' ' CB ' ' A' ' 100' ' ' TYR . 21.2 p90 -135.96 170.88 15.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.142 -0.973 . . . . 0.0 110.349 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 98' ' ' ILE . 43.5 m -121.31 132.24 54.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.399 -0.813 . . . . 0.0 109.941 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.572 HD11 ' O ' ' A' ' 87' ' ' GLU . 3.5 tp -98.53 126.03 43.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.177 -0.952 . . . . 0.0 110.153 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 86' ' ' ILE . 14.3 pt -105.12 -11.22 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.278 -0.889 . . . . 0.0 110.056 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.572 ' O ' HD11 ' A' ' 85' ' ' LEU . 4.3 tt0 -134.93 164.23 28.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.196 -0.94 . . . . 0.0 110.25 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.945 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 149.66 116.57 0.81 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -54.89 -20.2 8.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.24 -1.153 . . . . 0.0 110.171 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.575 ' O ' ' CE1' ' A' ' 132' ' ' HIS . . . -73.23 -8.91 57.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.366 -0.834 . . . . 0.0 110.213 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 88' ' ' GLY . 19.4 mt -81.54 -7.03 59.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.301 -0.874 . . . . 0.0 110.088 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 45.61 -170.43 0.02 OUTLIER Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -89.32 24.21 2.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -1.154 . . . . 0.0 109.885 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.1 p -118.18 -44.34 2.69 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.395 -0.815 . . . . 0.0 110.402 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.771 HD22 HG22 ' A' ' 122' ' ' THR . 3.1 mm? -79.93 162.71 24.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.392 -0.817 . . . . 0.0 110.388 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.443 ' CD ' ' HB2' ' A' ' 123' ' ' LYS . 10.5 mt-10 -146.16 -80.99 0.15 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.367 -0.833 . . . . 0.0 109.798 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.531 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 36.8 mttp -80.25 127.28 32.17 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.575 -0.703 . . . . 0.0 110.34 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.726 HG21 ' CE2' ' A' ' 100' ' ' TYR . 5.1 mm -117.68 137.5 51.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 120.446 -1.409 . . . . 0.0 110.0 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.513 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.3 OUTLIER -114.35 131.02 56.69 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.754 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.726 ' CE2' HG21 ' A' ' 98' ' ' ILE . 7.6 m-85 -125.42 134.8 51.99 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.317 -0.864 . . . . 0.0 110.576 -178.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 117' ' ' THR . 1.9 tt0 -138.95 131.46 28.73 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.413 -0.805 . . . . 0.0 110.128 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 61.0 m -132.99 142.07 48.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.308 -0.87 . . . . 0.0 109.855 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -134.38 143.2 47.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 0.0 110.527 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.66 HD23 HG12 ' A' ' 114' ' ' ILE . 14.2 mt -119.0 150.68 39.53 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.396 -0.815 . . . . 0.0 109.916 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.715 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -146.5 -168.99 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.177 -0.952 . . . . 0.0 110.061 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.715 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -124.19 160.9 26.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.313 -0.867 . . . . 0.0 110.14 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.45 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.5 p -119.42 170.17 7.14 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.912 . . . . 0.0 110.224 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.45 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 45.9 Cg_endo -72.32 -17.13 27.63 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.059 1.557 . . . . 0.0 110.484 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 59.8 p -93.28 -1.09 56.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.232 -0.918 . . . . 0.0 110.27 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.31 -36.98 4.04 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.489 ' HA2' ' HA ' ' A' ' 12' ' ' GLU . . . -54.3 -175.49 0.09 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.506 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 85.7 p -131.41 137.47 48.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.24 -1.153 . . . . 0.0 110.283 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.861 ' HA ' HG22 ' A' ' 10' ' ' THR . 16.6 mt -90.61 146.57 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.216 -0.928 . . . . 0.0 110.076 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.66 HG12 HD23 ' A' ' 104' ' ' LEU . 6.7 mt -128.32 127.13 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.283 -0.886 . . . . 0.0 110.134 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -119.77 108.79 14.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -0.912 . . . . 0.0 110.035 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.7 m -95.19 158.72 15.34 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.22 -0.925 . . . . 0.0 110.37 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 101' ' ' GLU . 60.6 m -160.13 122.44 3.31 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.386 -0.821 . . . . 0.0 109.903 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 94.8 p -126.18 171.19 11.09 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.137 -0.977 . . . . 0.0 110.466 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.61 ' CE1' HG23 ' A' ' 4' ' ' THR . 89.2 m-70 -145.27 140.05 27.54 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.334 -0.854 . . . . 0.0 110.288 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.765 ' O ' HG13 ' A' ' 2' ' ' VAL . 3.2 m-30 -105.84 146.66 29.62 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.322 -0.861 . . . . 0.0 110.634 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.531 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 59.6 m-70 -131.69 96.48 3.97 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.188 -0.945 . . . . 0.0 109.265 178.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.771 HG22 HD22 ' A' ' 95' ' ' LEU . 1.1 p -80.04 153.44 28.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.325 -0.859 . . . . 0.0 110.959 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.443 ' HB2' ' CD ' ' A' ' 96' ' ' GLU . 7.9 tttp -96.49 132.85 41.63 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.652 -0.655 . . . . 0.0 110.082 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 87.12 -144.88 19.53 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -118.65 74.0 0.94 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.296 -1.12 . . . . 0.0 110.17 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.431 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 21.8 m -131.9 167.19 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.226 -0.921 . . . . 0.0 110.139 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -128.4 152.91 47.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.206 -0.934 . . . . 0.0 110.236 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.798 HD12 ' CE1' ' A' ' 3' ' ' PHE . 3.5 mt -77.45 173.09 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.283 -0.886 . . . . 0.0 110.164 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.617 ' N ' HG22 ' A' ' 128' ' ' ILE . 27.1 mttt -104.78 141.63 36.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.406 -0.809 . . . . 0.0 110.025 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -54.52 -42.65 71.1 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.121 -0.987 . . . . 0.0 110.002 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -55.93 -38.28 70.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.245 -0.909 . . . . 0.0 109.897 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.575 ' CE1' ' O ' ' A' ' 90' ' ' ALA . 16.3 t-160 -69.47 -53.88 17.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.244 -0.91 . . . . 0.0 110.099 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.918 HG11 ' CE1' ' A' ' 5' ' ' TYR . 97.1 t -60.1 -38.39 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.416 -0.803 . . . . 0.0 109.87 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -71.06 -38.3 72.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.259 -0.901 . . . . 0.0 109.958 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.97 -20.83 62.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -0.869 . . . . 0.0 110.016 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.15 -25.7 54.51 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.492 ' HE3' HG12 ' A' ' 133' ' ' VAL . 82.7 mttt -77.24 -31.72 55.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.266 -1.138 . . . . 0.0 110.121 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -75.36 -31.74 60.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.334 -0.854 . . . . 0.0 110.028 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -73.88 -31.95 63.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 0.0 109.944 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.573 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -76.16 -35.41 59.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 110.161 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 84.5 p -67.52 -46.73 71.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.299 -0.876 . . . . 0.0 110.02 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -58.71 -46.16 87.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.187 -0.946 . . . . 0.0 110.008 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.6 HD23 HD12 ' A' ' 146' ' ' LEU . 19.6 mt -60.63 -36.36 78.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.913 . . . . 0.0 110.033 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.671 ' HA ' HD12 ' A' ' 147' ' ' ILE . 7.2 m-85 -63.35 -40.08 96.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.366 -0.834 . . . . 0.0 109.865 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 145' ' ' LYS . 11.8 tttp -73.43 -9.56 58.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.35 -0.843 . . . . 0.0 110.128 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.6 HD12 HD23 ' A' ' 143' ' ' LEU . 13.0 mt -84.72 -39.63 18.28 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.235 -0.915 . . . . 0.0 108.95 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.843 HD11 ' CE1' ' A' ' 22' ' ' PHE . 4.6 mt -68.61 -45.17 82.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.521 ' CG ' ' HB2' ' A' ' 11' ' ' SER . 84.4 mt-10 -58.59 -45.34 89.31 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.481 -0.762 . . . . 0.0 109.564 179.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 18.9 m -68.24 -32.1 72.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.111 -0.993 . . . . 0.0 109.576 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.671 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 92.7 t80 -57.26 -47.93 80.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.586 -0.696 . . . . 0.0 109.97 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.001 HD21 ' CE1' ' A' ' 158' ' ' TYR . 73.3 mt -74.52 -37.73 62.99 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.331 -0.855 . . . . 0.0 110.517 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.687 ' HB2' HD11 ' A' ' 13' ' ' ILE . 14.2 tttm -62.19 -13.62 29.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.248 -0.908 . . . . 0.0 109.59 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.492 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -119.96 -26.2 2.35 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.146 -1.581 . . . . 0.0 109.146 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.568 ' CD2' ' O ' ' A' ' 150' ' ' TYR . 12.8 m-70 -105.97 93.88 8.36 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.338 -1.095 . . . . 0.0 110.109 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.0 Cg_endo -73.23 5.06 3.34 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.111 1.585 . . . . 0.0 111.118 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 32.6 p30 -122.01 -4.8 9.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.006 -1.059 . . . . 0.0 109.833 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.671 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -47.8 110.85 0.36 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.43 -0.793 . . . . 0.0 110.193 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 1.04 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 0.4 OUTLIER 33.76 33.08 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.766 -0.583 . . . . 0.0 110.872 -179.431 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.537 ' HB3' ' NH2' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 117.98 -1.009 . . . . 0.0 109.769 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.637 HG13 ' O ' ' A' ' 120' ' ' TYR . 49.0 t -114.71 147.7 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.188 -1.183 . . . . 0.0 110.37 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.587 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 60.8 m-85 -106.72 165.77 11.07 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.336 -0.852 . . . . 0.0 110.336 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.923 HG23 ' CE1' ' A' ' 119' ' ' HIS . 66.5 m -146.85 98.27 3.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.269 -0.894 . . . . 0.0 110.305 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.617 ' CE1' HG11 ' A' ' 133' ' ' VAL . 87.7 m-85 -111.54 140.92 45.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.197 -0.94 . . . . 0.0 109.876 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 20.6 pt-20 -138.56 151.72 47.55 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.141 -0.975 . . . . 0.0 110.43 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.455 ' OG ' ' HB2' ' A' ' 116' ' ' SER . 88.2 p -123.23 157.12 33.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.328 -0.857 . . . . 0.0 109.782 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -137.28 121.85 18.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.16 -0.962 . . . . 0.0 110.434 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.635 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.3 p90 -148.63 -172.78 4.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.281 -0.887 . . . . 0.0 109.8 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.683 HG22 ' HA ' ' A' ' 113' ' ' ILE . 17.3 p -141.73 -178.96 5.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.167 -0.958 . . . . 0.0 110.731 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.402 ' OG ' ' CD ' ' A' ' 148' ' ' GLU . 3.0 t -160.01 160.1 32.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.471 -0.768 . . . . 0.0 110.226 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.433 ' HB2' ' HE2' ' A' ' 152' ' ' LYS . 97.2 mt-10 -84.45 -30.37 25.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.256 -0.903 . . . . 0.0 110.03 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.804 HG23 ' HD2' ' A' ' 14' ' ' PRO . 11.6 mm -70.58 150.27 95.5 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.46 -0.775 . . . . 0.0 109.942 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.804 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.1 Cg_endo -66.2 143.89 72.86 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.022 1.538 . . . . 0.0 110.384 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.672 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.2 Cg_endo -72.27 -31.41 11.76 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.983 1.517 . . . . 0.0 112.849 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.672 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.7 Cg_endo -69.41 -21.47 35.05 Favored 'Trans proline' 0 C--N 1.316 -1.154 0 N-CA-C 110.13 -0.758 . . . . 0.0 110.13 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.544 ' NE ' ' HB2' ' A' ' 159' ' ' ASN . 54.6 mtp180 -84.36 -46.13 12.06 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.78 ' C ' HD23 ' A' ' 18' ' ' LEU . 1.1 tt -69.61 -29.31 66.8 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.506 ' HB2' ' O ' ' A' ' 15' ' ' PRO . 76.5 t80 -66.7 -59.55 3.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.51 -0.744 . . . . 0.0 109.328 178.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.536 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 14.9 mttp -50.25 -35.3 26.38 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.199 179.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.031 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -77.51 -41.01 40.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.394 -0.816 . . . . 0.0 110.703 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.947 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 1.6 t80 -69.56 -43.74 72.3 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.253 -0.904 . . . . 0.0 111.128 -178.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.672 HG13 ' CE1' ' A' ' 81' ' ' TYR . 4.3 t -104.31 -52.41 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.062 -1.024 . . . . 0.0 111.664 -179.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.728 HD12 ' N ' ' A' ' 24' ' ' LEU . 7.2 mp -78.34 0.4 25.66 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.11 -0.994 . . . . 0.0 111.304 -178.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.586 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.4 OUTLIER -157.55 39.29 0.28 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.912 -1.118 . . . . 0.0 110.43 179.796 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.947 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -77.48 -24.81 50.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.279 -0.888 . . . . 0.0 110.128 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.488 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 87.3 m-20 -65.54 -16.46 63.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 110.145 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -129.9 13.04 5.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.352 -0.842 . . . . 0.0 110.016 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.675 HD13 HD11 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -99.84 -46.64 5.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.273 -0.892 . . . . 0.0 110.042 -179.944 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.793 HG11 HD13 ' A' ' 38' ' ' ILE . 3.5 t -84.92 -41.5 0.67 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.381 -0.824 . . . . 0.0 110.819 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.8 Cg_endo -78.98 9.93 3.13 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 O-C-N 123.47 1.247 . . . . 0.0 110.693 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.9 tptt -126.84 -34.44 2.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.079 -1.013 . . . . 0.0 109.428 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.675 HD11 HD13 ' A' ' 29' ' ' LEU . 62.3 mt -80.14 -43.35 22.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.569 -0.707 . . . . 0.0 109.546 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.441 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . . . -146.26 100.4 4.16 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.54 -0.725 . . . . 0.0 109.919 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 34' ' ' ALA . 44.3 Cg_endo -71.37 -0.27 7.89 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 124.108 1.583 . . . . 0.0 110.803 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -84.25 -12.44 54.72 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.097 -1.002 . . . . 0.0 109.627 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.764 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -99.89 -65.08 0.99 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.491 -0.755 . . . . 0.0 109.987 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.793 HD13 HG11 ' A' ' 30' ' ' VAL . 1.9 mp -113.82 117.83 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.428 -0.795 . . . . 0.0 109.86 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' A' ' 57' ' ' THR . 9.1 ttpt -72.02 -30.94 65.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.321 -0.862 . . . . 0.0 110.518 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.548 ' C ' ' CD2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -169.02 151.88 4.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.196 -0.94 . . . . 0.0 110.211 -179.674 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.9 m -130.17 123.63 30.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.468 -0.77 . . . . 0.0 109.793 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.529 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 68.6 tt0 -134.25 113.3 11.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.04 -1.037 . . . . 0.0 110.6 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.43 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 44.7 mt -59.15 141.83 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.207 -0.933 . . . . 0.0 109.898 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.505 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 32.4 mt -116.29 -28.21 6.6 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.239 -0.913 . . . . 0.0 110.546 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.713 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.8 m95 -123.7 163.99 20.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.098 -1.001 . . . . 0.0 110.633 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 45' ' ' TRP . . . 42.34 -144.01 1.11 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -146.78 25.7 1.16 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.282 -1.128 . . . . 0.0 110.133 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 117.34 -15.22 13.19 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.126 -1.589 . . . . 0.0 109.126 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.573 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -78.15 -167.6 31.04 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.39 129.48 13.91 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.026 1.54 . . . . 0.0 110.641 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.27 -11.16 54.86 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.523 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -72.2 157.47 37.67 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.524 -0.986 . . . . 0.0 109.839 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.713 HD12 ' CG ' ' A' ' 45' ' ' TRP . 57.6 mt -129.71 120.06 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.0 109.875 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 93.1 mttt -106.24 132.47 52.26 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.164 -0.96 . . . . 0.0 110.531 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.505 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 77.7 tttt -101.64 92.69 4.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.319 -0.863 . . . . 0.0 109.92 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.54 ' CG2' HG13 ' A' ' 38' ' ' ILE . 91.5 mt -79.95 144.29 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.931 . . . . 0.0 110.289 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 39' ' ' LYS . 2.6 p -117.8 156.07 28.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 110.486 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.572 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 16.1 m-85 -115.49 148.15 39.81 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.352 -0.843 . . . . 0.0 110.039 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.912 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.235 0.541 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.572 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -130.08 97.73 0.4 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.538 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 12.8 p90 -138.88 167.13 22.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.145 -1.209 . . . . 0.0 110.112 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.927 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.3 m -139.2 174.88 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.243 -0.911 . . . . 0.0 110.72 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 30.1 mttt -128.85 122.35 30.22 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.516 -0.74 . . . . 0.0 109.743 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.627 ' NE2' HD13 ' A' ' 85' ' ' LEU . 13.2 m170 -109.46 126.56 53.62 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.16 -0.962 . . . . 0.0 110.88 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 52' ' ' THR . 54.9 tttt -97.63 121.86 40.03 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.273 -0.892 . . . . 0.0 109.609 179.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.573 HG21 ' O ' ' A' ' 49' ' ' GLY . 30.7 mm -64.96 122.37 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.162 -0.961 . . . . 0.0 110.522 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 82' ' ' SER . 27.9 m-20 -98.18 -47.6 5.41 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.427 -0.796 . . . . 0.0 109.968 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 44.7 m -167.8 157.95 10.5 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.349 -0.845 . . . . 0.0 109.751 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.596 HG12 HG11 ' A' ' 23' ' ' VAL . 3.6 mt -135.35 160.52 40.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.228 -0.92 . . . . 0.0 110.355 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.597 ' HB2' ' HB2' ' A' ' 80' ' ' SER . 17.4 m-20 -132.7 83.1 2.04 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.606 -0.684 . . . . 0.0 110.161 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.663 ' NZ ' HD21 ' A' ' 24' ' ' LEU . 45.1 mttm -72.95 -10.1 59.43 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.354 -0.841 . . . . 0.0 110.218 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -93.14 -39.26 11.14 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.317 -0.864 . . . . 0.0 109.315 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.529 ' ND2' ' H ' ' A' ' 78' ' ' ASN . 1.1 p30 -111.78 12.25 20.97 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.466 0.651 . . . . 0.0 110.761 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.504 ' CZ ' ' HB3' ' A' ' 16' ' ' PRO . 7.3 m-85 54.19 60.79 3.37 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.449 -0.782 . . . . 0.0 112.858 178.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.597 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 1.1 m -128.03 156.87 42.07 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.954 -1.091 . . . . 0.0 109.484 177.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.683 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 31.2 t80 -142.13 137.32 30.83 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.158 -0.964 . . . . 0.0 110.444 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 50.7 m -140.74 125.98 18.61 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.447 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.683 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 7.2 p90 -141.69 176.53 8.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.281 -0.887 . . . . 0.0 110.02 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.555 HG23 ' O ' ' A' ' 98' ' ' ILE . 46.0 m -126.8 132.82 50.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.298 -0.876 . . . . 0.0 109.868 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.627 HD13 ' NE2' ' A' ' 69' ' ' HIS . 12.4 tp -98.16 121.87 40.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.171 -0.955 . . . . 0.0 110.227 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.7 pt -104.59 -16.63 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.294 -0.879 . . . . 0.0 110.531 -179.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.475 ' OE1' ' NZ ' ' A' ' 68' ' ' LYS . 54.4 tt0 -129.11 165.35 21.41 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.148 -0.97 . . . . 0.0 110.385 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.927 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 149.51 120.96 1.07 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -56.52 -19.31 14.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.299 -1.118 . . . . 0.0 110.183 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.99 -18.18 54.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.295 -0.878 . . . . 0.0 110.228 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 92' ' ' GLY . 77.1 mt -66.98 -27.61 67.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.223 -0.923 . . . . 0.0 110.162 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 50.15 179.51 0.02 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.445 ' OD1' HG23 ' A' ' 94' ' ' THR . 57.6 p-10 -79.64 5.65 12.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.243 -1.151 . . . . 0.0 110.07 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.536 ' O ' HG22 ' A' ' 122' ' ' THR . 43.0 p -93.65 -34.91 13.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.89 . . . . 0.0 110.099 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 1.026 HD23 HG23 ' A' ' 122' ' ' THR . 19.5 mt -104.83 162.05 13.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 110.034 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.438 ' CD ' ' HB2' ' A' ' 123' ' ' LYS . 54.4 mt-10 -142.68 -80.3 0.21 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.297 -0.877 . . . . 0.0 109.978 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.515 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 53.7 mttp -80.14 126.16 30.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.595 -0.691 . . . . 0.0 110.409 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.761 HG21 ' CE2' ' A' ' 100' ' ' TYR . 5.3 mm -115.52 140.55 36.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 120.615 -1.303 . . . . 0.0 109.826 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.482 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -118.35 128.24 54.46 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.676 -0.81 . . . . 0.0 108.941 178.874 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.761 ' CE2' HG21 ' A' ' 98' ' ' ILE . 11.0 m-85 -123.53 135.33 53.96 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.313 -0.867 . . . . 0.0 110.533 -178.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.481 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 72.8 tt0 -139.14 136.29 34.96 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.276 -0.89 . . . . 0.0 110.146 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 50.3 m -137.36 138.94 40.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -0.926 . . . . 0.0 110.234 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.8 tttt -133.05 147.01 52.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.196 -0.94 . . . . 0.0 110.391 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.754 HD23 HG12 ' A' ' 114' ' ' ILE . 7.8 mt -121.82 153.8 37.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.273 -0.892 . . . . 0.0 110.241 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.711 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -149.49 -168.78 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.19 -0.944 . . . . 0.0 110.061 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.711 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -126.01 150.27 48.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.329 -0.857 . . . . 0.0 110.213 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.461 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 2.7 p -108.13 169.65 6.37 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.934 . . . . 0.0 110.345 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.461 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.7 Cg_endo -73.11 -11.41 25.2 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 O-C-N 124.106 1.582 . . . . 0.0 110.448 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 58.5 p -96.89 5.74 49.95 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.157 -0.965 . . . . 0.0 110.293 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.08 -38.17 3.2 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -55.61 -172.91 0.12 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.5 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 5.7 p -131.97 138.29 48.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.255 -1.144 . . . . 0.0 110.271 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.683 ' HA ' HG22 ' A' ' 10' ' ' THR . 20.5 mt -89.96 149.81 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.29 -0.881 . . . . 0.0 110.151 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.754 HG12 HD23 ' A' ' 104' ' ' LEU . 11.5 mt -131.23 126.73 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.228 -0.92 . . . . 0.0 110.222 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -118.09 110.2 17.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.163 -0.96 . . . . 0.0 110.219 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.455 ' HB2' ' OG ' ' A' ' 7' ' ' SER . 1.6 m -98.57 160.71 14.1 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.236 -0.915 . . . . 0.0 110.44 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' A' ' 101' ' ' GLU . 52.9 m -160.03 124.46 3.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.376 -0.827 . . . . 0.0 109.984 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 90.5 p -129.03 157.5 41.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.201 -0.937 . . . . 0.0 110.469 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.923 ' CE1' HG23 ' A' ' 4' ' ' THR . 47.1 m-70 -134.52 161.45 35.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.263 -0.898 . . . . 0.0 110.037 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.637 ' O ' HG13 ' A' ' 2' ' ' VAL . 25.9 m-85 -128.35 142.03 51.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.231 -0.918 . . . . 0.0 110.722 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.584 ' CE1' HG11 ' A' ' 2' ' ' VAL . 87.8 m-70 -124.56 96.04 4.75 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.214 -0.929 . . . . 0.0 109.124 178.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 1.026 HG23 HD23 ' A' ' 95' ' ' LEU . 1.8 p -86.0 153.93 21.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.292 -0.88 . . . . 0.0 111.099 -178.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.438 ' HB2' ' CD ' ' A' ' 96' ' ' GLU . 20.7 tttt -101.92 121.64 42.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.547 -0.721 . . . . 0.0 109.963 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 105.4 -140.7 15.17 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -122.88 76.52 1.37 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.3 -1.117 . . . . 0.0 110.346 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.535 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 21.4 m -136.49 162.36 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.19 -0.944 . . . . 0.0 110.06 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.427 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 87.1 mt-10 -129.93 159.29 37.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.173 -0.955 . . . . 0.0 110.434 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.934 HD11 HD21 ' A' ' 95' ' ' LEU . 19.6 mm -66.96 173.1 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.332 -0.855 . . . . 0.0 110.149 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.586 ' N ' HG22 ' A' ' 128' ' ' ILE . 7.4 mtpp -113.02 135.14 54.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.386 -0.821 . . . . 0.0 109.95 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -44.03 -43.14 6.55 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.174 -0.954 . . . . 0.0 110.027 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.5 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 48.7 tt0 -62.92 -24.02 67.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -0.898 . . . . 0.0 109.891 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 129' ' ' LYS . 14.8 t-160 -79.9 -50.91 9.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.379 -0.826 . . . . 0.0 110.113 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.617 HG11 ' CE1' ' A' ' 5' ' ' TYR . 46.9 t -60.92 -40.03 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.324 -0.86 . . . . 0.0 109.973 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -75.73 -50.43 15.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.399 -0.813 . . . . 0.0 110.149 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.5 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -61.69 -28.17 69.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.214 -0.929 . . . . 0.0 110.049 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.5 -28.81 64.86 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 38.9 mttm -69.53 -31.48 69.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.262 -1.14 . . . . 0.0 110.085 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 142' ' ' ASN . 99.0 mt-10 -77.16 -32.53 56.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.32 -0.862 . . . . 0.0 110.163 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.693 ' O ' HD12 ' A' ' 143' ' ' LEU . 35.6 mttt -68.42 -31.62 71.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.313 -0.867 . . . . 0.0 110.22 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.567 ' O ' ' CD1' ' A' ' 144' ' ' PHE . . . -90.28 -41.52 11.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.308 -0.87 . . . . 0.0 110.201 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.3 m -68.98 -47.33 65.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.407 -0.808 . . . . 0.0 110.14 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 138' ' ' GLU . 97.1 m-20 -55.14 -47.68 74.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.183 -0.948 . . . . 0.0 110.035 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.693 HD12 ' O ' ' A' ' 139' ' ' LYS . 76.0 mt -57.54 -42.09 82.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.313 -0.867 . . . . 0.0 109.91 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.567 ' CD1' ' O ' ' A' ' 140' ' ' ALA . 4.8 m-85 -58.61 -36.33 73.87 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.304 -0.872 . . . . 0.0 109.774 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 33.8 tttm -64.25 -26.0 68.31 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.319 -0.863 . . . . 0.0 109.777 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.456 ' HB3' HG21 ' A' ' 33' ' ' ILE . 16.6 mt -78.23 -34.27 49.36 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.635 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 47.5 mt -69.22 -51.64 41.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.47 ' O ' ' HG3' ' A' ' 152' ' ' LYS . 94.6 mt-10 -54.56 -42.16 70.63 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.37 -0.831 . . . . 0.0 109.169 178.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.516 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 88.5 m -63.72 -44.4 93.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.369 -0.832 . . . . 0.0 109.375 179.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.565 ' O ' ' CD2' ' A' ' 154' ' ' HIS . 89.9 t80 -46.32 -44.96 17.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.577 -0.702 . . . . 0.0 109.704 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.957 HD21 ' CE1' ' A' ' 158' ' ' TYR . 77.2 mt -80.02 -31.34 39.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.434 -0.791 . . . . 0.0 110.231 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.55 ' HA ' HD11 ' A' ' 13' ' ' ILE . 45.0 mttt -65.39 -16.4 63.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.187 -0.946 . . . . 0.0 109.602 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.489 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -116.94 -28.17 2.53 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.565 ' CD2' ' O ' ' A' ' 150' ' ' TYR . 7.7 m-70 -106.04 93.2 7.43 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.329 -1.101 . . . . 0.0 110.028 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 46.6 Cg_endo -73.46 4.95 3.52 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.096 1.577 . . . . 0.0 110.951 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -116.25 -8.53 11.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.07 -1.019 . . . . 0.0 109.758 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.623 ' HB1' ' CZ ' ' A' ' 158' ' ' TYR . . . -48.48 107.76 0.14 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.407 -0.808 . . . . 0.0 110.059 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 1.031 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 35.61 30.85 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.599 -0.688 . . . . 0.0 110.644 -179.768 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.544 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.784 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 1.045 HG23 ' C ' ' A' ' 120' ' ' TYR . 7.4 p -91.62 154.0 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.262 -1.14 . . . . 0.0 110.386 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.602 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 15.3 m-85 -92.22 173.68 7.7 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.174 -0.953 . . . . 0.0 110.494 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.83 HG23 ' CE1' ' A' ' 119' ' ' HIS . 5.6 m -152.23 93.37 1.8 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.288 -0.882 . . . . 0.0 110.197 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.639 ' CZ ' ' CG2' ' A' ' 133' ' ' VAL . 81.4 m-85 -116.0 145.84 42.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.172 -0.955 . . . . 0.0 109.905 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.508 ' HB3' HG23 ' A' ' 117' ' ' THR . 21.4 pt-20 -141.99 152.62 43.6 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.169 -0.957 . . . . 0.0 110.534 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 52.6 m -126.58 146.47 50.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.323 -0.86 . . . . 0.0 109.888 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -121.5 129.04 52.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.166 -0.959 . . . . 0.0 110.485 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.64 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.3 p90 -149.18 -175.57 5.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.35 -0.844 . . . . 0.0 109.802 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.677 HG22 ' HA ' ' A' ' 113' ' ' ILE . 17.3 p -140.44 177.92 7.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.138 -0.976 . . . . 0.0 110.725 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.524 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 2.5 t -158.14 158.99 35.71 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.479 -0.763 . . . . 0.0 110.069 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -85.4 -15.4 43.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.288 -0.883 . . . . 0.0 110.054 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.781 HG23 ' HD2' ' A' ' 14' ' ' PRO . 11.4 mm -82.4 149.67 61.98 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.33 -0.856 . . . . 0.0 110.056 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.781 ' HD2' HG23 ' A' ' 13' ' ' ILE . 41.8 Cg_endo -66.93 145.59 74.8 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.03 1.542 . . . . 0.0 110.306 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.67 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.2 Cg_endo -71.39 -31.96 13.2 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.978 1.514 . . . . 0.0 112.848 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.67 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 40.6 Cg_endo -68.31 -22.31 40.07 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 122.51 0.742 . . . . 0.0 110.245 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.613 ' NH2' ' HB3' ' A' ' 157' ' ' ALA . 46.0 mtp180 -85.1 -42.89 14.37 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.75 ' C ' HD23 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -73.76 -33.37 64.24 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.947 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.583 ' N ' HD23 ' A' ' 18' ' ' LEU . 59.5 t80 -65.65 -55.54 16.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.396 -0.815 . . . . 0.0 109.281 178.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 25' ' ' ASP . 12.0 mttt -51.83 -40.17 60.04 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.825 -0.75 . . . . 0.0 109.436 179.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.063 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -73.96 -38.73 64.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.4 -0.813 . . . . 0.0 111.009 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.704 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.3 OUTLIER -75.26 -36.86 61.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.07 -1.019 . . . . 0.0 110.912 -179.231 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.671 HG13 ' CE1' ' A' ' 81' ' ' TYR . 5.1 t -107.26 -58.56 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.189 -0.944 . . . . 0.0 111.59 -179.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 24' ' ' LEU . 7.0 mp -76.54 -1.8 29.19 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.138 -0.976 . . . . 0.0 111.534 -178.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.594 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.8 OUTLIER -154.91 49.49 0.58 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.936 -1.103 . . . . 0.0 110.099 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.704 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -87.43 -29.58 21.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.306 -0.871 . . . . 0.0 110.69 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -61.95 -18.0 58.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 0.0 110.425 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.524 ' O ' ' CG ' ' A' ' 32' ' ' LYS . 4.6 p30 -126.08 11.5 7.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 110.065 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.631 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 0.4 OUTLIER -97.52 -53.82 3.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -0.859 . . . . 0.0 110.154 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.66 HG11 HD12 ' A' ' 38' ' ' ILE . 2.9 t -71.8 -41.46 9.28 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.273 -0.892 . . . . 0.0 110.876 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 30' ' ' VAL . 47.5 Cg_endo -76.77 7.44 3.54 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 O-C-N 123.399 1.21 . . . . 0.0 110.968 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.524 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 47.7 mmtm -127.24 -35.46 2.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.086 -1.009 . . . . 0.0 109.403 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.574 HD13 ' HB2' ' A' ' 150' ' ' TYR . 10.1 mt -80.12 -33.73 14.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.583 -0.698 . . . . 0.0 109.382 179.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.662 ' HB2' HD13 ' A' ' 146' ' ' LEU . . . -149.43 91.33 4.45 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.583 -0.698 . . . . 0.0 110.068 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.82 2.07 6.34 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.104 1.581 . . . . 0.0 110.797 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -87.34 -15.23 38.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.094 -1.004 . . . . 0.0 109.869 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -107.64 -43.97 4.37 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.3 -0.875 . . . . 0.0 110.188 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.66 HD12 HG11 ' A' ' 30' ' ' VAL . 3.4 mt -127.45 142.37 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.392 -0.817 . . . . 0.0 110.116 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.496 ' CB ' ' O ' ' A' ' 59' ' ' GLY . 8.7 tppt? -119.62 -21.06 7.47 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.282 -0.887 . . . . 0.0 110.689 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.564 ' C ' ' CD2' ' A' ' 40' ' ' HIS . 0.5 OUTLIER -153.46 152.48 31.05 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.05 -1.031 . . . . 0.0 110.465 -179.671 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.458 ' N ' ' CD2' ' A' ' 40' ' ' HIS . 17.5 m -150.99 118.31 6.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.509 -0.744 . . . . 0.0 109.573 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -133.97 109.3 8.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.181 -0.95 . . . . 0.0 110.788 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 21.9 mt -54.18 137.62 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.257 -0.902 . . . . 0.0 109.748 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.508 HD22 ' HE3' ' A' ' 68' ' ' LYS . 14.9 tp -107.07 -30.1 9.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.116 -0.99 . . . . 0.0 110.995 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.839 ' CG ' HD12 ' A' ' 53' ' ' ILE . 2.0 m95 -124.08 164.64 19.0 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.153 -0.967 . . . . 0.0 110.875 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.46 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 41.24 -137.91 2.04 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.429 ' CG ' ' O ' ' A' ' 47' ' ' ASP . 11.5 t0 -154.33 24.25 0.48 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.312 -1.111 . . . . 0.0 109.85 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 120.07 -17.83 9.82 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.498 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -68.29 -174.54 8.73 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.434 ' HA ' HG22 ' A' ' 71' ' ' ILE . 46.0 Cg_endo -73.74 128.34 12.42 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 123.937 1.493 . . . . 0.0 110.639 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.96 -13.12 56.14 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -66.59 162.13 21.63 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.516 -0.99 . . . . 0.0 109.629 179.672 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.839 HD12 ' CG ' ' A' ' 45' ' ' TRP . 48.2 mt -128.56 121.61 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.241 -0.912 . . . . 0.0 109.756 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 98.7 mttt -107.78 134.19 51.09 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.173 -0.955 . . . . 0.0 110.319 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.605 ' HE2' ' CD1' ' A' ' 66' ' ' TYR . 14.5 tptm -105.65 90.32 3.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.266 -0.896 . . . . 0.0 109.802 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.629 ' CG2' HD13 ' A' ' 38' ' ' ILE . 73.0 mt -79.96 145.63 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.32 -0.863 . . . . 0.0 110.339 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.578 HG22 ' HB3' ' A' ' 66' ' ' TYR . 0.6 OUTLIER -122.55 144.87 48.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.374 -0.829 . . . . 0.0 109.88 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.609 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 13.5 m-85 -113.26 170.27 8.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.087 -1.008 . . . . 0.0 110.142 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.496 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.673 ' CE1' ' CE2' ' A' ' 66' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.308 0.575 . . . . 0.0 109.927 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.609 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -145.82 60.98 0.48 Allowed Glycine 0 N--CA 1.483 1.829 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 179.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.673 ' CE2' ' CE1' ' A' ' 64' ' ' TYR . 10.5 p90 -125.12 166.19 16.87 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.206 -1.173 . . . . 0.0 109.894 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.929 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.3 m -140.54 172.26 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 110.68 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.508 ' HE3' HD22 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -120.72 120.46 35.73 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.64 -0.662 . . . . 0.0 109.555 179.507 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.503 ' CD2' HD12 ' A' ' 85' ' ' LEU . 12.6 m170 -110.42 119.36 38.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.126 -0.984 . . . . 0.0 111.106 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 52' ' ' THR . 13.4 tttp -96.69 99.4 11.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.183 -0.948 . . . . 0.0 109.444 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.525 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 30.1 mm -42.38 135.92 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.351 -0.843 . . . . 0.0 110.159 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.46 ' OD2' ' OG1' ' A' ' 84' ' ' THR . 90.2 m-20 -104.2 -39.83 6.36 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.291 -0.881 . . . . 0.0 110.033 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.531 ' C ' HD12 ' A' ' 74' ' ' ILE . 1.4 m -179.38 162.14 1.13 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.246 -0.909 . . . . 0.0 109.6 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.531 HD12 ' C ' ' A' ' 73' ' ' SER . 0.9 OUTLIER -143.99 153.2 15.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.024 -179.812 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.497 ' HB3' ' HB2' ' A' ' 78' ' ' ASN . 5.5 m-20 -134.58 78.49 1.75 Allowed 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.501 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.546 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 20.8 tttt -61.65 -15.74 42.5 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.221 -0.925 . . . . 0.0 110.167 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -92.39 -36.0 13.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.242 -0.912 . . . . 0.0 109.41 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.517 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.8 m-80 -96.52 -5.3 39.71 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.639 -0.663 . . . . 0.0 109.387 179.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.549 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 76.4 m-85 62.08 55.95 2.37 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.566 0.698 . . . . 0.0 110.619 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.477 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 1.3 m -132.33 159.15 40.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.365 -0.834 . . . . 0.0 109.714 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.692 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 64.7 t80 -146.56 146.09 30.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.19 -0.943 . . . . 0.0 109.811 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.533 ' OG ' ' CG ' ' A' ' 101' ' ' GLU . 0.2 OUTLIER -153.48 138.14 16.94 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.167 -0.958 . . . . 0.0 110.861 -179.729 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.692 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 11.5 p90 -150.89 173.43 14.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.427 -0.796 . . . . 0.0 110.2 179.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 98' ' ' ILE . 58.2 m -124.92 131.58 53.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.421 -0.799 . . . . 0.0 109.934 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.654 HD23 HG13 ' A' ' 98' ' ' ILE . 2.0 tp -100.1 129.09 46.1 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.201 -0.937 . . . . 0.0 110.044 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.466 HG12 ' HB3' ' A' ' 68' ' ' LYS . 12.8 pt -115.27 -13.56 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -0.891 . . . . 0.0 110.027 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.554 ' O ' HD11 ' A' ' 85' ' ' LEU . 18.1 tt0 -128.68 154.63 46.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.884 . . . . 0.0 110.232 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.929 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 154.8 128.28 1.16 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -64.9 -10.87 32.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.273 -1.133 . . . . 0.0 110.242 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.91 -17.35 41.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.275 -0.891 . . . . 0.0 110.166 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.478 HD21 HD23 ' A' ' 85' ' ' LEU . 51.2 mt -69.01 -19.08 64.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.893 . . . . 0.0 110.234 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 49.09 -177.36 0.02 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.488 ' OD1' HG23 ' A' ' 94' ' ' THR . 54.2 p-10 -84.36 11.88 7.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.259 -1.142 . . . . 0.0 110.173 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.488 HG23 ' OD1' ' A' ' 93' ' ' ASP . 69.7 p -102.84 -38.18 7.52 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.281 -0.887 . . . . 0.0 110.181 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.906 HD21 ' CD1' ' A' ' 128' ' ' ILE . 76.5 mt -95.17 166.22 12.02 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.381 -0.824 . . . . 0.0 109.995 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.472 ' HG3' ' HB2' ' A' ' 123' ' ' LYS . 9.9 mt-10 -146.64 -81.36 0.14 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.263 -0.898 . . . . 0.0 109.787 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 49.2 mttt -80.39 130.09 34.94 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.728 -0.607 . . . . 0.0 110.254 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.707 HG21 ' CE2' ' A' ' 100' ' ' TYR . 5.7 mm -118.0 140.61 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 120.921 -1.112 . . . . 0.0 109.778 178.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.5 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.5 OUTLIER -121.51 128.61 52.24 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.762 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.707 ' CE2' HG21 ' A' ' 98' ' ' ILE . 10.7 m-85 -123.62 134.99 53.7 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.346 -0.846 . . . . 0.0 110.433 -178.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.533 ' CG ' ' OG ' ' A' ' 82' ' ' SER . 7.7 mt-10 -133.61 141.56 47.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.32 -0.863 . . . . 0.0 109.945 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.487 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 18.9 m -138.27 142.88 39.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.092 -1.005 . . . . 0.0 109.975 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.13 138.54 38.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.242 -0.911 . . . . 0.0 110.327 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.728 HD23 HG12 ' A' ' 114' ' ' ILE . 5.2 mt -124.86 145.8 49.61 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.259 -0.901 . . . . 0.0 110.227 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.697 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -152.76 -168.54 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.405 -0.81 . . . . 0.0 109.945 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.697 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -113.89 141.01 47.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.266 -0.896 . . . . 0.0 110.001 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.743 ' HA ' HD11 ' A' ' 113' ' ' ILE . 1.3 p -96.12 170.3 7.77 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.118 -0.989 . . . . 0.0 110.406 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.474 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 50.0 Cg_endo -78.81 4.57 6.34 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.105 1.582 . . . . 0.0 110.456 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 51.9 m -110.15 5.22 21.8 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -0.871 . . . . 0.0 110.283 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 99.36 -27.65 19.11 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.453 ' O ' ' OG ' ' A' ' 107' ' ' SER . . . -75.77 -173.94 35.5 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 22.4 p -118.53 132.44 56.21 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.181 -1.188 . . . . 0.0 110.301 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.743 HD11 ' HA ' ' A' ' 107' ' ' SER . 23.9 mt -82.84 147.61 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 109.903 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.728 HG12 HD23 ' A' ' 104' ' ' LEU . 9.7 mt -130.63 122.69 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.305 -0.872 . . . . 0.0 110.566 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.7 tttp -111.93 117.33 32.44 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.383 -0.823 . . . . 0.0 109.762 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.469 ' HG ' ' HZ ' ' A' ' 144' ' ' PHE . 0.5 OUTLIER -110.83 152.69 26.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.246 -0.909 . . . . 0.0 110.69 -179.55 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.763 HG22 ' NE2' ' A' ' 119' ' ' HIS . 53.6 m -149.57 132.57 16.2 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.42 -0.8 . . . . 0.0 110.1 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.4 m -131.12 150.53 52.11 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.198 -0.939 . . . . 0.0 110.321 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.83 ' CE1' HG23 ' A' ' 4' ' ' THR . 20.9 m-70 -137.9 135.4 36.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.343 -0.848 . . . . 0.0 110.037 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 1.045 ' C ' HG23 ' A' ' 2' ' ' VAL . 11.5 m-85 -113.27 122.22 46.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.133 -0.979 . . . . 0.0 110.631 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.614 ' N ' HG23 ' A' ' 2' ' ' VAL . 88.7 m-70 -91.22 121.77 33.27 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.2 p -98.11 149.23 22.73 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.059 -1.025 . . . . 0.0 110.974 -178.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.472 ' HB2' ' HG3' ' A' ' 96' ' ' GLU . 20.2 tttt -104.09 108.7 20.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.54 -0.725 . . . . 0.0 110.163 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 108.65 -136.36 13.47 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 26.4 t30 -119.94 54.37 1.03 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.105 -1.232 . . . . 0.0 110.341 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 17.7 m -115.65 170.24 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.311 -0.868 . . . . 0.0 110.113 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.428 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 96.4 mt-10 -134.25 -177.79 4.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.199 -0.938 . . . . 0.0 110.333 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.906 ' CD1' HD21 ' A' ' 95' ' ' LEU . 8.2 mm -84.73 172.25 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.216 -0.928 . . . . 0.0 110.405 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.586 ' N ' HG22 ' A' ' 128' ' ' ILE . 47.5 mttt -94.95 131.03 41.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.437 -0.79 . . . . 0.0 109.825 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.444 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 95.9 mt-10 -48.97 -40.96 32.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.193 -0.942 . . . . 0.0 110.109 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.753 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 49.0 tt0 -66.67 -8.89 30.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.221 -0.924 . . . . 0.0 109.753 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.454 ' O ' ' HA3' ' A' ' 136' ' ' GLY . 8.4 t-160 -103.24 -55.02 2.49 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.896 . . . . 0.0 110.196 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.639 ' CG2' ' CZ ' ' A' ' 5' ' ' TYR . 2.1 p -61.62 -29.61 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.449 -0.782 . . . . 0.0 110.227 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.538 ' HA ' ' HE3' ' A' ' 137' ' ' LYS . 28.3 tttt -108.91 -71.85 0.75 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.952 . . . . 0.0 110.061 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.753 ' HB3' ' O ' ' A' ' 131' ' ' GLU . . . -55.79 -21.05 17.34 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 109.68 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' A' ' 132' ' ' HIS . . . -74.46 -30.91 59.6 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.538 ' HE3' ' HA ' ' A' ' 134' ' ' LYS . 6.0 mtmp? -66.74 -31.87 72.8 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.25 -1.147 . . . . 0.0 109.949 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -72.96 -34.24 66.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.298 -0.876 . . . . 0.0 109.959 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.484 ' O ' HD12 ' A' ' 143' ' ' LEU . 52.6 mttt -67.91 -38.83 83.43 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.404 -0.81 . . . . 0.0 109.804 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.83 -40.05 91.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.311 -0.868 . . . . 0.0 109.837 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.429 ' O ' ' HG3' ' A' ' 145' ' ' LYS . 22.8 t -56.71 -38.12 71.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.374 -0.829 . . . . 0.0 109.904 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.482 ' OD1' ' HA ' ' A' ' 139' ' ' LYS . 15.7 m120 -56.9 -48.49 78.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.304 -0.872 . . . . 0.0 109.997 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.484 HD12 ' O ' ' A' ' 139' ' ' LYS . 1.2 mp -61.68 -34.19 75.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.87 . . . . 0.0 109.962 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.577 ' HA ' HD12 ' A' ' 147' ' ' ILE . 19.8 m-85 -64.68 -38.22 90.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.291 -0.881 . . . . 0.0 109.728 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.429 ' HG3' ' O ' ' A' ' 141' ' ' SER . 57.7 mttt -71.67 -12.23 61.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 109.946 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.662 HD13 ' HB2' ' A' ' 34' ' ' ALA . 17.8 mt -81.3 -36.65 29.53 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.233 -0.917 . . . . 0.0 108.882 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.649 HD11 ' CE1' ' A' ' 22' ' ' PHE . 17.3 mt -69.56 -50.37 51.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.524 ' CG ' ' OG ' ' A' ' 11' ' ' SER . 57.1 mt-10 -58.37 -37.71 75.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.466 -0.771 . . . . 0.0 109.453 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 20.2 m -67.57 -33.76 75.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.166 -0.959 . . . . 0.0 109.511 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.575 ' O ' ' CD2' ' A' ' 154' ' ' HIS . 87.6 t80 -58.91 -45.87 89.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.392 -0.817 . . . . 0.0 109.613 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.967 HD21 ' CE1' ' A' ' 158' ' ' TYR . 70.9 mt -80.0 -28.88 39.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.385 -0.822 . . . . 0.0 110.029 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.706 ' HA ' HD11 ' A' ' 13' ' ' ILE . 82.5 tttt -65.34 -14.91 61.88 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.193 -0.942 . . . . 0.0 109.518 179.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.479 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -119.84 -27.45 2.1 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.591 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 6.1 m-70 -106.44 93.61 8.59 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.22 -1.165 . . . . 0.0 110.301 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.9 Cg_endo -74.21 4.6 4.19 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 124.07 1.563 . . . . 0.0 110.833 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -115.61 -7.33 12.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.069 -1.019 . . . . 0.0 109.791 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.613 ' HB3' ' NH2' ' A' ' 17' ' ' ARG . . . -51.35 108.26 0.24 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.433 -0.792 . . . . 0.0 110.077 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 1.063 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 35.73 30.7 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.615 -0.678 . . . . 0.0 110.672 -179.637 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.54 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.4 0 O-C-N 121.095 -1.003 . . . . 0.0 109.684 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.617 HG11 ' CE1' ' A' ' 121' ' ' HIS . 58.1 t -122.8 134.25 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.173 -1.193 . . . . 0.0 110.412 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.597 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 32.0 m-85 -89.19 161.11 16.63 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.258 -0.901 . . . . 0.0 110.235 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.831 HG23 ' CE1' ' A' ' 119' ' ' HIS . 92.1 m -144.26 96.57 2.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.229 -0.92 . . . . 0.0 110.079 179.822 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.622 ' CE1' ' CG2' ' A' ' 133' ' ' VAL . 77.8 m-85 -115.41 144.66 43.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.15 -0.969 . . . . 0.0 110.172 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 116' ' ' SER . 21.0 pt-20 -138.6 152.41 48.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 0.0 110.218 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 65.2 m -122.37 150.29 42.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.251 -0.906 . . . . 0.0 110.047 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -133.13 120.07 20.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 110.356 -179.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.644 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.7 p90 -149.37 -173.76 4.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.293 -0.879 . . . . 0.0 109.92 179.751 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.863 HG22 ' HA ' ' A' ' 113' ' ' ILE . 3.3 p -140.32 171.8 13.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.12 -0.987 . . . . 0.0 110.474 -179.657 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.475 ' HB3' ' OE2' ' A' ' 148' ' ' GLU . 99.7 p -151.46 136.05 17.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.297 -0.877 . . . . 0.0 110.157 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -61.78 -31.91 72.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.172 -0.955 . . . . 0.0 110.244 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.809 HG21 HD12 ' A' ' 151' ' ' LEU . 8.1 mm -70.94 149.21 94.9 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.381 -0.824 . . . . 0.0 109.951 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.774 ' HD2' HG23 ' A' ' 13' ' ' ILE . 39.9 Cg_endo -65.39 143.59 76.95 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.073 1.565 . . . . 0.0 110.676 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.673 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.9 Cg_endo -71.82 -31.56 12.72 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 124.073 1.565 . . . . 0.0 112.74 -179.37 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.673 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.3 Cg_endo -69.02 -21.91 36.25 Favored 'Trans proline' 0 C--N 1.318 -1.051 0 N-CA-C 110.01 -0.804 . . . . 0.0 110.01 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.904 ' HB3' HD13 ' A' ' 151' ' ' LEU . 41.5 mtp180 -82.08 -47.45 12.58 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.583 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 1.111 HD23 ' CG2' ' A' ' 147' ' ' ILE . 0.2 OUTLIER -70.38 -35.08 73.28 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.093 178.929 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.645 ' N ' HD13 ' A' ' 18' ' ' LEU . 80.4 t80 -61.0 -59.26 5.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.479 -0.763 . . . . 0.0 109.738 179.116 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.53 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 17.6 mttp -51.64 -35.9 43.86 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.724 -0.791 . . . . 0.0 109.503 179.622 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.997 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -77.55 -32.36 53.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.464 -0.772 . . . . 0.0 111.048 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 1.058 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -80.53 -41.9 23.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.233 -0.917 . . . . 0.0 111.081 -179.099 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.742 HG13 ' CE1' ' A' ' 81' ' ' TYR . 3.7 t -103.91 -51.17 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.118 -0.989 . . . . 0.0 111.386 -179.106 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.674 HD12 ' N ' ' A' ' 24' ' ' LEU . 7.3 mp -80.14 -9.8 59.73 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.132 -0.98 . . . . 0.0 111.684 -178.878 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 20' ' ' LYS . 1.2 m-20 -148.48 36.57 0.81 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.768 -1.207 . . . . 0.0 110.711 -179.664 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 1.058 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -76.98 -25.7 53.05 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.301 -0.875 . . . . 0.0 110.309 179.676 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -66.16 -15.25 62.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.195 -0.941 . . . . 0.0 109.919 179.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.56 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 4.4 p30 -130.55 11.26 5.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.343 -0.848 . . . . 0.0 109.953 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.703 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -94.42 -48.99 5.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.374 -0.829 . . . . 0.0 110.042 179.689 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.863 HG22 ' HD3' ' A' ' 31' ' ' PRO . 2.1 m -73.91 -29.65 1.04 Allowed Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.373 -0.829 . . . . 0.0 112.039 -179.826 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.863 ' HD3' HG22 ' A' ' 30' ' ' VAL . 52.9 Cg_endo -78.81 4.06 6.79 Favored 'Trans proline' 0 C--N 1.32 -0.946 0 O-C-N 122.714 0.85 . . . . 0.0 110.128 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -124.34 -36.08 2.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.301 -0.874 . . . . 0.0 109.103 179.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.622 HD11 ' CD1' ' A' ' 29' ' ' LEU . 53.2 mt -79.96 -25.25 11.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 121.622 0.725 . . . . 0.0 109.25 179.19 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.407 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . . . -169.89 91.97 0.52 Allowed Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.702 -0.624 . . . . 0.0 109.738 179.705 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 34' ' ' ALA . 44.6 Cg_endo -70.77 -2.85 11.56 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.0 1.526 . . . . 0.0 110.632 -179.676 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -91.98 10.73 27.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -0.913 . . . . 0.0 109.938 179.789 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.913 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -114.65 -49.74 2.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.326 -0.859 . . . . 0.0 109.995 179.854 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.913 HD12 ' C ' ' A' ' 37' ' ' ALA . 1.8 mp -119.87 134.63 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.486 -0.759 . . . . 0.0 109.905 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' A' ' 57' ' ' THR . 6.1 ttmm -87.59 -24.64 23.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.311 -0.868 . . . . 0.0 110.357 -179.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.546 ' C ' ' CD2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -179.32 153.53 0.59 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.2 -0.938 . . . . 0.0 110.172 -179.847 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 m -127.32 124.44 38.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.345 -0.847 . . . . 0.0 109.923 179.702 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.516 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 49.7 tt0 -136.44 111.81 9.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.173 -0.954 . . . . 0.0 110.46 -179.823 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 22.2 mt -57.88 134.11 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.22 -0.925 . . . . 0.0 110.052 179.789 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.54 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 19.0 mt -103.45 -28.67 11.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.188 -0.945 . . . . 0.0 110.675 -179.79 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.666 ' CG ' HD12 ' A' ' 53' ' ' ILE . 2.0 m95 -129.51 165.18 22.18 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.096 -1.003 . . . . 0.0 110.731 -179.751 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 45' ' ' TRP . . . 41.57 -135.26 3.11 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.658 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -157.2 19.7 0.3 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.299 -1.118 . . . . 0.0 110.099 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.74 -15.82 7.02 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.798 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.505 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -76.58 -170.4 31.61 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.67 129.33 13.48 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.028 1.541 . . . . 0.0 110.662 -179.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.98 -9.57 56.64 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 -179.643 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -73.23 159.04 34.06 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.601 -0.941 . . . . 0.0 109.84 179.835 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.666 HD12 ' CG ' ' A' ' 45' ' ' TRP . 55.5 mt -128.85 121.35 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.382 -0.823 . . . . 0.0 109.79 179.538 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 6.4 mtpm? -104.63 145.03 30.9 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.155 -0.966 . . . . 0.0 110.262 -179.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.54 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 13.1 tttt -115.62 89.99 3.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -0.856 . . . . 0.0 110.024 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.453 ' CG2' HG13 ' A' ' 38' ' ' ILE . 64.7 mt -79.98 136.07 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -0.926 . . . . 0.0 110.139 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.513 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 1.4 p -108.98 152.66 24.67 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.211 -0.931 . . . . 0.0 110.396 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.583 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 20.1 m-85 -115.51 152.53 32.81 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.249 -0.907 . . . . 0.0 110.072 179.53 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.953 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.192 0.52 . . . . 0.0 110.299 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.583 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -132.63 84.36 0.29 Allowed Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.679 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.517 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 13.8 p90 -131.09 164.01 26.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.283 -1.127 . . . . 0.0 110.027 -179.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.942 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.7 m -134.08 174.54 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.927 . . . . 0.0 110.583 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.529 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 28.9 mttt -128.17 121.0 28.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.483 -0.76 . . . . 0.0 109.604 179.583 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.501 ' CD2' HD12 ' A' ' 85' ' ' LEU . 15.5 m170 -110.52 122.28 47.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.14 -0.975 . . . . 0.0 110.969 -179.384 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 52' ' ' THR . 81.0 tttt -95.48 117.44 30.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.187 -0.945 . . . . 0.0 109.359 178.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.519 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 23.6 mm -61.98 124.6 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.201 -0.937 . . . . 0.0 110.6 -179.31 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 82' ' ' SER . 94.4 m-20 -99.79 -41.88 7.07 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.403 -0.811 . . . . 0.0 109.693 179.512 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.458 ' OG ' ' HB2' ' A' ' 82' ' ' SER . 90.0 p -171.24 158.35 5.4 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.299 -0.875 . . . . 0.0 109.848 179.617 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.488 HG12 HG11 ' A' ' 23' ' ' VAL . 4.9 mt -137.4 158.47 35.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.265 -0.897 . . . . 0.0 110.273 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.59 ' HB2' ' HB2' ' A' ' 80' ' ' SER . 3.2 m-20 -133.68 83.32 2.04 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.579 -0.7 . . . . 0.0 110.166 -179.589 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.458 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 20.8 mttt -73.43 -9.89 59.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.438 -0.789 . . . . 0.0 110.167 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -93.54 -38.97 11.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.249 -0.907 . . . . 0.0 109.289 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.517 ' ND2' ' H ' ' A' ' 78' ' ' ASN . 0.9 OUTLIER -111.3 7.45 21.06 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.466 0.651 . . . . 0.0 110.807 -179.772 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.568 ' CZ ' ' HB3' ' A' ' 16' ' ' PRO . 5.6 m-85 59.03 60.88 2.28 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.379 -0.826 . . . . 0.0 112.859 177.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.59 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 1.0 OUTLIER -127.9 156.01 43.28 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.989 -1.069 . . . . 0.0 109.329 177.875 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.742 ' CE1' HG13 ' A' ' 23' ' ' VAL . 24.7 t80 -140.76 136.55 32.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.14 -0.975 . . . . 0.0 110.49 -179.254 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 1.1 m -139.49 125.69 20.05 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.302 -0.874 . . . . 0.0 110.324 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.691 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 23.7 p90 -147.01 169.92 18.21 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.234 -0.916 . . . . 0.0 110.404 179.558 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.674 HG23 ' O ' ' A' ' 98' ' ' ILE . 60.7 m -122.06 132.04 54.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.449 -0.782 . . . . 0.0 109.998 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.609 HD23 HG13 ' A' ' 98' ' ' ILE . 2.5 tp -97.41 122.9 41.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.184 -0.947 . . . . 0.0 110.125 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 86' ' ' ILE . 13.9 pt -105.15 -15.2 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -0.926 . . . . 0.0 110.293 -179.648 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.58 ' O ' HD11 ' A' ' 85' ' ' LEU . 31.6 tt0 -131.14 162.4 29.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.187 -0.946 . . . . 0.0 110.5 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.942 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 152.18 117.46 0.73 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -52.94 -21.16 4.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.174 -1.192 . . . . 0.0 110.3 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.84 -22.96 55.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.896 . . . . 0.0 110.279 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.599 HD21 HD23 ' A' ' 85' ' ' LEU . 26.8 mt -66.64 -26.8 67.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.918 . . . . 0.0 110.178 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 49.27 -178.44 0.02 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 57.9 p30 -79.05 4.48 14.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -1.167 . . . . 0.0 110.226 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.494 ' O ' HG22 ' A' ' 122' ' ' THR . 43.9 p -90.69 -32.47 16.18 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.269 -0.894 . . . . 0.0 110.114 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.871 HD23 ' CG2' ' A' ' 122' ' ' THR . 62.8 mt -111.04 162.76 14.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.373 -0.829 . . . . 0.0 110.089 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.499 ' HG3' ' HB2' ' A' ' 123' ' ' LYS . 71.3 mm-40 -142.63 -80.01 0.22 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.124 -0.985 . . . . 0.0 110.201 -179.726 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 58.4 mttm -80.21 126.82 31.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.584 -0.698 . . . . 0.0 110.481 -179.823 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.731 HG21 ' CE2' ' A' ' 100' ' ' TYR . 5.7 mm -117.36 140.57 39.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 120.744 -1.223 . . . . 0.0 109.999 179.149 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.498 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -119.39 129.58 54.88 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.829 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.731 ' CE2' HG21 ' A' ' 98' ' ' ILE . 10.1 m-85 -124.54 135.55 53.26 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.274 -0.891 . . . . 0.0 110.609 -178.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.462 ' O ' ' N ' ' A' ' 117' ' ' THR . 6.4 mt-10 -138.54 128.79 25.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.335 -0.853 . . . . 0.0 110.039 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 79.3 m -131.25 146.12 52.18 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.135 -0.978 . . . . 0.0 110.202 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 115' ' ' LYS . 4.5 tttt -140.72 145.25 36.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.312 -0.868 . . . . 0.0 110.324 -179.834 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.863 HD23 HG12 ' A' ' 114' ' ' ILE . 4.5 mt -124.73 153.8 41.83 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.294 -0.879 . . . . 0.0 110.239 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.698 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -151.45 -168.94 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.177 -0.952 . . . . 0.0 109.982 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.698 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -122.76 160.73 25.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.261 -0.899 . . . . 0.0 110.317 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.463 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 2.1 p -117.35 170.26 6.34 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.302 -0.874 . . . . 0.0 110.197 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 47.2 Cg_endo -72.89 -17.11 25.7 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.022 1.538 . . . . 0.0 110.452 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 73.4 m -95.17 9.46 39.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.334 -0.854 . . . . 0.0 110.272 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 94.54 -33.42 5.33 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -55.51 -172.39 0.11 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 0.7 OUTLIER -136.53 137.47 40.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -1.148 . . . . 0.0 110.349 -179.998 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.863 ' HA ' HG22 ' A' ' 10' ' ' THR . 25.0 mt -90.39 147.74 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.349 -0.844 . . . . 0.0 110.017 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.863 HG12 HD23 ' A' ' 104' ' ' LEU . 23.2 mt -131.48 114.22 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.231 -0.918 . . . . 0.0 110.593 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 103' ' ' LYS . 16.6 tttt -102.9 130.91 50.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.221 -0.924 . . . . 0.0 109.758 179.467 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 3.3 t -123.03 160.09 27.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.096 -1.003 . . . . 0.0 110.558 -179.637 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.462 ' N ' ' O ' ' A' ' 101' ' ' GLU . 29.8 m -156.36 126.98 6.73 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.332 -0.855 . . . . 0.0 110.038 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 83.5 p -130.38 152.58 49.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.114 -0.991 . . . . 0.0 110.489 -179.75 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.831 ' CE1' HG23 ' A' ' 4' ' ' THR . 50.4 m-70 -134.93 158.12 45.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.371 -0.831 . . . . 0.0 109.917 179.599 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.629 ' HD1' HD12 ' A' ' 98' ' ' ILE . 26.8 m-85 -129.59 135.42 48.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.133 -0.979 . . . . 0.0 110.488 -179.624 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.617 ' CE1' HG11 ' A' ' 2' ' ' VAL . 87.5 m-70 -117.25 95.92 5.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.117 -0.99 . . . . 0.0 109.819 179.38 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.871 ' CG2' HD23 ' A' ' 95' ' ' LEU . 2.4 p -77.86 158.51 29.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.909 . . . . 0.0 110.616 -179.522 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.499 ' HB2' ' HG3' ' A' ' 96' ' ' GLU . 63.4 tttt -113.12 99.25 7.69 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.372 -0.83 . . . . 0.0 110.191 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 121.84 -128.98 7.47 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -125.9 71.37 1.24 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.336 -1.097 . . . . 0.0 110.173 -179.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.514 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 35.5 m -138.58 155.93 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.188 -0.945 . . . . 0.0 110.092 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -123.51 174.32 7.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.319 -0.863 . . . . 0.0 110.284 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.823 ' CD1' HD21 ' A' ' 95' ' ' LEU . 20.9 mm -76.93 171.77 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.28 -0.888 . . . . 0.0 110.047 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.546 ' N ' HG22 ' A' ' 128' ' ' ILE . 22.3 mttt -99.17 129.9 45.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.191 -0.943 . . . . 0.0 109.986 179.785 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.546 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 93.8 mt-10 -44.05 -43.6 6.9 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.214 -0.929 . . . . 0.0 109.947 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.974 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 47.8 tt0 -58.61 -24.13 60.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.245 -0.909 . . . . 0.0 109.845 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.479 ' N ' ' O ' ' A' ' 129' ' ' LYS . 14.8 t-160 -86.67 -57.05 3.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.328 -0.857 . . . . 0.0 110.135 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.636 HG13 ' HG3' ' A' ' 134' ' ' LYS . 2.3 p -63.04 -22.31 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.417 -0.802 . . . . 0.0 110.262 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.636 ' HG3' HG13 ' A' ' 133' ' ' VAL . 54.1 mttt -112.0 -73.74 0.66 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.143 -0.973 . . . . 0.0 110.328 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.974 ' HB3' ' O ' ' A' ' 131' ' ' GLU . . . -53.45 -20.53 4.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.901 . . . . 0.0 109.642 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.55 -29.55 65.62 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.071 -1.611 . . . . 0.0 109.071 179.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 23.7 mttm -64.21 -30.09 71.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.298 -1.119 . . . . 0.0 109.954 179.8 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 70.2 tt0 -77.4 -28.32 52.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.379 -0.825 . . . . 0.0 110.156 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.8 mmtp -73.9 -34.8 64.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 110.055 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -80.6 -34.68 34.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.873 . . . . 0.0 110.007 179.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 33.2 m -63.86 -45.15 90.76 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.401 -0.812 . . . . 0.0 109.943 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -54.94 -42.77 72.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.283 -0.886 . . . . 0.0 110.015 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.632 ' HA ' HD12 ' A' ' 146' ' ' LEU . 80.8 mt -60.59 -46.1 91.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.294 -0.879 . . . . 0.0 110.083 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -59.31 -37.32 77.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.374 -0.829 . . . . 0.0 109.818 179.793 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -72.15 -12.97 61.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.306 -0.872 . . . . 0.0 110.068 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.632 HD12 ' HA ' ' A' ' 143' ' ' LEU . 34.4 mt -83.72 -35.58 24.33 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.215 -0.928 . . . . 0.0 108.912 179.25 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 1.111 ' CG2' HD23 ' A' ' 18' ' ' LEU . 60.7 mt -68.9 -46.22 79.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.503 ' O ' HG13 ' A' ' 13' ' ' ILE . 84.7 mt-10 -50.43 -35.32 28.06 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.4 -0.812 . . . . 0.0 109.353 179.089 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 3.0 m -75.39 -20.48 58.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.222 -0.924 . . . . 0.0 109.49 179.321 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.579 ' CD1' HG12 ' A' ' 33' ' ' ILE . 80.1 t80 -69.5 -48.95 58.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.517 -0.739 . . . . 0.0 109.915 179.605 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.904 HD13 ' HB3' ' A' ' 17' ' ' ARG . 48.2 mt -80.03 -31.56 39.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.351 -0.843 . . . . 0.0 110.021 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.464 ' CA ' HD11 ' A' ' 13' ' ' ILE . 7.5 ttpp -64.74 -14.19 57.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.306 -0.872 . . . . 0.0 109.428 179.285 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.464 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -118.35 -30.54 1.7 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 179.708 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.597 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 5.7 m-70 -106.07 94.41 9.3 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.272 -1.134 . . . . 0.0 110.15 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.51 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.9 Cg_endo -73.96 4.58 4.08 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.985 1.519 . . . . 0.0 110.873 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -113.37 -8.8 13.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.972 -1.08 . . . . 0.0 109.819 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.597 ' HB3' ' NH2' ' A' ' 17' ' ' ARG . . . -53.65 104.47 0.1 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.374 -0.829 . . . . 0.0 109.979 179.762 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.997 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 35.33 30.96 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.733 -0.604 . . . . 0.0 110.703 -179.663 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.538 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.409 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.745 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.235 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.955 HG11 ' CE1' ' A' ' 121' ' ' HIS . 2.7 p -80.75 149.56 5.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.113 -1.228 . . . . 0.0 110.795 -179.491 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 5' ' ' TYR . 72.5 m-85 -93.76 169.01 10.63 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.611 -0.681 . . . . 0.0 110.49 -179.579 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.959 HG23 ' CE1' ' A' ' 119' ' ' HIS . 86.0 m -139.93 105.06 5.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.345 -0.847 . . . . 0.0 110.126 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.784 ' CE2' HG11 ' A' ' 133' ' ' VAL . 65.7 m-85 -114.23 144.68 42.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.909 . . . . 0.0 110.034 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 21.5 pt-20 -134.27 150.5 51.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.173 -0.954 . . . . 0.0 110.254 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.461 ' O ' ' CG ' ' A' ' 8' ' ' GLU . 24.8 p -125.95 169.38 12.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.344 -0.847 . . . . 0.0 109.986 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.461 ' CG ' ' O ' ' A' ' 7' ' ' SER . 80.9 mt-10 -153.95 117.19 4.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.163 -0.961 . . . . 0.0 110.628 -179.852 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.2 p90 -142.58 -178.05 5.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.325 -0.859 . . . . 0.0 109.875 179.562 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.558 HG22 HG12 ' A' ' 113' ' ' ILE . 16.5 p -136.71 179.78 6.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.182 -0.949 . . . . 0.0 110.544 -179.783 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 112' ' ' SER . 2.2 t -160.05 159.12 31.6 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.297 -0.877 . . . . 0.0 110.55 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -85.55 -12.11 52.44 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.207 -0.933 . . . . 0.0 109.824 179.805 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.815 HG23 ' HD2' ' A' ' 14' ' ' PRO . 2.3 mp -88.29 151.02 48.17 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.356 -0.84 . . . . 0.0 109.984 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.815 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.9 Cg_endo -66.69 139.9 54.39 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.046 1.55 . . . . 0.0 110.664 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.64 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 41.3 Cg_endo -73.25 -30.03 10.84 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 124.069 1.563 . . . . 0.0 112.843 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.64 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.9 Cg_endo -71.72 -23.56 22.61 Favored 'Trans proline' 0 C--N 1.319 -1.002 0 N-CA-C 110.052 -0.788 . . . . 0.0 110.052 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.565 ' CZ ' ' HA ' ' A' ' 159' ' ' ASN . 1.1 mtp85 -82.05 -44.89 16.0 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.008 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.96 HD23 ' CG2' ' A' ' 147' ' ' ILE . 0.2 OUTLIER -67.07 -34.0 76.71 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.528 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.626 ' N ' HD13 ' A' ' 18' ' ' LEU . 74.9 t80 -59.38 -56.59 20.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.639 -0.663 . . . . 0.0 109.642 178.738 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.551 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 29.6 mttp -52.35 -37.53 56.41 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.721 -0.791 . . . . 0.0 109.421 179.462 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.007 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -75.63 -43.38 48.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.466 -0.772 . . . . 0.0 110.76 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 1.051 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.3 OUTLIER -65.36 -45.8 82.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.341 -0.849 . . . . 0.0 111.074 -179.065 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 1.126 HG11 ' CD1' ' A' ' 74' ' ' ILE . 10.4 t -104.2 -60.89 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.084 -1.01 . . . . 0.0 111.766 -179.051 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.616 HD12 ' N ' ' A' ' 24' ' ' LEU . 7.5 mp -66.13 -11.36 48.66 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.171 -0.956 . . . . 0.0 111.537 -178.64 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.612 ' O ' HD23 ' A' ' 29' ' ' LEU . 1.2 m-20 -148.17 44.18 1.05 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.886 -1.134 . . . . 0.0 110.27 -179.778 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 1.051 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -82.8 -22.14 34.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.297 -0.877 . . . . 0.0 110.47 -179.831 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -68.76 -19.9 64.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.127 -0.983 . . . . 0.0 110.214 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.515 ' O ' ' CB ' ' A' ' 32' ' ' LYS . 4.6 p30 -125.34 13.15 8.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 0.0 109.772 179.836 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.612 HD23 ' O ' ' A' ' 25' ' ' ASP . 0.4 OUTLIER -97.01 -54.16 3.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.453 -0.779 . . . . 0.0 110.175 -179.939 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.984 HG11 HD13 ' A' ' 38' ' ' ILE . 2.6 t -70.28 -42.78 16.73 Favored Pre-proline 0 C--N 1.299 -1.597 0 O-C-N 121.296 -0.877 . . . . 0.0 110.57 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 50.3 Cg_endo -79.32 8.27 3.98 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.601 1.316 . . . . 0.0 110.617 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.515 ' CB ' ' O ' ' A' ' 28' ' ' ASN . 81.4 tttt -125.41 -31.39 3.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.187 -0.945 . . . . 0.0 109.745 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.669 HD13 ' HA ' ' A' ' 147' ' ' ILE . 22.0 mt -79.76 -35.53 16.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.523 -0.736 . . . . 0.0 109.701 179.578 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.404 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . . . -160.66 99.82 1.35 Allowed Pre-proline 0 N--CA 1.487 1.377 0 O-C-N 121.433 -0.792 . . . . 0.0 110.187 179.764 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 34' ' ' ALA . 47.0 Cg_endo -72.96 0.14 8.21 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.201 1.632 . . . . 0.0 110.516 179.907 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -86.26 -13.02 47.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.261 -0.899 . . . . 0.0 109.823 179.699 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -98.46 -49.38 4.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.374 -0.829 . . . . 0.0 110.401 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.984 HD13 HG11 ' A' ' 30' ' ' VAL . 1.2 mp -130.56 137.93 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.327 -0.858 . . . . 0.0 110.324 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.426 ' O ' ' HB3' ' A' ' 40' ' ' HIS . 7.1 ttmt -70.97 -39.72 72.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.409 -0.807 . . . . 0.0 110.411 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.548 ' C ' ' CD2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER 179.03 159.32 0.61 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.277 -0.889 . . . . 0.0 110.284 179.852 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.9 m -121.03 131.61 54.39 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.225 -0.922 . . . . 0.0 110.045 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -135.2 114.28 12.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -0.924 . . . . 0.0 110.428 -179.829 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.426 HG12 ' HG2' ' A' ' 54' ' ' LYS . 28.3 mt -60.37 138.39 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.185 -0.947 . . . . 0.0 110.031 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.577 HD11 ' HB2' ' A' ' 55' ' ' LYS . 22.8 mt -111.74 -29.28 7.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.917 . . . . 0.0 110.462 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.635 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.8 m95 -125.33 163.89 21.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.216 -0.927 . . . . 0.0 110.698 -179.773 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.447 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 42.06 -138.23 2.58 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -151.15 21.1 0.76 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -1.154 . . . . 0.0 110.208 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 123.3 -18.93 7.73 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.541 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -72.9 -172.83 23.01 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.412 ' HA ' HG22 ' A' ' 71' ' ' ILE . 43.5 Cg_endo -71.72 128.66 14.52 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.993 1.523 . . . . 0.0 110.683 -179.783 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.09 -14.09 48.59 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 -179.487 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -70.87 161.42 31.04 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.554 -0.968 . . . . 0.0 109.647 179.682 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.635 HD12 ' CG ' ' A' ' 45' ' ' TRP . 56.2 mt -130.7 120.7 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.334 -0.854 . . . . 0.0 109.887 179.599 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.891 ' CE ' HD11 ' A' ' 71' ' ' ILE . 58.6 mttm -105.53 140.98 37.79 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.168 -0.957 . . . . 0.0 110.394 -179.716 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.577 ' HB2' HD11 ' A' ' 44' ' ' LEU . 78.0 tttt -106.99 88.58 2.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.313 -0.867 . . . . 0.0 110.159 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.584 HD12 ' CE1' ' A' ' 69' ' ' HIS . 79.0 mt -79.86 137.46 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.265 -0.897 . . . . 0.0 110.15 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.743 ' O ' HG23 ' A' ' 38' ' ' ILE . 5.6 p -109.29 161.78 14.94 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.18 -0.95 . . . . 0.0 110.658 -179.786 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.584 ' HE2' HG13 ' A' ' 67' ' ' VAL . 31.5 m-85 -115.73 128.64 56.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.47 -0.769 . . . . 0.0 110.211 179.777 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.979 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.266 0.555 . . . . 0.0 110.312 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.552 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -137.59 119.12 1.8 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 179.678 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.539 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 15.4 p90 -158.01 168.56 26.77 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.038 -1.272 . . . . 0.0 110.072 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.934 HG12 ' HA2' ' A' ' 88' ' ' GLY . 7.1 m -139.49 173.32 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.249 -0.907 . . . . 0.0 110.899 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 27.8 mttt -125.13 117.78 24.65 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.372 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.809 ' CD2' HD12 ' A' ' 85' ' ' LEU . 17.8 m170 -103.81 125.39 50.22 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.214 -0.929 . . . . 0.0 111.085 -178.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 52' ' ' THR . 25.6 tttt -97.76 106.51 18.83 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.383 -0.823 . . . . 0.0 109.374 179.002 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.891 HD11 ' CE ' ' A' ' 54' ' ' LYS . 43.3 mm -44.35 133.97 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.09 -1.006 . . . . 0.0 110.153 -179.227 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.51 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 46.3 t0 -107.49 -54.11 2.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.481 -0.762 . . . . 0.0 109.899 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.424 ' O ' ' N ' ' A' ' 82' ' ' SER . 5.4 m -172.28 158.25 4.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.453 -0.779 . . . . 0.0 110.277 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 1.126 ' CD1' HG11 ' A' ' 23' ' ' VAL . 4.0 tt -149.77 165.54 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.274 -0.891 . . . . 0.0 110.03 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.549 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 0.6 OUTLIER -133.78 82.06 1.96 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.299 -0.876 . . . . 0.0 110.014 -179.788 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.604 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 90.3 mttt -55.29 -15.14 2.19 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.316 -0.865 . . . . 0.0 110.841 -179.863 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -92.5 -30.4 15.72 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.189 -0.945 . . . . 0.0 109.798 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.502 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -111.34 -1.33 16.05 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.552 -0.717 . . . . 0.0 109.63 179.962 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.648 ' O ' HD12 ' A' ' 104' ' ' LEU . 10.7 m-85 65.69 48.23 1.98 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.769 -0.582 . . . . 0.0 110.608 -179.864 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.549 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.5 OUTLIER -116.55 148.07 41.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.157 -0.964 . . . . 0.0 109.364 179.386 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.535 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 86.9 t80 -148.45 144.63 27.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.122 -0.987 . . . . 0.0 110.414 -179.261 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.504 ' HB3' ' HG3' ' A' ' 101' ' ' GLU . 4.8 p -151.45 145.23 25.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.271 -0.893 . . . . 0.0 110.349 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.608 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 18.0 p90 -148.13 172.02 14.97 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.219 -0.926 . . . . 0.0 110.471 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.626 HG23 ' O ' ' A' ' 98' ' ' ILE . 97.1 m -122.16 123.58 41.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.344 -0.848 . . . . 0.0 109.964 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.937 HD21 HD11 ' A' ' 91' ' ' LEU . 0.9 OUTLIER -90.61 129.25 36.76 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.148 -0.97 . . . . 0.0 110.249 -179.827 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 16.7 pt -112.03 0.65 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.279 -0.888 . . . . 0.0 110.298 -179.789 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.509 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 57.3 tt0 -145.66 154.87 42.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.272 -0.892 . . . . 0.0 110.171 -179.922 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.934 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 156.9 126.93 0.95 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -64.26 -25.97 68.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.334 -1.097 . . . . 0.0 110.208 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.552 ' O ' ' CE1' ' A' ' 132' ' ' HIS . . . -70.27 -25.44 63.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -0.916 . . . . 0.0 110.122 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.937 HD11 HD21 ' A' ' 85' ' ' LEU . 22.3 mt -64.68 -36.56 84.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.31 -0.868 . . . . 0.0 110.072 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.11 175.69 36.73 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -72.58 -2.29 19.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -1.152 . . . . 0.0 109.967 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 122' ' ' THR . 30.3 p -91.42 -38.8 12.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.895 . . . . 0.0 110.455 -179.866 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.681 HD21 HG13 ' A' ' 128' ' ' ILE . 2.4 mm? -79.88 154.92 28.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.262 -0.899 . . . . 0.0 110.964 -179.453 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.47 ' OE1' ' HB2' ' A' ' 123' ' ' LYS . 37.5 tt0 -142.44 -84.21 0.18 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.13 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.517 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 28.5 mttt -80.42 125.14 29.55 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.705 -0.622 . . . . 0.0 110.595 179.076 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.626 ' O ' HG23 ' A' ' 84' ' ' THR . 3.2 mm -118.02 137.96 50.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 120.575 -1.328 . . . . 0.0 109.151 178.199 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.489 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -118.31 129.67 55.58 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.325 -0.859 . . . . 0.0 109.299 179.306 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.613 ' CE2' HG21 ' A' ' 98' ' ' ILE . 8.8 m-85 -124.13 132.63 53.66 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.42 -0.8 . . . . 0.0 110.236 -179.282 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.504 ' HG3' ' HB3' ' A' ' 82' ' ' SER . 76.9 tt0 -134.5 138.7 44.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.18 -0.95 . . . . 0.0 110.21 179.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 90.5 m -141.34 125.51 17.39 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.161 -0.962 . . . . 0.0 110.199 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.468 ' HG3' ' HB3' ' A' ' 80' ' ' SER . 1.0 OUTLIER -116.86 149.42 40.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.881 . . . . 0.0 110.114 179.818 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.648 HD12 ' O ' ' A' ' 79' ' ' TYR . 14.7 mt -123.24 148.86 45.43 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.199 -0.938 . . . . 0.0 110.622 -179.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.685 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -149.5 -168.91 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.408 -0.807 . . . . 0.0 109.419 179.546 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.685 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -136.92 141.52 42.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.13 -0.981 . . . . 0.0 110.873 179.9 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.537 ' CB ' ' HD2' ' A' ' 108' ' ' PRO . 0.8 OUTLIER -91.79 -179.91 1.22 Allowed Pre-proline 0 C--N 1.302 -1.477 0 O-C-N 121.533 -0.729 . . . . 0.0 109.374 179.183 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.537 ' HD2' ' CB ' ' A' ' 107' ' ' SER . 40.7 Cg_endo -66.54 85.09 0.28 Allowed 'Trans proline' 0 C--N 1.303 -1.861 0 O-C-N 123.649 1.342 . . . . 0.0 109.646 179.376 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 108' ' ' PRO . 4.0 p 44.38 37.41 2.01 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.423 -0.798 . . . . 0.0 109.735 -178.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -125.75 38.16 2.33 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 11' ' ' SER . . . 98.11 -138.75 14.07 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 -179.495 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.531 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 3.7 p -149.43 143.38 25.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.279 -1.13 . . . . 0.0 109.835 179.653 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.558 HG12 HG22 ' A' ' 10' ' ' THR . 35.9 mt -91.4 147.9 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.24 -0.912 . . . . 0.0 110.307 -179.74 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.583 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 7.6 mt -134.02 111.62 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.186 -0.946 . . . . 0.0 110.208 -179.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 48.4 tttt -97.08 137.67 35.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.231 -0.918 . . . . 0.0 110.239 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 0.8 OUTLIER -134.44 154.55 51.33 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 0.0 110.376 -179.887 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.473 ' HB ' ' HB3' ' A' ' 101' ' ' GLU . 8.8 m -146.58 158.21 43.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.33 -0.856 . . . . 0.0 110.188 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 99.4 p -151.28 134.96 16.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 110.393 -179.9 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.959 ' CE1' HG23 ' A' ' 4' ' ' THR . 55.4 m-70 -120.78 147.9 44.71 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.287 -0.883 . . . . 0.0 110.384 -179.92 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.931 ' C ' HG23 ' A' ' 2' ' ' VAL . 9.3 m-85 -122.4 118.78 29.2 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.268 -0.895 . . . . 0.0 111.161 -179.445 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.955 ' CE1' HG11 ' A' ' 2' ' ' VAL . 90.0 m-70 -104.12 109.69 21.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.073 -1.017 . . . . 0.0 109.353 178.331 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.552 ' CG2' HG23 ' A' ' 126' ' ' VAL . 0.6 OUTLIER -88.95 136.5 32.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.294 -0.879 . . . . 0.0 110.866 -179.107 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.47 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 25.3 tttt -109.37 129.49 55.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.484 -0.76 . . . . 0.0 110.1 179.545 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.471 ' O ' ' CB ' ' A' ' 125' ' ' ASN . . . 110.44 15.33 11.47 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 9.1 t30 67.82 54.27 0.64 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.265 -1.138 . . . . 0.0 110.33 179.907 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.552 HG23 ' CG2' ' A' ' 122' ' ' THR . 20.3 m -133.4 160.34 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.351 -0.843 . . . . 0.0 109.948 179.744 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -121.3 162.16 20.77 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.225 -0.922 . . . . 0.0 110.576 -179.724 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.681 HG13 HD21 ' A' ' 95' ' ' LEU . 2.9 mp -83.95 173.45 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.393 -0.817 . . . . 0.0 109.96 179.766 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.604 ' N ' HG22 ' A' ' 128' ' ' ILE . 32.4 mttt -108.67 133.79 52.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.413 -0.804 . . . . 0.0 109.894 179.835 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -46.51 -36.26 6.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.183 -0.948 . . . . 0.0 110.198 -179.887 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -63.31 -29.94 71.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 110.09 179.885 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.552 ' CE1' ' O ' ' A' ' 90' ' ' ALA . 14.5 t-160 -78.18 -51.3 10.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 110.222 179.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.784 HG11 ' CE2' ' A' ' 5' ' ' TYR . 43.0 t -64.28 -43.45 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.356 -0.84 . . . . 0.0 110.098 179.882 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 7.1 tptm -67.1 -45.87 75.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 110.154 179.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.439 ' O ' ' HG3' ' A' ' 139' ' ' LYS . . . -62.27 -30.06 70.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.212 -0.93 . . . . 0.0 110.035 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.58 -29.39 69.78 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 83.5 mttt -66.99 -33.9 76.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.213 -1.169 . . . . 0.0 110.077 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -81.7 -29.93 32.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.892 . . . . 0.0 110.104 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.439 ' HG3' ' O ' ' A' ' 135' ' ' ALA . 93.9 mttt -67.29 -41.5 85.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.33 -0.856 . . . . 0.0 110.069 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.16 -41.0 51.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.198 -0.939 . . . . 0.0 110.065 179.847 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 137' ' ' LYS . 48.8 m -56.99 -48.17 79.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.453 -0.78 . . . . 0.0 110.031 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -55.52 -42.33 74.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.185 -0.947 . . . . 0.0 110.095 179.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.436 ' O ' HG13 ' A' ' 147' ' ' ILE . 61.4 mt -61.52 -40.77 95.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 109.976 179.869 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -60.56 -37.77 82.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.407 -0.808 . . . . 0.0 109.878 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.431 ' HA ' ' OE1' ' A' ' 148' ' ' GLU . 87.8 mttt -71.67 -17.5 62.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.317 -0.864 . . . . 0.0 110.039 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.542 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 34.4 mt -84.11 -35.92 23.34 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.281 -0.887 . . . . 0.0 108.967 179.386 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.96 ' CG2' HD23 ' A' ' 18' ' ' LEU . 53.4 mt -72.27 -42.46 65.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 119.678 -0.809 . . . . 0.0 108.836 178.735 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.753 ' HB3' HD13 ' A' ' 13' ' ' ILE . 69.4 mt-10 -56.18 -39.11 71.89 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.479 -0.763 . . . . 0.0 109.409 179.03 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.5 m -73.99 -24.43 59.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.944 . . . . 0.0 109.617 179.415 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.648 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 80.3 t80 -64.68 -49.3 71.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.383 -0.823 . . . . 0.0 110.083 179.822 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.12 HD21 ' CE2' ' A' ' 158' ' ' TYR . 84.8 mt -79.94 -29.34 39.67 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.225 -0.922 . . . . 0.0 110.059 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.683 ' HB2' HD11 ' A' ' 13' ' ' ILE . 78.3 tttt -70.21 -27.14 64.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.33 -0.856 . . . . 0.0 109.594 179.523 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.483 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -104.04 -33.27 4.07 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.718 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.577 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 5.4 m-70 -107.12 92.34 7.72 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.354 -1.086 . . . . 0.0 109.982 179.734 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 48.4 Cg_endo -74.23 6.35 3.1 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.04 1.547 . . . . 0.0 111.075 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -107.06 -4.94 18.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.999 -1.063 . . . . 0.0 109.756 179.772 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.67 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -75.18 102.44 4.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.411 -0.806 . . . . 0.0 110.019 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 1.12 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.4 OUTLIER 34.86 32.18 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.69 -0.631 . . . . 0.0 110.572 -179.521 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.565 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.71 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 1.043 HG23 ' C ' ' A' ' 120' ' ' TYR . 3.0 p -82.86 153.84 3.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.253 -1.145 . . . . 0.0 110.122 -179.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.791 ' CE1' HD12 ' A' ' 128' ' ' ILE . 8.4 m-85 -89.23 170.16 10.83 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.329 -0.857 . . . . 0.0 110.014 -179.658 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.815 HG23 ' CE1' ' A' ' 119' ' ' HIS . 50.0 m -137.76 107.56 6.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.111 -0.993 . . . . 0.0 110.364 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 1.185 ' CE1' HG21 ' A' ' 133' ' ' VAL . 47.7 m-85 -112.21 136.67 51.34 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.182 -0.949 . . . . 0.0 110.109 179.804 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 20.8 pt-20 -129.84 152.1 49.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.222 -0.924 . . . . 0.0 110.537 -179.794 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.3 t -139.28 156.22 47.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.401 -0.812 . . . . 0.0 109.902 179.791 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -147.62 124.37 11.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.154 -0.966 . . . . 0.0 110.391 -179.873 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.637 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.3 p90 -151.6 -176.38 5.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.388 -0.82 . . . . 0.0 109.892 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.849 HG22 ' HA ' ' A' ' 113' ' ' ILE . 8.8 p -141.74 174.41 10.6 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.114 -0.991 . . . . 0.0 110.661 -179.642 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.5 t -153.08 159.08 42.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.428 -0.795 . . . . 0.0 110.155 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -81.94 -20.48 38.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.234 -0.916 . . . . 0.0 110.237 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.834 HG23 ' HD2' ' A' ' 14' ' ' PRO . 8.1 mm -80.11 150.68 71.88 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.334 -0.854 . . . . 0.0 109.98 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.834 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.0 Cg_endo -65.55 143.09 74.07 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.073 1.565 . . . . 0.0 110.789 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.666 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 41.5 Cg_endo -73.34 -30.69 9.99 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 124.109 1.584 . . . . 0.0 113.066 -179.501 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.666 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.3 Cg_endo -69.9 -23.38 30.23 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 O-C-N 122.471 0.722 . . . . 0.0 110.228 -179.899 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.579 ' NH2' ' HA ' ' A' ' 159' ' ' ASN . 2.1 mtp180 -85.16 -43.48 13.8 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.108 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.749 ' C ' HD23 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -69.89 -30.27 67.66 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.845 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.54 ' N ' HD23 ' A' ' 18' ' ' LEU . 50.7 t80 -68.58 -53.7 21.23 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.393 -0.817 . . . . 0.0 109.549 179.126 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.55 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 10.8 mttt -53.41 -33.86 55.54 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.681 -0.807 . . . . 0.0 109.181 179.568 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.063 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -76.4 -53.65 7.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.485 -0.759 . . . . 0.0 111.158 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 1.072 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -60.0 -46.08 90.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.501 -0.749 . . . . 0.0 111.922 -178.429 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.642 HG13 ' CE1' ' A' ' 81' ' ' TYR . 3.3 t -100.88 -60.6 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.886 -1.134 . . . . 0.0 111.847 -178.665 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.614 HD12 ' N ' ' A' ' 24' ' ' LEU . 6.8 mp -67.96 -5.36 16.68 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.172 -0.955 . . . . 0.0 111.647 -178.494 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.68 ' HB3' HD23 ' A' ' 29' ' ' LEU . 1.1 m-20 -149.04 30.14 0.79 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.669 -1.269 . . . . 0.0 110.946 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 1.072 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -70.05 -23.88 63.17 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.21 -0.931 . . . . 0.0 110.675 179.798 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -69.68 -17.52 63.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.08 -1.013 . . . . 0.0 109.774 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.533 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 7.1 p30 -129.42 13.28 6.03 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.375 -0.828 . . . . 0.0 109.774 179.597 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.695 HD21 ' CZ ' ' A' ' 158' ' ' TYR . 0.3 OUTLIER -94.37 -49.16 5.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.437 -0.789 . . . . 0.0 110.138 179.812 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.974 HG21 HD13 ' A' ' 38' ' ' ILE . 5.8 p -73.2 -28.87 1.01 Allowed Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.141 -0.974 . . . . 0.0 112.051 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.848 ' HD3' HG12 ' A' ' 30' ' ' VAL . 52.1 Cg_endo -79.56 1.21 9.39 Favored 'Trans proline' 0 C--N 1.319 -1.019 0 O-C-N 122.717 0.851 . . . . 0.0 110.263 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.437 ' HD2' ' O ' ' A' ' 28' ' ' ASN . 51.8 mttm -124.68 -30.0 3.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.292 -0.88 . . . . 0.0 109.869 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.617 HD11 ' CD1' ' A' ' 29' ' ' LEU . 10.8 mt -77.57 -39.14 26.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.482 -0.761 . . . . 0.0 109.76 179.822 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -170.24 102.27 0.44 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.417 -0.802 . . . . 0.0 110.14 179.871 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.78 1.2 7.27 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.066 1.561 . . . . 0.0 110.647 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -87.27 -8.64 56.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.099 -1.0 . . . . 0.0 110.039 179.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.31 -51.02 3.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.312 -0.868 . . . . 0.0 110.308 -179.929 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.974 HD13 HG21 ' A' ' 30' ' ' VAL . 1.1 mp -127.11 138.87 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.426 -0.796 . . . . 0.0 110.11 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.43 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 37.7 ttmt -73.85 -40.53 63.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.318 -0.864 . . . . 0.0 110.098 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.534 ' C ' ' CD2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -178.49 156.11 0.9 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.336 -0.852 . . . . 0.0 110.252 179.752 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.4 m -120.0 119.93 34.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.23 -0.919 . . . . 0.0 109.996 179.889 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.518 ' O ' HD12 ' A' ' 44' ' ' LEU . 35.0 tp10 -124.25 114.39 19.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.289 -0.882 . . . . 0.0 110.387 -179.923 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.467 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 21.4 mt -60.04 145.03 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.189 -0.945 . . . . 0.0 110.069 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.518 HD12 ' O ' ' A' ' 42' ' ' GLU . 4.8 mp -121.77 -27.29 4.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.224 -0.923 . . . . 0.0 110.328 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.627 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.6 m95 -123.78 163.19 21.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.272 -0.893 . . . . 0.0 110.482 -179.833 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.431 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 43.12 -138.37 3.39 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.81 23.52 0.51 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.309 -1.112 . . . . 0.0 109.994 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 121.73 -13.9 9.23 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.481 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -81.54 -169.61 42.65 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.85 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.436 ' HA ' HG22 ' A' ' 71' ' ' ILE . 45.0 Cg_endo -72.79 129.5 14.53 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 124.086 1.572 . . . . 0.0 110.557 -179.905 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.49 -12.95 51.16 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 -179.569 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.544 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -71.52 161.3 31.24 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.589 -0.948 . . . . 0.0 109.374 179.635 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.627 HD12 ' CG ' ' A' ' 45' ' ' TRP . 58.3 mt -134.29 120.37 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.242 -0.911 . . . . 0.0 109.971 179.683 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 96.0 mttt -107.3 128.95 54.91 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.164 -0.96 . . . . 0.0 110.56 -179.595 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -93.01 91.38 7.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -0.881 . . . . 0.0 109.768 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.555 ' CG2' HG12 ' A' ' 38' ' ' ILE . 96.7 mt -80.02 144.11 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.2 -0.937 . . . . 0.0 110.212 -179.753 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.515 ' O ' HG23 ' A' ' 38' ' ' ILE . 7.2 p -117.62 163.73 16.01 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.201 -0.937 . . . . 0.0 110.744 -179.649 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.568 ' HE2' HG13 ' A' ' 67' ' ' VAL . 28.6 m-85 -122.4 141.38 51.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.323 -0.861 . . . . 0.0 110.118 179.283 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.343 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.953 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.181 0.515 . . . . 0.0 110.303 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -138.67 102.27 0.35 Allowed Glycine 0 N--CA 1.487 2.096 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 179.669 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.543 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 13.9 p90 -143.44 166.7 24.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.218 -1.166 . . . . 0.0 110.175 -179.685 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.885 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.1 m -139.35 174.13 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.354 -0.841 . . . . 0.0 110.618 179.78 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.517 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 20.1 mttt -125.56 122.04 35.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.529 -0.732 . . . . 0.0 109.642 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.573 ' NE2' HD13 ' A' ' 85' ' ' LEU . 10.8 m170 -108.56 123.75 49.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.179 -0.951 . . . . 0.0 110.854 -179.436 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 52' ' ' THR . 18.9 tttm -97.65 116.09 29.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.258 -0.901 . . . . 0.0 109.79 179.428 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.523 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 23.6 mm -58.04 132.43 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.994 -1.066 . . . . 0.0 110.365 -179.563 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 82' ' ' SER . 94.1 m-20 -105.34 -42.76 5.16 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.372 -0.83 . . . . 0.0 109.889 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.2 m -175.09 159.67 2.63 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.389 -0.82 . . . . 0.0 109.948 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.492 HG12 HG11 ' A' ' 23' ' ' VAL . 2.2 mt -138.62 159.84 30.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.193 -0.942 . . . . 0.0 110.209 179.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 79' ' ' TYR . 5.6 m-20 -137.58 80.56 1.81 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.489 -0.757 . . . . 0.0 110.392 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.433 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 22.3 tttt -63.28 -18.9 64.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.133 -0.979 . . . . 0.0 110.259 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -91.6 -32.24 15.58 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.275 -0.89 . . . . 0.0 109.363 179.755 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.503 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -101.25 -4.13 27.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.643 -0.661 . . . . 0.0 109.604 179.619 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.588 ' CE1' ' HB3' ' A' ' 16' ' ' PRO . 85.2 m-85 60.43 55.44 3.49 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.454 0.645 . . . . 0.0 110.581 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.487 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -129.93 165.61 21.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.434 -0.791 . . . . 0.0 109.876 179.495 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.696 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 42.6 t80 -149.71 143.79 25.68 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.219 -0.925 . . . . 0.0 109.903 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.464 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 25.9 m -148.76 131.45 15.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.122 -0.986 . . . . 0.0 111.223 -179.724 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.696 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 9.1 p90 -144.36 175.66 9.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.35 -0.844 . . . . 0.0 110.064 179.041 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 98' ' ' ILE . 27.1 m -127.25 128.42 45.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.348 -0.845 . . . . 0.0 109.824 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.573 HD13 ' NE2' ' A' ' 69' ' ' HIS . 7.4 tp -95.39 125.31 39.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.093 -1.004 . . . . 0.0 110.077 -179.85 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.6 pt -109.79 -12.65 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.244 -0.91 . . . . 0.0 110.333 -179.565 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.566 ' O ' HD11 ' A' ' 91' ' ' LEU . 18.0 tt0 -124.64 172.84 8.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 0.0 110.191 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.885 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 137.58 112.08 1.09 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.984 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -56.42 -16.83 6.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.319 -1.106 . . . . 0.0 110.205 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.63 -17.71 57.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 0.0 110.146 179.87 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.566 HD11 ' O ' ' A' ' 87' ' ' GLU . 65.7 mt -66.78 -23.82 66.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.284 -0.885 . . . . 0.0 110.209 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 50.56 -179.69 0.03 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -79.96 6.45 11.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.303 -1.116 . . . . 0.0 110.206 179.897 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.498 ' O ' HG21 ' A' ' 126' ' ' VAL . 39.4 p -94.36 -31.55 13.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.236 -0.915 . . . . 0.0 110.238 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.86 HD21 HD11 ' A' ' 128' ' ' ILE . 83.6 mt -107.29 163.93 12.61 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.351 -0.843 . . . . 0.0 110.092 179.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.466 ' HG2' ' N ' ' A' ' 97' ' ' LYS . 61.4 tt0 -144.77 -82.85 0.15 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.299 -0.876 . . . . 0.0 109.668 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.495 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 18.7 mttt -80.37 131.57 35.64 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.778 -0.576 . . . . 0.0 110.343 179.683 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.791 HG21 ' CE2' ' A' ' 100' ' ' TYR . 4.7 mm -119.53 138.67 49.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 120.845 -1.16 . . . . 0.0 109.63 178.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.476 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.3 m -118.85 123.27 44.31 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 119.711 -0.795 . . . . 0.0 108.985 178.786 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.791 ' CE2' HG21 ' A' ' 98' ' ' ILE . 13.0 m-85 -119.27 132.61 55.93 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.39 -0.819 . . . . 0.0 110.322 -179.076 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.467 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 85.1 tt0 -132.07 140.26 48.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.263 -0.898 . . . . 0.0 110.061 179.788 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.468 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 32.6 m -133.01 153.95 50.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.924 . . . . 0.0 109.929 179.939 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.477 ' O ' ' N ' ' A' ' 115' ' ' LYS . 7.7 mttt -149.66 133.05 16.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.143 -0.973 . . . . 0.0 110.456 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.87 HD23 HG12 ' A' ' 114' ' ' ILE . 3.5 mt -115.42 152.49 32.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.196 -0.94 . . . . 0.0 110.03 179.812 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.696 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.8 t -151.38 -169.52 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.227 -0.921 . . . . 0.0 110.185 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.696 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -124.52 145.64 49.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.35 -0.844 . . . . 0.0 110.305 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.443 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.3 p -103.8 171.12 5.39 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.281 -0.887 . . . . 0.0 110.2 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.443 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 45.7 Cg_endo -72.54 -13.79 27.53 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.074 1.565 . . . . 0.0 110.585 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 67.8 m -95.84 11.64 32.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.188 -0.945 . . . . 0.0 110.354 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 91.34 -34.93 4.1 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.847 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -55.18 -172.07 0.08 OUTLIER Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.785 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.52 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 1.4 p -134.98 134.19 40.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.124 -1.221 . . . . 0.0 110.387 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.849 ' HA ' HG22 ' A' ' 10' ' ' THR . 15.4 mt -85.74 147.12 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.37 -0.831 . . . . 0.0 109.91 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.87 HG12 HD23 ' A' ' 104' ' ' LEU . 19.4 mt -131.1 110.8 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.166 -0.959 . . . . 0.0 110.407 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 103' ' ' LYS . 63.3 tttm -97.93 134.87 40.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.191 -0.943 . . . . 0.0 109.683 179.444 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.67 147.99 51.51 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.219 -0.926 . . . . 0.0 110.354 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' A' ' 101' ' ' GLU . 32.9 m -148.54 148.06 29.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.4 -0.812 . . . . 0.0 110.292 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 88.5 p -148.36 155.08 40.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.29 -0.881 . . . . 0.0 110.136 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.815 ' CE1' HG23 ' A' ' 4' ' ' THR . 34.1 m-70 -139.14 129.81 26.0 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.168 -0.958 . . . . 0.0 110.373 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 1.043 ' C ' HG23 ' A' ' 2' ' ' VAL . 3.6 m-30 -99.56 120.58 39.88 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.279 -0.888 . . . . 0.0 110.599 -179.555 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.565 ' CE1' HG21 ' A' ' 2' ' ' VAL . 82.4 m-70 -95.51 107.56 19.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.196 -0.94 . . . . 0.0 109.674 179.074 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.6 p -77.81 157.39 29.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.917 . . . . 0.0 110.174 -179.854 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 37.6 tttt -114.46 114.0 25.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.193 -0.942 . . . . 0.0 110.237 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 93.26 -132.7 11.35 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -115.72 77.19 1.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.215 -1.168 . . . . 0.0 110.147 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.498 HG21 ' O ' ' A' ' 94' ' ' THR . 32.8 m -142.02 154.39 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.178 -0.951 . . . . 0.0 110.242 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -132.05 164.22 26.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.234 -0.916 . . . . 0.0 110.214 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.86 HD11 HD21 ' A' ' 95' ' ' LEU . 3.2 mp -92.05 171.83 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.154 -0.966 . . . . 0.0 110.375 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.623 ' N ' HG22 ' A' ' 128' ' ' ILE . 60.8 mmtt -113.71 129.98 56.49 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.481 -0.762 . . . . 0.0 109.768 179.742 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.505 ' O ' ' CB ' ' A' ' 134' ' ' LYS . 92.4 mt-10 -43.24 -50.63 6.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.134 -0.979 . . . . 0.0 110.026 -179.841 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -48.28 -23.53 0.92 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.208 -0.933 . . . . 0.0 109.892 179.702 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -87.49 -64.66 1.11 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.302 -0.874 . . . . 0.0 110.322 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 1.185 HG21 ' CE1' ' A' ' 5' ' ' TYR . 2.4 p -65.75 -28.48 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.394 -0.817 . . . . 0.0 110.086 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.505 ' CB ' ' O ' ' A' ' 130' ' ' GLU . 13.6 tptt -72.64 -48.79 36.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.163 -0.961 . . . . 0.0 109.937 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.62 -25.11 67.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.328 -0.858 . . . . 0.0 110.065 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.17 -31.34 69.15 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -64.92 -32.72 74.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.264 -1.139 . . . . 0.0 110.106 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -79.67 -40.24 29.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.334 -0.854 . . . . 0.0 110.005 179.81 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -69.71 -34.27 73.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.304 -0.873 . . . . 0.0 109.87 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.01 -35.39 66.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.323 -0.861 . . . . 0.0 109.885 179.718 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 48.0 m -66.48 -42.95 86.69 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.276 -0.89 . . . . 0.0 109.939 179.701 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -56.36 -48.96 75.77 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.273 -0.892 . . . . 0.0 109.932 179.81 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.611 HD13 ' O ' ' A' ' 143' ' ' LEU . 0.6 OUTLIER -55.8 -44.25 77.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.346 -0.846 . . . . 0.0 109.866 179.817 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.519 ' HA ' HD12 ' A' ' 147' ' ' ILE . 13.7 m-85 -55.81 -39.68 71.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.431 -0.793 . . . . 0.0 109.834 179.715 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.452 ' HA ' ' OE1' ' A' ' 148' ' ' GLU . 95.8 mttt -73.21 -12.46 60.88 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.405 -0.81 . . . . 0.0 110.229 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.481 HD12 HD22 ' A' ' 143' ' ' LEU . 16.3 mt -83.77 -36.02 23.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.16 -0.962 . . . . 0.0 108.989 179.396 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.623 HD11 ' CE1' ' A' ' 22' ' ' PHE . 19.9 mt -69.66 -45.51 77.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.491 ' O ' HG13 ' A' ' 13' ' ' ILE . 38.8 mt-10 -58.98 -43.12 91.33 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.702 -0.799 . . . . 0.0 109.471 179.113 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 17.9 m -66.26 -24.49 66.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.291 -0.88 . . . . 0.0 109.564 179.453 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.602 ' CD1' HG12 ' A' ' 33' ' ' ILE . 81.8 t80 -67.02 -46.99 72.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.508 -0.745 . . . . 0.0 109.952 179.794 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.171 HD21 ' CE2' ' A' ' 158' ' ' TYR . 68.4 mt -79.74 -30.22 40.8 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.141 -0.975 . . . . 0.0 110.006 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.538 ' HB2' ' CG1' ' A' ' 13' ' ' ILE . 21.0 tttm -71.23 -25.83 62.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.899 . . . . 0.0 109.289 179.062 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.422 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -102.9 -33.51 4.34 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.119 -1.593 . . . . 0.0 109.119 179.543 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.58 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 5.4 m-70 -108.61 92.76 10.69 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.277 -1.131 . . . . 0.0 109.933 179.692 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 46.9 Cg_endo -74.01 6.23 3.07 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.033 1.544 . . . . 0.0 111.168 -179.864 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -108.71 0.09 20.34 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.965 -1.084 . . . . 0.0 109.937 179.782 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.68 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -83.13 102.14 11.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.303 -0.873 . . . . 0.0 110.048 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 1.171 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.3 OUTLIER 35.67 31.27 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.725 -0.609 . . . . 0.0 110.184 -179.377 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.579 ' HA ' ' NH2' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.714 -179.723 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.997 HG23 ' C ' ' A' ' 120' ' ' TYR . 3.0 p -79.98 150.87 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.375 -1.073 . . . . 0.0 110.503 -179.795 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.517 ' CE2' HG12 ' A' ' 128' ' ' ILE . 3.9 m-85 -87.75 175.41 7.87 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.446 -0.784 . . . . 0.0 110.025 -179.87 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.881 HG23 ' CE1' ' A' ' 119' ' ' HIS . 44.8 m -147.56 101.97 3.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.115 -0.991 . . . . 0.0 110.463 179.899 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.427 ' CD1' HG13 ' A' ' 133' ' ' VAL . 88.0 m-85 -112.67 127.19 56.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.293 -0.879 . . . . 0.0 109.976 179.811 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.584 ' CG ' ' N ' ' A' ' 7' ' ' SER . 17.2 tt0 -110.66 175.48 5.41 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.265 -0.897 . . . . 0.0 109.95 -179.544 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.584 ' N ' ' CG ' ' A' ' 6' ' ' GLU . 0.2 OUTLIER -156.71 166.76 32.48 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.716 -0.615 . . . . 0.0 109.634 179.756 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.421 ' HG3' ' HG3' ' A' ' 115' ' ' LYS . 1.4 tt0 -156.53 132.3 9.59 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.983 -1.073 . . . . 0.0 110.955 -179.849 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.625 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 2.9 p90 -155.9 -175.82 5.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.505 -0.747 . . . . 0.0 109.581 179.43 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.511 HG22 ' HA ' ' A' ' 113' ' ' ILE . 23.4 p -134.7 179.23 6.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.019 -1.051 . . . . 0.0 110.887 -179.559 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.654 ' OG ' HD11 ' A' ' 114' ' ' ILE . 87.7 p -159.99 139.08 10.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.572 -0.705 . . . . 0.0 110.06 179.76 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -67.15 -29.85 69.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.129 -0.982 . . . . 0.0 110.287 -179.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 1.026 HD13 ' HB3' ' A' ' 148' ' ' GLU . 1.8 mp -71.7 151.8 93.47 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.291 -0.881 . . . . 0.0 109.793 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.825 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.3 Cg_endo -66.44 141.63 62.33 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 124.072 1.564 . . . . 0.0 110.522 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.633 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.9 Cg_endo -73.23 -30.4 10.49 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 124.092 1.575 . . . . 0.0 113.085 -179.256 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.6 Cg_endo -71.79 -21.65 24.7 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 N-CA-C 110.178 -0.739 . . . . 0.0 110.178 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.484 ' HD3' ' CG ' ' A' ' 14' ' ' PRO . 44.8 mtp180 -84.77 -46.04 11.78 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.084 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.771 ' C ' HD23 ' A' ' 18' ' ' LEU . 1.1 tt -67.81 -29.99 69.3 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.755 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.489 ' N ' HD23 ' A' ' 18' ' ' LEU . 76.3 t80 -66.84 -57.13 7.61 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.459 -0.776 . . . . 0.0 109.3 178.748 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.554 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 9.8 mttp -48.76 -36.74 17.17 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.266 179.441 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.046 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -74.69 -43.2 56.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.427 -0.795 . . . . 0.0 110.779 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.983 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -68.45 -48.24 65.06 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.521 -0.737 . . . . 0.0 111.672 -178.45 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.62 HG13 ' CE1' ' A' ' 81' ' ' TYR . 3.5 t -100.3 -51.87 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.835 -1.166 . . . . 0.0 111.603 -178.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.725 HD12 ' N ' ' A' ' 24' ' ' LEU . 7.2 mp -77.79 0.02 25.32 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.116 -0.99 . . . . 0.0 111.265 -179.015 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.597 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -154.15 30.92 0.44 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.97 -1.081 . . . . 0.0 110.515 179.881 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.983 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -67.33 -29.57 69.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.233 -0.917 . . . . 0.0 109.999 179.778 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -69.26 -15.6 63.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 0.0 110.069 179.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.482 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 78.8 m-20 -125.86 9.81 7.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -0.904 . . . . 0.0 110.196 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.798 HD21 ' CZ ' ' A' ' 158' ' ' TYR . 0.5 OUTLIER -100.34 -48.8 4.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.907 . . . . 0.0 110.245 179.906 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 1.128 HG11 HD13 ' A' ' 38' ' ' ILE . 2.9 t -74.46 -42.15 5.07 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.43 -0.793 . . . . 0.0 110.974 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 47.7 Cg_endo -78.15 9.01 3.24 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.499 1.263 . . . . 0.0 110.626 -179.919 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 28' ' ' ASN . 33.7 mttt -127.11 -37.27 2.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.185 -0.947 . . . . 0.0 109.464 179.678 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.54 HG12 ' CD1' ' A' ' 150' ' ' TYR . 6.8 mt -80.04 -39.44 19.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.537 -0.727 . . . . 0.0 109.562 179.536 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.422 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . . . -155.12 100.33 2.31 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.378 -0.827 . . . . 0.0 110.189 179.819 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 34' ' ' ALA . 46.3 Cg_endo -72.21 -0.85 9.22 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.978 1.515 . . . . 0.0 110.632 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -84.47 -8.0 59.09 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.102 -0.999 . . . . 0.0 109.816 179.75 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.662 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -98.24 -63.4 1.13 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.303 -0.873 . . . . 0.0 110.234 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 1.128 HD13 HG11 ' A' ' 30' ' ' VAL . 2.0 mp -115.56 137.56 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.378 -0.826 . . . . 0.0 110.191 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 57' ' ' THR . 13.7 ttpt -84.66 -19.2 33.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.381 -0.824 . . . . 0.0 110.207 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.545 ' C ' ' CD2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER 178.69 159.85 0.59 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.204 -0.935 . . . . 0.0 109.962 -179.961 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -135.4 126.13 27.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.366 -0.834 . . . . 0.0 109.936 179.798 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.462 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 36.9 tt0 -139.92 113.42 8.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.234 -0.916 . . . . 0.0 110.55 -179.826 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.4 mt -53.87 142.22 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.262 -0.899 . . . . 0.0 109.861 179.535 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.607 HD23 ' CB ' ' A' ' 55' ' ' LYS . 0.4 OUTLIER -114.64 -30.05 6.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.107 -0.996 . . . . 0.0 110.455 -179.862 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.876 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.7 m95 -126.48 164.97 19.99 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.261 -0.899 . . . . 0.0 110.416 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.445 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 41.78 -135.65 3.19 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.745 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.11 22.68 0.5 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.28 -1.13 . . . . 0.0 110.093 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 121.59 -19.14 8.57 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.475 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -71.82 -171.57 15.2 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.416 ' HA ' HG22 ' A' ' 71' ' ' ILE . 45.9 Cg_endo -73.19 129.11 13.65 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 123.939 1.494 . . . . 0.0 110.478 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.74 -14.0 53.35 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.499 -1.84 . . . . 0.0 108.499 -179.392 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.548 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -70.48 160.96 31.45 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.613 -0.933 . . . . 0.0 109.381 179.536 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.876 HD12 ' CG ' ' A' ' 45' ' ' TRP . 57.6 mt -128.99 119.54 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.221 -0.924 . . . . 0.0 110.059 179.782 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.926 ' HE3' HD11 ' A' ' 71' ' ' ILE . 20.6 mttm -101.2 129.82 47.19 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.292 -0.88 . . . . 0.0 110.134 -179.892 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.607 ' CB ' HD23 ' A' ' 44' ' ' LEU . 34.7 ttpt -100.79 91.84 4.8 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.21 -0.931 . . . . 0.0 110.155 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.474 ' HB ' HG23 ' A' ' 67' ' ' VAL . 88.8 mt -80.07 144.16 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.894 . . . . 0.0 110.208 -179.948 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.522 ' H ' ' HG1' ' A' ' 57' ' ' THR . 1.0 OUTLIER -113.87 150.97 32.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.312 -0.867 . . . . 0.0 110.303 -179.997 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.609 ' HE2' HG13 ' A' ' 67' ' ' VAL . 20.8 m-85 -115.47 147.55 40.48 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.269 -0.894 . . . . 0.0 110.142 179.744 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.887 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.208 0.528 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.577 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -131.8 84.88 0.3 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.533 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 11.7 p90 -128.12 163.17 25.22 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.23 -1.159 . . . . 0.0 110.262 -179.658 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.627 HG12 ' CA ' ' A' ' 88' ' ' GLY . 5.3 m -136.08 175.66 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.369 -0.832 . . . . 0.0 110.251 179.496 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.711 ' O ' HD12 ' A' ' 85' ' ' LEU . 26.8 mttm -135.56 104.87 5.97 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.382 -0.824 . . . . 0.0 109.829 179.754 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.994 ' CD2' HD13 ' A' ' 85' ' ' LEU . 14.2 m170 -95.6 130.08 42.58 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.301 -0.874 . . . . 0.0 111.121 -179.317 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 52' ' ' THR . 31.6 tttt -96.88 113.91 25.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.332 -0.855 . . . . 0.0 109.331 179.034 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.926 HD11 ' HE3' ' A' ' 54' ' ' LYS . 28.9 mm -53.52 131.11 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.197 -0.939 . . . . 0.0 110.313 -179.421 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 82' ' ' SER . 86.1 m-20 -106.09 -46.66 4.03 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.405 -0.809 . . . . 0.0 110.332 -179.799 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 48.0 m -164.94 159.15 17.83 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.324 -0.86 . . . . 0.0 110.039 -179.793 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.468 HG12 HG11 ' A' ' 23' ' ' VAL . 1.7 mt -145.23 157.9 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.189 -0.944 . . . . 0.0 110.655 -179.881 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.559 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 2.2 m-20 -136.93 80.0 1.79 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.611 -0.681 . . . . 0.0 109.938 179.35 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.48 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 44.7 tttt -63.46 -13.27 38.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.189 -0.944 . . . . 0.0 110.431 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -95.79 -30.45 13.69 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.249 -0.907 . . . . 0.0 109.458 179.665 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -106.52 -7.54 17.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.572 -0.705 . . . . 0.0 109.813 -179.956 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.562 ' HB2' ' HB2' ' A' ' 104' ' ' LEU . 2.8 m-85 68.62 51.12 0.64 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.558 -0.714 . . . . 0.0 110.177 -179.695 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.559 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -122.68 149.58 43.85 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.256 -0.903 . . . . 0.0 109.409 179.599 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.69 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 31.5 t80 -137.22 149.14 46.98 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.101 -0.999 . . . . 0.0 110.504 -179.204 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.458 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 75.0 m -154.92 129.0 8.84 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.177 -0.952 . . . . 0.0 110.922 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.69 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 26.1 p90 -148.17 169.5 19.9 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.328 -0.858 . . . . 0.0 110.536 179.318 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.805 HG23 ' O ' ' A' ' 98' ' ' ILE . 18.0 m -124.52 129.85 51.38 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.299 -0.876 . . . . 0.0 110.127 -179.8 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.994 HD13 ' CD2' ' A' ' 69' ' ' HIS . 16.0 tp -96.43 136.78 36.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.945 -1.097 . . . . 0.0 110.34 179.735 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.533 ' H ' HD12 ' A' ' 85' ' ' LEU . 11.4 pt -118.17 -30.87 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.212 -0.93 . . . . 0.0 110.364 -179.44 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.621 ' O ' HD11 ' A' ' 85' ' ' LEU . 64.3 tt0 -114.53 156.26 24.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.276 -0.89 . . . . 0.0 110.159 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.627 ' CA ' HG12 ' A' ' 67' ' ' VAL . . . 152.69 130.89 1.6 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.45 ' N ' ' OD1' ' A' ' 89' ' ' ASP . 36.9 p-10 -60.94 -15.31 29.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -1.138 . . . . 0.0 110.09 179.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.07 -19.94 53.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 110.166 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.473 ' O ' ' HB2' ' A' ' 95' ' ' LEU . 59.1 mt -70.09 -26.96 64.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.92 . . . . 0.0 110.054 179.909 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 44.74 -169.36 0.02 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -87.36 7.33 29.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.247 -1.149 . . . . 0.0 109.911 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.577 ' O ' HG21 ' A' ' 126' ' ' VAL . 30.1 p -98.84 -28.19 13.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.359 -0.838 . . . . 0.0 109.959 179.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 1.012 HD11 ' CD1' ' A' ' 128' ' ' ILE . 41.2 mt -111.91 169.56 8.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.449 -0.782 . . . . 0.0 110.156 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.416 ' HG2' ' C ' ' A' ' 95' ' ' LEU . 66.2 mm-40 -151.2 -81.38 0.1 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.318 -0.864 . . . . 0.0 109.877 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.48 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 19.4 mttt -80.33 133.78 35.98 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.727 -0.608 . . . . 0.0 110.564 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.805 ' O ' HG23 ' A' ' 84' ' ' THR . 6.7 mm -123.44 142.01 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.876 -1.14 . . . . 0.0 109.886 179.07 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.509 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.3 OUTLIER -123.42 134.41 53.96 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.39 -0.819 . . . . 0.0 109.021 178.866 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.664 ' HE2' HG21 ' A' ' 98' ' ' ILE . 7.2 m-85 -129.82 132.3 46.44 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.303 -0.873 . . . . 0.0 110.624 -179.021 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.405 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 70.4 tt0 -136.41 136.08 39.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.401 -0.812 . . . . 0.0 109.884 179.465 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 39.3 m -136.36 139.6 42.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 110.111 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 115' ' ' LYS . 1.1 tttp -134.52 143.24 47.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.241 -0.912 . . . . 0.0 110.502 -179.87 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.608 HD23 HG12 ' A' ' 114' ' ' ILE . 7.2 mt -124.52 151.91 44.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.247 -0.908 . . . . 0.0 109.844 179.587 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.699 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -150.06 -169.76 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.176 -0.953 . . . . 0.0 110.288 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.699 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -125.34 160.74 28.59 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.399 -0.813 . . . . 0.0 110.21 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.452 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 3.1 p -119.16 169.03 8.73 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.197 -0.939 . . . . 0.0 110.282 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 48.3 Cg_endo -73.37 -4.11 14.85 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.069 1.563 . . . . 0.0 110.7 -179.891 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 39.2 p -105.83 9.93 32.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.085 -1.009 . . . . 0.0 110.298 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 111' ' ' GLY . . . 93.38 -37.84 3.3 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.894 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 110' ' ' GLY . . . -54.27 -172.65 0.06 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.523 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 9.0 p -138.79 136.0 35.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.14 -1.212 . . . . 0.0 110.414 179.937 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.511 ' HA ' HG22 ' A' ' 10' ' ' THR . 61.4 mt -87.67 149.03 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.346 -0.846 . . . . 0.0 109.944 179.772 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.654 HD11 ' OG ' ' A' ' 11' ' ' SER . 4.6 mt -131.82 116.12 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.224 -0.922 . . . . 0.0 110.389 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 103' ' ' LYS . 39.5 tttt -100.12 148.29 24.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.374 -0.829 . . . . 0.0 110.011 179.708 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.2 t -145.55 155.39 43.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.184 -0.947 . . . . 0.0 110.388 -179.816 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.526 HG22 ' NE2' ' A' ' 119' ' ' HIS . 25.9 m -157.87 126.19 5.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.444 -0.785 . . . . 0.0 109.888 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 3.6 m -121.66 154.85 36.27 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.126 -0.984 . . . . 0.0 110.296 -179.851 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.881 ' CE1' HG23 ' A' ' 4' ' ' THR . 56.2 m-70 -137.87 147.27 44.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.276 -0.89 . . . . 0.0 110.392 -179.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.997 ' C ' HG23 ' A' ' 2' ' ' VAL . 58.8 m-85 -126.04 121.95 34.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.299 -0.876 . . . . 0.0 110.208 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.691 ' CE1' HG11 ' A' ' 2' ' ' VAL . 70.4 m-70 -95.55 103.95 15.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.277 -0.889 . . . . 0.0 109.956 179.793 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.582 HG23 HD23 ' A' ' 95' ' ' LEU . 0.9 OUTLIER -91.1 142.71 27.46 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.14 -0.975 . . . . 0.0 110.29 -179.792 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.6 tttt -103.73 124.98 49.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.328 -0.858 . . . . 0.0 110.325 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 98.1 -122.51 7.52 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -134.19 67.61 1.51 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.277 -1.131 . . . . 0.0 110.311 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.577 HG21 ' O ' ' A' ' 94' ' ' THR . 31.0 m -131.5 168.11 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 109.932 179.915 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.433 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 89.7 mt-10 -143.93 157.86 44.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.161 -0.962 . . . . 0.0 110.588 -179.828 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 1.012 ' CD1' HD11 ' A' ' 95' ' ' LEU . 20.5 mm -61.47 173.41 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.379 -0.826 . . . . 0.0 110.106 179.736 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.625 ' N ' HG22 ' A' ' 128' ' ' ILE . 22.9 mttt -96.62 130.8 43.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.334 -0.854 . . . . 0.0 109.66 179.456 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 129' ' ' LYS . 95.5 mt-10 -42.06 -42.9 3.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 110.307 -179.708 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.91 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 31.0 tt0 -55.51 -33.91 64.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.912 . . . . 0.0 109.892 179.636 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.519 ' HB3' ' CG2' ' A' ' 128' ' ' ILE . 5.9 t-160 -75.49 -56.77 4.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.275 -0.891 . . . . 0.0 110.431 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.517 HG23 ' CG2' ' A' ' 128' ' ' ILE . 86.7 t -60.82 -33.03 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.326 -0.858 . . . . 0.0 110.394 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 38.6 mttp -104.04 -71.17 0.74 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.148 -0.97 . . . . 0.0 110.499 -179.688 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.91 ' HB3' ' O ' ' A' ' 131' ' ' GLU . . . -55.93 -19.28 11.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.081 -1.012 . . . . 0.0 109.867 -179.883 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' A' ' 132' ' ' HIS . . . -76.71 -29.85 57.02 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.819 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 46.4 mttt -68.13 -32.36 72.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.269 -1.136 . . . . 0.0 110.222 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -79.06 -34.21 43.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 110.027 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -66.35 -39.07 88.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.33 -0.856 . . . . 0.0 110.002 179.864 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.87 -42.92 60.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.411 -0.806 . . . . 0.0 110.032 179.76 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 144' ' ' PHE . 23.0 t -54.55 -43.11 71.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.323 -0.861 . . . . 0.0 109.905 179.765 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -57.43 -44.82 84.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.349 -0.845 . . . . 0.0 109.919 179.702 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 46.5 mt -58.53 -38.08 77.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.285 -0.884 . . . . 0.0 109.836 179.713 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.4 ' HB2' ' O ' ' A' ' 141' ' ' SER . 16.2 m-85 -62.26 -33.94 75.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.425 -0.797 . . . . 0.0 109.705 179.543 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -72.94 -15.46 61.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.327 -0.858 . . . . 0.0 109.855 179.756 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.498 ' HA ' HD23 ' A' ' 146' ' ' LEU . 14.0 mt -82.34 -37.15 26.13 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.258 -0.901 . . . . 0.0 108.721 179.203 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.729 HD11 ' CE1' ' A' ' 22' ' ' PHE . 19.1 mt -68.69 -47.35 77.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.751 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 1.026 ' HB3' HD13 ' A' ' 13' ' ' ILE . 88.8 mt-10 -56.18 -43.86 78.82 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.498 -0.751 . . . . 0.0 109.466 179.037 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 42.8 m -65.2 -34.34 78.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.159 -0.963 . . . . 0.0 109.37 179.329 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.596 ' CE2' ' OH ' ' A' ' 158' ' ' TYR . 81.3 t80 -59.15 -47.61 84.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.562 -0.711 . . . . 0.0 109.581 179.341 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.915 HD21 ' CE2' ' A' ' 158' ' ' TYR . 32.8 mt -80.08 -33.37 38.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 110.222 179.655 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.87 ' HB2' HD11 ' A' ' 13' ' ' ILE . 27.4 tttt -60.09 -23.21 63.62 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.228 -0.92 . . . . 0.0 109.257 179.364 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.5 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -109.69 -30.5 3.49 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.607 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 5.4 m-70 -105.68 92.22 5.88 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.28 -1.13 . . . . 0.0 110.084 179.817 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 46.3 Cg_endo -72.18 2.93 4.43 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.009 1.531 . . . . 0.0 111.069 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -113.57 -11.5 13.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.067 -1.02 . . . . 0.0 109.764 179.729 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.664 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -46.84 102.31 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.412 -0.805 . . . . 0.0 109.688 179.615 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 1.046 ' CE2' ' HB2' ' A' ' 21' ' ' ALA . 0.0 OUTLIER 58.71 -59.12 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.458 0 CA-C-O 121.592 0.71 . . . . 0.0 110.543 -179.33 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.589 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--N 1.293 -1.874 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.169 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 58.5 t -122.31 137.12 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.201 -1.176 . . . . 0.0 110.319 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.66 ' CG ' HD13 ' A' ' 128' ' ' ILE . 11.6 m-85 -95.71 146.88 24.17 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.318 -0.864 . . . . 0.0 109.967 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.814 HG23 ' CE1' ' A' ' 119' ' ' HIS . 7.3 m -127.35 117.26 21.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.179 -0.95 . . . . 0.0 110.597 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.085 ' CE2' HG21 ' A' ' 133' ' ' VAL . 67.1 m-85 -129.74 132.86 46.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.381 -0.825 . . . . 0.0 109.655 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 23.1 pt-20 -130.22 153.53 48.49 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.146 -0.971 . . . . 0.0 110.703 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.472 ' O ' ' CG ' ' A' ' 8' ' ' GLU . 5.9 t -131.79 165.93 22.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.459 -0.776 . . . . 0.0 109.574 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.472 ' CG ' ' O ' ' A' ' 7' ' ' SER . 87.5 mt-10 -154.12 121.97 5.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.088 -1.007 . . . . 0.0 110.706 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.618 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.2 p90 -149.53 -178.31 6.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.355 -0.841 . . . . 0.0 109.625 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.864 HG22 ' HA ' ' A' ' 113' ' ' ILE . 8.6 p -142.37 174.57 10.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.196 -0.94 . . . . 0.0 110.651 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.484 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 4.7 t -159.79 162.19 34.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.461 -0.774 . . . . 0.0 110.125 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -83.48 -20.28 34.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.217 -0.927 . . . . 0.0 110.187 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.832 HD11 ' HB2' ' A' ' 152' ' ' LYS . 2.9 mp -74.08 149.66 87.45 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.317 -0.865 . . . . 0.0 110.072 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.804 ' HD2' HG23 ' A' ' 13' ' ' ILE . 41.3 Cg_endo -67.59 142.23 58.08 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.055 1.555 . . . . 0.0 110.473 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.656 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.2 Cg_endo -72.44 -30.95 11.88 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 124.013 1.533 . . . . 0.0 112.804 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.656 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.7 Cg_endo -70.4 -23.79 27.47 Favored 'Trans proline' 0 C--N 1.319 -0.983 0 N-CA-C 110.115 -0.764 . . . . 0.0 110.115 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.801 HH21 ' HB3' ' A' ' 157' ' ' ALA . 58.5 mtp180 -82.24 -44.11 16.75 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.22 -0.925 . . . . 0.0 108.662 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 1.057 HD23 ' CG2' ' A' ' 147' ' ' ILE . 0.2 OUTLIER -70.85 -31.4 68.09 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.04 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.626 ' N ' HD13 ' A' ' 18' ' ' LEU . 70.4 t80 -63.69 -58.82 5.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.478 -0.764 . . . . 0.0 109.509 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.525 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 75.1 mttt -50.23 -41.24 49.64 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.42 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.129 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -70.55 -36.25 73.57 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.406 -0.809 . . . . 0.0 110.928 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 1.052 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -79.18 -40.25 31.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.24 -0.912 . . . . 0.0 111.14 -178.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.739 HG13 ' CE1' ' A' ' 81' ' ' TYR . 7.5 t -103.75 -54.85 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.975 -1.078 . . . . 0.0 111.741 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.525 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 5.9 mp -80.02 -1.39 39.55 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.013 -1.054 . . . . 0.0 112.012 -178.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.575 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -146.52 14.49 1.24 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.68 -1.263 . . . . 0.0 110.61 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 1.052 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -60.65 -16.46 39.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.273 -0.892 . . . . 0.0 110.78 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -70.87 -22.11 62.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.065 -1.022 . . . . 0.0 110.556 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.524 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 6.9 p30 -132.1 3.27 4.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.106 -0.996 . . . . 0.0 110.427 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.966 ' HG ' ' HB1' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -92.27 -39.42 11.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.235 -0.916 . . . . 0.0 109.972 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 1.102 ' CG1' HD13 ' A' ' 38' ' ' ILE . 97.6 t -77.11 -40.77 2.38 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.398 -0.813 . . . . 0.0 110.961 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 30' ' ' VAL . 49.3 Cg_endo -77.85 7.87 3.72 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.32 1.168 . . . . 0.0 110.55 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -121.48 -38.22 2.8 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.159 -0.963 . . . . 0.0 109.078 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.652 HD11 ' CD1' ' A' ' 150' ' ' TYR . 5.6 mt -80.2 -39.13 18.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-O 121.563 0.697 . . . . 0.0 109.271 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.72 80.01 32.67 Favored Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.572 -0.705 . . . . 0.0 109.877 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -73.13 1.14 6.95 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.101 1.579 . . . . 0.0 110.83 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -87.97 -17.44 31.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.139 -0.976 . . . . 0.0 109.919 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -101.19 -56.44 2.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.394 -0.816 . . . . 0.0 110.038 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 1.102 HD13 ' CG1' ' A' ' 30' ' ' VAL . 1.3 mp -107.39 145.53 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.467 -0.771 . . . . 0.0 109.914 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -112.6 -23.46 10.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.891 . . . . 0.0 110.586 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.551 ' C ' ' CD2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -163.02 158.2 21.83 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.097 -1.002 . . . . 0.0 110.223 -179.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.8 m -140.87 124.5 16.91 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.295 -0.878 . . . . 0.0 109.917 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 60.3 tt0 -137.56 108.22 6.6 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.107 -0.996 . . . . 0.0 110.452 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.468 HG21 ' HA ' ' A' ' 47' ' ' ASP . 13.6 mt -54.84 131.44 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.191 -0.943 . . . . 0.0 110.008 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.525 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 20.3 mt -97.5 -34.86 10.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.921 . . . . 0.0 110.616 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.722 ' CD1' HD12 ' A' ' 53' ' ' ILE . 1.9 m95 -123.03 161.79 23.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.248 -0.907 . . . . 0.0 110.73 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.45 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 40.18 -133.57 2.39 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.468 ' HA ' HG21 ' A' ' 43' ' ' ILE . 0.5 OUTLIER -157.68 20.14 0.27 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.384 -1.068 . . . . 0.0 110.069 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.457 ' O ' HG21 ' A' ' 71' ' ' ILE . . . 128.57 -21.72 5.34 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.468 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -65.73 -175.91 6.01 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.405 ' HA ' HG22 ' A' ' 71' ' ' ILE . 46.1 Cg_endo -73.23 128.69 13.18 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 124.032 1.543 . . . . 0.0 110.559 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.19 -14.33 55.2 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.643 -1.783 . . . . 0.0 108.643 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.523 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -67.86 164.07 20.53 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.565 -0.962 . . . . 0.0 109.789 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.722 HD12 ' CD1' ' A' ' 45' ' ' TRP . 59.9 mt -131.95 121.59 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.398 -0.813 . . . . 0.0 109.467 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.553 ' NZ ' HD11 ' A' ' 71' ' ' ILE . 66.9 mttt -106.01 135.81 46.79 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.144 -0.972 . . . . 0.0 110.317 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.525 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 21.1 tttp -104.73 89.6 3.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.353 -0.842 . . . . 0.0 110.01 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.542 ' CG2' HG12 ' A' ' 38' ' ' ILE . 61.8 mt -79.91 138.69 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 109.867 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 1.4 p -116.49 152.94 33.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.908 . . . . 0.0 110.589 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.574 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 18.7 m-85 -115.27 169.82 8.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.435 -0.791 . . . . 0.0 110.012 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -136.05 29.93 2.78 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -54.08 -23.52 14.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.277 -1.131 . . . . 0.0 110.302 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -176.38 -166.87 34.28 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.2 p -64.58 -45.71 85.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.248 -1.148 . . . . 0.0 110.172 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -46.89 135.53 9.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 0.0 110.149 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.467 ' CD2' ' CD2' ' A' ' 66' ' ' TYR . 1.5 t80 -69.45 122.1 18.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 0.0 110.254 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.574 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -129.6 99.95 0.48 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.488 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 25.8 p90 -140.33 171.69 13.79 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -1.139 . . . . 0.0 110.304 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.874 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.8 m -141.08 173.81 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.335 -0.853 . . . . 0.0 110.563 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.516 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 23.2 mttt -123.2 127.31 48.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.499 -0.751 . . . . 0.0 109.625 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.511 ' O ' ' HA ' ' A' ' 53' ' ' ILE . 16.5 m170 -113.74 126.52 55.31 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.102 -0.999 . . . . 0.0 111.049 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 52' ' ' THR . 64.8 tttt -104.22 106.63 17.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.326 -0.859 . . . . 0.0 109.533 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.553 HD11 ' NZ ' ' A' ' 54' ' ' LYS . 31.1 mm -49.8 136.02 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.191 -0.943 . . . . 0.0 110.38 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.456 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 8.3 t0 -111.76 -39.86 4.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.359 -0.838 . . . . 0.0 109.55 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.461 ' OG ' ' HB2' ' A' ' 82' ' ' SER . 53.4 p -168.42 160.44 11.2 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.464 -0.773 . . . . 0.0 109.617 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 73' ' ' SER . 1.5 mt -147.52 154.9 10.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.192 -0.942 . . . . 0.0 110.292 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.553 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 4.7 m-20 -135.66 79.09 1.76 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.213 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.506 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 63.5 mttt -63.02 -12.82 28.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.153 -0.967 . . . . 0.0 110.066 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -95.61 -31.78 13.12 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.31 -0.869 . . . . 0.0 109.497 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -106.01 -5.86 19.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.593 -0.692 . . . . 0.0 109.673 179.825 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.598 ' O ' HD12 ' A' ' 104' ' ' LEU . 4.6 m-85 66.34 50.22 1.34 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.555 -0.716 . . . . 0.0 110.42 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.553 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -120.42 150.32 40.97 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.241 -0.912 . . . . 0.0 109.227 179.379 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.739 ' CE1' HG13 ' A' ' 23' ' ' VAL . 19.9 t80 -139.09 134.29 32.72 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.14 -0.975 . . . . 0.0 110.299 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.461 ' HB2' ' OG ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -140.6 120.22 13.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.272 -0.892 . . . . 0.0 110.695 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.629 ' CE2' ' CB ' ' A' ' 100' ' ' TYR . 19.5 p90 -138.0 170.97 15.11 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 110.246 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.643 HG23 ' O ' ' A' ' 98' ' ' ILE . 86.7 m -121.64 130.83 53.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.412 -0.805 . . . . 0.0 109.802 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.569 ' HB3' ' CG2' ' A' ' 98' ' ' ILE . 5.2 tp -95.32 137.88 33.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.091 -1.006 . . . . 0.0 110.124 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.437 HG12 ' HB2' ' A' ' 68' ' ' LYS . 15.1 pt -120.41 -15.04 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.322 -0.862 . . . . 0.0 110.389 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.538 ' O ' HD11 ' A' ' 85' ' ' LEU . 25.3 tt0 -129.37 158.64 38.58 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.134 -0.978 . . . . 0.0 110.262 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.874 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 151.16 115.76 0.7 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -50.44 -20.97 1.27 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.251 -1.146 . . . . 0.0 110.345 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.811 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -72.77 -18.75 61.46 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.19 -0.943 . . . . 0.0 110.41 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 95' ' ' LEU . 74.9 mt -69.33 -7.79 40.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.167 -0.958 . . . . 0.0 110.185 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 46.75 -171.8 0.03 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.439 ' OD1' HG23 ' A' ' 94' ' ' THR . 49.8 p-10 -91.64 34.68 0.97 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.214 -1.168 . . . . 0.0 109.675 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.439 HG23 ' OD1' ' A' ' 93' ' ' ASP . 7.1 p -131.31 -41.64 1.09 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.441 -0.787 . . . . 0.0 110.397 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.696 HD22 HG22 ' A' ' 122' ' ' THR . 3.1 mm? -79.91 157.02 27.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.906 . . . . 0.0 110.352 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.496 ' HG3' ' HB2' ' A' ' 123' ' ' LYS . 48.0 mm-40 -141.08 -80.9 0.25 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.326 -0.859 . . . . 0.0 109.631 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.527 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 36.8 mttp -80.31 126.53 31.27 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.484 -0.76 . . . . 0.0 110.318 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.707 HG21 ' CE2' ' A' ' 100' ' ' TYR . 5.7 mm -116.58 138.93 45.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 120.586 -1.321 . . . . 0.0 109.621 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.483 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -114.76 130.12 56.8 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.465 179.219 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.707 ' CE2' HG21 ' A' ' 98' ' ' ILE . 9.3 m-85 -125.36 134.01 52.34 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.42 -0.8 . . . . 0.0 110.032 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.478 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 78.0 tt0 -136.56 136.12 39.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 0.0 110.478 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.453 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 91.8 m -136.73 137.8 40.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.287 -0.883 . . . . 0.0 109.762 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -135.37 145.56 47.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.063 -1.023 . . . . 0.0 110.49 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.657 HD23 HG12 ' A' ' 114' ' ' ILE . 6.2 mt -126.43 151.79 47.26 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.33 -0.856 . . . . 0.0 110.067 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.708 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -150.97 -169.23 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.247 -0.908 . . . . 0.0 110.247 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.708 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -120.49 151.14 39.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.336 -0.852 . . . . 0.0 110.265 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.473 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 6.1 p -105.08 167.9 9.16 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 110.164 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.3 Cg_endo -72.7 -13.25 27.04 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.059 1.557 . . . . 0.0 110.438 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 74.1 m -97.02 12.45 32.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.184 -0.947 . . . . 0.0 110.252 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 92.29 -32.82 5.24 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -60.36 -175.0 1.11 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 28.8 p -130.57 135.36 47.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -1.16 . . . . 0.0 110.376 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.864 ' HA ' HG22 ' A' ' 10' ' ' THR . 11.0 mt -88.33 151.31 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.294 -0.879 . . . . 0.0 110.065 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.657 HG12 HD23 ' A' ' 104' ' ' LEU . 11.9 mt -131.49 116.67 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -0.936 . . . . 0.0 110.35 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.8 tttm -108.61 124.14 50.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.164 -0.96 . . . . 0.0 109.892 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.7 t -120.46 162.06 20.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.237 -0.914 . . . . 0.0 110.397 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.478 ' HB ' ' HB3' ' A' ' 101' ' ' GLU . 37.5 m -160.02 151.97 20.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.373 -0.829 . . . . 0.0 109.932 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 7.5 m -148.35 157.1 43.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.205 -0.935 . . . . 0.0 110.275 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.814 ' CE1' HG23 ' A' ' 4' ' ' THR . 68.4 m-70 -141.54 162.05 36.42 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.195 -0.94 . . . . 0.0 110.536 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.502 ' CD1' ' N ' ' A' ' 120' ' ' TYR . 11.1 m-85 -127.68 152.36 47.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.358 -0.839 . . . . 0.0 110.302 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.527 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 74.2 m-70 -134.99 86.69 2.27 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.201 -0.937 . . . . 0.0 109.518 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.696 HG22 HD22 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -70.79 146.75 49.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.397 -0.814 . . . . 0.0 110.74 -179.341 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.496 ' HB2' ' HG3' ' A' ' 96' ' ' GLU . 2.0 ttpt -92.83 119.1 31.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.373 -0.83 . . . . 0.0 110.057 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 105.58 -125.32 8.2 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -137.43 61.61 1.61 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.328 -1.101 . . . . 0.0 110.231 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.503 HG23 ' CG2' ' A' ' 122' ' ' THR . 35.5 m -124.28 179.32 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.246 -0.909 . . . . 0.0 110.08 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -140.52 158.53 43.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.177 -0.952 . . . . 0.0 110.345 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.683 HD12 ' H ' ' A' ' 128' ' ' ILE . 5.1 mp -78.23 172.98 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.247 -0.908 . . . . 0.0 110.183 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.605 ' N ' HG22 ' A' ' 128' ' ' ILE . 7.3 mttp -107.02 128.02 53.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.363 -0.835 . . . . 0.0 109.888 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.475 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 91.8 mt-10 -42.77 -53.45 4.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.214 -0.928 . . . . 0.0 110.244 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 51.1 tt0 -47.52 -26.19 1.33 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.188 -0.945 . . . . 0.0 109.912 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.811 ' NE2' ' HB1' ' A' ' 90' ' ' ALA . 11.3 t-160 -85.37 -62.39 1.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.297 -0.877 . . . . 0.0 110.137 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 1.085 HG21 ' CE2' ' A' ' 5' ' ' TYR . 7.7 p -62.36 -41.0 89.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.378 -0.826 . . . . 0.0 109.962 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.554 ' N ' HG13 ' A' ' 133' ' ' VAL . 27.6 tttp -64.8 -44.14 90.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.337 -0.852 . . . . 0.0 109.89 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 131' ' ' GLU . . . -63.86 -32.8 74.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.374 -0.829 . . . . 0.0 109.913 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -64.9 -31.86 82.33 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -60.53 -32.66 71.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.273 -1.133 . . . . 0.0 109.955 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 142' ' ' ASN . 99.0 mt-10 -83.6 -33.35 25.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.38 -0.825 . . . . 0.0 109.878 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 24.3 mttt -68.86 -35.06 76.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.34 -0.85 . . . . 0.0 109.881 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.427 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -86.18 -40.89 15.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.297 -0.877 . . . . 0.0 109.934 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.1 m -67.55 -53.45 28.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.419 -0.801 . . . . 0.0 109.846 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 138' ' ' GLU . 98.8 m-20 -49.43 -47.47 48.02 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.226 -0.921 . . . . 0.0 109.924 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.427 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 9.3 tp -55.6 -48.16 75.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.281 -0.887 . . . . 0.0 109.882 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.565 ' CE1' ' CE2' ' A' ' 22' ' ' PHE . 13.6 m-85 -53.31 -36.13 60.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.444 -0.785 . . . . 0.0 109.843 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -74.56 -16.51 60.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.359 -0.838 . . . . 0.0 109.862 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 146' ' ' LEU . 24.0 mt -84.41 -35.63 22.97 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.281 -0.887 . . . . 0.0 109.01 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 1.057 ' CG2' HD23 ' A' ' 18' ' ' LEU . 24.7 mt -68.26 -41.61 83.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.484 ' CG ' ' OG ' ' A' ' 11' ' ' SER . 97.2 mt-10 -48.36 -40.98 27.3 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.158 -0.964 . . . . 0.0 108.794 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.418 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 19.5 m -72.05 -26.74 62.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.28 -0.887 . . . . 0.0 109.351 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.652 ' CD1' HD11 ' A' ' 33' ' ' ILE . 62.7 t80 -57.89 -52.2 66.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.535 -0.728 . . . . 0.0 109.883 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.943 HD21 ' CE1' ' A' ' 158' ' ' TYR . 64.7 mt -80.01 -36.42 35.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.285 -0.884 . . . . 0.0 110.362 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.832 ' HB2' HD11 ' A' ' 13' ' ' ILE . 35.8 tttt -60.05 -19.69 54.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.163 -0.961 . . . . 0.0 109.236 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.48 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -111.1 -32.22 2.66 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.6 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 5.8 m-70 -105.97 93.0 7.04 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.324 -1.103 . . . . 0.0 110.039 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.503 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 46.6 Cg_endo -72.94 3.66 4.29 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.018 1.536 . . . . 0.0 110.96 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -114.19 -10.29 12.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.085 -1.009 . . . . 0.0 109.899 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.801 ' HB3' HH21 ' A' ' 17' ' ' ARG . . . -46.92 108.74 0.15 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.333 -0.855 . . . . 0.0 110.053 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 1.129 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 35.46 30.83 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.719 -0.613 . . . . 0.0 110.515 -179.624 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.525 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.701 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.616 HG22 ' ND1' ' A' ' 121' ' ' HIS . 63.6 t -122.93 122.53 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.191 -1.182 . . . . 0.0 110.264 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.579 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 43.1 m-85 -80.2 154.16 28.12 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.28 -0.887 . . . . 0.0 110.302 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.889 HG23 ' CE1' ' A' ' 119' ' ' HIS . 56.5 m -138.35 94.47 2.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.882 . . . . 0.0 110.1 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.592 ' CD1' HG23 ' A' ' 133' ' ' VAL . 75.1 m-85 -116.15 136.41 53.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.889 . . . . 0.0 110.026 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 116' ' ' SER . 21.5 pt-20 -135.92 151.91 50.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.202 -0.936 . . . . 0.0 110.404 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.3 m -121.38 157.83 29.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.337 -0.852 . . . . 0.0 109.92 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -135.44 121.11 19.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.115 -0.99 . . . . 0.0 110.386 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.638 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.9 p90 -146.03 -174.12 4.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.347 -0.846 . . . . 0.0 109.948 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.866 HG22 ' HA ' ' A' ' 113' ' ' ILE . 5.7 p -141.43 173.03 11.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.201 -0.937 . . . . 0.0 110.627 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.479 ' CB ' ' CD ' ' A' ' 148' ' ' GLU . 97.6 p -156.68 135.04 11.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.399 -0.813 . . . . 0.0 110.2 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -62.05 -31.02 71.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.211 -0.931 . . . . 0.0 110.134 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.873 HD11 ' HB2' ' A' ' 152' ' ' LYS . 2.3 mp -64.55 150.62 93.43 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.869 . . . . 0.0 109.944 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.818 ' HD2' HG23 ' A' ' 13' ' ' ILE . 42.0 Cg_endo -68.32 143.15 57.3 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.044 1.549 . . . . 0.0 110.771 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.669 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.5 Cg_endo -72.25 -30.92 12.42 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 O-C-N 124.042 1.549 . . . . 0.0 112.737 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.669 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.1 Cg_endo -69.53 -22.71 32.75 Favored 'Trans proline' 0 N--CA 1.485 0.988 0 N-CA-C 110.07 -0.781 . . . . 0.0 110.07 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.61 ' NH2' ' HB3' ' A' ' 157' ' ' ALA . 42.2 mtp180 -83.5 -42.89 16.37 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 1.039 HD23 HG21 ' A' ' 147' ' ' ILE . 0.3 OUTLIER -71.33 -32.69 68.87 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 178.833 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.581 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 81.4 t80 -63.02 -61.63 2.26 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.538 -0.726 . . . . 0.0 109.577 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.76 ' HG2' HD22 ' A' ' 24' ' ' LEU . 14.9 mttp -53.61 -32.88 53.0 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.383 -0.823 . . . . 0.0 109.351 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.005 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -74.26 -47.45 35.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.363 -0.836 . . . . 0.0 110.568 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 1.049 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -66.67 -46.76 74.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.542 -0.724 . . . . 0.0 111.215 -179.141 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 1.105 HG11 ' CD1' ' A' ' 74' ' ' ILE . 6.1 t -97.45 -60.3 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.109 -0.995 . . . . 0.0 111.914 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.76 HD22 ' HG2' ' A' ' 20' ' ' LYS . 8.5 mp -69.5 -0.19 6.23 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.16 -0.962 . . . . 0.0 111.824 -178.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.548 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -146.16 10.95 1.17 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.692 -1.255 . . . . 0.0 110.811 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 1.049 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -53.38 -19.02 3.0 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.164 -0.96 . . . . 0.0 110.863 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -80.01 -26.87 39.65 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.005 -1.059 . . . . 0.0 110.573 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -127.12 13.05 7.21 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.255 -0.903 . . . . 0.0 110.337 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.765 ' HG ' ' HB1' ' A' ' 21' ' ' ALA . 0.8 OUTLIER -103.9 -45.29 4.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.105 -0.997 . . . . 0.0 110.259 179.921 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.952 HG11 HD13 ' A' ' 38' ' ' ILE . 3.1 t -64.77 -41.83 59.22 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.326 -0.858 . . . . 0.0 110.556 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.0 Cg_endo -78.79 8.87 3.51 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.442 1.233 . . . . 0.0 110.628 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -118.64 -25.47 6.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.153 -0.967 . . . . 0.0 109.263 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.75 HD11 HD11 ' A' ' 29' ' ' LEU . 20.1 mt -80.01 -57.42 5.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 121.612 0.72 . . . . 0.0 109.427 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.422 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . . . -145.06 105.55 4.46 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.541 -0.724 . . . . 0.0 109.818 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 34' ' ' ALA . 44.2 Cg_endo -70.66 -0.77 8.18 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 124.042 1.549 . . . . 0.0 110.824 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -82.87 -10.42 58.84 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.075 -1.016 . . . . 0.0 109.645 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -101.93 -63.31 1.16 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.334 -0.853 . . . . 0.0 110.121 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.952 HD13 HG11 ' A' ' 30' ' ' VAL . 1.3 mp -113.09 154.2 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.446 -0.784 . . . . 0.0 109.985 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.544 ' HG2' ' N ' ' A' ' 59' ' ' GLY . 66.5 mmtt -114.16 -27.5 7.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 0.0 110.457 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.574 ' C ' ' CD2' ' A' ' 40' ' ' HIS . 0.1 OUTLIER -159.32 151.72 21.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.955 . . . . 0.0 110.179 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.1 m -138.13 120.71 16.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.393 -0.817 . . . . 0.0 109.677 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -134.09 109.97 9.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.157 -0.964 . . . . 0.0 110.785 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 29.9 mt -55.71 133.81 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.312 -0.868 . . . . 0.0 109.794 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 13.3 tp -105.28 -23.45 12.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.248 -0.908 . . . . 0.0 110.823 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.756 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.8 m95 -129.58 159.37 36.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.043 -1.036 . . . . 0.0 110.855 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.456 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 41.91 -136.23 3.12 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -151.25 21.54 0.75 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.307 -1.114 . . . . 0.0 110.068 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.498 ' O ' HG21 ' A' ' 71' ' ' ILE . . . 122.89 -20.96 7.58 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.517 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -67.8 -173.41 7.03 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -72.81 128.86 13.72 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.071 1.564 . . . . 0.0 110.517 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.45 -13.46 51.13 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 45' ' ' TRP . 1.0 OUTLIER -72.11 165.24 24.73 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.548 -0.972 . . . . 0.0 109.596 179.54 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.756 HD12 ' CG ' ' A' ' 45' ' ' TRP . 63.0 mt -135.35 120.57 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.333 -0.855 . . . . 0.0 109.697 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.665 ' CE ' HD11 ' A' ' 71' ' ' ILE . 39.3 mttm -103.53 128.6 50.72 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.208 -0.932 . . . . 0.0 110.27 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 54.9 tttt -97.6 91.65 5.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.197 -0.939 . . . . 0.0 109.874 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.556 ' CG2' HG12 ' A' ' 38' ' ' ILE . 89.4 mt -79.98 141.6 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.299 -0.876 . . . . 0.0 110.049 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.771 HG22 ' HB3' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -120.12 147.33 45.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 110.471 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.591 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 14.1 m-85 -114.21 162.27 16.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.325 -0.859 . . . . 0.0 110.003 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.544 ' N ' ' HG2' ' A' ' 39' ' ' LYS . . . -110.61 8.71 30.23 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -120.5 179.01 4.45 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.229 -1.159 . . . . 0.0 110.223 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 62' ' ' SER . . . 74.54 -165.58 54.77 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 61' ' ' GLY . 13.2 m -46.67 174.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -1.143 . . . . 0.0 110.239 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' A' ' 62' ' ' SER . 86.8 mt-30 -43.48 -84.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.921 . . . . 0.0 110.156 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.576 ' O ' ' CD1' ' A' ' 64' ' ' TYR . 2.3 p90 -80.93 131.16 35.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.344 -0.847 . . . . 0.0 110.208 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.591 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -142.48 85.79 0.19 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.771 ' HB3' HG22 ' A' ' 57' ' ' THR . 13.6 p90 -132.74 171.97 13.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.293 -1.122 . . . . 0.0 110.251 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.789 HG12 ' HA2' ' A' ' 88' ' ' GLY . 4.4 m -140.21 176.9 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.917 . . . . 0.0 110.477 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.642 ' O ' HD12 ' A' ' 85' ' ' LEU . 82.3 mttt -133.03 102.9 5.78 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.426 -0.796 . . . . 0.0 109.746 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.979 ' CD2' HD13 ' A' ' 85' ' ' LEU . 15.1 m170 -95.65 127.73 41.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.24 -0.912 . . . . 0.0 111.061 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.536 ' HA ' ' O ' ' A' ' 52' ' ' THR . 17.1 tttt -96.59 114.84 26.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 109.436 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.665 HD11 ' CE ' ' A' ' 54' ' ' LYS . 37.0 mm -52.81 132.07 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.142 -0.974 . . . . 0.0 110.347 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.539 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 23.5 t0 -105.21 -46.86 4.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.487 -0.758 . . . . 0.0 109.982 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.452 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 77.5 p -177.68 160.93 1.61 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.466 -0.771 . . . . 0.0 110.376 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 1.105 ' CD1' HG11 ' A' ' 23' ' ' VAL . 6.6 tt -153.24 170.06 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.375 -0.828 . . . . 0.0 109.703 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.5 m-20 -142.19 84.35 1.87 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.079 -1.013 . . . . 0.0 110.395 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.581 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 18.7 tttm -58.93 -14.26 8.67 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.12 -0.988 . . . . 0.0 110.273 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -92.82 -34.33 13.9 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.349 -0.845 . . . . 0.0 109.517 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.505 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 2.3 m-80 -102.71 -3.75 26.04 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.655 0.74 . . . . 0.0 109.267 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.647 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 76.1 m-85 62.39 55.48 2.3 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.338 0.589 . . . . 0.0 110.873 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.489 ' HB3' ' HG3' ' A' ' 103' ' ' LYS . 0.7 OUTLIER -131.09 153.87 48.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.449 -0.782 . . . . 0.0 109.523 179.124 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.614 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 76.0 t80 -151.99 149.48 28.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.183 -0.948 . . . . 0.0 110.352 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.482 ' HB2' ' HA ' ' A' ' 101' ' ' GLU . 13.5 t -157.63 151.14 23.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.249 -0.907 . . . . 0.0 110.386 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.614 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 7.2 p90 -152.18 177.03 10.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.441 -0.787 . . . . 0.0 110.734 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.717 HG23 ' O ' ' A' ' 98' ' ' ILE . 42.0 m -127.38 125.85 41.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.547 -0.721 . . . . 0.0 109.735 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.979 HD13 ' CD2' ' A' ' 69' ' ' HIS . 11.2 tp -95.77 133.63 39.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.006 -1.059 . . . . 0.0 110.407 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.555 ' N ' HD12 ' A' ' 85' ' ' LEU . 10.3 pt -111.53 -34.7 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.238 -0.914 . . . . 0.0 110.408 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.76 ' O ' HD11 ' A' ' 85' ' ' LEU . 76.9 tt0 -115.16 153.27 31.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.326 -0.859 . . . . 0.0 110.18 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.789 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 161.19 127.72 0.9 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -57.54 -20.29 30.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.271 -1.135 . . . . 0.0 110.095 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.83 -19.78 54.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.318 -0.864 . . . . 0.0 110.171 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.622 HD12 ' N ' ' A' ' 88' ' ' GLY . 55.1 mt -67.58 -28.21 67.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.931 . . . . 0.0 110.19 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 49.18 -178.09 0.02 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -81.99 8.23 11.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -1.166 . . . . 0.0 110.166 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.511 ' O ' HG22 ' A' ' 122' ' ' THR . 33.6 p -98.64 -32.71 11.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.206 -0.934 . . . . 0.0 110.144 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.935 HD21 ' CD1' ' A' ' 128' ' ' ILE . 76.5 mt -108.62 158.13 17.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.43 -0.793 . . . . 0.0 110.128 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.1 tp10 -139.35 -79.93 0.31 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.168 -0.957 . . . . 0.0 110.196 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.486 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 29.3 mttp -80.15 127.46 32.35 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.542 -0.724 . . . . 0.0 110.555 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.717 ' O ' HG23 ' A' ' 84' ' ' THR . 6.0 mm -117.83 142.78 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.885 -1.134 . . . . 0.0 110.027 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.473 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -123.64 133.67 53.89 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.409 -0.807 . . . . 0.0 109.112 178.859 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.641 ' HE2' HG21 ' A' ' 98' ' ' ILE . 6.8 m-85 -128.03 131.39 49.17 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.164 -0.96 . . . . 0.0 110.541 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.482 ' HA ' ' HB2' ' A' ' 82' ' ' SER . 85.1 tt0 -135.51 139.4 43.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.277 -0.889 . . . . 0.0 110.066 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.472 ' N ' ' O ' ' A' ' 81' ' ' TYR . 85.7 m -141.52 149.14 40.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 110.217 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.489 ' HG3' ' HB3' ' A' ' 80' ' ' SER . 0.0 OUTLIER -142.32 140.71 32.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.262 -0.899 . . . . 0.0 110.39 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.741 HD23 HG12 ' A' ' 114' ' ' ILE . 2.9 mt -115.37 155.68 26.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 110.063 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.707 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -151.48 -169.49 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.093 -1.005 . . . . 0.0 110.217 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.707 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -123.88 154.4 39.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.411 -0.806 . . . . 0.0 110.247 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.446 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.4 p -113.02 170.96 4.72 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.23 -0.919 . . . . 0.0 110.233 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.3 Cg_endo -72.11 -14.58 28.93 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.048 1.552 . . . . 0.0 110.553 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.2 p -97.82 11.41 37.35 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.224 -0.923 . . . . 0.0 110.174 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 91.92 -31.07 6.13 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -56.64 -172.57 0.17 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.513 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 1.1 p -136.46 135.95 39.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.168 -1.195 . . . . 0.0 110.277 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.866 ' HA ' HG22 ' A' ' 10' ' ' THR . 17.0 mt -89.23 149.47 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.33 -0.856 . . . . 0.0 110.024 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.741 HG12 HD23 ' A' ' 104' ' ' LEU . 23.3 mt -131.29 118.28 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 110.393 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 103' ' ' LYS . 72.2 tttt -105.8 120.75 42.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.945 . . . . 0.0 109.97 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 0.4 OUTLIER -113.04 151.68 30.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.234 -0.916 . . . . 0.0 110.528 -179.719 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.457 ' HB ' ' HB3' ' A' ' 101' ' ' GLU . 81.8 m -154.37 124.31 6.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.373 -0.829 . . . . 0.0 110.252 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.537 ' OG ' ' CE1' ' A' ' 100' ' ' TYR . 2.1 t -125.81 163.14 23.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 110.094 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.889 ' CE1' HG23 ' A' ' 4' ' ' THR . 71.0 m-70 -138.94 154.35 48.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -0.911 . . . . 0.0 110.177 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.531 ' HD1' HD12 ' A' ' 98' ' ' ILE . 21.4 m-85 -124.99 135.94 53.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.896 . . . . 0.0 110.44 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.616 ' ND1' HG22 ' A' ' 2' ' ' VAL . 73.6 m-70 -118.79 93.45 4.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.138 -0.976 . . . . 0.0 109.763 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.864 ' CG2' HD23 ' A' ' 95' ' ' LEU . 1.7 p -75.06 155.87 36.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.3 -0.875 . . . . 0.0 110.435 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.4 ttpt -107.94 100.93 10.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.344 -0.847 . . . . 0.0 110.157 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 121.4 -135.91 10.85 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -120.39 67.28 0.84 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.194 -1.18 . . . . 0.0 110.193 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.508 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 32.4 m -135.41 155.66 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.246 -0.909 . . . . 0.0 110.199 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.407 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 92.8 mt-10 -118.78 179.07 4.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.23 -0.919 . . . . 0.0 110.234 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.935 ' CD1' HD21 ' A' ' 95' ' ' LEU . 16.5 mm -80.18 172.69 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.276 -0.89 . . . . 0.0 110.227 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.588 ' N ' HG22 ' A' ' 128' ' ' ILE . 61.9 mttt -96.13 130.61 43.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 109.908 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.469 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 94.7 mt-10 -45.41 -35.17 3.5 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.232 -0.918 . . . . 0.0 110.207 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 1.001 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 59.2 tt0 -68.25 -21.9 64.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.203 -0.935 . . . . 0.0 110.005 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.458 ' N ' ' O ' ' A' ' 129' ' ' LYS . 13.4 t-160 -87.86 -49.41 7.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.247 -0.908 . . . . 0.0 110.176 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.592 HG23 ' CD1' ' A' ' 5' ' ' TYR . 2.6 p -69.47 -28.75 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.454 -0.779 . . . . 0.0 110.132 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -104.95 -69.74 0.8 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.181 -0.949 . . . . 0.0 110.089 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 1.001 ' HB3' ' O ' ' A' ' 131' ' ' GLU . . . -56.56 -19.63 16.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.193 -0.942 . . . . 0.0 109.811 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 132' ' ' HIS . . . -76.21 -30.23 57.36 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.465 ' CE ' ' O ' ' A' ' 133' ' ' VAL . 25.0 mttt -66.68 -30.91 71.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -1.159 . . . . 0.0 110.025 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -81.46 -29.58 33.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.259 -0.9 . . . . 0.0 110.008 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 18.7 mtpp -70.38 -45.99 64.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.9 . . . . 0.0 110.005 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -71.75 -33.28 68.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.318 -0.864 . . . . 0.0 110.067 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.9 t -58.84 -46.27 88.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.354 -0.842 . . . . 0.0 110.001 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -53.02 -43.38 66.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.242 -0.911 . . . . 0.0 109.985 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.622 ' HA ' HD12 ' A' ' 146' ' ' LEU . 14.1 tp -57.3 -50.13 73.9 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.348 -0.845 . . . . 0.0 109.911 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -54.02 -40.1 66.74 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.357 -0.839 . . . . 0.0 109.685 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -73.12 -15.12 61.49 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.295 -0.878 . . . . 0.0 110.089 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.622 HD12 ' HA ' ' A' ' 143' ' ' LEU . 29.9 mt -82.03 -35.4 28.84 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.152 -0.967 . . . . 0.0 108.86 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 1.039 HG21 HD23 ' A' ' 18' ' ' LEU . 23.5 mt -67.96 -47.49 78.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.759 ' HB3' HD13 ' A' ' 13' ' ' ILE . 77.6 mt-10 -47.85 -45.14 29.83 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.334 -0.854 . . . . 0.0 108.822 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.541 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 94.3 m -62.04 -39.58 92.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.269 -0.894 . . . . 0.0 109.313 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.695 ' CE2' HD21 ' A' ' 29' ' ' LEU . 57.5 t80 -47.08 -51.34 17.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.498 -0.751 . . . . 0.0 109.837 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.989 HD21 ' CE1' ' A' ' 158' ' ' TYR . 68.6 mt -80.11 -34.77 37.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.434 -0.792 . . . . 0.0 110.418 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.873 ' HB2' HD11 ' A' ' 13' ' ' ILE . 37.2 tttm -60.72 -14.81 23.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 109.18 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.494 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -120.12 -27.3 2.07 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.576 ' CD2' ' O ' ' A' ' 150' ' ' TYR . 10.3 m-70 -106.12 92.58 6.78 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.134 -1.215 . . . . 0.0 110.279 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.498 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 48.3 Cg_endo -73.86 2.23 6.2 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.035 1.545 . . . . 0.0 110.7 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -113.95 -5.14 13.18 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.064 -1.022 . . . . 0.0 110.019 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.61 ' HB3' ' NH2' ' A' ' 17' ' ' ARG . . . -57.78 108.32 0.56 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 109.957 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 1.005 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 0.3 OUTLIER 35.31 31.45 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.702 -0.624 . . . . 0.0 110.689 -179.748 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.539 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.901 -1.047 . . . . 0.0 109.78 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 60.3 t -114.2 126.69 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.232 -1.158 . . . . 0.0 110.274 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.574 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 41.8 m-85 -81.36 158.51 24.66 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.208 -0.932 . . . . 0.0 110.428 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.705 HG23 ' CE1' ' A' ' 119' ' ' HIS . 91.8 m -141.97 94.2 2.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.318 -0.864 . . . . 0.0 109.928 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.628 ' CE1' ' CG2' ' A' ' 133' ' ' VAL . 75.9 m-85 -116.04 138.04 51.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.193 -0.942 . . . . 0.0 110.069 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 116' ' ' SER . 12.5 pt-20 -140.05 154.29 47.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.239 -0.913 . . . . 0.0 110.41 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.7 m -135.64 135.94 40.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.311 -0.868 . . . . 0.0 109.805 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.49 ' HG3' ' HG3' ' A' ' 115' ' ' LYS . 5.5 tt0 -114.42 140.6 48.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.133 -0.979 . . . . 0.0 110.766 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.588 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 4.1 p90 -157.4 -172.73 4.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.541 -0.724 . . . . 0.0 109.581 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.825 HG22 ' HA ' ' A' ' 113' ' ' ILE . 8.8 p -140.0 173.13 11.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.091 -1.006 . . . . 0.0 110.6 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.439 ' HB2' ' CD ' ' A' ' 148' ' ' GLU . 86.0 p -156.04 134.68 11.74 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.44 -0.787 . . . . 0.0 110.094 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -59.73 -39.22 83.96 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.156 -0.965 . . . . 0.0 110.189 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.914 HD11 ' HB2' ' A' ' 152' ' ' LYS . 2.5 mp -59.94 150.62 68.47 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.432 -0.793 . . . . 0.0 109.892 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.811 ' HD2' HG23 ' A' ' 13' ' ' ILE . 41.5 Cg_endo -67.53 142.04 57.71 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.041 1.548 . . . . 0.0 110.559 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.658 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.0 Cg_endo -72.15 -31.08 12.5 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.982 1.517 . . . . 0.0 112.667 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.658 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.4 Cg_endo -70.33 -21.49 30.75 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 N-CA-C 110.086 -0.774 . . . . 0.0 110.086 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.675 ' NH2' ' HB3' ' A' ' 157' ' ' ALA . 36.3 mtp180 -82.94 -46.08 13.37 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.751 ' C ' HD23 ' A' ' 18' ' ' LEU . 0.8 OUTLIER -71.02 -32.53 69.33 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.595 ' N ' HD23 ' A' ' 18' ' ' LEU . 86.5 t80 -62.84 -59.3 5.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.555 -0.715 . . . . 0.0 109.512 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.521 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 29.5 mttt -50.99 -39.02 54.6 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.629 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.041 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -72.27 -42.53 65.46 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.451 -0.781 . . . . 0.0 110.838 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 1.05 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -72.72 -40.17 66.33 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.317 -0.865 . . . . 0.0 111.17 -178.9 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.807 HG13 ' CE1' ' A' ' 81' ' ' TYR . 4.2 t -103.52 -55.8 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.026 -1.046 . . . . 0.0 111.588 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.729 HD12 ' N ' ' A' ' 24' ' ' LEU . 7.3 mp -79.94 -1.12 38.0 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.06 -1.025 . . . . 0.0 111.889 -178.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.567 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.9 OUTLIER -153.36 30.62 0.48 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.658 -1.276 . . . . 0.0 110.726 -179.9 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 1.05 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -74.5 -23.39 58.84 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.224 -0.922 . . . . 0.0 110.39 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.4 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 94.7 m-20 -67.58 -17.33 64.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -0.936 . . . . 0.0 110.022 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.555 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 3.4 p30 -128.31 10.5 6.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.306 -0.871 . . . . 0.0 109.977 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.637 ' HG ' ' HB1' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -93.54 -49.8 5.72 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.336 -0.852 . . . . 0.0 110.283 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.837 HG22 ' HD3' ' A' ' 31' ' ' PRO . 2.2 m -74.96 -28.86 0.83 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.373 -0.829 . . . . 0.0 112.171 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.837 ' HD3' HG22 ' A' ' 30' ' ' VAL . 51.7 Cg_endo -78.65 5.6 5.47 Favored 'Trans proline' 0 C--N 1.319 -1.026 0 O-C-N 122.67 0.826 . . . . 0.0 110.5 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -126.91 -34.25 2.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 109.431 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.532 HD11 ' CD1' ' A' ' 29' ' ' LEU . 24.1 mt -80.01 -24.89 11.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 121.653 0.74 . . . . 0.0 109.219 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.419 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . . . -170.89 97.4 0.43 Allowed Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.637 -0.665 . . . . 0.0 109.725 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 34' ' ' ALA . 44.1 Cg_endo -69.89 -3.29 11.79 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.987 1.519 . . . . 0.0 110.664 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.448 ' HB2' ' OE2' ' A' ' 60' ' ' GLU . 12.0 pt20 -90.52 4.85 49.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 0.0 110.007 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.985 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -109.41 -45.39 3.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.321 -0.862 . . . . 0.0 110.033 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.985 HD12 ' C ' ' A' ' 37' ' ' ALA . 1.9 mp -131.47 126.6 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.371 -0.831 . . . . 0.0 110.049 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.44 ' N ' ' O ' ' A' ' 57' ' ' THR . 18.2 ttpt -78.05 -36.59 48.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.202 -0.936 . . . . 0.0 110.316 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.516 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -170.97 136.73 1.13 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.278 -0.889 . . . . 0.0 110.027 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.6 m -111.86 124.83 53.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.331 -0.856 . . . . 0.0 110.149 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.516 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 42.2 tt0 -133.41 109.32 9.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.213 -0.929 . . . . 0.0 110.32 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 43' ' ' ILE . 19.6 mt -56.29 133.68 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.236 -0.915 . . . . 0.0 110.019 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.453 HD22 ' HD2' ' A' ' 55' ' ' LYS . 14.4 tp -104.69 -27.52 11.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.284 -0.885 . . . . 0.0 110.547 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.592 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.9 m95 -127.6 160.56 31.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 0.0 110.775 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.459 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 42.18 -133.94 4.06 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -156.35 19.7 0.35 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.323 -1.104 . . . . 0.0 110.108 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.91 -17.04 6.81 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.468 ' O ' ' HB ' ' A' ' 71' ' ' ILE . . . -72.27 -172.77 19.65 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.422 ' HA ' HG22 ' A' ' 71' ' ' ILE . 44.9 Cg_endo -73.53 129.1 13.33 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.008 1.53 . . . . 0.0 110.567 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.18 -12.86 55.49 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -70.65 164.57 24.7 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.537 -0.978 . . . . 0.0 109.82 179.705 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.592 HD12 ' CG ' ' A' ' 45' ' ' TRP . 52.7 mt -134.21 121.19 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.388 -0.82 . . . . 0.0 109.79 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.603 ' HE2' HD11 ' A' ' 71' ' ' ILE . 4.9 mtmp? -106.07 138.52 42.11 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.118 -0.989 . . . . 0.0 110.281 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.458 ' HG2' ' HG2' ' A' ' 68' ' ' LYS . 2.1 mtpt -109.98 89.25 2.96 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.321 -0.862 . . . . 0.0 110.15 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.553 ' CG2' HG13 ' A' ' 38' ' ' ILE . 88.9 mt -79.95 141.82 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 110.011 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.529 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 3.5 p -115.06 159.6 20.64 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.268 -0.895 . . . . 0.0 110.517 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.525 ' N ' ' O ' ' A' ' 65' ' ' GLY . 16.4 m-85 -120.29 145.65 46.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.36 -0.838 . . . . 0.0 110.154 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -98.28 11.62 63.56 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.448 ' OE2' ' HB2' ' A' ' 36' ' ' GLN . 94.0 mt-10 -128.67 156.65 43.11 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.284 -1.127 . . . . 0.0 110.165 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 62' ' ' SER . . . 99.1 -155.77 19.99 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.417 ' O ' ' O ' ' A' ' 61' ' ' GLY . 83.1 p -55.0 -169.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.164 -1.198 . . . . 0.0 110.152 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -71.55 -25.71 62.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.187 -0.945 . . . . 0.0 110.198 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -129.13 111.18 12.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.231 -0.918 . . . . 0.0 110.16 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -134.33 87.29 0.26 Allowed Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.532 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 12.5 p90 -133.15 164.08 27.84 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.169 -1.195 . . . . 0.0 110.167 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.911 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.0 m -133.17 175.31 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.358 -0.839 . . . . 0.0 110.583 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.497 ' HB2' HG12 ' A' ' 86' ' ' ILE . 85.2 mttt -129.21 127.21 40.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.523 -0.736 . . . . 0.0 109.5 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.474 ' NE2' HD13 ' A' ' 85' ' ' LEU . 12.6 m170 -115.94 120.01 37.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.138 -0.976 . . . . 0.0 111.079 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 52' ' ' THR . 19.9 tttt -96.41 115.81 28.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 0.0 109.459 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.603 HD11 ' HE2' ' A' ' 54' ' ' LYS . 24.6 mm -61.08 129.69 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.206 -0.934 . . . . 0.0 110.491 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 82' ' ' SER . 93.8 m-20 -105.39 -42.95 5.1 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.368 -0.833 . . . . 0.0 110.204 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 35.3 m -166.9 158.65 12.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.367 -0.833 . . . . 0.0 109.946 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.518 HG12 HG11 ' A' ' 23' ' ' VAL . 1.7 mt -144.24 156.74 15.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.225 -0.922 . . . . 0.0 110.321 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.541 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 4.4 m-20 -135.13 78.8 1.75 Allowed 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.238 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.554 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 88.5 mttt -62.23 -12.98 23.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.131 -0.981 . . . . 0.0 110.062 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -95.14 -31.58 13.47 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.268 -0.895 . . . . 0.0 109.585 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -107.4 -4.27 18.71 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.528 -0.732 . . . . 0.0 109.725 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.679 ' O ' HD12 ' A' ' 104' ' ' LEU . 6.7 m-85 64.97 50.63 1.87 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.484 -0.76 . . . . 0.0 110.277 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.541 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -120.75 149.94 41.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.285 -0.885 . . . . 0.0 109.315 179.497 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.807 ' CE1' HG13 ' A' ' 23' ' ' VAL . 30.7 t80 -139.34 133.39 31.07 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.156 -0.965 . . . . 0.0 110.364 -179.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 19.2 m -137.06 124.92 22.59 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.29 -0.881 . . . . 0.0 110.486 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.681 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 20.5 p90 -143.24 170.76 15.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.251 -0.905 . . . . 0.0 110.396 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 98' ' ' ILE . 21.4 m -121.34 133.55 55.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.436 -0.79 . . . . 0.0 109.9 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.64 HD23 HG13 ' A' ' 98' ' ' ILE . 4.5 tp -100.31 126.62 46.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.826 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.497 HG12 ' HB2' ' A' ' 68' ' ' LYS . 10.6 pt -111.46 -11.95 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.201 -0.937 . . . . 0.0 110.331 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.533 ' O ' HD11 ' A' ' 85' ' ' LEU . 37.4 tp10 -128.67 167.3 17.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.183 -0.948 . . . . 0.0 110.426 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.911 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 140.99 112.84 0.98 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -48.13 -26.22 1.79 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.234 -1.157 . . . . 0.0 110.451 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.42 -19.68 65.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.197 -0.939 . . . . 0.0 110.315 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.462 ' O ' ' O ' ' A' ' 92' ' ' GLY . 64.2 mt -69.77 -31.42 69.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.143 -0.973 . . . . 0.0 110.253 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 48.65 -177.11 0.02 OUTLIER Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -79.16 3.4 17.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.19 -1.182 . . . . 0.0 110.125 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.499 HG22 ' HG ' ' A' ' 95' ' ' LEU . 1.8 m -88.46 -37.13 16.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.265 -0.897 . . . . 0.0 109.812 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.948 HD21 ' CD1' ' A' ' 128' ' ' ILE . 44.7 mt -109.72 167.19 10.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.285 -0.885 . . . . 0.0 109.936 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -147.03 -79.94 0.15 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.131 -0.981 . . . . 0.0 110.026 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.509 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 15.3 mttp -80.26 126.84 31.64 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.567 -0.708 . . . . 0.0 110.441 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.731 HG21 ' CE2' ' A' ' 100' ' ' TYR . 6.5 mm -115.37 141.65 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.775 -1.203 . . . . 0.0 109.978 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.501 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -119.09 129.7 55.21 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.433 -0.792 . . . . 0.0 108.97 178.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.731 ' CE2' HG21 ' A' ' 98' ' ' ILE . 10.0 m-85 -124.96 136.11 53.44 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.435 -0.791 . . . . 0.0 110.587 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -139.26 128.89 24.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.331 -0.856 . . . . 0.0 110.04 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 89.8 m -127.47 141.37 51.68 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.15 -0.969 . . . . 0.0 110.135 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 115' ' ' LYS . 2.5 mttt -136.52 139.65 42.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.932 . . . . 0.0 110.317 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.867 HD23 HG12 ' A' ' 114' ' ' ILE . 5.4 mt -123.27 152.63 41.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.237 -0.914 . . . . 0.0 110.093 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.711 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -149.72 -169.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.252 -0.905 . . . . 0.0 110.036 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.711 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -124.87 163.14 22.86 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.348 -0.845 . . . . 0.0 110.204 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.458 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 3.0 p -121.73 169.21 9.67 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.0 110.296 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 47.3 Cg_endo -73.03 -8.76 22.68 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.066 1.561 . . . . 0.0 110.606 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 79.8 p -102.77 9.8 38.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.187 -0.946 . . . . 0.0 110.376 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 111' ' ' GLY . . . 94.2 -36.91 3.56 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 110' ' ' GLY . . . -54.45 -174.5 0.09 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.501 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 13.9 p -135.51 136.61 41.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.161 -1.199 . . . . 0.0 110.372 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.825 ' HA ' HG22 ' A' ' 10' ' ' THR . 21.1 mt -90.38 147.08 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.324 -0.86 . . . . 0.0 110.151 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.867 HG12 HD23 ' A' ' 104' ' ' LEU . 19.3 mt -131.46 127.28 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.208 -0.933 . . . . 0.0 110.443 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.49 ' HG3' ' HG3' ' A' ' 8' ' ' GLU . 44.4 tttp -116.23 120.15 38.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.274 -0.891 . . . . 0.0 109.902 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 2.3 t -114.28 158.7 21.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.144 -0.972 . . . . 0.0 110.56 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.625 HG22 ' NE2' ' A' ' 119' ' ' HIS . 96.6 m -158.77 122.2 3.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.433 -0.792 . . . . 0.0 109.919 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.6 m -122.43 153.16 39.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 0.0 110.266 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.705 ' CE1' HG23 ' A' ' 4' ' ' THR . 28.7 m-70 -133.01 162.72 30.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.267 -0.896 . . . . 0.0 110.265 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.565 ' HD1' HD12 ' A' ' 98' ' ' ILE . 30.3 m-85 -131.68 137.98 48.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.273 -0.892 . . . . 0.0 110.466 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.509 ' HB2' ' HB2' ' A' ' 97' ' ' LYS . 69.5 m-70 -117.08 93.07 4.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.231 -0.918 . . . . 0.0 109.342 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.907 ' CG2' HD23 ' A' ' 95' ' ' LEU . 1.4 p -76.96 160.42 29.18 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.375 -0.828 . . . . 0.0 110.85 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 34.2 tttp -137.12 105.76 5.84 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.577 -0.702 . . . . 0.0 109.938 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.455 ' O ' ' CB ' ' A' ' 125' ' ' ASN . . . 126.35 20.62 1.95 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 2.7 t30 67.39 60.42 0.48 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.046 -1.267 . . . . 0.0 110.651 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.54 HG23 ' CG2' ' A' ' 122' ' ' THR . 20.5 m -138.62 145.54 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.176 -0.953 . . . . 0.0 109.739 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.439 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 92.4 mt-10 -104.37 -176.18 3.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.132 -0.98 . . . . 0.0 110.787 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.948 ' CD1' HD21 ' A' ' 95' ' ' LEU . 20.8 mm -86.17 173.39 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.375 -0.828 . . . . 0.0 110.229 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.59 ' N ' HG22 ' A' ' 128' ' ' ILE . 37.9 mttt -97.24 131.27 44.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.282 -0.886 . . . . 0.0 110.027 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.482 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 69.9 mm-40 -45.86 -41.51 11.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.093 -1.004 . . . . 0.0 110.189 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 1.009 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 39.7 tt0 -64.05 -18.01 63.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 109.975 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -93.0 -51.75 4.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 0.0 110.326 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.628 ' CG2' ' CE1' ' A' ' 5' ' ' TYR . 2.7 p -67.01 -26.43 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.893 . . . . 0.0 110.19 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -107.72 -70.05 0.82 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -0.918 . . . . 0.0 110.153 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 1.009 ' HB3' ' O ' ' A' ' 131' ' ' GLU . . . -55.55 -19.78 11.11 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.199 -0.938 . . . . 0.0 109.798 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -75.09 -28.88 61.46 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.441 ' HE2' ' O ' ' A' ' 133' ' ' VAL . 29.7 mttm -65.71 -31.66 72.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.285 -1.127 . . . . 0.0 109.951 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -79.86 -28.87 39.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.948 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -69.31 -35.38 75.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 0.0 109.939 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.03 -40.28 39.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.194 -0.941 . . . . 0.0 109.984 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.8 t -58.21 -47.49 83.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.381 -0.825 . . . . 0.0 109.937 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -54.82 -40.54 69.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.917 . . . . 0.0 109.985 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.574 ' HA ' HD12 ' A' ' 146' ' ' LEU . 21.7 mt -65.33 -39.29 92.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.89 . . . . 0.0 109.885 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.692 ' HA ' HD12 ' A' ' 147' ' ' ILE . 26.6 m-85 -62.6 -35.3 79.1 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.343 -0.848 . . . . 0.0 109.801 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 145' ' ' LYS . 21.9 tttm -71.72 -12.63 61.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.356 -0.84 . . . . 0.0 110.039 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.574 HD12 ' HA ' ' A' ' 143' ' ' LEU . 19.2 mt -83.22 -37.35 23.7 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.179 -0.951 . . . . 0.0 108.875 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.792 HD11 ' CE1' ' A' ' 22' ' ' PHE . 15.6 mt -67.57 -46.61 82.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.784 ' HB3' HD13 ' A' ' 13' ' ' ILE . 68.5 mt-10 -56.84 -45.59 82.26 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.459 -0.776 . . . . 0.0 109.516 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 23.3 m -62.84 -36.65 83.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 109.6 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.572 ' O ' ' CD2' ' A' ' 154' ' ' HIS . 87.7 t80 -54.19 -46.43 72.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.414 -0.804 . . . . 0.0 109.894 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.991 HD21 ' CE1' ' A' ' 158' ' ' TYR . 65.6 mt -79.99 -33.65 39.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.387 -0.821 . . . . 0.0 110.339 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.914 ' HB2' HD11 ' A' ' 13' ' ' ILE . 34.4 tttm -62.68 -16.86 59.16 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.229 -0.919 . . . . 0.0 109.562 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.478 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -115.3 -31.16 2.08 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.615 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 5.1 m-70 -105.95 94.2 8.78 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.36 -1.083 . . . . 0.0 110.19 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.511 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.8 Cg_endo -73.68 6.25 2.91 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.099 1.578 . . . . 0.0 111.049 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -115.42 -8.19 12.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.034 -1.041 . . . . 0.0 109.788 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.675 ' HB3' ' NH2' ' A' ' 17' ' ' ARG . . . -53.34 106.55 0.18 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.439 -0.788 . . . . 0.0 110.035 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 1.041 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 36.23 30.27 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.687 -0.633 . . . . 0.0 110.466 -179.617 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.537 ' CB ' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 118.07 -0.967 . . . . 0.0 109.661 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 92.3 t -114.04 135.1 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.288 -1.125 . . . . 0.0 110.179 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.746 ' CE1' HD12 ' A' ' 128' ' ' ILE . 13.2 m-85 -91.76 156.58 17.45 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.278 -0.889 . . . . 0.0 109.972 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.645 HG23 ' CE1' ' A' ' 119' ' ' HIS . 25.3 m -135.81 113.36 10.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.098 -1.001 . . . . 0.0 110.412 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.936 ' CE2' HG21 ' A' ' 133' ' ' VAL . 71.1 m-85 -128.46 145.22 51.17 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.372 -0.83 . . . . 0.0 109.945 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 22.1 pt-20 -140.13 152.62 46.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.139 -0.976 . . . . 0.0 110.676 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.2 p -143.06 136.37 28.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.484 -0.76 . . . . 0.0 109.624 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.415 ' HG3' ' HG3' ' A' ' 115' ' ' LYS . 4.8 tt0 -123.28 141.81 51.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.02 -1.05 . . . . 0.0 110.912 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.595 ' CE2' ' HB ' ' A' ' 114' ' ' ILE . 3.2 p90 -157.8 -178.08 7.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.517 -0.739 . . . . 0.0 109.592 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.948 HG22 ' HA ' ' A' ' 113' ' ' ILE . 11.5 p -141.53 175.42 9.7 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.057 -1.027 . . . . 0.0 110.707 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.424 ' OG ' ' CD ' ' A' ' 148' ' ' GLU . 3.5 t -159.05 161.78 36.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.502 -0.749 . . . . 0.0 110.22 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -81.34 -36.51 29.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.272 -0.893 . . . . 0.0 110.207 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.792 HG23 ' HD2' ' A' ' 14' ' ' PRO . 3.1 mp -60.68 150.4 75.74 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.347 -0.845 . . . . 0.0 109.869 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.792 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.1 Cg_endo -65.1 142.31 73.62 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.878 1.462 . . . . 0.0 110.59 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.627 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.0 Cg_endo -73.01 -30.82 10.46 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 124.042 1.549 . . . . 0.0 113.049 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 45.0 Cg_endo -73.12 -20.27 21.82 Favored 'Trans proline' 0 C--N 1.317 -1.114 0 N-CA-C 110.125 -0.76 . . . . 0.0 110.125 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.72 ' HG2' HD13 ' A' ' 151' ' ' LEU . 39.7 ttm180 -83.53 -50.52 8.18 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.772 ' C ' HD23 ' A' ' 18' ' ' LEU . 1.1 tt -62.14 -25.98 68.05 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.486 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 52.5 t80 -68.76 -55.38 11.47 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.537 0.684 . . . . 0.0 109.449 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.552 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 15.8 mttt -49.55 -33.69 15.52 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.173 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.881 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -78.98 -50.52 10.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.346 -0.846 . . . . 0.0 110.725 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 1.042 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -62.74 -37.41 86.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.496 -0.752 . . . . 0.0 111.47 -178.809 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.728 HG13 ' CE1' ' A' ' 81' ' ' TYR . 3.3 t -109.4 -55.62 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 120.973 -1.079 . . . . 0.0 111.731 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.733 HD12 ' N ' ' A' ' 24' ' ' LEU . 7.3 mp -76.43 0.1 20.92 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.998 -1.064 . . . . 0.0 111.278 -178.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.685 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -152.19 16.52 0.64 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.876 -1.14 . . . . 0.0 110.452 179.729 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 1.042 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -55.66 -41.62 73.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.164 -0.96 . . . . 0.0 109.891 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.451 ' HA ' ' CB ' ' A' ' 41' ' ' SER . 76.5 m-20 -57.26 -24.26 53.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.288 -0.883 . . . . 0.0 110.075 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.496 ' HB3' ' HE3' ' A' ' 32' ' ' LYS . 77.6 m-20 -120.45 13.9 11.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.383 -0.823 . . . . 0.0 110.056 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.736 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -100.78 -46.24 5.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.885 . . . . 0.0 110.094 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 1.016 HG11 HD13 ' A' ' 38' ' ' ILE . 2.8 t -70.22 -42.41 16.28 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.362 -0.836 . . . . 0.0 110.781 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 30' ' ' VAL . 46.9 Cg_endo -76.4 4.54 5.37 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.482 1.254 . . . . 0.0 110.671 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.496 ' HE3' ' HB3' ' A' ' 28' ' ' ASN . 21.1 mttm -120.02 -32.22 4.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.935 . . . . 0.0 109.077 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.607 HG12 ' CD1' ' A' ' 150' ' ' TYR . 6.8 mt -80.05 -35.27 15.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.444 0.64 . . . . 0.0 109.588 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -160.44 98.17 1.42 Allowed Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.442 -0.786 . . . . 0.0 110.17 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.22 0.1 8.4 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.989 1.521 . . . . 0.0 110.678 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -90.57 -19.37 23.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.141 -0.974 . . . . 0.0 110.36 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.92 -42.65 11.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.184 -0.948 . . . . 0.0 110.369 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 1.016 HD13 HG11 ' A' ' 30' ' ' VAL . 1.1 mp -128.81 144.13 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.415 -0.803 . . . . 0.0 110.328 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.467 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 37.9 ttmt -78.97 -41.76 28.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.325 -0.86 . . . . 0.0 109.854 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.545 ' C ' ' CD2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -178.42 161.57 1.39 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.327 -0.858 . . . . 0.0 110.166 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.451 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 15.5 m -123.3 122.39 38.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.138 -0.976 . . . . 0.0 110.037 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -127.9 111.91 14.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.183 -0.948 . . . . 0.0 110.558 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.447 HG13 ' OD2' ' A' ' 27' ' ' ASP . 24.9 mt -60.05 143.73 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.304 -0.873 . . . . 0.0 109.948 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.539 HD12 ' HB2' ' A' ' 55' ' ' LYS . 1.5 mt -119.26 -26.28 5.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 110.487 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.881 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.6 m95 -123.09 162.03 23.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.162 -0.961 . . . . 0.0 110.496 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.451 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 42.08 -141.95 1.45 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -149.08 24.6 0.92 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -1.13 . . . . 0.0 110.335 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 120.59 -15.59 9.78 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.441 ' O ' ' HB ' ' A' ' 71' ' ' ILE . . . -77.82 -172.87 39.69 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.501 ' HA ' HG22 ' A' ' 71' ' ' ILE . 43.5 Cg_endo -72.04 129.43 15.21 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 O-C-N 123.987 1.519 . . . . 0.0 110.59 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.43 -14.09 47.2 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.564 -1.814 . . . . 0.0 108.564 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -70.63 164.43 24.98 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.51 -0.994 . . . . 0.0 109.581 179.67 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.881 HD12 ' CG ' ' A' ' 45' ' ' TRP . 51.7 mt -135.28 121.23 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 109.997 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 96.2 mttt -107.77 140.72 40.42 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.187 -0.946 . . . . 0.0 110.401 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.539 ' HB2' HD12 ' A' ' 44' ' ' LEU . 25.9 tttt -109.2 90.6 3.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.243 -0.911 . . . . 0.0 110.144 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.562 ' CG2' HG12 ' A' ' 38' ' ' ILE . 82.1 mt -80.04 140.51 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.233 -0.917 . . . . 0.0 110.289 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.516 ' O ' HG23 ' A' ' 38' ' ' ILE . 3.0 p -111.11 158.66 18.62 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.311 -0.868 . . . . 0.0 110.83 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.725 ' HE2' HG13 ' A' ' 67' ' ' VAL . 29.8 m-85 -116.33 133.82 55.58 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.175 -0.953 . . . . 0.0 110.105 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.08 -32.25 83.49 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -60.11 161.03 7.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.202 -1.175 . . . . 0.0 110.229 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 62' ' ' SER . . . 49.74 71.41 0.62 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 61' ' ' GLY . 23.4 m -42.69 -27.76 0.19 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.28 -1.129 . . . . 0.0 110.272 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.404 ' N ' ' O ' ' A' ' 61' ' ' GLY . 69.6 mt-30 -51.54 -72.51 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.183 -0.948 . . . . 0.0 110.119 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -173.18 100.75 0.12 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.242 -0.911 . . . . 0.0 110.24 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -129.61 90.44 0.31 Allowed Glycine 0 N--CA 1.487 2.04 0 N-CA-C 108.29 -1.924 . . . . 0.0 108.29 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.532 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 16.9 p90 -140.36 165.45 27.38 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.055 -1.262 . . . . 0.0 110.304 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.893 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.1 m -131.54 173.48 14.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.459 -0.776 . . . . 0.0 110.321 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.518 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 22.9 mttt -125.49 124.5 41.51 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.62 -0.675 . . . . 0.0 109.656 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.508 ' NE2' HD13 ' A' ' 85' ' ' LEU . 14.7 m170 -112.29 122.01 46.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.191 -0.943 . . . . 0.0 110.777 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 52' ' ' THR . 86.6 tttt -98.62 111.23 23.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.184 -0.948 . . . . 0.0 109.516 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.518 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 24.1 mm -52.46 130.19 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.117 -0.989 . . . . 0.0 109.979 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.501 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 11.9 t0 -108.83 -45.86 3.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.354 -0.841 . . . . 0.0 110.377 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.3 m -164.91 157.68 16.4 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.317 -0.865 . . . . 0.0 109.921 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.544 HG12 HG11 ' A' ' 23' ' ' VAL . 1.9 mt -142.96 158.05 17.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.249 -0.907 . . . . 0.0 110.496 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.565 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 3.1 m-20 -132.79 77.81 1.76 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 120.078 -0.649 . . . . 0.0 109.973 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.486 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 84.4 mttt -61.26 -15.65 37.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.133 -0.979 . . . . 0.0 110.413 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -93.33 -31.06 14.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.191 -0.943 . . . . 0.0 109.645 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.483 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -106.69 -5.41 18.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.574 -0.704 . . . . 0.0 109.796 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.562 ' O ' HD12 ' A' ' 104' ' ' LEU . 5.3 m-85 66.02 50.46 1.45 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.504 -0.747 . . . . 0.0 110.292 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.565 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -120.12 154.67 34.39 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 0.0 109.447 179.51 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.728 ' CE1' HG13 ' A' ' 23' ' ' VAL . 24.5 t80 -142.94 129.74 20.45 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.117 -0.99 . . . . 0.0 110.439 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.48 ' OG ' ' HG3' ' A' ' 101' ' ' GLU . 73.8 m -136.41 120.33 17.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.397 -0.814 . . . . 0.0 110.332 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.642 ' CE2' ' CB ' ' A' ' 100' ' ' TYR . 11.8 p90 -135.06 174.92 10.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.272 -0.893 . . . . 0.0 110.207 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 98' ' ' ILE . 29.3 m -123.73 127.35 48.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.371 -0.831 . . . . 0.0 110.104 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.686 HD23 HG13 ' A' ' 98' ' ' ILE . 5.1 tp -95.37 136.62 35.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.302 -0.874 . . . . 0.0 109.669 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.4 pt -123.59 -14.61 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.233 -0.917 . . . . 0.0 110.48 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.518 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 20.2 tt0 -129.93 129.25 43.6 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.054 -1.029 . . . . 0.0 110.675 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.893 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 177.68 128.54 1.17 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -59.52 -13.66 9.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -1.134 . . . . 0.0 110.415 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.696 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -83.52 -32.01 26.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 110.299 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.599 HD13 ' O ' ' A' ' 96' ' ' GLU . 1.8 pp -90.99 -27.42 18.68 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.28 -0.888 . . . . 0.0 110.569 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.505 ' N ' ' HG ' ' A' ' 91' ' ' LEU . . . -59.69 -31.89 72.52 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.733 ' O ' HG23 ' A' ' 94' ' ' THR . 87.2 m-20 -45.5 -40.02 7.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -1.168 . . . . 0.0 110.414 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.733 HG23 ' O ' ' A' ' 93' ' ' ASP . 1.3 p -160.03 -33.73 0.06 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.274 -0.891 . . . . 0.0 110.682 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.777 HD21 HG13 ' A' ' 128' ' ' ILE . 1.6 mm? -79.99 167.47 20.42 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.14 -0.975 . . . . 0.0 110.656 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.599 ' O ' HD13 ' A' ' 91' ' ' LEU . 43.6 tt0 -128.36 -77.72 0.56 Allowed 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.489 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 89.4 mttt -80.19 145.13 32.43 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.621 -0.675 . . . . 0.0 109.565 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.732 HG21 ' CE2' ' A' ' 100' ' ' TYR . 8.0 mm -128.45 143.31 41.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 120.733 -1.229 . . . . 0.0 110.11 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.484 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -117.04 128.26 54.98 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.404 -0.81 . . . . 0.0 109.362 179.076 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.732 ' CE2' HG21 ' A' ' 98' ' ' ILE . 8.7 m-85 -124.38 134.05 53.24 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.216 -0.928 . . . . 0.0 110.256 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.48 ' HG3' ' OG ' ' A' ' 82' ' ' SER . 81.6 tt0 -138.58 133.74 32.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.254 -0.904 . . . . 0.0 110.333 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.471 ' N ' ' O ' ' A' ' 81' ' ' TYR . 41.2 m -131.75 152.62 50.8 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.225 -0.922 . . . . 0.0 110.091 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 115' ' ' LYS . 6.8 mttm -146.73 138.14 24.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.2 -0.938 . . . . 0.0 110.507 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.868 HD23 HG12 ' A' ' 114' ' ' ILE . 5.7 mt -120.0 152.09 38.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.205 -0.934 . . . . 0.0 109.831 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.707 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -148.65 -169.45 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.046 -1.034 . . . . 0.0 110.129 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.707 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -123.94 163.52 21.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.332 -0.855 . . . . 0.0 110.195 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.467 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 3.0 p -122.48 169.62 9.36 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.246 -0.909 . . . . 0.0 110.201 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.8 Cg_endo -72.9 -9.01 23.2 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.061 1.559 . . . . 0.0 110.491 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.8 p -103.16 9.6 38.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.24 -0.913 . . . . 0.0 110.274 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 111' ' ' GLY . . . 94.54 -39.43 2.9 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 110' ' ' GLY . . . -51.66 -176.44 0.03 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.507 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.4 p -133.68 135.92 44.4 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -1.163 . . . . 0.0 110.467 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.948 ' HA ' HG22 ' A' ' 10' ' ' THR . 17.2 mt -88.78 148.0 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -0.845 . . . . 0.0 109.716 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.868 HG12 HD23 ' A' ' 104' ' ' LEU . 18.8 mt -131.89 121.87 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.238 -0.914 . . . . 0.0 110.58 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 103' ' ' LYS . 14.4 tttp -109.99 128.63 55.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.0 109.787 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.9 152.41 44.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.094 -1.004 . . . . 0.0 110.444 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.662 HG22 ' NE2' ' A' ' 119' ' ' HIS . 38.6 m -152.56 134.91 15.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 110.094 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.441 ' C ' ' CD2' ' A' ' 119' ' ' HIS . 14.4 m -133.44 156.5 47.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.273 -0.892 . . . . 0.0 110.135 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.662 ' NE2' HG22 ' A' ' 117' ' ' THR . 20.2 m-70 -140.77 170.04 16.51 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.168 -0.957 . . . . 0.0 110.423 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.74 ' CB ' HD11 ' A' ' 128' ' ' ILE . 8.8 m-85 -129.7 156.36 44.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.306 -0.871 . . . . 0.0 110.453 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.489 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 83.6 m-70 -135.13 96.75 3.56 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.211 -0.93 . . . . 0.0 109.545 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.609 HG22 HD13 ' A' ' 95' ' ' LEU . 6.1 p -64.48 160.7 18.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.395 -0.816 . . . . 0.0 110.925 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.411 ' HB2' ' HB2' ' A' ' 96' ' ' GLU . 28.7 tttt -119.57 90.94 3.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.493 -0.754 . . . . 0.0 110.17 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 108.95 -109.22 2.75 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -132.15 79.8 1.88 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.253 -1.145 . . . . 0.0 110.252 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.575 HG23 ' HB ' ' A' ' 122' ' ' THR . 7.9 m -146.63 179.5 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.321 -0.862 . . . . 0.0 110.048 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.508 ' CG ' ' O ' ' A' ' 126' ' ' VAL . 81.7 mt-10 -156.13 167.09 31.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.203 -0.936 . . . . 0.0 110.277 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.777 HG13 HD21 ' A' ' 95' ' ' LEU . 2.8 mp -88.7 172.43 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.231 -0.918 . . . . 0.0 110.16 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.599 ' N ' HG22 ' A' ' 128' ' ' ILE . 8.8 mttm -110.42 127.61 55.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.376 -0.827 . . . . 0.0 109.729 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.487 ' HB3' ' CE ' ' A' ' 134' ' ' LYS . 93.6 mt-10 -44.7 -49.27 10.54 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.112 -0.993 . . . . 0.0 109.904 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.509 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 44.8 tt0 -52.83 -20.6 3.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.646 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.696 ' NE2' ' HB1' ' A' ' 90' ' ' ALA . 12.3 t-160 -87.21 -63.72 1.26 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.456 -0.777 . . . . 0.0 110.031 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.936 HG21 ' CE2' ' A' ' 5' ' ' TYR . 8.3 p -59.86 -38.56 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.339 -0.851 . . . . 0.0 109.834 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.509 ' N ' HG13 ' A' ' 133' ' ' VAL . 55.9 mttm -69.65 -46.51 65.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 0.0 109.743 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.509 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -65.6 -30.79 71.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.295 -0.878 . . . . 0.0 109.801 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.47 -32.79 75.75 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 39.9 mttt -61.87 -33.93 75.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.374 -1.074 . . . . 0.0 109.845 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.504 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 83.0 tt0 -83.89 -33.76 24.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 109.842 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 46.1 mttm -71.06 -34.57 71.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.433 -0.792 . . . . 0.0 109.741 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.98 -40.62 46.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.366 -0.833 . . . . 0.0 109.829 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.0 t -60.92 -39.41 89.27 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.429 -0.795 . . . . 0.0 109.929 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 138' ' ' GLU . 75.9 m-20 -60.46 -45.05 95.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.266 -0.896 . . . . 0.0 109.955 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.437 ' HA ' HD12 ' A' ' 146' ' ' LEU . 46.7 mt -59.68 -40.02 86.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.296 -0.878 . . . . 0.0 110.009 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -61.07 -40.4 93.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.449 -0.782 . . . . 0.0 109.95 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.431 ' HA ' ' OE1' ' A' ' 148' ' ' GLU . 87.6 mttt -70.37 -13.96 62.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.286 -0.884 . . . . 0.0 109.98 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.545 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 35.1 mt -83.84 -36.7 23.27 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.196 -0.94 . . . . 0.0 108.83 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.718 HD11 ' CE1' ' A' ' 22' ' ' PHE . 47.4 mt -68.32 -46.55 80.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.555 ' HB3' HD13 ' A' ' 13' ' ' ILE . 74.1 mt-10 -53.27 -44.57 68.33 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.361 -0.837 . . . . 0.0 109.284 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.428 ' O ' ' C ' ' A' ' 150' ' ' TYR . 42.3 m -70.31 -40.88 73.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.33 -0.856 . . . . 0.0 109.388 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.664 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 86.8 t80 -43.11 -45.32 5.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.444 -0.785 . . . . 0.0 109.73 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.158 HD21 ' CE2' ' A' ' 158' ' ' TYR . 51.3 mt -80.05 -45.62 17.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.37 -0.831 . . . . 0.0 110.459 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.735 ' HB2' HD11 ' A' ' 13' ' ' ILE . 21.7 ttpp -59.72 -15.23 18.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.365 -0.834 . . . . 0.0 109.525 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -112.41 -29.95 3.03 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.56 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 7.1 m-70 -114.18 96.01 40.82 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.294 -1.121 . . . . 0.0 110.012 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.423 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.1 Cg_endo -73.52 5.96 3.0 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.161 1.611 . . . . 0.0 111.267 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -108.28 -7.22 15.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.908 -1.12 . . . . 0.0 109.82 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.664 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -75.63 101.72 5.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.435 -0.791 . . . . 0.0 110.147 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 1.158 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.3 OUTLIER 34.71 32.67 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.461 0.648 . . . . 0.0 110.288 -179.417 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.527 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.871 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.657 HG11 ' CE1' ' A' ' 121' ' ' HIS . 22.2 t -124.21 138.24 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -1.139 . . . . 0.0 110.403 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.71 ' CE1' HD12 ' A' ' 128' ' ' ILE . 9.5 m-85 -103.21 156.57 17.62 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.318 -0.864 . . . . 0.0 109.897 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.599 HG23 ' CE1' ' A' ' 119' ' ' HIS . 7.1 m -126.58 112.75 15.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.131 -0.981 . . . . 0.0 110.592 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.036 ' CE1' HG11 ' A' ' 133' ' ' VAL . 59.7 m-85 -120.6 143.71 48.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.183 -0.948 . . . . 0.0 110.177 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 21.9 pt-20 -144.7 152.74 40.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.173 -0.954 . . . . 0.0 110.33 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.462 ' O ' ' CG ' ' A' ' 8' ' ' GLU . 2.3 t -128.23 171.1 12.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.334 -0.854 . . . . 0.0 109.989 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.462 ' CG ' ' O ' ' A' ' 7' ' ' SER . 78.7 mt-10 -154.18 115.98 4.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.931 . . . . 0.0 110.422 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.3 p90 -147.93 -174.65 4.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.396 -0.815 . . . . 0.0 109.731 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.867 HG22 ' HA ' ' A' ' 113' ' ' ILE . 7.7 p -141.91 175.66 9.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.091 -1.006 . . . . 0.0 110.527 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.469 ' HB2' ' HG2' ' A' ' 148' ' ' GLU . 85.6 p -157.36 126.91 6.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.543 -0.723 . . . . 0.0 110.23 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.45 ' HA ' ' HA2' ' A' ' 111' ' ' GLY . 98.2 mt-10 -53.64 -35.14 60.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.288 -0.882 . . . . 0.0 110.053 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.824 HG23 ' HD2' ' A' ' 14' ' ' PRO . 2.5 mp -65.18 150.78 95.07 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.309 -0.869 . . . . 0.0 109.881 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.824 ' HD2' HG23 ' A' ' 13' ' ' ILE . 41.8 Cg_endo -67.4 142.72 60.83 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.965 1.508 . . . . 0.0 110.619 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.667 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.6 Cg_endo -72.63 -31.04 11.24 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 124.036 1.545 . . . . 0.0 112.811 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.667 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.1 Cg_endo -70.18 -20.65 32.6 Favored 'Trans proline' 0 N--CA 1.485 1.013 0 N-CA-C 110.145 -0.752 . . . . 0.0 110.145 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.604 ' CZ ' HD22 ' A' ' 151' ' ' LEU . 43.4 mtp180 -84.71 -48.98 8.89 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.773 ' C ' HD23 ' A' ' 18' ' ' LEU . 1.3 tt -67.89 -28.36 67.45 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.571 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 83.5 t80 -68.39 -61.41 1.85 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.435 -0.791 . . . . 0.0 109.067 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.521 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 34.2 mttm -46.6 -32.81 3.69 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.751 -0.78 . . . . 0.0 109.114 179.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.047 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -79.85 -40.55 28.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.358 -0.839 . . . . 0.0 110.64 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.982 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -70.98 -42.51 69.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.33 -0.856 . . . . 0.0 111.429 -178.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.621 HG13 ' CE1' ' A' ' 81' ' ' TYR . 4.3 t -104.18 -51.53 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.064 -1.023 . . . . 0.0 111.47 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.694 HD12 ' N ' ' A' ' 24' ' ' LEU . 7.4 mp -80.05 0.44 31.83 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.183 -0.948 . . . . 0.0 111.37 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.594 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -155.66 30.44 0.37 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.838 -1.164 . . . . 0.0 110.97 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.982 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -70.27 -28.81 65.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.105 -0.997 . . . . 0.0 109.86 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.491 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 60.9 m-20 -68.18 -12.44 60.94 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.297 -0.877 . . . . 0.0 109.848 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.554 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 79.8 m-20 -131.0 8.86 4.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.351 -0.843 . . . . 0.0 109.948 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.697 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -94.4 -49.99 5.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.356 -0.84 . . . . 0.0 110.466 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.958 HG21 HD13 ' A' ' 38' ' ' ILE . 6.6 p -77.87 -26.94 0.54 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.367 -0.833 . . . . 0.0 112.457 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.795 ' HD3' HG12 ' A' ' 30' ' ' VAL . 50.5 Cg_endo -78.25 7.17 4.22 Favored 'Trans proline' 0 C--N 1.319 -0.994 0 O-C-N 122.592 0.785 . . . . 0.0 110.703 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -135.38 -32.9 0.91 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.23 -0.919 . . . . 0.0 110.066 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.546 HG12 ' CD1' ' A' ' 150' ' ' TYR . 9.6 mt -80.0 -40.05 20.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.363 -0.836 . . . . 0.0 109.993 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -158.96 98.61 1.65 Allowed Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.275 -0.89 . . . . 0.0 110.374 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.04 2.31 6.8 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.032 1.543 . . . . 0.0 110.585 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -88.75 -16.17 32.87 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.186 -0.946 . . . . 0.0 110.129 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.645 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -95.92 -32.7 12.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 110.256 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.958 HD13 HG21 ' A' ' 30' ' ' VAL . 1.1 mp -145.81 133.91 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.338 -0.851 . . . . 0.0 109.883 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 57' ' ' THR . 27.7 ttpp -82.63 -25.98 32.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.886 . . . . 0.0 110.44 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.539 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -175.31 157.84 2.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.194 -0.941 . . . . 0.0 110.261 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.2 m -135.45 121.29 19.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.421 -0.8 . . . . 0.0 109.565 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.539 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 48.3 tt0 -138.88 111.81 7.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.006 -1.059 . . . . 0.0 110.689 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.44 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 27.9 mt -50.63 143.24 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.412 -0.805 . . . . 0.0 109.896 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 11.6 tp -116.83 -21.8 8.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.308 -0.87 . . . . 0.0 110.348 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.733 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.7 m95 -131.5 163.29 28.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.237 -0.915 . . . . 0.0 110.615 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.451 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 42.63 -134.25 4.44 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -155.51 19.12 0.4 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -1.108 . . . . 0.0 110.231 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.69 -16.21 7.0 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.494 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -74.81 -173.73 31.94 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.415 ' HA ' HG22 ' A' ' 71' ' ' ILE . 44.6 Cg_endo -72.97 129.53 14.38 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 124.055 1.555 . . . . 0.0 110.466 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.3 -14.96 47.31 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.52 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -69.86 167.38 17.43 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.521 -0.988 . . . . 0.0 109.463 179.536 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.733 HD12 ' CG ' ' A' ' 45' ' ' TRP . 43.3 mt -134.94 120.75 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.202 -0.936 . . . . 0.0 110.18 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.488 ' HD2' HD11 ' A' ' 71' ' ' ILE . 17.7 mtpt -102.91 130.48 49.97 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.193 -0.942 . . . . 0.0 110.111 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -98.42 91.57 5.25 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.184 -0.948 . . . . 0.0 109.906 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.549 ' CG2' HG12 ' A' ' 38' ' ' ILE . 93.4 mt -80.02 138.73 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.371 -0.831 . . . . 0.0 110.046 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 3.1 p -114.93 155.9 26.02 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.232 -0.918 . . . . 0.0 110.476 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.594 ' CZ ' HG22 ' A' ' 67' ' ' VAL . 20.1 m-85 -117.93 142.46 47.32 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.358 -0.839 . . . . 0.0 110.038 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -113.93 34.22 5.08 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.4 -24.38 44.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.356 -1.085 . . . . 0.0 110.373 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 177.78 -163.88 32.5 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 65.7 m -63.7 -45.73 88.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -1.105 . . . . 0.0 110.196 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -46.47 134.06 9.48 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.264 -0.898 . . . . 0.0 110.146 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -72.09 127.21 31.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.291 -0.88 . . . . 0.0 110.27 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -140.74 113.38 0.86 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.539 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 15.6 p90 -154.65 170.65 21.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.082 -1.246 . . . . 0.0 110.122 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.897 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.0 m -141.28 174.52 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.27 -0.894 . . . . 0.0 110.764 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.507 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 25.1 mttt -126.21 120.7 30.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.547 -0.72 . . . . 0.0 109.489 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.729 ' CD2' HD12 ' A' ' 85' ' ' LEU . 18.3 m170 -108.76 129.13 55.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.223 -0.923 . . . . 0.0 111.037 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 52' ' ' THR . 44.3 tttp -100.43 112.95 25.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.225 -0.922 . . . . 0.0 109.474 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.537 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 31.0 mm -52.08 130.77 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.1 -1.0 . . . . 0.0 110.239 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.458 ' OD2' ' OG1' ' A' ' 84' ' ' THR . 58.8 m-20 -106.45 -36.85 6.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 0.0 110.258 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.647 ' C ' HD12 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -178.55 166.24 1.77 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.178 -0.952 . . . . 0.0 109.635 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.647 HD12 ' C ' ' A' ' 73' ' ' SER . 0.9 OUTLIER -151.82 155.9 6.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 119.016 -1.074 . . . . 0.0 111.386 -179.682 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.508 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 2.3 m-20 -132.78 76.12 1.67 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.303 0.573 . . . . 0.0 109.919 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.571 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 45.9 mttt -60.83 -12.51 11.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.226 -0.921 . . . . 0.0 110.406 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -92.82 -31.97 14.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.298 -0.876 . . . . 0.0 109.483 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.48 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -107.43 -6.16 17.25 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.534 -0.729 . . . . 0.0 109.839 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.774 ' O ' HD12 ' A' ' 104' ' ' LEU . 4.0 m-85 69.11 48.83 0.66 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.558 -0.714 . . . . 0.0 110.183 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.508 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.5 OUTLIER -119.58 147.18 44.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.232 -0.917 . . . . 0.0 109.543 179.626 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.68 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 76.1 t80 -140.35 143.28 35.67 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.093 -1.004 . . . . 0.0 110.6 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.447 ' C ' ' HB2' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -148.69 141.26 24.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -0.877 . . . . 0.0 110.098 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.68 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 10.7 p90 -151.52 175.66 12.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.144 -0.973 . . . . 0.0 110.699 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 98' ' ' ILE . 6.5 m -122.58 127.84 49.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.467 -0.771 . . . . 0.0 109.688 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.729 HD12 ' CD2' ' A' ' 69' ' ' HIS . 2.9 tp -94.98 128.25 41.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.166 -0.959 . . . . 0.0 110.314 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 14.3 pt -114.81 0.51 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.33 -0.856 . . . . 0.0 110.392 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.507 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 72.4 tt0 -149.32 154.42 38.96 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.253 -0.904 . . . . 0.0 110.198 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.897 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 150.94 130.55 1.72 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -57.34 -16.04 7.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.329 -1.1 . . . . 0.0 110.2 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.419 ' O ' ' CE1' ' A' ' 132' ' ' HIS . . . -66.44 -30.28 70.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.225 -0.922 . . . . 0.0 110.201 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 21.1 mt -58.06 -15.57 9.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -0.866 . . . . 0.0 110.036 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.765 ' O ' HG23 ' A' ' 94' ' ' THR . . . 48.12 30.73 7.77 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 92' ' ' GLY . 93.1 m-20 56.56 15.36 2.05 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.251 -1.147 . . . . 0.0 110.379 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.765 HG23 ' O ' ' A' ' 92' ' ' GLY . 65.6 p -108.18 -52.78 2.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.931 . . . . 0.0 109.604 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 1.018 HD21 ' CG1' ' A' ' 128' ' ' ILE . 14.9 mt -80.36 164.1 23.38 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.499 -0.751 . . . . 0.0 109.741 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.444 ' OE1' ' HD3' ' A' ' 123' ' ' LYS . 42.3 tt0 -132.19 -78.35 0.5 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 110.326 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.513 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 54.6 mttt -80.2 128.4 33.48 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.49 -0.756 . . . . 0.0 110.638 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.757 HG21 ' CE2' ' A' ' 100' ' ' TYR . 4.7 mm -120.45 141.53 40.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 120.682 -1.261 . . . . 0.0 109.692 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.491 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -122.38 126.59 48.33 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.429 -0.794 . . . . 0.0 108.986 178.79 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.757 ' CE2' HG21 ' A' ' 98' ' ' ILE . 12.7 m-85 -122.59 133.51 54.54 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.294 -0.879 . . . . 0.0 110.491 -179.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.509 ' N ' ' O ' ' A' ' 117' ' ' THR . 49.6 tt0 -136.24 134.38 38.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.36 -0.837 . . . . 0.0 110.259 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 94.0 m -131.67 140.56 49.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.263 -0.898 . . . . 0.0 110.069 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.76 139.34 50.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.307 -0.871 . . . . 0.0 110.229 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.784 HD23 HG12 ' A' ' 114' ' ' ILE . 11.4 mt -115.51 149.74 37.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.345 -0.847 . . . . 0.0 109.991 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.704 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -150.44 -168.43 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.202 -0.936 . . . . 0.0 110.21 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.704 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -121.37 158.47 28.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.285 -0.884 . . . . 0.0 110.115 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.471 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 9.5 p -114.91 167.04 10.44 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.19 -0.944 . . . . 0.0 110.321 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.9 Cg_endo -72.23 -4.23 14.82 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.074 1.565 . . . . 0.0 110.39 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 65.4 m -107.06 0.7 23.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.238 -0.914 . . . . 0.0 110.245 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.63 -41.07 2.26 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 12' ' ' GLU . . . -54.31 -177.61 0.13 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.517 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 6.7 p -124.61 140.29 53.08 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.226 -1.161 . . . . 0.0 110.321 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.867 ' HA ' HG22 ' A' ' 10' ' ' THR . 19.5 mt -92.9 147.55 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.33 -0.857 . . . . 0.0 110.129 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.784 HG12 HD23 ' A' ' 104' ' ' LEU . 8.7 mt -130.96 126.89 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.283 -0.886 . . . . 0.0 110.144 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -119.72 111.15 17.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.154 -0.966 . . . . 0.0 110.144 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 2.4 m -96.64 159.71 14.78 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.229 -0.919 . . . . 0.0 110.552 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 101' ' ' GLU . 25.4 m -160.11 117.98 2.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.516 -0.74 . . . . 0.0 109.959 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 99' ' ' SER . 96.7 p -125.31 161.78 26.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.09 -1.006 . . . . 0.0 110.453 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.599 ' CE1' HG23 ' A' ' 4' ' ' THR . 62.9 m-70 -140.15 131.84 27.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.307 -0.871 . . . . 0.0 110.225 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.72 ' CD2' HD13 ' A' ' 95' ' ' LEU . 3.2 m-85 -98.16 148.15 23.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.393 -0.817 . . . . 0.0 109.672 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.657 ' CE1' HG11 ' A' ' 2' ' ' VAL . 88.6 m-70 -129.13 93.19 3.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.055 -1.028 . . . . 0.0 110.054 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.661 ' CG2' HD23 ' A' ' 95' ' ' LEU . 2.0 p -66.41 156.93 33.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.249 -0.907 . . . . 0.0 110.228 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.444 ' HD3' ' OE1' ' A' ' 96' ' ' GLU . 17.6 tptt -116.54 115.83 26.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.336 -0.852 . . . . 0.0 110.197 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 99.57 -118.28 6.13 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -132.82 73.11 1.51 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.189 -1.183 . . . . 0.0 110.166 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.544 HG23 ' CG2' ' A' ' 122' ' ' THR . 14.1 m -139.69 153.11 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.262 -0.899 . . . . 0.0 110.154 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -126.37 170.04 12.34 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.215 -0.928 . . . . 0.0 110.28 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 1.018 ' CG1' HD21 ' A' ' 95' ' ' LEU . 3.4 mp -100.01 172.77 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.191 -0.943 . . . . 0.0 110.161 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.602 ' N ' HG22 ' A' ' 128' ' ' ILE . 10.5 mttt -116.32 132.18 56.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.896 . . . . 0.0 109.811 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 129' ' ' LYS . 95.0 mt-10 -42.55 -42.96 3.54 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.266 -0.897 . . . . 0.0 110.185 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -52.4 -37.99 57.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.157 -0.964 . . . . 0.0 109.911 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.419 ' CE1' ' O ' ' A' ' 90' ' ' ALA . 13.7 t-160 -74.54 -57.45 3.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.331 -0.856 . . . . 0.0 110.072 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 1.036 HG11 ' CE1' ' A' ' 5' ' ' TYR . 79.4 t -58.97 -36.35 61.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.421 -0.799 . . . . 0.0 109.891 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 31.0 tttt -71.69 -44.07 64.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.3 -0.875 . . . . 0.0 109.945 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.47 -27.55 68.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.998 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -74.15 -28.64 63.85 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -73.41 -34.04 65.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.294 -1.121 . . . . 0.0 110.006 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -82.1 -31.46 30.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 109.967 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.573 ' O ' HD12 ' A' ' 143' ' ' LEU . 43.3 mttm -72.57 -33.95 67.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.889 . . . . 0.0 110.004 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -80.31 -34.4 36.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 110.123 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 71.4 m -63.66 -41.56 98.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.332 -0.855 . . . . 0.0 110.045 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -58.66 -45.16 89.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.273 -0.892 . . . . 0.0 110.105 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.573 HD12 ' O ' ' A' ' 139' ' ' LYS . 2.6 mt -61.03 -40.25 92.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -0.885 . . . . 0.0 110.104 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.408 ' CE1' ' CE2' ' A' ' 22' ' ' PHE . 17.6 m-85 -62.35 -34.06 75.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.377 -0.827 . . . . 0.0 109.961 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 145' ' ' LYS . 30.3 tttm -76.04 -14.18 60.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.338 -0.851 . . . . 0.0 110.24 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 19.6 mt -84.07 -37.13 22.47 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.059 -1.026 . . . . 0.0 109.023 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.791 HD11 ' CE1' ' A' ' 22' ' ' PHE . 24.5 mt -69.14 -43.32 81.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.581 ' HB3' HD13 ' A' ' 13' ' ' ILE . 83.8 mt-10 -53.04 -44.65 67.56 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.392 -0.818 . . . . 0.0 109.347 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 28.5 m -66.69 -33.13 74.97 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 109.762 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.628 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 89.3 t80 -55.02 -49.65 71.0 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.409 -0.807 . . . . 0.0 110.04 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.021 HD21 ' CE1' ' A' ' 158' ' ' TYR . 74.7 mt -76.17 -36.08 58.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -0.872 . . . . 0.0 110.419 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.754 ' HB2' HD11 ' A' ' 13' ' ' ILE . 8.5 tttp -60.19 -15.35 23.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.253 -0.905 . . . . 0.0 109.308 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.492 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -120.05 -24.12 2.82 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.577 ' CD2' ' O ' ' A' ' 150' ' ' TYR . 12.9 m-70 -106.1 92.41 6.57 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.296 -1.12 . . . . 0.0 110.162 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.4 Cg_endo -73.2 4.17 4.02 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.025 1.54 . . . . 0.0 110.937 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -120.33 -6.73 9.83 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.994 -1.066 . . . . 0.0 109.919 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.675 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -53.91 106.11 0.17 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.889 . . . . 0.0 109.826 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 1.047 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 36.23 30.38 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.661 -0.649 . . . . 0.0 110.518 -179.466 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.542 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.802 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.984 HG23 ' C ' ' A' ' 120' ' ' TYR . 2.6 p -79.96 149.54 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.357 -1.084 . . . . 0.0 110.712 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.788 ' CE2' HD12 ' A' ' 128' ' ' ILE . 5.1 m-85 -86.74 169.65 12.45 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.664 -0.647 . . . . 0.0 110.145 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.536 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 3.3 m -123.82 129.82 51.63 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.102 -0.999 . . . . 0.0 110.47 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.584 ' CE2' ' HB2' ' A' ' 3' ' ' PHE . 39.1 m-85 -142.68 133.72 25.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.316 -0.865 . . . . 0.0 110.028 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.608 ' CG ' HG23 ' A' ' 117' ' ' THR . 30.9 mt-10 -143.9 145.22 32.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -0.926 . . . . 0.0 110.515 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.479 ' O ' ' HG2' ' A' ' 8' ' ' GLU . 5.6 t -118.5 169.88 9.4 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.395 -0.815 . . . . 0.0 109.85 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 7' ' ' SER . 60.7 mt-10 -152.53 123.07 7.29 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.14 -0.975 . . . . 0.0 110.643 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.637 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 1.9 p90 -148.93 -176.94 5.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.406 -0.809 . . . . 0.0 109.735 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.726 HG22 ' HA ' ' A' ' 113' ' ' ILE . 11.1 p -139.23 -179.91 6.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.132 -0.98 . . . . 0.0 110.696 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.2 t -159.99 168.65 25.16 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.429 -0.794 . . . . 0.0 110.102 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -92.04 -28.78 16.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.162 -0.961 . . . . 0.0 110.164 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.863 HD13 ' HB3' ' A' ' 148' ' ' GLU . 2.6 mp -70.6 151.04 95.51 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.319 -0.863 . . . . 0.0 110.129 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.836 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.3 Cg_endo -65.92 142.74 70.17 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.965 1.508 . . . . 0.0 110.509 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.646 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.7 Cg_endo -73.31 -30.48 10.26 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 O-C-N 123.992 1.522 . . . . 0.0 113.048 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.646 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.7 Cg_endo -71.13 -24.41 23.59 Favored 'Trans proline' 0 C--N 1.317 -1.084 0 N-CA-C 110.184 -0.737 . . . . 0.0 110.184 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.568 ' CZ ' ' HA ' ' A' ' 159' ' ' ASN . 1.5 mtp85 -83.05 -44.95 14.61 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.942 HD22 ' O ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -65.59 -30.93 71.72 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.727 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.573 ' N ' HD13 ' A' ' 18' ' ' LEU . 44.7 t80 -66.27 -54.94 18.98 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.413 -0.804 . . . . 0.0 109.685 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.642 ' HG2' HD22 ' A' ' 24' ' ' LEU . 20.1 mttt -51.98 -31.72 30.45 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.107 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.085 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -80.04 -46.44 16.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.612 -0.68 . . . . 0.0 110.87 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 1.046 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -66.44 -40.01 89.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.379 -0.826 . . . . 0.0 111.536 -178.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.613 HG13 ' CE1' ' A' ' 81' ' ' TYR . 3.4 t -107.6 -62.6 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.797 -1.19 . . . . 0.0 111.472 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.642 HD22 ' HG2' ' A' ' 20' ' ' LYS . 7.4 mp -62.78 -11.48 18.01 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.143 -0.973 . . . . 0.0 111.324 -178.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.566 ' HB3' HD23 ' A' ' 29' ' ' LEU . 1.2 m-20 -143.76 28.4 1.43 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.829 -1.169 . . . . 0.0 110.59 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 1.046 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -68.27 -21.03 64.82 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.246 -0.909 . . . . 0.0 110.296 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -72.35 -13.73 61.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -0.95 . . . . 0.0 110.173 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.511 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 5.5 p30 -133.74 8.96 3.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.372 -0.83 . . . . 0.0 110.01 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.908 HD21 ' OH ' ' A' ' 158' ' ' TYR . 0.3 OUTLIER -93.45 -45.72 7.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.325 -0.86 . . . . 0.0 109.913 179.872 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.976 HG11 HD13 ' A' ' 38' ' ' ILE . 2.5 t -73.37 -42.71 6.9 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.448 -0.782 . . . . 0.0 110.777 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.8 Cg_endo -78.01 7.57 3.93 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.448 1.236 . . . . 0.0 110.733 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.5 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 42.8 mmtm -124.32 -32.76 3.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.161 -0.962 . . . . 0.0 109.569 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.578 HD13 ' HA ' ' A' ' 147' ' ' ILE . 12.7 mt -80.04 -33.31 14.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.542 -0.724 . . . . 0.0 109.476 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -156.8 94.87 2.25 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.475 -0.766 . . . . 0.0 110.07 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.26 -1.2 9.77 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.046 1.551 . . . . 0.0 110.614 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -91.88 -6.66 51.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.147 -0.971 . . . . 0.0 110.248 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -99.21 -69.04 0.78 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.224 -0.922 . . . . 0.0 110.25 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.976 HD13 HG11 ' A' ' 30' ' ' VAL . 1.3 mp -103.46 149.1 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.35 -0.844 . . . . 0.0 110.154 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.461 ' O ' ' HB3' ' A' ' 40' ' ' HIS . 8.0 ttmm -86.93 -37.04 17.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 110.26 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.542 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER 177.71 134.77 0.07 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.186 -0.946 . . . . 0.0 110.502 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.5 m -94.67 135.73 35.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.158 -0.963 . . . . 0.0 109.804 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.542 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 42.4 tt0 -140.05 114.38 9.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.182 -0.948 . . . . 0.0 110.446 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 14.2 mt -61.85 138.28 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.164 -0.96 . . . . 0.0 109.962 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 13.3 tp -114.91 -25.86 8.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.23 -0.919 . . . . 0.0 110.468 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.504 ' HB2' ' CB ' ' A' ' 53' ' ' ILE . 1.8 m95 -127.77 163.99 23.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.217 -0.927 . . . . 0.0 110.588 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.46 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 42.23 -132.67 4.4 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.428 ' N ' ' OG1' ' A' ' 52' ' ' THR . 0.6 OUTLIER -156.34 20.23 0.35 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -1.12 . . . . 0.0 110.15 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.04 -22.97 6.65 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.455 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -71.11 -171.96 12.42 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.482 ' HA ' HG22 ' A' ' 71' ' ' ILE . 44.2 Cg_endo -72.12 128.97 14.5 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 124.045 1.55 . . . . 0.0 110.497 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.32 -15.45 42.75 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.55 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.1 m -72.03 161.71 30.51 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.594 -0.945 . . . . 0.0 109.382 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.504 ' CB ' ' HB2' ' A' ' 45' ' ' TRP . 50.0 mt -132.16 119.8 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.292 -0.88 . . . . 0.0 109.993 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 21.7 mtpt -102.29 134.76 45.06 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.151 -0.968 . . . . 0.0 110.339 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 17.9 tttm -102.39 93.7 5.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.32 -0.863 . . . . 0.0 110.008 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.547 ' CG2' HG12 ' A' ' 38' ' ' ILE . 84.7 mt -80.08 138.79 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.233 -0.917 . . . . 0.0 110.052 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.513 ' O ' HG23 ' A' ' 38' ' ' ILE . 1.4 p -113.73 151.75 31.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 0.0 110.446 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.574 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 24.0 m-85 -115.55 150.11 37.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.367 -0.833 . . . . 0.0 110.062 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -125.09 44.28 1.28 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -73.6 -23.66 59.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.342 -1.093 . . . . 0.0 110.336 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -165.11 -170.45 30.09 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 91.4 p -66.54 -40.59 89.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -1.155 . . . . 0.0 110.202 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -49.72 147.13 3.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.31 -0.869 . . . . 0.0 110.126 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -82.39 117.83 22.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.304 -0.872 . . . . 0.0 110.146 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.574 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -126.56 99.71 0.55 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.545 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 11.6 p90 -138.5 165.58 26.48 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.187 -1.184 . . . . 0.0 110.158 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.898 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.8 m -139.2 175.06 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.252 -0.905 . . . . 0.0 110.567 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 72.8 mttt -129.79 114.98 16.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.525 -0.735 . . . . 0.0 109.928 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.493 ' NE2' HD13 ' A' ' 85' ' ' LEU . 20.1 m170 -103.36 123.16 46.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.343 -0.848 . . . . 0.0 110.742 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 52' ' ' THR . 40.3 tttp -94.85 111.95 23.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 0.0 109.664 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.526 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 39.2 mm -47.3 137.13 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.209 -0.932 . . . . 0.0 110.417 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.553 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 11.1 t0 -112.11 -36.77 5.25 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.398 -0.814 . . . . 0.0 109.934 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.428 ' C ' HD12 ' A' ' 74' ' ' ILE . 1.0 OUTLIER 179.92 163.08 1.03 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.319 -0.863 . . . . 0.0 109.657 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.465 HG12 HG11 ' A' ' 23' ' ' VAL . 0.7 OUTLIER -146.75 155.75 11.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.056 -1.028 . . . . 0.0 111.157 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.54 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 2.5 m-20 -132.57 78.2 1.79 Allowed 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.011 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.546 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 34.0 mttp -61.03 -17.97 55.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.228 -0.92 . . . . 0.0 110.346 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -92.32 -31.01 15.53 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.226 -0.921 . . . . 0.0 109.567 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.482 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -103.78 -6.55 21.35 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.571 -0.706 . . . . 0.0 109.893 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.539 ' N ' ' O ' ' A' ' 75' ' ' ASP . 3.8 m-30 66.02 52.11 1.24 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.536 -0.727 . . . . 0.0 110.14 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.54 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.6 OUTLIER -125.18 147.66 48.95 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.246 -0.909 . . . . 0.0 109.672 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.642 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 58.1 t80 -137.26 135.63 37.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.146 -0.971 . . . . 0.0 110.118 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.421 ' O ' ' N ' ' A' ' 72' ' ' ASP . 26.3 m -141.31 127.58 19.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.077 -1.014 . . . . 0.0 110.779 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.642 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 10.9 p90 -138.72 174.52 10.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.373 -0.83 . . . . 0.0 109.966 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 98' ' ' ILE . 69.7 m -125.87 129.19 48.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 0.0 109.738 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.675 HD23 HG13 ' A' ' 98' ' ' ILE . 3.5 tp -97.07 132.69 42.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.11 -0.994 . . . . 0.0 110.318 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.3 pt -118.81 -24.25 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.394 -0.816 . . . . 0.0 110.148 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.493 ' O ' HD11 ' A' ' 85' ' ' LEU . 68.0 tt0 -121.73 147.17 46.25 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.262 -0.899 . . . . 0.0 110.159 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.898 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 165.03 124.65 0.72 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -52.05 -25.01 7.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -1.163 . . . . 0.0 110.22 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.32 -24.03 59.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.166 -0.959 . . . . 0.0 110.226 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.687 HD12 ' N ' ' A' ' 88' ' ' GLY . 72.1 mt -63.98 -32.55 74.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.903 . . . . 0.0 110.167 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 46.81 -173.48 0.02 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 52.3 p30 -83.19 7.02 17.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.262 -1.14 . . . . 0.0 110.163 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.709 ' O ' HG21 ' A' ' 126' ' ' VAL . 60.7 p -92.58 -33.72 14.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.319 -0.863 . . . . 0.0 110.137 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.941 HD21 ' CG1' ' A' ' 128' ' ' ILE . 61.9 mt -108.03 172.41 6.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.333 -0.854 . . . . 0.0 110.278 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.517 ' OE1' ' N ' ' A' ' 123' ' ' LYS . 48.5 mp0 -149.9 -82.36 0.11 Allowed 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.772 0.796 . . . . 0.0 109.311 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.509 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 59.7 mttt -80.44 127.57 32.57 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.782 -0.574 . . . . 0.0 110.72 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.753 HG21 ' CE2' ' A' ' 100' ' ' TYR . 5.4 mm -117.8 140.4 41.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 120.563 -1.336 . . . . 0.0 109.293 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.505 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -120.31 126.59 50.92 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.094 179.099 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.753 ' CE2' HG21 ' A' ' 98' ' ' ILE . 11.7 m-85 -122.61 135.55 54.65 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.407 -0.808 . . . . 0.0 110.367 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.527 ' CB ' ' HB ' ' A' ' 117' ' ' THR . 3.5 mt-10 -138.78 131.02 28.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.316 -0.865 . . . . 0.0 110.122 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 34.1 m -128.27 133.91 48.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.323 -0.86 . . . . 0.0 109.853 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.47 145.86 51.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.137 -0.977 . . . . 0.0 110.531 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.641 HD23 HG12 ' A' ' 114' ' ' ILE . 10.9 mt -122.47 153.59 38.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.3 -0.875 . . . . 0.0 110.01 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.701 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -151.12 -168.79 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.183 -0.948 . . . . 0.0 110.125 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.701 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -126.39 147.52 49.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.288 -0.883 . . . . 0.0 110.189 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.458 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 2.6 p -105.87 169.79 6.57 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.14 -0.975 . . . . 0.0 110.273 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 47.3 Cg_endo -73.19 -9.44 23.3 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.004 1.528 . . . . 0.0 110.403 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 63.1 p -97.37 6.63 47.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.305 -0.872 . . . . 0.0 110.326 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 96.18 -37.71 3.34 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -56.67 -172.42 0.17 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.5 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 25.1 p -133.99 137.14 44.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.259 -1.142 . . . . 0.0 110.276 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.726 ' HA ' HG22 ' A' ' 10' ' ' THR . 18.4 mt -86.77 150.31 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.313 -0.867 . . . . 0.0 110.218 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.641 HG12 HD23 ' A' ' 104' ' ' LEU . 16.5 mt -131.45 120.01 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.233 -0.917 . . . . 0.0 110.192 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.4 tttm -106.7 124.72 50.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.134 -0.979 . . . . 0.0 110.093 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -111.56 154.37 24.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.23 -0.919 . . . . 0.0 110.469 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.608 HG23 ' CG ' ' A' ' 6' ' ' GLU . 88.0 m -145.97 145.2 30.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.385 -0.822 . . . . 0.0 110.249 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.462 ' HG ' ' HE1' ' A' ' 100' ' ' TYR . 49.7 m -155.49 120.76 4.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.908 . . . . 0.0 109.857 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.505 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 41.1 m-70 -112.14 157.57 20.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.151 -0.968 . . . . 0.0 110.559 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.984 ' C ' HG23 ' A' ' 2' ' ' VAL . 10.2 m-85 -125.78 119.89 29.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.371 -0.831 . . . . 0.0 110.511 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.697 ' CE1' HG11 ' A' ' 2' ' ' VAL . 69.9 m-70 -98.79 101.84 13.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.265 -0.897 . . . . 0.0 109.601 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.694 HG23 HD23 ' A' ' 95' ' ' LEU . 0.8 OUTLIER -88.26 142.46 27.73 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.131 -0.981 . . . . 0.0 110.499 -179.507 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.517 ' N ' ' OE1' ' A' ' 96' ' ' GLU . 18.4 tttt -113.32 109.73 19.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.382 -0.824 . . . . 0.0 110.202 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 104.06 -153.26 17.73 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -97.62 77.71 2.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.323 -1.104 . . . . 0.0 110.206 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.709 HG21 ' O ' ' A' ' 94' ' ' THR . 22.3 m -142.76 161.68 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.2 -0.937 . . . . 0.0 110.133 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.404 ' HG3' ' C ' ' A' ' 126' ' ' VAL . 93.1 mt-10 -146.95 153.94 40.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.199 -0.938 . . . . 0.0 110.273 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.941 ' CG1' HD21 ' A' ' 95' ' ' LEU . 3.1 mt -80.18 172.98 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 110.115 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.595 ' N ' HG22 ' A' ' 128' ' ' ILE . 63.2 mttt -96.42 133.67 40.54 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.414 -0.804 . . . . 0.0 109.716 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 97.4 mt-10 -42.87 -36.53 1.53 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.268 -0.895 . . . . 0.0 110.169 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.84 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 81.2 tt0 -57.51 -42.17 82.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 109.922 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.537 ' HB3' ' CG2' ' A' ' 128' ' ' ILE . 6.1 t-160 -65.37 -53.66 40.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.333 -0.854 . . . . 0.0 110.221 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.463 HG13 ' CG ' ' A' ' 5' ' ' TYR . 96.6 t -67.7 -33.87 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.43 -0.794 . . . . 0.0 110.287 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 25.6 mttm -98.11 -69.33 0.76 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.212 -0.93 . . . . 0.0 110.205 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.84 ' HB3' ' O ' ' A' ' 131' ' ' GLU . . . -54.71 -19.61 6.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.18 -0.95 . . . . 0.0 109.626 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.451 ' HA3' ' O ' ' A' ' 132' ' ' HIS . . . -73.17 -30.23 63.25 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.484 ' CE ' ' HB3' ' A' ' 5' ' ' TYR . 66.0 mttm -79.5 -31.45 42.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.335 -1.097 . . . . 0.0 109.932 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -72.45 -52.92 13.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.281 -0.887 . . . . 0.0 109.93 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.52 ' HG3' ' N ' ' A' ' 140' ' ' ALA . 10.1 pttp -56.88 -41.26 77.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.41 -0.806 . . . . 0.0 109.821 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.52 ' N ' ' HG3' ' A' ' 139' ' ' LYS . . . -70.4 -39.73 74.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.349 -0.845 . . . . 0.0 109.853 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 137' ' ' LYS . 16.7 t -55.62 -43.41 76.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.414 -0.804 . . . . 0.0 109.852 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -57.34 -42.47 82.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.347 -0.846 . . . . 0.0 109.873 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.643 ' HA ' HD12 ' A' ' 146' ' ' LEU . 64.3 mt -57.85 -41.82 83.17 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.28 -0.887 . . . . 0.0 109.906 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -59.45 -36.79 76.62 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.422 -0.799 . . . . 0.0 109.845 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.413 ' HA ' ' OE1' ' A' ' 148' ' ' GLU . 95.6 mttt -71.68 -15.07 62.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.322 -0.861 . . . . 0.0 109.878 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.643 HD12 ' HA ' ' A' ' 143' ' ' LEU . 24.2 mt -84.95 -35.34 22.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.28 -0.887 . . . . 0.0 109.045 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.792 ' CG2' HD23 ' A' ' 18' ' ' LEU . 60.0 mt -70.47 -40.75 77.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 119.772 -0.771 . . . . 0.0 108.97 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.863 ' HB3' HD13 ' A' ' 13' ' ' ILE . 52.0 mt-10 -59.46 -44.08 93.06 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.423 -0.798 . . . . 0.0 109.329 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.504 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 33.7 m -67.75 -30.19 69.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.318 -0.864 . . . . 0.0 109.453 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.595 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 73.3 t80 -57.84 -49.72 75.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.463 -0.773 . . . . 0.0 109.802 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.145 HD21 ' CE2' ' A' ' 158' ' ' TYR . 77.5 mt -79.94 -26.61 40.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.209 -0.932 . . . . 0.0 109.983 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.688 ' HB2' HD11 ' A' ' 13' ' ' ILE . 50.8 tttt -72.65 -26.49 61.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.375 -0.828 . . . . 0.0 109.491 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.497 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -105.4 -32.02 4.11 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.553 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 6.6 m-70 -106.92 92.31 7.4 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.302 -1.117 . . . . 0.0 109.947 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.6 Cg_endo -73.84 6.9 2.62 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.131 1.595 . . . . 0.0 111.15 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -108.87 -4.49 16.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.936 -1.103 . . . . 0.0 110.008 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.667 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -77.65 101.72 6.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.382 -0.824 . . . . 0.0 110.1 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 1.145 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.3 OUTLIER 35.15 31.8 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.691 -0.63 . . . . 0.0 110.507 -179.49 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.568 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.744 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.575 HG13 ' O ' ' A' ' 120' ' ' TYR . 93.9 t -124.42 137.77 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -1.135 . . . . 0.0 110.206 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.804 ' CE1' HD12 ' A' ' 128' ' ' ILE . 10.1 m-85 -98.89 145.71 26.72 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.248 -0.908 . . . . 0.0 109.843 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.598 HG23 ' CE1' ' A' ' 119' ' ' HIS . 3.2 m -120.89 127.56 51.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.155 -0.966 . . . . 0.0 110.677 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.093 ' CE2' HG21 ' A' ' 133' ' ' VAL . 61.5 m-85 -139.92 131.21 26.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.395 -0.815 . . . . 0.0 109.765 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 22.4 pt-20 -131.75 153.3 50.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.043 -1.036 . . . . 0.0 110.774 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.419 ' HB2' ' HB3' ' A' ' 116' ' ' SER . 49.7 m -132.37 144.67 50.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.417 -0.802 . . . . 0.0 109.71 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -135.58 121.99 20.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.162 -0.961 . . . . 0.0 110.719 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.638 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.0 p90 -147.19 -177.03 5.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.363 -0.836 . . . . 0.0 109.691 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.89 HG22 ' HA ' ' A' ' 113' ' ' ILE . 5.7 p -142.52 170.35 15.88 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.115 -0.991 . . . . 0.0 110.739 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.427 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 1.4 t -155.06 157.48 37.61 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.41 -0.807 . . . . 0.0 110.243 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -76.07 -38.34 57.19 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.125 -0.984 . . . . 0.0 109.993 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.835 HD11 ' HB2' ' A' ' 152' ' ' LYS . 3.3 mp -58.37 150.02 56.52 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.44 -0.788 . . . . 0.0 109.98 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.759 ' HD2' HG23 ' A' ' 13' ' ' ILE . 39.6 Cg_endo -66.1 144.71 76.64 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.909 1.478 . . . . 0.0 110.116 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.652 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 38.4 Cg_endo -72.41 -31.46 11.31 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.961 1.506 . . . . 0.0 113.002 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.652 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 44.0 Cg_endo -71.72 -22.0 24.49 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 N-CA-C 109.757 -0.901 . . . . 0.0 109.757 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.803 ' HG2' HD22 ' A' ' 151' ' ' LEU . 42.0 ttm180 -81.89 -47.57 12.61 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.799 ' HA ' HD11 ' A' ' 151' ' ' LEU . 0.7 OUTLIER -66.26 -26.26 67.27 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.645 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.557 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 51.6 t80 -67.88 -50.72 54.76 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.513 0.673 . . . . 0.0 109.798 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.79 ' HG2' HD22 ' A' ' 24' ' ' LEU . 34.7 mttm -58.46 -33.63 69.96 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.624 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.056 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -80.04 -26.22 39.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.449 -0.782 . . . . 0.0 110.749 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.997 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 1.4 t80 -87.18 -46.72 9.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.17 -0.956 . . . . 0.0 111.474 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.704 HG13 ' CE1' ' A' ' 81' ' ' TYR . 3.5 t -98.84 -54.73 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.018 -1.051 . . . . 0.0 111.098 -179.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.79 HD22 ' HG2' ' A' ' 20' ' ' LYS . 8.0 mp -67.81 -5.59 17.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.174 -0.954 . . . . 0.0 110.735 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -144.35 17.82 1.71 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.118 -0.989 . . . . 0.0 110.443 -179.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.997 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -56.99 -23.12 43.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.188 -0.945 . . . . 0.0 110.164 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -79.55 -14.34 58.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.309 -0.869 . . . . 0.0 110.335 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.441 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 80.5 m-20 -132.37 9.14 4.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.183 -0.948 . . . . 0.0 110.415 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.654 HD23 ' OH ' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -105.3 -43.61 4.95 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.176 -0.952 . . . . 0.0 110.432 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.624 ' CG1' HD13 ' A' ' 38' ' ' ILE . 3.0 t -74.39 -41.4 4.84 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.339 -0.851 . . . . 0.0 110.956 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.9 Cg_endo -77.8 10.73 2.48 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.313 1.165 . . . . 0.0 110.896 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 28' ' ' ASN . 15.4 mttm -124.87 -34.92 2.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.115 -0.99 . . . . 0.0 109.355 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.663 HG21 ' HB3' ' A' ' 146' ' ' LEU . 6.7 mt -80.12 -44.15 22.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.487 -0.758 . . . . 0.0 109.628 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.87 95.06 14.1 Favored Pre-proline 0 N--CA 1.487 1.398 0 O-C-N 121.407 -0.808 . . . . 0.0 110.189 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.16 -0.41 9.09 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.047 1.551 . . . . 0.0 110.513 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -90.41 -27.42 19.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.218 -0.926 . . . . 0.0 110.039 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -87.53 -47.83 8.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.355 -0.841 . . . . 0.0 110.11 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.624 HD13 ' CG1' ' A' ' 30' ' ' VAL . 1.0 OUTLIER -125.68 130.19 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.495 -0.753 . . . . 0.0 109.926 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -89.17 -26.96 21.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.36 -0.837 . . . . 0.0 110.056 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.548 ' C ' ' CD2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -172.11 150.08 2.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.918 . . . . 0.0 110.197 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.6 m -128.58 123.3 33.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.339 -0.851 . . . . 0.0 109.904 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.548 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 69.5 tt0 -134.13 111.57 10.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.147 -0.97 . . . . 0.0 110.733 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 38.2 mt -53.65 143.61 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.292 -0.88 . . . . 0.0 109.892 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.432 ' HA ' HD12 ' A' ' 44' ' ' LEU . 30.3 tp -120.82 -27.3 5.06 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.224 -0.922 . . . . 0.0 110.447 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.676 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.7 m95 -123.92 162.83 22.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.294 -0.879 . . . . 0.0 110.516 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.45 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 42.84 -135.97 4.07 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.415 ' N ' ' OG1' ' A' ' 52' ' ' THR . 0.2 OUTLIER -152.64 22.95 0.6 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.392 -1.063 . . . . 0.0 110.052 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 120.09 -19.75 9.33 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.494 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -74.16 -169.82 21.43 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.435 ' HA ' HG22 ' A' ' 71' ' ' ILE . 45.3 Cg_endo -72.13 128.12 13.53 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 123.925 1.487 . . . . 0.0 110.649 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.4 -14.57 47.09 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.527 -1.829 . . . . 0.0 108.527 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.545 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.1 m -71.79 160.42 32.63 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.553 -0.969 . . . . 0.0 109.329 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.676 HD12 ' CG ' ' A' ' 45' ' ' TRP . 59.5 mt -132.48 119.36 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 110.276 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.635 ' CE ' HD11 ' A' ' 71' ' ' ILE . 48.6 mttm -102.56 124.8 48.77 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.355 -0.84 . . . . 0.0 110.163 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.4 tttt -92.31 93.9 8.87 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.29 -0.881 . . . . 0.0 110.004 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.548 ' CG2' HG12 ' A' ' 38' ' ' ILE . 70.7 mt -80.1 144.26 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.187 -0.945 . . . . 0.0 110.05 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.44 ' H ' ' HG1' ' A' ' 57' ' ' THR . 1.2 p -115.08 153.93 29.82 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.359 -0.838 . . . . 0.0 110.347 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.544 ' CZ ' HG22 ' A' ' 67' ' ' VAL . 19.3 m-85 -114.53 137.87 51.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.158 -0.964 . . . . 0.0 110.107 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.9 29.3 8.14 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.424 ' HG3' ' HB3' ' A' ' 58' ' ' PHE . 95.2 mt-10 -48.35 -29.45 3.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.182 -1.187 . . . . 0.0 110.201 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 118.64 -119.29 4.3 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.415 ' O ' ' HB2' ' A' ' 63' ' ' GLN . 55.7 p -60.27 165.42 3.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.288 -1.125 . . . . 0.0 110.316 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' A' ' 62' ' ' SER . 98.8 mt-30 54.42 97.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.29 -0.881 . . . . 0.0 110.349 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.403 ' C ' ' O ' ' A' ' 63' ' ' GLN . 0.7 OUTLIER -44.13 140.81 1.97 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.9 . . . . 0.0 110.095 179.869 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -138.78 116.53 1.28 Allowed Glycine 0 N--CA 1.486 2.033 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.545 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 13.9 p90 -156.4 174.47 15.37 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.088 -1.242 . . . . 0.0 110.208 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.734 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.8 m -144.16 174.97 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.872 . . . . 0.0 110.658 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.671 ' O ' HD12 ' A' ' 85' ' ' LEU . 22.7 mttm -132.22 104.36 6.72 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.515 -0.741 . . . . 0.0 109.687 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.981 ' CD2' HD13 ' A' ' 85' ' ' LEU . 12.5 m170 -95.57 126.09 40.62 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.26 -0.9 . . . . 0.0 111.103 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.545 ' HA ' ' O ' ' A' ' 52' ' ' THR . 23.8 tttt -98.48 108.67 21.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.351 -0.843 . . . . 0.0 109.434 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.635 HD11 ' CE ' ' A' ' 54' ' ' LYS . 30.2 mm -42.38 139.78 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.222 -0.924 . . . . 0.0 110.15 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.542 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 13.1 t0 -116.55 -41.22 3.11 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.187 -0.945 . . . . 0.0 110.46 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.485 ' C ' HD12 ' A' ' 74' ' ' ILE . 22.9 m -168.94 158.86 9.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 109.917 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.485 HD12 ' C ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -148.93 154.33 9.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 C-N-CA 119.142 -1.023 . . . . 0.0 111.131 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 79' ' ' TYR . 2.4 m-20 -133.91 77.82 1.73 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 120.269 -0.573 . . . . 0.0 110.092 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.557 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 36.7 tttm -61.6 -15.66 41.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.099 -1.001 . . . . 0.0 110.199 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -92.93 -30.53 15.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.259 -0.9 . . . . 0.0 109.593 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.2 m-80 -105.04 -9.15 18.04 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.69 -0.632 . . . . 0.0 109.882 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.578 ' CZ ' ' HB3' ' A' ' 16' ' ' PRO . 2.9 m-85 70.13 51.31 0.4 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.62 -0.675 . . . . 0.0 110.277 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.487 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -125.17 149.01 48.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.908 . . . . 0.0 109.669 179.711 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.704 ' CE1' HG13 ' A' ' 23' ' ' VAL . 58.5 t80 -138.86 139.96 38.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.162 -0.961 . . . . 0.0 110.235 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.434 ' O ' ' HB3' ' A' ' 72' ' ' ASP . 3.3 m -148.52 121.37 8.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.208 -0.932 . . . . 0.0 110.439 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.676 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 8.8 p90 -131.41 175.12 9.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.291 -0.881 . . . . 0.0 110.42 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 98' ' ' ILE . 19.7 m -127.82 126.06 40.96 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.346 -0.846 . . . . 0.0 109.948 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.981 HD13 ' CD2' ' A' ' 69' ' ' HIS . 14.0 tp -97.57 135.5 39.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.018 -1.051 . . . . 0.0 110.277 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.519 ' H ' HD12 ' A' ' 85' ' ' LEU . 9.5 pt -115.81 -31.27 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.219 -0.926 . . . . 0.0 110.255 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.489 ' C ' ' CD1' ' A' ' 91' ' ' LEU . 39.4 tt0 -107.86 165.65 11.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.28 -0.887 . . . . 0.0 110.09 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.734 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 151.55 140.17 3.1 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -60.04 -31.93 70.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.276 -1.132 . . . . 0.0 110.228 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.786 ' HB1' ' CE1' ' A' ' 132' ' ' HIS . . . -67.02 -39.61 87.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.29 -0.881 . . . . 0.0 110.213 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.654 ' CD2' HD21 ' A' ' 95' ' ' LEU . 11.4 mt -42.31 -51.96 4.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.367 -0.833 . . . . 0.0 110.135 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 43.54 -167.4 0.02 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.409 ' C ' ' OD1' ' A' ' 93' ' ' ASP . 55.8 p-10 -79.43 3.22 19.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -1.146 . . . . 0.0 110.176 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.514 ' O ' HG22 ' A' ' 122' ' ' THR . 0.1 OUTLIER -92.32 -51.93 4.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.231 -0.918 . . . . 0.0 110.185 -179.907 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.874 HD12 ' H ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -107.56 159.59 16.32 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.406 -0.809 . . . . 0.0 109.416 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.874 ' H ' HD12 ' A' ' 95' ' ' LEU . 62.9 tt0 -134.88 -80.33 0.44 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.306 -0.871 . . . . 0.0 110.182 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 46.8 mttt -80.27 152.74 28.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.633 -0.667 . . . . 0.0 110.78 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.726 HG21 ' CE2' ' A' ' 100' ' ' TYR . 4.7 mm -138.66 142.99 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.175 -0.953 . . . . 0.0 109.701 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.482 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.8 OUTLIER -121.38 127.39 51.16 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.356 -0.84 . . . . 0.0 109.151 178.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.726 ' CE2' HG21 ' A' ' 98' ' ' ILE . 10.3 m-85 -122.52 135.19 54.59 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 110.517 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.466 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 74.4 tt0 -138.14 141.38 40.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.312 -0.867 . . . . 0.0 110.356 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.53 ' N ' ' O ' ' A' ' 81' ' ' TYR . 32.7 m -137.66 149.94 46.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.412 -0.805 . . . . 0.0 109.732 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 115' ' ' LYS . 7.9 mttt -145.54 138.14 25.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.114 -0.991 . . . . 0.0 110.725 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.828 HD23 HG12 ' A' ' 114' ' ' ILE . 5.9 mt -118.75 151.69 37.56 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.298 -0.876 . . . . 0.0 109.497 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.701 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -150.23 -169.85 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.042 -1.036 . . . . 0.0 110.371 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.701 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -121.44 141.87 50.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.42 -0.8 . . . . 0.0 110.141 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.479 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 7.9 p -99.25 167.51 11.12 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.209 -0.932 . . . . 0.0 110.29 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.7 Cg_endo -72.32 -1.12 9.68 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.013 1.533 . . . . 0.0 110.596 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 52.0 p -106.65 4.14 27.58 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.248 -0.907 . . . . 0.0 110.303 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 100.21 -32.83 6.86 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -61.97 -172.11 1.27 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.508 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.0 OUTLIER -131.56 128.77 39.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.217 -1.167 . . . . 0.0 110.413 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.89 ' HA ' HG22 ' A' ' 10' ' ' THR . 10.3 mt -82.19 152.14 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.321 -0.862 . . . . 0.0 110.039 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.828 HG12 HD23 ' A' ' 104' ' ' LEU . 15.7 mt -132.31 119.03 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.2 -0.938 . . . . 0.0 110.436 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.486 ' O ' ' N ' ' A' ' 103' ' ' LYS . 26.6 tttt -108.63 119.04 38.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 110.075 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 2.0 t -110.87 158.16 19.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 110.306 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.466 ' HB ' ' HB3' ' A' ' 101' ' ' GLU . 43.1 m -160.01 139.74 11.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.21 -0.931 . . . . 0.0 110.3 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 41.9 t -143.58 159.67 42.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.214 -0.929 . . . . 0.0 110.116 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.598 ' CE1' HG23 ' A' ' 4' ' ' THR . 69.8 m-70 -142.34 159.1 42.9 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.157 -0.964 . . . . 0.0 110.527 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.596 ' HA ' HD13 ' A' ' 98' ' ' ILE . 8.7 m-85 -117.86 150.78 38.61 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.36 -0.837 . . . . 0.0 110.279 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.476 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 95.2 m-70 -128.39 82.76 2.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.138 -0.976 . . . . 0.0 109.896 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 94' ' ' THR . 1.2 p -71.74 152.13 43.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.347 -0.845 . . . . 0.0 110.082 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.419 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 7.3 ttpt -109.89 118.29 36.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.255 -0.903 . . . . 0.0 110.335 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 101.59 -143.44 16.07 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -112.72 73.41 0.81 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.302 -1.116 . . . . 0.0 110.207 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 5.9 m -140.67 156.49 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.273 -0.892 . . . . 0.0 110.147 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -128.2 154.7 45.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.266 -0.896 . . . . 0.0 110.261 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.804 HD12 ' CE1' ' A' ' 3' ' ' PHE . 3.0 mt -74.9 172.74 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.337 -0.852 . . . . 0.0 110.2 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.61 ' N ' HG22 ' A' ' 128' ' ' ILE . 40.9 mmtm -104.07 125.9 50.78 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.347 -0.846 . . . . 0.0 110.053 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 129' ' ' LYS . 96.0 mt-10 -43.65 -54.05 5.31 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.223 -0.923 . . . . 0.0 110.038 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 42.9 tt0 -46.32 -25.04 0.56 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.207 -0.933 . . . . 0.0 109.797 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.786 ' CE1' ' HB1' ' A' ' 90' ' ' ALA . 12.1 t-160 -81.54 -64.56 1.16 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.435 -0.791 . . . . 0.0 110.071 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 1.093 HG21 ' CE2' ' A' ' 5' ' ' TYR . 8.8 p -66.14 -39.47 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.359 -0.838 . . . . 0.0 110.031 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.519 ' N ' HG13 ' A' ' 133' ' ' VAL . 38.0 tttp -63.59 -42.46 98.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 109.968 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 131' ' ' GLU . . . -66.77 -32.27 73.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.353 -0.842 . . . . 0.0 109.883 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.64 -26.98 74.13 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.564 ' NZ ' HG22 ' A' ' 133' ' ' VAL . 45.1 mttp -65.11 -35.43 81.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.336 -1.096 . . . . 0.0 110.021 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -82.69 -36.48 25.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.32 -0.862 . . . . 0.0 109.868 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 41.0 mttt -73.29 -26.93 61.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.387 -0.821 . . . . 0.0 109.854 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.407 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -81.54 -38.77 25.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.368 -0.833 . . . . 0.0 109.92 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.9 t -64.01 -47.15 81.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.335 -0.853 . . . . 0.0 109.947 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -54.86 -44.68 74.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.247 -0.908 . . . . 0.0 109.867 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.474 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 9.4 tp -57.2 -45.88 83.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 0.0 109.859 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.557 ' HA ' HD12 ' A' ' 147' ' ' ILE . 28.0 m-85 -54.44 -41.32 69.26 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.234 -0.916 . . . . 0.0 109.507 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 18.7 mttp -72.82 -12.98 61.19 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.438 -0.789 . . . . 0.0 110.035 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.663 ' HB3' HG21 ' A' ' 33' ' ' ILE . 16.1 mt -83.75 -36.2 23.82 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.177 -0.952 . . . . 0.0 108.921 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.699 HD11 ' CE1' ' A' ' 22' ' ' PHE . 25.8 mt -68.05 -44.31 84.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.538 ' OE2' HD13 ' A' ' 18' ' ' LEU . 60.8 mm-40 -53.66 -46.22 70.53 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.533 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 25.7 m -65.83 -39.11 90.51 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.354 -0.841 . . . . 0.0 109.351 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.611 ' CD1' HD11 ' A' ' 33' ' ' ILE . 58.0 t80 -43.64 -56.85 3.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.435 -0.791 . . . . 0.0 109.829 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.803 HD22 ' HG2' ' A' ' 17' ' ' ARG . 12.4 mt -75.16 -39.72 60.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.541 -0.724 . . . . 0.0 110.432 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.835 ' HB2' HD11 ' A' ' 13' ' ' ILE . 25.1 tttm -60.83 -17.77 51.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.122 -0.986 . . . . 0.0 109.364 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.498 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -113.46 -29.59 2.9 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.538 ' CD2' ' O ' ' A' ' 150' ' ' TYR . 12.2 m-70 -105.82 89.84 3.87 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.285 -1.126 . . . . 0.0 110.009 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.554 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 45.6 Cg_endo -71.12 1.85 4.9 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.052 1.554 . . . . 0.0 110.989 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -108.33 -16.31 14.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.049 -1.032 . . . . 0.0 110.107 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.607 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -71.41 99.56 2.01 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.2 -0.937 . . . . 0.0 109.848 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 1.056 ' CE1' ' HB2' ' A' ' 21' ' ' ALA . 0.1 OUTLIER 35.06 32.54 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 CA-C-O 121.564 0.697 . . . . 0.0 109.569 -179.24 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.554 ' ND2' ' HA ' ' A' ' 155' ' ' PRO . 0.1 OUTLIER . . . . . 0 C--N 1.303 -1.451 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.94 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.456 ' O ' ' OG1' ' A' ' 122' ' ' THR . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.929 HG13 ' O ' ' A' ' 120' ' ' TYR . 77.4 t -125.29 138.57 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -1.157 . . . . 0.0 110.2 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.697 ' CE1' HD12 ' A' ' 128' ' ' ILE . 11.7 m-85 -98.02 136.13 38.72 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.205 -0.934 . . . . 0.0 109.624 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.681 HG23 ' ND1' ' A' ' 119' ' ' HIS . 8.5 m -119.19 136.81 54.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.093 -1.004 . . . . 0.0 110.815 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.006 ' CE2' HG21 ' A' ' 133' ' ' VAL . 57.0 m-85 -147.18 124.83 11.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.474 -0.766 . . . . 0.0 109.83 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 1.004 ' CG ' HG23 ' A' ' 117' ' ' THR . 5.0 mt-10 -123.54 132.77 53.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.277 -0.889 . . . . 0.0 110.494 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.444 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 50.7 m -119.01 157.8 27.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.325 -0.86 . . . . 0.0 109.898 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 7' ' ' SER . 50.5 mp0 -146.37 123.98 11.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.111 -0.993 . . . . 0.0 110.804 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.635 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.0 p90 -141.71 -175.88 4.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.886 . . . . 0.0 109.632 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.81 HG22 ' HA ' ' A' ' 113' ' ' ILE . 8.6 p -142.5 169.84 16.83 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.009 -1.057 . . . . 0.0 110.794 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 112' ' ' SER . 4.0 t -153.83 162.15 41.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.422 -0.799 . . . . 0.0 110.174 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -85.1 -28.47 25.57 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.127 -0.983 . . . . 0.0 110.164 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.79 HG23 ' HD2' ' A' ' 14' ' ' PRO . 9.1 mm -67.9 150.79 97.63 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 0.0 109.891 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.79 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.4 Cg_endo -66.12 143.35 71.3 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.932 1.491 . . . . 0.0 110.325 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.658 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.2 Cg_endo -72.55 -31.13 11.35 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 124.023 1.539 . . . . 0.0 112.888 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.658 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.6 Cg_endo -70.1 -23.83 28.83 Favored 'Trans proline' 0 C--N 1.316 -1.147 0 N-CA-C 110.177 -0.74 . . . . 0.0 110.177 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.731 HH21 ' HB3' ' A' ' 157' ' ' ALA . 46.2 mtp180 -83.68 -42.47 16.6 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.741 ' C ' HD23 ' A' ' 18' ' ' LEU . 0.6 OUTLIER -71.85 -31.56 66.62 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.619 ' N ' HD23 ' A' ' 18' ' ' LEU . 54.3 t80 -65.39 -54.93 21.56 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.461 -0.774 . . . . 0.0 109.042 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.533 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 70.1 mttt -48.63 -48.54 39.43 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.724 -0.79 . . . . 0.0 109.355 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.17 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -67.75 -28.77 67.91 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.334 -0.854 . . . . 0.0 111.135 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 1.066 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.9 OUTLIER -80.92 -46.54 15.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 111.411 -178.814 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.701 HG13 ' CE1' ' A' ' 81' ' ' TYR . 3.4 t -104.44 -51.36 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.942 -1.099 . . . . 0.0 111.761 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.678 HD12 ' N ' ' A' ' 24' ' ' LEU . 7.2 mp -79.97 -4.61 53.22 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.097 -1.002 . . . . 0.0 111.966 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.571 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 1.0 OUTLIER -149.17 23.95 0.93 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.717 -1.239 . . . . 0.0 110.643 -179.632 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 1.066 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -67.01 -32.94 74.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.17 -0.956 . . . . 0.0 110.301 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.427 ' HA ' ' OG ' ' A' ' 41' ' ' SER . 81.4 m-20 -56.54 -17.68 9.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.357 -0.839 . . . . 0.0 110.559 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.539 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 4.2 p30 -128.94 -0.93 5.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.15 -0.969 . . . . 0.0 110.523 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.758 ' HG ' ' HB1' ' A' ' 21' ' ' ALA . 1.1 tm? -88.57 -43.76 11.14 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.112 -0.992 . . . . 0.0 110.17 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 1.067 HG11 HD13 ' A' ' 38' ' ' ILE . 5.0 t -74.59 -40.86 4.36 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.437 -0.79 . . . . 0.0 111.319 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.0 Cg_endo -77.54 10.91 2.33 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 123.448 1.236 . . . . 0.0 111.005 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.486 ' CD ' ' O ' ' A' ' 28' ' ' ASN . 31.9 mtpt -120.65 -34.65 3.54 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.029 -1.044 . . . . 0.0 109.031 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.971 HG21 ' HB3' ' A' ' 146' ' ' LEU . 10.6 mt -80.19 -32.58 13.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 121.53 0.681 . . . . 0.0 109.657 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -159.65 98.35 1.54 Allowed Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.412 -0.805 . . . . 0.0 110.097 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.8 -0.75 8.86 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.034 1.544 . . . . 0.0 110.809 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -85.03 -19.08 32.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 109.788 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -85.76 -86.05 0.14 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.415 -0.803 . . . . 0.0 110.082 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 1.067 HD13 HG11 ' A' ' 30' ' ' VAL . 1.9 mp -90.75 139.94 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.279 -0.888 . . . . 0.0 110.112 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.425 ' O ' ' CB ' ' A' ' 40' ' ' HIS . 4.8 ttmm -87.81 -26.74 22.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.353 -0.842 . . . . 0.0 110.18 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.575 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER 177.03 157.19 0.31 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.177 -0.952 . . . . 0.0 110.193 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.427 ' OG ' ' HA ' ' A' ' 27' ' ' ASP . 79.4 p -117.3 134.21 55.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.356 -0.84 . . . . 0.0 110.023 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.575 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 29.0 tp10 -138.69 106.87 5.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.091 -1.005 . . . . 0.0 110.246 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 20.0 mt -62.59 137.16 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 110.098 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.899 HD22 ' CE ' ' A' ' 55' ' ' LYS . 13.0 tp -114.08 -23.51 9.49 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.239 -0.913 . . . . 0.0 110.534 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.701 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.7 m95 -127.06 161.61 28.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.049 -1.032 . . . . 0.0 110.63 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.446 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 41.76 -132.09 3.97 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -157.24 19.78 0.3 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.296 -1.12 . . . . 0.0 110.154 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.91 -18.22 7.09 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.472 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -74.51 -171.64 26.87 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.432 ' HA ' HG22 ' A' ' 71' ' ' ILE . 46.0 Cg_endo -73.38 129.54 13.99 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.103 1.581 . . . . 0.0 110.665 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.34 -9.44 49.55 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.509 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.1 m -76.88 167.17 22.29 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.567 -0.96 . . . . 0.0 109.921 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.701 HD12 ' CG ' ' A' ' 45' ' ' TRP . 65.6 mt -137.35 120.24 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.322 -0.861 . . . . 0.0 109.871 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 70.7 mttt -106.03 138.37 42.34 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.211 -0.93 . . . . 0.0 110.411 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.899 ' CE ' HD22 ' A' ' 44' ' ' LEU . 43.5 mttt -102.53 95.86 6.52 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.308 -0.87 . . . . 0.0 110.06 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.545 ' HB ' HG23 ' A' ' 67' ' ' VAL . 52.1 mt -80.05 135.41 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 109.846 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 1.6 p -104.77 155.8 18.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.374 -0.828 . . . . 0.0 110.452 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.741 ' HE2' HG13 ' A' ' 67' ' ' VAL . 23.9 m-85 -118.73 169.89 9.45 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.316 -0.865 . . . . 0.0 110.083 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -46.85 150.95 1.8 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 61' ' ' GLY . 79.8 tt0 -57.97 -40.25 80.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -1.177 . . . . 0.0 110.262 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' A' ' 60' ' ' GLU . . . 42.99 -163.61 0.03 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.8 m -67.21 -40.82 86.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -1.126 . . . . 0.0 110.032 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.416 ' O ' ' C ' ' A' ' 64' ' ' TYR . 95.3 mt-30 -123.7 140.91 52.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.343 -0.848 . . . . 0.0 110.018 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.515 ' CE2' ' CD2' ' A' ' 66' ' ' TYR . 8.5 t80 -43.32 141.04 1.4 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.172 -0.955 . . . . 0.0 110.075 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -129.31 136.18 8.84 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.562 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 11.7 p90 -179.49 161.38 1.04 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.349 -1.089 . . . . 0.0 109.952 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.844 HG12 ' HA2' ' A' ' 88' ' ' GLY . 7.1 m -141.95 171.83 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.681 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.513 ' O ' HD23 ' A' ' 85' ' ' LEU . 50.9 mttt -123.31 115.03 21.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.597 -0.689 . . . . 0.0 109.801 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -106.29 126.19 51.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.141 -0.974 . . . . 0.0 110.633 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 52' ' ' THR . 27.2 ttpp -97.43 126.58 42.77 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.322 -0.861 . . . . 0.0 109.77 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.508 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 26.1 mm -66.22 122.02 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 0.0 110.219 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -98.14 -43.34 7.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.359 -0.838 . . . . 0.0 110.118 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.8 m -169.0 159.42 9.28 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.382 -0.824 . . . . 0.0 109.616 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.5 mt -144.19 158.22 15.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.141 -0.975 . . . . 0.0 110.386 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.551 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 4.3 m-20 -134.39 78.76 1.77 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.088 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.432 ' HB2' ' HE3' ' A' ' 76' ' ' LYS . 38.1 mtmt -62.52 -14.03 37.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.195 -0.94 . . . . 0.0 110.233 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -93.68 -33.06 13.81 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.266 -0.896 . . . . 0.0 109.521 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.469 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -104.65 -8.18 19.1 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.605 -0.685 . . . . 0.0 109.841 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.636 ' O ' HD12 ' A' ' 104' ' ' LEU . 3.2 m-85 68.95 50.86 0.58 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.447 -0.783 . . . . 0.0 110.12 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.551 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -120.96 155.3 34.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.318 -0.864 . . . . 0.0 109.405 179.638 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.701 ' CE1' HG13 ' A' ' 23' ' ' VAL . 26.8 t80 -143.21 133.17 24.14 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.177 -0.952 . . . . 0.0 110.216 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 37.9 m -136.75 122.73 20.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 110.488 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.612 ' CD1' ' N ' ' A' ' 83' ' ' TYR . 3.1 p90 -139.42 179.98 6.23 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.179 -0.951 . . . . 0.0 110.039 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 1.001 HG23 ' O ' ' A' ' 98' ' ' ILE . 39.3 m -132.02 142.46 49.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 110.332 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.664 HD22 ' O ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -98.04 119.35 36.52 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.261 -0.9 . . . . 0.0 110.278 179.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.473 ' CG1' ' HB2' ' A' ' 68' ' ' LYS . 31.2 pt -102.64 -12.85 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.2 -0.938 . . . . 0.0 110.062 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.664 ' O ' HD22 ' A' ' 85' ' ' LEU . 47.8 tp10 -141.82 166.7 24.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.311 -0.868 . . . . 0.0 110.214 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.844 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 148.87 120.33 1.07 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -50.15 -24.39 2.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.341 -1.094 . . . . 0.0 110.229 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 1.039 ' HB1' ' NE2' ' A' ' 132' ' ' HIS . . . -74.09 -22.61 59.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.926 . . . . 0.0 110.27 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.465 ' O ' ' O ' ' A' ' 92' ' ' GLY . 37.7 mt -66.86 -27.09 67.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.229 -0.919 . . . . 0.0 110.307 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 48.91 -178.04 0.01 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 93' ' ' ASP . 38.1 p30 -81.61 8.67 9.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -1.16 . . . . 0.0 110.267 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.616 ' O ' HG21 ' A' ' 126' ' ' VAL . 71.2 p -96.3 -39.62 9.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -0.906 . . . . 0.0 110.182 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.915 HD21 ' CG1' ' A' ' 128' ' ' ILE . 47.3 mt -98.8 153.59 18.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.389 -0.819 . . . . 0.0 110.193 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.509 ' HG3' ' HB2' ' A' ' 123' ' ' LYS . 41.9 mm-40 -131.91 -80.31 0.51 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.242 -0.911 . . . . 0.0 110.253 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.507 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 17.6 mttt -80.19 128.73 33.86 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.595 -0.691 . . . . 0.0 110.756 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 1.001 ' O ' HG23 ' A' ' 84' ' ' THR . 11.3 mm -115.65 146.76 19.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 120.777 -1.202 . . . . 0.0 109.582 178.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.503 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.0 OUTLIER -123.41 123.77 41.41 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.258 -0.901 . . . . 0.0 109.046 178.564 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.806 ' CE2' HG21 ' A' ' 98' ' ' ILE . 15.0 m-85 -121.34 133.13 55.1 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.457 -0.777 . . . . 0.0 109.732 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.486 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 21.1 tt0 -142.07 144.05 33.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.09 -1.006 . . . . 0.0 110.782 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 62.1 m -140.13 146.03 38.32 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.455 -0.778 . . . . 0.0 109.594 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -139.52 138.38 36.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.096 -1.002 . . . . 0.0 110.658 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.826 HD23 HG12 ' A' ' 114' ' ' ILE . 7.1 mt -118.6 150.3 39.92 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.4 -0.813 . . . . 0.0 109.965 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.679 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.8 t -147.72 -171.38 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.188 -0.945 . . . . 0.0 110.212 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.679 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -122.75 138.19 54.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.419 -0.801 . . . . 0.0 110.171 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.44 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 4.2 p -99.2 167.74 10.77 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.289 -0.882 . . . . 0.0 110.22 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.44 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.1 Cg_endo -72.27 -4.27 14.9 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.12 1.59 . . . . 0.0 110.349 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 36.5 m -93.82 -18.73 21.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 110.309 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 118.18 -30.37 6.08 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.485 ' HA3' ' O ' ' A' ' 11' ' ' SER . . . -64.72 -142.96 0.03 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 11' ' ' SER . 26.4 p -155.71 128.57 7.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.287 -1.125 . . . . 0.0 109.968 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.81 ' HA ' HG22 ' A' ' 10' ' ' THR . 15.2 mt -79.96 149.14 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -0.908 . . . . 0.0 110.085 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.826 HG12 HD23 ' A' ' 104' ' ' LEU . 15.6 mt -131.36 119.45 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.414 -0.804 . . . . 0.0 110.25 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -104.83 121.35 43.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.098 -1.001 . . . . 0.0 110.072 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.411 ' C ' ' HG1' ' A' ' 117' ' ' THR . 0.0 OUTLIER -104.12 152.65 21.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -0.868 . . . . 0.0 110.216 -179.861 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 1.004 HG23 ' CG ' ' A' ' 6' ' ' GLU . 12.1 m -159.97 122.39 3.37 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.316 -0.865 . . . . 0.0 110.568 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.506 ' C ' ' CG ' ' A' ' 119' ' ' HIS . 15.0 t -133.55 160.13 38.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.361 -0.837 . . . . 0.0 109.669 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.681 ' ND1' HG23 ' A' ' 4' ' ' THR . 33.7 m-70 -147.19 164.2 33.89 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.061 -1.025 . . . . 0.0 110.642 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.929 ' O ' HG13 ' A' ' 2' ' ' VAL . 6.3 m-85 -126.93 150.53 49.29 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.253 -0.904 . . . . 0.0 110.443 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.507 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 93.6 m-70 -129.78 84.71 2.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.255 -0.903 . . . . 0.0 109.723 178.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.709 ' CG2' HD23 ' A' ' 95' ' ' LEU . 1.2 p -63.64 154.8 31.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.302 -0.874 . . . . 0.0 110.179 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.509 ' HB2' ' HG3' ' A' ' 96' ' ' GLU . 43.4 tttt -113.73 117.56 31.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 110.048 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 99.25 -115.95 5.45 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.476 ' O ' ' ND2' ' A' ' 125' ' ' ASN . 0.7 OUTLIER -138.27 67.4 1.41 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.301 -1.117 . . . . 0.0 110.138 179.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.616 HG21 ' O ' ' A' ' 94' ' ' THR . 27.9 m -131.92 167.23 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.886 . . . . 0.0 110.085 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -140.76 161.41 37.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 110.255 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.915 ' CG1' HD21 ' A' ' 95' ' ' LEU . 3.5 mp -84.17 172.8 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.252 -0.905 . . . . 0.0 110.127 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.614 ' N ' HG22 ' A' ' 128' ' ' ILE . 16.2 mttm -108.25 129.92 55.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.384 -0.823 . . . . 0.0 109.683 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.459 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 73.1 mm-40 -43.86 -49.69 8.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.079 -1.013 . . . . 0.0 109.885 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.506 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 51.6 tt0 -48.54 -23.09 0.87 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.154 -0.966 . . . . 0.0 109.651 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 1.039 ' NE2' ' HB1' ' A' ' 90' ' ' ALA . 13.5 t-160 -88.48 -66.42 0.92 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.372 -0.83 . . . . 0.0 110.142 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 1.006 HG21 ' CE2' ' A' ' 5' ' ' TYR . 7.3 p -59.91 -40.21 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.345 -0.847 . . . . 0.0 109.84 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.533 ' N ' HG13 ' A' ' 133' ' ' VAL . 31.5 tptt -66.69 -47.39 72.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.285 -0.884 . . . . 0.0 109.795 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.506 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -63.32 -34.18 77.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.74 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.86 -33.89 85.47 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.658 ' NZ ' HG22 ' A' ' 133' ' ' VAL . 21.9 mttp -62.87 -37.87 88.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.366 -1.079 . . . . 0.0 109.78 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -78.81 -37.54 40.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.491 -0.756 . . . . 0.0 109.826 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 135' ' ' ALA . 20.9 mttm -66.89 -33.24 75.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.411 -0.805 . . . . 0.0 109.801 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.1 -45.71 26.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.311 -0.868 . . . . 0.0 109.829 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.0 m -59.13 -42.8 91.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.425 -0.797 . . . . 0.0 109.798 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -59.88 -46.26 89.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.31 -0.869 . . . . 0.0 109.816 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.5 ' HA ' HD23 ' A' ' 143' ' ' LEU . 18.9 mt -58.13 -35.63 71.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.373 -0.829 . . . . 0.0 109.722 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.578 ' HA ' HD12 ' A' ' 147' ' ' ILE . 22.6 m-85 -64.27 -34.33 77.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.372 -0.83 . . . . 0.0 109.774 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -71.95 -16.9 62.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.332 -0.855 . . . . 0.0 109.848 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.971 ' HB3' HG21 ' A' ' 33' ' ' ILE . 19.5 mt -81.23 -36.65 29.73 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.231 -0.918 . . . . 0.0 108.728 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.661 HG21 ' HG ' ' A' ' 18' ' ' LEU . 27.8 mt -70.43 -49.03 56.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.504 ' O ' HG13 ' A' ' 13' ' ' ILE . 97.9 mt-10 -53.07 -38.83 62.84 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.379 -0.825 . . . . 0.0 109.056 178.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.477 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 35.2 m -76.49 -30.18 57.13 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.271 -0.893 . . . . 0.0 109.011 178.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.593 ' CD1' HD11 ' A' ' 33' ' ' ILE . 54.0 t80 -50.52 -52.95 33.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.591 -0.693 . . . . 0.0 109.566 179.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.964 HD21 ' CE1' ' A' ' 158' ' ' TYR . 40.6 mt -80.15 -25.0 40.01 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.457 -0.777 . . . . 0.0 109.812 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.545 ' HA ' HD11 ' A' ' 13' ' ' ILE . 14.4 tttp -63.38 -17.42 62.6 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.329 -0.857 . . . . 0.0 109.311 179.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.49 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -120.3 -27.14 2.07 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.626 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 4.0 m-70 -106.38 91.24 5.56 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.191 -1.182 . . . . 0.0 110.285 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.8 Cg_endo -73.38 2.51 5.6 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.022 1.538 . . . . 0.0 110.82 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -113.17 -9.58 13.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.12 -0.987 . . . . 0.0 109.879 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.731 ' HB3' HH21 ' A' ' 17' ' ' ARG . . . -47.8 111.08 0.38 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.386 -0.821 . . . . 0.0 110.176 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 1.17 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 35.13 31.56 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.695 -0.628 . . . . 0.0 110.658 -179.804 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.533 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.65 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 93.5 t -128.04 126.57 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -1.161 . . . . 0.0 110.226 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.604 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 38.9 m-85 -87.18 161.36 18.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 0.0 110.415 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.856 HG23 ' CE1' ' A' ' 119' ' ' HIS . 33.8 m -138.63 92.18 2.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.886 . . . . 0.0 110.272 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.651 ' CD1' HG11 ' A' ' 133' ' ' VAL . 72.5 m-85 -110.43 126.61 54.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.245 -0.909 . . . . 0.0 109.643 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 116' ' ' SER . 21.2 pt-20 -132.47 152.2 51.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -0.916 . . . . 0.0 110.699 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 61.6 m -129.87 138.86 51.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.367 -0.833 . . . . 0.0 109.581 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -112.99 139.92 48.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.117 -0.989 . . . . 0.0 110.816 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.598 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.8 p90 -155.97 -175.23 5.32 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.431 -0.793 . . . . 0.0 109.511 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.803 HG22 ' HA ' ' A' ' 113' ' ' ILE . 8.1 p -139.9 174.57 10.38 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.99 -1.069 . . . . 0.0 110.814 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.46 ' HB3' ' OE2' ' A' ' 148' ' ' GLU . 54.1 p -158.59 127.41 5.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.447 -0.783 . . . . 0.0 110.124 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -55.1 -38.24 67.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.231 -0.918 . . . . 0.0 110.036 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.836 HG21 HD12 ' A' ' 151' ' ' LEU . 3.1 mp -59.07 150.36 62.26 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.416 -0.803 . . . . 0.0 110.015 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.797 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.9 Cg_endo -66.41 142.29 65.19 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.938 1.493 . . . . 0.0 110.37 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.633 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.0 Cg_endo -72.4 -31.2 11.68 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.874 1.46 . . . . 0.0 112.881 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 44.2 Cg_endo -72.78 -19.85 23.41 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 N-CA-C 109.984 -0.814 . . . . 0.0 109.984 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.903 ' HG2' HD13 ' A' ' 151' ' ' LEU . 36.7 ttm180 -83.55 -47.62 11.11 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.773 ' C ' HD23 ' A' ' 18' ' ' LEU . 1.1 tt -67.51 -32.42 73.21 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.55 ' N ' HD23 ' A' ' 18' ' ' LEU . 57.2 t80 -64.17 -53.99 40.66 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.479 -0.763 . . . . 0.0 109.402 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.546 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 17.8 mttm -49.6 -41.43 42.09 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.801 -0.76 . . . . 0.0 109.326 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.036 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -76.65 -33.54 58.32 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.398 -0.814 . . . . 0.0 111.04 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.817 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.6 OUTLIER -71.49 -49.08 44.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.036 -1.04 . . . . 0.0 111.323 -178.803 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.58 ' HB ' HD12 ' A' ' 24' ' ' LEU . 4.9 t -104.75 -49.25 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.015 -1.053 . . . . 0.0 111.437 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.674 HD12 ' N ' ' A' ' 24' ' ' LEU . 7.2 mp -76.99 -5.42 48.61 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.088 -1.007 . . . . 0.0 111.218 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.573 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -157.2 54.98 0.51 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.861 -1.15 . . . . 0.0 110.418 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.817 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -92.04 -10.07 40.47 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.341 -0.849 . . . . 0.0 110.05 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.514 ' O ' ' CG ' ' A' ' 31' ' ' PRO . 41.8 t0 -73.26 -20.32 60.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.326 -0.859 . . . . 0.0 109.919 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -128.46 14.02 6.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.353 -0.842 . . . . 0.0 109.888 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.873 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 0.4 OUTLIER -98.23 -46.19 5.92 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.363 -0.836 . . . . 0.0 110.321 -179.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.657 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.4 m -89.16 -33.35 0.4 Allowed Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.369 -0.832 . . . . 0.0 111.074 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.3 Cg_endo -80.22 7.59 4.62 Favored 'Trans proline' 0 C--N 1.317 -1.097 0 O-C-N 123.06 1.032 . . . . 0.0 110.318 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 51.6 tttt -131.99 -33.24 1.37 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.298 -0.876 . . . . 0.0 109.972 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.575 HG12 ' CD1' ' A' ' 150' ' ' TYR . 11.9 mt -80.02 -43.0 22.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.386 -0.821 . . . . 0.0 109.876 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.717 ' HB2' HD13 ' A' ' 146' ' ' LEU . . . -152.2 95.47 3.16 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.298 -0.876 . . . . 0.0 110.233 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -76.92 6.2 4.38 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.125 1.592 . . . . 0.0 110.774 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -89.59 -9.44 49.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.077 -1.014 . . . . 0.0 110.214 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.733 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -104.12 -41.78 5.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 110.23 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.733 HD12 ' C ' ' A' ' 37' ' ' ALA . 1.4 mp -136.43 121.07 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.429 -0.794 . . . . 0.0 109.88 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 57' ' ' THR . 6.7 ttpp -56.79 -29.94 63.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -0.914 . . . . 0.0 110.249 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.548 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER 173.53 179.38 0.1 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.245 -0.91 . . . . 0.0 110.004 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.524 ' N ' ' CG ' ' A' ' 40' ' ' HIS . 56.3 m -139.97 148.46 41.94 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.234 -0.916 . . . . 0.0 110.245 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.548 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 36.4 tp10 -152.85 111.2 3.69 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.155 -0.965 . . . . 0.0 110.601 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 29.8 mt -60.51 133.1 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.198 -0.939 . . . . 0.0 109.895 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.54 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 18.2 mt -107.27 -27.06 10.75 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.176 -0.952 . . . . 0.0 110.686 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.716 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.8 m95 -126.18 161.19 28.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.118 -0.989 . . . . 0.0 110.826 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.454 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 41.95 -133.81 3.86 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.431 ' CG ' ' O ' ' A' ' 47' ' ' ASP . 9.5 t0 -154.67 19.17 0.46 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.309 -1.112 . . . . 0.0 110.011 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.01 -17.29 7.63 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.577 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -70.31 -172.55 11.15 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -73.62 129.08 13.23 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 O-C-N 124.093 1.575 . . . . 0.0 110.589 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.38 -11.66 56.82 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.528 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -71.71 164.75 25.37 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.522 -0.987 . . . . 0.0 109.699 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.716 HD12 ' CG ' ' A' ' 45' ' ' TRP . 47.3 mt -133.35 120.9 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.345 -0.847 . . . . 0.0 109.725 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.471 ' CE ' HD11 ' A' ' 71' ' ' ILE . 28.4 mttm -104.36 131.4 51.75 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.205 -0.935 . . . . 0.0 110.291 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.54 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 73.0 tttt -101.81 93.26 5.22 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.215 -0.928 . . . . 0.0 110.05 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.55 ' CG2' HG12 ' A' ' 38' ' ' ILE . 74.6 mt -80.0 147.34 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.216 -0.927 . . . . 0.0 110.065 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.576 ' O ' HG23 ' A' ' 38' ' ' ILE . 2.2 p -116.69 150.59 37.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.29 -0.881 . . . . 0.0 110.729 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.703 ' HE2' HG13 ' A' ' 67' ' ' VAL . 22.3 m-85 -113.79 126.84 55.66 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.411 -0.806 . . . . 0.0 110.037 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.437 ' N ' ' HB2' ' A' ' 39' ' ' LYS . . . -91.49 50.39 2.96 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -71.78 -25.1 61.88 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.336 -1.097 . . . . 0.0 110.294 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 173.07 -160.66 31.49 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 63' ' ' GLN . 8.7 t -61.16 -52.12 66.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -1.136 . . . . 0.0 110.205 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 62' ' ' SER . 92.4 mt-30 -42.81 147.61 0.29 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.251 -0.906 . . . . 0.0 110.154 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.86 113.8 23.86 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.24 -0.912 . . . . 0.0 110.175 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.576 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -120.98 94.49 0.55 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.537 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 11.8 p90 -131.17 169.13 16.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -1.182 . . . . 0.0 110.217 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.792 HG12 ' HA2' ' A' ' 88' ' ' GLY . 4.1 m -135.25 177.9 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.233 -0.917 . . . . 0.0 110.345 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.656 ' O ' HD12 ' A' ' 85' ' ' LEU . 83.2 mttt -134.91 106.8 7.02 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.377 -0.827 . . . . 0.0 109.872 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.983 ' CD2' HD13 ' A' ' 85' ' ' LEU . 14.5 m170 -98.32 125.78 43.57 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.217 -0.927 . . . . 0.0 111.247 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.577 ' CE ' ' CG2' ' A' ' 86' ' ' ILE . 5.8 mtmp? -93.3 119.13 32.09 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.29 -0.881 . . . . 0.0 109.496 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.577 HG21 ' O ' ' A' ' 49' ' ' GLY . 37.8 mm -58.36 128.39 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.128 -0.983 . . . . 0.0 110.519 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.483 ' HB2' ' OG ' ' A' ' 82' ' ' SER . 94.3 m-20 -101.81 -43.82 5.71 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.382 -0.824 . . . . 0.0 109.939 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.498 ' N ' ' OG ' ' A' ' 82' ' ' SER . 22.7 m -169.49 158.89 8.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.407 -0.808 . . . . 0.0 109.736 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.6 mt -142.99 158.27 17.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.175 -0.953 . . . . 0.0 110.465 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.552 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 4.4 m-20 -134.32 77.81 1.72 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.682 -0.636 . . . . 0.0 109.927 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.53 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 14.7 ttpp -61.14 -16.25 42.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.088 -1.008 . . . . 0.0 110.238 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -93.15 -30.34 15.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.287 -0.883 . . . . 0.0 109.623 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -106.38 -7.28 17.73 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.481 -0.762 . . . . 0.0 109.958 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.575 ' O ' HD12 ' A' ' 104' ' ' LEU . 2.7 m-85 67.59 51.19 0.85 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.49 -0.756 . . . . 0.0 110.008 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.552 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -123.41 151.2 42.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.305 -0.872 . . . . 0.0 109.324 179.618 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.684 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 31.1 t80 -137.93 141.07 40.58 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.174 -0.954 . . . . 0.0 110.414 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.498 ' OG ' ' N ' ' A' ' 73' ' ' SER . 1.2 p -143.38 126.48 16.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.243 -0.911 . . . . 0.0 110.56 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.684 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 26.8 p90 -149.17 170.86 17.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.33 -0.856 . . . . 0.0 110.233 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.857 HG23 ' O ' ' A' ' 98' ' ' ILE . 40.7 m -127.05 150.51 49.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.308 -0.87 . . . . 0.0 109.88 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.983 HD13 ' CD2' ' A' ' 69' ' ' HIS . 8.0 tp -111.42 124.79 52.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.0 -1.063 . . . . 0.0 110.354 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.577 ' CG2' ' CE ' ' A' ' 70' ' ' LYS . 14.4 pt -105.21 -27.08 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.382 -0.824 . . . . 0.0 110.23 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.611 ' O ' HD11 ' A' ' 85' ' ' LEU . 81.7 tt0 -123.38 155.73 36.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -0.86 . . . . 0.0 110.227 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.792 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 162.26 137.99 2.32 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -65.07 -19.21 65.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.22 -1.164 . . . . 0.0 110.16 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.93 -17.8 45.83 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.288 -0.882 . . . . 0.0 110.278 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.635 HD22 HD12 ' A' ' 98' ' ' ILE . 14.1 mt -61.38 -29.02 69.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.269 -0.894 . . . . 0.0 110.03 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 47.27 -175.61 0.01 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.575 ' OD1' HG23 ' A' ' 94' ' ' THR . 54.6 p30 -83.85 6.76 20.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.192 -1.181 . . . . 0.0 109.773 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.575 HG23 ' OD1' ' A' ' 93' ' ' ASP . 50.0 p -98.93 -42.42 7.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.366 -0.834 . . . . 0.0 110.225 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.921 HD21 HD11 ' A' ' 128' ' ' ILE . 74.6 mt -100.44 161.67 13.45 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.39 -0.819 . . . . 0.0 110.137 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -142.46 -81.27 0.21 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.307 -0.871 . . . . 0.0 109.609 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 7.8 mtpp -80.2 143.74 33.54 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.688 -0.632 . . . . 0.0 110.352 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.857 ' O ' HG23 ' A' ' 84' ' ' THR . 0.6 OUTLIER -138.06 134.86 45.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.049 -1.032 . . . . 0.0 109.489 179.092 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.499 ' CB ' ' HB2' ' A' ' 119' ' ' HIS . 0.1 OUTLIER -109.9 141.06 43.16 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.467 -0.771 . . . . 0.0 109.875 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.611 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 2.8 m-85 -127.8 143.16 51.14 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.319 -0.863 . . . . 0.0 110.341 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.476 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 68.2 tt0 -149.79 119.43 6.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.317 -0.864 . . . . 0.0 110.193 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 64.4 m -119.66 150.76 39.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.166 -0.959 . . . . 0.0 109.923 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 115' ' ' LYS . 20.8 mttt -142.65 133.71 25.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.237 -0.915 . . . . 0.0 110.515 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.927 HD23 HG12 ' A' ' 114' ' ' ILE . 5.4 mt -116.74 147.35 42.11 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.193 -0.942 . . . . 0.0 109.799 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.69 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -150.69 -168.75 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.195 -0.941 . . . . 0.0 110.107 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.69 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -112.75 156.15 23.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.356 -0.84 . . . . 0.0 109.973 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.452 ' HB3' HG13 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -114.42 170.21 5.71 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.257 -0.902 . . . . 0.0 110.36 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -76.04 0.77 8.95 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.069 1.563 . . . . 0.0 110.471 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 59.0 p -109.9 8.96 24.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.236 -0.915 . . . . 0.0 110.268 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 93.41 -26.39 15.91 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.428 ' C ' ' OG ' ' A' ' 107' ' ' SER . . . -70.24 -172.41 10.81 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.509 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 5.2 p -124.78 127.2 46.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.124 -1.221 . . . . 0.0 110.428 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.803 ' HA ' HG22 ' A' ' 10' ' ' THR . 73.9 mt -79.9 148.28 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.303 -0.873 . . . . 0.0 110.199 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.927 HG12 HD23 ' A' ' 104' ' ' LEU . 18.0 mt -132.45 127.48 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.188 -0.945 . . . . 0.0 110.563 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 103' ' ' LYS . 38.1 tttp -118.08 118.59 32.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.255 -0.903 . . . . 0.0 109.797 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.1 t -113.9 155.17 26.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.114 -0.991 . . . . 0.0 110.656 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.476 ' HB ' ' HB3' ' A' ' 101' ' ' GLU . 78.6 m -149.87 133.37 16.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.365 -0.834 . . . . 0.0 110.192 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 28.0 p -126.47 142.99 51.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.237 -0.914 . . . . 0.0 110.238 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.856 ' CE1' HG23 ' A' ' 4' ' ' THR . 85.5 m-70 -122.67 157.37 32.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.152 -0.967 . . . . 0.0 110.436 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.526 ' CD2' HG13 ' A' ' 128' ' ' ILE . 28.5 m-85 -128.32 137.34 51.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.248 -0.908 . . . . 0.0 110.354 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.487 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 47.4 m-70 -117.71 88.79 2.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.095 -1.003 . . . . 0.0 109.491 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.809 ' CG2' HD23 ' A' ' 95' ' ' LEU . 1.1 p -72.92 160.16 32.57 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.46 -0.775 . . . . 0.0 110.411 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 15.5 tttt -113.9 111.85 22.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.372 -0.83 . . . . 0.0 110.214 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 113.64 -133.87 11.49 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -123.5 64.33 1.02 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.217 -1.166 . . . . 0.0 110.255 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.452 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 24.2 m -130.73 162.52 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.258 -0.901 . . . . 0.0 110.142 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.423 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 93.0 mt-10 -134.67 161.62 34.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 0.0 110.307 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.921 HD11 HD21 ' A' ' 95' ' ' LEU . 20.6 mm -67.29 173.12 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 0.0 110.056 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.591 ' N ' HG22 ' A' ' 128' ' ' ILE . 12.5 mttt -111.75 132.8 54.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.0 110.029 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.434 ' OE1' ' HA ' ' A' ' 130' ' ' GLU . 69.4 mm-40 -44.61 -35.16 2.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.195 -0.941 . . . . 0.0 110.133 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -67.81 -23.81 65.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 109.967 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.472 ' N ' ' O ' ' A' ' 129' ' ' LYS . 16.4 t-160 -83.16 -49.33 9.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.297 -0.877 . . . . 0.0 110.217 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.651 HG11 ' CD1' ' A' ' 5' ' ' TYR . 98.8 t -59.61 -34.29 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.388 -0.82 . . . . 0.0 110.076 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -73.87 -51.14 17.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.893 . . . . 0.0 110.037 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.426 ' O ' ' HG3' ' A' ' 139' ' ' LYS . . . -59.29 -32.95 70.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.251 -0.905 . . . . 0.0 110.016 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.34 -27.93 73.11 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 81.0 mttt -78.9 -31.71 45.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.246 -1.15 . . . . 0.0 110.125 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -88.72 -30.03 19.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 0.0 109.92 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.426 ' HG3' ' O ' ' A' ' 135' ' ' ALA . 25.9 mttm -72.17 -31.11 65.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.349 -0.845 . . . . 0.0 109.94 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -86.64 -41.64 14.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.258 -0.901 . . . . 0.0 109.961 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 36.0 t -53.22 -43.25 67.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.338 -0.851 . . . . 0.0 110.088 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -57.38 -42.87 83.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -0.847 . . . . 0.0 110.005 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.463 HD23 HD12 ' A' ' 146' ' ' LEU . 52.7 mt -63.9 -37.75 88.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -0.914 . . . . 0.0 109.941 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -63.14 -35.15 79.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.433 -0.792 . . . . 0.0 109.857 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -75.15 -10.68 59.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.289 -0.882 . . . . 0.0 110.278 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.717 HD13 ' HB2' ' A' ' 34' ' ' ALA . 24.0 mt -85.18 -36.67 20.87 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.11 -0.994 . . . . 0.0 109.099 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.701 HD11 ' CE1' ' A' ' 22' ' ' PHE . 32.3 mt -71.2 -44.12 74.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.618 ' HB3' HD13 ' A' ' 13' ' ' ILE . 85.2 mt-10 -58.08 -42.22 85.14 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.446 -0.784 . . . . 0.0 109.614 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 28.2 m -70.19 -39.97 74.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.191 -0.943 . . . . 0.0 109.54 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.615 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 93.1 t80 -49.37 -42.44 42.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.437 -0.789 . . . . 0.0 109.995 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.903 HD13 ' HG2' ' A' ' 17' ' ' ARG . 42.6 mt -80.16 -44.72 19.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.322 -0.862 . . . . 0.0 110.33 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.745 ' HB2' HD11 ' A' ' 13' ' ' ILE . 29.9 tttt -61.03 -14.45 23.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.337 -0.852 . . . . 0.0 109.629 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -113.31 -30.05 2.8 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.56 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 8.0 m-70 -112.64 96.09 35.35 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.357 -1.084 . . . . 0.0 110.025 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.48 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.9 Cg_endo -73.78 7.68 2.28 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.155 1.608 . . . . 0.0 111.279 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 157' ' ' ALA . 39.3 p30 -109.84 -9.56 14.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.952 -1.093 . . . . 0.0 109.582 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.615 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -66.01 101.14 0.65 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.548 -0.72 . . . . 0.0 110.182 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 1.036 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 0.3 OUTLIER 35.05 32.63 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.218 0 CA-C-O 121.406 0.622 . . . . 0.0 110.164 -179.602 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.533 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.305 -1.365 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.935 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 1.043 HG23 ' C ' ' A' ' 120' ' ' TYR . 3.4 p -88.11 148.13 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.332 -1.099 . . . . 0.0 110.538 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -83.95 172.25 12.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.403 -0.811 . . . . 0.0 110.118 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 1.0 HG23 ' CE1' ' A' ' 119' ' ' HIS . 92.8 m -141.1 124.83 16.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.289 -0.882 . . . . 0.0 110.46 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.639 ' CZ ' HG11 ' A' ' 133' ' ' VAL . 74.4 m-85 -126.04 144.63 50.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.321 -0.862 . . . . 0.0 109.932 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.454 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 20.5 pt-20 -139.34 149.54 44.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.208 -0.932 . . . . 0.0 110.581 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -135.44 144.54 46.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.453 -0.779 . . . . 0.0 109.595 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -130.33 119.48 22.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.113 -0.992 . . . . 0.0 110.634 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.641 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.0 p90 -144.61 -177.89 5.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.393 -0.817 . . . . 0.0 109.793 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.89 HG22 ' HA ' ' A' ' 113' ' ' ILE . 9.4 p -141.9 171.89 13.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.175 -0.953 . . . . 0.0 110.678 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -152.36 154.99 36.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.46 -0.775 . . . . 0.0 110.247 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -77.01 -27.88 54.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.293 -0.88 . . . . 0.0 109.928 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.818 HG23 ' HD2' ' A' ' 14' ' ' PRO . 1.8 mp -71.39 150.54 94.07 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.351 -0.843 . . . . 0.0 109.849 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.818 ' HD2' HG23 ' A' ' 13' ' ' ILE . 41.0 Cg_endo -66.43 141.49 61.82 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.99 1.521 . . . . 0.0 110.498 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.636 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 41.2 Cg_endo -73.64 -30.21 9.94 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 124.068 1.562 . . . . 0.0 113.125 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 44.6 Cg_endo -71.56 -28.3 17.69 Favored 'Trans proline' 0 C--N 1.318 -1.034 0 N-CA-C 110.288 -0.697 . . . . 0.0 110.288 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.563 ' CZ ' ' HA ' ' A' ' 159' ' ' ASN . 6.3 mtp180 -79.92 -42.91 23.12 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.722 ' C ' HD23 ' A' ' 18' ' ' LEU . 0.4 OUTLIER -66.51 -30.07 70.32 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.575 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.608 ' N ' HD23 ' A' ' 18' ' ' LEU . 52.0 t80 -63.83 -51.99 62.16 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.51 0.671 . . . . 0.0 109.851 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.54 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 22.9 mttt -55.94 -40.04 72.59 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.525 -0.734 . . . . 0.0 109.94 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.068 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -77.86 -26.8 49.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.263 -0.898 . . . . 0.0 110.946 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 1.002 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 3.4 t80 -81.8 -49.12 10.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.095 -1.003 . . . . 0.0 111.579 -178.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.702 HG13 ' CE1' ' A' ' 81' ' ' TYR . 5.5 t -102.03 -53.71 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.098 -1.001 . . . . 0.0 111.462 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.622 HD12 ' N ' ' A' ' 24' ' ' LEU . 7.6 mp -66.0 -8.7 24.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.137 -0.977 . . . . 0.0 111.016 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.564 ' OD2' ' CE2' ' A' ' 158' ' ' TYR . 2.7 m-20 -145.0 21.79 1.58 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.963 -1.086 . . . . 0.0 110.524 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 1.002 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -59.73 -14.85 16.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.201 -0.937 . . . . 0.0 110.414 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -80.08 -25.03 40.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -0.914 . . . . 0.0 110.483 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.494 ' HB2' ' HE3' ' A' ' 32' ' ' LYS . 6.9 p30 -126.8 14.39 7.46 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.128 -0.982 . . . . 0.0 110.606 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.766 HD23 ' OH ' ' A' ' 158' ' ' TYR . 1.2 tm? -100.71 -43.09 6.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.239 -0.913 . . . . 0.0 109.858 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.93 HG11 HD13 ' A' ' 38' ' ' ILE . 4.8 t -77.41 -40.81 2.26 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.464 -0.772 . . . . 0.0 111.193 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 47.6 Cg_endo -77.6 10.65 2.45 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.444 1.234 . . . . 0.0 111.051 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.494 ' HE3' ' HB2' ' A' ' 28' ' ' ASN . 16.6 mttm -122.27 -30.74 3.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.985 -1.072 . . . . 0.0 109.496 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.93 HG21 ' HB3' ' A' ' 146' ' ' LEU . 7.5 mt -80.13 -55.48 8.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.579 -0.701 . . . . 0.0 109.821 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.51 103.96 5.02 Favored Pre-proline 0 C--N 1.304 -1.409 0 O-C-N 121.404 -0.81 . . . . 0.0 110.238 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.33 0.34 7.54 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.015 1.534 . . . . 0.0 110.526 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -81.62 -20.59 39.42 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.116 -0.99 . . . . 0.0 109.475 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -91.5 -42.32 10.33 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.467 -0.771 . . . . 0.0 109.927 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.93 HD13 HG11 ' A' ' 30' ' ' VAL . 1.1 mp -137.7 140.1 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.43 -0.794 . . . . 0.0 109.944 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.3 ttmm -82.25 -36.37 27.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 110.208 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.562 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -176.44 154.98 1.36 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.262 -0.898 . . . . 0.0 110.192 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.5 m -124.2 116.8 23.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.287 -0.883 . . . . 0.0 109.975 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.562 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 35.8 tp10 -122.79 113.27 18.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.193 -0.942 . . . . 0.0 110.449 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.482 HG12 ' HG2' ' A' ' 54' ' ' LYS . 23.2 mt -60.67 133.94 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.322 -0.861 . . . . 0.0 109.98 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.537 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 26.7 mt -106.97 -23.5 12.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.247 -0.908 . . . . 0.0 110.517 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.576 ' CD1' HD12 ' A' ' 53' ' ' ILE . 1.6 m95 -130.94 161.25 32.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.127 -0.983 . . . . 0.0 110.559 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.454 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 41.98 -133.56 3.95 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -157.7 20.65 0.27 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -1.104 . . . . 0.0 110.059 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.465 ' O ' HG21 ' A' ' 71' ' ' ILE . . . 125.49 -19.92 6.61 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.484 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -67.79 -175.21 8.48 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.426 ' HA ' HG22 ' A' ' 71' ' ' ILE . 47.1 Cg_endo -73.92 129.54 13.47 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 123.932 1.49 . . . . 0.0 110.66 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.94 -13.99 52.66 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -68.0 166.38 15.95 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.516 -0.991 . . . . 0.0 109.907 179.751 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.576 HD12 ' CD1' ' A' ' 45' ' ' TRP . 40.7 mt -133.27 121.68 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.315 -0.865 . . . . 0.0 109.662 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.52 ' HE3' HD11 ' A' ' 71' ' ' ILE . 20.7 mttm -111.15 132.29 54.41 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.144 -0.973 . . . . 0.0 110.411 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.537 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 17.7 tttt -101.36 89.93 3.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 109.904 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.551 ' CG2' HG12 ' A' ' 38' ' ' ILE . 83.0 mt -79.98 144.4 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.296 -0.877 . . . . 0.0 110.168 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.516 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 4.8 p -117.31 159.11 23.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.295 -0.878 . . . . 0.0 110.603 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' A' ' 65' ' ' GLY . 22.5 m-85 -119.61 149.54 41.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.381 -0.824 . . . . 0.0 110.076 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -111.91 30.69 7.55 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -48.74 -26.55 2.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.305 -1.115 . . . . 0.0 110.274 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 171.94 -160.85 32.68 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.6 m -63.05 -41.01 99.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.263 -1.139 . . . . 0.0 110.224 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -49.94 149.5 2.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.168 -0.957 . . . . 0.0 110.09 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -85.1 123.15 30.29 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.2 -0.938 . . . . 0.0 110.342 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -134.1 91.61 0.25 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.538 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 15.2 p90 -129.92 166.7 19.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.137 -1.213 . . . . 0.0 110.276 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.794 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.4 m -142.92 172.27 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 110.696 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.523 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 23.3 mttm -125.19 124.48 41.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.621 -0.675 . . . . 0.0 109.543 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.698 ' NE2' HD13 ' A' ' 85' ' ' LEU . 11.3 m170 -113.41 126.1 54.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.143 -0.973 . . . . 0.0 111.157 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 1.03 ' HE3' HD13 ' A' ' 86' ' ' ILE . 48.3 mttt -97.82 117.15 31.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.373 -0.829 . . . . 0.0 109.509 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.522 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 22.4 mm -60.07 128.64 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.082 -1.011 . . . . 0.0 110.311 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 82' ' ' SER . 89.4 m-20 -102.5 -45.34 5.09 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.314 -0.867 . . . . 0.0 110.179 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 19.1 m -168.08 159.07 10.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.385 -0.822 . . . . 0.0 110.094 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.483 HG12 HG11 ' A' ' 23' ' ' VAL . 2.0 mt -141.26 158.79 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.292 -0.88 . . . . 0.0 110.118 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.551 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 4.5 m-20 -135.37 80.02 1.81 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.502 -0.749 . . . . 0.0 110.116 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.564 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 17.8 mttt -62.39 -18.16 60.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.135 -0.978 . . . . 0.0 110.4 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -91.91 -31.79 15.53 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.133 -0.979 . . . . 0.0 109.633 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.476 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -103.58 -6.63 21.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.591 -0.693 . . . . 0.0 109.799 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.569 ' CZ ' ' HB3' ' A' ' 16' ' ' PRO . 4.1 m-85 65.91 51.8 1.32 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.494 -0.754 . . . . 0.0 110.056 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.551 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -123.38 157.9 32.33 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.081 -1.012 . . . . 0.0 109.595 179.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.702 ' CE1' HG13 ' A' ' 23' ' ' VAL . 32.3 t80 -144.56 141.01 29.16 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.196 -0.94 . . . . 0.0 110.259 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.6 OUTLIER -145.89 127.02 14.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.208 -0.932 . . . . 0.0 110.929 -179.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.688 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 20.0 p90 -146.6 170.67 16.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.436 -0.79 . . . . 0.0 109.796 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.606 HG23 ' O ' ' A' ' 98' ' ' ILE . 35.2 m -124.44 135.43 53.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.159 -0.963 . . . . 0.0 110.427 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.698 HD13 ' NE2' ' A' ' 69' ' ' HIS . 6.3 tp -99.49 124.35 44.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.283 -0.886 . . . . 0.0 109.702 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 1.03 HD13 ' HE3' ' A' ' 70' ' ' LYS . 14.3 pt -106.41 -15.77 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.387 -0.821 . . . . 0.0 110.459 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.523 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 24.9 tt0 -121.3 176.11 5.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.147 -0.97 . . . . 0.0 110.339 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.794 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 137.09 123.58 2.24 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -57.78 -15.37 7.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -1.142 . . . . 0.0 110.205 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.929 ' HB1' ' CE1' ' A' ' 132' ' ' HIS . . . -73.92 -40.48 63.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -0.88 . . . . 0.0 110.167 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.669 ' CD2' HD21 ' A' ' 95' ' ' LEU . 10.1 mt -42.17 -48.05 4.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.406 -0.809 . . . . 0.0 110.119 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 43.23 -164.72 0.03 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -81.19 2.57 27.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -1.142 . . . . 0.0 110.172 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 52.2 p -92.62 -42.51 9.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.287 -0.883 . . . . 0.0 110.17 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.873 HD12 ' H ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -119.55 159.91 23.43 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.367 -0.833 . . . . 0.0 109.339 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.873 ' H ' HD12 ' A' ' 95' ' ' LEU . 53.9 tt0 -136.32 -82.02 0.39 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.344 -0.848 . . . . 0.0 110.178 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.499 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 5.3 mttt -80.24 139.36 36.73 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.768 -0.583 . . . . 0.0 110.558 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.752 HG21 ' CE2' ' A' ' 100' ' ' TYR . 3.6 mm -123.06 139.97 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.963 -1.086 . . . . 0.0 109.887 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.513 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -117.48 126.77 53.19 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.279 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.752 ' CE2' HG21 ' A' ' 98' ' ' ILE . 8.7 m-85 -119.56 137.63 53.72 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.237 -0.914 . . . . 0.0 110.722 -178.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.469 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 80.9 tt0 -143.2 134.57 26.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.353 -0.842 . . . . 0.0 110.143 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.417 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 85.6 m -133.77 145.11 49.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -0.917 . . . . 0.0 110.18 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.6 mttt -140.53 140.72 35.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 0.0 110.671 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.794 HD23 HG12 ' A' ' 114' ' ' ILE . 10.1 mt -121.05 149.57 42.51 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.236 -0.915 . . . . 0.0 110.142 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.7 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -146.05 -169.71 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.207 -0.933 . . . . 0.0 110.03 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.7 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -126.68 160.56 30.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.256 -0.902 . . . . 0.0 110.275 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.423 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.2 p -119.32 170.55 6.54 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.225 -0.922 . . . . 0.0 110.144 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.423 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 45.7 Cg_endo -72.8 -14.8 26.89 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 124.11 1.584 . . . . 0.0 110.575 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 24.8 p -94.7 7.15 46.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -0.903 . . . . 0.0 110.273 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 94.46 -31.16 6.99 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -58.26 -172.41 0.34 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 10.4 p -137.25 137.63 39.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.194 -1.18 . . . . 0.0 110.39 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.89 ' HA ' HG22 ' A' ' 10' ' ' THR . 16.2 mt -92.58 149.59 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.402 -0.811 . . . . 0.0 110.088 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.794 HG12 HD23 ' A' ' 104' ' ' LEU . 18.5 mt -131.23 128.63 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.22 -0.925 . . . . 0.0 110.228 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.1 tttp -118.11 108.73 15.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.084 -1.01 . . . . 0.0 110.209 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.434 ' OG ' ' CZ ' ' A' ' 9' ' ' PHE . 0.9 OUTLIER -103.25 157.33 17.08 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.238 -0.914 . . . . 0.0 110.441 -179.854 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.704 HG22 ' NE2' ' A' ' 119' ' ' HIS . 24.8 m -154.87 119.56 4.83 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.337 -0.852 . . . . 0.0 110.438 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 86.5 p -119.01 148.1 43.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.403 -0.811 . . . . 0.0 110.041 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 1.0 ' CE1' HG23 ' A' ' 4' ' ' THR . 24.6 m-70 -132.42 152.93 51.29 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.201 -0.937 . . . . 0.0 110.668 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 1.043 ' C ' HG23 ' A' ' 2' ' ' VAL . 9.8 m-85 -121.82 119.92 33.05 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.271 -0.893 . . . . 0.0 110.614 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.566 ' N ' HG23 ' A' ' 2' ' ' VAL . 80.4 m-70 -92.62 104.1 16.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.558 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.468 HG21 ' HA ' ' A' ' 127' ' ' GLU . 0.8 OUTLIER -77.96 144.75 36.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.141 -0.975 . . . . 0.0 110.374 -179.593 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.418 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 31.5 tttp -105.57 126.93 52.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.278 -0.889 . . . . 0.0 110.207 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.37 -138.92 21.14 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -113.87 59.64 0.67 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -1.142 . . . . 0.0 110.274 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 26.2 m -131.28 161.7 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.319 -0.863 . . . . 0.0 110.194 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.468 ' HA ' HG21 ' A' ' 122' ' ' THR . 85.3 mt-10 -137.6 139.7 40.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.266 -0.896 . . . . 0.0 110.25 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.598 HG22 ' N ' ' A' ' 129' ' ' LYS . 2.7 mp -59.77 173.25 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.191 -0.943 . . . . 0.0 110.148 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.598 ' N ' HG22 ' A' ' 128' ' ' ILE . 21.4 mttm -92.45 127.41 37.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 110.089 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -45.39 -44.72 12.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.149 -0.969 . . . . 0.0 110.136 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 29.0 tp10 -53.29 -30.26 37.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.194 -0.941 . . . . 0.0 110.04 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.929 ' CE1' ' HB1' ' A' ' 90' ' ' ALA . 11.1 t-160 -76.35 -57.82 3.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -0.932 . . . . 0.0 110.239 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.639 HG11 ' CZ ' ' A' ' 5' ' ' TYR . 72.3 t -59.19 -34.22 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.377 -0.827 . . . . 0.0 110.063 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -72.41 -49.1 36.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.332 -0.855 . . . . 0.0 110.111 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.87 -29.66 69.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.095 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.72 -32.08 80.29 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.429 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 17.3 mttp -65.04 -36.84 85.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.251 -1.146 . . . . 0.0 110.036 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -75.35 -35.44 61.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.307 -0.87 . . . . 0.0 110.041 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -70.12 -30.84 68.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.363 -0.836 . . . . 0.0 109.92 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.482 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -74.61 -41.28 60.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.287 -0.883 . . . . 0.0 110.134 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 61.3 p -64.68 -39.36 93.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.371 -0.831 . . . . 0.0 109.991 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -60.87 -48.11 83.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 110.004 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 27.6 mt -57.87 -38.54 75.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.271 -0.893 . . . . 0.0 109.957 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.498 ' HA ' HD12 ' A' ' 147' ' ' ILE . 19.7 m-85 -62.87 -33.79 76.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.448 -0.783 . . . . 0.0 109.905 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.409 ' HA ' ' OE1' ' A' ' 148' ' ' GLU . 92.8 mttt -74.85 -15.03 60.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -0.904 . . . . 0.0 110.202 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.93 ' HB3' HG21 ' A' ' 33' ' ' ILE . 28.2 mt -85.25 -36.69 20.76 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.222 -0.923 . . . . 0.0 109.043 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.626 HD13 ' CD1' ' A' ' 22' ' ' PHE . 16.1 mt -72.09 -41.41 67.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.538 ' HB3' HD13 ' A' ' 13' ' ' ILE . 86.5 mt-10 -59.13 -42.81 91.5 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.49 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 15.5 m -74.12 -27.96 61.11 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.64 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 50.2 t80 -52.07 -61.85 2.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.563 -0.71 . . . . 0.0 109.836 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.548 HD21 ' CE1' ' A' ' 158' ' ' TYR . 36.0 mt -72.24 -30.08 64.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.346 -0.846 . . . . 0.0 109.71 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.554 ' HB2' HD11 ' A' ' 13' ' ' ILE . 27.8 tttp -65.27 -33.84 76.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.343 -0.848 . . . . 0.0 109.253 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.487 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -99.0 -30.74 6.56 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.59 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 5.4 m-70 -107.26 87.2 3.02 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.327 -1.101 . . . . 0.0 109.796 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 46.1 Cg_endo -72.08 2.62 4.71 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.068 1.562 . . . . 0.0 110.955 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -108.24 -12.61 15.05 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.96 -1.087 . . . . 0.0 110.197 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.64 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -69.2 99.71 1.19 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.253 -0.905 . . . . 0.0 109.846 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 1.068 ' CE1' ' HB2' ' A' ' 21' ' ' ALA . 0.1 OUTLIER 34.77 32.33 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 CA-C-O 121.518 0.675 . . . . 0.0 109.871 -179.21 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.563 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.446 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.826 -179.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.679 HG13 ' O ' ' A' ' 120' ' ' TYR . 40.4 t -126.85 139.95 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -1.135 . . . . 0.0 110.239 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.75 ' CE1' HD12 ' A' ' 128' ' ' ILE . 16.2 m-85 -101.94 160.6 14.35 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.213 -0.93 . . . . 0.0 109.728 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.785 HG23 ' CE1' ' A' ' 119' ' ' HIS . 5.1 m -124.42 108.32 12.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.118 -0.989 . . . . 0.0 110.508 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.759 ' CE1' HG11 ' A' ' 133' ' ' VAL . 25.3 m-85 -120.47 126.18 49.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.26 -0.9 . . . . 0.0 109.969 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.604 ' HB3' HG23 ' A' ' 117' ' ' THR . 25.8 pt-20 -139.37 159.66 41.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.924 . . . . 0.0 110.394 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.2 t -138.65 148.93 44.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.862 . . . . 0.0 110.012 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -131.81 123.28 27.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.195 -0.941 . . . . 0.0 110.257 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.638 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.0 p90 -145.94 -174.07 4.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.194 -0.941 . . . . 0.0 109.952 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.722 HG22 ' HA ' ' A' ' 113' ' ' ILE . 8.7 p -139.28 175.52 9.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.134 -0.979 . . . . 0.0 110.496 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.477 ' CB ' ' CD ' ' A' ' 148' ' ' GLU . 79.8 p -158.08 139.4 13.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.306 -0.871 . . . . 0.0 110.229 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -64.74 -28.71 69.77 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 0.0 109.888 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.805 HG23 ' HD2' ' A' ' 14' ' ' PRO . 8.3 mm -68.96 149.88 97.74 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.365 -0.835 . . . . 0.0 109.904 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.805 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.5 Cg_endo -65.6 146.47 84.57 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.971 1.511 . . . . 0.0 110.44 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.672 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.1 Cg_endo -71.51 -31.73 13.26 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.969 1.51 . . . . 0.0 112.828 -179.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.672 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 40.8 Cg_endo -69.41 -21.38 35.2 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 N-CA-C 110.059 -0.785 . . . . 0.0 110.059 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.753 ' HB3' HD13 ' A' ' 151' ' ' LEU . 52.7 mtp180 -85.68 -44.87 12.2 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.883 ' HG ' HG21 ' A' ' 147' ' ' ILE . 1.1 tt -71.34 -30.07 65.74 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.627 ' CZ ' HD11 ' A' ' 74' ' ' ILE . 71.4 t80 -66.88 -61.76 1.78 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.521 -0.737 . . . . 0.0 109.13 178.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.585 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 52.6 mttt -52.78 -34.33 52.84 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.338 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.95 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -72.21 -53.75 11.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.33 -0.856 . . . . 0.0 110.749 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.99 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.3 OUTLIER -59.86 -53.2 60.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.507 -0.745 . . . . 0.0 111.425 -178.897 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 1.004 HG11 HD12 ' A' ' 74' ' ' ILE . 11.1 t -91.26 -63.86 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.992 -1.068 . . . . 0.0 111.767 -178.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.585 ' HB2' ' HA ' ' A' ' 20' ' ' LYS . 4.7 mp -65.12 -3.57 3.9 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.22 -0.925 . . . . 0.0 111.793 -178.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.581 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.8 OUTLIER -140.46 9.54 2.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.658 -1.276 . . . . 0.0 110.788 179.882 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.99 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -51.57 -26.83 9.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.176 -0.953 . . . . 0.0 110.31 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -76.63 -13.95 60.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.947 . . . . 0.0 110.502 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.424 ' O ' ' HD2' ' A' ' 32' ' ' LYS . 72.0 m-80 -134.97 10.64 3.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.211 -0.93 . . . . 0.0 110.345 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.54 ' HG ' ' HB1' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -104.24 -40.97 5.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.185 -0.947 . . . . 0.0 110.38 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.848 ' CG1' HD13 ' A' ' 38' ' ' ILE . 2.8 t -81.08 -41.55 1.13 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.28 -0.888 . . . . 0.0 111.178 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.3 Cg_endo -77.17 11.17 2.14 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.387 1.204 . . . . 0.0 111.074 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.424 ' HD2' ' O ' ' A' ' 28' ' ' ASN . 17.1 mttm -123.25 -31.51 3.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.943 -1.098 . . . . 0.0 109.471 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.86 ' CG2' HD22 ' A' ' 146' ' ' LEU . 9.3 mt -80.12 -44.96 22.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.52 -0.737 . . . . 0.0 109.611 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.437 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . . . -141.07 99.11 6.66 Favored Pre-proline 0 C--N 1.304 -1.39 0 O-C-N 121.371 -0.831 . . . . 0.0 110.115 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 34' ' ' ALA . 44.9 Cg_endo -71.12 -2.82 11.71 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.951 1.501 . . . . 0.0 110.524 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.448 ' O ' ' HG3' ' A' ' 60' ' ' GLU . 13.5 pt20 -89.02 -23.15 22.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 109.949 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 58' ' ' PHE . . . -85.54 -70.39 0.59 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.323 -0.86 . . . . 0.0 110.06 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.848 HD13 ' CG1' ' A' ' 30' ' ' VAL . 1.8 mp -101.11 122.08 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.449 -0.782 . . . . 0.0 110.01 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 57' ' ' THR . 10.7 ttmt -75.2 -32.11 61.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.154 -0.966 . . . . 0.0 110.487 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.53 ' CD2' ' C ' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -176.25 148.41 0.78 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.162 -0.961 . . . . 0.0 110.171 -179.882 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.3 m -122.31 118.43 28.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.35 -0.844 . . . . 0.0 109.718 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.524 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 42.4 tt0 -129.18 110.37 11.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.149 -0.969 . . . . 0.0 110.422 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.413 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 38.3 mt -53.06 144.91 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.372 -0.83 . . . . 0.0 110.046 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.0 tp -119.72 -25.13 5.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.237 -0.914 . . . . 0.0 110.544 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.825 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.7 m95 -127.81 162.97 25.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.113 -0.992 . . . . 0.0 110.646 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.446 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 42.56 -140.3 2.21 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -149.2 24.79 0.91 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.285 -1.126 . . . . 0.0 110.017 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 118.4 -12.19 12.51 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.546 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -81.97 -168.95 42.27 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.402 ' HA ' HG22 ' A' ' 71' ' ' ILE . 44.2 Cg_endo -72.54 128.28 13.37 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.042 1.548 . . . . 0.0 110.694 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.88 -12.45 49.66 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.1 m -72.85 162.28 29.68 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.616 -0.931 . . . . 0.0 109.47 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.825 HD12 ' CG ' ' A' ' 45' ' ' TRP . 66.1 mt -133.84 119.4 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.235 -0.916 . . . . 0.0 110.103 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.701 ' HE3' HD11 ' A' ' 71' ' ' ILE . 52.5 mttt -102.59 130.72 49.55 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.2 -0.938 . . . . 0.0 110.179 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.526 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 53.6 tttm -102.24 92.42 4.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.242 -0.911 . . . . 0.0 110.164 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.432 ' HB ' HG23 ' A' ' 67' ' ' VAL . 97.5 mt -80.45 140.61 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.142 -0.974 . . . . 0.0 110.394 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 1.4 p -110.16 150.94 27.91 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.351 -0.843 . . . . 0.0 110.267 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.675 ' HE2' HG13 ' A' ' 67' ' ' VAL . 24.7 m-85 -113.83 149.08 35.53 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.221 -0.924 . . . . 0.0 110.077 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -101.79 6.95 54.98 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.448 ' HG3' ' O ' ' A' ' 36' ' ' GLN . 97.4 mt-10 -119.91 155.35 32.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -1.151 . . . . 0.0 110.225 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.91 -153.41 21.17 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 84.5 p -56.34 -172.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.2 -1.176 . . . . 0.0 110.25 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -73.66 -27.94 61.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.907 . . . . 0.0 110.204 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -120.53 101.59 7.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.289 -0.882 . . . . 0.0 110.228 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.571 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -130.26 88.69 0.3 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.539 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 13.7 p90 -133.77 166.68 22.07 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.192 -1.181 . . . . 0.0 110.292 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.855 HG12 ' HA2' ' A' ' 88' ' ' GLY . 4.4 m -133.93 175.74 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.384 -0.823 . . . . 0.0 110.253 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.711 ' O ' HD12 ' A' ' 85' ' ' LEU . 33.3 mttt -135.52 103.96 5.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.426 -0.797 . . . . 0.0 109.834 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.945 ' CD2' HD13 ' A' ' 85' ' ' LEU . 15.4 m170 -94.19 129.18 40.9 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.292 -0.88 . . . . 0.0 111.073 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 52' ' ' THR . 70.0 tttt -97.21 111.55 23.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.458 -0.776 . . . . 0.0 109.18 178.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.701 HD11 ' HE3' ' A' ' 54' ' ' LYS . 27.3 mm -52.91 125.61 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.093 -1.005 . . . . 0.0 110.354 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 82' ' ' SER . 95.0 m-20 -99.37 -48.6 4.74 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.374 -0.829 . . . . 0.0 109.666 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.4 m 177.8 160.68 0.51 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.544 -0.722 . . . . 0.0 110.054 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 1.004 HD12 HG11 ' A' ' 23' ' ' VAL . 3.2 tt -145.31 165.92 10.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.392 -0.817 . . . . 0.0 109.785 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.8 m-20 -128.95 76.89 1.75 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.099 -1.0 . . . . 0.0 110.132 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.59 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 65.3 mttm -55.43 -16.66 3.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.16 -0.962 . . . . 0.0 110.367 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -92.8 -30.67 15.35 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.348 -0.845 . . . . 0.0 109.705 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.516 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.2 m-80 -106.61 -0.13 24.01 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.561 -0.712 . . . . 0.0 109.475 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.608 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 72.8 m-85 62.06 52.84 3.15 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.297 0.57 . . . . 0.0 110.863 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.478 ' HB3' ' HG3' ' A' ' 103' ' ' LYS . 0.7 OUTLIER -130.56 152.01 50.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 109.84 179.305 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.677 ' CE1' HG13 ' A' ' 23' ' ' VAL . 74.5 t80 -149.46 133.86 17.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.022 -1.049 . . . . 0.0 110.368 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 36.1 m -139.66 147.08 40.52 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.176 -0.952 . . . . 0.0 110.525 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.668 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 7.8 p90 -148.47 177.88 9.08 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.346 -0.846 . . . . 0.0 110.666 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 98' ' ' ILE . 15.6 m -127.88 123.32 34.76 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.441 -0.787 . . . . 0.0 109.924 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.945 HD13 ' CD2' ' A' ' 69' ' ' HIS . 12.2 tp -94.34 134.0 37.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.021 -1.05 . . . . 0.0 110.292 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.548 ' H ' HD12 ' A' ' 85' ' ' LEU . 13.6 pt -114.89 -33.32 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 110.334 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.641 ' O ' HD11 ' A' ' 85' ' ' LEU . 29.3 tt0 -114.11 134.07 55.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 110.38 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.855 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . -176.92 122.38 0.84 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -55.77 -17.07 5.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.16 -1.2 . . . . 0.0 110.235 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -91.35 -34.15 15.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.934 . . . . 0.0 110.469 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.622 HD12 ' C ' ' A' ' 91' ' ' LEU . 1.9 pp -84.9 -16.97 39.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.256 -0.903 . . . . 0.0 110.404 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.87 -23.8 75.62 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -49.45 -65.56 0.55 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.288 -1.125 . . . . 0.0 110.358 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 80.5 p -137.28 8.4 2.91 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.463 -0.773 . . . . 0.0 110.175 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 1.048 HD21 ' CG1' ' A' ' 128' ' ' ILE . 11.4 mt -119.41 177.73 4.81 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.3 -0.875 . . . . 0.0 110.051 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.517 ' O ' HD13 ' A' ' 91' ' ' LEU . 39.4 tt0 -146.29 -78.73 0.17 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.332 -0.855 . . . . 0.0 109.772 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.499 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 16.1 mttm -80.16 142.57 34.63 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.87 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.732 HG21 ' HE2' ' A' ' 100' ' ' TYR . 5.2 mm -135.39 140.97 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.924 -1.11 . . . . 0.0 110.548 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.423 ' OG ' ' HD2' ' A' ' 119' ' ' HIS . 0.1 OUTLIER -118.55 137.15 53.42 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.59 -0.694 . . . . 0.0 109.235 178.434 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.732 ' HE2' HG21 ' A' ' 98' ' ' ILE . 8.4 m-85 -131.99 131.52 42.62 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.124 -0.985 . . . . 0.0 110.872 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.468 ' HG2' ' OG ' ' A' ' 82' ' ' SER . 7.1 mt-10 -129.52 133.47 47.26 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.409 -0.807 . . . . 0.0 109.91 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.51 ' N ' ' O ' ' A' ' 81' ' ' TYR . 43.4 m -127.41 144.9 50.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.925 . . . . 0.0 110.023 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.478 ' HG3' ' HB3' ' A' ' 80' ' ' SER . 2.2 mttt -141.94 136.49 30.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.944 . . . . 0.0 110.256 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.753 HD23 HG12 ' A' ' 114' ' ' ILE . 3.7 mt -120.91 151.01 40.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 110.102 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.713 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -151.62 -169.14 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.306 -0.872 . . . . 0.0 110.063 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.713 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -119.39 138.6 52.98 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.308 -0.87 . . . . 0.0 110.115 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.456 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 28.8 p -94.67 164.9 18.46 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.177 -0.952 . . . . 0.0 110.245 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.456 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.5 Cg_endo -72.5 -2.68 12.15 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.057 1.556 . . . . 0.0 110.59 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 81.8 p -102.14 0.86 35.4 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.225 -0.922 . . . . 0.0 110.263 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.73 -31.83 8.25 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -67.87 -173.98 7.59 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 1.1 p -126.29 131.42 51.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.235 -1.156 . . . . 0.0 110.237 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.722 ' HA ' HG22 ' A' ' 10' ' ' THR . 11.1 mt -82.3 150.26 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.415 -0.803 . . . . 0.0 110.196 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.753 HG12 HD23 ' A' ' 104' ' ' LEU . 15.4 mt -130.34 110.43 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 110.4 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.42 ' O ' ' N ' ' A' ' 103' ' ' LYS . 51.6 tttt -99.34 128.34 45.45 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.201 -0.937 . . . . 0.0 109.923 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 0.7 OUTLIER -123.02 153.39 39.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.182 -0.949 . . . . 0.0 110.537 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.604 HG23 ' HB3' ' A' ' 6' ' ' GLU . 28.7 m -159.99 127.71 4.67 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.396 -0.815 . . . . 0.0 110.286 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.486 ' HB2' ' CD1' ' A' ' 100' ' ' TYR . 24.6 p -132.13 160.16 36.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.242 -0.911 . . . . 0.0 110.225 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.785 ' CE1' HG23 ' A' ' 4' ' ' THR . 94.9 m-70 -132.3 135.76 46.44 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.11 -0.994 . . . . 0.0 110.625 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.679 ' O ' HG13 ' A' ' 2' ' ' VAL . 4.4 m-30 -97.66 146.84 24.93 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.293 -0.879 . . . . 0.0 110.108 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.499 ' HB2' ' HB2' ' A' ' 97' ' ' LYS . 94.0 m-70 -126.73 92.11 3.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.074 -1.016 . . . . 0.0 109.86 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.657 HG21 ' O ' ' A' ' 126' ' ' VAL . 1.8 p -66.62 164.38 16.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.449 -0.782 . . . . 0.0 110.311 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.431 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 34.4 tptt -147.48 114.81 6.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.368 -0.832 . . . . 0.0 110.257 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 125' ' ' ASN . . . 111.26 25.61 4.94 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 2.9 t30 65.1 62.45 0.71 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.198 -1.178 . . . . 0.0 110.179 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.657 ' O ' HG21 ' A' ' 122' ' ' THR . 20.2 m -140.35 143.44 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.244 -0.91 . . . . 0.0 110.316 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.469 ' N ' ' OE1' ' A' ' 127' ' ' GLU . 47.0 mp0 -114.03 165.99 12.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 110.257 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 1.048 ' CG1' HD21 ' A' ' 95' ' ' LEU . 3.1 mt -89.42 173.15 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.259 -0.901 . . . . 0.0 110.134 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.617 ' N ' HG22 ' A' ' 128' ' ' ILE . 8.1 mttm -111.55 152.66 27.28 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.361 -0.837 . . . . 0.0 110.009 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -58.57 -34.98 71.67 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.222 -0.924 . . . . 0.0 109.979 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.507 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 46.5 tt0 -62.57 -33.09 74.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.279 -0.888 . . . . 0.0 109.91 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 18.3 t-160 -76.45 -52.31 10.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -0.883 . . . . 0.0 110.104 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.759 HG11 ' CE1' ' A' ' 5' ' ' TYR . 57.8 t -62.28 -41.07 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.394 -0.816 . . . . 0.0 109.889 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -71.97 -47.26 53.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.268 -0.895 . . . . 0.0 109.854 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.507 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -61.57 -33.87 74.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.262 -0.899 . . . . 0.0 109.902 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.13 -29.7 66.29 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 37.1 mttm -74.15 -33.0 63.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.205 -1.174 . . . . 0.0 109.921 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -79.25 -35.73 41.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.354 -0.841 . . . . 0.0 109.933 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -70.2 -33.2 71.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.352 -0.842 . . . . 0.0 109.779 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.426 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -76.49 -41.04 48.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.348 -0.845 . . . . 0.0 109.957 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 35.3 t -59.87 -43.81 94.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.385 -0.822 . . . . 0.0 109.848 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -59.28 -42.41 91.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.299 -0.875 . . . . 0.0 109.881 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.91 ' HA ' HD12 ' A' ' 146' ' ' LEU . 18.7 mt -61.75 -36.36 80.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 109.946 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.786 ' HA ' HD12 ' A' ' 147' ' ' ILE . 30.1 m-85 -64.41 -37.12 86.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.348 -0.845 . . . . 0.0 109.568 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 25.9 mttm -70.28 -12.9 61.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.418 -0.801 . . . . 0.0 109.977 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.91 HD12 ' HA ' ' A' ' 143' ' ' LEU . 9.2 mt -81.57 -36.43 29.06 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.138 -0.976 . . . . 0.0 108.855 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.903 HD11 ' CE1' ' A' ' 22' ' ' PHE . 8.2 mt -68.39 -49.41 66.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.501 ' O ' HG13 ' A' ' 13' ' ' ILE . 69.9 mt-10 -52.62 -42.54 64.7 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.566 -0.709 . . . . 0.0 109.675 179.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.504 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 54.1 m -70.81 -34.66 71.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.065 -1.022 . . . . 0.0 109.526 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.575 ' CD2' ' OH ' ' A' ' 158' ' ' TYR . 51.9 t80 -51.24 -60.85 2.66 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.519 -0.738 . . . . 0.0 109.924 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.06 HD21 ' CE1' ' A' ' 158' ' ' TYR . 38.1 mt -73.07 -27.9 62.0 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.393 -0.817 . . . . 0.0 109.995 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.632 ' HA ' HD11 ' A' ' 13' ' ' ILE . 60.1 tttm -57.2 -19.96 23.97 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.201 -0.937 . . . . 0.0 108.486 178.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -128.08 -4.09 5.62 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.572 ' CG ' ' O ' ' A' ' 150' ' ' TYR . 63.6 m170 -113.39 86.52 10.08 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.171 -1.193 . . . . 0.0 110.235 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -73.59 2.21 6.05 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.038 1.546 . . . . 0.0 110.859 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -124.04 4.38 8.64 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.122 -0.987 . . . . 0.0 110.005 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.758 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -69.13 108.81 3.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.296 -0.877 . . . . 0.0 110.053 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 1.06 ' CE1' HD21 ' A' ' 151' ' ' LEU . 0.3 OUTLIER 35.3 35.14 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.633 -0.667 . . . . 0.0 110.952 -179.363 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.565 ' CB ' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.417 0 CA-C-O 117.953 -1.023 . . . . 0.0 109.824 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 1.045 HG23 ' C ' ' A' ' 120' ' ' TYR . 5.0 p -85.79 153.68 3.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 121.27 -1.135 . . . . 0.0 110.064 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.55 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 16.2 m-85 -89.92 167.36 12.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.309 -0.87 . . . . 0.0 110.433 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.913 HG23 ' CE1' ' A' ' 119' ' ' HIS . 55.1 m -145.67 102.26 3.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.302 -0.874 . . . . 0.0 110.221 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.915 ' CZ ' HG22 ' A' ' 133' ' ' VAL . 84.8 m-85 -116.09 151.76 34.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.316 -0.865 . . . . 0.0 109.936 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 19.6 pt-20 -143.01 151.63 41.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.142 -0.974 . . . . 0.0 110.366 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.4 t -128.6 151.77 49.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.41 -0.806 . . . . 0.0 109.839 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.477 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 92.8 mt-10 -134.3 116.05 14.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.947 . . . . 0.0 110.488 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.2 p90 -142.66 -175.12 4.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -0.852 . . . . 0.0 109.778 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.775 HG22 ' HA ' ' A' ' 113' ' ' ILE . 6.6 p -137.75 173.35 11.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.144 -0.973 . . . . 0.0 110.634 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.511 ' HB3' HD11 ' A' ' 114' ' ' ILE . 84.0 p -149.56 144.22 26.09 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.397 -0.815 . . . . 0.0 110.23 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -72.57 -32.37 65.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.226 -0.921 . . . . 0.0 109.958 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.813 HG23 ' HD2' ' A' ' 14' ' ' PRO . 6.5 mm -72.51 151.35 91.66 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.517 -0.739 . . . . 0.0 109.653 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.813 ' HD2' HG23 ' A' ' 13' ' ' ILE . 39.1 Cg_endo -64.61 140.58 69.16 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.889 1.468 . . . . 0.0 110.692 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.656 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 41.9 Cg_endo -73.08 -30.49 10.69 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 124.145 1.603 . . . . 0.0 112.871 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.656 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.3 Cg_endo -69.84 -23.57 30.31 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 O-C-N 122.448 0.71 . . . . 0.0 110.357 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.515 ' NH2' ' HD2' ' A' ' 20' ' ' LYS . 1.6 mmp_? -83.42 -46.8 12.11 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.774 ' C ' HD23 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -65.54 -31.05 71.9 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.601 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.519 ' N ' HD23 ' A' ' 18' ' ' LEU . 59.4 t80 -64.66 -54.49 30.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.56 -0.712 . . . . 0.0 109.26 178.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.54 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 25.2 mttt -47.99 -42.84 28.91 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.796 -0.761 . . . . 0.0 109.459 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.969 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -73.07 -35.61 66.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.469 -0.77 . . . . 0.0 110.927 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 1.033 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -74.57 -42.85 58.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 111.42 -178.659 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.629 HG13 ' CE1' ' A' ' 81' ' ' TYR . 5.7 t -107.5 -50.36 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.956 -1.09 . . . . 0.0 111.74 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.766 HD12 ' N ' ' A' ' 24' ' ' LEU . 7.3 mp -79.44 -5.64 55.14 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.077 -1.014 . . . . 0.0 111.483 -178.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.557 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 1.1 m-20 -151.2 30.36 0.62 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.796 -1.19 . . . . 0.0 110.651 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 1.033 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -72.87 -21.23 60.96 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.243 -0.91 . . . . 0.0 110.615 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.477 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 39.2 t0 -66.63 -24.14 66.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.014 -1.054 . . . . 0.0 110.201 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.558 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 4.4 p30 -124.55 12.81 8.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.33 -0.856 . . . . 0.0 110.078 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.767 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -94.08 -48.45 6.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.364 -0.835 . . . . 0.0 110.221 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 1.032 HG21 HD13 ' A' ' 38' ' ' ILE . 3.7 p -76.89 -28.37 0.66 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.305 -0.872 . . . . 0.0 112.231 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.855 ' HD3' HG12 ' A' ' 30' ' ' VAL . 52.5 Cg_endo -79.23 5.31 5.87 Favored 'Trans proline' 0 C--N 1.319 -1.026 0 O-C-N 122.672 0.827 . . . . 0.0 110.272 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -128.78 -37.38 1.75 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 109.346 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.55 HG12 ' CD1' ' A' ' 150' ' ' TYR . 11.3 mt -79.97 -25.9 11.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-O 121.646 0.736 . . . . 0.0 109.151 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -157.22 77.32 3.93 Favored Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 121.628 -0.67 . . . . 0.0 109.841 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.29 -5.49 16.65 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.984 1.518 . . . . 0.0 110.565 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -87.65 -15.74 36.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.0 109.8 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -93.71 -69.27 0.76 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.38 -0.825 . . . . 0.0 110.151 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 1.032 HD13 HG21 ' A' ' 30' ' ' VAL . 1.7 mp -99.86 126.96 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.315 -0.866 . . . . 0.0 110.086 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.522 ' HB2' ' N ' ' A' ' 59' ' ' GLY . 27.7 ttpt -76.3 -25.41 54.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.357 -0.839 . . . . 0.0 110.639 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.545 ' C ' ' CD2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER 179.75 164.67 1.1 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.065 -1.022 . . . . 0.0 110.497 -179.75 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.454 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 18.5 m -137.53 128.6 27.57 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.466 -0.771 . . . . 0.0 109.81 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.545 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 48.5 tt0 -135.54 111.55 9.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.149 -0.969 . . . . 0.0 110.596 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.443 HG12 ' HG2' ' A' ' 54' ' ' LYS . 21.2 mt -59.54 140.26 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 109.859 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.729 HD11 ' HB2' ' A' ' 55' ' ' LYS . 39.0 mt -115.68 -27.91 6.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.145 -0.972 . . . . 0.0 110.268 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.683 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.4 m95 -123.58 157.95 32.54 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.246 -0.908 . . . . 0.0 110.418 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.412 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 43.53 -134.08 5.56 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.58 20.67 0.4 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.302 -1.117 . . . . 0.0 109.995 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.432 ' O ' HG21 ' A' ' 71' ' ' ILE . . . 125.56 -20.31 6.53 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.024 -1.631 . . . . 0.0 109.024 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.489 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -69.98 -172.47 10.27 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.429 ' HA ' HG22 ' A' ' 71' ' ' ILE . 45.5 Cg_endo -73.47 129.61 13.99 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.991 1.522 . . . . 0.0 110.653 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.79 -11.4 53.08 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.654 -1.778 . . . . 0.0 108.654 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 45' ' ' TRP . 1.0 OUTLIER -72.73 164.83 25.93 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.519 -0.989 . . . . 0.0 109.958 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.683 HD12 ' CG ' ' A' ' 45' ' ' TRP . 59.3 mt -135.49 120.09 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.4 -0.812 . . . . 0.0 109.698 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.443 ' HG2' HG12 ' A' ' 43' ' ' ILE . 93.8 mttt -108.49 134.85 50.7 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.195 -0.941 . . . . 0.0 110.624 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.729 ' HB2' HD11 ' A' ' 44' ' ' LEU . 32.9 tttt -101.53 92.68 5.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.262 -0.899 . . . . 0.0 110.084 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.524 ' CG2' HG12 ' A' ' 38' ' ' ILE . 84.2 mt -79.92 141.26 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.179 -0.951 . . . . 0.0 110.197 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 2.1 p -115.12 158.77 21.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 110.412 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.613 ' HE2' HG13 ' A' ' 67' ' ' VAL . 28.6 m-85 -119.31 135.94 54.48 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.368 -0.832 . . . . 0.0 110.12 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.522 ' N ' ' HB2' ' A' ' 39' ' ' LYS . . . -92.66 -2.87 66.93 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -113.75 140.72 48.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.187 -1.184 . . . . 0.0 110.226 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 112.21 -153.12 17.57 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 60.5 p -56.15 -168.46 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.261 -1.141 . . . . 0.0 110.145 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -76.76 -29.48 56.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.201 -0.937 . . . . 0.0 110.24 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -125.91 105.86 9.23 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.102 -0.999 . . . . 0.0 110.402 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.545 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -136.36 94.71 0.23 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.533 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 17.2 p90 -139.43 168.8 19.01 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.163 -1.199 . . . . 0.0 110.336 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.975 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.2 m -139.38 173.29 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.375 -0.828 . . . . 0.0 110.507 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.516 ' CE ' ' OE1' ' A' ' 87' ' ' GLU . 22.1 mttm -124.01 126.28 46.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.554 -0.716 . . . . 0.0 109.629 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.645 ' CD2' ' CD1' ' A' ' 85' ' ' LEU . 16.4 m170 -110.56 134.39 52.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.167 -0.958 . . . . 0.0 110.788 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 52' ' ' THR . 29.6 ttpt -108.2 115.72 30.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.288 -0.883 . . . . 0.0 109.436 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.528 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 28.6 mm -62.95 120.67 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.3 -0.875 . . . . 0.0 110.561 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 82' ' ' SER . 83.8 m-20 -93.7 -42.58 9.08 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.521 -0.737 . . . . 0.0 109.717 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.469 ' OG ' ' HB2' ' A' ' 82' ' ' SER . 90.6 p -169.66 159.25 8.12 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.436 -0.79 . . . . 0.0 109.744 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.551 HG12 HG11 ' A' ' 23' ' ' VAL . 1.9 mt -142.34 156.36 19.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.213 -0.93 . . . . 0.0 110.354 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.548 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 5.1 m-20 -134.59 79.11 1.78 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.623 -0.673 . . . . 0.0 110.143 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.457 ' HZ2' HD21 ' A' ' 24' ' ' LEU . 67.5 mttm -62.83 -14.33 44.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.128 -0.982 . . . . 0.0 110.224 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -94.24 -32.29 13.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.241 -0.912 . . . . 0.0 109.592 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -104.75 -6.85 19.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.517 -0.739 . . . . 0.0 109.665 179.771 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.557 ' CZ ' ' HB3' ' A' ' 16' ' ' PRO . 4.1 m-85 67.21 50.62 0.98 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.571 -0.706 . . . . 0.0 110.224 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.548 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -121.11 151.53 39.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -0.922 . . . . 0.0 109.304 179.441 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.629 ' CE1' HG13 ' A' ' 23' ' ' VAL . 22.5 t80 -139.91 136.7 34.15 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.207 -0.933 . . . . 0.0 110.191 -178.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 4.8 m -139.45 121.55 15.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.93 . . . . 0.0 110.942 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.6 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 8.6 p90 -141.15 175.44 9.64 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.342 -0.849 . . . . 0.0 109.737 179.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.755 HG23 ' O ' ' A' ' 98' ' ' ILE . 82.1 m -131.77 143.11 49.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.912 . . . . 0.0 110.23 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.645 ' CD1' ' CD2' ' A' ' 69' ' ' HIS . 19.1 tp -96.67 121.01 38.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 110.126 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 20.3 pt -105.86 -17.95 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.392 -0.818 . . . . 0.0 109.982 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.516 ' OE1' ' CE ' ' A' ' 68' ' ' LYS . 83.1 tt0 -138.18 151.49 47.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -0.889 . . . . 0.0 110.374 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.975 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 164.94 133.5 1.51 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -64.18 -15.3 59.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.297 -1.119 . . . . 0.0 110.245 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.13 -18.59 45.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.302 -0.874 . . . . 0.0 110.207 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.647 HD22 ' CD1' ' A' ' 98' ' ' ILE . 16.4 mt -63.82 -19.8 65.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.225 -0.922 . . . . 0.0 110.073 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 46.29 -173.29 0.02 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.555 ' OD1' HG23 ' A' ' 94' ' ' THR . 59.5 p30 -87.93 12.36 13.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.133 -1.216 . . . . 0.0 109.823 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.734 HG22 HG11 ' A' ' 126' ' ' VAL . 23.2 p -107.07 -29.88 9.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.366 -0.834 . . . . 0.0 110.173 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.604 HD11 ' CD1' ' A' ' 128' ' ' ILE . 67.5 mt -107.95 161.29 15.07 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.269 -0.894 . . . . 0.0 110.405 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.401 ' OE2' ' HD2' ' A' ' 123' ' ' LYS . 55.9 mt-10 -142.28 -82.96 0.19 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.335 -0.853 . . . . 0.0 109.994 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.521 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 62.2 mttt -80.37 140.26 36.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.687 -0.633 . . . . 0.0 110.763 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.755 ' O ' HG23 ' A' ' 84' ' ' THR . 0.1 OUTLIER -135.0 135.55 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.967 -1.083 . . . . 0.0 109.602 178.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.485 ' HB2' ' CD2' ' A' ' 119' ' ' HIS . 0.5 OUTLIER -108.96 133.36 53.06 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.315 -0.866 . . . . 0.0 109.956 179.626 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.6 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 5.6 m-85 -122.78 132.3 54.16 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.312 -0.867 . . . . 0.0 110.252 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 117' ' ' THR . 2.9 mt-10 -134.65 130.43 36.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 0.0 110.242 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.475 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 26.0 m -129.41 135.94 49.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.222 -0.924 . . . . 0.0 109.858 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.4 mttm -134.18 135.78 43.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.156 -0.965 . . . . 0.0 110.599 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.887 HD23 HG12 ' A' ' 114' ' ' ILE . 7.1 mt -115.72 151.16 35.63 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.29 -0.882 . . . . 0.0 109.932 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.704 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -148.04 -169.04 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.133 -0.98 . . . . 0.0 110.0 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.704 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -124.37 154.09 40.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.288 -0.882 . . . . 0.0 110.137 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.457 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 5.1 p -113.7 168.1 8.39 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.896 . . . . 0.0 110.195 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 48.1 Cg_endo -72.92 -4.24 15.04 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.021 1.537 . . . . 0.0 110.474 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 34.3 p -104.89 8.71 34.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.284 -0.885 . . . . 0.0 110.279 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 94.5 -34.43 4.74 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -59.09 -171.78 0.4 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 3.1 p -134.82 136.05 42.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -1.167 . . . . 0.0 110.359 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.775 ' HA ' HG22 ' A' ' 10' ' ' THR . 22.4 mt -88.89 148.82 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.325 -0.859 . . . . 0.0 110.078 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.887 HG12 HD23 ' A' ' 104' ' ' LEU . 18.2 mt -132.3 124.51 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.205 -0.934 . . . . 0.0 110.46 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.477 ' HG3' ' HG2' ' A' ' 8' ' ' GLU . 75.3 tttt -113.59 109.82 19.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.2 -0.938 . . . . 0.0 110.014 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.447 ' OG ' ' CZ ' ' A' ' 9' ' ' PHE . 1.2 m -101.01 159.35 15.29 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.251 -0.906 . . . . 0.0 110.643 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.707 HG22 ' NE2' ' A' ' 119' ' ' HIS . 60.8 m -154.16 133.61 12.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.327 -0.858 . . . . 0.0 110.045 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.8 m -136.25 144.53 44.87 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.13 -0.981 . . . . 0.0 110.478 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.913 ' CE1' HG23 ' A' ' 4' ' ' THR . 20.8 m-70 -132.05 146.74 52.26 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.295 -0.878 . . . . 0.0 110.325 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 1.045 ' C ' HG23 ' A' ' 2' ' ' VAL . 40.2 m-85 -121.59 120.53 35.06 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.18 -0.95 . . . . 0.0 110.542 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.58 ' N ' HG23 ' A' ' 2' ' ' VAL . 87.2 m-70 -92.85 103.72 16.03 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.4 -0.812 . . . . 0.0 109.368 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.564 ' OG1' HG23 ' A' ' 126' ' ' VAL . 1.6 t -88.39 173.71 8.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.014 -1.054 . . . . 0.0 110.856 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.401 ' HD2' ' OE2' ' A' ' 96' ' ' GLU . 40.0 tttm -141.8 117.1 10.12 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 120.284 -0.567 . . . . 0.0 110.221 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 113.2 -123.98 6.4 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -133.25 62.03 1.66 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.313 -1.11 . . . . 0.0 110.204 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.734 HG11 HG22 ' A' ' 94' ' ' THR . 34.8 m -137.54 153.46 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.22 -0.925 . . . . 0.0 110.203 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.464 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 90.4 mt-10 -127.05 169.57 13.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.188 -0.945 . . . . 0.0 110.29 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.604 ' CD1' HD11 ' A' ' 95' ' ' LEU . 15.8 mm -67.77 173.09 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.884 . . . . 0.0 110.244 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.586 ' N ' HG22 ' A' ' 128' ' ' ILE . 17.5 mttp -99.08 149.53 22.94 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.265 -0.897 . . . . 0.0 110.041 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.12 -20.09 16.02 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.091 -1.006 . . . . 0.0 109.841 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.786 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 94.3 mt-10 -71.63 -39.91 70.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.369 -0.832 . . . . 0.0 109.904 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.486 ' HB2' ' CG2' ' A' ' 128' ' ' ILE . 6.3 m170 -65.18 -45.72 83.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.297 -0.877 . . . . 0.0 109.949 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.915 HG22 ' CZ ' ' A' ' 5' ' ' TYR . 58.3 t -64.95 -42.79 95.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.506 -0.746 . . . . 0.0 110.264 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 33.1 tttm -102.87 -63.57 1.15 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.283 -0.886 . . . . 0.0 110.31 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.786 ' HB3' ' O ' ' A' ' 131' ' ' GLU . . . -56.78 -19.54 17.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.122 -0.986 . . . . 0.0 110.025 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 131' ' ' GLU . . . -76.91 -31.16 54.39 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.221 -1.551 . . . . 0.0 109.221 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.491 ' CE ' ' O ' ' A' ' 133' ' ' VAL . 27.4 mttt -72.85 -30.07 63.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.324 -1.103 . . . . 0.0 110.18 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -82.91 -32.23 27.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.315 -0.866 . . . . 0.0 110.044 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 50.5 mttt -70.45 -38.46 74.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.391 -0.818 . . . . 0.0 110.028 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.402 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -78.74 -30.83 46.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.321 -0.862 . . . . 0.0 109.88 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.1 m -66.67 -45.29 79.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.35 -0.844 . . . . 0.0 110.011 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -50.99 -51.2 55.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.303 -0.873 . . . . 0.0 109.947 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.662 ' HA ' HD12 ' A' ' 146' ' ' LEU . 10.6 tp -55.47 -49.31 72.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.258 -0.901 . . . . 0.0 109.742 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.402 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 17.7 m-85 -53.62 -38.84 64.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.44 -0.788 . . . . 0.0 109.746 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -73.38 -16.72 61.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.273 -0.892 . . . . 0.0 109.852 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.662 HD12 ' HA ' ' A' ' 143' ' ' LEU . 17.7 mt -81.98 -35.68 28.69 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.234 -0.917 . . . . 0.0 108.706 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.662 HD11 ' CE1' ' A' ' 22' ' ' PHE . 53.5 mt -66.66 -47.17 84.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.498 ' O ' HG13 ' A' ' 13' ' ' ILE . 84.1 mt-10 -52.26 -45.42 65.39 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.307 -0.87 . . . . 0.0 109.324 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 36.4 m -64.68 -30.97 72.0 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.152 -0.968 . . . . 0.0 109.535 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.694 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 71.1 t80 -60.94 -50.48 73.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.474 -0.766 . . . . 0.0 109.815 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.143 HD21 ' CE1' ' A' ' 158' ' ' TYR . 92.5 mt -80.03 -36.92 35.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.223 -0.923 . . . . 0.0 110.03 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.594 ' HG3' HD11 ' A' ' 13' ' ' ILE . 16.6 tttt -64.03 -20.29 65.81 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.392 -0.817 . . . . 0.0 109.516 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -110.67 -32.78 2.6 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.581 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 5.8 m-70 -109.6 94.3 16.21 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.267 -1.137 . . . . 0.0 110.203 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.71 6.25 3.38 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.08 1.569 . . . . 0.0 111.046 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -109.8 -2.37 17.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.994 -1.066 . . . . 0.0 109.966 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.694 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -74.39 104.61 5.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.368 -0.832 . . . . 0.0 110.199 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 1.143 ' CE1' HD21 ' A' ' 151' ' ' LEU . 1.5 p90 34.65 37.28 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.726 -0.609 . . . . 0.0 110.842 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.498 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.69 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.501 HG22 ' ND1' ' A' ' 121' ' ' HIS . 98.7 t -128.02 132.07 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.208 -1.172 . . . . 0.0 110.205 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.708 ' CE1' HD12 ' A' ' 128' ' ' ILE . 12.3 m-85 -93.19 148.21 22.22 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.205 -0.934 . . . . 0.0 110.117 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.778 HG23 ' CE1' ' A' ' 119' ' ' HIS . 10.3 m -128.1 111.48 13.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.173 -0.955 . . . . 0.0 110.344 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.983 ' CE2' HG21 ' A' ' 133' ' ' VAL . 69.1 m-85 -123.38 140.25 53.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.341 -0.85 . . . . 0.0 110.16 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -140.28 151.33 45.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.224 -0.923 . . . . 0.0 110.359 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.7 t -138.77 160.97 38.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.386 -0.821 . . . . 0.0 109.918 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.431 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 85.8 mt-10 -142.14 115.77 9.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.102 -0.999 . . . . 0.0 110.368 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.6 p90 -140.42 -175.04 4.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.311 -0.868 . . . . 0.0 109.843 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.778 HG22 ' HA ' ' A' ' 113' ' ' ILE . 2.4 p -137.52 167.38 21.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.118 -0.989 . . . . 0.0 110.493 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.445 ' HB3' HD11 ' A' ' 114' ' ' ILE . 75.5 p -138.93 147.93 42.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.38 -0.825 . . . . 0.0 110.168 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -69.96 -32.96 71.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.236 -0.915 . . . . 0.0 110.254 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.756 HD13 ' CB ' ' A' ' 148' ' ' GLU . 2.6 mp -79.58 148.56 69.93 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.378 -0.826 . . . . 0.0 109.915 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.755 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.0 Cg_endo -64.99 152.72 81.4 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.937 1.493 . . . . 0.0 110.722 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.695 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 36.7 Cg_endo -63.35 -35.87 59.34 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.793 1.418 . . . . 0.0 113.035 -178.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.695 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 38.0 Cg_endo -63.89 -21.3 68.99 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 N-CA-C 109.811 -0.88 . . . . 0.0 109.811 178.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.761 ' HB3' HD13 ' A' ' 151' ' ' LEU . 6.6 mmp_? -80.28 -45.25 18.23 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.682 HD12 ' N ' ' A' ' 18' ' ' LEU . 9.3 mp -73.31 -40.87 64.16 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.251 -0.98 . . . . 0.0 108.576 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.617 ' CD1' ' HA ' ' A' ' 79' ' ' TYR . 36.9 t80 -52.72 -59.95 3.86 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 119.869 -0.733 . . . . 0.0 110.155 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.536 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 40.4 mttp -56.03 -38.27 70.33 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.404 -0.81 . . . . 0.0 110.18 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.056 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -78.56 -62.76 1.58 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.125 -0.984 . . . . 0.0 110.878 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 1.055 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.3 OUTLIER -49.2 -41.49 37.17 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.65 -0.656 . . . . 0.0 112.006 -178.847 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 1.047 HG11 HD12 ' A' ' 74' ' ' ILE . 11.5 t -106.32 -62.93 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.767 -1.208 . . . . 0.0 111.813 -178.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.649 HD12 ' N ' ' A' ' 24' ' ' LEU . 7.4 mp -68.5 -1.07 5.84 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.243 -0.911 . . . . 0.0 111.69 -178.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.9 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -149.63 15.7 0.88 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.704 -1.248 . . . . 0.0 110.756 179.743 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 1.055 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -57.45 -40.68 78.99 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.142 -0.974 . . . . 0.0 110.12 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.508 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 14.0 t70 -62.75 -11.42 17.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.268 -0.895 . . . . 0.0 109.901 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.514 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 84.7 m-20 -132.89 10.07 4.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.42 -0.8 . . . . 0.0 109.701 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.931 HD21 ' CZ ' ' A' ' 158' ' ' TYR . 0.2 OUTLIER -95.57 -49.06 5.56 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.396 -0.815 . . . . 0.0 110.387 -179.764 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.786 HG22 ' HD3' ' A' ' 31' ' ' PRO . 3.5 m -83.48 -26.22 0.39 Allowed Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.396 -0.815 . . . . 0.0 112.707 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.786 ' HD3' HG22 ' A' ' 30' ' ' VAL . 47.0 Cg_endo -76.88 2.93 7.01 Favored 'Trans proline' 0 C--N 1.318 -1.039 0 O-C-N 122.511 0.743 . . . . 0.0 110.476 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.7 tttm -128.95 -35.15 1.88 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.29 -0.882 . . . . 0.0 109.541 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.607 HG12 ' CD1' ' A' ' 150' ' ' TYR . 40.1 mt -80.03 -35.27 15.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.599 -0.688 . . . . 0.0 109.596 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -161.9 97.5 1.22 Allowed Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.582 -0.699 . . . . 0.0 109.833 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.57 2.21 6.05 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.069 1.563 . . . . 0.0 110.793 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -84.11 -10.09 58.07 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.146 -0.971 . . . . 0.0 109.812 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.94 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -97.88 -47.19 5.65 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.392 -0.817 . . . . 0.0 109.912 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.94 HD12 ' C ' ' A' ' 37' ' ' ALA . 2.1 mp -134.75 108.01 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.463 -0.773 . . . . 0.0 109.899 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 57' ' ' THR . 39.3 ttpt -55.29 -16.99 3.89 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.223 -0.923 . . . . 0.0 110.298 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.545 ' CG ' ' N ' ' A' ' 41' ' ' SER . 0.2 OUTLIER 173.03 175.16 0.11 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.081 -1.012 . . . . 0.0 110.11 -179.739 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.545 ' N ' ' CG ' ' A' ' 40' ' ' HIS . 25.2 m -152.11 149.77 29.17 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.361 -0.837 . . . . 0.0 109.827 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -155.56 112.15 3.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.163 -0.961 . . . . 0.0 110.711 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 41.1 mt -62.55 136.5 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.306 -0.871 . . . . 0.0 109.808 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.803 HD22 ' CE ' ' A' ' 55' ' ' LYS . 4.9 tp -114.19 -24.47 8.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.156 -0.965 . . . . 0.0 110.717 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.527 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.8 m95 -124.93 161.35 26.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.116 -0.99 . . . . 0.0 110.782 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.442 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 42.23 -139.73 2.19 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -147.85 24.79 1.06 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.368 -1.078 . . . . 0.0 109.878 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 117.88 -18.9 11.39 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.559 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -72.87 -169.27 14.09 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.21 128.9 13.39 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.093 1.575 . . . . 0.0 110.724 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.81 -11.55 49.52 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.519 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.1 m -75.08 163.84 27.15 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.643 -0.916 . . . . 0.0 109.78 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.986 HG21 ' HE2' ' A' ' 68' ' ' LYS . 85.6 mt -134.13 118.87 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 0.0 109.942 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.455 ' HE2' HD11 ' A' ' 71' ' ' ILE . 1.0 OUTLIER -106.55 124.11 49.11 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.322 -0.861 . . . . 0.0 110.567 -179.565 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.803 ' CE ' HD22 ' A' ' 44' ' ' LEU . 75.8 mttt -90.53 95.2 10.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.258 -0.901 . . . . 0.0 109.826 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.529 ' CG2' HG12 ' A' ' 38' ' ' ILE . 99.6 mt -79.98 139.97 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.142 -0.974 . . . . 0.0 110.083 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -112.99 146.65 38.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.315 -0.865 . . . . 0.0 110.434 -179.736 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.571 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 21.7 m-85 -110.04 154.8 22.7 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.289 -0.882 . . . . 0.0 110.052 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -103.62 -4.95 45.84 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -101.11 145.24 29.02 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.224 -1.163 . . . . 0.0 110.248 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.22 128.93 4.95 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.0 t -54.21 -43.88 71.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.21 -1.17 . . . . 0.0 110.178 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.409 ' O ' ' C ' ' A' ' 64' ' ' TYR . 91.1 mt-30 -96.12 157.86 15.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.27 -0.894 . . . . 0.0 110.183 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.499 ' HE1' HG22 ' A' ' 57' ' ' THR . 0.7 OUTLIER -43.71 140.96 1.66 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.28 -0.888 . . . . 0.0 110.321 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.571 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -132.61 90.25 0.27 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.991 -1.643 . . . . 0.0 108.991 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.538 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 12.1 p90 -130.29 166.57 20.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.081 -1.246 . . . . 0.0 110.158 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.628 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.3 m -140.02 175.64 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.337 -0.852 . . . . 0.0 110.579 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.986 ' HE2' HG21 ' A' ' 53' ' ' ILE . 69.6 tttt -131.17 103.09 6.29 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.506 -0.746 . . . . 0.0 109.875 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 1.008 ' CD2' HD13 ' A' ' 85' ' ' LEU . 13.4 m170 -98.15 121.77 40.48 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.207 -0.933 . . . . 0.0 111.036 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 52' ' ' THR . 82.8 tttt -91.45 120.35 32.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.301 -0.874 . . . . 0.0 109.348 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.559 HG21 ' O ' ' A' ' 49' ' ' GLY . 26.2 mm -58.62 126.88 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.165 -0.959 . . . . 0.0 110.229 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.473 ' O ' ' HB3' ' A' ' 73' ' ' SER . 90.9 m-20 -98.36 -51.1 4.09 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.447 -0.783 . . . . 0.0 109.769 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.473 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 91.3 p -178.45 159.2 1.16 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.5 -0.75 . . . . 0.0 110.316 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 1.047 HD12 HG11 ' A' ' 23' ' ' VAL . 3.5 tt -144.41 167.33 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.502 -0.749 . . . . 0.0 109.236 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -131.13 81.05 1.97 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.944 -1.098 . . . . 0.0 110.523 -179.376 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.593 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 82.1 tttt -55.99 -14.56 2.62 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.29 -0.881 . . . . 0.0 110.604 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -90.76 -30.44 17.04 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.24 -0.912 . . . . 0.0 109.658 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.494 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -113.3 -1.44 14.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.486 -0.759 . . . . 0.0 109.731 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.919 ' O ' HD12 ' A' ' 104' ' ' LEU . 56.1 m-85 64.87 50.04 2.05 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.389 0.614 . . . . 0.0 110.369 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.517 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.6 OUTLIER -118.51 152.57 35.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 109.524 179.394 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.643 ' CE1' HG13 ' A' ' 23' ' ' VAL . 82.5 t80 -151.04 140.85 21.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.066 -1.021 . . . . 0.0 110.262 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 74.3 m -147.81 147.61 30.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.259 -0.901 . . . . 0.0 110.442 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.622 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 8.8 p90 -149.82 175.59 11.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.344 -0.848 . . . . 0.0 110.361 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.585 HG23 ' O ' ' A' ' 98' ' ' ILE . 44.3 m -125.58 128.16 47.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.404 -0.81 . . . . 0.0 109.888 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 1.008 HD13 ' CD2' ' A' ' 69' ' ' HIS . 8.6 tp -98.77 131.64 44.75 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.216 -0.993 . . . . 0.0 110.284 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.888 HD11 ' HD3' ' A' ' 68' ' ' LYS . 9.1 pt -117.19 -29.51 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.199 -0.938 . . . . 0.0 110.419 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.613 ' O ' HD11 ' A' ' 85' ' ' LEU . 43.1 tt0 -110.39 138.77 46.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -0.888 . . . . 0.0 110.19 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.628 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 175.82 134.25 1.9 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -53.38 -31.22 43.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -1.112 . . . . 0.0 110.305 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.495 ' HB1' ' CE1' ' A' ' 132' ' ' HIS . . . -69.73 -38.73 76.98 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.297 -0.877 . . . . 0.0 110.243 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.625 HD23 ' CD2' ' A' ' 95' ' ' LEU . 15.5 mt -41.19 -61.71 0.97 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.503 -0.748 . . . . 0.0 110.284 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 49.14 -178.01 0.02 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -67.01 -7.5 23.02 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.25 -1.147 . . . . 0.0 110.213 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.446 ' O ' HG22 ' A' ' 122' ' ' THR . 61.2 p -79.98 -60.97 2.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 110.213 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.867 HD12 ' H ' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -102.25 159.39 15.44 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.352 -0.843 . . . . 0.0 109.387 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.867 ' H ' HD12 ' A' ' 95' ' ' LEU . 61.1 tt0 -137.74 -79.7 0.37 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.208 -0.932 . . . . 0.0 110.576 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.488 ' CB ' ' HB2' ' A' ' 121' ' ' HIS . 10.1 mttt -80.24 144.81 32.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.592 -0.692 . . . . 0.0 111.023 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.715 HG21 ' HE2' ' A' ' 100' ' ' TYR . 4.6 mm -133.1 144.7 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.208 -0.932 . . . . 0.0 109.487 178.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.482 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.1 m -123.9 127.72 48.41 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.28 -0.887 . . . . 0.0 109.377 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.715 ' HE2' HG21 ' A' ' 98' ' ' ILE . 12.0 m-85 -123.54 133.4 53.99 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.194 -0.941 . . . . 0.0 110.581 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.462 ' HG3' ' OG ' ' A' ' 82' ' ' SER . 62.9 tt0 -135.59 137.41 41.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.279 -0.888 . . . . 0.0 110.109 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.508 ' N ' ' O ' ' A' ' 81' ' ' TYR . 23.4 m -135.24 146.41 48.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.165 -0.959 . . . . 0.0 110.281 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 115' ' ' LYS . 12.1 mttt -138.94 139.53 38.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.328 -0.858 . . . . 0.0 110.131 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.989 HD23 HG12 ' A' ' 114' ' ' ILE . 2.7 mt -118.66 154.21 33.07 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.215 -0.928 . . . . 0.0 110.542 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.713 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -152.34 -169.35 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.332 -0.855 . . . . 0.0 109.925 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.713 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -121.45 158.47 28.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.329 -0.857 . . . . 0.0 110.215 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.462 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 5.8 p -118.01 168.08 10.06 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.235 -0.916 . . . . 0.0 110.176 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.6 Cg_endo -72.41 -12.66 27.48 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.003 1.528 . . . . 0.0 110.378 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 95.8 p -95.84 2.61 53.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.245 -0.909 . . . . 0.0 110.176 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 99.35 -29.04 12.7 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.08 -172.53 1.91 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 2.1 m -133.3 133.68 42.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -1.109 . . . . 0.0 110.378 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.778 ' HA ' HG22 ' A' ' 10' ' ' THR . 20.8 mt -86.05 144.67 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.358 -0.838 . . . . 0.0 109.939 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.989 HG12 HD23 ' A' ' 104' ' ' LEU . 20.6 mt -131.03 114.01 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.173 -0.954 . . . . 0.0 110.441 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 103' ' ' LYS . 35.2 tttt -100.48 120.77 40.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.914 . . . . 0.0 109.837 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.1 t -115.99 154.87 29.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.205 -0.935 . . . . 0.0 110.53 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.45 HG22 ' NE2' ' A' ' 119' ' ' HIS . 38.5 m -156.73 131.64 8.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.352 -0.842 . . . . 0.0 110.133 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 91.7 p -132.72 155.81 48.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.137 -0.977 . . . . 0.0 110.319 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.778 ' CE1' HG23 ' A' ' 4' ' ' THR . 32.3 m-70 -135.83 164.28 28.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.331 -0.856 . . . . 0.0 110.182 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.653 ' HA ' HD13 ' A' ' 98' ' ' ILE . 11.0 m-85 -124.77 148.54 48.06 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.292 -0.88 . . . . 0.0 110.196 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.501 ' ND1' HG22 ' A' ' 2' ' ' VAL . 97.1 m-70 -129.21 85.37 2.31 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.135 -0.978 . . . . 0.0 109.698 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.712 HG22 ' HA ' ' A' ' 95' ' ' LEU . 1.4 p -81.77 157.73 24.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.326 -0.859 . . . . 0.0 110.427 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.2 tttm -113.6 127.06 55.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.435 -0.791 . . . . 0.0 110.202 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 99.45 -153.24 19.62 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -102.97 64.17 0.84 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.219 -1.166 . . . . 0.0 110.182 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.531 HG23 ' HB ' ' A' ' 122' ' ' THR . 20.1 m -130.62 154.36 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.186 -0.946 . . . . 0.0 110.214 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -133.6 159.37 40.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.261 -0.899 . . . . 0.0 110.195 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.708 HD12 ' CE1' ' A' ' 3' ' ' PHE . 4.3 mp -80.86 173.24 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.27 -0.894 . . . . 0.0 110.211 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.588 ' N ' HG22 ' A' ' 128' ' ' ILE . 10.6 mttp -108.26 132.89 53.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.321 -0.862 . . . . 0.0 110.124 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.42 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 94.6 mt-10 -47.1 -47.73 23.1 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.191 -0.943 . . . . 0.0 110.169 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.503 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 54.7 tt0 -50.97 -28.59 10.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.202 -0.936 . . . . 0.0 109.973 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.495 ' CE1' ' HB1' ' A' ' 90' ' ' ALA . 14.2 t-160 -79.74 -60.63 2.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.268 -0.895 . . . . 0.0 110.114 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.983 HG21 ' CE2' ' A' ' 5' ' ' TYR . 7.3 p -65.55 -38.49 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.428 -0.795 . . . . 0.0 110.185 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.496 ' N ' HG13 ' A' ' 133' ' ' VAL . 26.1 tttp -68.77 -47.33 66.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.233 -0.917 . . . . 0.0 110.238 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.503 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -61.43 -27.02 68.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.91 . . . . 0.0 110.226 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.41 -28.09 71.74 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 49.0 mttt -69.58 -39.99 76.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.221 -1.164 . . . . 0.0 110.211 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -75.18 -34.82 61.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.407 -0.808 . . . . 0.0 110.054 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.449 ' O ' ' HG ' ' A' ' 143' ' ' LEU . 28.5 mttt -67.85 -32.85 73.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.33 -0.856 . . . . 0.0 109.925 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.7 -45.03 47.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.295 -0.878 . . . . 0.0 110.014 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 36.8 m -59.5 -38.62 81.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.444 -0.785 . . . . 0.0 110.049 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -61.52 -41.85 97.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.208 -0.932 . . . . 0.0 109.898 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 139' ' ' LYS . 38.1 mt -60.07 -41.73 93.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.269 -0.894 . . . . 0.0 109.859 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.448 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 24.7 m-85 -56.83 -37.3 71.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.441 -0.787 . . . . 0.0 109.982 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 55.9 mttt -66.5 -25.05 66.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.334 -0.854 . . . . 0.0 109.904 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.537 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 15.9 mt -83.02 -34.69 26.22 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.276 -0.89 . . . . 0.0 108.952 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.583 HD11 ' HE1' ' A' ' 22' ' ' PHE . 79.8 mt -69.54 -34.91 63.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.538 -0.726 . . . . 0.0 109.451 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.756 ' CB ' HD13 ' A' ' 13' ' ' ILE . 97.0 mt-10 -62.84 -39.06 93.2 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.494 -0.754 . . . . 0.0 109.869 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 86.1 m -72.15 -40.0 68.35 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.299 -0.875 . . . . 0.0 109.96 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.608 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 68.6 t80 -55.82 -50.54 70.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.479 -0.763 . . . . 0.0 110.023 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.933 HD21 ' CE1' ' A' ' 158' ' ' TYR . 33.6 mt -79.88 -40.2 28.86 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.331 -0.856 . . . . 0.0 110.464 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.634 ' HB2' HD11 ' A' ' 13' ' ' ILE . 40.5 tttp -66.12 -22.84 66.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.267 -0.896 . . . . 0.0 109.456 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -103.09 -35.97 3.52 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.613 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 3.8 m-70 -110.77 93.94 18.45 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.397 -1.061 . . . . 0.0 109.978 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.48 5.64 3.62 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.06 1.558 . . . . 0.0 111.022 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 41.6 p30 -107.54 -2.92 19.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.05 -1.031 . . . . 0.0 109.84 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.608 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -70.5 102.58 2.25 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.413 -0.804 . . . . 0.0 110.126 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 1.056 ' CE1' ' HB2' ' A' ' 21' ' ' ALA . 1.4 p90 33.72 36.67 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.737 -0.602 . . . . 0.0 110.729 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.526 ' HB2' ' CD ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.776 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.93 HG13 ' O ' ' A' ' 120' ' ' TYR . 82.3 t -135.78 144.92 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -1.161 . . . . 0.0 110.358 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.785 ' CE1' HD12 ' A' ' 128' ' ' ILE . 9.8 m-85 -107.71 134.23 50.98 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.238 -0.914 . . . . 0.0 110.031 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.731 HG23 ' CE1' ' A' ' 119' ' ' HIS . 16.6 m -101.8 111.09 23.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.233 -0.917 . . . . 0.0 110.328 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.832 ' CE1' HG11 ' A' ' 133' ' ' VAL . 28.7 m-85 -115.26 126.01 54.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.137 -0.977 . . . . 0.0 109.795 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 116' ' ' SER . 23.1 pt-20 -140.29 154.77 46.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.183 -0.948 . . . . 0.0 110.524 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.458 ' O ' ' HB3' ' A' ' 116' ' ' SER . 49.4 m -139.53 135.61 33.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.336 -0.853 . . . . 0.0 109.729 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.454 ' HG3' ' HG3' ' A' ' 115' ' ' LYS . 2.4 tt0 -116.15 138.86 50.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.1 -1.0 . . . . 0.0 110.72 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.631 ' CZ ' ' CG2' ' A' ' 114' ' ' ILE . 5.8 p90 -158.98 -173.04 4.04 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.506 -0.746 . . . . 0.0 109.814 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.891 HG22 ' HA ' ' A' ' 113' ' ' ILE . 7.4 p -141.57 172.02 13.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.137 -0.977 . . . . 0.0 110.519 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.452 ' HB3' ' CD ' ' A' ' 148' ' ' GLU . 89.9 p -159.95 140.2 11.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.282 -0.886 . . . . 0.0 110.264 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.524 ' HA ' ' HA2' ' A' ' 111' ' ' GLY . 97.2 mt-10 -64.32 -39.08 93.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.28 -0.887 . . . . 0.0 110.106 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 1.049 HD13 ' HB3' ' A' ' 148' ' ' GLU . 2.7 mp -51.37 150.2 6.62 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.313 -0.867 . . . . 0.0 109.791 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.824 ' HD2' HG23 ' A' ' 13' ' ' ILE . 41.7 Cg_endo -67.99 137.1 40.16 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.974 1.513 . . . . 0.0 110.505 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.614 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 41.8 Cg_endo -73.68 -28.95 11.18 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 124.072 1.564 . . . . 0.0 112.933 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 15' ' ' PRO . 43.4 Cg_endo -73.68 -21.33 19.2 Favored 'Trans proline' 0 C--N 1.319 -1.001 0 O-C-N 122.408 0.688 . . . . 0.0 110.534 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.958 ' NE ' HD22 ' A' ' 151' ' ' LEU . 57.6 ttt180 -85.7 -50.9 6.82 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.794 ' C ' HD23 ' A' ' 18' ' ' LEU . 1.7 tt -57.13 -27.66 62.03 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.555 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 64.9 t80 -69.57 -54.65 13.04 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.488 0.661 . . . . 0.0 109.477 178.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.605 ' HG2' HD22 ' A' ' 24' ' ' LEU . 49.5 mttt -55.31 -29.65 58.68 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 122.158 0.98 . . . . 0.0 108.376 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.002 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -77.36 -63.46 1.37 Allowed 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.647 0.737 . . . . 0.0 110.797 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 1.015 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -60.72 -28.92 69.02 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.612 -0.68 . . . . 0.0 111.401 -178.599 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.743 HG13 ' CD1' ' A' ' 81' ' ' TYR . 4.3 t -108.63 -66.39 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.046 -1.034 . . . . 0.0 111.406 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.678 HD12 ' N ' ' A' ' 24' ' ' LEU . 8.6 mp -68.91 -10.97 60.04 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.162 -0.961 . . . . 0.0 111.205 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.534 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -138.2 16.89 2.79 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.889 -1.132 . . . . 0.0 110.075 179.721 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 1.015 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -51.76 -44.91 63.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 110.177 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.479 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 61.8 m-20 -62.07 -12.41 19.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.181 -0.949 . . . . 0.0 110.157 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.531 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 77.8 m-20 -124.2 -7.71 7.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 110.42 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.747 HD12 ' N ' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -85.0 -46.04 11.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.201 -0.937 . . . . 0.0 110.37 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.948 ' CG1' HD13 ' A' ' 38' ' ' ILE . 2.9 t -69.51 -41.86 18.2 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.35 -0.844 . . . . 0.0 111.002 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 48.1 Cg_endo -78.55 9.72 3.08 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.54 1.284 . . . . 0.0 110.792 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.449 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 21.7 mttm -121.17 -29.43 4.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.174 -0.954 . . . . 0.0 109.307 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.75 HG21 ' HB3' ' A' ' 146' ' ' LEU . 14.9 mt -80.21 -64.99 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-O 121.607 0.718 . . . . 0.0 109.388 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.457 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . . . -136.01 106.51 9.61 Favored Pre-proline 0 C--N 1.303 -1.451 0 O-C-N 121.708 -0.62 . . . . 0.0 109.876 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.457 ' HD2' ' HA ' ' A' ' 34' ' ' ALA . 44.1 Cg_endo -70.3 0.49 5.97 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.078 1.567 . . . . 0.0 111.035 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -81.13 -13.3 58.81 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.032 -1.042 . . . . 0.0 109.418 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.591 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -96.95 -67.66 0.84 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.393 -0.817 . . . . 0.0 110.15 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.948 HD13 ' CG1' ' A' ' 30' ' ' VAL . 2.3 mp -109.6 127.82 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.491 -0.756 . . . . 0.0 110.158 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 57' ' ' THR . 22.2 ttpt -85.8 -27.68 24.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.272 -0.893 . . . . 0.0 110.366 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.554 ' C ' ' CD2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -163.39 148.83 11.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.122 -0.986 . . . . 0.0 110.037 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.468 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 4.2 m -131.54 122.97 27.02 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.314 -0.866 . . . . 0.0 109.953 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -138.15 111.25 7.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.14 -0.975 . . . . 0.0 110.661 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 28.5 mt -56.87 133.5 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.336 -0.852 . . . . 0.0 109.837 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.539 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 25.3 mt -104.67 -29.78 10.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.913 . . . . 0.0 110.605 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.651 ' CG ' HD12 ' A' ' 53' ' ' ILE . 2.0 m95 -122.46 160.43 25.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.208 -0.932 . . . . 0.0 110.706 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.451 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 41.39 -138.74 1.91 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -152.33 22.2 0.64 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -1.197 . . . . 0.0 110.15 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 126.35 -22.94 5.84 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.536 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -68.43 -174.35 8.79 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -72.33 128.8 14.11 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 123.986 1.519 . . . . 0.0 110.593 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.488 ' HA2' ' HE2' ' A' ' 70' ' ' LYS . . . 105.19 -13.54 48.45 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.504 -1.838 . . . . 0.0 108.504 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -71.74 160.73 32.11 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.616 -0.932 . . . . 0.0 109.327 179.589 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.651 HD12 ' CG ' ' A' ' 45' ' ' TRP . 80.6 mt -131.71 119.37 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 110.215 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 0.4 OUTLIER -101.54 126.47 48.36 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.276 -0.89 . . . . 0.0 110.03 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.539 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 22.2 tttm -96.97 90.68 5.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 110.101 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.588 ' CG2' ' CG1' ' A' ' 38' ' ' ILE . 94.1 mt -80.11 139.41 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.299 -0.876 . . . . 0.0 110.065 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.594 HG22 ' HB3' ' A' ' 66' ' ' TYR . 1.2 p -115.17 153.14 31.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.888 . . . . 0.0 110.301 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.581 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 14.7 m-85 -114.27 176.06 5.21 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.314 -0.866 . . . . 0.0 110.168 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 58' ' ' PHE . . . -43.68 141.82 2.57 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' A' ' 61' ' ' GLY . 80.9 tt0 -53.63 -34.83 59.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -1.179 . . . . 0.0 110.209 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 60' ' ' GLU . . . 43.43 -157.88 0.11 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.48 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 29.6 m -72.27 -29.28 63.75 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.341 -1.093 . . . . 0.0 110.193 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.48 ' NE2' ' O ' ' A' ' 62' ' ' SER . 76.0 mm-40 -140.02 158.41 44.1 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.267 -0.896 . . . . 0.0 110.177 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.562 ' O ' ' CD1' ' A' ' 64' ' ' TYR . 5.4 p90 -50.51 138.6 17.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.267 -0.896 . . . . 0.0 110.171 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.581 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -137.71 85.75 0.23 Allowed Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.594 ' HB3' HG22 ' A' ' 57' ' ' THR . 12.4 p90 -133.52 171.65 13.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -1.166 . . . . 0.0 110.249 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.842 HG12 ' HA2' ' A' ' 88' ' ' GLY . 4.0 m -140.3 177.66 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.332 -0.855 . . . . 0.0 110.35 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.664 ' O ' HD12 ' A' ' 85' ' ' LEU . 23.7 mttm -134.81 104.76 6.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.412 -0.805 . . . . 0.0 109.804 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 1.001 ' CD2' HD13 ' A' ' 85' ' ' LEU . 14.8 m170 -96.9 127.54 42.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.196 -0.94 . . . . 0.0 110.862 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 52' ' ' THR . 77.8 tttt -98.2 113.74 25.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.91 . . . . 0.0 109.414 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.536 HG21 ' O ' ' A' ' 49' ' ' GLY . 33.0 mm -44.53 136.19 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.101 -1.0 . . . . 0.0 110.162 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.547 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 23.8 t0 -109.89 -43.57 3.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.419 -0.801 . . . . 0.0 109.969 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.665 ' C ' HD12 ' A' ' 74' ' ' ILE . 62.3 p -170.81 161.2 7.17 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.484 -0.886 . . . . 0.0 109.947 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.665 HD12 ' C ' ' A' ' 73' ' ' SER . 0.9 OUTLIER -149.44 154.36 9.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 119.277 -0.969 . . . . 0.0 111.005 -179.754 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.548 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 2.3 m-20 -136.1 79.96 1.8 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.809 -0.557 . . . . 0.0 110.288 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.555 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 22.2 mttp -59.94 -14.85 17.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.246 -0.909 . . . . 0.0 110.365 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -93.65 -30.88 14.7 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.22 -0.925 . . . . 0.0 109.753 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.493 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -108.25 -3.82 18.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.533 -0.729 . . . . 0.0 109.723 -179.947 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.712 ' O ' HD12 ' A' ' 104' ' ' LEU . 5.5 m-85 65.36 47.24 2.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.469 -0.77 . . . . 0.0 110.361 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.548 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.6 OUTLIER -116.62 147.41 41.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -0.896 . . . . 0.0 109.289 179.534 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.743 ' CD1' HG13 ' A' ' 23' ' ' VAL . 90.3 t80 -141.88 139.89 32.72 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.07 -1.019 . . . . 0.0 110.344 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 72' ' ' ASP . 1.3 m -143.72 135.41 26.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.255 -0.903 . . . . 0.0 110.348 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.615 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 20.2 p90 -142.86 170.25 16.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.343 -0.848 . . . . 0.0 110.3 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.795 HG23 ' O ' ' A' ' 98' ' ' ILE . 93.5 m -127.31 125.58 41.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.33 -0.856 . . . . 0.0 109.763 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 1.001 HD13 ' CD2' ' A' ' 69' ' ' HIS . 10.8 tp -95.09 129.86 42.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.068 -1.02 . . . . 0.0 110.444 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.463 ' N ' HD12 ' A' ' 85' ' ' LEU . 11.0 pt -106.25 -32.89 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.323 -0.861 . . . . 0.0 110.175 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.717 ' O ' HD11 ' A' ' 85' ' ' LEU . 86.9 tt0 -118.5 160.72 21.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.337 -0.852 . . . . 0.0 110.107 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.842 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 151.86 151.65 5.69 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -73.27 -25.28 60.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -1.155 . . . . 0.0 110.185 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.19 -20.04 63.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.302 -0.874 . . . . 0.0 110.157 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 92' ' ' GLY . 77.0 mt -69.36 -33.57 73.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.269 -0.894 . . . . 0.0 110.137 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 49.77 -179.71 0.02 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -78.14 3.17 15.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.215 -1.168 . . . . 0.0 109.984 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.412 HG22 ' HG ' ' A' ' 95' ' ' LEU . 1.8 m -93.89 -49.81 5.64 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.204 -0.935 . . . . 0.0 109.849 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.83 HD23 ' CG2' ' A' ' 122' ' ' THR . 42.1 mt -93.6 163.16 13.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.443 -0.786 . . . . 0.0 109.914 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.416 ' CD ' ' HB2' ' A' ' 123' ' ' LYS . 12.3 mt-10 -140.38 -79.85 0.28 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.216 -0.928 . . . . 0.0 109.982 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.498 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 29.2 mtmt -80.14 141.24 35.91 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.586 -0.696 . . . . 0.0 109.999 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.795 ' O ' HG23 ' A' ' 84' ' ' THR . 6.3 mm -130.38 140.87 47.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 120.85 -1.157 . . . . 0.0 110.149 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.516 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -123.81 130.04 51.99 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.642 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.696 ' HE2' HG21 ' A' ' 98' ' ' ILE . 11.6 m-85 -125.35 134.72 52.1 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.21 -0.931 . . . . 0.0 110.603 -178.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.423 ' HG3' ' HB3' ' A' ' 82' ' ' SER . 6.3 mt-10 -134.52 131.15 37.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.436 -0.79 . . . . 0.0 110.211 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 32.3 m -130.26 140.71 50.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -0.894 . . . . 0.0 109.911 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.471 ' HB2' ' HB3' ' A' ' 115' ' ' LYS . 8.9 mttp -131.79 137.55 48.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.181 -0.95 . . . . 0.0 110.763 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.891 HD23 HG12 ' A' ' 114' ' ' ILE . 7.3 mt -116.5 150.66 37.54 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.277 -0.89 . . . . 0.0 109.839 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.705 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -150.91 -169.45 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.11 -0.993 . . . . 0.0 110.064 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.705 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -126.83 155.98 42.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.368 -0.833 . . . . 0.0 110.091 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.443 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.7 p -114.6 169.43 6.63 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.279 -0.888 . . . . 0.0 110.309 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.443 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.2 Cg_endo -72.62 -10.69 25.49 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.14 1.6 . . . . 0.0 110.49 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 95.5 p -98.19 5.53 48.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.273 -0.892 . . . . 0.0 110.37 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.1 -34.89 4.76 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' A' ' 12' ' ' GLU . . . -57.65 -173.86 0.33 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 54.0 p -133.76 138.41 45.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.198 -1.178 . . . . 0.0 110.434 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.891 ' HA ' HG22 ' A' ' 10' ' ' THR . 23.0 mt -91.36 147.26 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.367 -0.833 . . . . 0.0 110.085 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.891 HG12 HD23 ' A' ' 104' ' ' LEU . 22.8 mt -133.58 123.26 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.215 -0.928 . . . . 0.0 110.328 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.471 ' HB3' ' HB2' ' A' ' 103' ' ' LYS . 72.4 tttt -107.96 121.66 45.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.233 -0.917 . . . . 0.0 110.089 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.458 ' HB3' ' O ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -104.32 154.68 19.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.187 -0.946 . . . . 0.0 110.419 -179.854 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 20.9 m -158.76 148.82 19.52 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.432 -0.793 . . . . 0.0 110.2 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.428 ' OG ' ' HB2' ' A' ' 5' ' ' TYR . 86.2 p -157.03 156.28 32.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.297 -0.877 . . . . 0.0 110.154 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.731 ' CE1' HG23 ' A' ' 4' ' ' THR . 85.7 m-70 -134.9 137.95 43.66 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.162 -0.961 . . . . 0.0 110.51 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.93 ' O ' HG13 ' A' ' 2' ' ' VAL . 3.9 m-30 -104.01 139.29 39.33 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.345 -0.847 . . . . 0.0 110.262 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.498 ' HB2' ' HB2' ' A' ' 97' ' ' LYS . 92.1 m-70 -121.96 90.49 3.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.981 -1.074 . . . . 0.0 109.565 179.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.83 ' CG2' HD23 ' A' ' 95' ' ' LEU . 1.8 p -72.22 156.69 38.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.28 -0.888 . . . . 0.0 110.66 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.482 ' HG2' ' N ' ' A' ' 124' ' ' GLY . 42.4 tttt -100.31 149.01 24.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.461 -0.775 . . . . 0.0 109.946 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.482 ' N ' ' HG2' ' A' ' 123' ' ' LYS . . . 69.4 -122.88 13.04 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -138.69 70.28 1.38 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -1.195 . . . . 0.0 110.244 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.538 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 32.5 m -122.9 164.21 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 0.0 109.972 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -131.86 152.39 51.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.098 -1.001 . . . . 0.0 110.406 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.785 HD12 ' CE1' ' A' ' 3' ' ' PHE . 2.8 mp -84.35 172.4 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.269 -0.895 . . . . 0.0 110.205 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.594 ' N ' HG22 ' A' ' 128' ' ' ILE . 5.8 tttp -112.31 179.03 4.11 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.323 -0.86 . . . . 0.0 109.853 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -82.39 5.46 20.33 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.172 -0.955 . . . . 0.0 108.822 178.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -93.83 -31.56 14.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.386 -0.821 . . . . 0.0 109.906 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.406 ' HE1' HD12 ' A' ' 95' ' ' LEU . 15.8 t-160 -85.93 -36.16 20.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.29 -0.881 . . . . 0.0 110.083 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.832 HG11 ' CE1' ' A' ' 5' ' ' TYR . 37.0 t -77.56 -43.21 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.351 -0.843 . . . . 0.0 110.095 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 57.5 tttm -65.51 -44.21 87.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 0.0 110.114 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.44 -37.23 85.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.24 -0.913 . . . . 0.0 110.027 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -64.09 -30.72 78.57 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 81.0 mttt -61.9 -31.67 71.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.366 -1.079 . . . . 0.0 109.998 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.483 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 70.0 mm-40 -82.29 -36.92 26.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.319 -0.863 . . . . 0.0 109.962 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -70.48 -30.52 67.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.337 -0.852 . . . . 0.0 109.975 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.57 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -88.43 -37.74 15.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.894 . . . . 0.0 110.094 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.419 ' O ' ' HB2' ' A' ' 144' ' ' PHE . 66.3 m -71.24 -52.58 18.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.416 -0.802 . . . . 0.0 109.97 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.483 ' ND2' ' O ' ' A' ' 138' ' ' GLU . 92.3 m-20 -54.62 -43.41 72.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.275 -0.891 . . . . 0.0 109.971 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.623 ' HA ' HD12 ' A' ' 146' ' ' LEU . 13.0 tp -59.7 -42.74 93.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.895 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.717 ' HA ' HD12 ' A' ' 147' ' ' ILE . 7.7 m-85 -55.17 -39.1 69.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.331 -0.856 . . . . 0.0 109.587 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.46 ' O ' ' HG2' ' A' ' 145' ' ' LYS . 51.0 tttt -74.53 -15.02 60.88 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.419 -0.801 . . . . 0.0 109.859 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.75 ' HB3' HG21 ' A' ' 33' ' ' ILE . 29.2 mt -80.86 -35.15 33.11 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.178 -0.951 . . . . 0.0 108.712 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.78 HD11 ' CE1' ' A' ' 22' ' ' PHE . 17.4 mt -68.83 -51.59 43.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 1.049 ' HB3' HD13 ' A' ' 13' ' ' ILE . 52.6 mt-10 -56.46 -40.9 75.64 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.543 -0.723 . . . . 0.0 109.764 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 98.0 m -66.97 -41.81 86.2 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.144 -0.973 . . . . 0.0 109.811 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.619 ' CD1' HG12 ' A' ' 33' ' ' ILE . 87.1 t80 -56.19 -46.18 79.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.344 -0.847 . . . . 0.0 109.997 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.958 HD22 ' NE ' ' A' ' 17' ' ' ARG . 33.2 mt -80.15 -28.98 38.78 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.227 -0.921 . . . . 0.0 110.344 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.775 ' HB2' HD11 ' A' ' 13' ' ' ILE . 21.4 tttt -72.23 -28.06 62.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.327 -0.858 . . . . 0.0 109.822 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.493 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -101.47 -33.61 4.75 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.56 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 5.9 m-70 -106.94 92.4 7.54 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.339 -1.095 . . . . 0.0 109.71 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 48.5 Cg_endo -73.68 8.22 2.02 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.288 1.678 . . . . 0.0 111.439 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -112.5 1.47 15.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.915 -1.116 . . . . 0.0 109.817 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.615 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -73.4 100.98 3.35 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.367 -0.833 . . . . 0.0 110.421 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 1.002 ' CE1' ' HB2' ' A' ' 21' ' ' ALA . 0.3 OUTLIER 34.53 39.55 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.747 -0.596 . . . . 0.0 110.691 -179.737 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.589 ' CB ' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.416 0 CA-C-O 118.007 -0.996 . . . . 0.0 109.722 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.911 HG13 ' O ' ' A' ' 120' ' ' TYR . 70.9 t -140.21 125.32 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.197 -1.178 . . . . 0.0 110.169 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.619 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 66.0 m-85 -88.93 126.09 35.24 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.141 -0.974 . . . . 0.0 110.108 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.71 HG23 ' CE1' ' A' ' 119' ' ' HIS . 3.0 m -117.38 107.24 14.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.235 -0.916 . . . . 0.0 110.431 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.69 ' CE1' HG23 ' A' ' 133' ' ' VAL . 69.5 m-85 -111.49 126.11 54.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.184 -0.948 . . . . 0.0 110.164 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.468 ' HG2' ' OG1' ' A' ' 117' ' ' THR . 2.4 mt-10 -117.6 144.79 44.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.295 -0.878 . . . . 0.0 110.564 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.477 ' O ' ' HG2' ' A' ' 8' ' ' GLU . 20.0 m -128.0 164.64 21.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.331 -0.856 . . . . 0.0 109.842 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 7' ' ' SER . 68.4 mt-10 -153.12 124.65 7.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.064 -1.022 . . . . 0.0 110.757 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.636 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.0 p90 -145.24 -176.22 5.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.308 -0.87 . . . . 0.0 109.728 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.785 HG22 ' HA ' ' A' ' 113' ' ' ILE . 6.8 p -142.5 174.56 10.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.062 -1.024 . . . . 0.0 110.687 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.485 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 7.9 t -159.99 164.96 32.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.37 -0.831 . . . . 0.0 110.142 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -89.69 -22.85 22.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.306 -0.871 . . . . 0.0 110.213 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.844 HG21 HD12 ' A' ' 151' ' ' LEU . 8.4 mm -68.1 150.71 97.64 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.264 -0.898 . . . . 0.0 109.984 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.825 ' HD2' HG23 ' A' ' 13' ' ' ILE . 41.0 Cg_endo -66.98 145.05 72.63 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 124.029 1.541 . . . . 0.0 110.598 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.669 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.1 Cg_endo -71.18 -31.99 13.68 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.873 1.459 . . . . 0.0 112.765 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.669 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.1 Cg_endo -69.23 -22.76 34.06 Favored 'Trans proline' 0 C--N 1.318 -1.047 0 N-CA-C 109.988 -0.812 . . . . 0.0 109.988 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.726 HH21 ' HB3' ' A' ' 157' ' ' ALA . 52.3 mtp180 -81.79 -43.13 18.75 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 1.095 HD23 ' CG2' ' A' ' 147' ' ' ILE . 0.2 OUTLIER -73.53 -33.78 64.89 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.702 -0.799 . . . . 0.0 108.939 178.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.649 ' N ' HD13 ' A' ' 18' ' ' LEU . 59.8 t80 -60.27 -60.51 3.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.511 -0.743 . . . . 0.0 109.765 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.645 ' HG2' HD22 ' A' ' 24' ' ' LEU . 23.1 mttt -53.77 -38.9 64.92 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.735 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.058 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -69.17 -36.42 77.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.456 -0.778 . . . . 0.0 110.904 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 1.047 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.3 OUTLIER -79.09 -49.21 12.99 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.31 -0.869 . . . . 0.0 110.974 -179.127 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.608 ' HB ' HD12 ' A' ' 24' ' ' LEU . 3.7 t -94.34 -53.97 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.202 -0.936 . . . . 0.0 111.813 -178.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.765 HD12 ' N ' ' A' ' 24' ' ' LEU . 7.4 mp -80.03 -1.05 38.06 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.972 -1.08 . . . . 0.0 112.129 -178.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.587 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -147.78 23.46 1.1 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.704 -1.247 . . . . 0.0 110.725 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 1.047 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -65.76 -12.35 53.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.089 -1.007 . . . . 0.0 110.193 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.514 ' HA ' ' CB ' ' A' ' 41' ' ' SER . 92.0 m-20 -80.08 -13.76 59.05 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.205 -0.934 . . . . 0.0 110.443 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.402 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 4.6 p30 -135.46 6.19 3.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.192 -0.943 . . . . 0.0 110.595 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.682 ' HG ' ' HB1' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -96.59 -40.56 8.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.214 -0.929 . . . . 0.0 109.888 179.901 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.871 ' CG1' HD13 ' A' ' 38' ' ' ILE . 4.1 t -82.45 -41.01 0.92 Allowed Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.437 -0.79 . . . . 0.0 111.013 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.7 Cg_endo -78.95 11.43 2.57 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.365 1.192 . . . . 0.0 110.771 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -124.41 -34.04 2.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.065 -1.022 . . . . 0.0 109.438 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.617 HG21 ' HB3' ' A' ' 146' ' ' LEU . 7.5 mt -80.12 -38.75 18.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.489 -0.757 . . . . 0.0 109.399 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.77 96.68 7.43 Favored Pre-proline 0 C--N 1.304 -1.379 0 O-C-N 121.463 -0.773 . . . . 0.0 110.03 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.35 -2.52 11.37 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.003 1.528 . . . . 0.0 110.513 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -88.48 -26.41 22.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.135 -0.978 . . . . 0.0 109.711 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -86.08 -73.43 0.45 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.4 -0.813 . . . . 0.0 109.969 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.871 HD13 ' CG1' ' A' ' 30' ' ' VAL . 2.1 mp -102.6 137.15 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.407 -0.808 . . . . 0.0 110.045 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.2 ttpp -96.18 -32.28 12.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 110.376 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.593 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -167.94 156.68 9.29 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.213 -0.93 . . . . 0.0 110.09 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.514 ' CB ' ' HA ' ' A' ' 27' ' ' ASP . 11.0 p -115.83 144.89 43.37 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.273 -0.892 . . . . 0.0 110.266 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.593 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 73.3 tt0 -149.0 97.74 2.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.248 -0.908 . . . . 0.0 110.327 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.403 HG21 ' HA ' ' A' ' 47' ' ' ASP . 19.1 mt -57.52 130.78 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.173 -0.955 . . . . 0.0 110.06 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.532 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 31.0 mt -102.55 -35.25 8.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 110.64 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.807 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.9 m95 -122.91 162.85 21.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.108 -0.995 . . . . 0.0 110.658 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.446 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 41.79 -136.51 2.92 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.418 ' O ' ' CG ' ' A' ' 47' ' ' ASP . 11.1 t0 -154.26 22.41 0.49 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -1.143 . . . . 0.0 109.907 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 122.82 -20.47 7.7 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.819 -1.712 . . . . 0.0 108.819 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.454 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -68.42 -171.92 6.85 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.81 129.13 13.12 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.051 1.553 . . . . 0.0 110.626 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.84 -9.18 56.66 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.509 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -73.49 159.13 33.65 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.523 -0.986 . . . . 0.0 109.94 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.807 HD12 ' CG ' ' A' ' 45' ' ' TRP . 78.1 mt -126.85 119.61 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.354 -0.841 . . . . 0.0 109.406 179.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -105.15 135.25 46.84 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 110.451 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.532 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 76.7 tttt -104.22 93.43 4.82 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.364 -0.835 . . . . 0.0 110.05 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.549 ' HB ' HG23 ' A' ' 67' ' ' VAL . 66.3 mt -79.98 134.19 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.206 -0.934 . . . . 0.0 109.942 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.526 ' HA ' ' CB ' ' A' ' 66' ' ' TYR . 1.7 p -106.98 155.89 19.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.371 -0.831 . . . . 0.0 110.213 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.484 ' CE2' HG13 ' A' ' 67' ' ' VAL . 22.6 m-85 -111.48 151.24 28.84 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.319 -0.863 . . . . 0.0 110.205 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 58' ' ' PHE . . . -43.44 160.92 0.06 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -46.54 -86.42 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -1.139 . . . . 0.0 110.181 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.54 -94.01 0.22 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 79.2 p -87.49 -140.92 0.11 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.19 -1.182 . . . . 0.0 110.066 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -83.65 -28.65 28.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.182 -0.949 . . . . 0.0 110.115 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -178.44 131.4 0.13 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.233 -0.917 . . . . 0.0 109.934 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -135.92 133.94 6.92 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.544 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 10.5 p90 -178.16 169.34 1.9 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.335 -1.097 . . . . 0.0 110.181 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.865 HG12 ' HA2' ' A' ' 88' ' ' GLY . 4.1 m -141.92 176.92 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.395 -0.816 . . . . 0.0 110.54 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.705 ' HE2' HG21 ' A' ' 53' ' ' ILE . 68.8 tttt -127.69 122.95 34.29 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.363 -0.836 . . . . 0.0 109.792 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.425 ' NE2' ' HG ' ' A' ' 85' ' ' LEU . 9.0 m170 -116.26 126.62 53.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.088 -1.007 . . . . 0.0 110.993 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 52' ' ' THR . 15.2 tttt -102.76 117.23 34.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.295 -0.878 . . . . 0.0 109.403 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.531 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 25.5 mm -60.13 126.61 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.243 -0.911 . . . . 0.0 110.334 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.433 ' HB2' ' C ' ' A' ' 82' ' ' SER . 41.9 m-20 -97.95 -36.89 10.0 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.35 -0.844 . . . . 0.0 109.724 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.487 ' OG ' ' HB2' ' A' ' 82' ' ' SER . 35.0 p -178.58 157.33 0.97 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.327 -0.858 . . . . 0.0 109.887 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.401 HG12 HG11 ' A' ' 23' ' ' VAL . 1.3 mt -139.67 158.24 27.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.257 -0.902 . . . . 0.0 110.051 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.551 ' HB2' ' HB3' ' A' ' 80' ' ' SER . 0.8 OUTLIER -142.77 82.47 1.77 Allowed 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.537 179.698 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.549 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 48.7 tttm -66.21 -14.62 62.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.309 -0.869 . . . . 0.0 110.214 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -87.69 -29.37 21.17 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.395 -0.816 . . . . 0.0 108.907 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.489 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.2 m-80 -108.07 -5.66 16.9 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.403 0.62 . . . . 0.0 109.358 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.569 ' HA ' ' CD1' ' A' ' 19' ' ' PHE . 50.5 m-85 64.58 53.04 1.65 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.681 -0.637 . . . . 0.0 110.608 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.551 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 11.8 t -125.33 175.75 7.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 110.242 179.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.594 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 20.8 t80 -156.8 145.83 20.21 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.959 -0.697 . . . . 0.0 110.182 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.487 ' HB2' ' OG ' ' A' ' 73' ' ' SER . 0.4 OUTLIER -147.34 124.06 11.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.265 -0.897 . . . . 0.0 110.819 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.627 ' CD1' ' N ' ' A' ' 83' ' ' TYR . 2.5 p90 -145.77 -179.92 7.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.37 -0.831 . . . . 0.0 109.708 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 1.013 HG23 ' O ' ' A' ' 98' ' ' ILE . 18.6 m -135.62 146.88 48.34 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.132 -0.98 . . . . 0.0 110.567 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.65 HD12 ' HE2' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -102.43 117.82 35.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.29 -0.881 . . . . 0.0 110.257 179.67 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.606 HD11 ' HD3' ' A' ' 68' ' ' LYS . 22.3 pt -113.13 -6.12 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.228 -0.92 . . . . 0.0 110.138 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -145.92 128.29 15.89 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.319 -0.863 . . . . 0.0 110.39 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.865 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . -178.59 120.32 0.7 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -52.56 -27.33 16.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -1.161 . . . . 0.0 110.158 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.07 -20.98 62.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.935 . . . . 0.0 110.154 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.707 HD12 ' N ' ' A' ' 88' ' ' GLY . 32.9 mt -69.55 -24.74 63.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.237 -0.914 . . . . 0.0 110.222 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 50.03 -176.87 0.04 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -81.22 6.9 12.62 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -1.143 . . . . 0.0 110.222 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.423 ' O ' HG22 ' A' ' 122' ' ' THR . 26.2 p -94.21 -28.72 15.48 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.227 -0.921 . . . . 0.0 110.096 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 1.083 HD21 ' CD1' ' A' ' 128' ' ' ILE . 90.3 mt -110.35 151.66 27.17 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.302 -0.874 . . . . 0.0 110.014 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.427 ' HG3' ' HB2' ' A' ' 123' ' ' LYS . 11.5 mt-10 -133.79 -80.81 0.46 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.172 -0.955 . . . . 0.0 110.281 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.512 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 70.8 mttt -80.36 127.2 32.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.549 -0.719 . . . . 0.0 110.898 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 1.013 ' O ' HG23 ' A' ' 84' ' ' THR . 13.0 mm -116.98 146.73 21.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 120.722 -1.237 . . . . 0.0 109.664 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.511 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.5 OUTLIER -124.99 124.8 42.78 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.504 -0.879 . . . . 0.0 108.704 178.223 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.829 ' CE2' HG21 ' A' ' 98' ' ' ILE . 15.3 m-85 -121.15 140.81 51.5 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.366 -0.834 . . . . 0.0 110.454 -178.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.514 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 20.2 tt0 -145.42 136.92 25.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.284 -0.885 . . . . 0.0 110.331 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.478 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 60.6 m -135.16 129.69 34.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.32 -0.863 . . . . 0.0 109.635 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 80' ' ' SER . 0.0 OUTLIER -125.98 144.57 50.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.946 . . . . 0.0 110.691 -179.487 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.566 HD12 ' O ' ' A' ' 79' ' ' TYR . 7.4 mt -117.52 155.58 29.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.292 -0.88 . . . . 0.0 109.973 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.688 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -151.35 -169.2 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.133 -0.979 . . . . 0.0 110.185 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.688 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -121.87 144.07 49.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.37 -0.831 . . . . 0.0 110.234 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.458 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 3.4 p -101.2 169.41 7.81 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.182 -0.949 . . . . 0.0 110.253 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 47.6 Cg_endo -73.15 -10.91 24.84 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.111 1.585 . . . . 0.0 110.565 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.6 m -99.45 4.29 46.07 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.226 -0.921 . . . . 0.0 110.185 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 102.05 -36.93 3.92 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -56.79 178.17 0.79 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 20.6 p -122.76 130.0 52.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.228 -1.16 . . . . 0.0 110.284 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.785 ' HA ' HG22 ' A' ' 10' ' ' THR . 5.9 mt -80.33 149.41 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.252 -0.905 . . . . 0.0 110.077 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.586 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 6.5 mt -128.59 118.97 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 0.0 110.189 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 38.7 tttt -101.15 128.98 46.99 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.159 -0.963 . . . . 0.0 110.157 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.449 ' HB3' ' HB2' ' A' ' 7' ' ' SER . 0.0 OUTLIER -110.99 152.13 27.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.215 -0.928 . . . . 0.0 110.047 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.585 ' CG2' ' CE1' ' A' ' 119' ' ' HIS . 33.4 m -160.09 125.29 3.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.212 -0.93 . . . . 0.0 110.499 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.504 ' HB3' ' CE1' ' A' ' 100' ' ' TYR . 3.1 m -135.46 142.94 45.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.314 -0.866 . . . . 0.0 109.746 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.71 ' CE1' HG23 ' A' ' 4' ' ' THR . 33.1 m-70 -129.49 136.19 49.57 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.082 -1.011 . . . . 0.0 110.293 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.911 ' O ' HG13 ' A' ' 2' ' ' VAL . 3.0 m-30 -104.54 151.78 23.19 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.308 -0.87 . . . . 0.0 110.745 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.512 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 82.1 m-70 -129.78 86.97 2.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.297 -0.877 . . . . 0.0 109.43 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.685 ' CG2' HD23 ' A' ' 95' ' ' LEU . 1.4 p -63.23 156.11 26.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.375 -0.828 . . . . 0.0 110.56 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.427 ' HB2' ' HG3' ' A' ' 96' ' ' GLU . 4.3 tttm -103.86 106.52 17.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.399 -0.813 . . . . 0.0 110.07 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 103.45 -123.41 7.78 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -136.62 94.61 3.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.233 -1.157 . . . . 0.0 110.252 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.503 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 14.9 m -141.95 -177.77 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.277 -0.889 . . . . 0.0 110.128 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -134.23 144.5 48.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -0.933 . . . . 0.0 110.48 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 1.083 ' CD1' HD21 ' A' ' 95' ' ' LEU . 12.0 mm -64.94 172.54 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 110.154 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.596 ' N ' HG22 ' A' ' 128' ' ' ILE . 18.8 mttt -97.78 127.89 44.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.345 -0.847 . . . . 0.0 109.847 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 129' ' ' LYS . 94.6 mt-10 -44.13 -52.8 6.98 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.131 -0.981 . . . . 0.0 109.937 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.99 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 50.7 tt0 -52.54 -20.53 3.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.203 -0.935 . . . . 0.0 109.706 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.479 ' N ' ' O ' ' A' ' 129' ' ' LYS . 14.0 t-160 -85.31 -61.85 1.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.395 -0.816 . . . . 0.0 110.259 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.69 HG23 ' CE1' ' A' ' 5' ' ' TYR . 1.8 p -66.37 -20.92 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.306 -0.872 . . . . 0.0 110.285 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.532 ' HG3' HG13 ' A' ' 133' ' ' VAL . 26.3 mttt -104.42 -72.51 0.7 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.922 . . . . 0.0 110.027 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.99 ' HB3' ' O ' ' A' ' 131' ' ' GLU . . . -56.57 -22.4 33.28 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 109.77 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -75.46 -27.87 62.67 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -68.83 -33.9 74.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.174 -1.192 . . . . 0.0 110.145 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.419 ' O ' ' ND2' ' A' ' 142' ' ' ASN . 78.4 tt0 -75.95 -24.14 55.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.315 -0.866 . . . . 0.0 110.109 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 67.7 mttt -78.94 -27.98 43.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.335 -0.853 . . . . 0.0 109.991 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -81.85 -36.1 28.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.289 -0.882 . . . . 0.0 110.072 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.8 t -65.25 -46.32 81.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.4 -0.812 . . . . 0.0 110.141 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.419 ' ND2' ' O ' ' A' ' 138' ' ' GLU . 93.5 m-20 -51.69 -47.58 63.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.343 -0.848 . . . . 0.0 110.028 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.744 ' HA ' HD12 ' A' ' 146' ' ' LEU . 14.0 tp -56.68 -50.03 73.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.903 . . . . 0.0 109.936 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.467 ' CG ' ' CZ ' ' A' ' 9' ' ' PHE . 18.0 m-85 -55.87 -39.26 71.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.334 -0.854 . . . . 0.0 109.708 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -75.97 -11.09 59.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.417 -0.802 . . . . 0.0 110.089 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.744 HD12 ' HA ' ' A' ' 143' ' ' LEU . 11.7 mt -83.42 -37.84 22.7 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.211 -0.931 . . . . 0.0 108.804 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 1.095 ' CG2' HD23 ' A' ' 18' ' ' LEU . 63.5 mt -69.06 -48.49 69.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.513 ' O ' HG13 ' A' ' 13' ' ' ILE . 96.8 mt-10 -47.27 -38.01 11.69 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.414 -0.804 . . . . 0.0 109.009 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.482 ' HA ' ' HB3' ' A' ' 152' ' ' LYS . 11.0 m -79.94 -25.4 40.48 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.318 -0.864 . . . . 0.0 109.237 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.58 ' O ' ' CD2' ' A' ' 154' ' ' HIS . 64.9 t80 -54.85 -51.8 64.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.583 -0.698 . . . . 0.0 109.824 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.002 HD21 ' CE1' ' A' ' 158' ' ' TYR . 45.0 mt -79.89 -28.97 39.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.479 -0.763 . . . . 0.0 109.994 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.49 ' HA ' HD11 ' A' ' 13' ' ' ILE . 21.1 tttt -64.18 -13.04 45.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.317 -0.864 . . . . 0.0 109.488 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.502 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -124.19 -24.13 1.86 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.58 ' CD2' ' O ' ' A' ' 150' ' ' TYR . 10.4 m-70 -105.53 93.62 7.36 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.147 -1.208 . . . . 0.0 110.165 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.0 Cg_endo -73.43 4.12 4.19 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 124.12 1.589 . . . . 0.0 111.038 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -119.44 -1.53 10.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.023 -1.048 . . . . 0.0 110.126 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.726 ' HB3' HH21 ' A' ' 17' ' ' ARG . . . -59.76 105.51 0.38 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.339 -0.85 . . . . 0.0 110.159 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 1.058 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 0.3 OUTLIER 35.64 30.53 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.606 -0.684 . . . . 0.0 110.738 -179.754 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.536 ' CB ' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.726 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 1.026 HG23 ' C ' ' A' ' 120' ' ' TYR . 2.8 p -80.47 151.56 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.297 -1.119 . . . . 0.0 110.219 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.677 ' CE1' HD12 ' A' ' 128' ' ' ILE . 15.9 m-85 -90.14 176.39 6.79 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.276 -0.89 . . . . 0.0 110.046 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.826 HG23 ' CE1' ' A' ' 119' ' ' HIS . 94.9 m -140.88 106.11 5.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.247 -0.908 . . . . 0.0 110.294 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.657 ' CD1' HG13 ' A' ' 133' ' ' VAL . 22.2 m-85 -113.36 129.5 56.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -0.895 . . . . 0.0 109.987 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 22.4 pt-20 -130.41 152.99 49.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.233 -0.917 . . . . 0.0 110.569 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.3 m -138.18 147.18 43.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.373 -0.829 . . . . 0.0 109.84 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -131.36 117.12 18.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.132 -0.98 . . . . 0.0 110.556 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.4 p90 -139.21 -176.72 4.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.313 -0.867 . . . . 0.0 110.014 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.548 HG22 HG12 ' A' ' 113' ' ' ILE . 7.6 p -136.05 174.95 10.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.188 -0.945 . . . . 0.0 110.662 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.49 ' HB3' ' OE2' ' A' ' 148' ' ' GLU . 80.5 p -160.02 128.51 4.88 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.392 -0.817 . . . . 0.0 110.288 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.428 ' HA ' ' CA ' ' A' ' 111' ' ' GLY . 96.6 mt-10 -60.61 -28.86 68.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.195 -0.941 . . . . 0.0 109.924 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.939 HD13 ' HB3' ' A' ' 148' ' ' GLU . 1.3 mp -65.89 148.33 98.34 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.334 -0.854 . . . . 0.0 109.828 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.654 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.7 Cg_endo -66.49 141.65 62.09 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.892 1.469 . . . . 0.0 110.491 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.646 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.3 Cg_endo -72.87 -30.88 10.79 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 124.017 1.535 . . . . 0.0 112.886 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.646 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 42.6 Cg_endo -70.68 -22.33 28.0 Favored 'Trans proline' 0 C--N 1.319 -1.001 0 N-CA-C 110.195 -0.733 . . . . 0.0 110.195 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.638 HH21 ' HB3' ' A' ' 157' ' ' ALA . 43.4 mtp180 -84.31 -43.28 14.95 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 1.049 HD23 ' CG2' ' A' ' 147' ' ' ILE . 0.2 OUTLIER -72.73 -34.74 67.27 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.018 179.05 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.624 ' N ' HD13 ' A' ' 18' ' ' LEU . 52.5 t80 -64.5 -56.21 15.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.333 -0.854 . . . . 0.0 109.573 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.539 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 28.7 mttt -52.74 -36.41 57.68 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.734 -0.787 . . . . 0.0 109.564 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.007 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -78.03 -36.58 48.38 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.372 -0.83 . . . . 0.0 111.056 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 1.03 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.3 OUTLIER -73.91 -42.71 60.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.195 -0.94 . . . . 0.0 111.191 -179.057 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.628 ' HB ' HD12 ' A' ' 24' ' ' LEU . 4.6 t -105.99 -49.97 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.018 -1.051 . . . . 0.0 111.61 -178.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.676 HD12 ' N ' ' A' ' 24' ' ' LEU . 7.1 mp -79.84 -9.95 59.72 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.26 -0.9 . . . . 0.0 111.399 -178.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.559 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.9 OUTLIER -149.44 38.82 0.79 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.85 -1.156 . . . . 0.0 110.555 -179.755 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 1.03 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -78.92 -24.97 43.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.333 -0.854 . . . . 0.0 110.504 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.484 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 91.8 m-20 -65.34 -21.15 66.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.154 -0.966 . . . . 0.0 110.221 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.554 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 4.1 p30 -125.4 13.0 8.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.315 -0.866 . . . . 0.0 109.89 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.752 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -94.28 -52.04 4.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.441 -0.787 . . . . 0.0 110.327 -179.89 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 1.112 HG21 HD13 ' A' ' 38' ' ' ILE . 3.8 p -75.1 -28.87 0.82 Allowed Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.275 -0.89 . . . . 0.0 112.288 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.844 ' HD3' HG12 ' A' ' 30' ' ' VAL . 51.9 Cg_endo -79.1 7.58 4.3 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 O-C-N 122.704 0.844 . . . . 0.0 110.581 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -129.66 -29.73 2.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.172 -0.955 . . . . 0.0 110.009 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.698 HD11 HD13 ' A' ' 29' ' ' LEU . 75.5 mt -80.04 -44.13 22.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.41 -0.806 . . . . 0.0 109.788 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -160.43 103.21 1.35 Allowed Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.376 -0.827 . . . . 0.0 110.121 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.46 0.29 7.69 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.077 1.567 . . . . 0.0 110.641 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -83.48 -15.57 49.0 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.182 -0.949 . . . . 0.0 109.67 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -92.13 -64.84 1.06 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.414 -0.804 . . . . 0.0 109.993 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 1.112 HD13 HG21 ' A' ' 30' ' ' VAL . 2.1 mp -114.88 131.19 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.426 -0.796 . . . . 0.0 109.941 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 57' ' ' THR . 15.8 ttpt -77.42 -23.43 50.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.203 -0.936 . . . . 0.0 110.48 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.566 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -178.94 161.45 1.18 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.106 -0.996 . . . . 0.0 110.102 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.4 m -134.61 124.34 25.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.329 -0.857 . . . . 0.0 109.977 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.566 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 44.5 tt0 -137.68 110.92 7.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -0.938 . . . . 0.0 110.661 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.416 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 33.8 mt -56.25 136.27 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.33 -0.857 . . . . 0.0 109.787 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.727 HD13 ' HD2' ' A' ' 55' ' ' LYS . 7.6 tp -108.76 -26.1 10.48 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.174 -0.953 . . . . 0.0 110.575 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.483 ' HB2' ' CB ' ' A' ' 53' ' ' ILE . 2.0 m95 -128.65 163.3 25.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.123 -0.985 . . . . 0.0 110.845 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.448 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 41.8 -137.72 2.55 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.94 24.13 0.66 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.326 -1.102 . . . . 0.0 110.02 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 119.04 -16.32 10.88 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.519 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -73.66 -170.02 19.66 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.75 128.85 12.88 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.99 1.521 . . . . 0.0 110.559 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.465 ' HA2' ' HE3' ' A' ' 70' ' ' LYS . . . 102.64 -12.32 56.55 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 108.707 -1.757 . . . . 0.0 108.707 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.539 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -71.36 161.6 30.8 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.534 -0.98 . . . . 0.0 109.56 179.674 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.483 ' CB ' ' HB2' ' A' ' 45' ' ' TRP . 45.0 mt -130.78 119.93 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.329 -0.857 . . . . 0.0 109.959 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.784 ' CE ' HD11 ' A' ' 71' ' ' ILE . 29.3 mttm -103.11 127.17 50.49 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.151 -0.968 . . . . 0.0 110.228 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.727 ' HD2' HD13 ' A' ' 44' ' ' LEU . 7.8 mtpt -96.06 92.69 6.57 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.378 -0.826 . . . . 0.0 110.098 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.542 ' CG2' HG12 ' A' ' 38' ' ' ILE . 95.2 mt -79.95 141.87 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 109.914 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 2.4 p -116.4 152.07 34.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.3 -0.875 . . . . 0.0 110.582 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.594 ' HE2' HG13 ' A' ' 67' ' ' VAL . 23.5 m-85 -117.5 145.87 43.92 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.37 -0.832 . . . . 0.0 110.104 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -70.12 122.0 10.92 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -144.94 165.61 27.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -1.161 . . . . 0.0 110.143 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.25 -133.84 0.07 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 92.3 p -60.08 -29.13 68.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.214 -1.168 . . . . 0.0 110.21 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -81.66 142.84 32.35 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.21 -0.932 . . . . 0.0 110.163 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -96.62 145.8 25.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.165 -0.96 . . . . 0.0 110.228 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.577 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -135.53 96.61 0.27 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.546 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 13.6 p90 -136.1 169.13 18.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -1.182 . . . . 0.0 110.197 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.72 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.5 m -139.54 175.32 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.233 -0.917 . . . . 0.0 110.636 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.68 ' O ' HD12 ' A' ' 85' ' ' LEU . 42.7 mttt -133.41 104.63 6.51 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.465 -0.772 . . . . 0.0 109.905 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.971 ' CD2' HD13 ' A' ' 85' ' ' LEU . 13.3 m170 -96.13 129.6 43.38 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.197 -0.94 . . . . 0.0 111.138 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 52' ' ' THR . 21.6 tttp -96.92 116.7 29.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.327 -0.858 . . . . 0.0 109.395 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.784 HD11 ' CE ' ' A' ' 54' ' ' LYS . 26.8 mm -57.26 128.59 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.172 -0.955 . . . . 0.0 110.346 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 82' ' ' SER . 85.0 m-20 -101.58 -43.79 5.78 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.341 -0.849 . . . . 0.0 110.013 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.423 ' OG ' ' HB2' ' A' ' 82' ' ' SER . 62.0 p -173.67 158.67 3.38 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.434 -0.791 . . . . 0.0 109.946 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.48 HG12 HG11 ' A' ' 23' ' ' VAL . 2.0 mt -139.3 157.4 27.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.229 -0.92 . . . . 0.0 110.228 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 79' ' ' TYR . 4.5 m-20 -135.41 79.2 1.77 Allowed 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.371 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -61.38 -17.74 55.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -0.923 . . . . 0.0 110.174 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -92.48 -30.68 15.59 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.28 -0.887 . . . . 0.0 109.577 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.497 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -104.15 -3.22 24.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.566 -0.709 . . . . 0.0 109.574 179.731 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.716 ' HB3' HD12 ' A' ' 104' ' ' LEU . 70.0 m-85 60.18 54.57 3.99 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.599 -0.688 . . . . 0.0 110.756 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.508 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 0.9 OUTLIER -129.47 157.62 41.49 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.278 -0.889 . . . . 0.0 109.689 179.435 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.686 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 45.3 t80 -142.54 138.86 31.18 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.259 -0.901 . . . . 0.0 110.104 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 4.3 m -142.12 132.2 24.65 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.826 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.686 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 21.3 p90 -149.65 170.94 17.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.358 -0.839 . . . . 0.0 110.407 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.858 HG23 ' O ' ' A' ' 98' ' ' ILE . 50.4 m -126.72 129.52 48.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.436 -0.79 . . . . 0.0 110.077 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.971 HD13 ' CD2' ' A' ' 69' ' ' HIS . 10.7 tp -95.84 133.55 39.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.084 -1.01 . . . . 0.0 110.378 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.529 ' H ' HD12 ' A' ' 85' ' ' LEU . 9.8 pt -111.22 -33.49 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.199 -0.938 . . . . 0.0 110.209 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.685 ' O ' HD11 ' A' ' 85' ' ' LEU . 77.3 tt0 -116.17 155.3 28.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.376 -0.828 . . . . 0.0 110.139 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.72 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 156.29 129.38 1.17 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -60.15 -20.21 57.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -1.161 . . . . 0.0 110.222 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.69 -16.14 60.77 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.276 -0.89 . . . . 0.0 110.252 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.46 ' O ' ' HB2' ' A' ' 95' ' ' LEU . 75.7 mt -69.1 -25.51 64.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.278 -0.889 . . . . 0.0 110.189 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 49.28 -178.66 0.02 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.544 ' OD1' HG23 ' A' ' 94' ' ' THR . 55.1 p30 -83.15 10.27 8.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.229 -1.16 . . . . 0.0 110.171 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.728 ' O ' HG21 ' A' ' 126' ' ' VAL . 29.7 p -103.08 -33.84 9.1 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.235 -0.916 . . . . 0.0 110.098 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.902 HD21 HD11 ' A' ' 128' ' ' ILE . 96.7 mt -103.8 160.6 14.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 110.052 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.46 ' HG2' ' N ' ' A' ' 97' ' ' LYS . 54.4 tt0 -140.05 -82.18 0.26 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.337 -0.852 . . . . 0.0 109.689 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.5 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 42.0 mttm -80.43 135.66 36.2 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.625 -0.672 . . . . 0.0 110.139 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.858 ' O ' HG23 ' A' ' 84' ' ' THR . 4.2 mm -123.1 139.29 50.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 120.866 -1.146 . . . . 0.0 109.982 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.496 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.4 OUTLIER -121.96 129.34 52.41 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.783 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.699 ' HE2' HG21 ' A' ' 98' ' ' ILE . 9.9 m-85 -123.3 133.66 54.14 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.158 -0.964 . . . . 0.0 110.876 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -135.49 129.95 33.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.444 -0.785 . . . . 0.0 109.711 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 37.4 m -134.14 144.13 48.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.186 -0.946 . . . . 0.0 110.494 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.491 ' HG3' ' HB3' ' A' ' 80' ' ' SER . 5.1 tttt -139.45 144.67 38.14 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.346 -0.846 . . . . 0.0 110.303 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.716 HD12 ' HB3' ' A' ' 79' ' ' TYR . 12.7 mt -109.37 155.09 21.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.225 -0.922 . . . . 0.0 110.461 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.693 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -151.17 -168.86 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.359 -0.838 . . . . 0.0 109.608 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.693 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -122.59 154.67 37.63 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.173 -0.955 . . . . 0.0 110.526 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.457 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 55.4 p -114.52 164.56 16.08 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.389 -0.819 . . . . 0.0 110.064 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 47.6 Cg_endo -72.63 -1.77 10.82 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.959 1.505 . . . . 0.0 110.505 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.7 t -97.24 -22.6 16.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.103 -0.998 . . . . 0.0 110.31 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 111' ' ' GLY . . . 125.42 -38.11 2.37 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 110' ' ' GLY . . . -60.29 -147.13 0.01 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 47.5 p -150.43 133.21 15.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.173 -1.193 . . . . 0.0 110.148 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.548 HG12 HG22 ' A' ' 10' ' ' THR . 23.4 mt -82.6 149.52 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.246 -0.909 . . . . 0.0 110.241 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.694 HG23 HD23 ' A' ' 104' ' ' LEU . 10.1 mt -129.74 113.47 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.894 . . . . 0.0 110.02 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.424 ' N ' ' O ' ' A' ' 103' ' ' LYS . 15.3 ttpt -94.99 122.26 37.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.088 -1.007 . . . . 0.0 110.216 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.91 147.27 42.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.895 . . . . 0.0 110.293 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 81.6 m -150.22 129.14 12.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.363 -0.836 . . . . 0.0 110.327 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.471 ' OG ' ' CE1' ' A' ' 100' ' ' TYR . 15.4 t -128.4 154.18 46.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.271 -0.893 . . . . 0.0 110.198 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.826 ' CE1' HG23 ' A' ' 4' ' ' THR . 91.5 m-70 -132.87 121.8 23.44 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.348 -0.845 . . . . 0.0 110.3 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 1.026 ' C ' HG23 ' A' ' 2' ' ' VAL . 5.7 m-30 -95.3 119.37 33.69 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.183 -0.948 . . . . 0.0 110.489 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.553 ' CE1' HG21 ' A' ' 2' ' ' VAL . 76.4 m-70 -95.47 107.45 19.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.358 -0.839 . . . . 0.0 109.558 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.7 p -77.85 155.79 30.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.107 -0.995 . . . . 0.0 110.387 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.448 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 36.9 tttp -119.6 113.51 20.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.378 -0.826 . . . . 0.0 110.226 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.38 -135.89 12.61 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -113.2 76.39 0.98 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.258 -1.143 . . . . 0.0 110.235 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.728 HG21 ' O ' ' A' ' 94' ' ' THR . 33.5 m -137.09 161.73 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.223 -0.923 . . . . 0.0 110.105 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -141.94 155.69 45.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 110.192 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.902 HD11 HD21 ' A' ' 95' ' ' LEU . 1.9 mp -84.03 173.43 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.22 -0.925 . . . . 0.0 110.113 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.608 ' N ' HG22 ' A' ' 128' ' ' ILE . 9.0 mttt -119.24 142.98 47.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.451 -0.78 . . . . 0.0 109.901 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' A' ' 134' ' ' LYS . 93.6 mt-10 -48.17 -34.47 10.04 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.154 -0.966 . . . . 0.0 110.152 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.498 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 69.1 tt0 -63.84 -32.33 73.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 0.0 109.971 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 13.9 t-160 -77.66 -51.61 10.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.296 -0.877 . . . . 0.0 110.048 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.657 HG13 ' CD1' ' A' ' 5' ' ' TYR . 49.6 t -60.69 -38.66 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.39 -0.819 . . . . 0.0 109.979 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 130' ' ' GLU . 62.2 mmtt -77.37 -45.01 27.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.316 -0.865 . . . . 0.0 110.122 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.498 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -62.25 -38.31 88.78 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.304 -0.872 . . . . 0.0 110.019 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -63.43 -30.77 78.59 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 77.5 mttt -77.33 -30.93 54.24 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.353 -1.087 . . . . 0.0 110.0 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -75.65 -34.1 60.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.367 -0.833 . . . . 0.0 109.959 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 39.3 mttt -73.36 -37.29 66.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.376 -0.828 . . . . 0.0 109.815 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.512 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -74.76 -32.37 62.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.251 -0.906 . . . . 0.0 109.88 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.6 m -66.93 -49.33 65.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -0.881 . . . . 0.0 109.904 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -51.56 -47.3 63.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.25 -0.906 . . . . 0.0 109.895 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.433 ' O ' HG13 ' A' ' 147' ' ' ILE . 13.7 tp -57.14 -50.02 74.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -0.899 . . . . 0.0 109.732 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.512 ' CD2' ' O ' ' A' ' 140' ' ' ALA . 21.6 m-85 -52.9 -35.17 57.76 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.388 -0.82 . . . . 0.0 109.673 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 37.2 mttt -78.18 -18.25 55.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.376 -0.828 . . . . 0.0 109.811 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 143' ' ' LEU . 26.0 mt -82.43 -35.76 27.28 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.255 -0.903 . . . . 0.0 108.778 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 1.049 ' CG2' HD23 ' A' ' 18' ' ' LEU . 34.7 mt -69.6 -45.47 77.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.939 ' HB3' HD13 ' A' ' 13' ' ' ILE . 91.9 mt-10 -53.21 -40.16 64.27 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.353 -0.842 . . . . 0.0 109.428 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.2 m -67.27 -28.23 67.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.309 -0.869 . . . . 0.0 109.447 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.591 ' CD1' HG12 ' A' ' 33' ' ' ILE . 80.5 t80 -63.42 -48.08 79.29 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.517 -0.74 . . . . 0.0 109.817 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.014 HD21 ' CE1' ' A' ' 158' ' ' TYR . 81.6 mt -79.91 -37.67 34.17 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.309 -0.87 . . . . 0.0 110.211 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.928 ' HB2' HD11 ' A' ' 13' ' ' ILE . 43.5 tptt -60.7 -16.99 45.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.362 -0.836 . . . . 0.0 109.318 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.484 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -116.39 -30.13 2.14 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.573 ' CD2' ' O ' ' A' ' 150' ' ' TYR . 8.2 m-70 -106.05 93.97 8.6 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.222 -1.164 . . . . 0.0 110.223 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 48.1 Cg_endo -74.02 6.25 3.06 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 124.066 1.561 . . . . 0.0 111.048 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 35.4 p30 -115.77 -5.68 12.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.014 -1.054 . . . . 0.0 109.906 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.638 ' HB3' HH21 ' A' ' 17' ' ' ARG . . . -57.76 107.38 0.45 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.379 -0.826 . . . . 0.0 110.112 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 1.014 ' CE1' HD21 ' A' ' 151' ' ' LEU . 0.2 OUTLIER 36.56 29.61 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.654 -0.654 . . . . 0.0 110.573 -179.429 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.573 ' CB ' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.644 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.923 HG13 ' O ' ' A' ' 120' ' ' TYR . 94.9 t -118.97 146.54 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.214 -1.168 . . . . 0.0 110.331 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.654 ' CE1' HD12 ' A' ' 128' ' ' ILE . 9.8 m-85 -101.03 142.55 32.34 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.285 -0.884 . . . . 0.0 109.518 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 m -118.45 131.88 56.25 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.982 -1.074 . . . . 0.0 110.887 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.138 ' CE2' HG21 ' A' ' 133' ' ' VAL . 72.0 m-85 -141.25 124.57 16.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.434 -0.791 . . . . 0.0 109.836 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.994 ' CG ' HG23 ' A' ' 117' ' ' THR . 10.2 mt-10 -132.23 136.34 46.92 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 0.0 110.319 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.414 ' C ' ' HG3' ' A' ' 8' ' ' GLU . 50.0 m -125.51 164.08 21.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.235 -0.916 . . . . 0.0 110.093 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.459 ' HG2' ' HG3' ' A' ' 115' ' ' LYS . 87.1 mt-10 -146.26 127.18 14.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.298 -0.876 . . . . 0.0 110.445 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.633 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.1 p90 -147.32 -175.17 4.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.308 -0.87 . . . . 0.0 109.818 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.85 HG22 ' HA ' ' A' ' 113' ' ' ILE . 5.1 p -142.04 170.78 15.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.097 -1.002 . . . . 0.0 110.64 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.47 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 5.0 t -148.93 164.29 34.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.388 -0.82 . . . . 0.0 110.062 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -85.85 -22.0 27.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.267 -0.895 . . . . 0.0 110.192 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.816 HG23 ' HD2' ' A' ' 14' ' ' PRO . 8.8 mm -80.9 150.22 68.59 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.316 -0.865 . . . . 0.0 110.07 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.816 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.6 Cg_endo -66.17 146.36 81.33 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.044 1.55 . . . . 0.0 110.377 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.68 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.2 Cg_endo -71.18 -31.95 13.75 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.897 1.472 . . . . 0.0 112.912 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.68 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.1 Cg_endo -68.51 -20.59 41.28 Favored 'Trans proline' 0 C--N 1.317 -1.107 0 N-CA-C 110.114 -0.764 . . . . 0.0 110.114 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.775 ' HB3' HD13 ' A' ' 151' ' ' LEU . 47.9 mtp180 -85.78 -43.77 13.05 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.779 ' C ' HD23 ' A' ' 18' ' ' LEU . 1.2 tt -75.21 -34.45 61.49 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.567 ' N ' HD23 ' A' ' 18' ' ' LEU . 60.8 t80 -65.75 -55.42 17.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.394 -0.816 . . . . 0.0 109.342 179.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.522 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 64.3 mttt -53.62 -38.44 64.05 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.884 -0.727 . . . . 0.0 109.558 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.019 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -74.4 -39.74 62.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.465 -0.772 . . . . 0.0 110.961 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.96 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -75.21 -38.47 60.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.315 -0.865 . . . . 0.0 111.073 -178.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.668 HG13 ' CE1' ' A' ' 81' ' ' TYR . 4.5 t -105.22 -55.21 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.039 -1.038 . . . . 0.0 111.691 -179.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.676 HD12 ' N ' ' A' ' 24' ' ' LEU . 7.3 mp -80.03 -4.64 53.5 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.178 -0.952 . . . . 0.0 111.841 -178.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.533 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 1.0 OUTLIER -150.7 32.49 0.62 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.706 -1.246 . . . . 0.0 110.724 -179.61 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.96 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -74.44 -20.63 59.96 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.257 -0.902 . . . . 0.0 110.321 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.46 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 94.8 m-20 -67.75 -24.45 65.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.232 -0.918 . . . . 0.0 110.103 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.572 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 4.4 p30 -123.51 12.93 9.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.326 -0.859 . . . . 0.0 109.897 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.691 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -92.92 -50.33 5.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.356 -0.84 . . . . 0.0 110.184 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.87 HG22 ' HD3' ' A' ' 31' ' ' PRO . 2.2 m -74.26 -29.44 0.97 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.353 -0.842 . . . . 0.0 112.166 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.87 ' HD3' HG22 ' A' ' 30' ' ' VAL . 53.1 Cg_endo -79.15 3.57 7.33 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 O-C-N 122.785 0.887 . . . . 0.0 110.287 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -124.66 -34.71 2.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.319 -0.863 . . . . 0.0 109.326 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.593 HG12 ' CD1' ' A' ' 150' ' ' TYR . 18.4 mt -79.99 -36.65 17.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.625 -0.672 . . . . 0.0 109.837 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -175.33 102.95 0.26 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.545 -0.722 . . . . 0.0 109.831 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.77 1.57 6.26 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.031 1.543 . . . . 0.0 110.808 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -84.54 0.05 51.33 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.141 -0.974 . . . . 0.0 109.894 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.858 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -101.03 -51.17 3.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.28 -0.887 . . . . 0.0 110.024 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.858 HD12 ' C ' ' A' ' 37' ' ' ALA . 1.8 mp -134.45 125.09 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.449 -0.782 . . . . 0.0 109.948 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' A' ' 57' ' ' THR . 21.8 ttpt -61.47 -26.82 68.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.25 -0.906 . . . . 0.0 110.319 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.595 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER 173.24 162.08 0.14 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.153 -0.967 . . . . 0.0 110.107 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.1 m -128.34 125.11 38.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.384 -0.822 . . . . 0.0 110.048 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.595 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 40.5 tt0 -130.16 111.37 12.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.195 -0.94 . . . . 0.0 110.426 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.447 HG12 ' HG2' ' A' ' 54' ' ' LYS . 36.3 mt -63.35 135.44 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.351 -0.843 . . . . 0.0 110.044 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 16.0 tp -110.45 -27.47 9.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.246 -0.909 . . . . 0.0 110.362 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.75 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.8 m95 -124.14 159.48 29.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -0.958 . . . . 0.0 110.605 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 45' ' ' TRP . . . 42.06 -136.82 3.07 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.419 ' O ' ' CG ' ' A' ' 47' ' ' ASP . 11.9 t0 -152.72 24.75 0.58 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.361 -1.082 . . . . 0.0 109.77 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.47 ' O ' HG21 ' A' ' 71' ' ' ILE . . . 119.97 -21.97 8.73 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.494 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -65.17 -172.82 3.62 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.454 ' HA ' HG22 ' A' ' 71' ' ' ILE . 46.1 Cg_endo -73.44 128.64 12.95 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.997 1.525 . . . . 0.0 110.612 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.32 -13.23 54.98 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.524 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -68.61 163.25 24.12 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.569 -0.959 . . . . 0.0 109.663 179.729 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.75 HD12 ' CG ' ' A' ' 45' ' ' TRP . 61.6 mt -133.09 120.53 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.305 -0.872 . . . . 0.0 109.748 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.447 ' HG2' HG12 ' A' ' 43' ' ' ILE . 89.8 mttt -109.57 130.52 55.5 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.159 -0.963 . . . . 0.0 110.487 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -96.03 96.3 8.78 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.275 -0.891 . . . . 0.0 109.869 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.54 ' CG2' HG12 ' A' ' 38' ' ' ILE . 73.1 mt -79.87 143.82 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 109.998 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 39' ' ' LYS . 2.4 p -116.67 155.84 28.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 110.863 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.675 ' HE2' HG13 ' A' ' 67' ' ' VAL . 27.2 m-85 -119.07 154.76 32.65 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.473 -0.767 . . . . 0.0 109.917 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -118.62 39.44 2.56 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -57.46 -26.04 60.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.26 -1.141 . . . . 0.0 110.26 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 167.02 -166.04 38.93 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.0 m -52.41 -47.78 66.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -1.134 . . . . 0.0 110.289 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -45.68 150.72 0.48 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.259 -0.9 . . . . 0.0 110.231 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -88.54 124.85 34.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 110.284 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -134.89 113.86 1.19 Allowed Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.634 -1.787 . . . . 0.0 108.634 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.544 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 12.6 p90 -155.93 162.24 40.41 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.113 -1.228 . . . . 0.0 110.208 -179.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.815 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.7 m -135.01 172.68 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.301 -0.874 . . . . 0.0 110.542 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.526 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 22.5 mttt -119.07 131.34 55.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.549 -0.719 . . . . 0.0 109.71 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.644 ' CD2' ' CD1' ' A' ' 85' ' ' LEU . 11.6 m170 -116.11 129.99 56.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.17 -0.956 . . . . 0.0 110.758 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 52' ' ' THR . 13.5 ttpt -107.71 108.84 20.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.279 -0.888 . . . . 0.0 109.547 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.722 HG23 HD11 ' A' ' 74' ' ' ILE . 27.8 mm -53.03 124.4 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.243 -0.911 . . . . 0.0 110.437 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 82' ' ' SER . 93.4 m-20 -96.71 -43.04 7.72 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.445 -0.784 . . . . 0.0 109.723 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.873 ' C ' HD12 ' A' ' 74' ' ' ILE . 15.2 m -170.79 157.55 5.58 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.338 -0.851 . . . . 0.0 109.685 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.873 HD12 ' C ' ' A' ' 73' ' ' SER . 1.4 mp -135.66 149.66 28.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 110.226 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 79' ' ' TYR . 9.3 m-20 -131.22 77.26 1.77 Allowed 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.711 -0.795 . . . . 0.0 110.677 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 35.8 mttp -63.71 -16.0 59.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.182 -0.949 . . . . 0.0 109.888 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -93.8 -34.66 13.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.351 -0.843 . . . . 0.0 109.301 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.507 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -99.18 -4.11 32.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.595 -0.691 . . . . 0.0 109.452 179.362 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.582 ' CE1' ' HB3' ' A' ' 16' ' ' PRO . 65.5 m-85 60.11 57.02 3.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.558 -0.714 . . . . 0.0 110.305 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.487 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -130.73 163.08 28.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.383 -0.823 . . . . 0.0 109.595 179.539 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.668 ' CE1' HG13 ' A' ' 23' ' ' VAL . 15.2 t80 -144.64 138.33 27.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.921 . . . . 0.0 109.975 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 38.2 m -140.12 121.58 15.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.161 -0.962 . . . . 0.0 111.064 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.614 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 5.3 p90 -139.07 177.69 7.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.457 -0.777 . . . . 0.0 109.556 178.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 98' ' ' ILE . 44.3 m -133.75 137.06 44.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.064 -1.023 . . . . 0.0 110.522 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.644 ' CD1' ' CD2' ' A' ' 69' ' ' HIS . 16.5 tp -93.37 118.31 31.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.236 -0.915 . . . . 0.0 109.831 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.7 pt -107.44 -22.23 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.427 -0.796 . . . . 0.0 110.036 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.526 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 64.9 tt0 -129.59 130.6 45.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.207 -0.933 . . . . 0.0 110.627 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.815 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . -176.87 107.94 0.25 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 90' ' ' ALA . 29.4 p-10 -42.34 -25.99 0.09 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.253 -1.145 . . . . 0.0 110.504 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.476 ' N ' ' OD1' ' A' ' 89' ' ' ASP . . . -75.47 -37.93 59.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.083 -1.01 . . . . 0.0 110.445 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.496 HD12 ' C ' ' A' ' 91' ' ' LEU . 1.6 pp -86.99 -25.7 24.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.885 . . . . 0.0 110.537 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.435 ' N ' ' HG ' ' A' ' 91' ' ' LEU . . . -63.11 -36.11 93.0 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.724 ' O ' HG23 ' A' ' 94' ' ' THR . 57.1 t0 -44.11 -34.91 1.95 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.174 -1.192 . . . . 0.0 110.403 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.724 HG23 ' O ' ' A' ' 93' ' ' ASP . 1.7 p -160.05 -35.07 0.06 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.273 -0.892 . . . . 0.0 110.432 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 1.044 HD21 ' CG1' ' A' ' 128' ' ' ILE . 5.9 mt -79.96 177.71 8.73 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.213 -0.929 . . . . 0.0 110.286 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.454 ' O ' HD13 ' A' ' 91' ' ' LEU . 45.5 tt0 -148.64 -78.98 0.14 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.363 -0.836 . . . . 0.0 109.479 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.526 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 8.1 mttt -80.14 135.59 36.34 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.63 -0.669 . . . . 0.0 110.486 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.584 ' O ' HG23 ' A' ' 84' ' ' THR . 0.3 OUTLIER -136.34 132.35 49.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 120.704 -1.247 . . . . 0.0 109.292 178.651 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.434 ' HG ' ' HE2' ' A' ' 121' ' ' HIS . 0.6 OUTLIER -107.37 132.6 52.98 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.383 -0.823 . . . . 0.0 109.909 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.614 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 5.8 m-85 -122.74 132.73 54.37 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.495 -0.753 . . . . 0.0 110.316 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.477 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 9.3 tt0 -135.81 125.31 25.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.205 -0.934 . . . . 0.0 110.295 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.471 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 72.2 m -118.5 154.83 31.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.232 -0.917 . . . . 0.0 109.516 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.449 ' N ' ' O ' ' A' ' 115' ' ' LYS . 31.4 mttt -144.1 132.35 21.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.028 -1.045 . . . . 0.0 110.389 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.847 HD23 HG12 ' A' ' 114' ' ' ILE . 2.8 mt -120.01 145.45 46.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.284 -0.885 . . . . 0.0 110.177 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.702 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -153.07 -168.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.378 -0.826 . . . . 0.0 109.891 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.702 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -114.76 140.91 48.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.356 -0.84 . . . . 0.0 110.117 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.488 ' HA ' HD11 ' A' ' 113' ' ' ILE . 53.9 p -97.22 162.99 20.84 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.249 -0.907 . . . . 0.0 110.21 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.425 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.3 Cg_endo -71.92 -2.99 12.35 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.982 1.517 . . . . 0.0 110.393 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 52.9 p -100.98 2.84 41.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.295 -0.878 . . . . 0.0 110.207 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 101.2 -31.48 8.6 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -70.73 -172.55 12.15 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.511 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 24.5 p -122.03 131.37 53.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.278 -1.131 . . . . 0.0 110.369 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.85 ' HA ' HG22 ' A' ' 10' ' ' THR . 21.7 mt -80.07 143.88 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.887 . . . . 0.0 109.742 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.847 HG12 HD23 ' A' ' 104' ' ' LEU . 19.4 mt -131.08 109.78 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.104 -0.997 . . . . 0.0 110.63 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.459 ' HG3' ' HG2' ' A' ' 8' ' ' GLU . 30.0 tttt -99.33 130.5 45.62 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.277 -0.889 . . . . 0.0 109.825 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.83 151.58 39.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.958 . . . . 0.0 110.53 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.994 HG23 ' CG ' ' A' ' 6' ' ' GLU . 25.9 m -146.72 151.84 37.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.35 -0.844 . . . . 0.0 110.302 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 91.3 p -155.84 139.96 16.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.915 . . . . 0.0 110.282 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.455 ' CE1' HG22 ' A' ' 117' ' ' THR . 54.4 m-70 -127.92 157.02 41.7 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.211 -0.931 . . . . 0.0 110.394 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.923 ' O ' HG13 ' A' ' 2' ' ' VAL . 7.0 m-85 -120.41 141.62 49.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.197 -0.939 . . . . 0.0 110.733 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.526 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 98.2 m-70 -122.29 96.65 5.13 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.109 -0.994 . . . . 0.0 109.857 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.835 HG23 HD23 ' A' ' 95' ' ' LEU . 1.3 p -75.93 156.39 34.26 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.351 -0.843 . . . . 0.0 110.323 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 44.4 tttm -113.17 108.3 17.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.216 -0.927 . . . . 0.0 110.266 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 105.4 -124.07 7.79 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -127.9 75.05 1.58 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.269 -1.136 . . . . 0.0 110.204 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.466 HG23 ' CG2' ' A' ' 122' ' ' THR . 16.4 m -141.49 152.71 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.236 -0.915 . . . . 0.0 110.279 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -127.77 161.78 28.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.298 -0.877 . . . . 0.0 110.098 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 1.044 ' CG1' HD21 ' A' ' 95' ' ' LEU . 5.1 mp -86.66 172.36 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.248 -0.907 . . . . 0.0 110.378 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.602 ' N ' HG22 ' A' ' 128' ' ' ILE . 10.0 mttp -108.01 127.16 53.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.414 -0.804 . . . . 0.0 109.539 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.493 ' CA ' ' HG3' ' A' ' 134' ' ' LYS . 97.4 mt-10 -42.86 -55.03 3.88 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.214 -0.929 . . . . 0.0 110.069 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.404 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 49.0 tt0 -47.22 -24.24 0.68 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.936 . . . . 0.0 109.751 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.477 ' N ' ' O ' ' A' ' 129' ' ' LYS . 9.7 t-160 -86.19 -64.89 1.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.361 -0.837 . . . . 0.0 110.175 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 1.138 HG21 ' CE2' ' A' ' 5' ' ' TYR . 7.2 p -63.38 -41.46 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.399 -0.813 . . . . 0.0 110.222 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.531 ' N ' HG13 ' A' ' 133' ' ' VAL . 27.5 mttt -63.04 -43.55 98.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.175 -0.953 . . . . 0.0 109.823 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.451 ' O ' ' HG3' ' A' ' 139' ' ' LYS . . . -67.94 -26.15 65.82 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.339 -0.851 . . . . 0.0 109.792 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -71.66 -33.02 63.76 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.499 ' HE2' ' CD1' ' A' ' 5' ' ' TYR . 25.9 mttp -63.37 -34.67 78.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -1.129 . . . . 0.0 109.894 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -79.07 -31.94 44.6 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.366 -0.834 . . . . 0.0 109.936 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 135' ' ' ALA . 83.6 mttt -65.46 -39.36 91.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.347 -0.846 . . . . 0.0 109.857 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.85 -46.6 52.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.875 . . . . 0.0 109.916 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.6 t -55.97 -42.32 76.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.421 -0.799 . . . . 0.0 109.917 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -59.2 -43.03 92.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.922 . . . . 0.0 109.882 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 47.5 mt -60.57 -36.74 79.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.261 -0.899 . . . . 0.0 109.783 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.539 ' HA ' HD12 ' A' ' 147' ' ' ILE . 22.7 m-85 -63.2 -31.93 73.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.377 -0.827 . . . . 0.0 109.823 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -73.64 -18.59 61.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.286 -0.884 . . . . 0.0 109.916 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.504 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 32.2 mt -82.19 -35.57 28.19 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.271 -0.893 . . . . 0.0 108.701 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.727 HD11 ' CE1' ' A' ' 22' ' ' PHE . 26.8 mt -73.0 -47.06 49.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 178.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.509 ' O ' HG13 ' A' ' 13' ' ' ILE . 90.8 mt-10 -57.57 -33.75 68.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.475 -0.766 . . . . 0.0 109.406 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 19.8 m -77.1 -26.19 53.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.206 -0.934 . . . . 0.0 109.267 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.597 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 87.9 t80 -62.28 -51.38 67.94 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.605 -0.684 . . . . 0.0 110.03 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.058 HD21 ' CE2' ' A' ' 158' ' ' TYR . 71.4 mt -74.53 -29.13 61.27 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.331 -0.856 . . . . 0.0 110.196 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.599 ' HA ' HD11 ' A' ' 13' ' ' ILE . 65.9 tttt -63.19 -17.76 62.76 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.231 -0.918 . . . . 0.0 109.593 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.484 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -122.29 -19.7 3.14 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.573 ' CD2' ' O ' ' A' ' 150' ' ' TYR . 14.4 m-70 -106.91 91.74 6.7 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.128 -1.219 . . . . 0.0 110.3 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 49.1 Cg_endo -73.92 4.76 3.91 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.054 1.555 . . . . 0.0 110.871 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -117.55 -6.12 11.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.095 -1.003 . . . . 0.0 109.809 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.64 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -59.81 104.92 0.33 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.345 -0.847 . . . . 0.0 110.131 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 1.058 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.2 OUTLIER 35.77 31.12 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.662 -0.649 . . . . 0.0 110.507 -179.492 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.546 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.792 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.765 HG13 ' O ' ' A' ' 120' ' ' TYR . 39.1 t -124.37 142.84 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.236 -1.155 . . . . 0.0 110.338 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.798 ' CE1' HD12 ' A' ' 128' ' ' ILE . 7.9 m-85 -104.62 147.01 28.11 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.339 -0.851 . . . . 0.0 109.667 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.61 HG23 ' CE1' ' A' ' 119' ' ' HIS . 4.0 m -113.28 110.17 19.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.047 -1.033 . . . . 0.0 110.756 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.918 ' CE1' HG11 ' A' ' 133' ' ' VAL . 28.8 m-85 -119.58 125.98 50.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.295 -0.878 . . . . 0.0 109.977 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.452 ' HB2' ' HG1' ' A' ' 117' ' ' THR . 22.7 pt-20 -139.99 154.17 47.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.151 -0.968 . . . . 0.0 110.363 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.1 t -127.04 162.93 24.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.312 -0.867 . . . . 0.0 109.992 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -142.82 121.4 12.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.183 -0.948 . . . . 0.0 110.368 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.651 ' CZ ' ' CD2' ' A' ' 144' ' ' PHE . 3.0 p90 -149.24 -172.69 4.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.347 -0.845 . . . . 0.0 109.765 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.861 HG22 ' HA ' ' A' ' 113' ' ' ILE . 9.4 p -142.16 173.21 11.73 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.216 -0.928 . . . . 0.0 110.695 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.521 ' HB2' ' CG ' ' A' ' 148' ' ' GLU . 22.9 p -158.03 134.06 9.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.499 -0.75 . . . . 0.0 110.199 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.489 ' HA ' ' HA2' ' A' ' 111' ' ' GLY . 97.6 mt-10 -61.11 -39.18 89.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 110.111 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.809 HG23 ' HD2' ' A' ' 14' ' ' PRO . 3.0 mp -53.99 150.4 14.99 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.43 -0.794 . . . . 0.0 109.998 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.809 ' HD2' HG23 ' A' ' 13' ' ' ILE . 41.1 Cg_endo -66.89 141.07 57.38 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.958 1.504 . . . . 0.0 110.466 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.633 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.7 Cg_endo -73.44 -30.11 10.41 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 O-C-N 124.04 1.548 . . . . 0.0 112.996 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.2 Cg_endo -71.11 -22.74 25.62 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 O-C-N 122.443 0.707 . . . . 0.0 110.398 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.613 ' NH2' ' HB3' ' A' ' 157' ' ' ALA . 39.7 mtp180 -84.8 -45.58 12.21 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.774 ' C ' HD23 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -66.44 -30.14 70.43 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.663 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.543 ' CE2' ' HA ' ' A' ' 76' ' ' LYS . 69.0 t80 -67.19 -59.72 3.2 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.484 -0.76 . . . . 0.0 109.561 178.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.544 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 8.5 mttp -49.34 -29.4 6.09 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.04 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -75.63 -65.72 0.86 Allowed 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.708 0.765 . . . . 0.0 110.934 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.849 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -57.59 -33.57 68.34 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.775 -0.578 . . . . 0.0 111.754 -178.382 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.794 HG13 ' CE1' ' A' ' 81' ' ' TYR . 3.9 t -104.39 -61.46 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.853 -1.154 . . . . 0.0 111.49 -178.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.688 HD12 ' N ' ' A' ' 24' ' ' LEU . 7.9 mp -77.01 -0.14 23.39 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.166 -0.959 . . . . 0.0 111.599 -178.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.593 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -142.2 6.88 1.75 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.753 -1.217 . . . . 0.0 110.83 179.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.849 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -47.35 -41.78 20.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.089 -1.007 . . . . 0.0 110.044 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.479 ' O ' ' HG3' ' A' ' 31' ' ' PRO . 86.7 m-20 -64.13 -18.12 64.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -0.893 . . . . 0.0 110.034 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.511 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 81.5 m-20 -127.96 11.13 6.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.875 . . . . 0.0 110.158 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.793 HD12 ' C ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -95.95 -46.73 6.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.332 -0.855 . . . . 0.0 110.153 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 1.069 HG21 HD13 ' A' ' 38' ' ' ILE . 6.8 p -78.09 -26.9 0.53 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.898 . . . . 0.0 112.333 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.807 ' HD3' HG12 ' A' ' 30' ' ' VAL . 49.9 Cg_endo -78.14 5.82 5.12 Favored 'Trans proline' 0 C--N 1.318 -1.057 0 O-C-N 122.656 0.819 . . . . 0.0 110.539 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -126.15 -27.62 3.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.194 -0.941 . . . . 0.0 109.815 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.575 HG12 ' CD1' ' A' ' 150' ' ' TYR . 14.1 mt -79.96 -43.06 22.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.427 -0.796 . . . . 0.0 109.734 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -161.37 102.63 1.22 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.436 -0.79 . . . . 0.0 110.142 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.65 -0.51 8.96 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.045 1.55 . . . . 0.0 110.546 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -84.16 -17.04 41.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 0.0 109.712 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.41 -70.45 0.66 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.427 -0.796 . . . . 0.0 109.96 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 1.069 HD13 HG21 ' A' ' 30' ' ' VAL . 1.6 mp -103.96 129.28 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.456 -0.778 . . . . 0.0 109.904 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.508 ' CE ' ' HB2' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -72.65 -27.66 62.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.262 -0.899 . . . . 0.0 110.433 -179.941 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.545 ' C ' ' CD2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER 178.0 155.45 0.36 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.069 -1.019 . . . . 0.0 110.198 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.9 m -130.75 123.55 29.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.339 -0.851 . . . . 0.0 109.965 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.545 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 79.6 tt0 -133.98 111.87 10.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.098 -1.001 . . . . 0.0 110.52 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.457 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 21.3 mt -54.58 142.64 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.327 -0.858 . . . . 0.0 110.02 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.9 tp -118.56 -25.95 6.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.296 -0.878 . . . . 0.0 110.293 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.533 ' HB2' ' N ' ' A' ' 53' ' ' ILE . 1.6 m95 -123.76 158.07 32.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.332 -0.855 . . . . 0.0 110.471 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.439 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 43.21 -139.61 2.98 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -150.17 24.59 0.82 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.4 -1.059 . . . . 0.0 109.896 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 121.43 -18.41 8.79 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.456 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -72.09 -173.33 19.99 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.482 ' HA ' HG22 ' A' ' 71' ' ' ILE . 44.2 Cg_endo -72.57 129.01 14.11 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 124.005 1.529 . . . . 0.0 110.613 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.2 -14.31 48.03 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.538 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -69.87 166.3 19.76 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.574 -0.956 . . . . 0.0 109.412 179.565 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.533 ' N ' ' HB2' ' A' ' 45' ' ' TRP . 51.6 mt -138.46 119.99 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 110.151 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -104.13 127.26 51.71 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.232 -0.917 . . . . 0.0 110.456 -179.909 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.4 tttt -95.4 90.95 5.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.273 -0.892 . . . . 0.0 109.955 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.547 ' CG2' HG12 ' A' ' 38' ' ' ILE . 94.5 mt -79.97 140.37 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.279 -0.888 . . . . 0.0 110.353 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 2.4 p -111.1 161.78 15.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.327 -0.858 . . . . 0.0 110.025 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.689 ' HE2' HG13 ' A' ' 67' ' ' VAL . 22.0 m-85 -116.97 166.07 12.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.194 -0.941 . . . . 0.0 110.344 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 58' ' ' PHE . . . -43.53 137.49 4.25 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.508 ' HB2' ' CE ' ' A' ' 39' ' ' LYS . 73.5 tt0 -89.89 139.39 30.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.235 -1.156 . . . . 0.0 110.165 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -160.37 -132.37 1.34 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.45 ' C ' ' HG3' ' A' ' 63' ' ' GLN . 19.7 m -65.21 -17.33 64.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.171 -1.194 . . . . 0.0 110.178 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.45 ' HG3' ' C ' ' A' ' 62' ' ' SER . 87.1 mt-30 -146.09 152.24 38.99 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.237 -0.915 . . . . 0.0 110.12 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -76.76 143.49 39.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.246 -0.909 . . . . 0.0 110.198 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.482 ' O ' ' HB3' ' A' ' 66' ' ' TYR . . . -133.58 134.22 7.36 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 108.609 -1.797 . . . . 0.0 108.609 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.555 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 11.6 p90 -178.78 162.86 1.37 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.173 -1.192 . . . . 0.0 110.162 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.945 HG12 ' HA2' ' A' ' 88' ' ' GLY . 4.4 m -142.62 173.59 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.316 -0.865 . . . . 0.0 110.33 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.467 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 77.7 mttt -125.01 124.37 41.84 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.564 -0.71 . . . . 0.0 109.768 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.516 ' CD2' HD12 ' A' ' 85' ' ' LEU . 15.2 m170 -112.97 122.85 48.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.171 -0.956 . . . . 0.0 110.809 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 52' ' ' THR . 46.7 tttp -101.98 109.72 21.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.323 -0.86 . . . . 0.0 109.549 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.529 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 27.9 mm -48.7 136.64 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.123 -0.986 . . . . 0.0 110.21 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.493 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 14.4 t0 -114.41 -43.02 3.23 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.853 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.451 ' HB2' ' HB2' ' A' ' 82' ' ' SER . 16.7 m -165.4 158.69 16.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.457 -0.777 . . . . 0.0 109.855 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.421 HG12 HG11 ' A' ' 23' ' ' VAL . 1.4 mt -145.77 156.01 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.208 -0.933 . . . . 0.0 110.249 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.563 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 2.7 m-20 -135.56 79.21 1.77 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.547 -0.721 . . . . 0.0 110.086 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.543 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 22.1 tttp -61.78 -13.31 22.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.319 -0.863 . . . . 0.0 110.275 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -94.47 -31.23 14.04 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.237 -0.914 . . . . 0.0 109.724 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.498 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -108.47 -3.42 18.17 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.458 -0.776 . . . . 0.0 109.735 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.577 ' O ' HD12 ' A' ' 104' ' ' LEU . 7.2 m-30 64.68 50.39 2.1 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.568 -0.707 . . . . 0.0 110.304 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.563 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.6 OUTLIER -118.53 153.44 34.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.316 -0.865 . . . . 0.0 109.25 179.352 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.794 ' CE1' HG13 ' A' ' 23' ' ' VAL . 22.0 t80 -141.41 132.46 26.18 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.047 -1.033 . . . . 0.0 110.398 -179.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.451 ' HB2' ' HB2' ' A' ' 73' ' ' SER . 4.3 m -137.6 120.06 15.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.161 -0.962 . . . . 0.0 110.665 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.626 ' CE2' ' CB ' ' A' ' 100' ' ' TYR . 21.2 p90 -135.96 170.88 15.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.142 -0.973 . . . . 0.0 110.349 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 98' ' ' ILE . 43.5 m -121.31 132.24 54.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.399 -0.813 . . . . 0.0 109.941 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.572 HD11 ' O ' ' A' ' 87' ' ' GLU . 3.5 tp -98.53 126.03 43.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.177 -0.952 . . . . 0.0 110.153 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 86' ' ' ILE . 14.3 pt -105.12 -11.22 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.278 -0.889 . . . . 0.0 110.056 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.572 ' O ' HD11 ' A' ' 85' ' ' LEU . 4.3 tt0 -134.93 164.23 28.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.196 -0.94 . . . . 0.0 110.25 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.945 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 149.66 116.57 0.81 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -54.89 -20.2 8.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.24 -1.153 . . . . 0.0 110.171 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.575 ' O ' ' CE1' ' A' ' 132' ' ' HIS . . . -73.23 -8.91 57.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.366 -0.834 . . . . 0.0 110.213 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 88' ' ' GLY . 19.4 mt -81.54 -7.03 59.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.301 -0.874 . . . . 0.0 110.088 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 45.61 -170.43 0.02 OUTLIER Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -89.32 24.21 2.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -1.154 . . . . 0.0 109.885 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.1 p -118.18 -44.34 2.69 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.395 -0.815 . . . . 0.0 110.402 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.771 HD22 HG22 ' A' ' 122' ' ' THR . 3.1 mm? -79.93 162.71 24.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.392 -0.817 . . . . 0.0 110.388 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.443 ' CD ' ' HB2' ' A' ' 123' ' ' LYS . 10.5 mt-10 -146.16 -80.99 0.15 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.367 -0.833 . . . . 0.0 109.798 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.531 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 36.8 mttp -80.25 127.28 32.17 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.575 -0.703 . . . . 0.0 110.34 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.726 HG21 ' CE2' ' A' ' 100' ' ' TYR . 5.1 mm -117.68 137.5 51.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 120.446 -1.409 . . . . 0.0 110.0 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.513 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.3 OUTLIER -114.35 131.02 56.69 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.754 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.726 ' CE2' HG21 ' A' ' 98' ' ' ILE . 7.6 m-85 -125.42 134.8 51.99 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.317 -0.864 . . . . 0.0 110.576 -178.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 117' ' ' THR . 1.9 tt0 -138.95 131.46 28.73 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.413 -0.805 . . . . 0.0 110.128 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 61.0 m -132.99 142.07 48.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.308 -0.87 . . . . 0.0 109.855 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -134.38 143.2 47.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 0.0 110.527 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.66 HD23 HG12 ' A' ' 114' ' ' ILE . 14.2 mt -119.0 150.68 39.53 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.396 -0.815 . . . . 0.0 109.916 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.715 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -146.5 -168.99 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.177 -0.952 . . . . 0.0 110.061 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.715 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -124.19 160.9 26.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.313 -0.867 . . . . 0.0 110.14 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.45 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.5 p -119.42 170.17 7.14 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.912 . . . . 0.0 110.224 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.45 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 45.9 Cg_endo -72.32 -17.13 27.63 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.059 1.557 . . . . 0.0 110.484 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 59.8 p -93.28 -1.09 56.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.232 -0.918 . . . . 0.0 110.27 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.31 -36.98 4.04 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.489 ' HA2' ' HA ' ' A' ' 12' ' ' GLU . . . -54.3 -175.49 0.09 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.506 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 85.7 p -131.41 137.47 48.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.24 -1.153 . . . . 0.0 110.283 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.861 ' HA ' HG22 ' A' ' 10' ' ' THR . 16.6 mt -90.61 146.57 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.216 -0.928 . . . . 0.0 110.076 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.66 HG12 HD23 ' A' ' 104' ' ' LEU . 6.7 mt -128.32 127.13 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.283 -0.886 . . . . 0.0 110.134 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -119.77 108.79 14.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -0.912 . . . . 0.0 110.035 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.7 m -95.19 158.72 15.34 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.22 -0.925 . . . . 0.0 110.37 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 101' ' ' GLU . 60.6 m -160.13 122.44 3.31 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.386 -0.821 . . . . 0.0 109.903 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 94.8 p -126.18 171.19 11.09 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.137 -0.977 . . . . 0.0 110.466 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.61 ' CE1' HG23 ' A' ' 4' ' ' THR . 89.2 m-70 -145.27 140.05 27.54 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.334 -0.854 . . . . 0.0 110.288 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.765 ' O ' HG13 ' A' ' 2' ' ' VAL . 3.2 m-30 -105.84 146.66 29.62 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.322 -0.861 . . . . 0.0 110.634 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.531 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 59.6 m-70 -131.69 96.48 3.97 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.188 -0.945 . . . . 0.0 109.265 178.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.771 HG22 HD22 ' A' ' 95' ' ' LEU . 1.1 p -80.04 153.44 28.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.325 -0.859 . . . . 0.0 110.959 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.443 ' HB2' ' CD ' ' A' ' 96' ' ' GLU . 7.9 tttp -96.49 132.85 41.63 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.652 -0.655 . . . . 0.0 110.082 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 87.12 -144.88 19.53 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -118.65 74.0 0.94 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.296 -1.12 . . . . 0.0 110.17 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.431 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 21.8 m -131.9 167.19 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.226 -0.921 . . . . 0.0 110.139 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -128.4 152.91 47.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.206 -0.934 . . . . 0.0 110.236 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.798 HD12 ' CE1' ' A' ' 3' ' ' PHE . 3.5 mt -77.45 173.09 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.283 -0.886 . . . . 0.0 110.164 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.617 ' N ' HG22 ' A' ' 128' ' ' ILE . 27.1 mttt -104.78 141.63 36.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.406 -0.809 . . . . 0.0 110.025 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -54.52 -42.65 71.1 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.121 -0.987 . . . . 0.0 110.002 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -55.93 -38.28 70.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.245 -0.909 . . . . 0.0 109.897 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.575 ' CE1' ' O ' ' A' ' 90' ' ' ALA . 16.3 t-160 -69.47 -53.88 17.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.244 -0.91 . . . . 0.0 110.099 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.918 HG11 ' CE1' ' A' ' 5' ' ' TYR . 97.1 t -60.1 -38.39 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.416 -0.803 . . . . 0.0 109.87 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -71.06 -38.3 72.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.259 -0.901 . . . . 0.0 109.958 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.97 -20.83 62.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -0.869 . . . . 0.0 110.016 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.15 -25.7 54.51 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.492 ' HE3' HG12 ' A' ' 133' ' ' VAL . 82.7 mttt -77.24 -31.72 55.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.266 -1.138 . . . . 0.0 110.121 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -75.36 -31.74 60.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.334 -0.854 . . . . 0.0 110.028 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -73.88 -31.95 63.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 0.0 109.944 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.573 ' O ' ' CD2' ' A' ' 144' ' ' PHE . . . -76.16 -35.41 59.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 110.161 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 84.5 p -67.52 -46.73 71.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.299 -0.876 . . . . 0.0 110.02 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -58.71 -46.16 87.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.187 -0.946 . . . . 0.0 110.008 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.6 HD23 HD12 ' A' ' 146' ' ' LEU . 19.6 mt -60.63 -36.36 78.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.913 . . . . 0.0 110.033 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.671 ' HA ' HD12 ' A' ' 147' ' ' ILE . 7.2 m-85 -63.35 -40.08 96.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.366 -0.834 . . . . 0.0 109.865 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 145' ' ' LYS . 11.8 tttp -73.43 -9.56 58.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.35 -0.843 . . . . 0.0 110.128 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.6 HD12 HD23 ' A' ' 143' ' ' LEU . 13.0 mt -84.72 -39.63 18.28 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.235 -0.915 . . . . 0.0 108.95 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.843 HD11 ' CE1' ' A' ' 22' ' ' PHE . 4.6 mt -68.61 -45.17 82.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.521 ' CG ' ' HB2' ' A' ' 11' ' ' SER . 84.4 mt-10 -58.59 -45.34 89.31 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.481 -0.762 . . . . 0.0 109.564 179.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 18.9 m -68.24 -32.1 72.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.111 -0.993 . . . . 0.0 109.576 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.671 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 92.7 t80 -57.26 -47.93 80.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.586 -0.696 . . . . 0.0 109.97 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.001 HD21 ' CE1' ' A' ' 158' ' ' TYR . 73.3 mt -74.52 -37.73 62.99 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.331 -0.855 . . . . 0.0 110.517 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.687 ' HB2' HD11 ' A' ' 13' ' ' ILE . 14.2 tttm -62.19 -13.62 29.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.248 -0.908 . . . . 0.0 109.59 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.492 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -119.96 -26.2 2.35 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.146 -1.581 . . . . 0.0 109.146 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.568 ' CD2' ' O ' ' A' ' 150' ' ' TYR . 12.8 m-70 -105.97 93.88 8.36 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.338 -1.095 . . . . 0.0 110.109 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.0 Cg_endo -73.23 5.06 3.34 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.111 1.585 . . . . 0.0 111.118 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 32.6 p30 -122.01 -4.8 9.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.006 -1.059 . . . . 0.0 109.833 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.671 ' HB1' ' HE2' ' A' ' 150' ' ' TYR . . . -47.8 110.85 0.36 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.43 -0.793 . . . . 0.0 110.193 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 1.04 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 0.4 OUTLIER 33.76 33.08 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.766 -0.583 . . . . 0.0 110.872 -179.431 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.537 ' HB3' ' NH2' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 117.98 -1.009 . . . . 0.0 109.769 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.637 HG13 ' O ' ' A' ' 120' ' ' TYR . 49.0 t -114.71 147.7 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.188 -1.183 . . . . 0.0 110.37 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.587 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 60.8 m-85 -106.72 165.77 11.07 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.336 -0.852 . . . . 0.0 110.336 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.923 HG23 ' CE1' ' A' ' 119' ' ' HIS . 66.5 m -146.85 98.27 3.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.269 -0.894 . . . . 0.0 110.305 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.617 ' CE1' HG11 ' A' ' 133' ' ' VAL . 87.7 m-85 -111.54 140.92 45.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.197 -0.94 . . . . 0.0 109.876 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 20.6 pt-20 -138.56 151.72 47.55 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.141 -0.975 . . . . 0.0 110.43 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.455 ' OG ' ' HB2' ' A' ' 116' ' ' SER . 88.2 p -123.23 157.12 33.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.328 -0.857 . . . . 0.0 109.782 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -137.28 121.85 18.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.16 -0.962 . . . . 0.0 110.434 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.635 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.3 p90 -148.63 -172.78 4.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.281 -0.887 . . . . 0.0 109.8 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.683 HG22 ' HA ' ' A' ' 113' ' ' ILE . 17.3 p -141.73 -178.96 5.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.167 -0.958 . . . . 0.0 110.731 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.402 ' OG ' ' CD ' ' A' ' 148' ' ' GLU . 3.0 t -160.01 160.1 32.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.471 -0.768 . . . . 0.0 110.226 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.433 ' HB2' ' HE2' ' A' ' 152' ' ' LYS . 97.2 mt-10 -84.45 -30.37 25.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.256 -0.903 . . . . 0.0 110.03 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.804 HG23 ' HD2' ' A' ' 14' ' ' PRO . 11.6 mm -70.58 150.27 95.5 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.46 -0.775 . . . . 0.0 109.942 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.804 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.1 Cg_endo -66.2 143.89 72.86 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.022 1.538 . . . . 0.0 110.384 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.672 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.2 Cg_endo -72.27 -31.41 11.76 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.983 1.517 . . . . 0.0 112.849 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.672 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.7 Cg_endo -69.41 -21.47 35.05 Favored 'Trans proline' 0 C--N 1.316 -1.154 0 N-CA-C 110.13 -0.758 . . . . 0.0 110.13 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.544 ' NE ' ' HB2' ' A' ' 159' ' ' ASN . 54.6 mtp180 -84.36 -46.13 12.06 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.78 ' C ' HD23 ' A' ' 18' ' ' LEU . 1.1 tt -69.61 -29.31 66.8 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.506 ' HB2' ' O ' ' A' ' 15' ' ' PRO . 76.5 t80 -66.7 -59.55 3.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.51 -0.744 . . . . 0.0 109.328 178.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.536 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 14.9 mttp -50.25 -35.3 26.38 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.199 179.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.031 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -77.51 -41.01 40.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.394 -0.816 . . . . 0.0 110.703 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.947 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 1.6 t80 -69.56 -43.74 72.3 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.253 -0.904 . . . . 0.0 111.128 -178.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.672 HG13 ' CE1' ' A' ' 81' ' ' TYR . 4.3 t -104.31 -52.41 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.062 -1.024 . . . . 0.0 111.664 -179.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.728 HD12 ' N ' ' A' ' 24' ' ' LEU . 7.2 mp -78.34 0.4 25.66 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.11 -0.994 . . . . 0.0 111.304 -178.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.586 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.4 OUTLIER -157.55 39.29 0.28 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.912 -1.118 . . . . 0.0 110.43 179.796 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.947 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -77.48 -24.81 50.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.279 -0.888 . . . . 0.0 110.128 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.488 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 87.3 m-20 -65.54 -16.46 63.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 110.145 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -129.9 13.04 5.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.352 -0.842 . . . . 0.0 110.016 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.675 HD13 HD11 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -99.84 -46.64 5.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.273 -0.892 . . . . 0.0 110.042 -179.944 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.793 HG11 HD13 ' A' ' 38' ' ' ILE . 3.5 t -84.92 -41.5 0.67 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.381 -0.824 . . . . 0.0 110.819 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 49.8 Cg_endo -78.98 9.93 3.13 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 O-C-N 123.47 1.247 . . . . 0.0 110.693 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.9 tptt -126.84 -34.44 2.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.079 -1.013 . . . . 0.0 109.428 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.675 HD11 HD13 ' A' ' 29' ' ' LEU . 62.3 mt -80.14 -43.35 22.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.569 -0.707 . . . . 0.0 109.546 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.441 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . . . -146.26 100.4 4.16 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.54 -0.725 . . . . 0.0 109.919 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 34' ' ' ALA . 44.3 Cg_endo -71.37 -0.27 7.89 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 124.108 1.583 . . . . 0.0 110.803 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -84.25 -12.44 54.72 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.097 -1.002 . . . . 0.0 109.627 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.764 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -99.89 -65.08 0.99 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.491 -0.755 . . . . 0.0 109.987 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.793 HD13 HG11 ' A' ' 30' ' ' VAL . 1.9 mp -113.82 117.83 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.428 -0.795 . . . . 0.0 109.86 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' A' ' 57' ' ' THR . 9.1 ttpt -72.02 -30.94 65.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.321 -0.862 . . . . 0.0 110.518 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.548 ' C ' ' CD2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -169.02 151.88 4.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.196 -0.94 . . . . 0.0 110.211 -179.674 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.9 m -130.17 123.63 30.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.468 -0.77 . . . . 0.0 109.793 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.529 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 68.6 tt0 -134.25 113.3 11.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.04 -1.037 . . . . 0.0 110.6 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.43 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 44.7 mt -59.15 141.83 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.207 -0.933 . . . . 0.0 109.898 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.505 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 32.4 mt -116.29 -28.21 6.6 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.239 -0.913 . . . . 0.0 110.546 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.713 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.8 m95 -123.7 163.99 20.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.098 -1.001 . . . . 0.0 110.633 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 45' ' ' TRP . . . 42.34 -144.01 1.11 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -146.78 25.7 1.16 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.282 -1.128 . . . . 0.0 110.133 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 117.34 -15.22 13.19 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.126 -1.589 . . . . 0.0 109.126 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.573 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -78.15 -167.6 31.04 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.39 129.48 13.91 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.026 1.54 . . . . 0.0 110.641 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.27 -11.16 54.86 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.523 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -72.2 157.47 37.67 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.524 -0.986 . . . . 0.0 109.839 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.713 HD12 ' CG ' ' A' ' 45' ' ' TRP . 57.6 mt -129.71 120.06 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.0 109.875 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 93.1 mttt -106.24 132.47 52.26 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.164 -0.96 . . . . 0.0 110.531 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.505 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 77.7 tttt -101.64 92.69 4.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.319 -0.863 . . . . 0.0 109.92 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.54 ' CG2' HG13 ' A' ' 38' ' ' ILE . 91.5 mt -79.95 144.29 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.931 . . . . 0.0 110.289 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 39' ' ' LYS . 2.6 p -117.8 156.07 28.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 110.486 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.572 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 16.1 m-85 -115.49 148.15 39.81 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.352 -0.843 . . . . 0.0 110.039 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.21 35.6 3.96 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -61.44 -28.14 69.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.271 -1.134 . . . . 0.0 110.207 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 62' ' ' SER . . . 77.98 -179.81 51.01 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 61' ' ' GLY . 0.4 OUTLIER 58.96 -89.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.265 -1.138 . . . . 0.0 110.243 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -100.15 128.88 46.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.183 -0.948 . . . . 0.0 110.189 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -50.03 132.19 23.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 110.209 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.572 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -130.08 97.73 0.4 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.538 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 12.8 p90 -138.88 167.13 22.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.145 -1.209 . . . . 0.0 110.112 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.927 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.3 m -139.2 174.88 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.243 -0.911 . . . . 0.0 110.72 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 30.1 mttt -128.85 122.35 30.22 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.516 -0.74 . . . . 0.0 109.743 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.627 ' NE2' HD13 ' A' ' 85' ' ' LEU . 13.2 m170 -109.46 126.56 53.62 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.16 -0.962 . . . . 0.0 110.88 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 52' ' ' THR . 54.9 tttt -97.63 121.86 40.03 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.273 -0.892 . . . . 0.0 109.609 179.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.573 HG21 ' O ' ' A' ' 49' ' ' GLY . 30.7 mm -64.96 122.37 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.162 -0.961 . . . . 0.0 110.522 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 82' ' ' SER . 27.9 m-20 -98.18 -47.6 5.41 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.427 -0.796 . . . . 0.0 109.968 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 44.7 m -167.8 157.95 10.5 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.349 -0.845 . . . . 0.0 109.751 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.596 HG12 HG11 ' A' ' 23' ' ' VAL . 3.6 mt -135.35 160.52 40.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.228 -0.92 . . . . 0.0 110.355 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.597 ' HB2' ' HB2' ' A' ' 80' ' ' SER . 17.4 m-20 -132.7 83.1 2.04 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.606 -0.684 . . . . 0.0 110.161 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.663 ' NZ ' HD21 ' A' ' 24' ' ' LEU . 45.1 mttm -72.95 -10.1 59.43 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.354 -0.841 . . . . 0.0 110.218 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -93.14 -39.26 11.14 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.317 -0.864 . . . . 0.0 109.315 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.529 ' ND2' ' H ' ' A' ' 78' ' ' ASN . 1.1 p30 -111.78 12.25 20.97 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.466 0.651 . . . . 0.0 110.761 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.504 ' CZ ' ' HB3' ' A' ' 16' ' ' PRO . 7.3 m-85 54.19 60.79 3.37 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.449 -0.782 . . . . 0.0 112.858 178.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.597 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 1.1 m -128.03 156.87 42.07 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.954 -1.091 . . . . 0.0 109.484 177.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.683 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 31.2 t80 -142.13 137.32 30.83 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.158 -0.964 . . . . 0.0 110.444 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 50.7 m -140.74 125.98 18.61 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.447 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.683 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 7.2 p90 -141.69 176.53 8.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.281 -0.887 . . . . 0.0 110.02 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.555 HG23 ' O ' ' A' ' 98' ' ' ILE . 46.0 m -126.8 132.82 50.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.298 -0.876 . . . . 0.0 109.868 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.627 HD13 ' NE2' ' A' ' 69' ' ' HIS . 12.4 tp -98.16 121.87 40.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.171 -0.955 . . . . 0.0 110.227 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.7 pt -104.59 -16.63 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.294 -0.879 . . . . 0.0 110.531 -179.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.475 ' OE1' ' NZ ' ' A' ' 68' ' ' LYS . 54.4 tt0 -129.11 165.35 21.41 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.148 -0.97 . . . . 0.0 110.385 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.927 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 149.51 120.96 1.07 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -56.52 -19.31 14.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.299 -1.118 . . . . 0.0 110.183 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.99 -18.18 54.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.295 -0.878 . . . . 0.0 110.228 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 92' ' ' GLY . 77.1 mt -66.98 -27.61 67.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.223 -0.923 . . . . 0.0 110.162 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 50.15 179.51 0.02 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.445 ' OD1' HG23 ' A' ' 94' ' ' THR . 57.6 p-10 -79.64 5.65 12.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.243 -1.151 . . . . 0.0 110.07 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.536 ' O ' HG22 ' A' ' 122' ' ' THR . 43.0 p -93.65 -34.91 13.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.89 . . . . 0.0 110.099 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 1.026 HD23 HG23 ' A' ' 122' ' ' THR . 19.5 mt -104.83 162.05 13.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 110.034 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.438 ' CD ' ' HB2' ' A' ' 123' ' ' LYS . 54.4 mt-10 -142.68 -80.3 0.21 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.297 -0.877 . . . . 0.0 109.978 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.515 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 53.7 mttp -80.14 126.16 30.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.595 -0.691 . . . . 0.0 110.409 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.761 HG21 ' CE2' ' A' ' 100' ' ' TYR . 5.3 mm -115.52 140.55 36.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 120.615 -1.303 . . . . 0.0 109.826 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.482 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -118.35 128.24 54.46 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.676 -0.81 . . . . 0.0 108.941 178.874 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.761 ' CE2' HG21 ' A' ' 98' ' ' ILE . 11.0 m-85 -123.53 135.33 53.96 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.313 -0.867 . . . . 0.0 110.533 -178.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.481 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 72.8 tt0 -139.14 136.29 34.96 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.276 -0.89 . . . . 0.0 110.146 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 50.3 m -137.36 138.94 40.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -0.926 . . . . 0.0 110.234 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.8 tttt -133.05 147.01 52.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.196 -0.94 . . . . 0.0 110.391 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.754 HD23 HG12 ' A' ' 114' ' ' ILE . 7.8 mt -121.82 153.8 37.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.273 -0.892 . . . . 0.0 110.241 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.711 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -149.49 -168.78 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.19 -0.944 . . . . 0.0 110.061 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.711 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -126.01 150.27 48.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.329 -0.857 . . . . 0.0 110.213 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.461 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 2.7 p -108.13 169.65 6.37 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.934 . . . . 0.0 110.345 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.461 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 46.7 Cg_endo -73.11 -11.41 25.2 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 O-C-N 124.106 1.582 . . . . 0.0 110.448 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 58.5 p -96.89 5.74 49.95 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.157 -0.965 . . . . 0.0 110.293 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.08 -38.17 3.2 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -55.61 -172.91 0.12 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.5 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 5.7 p -131.97 138.29 48.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.255 -1.144 . . . . 0.0 110.271 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.683 ' HA ' HG22 ' A' ' 10' ' ' THR . 20.5 mt -89.96 149.81 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.29 -0.881 . . . . 0.0 110.151 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.754 HG12 HD23 ' A' ' 104' ' ' LEU . 11.5 mt -131.23 126.73 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.228 -0.92 . . . . 0.0 110.222 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -118.09 110.2 17.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.163 -0.96 . . . . 0.0 110.219 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.455 ' HB2' ' OG ' ' A' ' 7' ' ' SER . 1.6 m -98.57 160.71 14.1 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.236 -0.915 . . . . 0.0 110.44 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' A' ' 101' ' ' GLU . 52.9 m -160.03 124.46 3.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.376 -0.827 . . . . 0.0 109.984 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 90.5 p -129.03 157.5 41.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.201 -0.937 . . . . 0.0 110.469 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.923 ' CE1' HG23 ' A' ' 4' ' ' THR . 47.1 m-70 -134.52 161.45 35.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.263 -0.898 . . . . 0.0 110.037 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.637 ' O ' HG13 ' A' ' 2' ' ' VAL . 25.9 m-85 -128.35 142.03 51.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.231 -0.918 . . . . 0.0 110.722 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.584 ' CE1' HG11 ' A' ' 2' ' ' VAL . 87.8 m-70 -124.56 96.04 4.75 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.214 -0.929 . . . . 0.0 109.124 178.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 1.026 HG23 HD23 ' A' ' 95' ' ' LEU . 1.8 p -86.0 153.93 21.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.292 -0.88 . . . . 0.0 111.099 -178.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.438 ' HB2' ' CD ' ' A' ' 96' ' ' GLU . 20.7 tttt -101.92 121.64 42.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.547 -0.721 . . . . 0.0 109.963 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 105.4 -140.7 15.17 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -122.88 76.52 1.37 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.3 -1.117 . . . . 0.0 110.346 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.535 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 21.4 m -136.49 162.36 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.19 -0.944 . . . . 0.0 110.06 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.427 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 87.1 mt-10 -129.93 159.29 37.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.173 -0.955 . . . . 0.0 110.434 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.934 HD11 HD21 ' A' ' 95' ' ' LEU . 19.6 mm -66.96 173.1 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.332 -0.855 . . . . 0.0 110.149 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.586 ' N ' HG22 ' A' ' 128' ' ' ILE . 7.4 mtpp -113.02 135.14 54.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.386 -0.821 . . . . 0.0 109.95 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -44.03 -43.14 6.55 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.174 -0.954 . . . . 0.0 110.027 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.5 ' O ' ' CB ' ' A' ' 135' ' ' ALA . 48.7 tt0 -62.92 -24.02 67.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -0.898 . . . . 0.0 109.891 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 129' ' ' LYS . 14.8 t-160 -79.9 -50.91 9.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.379 -0.826 . . . . 0.0 110.113 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.617 HG11 ' CE1' ' A' ' 5' ' ' TYR . 46.9 t -60.92 -40.03 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.324 -0.86 . . . . 0.0 109.973 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -75.73 -50.43 15.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.399 -0.813 . . . . 0.0 110.149 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.5 ' CB ' ' O ' ' A' ' 131' ' ' GLU . . . -61.69 -28.17 69.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.214 -0.929 . . . . 0.0 110.049 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.5 -28.81 64.86 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 38.9 mttm -69.53 -31.48 69.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.262 -1.14 . . . . 0.0 110.085 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 142' ' ' ASN . 99.0 mt-10 -77.16 -32.53 56.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.32 -0.862 . . . . 0.0 110.163 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.693 ' O ' HD12 ' A' ' 143' ' ' LEU . 35.6 mttt -68.42 -31.62 71.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.313 -0.867 . . . . 0.0 110.22 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.567 ' O ' ' CD1' ' A' ' 144' ' ' PHE . . . -90.28 -41.52 11.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.308 -0.87 . . . . 0.0 110.201 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.3 m -68.98 -47.33 65.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.407 -0.808 . . . . 0.0 110.14 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 138' ' ' GLU . 97.1 m-20 -55.14 -47.68 74.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.183 -0.948 . . . . 0.0 110.035 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.693 HD12 ' O ' ' A' ' 139' ' ' LYS . 76.0 mt -57.54 -42.09 82.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.313 -0.867 . . . . 0.0 109.91 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.567 ' CD1' ' O ' ' A' ' 140' ' ' ALA . 4.8 m-85 -58.61 -36.33 73.87 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.304 -0.872 . . . . 0.0 109.774 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 33.8 tttm -64.25 -26.0 68.31 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.319 -0.863 . . . . 0.0 109.777 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.456 ' HB3' HG21 ' A' ' 33' ' ' ILE . 16.6 mt -78.23 -34.27 49.36 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.635 ' CD1' ' CE1' ' A' ' 22' ' ' PHE . 47.5 mt -69.22 -51.64 41.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.47 ' O ' ' HG3' ' A' ' 152' ' ' LYS . 94.6 mt-10 -54.56 -42.16 70.63 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.37 -0.831 . . . . 0.0 109.169 178.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.516 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 88.5 m -63.72 -44.4 93.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.369 -0.832 . . . . 0.0 109.375 179.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.565 ' O ' ' CD2' ' A' ' 154' ' ' HIS . 89.9 t80 -46.32 -44.96 17.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.577 -0.702 . . . . 0.0 109.704 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.957 HD21 ' CE1' ' A' ' 158' ' ' TYR . 77.2 mt -80.02 -31.34 39.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.434 -0.791 . . . . 0.0 110.231 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.55 ' HA ' HD11 ' A' ' 13' ' ' ILE . 45.0 mttt -65.39 -16.4 63.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.187 -0.946 . . . . 0.0 109.602 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.489 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -116.94 -28.17 2.53 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.565 ' CD2' ' O ' ' A' ' 150' ' ' TYR . 7.7 m-70 -106.04 93.2 7.43 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.329 -1.101 . . . . 0.0 110.028 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 46.6 Cg_endo -73.46 4.95 3.52 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.096 1.577 . . . . 0.0 110.951 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -116.25 -8.53 11.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.07 -1.019 . . . . 0.0 109.758 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.623 ' HB1' ' CZ ' ' A' ' 158' ' ' TYR . . . -48.48 107.76 0.14 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.407 -0.808 . . . . 0.0 110.059 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 1.031 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 35.61 30.85 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.599 -0.688 . . . . 0.0 110.644 -179.768 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.544 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.784 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 1.045 HG23 ' C ' ' A' ' 120' ' ' TYR . 7.4 p -91.62 154.0 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.262 -1.14 . . . . 0.0 110.386 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.602 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 15.3 m-85 -92.22 173.68 7.7 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.174 -0.953 . . . . 0.0 110.494 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.83 HG23 ' CE1' ' A' ' 119' ' ' HIS . 5.6 m -152.23 93.37 1.8 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.288 -0.882 . . . . 0.0 110.197 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.639 ' CZ ' ' CG2' ' A' ' 133' ' ' VAL . 81.4 m-85 -116.0 145.84 42.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.172 -0.955 . . . . 0.0 109.905 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.508 ' HB3' HG23 ' A' ' 117' ' ' THR . 21.4 pt-20 -141.99 152.62 43.6 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.169 -0.957 . . . . 0.0 110.534 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 52.6 m -126.58 146.47 50.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.323 -0.86 . . . . 0.0 109.888 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -121.5 129.04 52.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.166 -0.959 . . . . 0.0 110.485 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.64 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.3 p90 -149.18 -175.57 5.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.35 -0.844 . . . . 0.0 109.802 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.677 HG22 ' HA ' ' A' ' 113' ' ' ILE . 17.3 p -140.44 177.92 7.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.138 -0.976 . . . . 0.0 110.725 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.524 ' OG ' ' CG ' ' A' ' 148' ' ' GLU . 2.5 t -158.14 158.99 35.71 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.479 -0.763 . . . . 0.0 110.069 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -85.4 -15.4 43.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.288 -0.883 . . . . 0.0 110.054 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.781 HG23 ' HD2' ' A' ' 14' ' ' PRO . 11.4 mm -82.4 149.67 61.98 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.33 -0.856 . . . . 0.0 110.056 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.781 ' HD2' HG23 ' A' ' 13' ' ' ILE . 41.8 Cg_endo -66.93 145.59 74.8 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.03 1.542 . . . . 0.0 110.306 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.67 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.2 Cg_endo -71.39 -31.96 13.2 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.978 1.514 . . . . 0.0 112.848 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.67 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 40.6 Cg_endo -68.31 -22.31 40.07 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 122.51 0.742 . . . . 0.0 110.245 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.613 ' NH2' ' HB3' ' A' ' 157' ' ' ALA . 46.0 mtp180 -85.1 -42.89 14.37 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.75 ' C ' HD23 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -73.76 -33.37 64.24 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.947 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.583 ' N ' HD23 ' A' ' 18' ' ' LEU . 59.5 t80 -65.65 -55.54 16.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.396 -0.815 . . . . 0.0 109.281 178.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 25' ' ' ASP . 12.0 mttt -51.83 -40.17 60.04 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.825 -0.75 . . . . 0.0 109.436 179.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.063 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -73.96 -38.73 64.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.4 -0.813 . . . . 0.0 111.009 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.704 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.3 OUTLIER -75.26 -36.86 61.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.07 -1.019 . . . . 0.0 110.912 -179.231 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.671 HG13 ' CE1' ' A' ' 81' ' ' TYR . 5.1 t -107.26 -58.56 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.189 -0.944 . . . . 0.0 111.59 -179.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 24' ' ' LEU . 7.0 mp -76.54 -1.8 29.19 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.138 -0.976 . . . . 0.0 111.534 -178.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.594 ' O ' HD23 ' A' ' 29' ' ' LEU . 0.8 OUTLIER -154.91 49.49 0.58 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.936 -1.103 . . . . 0.0 110.099 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.704 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -87.43 -29.58 21.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.306 -0.871 . . . . 0.0 110.69 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -61.95 -18.0 58.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 0.0 110.425 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.524 ' O ' ' CG ' ' A' ' 32' ' ' LYS . 4.6 p30 -126.08 11.5 7.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 110.065 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.631 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 0.4 OUTLIER -97.52 -53.82 3.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -0.859 . . . . 0.0 110.154 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.66 HG11 HD12 ' A' ' 38' ' ' ILE . 2.9 t -71.8 -41.46 9.28 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.273 -0.892 . . . . 0.0 110.876 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 30' ' ' VAL . 47.5 Cg_endo -76.77 7.44 3.54 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 O-C-N 123.399 1.21 . . . . 0.0 110.968 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.524 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 47.7 mmtm -127.24 -35.46 2.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.086 -1.009 . . . . 0.0 109.403 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.574 HD13 ' HB2' ' A' ' 150' ' ' TYR . 10.1 mt -80.12 -33.73 14.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.583 -0.698 . . . . 0.0 109.382 179.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.662 ' HB2' HD13 ' A' ' 146' ' ' LEU . . . -149.43 91.33 4.45 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.583 -0.698 . . . . 0.0 110.068 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.82 2.07 6.34 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.104 1.581 . . . . 0.0 110.797 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -87.34 -15.23 38.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.094 -1.004 . . . . 0.0 109.869 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -107.64 -43.97 4.37 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.3 -0.875 . . . . 0.0 110.188 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.66 HD12 HG11 ' A' ' 30' ' ' VAL . 3.4 mt -127.45 142.37 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.392 -0.817 . . . . 0.0 110.116 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.496 ' CB ' ' O ' ' A' ' 59' ' ' GLY . 8.7 tppt? -119.62 -21.06 7.47 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.282 -0.887 . . . . 0.0 110.689 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.564 ' C ' ' CD2' ' A' ' 40' ' ' HIS . 0.5 OUTLIER -153.46 152.48 31.05 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.05 -1.031 . . . . 0.0 110.465 -179.671 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.458 ' N ' ' CD2' ' A' ' 40' ' ' HIS . 17.5 m -150.99 118.31 6.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.509 -0.744 . . . . 0.0 109.573 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -133.97 109.3 8.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.181 -0.95 . . . . 0.0 110.788 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 21.9 mt -54.18 137.62 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.257 -0.902 . . . . 0.0 109.748 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.508 HD22 ' HE3' ' A' ' 68' ' ' LYS . 14.9 tp -107.07 -30.1 9.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.116 -0.99 . . . . 0.0 110.995 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.839 ' CG ' HD12 ' A' ' 53' ' ' ILE . 2.0 m95 -124.08 164.64 19.0 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.153 -0.967 . . . . 0.0 110.875 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.46 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 41.24 -137.91 2.04 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.429 ' CG ' ' O ' ' A' ' 47' ' ' ASP . 11.5 t0 -154.33 24.25 0.48 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.312 -1.111 . . . . 0.0 109.85 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 120.07 -17.83 9.82 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.498 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -68.29 -174.54 8.73 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.434 ' HA ' HG22 ' A' ' 71' ' ' ILE . 46.0 Cg_endo -73.74 128.34 12.42 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 123.937 1.493 . . . . 0.0 110.639 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.96 -13.12 56.14 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -66.59 162.13 21.63 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.516 -0.99 . . . . 0.0 109.629 179.672 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.839 HD12 ' CG ' ' A' ' 45' ' ' TRP . 48.2 mt -128.56 121.61 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.241 -0.912 . . . . 0.0 109.756 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 98.7 mttt -107.78 134.19 51.09 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.173 -0.955 . . . . 0.0 110.319 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.605 ' HE2' ' CD1' ' A' ' 66' ' ' TYR . 14.5 tptm -105.65 90.32 3.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.266 -0.896 . . . . 0.0 109.802 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.629 ' CG2' HD13 ' A' ' 38' ' ' ILE . 73.0 mt -79.96 145.63 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.32 -0.863 . . . . 0.0 110.339 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.578 HG22 ' HB3' ' A' ' 66' ' ' TYR . 0.6 OUTLIER -122.55 144.87 48.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.374 -0.829 . . . . 0.0 109.88 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.609 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 13.5 m-85 -113.26 170.27 8.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.087 -1.008 . . . . 0.0 110.142 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.496 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . 59.15 173.7 0.57 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.488 ' HA ' ' CE ' ' A' ' 39' ' ' LYS . 97.6 mt-10 -72.89 -25.96 61.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.324 -1.103 . . . . 0.0 110.263 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 62' ' ' SER . . . 138.17 -17.73 3.35 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 61' ' ' GLY . 20.3 m -42.86 -42.46 3.67 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.275 -1.132 . . . . 0.0 110.245 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -124.02 176.15 6.53 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.189 -0.945 . . . . 0.0 110.212 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.673 ' CE1' ' CE2' ' A' ' 66' ' ' TYR . 0.1 OUTLIER -88.79 112.41 23.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.909 . . . . 0.0 109.927 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.609 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -145.82 60.98 0.48 Allowed Glycine 0 N--CA 1.483 1.829 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 179.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.673 ' CE2' ' CE1' ' A' ' 64' ' ' TYR . 10.5 p90 -125.12 166.19 16.87 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.206 -1.173 . . . . 0.0 109.894 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.929 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.3 m -140.54 172.26 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 110.68 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.508 ' HE3' HD22 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -120.72 120.46 35.73 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.64 -0.662 . . . . 0.0 109.555 179.507 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.503 ' CD2' HD12 ' A' ' 85' ' ' LEU . 12.6 m170 -110.42 119.36 38.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.126 -0.984 . . . . 0.0 111.106 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 52' ' ' THR . 13.4 tttp -96.69 99.4 11.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.183 -0.948 . . . . 0.0 109.444 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.525 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 30.1 mm -42.38 135.92 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.351 -0.843 . . . . 0.0 110.159 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.46 ' OD2' ' OG1' ' A' ' 84' ' ' THR . 90.2 m-20 -104.2 -39.83 6.36 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.291 -0.881 . . . . 0.0 110.033 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.531 ' C ' HD12 ' A' ' 74' ' ' ILE . 1.4 m -179.38 162.14 1.13 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.246 -0.909 . . . . 0.0 109.6 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.531 HD12 ' C ' ' A' ' 73' ' ' SER . 0.9 OUTLIER -143.99 153.2 15.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.024 -179.812 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.497 ' HB3' ' HB2' ' A' ' 78' ' ' ASN . 5.5 m-20 -134.58 78.49 1.75 Allowed 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.501 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.546 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 20.8 tttt -61.65 -15.74 42.5 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.221 -0.925 . . . . 0.0 110.167 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -92.39 -36.0 13.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.242 -0.912 . . . . 0.0 109.41 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.517 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.8 m-80 -96.52 -5.3 39.71 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.639 -0.663 . . . . 0.0 109.387 179.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.549 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 76.4 m-85 62.08 55.95 2.37 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.566 0.698 . . . . 0.0 110.619 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.477 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 1.3 m -132.33 159.15 40.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.365 -0.834 . . . . 0.0 109.714 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.692 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 64.7 t80 -146.56 146.09 30.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.19 -0.943 . . . . 0.0 109.811 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.533 ' OG ' ' CG ' ' A' ' 101' ' ' GLU . 0.2 OUTLIER -153.48 138.14 16.94 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.167 -0.958 . . . . 0.0 110.861 -179.729 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.692 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 11.5 p90 -150.89 173.43 14.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.427 -0.796 . . . . 0.0 110.2 179.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 98' ' ' ILE . 58.2 m -124.92 131.58 53.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.421 -0.799 . . . . 0.0 109.934 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.654 HD23 HG13 ' A' ' 98' ' ' ILE . 2.0 tp -100.1 129.09 46.1 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.201 -0.937 . . . . 0.0 110.044 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.466 HG12 ' HB3' ' A' ' 68' ' ' LYS . 12.8 pt -115.27 -13.56 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -0.891 . . . . 0.0 110.027 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.554 ' O ' HD11 ' A' ' 85' ' ' LEU . 18.1 tt0 -128.68 154.63 46.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.884 . . . . 0.0 110.232 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.929 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 154.8 128.28 1.16 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -64.9 -10.87 32.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.273 -1.133 . . . . 0.0 110.242 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.91 -17.35 41.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.275 -0.891 . . . . 0.0 110.166 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.478 HD21 HD23 ' A' ' 85' ' ' LEU . 51.2 mt -69.01 -19.08 64.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.893 . . . . 0.0 110.234 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 49.09 -177.36 0.02 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.488 ' OD1' HG23 ' A' ' 94' ' ' THR . 54.2 p-10 -84.36 11.88 7.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.259 -1.142 . . . . 0.0 110.173 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.488 HG23 ' OD1' ' A' ' 93' ' ' ASP . 69.7 p -102.84 -38.18 7.52 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.281 -0.887 . . . . 0.0 110.181 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.906 HD21 ' CD1' ' A' ' 128' ' ' ILE . 76.5 mt -95.17 166.22 12.02 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.381 -0.824 . . . . 0.0 109.995 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.472 ' HG3' ' HB2' ' A' ' 123' ' ' LYS . 9.9 mt-10 -146.64 -81.36 0.14 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.263 -0.898 . . . . 0.0 109.787 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 49.2 mttt -80.39 130.09 34.94 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.728 -0.607 . . . . 0.0 110.254 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.707 HG21 ' CE2' ' A' ' 100' ' ' TYR . 5.7 mm -118.0 140.61 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 120.921 -1.112 . . . . 0.0 109.778 178.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.5 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.5 OUTLIER -121.51 128.61 52.24 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.762 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.707 ' CE2' HG21 ' A' ' 98' ' ' ILE . 10.7 m-85 -123.62 134.99 53.7 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.346 -0.846 . . . . 0.0 110.433 -178.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.533 ' CG ' ' OG ' ' A' ' 82' ' ' SER . 7.7 mt-10 -133.61 141.56 47.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.32 -0.863 . . . . 0.0 109.945 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.487 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 18.9 m -138.27 142.88 39.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.092 -1.005 . . . . 0.0 109.975 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.13 138.54 38.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.242 -0.911 . . . . 0.0 110.327 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.728 HD23 HG12 ' A' ' 114' ' ' ILE . 5.2 mt -124.86 145.8 49.61 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.259 -0.901 . . . . 0.0 110.227 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.697 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -152.76 -168.54 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.405 -0.81 . . . . 0.0 109.945 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.697 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -113.89 141.01 47.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.266 -0.896 . . . . 0.0 110.001 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.743 ' HA ' HD11 ' A' ' 113' ' ' ILE . 1.3 p -96.12 170.3 7.77 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.118 -0.989 . . . . 0.0 110.406 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.474 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 50.0 Cg_endo -78.81 4.57 6.34 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.105 1.582 . . . . 0.0 110.456 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 51.9 m -110.15 5.22 21.8 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -0.871 . . . . 0.0 110.283 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 99.36 -27.65 19.11 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.453 ' O ' ' OG ' ' A' ' 107' ' ' SER . . . -75.77 -173.94 35.5 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 22.4 p -118.53 132.44 56.21 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.181 -1.188 . . . . 0.0 110.301 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.743 HD11 ' HA ' ' A' ' 107' ' ' SER . 23.9 mt -82.84 147.61 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 109.903 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.728 HG12 HD23 ' A' ' 104' ' ' LEU . 9.7 mt -130.63 122.69 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.305 -0.872 . . . . 0.0 110.566 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.7 tttp -111.93 117.33 32.44 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.383 -0.823 . . . . 0.0 109.762 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.469 ' HG ' ' HZ ' ' A' ' 144' ' ' PHE . 0.5 OUTLIER -110.83 152.69 26.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.246 -0.909 . . . . 0.0 110.69 -179.55 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.763 HG22 ' NE2' ' A' ' 119' ' ' HIS . 53.6 m -149.57 132.57 16.2 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.42 -0.8 . . . . 0.0 110.1 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.4 m -131.12 150.53 52.11 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.198 -0.939 . . . . 0.0 110.321 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.83 ' CE1' HG23 ' A' ' 4' ' ' THR . 20.9 m-70 -137.9 135.4 36.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.343 -0.848 . . . . 0.0 110.037 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 1.045 ' C ' HG23 ' A' ' 2' ' ' VAL . 11.5 m-85 -113.27 122.22 46.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.133 -0.979 . . . . 0.0 110.631 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.614 ' N ' HG23 ' A' ' 2' ' ' VAL . 88.7 m-70 -91.22 121.77 33.27 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.2 p -98.11 149.23 22.73 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.059 -1.025 . . . . 0.0 110.974 -178.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.472 ' HB2' ' HG3' ' A' ' 96' ' ' GLU . 20.2 tttt -104.09 108.7 20.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.54 -0.725 . . . . 0.0 110.163 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 108.65 -136.36 13.47 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 26.4 t30 -119.94 54.37 1.03 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.105 -1.232 . . . . 0.0 110.341 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 17.7 m -115.65 170.24 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.311 -0.868 . . . . 0.0 110.113 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.428 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 96.4 mt-10 -134.25 -177.79 4.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.199 -0.938 . . . . 0.0 110.333 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.906 ' CD1' HD21 ' A' ' 95' ' ' LEU . 8.2 mm -84.73 172.25 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.216 -0.928 . . . . 0.0 110.405 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.586 ' N ' HG22 ' A' ' 128' ' ' ILE . 47.5 mttt -94.95 131.03 41.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.437 -0.79 . . . . 0.0 109.825 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.444 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 95.9 mt-10 -48.97 -40.96 32.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.193 -0.942 . . . . 0.0 110.109 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.753 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 49.0 tt0 -66.67 -8.89 30.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.221 -0.924 . . . . 0.0 109.753 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.454 ' O ' ' HA3' ' A' ' 136' ' ' GLY . 8.4 t-160 -103.24 -55.02 2.49 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.896 . . . . 0.0 110.196 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.639 ' CG2' ' CZ ' ' A' ' 5' ' ' TYR . 2.1 p -61.62 -29.61 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.449 -0.782 . . . . 0.0 110.227 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.538 ' HA ' ' HE3' ' A' ' 137' ' ' LYS . 28.3 tttt -108.91 -71.85 0.75 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.952 . . . . 0.0 110.061 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.753 ' HB3' ' O ' ' A' ' 131' ' ' GLU . . . -55.79 -21.05 17.34 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 109.68 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' A' ' 132' ' ' HIS . . . -74.46 -30.91 59.6 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.538 ' HE3' ' HA ' ' A' ' 134' ' ' LYS . 6.0 mtmp? -66.74 -31.87 72.8 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.25 -1.147 . . . . 0.0 109.949 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -72.96 -34.24 66.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.298 -0.876 . . . . 0.0 109.959 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.484 ' O ' HD12 ' A' ' 143' ' ' LEU . 52.6 mttt -67.91 -38.83 83.43 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.404 -0.81 . . . . 0.0 109.804 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.83 -40.05 91.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.311 -0.868 . . . . 0.0 109.837 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.429 ' O ' ' HG3' ' A' ' 145' ' ' LYS . 22.8 t -56.71 -38.12 71.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.374 -0.829 . . . . 0.0 109.904 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.482 ' OD1' ' HA ' ' A' ' 139' ' ' LYS . 15.7 m120 -56.9 -48.49 78.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.304 -0.872 . . . . 0.0 109.997 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.484 HD12 ' O ' ' A' ' 139' ' ' LYS . 1.2 mp -61.68 -34.19 75.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.87 . . . . 0.0 109.962 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.577 ' HA ' HD12 ' A' ' 147' ' ' ILE . 19.8 m-85 -64.68 -38.22 90.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.291 -0.881 . . . . 0.0 109.728 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.429 ' HG3' ' O ' ' A' ' 141' ' ' SER . 57.7 mttt -71.67 -12.23 61.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 109.946 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.662 HD13 ' HB2' ' A' ' 34' ' ' ALA . 17.8 mt -81.3 -36.65 29.53 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.233 -0.917 . . . . 0.0 108.882 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.649 HD11 ' CE1' ' A' ' 22' ' ' PHE . 17.3 mt -69.56 -50.37 51.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.524 ' CG ' ' OG ' ' A' ' 11' ' ' SER . 57.1 mt-10 -58.37 -37.71 75.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.466 -0.771 . . . . 0.0 109.453 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 20.2 m -67.57 -33.76 75.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.166 -0.959 . . . . 0.0 109.511 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.575 ' O ' ' CD2' ' A' ' 154' ' ' HIS . 87.6 t80 -58.91 -45.87 89.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.392 -0.817 . . . . 0.0 109.613 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.967 HD21 ' CE1' ' A' ' 158' ' ' TYR . 70.9 mt -80.0 -28.88 39.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.385 -0.822 . . . . 0.0 110.029 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.706 ' HA ' HD11 ' A' ' 13' ' ' ILE . 82.5 tttt -65.34 -14.91 61.88 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.193 -0.942 . . . . 0.0 109.518 179.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.479 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -119.84 -27.45 2.1 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.591 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 6.1 m-70 -106.44 93.61 8.59 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.22 -1.165 . . . . 0.0 110.301 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 47.9 Cg_endo -74.21 4.6 4.19 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 124.07 1.563 . . . . 0.0 110.833 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -115.61 -7.33 12.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.069 -1.019 . . . . 0.0 109.791 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.613 ' HB3' ' NH2' ' A' ' 17' ' ' ARG . . . -51.35 108.26 0.24 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.433 -0.792 . . . . 0.0 110.077 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 1.063 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 35.73 30.7 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.615 -0.678 . . . . 0.0 110.672 -179.637 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.54 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.4 0 O-C-N 121.095 -1.003 . . . . 0.0 109.684 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.617 HG11 ' CE1' ' A' ' 121' ' ' HIS . 58.1 t -122.8 134.25 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.173 -1.193 . . . . 0.0 110.412 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.597 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 32.0 m-85 -89.19 161.11 16.63 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.258 -0.901 . . . . 0.0 110.235 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.831 HG23 ' CE1' ' A' ' 119' ' ' HIS . 92.1 m -144.26 96.57 2.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.229 -0.92 . . . . 0.0 110.079 179.822 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.622 ' CE1' ' CG2' ' A' ' 133' ' ' VAL . 77.8 m-85 -115.41 144.66 43.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.15 -0.969 . . . . 0.0 110.172 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 116' ' ' SER . 21.0 pt-20 -138.6 152.41 48.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 0.0 110.218 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 65.2 m -122.37 150.29 42.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.251 -0.906 . . . . 0.0 110.047 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -133.13 120.07 20.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 110.356 -179.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.644 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.7 p90 -149.37 -173.76 4.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.293 -0.879 . . . . 0.0 109.92 179.751 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.863 HG22 ' HA ' ' A' ' 113' ' ' ILE . 3.3 p -140.32 171.8 13.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.12 -0.987 . . . . 0.0 110.474 -179.657 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.475 ' HB3' ' OE2' ' A' ' 148' ' ' GLU . 99.7 p -151.46 136.05 17.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.297 -0.877 . . . . 0.0 110.157 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -61.78 -31.91 72.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.172 -0.955 . . . . 0.0 110.244 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.809 HG21 HD12 ' A' ' 151' ' ' LEU . 8.1 mm -70.94 149.21 94.9 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.381 -0.824 . . . . 0.0 109.951 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.774 ' HD2' HG23 ' A' ' 13' ' ' ILE . 39.9 Cg_endo -65.39 143.59 76.95 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.073 1.565 . . . . 0.0 110.676 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.673 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.9 Cg_endo -71.82 -31.56 12.72 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 124.073 1.565 . . . . 0.0 112.74 -179.37 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.673 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 41.3 Cg_endo -69.02 -21.91 36.25 Favored 'Trans proline' 0 C--N 1.318 -1.051 0 N-CA-C 110.01 -0.804 . . . . 0.0 110.01 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.904 ' HB3' HD13 ' A' ' 151' ' ' LEU . 41.5 mtp180 -82.08 -47.45 12.58 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.583 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 1.111 HD23 ' CG2' ' A' ' 147' ' ' ILE . 0.2 OUTLIER -70.38 -35.08 73.28 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.093 178.929 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.645 ' N ' HD13 ' A' ' 18' ' ' LEU . 80.4 t80 -61.0 -59.26 5.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.479 -0.763 . . . . 0.0 109.738 179.116 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.53 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 17.6 mttp -51.64 -35.9 43.86 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.724 -0.791 . . . . 0.0 109.503 179.622 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.997 ' HB2' ' CZ ' ' A' ' 158' ' ' TYR . . . -77.55 -32.36 53.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.464 -0.772 . . . . 0.0 111.048 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 1.058 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -80.53 -41.9 23.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.233 -0.917 . . . . 0.0 111.081 -179.099 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.742 HG13 ' CE1' ' A' ' 81' ' ' TYR . 3.7 t -103.91 -51.17 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.118 -0.989 . . . . 0.0 111.386 -179.106 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.674 HD12 ' N ' ' A' ' 24' ' ' LEU . 7.3 mp -80.14 -9.8 59.73 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.132 -0.98 . . . . 0.0 111.684 -178.878 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 20' ' ' LYS . 1.2 m-20 -148.48 36.57 0.81 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.768 -1.207 . . . . 0.0 110.711 -179.664 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 1.058 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -76.98 -25.7 53.05 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.301 -0.875 . . . . 0.0 110.309 179.676 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -66.16 -15.25 62.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.195 -0.941 . . . . 0.0 109.919 179.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.56 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 4.4 p30 -130.55 11.26 5.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.343 -0.848 . . . . 0.0 109.953 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.703 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -94.42 -48.99 5.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.374 -0.829 . . . . 0.0 110.042 179.689 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.863 HG22 ' HD3' ' A' ' 31' ' ' PRO . 2.1 m -73.91 -29.65 1.04 Allowed Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.373 -0.829 . . . . 0.0 112.039 -179.826 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.863 ' HD3' HG22 ' A' ' 30' ' ' VAL . 52.9 Cg_endo -78.81 4.06 6.79 Favored 'Trans proline' 0 C--N 1.32 -0.946 0 O-C-N 122.714 0.85 . . . . 0.0 110.128 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -124.34 -36.08 2.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.301 -0.874 . . . . 0.0 109.103 179.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.622 HD11 ' CD1' ' A' ' 29' ' ' LEU . 53.2 mt -79.96 -25.25 11.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 121.622 0.725 . . . . 0.0 109.25 179.19 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.407 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . . . -169.89 91.97 0.52 Allowed Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.702 -0.624 . . . . 0.0 109.738 179.705 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 34' ' ' ALA . 44.6 Cg_endo -70.77 -2.85 11.56 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.0 1.526 . . . . 0.0 110.632 -179.676 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -91.98 10.73 27.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -0.913 . . . . 0.0 109.938 179.789 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.913 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -114.65 -49.74 2.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.326 -0.859 . . . . 0.0 109.995 179.854 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.913 HD12 ' C ' ' A' ' 37' ' ' ALA . 1.8 mp -119.87 134.63 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.486 -0.759 . . . . 0.0 109.905 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' A' ' 57' ' ' THR . 6.1 ttmm -87.59 -24.64 23.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.311 -0.868 . . . . 0.0 110.357 -179.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.546 ' C ' ' CD2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -179.32 153.53 0.59 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.2 -0.938 . . . . 0.0 110.172 -179.847 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 m -127.32 124.44 38.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.345 -0.847 . . . . 0.0 109.923 179.702 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.516 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 49.7 tt0 -136.44 111.81 9.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.173 -0.954 . . . . 0.0 110.46 -179.823 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 22.2 mt -57.88 134.11 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.22 -0.925 . . . . 0.0 110.052 179.789 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.54 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 19.0 mt -103.45 -28.67 11.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.188 -0.945 . . . . 0.0 110.675 -179.79 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.666 ' CG ' HD12 ' A' ' 53' ' ' ILE . 2.0 m95 -129.51 165.18 22.18 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.096 -1.003 . . . . 0.0 110.731 -179.751 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 45' ' ' TRP . . . 41.57 -135.26 3.11 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.658 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -157.2 19.7 0.3 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.299 -1.118 . . . . 0.0 110.099 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.74 -15.82 7.02 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.798 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.505 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -76.58 -170.4 31.61 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.67 129.33 13.48 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.028 1.541 . . . . 0.0 110.662 -179.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.98 -9.57 56.64 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 -179.643 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -73.23 159.04 34.06 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.601 -0.941 . . . . 0.0 109.84 179.835 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.666 HD12 ' CG ' ' A' ' 45' ' ' TRP . 55.5 mt -128.85 121.35 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.382 -0.823 . . . . 0.0 109.79 179.538 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 6.4 mtpm? -104.63 145.03 30.9 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.155 -0.966 . . . . 0.0 110.262 -179.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.54 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 13.1 tttt -115.62 89.99 3.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -0.856 . . . . 0.0 110.024 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.453 ' CG2' HG13 ' A' ' 38' ' ' ILE . 64.7 mt -79.98 136.07 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -0.926 . . . . 0.0 110.139 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.513 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 1.4 p -108.98 152.66 24.67 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.211 -0.931 . . . . 0.0 110.396 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.583 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 20.1 m-85 -115.51 152.53 32.81 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.249 -0.907 . . . . 0.0 110.072 179.53 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -106.26 -7.88 34.35 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -107.7 146.68 31.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.275 -1.132 . . . . 0.0 110.298 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.73 -152.66 18.25 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 95.3 p -56.73 177.8 0.07 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.214 -1.168 . . . . 0.0 110.162 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -64.88 -40.22 94.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 110.244 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -110.58 105.4 14.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.215 -0.928 . . . . 0.0 110.299 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.583 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -132.63 84.36 0.29 Allowed Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.679 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.517 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 13.8 p90 -131.09 164.01 26.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.283 -1.127 . . . . 0.0 110.027 -179.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.942 HG12 ' HA2' ' A' ' 88' ' ' GLY . 5.7 m -134.08 174.54 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.927 . . . . 0.0 110.583 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.529 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 28.9 mttt -128.17 121.0 28.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.483 -0.76 . . . . 0.0 109.604 179.583 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.501 ' CD2' HD12 ' A' ' 85' ' ' LEU . 15.5 m170 -110.52 122.28 47.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.14 -0.975 . . . . 0.0 110.969 -179.384 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 52' ' ' THR . 81.0 tttt -95.48 117.44 30.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.187 -0.945 . . . . 0.0 109.359 178.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.519 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 23.6 mm -61.98 124.6 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.201 -0.937 . . . . 0.0 110.6 -179.31 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 82' ' ' SER . 94.4 m-20 -99.79 -41.88 7.07 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.403 -0.811 . . . . 0.0 109.693 179.512 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.458 ' OG ' ' HB2' ' A' ' 82' ' ' SER . 90.0 p -171.24 158.35 5.4 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.299 -0.875 . . . . 0.0 109.848 179.617 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.488 HG12 HG11 ' A' ' 23' ' ' VAL . 4.9 mt -137.4 158.47 35.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.265 -0.897 . . . . 0.0 110.273 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.59 ' HB2' ' HB2' ' A' ' 80' ' ' SER . 3.2 m-20 -133.68 83.32 2.04 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.579 -0.7 . . . . 0.0 110.166 -179.589 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.458 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 20.8 mttt -73.43 -9.89 59.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.438 -0.789 . . . . 0.0 110.167 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -93.54 -38.97 11.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.249 -0.907 . . . . 0.0 109.289 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.517 ' ND2' ' H ' ' A' ' 78' ' ' ASN . 0.9 OUTLIER -111.3 7.45 21.06 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.466 0.651 . . . . 0.0 110.807 -179.772 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.568 ' CZ ' ' HB3' ' A' ' 16' ' ' PRO . 5.6 m-85 59.03 60.88 2.28 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.379 -0.826 . . . . 0.0 112.859 177.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.59 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 1.0 OUTLIER -127.9 156.01 43.28 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.989 -1.069 . . . . 0.0 109.329 177.875 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.742 ' CE1' HG13 ' A' ' 23' ' ' VAL . 24.7 t80 -140.76 136.55 32.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.14 -0.975 . . . . 0.0 110.49 -179.254 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 1.1 m -139.49 125.69 20.05 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.302 -0.874 . . . . 0.0 110.324 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.691 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 23.7 p90 -147.01 169.92 18.21 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.234 -0.916 . . . . 0.0 110.404 179.558 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.674 HG23 ' O ' ' A' ' 98' ' ' ILE . 60.7 m -122.06 132.04 54.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.449 -0.782 . . . . 0.0 109.998 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.609 HD23 HG13 ' A' ' 98' ' ' ILE . 2.5 tp -97.41 122.9 41.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.184 -0.947 . . . . 0.0 110.125 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 86' ' ' ILE . 13.9 pt -105.15 -15.2 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -0.926 . . . . 0.0 110.293 -179.648 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.58 ' O ' HD11 ' A' ' 85' ' ' LEU . 31.6 tt0 -131.14 162.4 29.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.187 -0.946 . . . . 0.0 110.5 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.942 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 152.18 117.46 0.73 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -52.94 -21.16 4.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.174 -1.192 . . . . 0.0 110.3 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.84 -22.96 55.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.896 . . . . 0.0 110.279 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.599 HD21 HD23 ' A' ' 85' ' ' LEU . 26.8 mt -66.64 -26.8 67.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.918 . . . . 0.0 110.178 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 49.27 -178.44 0.02 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 57.9 p30 -79.05 4.48 14.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -1.167 . . . . 0.0 110.226 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.494 ' O ' HG22 ' A' ' 122' ' ' THR . 43.9 p -90.69 -32.47 16.18 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.269 -0.894 . . . . 0.0 110.114 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.871 HD23 ' CG2' ' A' ' 122' ' ' THR . 62.8 mt -111.04 162.76 14.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.373 -0.829 . . . . 0.0 110.089 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.499 ' HG3' ' HB2' ' A' ' 123' ' ' LYS . 71.3 mm-40 -142.63 -80.01 0.22 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.124 -0.985 . . . . 0.0 110.201 -179.726 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 58.4 mttm -80.21 126.82 31.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.584 -0.698 . . . . 0.0 110.481 -179.823 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.731 HG21 ' CE2' ' A' ' 100' ' ' TYR . 5.7 mm -117.36 140.57 39.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 120.744 -1.223 . . . . 0.0 109.999 179.149 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.498 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -119.39 129.58 54.88 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.829 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.731 ' CE2' HG21 ' A' ' 98' ' ' ILE . 10.1 m-85 -124.54 135.55 53.26 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.274 -0.891 . . . . 0.0 110.609 -178.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.462 ' O ' ' N ' ' A' ' 117' ' ' THR . 6.4 mt-10 -138.54 128.79 25.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.335 -0.853 . . . . 0.0 110.039 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 79.3 m -131.25 146.12 52.18 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.135 -0.978 . . . . 0.0 110.202 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 115' ' ' LYS . 4.5 tttt -140.72 145.25 36.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.312 -0.868 . . . . 0.0 110.324 -179.834 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.863 HD23 HG12 ' A' ' 114' ' ' ILE . 4.5 mt -124.73 153.8 41.83 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.294 -0.879 . . . . 0.0 110.239 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.698 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -151.45 -168.94 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.177 -0.952 . . . . 0.0 109.982 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.698 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -122.76 160.73 25.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.261 -0.899 . . . . 0.0 110.317 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.463 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 2.1 p -117.35 170.26 6.34 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.302 -0.874 . . . . 0.0 110.197 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 47.2 Cg_endo -72.89 -17.11 25.7 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.022 1.538 . . . . 0.0 110.452 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 73.4 m -95.17 9.46 39.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.334 -0.854 . . . . 0.0 110.272 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 94.54 -33.42 5.33 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -55.51 -172.39 0.11 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 0.7 OUTLIER -136.53 137.47 40.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -1.148 . . . . 0.0 110.349 -179.998 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.863 ' HA ' HG22 ' A' ' 10' ' ' THR . 25.0 mt -90.39 147.74 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.349 -0.844 . . . . 0.0 110.017 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.863 HG12 HD23 ' A' ' 104' ' ' LEU . 23.2 mt -131.48 114.22 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.231 -0.918 . . . . 0.0 110.593 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 103' ' ' LYS . 16.6 tttt -102.9 130.91 50.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.221 -0.924 . . . . 0.0 109.758 179.467 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 3.3 t -123.03 160.09 27.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.096 -1.003 . . . . 0.0 110.558 -179.637 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.462 ' N ' ' O ' ' A' ' 101' ' ' GLU . 29.8 m -156.36 126.98 6.73 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.332 -0.855 . . . . 0.0 110.038 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 83.5 p -130.38 152.58 49.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.114 -0.991 . . . . 0.0 110.489 -179.75 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.831 ' CE1' HG23 ' A' ' 4' ' ' THR . 50.4 m-70 -134.93 158.12 45.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.371 -0.831 . . . . 0.0 109.917 179.599 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.629 ' HD1' HD12 ' A' ' 98' ' ' ILE . 26.8 m-85 -129.59 135.42 48.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.133 -0.979 . . . . 0.0 110.488 -179.624 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.617 ' CE1' HG11 ' A' ' 2' ' ' VAL . 87.5 m-70 -117.25 95.92 5.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.117 -0.99 . . . . 0.0 109.819 179.38 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.871 ' CG2' HD23 ' A' ' 95' ' ' LEU . 2.4 p -77.86 158.51 29.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.909 . . . . 0.0 110.616 -179.522 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.499 ' HB2' ' HG3' ' A' ' 96' ' ' GLU . 63.4 tttt -113.12 99.25 7.69 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.372 -0.83 . . . . 0.0 110.191 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 121.84 -128.98 7.47 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -125.9 71.37 1.24 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.336 -1.097 . . . . 0.0 110.173 -179.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.514 ' CG2' ' HB ' ' A' ' 122' ' ' THR . 35.5 m -138.58 155.93 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.188 -0.945 . . . . 0.0 110.092 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -123.51 174.32 7.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.319 -0.863 . . . . 0.0 110.284 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.823 ' CD1' HD21 ' A' ' 95' ' ' LEU . 20.9 mm -76.93 171.77 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.28 -0.888 . . . . 0.0 110.047 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.546 ' N ' HG22 ' A' ' 128' ' ' ILE . 22.3 mttt -99.17 129.9 45.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.191 -0.943 . . . . 0.0 109.986 179.785 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.546 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 93.8 mt-10 -44.05 -43.6 6.9 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.214 -0.929 . . . . 0.0 109.947 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.974 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 47.8 tt0 -58.61 -24.13 60.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.245 -0.909 . . . . 0.0 109.845 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.479 ' N ' ' O ' ' A' ' 129' ' ' LYS . 14.8 t-160 -86.67 -57.05 3.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.328 -0.857 . . . . 0.0 110.135 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.636 HG13 ' HG3' ' A' ' 134' ' ' LYS . 2.3 p -63.04 -22.31 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.417 -0.802 . . . . 0.0 110.262 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.636 ' HG3' HG13 ' A' ' 133' ' ' VAL . 54.1 mttt -112.0 -73.74 0.66 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.143 -0.973 . . . . 0.0 110.328 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.974 ' HB3' ' O ' ' A' ' 131' ' ' GLU . . . -53.45 -20.53 4.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.901 . . . . 0.0 109.642 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.55 -29.55 65.62 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.071 -1.611 . . . . 0.0 109.071 179.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 23.7 mttm -64.21 -30.09 71.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.298 -1.119 . . . . 0.0 109.954 179.8 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 70.2 tt0 -77.4 -28.32 52.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.379 -0.825 . . . . 0.0 110.156 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.8 mmtp -73.9 -34.8 64.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 110.055 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -80.6 -34.68 34.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.873 . . . . 0.0 110.007 179.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 33.2 m -63.86 -45.15 90.76 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.401 -0.812 . . . . 0.0 109.943 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -54.94 -42.77 72.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.283 -0.886 . . . . 0.0 110.015 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.632 ' HA ' HD12 ' A' ' 146' ' ' LEU . 80.8 mt -60.59 -46.1 91.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.294 -0.879 . . . . 0.0 110.083 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -59.31 -37.32 77.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.374 -0.829 . . . . 0.0 109.818 179.793 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -72.15 -12.97 61.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.306 -0.872 . . . . 0.0 110.068 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.632 HD12 ' HA ' ' A' ' 143' ' ' LEU . 34.4 mt -83.72 -35.58 24.33 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.215 -0.928 . . . . 0.0 108.912 179.25 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 1.111 ' CG2' HD23 ' A' ' 18' ' ' LEU . 60.7 mt -68.9 -46.22 79.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.503 ' O ' HG13 ' A' ' 13' ' ' ILE . 84.7 mt-10 -50.43 -35.32 28.06 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.4 -0.812 . . . . 0.0 109.353 179.089 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 3.0 m -75.39 -20.48 58.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.222 -0.924 . . . . 0.0 109.49 179.321 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.579 ' CD1' HG12 ' A' ' 33' ' ' ILE . 80.1 t80 -69.5 -48.95 58.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.517 -0.739 . . . . 0.0 109.915 179.605 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.904 HD13 ' HB3' ' A' ' 17' ' ' ARG . 48.2 mt -80.03 -31.56 39.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.351 -0.843 . . . . 0.0 110.021 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.464 ' CA ' HD11 ' A' ' 13' ' ' ILE . 7.5 ttpp -64.74 -14.19 57.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.306 -0.872 . . . . 0.0 109.428 179.285 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.464 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -118.35 -30.54 1.7 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 179.708 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.597 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 5.7 m-70 -106.07 94.41 9.3 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.272 -1.134 . . . . 0.0 110.15 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.51 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 47.9 Cg_endo -73.96 4.58 4.08 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.985 1.519 . . . . 0.0 110.873 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -113.37 -8.8 13.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.972 -1.08 . . . . 0.0 109.819 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.597 ' HB3' ' NH2' ' A' ' 17' ' ' ARG . . . -53.65 104.47 0.1 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.374 -0.829 . . . . 0.0 109.979 179.762 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.997 ' CZ ' ' HB2' ' A' ' 21' ' ' ALA . 0.2 OUTLIER 35.33 30.96 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.733 -0.604 . . . . 0.0 110.703 -179.663 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.538 ' HB2' ' NE ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.409 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.745 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.235 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.955 HG11 ' CE1' ' A' ' 121' ' ' HIS . 2.7 p -80.75 149.56 5.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.113 -1.228 . . . . 0.0 110.795 -179.491 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 5' ' ' TYR . 72.5 m-85 -93.76 169.01 10.63 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.611 -0.681 . . . . 0.0 110.49 -179.579 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.959 HG23 ' CE1' ' A' ' 119' ' ' HIS . 86.0 m -139.93 105.06 5.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.345 -0.847 . . . . 0.0 110.126 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.784 ' CE2' HG11 ' A' ' 133' ' ' VAL . 65.7 m-85 -114.23 144.68 42.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.909 . . . . 0.0 110.034 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 21.5 pt-20 -134.27 150.5 51.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.173 -0.954 . . . . 0.0 110.254 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.461 ' O ' ' CG ' ' A' ' 8' ' ' GLU . 24.8 p -125.95 169.38 12.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.344 -0.847 . . . . 0.0 109.986 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.461 ' CG ' ' O ' ' A' ' 7' ' ' SER . 80.9 mt-10 -153.95 117.19 4.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.163 -0.961 . . . . 0.0 110.628 -179.852 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.2 p90 -142.58 -178.05 5.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.325 -0.859 . . . . 0.0 109.875 179.562 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.558 HG22 HG12 ' A' ' 113' ' ' ILE . 16.5 p -136.71 179.78 6.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.182 -0.949 . . . . 0.0 110.544 -179.783 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 112' ' ' SER . 2.2 t -160.05 159.12 31.6 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.297 -0.877 . . . . 0.0 110.55 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -85.55 -12.11 52.44 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.207 -0.933 . . . . 0.0 109.824 179.805 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.815 HG23 ' HD2' ' A' ' 14' ' ' PRO . 2.3 mp -88.29 151.02 48.17 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.356 -0.84 . . . . 0.0 109.984 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.815 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.9 Cg_endo -66.69 139.9 54.39 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.046 1.55 . . . . 0.0 110.664 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.64 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 41.3 Cg_endo -73.25 -30.03 10.84 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 124.069 1.563 . . . . 0.0 112.843 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.64 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.9 Cg_endo -71.72 -23.56 22.61 Favored 'Trans proline' 0 C--N 1.319 -1.002 0 N-CA-C 110.052 -0.788 . . . . 0.0 110.052 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.565 ' CZ ' ' HA ' ' A' ' 159' ' ' ASN . 1.1 mtp85 -82.05 -44.89 16.0 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.008 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.96 HD23 ' CG2' ' A' ' 147' ' ' ILE . 0.2 OUTLIER -67.07 -34.0 76.71 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.528 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.626 ' N ' HD13 ' A' ' 18' ' ' LEU . 74.9 t80 -59.38 -56.59 20.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.639 -0.663 . . . . 0.0 109.642 178.738 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.551 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 29.6 mttp -52.35 -37.53 56.41 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.721 -0.791 . . . . 0.0 109.421 179.462 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.007 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -75.63 -43.38 48.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.466 -0.772 . . . . 0.0 110.76 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 1.051 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.3 OUTLIER -65.36 -45.8 82.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.341 -0.849 . . . . 0.0 111.074 -179.065 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 1.126 HG11 ' CD1' ' A' ' 74' ' ' ILE . 10.4 t -104.2 -60.89 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.084 -1.01 . . . . 0.0 111.766 -179.051 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.616 HD12 ' N ' ' A' ' 24' ' ' LEU . 7.5 mp -66.13 -11.36 48.66 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.171 -0.956 . . . . 0.0 111.537 -178.64 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.612 ' O ' HD23 ' A' ' 29' ' ' LEU . 1.2 m-20 -148.17 44.18 1.05 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.886 -1.134 . . . . 0.0 110.27 -179.778 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 1.051 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -82.8 -22.14 34.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.297 -0.877 . . . . 0.0 110.47 -179.831 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -68.76 -19.9 64.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.127 -0.983 . . . . 0.0 110.214 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.515 ' O ' ' CB ' ' A' ' 32' ' ' LYS . 4.6 p30 -125.34 13.15 8.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 0.0 109.772 179.836 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.612 HD23 ' O ' ' A' ' 25' ' ' ASP . 0.4 OUTLIER -97.01 -54.16 3.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.453 -0.779 . . . . 0.0 110.175 -179.939 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.984 HG11 HD13 ' A' ' 38' ' ' ILE . 2.6 t -70.28 -42.78 16.73 Favored Pre-proline 0 C--N 1.299 -1.597 0 O-C-N 121.296 -0.877 . . . . 0.0 110.57 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 50.3 Cg_endo -79.32 8.27 3.98 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.601 1.316 . . . . 0.0 110.617 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.515 ' CB ' ' O ' ' A' ' 28' ' ' ASN . 81.4 tttt -125.41 -31.39 3.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.187 -0.945 . . . . 0.0 109.745 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.669 HD13 ' HA ' ' A' ' 147' ' ' ILE . 22.0 mt -79.76 -35.53 16.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.523 -0.736 . . . . 0.0 109.701 179.578 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.404 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . . . -160.66 99.82 1.35 Allowed Pre-proline 0 N--CA 1.487 1.377 0 O-C-N 121.433 -0.792 . . . . 0.0 110.187 179.764 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 34' ' ' ALA . 47.0 Cg_endo -72.96 0.14 8.21 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.201 1.632 . . . . 0.0 110.516 179.907 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -86.26 -13.02 47.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.261 -0.899 . . . . 0.0 109.823 179.699 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -98.46 -49.38 4.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.374 -0.829 . . . . 0.0 110.401 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.984 HD13 HG11 ' A' ' 30' ' ' VAL . 1.2 mp -130.56 137.93 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.327 -0.858 . . . . 0.0 110.324 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.426 ' O ' ' HB3' ' A' ' 40' ' ' HIS . 7.1 ttmt -70.97 -39.72 72.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.409 -0.807 . . . . 0.0 110.411 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.548 ' C ' ' CD2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER 179.03 159.32 0.61 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.277 -0.889 . . . . 0.0 110.284 179.852 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.9 m -121.03 131.61 54.39 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.225 -0.922 . . . . 0.0 110.045 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -135.2 114.28 12.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -0.924 . . . . 0.0 110.428 -179.829 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.426 HG12 ' HG2' ' A' ' 54' ' ' LYS . 28.3 mt -60.37 138.39 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.185 -0.947 . . . . 0.0 110.031 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.577 HD11 ' HB2' ' A' ' 55' ' ' LYS . 22.8 mt -111.74 -29.28 7.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.917 . . . . 0.0 110.462 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.635 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.8 m95 -125.33 163.89 21.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.216 -0.927 . . . . 0.0 110.698 -179.773 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.447 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 42.06 -138.23 2.58 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -151.15 21.1 0.76 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -1.154 . . . . 0.0 110.208 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 123.3 -18.93 7.73 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.541 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -72.9 -172.83 23.01 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.412 ' HA ' HG22 ' A' ' 71' ' ' ILE . 43.5 Cg_endo -71.72 128.66 14.52 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.993 1.523 . . . . 0.0 110.683 -179.783 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.09 -14.09 48.59 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 -179.487 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -70.87 161.42 31.04 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.554 -0.968 . . . . 0.0 109.647 179.682 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.635 HD12 ' CG ' ' A' ' 45' ' ' TRP . 56.2 mt -130.7 120.7 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.334 -0.854 . . . . 0.0 109.887 179.599 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.891 ' CE ' HD11 ' A' ' 71' ' ' ILE . 58.6 mttm -105.53 140.98 37.79 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.168 -0.957 . . . . 0.0 110.394 -179.716 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.577 ' HB2' HD11 ' A' ' 44' ' ' LEU . 78.0 tttt -106.99 88.58 2.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.313 -0.867 . . . . 0.0 110.159 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.584 HD12 ' CE1' ' A' ' 69' ' ' HIS . 79.0 mt -79.86 137.46 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.265 -0.897 . . . . 0.0 110.15 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.743 ' O ' HG23 ' A' ' 38' ' ' ILE . 5.6 p -109.29 161.78 14.94 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.18 -0.95 . . . . 0.0 110.658 -179.786 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.584 ' HE2' HG13 ' A' ' 67' ' ' VAL . 31.5 m-85 -115.73 128.64 56.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.47 -0.769 . . . . 0.0 110.211 179.777 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.26 -23.91 77.21 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -94.6 142.52 27.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.295 -1.12 . . . . 0.0 110.238 179.924 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.32 148.68 4.83 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.3 m -59.87 -35.41 74.75 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.321 -1.105 . . . . 0.0 110.159 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -137.07 -83.6 0.35 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.208 -0.933 . . . . 0.0 110.254 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.9 131.7 49.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.23 -0.918 . . . . 0.0 110.312 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.552 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -137.59 119.12 1.8 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 179.678 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.539 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 15.4 p90 -158.01 168.56 26.77 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.038 -1.272 . . . . 0.0 110.072 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.934 HG12 ' HA2' ' A' ' 88' ' ' GLY . 7.1 m -139.49 173.32 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.249 -0.907 . . . . 0.0 110.899 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 27.8 mttt -125.13 117.78 24.65 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.372 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.809 ' CD2' HD12 ' A' ' 85' ' ' LEU . 17.8 m170 -103.81 125.39 50.22 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.214 -0.929 . . . . 0.0 111.085 -178.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 52' ' ' THR . 25.6 tttt -97.76 106.51 18.83 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.383 -0.823 . . . . 0.0 109.374 179.002 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.891 HD11 ' CE ' ' A' ' 54' ' ' LYS . 43.3 mm -44.35 133.97 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.09 -1.006 . . . . 0.0 110.153 -179.227 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.51 ' N ' ' HA ' ' A' ' 83' ' ' TYR . 46.3 t0 -107.49 -54.11 2.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.481 -0.762 . . . . 0.0 109.899 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.424 ' O ' ' N ' ' A' ' 82' ' ' SER . 5.4 m -172.28 158.25 4.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.453 -0.779 . . . . 0.0 110.277 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 1.126 ' CD1' HG11 ' A' ' 23' ' ' VAL . 4.0 tt -149.77 165.54 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.274 -0.891 . . . . 0.0 110.03 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.549 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 0.6 OUTLIER -133.78 82.06 1.96 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.299 -0.876 . . . . 0.0 110.014 -179.788 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.604 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 90.3 mttt -55.29 -15.14 2.19 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.316 -0.865 . . . . 0.0 110.841 -179.863 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -92.5 -30.4 15.72 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.189 -0.945 . . . . 0.0 109.798 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.502 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -111.34 -1.33 16.05 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.552 -0.717 . . . . 0.0 109.63 179.962 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.648 ' O ' HD12 ' A' ' 104' ' ' LEU . 10.7 m-85 65.69 48.23 1.98 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.769 -0.582 . . . . 0.0 110.608 -179.864 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.549 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.5 OUTLIER -116.55 148.07 41.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.157 -0.964 . . . . 0.0 109.364 179.386 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.535 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 86.9 t80 -148.45 144.63 27.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.122 -0.987 . . . . 0.0 110.414 -179.261 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.504 ' HB3' ' HG3' ' A' ' 101' ' ' GLU . 4.8 p -151.45 145.23 25.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.271 -0.893 . . . . 0.0 110.349 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.608 ' CZ ' ' HB3' ' A' ' 100' ' ' TYR . 18.0 p90 -148.13 172.02 14.97 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.219 -0.926 . . . . 0.0 110.471 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.626 HG23 ' O ' ' A' ' 98' ' ' ILE . 97.1 m -122.16 123.58 41.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.344 -0.848 . . . . 0.0 109.964 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.937 HD21 HD11 ' A' ' 91' ' ' LEU . 0.9 OUTLIER -90.61 129.25 36.76 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.148 -0.97 . . . . 0.0 110.249 -179.827 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 16.7 pt -112.03 0.65 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.279 -0.888 . . . . 0.0 110.298 -179.789 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.509 ' OE1' ' CD ' ' A' ' 68' ' ' LYS . 57.3 tt0 -145.66 154.87 42.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.272 -0.892 . . . . 0.0 110.171 -179.922 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.934 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 156.9 126.93 0.95 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -64.26 -25.97 68.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.334 -1.097 . . . . 0.0 110.208 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.552 ' O ' ' CE1' ' A' ' 132' ' ' HIS . . . -70.27 -25.44 63.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -0.916 . . . . 0.0 110.122 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.937 HD11 HD21 ' A' ' 85' ' ' LEU . 22.3 mt -64.68 -36.56 84.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.31 -0.868 . . . . 0.0 110.072 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.11 175.69 36.73 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -72.58 -2.29 19.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -1.152 . . . . 0.0 109.967 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 122' ' ' THR . 30.3 p -91.42 -38.8 12.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.895 . . . . 0.0 110.455 -179.866 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.681 HD21 HG13 ' A' ' 128' ' ' ILE . 2.4 mm? -79.88 154.92 28.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.262 -0.899 . . . . 0.0 110.964 -179.453 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.47 ' OE1' ' HB2' ' A' ' 123' ' ' LYS . 37.5 tt0 -142.44 -84.21 0.18 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.13 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.517 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 28.5 mttt -80.42 125.14 29.55 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.705 -0.622 . . . . 0.0 110.595 179.076 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.626 ' O ' HG23 ' A' ' 84' ' ' THR . 3.2 mm -118.02 137.96 50.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 120.575 -1.328 . . . . 0.0 109.151 178.199 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.489 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.6 OUTLIER -118.31 129.67 55.58 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.325 -0.859 . . . . 0.0 109.299 179.306 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.613 ' CE2' HG21 ' A' ' 98' ' ' ILE . 8.8 m-85 -124.13 132.63 53.66 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.42 -0.8 . . . . 0.0 110.236 -179.282 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.504 ' HG3' ' HB3' ' A' ' 82' ' ' SER . 76.9 tt0 -134.5 138.7 44.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.18 -0.95 . . . . 0.0 110.21 179.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 90.5 m -141.34 125.51 17.39 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.161 -0.962 . . . . 0.0 110.199 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.468 ' HG3' ' HB3' ' A' ' 80' ' ' SER . 1.0 OUTLIER -116.86 149.42 40.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.881 . . . . 0.0 110.114 179.818 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.648 HD12 ' O ' ' A' ' 79' ' ' TYR . 14.7 mt -123.24 148.86 45.43 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.199 -0.938 . . . . 0.0 110.622 -179.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.685 HG12 ' H ' ' A' ' 106' ' ' ALA . 2.0 t -149.5 -168.91 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.408 -0.807 . . . . 0.0 109.419 179.546 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.685 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -136.92 141.52 42.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.13 -0.981 . . . . 0.0 110.873 179.9 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.537 ' CB ' ' HD2' ' A' ' 108' ' ' PRO . 0.8 OUTLIER -91.79 -179.91 1.22 Allowed Pre-proline 0 C--N 1.302 -1.477 0 O-C-N 121.533 -0.729 . . . . 0.0 109.374 179.183 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.537 ' HD2' ' CB ' ' A' ' 107' ' ' SER . 40.7 Cg_endo -66.54 85.09 0.28 Allowed 'Trans proline' 0 C--N 1.303 -1.861 0 O-C-N 123.649 1.342 . . . . 0.0 109.646 179.376 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 108' ' ' PRO . 4.0 p 44.38 37.41 2.01 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.423 -0.798 . . . . 0.0 109.735 -178.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -125.75 38.16 2.33 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 11' ' ' SER . . . 98.11 -138.75 14.07 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 -179.495 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.531 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 3.7 p -149.43 143.38 25.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.279 -1.13 . . . . 0.0 109.835 179.653 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.558 HG12 HG22 ' A' ' 10' ' ' THR . 35.9 mt -91.4 147.9 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.24 -0.912 . . . . 0.0 110.307 -179.74 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.583 ' HB ' ' CE2' ' A' ' 9' ' ' PHE . 7.6 mt -134.02 111.62 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.186 -0.946 . . . . 0.0 110.208 -179.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 48.4 tttt -97.08 137.67 35.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.231 -0.918 . . . . 0.0 110.239 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 0.8 OUTLIER -134.44 154.55 51.33 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 0.0 110.376 -179.887 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.473 ' HB ' ' HB3' ' A' ' 101' ' ' GLU . 8.8 m -146.58 158.21 43.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.33 -0.856 . . . . 0.0 110.188 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 99.4 p -151.28 134.96 16.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 110.393 -179.9 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.959 ' CE1' HG23 ' A' ' 4' ' ' THR . 55.4 m-70 -120.78 147.9 44.71 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.287 -0.883 . . . . 0.0 110.384 -179.92 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.931 ' C ' HG23 ' A' ' 2' ' ' VAL . 9.3 m-85 -122.4 118.78 29.2 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.268 -0.895 . . . . 0.0 111.161 -179.445 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.955 ' CE1' HG11 ' A' ' 2' ' ' VAL . 90.0 m-70 -104.12 109.69 21.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.073 -1.017 . . . . 0.0 109.353 178.331 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.552 ' CG2' HG23 ' A' ' 126' ' ' VAL . 0.6 OUTLIER -88.95 136.5 32.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.294 -0.879 . . . . 0.0 110.866 -179.107 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.47 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 25.3 tttt -109.37 129.49 55.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.484 -0.76 . . . . 0.0 110.1 179.545 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.471 ' O ' ' CB ' ' A' ' 125' ' ' ASN . . . 110.44 15.33 11.47 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 9.1 t30 67.82 54.27 0.64 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.265 -1.138 . . . . 0.0 110.33 179.907 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.552 HG23 ' CG2' ' A' ' 122' ' ' THR . 20.3 m -133.4 160.34 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.351 -0.843 . . . . 0.0 109.948 179.744 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -121.3 162.16 20.77 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.225 -0.922 . . . . 0.0 110.576 -179.724 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.681 HG13 HD21 ' A' ' 95' ' ' LEU . 2.9 mp -83.95 173.45 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.393 -0.817 . . . . 0.0 109.96 179.766 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.604 ' N ' HG22 ' A' ' 128' ' ' ILE . 32.4 mttt -108.67 133.79 52.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.413 -0.804 . . . . 0.0 109.894 179.835 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -46.51 -36.26 6.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.183 -0.948 . . . . 0.0 110.198 -179.887 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -63.31 -29.94 71.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 110.09 179.885 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.552 ' CE1' ' O ' ' A' ' 90' ' ' ALA . 14.5 t-160 -78.18 -51.3 10.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 110.222 179.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.784 HG11 ' CE2' ' A' ' 5' ' ' TYR . 43.0 t -64.28 -43.45 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.356 -0.84 . . . . 0.0 110.098 179.882 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 7.1 tptm -67.1 -45.87 75.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 110.154 179.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.439 ' O ' ' HG3' ' A' ' 139' ' ' LYS . . . -62.27 -30.06 70.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.212 -0.93 . . . . 0.0 110.035 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.58 -29.39 69.78 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 133' ' ' VAL . 83.5 mttt -66.99 -33.9 76.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.213 -1.169 . . . . 0.0 110.077 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -81.7 -29.93 32.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.892 . . . . 0.0 110.104 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.439 ' HG3' ' O ' ' A' ' 135' ' ' ALA . 93.9 mttt -67.29 -41.5 85.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.33 -0.856 . . . . 0.0 110.069 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.16 -41.0 51.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.198 -0.939 . . . . 0.0 110.065 179.847 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 137' ' ' LYS . 48.8 m -56.99 -48.17 79.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.453 -0.78 . . . . 0.0 110.031 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -55.52 -42.33 74.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.185 -0.947 . . . . 0.0 110.095 179.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.436 ' O ' HG13 ' A' ' 147' ' ' ILE . 61.4 mt -61.52 -40.77 95.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 109.976 179.869 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -60.56 -37.77 82.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.407 -0.808 . . . . 0.0 109.878 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.431 ' HA ' ' OE1' ' A' ' 148' ' ' GLU . 87.8 mttt -71.67 -17.5 62.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.317 -0.864 . . . . 0.0 110.039 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.542 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 34.4 mt -84.11 -35.92 23.34 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.281 -0.887 . . . . 0.0 108.967 179.386 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.96 ' CG2' HD23 ' A' ' 18' ' ' LEU . 53.4 mt -72.27 -42.46 65.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 119.678 -0.809 . . . . 0.0 108.836 178.735 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.753 ' HB3' HD13 ' A' ' 13' ' ' ILE . 69.4 mt-10 -56.18 -39.11 71.89 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.479 -0.763 . . . . 0.0 109.409 179.03 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.5 m -73.99 -24.43 59.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.944 . . . . 0.0 109.617 179.415 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.648 ' HE2' ' HB1' ' A' ' 157' ' ' ALA . 80.3 t80 -64.68 -49.3 71.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.383 -0.823 . . . . 0.0 110.083 179.822 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.12 HD21 ' CE2' ' A' ' 158' ' ' TYR . 84.8 mt -79.94 -29.34 39.67 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.225 -0.922 . . . . 0.0 110.059 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.683 ' HB2' HD11 ' A' ' 13' ' ' ILE . 78.3 tttt -70.21 -27.14 64.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.33 -0.856 . . . . 0.0 109.594 179.523 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.483 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -104.04 -33.27 4.07 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.718 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.577 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 5.4 m-70 -107.12 92.34 7.72 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.354 -1.086 . . . . 0.0 109.982 179.734 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 48.4 Cg_endo -74.23 6.35 3.1 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.04 1.547 . . . . 0.0 111.075 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -107.06 -4.94 18.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.999 -1.063 . . . . 0.0 109.756 179.772 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.67 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -75.18 102.44 4.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.411 -0.806 . . . . 0.0 110.019 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 1.12 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.4 OUTLIER 34.86 32.18 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.69 -0.631 . . . . 0.0 110.572 -179.521 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.565 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.71 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 1.043 HG23 ' C ' ' A' ' 120' ' ' TYR . 3.0 p -82.86 153.84 3.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.253 -1.145 . . . . 0.0 110.122 -179.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.791 ' CE1' HD12 ' A' ' 128' ' ' ILE . 8.4 m-85 -89.23 170.16 10.83 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.329 -0.857 . . . . 0.0 110.014 -179.658 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.815 HG23 ' CE1' ' A' ' 119' ' ' HIS . 50.0 m -137.76 107.56 6.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.111 -0.993 . . . . 0.0 110.364 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.185 ' CE1' HG21 ' A' ' 133' ' ' VAL . 47.7 m-85 -112.21 136.67 51.34 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.182 -0.949 . . . . 0.0 110.109 179.804 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 20.8 pt-20 -129.84 152.1 49.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.222 -0.924 . . . . 0.0 110.537 -179.794 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.3 t -139.28 156.22 47.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.401 -0.812 . . . . 0.0 109.902 179.791 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -147.62 124.37 11.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.154 -0.966 . . . . 0.0 110.391 -179.873 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.637 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.3 p90 -151.6 -176.38 5.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.388 -0.82 . . . . 0.0 109.892 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.849 HG22 ' HA ' ' A' ' 113' ' ' ILE . 8.8 p -141.74 174.41 10.6 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.114 -0.991 . . . . 0.0 110.661 -179.642 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.5 t -153.08 159.08 42.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.428 -0.795 . . . . 0.0 110.155 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -81.94 -20.48 38.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.234 -0.916 . . . . 0.0 110.237 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.834 HG23 ' HD2' ' A' ' 14' ' ' PRO . 8.1 mm -80.11 150.68 71.88 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.334 -0.854 . . . . 0.0 109.98 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.834 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.0 Cg_endo -65.55 143.09 74.07 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.073 1.565 . . . . 0.0 110.789 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.666 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 41.5 Cg_endo -73.34 -30.69 9.99 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 124.109 1.584 . . . . 0.0 113.066 -179.501 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.666 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.3 Cg_endo -69.9 -23.38 30.23 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 O-C-N 122.471 0.722 . . . . 0.0 110.228 -179.899 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.579 ' NH2' ' HA ' ' A' ' 159' ' ' ASN . 2.1 mtp180 -85.16 -43.48 13.8 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.108 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.749 ' C ' HD23 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -69.89 -30.27 67.66 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.845 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.54 ' N ' HD23 ' A' ' 18' ' ' LEU . 50.7 t80 -68.58 -53.7 21.23 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.393 -0.817 . . . . 0.0 109.549 179.126 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.55 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 10.8 mttt -53.41 -33.86 55.54 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.681 -0.807 . . . . 0.0 109.181 179.568 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.063 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -76.4 -53.65 7.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.485 -0.759 . . . . 0.0 111.158 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 1.072 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -60.0 -46.08 90.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.501 -0.749 . . . . 0.0 111.922 -178.429 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.642 HG13 ' CE1' ' A' ' 81' ' ' TYR . 3.3 t -100.88 -60.6 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.886 -1.134 . . . . 0.0 111.847 -178.665 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.614 HD12 ' N ' ' A' ' 24' ' ' LEU . 6.8 mp -67.96 -5.36 16.68 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.172 -0.955 . . . . 0.0 111.647 -178.494 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.68 ' HB3' HD23 ' A' ' 29' ' ' LEU . 1.1 m-20 -149.04 30.14 0.79 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.669 -1.269 . . . . 0.0 110.946 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 1.072 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -70.05 -23.88 63.17 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.21 -0.931 . . . . 0.0 110.675 179.798 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -69.68 -17.52 63.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.08 -1.013 . . . . 0.0 109.774 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.533 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 7.1 p30 -129.42 13.28 6.03 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.375 -0.828 . . . . 0.0 109.774 179.597 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.695 HD21 ' CZ ' ' A' ' 158' ' ' TYR . 0.3 OUTLIER -94.37 -49.16 5.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.437 -0.789 . . . . 0.0 110.138 179.812 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.974 HG21 HD13 ' A' ' 38' ' ' ILE . 5.8 p -73.2 -28.87 1.01 Allowed Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.141 -0.974 . . . . 0.0 112.051 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.848 ' HD3' HG12 ' A' ' 30' ' ' VAL . 52.1 Cg_endo -79.56 1.21 9.39 Favored 'Trans proline' 0 C--N 1.319 -1.019 0 O-C-N 122.717 0.851 . . . . 0.0 110.263 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.437 ' HD2' ' O ' ' A' ' 28' ' ' ASN . 51.8 mttm -124.68 -30.0 3.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.292 -0.88 . . . . 0.0 109.869 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.617 HD11 ' CD1' ' A' ' 29' ' ' LEU . 10.8 mt -77.57 -39.14 26.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.482 -0.761 . . . . 0.0 109.76 179.822 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -170.24 102.27 0.44 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.417 -0.802 . . . . 0.0 110.14 179.871 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.78 1.2 7.27 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.066 1.561 . . . . 0.0 110.647 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -87.27 -8.64 56.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.099 -1.0 . . . . 0.0 110.039 179.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.31 -51.02 3.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.312 -0.868 . . . . 0.0 110.308 -179.929 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.974 HD13 HG21 ' A' ' 30' ' ' VAL . 1.1 mp -127.11 138.87 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.426 -0.796 . . . . 0.0 110.11 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.43 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 37.7 ttmt -73.85 -40.53 63.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.318 -0.864 . . . . 0.0 110.098 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.534 ' C ' ' CD2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER -178.49 156.11 0.9 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.336 -0.852 . . . . 0.0 110.252 179.752 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.4 m -120.0 119.93 34.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.23 -0.919 . . . . 0.0 109.996 179.889 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.518 ' O ' HD12 ' A' ' 44' ' ' LEU . 35.0 tp10 -124.25 114.39 19.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.289 -0.882 . . . . 0.0 110.387 -179.923 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.467 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 21.4 mt -60.04 145.03 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.189 -0.945 . . . . 0.0 110.069 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.518 HD12 ' O ' ' A' ' 42' ' ' GLU . 4.8 mp -121.77 -27.29 4.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.224 -0.923 . . . . 0.0 110.328 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.627 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.6 m95 -123.78 163.19 21.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.272 -0.893 . . . . 0.0 110.482 -179.833 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.431 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 43.12 -138.37 3.39 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.81 23.52 0.51 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.309 -1.112 . . . . 0.0 109.994 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 121.73 -13.9 9.23 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.481 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -81.54 -169.61 42.65 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.85 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.436 ' HA ' HG22 ' A' ' 71' ' ' ILE . 45.0 Cg_endo -72.79 129.5 14.53 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 124.086 1.572 . . . . 0.0 110.557 -179.905 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.49 -12.95 51.16 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 -179.569 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.544 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -71.52 161.3 31.24 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.589 -0.948 . . . . 0.0 109.374 179.635 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.627 HD12 ' CG ' ' A' ' 45' ' ' TRP . 58.3 mt -134.29 120.37 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.242 -0.911 . . . . 0.0 109.971 179.683 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 96.0 mttt -107.3 128.95 54.91 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.164 -0.96 . . . . 0.0 110.56 -179.595 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -93.01 91.38 7.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -0.881 . . . . 0.0 109.768 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.555 ' CG2' HG12 ' A' ' 38' ' ' ILE . 96.7 mt -80.02 144.11 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.2 -0.937 . . . . 0.0 110.212 -179.753 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.515 ' O ' HG23 ' A' ' 38' ' ' ILE . 7.2 p -117.62 163.73 16.01 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.201 -0.937 . . . . 0.0 110.744 -179.649 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.568 ' HE2' HG13 ' A' ' 67' ' ' VAL . 28.6 m-85 -122.4 141.38 51.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.323 -0.861 . . . . 0.0 110.118 179.283 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -88.56 38.14 3.23 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -49.09 -26.59 2.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.287 -1.125 . . . . 0.0 110.148 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.62 -143.06 13.71 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.98 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 21.4 m -61.8 -42.93 99.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.182 -1.187 . . . . 0.0 110.201 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -58.87 148.48 29.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.296 -0.878 . . . . 0.0 110.142 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -89.25 125.51 35.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.234 -0.917 . . . . 0.0 110.303 -179.911 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -138.67 102.27 0.35 Allowed Glycine 0 N--CA 1.487 2.096 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 179.669 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.543 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 13.9 p90 -143.44 166.7 24.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.218 -1.166 . . . . 0.0 110.175 -179.685 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.885 HG12 ' HA2' ' A' ' 88' ' ' GLY . 6.1 m -139.35 174.13 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.354 -0.841 . . . . 0.0 110.618 179.78 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.517 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 20.1 mttt -125.56 122.04 35.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.529 -0.732 . . . . 0.0 109.642 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.573 ' NE2' HD13 ' A' ' 85' ' ' LEU . 10.8 m170 -108.56 123.75 49.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.179 -0.951 . . . . 0.0 110.854 -179.436 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 52' ' ' THR . 18.9 tttm -97.65 116.09 29.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.258 -0.901 . . . . 0.0 109.79 179.428 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.523 ' CD1' ' OH ' ' A' ' 81' ' ' TYR . 23.6 mm -58.04 132.43 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.994 -1.066 . . . . 0.0 110.365 -179.563 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 82' ' ' SER . 94.1 m-20 -105.34 -42.76 5.16 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.372 -0.83 . . . . 0.0 109.889 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.2 m -175.09 159.67 2.63 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.389 -0.82 . . . . 0.0 109.948 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.492 HG12 HG11 ' A' ' 23' ' ' VAL . 2.2 mt -138.62 159.84 30.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.193 -0.942 . . . . 0.0 110.209 179.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 79' ' ' TYR . 5.6 m-20 -137.58 80.56 1.81 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.489 -0.757 . . . . 0.0 110.392 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.433 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 22.3 tttt -63.28 -18.9 64.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.133 -0.979 . . . . 0.0 110.259 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -91.6 -32.24 15.58 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.275 -0.89 . . . . 0.0 109.363 179.755 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.503 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -101.25 -4.13 27.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.643 -0.661 . . . . 0.0 109.604 179.619 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.588 ' CE1' ' HB3' ' A' ' 16' ' ' PRO . 85.2 m-85 60.43 55.44 3.49 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.454 0.645 . . . . 0.0 110.581 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.487 ' HB2' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -129.93 165.61 21.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.434 -0.791 . . . . 0.0 109.876 179.495 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.696 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 42.6 t80 -149.71 143.79 25.68 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.219 -0.925 . . . . 0.0 109.903 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.464 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 25.9 m -148.76 131.45 15.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.122 -0.986 . . . . 0.0 111.223 -179.724 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.696 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 9.1 p90 -144.36 175.66 9.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.35 -0.844 . . . . 0.0 110.064 179.041 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 98' ' ' ILE . 27.1 m -127.25 128.42 45.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.348 -0.845 . . . . 0.0 109.824 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.573 HD13 ' NE2' ' A' ' 69' ' ' HIS . 7.4 tp -95.39 125.31 39.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.093 -1.004 . . . . 0.0 110.077 -179.85 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.6 pt -109.79 -12.65 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.244 -0.91 . . . . 0.0 110.333 -179.565 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.566 ' O ' HD11 ' A' ' 91' ' ' LEU . 18.0 tt0 -124.64 172.84 8.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 0.0 110.191 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.885 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 137.58 112.08 1.09 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.984 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -56.42 -16.83 6.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.319 -1.106 . . . . 0.0 110.205 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.63 -17.71 57.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 0.0 110.146 179.87 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.566 HD11 ' O ' ' A' ' 87' ' ' GLU . 65.7 mt -66.78 -23.82 66.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.284 -0.885 . . . . 0.0 110.209 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 50.56 -179.69 0.03 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -79.96 6.45 11.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.303 -1.116 . . . . 0.0 110.206 179.897 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.498 ' O ' HG21 ' A' ' 126' ' ' VAL . 39.4 p -94.36 -31.55 13.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.236 -0.915 . . . . 0.0 110.238 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.86 HD21 HD11 ' A' ' 128' ' ' ILE . 83.6 mt -107.29 163.93 12.61 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.351 -0.843 . . . . 0.0 110.092 179.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.466 ' HG2' ' N ' ' A' ' 97' ' ' LYS . 61.4 tt0 -144.77 -82.85 0.15 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.299 -0.876 . . . . 0.0 109.668 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.495 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 18.7 mttt -80.37 131.57 35.64 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.778 -0.576 . . . . 0.0 110.343 179.683 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.791 HG21 ' CE2' ' A' ' 100' ' ' TYR . 4.7 mm -119.53 138.67 49.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 120.845 -1.16 . . . . 0.0 109.63 178.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.476 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 1.3 m -118.85 123.27 44.31 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 119.711 -0.795 . . . . 0.0 108.985 178.786 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.791 ' CE2' HG21 ' A' ' 98' ' ' ILE . 13.0 m-85 -119.27 132.61 55.93 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.39 -0.819 . . . . 0.0 110.322 -179.076 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.467 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 85.1 tt0 -132.07 140.26 48.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.263 -0.898 . . . . 0.0 110.061 179.788 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.468 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 32.6 m -133.01 153.95 50.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.924 . . . . 0.0 109.929 179.939 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.477 ' O ' ' N ' ' A' ' 115' ' ' LYS . 7.7 mttt -149.66 133.05 16.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.143 -0.973 . . . . 0.0 110.456 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.87 HD23 HG12 ' A' ' 114' ' ' ILE . 3.5 mt -115.42 152.49 32.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.196 -0.94 . . . . 0.0 110.03 179.812 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.696 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.8 t -151.38 -169.52 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.227 -0.921 . . . . 0.0 110.185 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.696 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -124.52 145.64 49.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.35 -0.844 . . . . 0.0 110.305 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.443 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.3 p -103.8 171.12 5.39 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.281 -0.887 . . . . 0.0 110.2 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.443 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 45.7 Cg_endo -72.54 -13.79 27.53 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.074 1.565 . . . . 0.0 110.585 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 67.8 m -95.84 11.64 32.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.188 -0.945 . . . . 0.0 110.354 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 91.34 -34.93 4.1 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.847 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -55.18 -172.07 0.08 OUTLIER Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.785 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.52 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 1.4 p -134.98 134.19 40.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.124 -1.221 . . . . 0.0 110.387 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.849 ' HA ' HG22 ' A' ' 10' ' ' THR . 15.4 mt -85.74 147.12 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.37 -0.831 . . . . 0.0 109.91 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.87 HG12 HD23 ' A' ' 104' ' ' LEU . 19.4 mt -131.1 110.8 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.166 -0.959 . . . . 0.0 110.407 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 103' ' ' LYS . 63.3 tttm -97.93 134.87 40.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.191 -0.943 . . . . 0.0 109.683 179.444 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.67 147.99 51.51 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.219 -0.926 . . . . 0.0 110.354 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' A' ' 101' ' ' GLU . 32.9 m -148.54 148.06 29.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.4 -0.812 . . . . 0.0 110.292 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 88.5 p -148.36 155.08 40.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.29 -0.881 . . . . 0.0 110.136 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.815 ' CE1' HG23 ' A' ' 4' ' ' THR . 34.1 m-70 -139.14 129.81 26.0 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.168 -0.958 . . . . 0.0 110.373 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 1.043 ' C ' HG23 ' A' ' 2' ' ' VAL . 3.6 m-30 -99.56 120.58 39.88 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.279 -0.888 . . . . 0.0 110.599 -179.555 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.565 ' CE1' HG21 ' A' ' 2' ' ' VAL . 82.4 m-70 -95.51 107.56 19.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.196 -0.94 . . . . 0.0 109.674 179.074 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.6 p -77.81 157.39 29.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.917 . . . . 0.0 110.174 -179.854 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 37.6 tttt -114.46 114.0 25.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.193 -0.942 . . . . 0.0 110.237 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 93.26 -132.7 11.35 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -115.72 77.19 1.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.215 -1.168 . . . . 0.0 110.147 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.498 HG21 ' O ' ' A' ' 94' ' ' THR . 32.8 m -142.02 154.39 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.178 -0.951 . . . . 0.0 110.242 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -132.05 164.22 26.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.234 -0.916 . . . . 0.0 110.214 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.86 HD11 HD21 ' A' ' 95' ' ' LEU . 3.2 mp -92.05 171.83 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.154 -0.966 . . . . 0.0 110.375 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.623 ' N ' HG22 ' A' ' 128' ' ' ILE . 60.8 mmtt -113.71 129.98 56.49 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.481 -0.762 . . . . 0.0 109.768 179.742 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.505 ' O ' ' CB ' ' A' ' 134' ' ' LYS . 92.4 mt-10 -43.24 -50.63 6.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.134 -0.979 . . . . 0.0 110.026 -179.841 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -48.28 -23.53 0.92 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.208 -0.933 . . . . 0.0 109.892 179.702 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -87.49 -64.66 1.11 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.302 -0.874 . . . . 0.0 110.322 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 1.185 HG21 ' CE1' ' A' ' 5' ' ' TYR . 2.4 p -65.75 -28.48 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.394 -0.817 . . . . 0.0 110.086 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.505 ' CB ' ' O ' ' A' ' 130' ' ' GLU . 13.6 tptt -72.64 -48.79 36.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.163 -0.961 . . . . 0.0 109.937 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.62 -25.11 67.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.328 -0.858 . . . . 0.0 110.065 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.17 -31.34 69.15 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -64.92 -32.72 74.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.264 -1.139 . . . . 0.0 110.106 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -79.67 -40.24 29.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.334 -0.854 . . . . 0.0 110.005 179.81 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -69.71 -34.27 73.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.304 -0.873 . . . . 0.0 109.87 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.01 -35.39 66.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.323 -0.861 . . . . 0.0 109.885 179.718 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 48.0 m -66.48 -42.95 86.69 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.276 -0.89 . . . . 0.0 109.939 179.701 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -56.36 -48.96 75.77 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.273 -0.892 . . . . 0.0 109.932 179.81 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.611 HD13 ' O ' ' A' ' 143' ' ' LEU . 0.6 OUTLIER -55.8 -44.25 77.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.346 -0.846 . . . . 0.0 109.866 179.817 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.519 ' HA ' HD12 ' A' ' 147' ' ' ILE . 13.7 m-85 -55.81 -39.68 71.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.431 -0.793 . . . . 0.0 109.834 179.715 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.452 ' HA ' ' OE1' ' A' ' 148' ' ' GLU . 95.8 mttt -73.21 -12.46 60.88 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.405 -0.81 . . . . 0.0 110.229 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.481 HD12 HD22 ' A' ' 143' ' ' LEU . 16.3 mt -83.77 -36.02 23.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.16 -0.962 . . . . 0.0 108.989 179.396 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.623 HD11 ' CE1' ' A' ' 22' ' ' PHE . 19.9 mt -69.66 -45.51 77.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.491 ' O ' HG13 ' A' ' 13' ' ' ILE . 38.8 mt-10 -58.98 -43.12 91.33 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.702 -0.799 . . . . 0.0 109.471 179.113 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 17.9 m -66.26 -24.49 66.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.291 -0.88 . . . . 0.0 109.564 179.453 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.602 ' CD1' HG12 ' A' ' 33' ' ' ILE . 81.8 t80 -67.02 -46.99 72.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.508 -0.745 . . . . 0.0 109.952 179.794 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.171 HD21 ' CE2' ' A' ' 158' ' ' TYR . 68.4 mt -79.74 -30.22 40.8 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.141 -0.975 . . . . 0.0 110.006 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.538 ' HB2' ' CG1' ' A' ' 13' ' ' ILE . 21.0 tttm -71.23 -25.83 62.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.899 . . . . 0.0 109.289 179.062 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.422 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -102.9 -33.51 4.34 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.119 -1.593 . . . . 0.0 109.119 179.543 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.58 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 5.4 m-70 -108.61 92.76 10.69 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.277 -1.131 . . . . 0.0 109.933 179.692 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 46.9 Cg_endo -74.01 6.23 3.07 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.033 1.544 . . . . 0.0 111.168 -179.864 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -108.71 0.09 20.34 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.965 -1.084 . . . . 0.0 109.937 179.782 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.68 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -83.13 102.14 11.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.303 -0.873 . . . . 0.0 110.048 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 1.171 ' CE2' HD21 ' A' ' 151' ' ' LEU . 0.3 OUTLIER 35.67 31.27 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.725 -0.609 . . . . 0.0 110.184 -179.377 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.579 ' HA ' ' NH2' ' A' ' 17' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.714 -179.723 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.997 HG23 ' C ' ' A' ' 120' ' ' TYR . 3.0 p -79.98 150.87 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.375 -1.073 . . . . 0.0 110.503 -179.795 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.517 ' CE2' HG12 ' A' ' 128' ' ' ILE . 3.9 m-85 -87.75 175.41 7.87 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.446 -0.784 . . . . 0.0 110.025 -179.87 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.881 HG23 ' CE1' ' A' ' 119' ' ' HIS . 44.8 m -147.56 101.97 3.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.115 -0.991 . . . . 0.0 110.463 179.899 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.427 ' CD1' HG13 ' A' ' 133' ' ' VAL . 88.0 m-85 -112.67 127.19 56.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.293 -0.879 . . . . 0.0 109.976 179.811 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.584 ' CG ' ' N ' ' A' ' 7' ' ' SER . 17.2 tt0 -110.66 175.48 5.41 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.265 -0.897 . . . . 0.0 109.95 -179.544 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.584 ' N ' ' CG ' ' A' ' 6' ' ' GLU . 0.2 OUTLIER -156.71 166.76 32.48 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.716 -0.615 . . . . 0.0 109.634 179.756 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.421 ' HG3' ' HG3' ' A' ' 115' ' ' LYS . 1.4 tt0 -156.53 132.3 9.59 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.983 -1.073 . . . . 0.0 110.955 -179.849 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.625 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 2.9 p90 -155.9 -175.82 5.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.505 -0.747 . . . . 0.0 109.581 179.43 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.511 HG22 ' HA ' ' A' ' 113' ' ' ILE . 23.4 p -134.7 179.23 6.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.019 -1.051 . . . . 0.0 110.887 -179.559 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.654 ' OG ' HD11 ' A' ' 114' ' ' ILE . 87.7 p -159.99 139.08 10.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.572 -0.705 . . . . 0.0 110.06 179.76 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -67.15 -29.85 69.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.129 -0.982 . . . . 0.0 110.287 -179.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 1.026 HD13 ' HB3' ' A' ' 148' ' ' GLU . 1.8 mp -71.7 151.8 93.47 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.291 -0.881 . . . . 0.0 109.793 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.825 ' HD2' HG23 ' A' ' 13' ' ' ILE . 40.3 Cg_endo -66.44 141.63 62.33 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 124.072 1.564 . . . . 0.0 110.522 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.633 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 40.9 Cg_endo -73.23 -30.4 10.49 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 124.092 1.575 . . . . 0.0 113.085 -179.256 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 43.6 Cg_endo -71.79 -21.65 24.7 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 N-CA-C 110.178 -0.739 . . . . 0.0 110.178 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.484 ' HD3' ' CG ' ' A' ' 14' ' ' PRO . 44.8 mtp180 -84.77 -46.04 11.78 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.084 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.771 ' C ' HD23 ' A' ' 18' ' ' LEU . 1.1 tt -67.81 -29.99 69.3 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.755 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.489 ' N ' HD23 ' A' ' 18' ' ' LEU . 76.3 t80 -66.84 -57.13 7.61 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.459 -0.776 . . . . 0.0 109.3 178.748 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.554 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 9.8 mttp -48.76 -36.74 17.17 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.266 179.441 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.046 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . . . -74.69 -43.2 56.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.427 -0.795 . . . . 0.0 110.779 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.983 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -68.45 -48.24 65.06 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.521 -0.737 . . . . 0.0 111.672 -178.45 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.62 HG13 ' CE1' ' A' ' 81' ' ' TYR . 3.5 t -100.3 -51.87 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.835 -1.166 . . . . 0.0 111.603 -178.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.725 HD12 ' N ' ' A' ' 24' ' ' LEU . 7.2 mp -77.79 0.02 25.32 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.116 -0.99 . . . . 0.0 111.265 -179.015 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.597 ' CB ' ' HA ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -154.15 30.92 0.44 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.97 -1.081 . . . . 0.0 110.515 179.881 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.983 ' HB2' ' O ' ' A' ' 22' ' ' PHE . . . -67.33 -29.57 69.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.233 -0.917 . . . . 0.0 109.999 179.778 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -69.26 -15.6 63.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 0.0 110.069 179.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.482 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 78.8 m-20 -125.86 9.81 7.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -0.904 . . . . 0.0 110.196 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.798 HD21 ' CZ ' ' A' ' 158' ' ' TYR . 0.5 OUTLIER -100.34 -48.8 4.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.907 . . . . 0.0 110.245 179.906 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 1.128 HG11 HD13 ' A' ' 38' ' ' ILE . 2.9 t -74.46 -42.15 5.07 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.43 -0.793 . . . . 0.0 110.974 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 30' ' ' VAL . 47.7 Cg_endo -78.15 9.01 3.24 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.499 1.263 . . . . 0.0 110.626 -179.919 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 28' ' ' ASN . 33.7 mttt -127.11 -37.27 2.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.185 -0.947 . . . . 0.0 109.464 179.678 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.54 HG12 ' CD1' ' A' ' 150' ' ' TYR . 6.8 mt -80.04 -39.44 19.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.537 -0.727 . . . . 0.0 109.562 179.536 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.422 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . . . -155.12 100.33 2.31 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.378 -0.827 . . . . 0.0 110.189 179.819 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 34' ' ' ALA . 46.3 Cg_endo -72.21 -0.85 9.22 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.978 1.515 . . . . 0.0 110.632 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -84.47 -8.0 59.09 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.102 -0.999 . . . . 0.0 109.816 179.75 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.662 ' C ' HD12 ' A' ' 38' ' ' ILE . . . -98.24 -63.4 1.13 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.303 -0.873 . . . . 0.0 110.234 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 1.128 HD13 HG11 ' A' ' 30' ' ' VAL . 2.0 mp -115.56 137.56 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.378 -0.826 . . . . 0.0 110.191 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 57' ' ' THR . 13.7 ttpt -84.66 -19.2 33.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.381 -0.824 . . . . 0.0 110.207 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.545 ' C ' ' CD2' ' A' ' 40' ' ' HIS . 0.0 OUTLIER 178.69 159.85 0.59 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.204 -0.935 . . . . 0.0 109.962 -179.961 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -135.4 126.13 27.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.366 -0.834 . . . . 0.0 109.936 179.798 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.462 ' HB2' ' CE1' ' A' ' 40' ' ' HIS . 36.9 tt0 -139.92 113.42 8.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.234 -0.916 . . . . 0.0 110.55 -179.826 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.4 mt -53.87 142.22 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.262 -0.899 . . . . 0.0 109.861 179.535 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.607 HD23 ' CB ' ' A' ' 55' ' ' LYS . 0.4 OUTLIER -114.64 -30.05 6.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.107 -0.996 . . . . 0.0 110.455 -179.862 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.876 ' CG ' HD12 ' A' ' 53' ' ' ILE . 1.7 m95 -126.48 164.97 19.99 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.261 -0.899 . . . . 0.0 110.416 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.445 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . 41.78 -135.65 3.19 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.745 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.11 22.68 0.5 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.28 -1.13 . . . . 0.0 110.093 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 121.59 -19.14 8.57 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.475 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -71.82 -171.57 15.2 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.416 ' HA ' HG22 ' A' ' 71' ' ' ILE . 45.9 Cg_endo -73.19 129.11 13.65 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 123.939 1.494 . . . . 0.0 110.478 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.74 -14.0 53.35 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.499 -1.84 . . . . 0.0 108.499 -179.392 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.548 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -70.48 160.96 31.45 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.613 -0.933 . . . . 0.0 109.381 179.536 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.876 HD12 ' CG ' ' A' ' 45' ' ' TRP . 57.6 mt -128.99 119.54 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.221 -0.924 . . . . 0.0 110.059 179.782 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.926 ' HE3' HD11 ' A' ' 71' ' ' ILE . 20.6 mttm -101.2 129.82 47.19 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.292 -0.88 . . . . 0.0 110.134 -179.892 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.607 ' CB ' HD23 ' A' ' 44' ' ' LEU . 34.7 ttpt -100.79 91.84 4.8 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.21 -0.931 . . . . 0.0 110.155 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.474 ' HB ' HG23 ' A' ' 67' ' ' VAL . 88.8 mt -80.07 144.16 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.894 . . . . 0.0 110.208 -179.948 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.522 ' H ' ' HG1' ' A' ' 57' ' ' THR . 1.0 OUTLIER -113.87 150.97 32.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.312 -0.867 . . . . 0.0 110.303 -179.997 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.609 ' HE2' HG13 ' A' ' 67' ' ' VAL . 20.8 m-85 -115.47 147.55 40.48 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.269 -0.894 . . . . 0.0 110.142 179.744 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -103.71 14.93 53.19 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -129.59 163.26 26.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.167 -1.196 . . . . 0.0 110.26 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 62' ' ' SER . . . 88.95 -152.5 22.97 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.446 ' O ' ' O ' ' A' ' 61' ' ' GLY . 91.8 p -54.03 -168.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.186 -1.184 . . . . 0.0 110.116 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -73.3 -36.19 66.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.22 -0.925 . . . . 0.0 110.196 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -117.79 111.85 19.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.287 -0.883 . . . . 0.0 110.209 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.577 ' O ' ' CD2' ' A' ' 58' ' ' PHE . . . -131.8 84.88 0.3 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.533 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 11.7 p90 -128.12 163.17 25.22 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.23 -1.159 . . . . 0.0 110.262 -179.658 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.627 HG12 ' CA ' ' A' ' 88' ' ' GLY . 5.3 m -136.08 175.66 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.369 -0.832 . . . . 0.0 110.251 179.496 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.711 ' O ' HD12 ' A' ' 85' ' ' LEU . 26.8 mttm -135.56 104.87 5.97 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.382 -0.824 . . . . 0.0 109.829 179.754 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.994 ' CD2' HD13 ' A' ' 85' ' ' LEU . 14.2 m170 -95.6 130.08 42.58 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.301 -0.874 . . . . 0.0 111.121 -179.317 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 52' ' ' THR . 31.6 tttt -96.88 113.91 25.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.332 -0.855 . . . . 0.0 109.331 179.034 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.926 HD11 ' HE3' ' A' ' 54' ' ' LYS . 28.9 mm -53.52 131.11 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.197 -0.939 . . . . 0.0 110.313 -179.421 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 82' ' ' SER . 86.1 m-20 -106.09 -46.66 4.03 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.405 -0.809 . . . . 0.0 110.332 -179.799 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 48.0 m -164.94 159.15 17.83 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.324 -0.86 . . . . 0.0 110.039 -179.793 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.468 HG12 HG11 ' A' ' 23' ' ' VAL . 1.7 mt -145.23 157.9 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.189 -0.944 . . . . 0.0 110.655 -179.881 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.559 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 2.2 m-20 -136.93 80.0 1.79 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.611 -0.681 . . . . 0.0 109.938 179.35 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.48 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 44.7 tttt -63.46 -13.27 38.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.189 -0.944 . . . . 0.0 110.431 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -95.79 -30.45 13.69 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.249 -0.907 . . . . 0.0 109.458 179.665 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -106.52 -7.54 17.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.572 -0.705 . . . . 0.0 109.813 -179.956 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.562 ' HB2' ' HB2' ' A' ' 104' ' ' LEU . 2.8 m-85 68.62 51.12 0.64 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.558 -0.714 . . . . 0.0 110.177 -179.695 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.559 ' CB ' ' HB2' ' A' ' 75' ' ' ASP . 0.7 OUTLIER -122.68 149.58 43.85 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.256 -0.903 . . . . 0.0 109.409 179.599 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.69 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 31.5 t80 -137.22 149.14 46.98 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.101 -0.999 . . . . 0.0 110.504 -179.204 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.458 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 75.0 m -154.92 129.0 8.84 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.177 -0.952 . . . . 0.0 110.922 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.69 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 26.1 p90 -148.17 169.5 19.9 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.328 -0.858 . . . . 0.0 110.536 179.318 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.805 HG23 ' O ' ' A' ' 98' ' ' ILE . 18.0 m -124.52 129.85 51.38 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.299 -0.876 . . . . 0.0 110.127 -179.8 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.994 HD13 ' CD2' ' A' ' 69' ' ' HIS . 16.0 tp -96.43 136.78 36.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.945 -1.097 . . . . 0.0 110.34 179.735 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.533 ' H ' HD12 ' A' ' 85' ' ' LEU . 11.4 pt -118.17 -30.87 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.212 -0.93 . . . . 0.0 110.364 -179.44 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.621 ' O ' HD11 ' A' ' 85' ' ' LEU . 64.3 tt0 -114.53 156.26 24.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.276 -0.89 . . . . 0.0 110.159 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.627 ' CA ' HG12 ' A' ' 67' ' ' VAL . . . 152.69 130.89 1.6 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.45 ' N ' ' OD1' ' A' ' 89' ' ' ASP . 36.9 p-10 -60.94 -15.31 29.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -1.138 . . . . 0.0 110.09 179.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.07 -19.94 53.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 110.166 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.473 ' O ' ' HB2' ' A' ' 95' ' ' LEU . 59.1 mt -70.09 -26.96 64.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.92 . . . . 0.0 110.054 179.909 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . 44.74 -169.36 0.02 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -87.36 7.33 29.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.247 -1.149 . . . . 0.0 109.911 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.577 ' O ' HG21 ' A' ' 126' ' ' VAL . 30.1 p -98.84 -28.19 13.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.359 -0.838 . . . . 0.0 109.959 179.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 1.012 HD11 ' CD1' ' A' ' 128' ' ' ILE . 41.2 mt -111.91 169.56 8.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.449 -0.782 . . . . 0.0 110.156 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.416 ' HG2' ' C ' ' A' ' 95' ' ' LEU . 66.2 mm-40 -151.2 -81.38 0.1 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.318 -0.864 . . . . 0.0 109.877 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.48 ' HB2' ' HB2' ' A' ' 121' ' ' HIS . 19.4 mttt -80.33 133.78 35.98 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.727 -0.608 . . . . 0.0 110.564 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.805 ' O ' HG23 ' A' ' 84' ' ' THR . 6.7 mm -123.44 142.01 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.876 -1.14 . . . . 0.0 109.886 179.07 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.509 ' HB2' ' HB2' ' A' ' 119' ' ' HIS . 0.3 OUTLIER -123.42 134.41 53.96 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.39 -0.819 . . . . 0.0 109.021 178.866 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.664 ' HE2' HG21 ' A' ' 98' ' ' ILE . 7.2 m-85 -129.82 132.3 46.44 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.303 -0.873 . . . . 0.0 110.624 -179.021 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.405 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 70.4 tt0 -136.41 136.08 39.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.401 -0.812 . . . . 0.0 109.884 179.465 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 39.3 m -136.36 139.6 42.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 110.111 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 115' ' ' LYS . 1.1 tttp -134.52 143.24 47.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.241 -0.912 . . . . 0.0 110.502 -179.87 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.608 HD23 HG12 ' A' ' 114' ' ' ILE . 7.2 mt -124.52 151.91 44.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.247 -0.908 . . . . 0.0 109.844 179.587 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.699 HG12 ' H ' ' A' ' 106' ' ' ALA . 1.9 t -150.06 -169.76 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.176 -0.953 . . . . 0.0 110.288 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.699 ' H ' HG12 ' A' ' 105' ' ' VAL . . . -125.34 160.74 28.59 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.399 -0.813 . . . . 0.0 110.21 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.452 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 3.1 p -119.16 169.03 8.73 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.197 -0.939 . . . . 0.0 110.282 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 107' ' ' SER . 48.3 Cg_endo -73.37 -4.11 14.85 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.069 1.563 . . . . 0.0 110.7 -179.891 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 39.2 p -105.83 9.93 32.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.085 -1.009 . . . . 0.0 110.298 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 111' ' ' GLY . . . 93.38 -37.84 3.3 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.894 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 110' ' ' GLY . . . -54.27 -172.65 0.06 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.523 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 9.0 p -138.79 136.0 35.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.14 -1.212 . . . . 0.0 110.414 179.937 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.511 ' HA ' HG22 ' A' ' 10' ' ' THR . 61.4 mt -87.67 149.03 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.346 -0.846 . . . . 0.0 109.944 179.772 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.654 HD11 ' OG ' ' A' ' 11' ' ' SER . 4.6 mt -131.82 116.12 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.224 -0.922 . . . . 0.0 110.389 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 103' ' ' LYS . 39.5 tttt -100.12 148.29 24.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.374 -0.829 . . . . 0.0 110.011 179.708 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.2 t -145.55 155.39 43.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.184 -0.947 . . . . 0.0 110.388 -179.816 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.526 HG22 ' NE2' ' A' ' 119' ' ' HIS . 25.9 m -157.87 126.19 5.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.444 -0.785 . . . . 0.0 109.888 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 3.6 m -121.66 154.85 36.27 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.126 -0.984 . . . . 0.0 110.296 -179.851 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.881 ' CE1' HG23 ' A' ' 4' ' ' THR . 56.2 m-70 -137.87 147.27 44.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.276 -0.89 . . . . 0.0 110.392 -179.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.997 ' C ' HG23 ' A' ' 2' ' ' VAL . 58.8 m-85 -126.04 121.95 34.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.299 -0.876 . . . . 0.0 110.208 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.691 ' CE1' HG11 ' A' ' 2' ' ' VAL . 70.4 m-70 -95.55 103.95 15.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.277 -0.889 . . . . 0.0 109.956 179.793 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.582 HG23 HD23 ' A' ' 95' ' ' LEU . 0.9 OUTLIER -91.1 142.71 27.46 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.14 -0.975 . . . . 0.0 110.29 -179.792 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 27.6 tttt -103.73 124.98 49.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.328 -0.858 . . . . 0.0 110.325 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 98.1 -122.51 7.52 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -134.19 67.61 1.51 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.277 -1.131 . . . . 0.0 110.311 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.577 HG21 ' O ' ' A' ' 94' ' ' THR . 31.0 m -131.5 168.11 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 109.932 179.915 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.433 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 89.7 mt-10 -143.93 157.86 44.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.161 -0.962 . . . . 0.0 110.588 -179.828 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 1.012 ' CD1' HD11 ' A' ' 95' ' ' LEU . 20.5 mm -61.47 173.41 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.379 -0.826 . . . . 0.0 110.106 179.736 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.625 ' N ' HG22 ' A' ' 128' ' ' ILE . 22.9 mttt -96.62 130.8 43.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.334 -0.854 . . . . 0.0 109.66 179.456 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 129' ' ' LYS . 95.5 mt-10 -42.06 -42.9 3.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 110.307 -179.708 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.91 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 31.0 tt0 -55.51 -33.91 64.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.912 . . . . 0.0 109.892 179.636 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.519 ' HB3' ' CG2' ' A' ' 128' ' ' ILE . 5.9 t-160 -75.49 -56.77 4.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.275 -0.891 . . . . 0.0 110.431 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.517 HG23 ' CG2' ' A' ' 128' ' ' ILE . 86.7 t -60.82 -33.03 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.326 -0.858 . . . . 0.0 110.394 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 38.6 mttp -104.04 -71.17 0.74 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.148 -0.97 . . . . 0.0 110.499 -179.688 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.91 ' HB3' ' O ' ' A' ' 131' ' ' GLU . . . -55.93 -19.28 11.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.081 -1.012 . . . . 0.0 109.867 -179.883 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' A' ' 132' ' ' HIS . . . -76.71 -29.85 57.02 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.819 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 46.4 mttt -68.13 -32.36 72.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.269 -1.136 . . . . 0.0 110.222 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -79.06 -34.21 43.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 110.027 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -66.35 -39.07 88.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.33 -0.856 . . . . 0.0 110.002 179.864 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.87 -42.92 60.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.411 -0.806 . . . . 0.0 110.032 179.76 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 144' ' ' PHE . 23.0 t -54.55 -43.11 71.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.323 -0.861 . . . . 0.0 109.905 179.765 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -57.43 -44.82 84.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.349 -0.845 . . . . 0.0 109.919 179.702 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 146' ' ' LEU . 46.5 mt -58.53 -38.08 77.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.285 -0.884 . . . . 0.0 109.836 179.713 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.4 ' HB2' ' O ' ' A' ' 141' ' ' SER . 16.2 m-85 -62.26 -33.94 75.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.425 -0.797 . . . . 0.0 109.705 179.543 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -72.94 -15.46 61.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.327 -0.858 . . . . 0.0 109.855 179.756 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.498 ' HA ' HD23 ' A' ' 146' ' ' LEU . 14.0 mt -82.34 -37.15 26.13 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.258 -0.901 . . . . 0.0 108.721 179.203 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.729 HD11 ' CE1' ' A' ' 22' ' ' PHE . 19.1 mt -68.69 -47.35 77.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.751 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 1.026 ' HB3' HD13 ' A' ' 13' ' ' ILE . 88.8 mt-10 -56.18 -43.86 78.82 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.498 -0.751 . . . . 0.0 109.466 179.037 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 42.8 m -65.2 -34.34 78.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.159 -0.963 . . . . 0.0 109.37 179.329 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.596 ' CE2' ' OH ' ' A' ' 158' ' ' TYR . 81.3 t80 -59.15 -47.61 84.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.562 -0.711 . . . . 0.0 109.581 179.341 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.915 HD21 ' CE2' ' A' ' 158' ' ' TYR . 32.8 mt -80.08 -33.37 38.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 110.222 179.655 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.87 ' HB2' HD11 ' A' ' 13' ' ' ILE . 27.4 tttt -60.09 -23.21 63.62 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.228 -0.92 . . . . 0.0 109.257 179.364 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.5 ' O ' ' HD3' ' A' ' 155' ' ' PRO . . . -109.69 -30.5 3.49 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.607 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 5.4 m-70 -105.68 92.22 5.88 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.28 -1.13 . . . . 0.0 110.084 179.817 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 153' ' ' GLY . 46.3 Cg_endo -72.18 2.93 4.43 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.009 1.531 . . . . 0.0 111.069 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -113.57 -11.5 13.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.067 -1.02 . . . . 0.0 109.764 179.729 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.664 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -46.84 102.31 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.412 -0.805 . . . . 0.0 109.688 179.615 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 1.046 ' CE2' ' HB2' ' A' ' 21' ' ' ALA . 0.0 OUTLIER 58.71 -59.12 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.458 0 CA-C-O 121.592 0.71 . . . . 0.0 110.543 -179.33 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.589 ' N ' ' O ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--N 1.293 -1.874 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.169 -179.771 . . . . . . . . 2 2 . 1 stop_ save_